data_2mf2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mf2 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 N--CA 1.426 -1.638 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -103.38 144.33 31.52 Favored 'General case' 1 N--CA 1.374 -4.244 0 C-N-CA 123.611 0.765 . . . . 0.0 109.131 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -71.1 120.57 16.85 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 99.36 -1.16 57.2 Favored Glycine 0 C--N 1.305 -1.161 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.972 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -97.32 119.55 36.05 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.425 HG21 HG23 ' A' ' 104' ' ' THR . 87.6 t -83.81 128.26 39.0 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 C-N-CA 123.201 0.6 . . . . 0.0 112.288 -172.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 48.8 m-85 -115.29 141.38 48.11 Favored 'General case' 0 C--N 1.273 -2.721 0 C-N-CA 125.236 1.414 . . . . 0.0 111.425 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.26 148.66 39.24 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 167.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.02 149.4 34.05 Favored 'General case' 0 C--N 1.262 -3.215 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.233 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -96.91 76.68 2.74 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.532 ' O ' HG11 ' A' ' 27' ' ' VAL 0.264 3.0 tt -71.58 -18.16 62.25 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.089 -2.778 . . . . 0.0 108.437 -173.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.1 m -32.82 -178.19 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.935 0 C-N-CA 129.739 3.216 . . . . 0.0 116.384 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HB2' ' NE2' ' B' ' 28' ' ' GLN . 0.1 OUTLIER 25.95 43.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.137 0 C-N-CA 124.317 3.345 . . . . 0.0 116.648 -151.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.608 ' HB ' ' CB ' ' A' ' 31' ' ' GLU . 2.8 m -70.07 142.2 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.402 169.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.5 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 35.2 mm-40 -90.31 134.17 34.48 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 114.887 -1.052 . . . . 0.0 113.222 -172.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.84 -108.84 0.69 Allowed Glycine 0 N--CA 1.442 -0.923 0 O-C-N 124.564 1.165 . . . . 0.0 114.654 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 m -94.05 8.28 42.06 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.608 ' CB ' ' HB ' ' A' ' 27' ' ' VAL . 31.8 mt-10 -62.08 143.46 56.62 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -103.49 112.31 25.15 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.174 0.512 . . . . 0.0 110.872 -175.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.04 -178.62 40.61 Favored Glycine 0 N--CA 1.408 -3.179 0 C-N-CA 119.807 -1.187 . . . . 0.0 115.012 174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 24' ' ' LEU . . . 178.08 -160.09 26.12 Favored Glycine 0 C--N 1.266 -3.313 1 N-CA-C 101.972 -4.451 . . . . 0.0 101.972 -178.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.9 p -73.73 120.04 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.124 0 CA-C-N 120.859 2.329 . . . . 0.0 109.071 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.411 ' NH1' ' HA ' ' A' ' 59' ' ' THR . 73.2 mtt180 -152.73 166.07 16.2 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.423 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HB2' HD13 ' A' ' 58' ' ' ILE . 11.0 Cg_exo -71.76 144.56 44.16 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.595 1.53 . . . . 0.0 109.978 169.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 28.7 m -128.19 158.26 40.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.495 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 35.9 m -101.76 130.33 51.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.832 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.9 mm -84.19 105.46 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.97 -10.19 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.035 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.664 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 2.5 tt0 -60.63 164.51 4.54 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -169.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.489 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 26.6 p-10 -68.38 -174.7 0.55 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.387 -1.733 . . . . 0.0 111.466 175.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -88.34 -38.36 15.2 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.194 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.426 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 4.0 m -81.83 -22.26 37.13 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.776 -0.578 . . . . 0.0 112.521 -171.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.63 -31.03 76.38 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -71.09 -35.31 71.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.249 0.547 . . . . 0.0 110.563 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' A' ' 45' ' ' THR . 34.4 mttp -79.63 -48.28 14.01 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -115.51 -27.79 7.03 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -172.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 61.9 m -86.12 148.33 47.41 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.992 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.9 -17.01 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.579 1.519 . . . . 0.0 110.221 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.2 p -91.65 151.08 20.84 Favored 'General case' 0 N--CA 1.421 -1.894 0 C-N-CA 124.635 1.174 . . . . 0.0 111.982 -174.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.664 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 61.8 t -135.12 139.02 47.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.475 HG23 ' HG3' ' A' ' 42' ' ' GLN . 10.3 tt -93.14 134.51 30.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.094 0.473 . . . . 0.0 110.196 170.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 22.1 m -139.62 164.22 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.368 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.495 ' HB1' ' CG2' ' A' ' 39' ' ' VAL . . . -122.82 138.29 54.69 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.1 132.43 45.83 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.505 HG12 HD11 ' A' ' 86' ' ' ILE . 63.3 mt -92.09 136.84 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.901 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.411 ' HA ' ' NH1' ' A' ' 36' ' ' ARG . 95.8 m -129.52 139.89 51.41 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . . . . . . 0 C--O 1.222 -0.656 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.0 mt . . . . . 0 N--CA 1.435 -1.212 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.64 1.85 3.99 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 121.951 1.767 . . . . 0.0 113.069 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.0 p -98.71 -18.8 17.84 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.394 0.616 . . . . 0.0 109.872 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -97.88 129.95 44.8 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.815 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.58 142.7 43.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -103.93 148.69 25.88 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.955 0.407 . . . . 0.0 110.969 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.2 pt -124.6 134.46 66.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.461 ' O ' ' HD1' ' A' ' 78' ' ' TYR . 2.7 mp0 -59.96 115.71 3.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.373 1.069 . . . . 0.0 113.423 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -50.56 -36.42 34.43 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.965 0.906 . . . . 0.0 112.214 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -52.35 -53.16 48.2 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 113.326 -1.761 . . . . 0.0 112.627 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -92.64 -37.65 12.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.552 0.692 . . . . 0.0 111.996 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.514 ' CE2' ' HA ' ' A' ' 106' ' ' LEU . 71.3 m-85 -75.37 -5.92 47.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.921 -172.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 75.5 24.1 1.39 Allowed 'General case' 0 C--N 1.348 0.521 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 167.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.67 179.0 4.4 Favored 'General case' 0 CA--C 1.489 -1.396 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.265 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.22 -5.29 40.74 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.485 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -140.89 150.51 43.29 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.193 -176.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -75.3 128.07 34.59 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 6.1 t -102.78 163.58 12.14 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -170.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.46 141.3 41.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.505 HD11 HG12 ' A' ' 58' ' ' ILE . 17.2 mm -107.48 133.2 52.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.9 mt -106.18 109.38 21.3 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.94 -2.68 57.02 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.509 0.671 . . . . 0.0 111.991 -175.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -97.0 -34.11 11.31 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.323 1.059 . . . . 0.0 109.677 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -94.56 80.0 3.83 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.625 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.493 ' O ' ' HB ' ' B' ' 93' ' ' THR . 2.1 pp -122.71 -177.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -173.71 -178.24 1.56 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 123.784 0.677 . . . . 0.0 112.502 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 53.9 m -123.67 126.05 45.89 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 74.7 mt -132.07 133.69 44.65 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.656 1.183 . . . . 0.0 109.784 -173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.5 p-10 -78.09 153.84 31.86 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -44.78 -21.11 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.796 1.638 . . . . 0.0 115.015 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -74.17 -17.51 60.9 Favored 'General case' 0 CA--C 1.564 1.498 0 CA-C-O 121.209 0.528 . . . . 0.0 110.604 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HD2' ' CB ' ' B' ' 28' ' ' GLN . 4.8 mmp_? -84.34 -38.52 20.25 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.073 0.549 . . . . 0.0 111.23 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.48 121.91 16.83 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 123.885 0.874 . . . . 0.0 111.1 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -92.34 -62.55 1.38 Allowed 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.784 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.1 pt-20 -159.73 143.47 14.49 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.291 0.567 . . . . 0.0 112.075 -170.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.27 123.75 20.78 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.719 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.671 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 22.1 tp -114.3 -61.92 1.67 Allowed 'General case' 0 N--CA 1.414 -2.255 0 CA-C-O 122.394 1.092 . . . . 0.0 110.435 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.671 ' OG1' ' HG ' ' A' ' 103' ' ' LEU 0.26 3.7 m -126.54 -174.8 3.22 Favored 'General case' 0 N--CA 1.401 -2.892 0 CA-C-N 113.283 -1.78 . . . . 0.0 111.93 -164.07 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.502 ' H ' ' CG2' ' A' ' 104' ' ' THR . 0.4 OUTLIER -159.73 137.17 9.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.483 1.513 . . . . 0.0 109.645 -167.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.514 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . 6.9 mt -98.22 164.02 12.49 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.775 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.8 m -98.62 159.98 14.58 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 111' ' ' MET . 21.2 m-20 -63.59 -31.61 72.83 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.314 0.578 . . . . 0.0 112.307 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.76 -41.5 83.25 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 122.077 -0.389 . . . . 0.0 109.971 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -74.57 -24.21 58.88 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.378 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.473 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -56.59 -39.75 74.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 123.819 0.847 . . . . 0.0 108.857 170.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 8.4 mmpt? -79.99 -11.09 59.81 Favored 'General case' 0 N--CA 1.39 -3.474 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.233 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -88.94 -49.42 6.8 Favored 'General case' 0 N--CA 1.39 -3.426 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -50.26 -58.77 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.199 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.78 -39.5 77.62 Favored 'General case' 0 N--CA 1.515 2.825 0 CA-C-O 123.452 1.596 . . . . 0.0 111.931 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 112' ' ' LYS 0.257 6.4 t30 -83.98 -46.62 11.87 Favored 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 112.424 -2.171 . . . . 0.0 112.77 -170.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.54 -36.16 73.44 Favored 'General case' 0 CA--C 1.47 -2.102 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 7.4 tp -62.56 -47.11 85.32 Favored 'General case' 1 N--CA 1.363 -4.782 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.104 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.622 ' SD ' ' HA ' ' A' ' 125' ' ' ASN 0.275 7.8 ptp -68.14 -22.59 64.86 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 178.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.3 mt -72.22 -51.98 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.426 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 t -55.52 -34.66 64.86 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 113.197 -1.82 . . . . 0.0 111.669 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 17.0 mt -110.38 8.4 23.28 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.769 -0.582 . . . . 0.0 111.266 -177.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.53 21.49 64.79 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 171.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.511 HD13 HD13 ' B' ' 124' ' ' LEU . 0.6 OUTLIER -99.95 13.91 32.29 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 118.56 1.18 . . . . 0.0 111.485 -176.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.622 ' HA ' ' SD ' ' A' ' 119' ' ' MET . 20.1 m120 . . . . . 0 N--CA 1.482 1.133 0 O-C-N 124.509 1.13 . . . . 0.0 113.357 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.7 mt . . . . . 0 N--CA 1.424 -1.775 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -102.78 146.1 28.76 Favored 'General case' 1 N--CA 1.377 -4.106 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.58 118.93 15.02 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 100.6 -0.66 55.51 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.971 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.43 119.39 35.87 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 86.0 t -83.72 128.51 38.75 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 123.235 0.614 . . . . 0.0 112.255 -172.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 48.7 m-85 -115.78 140.39 49.26 Favored 'General case' 0 C--N 1.272 -2.784 0 C-N-CA 125.438 1.495 . . . . 0.0 111.329 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.02 148.38 42.06 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 166.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.41 148.87 33.8 Favored 'General case' 0 C--N 1.259 -3.361 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.055 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.407 ' HB3' ' NH1' ' B' ' 98' ' ' ARG . 33.0 t70 -96.11 79.48 3.2 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.523 ' O ' HG11 ' B' ' 27' ' ' VAL 0.262 3.0 tt -74.46 -16.96 60.84 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 111.553 -2.567 . . . . 0.0 108.477 -173.251 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.405 ' CB ' ' HD2' ' B' ' 26' ' ' PRO . 3.6 m -32.68 -178.12 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.922 0 C-N-CA 130.652 3.581 . . . . 0.0 116.432 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.5 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 0.1 OUTLIER 24.91 44.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.404 3.486 0 C-N-CA 124.343 3.362 . . . . 0.0 116.373 -152.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.566 ' HB ' ' CB ' ' B' ' 31' ' ' GLU . 2.6 m -69.79 140.56 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 113.512 -1.676 . . . . 0.0 109.591 168.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 26' ' ' PRO . 33.7 mm-40 -89.83 132.83 35.05 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.766 -172.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.08 -108.61 0.68 Allowed Glycine 0 CA--C 1.501 -0.796 0 CA-C-N 114.735 -1.121 . . . . 0.0 114.81 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -93.99 6.92 46.96 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -174.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.566 ' CB ' ' HB ' ' B' ' 27' ' ' VAL . 33.7 mt-10 -63.53 140.09 58.84 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . 0.429 ' HB3' ' HG2' ' B' ' 90' ' ' GLN . 0.6 OUTLIER -101.28 119.42 38.73 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 120.828 0.347 . . . . 0.0 111.37 -176.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.72 -179.33 37.17 Favored Glycine 1 N--CA 1.393 -4.191 0 C-N-CA 118.717 -1.706 . . . . 0.0 114.785 170.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' B' ' 24' ' ' LEU . . . -177.9 -158.69 21.31 Favored Glycine 1 C--N 1.253 -4.06 1 N-CA-C 102.801 -4.12 . . . . 0.0 102.801 -178.815 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.98 108.72 8.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 120.208 2.004 . . . . 0.0 110.551 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -141.22 165.68 27.4 Favored Pre-proline 0 C--N 1.277 -2.587 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.33 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.461 ' HB2' HD13 ' B' ' 58' ' ' ILE . 11.6 Cg_exo -70.47 144.04 49.13 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.487 1.458 . . . . 0.0 109.871 169.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 29.3 m -128.02 158.7 39.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.489 ' CG2' ' HB1' ' B' ' 56' ' ' ALA . 35.1 m -102.08 130.46 51.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.891 177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 34.7 mm -84.37 105.72 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -10.66 8.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.813 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.468 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.0 OUTLIER -58.61 161.95 4.25 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 125.274 1.43 . . . . 0.0 114.723 -171.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -67.26 -172.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.771 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' B' ' 48' ' ' LYS . 14.7 t70 -89.67 -41.28 12.02 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.204 -177.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.43 ' HA ' ' HD2' ' B' ' 48' ' ' LYS . 5.2 m -78.7 -21.91 47.46 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 -32.32 81.16 Favored Glycine 0 C--O 1.219 -0.811 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -69.76 -36.95 76.22 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.227 0.536 . . . . 0.0 110.494 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' B' ' 44' ' ' ASP . 33.9 mttp -77.5 -50.13 13.28 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -115.4 -25.08 8.1 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -88.32 150.02 46.0 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.939 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.68 -16.4 6.69 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.506 1.471 . . . . 0.0 110.618 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -95.8 143.04 27.37 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 124.539 1.136 . . . . 0.0 112.18 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.21 139.48 51.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.468 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 10.2 tt -92.14 134.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 120.948 0.404 . . . . 0.0 109.954 170.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 22.0 m -139.9 165.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 120.968 0.413 . . . . 0.0 110.255 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.489 ' HB1' ' CG2' ' B' ' 39' ' ' VAL . . . -124.15 138.83 54.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.52 134.54 47.8 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.483 HG12 ' CD1' ' B' ' 86' ' ' ILE . 64.7 mt -93.45 139.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.011 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 96.9 m -131.69 140.15 49.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' B' ' 84' ' ' SER . . . . . . . . 0 C--O 1.219 -0.816 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.8 mt . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.01 0.51 4.34 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.106 1.871 . . . . 0.0 113.255 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 58.0 p -100.58 -18.83 16.42 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.32 0.581 . . . . 0.0 110.368 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -97.33 129.99 44.54 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.86 144.44 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -104.9 151.36 23.96 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.931 0.396 . . . . 0.0 110.653 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . . . . . . . . . 24.7 pt -127.17 137.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.489 ' O ' ' HD1' ' B' ' 78' ' ' TYR . 27.9 mp0 -60.44 116.25 4.17 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.399 1.08 . . . . 0.0 113.217 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -50.39 -36.72 33.98 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.704 0.764 . . . . 0.0 112.627 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -53.58 -52.7 58.93 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 113.342 -1.754 . . . . 0.0 113.072 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -92.32 -36.78 12.99 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.592 0.711 . . . . 0.0 111.358 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.5 ' CE2' ' HA ' ' B' ' 106' ' ' LEU . 76.6 m-85 -76.08 -7.39 54.6 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.766 -173.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 74.86 28.19 1.14 Allowed 'General case' 0 C--N 1.35 0.619 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 167.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 mp -107.69 -177.51 3.36 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.687 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -91.56 -19.45 22.74 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.814 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.413 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -128.46 153.79 46.75 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.061 -173.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -75.87 128.96 36.22 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' B' ' 60' ' ' GLY . 6.8 t -102.83 164.49 11.59 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -169.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.2 t -122.42 141.25 43.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.483 ' CD1' HG12 ' B' ' 58' ' ' ILE . 14.3 mm -108.31 132.72 55.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 177.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -105.54 108.26 19.68 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.195 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.83 -3.98 55.32 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.134 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -95.87 -35.98 11.28 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.275 1.036 . . . . 0.0 109.804 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . 0.429 ' HG2' ' HB3' ' B' ' 32' ' ' GLN . 8.0 tp60 -93.05 80.6 4.55 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.63 177.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.484 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.1 pp -122.53 -177.62 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -173.17 -178.07 1.68 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.453 0.644 . . . . 0.0 112.503 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 54.1 m -124.36 126.0 45.26 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 81.6 mt -131.82 134.78 46.16 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.589 1.156 . . . . 0.0 109.816 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -78.23 153.93 31.47 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -44.6 -21.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.762 1.625 . . . . 0.0 114.897 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -71.96 -18.62 61.98 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.683 0.793 . . . . 0.0 110.484 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.407 ' NH1' ' HB3' ' B' ' 23' ' ' ASP . 3.0 mmp_? -86.55 -36.38 18.96 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.174 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.79 126.06 28.56 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.791 0.805 . . . . 0.0 110.418 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -95.62 -64.48 1.05 Allowed 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.301 -1.318 . . . . 0.0 113.489 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 16.9 pt-20 -157.93 143.6 17.09 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.35 0.595 . . . . 0.0 111.558 -170.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.1 OUTLIER -66.38 123.88 21.21 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.413 -1.721 . . . . 0.0 110.706 174.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.685 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 24.9 tp -114.38 -62.14 1.64 Allowed 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.56 1.171 . . . . 0.0 110.57 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.685 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 5.1 m -125.14 -175.79 3.4 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 112.837 -1.983 . . . . 0.0 111.872 -163.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.505 ' H ' ' CG2' ' B' ' 104' ' ' THR . 0.4 OUTLIER -159.52 139.31 11.61 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 125.77 1.628 . . . . 0.0 109.384 -168.07 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.5 ' HA ' ' CE2' ' B' ' 78' ' ' TYR . 6.9 mt -101.54 159.62 15.14 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.955 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m -90.4 158.37 17.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.093 174.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' B' ' 111' ' ' MET . 8.7 m-20 -64.48 -28.48 69.69 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.513 0.673 . . . . 0.0 111.952 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.89 -33.52 64.06 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.944 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.442 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 4.6 mptp? -79.96 -22.64 42.38 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.825 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.509 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -56.59 -38.76 72.46 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 170.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.453 ' CE ' ' HA ' ' B' ' 112' ' ' LYS . 6.9 mmpt? -78.8 -12.89 60.04 Favored 'General case' 0 N--CA 1.381 -3.921 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.91 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -88.94 -50.47 6.17 Favored 'General case' 0 N--CA 1.391 -3.385 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 t -48.99 -59.6 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.224 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 5.0 m-20 -57.14 -41.87 79.9 Favored 'General case' 0 N--CA 1.514 2.726 0 CA-C-O 123.661 1.696 . . . . 0.0 112.352 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.563 ' O ' HD13 ' B' ' 120' ' ' ILE 0.345 22.0 t30 -83.64 -46.63 12.12 Favored 'General case' 0 C--N 1.251 -3.696 0 CA-C-N 112.319 -2.219 . . . . 0.0 112.285 -168.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.19 -32.52 72.28 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.563 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 7.6 tp -62.38 -46.9 86.54 Favored 'General case' 1 N--CA 1.365 -4.684 0 CA-C-N 113.514 -1.676 . . . . 0.0 109.601 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.678 ' SD ' ' HA ' ' B' ' 125' ' ' ASN 0.288 7.9 ptp -66.55 -25.42 66.64 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 177.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.563 HD13 ' O ' ' B' ' 116' ' ' ASN . 4.5 mp -72.05 -46.66 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 C-N-CA 117.756 -1.577 . . . . 0.0 108.288 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 14.9 t -58.05 -34.37 70.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.316 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 13.7 mt -110.41 7.91 23.02 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.56 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.17 20.77 67.52 Favored Glycine 0 N--CA 1.468 0.808 0 N-CA-C 116.983 1.553 . . . . 0.0 116.983 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.511 HD13 HD13 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -101.26 18.64 19.43 Favored 'General case' 0 CA--C 1.496 -1.135 0 CA-C-N 118.361 1.08 . . . . 0.0 111.309 -177.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.678 ' HA ' ' SD ' ' B' ' 119' ' ' MET . 20.3 m120 . . . . . 0 N--CA 1.475 0.815 0 O-C-N 124.175 0.922 . . . . 0.0 112.21 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -102.91 121.91 43.49 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.982 -174.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -59.45 126.26 26.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.84 -7.05 44.67 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.204 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -97.56 -178.6 4.18 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 14.2 t -135.49 136.32 50.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 C-N-CA 123.679 0.792 . . . . 0.0 110.622 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 33.2 m-85 -132.2 146.24 51.88 Favored 'General case' 0 CA--C 1.466 -2.281 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.0 mp -77.84 152.73 33.28 Favored 'General case' 0 N--CA 1.395 -3.184 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.647 170.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -130.07 144.03 51.12 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.897 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.435 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 13.3 t70 -89.33 86.66 6.87 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.261 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.505 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 4.5 mm? -88.89 41.07 1.01 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.196 1.398 . . . . 0.0 112.496 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.562 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 31.7 m -73.48 174.29 4.96 Favored Pre-proline 0 C--N 1.251 -3.698 0 C-N-CA 126.123 1.769 . . . . 0.0 108.232 171.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER 4.79 51.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.41 3.81 1 C-N-CA 127.971 5.781 . . . . 0.0 118.65 -178.01 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.09 176.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.779 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 33.5 mm-40 -104.04 133.14 49.49 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.389 -176.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.76 -120.65 19.85 Favored Glycine 0 CA--C 1.505 -0.594 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.937 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.8 m -91.58 13.39 17.98 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -61.34 152.57 29.05 Favored 'General case' 0 C--O 1.252 1.225 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.71 177.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.509 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -71.88 120.86 18.08 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.157 -171.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -101.03 142.36 15.74 Favored Glycine 0 CA--C 1.476 -2.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.431 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 108.76 141.02 9.31 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 114.401 -0.899 . . . . 0.0 111.122 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.57 117.63 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -139.33 148.31 56.3 Favored Pre-proline 0 C--N 1.253 -3.613 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.61 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 50.0 Cg_exo -63.0 138.48 68.15 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.823 2.349 . . . . 0.0 111.654 171.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.6 m -123.93 156.22 31.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 32.9 m -100.93 132.05 47.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 120.809 0.338 . . . . 0.0 110.329 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.441 ' CG2' ' HG2' ' A' ' 42' ' ' GLN . 23.4 mm -91.59 106.66 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.413 HD11 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -104.37 -9.76 9.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.517 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.512 ' OE1' HG13 ' A' ' 53' ' ' VAL . 4.5 pt20 -51.46 162.5 0.36 Allowed 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -168.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -65.42 -177.08 0.38 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.285 -1.779 . . . . 0.0 111.765 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -73.89 -53.73 9.52 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 114.55 -1.204 . . . . 0.0 112.677 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 20.3 m -82.9 -22.39 33.95 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -166.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.58 -40.18 86.85 Favored Glycine 0 C--O 1.213 -1.219 0 O-C-N 123.059 0.224 . . . . 0.0 113.316 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.507 ' N ' HE22 ' A' ' 42' ' ' GLN . 11.0 p30 -71.05 -20.72 62.34 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 45' ' ' THR . 2.5 mptp? -86.16 -68.03 0.77 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.157 0.503 . . . . 0.0 110.517 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.35 -29.51 24.41 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -168.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 m -91.12 143.35 28.32 Favored Pre-proline 0 N--CA 1.414 -2.238 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.54 -26.45 23.91 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 120.955 1.103 . . . . 0.0 109.709 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.0 p -82.01 147.9 28.93 Favored 'General case' 0 N--CA 1.414 -2.258 0 C-N-CA 125.915 1.686 . . . . 0.0 113.619 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.512 HG13 ' OE1' ' A' ' 42' ' ' GLN . 93.3 t -132.16 140.39 47.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 92' ' ' ARG . 5.0 tp -103.86 124.72 58.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.416 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 25.1 m -134.02 167.92 25.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.988 -175.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.458 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . . . -126.13 139.52 53.31 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.83 137.38 41.82 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.414 HD11 ' HB2' ' A' ' 37' ' ' PRO . 60.4 mt -95.6 134.99 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-N 113.115 -1.857 . . . . 0.0 108.468 175.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 m -103.6 124.78 49.44 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.583 0 C-N-CA 121.249 -0.501 . . . . 0.0 111.984 -176.555 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.526 HD13 ' H ' ' A' ' 67' ' ' ILE . 1.3 mp . . . . . 0 C--O 1.218 -0.577 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.94 1.18 2.01 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.677 2.251 . . . . 0.0 113.706 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.9 p -91.69 -16.26 27.23 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-O 122.301 1.048 . . . . 0.0 108.288 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -107.34 129.31 54.92 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 67.8 t -126.18 127.15 70.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.618 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.25 124.63 37.36 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.667 0.746 . . . . 0.0 109.8 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.492 HG22 ' CE1' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -108.75 156.34 9.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.297 -175.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -63.25 119.78 10.27 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 123.779 0.674 . . . . 0.0 112.619 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -46.12 -46.77 17.28 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 126.071 1.748 . . . . 0.0 110.336 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -58.2 -32.31 68.15 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 126.673 1.989 . . . . 0.0 112.826 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -91.14 -39.04 12.36 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.712 0.768 . . . . 0.0 110.792 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.492 ' CE1' HG22 ' A' ' 73' ' ' ILE . 4.2 m-85 -83.22 -9.45 59.14 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.793 -177.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 67.09 40.87 2.77 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.921 0.889 . . . . 0.0 111.096 174.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.41 -179.71 3.96 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.836 0.827 . . . . 0.0 111.073 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.8 -10.78 41.58 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.258 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -139.8 161.26 37.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.34 142.12 50.42 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.7 t -110.0 155.76 21.39 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.545 -171.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 12.6 t -117.74 128.11 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.403 HD12 ' CG1' ' A' ' 73' ' ' ILE . 1.6 mp -103.52 125.53 58.06 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.94 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.0 mt -100.97 110.61 22.67 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 113.228 -1.806 . . . . 0.0 110.04 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.6 mm? -83.84 3.25 34.48 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.732 -175.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -119.03 4.2 11.4 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.787 1.28 . . . . 0.0 108.39 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -122.85 35.1 4.96 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.535 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' B' ' 93' ' ' THR . 2.1 pp -85.94 -178.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.186 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.509 ' NH2' ' HB3' ' A' ' 32' ' ' GLN . 9.3 ptp85 -167.66 168.6 12.5 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 16.2 m -122.41 118.87 29.41 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.609 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 60.7 mt -131.89 140.1 48.97 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.255 -173.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.519 ' OD2' ' HB3' ' A' ' 97' ' ' LYS . 4.7 p-10 -72.89 151.26 42.01 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.635 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -45.54 -35.5 3.96 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 7.4 ttpm? -61.29 -26.1 67.56 Favored 'General case' 0 C--N 1.273 -2.753 0 C-N-CA 123.879 0.872 . . . . 0.0 112.634 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.435 ' NH1' ' HB3' ' A' ' 23' ' ' ASP . 2.3 mmp_? -75.53 -28.48 59.11 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.171 0.51 . . . . 0.0 110.813 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.05 124.22 24.5 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.492 1.117 . . . . 0.0 110.12 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -87.72 -63.64 1.27 Allowed 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.21 -1.359 . . . . 0.0 113.305 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.1 pt-20 -161.11 142.39 11.68 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 121.403 0.62 . . . . 0.0 111.969 -170.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -60.94 120.92 11.13 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 126.186 1.794 . . . . 0.0 110.731 174.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.53 -62.83 1.54 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.485 HG22 HG11 ' A' ' 19' ' ' VAL . 4.8 t -125.41 -167.0 1.62 Allowed 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.263 -1.375 . . . . 0.0 111.626 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -161.2 135.18 6.86 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 124.092 0.957 . . . . 0.0 111.831 -171.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -105.4 163.36 12.69 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.176 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.5 p -90.86 170.14 10.34 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.282 0.563 . . . . 0.0 112.459 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 111' ' ' MET . 27.6 t70 -65.82 -30.82 71.5 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.292 1.037 . . . . 0.0 112.492 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -75.44 -24.26 57.03 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 122.035 -0.415 . . . . 0.0 110.491 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.409 ' O ' HG21 ' A' ' 114' ' ' VAL . 0.7 OUTLIER -75.13 -26.65 59.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.356 174.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.497 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -55.01 -39.32 68.96 Favored 'General case' 0 CA--C 1.471 -2.085 0 CA-C-O 122.04 0.924 . . . . 0.0 109.818 172.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.497 ' HE2' ' C ' ' A' ' 111' ' ' MET . 8.3 mmpt? -74.28 -15.21 60.98 Favored 'General case' 0 N--CA 1.393 -3.292 0 CA-C-N 114.214 -1.357 . . . . 0.0 113.112 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -86.93 -56.03 3.57 Favored 'General case' 0 N--CA 1.389 -3.51 0 C-N-CA 117.649 -1.62 . . . . 0.0 109.245 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 110' ' ' LYS . 22.0 m -57.33 -47.7 84.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -174.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.403 ' HB3' ' HG ' ' B' ' 124' ' ' LEU . 44.5 m-20 -60.53 -48.02 83.6 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 123.536 1.636 . . . . 0.0 109.931 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.435 ' O ' HG13 ' A' ' 120' ' ' ILE . 12.1 t30 -76.06 -39.87 54.49 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 112.267 -2.242 . . . . 0.0 112.647 -168.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.483 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -60.25 -38.51 83.68 Favored 'General case' 0 CA--C 1.469 -2.142 0 CA-C-O 122.279 1.038 . . . . 0.0 108.605 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.0 -27.82 30.12 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.297 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.423 ' HB3' ' O ' ' A' ' 116' ' ' ASN . 3.7 ttp -60.27 -30.09 69.23 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 124.079 0.951 . . . . 0.0 108.552 172.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 116' ' ' ASN . 52.9 mt -81.22 -55.61 7.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.9 t -49.76 -43.25 47.91 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.938 1.695 . . . . 0.0 111.935 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.419 ' HG ' HG12 ' B' ' 54' ' ' ILE . 9.0 mp -82.12 5.65 18.93 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.28 5.41 76.09 Favored Glycine 0 C--N 1.341 0.857 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.436 ' HG ' ' HB3' ' B' ' 115' ' ' ASP . 3.5 mp -73.23 -42.76 62.22 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.484 1.142 . . . . 0.0 108.63 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.435 -1.218 0 C-N-CA 126.501 1.921 . . . . 0.0 114.836 177.933 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--O 1.244 0.766 0 CA-C-O 121.296 0.569 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -104.44 122.41 45.46 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.058 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -59.55 124.97 21.81 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 120.969 0.414 . . . . 0.0 110.105 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.51 -7.42 46.47 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.501 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -97.17 179.2 4.99 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 17.4 t -134.17 137.48 51.83 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 C-N-CA 123.546 0.738 . . . . 0.0 111.031 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 27.7 m-85 -132.99 145.41 50.85 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.3 mp -76.62 151.36 36.25 Favored 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.664 170.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.63 143.83 51.0 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.341 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -87.36 84.45 7.19 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.167 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.535 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 4.4 mm? -88.17 40.93 0.98 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 123.172 1.463 . . . . 0.0 112.444 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.547 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.257 14.7 m -73.67 174.76 4.35 Favored Pre-proline 1 C--N 1.242 -4.097 0 CA-C-N 113.279 -1.782 . . . . 0.0 108.162 172.612 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 13.9 Cg_exo 3.19 53.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.406 3.571 1 C-N-CA 128.129 5.886 . . . . 0.0 118.077 -179.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 m -69.4 -178.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 113.44 -1.709 . . . . 0.0 111.836 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' B' ' 31' ' ' GLU . 33.1 mm-40 -109.79 132.7 53.91 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.624 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.87 -125.74 40.6 Favored Glycine 0 CA--C 1.499 -0.964 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.263 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 39.6 m -93.55 22.18 5.62 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.38 -0.41 . . . . 0.0 112.03 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' B' ' 28' ' ' GLN . 0.0 OUTLIER -64.24 162.46 14.61 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.388 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . 0.545 ' HB3' ' NH2' ' B' ' 92' ' ' ARG . 0.9 OUTLIER -79.92 117.42 20.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 120.87 0.367 . . . . 0.0 110.262 -173.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -98.07 145.8 17.93 Favored Glycine 0 CA--C 1.473 -2.556 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.514 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 106.54 138.96 9.24 Favored Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 114.431 -0.884 . . . . 0.0 111.18 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 t -56.93 119.42 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . 0.427 ' NH1' ' HA ' ' B' ' 59' ' ' THR . 58.7 mtt180 -140.7 148.43 52.87 Favored Pre-proline 0 C--N 1.256 -3.488 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.431 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 35.2 Cg_exo -64.1 138.49 62.2 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.707 2.271 . . . . 0.0 111.454 171.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.54 156.41 30.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.452 ' CG2' ' HB2' ' B' ' 56' ' ' ALA . 33.1 m -100.86 132.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.896 0.379 . . . . 0.0 110.439 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.46 ' CG2' ' HG2' ' B' ' 42' ' ' GLN . 24.3 mm -91.69 107.15 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.426 HD11 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -104.48 -9.99 9.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.554 ' OE1' HG12 ' B' ' 53' ' ' VAL . 4.7 pt20 -51.67 162.19 0.43 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -168.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -67.04 -179.88 1.02 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.263 -1.79 . . . . 0.0 111.852 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.25 -55.17 15.09 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.01 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.471 ' HA ' ' HD3' ' B' ' 48' ' ' LYS . 10.4 m -84.92 -22.3 29.32 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -164.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.64 -38.57 82.54 Favored Glycine 0 C--O 1.21 -1.381 0 O-C-N 123.236 0.335 . . . . 0.0 113.136 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.497 ' N ' HE22 ' B' ' 42' ' ' GLN . 10.2 p30 -71.79 -20.95 61.78 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' B' ' 45' ' ' THR . 2.8 mptp? -86.57 -67.75 0.79 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.138 0.494 . . . . 0.0 110.408 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.37 -35.78 24.86 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -169.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 18.7 m -86.09 143.31 37.06 Favored Pre-proline 0 N--CA 1.415 -2.215 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.28 -25.69 21.67 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.025 1.15 . . . . 0.0 109.309 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -82.71 145.97 29.3 Favored 'General case' 0 N--CA 1.415 -2.188 0 C-N-CA 125.545 1.538 . . . . 0.0 113.579 -173.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.554 HG12 ' OE1' ' B' ' 42' ' ' GLN . 98.0 t -130.01 140.52 48.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 176.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.466 HD12 ' O ' ' B' ' 92' ' ' ARG . 5.1 tp -103.76 124.57 58.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 121.291 0.567 . . . . 0.0 109.697 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.412 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 24.8 m -134.15 167.09 26.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.965 -175.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.452 ' HB2' ' CG2' ' B' ' 39' ' ' VAL . . . -125.53 139.54 53.52 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.49 135.78 42.23 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' B' ' 37' ' ' PRO . 59.4 mt -93.98 135.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 113.248 -1.796 . . . . 0.0 108.05 174.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' THR . . . . . 0.427 ' HA ' ' NH1' ' B' ' 36' ' ' ARG . 19.2 m -101.92 127.22 48.86 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.659 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.76 -176.104 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.477 ' H ' HD13 ' B' ' 67' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--O 1.218 -0.575 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.09 3.34 1.32 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.768 2.312 . . . . 0.0 113.755 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 58.9 p -92.4 -15.9 26.62 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.455 1.121 . . . . 0.0 108.504 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -108.64 129.76 55.33 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 62.9 t -125.42 127.06 71.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 O-C-N 121.611 -0.681 . . . . 0.0 110.736 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.34 120.62 32.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.493 HG22 ' CE1' ' B' ' 78' ' ' TYR . 0.1 OUTLIER -106.6 154.28 7.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.449 -175.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -62.01 119.48 8.96 Favored 'General case' 0 C--O 1.251 1.176 0 O-C-N 124.202 0.939 . . . . 0.0 112.619 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -46.55 -46.33 19.27 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.147 1.779 . . . . 0.0 110.48 172.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -59.73 -31.33 69.52 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 126.219 1.807 . . . . 0.0 112.938 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -90.73 -39.44 12.42 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.199 0.523 . . . . 0.0 110.631 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.493 ' CE1' HG22 ' B' ' 73' ' ' ILE . 4.3 m-85 -83.29 -10.8 58.31 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.879 -177.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 tttp 70.41 34.2 2.3 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.31 1.044 . . . . 0.0 111.851 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.69 -179.79 4.07 Favored 'General case' 0 CA--C 1.492 -1.259 0 O-C-N 120.973 -1.08 . . . . 0.0 111.613 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.82 -13.41 42.24 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.785 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -140.35 161.65 37.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.98 144.8 52.21 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t -112.4 157.28 21.24 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 11.0 t -118.2 128.31 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.424 HD12 ' CG1' ' B' ' 73' ' ' ILE . 1.6 mp -103.12 124.75 57.44 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 74.5 mt -100.18 111.5 23.78 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.054 -175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.6 mm? -84.06 2.75 37.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.614 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -119.15 4.79 11.29 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.818 1.294 . . . . 0.0 108.477 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -123.61 35.33 4.87 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.159 -1.837 . . . . 0.0 106.481 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.51 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.1 pp -85.81 -178.31 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.192 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.545 ' NH2' ' HB3' ' B' ' 32' ' ' GLN . 9.6 ptp85 -167.53 168.93 12.49 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 11.0 m -122.37 118.29 28.08 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.594 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 64.8 mt -132.0 139.86 48.76 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.403 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' B' ' 97' ' ' LYS . 6.2 p-10 -71.47 151.59 43.81 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.193 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -46.21 -37.0 6.57 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.513 ' HB3' ' OD2' ' B' ' 95' ' ' ASP . 7.0 ttpm? -61.59 -24.47 66.7 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.667 176.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -74.6 -30.11 61.56 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.481 -0.762 . . . . 0.0 110.352 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -71.31 124.93 25.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.499 1.12 . . . . 0.0 110.428 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -88.22 -64.68 1.11 Allowed 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.745 -1.571 . . . . 0.0 112.732 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 9.9 pt-20 -161.25 142.12 11.28 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 121.502 0.668 . . . . 0.0 112.523 -171.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.2 OUTLIER -60.45 121.31 11.78 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 126.491 1.916 . . . . 0.0 110.938 174.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -114.82 -63.0 1.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.345 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.489 HG22 HG11 ' B' ' 19' ' ' VAL . 3.3 t -125.25 -166.54 1.55 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.172 -1.411 . . . . 0.0 111.816 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -161.13 135.87 7.37 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.002 0.921 . . . . 0.0 112.112 -170.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 pp -108.79 157.4 18.61 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.02 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 7.1 p -86.82 175.49 8.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' B' ' 111' ' ' MET . 22.9 t70 -72.21 -29.47 64.0 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.151 0.5 . . . . 0.0 111.812 -174.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -70.2 -23.38 62.94 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.355 0.597 . . . . 0.0 109.91 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.443 ' O ' HG21 ' B' ' 114' ' ' VAL . 0.6 OUTLIER -78.8 -27.4 44.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 174.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.464 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.0 OUTLIER -55.51 -39.44 70.5 Favored 'General case' 0 CA--C 1.46 -2.487 0 CA-C-O 122.336 1.065 . . . . 0.0 109.131 172.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.464 ' HE2' ' C ' ' B' ' 111' ' ' MET . 6.9 mmpt? -71.98 -17.16 62.08 Favored 'General case' 1 N--CA 1.378 -4.053 0 CA-C-N 113.725 -1.579 . . . . 0.0 113.841 -178.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.97 -57.98 2.76 Favored 'General case' 0 N--CA 1.39 -3.436 0 C-N-CA 117.561 -1.656 . . . . 0.0 109.198 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.443 HG21 ' O ' ' B' ' 110' ' ' LYS . 22.9 m -54.85 -47.02 75.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.436 ' HB3' ' HG ' ' A' ' 124' ' ' LEU . 55.6 m-20 -61.3 -48.97 78.93 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.636 1.684 . . . . 0.0 110.535 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' B' ' 119' ' ' MET 0.349 27.0 t30 -77.13 -38.69 51.51 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.539 -167.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.418 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -62.63 -37.56 86.8 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-O 122.267 1.032 . . . . 0.0 108.812 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.66 -27.44 31.32 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.888 -174.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.439 ' HB3' ' O ' ' B' ' 116' ' ' ASN . 4.0 ttp -60.25 -31.44 70.21 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 59.6 mt -79.03 -56.39 7.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.2 t -48.64 -43.45 36.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.114 1.366 . . . . 0.0 112.235 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.434 ' HG ' HG12 ' A' ' 54' ' ' ILE . 8.6 mp -81.64 6.06 16.3 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.36 7.28 79.83 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 115.661 1.025 . . . . 0.0 115.661 172.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' B' ' 119' ' ' MET . 3.8 mp -73.59 -43.82 58.78 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 118.328 1.064 . . . . 0.0 108.422 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 . . . . . 0 N--CA 1.432 -1.355 0 C-N-CA 126.689 1.995 . . . . 0.0 114.72 178.522 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.7 mt . . . . . 0 N--CA 1.444 -0.766 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.43 ' HG2' ' OD2' ' A' ' 18' ' ' ASP . 8.4 ptp180 -121.59 157.99 29.54 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 171.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 28.6 ptt85 -69.36 113.65 6.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 168.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.481 ' HA2' ' SD ' ' A' ' 111' ' ' MET . . . 131.76 -9.07 5.51 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.875 -173.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.43 ' OD2' ' HG2' ' A' ' 15' ' ' ARG . 32.9 m-20 -96.46 173.19 7.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 122.016 0.912 . . . . 0.0 109.713 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 12.4 t -132.3 134.22 59.47 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.794 178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 50.7 m-85 -135.62 144.01 45.86 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 125.325 1.45 . . . . 0.0 108.977 176.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.9 mp -79.42 149.49 31.59 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-O 121.539 0.685 . . . . 0.0 111.097 173.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.67 134.23 33.37 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.177 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 25' ' ' SER 0.326 3.2 p-10 -81.64 104.72 12.25 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 117.931 -1.508 . . . . 0.0 111.346 176.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 5.4 mt -90.55 37.78 0.92 Allowed 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 124.92 2.295 . . . . 0.0 110.273 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.544 ' H ' ' C ' ' A' ' 23' ' ' ASP 0.282 7.3 m -63.62 171.91 2.02 Favored Pre-proline 1 C--N 1.223 -4.904 0 CA-C-N 109.364 -3.562 . . . . 0.0 107.314 167.599 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 1.0 OUTLIER 6.04 53.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.401 3.307 1 C-N-CA 126.977 5.118 . . . . 0.0 118.227 -174.73 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.32 -178.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.717 166.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -108.01 126.46 52.75 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.89 -117.9 9.82 Favored Glycine 0 N--CA 1.425 -2.058 0 CA-C-N 113.781 -1.554 . . . . 0.0 114.329 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.9 m -93.89 22.08 6.01 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.445 -0.878 . . . . 0.0 112.869 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.96 -176.36 0.68 Allowed 'General case' 0 C--O 1.247 0.948 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.934 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.8 109.11 19.9 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.56 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.18 143.27 16.45 Favored Glycine 0 CA--C 1.472 -2.636 0 CA-C-N 115.149 -0.932 . . . . 0.0 114.281 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 108.07 137.1 8.12 Favored Glycine 0 N--CA 1.418 -2.535 0 CA-C-N 113.85 -1.175 . . . . 0.0 110.811 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 p -61.93 126.71 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 122.455 1.121 . . . . 0.0 111.053 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -149.61 166.27 15.62 Favored Pre-proline 0 C--N 1.266 -3.04 0 CA-C-N 112.927 -1.942 . . . . 0.0 108.2 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 3.8 Cg_exo -75.92 143.9 26.76 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 121.903 1.735 . . . . 0.0 111.555 174.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 20' ' ' TYR . 28.6 m -118.45 158.53 19.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.517 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 34.3 m -102.36 133.05 47.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.767 0.318 . . . . 0.0 110.729 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 mm -88.72 104.9 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.429 HD13 ' C ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -104.4 -20.81 5.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.114 -178.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -54.88 165.95 0.56 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -170.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -60.66 164.03 4.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.051 -1.886 . . . . 0.0 112.527 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.08 -39.32 79.13 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.52 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 m -86.97 -26.56 23.76 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -171.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.89 -37.2 92.22 Favored Glycine 0 C--O 1.201 -1.919 0 CA-C-N 116.354 -0.385 . . . . 0.0 113.402 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.519 ' OD1' ' HD2' ' A' ' 48' ' ' LYS . 27.5 p30 -69.55 -19.69 63.68 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HD2' ' OD1' ' A' ' 47' ' ' ASN . 13.0 mptt -84.51 -61.73 1.73 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 109.901 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -89.13 -21.93 23.11 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -168.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.2 m -105.94 139.71 20.52 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.668 -0.645 . . . . 0.0 109.652 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.48 -22.26 14.17 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.437 1.425 . . . . 0.0 109.597 174.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 p -96.17 133.69 40.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.456 1.102 . . . . 0.0 111.889 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.24 145.96 34.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.3 tt -96.68 132.68 40.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.543 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.439 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 30.0 m -137.77 172.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.383 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.517 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . . . -126.0 139.55 53.33 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.53 142.76 42.75 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.45 HD12 ' HB2' ' A' ' 37' ' ' PRO . 82.7 mt -101.86 129.53 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.759 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.8 m -119.27 105.31 11.21 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.428 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.178 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.5 mt . . . . . 0 N--CA 1.437 -1.087 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.14 -11.29 21.33 Favored 'Trans proline' 0 CA--C 1.563 1.927 0 C-N-CA 122.199 1.933 . . . . 0.0 113.723 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.7 p -90.21 -19.02 24.67 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.353 0.597 . . . . 0.0 110.702 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -95.1 130.27 41.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.49 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.82 132.87 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.34 132.95 52.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.298 0.571 . . . . 0.0 110.909 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.481 HG13 ' CZ ' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -107.53 165.53 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.021 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -69.54 110.08 4.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 124.074 0.95 . . . . 0.0 109.828 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 20.8 pttm -58.09 -35.89 72.08 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.563 0.696 . . . . 0.0 112.115 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -51.61 -45.72 63.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.327 -1.76 . . . . 0.0 111.03 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -82.98 -34.68 26.34 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.288 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CZ ' HG13 ' A' ' 73' ' ' ILE . 1.8 m-85 -73.35 -11.52 60.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.031 -177.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.2 tptt 78.45 18.94 0.99 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.879 1.272 . . . . 0.0 111.732 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.13 179.36 4.51 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.285 1.04 . . . . 0.0 110.988 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -97.11 -24.8 15.58 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.977 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -130.33 155.25 46.66 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.108 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 4.5 m-20 -56.74 142.68 39.48 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 122.021 0.915 . . . . 0.0 113.203 -175.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.9 m -108.02 128.63 54.83 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.158 -174.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.3 t -115.82 130.22 70.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.22 129.68 60.61 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.843 0 CA-C-O 122.196 0.998 . . . . 0.0 108.575 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.0 mt -103.42 108.34 19.55 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 113.194 -1.821 . . . . 0.0 109.214 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.41 4.35 18.33 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.373 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.12 -38.0 6.13 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.378 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.48 53.35 2.78 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.545 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.507 HG21 ' CB ' ' A' ' 56' ' ' ALA . 2.0 pp -97.21 -176.16 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -173.96 178.11 2.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 45.4 m -121.76 129.15 52.48 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.884 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 mt -133.17 145.56 50.74 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 124.373 1.069 . . . . 0.0 109.328 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 97' ' ' LYS . 2.2 p-10 -79.73 151.16 30.57 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.284 -1.367 . . . . 0.0 110.115 173.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -39.14 -41.06 0.79 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.994 2.117 . . . . 0.0 114.521 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 7.0 ttpm? -63.65 -13.74 45.43 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 124.122 0.969 . . . . 0.0 112.401 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.5 ' HA ' ' NE ' ' A' ' 98' ' ' ARG . 3.7 mmp_? -89.73 -26.94 20.38 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.166 -0.959 . . . . 0.0 110.912 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -74.89 108.56 7.7 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-O 122.14 0.971 . . . . 0.0 109.514 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -93.83 -59.28 2.03 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -143.66 130.41 20.31 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.918 0.866 . . . . 0.0 113.232 -171.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.2 tttp -60.77 119.9 9.07 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 127.266 2.226 . . . . 0.0 108.184 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.7 tp -114.5 -62.38 1.61 Allowed 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.804 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.435 HG21 HG22 ' A' ' 19' ' ' VAL . 6.1 t -127.75 -160.49 1.02 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.238 -1.385 . . . . 0.0 112.457 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -159.37 149.97 19.42 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.371 1.868 . . . . 0.0 109.158 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -101.82 147.49 26.43 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.688 -177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -64.32 143.16 58.1 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 125.1 1.36 . . . . 0.0 108.608 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 111' ' ' MET . 7.0 p-10 -58.45 -37.39 75.34 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.29 -34.47 63.55 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.809 0.337 . . . . 0.0 110.606 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -67.67 -33.58 75.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -51.31 -46.18 62.47 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.693 173.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.685 ' HA ' ' OD2' ' A' ' 115' ' ' ASP . 0.5 OUTLIER -69.69 -17.78 63.5 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.72 -178.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -83.54 -38.67 21.41 Favored 'General case' 0 CA--C 1.442 -3.175 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.21 -42.99 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.671 0 O-C-N 126.13 2.144 . . . . 0.0 109.999 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.685 ' OD2' ' HA ' ' A' ' 112' ' ' LYS . 44.8 m-20 -57.4 -58.92 6.16 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.494 ' O ' HG13 ' A' ' 120' ' ' ILE . 1.7 m-80 -59.38 -47.39 85.63 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.3 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.09 -43.81 64.09 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 124.341 1.056 . . . . 0.0 110.852 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 tp -67.21 -45.93 75.38 Favored 'General case' 1 N--CA 1.374 -4.252 0 C-N-CA 124.336 1.054 . . . . 0.0 109.971 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.2 mtp -67.82 -20.08 65.13 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 121.477 -0.765 . . . . 0.0 112.891 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 116' ' ' ASN . 49.4 mt -77.24 -55.75 9.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 26.2 t -53.22 -42.65 66.57 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.759 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.4 mp -90.06 -1.14 57.91 Favored 'General case' 0 N--CA 1.403 -2.782 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.65 13.14 82.84 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 116.571 1.389 . . . . 0.0 116.571 170.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.57 -59.84 2.59 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 118.624 1.212 . . . . 0.0 110.985 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 CA--C 1.568 1.649 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.65 -168.468 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -117.35 159.14 23.21 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 27.0 ptt85 -70.0 113.54 7.31 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.414 ' HA2' ' SD ' ' B' ' 111' ' ' MET . . . 133.34 -15.3 4.74 Favored Glycine 0 C--N 1.305 -1.163 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.666 -173.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -89.72 171.92 9.3 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 121.946 0.879 . . . . 0.0 109.047 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.461 HG22 ' CG2' ' B' ' 104' ' ' THR . 13.3 t -131.19 132.88 63.09 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.774 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.841 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 75.6 m-85 -133.65 143.69 48.74 Favored 'General case' 0 CA--C 1.474 -1.957 0 C-N-CA 125.199 1.4 . . . . 0.0 109.463 176.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.9 mp -81.49 148.42 29.21 Favored 'General case' 0 N--CA 1.397 -3.095 0 CA-C-O 121.687 0.756 . . . . 0.0 110.99 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -136.59 134.73 37.72 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 113.177 -1.829 . . . . 0.0 107.209 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' B' ' 25' ' ' SER 0.333 3.6 p-10 -81.95 102.51 10.97 Favored 'General case' 0 C--N 1.279 -2.467 0 C-N-CA 117.975 -1.49 . . . . 0.0 111.658 175.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 4.9 mt -87.8 39.1 0.87 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 125.085 2.374 . . . . 0.0 110.396 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.547 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.287 6.6 m -64.62 171.87 2.55 Favored Pre-proline 1 C--N 1.22 -5.027 0 CA-C-N 109.363 -3.562 . . . . 0.0 107.219 167.083 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.3 OUTLIER 5.85 53.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.173 1 C-N-CA 127.153 5.235 . . . . 0.0 118.386 -174.746 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 28.5 m -69.29 -179.1 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.534 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -106.52 130.95 54.21 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.99 -117.9 7.37 Favored Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 113.751 -1.568 . . . . 0.0 113.82 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -94.18 18.08 11.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.34 -0.93 . . . . 0.0 113.188 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.52 178.1 1.04 Allowed 'General case' 0 C--O 1.249 1.063 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.942 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . 0.441 ' OE1' ' HD2' ' B' ' 36' ' ' ARG . 1.0 OUTLIER -83.52 108.81 16.89 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.522 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.79 138.52 14.11 Favored Glycine 0 CA--C 1.479 -2.212 0 CA-C-N 114.904 -1.043 . . . . 0.0 114.324 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 117.5 136.92 5.71 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 113.813 -1.193 . . . . 0.0 110.512 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 p -63.85 121.21 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 122.497 1.141 . . . . 0.0 110.9 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . 0.441 ' HD2' ' OE1' ' B' ' 32' ' ' GLN . 87.8 mtt180 -144.51 166.69 17.52 Favored Pre-proline 0 C--N 1.26 -3.319 0 CA-C-N 112.846 -1.979 . . . . 0.0 109.028 -174.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 5.4 Cg_exo -76.05 142.7 25.07 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 122.003 1.802 . . . . 0.0 111.507 174.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.496 HG21 ' O ' ' B' ' 20' ' ' TYR . 31.0 m -118.07 158.08 19.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.507 ' CG2' ' HB2' ' B' ' 56' ' ' ALA . 34.2 m -102.22 132.42 48.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.807 0.336 . . . . 0.0 110.79 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 24.0 mm -88.09 104.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.425 HD13 ' C ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -103.47 -20.8 5.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.004 -178.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -55.64 165.91 0.77 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 -170.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -59.77 163.3 4.54 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 112.709 -2.042 . . . . 0.0 112.784 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.0 -37.97 75.83 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.498 -175.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 25.8 m -87.23 -28.35 22.42 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.03 -36.06 86.65 Favored Glycine 0 C--O 1.2 -1.99 0 CA-C-O 120.077 -0.291 . . . . 0.0 113.336 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.534 ' OD1' ' HD2' ' B' ' 48' ' ' LYS . 26.6 p30 -69.21 -19.58 63.97 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.534 ' HD2' ' OD1' ' B' ' 47' ' ' ASN . 13.1 mptt -85.66 -59.44 2.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.222 0.534 . . . . 0.0 110.369 174.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -89.25 -29.75 19.0 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -169.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.7 m -99.45 138.41 20.48 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -74.7 -22.09 15.89 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.281 1.32 . . . . 0.0 109.708 173.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 3.1 p -95.43 132.7 40.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.546 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.32 146.38 34.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 4.8 tt -96.97 132.85 40.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 123.112 0.565 . . . . 0.0 110.317 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.449 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 28.3 m -138.03 171.93 14.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.556 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.507 ' HB2' ' CG2' ' B' ' 39' ' ' VAL . . . -125.05 139.8 53.47 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.12 142.03 41.77 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.468 HD12 ' HB2' ' B' ' 37' ' ' PRO . 85.2 mt -100.2 133.11 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.281 -1.781 . . . . 0.0 109.389 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 95.7 m -123.41 104.72 9.26 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.601 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.249 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 13.2 mt . . . . . 0 N--CA 1.437 -1.119 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.98 -12.69 33.35 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 122.157 1.905 . . . . 0.0 113.671 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -88.78 -19.09 26.45 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.395 0.617 . . . . 0.0 110.651 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -96.21 130.26 43.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.38 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 95.1 t -126.53 130.45 71.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 O-C-N 122.174 -0.329 . . . . 0.0 110.359 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -101.32 139.49 36.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.459 HG13 ' CZ ' ' B' ' 78' ' ' TYR . 0.7 OUTLIER -115.36 162.96 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 123.157 0.583 . . . . 0.0 111.754 -173.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.3 109.91 2.86 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 123.785 0.834 . . . . 0.0 110.409 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . 0.431 ' HB3' ' HA ' ' B' ' 83' ' ' ASP . 20.0 pttm -58.13 -34.98 70.82 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.873 0.844 . . . . 0.0 112.066 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -53.32 -44.19 68.21 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.177 -1.828 . . . . 0.0 110.941 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -84.51 -35.2 23.06 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.472 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.459 ' CZ ' HG13 ' B' ' 73' ' ' ILE . 1.6 m-85 -73.43 -11.49 60.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.926 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 81.59 13.81 0.61 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.222 1.409 . . . . 0.0 112.089 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.8 179.29 5.02 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 122.328 1.061 . . . . 0.0 111.189 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -96.27 -25.04 15.93 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 113.673 -1.603 . . . . 0.0 109.845 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -130.34 156.02 45.38 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . 0.431 ' HA ' ' HB3' ' B' ' 75' ' ' LYS . 2.1 m-20 -54.08 144.22 20.09 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.959 0.885 . . . . 0.0 113.239 -175.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 13.1 m -108.27 128.18 54.5 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.644 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.5 t -115.76 129.94 71.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.446 HG23 HD22 ' B' ' 88' ' ' LEU . 1.6 mp -107.4 129.88 60.55 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 mt -102.9 108.87 20.23 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 113.563 -1.653 . . . . 0.0 109.019 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.446 HD22 HG23 ' B' ' 86' ' ' ILE . 3.8 mm? -80.01 4.48 16.87 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.585 0.707 . . . . 0.0 112.451 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.15 -38.9 5.87 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.96 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -85.55 63.67 8.2 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.116 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.505 HG21 ' CB ' ' B' ' 56' ' ' ALA . 2.0 pp -108.66 -176.68 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -174.39 178.98 1.89 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 31.5 m -122.38 129.31 51.98 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.768 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 41.8 mt -133.49 145.46 50.21 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 124.513 1.125 . . . . 0.0 109.471 -174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' B' ' 97' ' ' LYS . 2.0 p30 -79.4 151.18 31.07 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 117.977 -1.489 . . . . 0.0 110.284 172.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -37.39 -42.25 0.48 Allowed 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 127.402 2.281 . . . . 0.0 114.685 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.477 ' HB3' ' HZ2' ' B' ' 97' ' ' LYS . 7.5 ttpm? -61.17 -18.05 56.14 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 124.665 1.186 . . . . 0.0 112.472 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.56 ' NE ' ' HA ' ' B' ' 98' ' ' ARG . 4.0 mmp_? -88.31 -22.45 23.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.363 -0.835 . . . . 0.0 111.622 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.31 107.83 11.2 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 121.976 0.894 . . . . 0.0 108.974 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -95.24 -57.98 2.27 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 116.823 2.156 . . . . 0.0 116.823 -173.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 12.0 pt-20 -140.15 131.93 27.47 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.979 0.895 . . . . 0.0 112.737 -171.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -63.67 119.46 9.92 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 127.151 2.18 . . . . 0.0 108.429 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.1 -63.66 1.43 Allowed 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 118.564 -1.255 . . . . 0.0 112.048 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.461 ' CG2' HG22 ' B' ' 19' ' ' VAL . 6.1 t -125.57 -160.48 0.97 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 117.645 -1.622 . . . . 0.0 112.897 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -159.75 150.89 19.54 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 126.803 2.041 . . . . 0.0 108.324 -173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.34 155.69 17.66 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -70.96 145.76 49.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' B' ' 111' ' ' MET . 2.8 p-10 -62.85 -35.43 79.93 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -176.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.0 -33.17 63.71 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.202 0.525 . . . . 0.0 109.917 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.419 ' HG2' HG21 ' B' ' 73' ' ' ILE . 16.6 tppt? -68.65 -32.96 73.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.531 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -51.83 -45.48 63.97 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.958 173.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.687 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -69.3 -16.88 63.66 Favored 'General case' 0 CA--C 1.477 -1.863 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.237 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . 0.53 ' HA ' ' ND2' ' B' ' 116' ' ' ASN . 32.6 mt-10 -85.53 -38.37 18.6 Favored 'General case' 1 N--CA 1.368 -4.55 0 C-N-CA 117.202 -1.799 . . . . 0.0 108.641 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.0 t -56.62 -44.36 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.141 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.03 172.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.634 ' OD2' ' HA ' ' B' ' 112' ' ' LYS . 25.2 m-20 -56.32 -58.1 9.41 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.557 1.17 . . . . 0.0 108.991 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.542 ' O ' HG13 ' B' ' 120' ' ' ILE . 1.3 p30 -66.34 -40.49 89.87 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.011 -1.449 . . . . 0.0 112.019 -173.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' B' ' 88' ' ' LEU . . . -59.14 -37.81 78.17 Favored 'General case' 0 CA--C 1.49 -1.364 0 O-C-N 123.636 0.585 . . . . 0.0 109.74 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.6 tp -69.56 -44.56 70.64 Favored 'General case' 1 N--CA 1.373 -4.294 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.871 -178.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 39.2 mtp -68.39 -19.92 64.65 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.643 -0.661 . . . . 0.0 112.124 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.542 HG13 ' O ' ' B' ' 116' ' ' ASN . 45.6 mt -78.18 -55.43 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 173.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 34.3 t -52.21 -43.9 64.47 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.113 1.365 . . . . 0.0 111.843 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 8.1 mp -87.74 -2.37 58.57 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.53 7.42 87.53 Favored Glycine 0 C--O 1.241 0.551 0 N-CA-C 117.116 1.606 . . . . 0.0 117.116 170.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.8 -59.19 2.86 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 118.632 1.216 . . . . 0.0 110.937 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 C--N 1.3 -1.559 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.552 -169.616 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -134.42 157.39 46.55 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 42' ' ' GLN . 20.3 ttt85 -67.86 130.5 43.17 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.33 173.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.34 -19.27 11.74 Favored Glycine 0 C--N 1.307 -1.034 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.158 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -93.51 176.06 6.52 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 122.112 0.958 . . . . 0.0 110.461 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.547 HG22 ' CG2' ' A' ' 104' ' ' THR . 17.4 t -128.32 135.76 61.79 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.194 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.119 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 8.0 m-85 -128.59 145.44 51.14 Favored 'General case' 0 CA--C 1.462 -2.411 0 C-N-CA 124.461 1.104 . . . . 0.0 108.996 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.3 mp -78.9 148.42 32.74 Favored 'General case' 0 N--CA 1.391 -3.411 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 168.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.1 134.48 17.3 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.397 1.06 . . . . 0.0 110.654 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.92 88.58 1.85 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.237 171.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.56 ' O ' HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -109.13 25.45 11.79 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 123.265 1.507 . . . . 0.0 109.542 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.529 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 20.2 p -94.28 62.11 0.01 OUTLIER Pre-proline 0 N--CA 1.409 -2.509 0 CA-C-N 112.95 -1.932 . . . . 0.0 116.205 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HB2' ' HB2' ' B' ' 26' ' ' PRO . 13.7 Cg_endo -113.48 29.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.556 0 N-CA-C 106.288 -2.235 . . . . 0.0 106.288 153.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 35.3 m -73.5 165.21 3.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.645 -176.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.09 141.42 30.03 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.086 -1.416 . . . . 0.0 113.307 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.83 -108.82 2.31 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.786 -1.097 . . . . 0.0 115.354 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -84.46 -5.94 59.33 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 124.264 1.025 . . . . 0.0 113.074 -173.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 71.2 mt-10 -77.4 161.65 27.84 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.417 ' HG3' ' OE1' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -125.33 156.5 38.59 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.71 -149.07 18.52 Favored Glycine 0 N--CA 1.407 -3.283 0 C-N-CA 118.462 -1.828 . . . . 0.0 114.417 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 25' ' ' SER . . . 140.55 -156.14 25.11 Favored Glycine 0 C--N 1.276 -2.772 0 N-CA-C 103.61 -3.796 . . . . 0.0 103.61 -171.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.0 100.07 10.27 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.168 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 165.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -131.63 146.45 61.92 Favored Pre-proline 0 C--N 1.258 -3.398 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.671 -167.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 47.6 Cg_exo -56.28 134.36 63.78 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.395 2.063 . . . . 0.0 111.203 171.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 29.4 m -125.28 159.11 32.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.479 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 32.9 m -97.89 130.26 46.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.55 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.8 mm -88.73 101.88 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.69 -20.36 5.54 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.863 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.571 ' HG3' HG23 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -54.86 158.91 2.5 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -170.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 19.0 p-10 -63.51 175.41 1.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.886 -1.507 . . . . 0.0 112.418 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -52.89 52.46 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.27 -1.786 . . . . 0.0 112.937 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -80.55 -24.17 39.47 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -163.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.69 -26.35 72.97 Favored Glycine 0 C--O 1.212 -1.23 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.991 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -73.96 -32.76 63.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.497 0.665 . . . . 0.0 110.162 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -85.45 -64.48 1.15 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.689 -173.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -96.5 -28.67 14.3 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -171.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.1 m -86.4 155.02 57.15 Favored Pre-proline 0 C--N 1.298 -1.659 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.149 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.496 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . 61.6 Cg_endo -98.26 17.05 0.51 Allowed 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 122.779 2.319 . . . . 0.0 111.425 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 p -130.56 145.8 51.95 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.415 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.563 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -146.2 139.28 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.588 0.555 . . . . 0.0 111.565 174.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.571 HG23 ' HG3' ' A' ' 42' ' ' GLN . 8.9 tt -82.2 133.71 28.59 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 CA-C-O 121.663 0.744 . . . . 0.0 111.392 175.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.406 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 29.9 m -135.85 162.56 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.712 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.513 ' CB ' HG23 ' A' ' 91' ' ' ILE . . . -123.48 139.23 54.23 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.05 134.78 47.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.467 HG12 HD12 ' A' ' 86' ' ' ILE . 54.9 mt -93.25 112.71 26.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.038 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.5 m -99.85 119.56 38.38 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.349 0.659 . . . . 0.0 109.747 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.704 0 C-N-CA 120.581 -0.818 . . . . 0.0 114.992 -172.742 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 N--CA 1.443 -0.78 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.38 5.51 0.32 Allowed 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.436 2.757 . . . . 0.0 115.583 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.484 ' HA ' ' OG ' ' A' ' 121' ' ' SER . 68.4 p -96.77 -18.46 19.59 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 122.23 1.014 . . . . 0.0 109.137 176.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -102.03 129.91 48.46 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.3 p -124.62 137.55 56.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.252 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -92.92 148.13 22.27 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.166 0.507 . . . . 0.0 111.352 -176.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.413 ' O ' HD12 ' A' ' 73' ' ' ILE . 1.9 pp -124.6 148.15 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.816 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -90.55 108.82 20.04 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.676 0.75 . . . . 0.0 109.561 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.513 ' HD2' ' C ' ' A' ' 81' ' ' ASP . 37.6 pttt -45.06 -39.07 5.43 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 126.217 1.807 . . . . 0.0 115.217 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -45.89 -49.38 15.62 Favored 'General case' 0 C--N 1.267 -2.984 0 C-N-CA 126.131 1.772 . . . . 0.0 111.8 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -91.76 -41.21 10.81 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 118.805 -1.158 . . . . 0.0 112.266 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.495 ' HD1' ' O ' ' A' ' 105' ' ' TYR . 2.3 m-85 -110.8 -19.48 12.82 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -164.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -154.78 46.56 0.54 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 117.242 -1.783 . . . . 0.0 114.644 -167.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER 65.81 -131.66 0.22 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.432 0.693 . . . . 0.0 111.151 163.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.513 ' C ' ' HD2' ' A' ' 75' ' ' LYS . 23.6 t70 -88.57 -5.76 57.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.652 1.181 . . . . 0.0 109.437 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -106.67 116.33 31.75 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.4 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 5.0 p-10 -83.22 117.11 22.72 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.4 ' O ' HG13 ' A' ' 73' ' ' ILE . 13.2 t -113.65 157.93 21.51 Favored 'General case' 0 N--CA 1.406 -2.658 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.676 -166.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.01 139.16 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.467 HD12 HG12 ' A' ' 58' ' ' ILE . 17.3 mm -105.27 129.95 57.25 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 52.0 mt -101.24 110.56 22.59 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.42 HD12 HD11 ' A' ' 118' ' ' LEU . 3.2 mm? -84.01 -7.33 59.43 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 121.677 0.751 . . . . 0.0 111.168 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.546 ' O ' HG23 ' B' ' 93' ' ' THR . 10.4 pt-20 -84.74 -42.25 15.41 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.185 173.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.417 ' OE1' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -92.85 73.84 4.88 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.995 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.601 ' O ' ' HB ' ' B' ' 93' ' ' THR . 2.4 pp -117.58 179.73 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.91 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.459 ' NH1' HG13 ' A' ' 27' ' ' VAL 0.261 11.5 ptp180 -174.94 157.76 2.42 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 99.4 m -105.19 126.5 52.15 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.591 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.2 mt -131.36 150.13 52.27 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 124.137 0.898 . . . . 0.0 111.184 -169.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -51.52 141.56 15.72 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.707 0.629 . . . . 0.0 110.108 170.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 51' ' ' PRO . 44.4 mtmt -64.5 -18.82 65.15 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 120.981 0.42 . . . . 0.0 111.971 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -75.5 -9.64 58.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.11 0.481 . . . . 0.0 110.914 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.504 ' HA ' ' NE ' ' A' ' 98' ' ' ARG . 3.8 mmp_? -86.63 -36.5 18.77 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -73.39 121.74 20.96 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.616 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -106.05 -61.16 1.55 Allowed 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.2 pt-20 -143.1 130.6 21.16 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -168.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 22.0 ttmm -60.75 113.19 2.35 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 112.221 -2.263 . . . . 0.0 109.045 174.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.3 tp -112.97 -63.27 1.47 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.547 ' CG2' HG22 ' A' ' 19' ' ' VAL 0.273 5.7 t -120.89 -167.08 1.42 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 117.703 -1.599 . . . . 0.0 111.115 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.495 ' O ' ' HD1' ' A' ' 78' ' ' TYR . 13.8 p90 -160.29 142.93 13.28 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 123.687 0.795 . . . . 0.0 111.66 -169.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 32.3 mt -111.55 161.4 16.22 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.142 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' ' 111' ' ' MET . 30.2 p -92.63 167.14 12.11 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 123.906 0.882 . . . . 0.0 109.878 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.35 -31.41 72.52 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.458 0.647 . . . . 0.0 111.394 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.07 -38.51 79.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.858 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -70.86 -35.14 72.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -52.71 -49.21 65.81 Favored 'General case' 0 CA--C 1.483 -1.607 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.011 177.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.65 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 28.9 mtmm -50.08 -41.74 48.73 Favored 'General case' 0 CA--C 1.477 -1.836 0 O-C-N 124.319 1.012 . . . . 0.0 112.62 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -80.21 -32.17 38.58 Favored 'General case' 0 CA--C 1.443 -3.166 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -165.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.63 -55.64 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.761 0 CA-C-N 112.776 -2.011 . . . . 0.0 109.968 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 62.3 m-20 -57.46 -50.94 71.41 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 122.237 1.018 . . . . 0.0 110.495 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.65 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -61.6 -46.57 89.27 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.703 -178.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.409 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -58.76 -42.66 89.42 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.64 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 12.7 tp -65.56 -47.07 77.09 Favored 'General case' 0 N--CA 1.402 -2.874 0 C-N-CA 125.184 1.394 . . . . 0.0 110.299 -175.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.437 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.19 -29.46 57.94 Favored 'General case' 0 N--CA 1.414 -2.245 0 C-N-CA 124.832 1.253 . . . . 0.0 111.212 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 116' ' ' ASN . 40.6 mt -86.44 -54.0 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.484 ' OG ' ' HA ' ' A' ' 69' ' ' THR . 72.8 m -46.88 -33.56 4.64 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.516 -1.674 . . . . 0.0 112.757 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 21.7 mt -100.5 -0.29 38.17 Favored 'General case' 0 C--O 1.189 -2.113 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.999 -177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.51 7.78 71.69 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 119.591 -1.29 . . . . 0.0 116.295 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' A' ' 122' ' ' LEU . 4.9 mp -63.71 -50.17 70.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 122.7 1.238 . . . . 0.0 108.353 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.609 ' C ' HD21 ' A' ' 125' ' ' ASN 0.305 0.0 OUTLIER . . . . . 1 N--CA 1.362 -4.847 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 170.438 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 58.8 mt . . . . . 0 N--CA 1.418 -2.056 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.433 ' HE ' ' CG ' ' B' ' 18' ' ' ASP . 19.2 ptt180 -127.97 159.13 35.93 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' B' ' 42' ' ' GLN . 21.0 ttt85 -69.44 130.74 43.35 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.75 -20.34 10.08 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.002 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . 0.433 ' CG ' ' HE ' ' B' ' 15' ' ' ARG . 57.0 m-20 -93.74 175.47 6.72 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-O 122.272 1.034 . . . . 0.0 110.736 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.538 HG22 ' CG2' ' B' ' 104' ' ' THR . 12.7 t -128.38 135.95 61.28 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.0 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.601 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 5.9 m-85 -129.16 145.93 51.2 Favored 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 124.506 1.122 . . . . 0.0 109.061 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.4 mp -79.47 148.32 31.92 Favored 'General case' 0 N--CA 1.394 -3.254 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 167.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -150.83 134.75 16.66 Favored 'General case' 0 C--N 1.265 -3.099 0 O-C-N 124.361 1.038 . . . . 0.0 111.014 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.8 86.72 1.26 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 171.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.528 HD13 ' O ' ' B' ' 34' ' ' GLY 0.252 0.0 OUTLIER -104.81 23.73 12.99 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 123.156 1.455 . . . . 0.0 109.643 -179.62 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.538 ' HB3' ' HA2' ' B' ' 34' ' ' GLY . 3.5 p -94.54 62.58 0.01 OUTLIER Pre-proline 0 N--CA 1.405 -2.676 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.485 ' HB2' ' HB2' ' A' ' 26' ' ' PRO . 15.5 Cg_endo -113.72 27.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.574 0 N-CA-C 106.822 -2.03 . . . . 0.0 106.822 153.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 34.1 m -72.84 165.87 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.886 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.19 140.98 29.64 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.863 -1.517 . . . . 0.0 113.698 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.65 -108.38 2.19 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -79.41 -15.49 57.75 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 124.011 0.925 . . . . 0.0 112.5 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.533 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 71.6 mt-10 -69.65 165.92 20.2 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.63 130.98 49.91 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -172.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.35 -163.11 36.36 Favored Glycine 0 N--CA 1.408 -3.212 0 C-N-CA 117.735 -2.174 . . . . 0.0 115.278 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' B' ' 25' ' ' SER . . . 158.9 -162.05 32.33 Favored Glycine 0 C--N 1.266 -3.321 1 N-CA-C 102.664 -4.174 . . . . 0.0 102.664 -171.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.424 HG11 ' O ' ' B' ' 35' ' ' VAL . 3.4 p -89.42 99.85 9.94 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 166.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -132.44 147.19 64.68 Favored Pre-proline 0 C--N 1.257 -3.418 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.606 -167.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 51.3 Cg_exo -55.48 135.41 69.09 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.538 2.159 . . . . 0.0 112.034 173.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 28.2 m -126.21 158.65 35.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 123.849 0.86 . . . . 0.0 108.969 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.475 ' CG2' ' HB1' ' B' ' 56' ' ' ALA . 32.9 m -98.01 130.55 46.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.672 0.272 . . . . 0.0 110.666 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 18.6 mm -88.91 102.09 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.22 -20.38 5.53 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.897 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.543 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 0.0 OUTLIER -55.06 159.34 2.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -170.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.419 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 19.1 p-10 -62.47 178.95 0.37 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.491 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.72 -46.59 30.2 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.958 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -79.4 -26.49 41.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -166.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.27 -26.74 72.64 Favored Glycine 0 C--O 1.209 -1.461 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.25 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -73.69 -31.16 63.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.759 0.79 . . . . 0.0 110.263 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -85.08 -66.64 0.87 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.59 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -96.37 -27.55 14.89 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 43.5 m -86.07 154.15 57.56 Favored Pre-proline 0 C--N 1.295 -1.803 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.465 ' HA ' ' HE2' ' B' ' 96' ' ' LYS . 68.7 Cg_endo -98.52 15.01 0.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.643 2.229 . . . . 0.0 111.231 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.7 p -128.14 147.01 50.53 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.295 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.543 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -147.07 139.24 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 123.632 0.582 . . . . 0.0 111.254 174.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.536 HG23 ' HG3' ' B' ' 42' ' ' GLN . 8.5 tt -82.22 133.7 28.61 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 CA-C-O 121.73 0.776 . . . . 0.0 111.422 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 29.7 m -135.72 160.04 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.859 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.504 ' CB ' HG23 ' B' ' 91' ' ' ILE . . . -120.68 139.16 53.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.44 135.27 45.72 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.456 HG12 HD12 ' B' ' 86' ' ' ILE . 55.3 mt -90.97 113.74 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.457 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 41.1 m -101.03 110.05 22.03 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 121.769 0.795 . . . . 0.0 111.371 -175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.488 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 172.697 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 tt . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.11 5.14 0.17 Allowed 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.489 2.793 . . . . 0.0 115.845 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' THR . . . . . 0.452 ' HA ' ' OG ' ' B' ' 121' ' ' SER . 64.7 p -98.75 -18.62 17.9 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 122.16 0.981 . . . . 0.0 109.238 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -103.5 129.56 50.7 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.91 135.38 64.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.377 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.67 143.98 26.36 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-O 121.347 0.594 . . . . 0.0 111.642 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.414 ' O ' HD12 ' B' ' 73' ' ' ILE . 2.0 pp -119.26 150.76 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.002 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -94.85 109.66 21.62 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.769 0.795 . . . . 0.0 110.565 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . 0.483 ' HD2' ' C ' ' B' ' 81' ' ' ASP . 38.6 pttt -43.67 -42.0 5.05 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.528 1.931 . . . . 0.0 115.252 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -46.0 -46.94 16.79 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 126.456 1.902 . . . . 0.0 111.736 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -92.19 -42.92 9.62 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.074 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.561 ' HD1' ' O ' ' B' ' 105' ' ' TYR . 7.1 m-85 -111.82 -18.3 12.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -164.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -156.09 47.84 0.48 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 117.756 -1.578 . . . . 0.0 114.478 -167.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' B' ' 75' ' ' LYS . 0.0 OUTLIER 63.68 -133.73 0.37 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.962 0.905 . . . . 0.0 111.203 164.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.483 ' C ' ' HD2' ' B' ' 75' ' ' LYS . 12.7 t70 -86.08 -6.71 58.97 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 125.08 1.352 . . . . 0.0 110.057 175.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -105.47 114.95 29.43 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 119.383 -0.927 . . . . 0.0 113.349 -174.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.11 117.34 20.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.4 ' O ' HG13 ' B' ' 73' ' ' ILE . 14.7 t -114.11 158.26 21.51 Favored 'General case' 0 N--CA 1.407 -2.624 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.579 -168.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 t -116.57 139.73 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.456 HD12 HG12 ' B' ' 58' ' ' ILE . 18.7 mm -104.96 129.98 56.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.27 110.32 22.55 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' B' ' 117' ' ' ALA . 3.2 mm? -84.02 -6.76 59.47 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.637 0.732 . . . . 0.0 111.013 -175.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . 0.557 ' O ' HG23 ' A' ' 93' ' ' THR . 10.5 pt-20 -86.99 -39.64 15.49 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.631 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 73.93 3.75 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.927 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.602 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.4 pp -117.76 179.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.949 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.462 ' NH1' HG13 ' B' ' 27' ' ' VAL 0.254 12.1 ptp180 -174.98 157.42 2.34 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 172.179 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 97.2 m -105.09 126.87 52.54 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.622 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 49.1 mt -131.28 150.18 52.25 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 124.246 0.966 . . . . 0.0 111.143 -169.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -50.65 140.01 15.22 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.23 0.612 . . . . 0.0 109.764 170.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' B' ' 51' ' ' PRO . 43.1 mtmt -61.45 -23.02 65.56 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 122.68 0.392 . . . . 0.0 111.622 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -70.3 -17.95 63.09 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.431 ' NE ' ' HA ' ' B' ' 98' ' ' ARG . 4.5 mmp_? -80.38 -33.32 37.27 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.827 -0.546 . . . . 0.0 109.937 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.8 mp -74.89 117.43 16.73 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.966 0.889 . . . . 0.0 109.759 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -100.64 -59.35 1.72 Allowed 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -147.28 133.95 19.94 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -170.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 21.6 ttmm -60.76 114.29 2.95 Favored 'General case' 0 C--N 1.284 -2.253 0 C-N-CA 127.458 2.303 . . . . 0.0 108.778 174.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 tp -112.78 -62.89 1.52 Allowed 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.538 ' CG2' HG22 ' B' ' 19' ' ' VAL . 5.0 t -122.1 -167.12 1.5 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.119 -1.432 . . . . 0.0 111.022 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.561 ' O ' ' HD1' ' B' ' 78' ' ' TYR . 15.7 p90 -160.21 141.3 12.24 Favored 'General case' 0 CA--C 1.488 -1.428 0 C-N-CA 123.818 0.847 . . . . 0.0 111.359 -170.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.483 ' HA ' ' CD1' ' B' ' 78' ' ' TYR . 32.1 mt -107.23 168.18 9.4 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 124.305 1.003 . . . . 0.0 108.872 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' SER . . . . . 0.469 ' O ' ' HG2' ' B' ' 111' ' ' MET . 39.6 p -95.69 167.62 11.17 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.151 0.58 . . . . 0.0 109.6 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -67.4 -29.7 69.28 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.897 0.856 . . . . 0.0 109.913 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.16 -39.9 78.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.231 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -71.42 -32.58 68.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' B' ' 107' ' ' SER . 0.5 OUTLIER -53.99 -48.77 70.06 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.836 177.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.704 ' O ' ' HB3' ' B' ' 116' ' ' ASN 0.271 20.1 mtmm -49.27 -43.23 42.84 Favored 'General case' 0 CA--C 1.467 -2.236 0 O-C-N 124.583 1.177 . . . . 0.0 111.96 175.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -79.44 -33.5 42.44 Favored 'General case' 0 CA--C 1.446 -3.037 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -163.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.18 -53.37 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.644 0 CA-C-N 112.548 -2.115 . . . . 0.0 110.263 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 69.3 m-20 -58.63 -52.14 66.94 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 122.437 1.113 . . . . 0.0 110.219 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.704 ' HB3' ' O ' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -67.9 -30.51 69.87 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.394 -175.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.402 ' HB2' ' HG ' ' B' ' 88' ' ' LEU . . . -71.64 -45.52 61.77 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.649 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 11.0 tp -60.03 -47.38 86.1 Favored 'General case' 0 N--CA 1.4 -2.97 0 C-N-CA 125.78 1.632 . . . . 0.0 110.416 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.43 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 0.1 OUTLIER -54.14 -33.08 57.02 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 124.567 1.147 . . . . 0.0 111.303 178.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.415 HG13 ' O ' ' B' ' 116' ' ' ASN . 56.5 mt -82.79 -53.35 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' B' ' 69' ' ' THR . 44.2 m -47.55 -33.07 6.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.724 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 20.3 mt -100.3 -1.63 35.75 Favored 'General case' 0 C--O 1.189 -2.089 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.975 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.73 8.28 70.18 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 173.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.466 ' CD1' ' HB2' ' B' ' 122' ' ' LEU . 4.9 mp -63.58 -48.08 78.89 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.693 1.235 . . . . 0.0 108.683 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.616 ' C ' HD21 ' B' ' 125' ' ' ASN 0.292 0.0 OUTLIER . . . . . 1 N--CA 1.366 -4.65 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 170.127 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.241 0.643 0 CA-C-O 120.807 0.337 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -115.6 138.49 51.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 13.8 ptm180 -61.76 134.96 57.39 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.632 170.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.32 -12.81 36.71 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.811 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.79 166.71 22.6 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.512 1.149 . . . . 0.0 110.984 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.49 ' CG1' ' HB2' ' A' ' 103' ' ' LEU . 42.6 t -130.68 122.7 53.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.949 0 CA-C-N 112.71 -2.041 . . . . 0.0 108.994 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 88.3 m-85 -129.13 147.66 51.0 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 125.872 1.669 . . . . 0.0 110.571 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.3 mp -77.04 148.21 36.31 Favored 'General case' 0 N--CA 1.395 -3.181 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 167.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -139.97 146.6 39.33 Favored 'General case' 0 C--N 1.252 -3.662 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.904 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.551 ' O ' ' HD2' ' A' ' 98' ' ' ARG . 35.1 t70 -84.29 72.29 10.57 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 173.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.495 HD22 ' HA3' ' A' ' 33' ' ' GLY . 3.2 tt -76.79 -36.78 56.74 Favored 'General case' 0 N--CA 1.384 -3.756 0 CA-C-N 111.789 -2.459 . . . . 0.0 110.413 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.567 ' CB ' ' H ' ' A' ' 34' ' ' GLY . 71.4 m -118.5 114.75 36.03 Favored Pre-proline 0 N--CA 1.398 -3.063 1 N-CA-C 121.812 4.005 . . . . 0.0 121.812 -168.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -106.78 27.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.419 -2.902 0 C-N-CA 123.616 2.878 . . . . 0.0 106.015 152.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.579 ' C ' HE21 ' A' ' 28' ' ' GLN . 26.7 m -88.48 158.42 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 122.191 0.996 . . . . 0.0 112.816 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.716 HE21 ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -152.29 155.83 38.45 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 113.03 -1.895 . . . . 0.0 107.498 175.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.54 -130.93 10.42 Favored Glycine 0 N--CA 1.416 -2.696 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' B' ' 95' ' ' ASP . 4.7 m -93.92 -7.83 41.91 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.794 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.522 ' HG2' HH12 ' B' ' 92' ' ' ARG . 1.7 mp0 -70.87 155.98 40.14 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.624 -0.831 . . . . 0.0 110.264 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -133.75 120.63 20.79 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -171.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.495 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -155.75 -94.23 0.1 Allowed Glycine 1 N--CA 1.392 -4.292 0 C-N-CA 119.001 -1.571 . . . . 0.0 113.677 172.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.567 ' H ' ' CB ' ' A' ' 25' ' ' SER . . . 79.41 172.81 43.62 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -171.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 4.2 p -75.42 102.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 172.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -144.89 155.23 55.78 Favored Pre-proline 0 C--N 1.263 -3.177 0 CA-C-N 113.48 -1.691 . . . . 0.0 107.983 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 24.5 Cg_exo -66.39 139.33 53.93 Favored 'Trans proline' 0 C--O 1.247 0.964 0 C-N-CA 122.169 1.912 . . . . 0.0 112.803 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.1 m -127.49 163.36 30.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.123 0.969 . . . . 0.0 109.817 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.37 134.31 48.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.329 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -89.38 108.99 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -105.34 -8.07 9.95 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.701 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.64 -178.019 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -62.89 169.1 3.44 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -170.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -65.18 175.44 1.64 Allowed 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.923 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.64 -49.66 37.9 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.328 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -86.88 -21.3 26.42 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -169.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.16 -37.02 53.76 Favored Glycine 0 C--O 1.196 -2.273 0 CA-C-N 117.9 0.318 . . . . 0.0 112.682 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -63.62 -19.38 64.81 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -82.56 -63.82 1.3 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.039 0.536 . . . . 0.0 110.128 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -83.28 -35.36 25.35 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -172.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.1 m -83.03 136.52 43.87 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.45 -18.53 17.71 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 N-CA-C 108.34 -1.446 . . . . 0.0 108.34 170.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 11.4 p -91.4 150.67 21.16 Favored 'General case' 0 N--CA 1.415 -2.199 0 C-N-CA 125.201 1.4 . . . . 0.0 111.941 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.1 t -133.39 140.11 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 173.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.1 tt -110.23 128.7 66.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 CA-C-O 121.183 0.516 . . . . 0.0 109.929 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.499 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 32.7 m -132.39 173.18 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.941 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.423 ' CB ' HG21 ' A' ' 91' ' ' ILE . . . -128.41 143.68 51.03 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.02 132.77 41.58 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.3 mt -89.05 119.09 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.372 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.9 m -121.53 116.47 24.73 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 121.317 0.58 . . . . 0.0 110.834 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.425 ' HA3' ' HD2' ' A' ' 82' ' ' LYS . . . . . . . . 0 N--CA 1.422 -2.288 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.0 tt . . . . . 0 N--CA 1.425 -1.685 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.28 -4.22 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.64 2.894 . . . . 0.0 116.546 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.9 p -101.97 -18.84 15.48 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.913 -0.492 . . . . 0.0 111.039 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -112.24 128.92 56.39 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -117.09 133.0 65.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.727 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.1 128.57 53.41 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.288 0.566 . . . . 0.0 110.559 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.504 HG21 ' CZ ' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -124.81 154.88 32.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 123.585 0.754 . . . . 0.0 112.046 -176.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.78 141.0 53.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.764 0.792 . . . . 0.0 112.246 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -60.85 -34.58 74.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.358 -1.746 . . . . 0.0 109.2 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -55.27 -53.07 60.78 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.479 -1.691 . . . . 0.0 114.395 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -88.52 -35.83 16.75 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.094 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.504 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 6.6 m-85 -78.35 -5.15 51.36 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.727 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt 50.44 36.62 13.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.698 1.999 . . . . 0.0 115.183 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 78' ' ' TYR . 8.8 mp -87.21 -176.78 5.8 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 122.106 0.955 . . . . 0.0 110.892 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.34 -7.34 48.15 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.82 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HD2' ' HA3' ' A' ' 60' ' ' GLY . 10.2 ptpp? -153.52 164.23 38.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -56.66 147.5 22.43 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.228 0.537 . . . . 0.0 111.001 173.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.3 m -108.09 132.51 53.5 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.744 -172.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.3 t -118.44 124.45 73.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.417 HG22 HD22 ' A' ' 88' ' ' LEU . 1.7 mp -110.71 127.57 67.68 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.013 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.7 mt -99.91 103.64 15.23 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.241 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.417 HD22 HG22 ' A' ' 86' ' ' ILE . 3.3 mm? -86.11 70.89 10.62 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -176.83 -48.54 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.47 84.79 4.77 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 55' ' ' VAL . 2.0 pp -121.11 179.12 2.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.07 -175.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.506 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 12.1 tpt85 -152.31 146.79 25.66 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.7 m -115.5 120.11 38.43 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.506 ' HG ' ' HG3' ' A' ' 92' ' ' ARG . 29.4 mt -130.99 143.99 51.14 Favored 'General case' 0 C--O 1.198 -1.606 0 C-N-CA 125.235 1.414 . . . . 0.0 110.343 -171.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 0.2 OUTLIER -77.03 152.4 35.14 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 117.075 -1.85 . . . . 0.0 110.957 170.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -42.31 -27.12 0.13 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 126.551 1.94 . . . . 0.0 115.767 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 9.5 ptpp? -71.25 -21.93 62.04 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 118.736 0.698 . . . . 0.0 111.465 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 36.2 mmt180 -68.35 -33.77 74.88 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.773 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.63 115.75 10.14 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 124.436 1.094 . . . . 0.0 110.939 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -96.89 -63.83 1.1 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.183 -1.372 . . . . 0.0 114.213 -174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.6 pt-20 -156.05 143.77 19.52 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-O 121.939 0.876 . . . . 0.0 111.665 -172.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttmm -66.82 123.61 20.62 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 112.468 -2.151 . . . . 0.0 111.558 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.49 ' HB2' ' CG1' ' A' ' 19' ' ' VAL . 3.8 mm? -93.43 -62.82 1.29 Allowed 'General case' 0 CA--C 1.472 -2.042 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.447 HG23 ' HA ' ' A' ' 78' ' ' TYR . 7.2 t -150.87 -155.66 0.64 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.038 -1.892 . . . . 0.0 111.678 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -161.37 148.3 14.69 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.974 1.71 . . . . 0.0 109.538 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.34 153.0 39.56 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.766 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.3 p -83.71 161.2 21.11 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.12 -40.38 95.72 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.036 0.922 . . . . 0.0 110.981 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.54 -16.3 62.37 Favored 'General case' 0 C--O 1.194 -1.829 0 C-N-CA 125.107 1.363 . . . . 0.0 111.282 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.449 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 67.1 mttm -91.33 -36.65 13.73 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 120.468 -1.395 . . . . 0.0 109.898 168.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.411 ' HG2' ' OD2' ' A' ' 115' ' ' ASP 0.327 38.5 ttm -64.4 -26.04 68.29 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -177.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.656 ' NZ ' ' HG3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -57.87 -14.5 6.21 Favored 'General case' 0 C--N 1.248 -3.818 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 173.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.656 ' HG3' ' NZ ' ' A' ' 112' ' ' LYS . 42.8 mt-10 -87.65 -54.44 4.26 Favored 'General case' 1 C--O 1.148 -4.254 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 171.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 t -47.05 -52.34 4.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-N 113.862 -1.517 . . . . 0.0 114.176 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.545 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 22.4 m-20 -66.05 -45.4 81.5 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 123.536 1.636 . . . . 0.0 110.838 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 112' ' ' LYS 0.256 9.3 t30 -73.83 -39.84 63.76 Favored 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 112.937 -1.938 . . . . 0.0 113.037 -171.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.4 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -58.6 -39.05 79.32 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 125.447 1.499 . . . . 0.0 108.077 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.545 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 8.8 tp -70.06 -38.12 75.71 Favored 'General case' 1 N--CA 1.373 -4.286 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.964 -175.184 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 47.7 mtp -68.51 -19.59 64.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.891 -0.505 . . . . 0.0 111.31 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.5 mt -82.22 -59.15 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.1 m -48.15 -47.69 34.67 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 125.067 1.479 . . . . 0.0 111.975 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.19 -0.39 57.04 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.84 19.11 73.1 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.52 -50.29 39.26 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 118.571 1.186 . . . . 0.0 108.508 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.435 -1.224 0 CA-C-N 113.162 -1.835 . . . . 0.0 109.613 -174.113 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 69.2 mt . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -115.9 137.98 51.6 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 13.9 ptm180 -63.12 128.89 37.93 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.144 -1.023 . . . . 0.0 109.008 171.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.17 -11.94 26.58 Favored Glycine 0 N--CA 1.426 -2.017 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.458 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -76.42 166.99 22.65 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 122.544 1.164 . . . . 0.0 110.836 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.487 ' CG1' ' HB2' ' B' ' 103' ' ' LEU . 40.9 t -130.92 124.25 55.84 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.066 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.757 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 96.1 m-85 -131.0 148.3 52.74 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 125.79 1.636 . . . . 0.0 110.015 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 1.3 mp -77.13 147.59 36.48 Favored 'General case' 0 N--CA 1.395 -3.207 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 167.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -140.82 145.42 36.26 Favored 'General case' 0 C--N 1.248 -3.82 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.161 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.603 ' O ' ' HD2' ' B' ' 98' ' ' ARG . 35.7 t70 -85.28 78.14 9.85 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 172.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.531 ' HB3' ' O ' ' B' ' 34' ' ' GLY . 3.4 tt -79.34 -35.22 41.36 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 111.796 -2.456 . . . . 0.0 110.155 -167.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.579 ' CB ' ' H ' ' B' ' 34' ' ' GLY . 73.3 m -118.25 113.64 37.06 Favored Pre-proline 0 N--CA 1.405 -2.692 1 N-CA-C 122.231 4.16 . . . . 0.0 122.231 -168.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -103.95 24.14 0.11 Allowed 'Trans proline' 0 N--CA 1.418 -2.964 0 C-N-CA 123.056 2.504 . . . . 0.0 106.38 152.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' B' ' 25' ' ' SER . 19.3 m -85.82 165.02 2.32 Favored 'Isoleucine or valine' 0 C--N 1.373 1.624 0 CA-C-O 121.899 0.857 . . . . 0.0 112.337 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.93 159.13 34.56 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 113.187 -1.824 . . . . 0.0 106.77 174.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.96 -135.8 12.63 Favored Glycine 0 N--CA 1.421 -2.351 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 5.4 m -93.68 -0.6 55.98 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.797 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.465 ' HG2' HH12 ' A' ' 92' ' ' ARG . 1.4 mp0 -73.07 159.98 32.74 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.793 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -136.95 119.08 15.46 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -155.88 -95.16 0.11 Allowed Glycine 0 N--CA 1.4 -3.707 0 C-N-CA 118.928 -1.606 . . . . 0.0 114.095 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.579 ' H ' ' CB ' ' B' ' 25' ' ' SER . . . 80.27 -177.94 54.1 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -171.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 3.5 p -83.27 99.91 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 CA-C-O 123.586 1.66 . . . . 0.0 107.175 172.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -140.66 154.03 68.63 Favored Pre-proline 0 C--N 1.257 -3.428 0 CA-C-N 113.023 -1.899 . . . . 0.0 108.149 -168.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 25.9 Cg_exo -66.11 138.56 52.43 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 122.239 1.959 . . . . 0.0 112.504 174.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.2 163.06 28.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 123.931 0.893 . . . . 0.0 109.902 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.85 134.1 48.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.364 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 27.2 mm -89.29 109.98 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.426 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -105.59 -8.22 10.05 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.734 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.534 -178.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.473 ' OE1' HG11 ' B' ' 53' ' ' VAL . 5.4 pt20 -64.22 169.61 4.4 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -169.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -65.08 173.37 2.45 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.458 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.95 -46.35 52.9 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.623 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 8.5 m -87.79 -21.59 25.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.58 -35.82 57.69 Favored Glycine 0 C--O 1.195 -2.288 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -64.77 -19.05 65.6 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -81.91 -62.11 1.73 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 122.928 0.491 . . . . 0.0 109.701 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -83.94 -34.57 24.42 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 46.5 m -85.98 141.09 35.21 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -77.07 -19.84 13.41 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 121.222 1.281 . . . . 0.0 108.78 170.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 5.3 p -90.4 150.56 21.81 Favored 'General case' 0 N--CA 1.413 -2.298 0 C-N-CA 124.818 1.247 . . . . 0.0 112.111 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.473 HG11 ' OE1' ' B' ' 42' ' ' GLN . 94.4 t -132.28 140.06 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 tt -111.08 126.48 68.48 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-O 121.294 0.569 . . . . 0.0 110.012 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.492 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 27.1 m -131.21 173.23 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.034 -174.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.424 ' CB ' HG21 ' B' ' 91' ' ' ILE . . . -128.21 143.91 51.08 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.67 134.95 40.44 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 62.7 mt -90.75 122.39 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 113.056 -1.883 . . . . 0.0 106.727 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 98.3 m -123.51 117.04 24.2 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.461 0.648 . . . . 0.0 110.666 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.915 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 173.702 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tt . . . . . 0 N--CA 1.421 -1.879 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.72 -18.35 12.04 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.759 2.972 . . . . 0.0 116.47 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 77.4 p -91.53 -19.13 23.1 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.079 0.399 . . . . 0.0 111.664 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -109.97 128.81 55.61 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.37 132.01 68.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.813 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.89 130.83 54.5 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.313 0.577 . . . . 0.0 110.275 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.5 HG21 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -125.24 154.64 33.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.634 -176.172 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.47 136.47 53.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.557 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -57.4 -34.22 68.65 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.385 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -55.78 -53.25 58.98 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.589 -1.641 . . . . 0.0 113.942 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -89.68 -31.86 17.3 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.052 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.5 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 6.2 m-85 -81.02 -5.68 57.89 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.735 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt 50.14 38.0 15.95 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.697 1.999 . . . . 0.0 115.151 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.428 HD12 ' O ' ' B' ' 78' ' ' TYR . 9.2 mp -88.93 -178.09 5.64 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.567 1.175 . . . . 0.0 111.032 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.84 -4.78 56.33 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.503 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -156.41 165.02 37.56 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -54.27 152.04 6.72 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.192 0.52 . . . . 0.0 110.953 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 15.9 m -111.51 131.42 55.24 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.167 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 8.0 t -117.79 124.33 72.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.409 HG22 HD22 ' B' ' 88' ' ' LEU . 1.6 mp -110.74 126.59 68.09 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 56.0 mt -98.47 102.22 13.89 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.215 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.412 ' HG ' ' HB1' ' B' ' 117' ' ' ALA . 3.6 mm? -83.95 72.06 10.46 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.753 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -178.39 -48.57 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.44 85.54 5.38 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 2.0 pp -122.19 179.05 2.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.153 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.522 HH12 ' HG2' ' A' ' 31' ' ' GLU . 12.2 tpt85 -152.41 146.76 25.57 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 86.0 m -115.92 119.49 36.1 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.51 ' HG ' ' HG3' ' B' ' 92' ' ' ARG . 22.7 mt -130.95 143.55 50.81 Favored 'General case' 0 C--O 1.196 -1.751 0 C-N-CA 125.352 1.461 . . . . 0.0 110.397 -171.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 0.3 OUTLIER -76.79 152.38 35.58 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.661 170.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -41.91 -27.51 0.12 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.416 1.886 . . . . 0.0 115.549 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -69.38 -21.84 63.76 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.697 0.681 . . . . 0.0 111.589 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.603 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 37.7 mmt180 -69.85 -35.68 74.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.105 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.19 114.47 8.37 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 124.113 0.965 . . . . 0.0 110.735 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -94.96 -65.75 0.96 Allowed 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.087 -1.415 . . . . 0.0 114.164 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.2 pt-20 -154.92 139.47 16.92 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 121.742 0.782 . . . . 0.0 111.837 -169.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 22.4 ttmm -64.56 121.28 14.07 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 127.595 2.358 . . . . 0.0 111.628 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.487 ' HB2' ' CG1' ' B' ' 19' ' ' VAL . 3.8 mm? -91.91 -63.04 1.3 Allowed 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 7.2 t -149.13 -156.27 0.71 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.827 -174.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -161.54 145.94 13.1 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 125.949 1.7 . . . . 0.0 109.886 -170.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.17 148.93 44.33 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.294 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.5 p -81.76 158.32 24.19 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.179 -0.918 . . . . 0.0 113.075 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -57.26 -42.36 81.4 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.621 1.168 . . . . 0.0 112.034 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.09 -16.51 64.0 Favored 'General case' 0 C--O 1.178 -2.681 0 C-N-CA 124.71 1.204 . . . . 0.0 111.366 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.45 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 66.3 mttm -90.63 -33.68 15.75 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.525 -1.359 . . . . 0.0 109.563 169.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.465 ' HE1' ' HB2' ' B' ' 111' ' ' MET 0.307 34.7 ttm -65.06 -25.16 67.69 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.666 ' HE3' ' N ' ' B' ' 113' ' ' GLU . 0.0 OUTLIER -58.87 -13.8 7.26 Favored 'General case' 0 C--N 1.248 -3.826 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 174.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . 0.666 ' N ' ' HE3' ' B' ' 112' ' ' LYS . 43.8 mt-10 -87.22 -54.47 4.29 Favored 'General case' 0 CA--C 1.429 -3.703 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 172.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 t -47.17 -52.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.01 -1.904 . . . . 0.0 113.93 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 16.7 m-20 -64.21 -48.48 75.73 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 123.331 1.539 . . . . 0.0 111.145 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.43 ' O ' HG13 ' B' ' 120' ' ' ILE 0.316 9.0 t30 -72.03 -39.09 69.37 Favored 'General case' 0 C--N 1.268 -2.953 0 C-N-CA 126.77 2.028 . . . . 0.0 112.795 -170.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.412 ' HB1' ' HG ' ' B' ' 88' ' ' LEU . . . -62.23 -37.97 87.45 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 124.284 1.033 . . . . 0.0 108.565 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.9 tp -69.18 -36.48 77.38 Favored 'General case' 1 N--CA 1.366 -4.627 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.682 -176.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 46.5 mtp -69.28 -19.71 63.91 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 121.997 -0.439 . . . . 0.0 110.932 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.43 HG13 ' O ' ' B' ' 116' ' ' ASN . 52.1 mt -81.88 -58.39 3.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.2 m -52.18 -44.55 64.73 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.263 0.977 . . . . 0.0 111.433 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 7.2 mp -86.72 -1.82 58.04 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.8 17.5 71.36 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 116.696 1.439 . . . . 0.0 116.696 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 6.8 mp -68.58 -49.23 61.01 Favored 'General case' 0 CA--C 1.474 -1.975 0 CA-C-N 118.735 1.267 . . . . 0.0 108.042 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 N--CA 1.425 -1.702 0 CA-C-N 113.008 -1.906 . . . . 0.0 110.196 -175.76 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.6 mt . . . . . 0 N--CA 1.424 -1.729 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -102.3 129.4 48.73 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.58 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 1.1 ptm180 -61.99 118.08 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 128.07 -10.67 6.59 Favored Glycine 0 C--N 1.295 -1.719 0 C-N-CA 120.063 -1.065 . . . . 0.0 111.125 -172.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.427 ' CG ' ' HZ2' ' A' ' 102' ' ' LYS . 4.0 m-20 -92.72 175.33 6.85 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 122.574 1.178 . . . . 0.0 110.988 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.525 HG22 HG23 ' A' ' 104' ' ' THR . 10.8 t -133.39 134.72 56.92 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.936 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.596 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 27.6 m-85 -133.22 147.82 52.0 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 124.988 1.315 . . . . 0.0 108.11 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mp -81.01 150.69 28.77 Favored 'General case' 0 N--CA 1.408 -2.546 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.053 170.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.26 138.34 49.26 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.2 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.408 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 20.7 t70 -79.94 90.38 5.34 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.966 0.888 . . . . 0.0 109.777 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.603 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 14.9 mt -100.1 19.37 16.49 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 124.055 1.883 . . . . 0.0 109.591 -176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.49 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.266 15.0 m -61.94 167.55 4.66 Favored Pre-proline 1 C--N 1.229 -4.656 0 CA-C-N 111.41 -2.632 . . . . 0.0 108.295 169.84 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.2 OUTLIER 9.6 50.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.397 3.092 1 C-N-CA 127.367 5.378 . . . . 0.0 118.011 -175.03 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.9 m -68.74 -178.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 113.764 -1.562 . . . . 0.0 111.887 170.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 13.6 mm100 -107.44 132.14 53.52 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.565 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.74 -135.66 35.64 Favored Glycine 0 N--CA 1.425 -2.09 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.853 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -91.77 20.35 5.67 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.87 -0.665 . . . . 0.0 111.088 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 0.1 OUTLIER -65.57 152.41 44.15 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 175.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.15 110.31 13.02 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.769 -0.582 . . . . 0.0 110.786 -167.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -86.52 129.18 9.27 Favored Glycine 0 CA--C 1.49 -1.529 0 N-CA-C 116.244 1.257 . . . . 0.0 116.244 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 131.41 137.06 3.99 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 113.427 -1.387 . . . . 0.0 110.076 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.91 119.37 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 CA-C-O 122.248 1.023 . . . . 0.0 109.775 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -142.53 158.02 61.2 Favored Pre-proline 0 C--N 1.271 -2.838 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.697 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 4.6 Cg_exo -72.15 142.2 37.54 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 121.971 1.781 . . . . 0.0 111.386 174.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 20' ' ' TYR . 31.6 m -118.07 156.83 19.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.553 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.493 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 36.0 m -97.91 126.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.337 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.5 mm -87.2 103.92 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.415 HD11 ' C ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -100.7 -18.94 6.14 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.524 177.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.629 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -56.07 157.99 4.24 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -173.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 28.5 p-10 -71.19 -167.48 0.23 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.807 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -89.55 -38.69 13.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.841 -175.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.1 m -83.78 -28.22 28.3 Favored 'General case' 0 C--O 1.249 1.074 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.718 -170.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.88 -38.77 97.1 Favored Glycine 0 C--O 1.206 -1.647 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.511 ' N ' HE22 ' A' ' 42' ' ' GLN . 9.7 p30 -83.67 -20.72 33.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.237 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 4.2 mptp? -76.02 -65.24 0.94 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.811 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.527 ' CD1' ' HB3' ' A' ' 48' ' ' LYS . 85.9 m-85 -99.02 -28.2 13.51 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -171.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.5 m -93.07 154.68 41.66 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.52 -18.92 10.48 Favored 'Trans proline' 0 C--O 1.21 -0.913 0 C-N-CA 121.69 1.593 . . . . 0.0 111.603 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 p -91.93 146.27 23.88 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.253 1.021 . . . . 0.0 113.081 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.629 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -142.0 139.0 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.384 0.428 . . . . 0.0 110.491 172.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.487 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -88.43 130.25 38.26 Favored 'Isoleucine or valine' 0 C--O 1.249 1.071 0 CA-C-O 121.799 0.809 . . . . 0.0 110.334 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.37 167.55 24.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.397 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.493 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -123.5 146.43 48.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.91 136.31 36.62 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.473 HD13 ' HB2' ' A' ' 37' ' ' PRO . 19.2 mt -87.3 130.66 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.708 172.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.9 m -122.29 157.44 31.73 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.563 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.078 179.815 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.451 ' C ' ' H ' ' A' ' 69' ' ' THR 0.619 23.5 mm . . . . . 0 CA--C 1.508 -0.651 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.36 1.94 1.09 Allowed 'Trans proline' 0 C--O 1.219 -0.433 0 CA-C-N 121.828 1.688 . . . . 0.0 114.289 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 67' ' ' ILE . 23.1 p -132.38 -10.86 3.23 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.9 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -133.82 129.11 36.06 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -174.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 p -130.51 131.71 64.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.223 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.63 124.14 28.27 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.516 HD12 ' CD2' ' A' ' 78' ' ' TYR . 13.0 pt -99.49 135.68 33.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.441 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -65.83 114.8 5.33 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.16 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -51.46 -39.42 57.42 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.637 0.732 . . . . 0.0 112.141 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -68.4 -19.05 64.59 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.308 -1.315 . . . . 0.0 113.212 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -92.46 -36.18 13.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.94 0.876 . . . . 0.0 109.4 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.516 ' CD2' HD12 ' A' ' 73' ' ' ILE . 19.1 m-85 -92.83 7.53 43.36 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.669 -1.605 . . . . 0.0 113.471 -173.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 tptm 61.23 20.38 10.95 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 121.798 0.808 . . . . 0.0 110.746 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.2 mt -98.89 175.33 5.98 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.665 0.745 . . . . 0.0 111.011 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.56 -44.76 14.29 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.619 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.423 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -129.92 158.72 38.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.552 -176.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -72.26 137.72 46.95 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.495 ' O ' HG12 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -120.76 160.51 23.22 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -172.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -111.22 139.89 33.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.55 -0.719 . . . . 0.0 109.214 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 58' ' ' ILE . 20.8 mm -104.37 135.99 39.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.8 mt -104.79 106.27 16.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.429 ' HG ' ' HB1' ' A' ' 117' ' ' ALA . 3.5 mm? -88.44 14.04 10.56 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.881 0.848 . . . . 0.0 111.505 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -112.91 -34.85 5.63 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.173 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.38 65.79 4.58 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.584 ' O ' ' HB ' ' B' ' 93' ' ' THR . 1.8 pp -102.66 173.81 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.04 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.594 ' NH1' HD23 ' A' ' 24' ' ' LEU . 10.1 ptt180 -164.29 155.45 15.61 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.585 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 52.6 m -114.73 120.65 40.79 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.0 mt -131.58 144.58 51.18 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.98 -170.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.54 152.45 43.95 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.009 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -55.24 -18.34 5.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -85.36 -19.21 31.78 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.912 0.386 . . . . 0.0 110.347 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 23' ' ' ASP . 3.0 mmp_? -70.51 -34.39 72.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 7.7 mp -74.23 121.05 20.64 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.384 173.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -95.44 -57.41 2.4 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.308 -1.315 . . . . 0.0 114.083 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.596 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.0 pt-20 -148.88 135.6 19.7 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 122.069 0.938 . . . . 0.0 113.322 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.427 ' HZ2' ' CG ' ' A' ' 18' ' ' ASP . 55.3 tttp -60.89 110.71 1.41 Allowed 'General case' 0 C--N 1.279 -2.478 0 C-N-CA 128.625 2.77 . . . . 0.0 107.564 172.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 tp -111.13 -62.6 1.52 Allowed 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.299 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.525 HG23 HG22 ' A' ' 19' ' ' VAL . 6.0 t -127.03 -161.17 1.05 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.111 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -154.03 154.41 33.67 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 124.237 1.015 . . . . 0.0 110.803 -171.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.431 HD22 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -102.79 161.95 13.32 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.977 -177.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 m -98.59 164.23 12.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 111' ' ' MET . 25.5 t70 -67.09 -33.3 75.19 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.481 0.582 . . . . 0.0 110.712 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.47 -47.43 85.71 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.612 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.601 ' O ' HG21 ' A' ' 114' ' ' VAL . 11.8 tptt -62.82 -32.97 74.27 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 173.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -51.01 -49.21 60.91 Favored 'General case' 0 CA--C 1.456 -2.662 0 CA-C-N 118.3 0.5 . . . . 0.0 109.656 169.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 9.3 mmpt? -75.17 -11.89 60.18 Favored 'General case' 0 N--CA 1.392 -3.371 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.545 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.252 30.4 mt-10 -87.48 -56.41 3.37 Favored 'General case' 0 N--CA 1.39 -3.462 0 C-N-CA 117.136 -1.826 . . . . 0.0 111.17 166.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.601 HG21 ' O ' ' A' ' 110' ' ' LYS . 35.7 m -61.18 -48.18 90.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.25 -48.13 82.87 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 123.488 1.613 . . . . 0.0 109.307 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 18.7 t30 -74.01 -42.05 60.93 Favored 'General case' 0 C--N 1.265 -3.07 0 CA-C-N 111.813 -2.449 . . . . 0.0 112.684 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.429 ' HB1' ' HG ' ' A' ' 88' ' ' LEU . . . -61.44 -40.93 96.27 Favored 'General case' 0 CA--C 1.46 -2.513 0 CA-C-O 122.365 1.079 . . . . 0.0 108.567 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.408 ' O ' HD11 ' A' ' 122' ' ' LEU . 0.6 OUTLIER -79.91 -25.44 40.56 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.939 -172.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.478 ' O ' ' HB2' ' A' ' 124' ' ' LEU . 1.6 ttp -63.8 -26.82 68.8 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-O 121.924 0.869 . . . . 0.0 108.665 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 60.9 mt -84.23 -56.94 4.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.1 t -47.2 -43.94 21.91 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.817 1.647 . . . . 0.0 112.116 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.468 ' HG ' HG21 ' B' ' 54' ' ' ILE . 8.3 mp -82.0 5.19 20.05 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.64 1.33 77.63 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 117.972 1.949 . . . . 0.0 117.972 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 119' ' ' MET . 1.2 mm? -67.28 -48.91 66.26 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 120.098 1.949 . . . . 0.0 107.804 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 N--CA 1.429 -1.491 0 CA-C-N 112.287 -2.233 . . . . 0.0 113.083 179.15 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 66.6 mt . . . . . 0 N--CA 1.419 -2.012 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -99.73 129.06 45.82 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.589 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 0.9 OUTLIER -61.14 119.63 8.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 169.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.54 -6.65 8.51 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.469 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.35 175.36 6.46 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.206 1.003 . . . . 0.0 110.587 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.528 HG22 HG23 ' B' ' 104' ' ' THR . 16.2 t -132.98 134.33 58.13 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 113.296 -1.774 . . . . 0.0 110.355 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 32.2 m-85 -132.7 148.0 52.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 124.912 1.285 . . . . 0.0 108.314 174.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.6 mp -81.47 152.11 27.51 Favored 'General case' 0 N--CA 1.411 -2.409 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.043 170.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.33 138.21 46.26 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.703 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.429 ' HB3' ' NH1' ' B' ' 98' ' ' ARG . 27.2 t70 -78.32 89.87 4.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.984 0.897 . . . . 0.0 110.022 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.619 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 15.8 mt -98.2 17.1 19.39 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 123.895 1.807 . . . . 0.0 109.299 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.262 15.7 m -60.33 166.65 3.81 Favored Pre-proline 1 C--N 1.236 -4.338 0 CA-C-N 111.916 -2.402 . . . . 0.0 107.955 169.729 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.1 OUTLIER 10.14 50.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.458 1 C-N-CA 127.209 5.273 . . . . 0.0 118.271 -174.764 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' B' ' 31' ' ' GLU . 24.3 m -68.83 -178.69 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 113.663 -1.608 . . . . 0.0 111.68 169.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' B' ' 31' ' ' GLU . 14.5 mm100 -108.36 129.66 55.23 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.388 -1.278 . . . . 0.0 113.569 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.74 -134.75 24.17 Favored Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.612 -1.177 . . . . 0.0 112.16 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.9 m -93.48 22.1 5.64 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 122.936 0.494 . . . . 0.0 111.104 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' B' ' 28' ' ' GLN . 0.1 OUTLIER -66.43 151.94 46.14 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 174.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -77.52 110.1 12.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.867 0.365 . . . . 0.0 111.425 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . 0.619 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -86.54 139.88 16.9 Favored Glycine 0 CA--C 1.481 -2.049 0 CA-C-N 114.975 -1.011 . . . . 0.0 115.206 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 116.67 137.29 5.95 Favored Glycine 0 N--CA 1.42 -2.389 0 CA-C-N 113.652 -1.274 . . . . 0.0 110.048 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.2 124.47 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-O 121.942 0.877 . . . . 0.0 109.583 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -145.2 158.43 51.63 Favored Pre-proline 0 C--N 1.276 -2.629 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.299 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 3.7 Cg_exo -72.85 142.47 35.31 Favored 'Trans proline' 0 N--CA 1.437 -1.805 0 C-N-CA 122.053 1.835 . . . . 0.0 111.593 174.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.431 HG23 ' O ' ' B' ' 20' ' ' TYR . 29.9 m -118.34 156.7 20.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.496 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.489 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 27.3 m -97.82 126.98 50.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.416 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 20.6 mm -87.85 104.51 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.77 -18.69 6.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.364 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.613 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 0.0 OUTLIER -56.51 158.26 4.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -173.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.433 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 25.9 p-10 -71.51 -167.22 0.24 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 123.124 1.44 . . . . 0.0 112.835 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -90.65 -38.37 13.15 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.782 -2.008 . . . . 0.0 112.909 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 3.6 m -83.75 -27.51 28.86 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.127 -170.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -64.62 -37.51 94.49 Favored Glycine 0 C--O 1.202 -1.861 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.478 ' N ' HE22 ' B' ' 42' ' ' GLN . 9.9 p30 -83.82 -20.89 32.42 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.761 -0.775 . . . . 0.0 110.234 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.473 ' HB3' ' CD1' ' B' ' 49' ' ' TYR . 4.9 mptp? -76.2 -66.35 0.81 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.603 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.473 ' CD1' ' HB3' ' B' ' 48' ' ' LYS . 87.7 m-85 -95.18 -30.18 14.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.785 -171.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 23.5 m -93.45 154.35 41.29 Favored Pre-proline 0 C--N 1.292 -1.931 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.82 -16.51 8.88 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.56 1.507 . . . . 0.0 111.209 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 9.0 p -92.9 146.43 23.64 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.231 1.013 . . . . 0.0 112.868 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.613 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -142.34 138.79 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 123.649 0.593 . . . . 0.0 110.29 172.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.486 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -88.75 130.15 38.65 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 CA-C-O 121.742 0.782 . . . . 0.0 110.287 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.25 168.2 22.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.424 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.489 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -124.02 146.74 48.33 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.35 136.37 37.68 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.477 HD13 ' HB2' ' B' ' 37' ' ' PRO . 20.8 mt -88.49 127.25 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.14 -1.391 . . . . 0.0 107.352 172.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 60.2 m -117.77 160.33 21.53 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.911 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.984 179.481 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.5 ' C ' ' H ' ' B' ' 69' ' ' THR 0.602 24.1 mm . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 120.24 3.422 . . . . 0.0 120.24 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.35 2.32 0.94 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 CA-C-N 121.691 1.64 . . . . 0.0 113.991 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' THR . . . . . 0.5 ' H ' ' C ' ' B' ' 67' ' ' ILE . 28.8 p -132.39 -11.94 3.15 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.768 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -135.48 129.21 32.8 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -173.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 p -131.35 133.17 62.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.648 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.86 125.76 29.8 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.498 HD12 ' CD2' ' B' ' 78' ' ' TYR . 12.3 pt -99.28 133.37 42.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.692 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -64.62 117.28 7.18 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 123.848 0.717 . . . . 0.0 110.39 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' B' ' 81' ' ' ASP . 21.2 pttp -53.65 -38.92 64.59 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.28 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -69.07 -19.28 64.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.546 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -91.61 -35.15 14.4 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.865 0.84 . . . . 0.0 109.106 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.498 ' CD2' HD12 ' B' ' 73' ' ' ILE . 17.1 m-85 -93.3 7.79 42.96 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.548 -173.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 23.2 tptm 61.42 23.41 13.67 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 121.802 0.81 . . . . 0.0 109.996 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 29.3 mt -100.6 177.08 5.11 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.485 0.659 . . . . 0.0 111.058 -174.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' B' ' 75' ' ' LYS . 20.3 t70 -83.21 -47.74 11.23 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.913 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -128.96 159.15 36.77 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.835 -175.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.73 145.22 52.45 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.498 ' O ' HG12 ' B' ' 73' ' ' ILE . 0.3 OUTLIER -129.31 158.79 38.11 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -173.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -110.23 140.59 28.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.477 ' CD1' HG12 ' B' ' 58' ' ' ILE . 22.9 mm -105.01 136.14 40.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 35.6 mt -104.79 105.55 15.67 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.4 ' HG ' ' HB1' ' B' ' 117' ' ' ALA . 3.5 mm? -87.68 11.97 13.88 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.006 0.907 . . . . 0.0 111.324 -174.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -110.62 -34.25 6.34 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.178 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.05 66.58 3.57 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.585 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.9 pp -102.59 174.24 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.543 ' NH1' HD21 ' B' ' 24' ' ' LEU . 10.4 ptt180 -164.53 154.54 14.11 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 49.5 m -113.41 120.69 41.95 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.013 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 58.7 mt -131.43 144.47 51.21 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.825 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -71.4 152.37 43.2 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.0 174.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -50.57 -25.49 4.18 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -81.44 -18.83 43.94 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.341 0.519 . . . . 0.0 110.93 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.429 ' NH1' ' HB3' ' B' ' 23' ' ' ASP . 3.3 mmp_? -69.17 -33.89 74.09 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' B' ' 21' ' ' LEU . 7.8 mp -73.54 124.15 25.33 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.361 173.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -99.02 -53.52 3.24 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.098 -1.41 . . . . 0.0 114.68 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 13.5 pt-20 -154.92 138.78 16.26 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 122.085 0.945 . . . . 0.0 113.163 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.77 112.25 2.2 Favored 'General case' 0 C--N 1.282 -2.354 0 C-N-CA 128.66 2.784 . . . . 0.0 107.358 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -112.2 -62.77 1.52 Allowed 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.244 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.528 HG23 HG22 ' B' ' 19' ' ' VAL . 6.7 t -125.59 -157.97 0.82 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.204 -1.398 . . . . 0.0 111.486 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -156.34 152.94 28.22 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 124.311 1.044 . . . . 0.0 111.005 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.433 HD22 ' HH ' ' B' ' 78' ' ' TYR . 0.7 OUTLIER -105.1 151.54 23.88 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.289 -178.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 19.8 m -90.43 166.79 13.07 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' B' ' 111' ' ' MET . 33.8 t70 -67.44 -34.28 76.89 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.029 0.442 . . . . 0.0 111.23 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -62.11 -46.71 87.86 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.613 ' O ' HG21 ' B' ' 114' ' ' VAL . 11.9 tptt -62.86 -32.07 73.22 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.539 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -51.62 -47.94 63.47 Favored 'General case' 0 CA--C 1.445 -3.074 0 CA-C-O 121.245 0.545 . . . . 0.0 109.867 169.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.4 ' CE ' ' HA ' ' B' ' 112' ' ' LYS . 8.3 mmpt? -74.88 -14.06 60.62 Favored 'General case' 0 N--CA 1.384 -3.767 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . 0.252 31.6 mt-10 -87.17 -56.61 3.3 Favored 'General case' 0 N--CA 1.386 -3.633 0 C-N-CA 116.763 -1.975 . . . . 0.0 111.234 168.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.613 HG21 ' O ' ' B' ' 110' ' ' LYS . 36.0 m -60.56 -47.81 91.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.95 -50.87 71.65 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 123.365 1.555 . . . . 0.0 109.665 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.316 26.9 t30 -73.2 -40.47 64.73 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-N 112.1 -2.318 . . . . 0.0 112.792 -172.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.4 ' HB1' ' HG ' ' B' ' 88' ' ' LEU . . . -62.38 -40.04 95.15 Favored 'General case' 0 CA--C 1.46 -2.484 0 CA-C-O 122.225 1.012 . . . . 0.0 108.666 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.56 -25.28 41.65 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.739 -173.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 1.8 ttp -63.47 -27.5 69.33 Favored 'General case' 0 N--CA 1.399 -3.014 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.47 HG22 ' ND2' ' B' ' 125' ' ' ASN . 64.1 mt -83.98 -56.99 4.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 21.9 t -47.09 -43.45 20.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.216 1.406 . . . . 0.0 112.283 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.466 ' HG ' HG21 ' A' ' 54' ' ' ILE . 8.2 mp -82.2 5.36 20.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . 0.406 ' CA ' ' HB3' ' A' ' 43' ' ' ASN . . . 89.66 1.39 77.49 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 117.862 1.905 . . . . 0.0 117.862 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 119' ' ' MET . 1.1 mm? -67.41 -49.58 63.18 Favored 'General case' 0 C--O 1.249 1.048 0 CA-C-N 120.271 2.035 . . . . 0.0 107.749 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.47 ' ND2' HG22 ' B' ' 120' ' ' ILE . 1.5 t-20 . . . . . 0 N--CA 1.439 -1.016 0 CA-C-N 112.514 -2.13 . . . . 0.0 113.01 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.48 ' HA ' ' HH ' ' A' ' 20' ' ' TYR . 59.3 mt . . . . . 0 N--CA 1.438 -1.029 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.3 mmt-85 -117.22 152.75 34.16 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -64.25 122.0 15.61 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 113.33 -11.97 23.88 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.12 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -78.01 156.55 30.07 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 122.108 0.956 . . . . 0.0 110.123 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 93.3 t -116.24 118.81 60.0 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.391 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.345 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 44.2 m-85 -116.43 138.98 50.93 Favored 'General case' 0 C--O 1.181 -2.509 0 C-N-CA 126.072 1.749 . . . . 0.0 111.207 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.8 mp -82.48 147.87 28.46 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 121.392 0.615 . . . . 0.0 109.9 169.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -144.0 142.17 30.55 Favored 'General case' 0 C--N 1.274 -2.717 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.985 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.24 95.27 5.61 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 123.059 1.409 . . . . 0.0 110.256 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.804 ' O ' HG11 ' A' ' 27' ' ' VAL . 66.7 mt -88.42 -14.58 37.67 Favored 'General case' 0 C--O 1.177 -2.763 0 CA-C-N 113.214 -1.812 . . . . 0.0 112.554 -175.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.421 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 4.6 p -87.3 56.48 0.0 OUTLIER Pre-proline 0 C--N 1.256 -3.497 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -127.63 41.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 124.216 3.277 . . . . 0.0 106.709 142.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.804 HG11 ' O ' ' A' ' 24' ' ' LEU . 6.6 m -69.02 176.16 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.467 HE22 ' HB2' ' B' ' 26' ' ' PRO . 35.7 mm-40 -89.71 109.69 20.64 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.462 -1.699 . . . . 0.0 112.5 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.97 -108.56 0.56 Allowed Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.262 -1.335 . . . . 0.0 114.924 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.8 m -89.15 17.92 5.5 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 39.1 mt-10 -67.76 -175.06 0.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.969 172.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -99.09 121.17 40.63 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.78 164.29 13.9 Favored Glycine 0 CA--C 1.478 -2.252 0 CA-C-O 122.012 0.784 . . . . 0.0 114.99 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 115.68 156.71 11.07 Favored Glycine 0 N--CA 1.419 -2.48 0 CA-C-N 113.431 -1.385 . . . . 0.0 109.666 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -82.74 100.48 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.342 0 CA-C-O 123.904 1.811 . . . . 0.0 107.604 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -127.26 161.34 54.89 Favored Pre-proline 0 C--N 1.255 -3.502 0 CA-C-N 112.253 -2.249 . . . . 0.0 108.888 -170.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 5.2 Cg_exo -76.74 142.07 22.4 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 C-N-CA 121.772 1.648 . . . . 0.0 112.146 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 20' ' ' TYR . 27.6 m -119.84 156.81 22.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 124.419 1.087 . . . . 0.0 108.475 177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 m -105.57 133.82 48.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.3 mm -81.85 103.24 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -98.37 -19.22 6.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.777 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.568 HE22 ' N ' ' A' ' 47' ' ' ASN . 3.1 tt0 -57.05 163.8 1.9 Allowed 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 125.51 1.524 . . . . 0.0 114.567 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.512 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 27.4 p-10 -65.85 177.76 1.23 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.539 -1.664 . . . . 0.0 112.423 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.38 -41.56 56.06 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.556 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.8 m -85.28 -26.36 26.68 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.484 -171.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.3 -33.21 79.61 Favored Glycine 0 C--O 1.213 -1.214 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.568 ' N ' HE22 ' A' ' 42' ' ' GLN 0.262 6.7 p30 -69.63 -18.97 63.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -92.35 -68.02 0.82 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.106 0.479 . . . . 0.0 110.297 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -91.89 -16.24 26.96 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -165.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.5 m -90.73 133.83 31.74 Favored Pre-proline 0 N--CA 1.417 -2.105 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -65.68 -27.97 52.5 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 121.752 1.635 . . . . 0.0 108.698 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -94.35 137.98 32.87 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 113.333 -1.758 . . . . 0.0 112.115 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.527 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 90.4 t -122.06 140.16 46.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.523 HG21 ' CD2' ' B' ' 122' ' ' LEU . 1.5 tp -106.09 125.73 61.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-O 121.7 0.762 . . . . 0.0 110.943 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.34 171.11 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.103 -176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.483 ' CB ' HG21 ' A' ' 91' ' ' ILE . . . -124.78 142.83 51.15 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.434 ' HB1' HH11 ' A' ' 92' ' ' ARG . . . -84.18 142.53 30.26 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.564 HG12 ' CD1' ' A' ' 86' ' ' ILE . 16.2 mt -85.59 138.49 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.963 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 m -119.79 134.75 55.12 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.439 0 CA-C-O 121.36 0.422 . . . . 0.0 112.567 -179.484 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 tt . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.92 -3.61 0.71 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 124.048 3.165 . . . . 0.0 116.435 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.4 p -90.45 -18.96 24.47 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 118.921 0.782 . . . . 0.0 109.641 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -86.25 129.59 34.8 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.065 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.44 120.6 59.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -86.08 132.34 34.06 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.478 HD11 ' CG ' ' A' ' 78' ' ' TYR . 2.8 pp -84.6 157.33 3.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.987 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HG2' ' CG ' ' A' ' 76' ' ' LYS . 19.8 tt0 -77.59 107.88 10.37 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 81' ' ' ASP . 62.7 pttt -55.22 -42.17 73.0 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.453 ' CG ' ' HG2' ' A' ' 74' ' ' GLU . 11.1 ptmm? -59.02 -32.75 70.01 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.222 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -91.39 -26.7 18.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.681 0.753 . . . . 0.0 109.84 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.478 ' CG ' HD11 ' A' ' 73' ' ' ILE . 2.8 m-85 -80.44 2.7 24.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.274 -178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 71.63 20.65 4.64 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.502 1.121 . . . . 0.0 111.068 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 mt -110.89 168.57 9.38 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.852 0.834 . . . . 0.0 111.248 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.444 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 14.7 t70 -93.2 -35.36 13.18 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.928 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -119.65 145.81 46.13 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.076 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 8.4 p-10 -76.08 147.39 38.68 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.389 0.614 . . . . 0.0 110.113 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.2 t -112.57 175.9 5.24 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.06 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 t -127.76 141.41 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.564 ' CD1' HG12 ' A' ' 58' ' ' ILE . 25.1 mm -109.36 133.36 54.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.5 mt -102.52 107.54 18.54 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.52 15.63 1.25 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.789 0.835 . . . . 0.0 112.46 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.27 -39.79 3.01 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.649 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -83.68 51.96 2.15 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 125.332 1.453 . . . . 0.0 108.237 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.483 HG21 ' CB ' ' A' ' 56' ' ' ALA . 2.0 pp -96.29 -179.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.63 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.436 ' O ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -168.0 163.13 13.62 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 18.6 m -117.77 119.93 36.39 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.414 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.2 mt -131.44 137.75 48.76 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.895 -171.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -74.35 153.16 39.42 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.445 175.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -38.99 -36.76 0.31 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 126.231 1.812 . . . . 0.0 112.837 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -64.52 -22.34 66.94 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.943 0.897 . . . . 0.0 111.54 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.7 mmp_? -79.83 -33.54 40.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.257 0.551 . . . . 0.0 109.577 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.53 101.89 4.33 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 122.601 1.191 . . . . 0.0 111.715 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -86.7 -65.09 1.05 Allowed 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 113.518 -1.674 . . . . 0.0 115.13 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 9.3 pt-20 -139.46 126.66 21.25 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 18.8 ptmt -71.45 114.07 9.14 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.319 -1.764 . . . . 0.0 110.986 171.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.6 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 24.0 tp -103.49 -56.73 2.16 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.005 -173.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.6 ' OG1' ' HG ' ' A' ' 103' ' ' LEU 0.285 3.5 m -135.42 -174.05 3.52 Favored 'General case' 0 N--CA 1.391 -3.384 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.573 -165.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.533 ' H ' ' CG2' ' A' ' 104' ' ' THR . 0.6 OUTLIER -160.64 134.93 7.24 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.489 1.516 . . . . 0.0 110.92 -166.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.59 153.4 22.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.345 0.658 . . . . 0.0 112.539 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.0 m -75.87 159.7 30.68 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.888 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 111' ' ' MET . 38.1 t70 -58.45 -51.93 67.76 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.426 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 3.5 p-10 -73.14 -26.69 61.3 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.717 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -67.41 -27.26 66.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.585 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.408 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -57.38 -39.78 76.78 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 123.527 0.731 . . . . 0.0 110.473 174.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.577 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -74.11 -19.8 60.46 Favored 'General case' 0 CA--C 1.483 -1.622 0 C-N-CA 123.245 0.618 . . . . 0.0 111.386 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.485 ' HA ' ' ND2' ' A' ' 116' ' ' ASN . 21.0 mt-10 -85.83 -36.87 19.76 Favored 'General case' 0 N--CA 1.399 -2.983 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.68 -46.77 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-N 113.153 -1.84 . . . . 0.0 109.829 170.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.468 ' OD2' ' HA ' ' A' ' 112' ' ' LYS . 37.4 m-20 -60.21 -57.74 11.49 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.88 0.848 . . . . 0.0 109.976 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.495 ' O ' HG13 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -64.88 -39.43 93.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.624 -172.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.99 -40.26 84.3 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 2.8 tp -68.36 -38.02 81.03 Favored 'General case' 1 N--CA 1.365 -4.705 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.356 -175.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 46.2 mtp -66.17 -29.67 70.0 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 121.755 -0.59 . . . . 0.0 111.261 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 116' ' ' ASN . 26.5 mt -77.33 -54.35 12.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.5 t -52.67 -36.81 57.68 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.565 -1.652 . . . . 0.0 111.358 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.522 ' HB3' ' CD1' ' B' ' 41' ' ' ILE . 42.0 mt -101.49 7.32 42.48 Favored 'General case' 0 N--CA 1.428 -1.529 0 O-C-N 121.961 -0.462 . . . . 0.0 111.512 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.91 75.24 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 116.794 1.478 . . . . 0.0 116.794 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -78.46 -46.94 18.51 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 118.829 1.315 . . . . 0.0 109.292 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.438 -1.053 0 CA-C-N 113.274 -1.785 . . . . 0.0 110.229 -172.241 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . 0.42 ' HA ' ' HH ' ' B' ' 20' ' ' TYR . 66.0 mt . . . . . 0 N--CA 1.445 -0.716 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.9 mmt-85 -119.44 154.56 33.52 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -64.27 120.36 12.01 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 116.46 -13.93 15.53 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.998 -178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -75.67 155.05 36.14 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.33 1.062 . . . . 0.0 110.844 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 89.9 t -115.56 118.59 59.28 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.516 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.894 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.569 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 48.2 m-85 -115.52 140.44 49.15 Favored 'General case' 0 CA--C 1.455 -2.707 0 C-N-CA 125.986 1.714 . . . . 0.0 110.671 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -82.34 148.68 28.15 Favored 'General case' 0 N--CA 1.392 -3.33 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.782 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -146.07 143.6 29.5 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.733 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' B' ' 25' ' ' SER . 4.8 p-10 -75.52 93.1 2.95 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 122.325 1.059 . . . . 0.0 110.001 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.701 ' O ' HG11 ' B' ' 27' ' ' VAL . 69.5 mt -89.6 21.8 3.3 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -176.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.507 ' HB2' ' HD2' ' B' ' 26' ' ' PRO 0.264 5.4 p -79.54 -165.62 0.07 OUTLIER Pre-proline 0 N--CA 1.39 -3.427 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 176.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' B' ' 25' ' ' SER . 31.7 Cg_exo 18.39 40.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.42 1 C-N-CA 125.385 4.057 . . . . 0.0 118.193 -156.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.701 HG11 ' O ' ' B' ' 24' ' ' LEU . 7.0 m -70.56 177.8 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 122.213 1.006 . . . . 0.0 112.786 174.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -90.08 109.15 20.22 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.117 -1.401 . . . . 0.0 112.724 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.39 -108.49 0.31 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.69 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -87.28 17.65 4.25 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.0 -170.57 0.11 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 118.87 0.759 . . . . 0.0 111.292 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -103.67 118.85 37.68 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.88 167.04 16.91 Favored Glycine 0 CA--C 1.473 -2.583 0 CA-C-O 122.218 0.899 . . . . 0.0 115.306 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 113.36 154.2 11.42 Favored Glycine 0 N--CA 1.408 -3.191 0 CA-C-N 112.861 -1.669 . . . . 0.0 109.719 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.401 ' O ' HG11 ' B' ' 35' ' ' VAL . 3.1 p -80.84 103.05 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-O 123.167 1.46 . . . . 0.0 107.287 177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -130.54 161.71 59.15 Favored Pre-proline 0 C--N 1.254 -3.582 0 CA-C-N 113.267 -1.788 . . . . 0.0 108.949 -170.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 4.7 Cg_exo -75.57 141.81 25.49 Favored 'Trans proline' 0 N--CA 1.431 -2.193 0 C-N-CA 121.812 1.675 . . . . 0.0 112.33 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -120.86 156.95 24.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 124.568 1.147 . . . . 0.0 108.512 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 m -105.46 133.6 49.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.502 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 30.6 mm -81.69 102.02 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.3 -19.31 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.637 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.577 HE22 ' N ' ' B' ' 47' ' ' ASN . 2.6 tt0 -56.67 162.19 2.41 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 125.462 1.505 . . . . 0.0 114.475 -173.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.525 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 21.8 p-10 -63.8 -175.86 0.16 Allowed 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.472 -1.694 . . . . 0.0 112.492 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.76 -42.73 17.6 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.63 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 9.7 m -85.15 -26.17 27.0 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.545 -170.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.1 -34.49 84.08 Favored Glycine 0 C--O 1.217 -0.909 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.577 ' N ' HE22 ' B' ' 42' ' ' GLN 0.264 8.8 p30 -69.1 -18.77 64.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -92.65 -67.37 0.86 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.231 0.539 . . . . 0.0 110.782 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -93.43 -11.79 31.33 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -166.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 69.4 m -94.65 134.47 25.16 Favored Pre-proline 0 N--CA 1.42 -1.943 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.55 -27.51 39.09 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 121.872 1.715 . . . . 0.0 109.044 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.7 p -94.82 137.7 33.57 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.834 -174.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.504 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 89.4 t -121.86 140.21 46.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.516 HG21 ' CD2' ' A' ' 122' ' ' LEU . 1.4 tp -105.9 125.66 61.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-O 121.668 0.746 . . . . 0.0 111.257 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.32 172.44 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.994 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.492 ' CB ' HG21 ' B' ' 91' ' ' ILE . . . -127.03 142.5 51.53 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.45 ' HB1' HH11 ' B' ' 92' ' ' ARG . . . -83.3 142.95 30.71 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.576 HG12 ' CD1' ' B' ' 86' ' ' ILE . 17.2 mt -88.31 135.36 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.442 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 38.3 m -116.16 134.78 54.55 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.454 0 CA-C-O 121.732 0.629 . . . . 0.0 112.327 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.15 -12.53 5.41 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 124.038 3.158 . . . . 0.0 116.258 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 59.2 p -83.95 -19.11 35.22 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.63 0.729 . . . . 0.0 109.829 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -85.38 129.1 34.89 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.09 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.91 121.67 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -87.77 133.5 33.86 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' B' ' 78' ' ' TYR . 2.8 pp -85.9 156.46 3.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.369 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.423 ' HG2' ' CG ' ' B' ' 76' ' ' LYS . 16.0 tt0 -76.26 107.45 8.51 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' B' ' 83' ' ' ASP . 62.2 pttt -56.25 -41.83 76.39 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . 0.423 ' CG ' ' HG2' ' B' ' 74' ' ' GLU . 10.8 ptmm? -59.71 -30.78 69.04 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.503 -1.226 . . . . 0.0 113.367 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -91.47 -31.18 16.08 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.561 0.696 . . . . 0.0 109.404 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.487 ' CG ' HD11 ' B' ' 73' ' ' ILE . 3.0 m-85 -76.39 1.3 16.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.442 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 74.55 12.78 3.77 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.994 1.318 . . . . 0.0 111.816 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 19.2 mt -104.46 168.48 9.06 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.873 0.844 . . . . 0.0 111.896 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -91.51 -35.85 14.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.131 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.28 147.85 44.46 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.636 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . 0.406 ' HA ' ' HB3' ' B' ' 75' ' ' LYS . 7.3 p-10 -76.84 147.97 36.81 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.157 0.503 . . . . 0.0 110.324 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -113.19 175.2 5.55 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.091 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t -126.82 141.79 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.576 ' CD1' HG12 ' B' ' 58' ' ' ILE . 25.0 mm -109.07 133.04 55.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 61.9 mt -102.22 107.07 18.01 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.994 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.01 14.02 1.56 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.821 0.849 . . . . 0.0 112.439 -174.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -116.61 -39.4 3.33 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.881 0.848 . . . . 0.0 108.944 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -84.04 52.0 2.2 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 125.229 1.412 . . . . 0.0 108.291 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.492 HG21 ' CB ' ' B' ' 56' ' ' ALA . 2.0 pp -96.46 -179.59 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.693 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.45 HH11 ' HB1' ' B' ' 57' ' ' ALA . 0.0 OUTLIER -167.92 163.12 13.8 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 17.9 m -118.1 119.59 35.21 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.48 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 51.4 mt -131.47 138.38 48.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.113 -171.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -74.03 152.9 39.89 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.707 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -38.27 -32.74 0.08 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 126.853 2.061 . . . . 0.0 113.697 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -69.31 -25.51 64.26 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.279 0.632 . . . . 0.0 110.901 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 2.1 mmp_? -76.41 -33.36 58.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -73.32 103.65 4.07 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.108 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -87.14 -61.88 1.63 Allowed 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.3 pt-20 -144.39 130.24 19.3 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.846 0.832 . . . . 0.0 113.003 -171.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . 0.521 ' HB3' ' CZ ' ' B' ' 20' ' ' TYR . 19.4 ptmt -73.75 110.84 8.36 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.111 173.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.617 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 23.9 tp -101.48 -56.63 2.25 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.796 -172.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.617 ' OG1' ' HG ' ' B' ' 103' ' ' LEU 0.285 4.1 m -134.48 -175.0 3.73 Favored 'General case' 0 N--CA 1.387 -3.613 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.31 -166.016 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.551 ' H ' ' CG2' ' B' ' 104' ' ' THR . 0.4 OUTLIER -160.6 134.96 7.3 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.476 1.51 . . . . 0.0 110.383 -166.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 11.1 mt -85.67 157.3 20.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.523 0.729 . . . . 0.0 112.517 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 2.3 m -78.97 165.5 23.4 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.775 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' B' ' 111' ' ' MET . 27.8 t70 -61.29 -53.01 62.23 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 3.7 p-10 -72.35 -28.52 63.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.446 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -66.51 -26.9 67.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.748 0.308 . . . . 0.0 111.221 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.442 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -59.03 -40.03 83.78 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.199 0.599 . . . . 0.0 110.397 173.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.587 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -75.37 -16.91 60.34 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.056 0.455 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . 0.452 ' HA ' ' ND2' ' B' ' 116' ' ' ASN . 48.7 mt-10 -84.54 -38.32 20.15 Favored 'General case' 0 CA--C 1.443 -3.152 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.28 -48.55 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.994 0 CA-C-N 112.685 -2.052 . . . . 0.0 110.022 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.52 ' OD2' ' HA ' ' B' ' 112' ' ' LYS . 49.0 m-20 -59.56 -59.02 6.11 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.726 0.774 . . . . 0.0 110.461 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 0.5 OUTLIER -64.82 -37.55 88.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.017 -172.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.15 -39.45 86.38 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.498 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 3.0 tp -69.78 -38.26 76.64 Favored 'General case' 1 N--CA 1.366 -4.661 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.984 -175.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 48.4 mtp -65.52 -34.77 79.04 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 121.769 -0.582 . . . . 0.0 110.927 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.441 HG13 ' O ' ' B' ' 116' ' ' ASN . 23.7 mt -71.89 -53.95 18.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 20.3 t -52.76 -35.78 56.85 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.784 1.234 . . . . 0.0 111.443 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.523 ' CD2' HG21 ' A' ' 54' ' ' ILE . 39.8 mt -102.34 6.54 40.41 Favored 'General case' 0 N--CA 1.428 -1.548 0 O-C-N 121.894 -0.504 . . . . 0.0 111.508 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.26 20.69 76.88 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.48 -49.31 15.03 Favored 'General case' 0 CA--C 1.478 -1.791 0 CA-C-N 118.876 1.338 . . . . 0.0 109.056 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.437 -1.083 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.148 -172.108 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.437 ' HB ' ' OD1' ' A' ' 47' ' ' ASN . 65.1 mt . . . . . 0 N--CA 1.444 -0.761 0 CA-C-O 121.196 0.522 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -103.28 138.82 39.54 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -76.59 134.43 39.37 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.353 -1.339 . . . . 0.0 108.334 173.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.31 -5.53 55.42 Favored Glycine 0 C--N 1.302 -1.356 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.93 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.25 166.69 11.78 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.582 0.706 . . . . 0.0 110.114 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 37.4 t -120.05 133.7 65.95 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.422 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 44.4 m-85 -136.67 147.34 46.77 Favored 'General case' 0 CA--C 1.469 -2.165 0 C-N-CA 124.623 1.169 . . . . 0.0 107.957 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.7 mp -74.42 148.86 40.77 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.087 171.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -143.63 135.3 26.3 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.097 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.19 94.46 3.53 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.77 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.618 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.2 mt -89.45 5.0 47.26 Favored 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 124.776 1.23 . . . . 0.0 110.086 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.453 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 4.6 m -52.96 -177.66 0.04 OUTLIER Pre-proline 1 C--N 1.241 -4.142 0 C-N-CA 126.817 2.047 . . . . 0.0 113.283 174.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 19.97 35.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.41 3.784 1 C-N-CA 125.716 4.277 . . . . 0.0 119.465 -157.956 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 24' ' ' LEU . 5.8 m -70.89 173.47 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.565 168.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -111.71 141.4 45.36 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.89 -111.87 1.43 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 114.786 -1.097 . . . . 0.0 115.023 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -94.16 4.4 53.94 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 123.425 0.69 . . . . 0.0 112.697 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 77.2 mt-10 -64.05 144.0 57.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.502 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 5.8 tp60 -117.73 111.47 19.16 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -170.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -126.64 -109.44 1.63 Allowed Glycine 1 N--CA 1.383 -4.844 0 C-N-CA 118.361 -1.876 . . . . 0.0 116.453 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 75.97 177.08 41.9 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 -168.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 35' ' ' VAL . 4.5 p -91.44 106.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.288 0 O-C-N 120.617 -1.519 . . . . 0.0 108.897 176.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.502 ' NH2' ' HG3' ' A' ' 32' ' ' GLN . 62.8 mtm180 -135.17 157.8 76.07 Favored Pre-proline 0 C--N 1.275 -2.672 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.648 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 31.9 Cg_exo -66.12 138.55 52.34 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.098 2.532 . . . . 0.0 112.132 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 20' ' ' TYR . 20.5 m -126.35 164.03 27.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 C-N-CA 123.5 0.72 . . . . 0.0 110.234 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 27.4 m -105.73 134.5 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.9 mm -95.01 118.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 123.093 0.557 . . . . 0.0 110.195 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -8.62 12.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.587 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.465 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 5.9 pt20 -63.42 165.66 7.49 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -167.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -75.29 -173.14 1.95 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 111.823 -2.444 . . . . 0.0 113.423 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -79.55 -43.98 22.01 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.076 -1.874 . . . . 0.0 113.411 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 m -86.19 -25.73 25.49 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -168.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.52 -20.97 78.74 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.457 ' N ' HE22 ' A' ' 42' ' ' GLN . 31.2 t-20 -72.86 -32.33 65.36 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.834 -1.183 . . . . 0.0 108.526 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -90.04 -66.73 0.9 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.534 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -98.81 -35.62 10.07 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -168.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.596 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 15.2 t -75.54 128.76 83.4 Favored Pre-proline 0 N--CA 1.435 -1.199 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.801 -174.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.548 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 61.2 Cg_endo -74.72 -11.75 22.05 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.985 1.79 . . . . 0.0 110.155 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 p -107.56 121.39 44.55 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.935 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.465 ' HB ' ' OE1' ' A' ' 42' ' ' GLN . 1.3 m -121.73 167.5 15.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.856 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 13.7 tt -108.29 125.07 65.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 123.575 0.75 . . . . 0.0 112.054 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.648 HG22 ' CD2' ' A' ' 94' ' ' LEU . 3.7 m -137.48 163.56 30.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.59 ' CA ' HG13 ' A' ' 91' ' ' ILE . . . -123.08 131.21 53.6 Favored 'General case' 0 N--CA 1.416 -2.16 0 O-C-N 123.365 0.416 . . . . 0.0 111.172 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.587 ' H ' ' CG1' ' A' ' 91' ' ' ILE . . . -66.0 130.63 43.91 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.467 HG12 ' CD1' ' A' ' 86' ' ' ILE . 56.4 mt -85.49 138.31 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 112.661 -2.063 . . . . 0.0 106.994 174.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.2 t -148.36 179.99 7.37 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.469 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.376 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.441 -0.899 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.4 9.34 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.254 1.969 . . . . 0.0 114.145 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.0 p -118.5 -6.49 10.71 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.083 0.468 . . . . 0.0 110.613 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.464 ' CD2' HD23 ' A' ' 87' ' ' LEU . 43.4 m170 -122.6 129.32 51.76 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.2 m -122.02 139.4 49.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.618 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -94.75 129.71 41.56 Favored 'General case' 0 C--O 1.251 1.177 0 CA-C-O 121.567 0.699 . . . . 0.0 111.081 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.573 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -120.6 158.57 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.23 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -79.18 128.65 33.57 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.681 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -47.48 -48.35 27.04 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 125.369 1.468 . . . . 0.0 110.699 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -56.35 -45.0 80.63 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 126.489 1.916 . . . . 0.0 112.64 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -71.79 -34.99 69.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.98 -175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.573 ' CE1' HG21 ' A' ' 73' ' ' ILE . 3.6 m-85 -95.3 -9.89 31.77 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.192 -176.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 61.46 29.95 18.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.883 1.273 . . . . 0.0 112.863 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 7.6 mp -88.73 -179.56 6.03 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.629 1.204 . . . . 0.0 112.973 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -73.7 -26.0 60.5 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.871 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -147.83 166.87 26.28 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -59.25 141.86 53.3 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 m -103.08 137.34 41.39 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.808 -168.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.42 137.62 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 58' ' ' ILE . 20.3 mm -116.17 138.44 46.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.464 HD23 ' CD2' ' A' ' 70' ' ' HIS . 36.6 mt -104.46 140.78 37.46 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.482 ' HG ' ' HB2' ' A' ' 117' ' ' ALA . 3.3 mm? -111.83 2.01 16.86 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 122.28 1.038 . . . . 0.0 111.27 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -99.98 -33.45 10.5 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.93 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.587 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . 1.1 tm0? -80.42 -2.71 46.84 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.861 -171.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.772 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -150.91 148.22 15.15 Favored 'Isoleucine or valine' 1 CA--C 1.421 -4.01 0 CA-C-O 117.516 -1.23 . . . . 0.0 112.651 -163.538 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.772 ' HG3' ' O ' ' A' ' 91' ' ' ILE 0.264 40.0 mtm-85 179.84 -53.04 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.767 1 N-CA-C 121.934 4.05 . . . . 0.0 121.934 -174.982 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.706 ' OG1' ' HB2' ' B' ' 92' ' ' ARG . 42.2 m -123.2 101.0 7.14 Favored 'General case' 0 N--CA 1.531 3.599 0 O-C-N 121.009 -1.057 . . . . 0.0 112.994 -170.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.648 ' CD2' HG22 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -132.1 126.11 32.96 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.646 -172.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 15.7 t0 -56.25 146.3 24.04 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.46 0.704 . . . . 0.0 111.375 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.596 ' HE2' ' O ' ' A' ' 50' ' ' SER . 67.8 mttm -53.95 -33.36 56.64 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.306 1.042 . . . . 0.0 111.692 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HG3' ' OD1' ' A' ' 95' ' ' ASP . 48.1 mttp -61.73 -22.16 65.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.28 0.632 . . . . 0.0 111.102 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 34.1 mtp180 -79.3 -37.85 36.72 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.2 mp -71.25 118.25 13.81 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.284 1.033 . . . . 0.0 111.242 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -99.2 -66.92 0.87 Allowed 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.3 pt-20 -156.11 144.46 19.96 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.475 0.655 . . . . 0.0 112.561 -165.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.633 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -65.38 119.89 11.81 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 128.243 2.617 . . . . 0.0 113.656 -178.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.505 HD23 HG13 ' A' ' 19' ' ' VAL 0.295 1.7 mm? -100.42 -64.1 1.07 Allowed 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 123.402 1.572 . . . . 0.0 110.405 174.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.568 ' CG2' ' H ' ' A' ' 105' ' ' TYR . 18.4 m -127.08 -178.96 4.62 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 111.608 -2.542 . . . . 0.0 111.871 -162.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.568 ' H ' ' CG2' ' A' ' 104' ' ' THR . 12.8 p90 -160.77 131.6 5.42 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.999 1.72 . . . . 0.0 110.473 -172.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -107.22 162.19 14.1 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.295 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 p -90.22 170.5 10.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.571 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 111' ' ' MET . 6.7 p-10 -63.6 -30.83 71.88 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.789 0.836 . . . . 0.0 112.901 -173.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -69.32 -36.86 77.39 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.52 0.676 . . . . 0.0 110.157 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 114' ' ' VAL . 72.3 mmtt -78.28 -29.73 48.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.877 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.498 ' HA ' ' HE2' ' A' ' 111' ' ' MET . 0.2 OUTLIER -52.69 -42.61 64.95 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 124.122 0.969 . . . . 0.0 109.483 169.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.515 ' CE ' ' HA ' ' A' ' 112' ' ' LYS . 7.2 mmpt? -68.04 -46.74 70.32 Favored 'General case' 1 N--CA 1.377 -4.119 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.27 -34.19 76.89 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 118.661 -1.216 . . . . 0.0 111.761 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 110' ' ' LYS . 20.9 m -71.24 -45.3 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.276 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.36 -52.87 62.99 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.365 0.602 . . . . 0.0 110.153 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . 0.326 51.2 m-20 -60.86 -52.87 63.23 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.91 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.482 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -51.32 -39.8 57.71 Favored 'General case' 0 CA--C 1.461 -2.472 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.748 -174.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.685 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 1.6 tp -68.43 -46.09 70.8 Favored 'General case' 1 N--CA 1.362 -4.84 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.455 -179.24 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 43.4 mtp -64.81 -34.59 78.72 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 56.4 mt -63.45 -52.7 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.6 t -53.91 -21.48 7.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.973 -1.921 . . . . 0.0 112.735 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 34.4 mt -111.36 -5.6 14.62 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.444 ' N ' ' HB3' ' B' ' 43' ' ' ASN . . . 76.63 23.97 68.76 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.399 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.422 ' HB3' ' SD ' ' B' ' 119' ' ' MET . 58.0 mt -83.02 -59.65 2.41 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.833 0.349 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -105.0 134.46 48.06 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -74.85 123.8 25.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 118.611 -1.235 . . . . 0.0 109.165 174.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.29 -5.98 28.51 Favored Glycine 0 C--N 1.301 -1.411 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.763 -176.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.29 165.23 12.49 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 121.574 0.702 . . . . 0.0 109.679 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 35.7 t -118.48 133.0 66.7 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.523 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.636 ' O ' HG23 ' B' ' 38' ' ' VAL . 39.6 m-85 -135.82 146.5 47.6 Favored 'General case' 0 C--O 1.188 -2.165 0 C-N-CA 124.857 1.263 . . . . 0.0 108.411 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 1.8 mp -74.32 148.94 40.91 Favored 'General case' 0 N--CA 1.407 -2.61 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.989 171.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -144.42 136.21 25.93 Favored 'General case' 0 C--N 1.264 -3.133 0 O-C-N 124.416 1.073 . . . . 0.0 110.163 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.87 94.4 3.33 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.082 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 9.5 mt -89.36 4.74 47.96 Favored 'General case' 0 C--O 1.199 -1.6 0 C-N-CA 124.6 1.16 . . . . 0.0 110.222 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.446 ' CB ' ' HD2' ' B' ' 26' ' ' PRO . 4.1 m -53.96 -177.11 0.04 OUTLIER Pre-proline 1 C--N 1.241 -4.132 0 C-N-CA 126.733 2.013 . . . . 0.0 112.564 173.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' B' ' 25' ' ' SER . 0.0 OUTLIER 20.17 35.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.405 3.549 1 C-N-CA 125.942 4.428 . . . . 0.0 119.414 -157.511 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 3.7 m -71.08 172.85 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.1 167.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -112.27 135.61 52.73 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.75 -112.15 4.12 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 114.785 -1.098 . . . . 0.0 114.362 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -93.43 -0.43 56.48 Favored 'General case' 0 N--CA 1.417 -2.102 0 C-N-CA 123.405 0.682 . . . . 0.0 112.275 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 77.4 mt-10 -61.14 141.1 57.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . 0.497 ' HG3' ' NH2' ' B' ' 36' ' ' ARG . 5.3 tp60 -116.05 112.81 22.31 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -169.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -127.95 -106.77 1.36 Allowed Glycine 1 N--CA 1.378 -5.208 0 C-N-CA 118.149 -1.977 . . . . 0.0 116.688 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 74.48 175.44 34.09 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 107.663 -2.175 . . . . 0.0 107.663 -168.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 p -89.19 108.98 19.72 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.393 0 O-C-N 120.475 -1.603 . . . . 0.0 108.73 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . 0.497 ' NH2' ' HG3' ' B' ' 32' ' ' GLN . 65.1 mtm180 -137.76 157.72 72.94 Favored Pre-proline 0 C--N 1.281 -2.397 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.429 -174.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.3 Cg_exo -66.29 138.65 51.9 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.061 2.507 . . . . 0.0 111.902 173.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.636 HG23 ' O ' ' B' ' 20' ' ' TYR . 20.6 m -126.9 162.71 31.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 123.74 0.816 . . . . 0.0 110.074 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.415 ' CG2' ' HB2' ' B' ' 56' ' ' ALA . 27.1 m -104.57 134.28 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 31.9 mm -94.23 118.64 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 122.835 0.454 . . . . 0.0 110.054 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 -8.8 12.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.577 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.461 HE22 ' N ' ' B' ' 47' ' ' ASN . 6.3 pt20 -63.51 165.71 7.6 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 -167.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.444 ' HB3' ' N ' ' A' ' 123' ' ' GLY . 14.3 p-10 -77.46 -174.19 3.23 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 112.088 -2.324 . . . . 0.0 113.413 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' B' ' 47' ' ' ASN . 2.7 t70 -72.44 -47.4 49.24 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 112.837 -1.983 . . . . 0.0 113.909 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -86.65 -25.71 24.73 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -165.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.75 -21.23 77.91 Favored Glycine 0 C--O 1.218 -0.889 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.461 ' N ' HE22 ' B' ' 42' ' ' GLN . 39.1 t-20 -72.77 -32.04 65.32 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.703 -1.248 . . . . 0.0 108.259 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.407 ' HZ2' ' CG ' ' B' ' 44' ' ' ASP . 24.0 mttt -91.64 -65.38 1.01 Allowed 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -100.15 -35.56 9.62 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -168.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.577 ' O ' ' HE2' ' B' ' 96' ' ' LYS . 14.6 t -76.93 132.23 71.62 Favored Pre-proline 0 N--CA 1.433 -1.323 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 62.3 Cg_endo -77.53 -11.12 17.25 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.792 1.661 . . . . 0.0 110.154 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 1.9 p -106.38 121.83 45.03 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.745 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.45 ' HB ' ' OE1' ' B' ' 42' ' ' GLN . 1.3 m -121.82 167.96 14.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.71 ' HA ' ' O ' ' B' ' 92' ' ' ARG . 13.8 tt -109.2 125.24 66.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 123.695 0.798 . . . . 0.0 112.099 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.644 HG22 ' CD2' ' B' ' 94' ' ' LEU . 3.7 m -137.72 163.97 29.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.593 ' CA ' HG13 ' B' ' 91' ' ' ILE . . . -123.47 130.8 53.22 Favored 'General case' 0 N--CA 1.415 -2.176 0 O-C-N 123.387 0.429 . . . . 0.0 111.317 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.577 ' H ' ' CG1' ' B' ' 91' ' ' ILE . . . -65.04 132.69 49.88 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.467 HG12 ' CD1' ' B' ' 86' ' ' ILE . 57.6 mt -89.26 134.08 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 112.645 -2.07 . . . . 0.0 107.346 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -144.88 179.68 7.17 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.887 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.567 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -69.35 9.79 0.49 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.135 1.89 . . . . 0.0 113.599 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 72.9 p -117.61 -7.85 11.0 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.079 0.466 . . . . 0.0 110.748 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . 0.579 ' CD2' HD23 ' B' ' 87' ' ' LEU . 61.9 m170 -123.23 129.34 51.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.19 139.72 48.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.541 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -97.11 130.6 44.36 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.698 0.761 . . . . 0.0 111.439 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.573 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -123.54 154.2 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.666 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -74.77 127.04 32.21 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.197 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -45.95 -44.76 15.09 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.173 1.389 . . . . 0.0 111.5 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -59.86 -45.31 92.86 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 126.392 1.877 . . . . 0.0 112.478 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -72.41 -35.19 68.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.93 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.573 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.8 m-85 -95.78 -6.02 40.57 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.704 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 57.06 31.68 20.36 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.439 1.096 . . . . 0.0 112.864 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.476 ' CD1' ' HB3' ' B' ' 78' ' ' TYR . 6.8 mp -87.8 -178.82 6.14 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.652 1.215 . . . . 0.0 112.844 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -75.51 -25.42 57.26 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.935 -1.939 . . . . 0.0 109.735 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -148.04 168.79 21.43 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -60.34 144.42 50.72 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.098 0.475 . . . . 0.0 109.826 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 8.0 m -103.25 136.79 42.37 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.61 -168.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.29 135.87 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' B' ' 58' ' ' ILE . 21.0 mm -114.89 138.1 46.23 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.834 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.579 HD23 ' CD2' ' B' ' 70' ' ' HIS . 31.4 mt -104.25 141.32 36.49 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.474 ' HB3' ' HA ' ' B' ' 118' ' ' LEU . 3.4 mm? -111.59 1.42 16.82 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-O 122.173 0.987 . . . . 0.0 111.296 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -100.77 -33.44 10.25 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.021 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . 0.579 ' HB3' HD12 ' B' ' 91' ' ' ILE . 1.0 OUTLIER -81.24 -2.03 47.21 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.531 -171.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.764 ' O ' ' HG3' ' B' ' 92' ' ' ARG . 0.0 OUTLIER -150.8 147.68 15.59 Favored 'Isoleucine or valine' 1 CA--C 1.418 -4.103 0 CA-C-O 117.6 -1.19 . . . . 0.0 112.429 -163.715 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.764 ' HG3' ' O ' ' B' ' 91' ' ' ILE 0.273 41.2 mtm-85 179.83 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.752 1 N-CA-C 121.929 4.048 . . . . 0.0 121.929 -174.913 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.691 ' OG1' ' HB2' ' A' ' 92' ' ' ARG . 29.8 m -122.84 101.04 7.21 Favored 'General case' 0 N--CA 1.531 3.593 0 O-C-N 121.029 -1.044 . . . . 0.0 112.871 -171.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.644 ' CD2' HG22 ' B' ' 55' ' ' VAL . 0.1 OUTLIER -132.17 125.72 31.89 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.57 -173.155 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.54 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 11.0 t0 -56.94 147.47 23.71 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.439 0.696 . . . . 0.0 111.674 172.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.577 ' HE2' ' O ' ' B' ' 50' ' ' SER . 67.8 mttm -54.49 -33.0 58.99 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.455 1.102 . . . . 0.0 111.833 177.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.44 ' HG3' ' OD1' ' B' ' 95' ' ' ASP . 44.9 mttp -62.26 -23.36 66.65 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.257 0.623 . . . . 0.0 111.192 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 32.9 mtp180 -78.13 -38.51 43.64 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' B' ' 21' ' ' LEU . 8.1 mp -70.26 118.1 12.66 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 124.189 0.995 . . . . 0.0 111.121 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -97.41 -69.67 0.75 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.678 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.8 pt-20 -156.52 149.08 23.59 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.584 0.707 . . . . 0.0 112.476 -166.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . 0.616 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 2.3 ptmt -67.71 124.74 24.11 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 127.449 2.3 . . . . 0.0 114.93 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.505 HD23 HG13 ' B' ' 19' ' ' VAL 0.287 2.0 mm? -102.27 -63.73 1.13 Allowed 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 123.389 1.566 . . . . 0.0 110.548 174.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.543 ' CG2' ' H ' ' B' ' 105' ' ' TYR . 22.8 m -131.13 -177.75 4.53 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 111.508 -2.587 . . . . 0.0 112.299 -161.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.543 ' H ' ' CG2' ' B' ' 104' ' ' THR . 13.7 p90 -160.93 132.57 5.7 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.502 1.521 . . . . 0.0 111.185 -171.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 pp -107.0 161.83 14.39 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.276 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 5.1 p -90.66 172.69 8.49 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.082 0.467 . . . . 0.0 111.857 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.39 -31.59 72.87 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.705 0.802 . . . . 0.0 112.644 -174.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -69.2 -35.68 76.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.558 0.695 . . . . 0.0 109.277 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.557 ' O ' HG23 ' B' ' 114' ' ' VAL . 73.3 mmtt -79.15 -30.27 43.51 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.178 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.497 ' HE2' ' HA ' ' B' ' 111' ' ' MET . 0.2 OUTLIER -52.23 -41.79 63.04 Favored 'General case' 0 N--CA 1.42 -1.96 0 O-C-N 124.142 0.902 . . . . 0.0 109.132 169.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.536 ' HA ' ' CE ' ' B' ' 112' ' ' LYS . 6.5 mmpt? -67.9 -47.57 68.41 Favored 'General case' 1 N--CA 1.375 -4.212 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -178.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -64.8 -38.23 90.28 Favored 'General case' 0 N--CA 1.41 -2.437 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.469 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.557 HG23 ' O ' ' B' ' 110' ' ' LYS . 25.6 m -68.93 -46.58 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.651 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -57.33 -52.91 63.45 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.12 0.486 . . . . 0.0 110.421 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.358 86.2 m-20 -59.19 -54.29 48.55 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.004 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.43 ' HB2' ' HG ' ' B' ' 88' ' ' LEU . . . -56.22 -37.29 69.48 Favored 'General case' 0 CA--C 1.46 -2.512 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.072 -171.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.689 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.6 tp -66.22 -45.36 80.95 Favored 'General case' 1 N--CA 1.358 -5.042 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.846 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' A' ' 124' ' ' LEU . 47.0 mtp -66.15 -32.61 74.16 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 53.7 mt -64.49 -54.6 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.1 t -50.52 -22.59 2.02 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.184 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 31.5 mt -111.14 -4.65 14.96 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.1 23.28 74.76 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.449 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 52.4 mt -81.37 -58.62 2.96 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 CA--C 1.554 1.098 0 C-N-CA 127.118 2.167 . . . . 0.0 116.264 -179.667 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.8 mt . . . . . 0 C--O 1.242 0.662 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -108.69 151.01 26.75 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -71.2 124.11 23.74 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.65 -2.91 29.1 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.479 -1.343 . . . . 0.0 112.968 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -84.84 161.1 20.04 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 104' ' ' THR . 78.4 t -121.92 108.01 21.14 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.655 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.85 174.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.56 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.2 m-85 -99.56 147.02 25.78 Favored 'General case' 0 C--N 1.255 -3.506 0 C-N-CA 124.809 1.244 . . . . 0.0 109.567 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.5 mp -83.08 146.67 28.56 Favored 'General case' 0 N--CA 1.382 -3.851 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.33 140.09 32.02 Favored 'General case' 0 C--N 1.256 -3.497 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.972 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -84.98 90.48 7.84 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.571 ' O ' HG11 ' A' ' 27' ' ' VAL . 51.3 mt -73.58 -21.67 60.27 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.966 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.432 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 4.4 m -32.91 174.46 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.738 0 C-N-CA 129.064 2.945 . . . . 0.0 115.684 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.551 ' HB2' HE22 ' B' ' 28' ' ' GLN . 0.0 OUTLIER 23.38 52.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.414 -3.199 0 C-N-CA 123.094 2.529 . . . . 0.0 114.555 -151.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.571 HG11 ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -68.33 141.48 17.53 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 CA-C-N 112.385 -2.189 . . . . 0.0 110.026 171.093 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.583 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 84.8 mm-40 -89.84 120.16 30.84 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.965 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.19 -110.7 1.64 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.061 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.4 m -94.1 10.16 34.84 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 98.3 mt-10 -61.64 143.17 56.52 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.3 118.51 31.36 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.424 -169.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.05 -171.17 23.48 Favored Glycine 0 N--CA 1.414 -2.783 0 N-CA-C 120.093 2.797 . . . . 0.0 120.093 162.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.28 -152.58 6.9 Favored Glycine 0 C--N 1.264 -3.471 1 N-CA-C 102.349 -4.301 . . . . 0.0 102.349 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.1 113.22 15.93 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-N 121.125 2.462 . . . . 0.0 109.953 176.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -143.73 162.04 43.42 Favored Pre-proline 0 C--N 1.277 -2.569 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.195 -175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 19.9 Cg_exo -72.29 143.44 39.38 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.479 2.119 . . . . 0.0 111.5 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 28.6 m -128.69 160.09 39.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 124.197 0.999 . . . . 0.0 109.531 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.0 m -104.92 131.84 53.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.608 0.242 . . . . 0.0 110.553 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.3 mm -89.85 108.44 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.404 ' C ' HD12 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -106.8 -18.34 7.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.701 178.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.618 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -52.81 156.84 1.84 Allowed 'General case' 0 C--O 1.245 0.846 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -171.151 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -56.83 155.36 7.94 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-N 113.248 -1.796 . . . . 0.0 112.075 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.18 -27.44 62.57 Favored 'General case' 0 C--N 1.264 -3.112 0 CA-C-N 113.593 -1.64 . . . . 0.0 112.386 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.3 m -83.85 -37.18 22.79 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.29 -0.256 . . . . 0.0 111.102 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.01 -27.34 73.7 Favored Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.96 -33.66 70.89 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.127 0.489 . . . . 0.0 109.859 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 10.2 mmmm -93.22 -60.69 1.73 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.956 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.512 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 71.0 m-85 -93.83 -36.14 12.39 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -165.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.6 m -80.82 138.65 50.18 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.02 -17.9 40.72 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 121.899 1.733 . . . . 0.0 111.077 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 4.7 p -98.54 158.49 15.56 Favored 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 124.856 1.263 . . . . 0.0 111.498 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.618 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -152.51 138.87 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.196 0.598 . . . . 0.0 110.454 170.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.576 HG23 ' HG3' ' A' ' 42' ' ' GLN . 8.6 tt -83.69 135.06 25.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 CA-C-O 121.4 0.619 . . . . 0.0 110.476 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 32.8 m -139.27 156.26 27.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.481 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.473 ' CB ' HG23 ' A' ' 91' ' ' ILE . . . -115.79 139.33 50.28 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 138.45 43.78 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.575 HG12 ' CD1' ' A' ' 86' ' ' ILE . 64.1 mt -96.13 134.65 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 113.129 -1.85 . . . . 0.0 107.533 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.1 t -137.29 143.53 42.2 Favored 'General case' 0 N--CA 1.414 -2.27 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.591 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.372 0 N-CA-C 107.106 -2.398 . . . . 0.0 107.106 170.385 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 N--CA 1.434 -1.241 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -62.05 -10.93 19.44 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.647 2.231 . . . . 0.0 115.53 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.3 p -98.22 -16.38 19.46 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -113.1 128.7 56.56 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.91 125.7 70.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.372 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -91.7 118.63 30.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.51 0.672 . . . . 0.0 109.508 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.68 HG21 ' CE1' ' A' ' 78' ' ' TYR . 3.2 mm -96.09 158.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.607 -173.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.08 120.2 14.56 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 123.743 0.817 . . . . 0.0 110.221 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 85.6 tttt -46.67 -51.27 16.33 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 126.198 1.799 . . . . 0.0 111.575 176.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -56.93 -49.48 75.48 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 126.282 1.833 . . . . 0.0 112.111 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.441 ' HD3' ' OG ' ' A' ' 107' ' ' SER . 39.4 ttmt -69.22 -33.61 73.58 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.425 0.69 . . . . 0.0 110.535 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.68 ' CE1' HG21 ' A' ' 73' ' ' ILE . 3.2 m-85 -88.63 -11.19 46.1 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.617 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.4 tttm 67.22 24.63 9.13 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.433 0.693 . . . . 0.0 111.16 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.408 HD13 ' HB3' ' A' ' 78' ' ' TYR . 7.2 mp -94.86 178.62 5.51 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-O 122.616 1.198 . . . . 0.0 112.44 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.411 ' O ' ' HE3' ' A' ' 75' ' ' LYS . 2.2 m-20 -73.54 -20.71 60.57 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 112.555 -2.111 . . . . 0.0 111.733 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 83' ' ' ASP . 11.6 ptmm? -158.48 169.97 23.25 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 9.9 p-10 -51.85 135.96 29.0 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 m -109.12 135.5 50.16 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.4 t -107.69 135.86 44.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.575 ' CD1' HG12 ' A' ' 58' ' ' ILE . 18.2 mm -112.19 135.39 51.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.0 mt -104.49 106.23 16.65 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.409 ' HG ' ' HB2' ' A' ' 117' ' ' ALA . 3.7 mm? -84.05 -5.61 59.26 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.687 -174.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -91.62 -39.56 11.81 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.986 174.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.05 79.32 4.07 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.325 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.473 HG23 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -114.73 -176.78 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -166.61 173.68 9.49 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.865 0.364 . . . . 0.0 111.57 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 67.5 m -123.34 124.32 42.69 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.2 mt -130.88 142.8 50.4 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.688 -171.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.9 p30 -74.56 152.39 39.32 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.352 174.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -47.54 -27.5 1.83 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.902 1.281 . . . . 0.0 114.31 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.3 -18.49 57.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 120.867 0.365 . . . . 0.0 111.433 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.21 -34.09 65.73 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.8 mp -76.63 126.16 30.49 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.248 1.419 . . . . 0.0 110.145 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -91.96 -67.33 0.86 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.744 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 14.6 pt-20 -153.25 152.88 31.67 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.518 -166.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.431 ' HE2' ' OH ' ' A' ' 20' ' ' TYR . 70.6 mttt -73.41 123.94 24.82 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.776 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.546 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 18.8 tp -109.38 -60.99 1.69 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 122.653 1.216 . . . . 0.0 108.438 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.546 ' OG1' ' HG ' ' A' ' 103' ' ' LEU . 2.3 m -127.36 178.72 5.87 Favored 'General case' 0 N--CA 1.381 -3.879 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.227 -166.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.43 ' N ' HG22 ' A' ' 104' ' ' THR . 2.9 p90 -160.45 139.69 10.72 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 125.121 1.368 . . . . 0.0 109.903 -169.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 pp -115.05 161.59 18.15 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.252 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.441 ' OG ' ' HD3' ' A' ' 77' ' ' LYS . 34.3 p -88.12 172.66 9.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.174 0.512 . . . . 0.0 111.628 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 111' ' ' MET . 28.3 t70 -66.14 -30.35 70.81 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.112 0.565 . . . . 0.0 111.855 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -69.47 -30.61 68.53 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.431 ' O ' HG22 ' A' ' 114' ' ' VAL . 14.4 tppt? -77.65 -30.11 51.99 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.585 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -49.04 -47.12 45.01 Favored 'General case' 0 CA--C 1.48 -1.738 0 O-C-N 123.896 0.747 . . . . 0.0 110.75 171.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.753 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -65.64 -34.58 78.56 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.807 -178.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.84 -41.68 59.4 Favored 'General case' 0 N--CA 1.4 -2.944 0 C-N-CA 118.176 -1.41 . . . . 0.0 112.121 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 110' ' ' LYS . 19.7 m -67.16 -45.35 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 118.921 -0.561 . . . . 0.0 112.103 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -54.28 -51.69 63.78 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 123.2 1.476 . . . . 0.0 109.397 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.753 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -76.31 -30.58 57.76 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 112.998 -1.91 . . . . 0.0 115.031 -172.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.409 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -70.68 -41.9 71.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 1.9 tp -62.33 -44.19 97.08 Favored 'General case' 0 N--CA 1.394 -3.237 0 C-N-CA 125.479 1.511 . . . . 0.0 108.741 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.657 ' CG ' ' HA ' ' A' ' 125' ' ' ASN . 21.2 ttm -48.61 -37.46 18.22 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.5 mt -82.5 -50.12 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.665 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.5 m -48.81 -35.56 14.75 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.02 -1.9 . . . . 0.0 112.722 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 23.1 mt -103.19 -3.03 26.32 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 120.055 -0.658 . . . . 0.0 112.028 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.34 29.52 58.17 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 117.359 1.704 . . . . 0.0 117.359 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.467 HD11 HD11 ' B' ' 124' ' ' LEU . 0.2 OUTLIER -100.05 -46.02 5.47 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 118.947 1.373 . . . . 0.0 111.897 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.657 ' HA ' ' CG ' ' A' ' 119' ' ' MET . 1.6 t-20 . . . . . 0 C--N 1.296 -1.737 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.087 -168.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -108.88 145.71 34.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -66.23 125.98 27.27 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.65 -5.81 31.25 Favored Glycine 0 N--CA 1.426 -1.974 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.694 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -83.4 162.97 20.85 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.42 HG23 HG22 ' B' ' 104' ' ' THR . 75.1 t -122.53 110.14 26.02 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.766 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.732 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 30.3 m-85 -101.44 146.3 27.8 Favored 'General case' 0 C--N 1.26 -3.32 0 C-N-CA 124.875 1.27 . . . . 0.0 109.779 176.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 3.8 mp -81.13 146.14 30.7 Favored 'General case' 0 N--CA 1.388 -3.569 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 166.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.33 141.11 33.88 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.931 -173.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -85.58 89.19 7.65 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.597 ' O ' HG11 ' B' ' 27' ' ' VAL . 56.9 mt -73.03 -22.09 60.7 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.073 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 3.8 m -33.14 175.02 0.0 OUTLIER Pre-proline 0 CA--C 1.573 1.859 0 C-N-CA 129.433 3.093 . . . . 0.0 115.603 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.583 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 0.0 OUTLIER 23.8 50.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.119 0 C-N-CA 123.205 2.603 . . . . 0.0 114.998 -152.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.597 HG11 ' O ' ' B' ' 24' ' ' LEU . 0.5 OUTLIER -68.18 143.09 15.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.107 172.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . 0.551 HE22 ' HB2' ' A' ' 26' ' ' PRO . 82.8 mm-40 -89.72 118.86 29.63 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.942 -1.481 . . . . 0.0 112.301 -173.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.3 -108.72 1.4 Allowed Glycine 0 C--N 1.309 -0.935 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.584 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 43.9 m -94.71 8.67 41.69 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.491 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 98.8 mt-10 -61.56 142.59 56.99 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 173.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.84 117.65 30.38 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 122.374 -0.204 . . . . 0.0 111.351 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.36 -173.85 22.54 Favored Glycine 0 N--CA 1.412 -2.942 0 N-CA-C 120.327 2.891 . . . . 0.0 120.327 163.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . -161.28 -151.87 6.42 Favored Glycine 0 C--N 1.264 -3.459 1 N-CA-C 102.124 -4.391 . . . . 0.0 102.124 177.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.49 114.96 18.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-N 120.997 2.399 . . . . 0.0 109.867 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -145.21 161.6 41.2 Favored Pre-proline 0 C--N 1.284 -2.271 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.113 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 21.2 Cg_exo -71.91 143.15 40.35 Favored 'Trans proline' 0 CA--C 1.551 1.366 0 C-N-CA 122.599 2.199 . . . . 0.0 111.86 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 29.7 m -127.91 159.64 38.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 124.129 0.971 . . . . 0.0 109.754 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 34.1 m -103.76 132.56 49.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 CA-C-O 120.642 0.258 . . . . 0.0 110.357 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 24.4 mm -91.04 107.13 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.86 -18.89 6.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.89 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.599 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 0.0 OUTLIER -52.14 157.24 1.4 Allowed 'General case' 0 C--O 1.245 0.845 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -170.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.412 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 10.9 p-10 -56.88 158.17 5.03 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 113.182 -1.826 . . . . 0.0 112.325 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.49 -28.76 62.1 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 113.615 -1.629 . . . . 0.0 112.096 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 56.9 m -85.2 -35.24 21.76 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.175 -0.328 . . . . 0.0 111.764 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.5 -26.2 74.48 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -60.39 -32.74 71.6 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.12 0.486 . . . . 0.0 109.845 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 11.0 mmmm -93.1 -63.35 1.23 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.136 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.522 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 67.6 m-85 -91.89 -35.82 13.83 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -166.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 45.5 m -82.06 138.49 45.97 Favored Pre-proline 0 C--N 1.308 -1.212 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.66 -18.74 37.3 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 121.927 1.752 . . . . 0.0 111.178 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 3.0 p -98.81 155.64 17.26 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 124.781 1.232 . . . . 0.0 111.269 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.599 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -150.25 138.75 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 O-C-N 123.585 0.553 . . . . 0.0 110.387 171.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.544 HG23 ' HG3' ' B' ' 42' ' ' GLN . 8.8 tt -83.45 134.02 27.85 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 CA-C-O 121.46 0.647 . . . . 0.0 110.576 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 32.3 m -138.47 155.25 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.494 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.486 ' CB ' HG23 ' B' ' 91' ' ' ILE . . . -115.26 139.54 49.87 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.09 138.43 43.94 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.551 HG12 ' CD1' ' B' ' 86' ' ' ILE . 61.2 mt -96.14 134.48 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.285 -1.78 . . . . 0.0 107.422 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -137.46 141.42 41.58 Favored 'General case' 0 N--CA 1.405 -2.718 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.87 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.455 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 169.296 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 7.9 tt . . . . . 0 N--CA 1.431 -1.382 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.21 -5.84 7.23 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.797 2.331 . . . . 0.0 115.538 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 80.6 p -102.05 -16.19 16.52 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.334 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . 0.424 ' CD2' HD21 ' B' ' 87' ' ' LEU . 46.4 m170 -112.34 128.5 56.3 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -126.57 126.3 68.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.76 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -92.6 123.35 35.83 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.556 0.693 . . . . 0.0 109.373 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.66 HG21 ' CE1' ' B' ' 78' ' ' TYR . 2.8 mm -100.77 155.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.946 -173.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.73 119.98 11.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 123.996 0.918 . . . . 0.0 110.527 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . 0.489 ' HE3' ' O ' ' B' ' 81' ' ' ASP . 85.7 tttt -48.2 -49.08 34.23 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 126.504 1.922 . . . . 0.0 111.408 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -60.6 -45.85 92.44 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 125.871 1.668 . . . . 0.0 111.76 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -72.27 -33.78 67.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.71 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.66 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.2 m-85 -87.83 -11.1 48.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.247 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 66.44 26.34 10.09 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 121.748 0.785 . . . . 0.0 111.07 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.413 HD11 ' O ' ' B' ' 78' ' ' TYR . 6.8 mp -95.09 -178.76 4.58 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-O 122.448 1.118 . . . . 0.0 112.658 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.489 ' O ' ' HE3' ' B' ' 75' ' ' LYS . 4.9 m-20 -70.57 -28.64 65.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.104 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -154.04 171.21 19.45 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -53.69 135.66 40.68 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 7.1 m -109.44 135.49 50.39 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 t -107.73 136.55 42.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.551 ' CD1' HG12 ' B' ' 58' ' ' ILE . 13.7 mm -113.78 135.36 53.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.424 HD21 ' CD2' ' B' ' 70' ' ' HIS . 44.5 mt -104.78 104.88 14.74 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.28 -7.41 59.63 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.594 -174.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -90.99 -38.49 12.8 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.1 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.26 77.73 3.46 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.26 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.486 HG23 ' CB ' ' B' ' 56' ' ' ALA . 2.4 pp -113.45 -176.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -166.47 174.06 9.3 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 123.329 0.393 . . . . 0.0 111.55 172.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 68.8 m -123.63 124.62 43.18 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 74.7 mt -131.28 142.98 50.21 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.8 -171.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 3.9 p-10 -74.95 152.66 38.79 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.412 174.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -46.04 -30.0 1.69 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.019 1.328 . . . . 0.0 114.222 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.05 -19.75 60.52 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 120.945 0.402 . . . . 0.0 111.289 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -72.32 -34.11 67.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.407 ' HB3' ' CD2' ' B' ' 20' ' ' TYR . 7.8 mp -77.17 125.76 29.85 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.147 1.379 . . . . 0.0 110.174 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -93.3 -64.72 1.06 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.37 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -155.06 151.1 27.97 Favored 'General case' 0 N--CA 1.407 -2.587 0 CA-C-O 121.632 0.73 . . . . 0.0 111.283 -169.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . 0.453 ' HE2' ' OH ' ' B' ' 20' ' ' TYR . 67.2 mttt -70.85 126.19 28.91 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.755 174.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.48 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 18.8 tp -112.14 -62.02 1.63 Allowed 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.731 1.253 . . . . 0.0 108.657 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.48 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 1.6 m -125.98 178.44 5.75 Favored 'General case' 0 N--CA 1.383 -3.823 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.356 -166.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.434 ' H ' ' CG2' ' B' ' 104' ' ' THR . 6.1 p90 -160.74 137.7 8.97 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.825 1.25 . . . . 0.0 109.991 -170.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -110.98 164.0 13.25 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.748 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -91.96 171.56 9.04 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.548 0.213 . . . . 0.0 111.177 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' B' ' 111' ' ' MET . 27.6 t70 -62.75 -28.69 70.14 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.232 0.539 . . . . 0.0 111.39 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -70.11 -29.11 65.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.837 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.485 ' O ' HG21 ' B' ' 114' ' ' VAL . 14.1 tppt? -81.16 -29.26 34.74 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.812 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.1 OUTLIER -47.81 -43.5 27.92 Favored 'General case' 0 CA--C 1.445 -3.078 0 O-C-N 124.173 0.921 . . . . 0.0 109.964 170.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.493 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 6.9 mmpt? -61.15 -54.02 49.66 Favored 'General case' 1 N--CA 1.37 -4.451 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.675 -178.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . 0.435 ' CD ' ' HZ3' ' B' ' 110' ' ' LYS . 29.2 mt-10 -62.41 -43.88 97.76 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.092 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.485 HG21 ' O ' ' B' ' 110' ' ' LYS . 20.6 m -63.21 -43.14 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 123.67 0.606 . . . . 0.0 111.814 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -56.5 -54.85 40.96 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 123.479 0.487 . . . . 0.0 111.08 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' B' ' 119' ' ' MET 0.273 17.3 m-80 -61.7 -45.26 94.74 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.242 0.544 . . . . 0.0 110.252 -177.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.54 -43.86 97.77 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.003 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.6 tp -63.03 -46.59 86.86 Favored 'General case' 0 N--CA 1.387 -3.612 0 C-N-CA 124.287 1.035 . . . . 0.0 108.338 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.741 ' SD ' ' HA ' ' B' ' 125' ' ' ASN . 15.4 ttm -49.63 -44.08 47.15 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 29.9 mt -72.34 -50.87 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 45.8 m -49.79 -34.07 18.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.485 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 22.3 mt -102.8 -4.19 25.29 Favored 'General case' 0 C--O 1.198 -1.627 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.116 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.78 30.76 55.6 Favored Glycine 0 C--N 1.341 0.848 0 N-CA-C 117.469 1.747 . . . . 0.0 117.469 172.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -101.89 -47.27 4.64 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.696 1.248 . . . . 0.0 112.511 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.741 ' HA ' ' SD ' ' B' ' 119' ' ' MET 0.345 14.1 m120 . . . . . 0 C--N 1.302 -1.476 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.528 -167.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.5 mt . . . . . 0 N--CA 1.419 -1.985 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -146.77 160.72 41.9 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -77.64 122.11 24.87 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.533 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' HA2' ' SD ' ' A' ' 111' ' ' MET . . . 142.8 -30.63 2.04 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 119.395 -1.383 . . . . 0.0 113.996 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -100.43 173.87 6.37 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 118.075 0.937 . . . . 0.0 111.658 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 105' ' ' TYR . 54.0 t -110.98 138.71 38.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.836 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.516 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 92.2 m-85 -137.32 147.11 45.37 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 126.26 1.824 . . . . 0.0 108.731 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.2 mp -86.57 157.38 19.75 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 171.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.7 146.6 32.29 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.865 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -82.46 108.77 16.12 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.643 0.735 . . . . 0.0 109.63 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.578 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 15.4 mt -108.91 28.26 8.64 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 123.698 1.713 . . . . 0.0 109.073 -175.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.523 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 15.1 m -73.55 -178.62 0.75 Allowed Pre-proline 1 C--N 1.213 -5.358 0 CA-C-N 112.732 -2.031 . . . . 0.0 108.714 169.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.1 OUTLIER 17.23 42.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.148 0 C-N-CA 124.976 3.784 . . . . 0.0 118.016 -159.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 24' ' ' LEU . 5.2 m -70.2 174.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.054 0 CA-C-O 122.328 1.061 . . . . 0.0 112.234 172.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -92.49 110.56 21.97 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.005 -1.452 . . . . 0.0 114.198 -174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.65 -108.69 0.75 Allowed Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 113.918 -1.492 . . . . 0.0 114.784 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.7 m -86.58 13.85 7.85 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 36.0 mt-10 -67.4 -175.29 0.47 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.887 0.851 . . . . 0.0 112.063 173.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.58 ' NE2' ' HG3' ' A' ' 36' ' ' ARG . 12.1 tm0? -106.47 126.59 52.45 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -111.54 163.65 12.2 Favored Glycine 0 CA--C 1.498 -0.989 0 N-CA-C 116.871 1.508 . . . . 0.0 116.871 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.8 171.64 18.96 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 113.614 -1.293 . . . . 0.0 110.51 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.53 102.08 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.669 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.58 ' HG3' ' NE2' ' A' ' 32' ' ' GLN . 26.0 mmt180 -128.55 151.91 77.58 Favored Pre-proline 0 C--N 1.251 -3.715 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.88 -174.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 23.4 Cg_exo -65.46 144.92 81.32 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.839 2.359 . . . . 0.0 112.54 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 30.1 m -129.23 154.97 40.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.619 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.559 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 29.7 m -99.32 128.69 50.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.496 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.5 mm -92.24 106.44 17.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.06 -6.57 10.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.817 0.817 . . . . 0.0 109.085 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.529 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -51.15 146.64 6.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 125.853 1.661 . . . . 0.0 113.946 -170.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -60.95 -179.01 0.11 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.098 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 19.0 t70 -77.27 -48.54 17.2 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.151 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -70.25 -28.58 65.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.542 -171.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.01 -28.15 73.7 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.518 ' N ' HE22 ' A' ' 42' ' ' GLN . 87.0 m-20 -75.84 -37.59 58.88 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.278 0.561 . . . . 0.0 110.174 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HB2' ' CD2' ' A' ' 49' ' ' TYR . 49.8 mmtt -79.31 -61.6 1.95 Allowed 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.257 -176.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 55.7 m-85 -111.24 6.6 20.71 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -167.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -119.84 141.6 31.59 Favored Pre-proline 0 C--N 1.306 -1.298 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.314 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -74.17 -23.34 15.83 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.073 1.848 . . . . 0.0 110.366 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -85.17 154.71 21.82 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.813 -175.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.447 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 57.9 t -138.4 140.07 40.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.529 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 3.8 tp -99.08 125.56 52.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 171.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 21.6 m -132.68 166.54 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.743 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.559 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . . . -124.88 141.19 52.28 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.53 130.76 42.06 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.486 HG12 HD13 ' A' ' 86' ' ' ILE . 56.1 mt -90.13 120.42 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.085 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.9 m -119.3 155.47 31.76 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 175.224 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 tt . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.71 -1.1 4.47 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.198 2.599 . . . . 0.0 115.869 -175.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.1 p -91.32 -18.74 23.83 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-O 121.728 0.775 . . . . 0.0 109.432 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -101.5 129.26 47.53 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.18 127.81 69.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -99.08 131.08 45.38 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.088 0.47 . . . . 0.0 110.472 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.417 HD11 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -124.78 145.99 31.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.47 123.91 13.38 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 126.304 1.842 . . . . 0.0 113.332 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -58.67 -39.4 80.54 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.702 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -61.48 -27.76 68.8 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.974 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -91.43 -35.47 14.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.103 0.954 . . . . 0.0 109.549 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.403 ' OH ' HD22 ' A' ' 106' ' ' LEU . 32.9 m-85 -96.16 13.41 27.42 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.366 -171.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt 59.7 39.29 21.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.566 1.146 . . . . 0.0 114.064 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.86 174.31 7.62 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.792 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.0 -16.25 26.77 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.076 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -133.34 152.06 51.9 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.11 157.17 37.39 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.902 0.382 . . . . 0.0 110.308 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.3 t -103.41 151.79 22.36 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.388 -172.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.37 124.32 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.486 HD13 HG12 ' A' ' 58' ' ' ILE . 20.1 mm -100.95 130.36 50.45 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.662 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 76.6 mt -102.59 102.91 13.18 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.41 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -82.58 6.29 18.13 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.901 -174.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.16 -38.31 6.31 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.285 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -83.82 69.33 10.21 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.826 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.482 HG21 ' CB ' ' A' ' 56' ' ' ALA . 2.1 pp -111.44 -179.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.723 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.423 ' O ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -167.28 165.31 15.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.2 m -118.19 118.73 32.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.1 mt -131.69 138.51 48.72 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.8 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 4.5 p-10 -73.91 152.1 40.24 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.015 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -47.69 -20.52 0.28 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.825 1.65 . . . . 0.0 115.197 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -71.39 -26.36 62.74 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.91 0.884 . . . . 0.0 110.735 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -74.26 -34.5 63.61 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.205 0.526 . . . . 0.0 110.212 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.52 124.98 26.32 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.657 1.183 . . . . 0.0 109.973 176.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -101.93 -60.17 1.58 Allowed 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -147.88 138.61 23.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.716 0.77 . . . . 0.0 112.719 -166.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 28.9 tttp -66.1 116.14 6.88 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 127.673 2.389 . . . . 0.0 107.414 174.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -110.16 -60.23 1.83 Allowed 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.76 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.479 HG21 HG22 ' A' ' 19' ' ' VAL . 10.6 t -127.64 -157.41 0.81 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.591 ' O ' HG23 ' A' ' 19' ' ' VAL . 38.0 m-85 -123.48 -89.0 0.6 Allowed 'General case' 0 C--O 1.177 -2.763 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.573 -172.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 1.5 mt 139.75 151.97 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 131.358 3.863 . . . . 0.0 105.484 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 79.0 p -97.59 154.49 17.5 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.746 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.485 ' O ' ' HD2' ' A' ' 112' ' ' LYS . 4.9 m-20 -58.54 -36.96 74.7 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 18.4 p-10 -76.74 -41.52 44.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.396 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -67.64 -25.63 65.83 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.544 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.479 ' HA ' ' HE3' ' A' ' 111' ' ' MET . 0.0 OUTLIER -53.71 -42.28 67.86 Favored 'General case' 0 N--CA 1.416 -2.146 0 C-N-CA 124.122 0.969 . . . . 0.0 110.421 171.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.65 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -71.25 -25.44 62.47 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.367 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.55 ' HA ' ' ND2' ' A' ' 116' ' ' ASN . 10.6 mt-10 -87.08 -35.19 18.85 Favored 'General case' 0 N--CA 1.394 -3.227 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.762 -171.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.75 -47.04 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.016 0 CA-C-N 112.856 -1.975 . . . . 0.0 108.501 169.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.505 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 68.5 m-20 -58.39 -52.82 63.98 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.129 0.49 . . . . 0.0 111.054 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.617 ' O ' HG13 ' A' ' 120' ' ' ILE . 3.8 p30 -64.85 -42.96 94.47 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.109 -0.637 . . . . 0.0 111.743 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.41 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.32 -38.21 71.0 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.22 0.534 . . . . 0.0 109.903 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.505 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 8.9 tp -69.94 -46.27 65.66 Favored 'General case' 0 N--CA 1.392 -3.374 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.921 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.529 ' O ' ' HB2' ' A' ' 124' ' ' LEU . 3.1 ttp -68.06 -23.48 64.96 Favored 'General case' 0 N--CA 1.408 -2.566 0 C-N-CA 124.161 0.984 . . . . 0.0 110.298 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.617 HG13 ' O ' ' A' ' 116' ' ' ASN . 49.7 mt -79.9 -54.47 11.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 174.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.5 t -47.71 -44.79 28.03 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 125.787 1.635 . . . . 0.0 112.584 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.7 mp -82.85 10.65 7.3 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.86 85.17 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 119' ' ' MET . 1.3 mm? -67.74 -63.48 1.05 Allowed 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 118.106 0.953 . . . . 0.0 109.121 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 C--N 1.305 -1.359 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.244 -173.281 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.426 -1.659 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -146.03 160.45 41.86 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -76.22 125.81 29.84 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.469 ' HA2' ' SD ' ' B' ' 111' ' ' MET . . . 140.12 -34.49 2.0 Allowed Glycine 0 N--CA 1.425 -2.081 0 C-N-CA 119.507 -1.33 . . . . 0.0 113.617 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -100.11 174.21 6.27 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 118.078 0.939 . . . . 0.0 111.992 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 105' ' ' TYR . 53.5 t -110.36 139.42 33.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.115 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.573 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 89.7 m-85 -137.57 147.67 45.28 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 126.072 1.749 . . . . 0.0 109.191 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.0 mp -88.16 156.33 19.3 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.19 147.64 32.67 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.956 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -82.61 107.66 15.42 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.205 1.003 . . . . 0.0 110.346 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.647 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 10.8 mt -108.9 28.01 8.9 Favored 'General case' 0 CA--C 1.484 -1.578 0 CA-C-O 123.451 1.596 . . . . 0.0 109.206 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.526 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 15.3 m -76.45 -178.62 0.97 Allowed Pre-proline 1 C--N 1.216 -5.223 0 CA-C-N 112.785 -2.007 . . . . 0.0 107.759 170.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 17.1 43.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.393 2.873 1 C-N-CA 125.396 4.064 . . . . 0.0 118.029 -160.374 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 4.9 m -70.4 177.93 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.972 0 CA-C-O 122.171 0.986 . . . . 0.0 112.154 172.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -94.05 116.3 28.71 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.59 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.97 -108.65 0.77 Allowed Glycine 0 CA--C 1.499 -0.91 0 CA-C-N 114.622 -1.172 . . . . 0.0 114.966 172.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 10.3 m -90.97 10.55 26.08 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.544 -0.828 . . . . 0.0 113.06 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 34.9 mt-10 -62.82 -179.97 0.32 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.868 0.842 . . . . 0.0 112.777 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . 0.58 ' NE2' ' HG3' ' B' ' 36' ' ' ARG . 0.0 OUTLIER -100.2 121.71 41.88 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -106.01 155.0 16.88 Favored Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.88 176.63 15.52 Favored Glycine 0 C--N 1.307 -1.08 0 CA-C-N 113.383 -1.409 . . . . 0.0 110.19 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.97 99.67 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . 0.58 ' HG3' ' NE2' ' B' ' 32' ' ' GLN . 29.5 mmt180 -126.52 150.96 72.14 Favored Pre-proline 0 C--N 1.245 -3.974 0 CA-C-N 113.822 -1.536 . . . . 0.0 111.02 -172.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 25.1 Cg_exo -64.92 144.99 84.75 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 122.439 2.093 . . . . 0.0 112.208 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 31.0 m -129.15 155.23 41.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.453 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.555 ' CG2' ' HB2' ' B' ' 56' ' ' ALA . 30.7 m -99.87 129.01 51.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 21.7 mm -92.37 107.07 18.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.31 -7.52 10.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.679 0.752 . . . . 0.0 109.129 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.53 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.6 OUTLIER -49.82 148.68 2.97 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 126.099 1.759 . . . . 0.0 113.951 -170.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -61.83 -178.41 0.15 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.898 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' B' ' 48' ' ' LYS . 15.9 t70 -80.04 -47.56 14.7 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.483 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.6 m -69.97 -30.97 68.45 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.749 -172.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.23 -27.29 72.21 Favored Glycine 0 C--O 1.214 -1.129 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.537 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.516 ' N ' HE22 ' B' ' 42' ' ' GLN . 79.6 m-20 -78.37 -35.28 47.55 Favored 'General case' 0 CA--C 1.491 -1.318 0 O-C-N 122.554 -0.38 . . . . 0.0 110.586 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' B' ' 44' ' ' ASP . 51.7 mmtt -78.27 -60.83 2.21 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.358 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' B' ' 48' ' ' LYS . 69.1 m-85 -107.67 -11.07 15.5 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -167.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 19.1 t -106.14 143.03 26.11 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 121.711 -0.618 . . . . 0.0 109.515 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -75.79 -22.36 13.55 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.146 1.897 . . . . 0.0 110.323 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 0.8 OUTLIER -84.91 152.16 23.73 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.6 -175.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.47 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 58.9 t -136.47 140.05 44.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.53 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 4.1 tp -99.27 124.39 52.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 171.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 22.1 m -132.19 166.04 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.817 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.555 ' HB2' ' CG2' ' B' ' 39' ' ' VAL . . . -124.09 141.36 52.12 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.1 129.06 37.6 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.489 HG12 HD13 ' B' ' 86' ' ' ILE . 53.7 mt -87.61 123.02 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.915 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 25.8 m -120.42 159.6 24.77 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.389 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 176.97 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.2 tt . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -66.54 7.89 0.36 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 123.346 2.698 . . . . 0.0 115.704 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 74.8 p -98.37 -18.83 18.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.899 0.857 . . . . 0.0 108.738 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -101.25 129.41 47.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.57 130.34 70.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -101.23 130.69 47.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.927 0.394 . . . . 0.0 110.179 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.435 HD11 HG12 ' B' ' 86' ' ' ILE . 0.0 OUTLIER -124.04 147.75 28.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.94 125.42 20.26 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 125.252 1.421 . . . . 0.0 113.287 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -61.96 -38.45 88.55 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.754 0.787 . . . . 0.0 111.234 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -61.75 -27.35 68.67 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.903 -1.499 . . . . 0.0 112.991 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -90.67 -37.1 13.97 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.976 0.893 . . . . 0.0 109.406 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.41 ' OH ' HD22 ' B' ' 106' ' ' LEU . 31.2 m-85 -94.3 12.4 27.03 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.372 -171.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt 61.0 38.43 17.36 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.549 1.139 . . . . 0.0 113.724 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 22.2 mt -123.36 174.53 7.28 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.528 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.95 -11.81 26.03 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.062 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -136.05 149.89 48.96 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -68.26 156.07 38.42 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.464 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 19.7 t -103.07 149.89 24.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.365 -171.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 41.4 t -123.58 124.81 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.288 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.489 HD13 HG12 ' B' ' 58' ' ' ILE . 19.4 mm -101.14 130.86 49.91 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.515 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 76.5 mt -102.76 102.52 12.68 Favored 'General case' 0 N--CA 1.406 -2.653 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.7 2.5 29.46 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.793 -174.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -101.79 -39.19 7.52 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.204 173.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -83.53 68.93 9.97 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.277 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.509 HG21 ' CB ' ' B' ' 56' ' ' ALA . 2.1 pp -110.23 -179.15 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.767 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.572 ' NH1' HD21 ' B' ' 24' ' ' LEU . 0.0 OUTLIER -167.25 165.03 15.47 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 50.1 m -117.8 118.66 32.64 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 62.0 mt -131.54 138.61 48.98 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.83 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 4.2 p-10 -73.87 151.82 40.37 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 118.901 -1.12 . . . . 0.0 109.825 173.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -48.28 -20.98 0.44 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.83 1.652 . . . . 0.0 114.983 -175.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -72.91 -23.87 60.76 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.458 0.703 . . . . 0.0 110.575 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -74.32 -33.49 63.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.343 0.592 . . . . 0.0 109.867 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.25 122.8 23.41 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.39 1.076 . . . . 0.0 110.73 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -99.5 -62.13 1.28 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.4 pt-20 -143.42 148.7 36.55 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 122.054 0.931 . . . . 0.0 112.551 -167.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -79.3 111.34 15.45 Favored 'General case' 0 C--N 1.276 -2.596 0 C-N-CA 127.769 2.428 . . . . 0.0 107.89 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -105.65 -61.94 1.43 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.357 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.486 HG21 HG22 ' B' ' 19' ' ' VAL . 8.3 t -125.44 -159.21 0.88 Allowed 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.53 ' O ' HG23 ' B' ' 19' ' ' VAL . 37.9 m-85 -122.73 -87.39 0.64 Allowed 'General case' 0 C--O 1.176 -2.796 0 C-N-CA 118.387 -1.325 . . . . 0.0 112.445 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' B' ' 17' ' ' GLY . 1.5 mt 137.78 155.22 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 130.962 3.705 . . . . 0.0 106.035 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 88.2 p -100.88 155.65 17.82 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.33 -0.948 . . . . 0.0 108.709 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' B' ' 111' ' ' MET . 12.9 m-20 -58.29 -40.34 81.7 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -74.23 -39.07 63.33 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.72 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -70.67 -24.96 62.78 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.433 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.484 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -54.08 -41.98 68.81 Favored 'General case' 0 N--CA 1.413 -2.283 0 C-N-CA 123.742 0.817 . . . . 0.0 110.256 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.671 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 0.6 OUTLIER -70.69 -23.98 62.58 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.285 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . 0.611 ' HA ' ' ND2' ' B' ' 116' ' ' ASN 0.263 18.5 mt-10 -86.82 -37.63 17.6 Favored 'General case' 0 N--CA 1.387 -3.587 0 C-N-CA 118.363 -1.335 . . . . 0.0 110.533 -173.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.34 -46.58 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.282 0 CA-C-N 112.79 -2.004 . . . . 0.0 108.675 169.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 66.4 m-20 -60.34 -53.56 56.22 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 111.186 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.611 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 4.0 p30 -66.36 -40.58 89.87 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.256 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.9 -35.38 74.74 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 121.217 0.532 . . . . 0.0 109.579 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.53 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 8.9 tp -71.05 -45.92 62.96 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.38 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.501 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 3.0 ttp -67.23 -25.14 65.94 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.333 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.526 HG13 ' O ' ' B' ' 116' ' ' ASN . 45.7 mt -80.1 -53.35 13.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 33.8 t -47.65 -45.68 28.17 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.043 1.337 . . . . 0.0 112.248 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.435 ' HG ' HG12 ' A' ' 54' ' ' ILE . 9.6 mp -81.93 10.56 6.23 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.64 9.34 83.31 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 170.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' B' ' 119' ' ' MET . 1.4 mm? -72.49 -62.08 1.57 Allowed 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 118.284 1.042 . . . . 0.0 108.884 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--N 1.303 -1.43 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.857 -173.529 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.454 HD12 ' HZ3' ' A' ' 96' ' ' LYS . 59.8 mt . . . . . 0 N--CA 1.424 -1.734 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -144.4 160.62 40.74 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.545 ' HD3' ' O ' ' A' ' 41' ' ' ILE . 49.8 ttp180 -72.8 113.55 9.97 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.711 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 144.78 -27.88 1.9 Allowed Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.069 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.97 138.49 35.21 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 121.25 0.547 . . . . 0.0 111.045 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 62.8 t -89.89 121.14 39.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.706 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 23.0 m-85 -110.9 145.87 37.53 Favored 'General case' 0 C--N 1.264 -3.122 0 C-N-CA 124.135 0.974 . . . . 0.0 109.892 173.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.9 mp -84.34 151.45 24.72 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.5 154.7 36.02 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-O 121.794 0.807 . . . . 0.0 111.395 -173.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -88.99 95.14 10.2 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 27' ' ' VAL 0.259 1.3 tt -92.09 -11.17 36.49 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -174.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.461 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 4.5 m -33.71 -177.64 0.0 OUTLIER Pre-proline 0 CA--C 1.596 2.738 0 C-N-CA 129.589 3.156 . . . . 0.0 114.978 171.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 31.76 37.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 123.796 2.997 . . . . 0.0 117.404 -154.272 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 24' ' ' LEU . 8.5 m -73.19 146.83 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.616 163.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -114.75 124.43 51.76 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.42 -109.08 1.94 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 114.941 -1.027 . . . . 0.0 114.659 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.6 m -64.29 -21.23 66.53 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 124.76 1.224 . . . . 0.0 112.873 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.439 ' CB ' ' HB ' ' A' ' 27' ' ' VAL . 79.2 mt-10 -69.97 142.92 52.78 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -126.73 115.58 19.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' A' ' 24' ' ' LEU . . . -160.26 -88.52 0.07 OUTLIER Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 118.958 -1.592 . . . . 0.0 114.32 173.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.99 -145.93 27.6 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 -168.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.96 122.11 54.95 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.266 0 CA-C-N 119.804 1.802 . . . . 0.0 108.486 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -146.91 163.04 30.87 Favored Pre-proline 0 C--N 1.288 -2.076 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.967 -174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 17.0 Cg_exo -70.02 138.25 36.58 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 121.74 1.627 . . . . 0.0 109.208 167.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.83 162.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 31.6 m -102.3 128.83 54.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.054 175.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.8 mm -87.14 109.56 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.545 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -105.58 -17.87 7.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.764 -177.15 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.63 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 7.1 tt0 -64.3 164.62 10.85 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -170.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.608 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 21.4 p-10 -62.63 180.0 0.3 Allowed 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.844 1.658 . . . . 0.0 111.913 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.34 -48.04 37.56 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.674 -1.603 . . . . 0.0 113.069 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.3 m -86.6 -25.22 25.07 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -162.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 50' ' ' SER . . . -63.19 -30.15 76.63 Favored Glycine 0 C--O 1.192 -2.486 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -68.23 -36.44 79.5 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.428 0.633 . . . . 0.0 110.24 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -81.99 -50.39 9.17 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.615 -172.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -97.67 -15.37 20.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -172.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 23.1 t -114.45 145.92 34.79 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.14 -3.01 10.25 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.468 2.112 . . . . 0.0 111.67 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 p -111.66 139.33 47.21 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.487 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.63 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -137.65 139.72 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 120.811 0.338 . . . . 0.0 111.549 176.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 5.1 tt -87.51 129.02 39.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.014 0 CA-C-O 121.595 0.712 . . . . 0.0 112.477 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.454 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 21.9 m -133.88 168.21 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.229 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.548 ' CB ' HG23 ' A' ' 91' ' ' ILE . . . -125.69 140.68 52.5 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.68 128.76 37.19 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.574 HG12 ' CD1' ' A' ' 86' ' ' ILE . 62.7 mt -86.85 130.34 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.486 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.5 m -128.23 114.72 17.3 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.268 0.556 . . . . 0.0 111.931 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.712 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 176.043 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 tt . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.95 -5.05 6.92 Favored 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.979 3.119 . . . . 0.0 116.253 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.2 p -92.78 -12.3 31.59 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.857 0.836 . . . . 0.0 109.522 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -107.45 129.59 54.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.2 p -128.15 136.34 60.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.745 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -99.55 137.98 37.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.992 0.901 . . . . 0.0 112.316 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.687 HG22 ' CE1' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -119.92 160.69 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.117 -179.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.3 117.57 18.11 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 31.9 pttt -53.09 -44.6 67.7 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -52.37 -39.58 60.97 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 125.455 1.502 . . . . 0.0 111.15 177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.465 ' HD3' ' OG ' ' A' ' 107' ' ' SER . 40.2 ttmt -74.62 -35.75 62.92 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 -176.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.687 ' CE1' HG22 ' A' ' 73' ' ' ILE . 2.7 m-85 -97.51 8.86 43.83 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.645 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.3 tttm 71.81 11.32 6.29 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 125.185 1.394 . . . . 0.0 113.495 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.02 170.92 11.14 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-O 122.384 1.088 . . . . 0.0 109.948 174.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -108.39 -4.85 17.03 Favored 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.994 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -128.63 147.42 50.73 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 2.4 m-20 -52.74 134.24 36.5 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 124.045 0.84 . . . . 0.0 110.72 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 73' ' ' ILE . 13.9 m -102.14 122.96 45.16 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.163 -169.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 37.3 t -113.82 135.8 52.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.574 ' CD1' HG12 ' A' ' 58' ' ' ILE . 16.5 mm -106.14 136.64 39.83 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 N-CA-C 106.33 -1.729 . . . . 0.0 106.33 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.32 107.58 18.66 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.57 14.89 6.16 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.015 0.912 . . . . 0.0 111.498 -173.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -114.57 -44.34 3.09 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.158 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 80.78 6.62 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.548 HG23 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -122.95 -178.14 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.915 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . 0.254 13.5 ptp180 -175.3 167.27 3.38 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 171.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' ILE . 94.1 m -108.65 121.78 45.73 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.188 -178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.1 mt -131.1 145.61 52.06 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 124.548 1.155 . . . . 0.0 111.142 -169.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.616 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 20.1 t70 -50.94 137.07 21.72 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.632 1.173 . . . . 0.0 112.782 172.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.454 ' HZ3' HD12 ' A' ' 14' ' ' ILE . 30.0 mtpp -55.9 -29.51 60.14 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.829 0.852 . . . . 0.0 112.435 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 9.1 mtmp? -87.75 -9.58 53.58 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.888 -175.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 12.1 ptm180 -90.65 -17.19 27.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.668 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.34 127.02 31.57 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 161.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -99.0 -59.73 1.67 Allowed 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -172.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 13.3 pt-20 -147.98 131.71 16.95 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -169.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -63.67 108.94 1.53 Allowed 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 128.552 2.741 . . . . 0.0 107.118 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.686 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 57.2 tp -106.32 -63.07 1.3 Allowed 'General case' 0 N--CA 1.411 -2.4 0 CA-C-O 122.386 1.089 . . . . 0.0 111.435 -171.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.686 ' OG1' ' HG ' ' A' ' 103' ' ' LEU 0.291 19.9 m -138.32 -157.06 0.74 Allowed 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 113.76 -1.563 . . . . 0.0 111.437 -165.082 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.54 ' H ' HG22 ' A' ' 104' ' ' THR . 12.9 t80 -159.15 151.84 21.74 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 119.653 1.115 . . . . 0.0 110.513 -161.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.474 ' CG ' ' HH ' ' A' ' 78' ' ' TYR . 6.2 mp -115.1 138.37 50.96 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.37 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.465 ' OG ' ' HD3' ' A' ' 77' ' ' LYS . 19.7 m -79.79 157.33 27.1 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.534 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 111' ' ' MET . 26.1 t70 -63.61 -37.39 87.16 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.195 0.598 . . . . 0.0 112.197 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.23 -40.35 95.85 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 123.329 0.652 . . . . 0.0 110.696 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.423 ' HE3' HG23 ' A' ' 73' ' ' ILE . 14.9 tppt? -77.98 -27.42 49.12 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.957 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.527 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 1.3 mmt -50.09 -46.84 53.84 Favored 'General case' 0 CA--C 1.461 -2.447 0 CA-C-O 122.223 1.011 . . . . 0.0 109.345 171.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.414 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 8.0 mmpt? -72.94 -12.36 60.92 Favored 'General case' 0 N--CA 1.392 -3.337 0 CA-C-N 113.853 -1.521 . . . . 0.0 114.012 -177.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -90.7 -52.1 5.05 Favored 'General case' 0 N--CA 1.385 -3.709 0 C-N-CA 117.469 -1.692 . . . . 0.0 107.59 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -51.87 -59.28 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 113.217 -1.81 . . . . 0.0 113.141 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 56.7 m-20 -59.22 -39.37 82.48 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 123.534 1.635 . . . . 0.0 110.732 -177.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -80.56 -41.95 23.2 Favored 'General case' 0 C--N 1.256 -3.468 0 CA-C-N 112.442 -2.163 . . . . 0.0 112.722 -172.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.45 -35.38 73.93 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 122.191 0.996 . . . . 0.0 108.332 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 3.9 tp -68.09 -40.36 82.68 Favored 'General case' 0 N--CA 1.384 -3.757 0 CA-C-N 113.211 -1.813 . . . . 0.0 110.141 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.2 ttp -72.02 -19.94 61.78 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.33 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 54.1 mt -84.7 -52.75 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.8 t -47.93 -46.33 31.95 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.938 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.06 5.71 13.46 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.04 81.91 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 116.48 1.352 . . . . 0.0 116.48 171.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.28 -52.51 13.7 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 117.413 -1.715 . . . . 0.0 107.867 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.2 m120 . . . . . 0 C--N 1.313 -1.019 0 CA-C-N 113.191 -1.822 . . . . 0.0 115.149 -178.721 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . 0.421 HD13 ' NZ ' ' B' ' 96' ' ' LYS . 62.1 mt . . . . . 0 N--CA 1.43 -1.426 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -144.87 160.73 40.82 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' B' ' 41' ' ' ILE . 50.5 ttp180 -71.39 114.4 9.41 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 143.31 -27.74 2.11 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.388 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -97.73 138.51 35.0 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.244 0.545 . . . . 0.0 111.05 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -89.76 123.44 41.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.528 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 31.1 m-85 -113.04 146.29 39.38 Favored 'General case' 0 C--N 1.267 -3.016 0 C-N-CA 124.122 0.969 . . . . 0.0 109.806 172.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.1 mp -83.34 152.21 25.19 Favored 'General case' 0 N--CA 1.399 -2.983 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 167.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.38 156.84 40.34 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-O 121.785 0.802 . . . . 0.0 111.428 -173.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.98 93.88 8.99 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.529 ' O ' HG13 ' B' ' 27' ' ' VAL 0.25 1.6 tt -90.58 -11.24 40.59 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -174.401 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 9.2 m -33.55 -177.45 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.668 0 C-N-CA 129.497 3.119 . . . . 0.0 115.364 170.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 31.59 36.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 123.751 2.968 . . . . 0.0 117.421 -154.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.529 HG13 ' O ' ' B' ' 24' ' ' LEU . 6.9 m -73.24 148.51 8.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.61 164.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -117.48 122.51 43.93 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.75 -111.89 4.14 Favored Glycine 0 C--N 1.32 -0.344 0 CA-C-N 115.087 -0.96 . . . . 0.0 114.121 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 18.2 m -60.17 -21.86 62.19 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.651 1.18 . . . . 0.0 113.122 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.466 ' CB ' ' HB ' ' B' ' 27' ' ' VAL . 73.2 mt-10 -70.3 143.48 52.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -128.25 117.22 21.12 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . 0.434 ' HA3' HD21 ' B' ' 24' ' ' LEU . . . -160.51 -91.66 0.08 OUTLIER Glycine 0 N--CA 1.415 -2.757 0 C-N-CA 119.437 -1.363 . . . . 0.0 113.964 173.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.96 -147.45 27.66 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 105.391 -3.084 . . . . 0.0 105.391 -167.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.95 122.08 51.41 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 119.766 1.783 . . . . 0.0 108.821 172.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -145.86 162.94 33.68 Favored Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.9 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 18.4 Cg_exo -69.98 138.46 37.15 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.855 1.704 . . . . 0.0 109.008 167.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.54 161.98 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.505 ' CG2' ' HB2' ' B' ' 56' ' ' ALA . 29.1 m -101.5 129.44 52.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.186 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 33.9 mm -88.26 109.58 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.474 ' O ' ' HD3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -105.64 -18.01 7.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.734 -177.081 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.631 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 7.0 tt0 -64.92 163.73 13.9 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -170.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.622 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 13.3 p-10 -65.11 178.89 0.78 Allowed 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.876 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.05 -47.76 49.25 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 112.827 -1.988 . . . . 0.0 113.039 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 3.5 m -87.28 -24.16 24.44 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -162.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.69 -30.27 77.15 Favored Glycine 0 C--O 1.2 -1.986 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -66.29 -40.25 89.92 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 120.886 0.374 . . . . 0.0 110.624 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -78.76 -54.9 5.61 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-O 121.06 0.457 . . . . 0.0 112.04 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -88.07 -25.06 23.25 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 13.9 t -107.6 144.83 30.05 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.93 -6.1 12.26 Favored 'Trans proline' 0 C--O 1.241 0.639 0 C-N-CA 122.433 2.089 . . . . 0.0 111.631 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 3.7 p -107.68 142.3 37.87 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.336 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.631 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.1 OUTLIER -140.5 139.64 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 120.803 0.335 . . . . 0.0 111.6 176.067 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' B' ' 93' ' ' THR . 4.8 tt -87.7 130.08 38.0 Favored 'Isoleucine or valine' 0 C--O 1.247 0.941 0 CA-C-O 121.611 0.72 . . . . 0.0 112.901 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.478 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 20.0 m -134.67 167.91 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.169 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.505 ' HB2' ' CG2' ' B' ' 39' ' ' VAL . . . -125.15 140.25 53.04 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.97 127.75 33.94 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.558 HG12 ' CD1' ' B' ' 86' ' ' ILE . 60.0 mt -85.54 130.81 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.535 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 91.7 m -128.26 112.76 14.83 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.43 0.633 . . . . 0.0 111.856 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.053 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 175.52 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.8 tt . . . . . 0 CA--C 1.548 0.894 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.24 -12.99 21.95 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.854 3.036 . . . . 0.0 116.272 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 69.9 p -87.27 -13.51 43.51 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.763 0.792 . . . . 0.0 110.038 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -105.7 130.44 53.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 9.9 p -129.02 136.75 58.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.798 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -98.37 137.68 36.73 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-O 121.925 0.869 . . . . 0.0 112.025 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.67 HG22 ' CE1' ' B' ' 78' ' ' TYR . 0.3 OUTLIER -120.13 158.22 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.394 -179.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -72.95 116.19 13.16 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . 0.402 ' HB3' ' HA ' ' B' ' 83' ' ' ASP . 35.0 pttt -53.2 -43.28 67.07 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -53.22 -43.33 67.18 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 125.127 1.371 . . . . 0.0 111.011 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . 0.505 ' HD3' ' OG ' ' B' ' 107' ' ' SER . 41.0 ttmt -71.82 -34.57 69.44 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.208 -175.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.67 ' CE1' HG22 ' B' ' 73' ' ' ILE . 3.1 m-85 -96.82 7.97 45.41 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.369 0.604 . . . . 0.0 111.106 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 61.2 tttm 70.5 13.35 7.43 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.957 1.303 . . . . 0.0 113.206 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.58 167.29 13.52 Favored 'General case' 0 CA--C 1.478 -1.796 0 CA-C-O 122.212 1.006 . . . . 0.0 110.235 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -99.86 -11.74 20.47 Favored 'General case' 0 C--N 1.271 -2.825 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.041 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -126.29 149.6 49.02 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' B' ' 75' ' ' LYS . 2.7 m-20 -52.45 132.96 35.48 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 124.225 0.953 . . . . 0.0 110.116 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.4 ' O ' HG12 ' B' ' 73' ' ' ILE . 10.9 m -102.39 121.99 43.41 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.826 -169.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 39.1 t -113.49 135.03 54.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.558 ' CD1' HG12 ' B' ' 58' ' ' ILE . 17.2 mm -104.94 135.91 40.9 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.853 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.4 mt -105.14 107.68 18.8 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' B' ' 118' ' ' LEU . 3.7 mm? -85.64 12.28 9.09 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.908 0.861 . . . . 0.0 111.567 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.39 -44.01 3.43 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.492 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.23 80.56 6.87 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.254 1.026 . . . . 0.0 108.252 178.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 2.2 pp -123.1 -178.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.033 -1.439 . . . . 0.0 108.192 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -175.3 167.56 3.37 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 171.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' B' ' 54' ' ' ILE . 96.0 m -108.5 121.84 45.81 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.173 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.408 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 71.7 mt -131.22 145.33 51.88 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 124.707 1.254 . . . . 0.0 110.93 -169.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.607 ' O ' ' HG2' ' B' ' 98' ' ' ARG . 27.5 t70 -52.52 136.42 32.17 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.977 0.911 . . . . 0.0 112.911 172.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.421 ' NZ ' HD13 ' B' ' 14' ' ' ILE . 29.0 mtpp -54.65 -29.85 53.53 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.115 0.966 . . . . 0.0 112.371 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' OD2' ' B' ' 95' ' ' ASP . 9.8 mtmp? -83.7 -17.95 39.58 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.585 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' B' ' 95' ' ' ASP . 11.8 ptm180 -86.25 -17.85 33.64 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.814 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.68 121.35 16.27 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 162.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -92.19 -60.39 1.86 Allowed 'General case' 0 C--N 1.268 -2.938 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -170.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.6 pt-20 -148.68 130.19 14.86 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-O 122.512 1.149 . . . . 0.0 114.044 -168.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -61.14 110.89 1.51 Allowed 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 128.497 2.719 . . . . 0.0 106.924 173.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.66 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 53.7 tp -107.44 -64.19 1.22 Allowed 'General case' 0 N--CA 1.402 -2.853 0 CA-C-O 121.94 0.876 . . . . 0.0 111.05 -172.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.66 ' OG1' ' HG ' ' B' ' 103' ' ' LEU 0.291 17.4 m -138.12 -157.12 0.74 Allowed 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.216 -164.2 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.529 ' H ' ' CG2' ' B' ' 104' ' ' THR . 11.9 t80 -158.32 153.63 25.78 Favored 'General case' 0 N--CA 1.402 -2.859 0 CA-C-N 119.703 1.138 . . . . 0.0 110.1 -161.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.04 138.9 50.34 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.351 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' SER . . . . . 0.505 ' OG ' ' HD3' ' B' ' 77' ' ' LYS . 27.7 m -82.76 156.75 23.54 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.411 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' B' ' 111' ' ' MET . 20.0 t70 -61.96 -36.78 82.46 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.42 0.629 . . . . 0.0 111.765 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -62.1 -40.95 97.61 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.623 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.485 ' HG2' ' HH ' ' B' ' 78' ' ' TYR . 13.6 tppt? -77.24 -28.74 53.75 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.175 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.5 OUTLIER -49.33 -46.17 46.46 Favored 'General case' 0 CA--C 1.459 -2.536 0 CA-C-O 122.143 0.973 . . . . 0.0 109.088 171.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.468 ' HA ' ' CE ' ' B' ' 112' ' ' LYS . 6.1 mmpt? -71.48 -16.22 62.35 Favored 'General case' 0 N--CA 1.38 -3.926 0 CA-C-N 113.841 -1.527 . . . . 0.0 114.848 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -89.89 -51.59 5.41 Favored 'General case' 0 N--CA 1.388 -3.566 0 C-N-CA 117.014 -1.874 . . . . 0.0 107.27 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.72 -59.62 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 113.36 -1.745 . . . . 0.0 113.293 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 49.1 m-20 -59.47 -40.3 86.49 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 123.713 1.721 . . . . 0.0 111.32 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.407 ' O ' HG13 ' B' ' 120' ' ' ILE 0.351 25.9 t30 -80.74 -40.38 25.34 Favored 'General case' 0 C--N 1.255 -3.54 0 CA-C-N 112.711 -2.04 . . . . 0.0 112.391 -171.397 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.98 74.61 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 121.981 0.896 . . . . 0.0 108.681 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.8 tp -67.45 -39.67 85.35 Favored 'General case' 0 N--CA 1.38 -3.939 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.576 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 8.6 ttp -71.83 -20.37 61.84 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 123.61 0.764 . . . . 0.0 110.042 -175.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.407 HG13 ' O ' ' B' ' 116' ' ' ASN . 63.5 mt -84.3 -53.17 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.2 t -47.72 -46.09 29.32 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.993 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.401 HD12 ' O ' ' B' ' 118' ' ' LEU . 8.7 mp -79.75 5.83 12.44 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.65 9.77 79.0 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 116.195 1.238 . . . . 0.0 116.195 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 mt -71.56 -54.37 10.71 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 119.498 1.649 . . . . 0.0 107.762 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 21.3 m120 . . . . . 0 C--N 1.312 -1.045 0 CA-C-N 113.049 -1.887 . . . . 0.0 115.031 -177.645 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mt . . . . . 0 N--CA 1.438 -1.037 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -115.6 144.36 44.01 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 19.7 ptt180 -73.87 152.3 40.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.879 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.17 -2.71 79.28 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.977 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -97.71 177.88 5.33 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 3.9 t -133.62 134.45 56.55 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 C-N-CA 122.806 0.442 . . . . 0.0 111.844 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 12.5 m-85 -131.51 144.32 51.04 Favored 'General case' 0 CA--C 1.467 -2.232 0 C-N-CA 124.46 1.104 . . . . 0.0 110.146 177.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mp -79.58 151.49 30.62 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 169.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.01 139.47 23.64 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.278 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -74.37 92.65 2.32 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.146 0.974 . . . . 0.0 109.773 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.556 ' O ' HG13 ' A' ' 27' ' ' VAL . 83.7 mt -82.19 -12.41 58.14 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-N 113.892 -1.504 . . . . 0.0 112.11 -177.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.83 61.79 0.0 OUTLIER Pre-proline 0 C--N 1.257 -3.453 0 N-CA-C 119.754 3.242 . . . . 0.0 119.754 -176.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HB2' ' O ' ' B' ' 26' ' ' PRO . 1.1 Cg_endo -117.68 22.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 N-CA-C 108.46 -1.4 . . . . 0.0 108.46 148.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 24' ' ' LEU . 14.1 m -72.81 157.97 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.943 0.878 . . . . 0.0 113.364 -172.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -124.01 156.3 36.71 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.721 -1.581 . . . . 0.0 107.163 175.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.95 -135.44 15.09 Favored Glycine 0 N--CA 1.418 -2.556 0 O-C-N 124.131 0.894 . . . . 0.0 112.068 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.6 m -94.34 6.93 47.2 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.476 -0.362 . . . . 0.0 111.686 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.33 153.14 42.58 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 119.374 -0.931 . . . . 0.0 112.959 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -81.85 119.15 23.55 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -171.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.4 158.97 17.19 Favored Glycine 0 CA--C 1.472 -2.651 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.495 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 111.63 137.97 7.39 Favored Glycine 0 C--N 1.276 -2.793 0 CA-C-N 113.016 -1.592 . . . . 0.0 109.972 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 p -64.6 119.13 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.124 0 CA-C-O 122.365 1.079 . . . . 0.0 109.039 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -144.93 149.22 41.77 Favored Pre-proline 0 C--N 1.267 -3.015 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.209 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 33.3 Cg_exo -58.76 136.59 74.82 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.311 2.007 . . . . 0.0 111.37 171.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 20' ' ' TYR . 29.4 m -122.51 161.68 23.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 123.933 0.893 . . . . 0.0 108.721 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.403 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 32.6 m -101.48 132.11 47.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 120.722 0.296 . . . . 0.0 110.697 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mm -86.04 105.12 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.451 HD13 ' C ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -97.39 -23.46 4.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.535 -177.081 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.586 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -64.5 168.49 5.8 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -167.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.557 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 12.9 p-10 -66.53 177.62 1.5 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.464 -1.698 . . . . 0.0 110.632 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 16.8 t70 -89.18 -29.56 19.21 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.188 -176.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.567 ' HA ' ' CD ' ' A' ' 48' ' ' LYS . 45.1 m -82.79 -26.17 32.06 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.42 -21.69 74.44 Favored Glycine 0 C--O 1.196 -2.238 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -82.12 -26.79 33.25 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.273 0.559 . . . . 0.0 109.931 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.567 ' CD ' ' HA ' ' A' ' 45' ' ' THR . 6.6 mtpp -82.94 -57.98 3.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.978 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -96.35 -35.86 11.06 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.6 m -90.84 158.74 41.71 Favored Pre-proline 0 C--N 1.29 -2.02 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -87.86 -11.45 4.69 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.38 1.387 . . . . 0.0 110.849 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 17.0 p -96.26 149.88 21.17 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.489 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -148.58 137.95 15.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.363 170.511 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.586 HG22 ' HG3' ' A' ' 42' ' ' GLN . 15.0 tt -86.47 135.32 25.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-O 121.444 0.64 . . . . 0.0 110.29 175.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.99 146.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.994 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 91' ' ' ILE . . . -109.76 135.64 50.36 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.78 145.1 48.93 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.435 HG12 HD11 ' A' ' 86' ' ' ILE . 49.1 mt -100.79 143.74 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.969 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 m -92.35 173.37 7.84 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.888 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 171.082 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 mt . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.0 2.44 2.14 Favored 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.101 1.867 . . . . 0.0 113.841 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 p -100.91 -18.93 16.13 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.483 0.659 . . . . 0.0 109.728 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -102.03 130.09 48.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.28 136.94 52.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.568 173.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 10.2 pt-20 -101.38 146.61 27.36 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.082 0.468 . . . . 0.0 112.188 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.8 pt -112.75 146.08 17.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.11 109.0 6.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.842 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -60.32 -36.15 77.26 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.637 0.732 . . . . 0.0 112.789 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -51.4 -52.1 48.91 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.19 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -91.05 -25.62 19.57 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.361 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.57 ' CE2' ' HA ' ' A' ' 106' ' ' LEU . 1.9 m-85 -88.55 20.5 3.36 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 123.635 0.774 . . . . 0.0 111.858 -172.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 56.75 27.61 13.02 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.31 170.76 8.0 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.843 0.83 . . . . 0.0 109.718 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -99.8 -16.94 17.91 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.231 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.73 140.0 52.27 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.027 -173.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.81 102.8 14.0 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.0 t -103.28 172.75 6.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -165.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 37.7 t -123.9 142.97 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.435 HD11 HG12 ' A' ' 58' ' ' ILE . 20.9 mm -106.44 133.31 51.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.8 mt -105.95 107.06 17.87 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 121.462 0.648 . . . . 0.0 109.737 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.26 16.96 2.73 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.608 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.03 -40.28 3.52 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 122.13 0.967 . . . . 0.0 109.019 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.19 72.82 4.61 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.565 ' O ' ' HB ' ' B' ' 93' ' ' THR . 8.0 mt -106.62 -174.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.461 ' NH1' HD22 ' A' ' 24' ' ' LEU . 5.7 ptp180 -175.14 174.89 2.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 124.004 0.922 . . . . 0.0 109.733 166.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 68.0 m -125.27 130.05 51.26 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -132.99 143.08 49.2 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -80.54 153.05 28.32 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.876 175.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -47.12 -18.21 0.08 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 126.523 1.929 . . . . 0.0 115.333 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -74.31 -27.15 60.58 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.317 0.58 . . . . 0.0 111.132 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -74.84 -35.73 62.38 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.449 0.7 . . . . 0.0 110.47 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mp -74.6 122.98 23.98 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.398 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.45 -59.61 1.84 Allowed 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -154.85 135.55 13.56 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.478 0.656 . . . . 0.0 112.6 -168.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.631 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -64.62 121.26 14.04 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.608 173.462 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -113.78 -61.92 1.67 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.446 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.532 HG22 HG12 ' A' ' 19' ' ' VAL . 5.2 t -126.3 -164.35 1.32 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.069 -1.452 . . . . 0.0 112.348 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -159.84 147.14 16.61 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.812 0.845 . . . . 0.0 112.651 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.57 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . 13.1 mt -98.65 155.34 17.36 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.959 -1.473 . . . . 0.0 108.476 177.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.8 m -86.36 167.86 14.37 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 111' ' ' MET . 22.2 t70 -56.58 -43.62 80.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.69 0.796 . . . . 0.0 112.381 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.13 -41.55 98.36 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -67.23 -33.66 75.83 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.512 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -55.1 -42.41 72.85 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 123.967 0.907 . . . . 0.0 110.313 175.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.64 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -76.22 -11.98 60.01 Favored 'General case' 0 CA--C 1.472 -2.046 0 C-N-CA 122.947 0.499 . . . . 0.0 111.544 179.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -86.67 -43.47 12.59 Favored 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -55.92 -58.92 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.111 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.316 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.89 -49.92 62.06 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-O 123.311 1.529 . . . . 0.0 110.344 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.633 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 1.3 t30 -68.97 -49.76 55.07 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 112.203 -2.272 . . . . 0.0 112.743 -173.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.07 -39.75 83.08 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 2.4 tp -64.32 -47.36 79.73 Favored 'General case' 1 N--CA 1.378 -4.07 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.498 -175.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.575 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 1.9 ptm -71.19 -19.74 62.36 Favored 'General case' 0 C--O 1.202 -1.424 0 O-C-N 121.568 -0.707 . . . . 0.0 112.513 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 116' ' ' ASN . 54.2 mt -76.76 -53.54 14.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -55.89 -30.94 62.35 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.236 -1.802 . . . . 0.0 111.555 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 44.2 mt -101.6 5.48 41.66 Favored 'General case' 0 N--CA 1.425 -1.696 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.527 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.38 5.36 72.53 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 117.729 1.851 . . . . 0.0 117.729 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 119' ' ' MET . 6.9 mp -71.26 -45.18 63.77 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 120.544 2.172 . . . . 0.0 108.665 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.6 m120 . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 126.532 1.933 . . . . 0.0 116.006 177.08 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -114.5 144.83 42.72 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.548 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 19.9 ptt180 -75.31 147.4 40.2 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.777 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.02 -2.88 60.07 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.32 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -97.25 174.87 6.5 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 5.6 t -132.94 131.6 59.07 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.9 0 C-N-CA 123.596 0.759 . . . . 0.0 111.49 -176.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 8.4 m-85 -129.26 144.16 51.12 Favored 'General case' 0 CA--C 1.465 -2.296 0 C-N-CA 124.167 0.987 . . . . 0.0 110.396 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -79.94 151.1 30.27 Favored 'General case' 0 N--CA 1.4 -2.942 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.03 139.71 23.82 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.155 -175.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.64 92.29 1.95 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.048 0.928 . . . . 0.0 109.455 173.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.534 ' O ' HG13 ' B' ' 27' ' ' VAL . 90.2 mt -83.09 -9.97 58.94 Favored 'General case' 0 CA--C 1.474 -1.947 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.787 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.91 61.3 0.0 OUTLIER Pre-proline 0 C--N 1.247 -3.879 0 N-CA-C 119.262 3.06 . . . . 0.0 119.262 -176.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -117.74 21.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.255 0 N-CA-C 108.476 -1.394 . . . . 0.0 108.476 150.157 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.534 HG13 ' O ' ' B' ' 24' ' ' LEU . 15.2 m -72.62 157.91 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-O 122.085 0.945 . . . . 0.0 113.154 -171.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -124.05 155.98 37.35 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.354 -1.748 . . . . 0.0 107.679 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.26 -135.32 14.02 Favored Glycine 0 N--CA 1.421 -2.326 0 O-C-N 123.997 0.811 . . . . 0.0 112.109 173.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -94.75 8.41 42.63 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 122.661 0.384 . . . . 0.0 111.846 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.08 151.9 42.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.58 118.45 21.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 121.16 0.505 . . . . 0.0 109.857 -171.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.89 155.62 18.75 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-N 114.701 -1.136 . . . . 0.0 115.264 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 112.43 137.84 7.13 Favored Glycine 0 N--CA 1.418 -2.524 0 CA-C-N 113.023 -1.588 . . . . 0.0 110.364 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 p -63.62 119.67 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-O 122.4 1.095 . . . . 0.0 108.86 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -145.49 149.74 41.68 Favored Pre-proline 0 C--N 1.265 -3.068 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.304 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.2 Cg_exo -59.07 136.85 75.91 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.137 1.891 . . . . 0.0 111.201 171.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.494 HG21 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -122.76 161.02 24.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 123.968 0.907 . . . . 0.0 108.61 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 30.0 m -100.93 132.05 47.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 120.748 0.308 . . . . 0.0 110.723 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 26.1 mm -86.06 105.91 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.457 HD13 ' C ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -97.53 -25.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.383 -177.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.581 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.1 OUTLIER -63.12 167.85 4.65 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -167.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.56 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 14.5 p-10 -66.41 176.26 1.92 Allowed 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.083 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.98 -30.13 21.5 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.648 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' THR . . . . . 0.507 ' HA ' ' CD ' ' B' ' 48' ' ' LYS . 28.3 m -84.0 -25.52 29.89 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -170.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -68.61 -21.46 74.69 Favored Glycine 0 C--O 1.194 -2.394 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 176.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -82.88 -27.94 30.38 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.181 0.515 . . . . 0.0 110.018 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.507 ' CD ' ' HA ' ' B' ' 45' ' ' THR . 4.4 mtpp -80.74 -58.48 3.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.869 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -97.39 -35.89 10.54 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -172.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 38.5 m -88.11 156.59 51.74 Favored Pre-proline 0 C--N 1.292 -1.91 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.193 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -86.97 -12.32 5.06 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 121.22 1.28 . . . . 0.0 110.663 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 19.0 p -96.14 149.29 21.79 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.478 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.8 OUTLIER -148.1 137.87 16.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 O-C-N 123.94 0.775 . . . . 0.0 109.258 170.499 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.581 HG22 ' HG3' ' B' ' 42' ' ' GLN . 15.6 tt -86.54 135.47 25.05 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 CA-C-O 121.278 0.561 . . . . 0.0 110.277 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.67 145.65 29.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.965 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.59 135.17 51.0 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.76 145.87 48.47 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.443 HG12 HD11 ' B' ' 86' ' ' ILE . 45.6 mt -101.91 145.22 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.859 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 5.0 m -93.6 176.85 6.21 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.074 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 171.37 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.0 mt . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.05 6.86 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 122.32 2.013 . . . . 0.0 113.695 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -106.05 -18.52 14.0 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.529 0.681 . . . . 0.0 109.476 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -102.43 130.18 49.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.26 137.39 50.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 8.6 pt-20 -101.08 150.67 22.68 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.998 0.428 . . . . 0.0 112.152 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . . . . . . . . . 21.0 pt -117.16 144.41 25.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.78 109.76 5.16 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.869 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.6 -38.55 85.06 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.343 0.592 . . . . 0.0 112.499 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -51.22 -51.76 50.87 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.591 -1.64 . . . . 0.0 113.55 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -88.12 -26.43 22.49 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 118.764 -1.175 . . . . 0.0 112.022 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.538 ' CE2' ' HA ' ' B' ' 106' ' ' LEU . 1.7 m-85 -89.79 19.14 4.94 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 123.722 0.809 . . . . 0.0 111.547 -171.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 60.23 23.83 13.21 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 124.542 1.137 . . . . 0.0 113.818 169.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 mt -110.59 165.84 11.48 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.058 0.933 . . . . 0.0 110.52 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.52 -14.3 25.22 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.404 -1.726 . . . . 0.0 108.853 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.68 139.16 53.79 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.005 -174.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -85.13 103.77 14.42 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 41.8 t -104.56 172.83 6.58 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -164.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' B' ' 72' ' ' GLU . 38.4 t -124.42 142.68 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.443 HD11 HG12 ' B' ' 58' ' ' ILE . 19.8 mm -106.26 133.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 80.1 mt -106.04 106.99 17.76 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.495 0.664 . . . . 0.0 109.541 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.31 16.47 3.03 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.771 0.796 . . . . 0.0 111.599 -174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.6 -40.28 3.41 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 122.254 1.026 . . . . 0.0 109.168 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.49 74.16 5.18 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.566 ' O ' ' HB ' ' A' ' 93' ' ' THR . 8.4 mt -107.64 -174.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.496 ' NH1' ' HB3' ' B' ' 24' ' ' LEU . 5.8 ptp180 -174.48 173.76 2.87 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 123.923 0.889 . . . . 0.0 109.659 167.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 59.7 m -126.02 128.13 46.97 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -132.26 142.7 49.49 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.889 -172.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 0.8 OUTLIER -80.09 153.34 28.8 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.009 175.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -46.56 -20.78 0.13 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 126.5 1.92 . . . . 0.0 115.082 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -75.59 -22.41 56.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.023 0.439 . . . . 0.0 111.391 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -77.74 -36.82 50.33 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 122.994 0.518 . . . . 0.0 110.127 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.73 124.49 26.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 124.072 0.949 . . . . 0.0 110.547 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -96.0 -60.66 1.59 Allowed 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.3 pt-20 -154.72 135.24 13.42 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.396 0.617 . . . . 0.0 112.503 -167.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -63.94 122.6 16.89 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.837 172.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.3 tp -114.52 -62.48 1.59 Allowed 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.806 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.518 HG22 HG12 ' B' ' 19' ' ' VAL . 5.2 t -125.81 -164.68 1.33 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.702 -1.599 . . . . 0.0 112.458 -176.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -159.77 145.05 15.42 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.635 0.774 . . . . 0.0 111.866 -172.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.538 ' HA ' ' CE2' ' B' ' 78' ' ' TYR . 14.6 mt -98.22 156.43 16.7 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.526 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 49.7 m -84.08 169.22 15.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.389 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.527 ' O ' ' HB3' ' B' ' 111' ' ' MET . 12.1 t70 -59.0 -44.84 91.73 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.905 0.882 . . . . 0.0 111.875 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.31 -40.0 96.12 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.22 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -67.88 -33.11 74.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.527 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -55.08 -42.87 73.35 Favored 'General case' 0 N--CA 1.41 -2.431 0 C-N-CA 123.617 0.767 . . . . 0.0 110.205 175.068 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.705 ' O ' ' HB3' ' B' ' 116' ' ' ASN . 0.4 OUTLIER -74.94 -13.25 60.51 Favored 'General case' 0 CA--C 1.466 -2.276 0 C-N-CA 122.568 0.347 . . . . 0.0 111.738 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -86.01 -43.3 13.26 Favored 'General case' 0 N--CA 1.39 -3.435 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.78 -57.54 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.961 0 CA-C-N 112.906 -1.952 . . . . 0.0 111.922 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.7 -51.97 58.1 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 122.958 1.361 . . . . 0.0 109.56 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.705 ' HB3' ' O ' ' B' ' 112' ' ' LYS . 0.1 OUTLIER -70.06 -42.31 72.99 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 112.658 -2.065 . . . . 0.0 113.826 -171.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.91 97.0 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.512 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 2.5 tp -62.37 -45.89 91.12 Favored 'General case' 0 N--CA 1.382 -3.832 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.181 -176.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.564 ' HB2' ' HB2' ' B' ' 124' ' ' LEU . 2.0 ptm -72.14 -19.4 61.78 Favored 'General case' 0 C--O 1.205 -1.247 0 O-C-N 121.638 -0.664 . . . . 0.0 112.603 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.458 HG13 ' O ' ' B' ' 116' ' ' ASN . 59.0 mt -77.54 -53.72 13.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 173.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 9.9 t -55.37 -31.08 61.47 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.62 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 46.0 mt -101.41 5.62 42.18 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.13 10.42 71.59 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 117.419 1.727 . . . . 0.0 117.419 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.564 ' HB2' ' HB2' ' B' ' 119' ' ' MET . 7.0 mp -74.33 -44.11 53.86 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 120.402 2.101 . . . . 0.0 108.277 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 21.3 m120 . . . . . 0 N--CA 1.488 1.454 0 C-N-CA 126.716 2.007 . . . . 0.0 116.328 176.84 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.7 mt . . . . . 0 C--O 1.241 0.635 0 CA-C-O 120.882 0.372 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -114.97 153.87 29.8 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.52 ' HG2' ' SD ' ' A' ' 111' ' ' MET . 43.5 ttt180 -73.02 114.0 10.69 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.58 -7.54 10.35 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.478 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -81.31 172.34 13.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.153 0.978 . . . . 0.0 109.305 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.518 HG21 HG23 ' A' ' 104' ' ' THR . 19.6 t -133.07 135.14 57.25 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.129 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.457 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.1 m-85 -134.84 148.7 50.21 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -81.33 151.59 27.94 Favored 'General case' 0 N--CA 1.401 -2.906 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.455 171.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.74 133.91 47.3 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.038 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.476 ' HA ' ' HB ' ' A' ' 35' ' ' VAL 0.293 2.3 p-10 -88.47 99.71 12.49 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 117.875 -1.53 . . . . 0.0 111.282 178.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 4.5 mm? -84.84 40.22 0.79 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.788 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.292 2.7 m -67.74 170.22 7.64 Favored Pre-proline 0 C--N 1.261 -3.266 0 C-N-CA 127.835 2.454 . . . . 0.0 107.798 170.278 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.1 OUTLIER 2.23 53.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.408 3.688 1 C-N-CA 127.38 5.387 . . . . 0.0 118.051 -173.397 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.17 178.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.459 172.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -104.14 116.36 32.06 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -175.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.55 -117.69 11.71 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.297 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -94.48 19.57 9.52 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 160.41 30.09 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 173.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.575 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -75.57 119.26 19.39 Favored 'General case' 0 C--O 1.192 -1.967 0 CA-C-O 120.613 0.244 . . . . 0.0 110.705 -172.01 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -90.69 146.17 18.32 Favored Glycine 0 CA--C 1.474 -2.529 0 CA-C-O 121.636 0.576 . . . . 0.0 113.736 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.572 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 104.9 136.87 8.87 Favored Glycine 0 N--CA 1.421 -2.338 0 CA-C-N 113.511 -1.345 . . . . 0.0 111.343 176.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 1.3 p -67.76 120.01 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 CA-C-O 122.694 1.235 . . . . 0.0 110.324 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -139.68 156.77 70.95 Favored Pre-proline 0 C--N 1.266 -3.036 0 CA-C-N 112.814 -1.994 . . . . 0.0 110.434 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 34.5 Cg_exo -65.81 143.95 75.54 Favored 'Trans proline' 0 CA--C 1.555 1.531 0 C-N-CA 122.776 2.318 . . . . 0.0 112.216 172.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 20' ' ' TYR . 28.7 m -127.22 158.66 38.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.867 0.867 . . . . 0.0 109.218 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.71 134.76 45.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 O-C-N 123.154 0.284 . . . . 0.0 110.699 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 mm -82.12 96.94 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.436 HD11 ' C ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.43 -26.01 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.45 -178.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.5 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 4.5 pt20 -61.63 168.77 2.73 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 117.036 2.236 . . . . 0.0 117.036 -171.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -64.33 170.05 4.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 113.488 -1.687 . . . . 0.0 111.771 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.438 ' HA ' ' ND2' ' A' ' 47' ' ' ASN . 17.8 m-20 -81.07 -28.74 35.19 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 m -76.75 -34.93 58.03 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 122.197 -0.315 . . . . 0.0 110.607 -172.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.39 -25.68 74.64 Favored Glycine 0 C--O 1.21 -1.398 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.671 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' A' ' 44' ' ' ASP . 91.5 m-20 -63.1 -31.75 72.96 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.541 0.686 . . . . 0.0 109.983 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 20.0 mmmt -92.29 -64.21 1.14 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.947 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 54.9 m-85 -78.47 -36.19 45.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -167.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.532 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 58.9 m -93.63 133.21 28.44 Favored Pre-proline 0 N--CA 1.416 -2.13 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.363 -173.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -69.75 -21.52 33.41 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.631 1.554 . . . . 0.0 109.117 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.9 p -89.78 133.44 34.7 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.066 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.5 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 85.5 t -121.07 140.81 44.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.01 124.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 122.213 1.006 . . . . 0.0 109.911 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.441 HG11 HG11 ' A' ' 53' ' ' VAL . 24.5 m -133.59 173.03 15.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.989 -173.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.483 ' CB ' HG23 ' A' ' 91' ' ' ILE . . . -124.94 146.38 49.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.72 131.23 41.38 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.552 HG12 ' CD1' ' A' ' 86' ' ' ILE . 64.8 mt -90.07 124.66 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 113.891 -1.504 . . . . 0.0 107.356 172.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.461 ' HB ' HG23 ' A' ' 85' ' ' VAL . 64.7 m -123.07 154.24 38.82 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.543 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.113 -178.372 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.52 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 64.7 Cg_endo -71.56 35.79 0.29 Allowed 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 121.68 1.586 . . . . 0.0 113.906 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.9 p -124.02 -19.05 5.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.032 0.92 . . . . 0.0 108.576 171.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.489 ' CD2' HD21 ' A' ' 87' ' ' LEU . 36.1 m170 -124.24 129.91 51.61 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.3 p -125.88 136.35 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.457 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.99 135.54 45.3 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.744 0.783 . . . . 0.0 111.898 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.606 ' CG2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -120.3 155.39 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.334 0 CA-C-N 113.877 -1.511 . . . . 0.0 112.646 -173.183 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -67.83 112.36 4.84 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 125.38 1.472 . . . . 0.0 108.871 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -44.06 -50.77 8.3 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.694 1.598 . . . . 0.0 112.68 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -66.18 -23.65 66.5 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 124.944 1.298 . . . . 0.0 114.398 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -84.86 -31.42 23.78 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.148 0.975 . . . . 0.0 109.496 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.542 ' CZ ' HG22 ' A' ' 73' ' ' ILE . 4.2 m-85 -90.42 -8.22 51.13 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.631 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 62.15 25.7 15.4 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.866 1.267 . . . . 0.0 112.599 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 7.4 mp -85.07 172.52 11.2 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-O 122.992 1.377 . . . . 0.0 113.828 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.97 -23.97 61.52 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 111.518 -2.583 . . . . 0.0 110.651 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -152.31 160.03 43.39 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.377 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -56.04 136.36 52.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 123.993 0.808 . . . . 0.0 110.991 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 m -103.28 135.03 45.67 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.376 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.461 HG23 ' HB ' ' A' ' 59' ' ' THR . 1.1 m -116.84 131.62 68.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.552 ' CD1' HG12 ' A' ' 58' ' ' ILE . 23.1 mm -107.37 127.46 63.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.489 HD21 ' CD2' ' A' ' 70' ' ' HIS . 22.7 mt -103.69 109.82 21.67 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.84 8.18 27.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.275 -172.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -110.27 -35.82 5.98 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 122.122 0.963 . . . . 0.0 108.502 172.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.409 ' OE1' HG23 ' B' ' 52' ' ' THR . 5.8 tp60 -87.22 64.33 8.28 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.181 -1.372 . . . . 0.0 107.747 175.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.483 HG23 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -108.23 -176.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.418 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.575 ' NH2' ' HB3' ' A' ' 32' ' ' GLN . 8.2 ptp85 -164.98 163.89 20.7 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 52.3 m -122.5 116.39 23.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.3 mt -131.83 141.52 49.46 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.328 1.051 . . . . 0.0 109.412 -170.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -71.12 152.05 43.84 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.109 174.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.532 ' HE3' ' O ' ' A' ' 50' ' ' SER . 94.7 mttt -44.74 -26.03 0.35 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 126.245 1.818 . . . . 0.0 114.798 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -86.97 -14.6 41.26 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -81.59 -27.66 34.14 Favored 'General case' 0 N--CA 1.395 -3.188 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.34 117.89 15.63 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 169.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -89.35 -58.85 2.38 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.0 pt-20 -151.35 133.54 15.25 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 121.845 0.831 . . . . 0.0 112.6 -170.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -60.57 115.74 3.83 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 127.485 2.314 . . . . 0.0 107.61 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -111.71 -62.77 1.51 Allowed 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.664 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.518 HG23 HG21 ' A' ' 19' ' ' VAL . 3.5 t -129.63 -163.61 1.32 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.486 -1.285 . . . . 0.0 111.794 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -160.98 147.02 14.67 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 123.976 0.91 . . . . 0.0 111.028 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -114.68 161.69 17.78 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.615 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 p -82.97 151.64 25.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.56 ' O ' ' HB3' ' A' ' 111' ' ' MET . 25.5 t70 -59.16 -36.41 75.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.09 -23.04 59.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.46 0.648 . . . . 0.0 110.82 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.606 ' HD3' ' CG2' ' A' ' 73' ' ' ILE . 15.8 ttmm -85.94 -24.58 26.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.751 0.786 . . . . 0.0 109.578 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.56 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -53.73 -33.89 57.1 Favored 'General case' 0 N--CA 1.422 -1.841 0 C-N-CA 124.462 1.105 . . . . 0.0 109.818 170.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.571 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 7.1 mmpt? -69.78 -23.3 63.33 Favored 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.398 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -84.32 -31.25 24.95 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -173.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 1.6 t -67.15 -40.29 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.267 173.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.529 ' OD1' ' HG ' ' B' ' 124' ' ' LEU . 31.4 m-20 -63.07 -31.31 72.42 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.742 1.258 . . . . 0.0 110.607 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.751 ' O ' HD13 ' A' ' 120' ' ' ILE . 10.3 m-80 -80.06 -9.02 59.67 Favored 'General case' 1 N--CA 1.569 5.487 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.514 -176.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 68' ' ' PRO 0.275 . . -99.57 -49.0 4.55 Favored 'General case' 2 N--CA 1.344 -5.732 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 175.573 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 4.2 tp -67.61 -45.65 74.83 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.475 ' HE2' HD11 ' A' ' 120' ' ' ILE . 3.6 ttp -66.1 -22.48 66.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.653 0.781 . . . . 0.0 109.92 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.751 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -88.18 -51.56 12.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 17.3 t -54.15 -27.6 34.62 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 126.607 1.963 . . . . 0.0 111.926 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 56.0 mt -102.23 7.11 40.87 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.594 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.54 1.66 85.5 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.511 ' HG ' ' OD1' ' B' ' 115' ' ' ASP . 3.2 mp -65.96 -52.46 49.44 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.81 1.305 . . . . 0.0 109.217 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.7 m120 . . . . . 0 C--N 1.311 -1.088 0 CA-C-N 113.789 -1.55 . . . . 0.0 113.353 178.251 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt . . . . . 0 C--O 1.241 0.648 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -117.85 149.39 40.93 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.537 ' HG2' ' SD ' ' B' ' 111' ' ' MET . 42.7 ttt180 -68.38 114.23 6.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.52 1.6 19.86 Favored Glycine 0 N--CA 1.43 -1.7 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.377 -176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -90.97 173.96 7.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.514 HG21 HG23 ' B' ' 104' ' ' THR . 22.3 t -134.18 134.34 55.29 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.096 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.55 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 28.9 m-85 -133.93 148.72 51.23 Favored 'General case' 0 CA--C 1.475 -1.912 0 C-N-CA 124.645 1.178 . . . . 0.0 107.924 177.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.4 mp -82.39 150.59 27.05 Favored 'General case' 0 N--CA 1.401 -2.881 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.485 171.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.36 134.38 48.84 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.124 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' B' ' 25' ' ' SER 0.277 3.6 p-10 -90.27 99.13 12.2 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.693 -1.603 . . . . 0.0 111.314 178.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 4.2 mm? -83.09 40.44 0.7 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.54 -1.663 . . . . 0.0 111.679 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.46 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.272 5.6 m -66.55 166.66 16.64 Favored Pre-proline 0 C--N 1.269 -2.93 0 C-N-CA 127.528 2.331 . . . . 0.0 108.299 170.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 1.1 Cg_exo 5.66 53.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.399 3.228 1 C-N-CA 127.439 5.426 . . . . 0.0 117.674 -176.012 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.16 177.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 113.594 -1.639 . . . . 0.0 111.449 171.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -103.02 116.93 33.48 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.23 -176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.68 -121.19 19.16 Favored Glycine 0 CA--C 1.488 -1.631 0 CA-C-N 114.707 -1.133 . . . . 0.0 113.744 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.1 m -93.39 21.49 6.08 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.49 163.2 23.97 Favored 'General case' 0 C--O 1.256 1.443 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 172.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . 0.584 ' HB3' ' NH2' ' B' ' 92' ' ' ARG . 0.8 OUTLIER -78.22 116.8 18.92 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 122.768 0.427 . . . . 0.0 109.989 -174.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -91.34 142.46 16.11 Favored Glycine 0 CA--C 1.465 -3.061 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.817 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 111.81 137.73 7.27 Favored Glycine 0 N--CA 1.422 -2.275 0 CA-C-N 114.299 -0.95 . . . . 0.0 111.219 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' B' ' 23' ' ' ASP . 0.8 OUTLIER -72.82 121.64 23.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-O 122.499 1.142 . . . . 0.0 109.292 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -139.74 156.32 71.01 Favored Pre-proline 0 C--N 1.262 -3.198 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.366 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.3 Cg_exo -65.6 143.93 76.84 Favored 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 122.725 2.283 . . . . 0.0 111.898 172.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.478 HG23 ' O ' ' B' ' 20' ' ' TYR . 27.9 m -127.19 158.36 38.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 123.6 0.76 . . . . 0.0 109.185 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.89 134.34 45.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.514 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.89 97.03 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.433 ' C ' HD11 ' B' ' 41' ' ' ILE . 0.0 OUTLIER -93.81 -24.74 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.376 -178.449 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.519 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 4.1 pt20 -61.52 168.01 3.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 117.287 2.328 . . . . 0.0 117.287 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -62.54 169.57 2.94 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.971 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.06 -28.82 32.2 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -75.95 -38.01 58.03 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 122.293 -0.254 . . . . 0.0 110.539 -172.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.18 -28.55 73.68 Favored Glycine 0 C--O 1.212 -1.244 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -59.18 -34.15 71.79 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.779 0.8 . . . . 0.0 110.26 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.506 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 19.8 mmmt -92.01 -61.23 1.67 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.298 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.506 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 60.3 m-85 -80.44 -35.66 34.7 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -167.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.476 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 19.6 m -94.32 134.5 25.53 Favored Pre-proline 0 C--N 1.292 -1.921 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.587 -174.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.91 -20.08 29.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.931 1.754 . . . . 0.0 109.736 173.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' THR . . . . . 0.409 HG23 ' OE1' ' A' ' 90' ' ' GLN . 3.0 p -92.61 136.04 33.57 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.107 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.519 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 93.3 t -121.34 140.53 45.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.01 123.97 68.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-O 122.153 0.978 . . . . 0.0 109.705 175.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.429 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 27.7 m -133.07 172.8 15.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.957 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.471 ' CB ' HG23 ' B' ' 91' ' ' ILE . . . -124.58 146.04 49.27 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.3 131.36 41.84 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.55 HG12 ' CD1' ' B' ' 86' ' ' ILE . 60.8 mt -89.84 125.76 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' THR . . . . . 0.475 ' HB ' HG23 ' B' ' 85' ' ' VAL . 41.2 m -123.55 149.58 45.09 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.672 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.578 179.933 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.402 ' H ' HD13 ' B' ' 67' ' ' ILE . 2.5 mp . . . . . 0 CA--C 1.494 -1.176 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . 0.404 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 59.1 Cg_endo -69.82 37.1 0.24 Allowed 'Trans proline' 0 CA--C 1.553 1.464 0 C-N-CA 122.16 1.907 . . . . 0.0 113.877 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 59.4 p -127.03 -19.11 4.46 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . 0.54 ' CD2' HD23 ' B' ' 87' ' ' LEU . 31.9 m170 -123.49 129.94 51.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.68 136.25 61.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.171 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.13 139.82 37.24 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-O 121.294 0.569 . . . . 0.0 111.603 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.572 HG22 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -125.59 155.1 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.499 -174.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -66.74 114.78 5.9 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.033 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -45.62 -53.89 8.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.327 1.451 . . . . 0.0 112.163 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -61.45 -27.26 68.44 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -82.3 -34.25 28.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.705 0.764 . . . . 0.0 109.734 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.572 ' CZ ' HG22 ' B' ' 73' ' ' ILE . 4.1 m-85 -86.92 -7.96 57.69 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.647 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 65.22 23.14 12.22 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.982 1.313 . . . . 0.0 112.66 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.04 173.77 10.24 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 123.018 1.39 . . . . 0.0 114.051 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.74 -23.21 56.0 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 111.917 -2.401 . . . . 0.0 110.56 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -149.06 159.59 44.09 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.3 138.16 57.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 123.74 0.65 . . . . 0.0 110.464 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 11.3 m -103.11 134.2 46.93 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.079 -167.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' B' ' 59' ' ' THR . 1.1 m -116.64 131.99 67.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.55 ' CD1' HG12 ' B' ' 58' ' ' ILE . 23.6 mm -107.42 127.74 63.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 175.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.54 HD23 ' CD2' ' B' ' 70' ' ' HIS . 24.0 mt -103.06 109.22 20.7 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -177.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.83 7.7 32.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.71 0.767 . . . . 0.0 112.179 -172.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -108.76 -34.43 6.68 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-O 122.359 1.076 . . . . 0.0 108.542 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . 0.646 HE22 ' NH2' ' B' ' 92' ' ' ARG . 0.3 OUTLIER -92.79 72.85 4.91 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.477 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.3 pp -114.74 -175.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.712 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.646 ' NH2' HE22 ' B' ' 90' ' ' GLN . 8.5 ptp85 -164.91 164.67 20.74 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 53.5 m -122.58 115.52 22.3 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 68.4 mt -131.81 141.18 49.38 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.396 1.078 . . . . 0.0 109.344 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -72.16 152.68 42.12 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.301 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.476 ' HE3' ' O ' ' B' ' 50' ' ' SER . 93.3 mttt -46.65 -21.21 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.199 1.8 . . . . 0.0 115.145 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -89.0 -18.31 27.63 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -79.69 -27.34 40.73 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.71 120.53 19.43 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -91.87 -57.72 2.64 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 12.8 pt-20 -151.29 134.7 16.15 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.93 0.871 . . . . 0.0 112.728 -170.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -62.02 113.38 2.79 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 127.647 2.379 . . . . 0.0 108.8 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -109.81 -62.08 1.55 Allowed 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.769 -176.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.514 HG23 HG21 ' B' ' 19' ' ' VAL . 2.0 t -131.18 -164.48 1.44 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.45 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -161.05 145.01 13.37 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 123.838 0.855 . . . . 0.0 111.558 -171.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.78 162.37 16.39 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.542 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.8 p -83.18 149.56 26.77 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.151 0.58 . . . . 0.0 112.105 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' B' ' 111' ' ' MET . 26.9 t70 -59.55 -32.71 70.58 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.875 0.87 . . . . 0.0 113.129 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' B' ' 112' ' ' LYS . 27.2 t70 -76.81 -25.36 53.21 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.196 0.522 . . . . 0.0 110.596 178.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.56 ' HD3' ' CG2' ' B' ' 73' ' ' ILE . 15.8 ttmm -85.08 -24.62 28.02 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.877 0.846 . . . . 0.0 109.207 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.537 ' SD ' ' HG2' ' B' ' 16' ' ' ARG . 0.1 OUTLIER -52.92 -34.38 54.86 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 124.708 1.203 . . . . 0.0 109.983 169.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.554 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 7.1 mmpt? -69.78 -24.05 63.45 Favored 'General case' 0 N--CA 1.402 -2.866 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.25 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -85.21 -32.49 22.61 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.53 -42.15 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.48 0 CA-C-N 112.692 -2.049 . . . . 0.0 109.934 171.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.511 ' OD1' ' HG ' ' A' ' 124' ' ' LEU . 42.8 m-20 -60.31 -40.88 92.12 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 122.035 0.921 . . . . 0.0 109.87 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.728 ' O ' HD13 ' B' ' 120' ' ' ILE . 1.1 m-80 -64.29 -21.56 66.64 Favored 'General case' 0 N--CA 1.52 3.063 0 C-N-CA 125.362 1.465 . . . . 0.0 112.604 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' B' ' 68' ' ' PRO . . . -84.48 -53.03 5.71 Favored 'General case' 2 C--N 1.23 -4.605 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 4.1 tp -65.41 -46.76 78.73 Favored 'General case' 0 N--CA 1.4 -2.955 0 C-N-CA 124.494 1.117 . . . . 0.0 113.978 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.456 ' HE2' HD11 ' B' ' 120' ' ' ILE . 3.6 ttp -66.98 -24.85 66.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 123.644 0.778 . . . . 0.0 109.999 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.728 HD13 ' O ' ' B' ' 116' ' ' ASN . 2.5 mp -88.52 -45.83 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.0 t -55.18 -29.85 58.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.928 1.291 . . . . 0.0 111.359 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 58.4 mt -99.96 7.43 44.81 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 120.201 -0.599 . . . . 0.0 112.149 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.41 1.06 89.44 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 116.215 1.246 . . . . 0.0 116.215 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.529 ' HG ' ' OD1' ' A' ' 115' ' ' ASP . 3.4 mp -64.96 -51.08 63.73 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 118.832 1.316 . . . . 0.0 109.302 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m120 . . . . . 0 C--N 1.309 -1.179 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.513 179.211 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.414 -2.227 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -125.5 158.42 34.53 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.59 132.49 39.5 Favored 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.81 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.17 -6.17 56.14 Favored Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.165 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.43 ' CG ' ' HZ3' ' A' ' 102' ' ' LYS . 5.6 t70 -97.12 178.08 5.37 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 4.1 t -135.57 130.61 50.29 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 CA-C-O 121.491 0.662 . . . . 0.0 112.075 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 39.9 m-85 -130.49 145.53 51.87 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.316 176.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -80.31 149.83 30.17 Favored 'General case' 0 N--CA 1.395 -3.189 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 170.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.62 141.68 37.09 Favored 'General case' 0 C--N 1.257 -3.45 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.622 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.29 84.06 6.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.563 ' O ' HG11 ' A' ' 27' ' ' VAL . 91.6 mt -65.53 -27.81 68.72 Favored 'General case' 0 CA--C 1.468 -2.176 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.251 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.1 m -33.82 176.0 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.164 0 C-N-CA 128.375 2.67 . . . . 0.0 114.599 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.573 ' HB2' ' NE2' ' B' ' 28' ' ' GLN . 0.1 OUTLIER 22.92 51.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.108 0 C-N-CA 123.108 2.538 . . . . 0.0 115.554 -152.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.563 HG11 ' O ' ' A' ' 24' ' ' LEU . 14.9 m -72.02 -178.27 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.421 165.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.521 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 31.8 mm-40 -115.04 124.43 51.59 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.581 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.96 -109.1 1.67 Allowed Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 113.728 -1.578 . . . . 0.0 115.779 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -93.06 8.81 38.45 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 48.9 mt-10 -64.65 156.34 30.46 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 118.203 -1.399 . . . . 0.0 109.603 174.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.33 108.92 6.47 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -175.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.16 147.73 19.37 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 116.136 1.215 . . . . 0.0 116.136 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.48 157.19 12.38 Favored Glycine 0 N--CA 1.414 -2.83 0 CA-C-N 113.319 -1.44 . . . . 0.0 110.276 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -77.92 112.44 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 122.583 1.182 . . . . 0.0 108.283 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -134.16 158.73 74.62 Favored Pre-proline 0 C--N 1.259 -3.345 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.891 -172.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 36.0 Cg_exo -64.56 134.86 43.04 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.656 2.238 . . . . 0.0 110.984 173.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 20' ' ' TYR . 35.4 m -121.1 160.4 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.474 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 29.8 m -98.8 129.75 48.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -86.66 101.22 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.43 -20.71 5.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.636 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.493 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -55.02 158.54 2.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.232 1.413 . . . . 0.0 114.675 -170.668 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 172.28 4.89 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.322 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.21 -47.22 65.44 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.596 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -71.18 -34.17 70.67 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.919 -169.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.31 75.53 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.805 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -63.54 -35.17 79.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.187 0.517 . . . . 0.0 110.231 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -87.17 -53.39 4.88 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.301 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -96.64 -10.43 27.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -167.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.1 t -113.26 143.3 28.99 Favored Pre-proline 0 C--N 1.294 -1.83 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.191 -177.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 33.6 Cg_endo -71.39 -27.62 19.07 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.734 1.623 . . . . 0.0 109.892 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 p -97.18 142.8 28.65 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.117 -175.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.48 141.02 36.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.493 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 12.1 tt -82.02 133.79 28.44 Favored 'Isoleucine or valine' 0 C--O 1.257 1.451 0 CA-C-O 121.512 0.673 . . . . 0.0 110.739 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -136.27 155.49 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.283 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.474 ' HB1' ' CG2' ' A' ' 39' ' ' VAL . . . -121.01 141.13 51.02 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.06 129.8 38.56 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.493 HG12 ' CD1' ' A' ' 86' ' ' ILE . 57.7 mt -86.38 115.41 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 173.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.3 m -101.24 104.95 16.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.488 0.661 . . . . 0.0 110.903 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.855 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.66 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.5 tt . . . . . 0 N--CA 1.439 -1.004 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.444 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 9.3 Cg_endo -52.29 -34.07 58.23 Favored 'Trans proline' 0 C--O 1.208 -1.015 0 C-N-CA 122.832 2.355 . . . . 0.0 114.139 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 p -73.6 -18.96 60.99 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-N 118.238 0.472 . . . . 0.0 112.043 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -104.42 129.17 52.4 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 87.7 t -118.7 112.68 38.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.186 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -82.3 118.89 23.48 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.632 HD11 ' CE2' ' A' ' 78' ' ' TYR . 8.0 pt -101.74 133.27 45.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.268 -174.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.45 118.45 4.47 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.294 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.674 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 43.6 mttp -43.05 -48.6 6.15 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.653 1.216 . . . . 0.0 109.266 173.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -62.46 -29.13 70.3 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 112.781 -2.008 . . . . 0.0 113.28 -173.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -91.72 -29.03 17.05 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.489 0.661 . . . . 0.0 111.093 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.632 ' CE2' HD11 ' A' ' 73' ' ' ILE . 23.0 m-85 -95.84 9.58 40.04 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.256 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 tttm 61.63 27.84 17.17 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.385 1.088 . . . . 0.0 110.148 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.31 176.47 5.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.936 0.874 . . . . 0.0 109.915 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -102.79 -8.63 20.65 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.875 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.508 ' C ' ' HG2' ' A' ' 75' ' ' LYS . 9.9 ptpp? -144.1 143.56 31.19 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.674 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 34.0 m-20 -70.63 120.1 15.75 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 73' ' ' ILE . 25.3 t -104.57 174.05 6.04 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -175.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 13.3 t -122.39 139.5 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.493 ' CD1' HG12 ' A' ' 58' ' ' ILE . 19.6 mm -104.16 127.41 58.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 172.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.5 mt -102.41 104.9 15.4 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.557 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.423 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 4.0 mm? -83.06 3.33 30.88 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.653 0.74 . . . . 0.0 112.195 -175.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -97.79 -36.23 10.28 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 122.25 1.024 . . . . 0.0 108.352 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.428 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 3.1 tp60 -94.92 76.5 3.58 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.851 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.447 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -125.78 175.88 7.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -165.06 173.59 11.32 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 45.3 m -118.47 121.73 41.0 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.609 -175.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.415 ' HB3' ' HG3' ' A' ' 98' ' ' ARG . 77.0 mt -131.94 149.34 52.46 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.949 -173.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -57.55 143.64 40.17 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 170.17 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 19.0 pttm -53.8 -33.55 56.39 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.988 0.899 . . . . 0.0 112.565 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 95' ' ' ASP . 28.9 mtpt -47.5 -31.38 4.23 Favored 'General case' 0 C--N 1.278 -2.542 0 C-N-CA 127.062 2.145 . . . . 0.0 113.436 170.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.415 ' HG3' ' HB3' ' A' ' 94' ' ' LEU . 2.4 mmp_? -69.57 -31.22 69.27 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.508 0.67 . . . . 0.0 110.323 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 7.2 mp -70.75 131.45 43.87 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.181 1.393 . . . . 0.0 110.712 175.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -99.97 -57.45 2.13 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.281 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 13.2 pt-20 -159.26 146.59 17.19 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-O 121.39 0.614 . . . . 0.0 111.377 -169.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 64.9 tttp -62.65 125.62 24.55 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 126.601 1.96 . . . . 0.0 110.559 173.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 tp -114.74 -61.75 1.7 Allowed 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.179 174.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.501 HG23 HG21 ' A' ' 19' ' ' VAL . 5.3 t -129.35 -159.84 0.99 Allowed 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.554 -1.259 . . . . 0.0 111.98 -177.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -161.05 142.29 11.7 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.258 1.423 . . . . 0.0 109.519 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -105.31 156.57 18.02 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 m -81.81 158.93 23.91 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.475 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.32 -32.33 71.13 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.866 1.267 . . . . 0.0 112.007 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 5.4 p-10 -66.91 -28.23 68.14 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.565 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -73.67 -28.76 61.93 Favored 'General case' 0 CA--C 1.483 -1.622 0 O-C-N 123.404 0.44 . . . . 0.0 111.443 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.425 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -53.06 -48.02 68.01 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-O 121.987 0.899 . . . . 0.0 108.847 174.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.425 ' HE2' ' C ' ' A' ' 111' ' ' MET . 9.0 mmpt? -79.46 -9.82 59.68 Favored 'General case' 0 N--CA 1.39 -3.444 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.655 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 109' ' ' ASP . 38.1 mt-10 -86.54 -43.73 12.49 Favored 'General case' 0 CA--C 1.471 -2.095 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 176.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.0 t -49.81 -47.17 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.037 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.411 ' CG ' ' HZ3' ' A' ' 112' ' ' LYS . 3.9 m-20 -53.87 -41.64 67.75 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.091 0.948 . . . . 0.0 111.262 176.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.612 ' O ' HD13 ' A' ' 120' ' ' ILE . 24.1 m-80 -80.41 -22.93 40.75 Favored 'General case' 0 CA--C 1.434 -3.502 0 CA-C-O 123.315 1.531 . . . . 0.0 110.21 -173.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.616 ' O ' ' HB2' ' A' ' 121' ' ' SER . . . -84.37 -37.65 21.27 Favored 'General case' 2 N--CA 1.342 -5.844 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.625 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.719 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -82.67 -55.35 4.49 Favored 'General case' 1 N--CA 1.372 -4.352 0 C-N-CA 123.124 0.57 . . . . 0.0 112.23 -175.159 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.3 mtp -56.85 -35.52 68.95 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -75.27 -45.33 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.445 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.616 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 7.7 t -62.05 -32.12 72.6 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.257 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 13.0 mt -101.17 1.51 39.18 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.434 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.5 16.24 80.54 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.3 mp -67.99 -52.15 39.05 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-N 119.413 1.606 . . . . 0.0 110.411 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 m120 . . . . . 0 C--N 1.313 -0.984 0 O-C-N 125.654 1.846 . . . . 0.0 114.374 -174.633 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 70.2 mt . . . . . 0 N--CA 1.422 -1.873 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -119.79 157.55 28.38 Favored 'General case' 0 C--N 1.275 -2.666 0 O-C-N 123.828 0.705 . . . . 0.0 110.061 -172.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.27 125.81 29.92 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.846 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.28 -6.86 32.28 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.835 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -97.09 177.83 5.46 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 4.8 t -134.65 130.47 53.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-O 121.411 0.624 . . . . 0.0 112.039 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 39.4 m-85 -130.12 145.17 51.68 Favored 'General case' 0 CA--C 1.472 -2.023 0 C-N-CA 124.993 1.317 . . . . 0.0 109.118 176.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' B' ' 99' ' ' LEU . 4.3 mp -79.28 151.75 30.94 Favored 'General case' 0 N--CA 1.395 -3.179 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 170.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.71 141.68 33.31 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.925 -176.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.8 83.96 6.43 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.551 ' O ' HG11 ' B' ' 27' ' ' VAL . 90.8 mt -64.92 -26.88 68.5 Favored 'General case' 0 CA--C 1.469 -2.162 0 CA-C-N 112.995 -1.911 . . . . 0.0 111.137 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.416 ' CB ' ' HD2' ' B' ' 26' ' ' PRO . 2.7 m -34.13 178.35 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.351 0 C-N-CA 128.709 2.804 . . . . 0.0 114.883 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.521 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 0.1 OUTLIER 22.44 50.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.676 0 C-N-CA 122.961 2.441 . . . . 0.0 115.277 -153.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.551 HG11 ' O ' ' B' ' 24' ' ' LEU . 11.5 m -71.3 -178.95 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.612 166.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . 0.573 ' NE2' ' HB2' ' A' ' 26' ' ' PRO . 31.1 mm-40 -115.14 128.57 56.28 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.36 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.52 -108.97 0.9 Allowed Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.152 -1.385 . . . . 0.0 115.248 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 66.8 m -93.44 7.66 43.65 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.548 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 50.1 mt-10 -62.57 159.98 14.8 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 117.852 -1.539 . . . . 0.0 109.981 175.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.61 110.23 9.84 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -176.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.04 146.93 18.62 Favored Glycine 0 CA--C 1.484 -1.879 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -174.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.85 157.54 11.69 Favored Glycine 0 N--CA 1.412 -2.9 0 CA-C-N 113.331 -1.435 . . . . 0.0 110.29 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -77.68 113.58 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 122.631 1.205 . . . . 0.0 107.78 175.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -135.63 158.77 73.57 Favored Pre-proline 0 C--N 1.259 -3.369 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.121 -171.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.2 Cg_exo -64.62 134.24 40.21 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.59 2.193 . . . . 0.0 110.925 172.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.467 HG22 ' O ' ' B' ' 20' ' ' TYR . 35.0 m -120.92 160.11 22.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 ' CG2' ' HB1' ' B' ' 56' ' ' ALA . 32.8 m -98.78 130.09 48.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -87.14 100.6 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.08 -20.99 5.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.522 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.498 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.0 OUTLIER -54.61 158.4 2.56 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -170.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.03 170.72 6.38 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.196 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.52 -44.81 70.27 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.443 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 18.7 m -72.17 -34.83 68.76 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 122.697 0.399 . . . . 0.0 111.658 -170.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.78 -30.38 76.84 Favored Glycine 0 C--O 1.219 -0.822 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.71 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -64.67 -27.23 68.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.952 0.406 . . . . 0.0 110.512 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.421 ' HB2' ' CD2' ' B' ' 49' ' ' TYR . 6.7 mmtt -93.17 -53.98 3.9 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.421 ' CD2' ' HB2' ' B' ' 48' ' ' LYS . 96.0 m-85 -100.77 1.2 40.05 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -166.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -121.16 142.05 34.22 Favored Pre-proline 0 C--N 1.292 -1.929 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.533 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.553 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 37.4 Cg_endo -71.61 -27.04 19.06 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.489 1.46 . . . . 0.0 109.539 174.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.0 146.7 24.4 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.064 -176.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.05 140.49 27.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.498 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 12.4 tt -82.13 133.41 29.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.237 0 CA-C-O 121.375 0.607 . . . . 0.0 110.677 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.59 156.33 37.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.349 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.47 ' HB1' ' CG2' ' B' ' 39' ' ' VAL . . . -121.6 140.41 52.28 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.85 128.81 36.52 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.46 HG12 ' CD1' ' B' ' 86' ' ' ILE . 55.5 mt -86.09 117.05 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 173.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.2 m -102.4 105.16 15.7 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.217 0.532 . . . . 0.0 111.077 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.439 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.802 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.435 -1.176 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 8.5 Cg_endo -52.71 -32.1 53.7 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 122.672 2.248 . . . . 0.0 114.375 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 32.4 p -73.8 -19.33 60.79 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.082 0.468 . . . . 0.0 112.038 -172.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -104.83 129.54 53.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 96.2 t -118.68 114.11 43.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.599 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.76 117.11 22.43 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.637 HD11 ' CE2' ' B' ' 78' ' ' TYR . 8.8 pt -101.43 132.95 46.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.18 -174.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.44 119.5 6.15 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.211 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 39.9 mttp -43.19 -49.21 6.56 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.587 1.155 . . . . 0.0 109.059 173.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -61.57 -29.59 70.12 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.902 -1.954 . . . . 0.0 113.198 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -91.71 -29.72 16.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.329 0.585 . . . . 0.0 111.076 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.637 ' CE2' HD11 ' B' ' 73' ' ' ILE . 21.0 m-85 -95.9 7.99 44.85 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.035 -176.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 tttm 60.8 31.83 20.09 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 122.324 1.059 . . . . 0.0 109.972 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -111.86 176.29 5.08 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.495 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . 0.404 ' O ' ' HD3' ' B' ' 75' ' ' LYS . 7.3 p-10 -99.48 -9.83 22.89 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.914 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.493 ' C ' ' HG2' ' B' ' 75' ' ' LYS . 10.0 ptpp? -141.77 143.64 33.57 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.102 -174.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . 0.655 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 27.3 m-20 -71.5 119.27 15.41 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 173.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.495 ' O ' HG12 ' B' ' 73' ' ' ILE . 23.3 t -105.25 173.28 6.37 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 13.4 t -120.43 139.94 46.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.46 ' CD1' HG12 ' B' ' 58' ' ' ILE . 19.1 mm -104.18 127.68 58.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 172.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 88.0 mt -103.23 105.95 16.36 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.9 mm? -83.33 -3.98 58.02 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.039 -176.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.52 -34.48 15.53 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.256 1.027 . . . . 0.0 108.778 174.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . 0.458 ' OE1' ' HA ' ' B' ' 31' ' ' GLU . 3.5 tp60 -97.02 76.71 2.7 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.168 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.459 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.3 pp -125.13 176.6 5.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -165.43 173.83 10.66 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 47.4 m -118.8 122.23 41.91 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 64.9 mt -131.92 150.37 52.17 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.894 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.553 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 0.7 OUTLIER -58.44 142.47 48.52 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 169.581 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' B' ' 99' ' ' LEU . 18.0 pttm -51.82 -36.26 47.34 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.7 0.762 . . . . 0.0 112.435 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -44.42 -34.63 2.1 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 126.684 1.994 . . . . 0.0 113.637 171.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -67.43 -29.55 69.05 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.568 0.747 . . . . 0.0 110.71 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 96' ' ' LYS . 7.5 mp -72.48 129.63 38.78 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 125.52 1.528 . . . . 0.0 110.611 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -95.95 -58.04 2.2 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.443 -1.253 . . . . 0.0 114.097 -175.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 16.1 pt-20 -161.06 147.18 14.63 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.535 0.683 . . . . 0.0 111.847 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 64.8 tttp -61.17 124.33 20.24 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 126.974 2.11 . . . . 0.0 110.609 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.7 tp -114.57 -61.45 1.75 Allowed 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.348 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.488 HG23 HG21 ' B' ' 19' ' ' VAL . 5.8 t -129.72 -158.25 0.88 Allowed 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 118.179 -1.409 . . . . 0.0 112.063 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -160.28 148.83 16.9 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 126.063 1.745 . . . . 0.0 109.038 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.42 ' HB3' ' CZ ' ' B' ' 78' ' ' TYR . 3.8 pp -112.4 154.77 25.28 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.8 m -80.6 161.13 24.87 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.374 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.67 -32.98 73.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.87 0.868 . . . . 0.0 112.522 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.534 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 5.4 p-10 -62.4 -32.02 72.79 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -70.78 -28.85 64.97 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.441 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.1 OUTLIER -54.65 -47.78 73.11 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.462 ' HZ3' ' CG ' ' B' ' 115' ' ' ASP . 9.0 mmpt? -78.38 -12.27 59.99 Favored 'General case' 0 N--CA 1.389 -3.496 0 CA-C-N 114.508 -1.224 . . . . 0.0 113.754 -177.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' B' ' 109' ' ' ASP . 44.3 mt-10 -85.85 -41.64 14.83 Favored 'General case' 0 CA--C 1.47 -2.1 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 177.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 t -51.6 -47.02 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-N 112.911 -1.949 . . . . 0.0 110.731 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.462 ' CG ' ' HZ3' ' B' ' 112' ' ' LYS . 2.7 m-20 -53.04 -48.83 67.34 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.688 0.756 . . . . 0.0 110.276 174.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.67 ' O ' HD13 ' B' ' 120' ' ' ILE . 10.3 m-80 -69.82 -24.3 63.45 Favored 'General case' 0 N--CA 1.512 2.643 0 C-N-CA 125.004 1.322 . . . . 0.0 112.184 -176.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.446 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -83.41 -44.38 14.86 Favored 'General case' 2 C--N 1.231 -4.546 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.035 177.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.74 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.0 OUTLIER -73.51 -55.72 5.97 Favored 'General case' 1 N--CA 1.374 -4.269 0 C-N-CA 123.349 0.66 . . . . 0.0 112.162 -173.634 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 38.8 mtp -56.88 -37.88 71.97 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.67 HD13 ' O ' ' B' ' 116' ' ' ASN . 1.5 mp -77.06 -39.84 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 60.7 m -58.54 -35.87 72.97 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.625 0.726 . . . . 0.0 110.818 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.74 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 11.0 mt -101.17 -0.01 36.81 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.706 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.85 17.72 79.56 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 115.81 1.084 . . . . 0.0 115.81 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.43 -54.35 21.05 Favored 'General case' 0 CA--C 1.479 -1.753 0 CA-C-N 119.111 1.455 . . . . 0.0 110.021 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 m120 . . . . . 0 C--N 1.305 -1.364 0 CA-C-N 113.575 -1.648 . . . . 0.0 113.937 -173.831 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.433 -1.284 0 CA-C-O 120.76 0.315 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -121.45 153.55 37.73 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.456 172.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -75.43 139.67 42.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.799 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.13 -11.19 51.8 Favored Glycine 0 C--N 1.306 -1.101 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.007 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -97.31 173.46 7.2 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 4.6 t -130.68 130.55 64.72 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 C-N-CA 123.21 0.604 . . . . 0.0 111.763 -175.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 85.4 m-85 -127.03 143.95 51.15 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.907 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.16 147.56 40.36 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 169.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -135.86 129.42 32.32 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.706 -1.588 . . . . 0.0 107.635 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 10.1 t70 -84.99 91.08 7.98 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.351 174.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.606 HD21 ' O ' ' A' ' 24' ' ' LEU 0.432 0.0 OUTLIER -114.82 62.1 0.68 Allowed 'General case' 0 N--CA 1.385 -3.699 0 CA-C-O 124.203 1.954 . . . . 0.0 111.999 175.788 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.436 ' OG ' ' HA2' ' A' ' 34' ' ' GLY . 1.4 m -107.04 60.39 0.2 Allowed Pre-proline 0 C--N 1.266 -3.03 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.554 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -115.27 23.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.276 0 N-CA-C 108.456 -1.402 . . . . 0.0 108.456 158.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 20.1 m -88.65 158.13 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -172.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.456 ' NE2' HH22 ' B' ' 98' ' ' ARG . 0.0 OUTLIER -155.74 160.57 40.42 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 113.005 -1.907 . . . . 0.0 107.049 178.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.51 -142.82 17.47 Favored Glycine 0 C--N 1.297 -1.624 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.405 ' HB2' ' CB ' ' B' ' 95' ' ' ASP . 22.3 m -94.46 15.33 18.06 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 117.053 0.427 . . . . 0.0 110.99 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 46.3 mt-10 -70.33 157.62 37.4 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -134.99 112.87 10.95 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.42 ' HA3' HD21 ' A' ' 24' ' ' LEU . . . -145.0 -109.86 0.66 Allowed Glycine 0 N--CA 1.411 -2.975 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.545 176.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.436 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 82.95 178.11 52.24 Favored Glycine 0 N--CA 1.4 -3.76 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -172.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 1.4 p -87.45 99.36 8.47 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-O 123.556 1.646 . . . . 0.0 107.44 173.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -140.9 153.03 67.03 Favored Pre-proline 0 C--N 1.268 -2.944 0 CA-C-N 111.724 -2.489 . . . . 0.0 109.01 -168.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HB2' HD13 ' A' ' 58' ' ' ILE . 33.5 Cg_exo -60.88 141.09 93.65 Favored 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 122.623 2.216 . . . . 0.0 112.9 175.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 20' ' ' TYR . 27.4 m -126.15 157.87 36.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.491 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 34.6 m -100.1 129.86 50.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.9 mm -88.73 98.06 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -18.86 6.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.533 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.601 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -51.26 152.78 2.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -173.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -43.11 146.28 0.44 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.556 2.343 . . . . 0.0 113.23 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -66.26 -37.53 85.69 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.544 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 m -87.68 -30.67 20.22 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.374 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.07 -31.33 78.4 Favored Glycine 0 C--O 1.206 -1.626 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.478 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.538 ' N ' HE22 ' A' ' 42' ' ' GLN . 30.0 p30 -71.95 -20.85 61.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.172 0.511 . . . . 0.0 111.019 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -86.63 -51.64 6.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -85.48 -36.07 20.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -171.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.5 m -97.15 145.92 30.44 Favored Pre-proline 0 C--N 1.291 -1.975 0 O-C-N 121.988 -0.445 . . . . 0.0 110.986 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -80.27 -15.09 11.6 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.916 1.744 . . . . 0.0 109.838 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 1.9 p -96.29 146.09 25.02 Favored 'General case' 0 N--CA 1.42 -1.927 0 C-N-CA 125.007 1.323 . . . . 0.0 110.412 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.75 138.6 22.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.236 0.541 . . . . 0.0 110.746 173.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.601 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -85.34 124.64 40.2 Favored 'Isoleucine or valine' 0 C--O 1.253 1.244 0 C-N-CA 124.435 1.094 . . . . 0.0 110.19 177.059 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.67 171.11 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.419 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.491 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . . . -129.65 142.76 50.67 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.97 129.68 37.27 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.49 HG12 HD13 ' A' ' 86' ' ' ILE . 59.3 mt -85.52 117.57 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.5 174.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.4 m -107.21 111.87 24.47 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.863 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.863 -176.203 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.2 tt . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.596 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 12.4 Cg_endo -56.12 -28.48 70.37 Favored 'Trans proline' 0 C--O 1.2 -1.41 0 C-N-CA 122.363 2.042 . . . . 0.0 114.274 -176.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.0 p -74.08 -18.92 60.76 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.064 0.459 . . . . 0.0 111.515 -174.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.8 m170 -104.64 128.95 52.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.22 124.68 58.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -98.34 133.46 42.71 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.479 HG21 ' CZ ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -115.53 158.37 15.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.907 -173.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.484 ' OE1' ' HE3' ' A' ' 110' ' ' LYS . 2.3 mp0 -66.3 113.58 4.71 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.093 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -52.51 -42.11 64.04 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.716 0.806 . . . . 0.0 112.556 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -61.06 -30.7 70.49 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.465 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 5.0 ttmp? -85.75 -34.99 21.05 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.716 0.769 . . . . 0.0 109.259 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.479 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 4.7 m-85 -84.71 5.29 28.87 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.937 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt 68.06 26.47 7.25 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.761 1.224 . . . . 0.0 111.227 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.8 mt -117.56 179.2 4.13 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.456 0.646 . . . . 0.0 110.759 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -108.87 -18.89 13.58 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.51 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -118.51 147.23 43.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.25 123.71 22.85 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 t -102.93 150.72 23.25 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.082 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.3 136.26 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.49 HD13 HG12 ' A' ' 58' ' ' ILE . 19.4 mm -104.49 131.14 54.12 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.967 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.8 mt -100.97 102.57 13.62 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.415 ' HG ' ' HB1' ' A' ' 117' ' ' ALA . 3.9 mm? -82.92 4.62 24.94 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.003 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.52 -42.91 7.47 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.912 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.406 ' HA ' HG23 ' B' ' 93' ' ' THR . 0.0 OUTLIER -91.01 76.71 6.17 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.668 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.428 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -117.02 178.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.479 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -173.81 163.3 4.14 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 54' ' ' ILE . 61.4 m -107.77 124.18 49.66 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.421 -178.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.2 mt -132.42 145.62 51.35 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.73 -172.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.438 ' CB ' ' HB2' ' B' ' 30' ' ' SER . 3.1 p30 -76.32 153.63 35.72 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.981 175.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -44.37 -22.14 0.06 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.463 1.905 . . . . 0.0 115.352 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.22 -18.6 60.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 118.206 0.457 . . . . 0.0 110.739 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 32.4 mmt180 -75.12 -38.81 60.95 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.6 mp -68.15 125.21 25.66 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.697 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -103.99 -64.95 1.05 Allowed 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.304 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.4 pt-20 -150.88 144.28 24.9 Favored 'General case' 0 N--CA 1.412 -2.337 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.069 -166.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -70.59 125.88 28.06 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.425 -1.716 . . . . 0.0 111.098 176.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 tp -114.57 -62.01 1.66 Allowed 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.069 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.501 HG21 HG11 ' A' ' 19' ' ' VAL . 3.8 t -127.81 -167.22 1.72 Allowed 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.639 -1.625 . . . . 0.0 111.626 -177.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -160.81 143.98 13.12 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 124.73 1.212 . . . . 0.0 109.512 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.6 pp -114.18 159.63 19.88 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.762 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.2 t -82.38 159.33 23.04 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.793 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 111' ' ' MET . 18.9 t70 -63.59 -33.31 75.33 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.439 0.638 . . . . 0.0 111.303 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.5 -28.06 65.73 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.102 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.484 ' HE3' ' OE1' ' A' ' 74' ' ' GLU . 5.7 mptp? -76.17 -29.0 57.54 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.078 0.466 . . . . 0.0 110.263 175.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.486 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -59.18 -36.31 75.11 Favored 'General case' 0 N--CA 1.416 -2.146 0 C-N-CA 123.521 0.728 . . . . 0.0 109.533 174.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.479 ' HE2' ' C ' ' A' ' 111' ' ' MET . 7.6 mmpt? -78.08 -10.99 59.88 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.34 -38.43 18.8 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.475 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 1.7 t -54.61 -39.86 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 112.432 -2.167 . . . . 0.0 110.884 173.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.44 -35.18 69.77 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 122.243 1.02 . . . . 0.0 111.801 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.472 ' O ' HD13 ' A' ' 120' ' ' ILE . 16.4 m-80 -83.89 -18.81 36.18 Favored 'General case' 0 CA--C 1.433 -3.528 0 C-N-CA 125.235 1.414 . . . . 0.0 110.083 -171.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 68' ' ' PRO . . . -84.56 -57.14 3.26 Favored 'General case' 2 N--CA 1.34 -5.952 0 CA-C-N 111.881 -2.418 . . . . 0.0 108.921 171.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 tp -67.34 -45.37 76.61 Favored 'General case' 0 N--CA 1.404 -2.727 0 C-N-CA 125.984 1.714 . . . . 0.0 113.592 -170.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 34.1 mtp -67.64 -22.06 65.34 Favored 'General case' 0 C--O 1.199 -1.575 0 O-C-N 121.704 -0.622 . . . . 0.0 111.839 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.472 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.0 OUTLIER -87.13 -45.56 16.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -178.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 10.8 t -56.31 -46.82 79.67 Favored 'General case' 0 C--N 1.277 -2.584 0 C-N-CA 126.618 1.967 . . . . 0.0 111.251 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.481 ' HG ' HG22 ' B' ' 54' ' ' ILE . 7.8 mp -89.44 3.84 51.03 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 123.149 0.579 . . . . 0.0 111.254 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.24 32.66 84.89 Favored Glycine 0 CA--C 1.539 1.583 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 175.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.422 ' N ' HD13 ' A' ' 124' ' ' LEU . 7.3 mp -78.19 -34.21 49.63 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 118.651 1.226 . . . . 0.0 109.024 175.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 . . . . . 0 CA--C 1.549 0.929 0 C-N-CA 129.216 3.006 . . . . 0.0 117.565 179.597 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 53.7 mt . . . . . 0 N--CA 1.441 -0.901 0 CA-C-O 120.685 0.279 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -119.73 156.64 30.15 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.696 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -77.76 139.67 39.39 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.089 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.36 -11.94 51.25 Favored Glycine 0 C--N 1.309 -0.941 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.496 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -97.18 176.74 5.82 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 4.9 t -132.93 129.54 57.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-O 121.44 0.638 . . . . 0.0 112.209 -175.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 83.1 m-85 -126.89 143.08 51.37 Favored 'General case' 0 CA--C 1.46 -2.486 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.458 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.468 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -79.41 149.88 31.49 Favored 'General case' 0 N--CA 1.39 -3.43 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.905 170.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -136.76 131.48 33.46 Favored 'General case' 0 C--N 1.259 -3.364 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.132 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.517 ' O ' ' HD2' ' B' ' 98' ' ' ARG . 8.8 t70 -81.84 96.1 7.52 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.037 171.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.618 HD21 ' O ' ' B' ' 24' ' ' LEU 0.475 0.0 OUTLIER -118.19 60.23 0.79 Allowed 'General case' 1 N--CA 1.376 -4.175 0 CA-C-O 124.078 1.894 . . . . 0.0 111.963 172.158 . . . . . . . . 5 4 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.463 ' OG ' ' HA2' ' B' ' 34' ' ' GLY . 1.3 m -105.08 59.89 0.12 Allowed Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 113.264 -1.789 . . . . 0.0 111.687 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -116.95 24.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.594 0 N-CA-C 108.054 -1.556 . . . . 0.0 108.054 158.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 21.7 m -91.46 153.6 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . 0.627 HE21 ' N ' ' B' ' 28' ' ' GLN 0.467 0.0 OUTLIER -128.1 -64.61 0.95 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 119.336 3.087 . . . . 0.0 119.336 -177.385 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.5 -114.65 0.02 OUTLIER Glycine 0 C--N 1.313 -0.696 0 C-N-CA 120.555 -0.831 . . . . 0.0 114.076 -173.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.438 ' HB2' ' CB ' ' A' ' 95' ' ' ASP . 19.4 m -94.15 20.36 8.11 Favored 'General case' 0 C--N 1.271 -2.808 0 O-C-N 122.003 -0.704 . . . . 0.0 109.503 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.504 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 45.6 mt-10 -75.64 162.83 27.92 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -138.41 112.71 8.7 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . 0.44 ' HA3' HD21 ' B' ' 24' ' ' LEU . . . -147.18 -113.69 0.78 Allowed Glycine 0 N--CA 1.411 -2.999 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.124 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.463 ' HA2' ' OG ' ' B' ' 25' ' ' SER . . . 86.99 176.53 49.18 Favored Glycine 0 N--CA 1.399 -3.826 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 -172.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 1.6 p -84.53 99.58 6.97 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -141.46 151.17 60.15 Favored Pre-proline 0 C--N 1.262 -3.224 0 CA-C-N 112.096 -2.32 . . . . 0.0 109.26 -169.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 52.1 Cg_exo -59.0 139.69 91.99 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.825 2.35 . . . . 0.0 112.878 174.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -125.75 158.36 34.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.48 ' CG2' ' HB2' ' B' ' 56' ' ' ALA . 34.5 m -100.39 129.59 50.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 24.3 mm -88.23 98.47 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.95 -18.82 6.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.486 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.584 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.0 OUTLIER -50.81 152.07 2.23 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.29 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -41.74 145.99 0.28 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 127.69 2.396 . . . . 0.0 113.761 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.76 -39.4 93.55 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.975 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -87.73 -29.33 21.16 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.13 0.491 . . . . 0.0 110.949 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.25 -30.95 77.46 Favored Glycine 0 C--O 1.206 -1.65 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.039 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.58 ' N ' HE22 ' B' ' 42' ' ' GLN . 29.8 p30 -72.54 -20.55 61.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.064 0.459 . . . . 0.0 111.166 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.12 -53.91 4.78 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.151 0.501 . . . . 0.0 109.817 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -82.79 -35.72 26.24 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.409 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 70.1 m -94.84 143.2 25.76 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-O 120.855 0.36 . . . . 0.0 111.192 -176.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.88 -14.54 12.38 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.072 1.848 . . . . 0.0 109.524 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 1.9 p -97.18 147.93 23.59 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 125.11 1.364 . . . . 0.0 110.052 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.33 138.94 20.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.291 0.567 . . . . 0.0 110.888 173.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.584 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -85.01 124.19 39.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 C-N-CA 124.675 1.19 . . . . 0.0 109.881 177.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.78 171.15 17.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.429 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.59 ' CB ' HG23 ' B' ' 91' ' ' ILE . . . -129.82 142.97 50.6 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.0 130.31 38.21 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.485 HG12 HD13 ' B' ' 86' ' ' ILE . 57.8 mt -85.46 117.23 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.513 174.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 22.0 m -105.05 108.83 20.57 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.067 -177.241 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.4 tt . . . . . 0 N--CA 1.416 -2.164 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . 0.565 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 12.4 Cg_endo -56.72 -28.41 75.64 Favored 'Trans proline' 0 C--O 1.204 -1.18 0 C-N-CA 122.257 1.971 . . . . 0.0 114.182 -177.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 62.4 p -73.95 -19.17 60.76 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.046 0.45 . . . . 0.0 111.68 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -105.38 129.07 53.78 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 70.8 t -130.31 125.85 60.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.41 134.38 39.66 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.51 HG21 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -118.14 153.95 20.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.272 -174.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.538 ' OE1' ' HE3' ' B' ' 110' ' ' LYS . 3.7 mp0 -65.02 113.04 3.62 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.49 -178.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -50.71 -41.64 56.28 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 124.272 1.029 . . . . 0.0 112.634 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -22.04 66.17 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.252 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . 0.443 ' HZ1' ' HB2' ' B' ' 77' ' ' LYS . 4.9 ttmp? -91.36 -36.32 13.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.644 0.735 . . . . 0.0 109.071 177.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.51 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 4.5 m-85 -83.38 8.11 14.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.433 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 67.09 20.38 10.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.824 1.249 . . . . 0.0 111.757 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -111.0 179.66 3.98 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.1 0.476 . . . . 0.0 110.798 -174.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.86 -24.44 12.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.199 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -116.64 147.33 42.01 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.07 123.09 23.74 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.546 0.689 . . . . 0.0 109.237 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 22.6 t -102.88 154.11 19.53 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.72 -167.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.0 t -116.18 136.08 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.485 HD13 HG12 ' B' ' 58' ' ' ILE . 21.3 mm -104.66 131.87 52.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.932 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 66.2 mt -101.65 103.14 13.93 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.489 ' HG ' ' HB1' ' B' ' 117' ' ' ALA . 3.9 mm? -82.88 -0.41 48.17 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.535 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -94.37 -40.67 9.81 Favored 'General case' 0 N--CA 1.413 -2.294 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.94 173.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . 0.412 ' HA ' HG23 ' A' ' 93' ' ' THR . 0.0 OUTLIER -91.04 76.67 6.16 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.27 1.033 . . . . 0.0 108.59 178.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.59 HG23 ' CB ' ' B' ' 56' ' ' ALA . 2.5 pp -117.33 178.77 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.584 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -173.8 163.58 4.18 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 174.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' B' ' 54' ' ' ILE . 65.5 m -108.15 124.21 49.91 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.569 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 45.7 mt -132.34 145.85 51.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.739 -172.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 1.9 p-10 -77.8 153.5 32.77 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.412 176.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 50' ' ' SER . 99.5 mttt -44.69 -21.76 0.06 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.129 1.772 . . . . 0.0 115.446 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -73.7 -19.17 60.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.11 0.481 . . . . 0.0 110.745 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 31.5 mmt180 -74.98 -38.73 61.57 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.876 -0.515 . . . . 0.0 109.875 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.5 123.12 20.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.092 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -102.67 -65.08 1.01 Allowed 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 114.165 -1.379 . . . . 0.0 113.46 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.0 pt-20 -149.03 139.83 22.77 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.328 0.585 . . . . 0.0 111.349 -165.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.2 OUTLIER -69.76 123.5 21.57 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.754 -1.566 . . . . 0.0 111.592 176.203 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.07 -62.37 1.61 Allowed 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.249 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.51 HG21 HG11 ' B' ' 19' ' ' VAL . 3.2 t -126.91 -168.25 1.85 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 117.432 -1.707 . . . . 0.0 112.434 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -160.49 142.28 12.53 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 124.468 1.107 . . . . 0.0 110.205 -175.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -112.14 159.33 18.64 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.647 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 32.5 t -82.59 161.91 22.1 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' B' ' 111' ' ' MET . 16.7 t70 -62.1 -34.2 75.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.758 0.823 . . . . 0.0 111.373 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.01 -27.56 62.81 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.538 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 5.6 mptp? -75.0 -29.27 60.83 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 120.874 0.368 . . . . 0.0 110.02 175.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.473 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -57.54 -38.31 74.5 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.655 174.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.45 ' HE2' ' C ' ' B' ' 111' ' ' MET . 7.6 mmpt? -77.34 -13.74 59.87 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.13 -35.37 21.8 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 t -56.88 -41.36 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.568 0 CA-C-N 112.32 -2.218 . . . . 0.0 110.099 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -44.54 76.98 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.831 0.824 . . . . 0.0 110.489 174.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.736 ' O ' HD12 ' B' ' 120' ' ' ILE . 1.1 m-80 -70.61 -20.91 62.71 Favored 'General case' 0 CA--C 1.474 -1.98 0 CA-C-O 122.384 1.088 . . . . 0.0 111.135 -176.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' B' ' 68' ' ' PRO . . . -84.26 -53.85 5.2 Favored 'General case' 2 C--N 1.235 -4.405 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.291 173.35 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.67 -46.77 74.61 Favored 'General case' 0 N--CA 1.403 -2.798 0 C-N-CA 126.194 1.798 . . . . 0.0 113.471 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 38.4 mtp -66.05 -24.91 66.82 Favored 'General case' 0 C--O 1.2 -1.504 0 O-C-N 121.754 -0.591 . . . . 0.0 111.395 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.736 HD12 ' O ' ' B' ' 116' ' ' ASN . 1.3 mp -86.95 -40.77 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 70.5 m -57.12 -46.88 82.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 122.124 0.964 . . . . 0.0 111.145 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.488 ' HG ' HG22 ' A' ' 54' ' ' ILE . 7.4 mp -88.4 3.37 50.18 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.806 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.5 32.0 79.62 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.28 -37.04 63.8 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 119.041 1.421 . . . . 0.0 108.696 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.505 HD21 HG13 ' B' ' 120' ' ' ILE . 5.0 t-20 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 128.489 2.716 . . . . 0.0 117.443 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 N--CA 1.429 -1.512 0 CA-C-O 121.915 0.864 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -110.02 154.64 22.91 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.906 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -84.63 129.89 34.78 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.021 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.6 0.38 43.0 Favored Glycine 0 C--N 1.308 -0.992 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.644 -175.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -97.33 170.14 9.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 12.0 t -131.73 133.9 60.87 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 C-N-CA 124.063 0.945 . . . . 0.0 112.021 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.518 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 93.1 m-85 -132.41 145.83 51.51 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.573 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER -76.96 148.64 36.2 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 169.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.537 ' O ' HG21 ' A' ' 35' ' ' VAL . . . -143.78 149.07 36.52 Favored 'General case' 0 C--N 1.257 -3.452 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.669 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -74.45 85.78 2.02 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 124.238 1.971 . . . . 0.0 108.044 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 24' ' ' LEU . 2.0 tm? -87.94 13.15 11.52 Favored 'General case' 0 N--CA 1.407 -2.615 0 CA-C-N 111.198 -2.728 . . . . 0.0 111.662 -166.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 p -104.67 62.23 0.11 Allowed Pre-proline 0 N--CA 1.414 -2.236 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -113.47 23.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 121.712 1.608 . . . . 0.0 108.314 158.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 12.8 m -78.87 -179.1 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.702 -173.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.9 154.29 50.51 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.658 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.42 -108.99 1.16 Allowed Glycine 0 CA--C 1.502 -0.77 0 N-CA-C 116.271 1.268 . . . . 0.0 116.271 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 m -93.75 -6.63 45.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.236 -174.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 50.2 mt-10 -60.24 159.17 10.25 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.454 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.21 113.02 19.07 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -173.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.75 159.51 15.87 Favored Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 115.626 1.011 . . . . 0.0 115.626 -177.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 24' ' ' LEU . . . 110.43 146.31 10.89 Favored Glycine 0 N--CA 1.415 -2.764 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 22' ' ' ALA . 3.6 p -61.55 122.61 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 CA-C-O 122.507 1.146 . . . . 0.0 109.382 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -141.3 162.23 48.69 Favored Pre-proline 0 C--N 1.264 -3.124 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.753 -169.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HB2' HD11 ' A' ' 58' ' ' ILE . 1.3 Cg_endo -80.08 142.35 15.33 Favored 'Trans proline' 0 N--CA 1.427 -2.429 0 C-N-CA 121.785 1.657 . . . . 0.0 109.736 171.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 22.4 m -123.54 155.17 29.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.068 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 35.5 m -99.38 132.9 43.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.79 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.9 mm -90.97 105.2 16.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.509 HD11 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -99.56 -15.58 7.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.817 -179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.633 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 2.8 tt0 -55.47 162.65 1.5 Allowed 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 126.035 1.734 . . . . 0.0 114.518 -168.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.505 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 1.5 p30 -75.93 177.12 7.25 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.829 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.438 ' CG ' ' HZ1' ' A' ' 48' ' ' LYS . 25.3 t70 -78.24 -34.53 49.12 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 m -75.3 -24.62 57.49 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.128 0.49 . . . . 0.0 110.504 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.38 -23.06 73.35 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -83.44 -19.7 35.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.451 0.643 . . . . 0.0 109.91 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HZ1' ' CG ' ' A' ' 44' ' ' ASP . 14.6 mptt -89.93 -66.77 0.89 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.315 176.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -107.87 2.13 23.23 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.3 m -108.09 134.4 20.16 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.51 -22.92 20.68 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 121.671 1.58 . . . . 0.0 109.364 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 p -86.97 158.94 19.16 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.631 -1.622 . . . . 0.0 111.551 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.633 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 66.2 t -137.64 140.4 41.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 173.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.444 HG21 ' CD2' ' B' ' 122' ' ' LEU . 5.8 tt -105.9 127.48 60.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.516 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 34.1 m -132.01 174.65 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.263 -174.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -131.52 146.51 52.27 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.81 138.44 38.97 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 37' ' ' PRO . 81.6 mt -99.89 127.32 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.707 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -141.67 138.28 32.37 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.004 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.089 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 176.879 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tt . . . . . 0 N--CA 1.432 -1.359 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.543 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 27.0 Cg_exo -62.54 -35.04 73.29 Favored 'Trans proline' 0 C--O 1.196 -1.62 0 C-N-CA 121.431 1.421 . . . . 0.0 114.136 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.2 p -73.36 -18.59 61.16 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -114.67 128.97 56.61 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.1 127.73 75.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 118.704 0.684 . . . . 0.0 109.863 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -97.76 130.3 44.72 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.139 0.495 . . . . 0.0 110.406 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.473 HG13 ' CZ ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -110.31 169.61 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -89.04 137.17 32.56 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.385 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 82' ' ' LYS . 58.4 tttm -50.36 -42.46 53.21 Favored 'General case' 0 C--O 1.207 -1.141 0 O-C-N 124.351 1.032 . . . . 0.0 109.997 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -54.11 -49.67 68.61 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 125.623 1.569 . . . . 0.0 111.494 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.02 -40.45 38.88 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.539 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 2.4 m-85 -77.4 -8.84 58.35 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 78' ' ' TYR . 17.4 ptmt 52.74 34.0 15.22 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.571 1.549 . . . . 0.0 110.692 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.66 -173.83 2.64 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.246 -171.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.13 -29.43 67.48 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.068 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.42 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 14.4 ptmm? -166.87 168.14 14.31 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -52.4 138.46 27.11 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.48 137.98 53.44 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -169.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 t -107.97 142.05 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.478 HD11 HG12 ' A' ' 58' ' ' ILE . 16.6 mm -109.9 135.3 49.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.62 106.88 17.58 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.5 10.4 22.96 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.602 0.715 . . . . 0.0 111.79 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.4 -34.28 6.83 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.955 0.883 . . . . 0.0 109.662 173.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.469 ' HA ' HG22 ' B' ' 93' ' ' THR . 0.3 OUTLIER -101.2 88.39 3.48 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.687 177.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.559 ' O ' ' HD2' ' A' ' 92' ' ' ARG . 2.1 pp -121.97 178.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.943 -174.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.559 ' HD2' ' O ' ' A' ' 91' ' ' ILE . 18.2 mmm180 -136.76 172.97 12.23 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.75 0.786 . . . . 0.0 111.521 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.444 HG22 ' HA ' ' B' ' 90' ' ' GLN . 52.9 m -139.84 119.21 12.93 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 171.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 64.2 mt -134.27 145.05 48.73 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.807 0.843 . . . . 0.0 111.345 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.83 145.49 52.5 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 119.503 1.047 . . . . 0.0 109.656 165.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -49.36 -34.91 17.18 Favored 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -57.03 -23.8 49.11 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 125.374 1.469 . . . . 0.0 112.64 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 6.2 mmp_? -74.5 -27.73 60.68 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.556 0.693 . . . . 0.0 109.445 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.29 107.86 8.83 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 122.944 1.354 . . . . 0.0 110.937 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.62 -63.5 1.36 Allowed 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 113.039 -1.891 . . . . 0.0 114.875 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.5 pt-20 -158.29 150.02 21.42 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-O 121.814 0.816 . . . . 0.0 111.485 -170.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 66.2 mttm -61.3 126.44 27.37 Favored 'General case' 0 C--N 1.273 -2.738 0 C-N-CA 127.284 2.234 . . . . 0.0 111.832 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 tp -115.63 -62.45 1.59 Allowed 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.725 171.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.497 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 2.7 t -127.98 -167.16 1.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.142 -1.423 . . . . 0.0 112.33 -177.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.74 135.23 8.33 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 125.598 1.559 . . . . 0.0 110.712 -172.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 mt -87.08 157.48 19.4 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 124.098 0.959 . . . . 0.0 111.344 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.5 m -84.08 161.22 20.75 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.4 -36.52 82.59 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.538 0.735 . . . . 0.0 112.576 -176.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -79.79 -26.63 40.52 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.576 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.421 ' HG3' ' OE1' ' A' ' 113' ' ' GLU . 2.5 mptp? -70.54 -26.45 63.56 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.98 0.419 . . . . 0.0 110.687 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.479 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -57.26 -39.18 75.1 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 123.903 0.881 . . . . 0.0 109.667 172.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HZ1' ' CG ' ' A' ' 115' ' ' ASP . 7.9 mmpt? -83.36 -11.1 58.0 Favored 'General case' 0 N--CA 1.397 -3.117 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.421 ' OE1' ' HG3' ' A' ' 110' ' ' LYS . 36.7 mt-10 -84.78 -37.16 21.14 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 1.4 t -55.04 -36.91 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-N 112.835 -1.984 . . . . 0.0 110.617 172.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.515 ' CG ' ' HZ1' ' A' ' 112' ' ' LYS . 2.0 m-20 -64.56 -35.36 80.73 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.401 1.096 . . . . 0.0 111.153 174.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.669 ' O ' HD11 ' A' ' 120' ' ' ILE . 13.4 m-80 -81.13 -15.03 57.04 Favored 'General case' 1 N--CA 1.555 4.823 0 CA-C-O 124.165 1.936 . . . . 0.0 109.596 -174.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 68' ' ' PRO 0.337 . . -91.01 -51.31 5.4 Favored 'General case' 2 N--CA 1.346 -5.635 0 CA-C-N 111.867 -2.424 . . . . 0.0 105.254 175.109 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 3.3 tp -69.27 -47.47 64.53 Favored 'General case' 0 N--CA 1.393 -3.29 0 C-N-CA 124.518 1.127 . . . . 0.0 113.165 -171.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.5 mtp -64.77 -28.34 69.51 Favored 'General case' 0 C--O 1.195 -1.804 0 O-C-N 121.451 -0.78 . . . . 0.0 111.608 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.669 HD11 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -77.86 -48.67 23.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 23.1 t -56.48 -33.55 66.08 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 113.076 -1.875 . . . . 0.0 111.286 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 20.1 mt -104.48 7.32 35.34 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.021 0.439 . . . . 0.0 110.664 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.44 78.21 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.9 mp -80.51 -51.38 8.85 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 119.113 1.456 . . . . 0.0 108.927 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 CA--C 1.557 1.215 0 CA-C-N 113.068 -1.878 . . . . 0.0 112.833 -173.215 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.432 -1.341 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -113.59 155.99 24.46 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.879 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.21 135.08 34.5 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.95 2.17 58.33 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.743 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -97.79 168.4 10.34 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 13.6 t -131.88 133.84 60.63 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 C-N-CA 123.805 0.842 . . . . 0.0 112.252 -176.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 89.9 m-85 -132.44 145.52 51.26 Favored 'General case' 0 CA--C 1.483 -1.628 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.417 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 0.8 OUTLIER -76.25 149.2 37.19 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 169.448 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.504 ' O ' HG23 ' B' ' 35' ' ' VAL . . . -144.35 148.66 35.02 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.891 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.5 85.64 1.54 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 124.022 1.868 . . . . 0.0 107.741 172.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.535 ' O ' HD12 ' B' ' 24' ' ' LEU . 2.1 tm? -88.8 12.95 13.66 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 111.33 -2.668 . . . . 0.0 111.769 -166.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 17.8 p -104.59 62.38 0.1 Allowed Pre-proline 0 CA--C 1.582 2.202 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -112.82 23.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 121.676 1.584 . . . . 0.0 108.316 159.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 16.1 m -78.42 -179.17 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.327 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.68 154.17 48.59 Favored 'General case' 0 C--O 1.206 -1.228 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.775 175.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.11 -112.0 3.26 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 115.307 0.883 . . . . 0.0 115.307 170.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -94.51 -2.85 50.96 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.532 0.333 . . . . 0.0 110.816 -173.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.518 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 51.7 mt-10 -60.71 158.84 11.91 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.167 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.98 112.28 18.23 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -172.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.53 156.25 17.79 Favored Glycine 0 CA--C 1.473 -2.553 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' B' ' 24' ' ' LEU . . . 114.18 149.3 10.01 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 22' ' ' ALA . 3.2 p -63.53 125.73 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-O 122.526 1.155 . . . . 0.0 108.933 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 9.7 mmt85 -142.09 160.98 53.25 Favored Pre-proline 0 C--N 1.268 -2.952 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.068 -168.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.466 ' HB2' HD11 ' B' ' 58' ' ' ILE . 0.9 OUTLIER -80.62 142.06 14.19 Favored 'Trans proline' 0 N--CA 1.426 -2.442 0 C-N-CA 121.714 1.609 . . . . 0.0 109.38 170.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 24.3 m -123.22 155.59 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.18 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 35.7 m -99.65 132.97 44.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.789 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 22.7 mm -91.52 105.42 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.5 HD11 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -99.44 -16.15 7.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.844 -179.23 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.641 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 2.8 tt0 -54.89 162.81 1.14 Allowed 'General case' 0 N--CA 1.424 -1.743 0 C-N-CA 126.369 1.868 . . . . 0.0 114.986 -167.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.504 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 2.2 p30 -74.78 175.83 7.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.934 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.465 ' CG ' ' HZ1' ' B' ' 48' ' ' LYS . 31.5 t70 -77.24 -34.78 55.81 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 21.6 m -75.39 -25.53 57.71 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.156 0.503 . . . . 0.0 110.222 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.63 -23.99 72.41 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -83.23 -20.22 34.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.986 0.422 . . . . 0.0 110.28 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.465 ' HZ1' ' CG ' ' B' ' 44' ' ' ASP . 14.4 mptt -88.87 -66.95 0.87 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.994 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -100.15 -23.4 14.86 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -167.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 15.2 m -83.85 136.17 41.94 Favored Pre-proline 0 N--CA 1.423 -1.822 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.27 -21.72 17.32 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 121.706 1.604 . . . . 0.0 108.754 173.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -89.18 158.11 18.02 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 113.342 -1.754 . . . . 0.0 111.276 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.641 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 60.4 t -137.82 140.29 41.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.459 HG21 ' CD2' ' A' ' 122' ' ' LEU . 5.6 tt -106.43 127.91 61.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 174.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.536 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 33.9 m -132.91 174.16 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.212 -173.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.504 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -130.74 146.71 52.28 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.53 137.43 38.62 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.491 HG12 HD11 ' B' ' 86' ' ' ILE . 82.0 mt -98.35 128.56 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 113.323 -1.762 . . . . 0.0 107.736 176.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.5 t -140.89 141.38 34.58 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 119.581 -0.847 . . . . 0.0 111.621 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.242 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.149 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.2 tt . . . . . 0 N--CA 1.44 -0.973 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 74.9 Cg_exo -54.41 -40.57 82.52 Favored 'Trans proline' 0 C--O 1.208 -1.017 0 C-N-CA 122.187 1.924 . . . . 0.0 114.659 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 57.8 p -72.63 -18.47 61.58 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -168.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . 0.467 ' CD2' HD21 ' B' ' 87' ' ' LEU . 53.6 m170 -113.47 128.88 56.6 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 57.3 t -121.32 130.01 75.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 O-C-N 121.545 -0.722 . . . . 0.0 109.854 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -98.53 135.72 39.67 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.114 0.483 . . . . 0.0 109.735 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' B' ' 78' ' ' TYR . 1.2 mm -112.32 174.95 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -92.99 139.08 30.9 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.223 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -51.79 -41.08 61.42 Favored 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 124.724 1.21 . . . . 0.0 109.697 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -59.21 -41.24 88.13 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 125.961 1.704 . . . . 0.0 111.686 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . 0.423 ' O ' ' HE3' ' B' ' 77' ' ' LYS . 0.2 OUTLIER -84.77 -39.05 18.89 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -176.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.555 ' O ' ' HG2' ' B' ' 79' ' ' LYS . 2.3 m-85 -79.14 -7.85 58.52 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.521 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' B' ' 78' ' ' TYR . 17.8 ptmt 52.71 33.25 13.51 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.63 1.572 . . . . 0.0 110.593 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.34 -175.89 3.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.463 -172.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.79 -29.88 70.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.93 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -165.99 165.96 17.65 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -50.91 135.31 24.59 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.08 139.38 49.93 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -169.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.09 142.6 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.491 HD11 HG12 ' B' ' 58' ' ' ILE . 16.2 mm -111.71 136.17 48.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.467 HD21 ' CD2' ' B' ' 70' ' ' HIS . 42.9 mt -106.35 106.25 16.68 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' B' ' 117' ' ' ALA . 3.8 mm? -89.07 10.39 21.9 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.714 0.769 . . . . 0.0 112.07 -175.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.67 -34.26 6.76 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.723 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . 0.444 ' HA ' HG22 ' A' ' 93' ' ' THR . 0.3 OUTLIER -100.99 87.56 3.31 Favored 'General case' 0 N--CA 1.406 -2.647 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.553 ' O ' ' HD2' ' B' ' 92' ' ' ARG . 2.1 pp -121.49 178.91 2.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.061 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' B' ' 91' ' ' ILE . 18.3 mmm180 -136.8 172.46 12.97 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.73 0.776 . . . . 0.0 111.312 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 90' ' ' GLN . 54.6 m -139.82 119.35 13.09 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 170.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 65.9 mt -134.18 146.79 50.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 110.874 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -63.26 151.12 41.47 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.073 1.306 . . . . 0.0 109.668 165.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -51.22 -34.67 33.19 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -56.23 -25.42 47.51 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 125.076 1.35 . . . . 0.0 112.912 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 5.7 mmp_? -73.91 -29.17 61.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.397 0.618 . . . . 0.0 109.733 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.2 mp -75.46 107.73 7.79 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 125.045 1.338 . . . . 0.0 111.051 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.79 -65.77 0.97 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 112.882 -1.963 . . . . 0.0 114.932 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.2 pt-20 -156.32 146.34 21.25 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-O 121.504 0.669 . . . . 0.0 111.25 -169.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 67.6 mttm -60.52 126.43 27.4 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 126.639 1.976 . . . . 0.0 111.902 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -115.09 -61.92 1.68 Allowed 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.503 172.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.519 ' O ' ' HB ' ' B' ' 19' ' ' VAL . 3.4 t -127.23 -168.22 1.85 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 117.99 -1.484 . . . . 0.0 112.432 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -160.12 133.6 6.96 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 125.584 1.554 . . . . 0.0 110.456 -171.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 mt -84.29 162.67 20.01 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 124.009 0.924 . . . . 0.0 112.021 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.7 m -87.94 162.08 17.08 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.701 171.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.76 -31.79 71.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.45 -30.81 42.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.535 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -67.78 -28.91 68.0 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.011 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.474 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.0 OUTLIER -55.46 -38.8 69.54 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 123.907 0.883 . . . . 0.0 109.988 172.61 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.561 ' HZ1' ' CG ' ' B' ' 115' ' ' ASP . 7.8 mmpt? -83.99 -13.08 54.21 Favored 'General case' 0 N--CA 1.399 -2.998 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -84.4 -33.43 23.75 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' B' ' 117' ' ' ALA . 1.4 t -58.02 -39.71 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.404 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.2 172.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.561 ' CG ' ' HZ1' ' B' ' 112' ' ' LYS . 4.3 m-20 -61.05 -42.6 98.79 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.009 0.909 . . . . 0.0 110.067 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.58 ' O ' HD11 ' B' ' 120' ' ' ILE . 10.4 m-80 -69.51 -21.01 63.7 Favored 'General case' 0 CA--C 1.456 -2.639 0 C-N-CA 125.01 1.324 . . . . 0.0 111.923 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' B' ' 68' ' ' PRO . . . -83.39 -50.57 8.2 Favored 'General case' 2 N--CA 1.366 -4.666 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.839 173.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 3.3 tp -71.77 -48.21 48.33 Favored 'General case' 0 N--CA 1.393 -3.296 0 C-N-CA 124.546 1.138 . . . . 0.0 113.098 -171.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 37.7 mtp -63.66 -31.35 72.5 Favored 'General case' 0 C--O 1.197 -1.662 0 O-C-N 121.451 -0.781 . . . . 0.0 111.076 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.58 HD11 ' O ' ' B' ' 116' ' ' ASN . 1.4 mp -78.78 -42.93 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -56.71 -35.48 68.57 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.028 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 19.3 mt -104.18 6.57 35.74 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.936 -0.478 . . . . 0.0 111.151 -176.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.74 23.16 78.08 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 115.891 1.117 . . . . 0.0 115.891 173.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' B' ' 122' ' ' LEU . 7.1 mp -79.55 -51.86 8.76 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 118.954 1.377 . . . . 0.0 108.361 177.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.482 ' ND2' HG13 ' B' ' 120' ' ' ILE . 1.6 t-20 . . . . . 0 C--N 1.306 -1.312 0 CA-C-N 113.118 -1.855 . . . . 0.0 112.748 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.246 0.885 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -146.89 161.41 40.78 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.9 ptm85 -84.05 122.03 28.23 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.823 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 130.76 -19.44 4.99 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.039 -175.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -92.42 147.31 23.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.957 0.884 . . . . 0.0 110.261 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.447 ' HB ' ' H ' ' A' ' 104' ' ' THR . 51.6 t -98.62 118.15 44.72 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.271 173.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.431 ' O ' HG22 ' A' ' 38' ' ' VAL . 19.9 m-85 -108.46 145.73 34.22 Favored 'General case' 0 CA--C 1.458 -2.562 0 C-N-CA 124.673 1.189 . . . . 0.0 112.24 176.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.7 145.58 31.51 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 166.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.92 133.12 23.05 Favored 'General case' 0 C--N 1.259 -3.343 0 CA-C-N 113.743 -1.572 . . . . 0.0 108.383 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -88.57 85.35 6.81 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-O 121.593 0.711 . . . . 0.0 109.925 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.591 ' O ' HD23 ' A' ' 24' ' ' LEU 0.459 0.0 OUTLIER -107.2 60.82 0.62 Allowed 'General case' 0 N--CA 1.393 -3.295 0 C-N-CA 116.887 -1.925 . . . . 0.0 113.121 178.557 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.508 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 25.2 p -113.59 62.48 0.95 Allowed Pre-proline 0 C--N 1.271 -2.829 0 CA-C-N 113.491 -1.686 . . . . 0.0 113.62 173.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 24' ' ' LEU . 24.4 Cg_endo -115.41 26.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.26 0 N-CA-C 107.883 -1.622 . . . . 0.0 107.883 159.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.554 ' HB ' ' CB ' ' A' ' 31' ' ' GLU . 17.4 m -94.32 159.61 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.457 -173.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.58 151.72 36.73 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.548 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.34 -132.2 11.52 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.302 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -93.85 11.94 27.61 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.554 ' CB ' ' HB ' ' A' ' 27' ' ' VAL . 42.6 mt-10 -68.09 151.51 46.92 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 170.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -131.58 114.96 15.48 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.405 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . -147.72 -120.21 1.15 Allowed Glycine 0 N--CA 1.406 -3.347 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.964 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 25' ' ' SER . . . 98.54 172.79 32.17 Favored Glycine 0 N--CA 1.408 -3.175 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 -171.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 p -88.94 104.09 14.56 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.075 0 CA-C-O 123.033 1.396 . . . . 0.0 108.303 173.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -133.13 163.35 51.74 Favored Pre-proline 0 C--N 1.271 -2.829 0 CA-C-N 112.536 -2.12 . . . . 0.0 110.894 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HB2' HD11 ' A' ' 58' ' ' ILE . 14.5 Cg_exo -70.87 141.3 40.38 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.746 1.631 . . . . 0.0 109.749 166.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 20' ' ' TYR . 32.3 m -127.12 162.52 31.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 124.511 1.125 . . . . 0.0 108.182 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 34.8 m -104.1 128.89 57.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.671 176.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.0 mm -88.61 104.96 15.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -99.96 -16.34 7.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.588 HE22 ' N ' ' A' ' 47' ' ' ASN . 0.6 OUTLIER -43.75 139.28 2.32 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 127.168 2.187 . . . . 0.0 114.667 -170.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -46.81 145.64 1.9 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.448 ' CG ' ' HZ2' ' A' ' 48' ' ' LYS . 21.0 t70 -67.22 -32.81 74.11 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -79.11 -25.76 42.95 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.408 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.77 -33.46 80.32 Favored Glycine 0 C--O 1.199 -2.058 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.588 ' N ' HE22 ' A' ' 42' ' ' GLN 0.257 20.1 p30 -75.45 -19.68 59.3 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.366 -178.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HZ2' ' CG ' ' A' ' 44' ' ' ASP . 14.1 mptt -85.46 -59.3 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.235 172.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.52 -19.06 18.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -167.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 m -102.22 135.91 19.53 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.524 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.69 -12.55 16.59 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.066 1.844 . . . . 0.0 110.783 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.0 p -100.21 134.14 43.57 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.485 -176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 93' ' ' THR . 61.4 t -121.37 140.19 46.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.54 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 3.3 tp -105.72 125.1 61.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 123.543 0.737 . . . . 0.0 109.28 173.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.699 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 14.0 m -130.64 162.28 38.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.335 -175.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 91' ' ' ILE . . . -118.99 132.37 56.06 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.056 0.942 . . . . 0.0 108.93 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.74 128.89 38.01 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 37' ' ' PRO . 61.1 mt -85.63 132.67 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.795 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.3 m -125.92 133.92 51.72 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.192 0.52 . . . . 0.0 111.44 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 177.047 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.9 tt . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.71 2.12 2.24 Favored 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 123.103 2.536 . . . . 0.0 116.018 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.9 p -92.0 -19.15 22.69 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 122.497 1.141 . . . . 0.0 108.715 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.447 ' CD2' HD22 ' A' ' 87' ' ' LEU . 28.9 m170 -101.15 133.35 45.82 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 171.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 4.4 p -133.44 145.51 33.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 117.046 -1.862 . . . . 0.0 112.434 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -87.66 124.54 33.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.636 1.174 . . . . 0.0 112.88 -173.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.561 HG23 ' CZ ' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -128.54 143.97 39.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.814 0.816 . . . . 0.0 112.852 175.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.417 ' OE2' ' HE3' ' A' ' 110' ' ' LYS . 1.3 mp0 -60.74 133.1 55.77 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.727 -178.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 83.8 tttt -55.11 -46.44 75.58 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.751 1.62 . . . . 0.0 109.889 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.413 ' HB3' ' HZ1' ' A' ' 76' ' ' LYS . 7.6 mtpm? -58.5 -48.72 79.9 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 113.129 -1.85 . . . . 0.0 113.305 -174.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HE2' ' OG ' ' A' ' 107' ' ' SER . 3.8 tmtm? -80.29 -38.27 31.11 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -171.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.561 ' CZ ' HG23 ' A' ' 73' ' ' ILE . 4.5 m-85 -84.3 -7.03 59.45 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.601 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 67.93 28.12 6.99 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.43 179.4 5.54 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.533 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' ' HE3' ' A' ' 75' ' ' LYS . 9.9 t70 -68.82 -28.09 66.43 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.605 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.434 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -150.25 166.8 28.82 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -176.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -60.31 146.48 43.85 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.0 t -120.55 160.03 24.01 Favored 'General case' 0 N--CA 1.414 -2.247 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.558 -168.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 26.5 t -127.91 127.1 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 174.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.422 HG22 HD23 ' A' ' 88' ' ' LEU . 1.5 mp -100.96 131.62 48.27 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.447 HD22 ' CD2' ' A' ' 70' ' ' HIS . 22.6 mt -99.13 109.28 22.0 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 113.771 -1.559 . . . . 0.0 107.825 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.422 HD23 HG22 ' A' ' 86' ' ' ILE . 3.1 mm? -88.04 0.08 56.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.591 0.71 . . . . 0.0 111.313 -174.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -98.69 -24.71 14.95 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-O 122.263 1.03 . . . . 0.0 109.654 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.47 ' HA ' HG22 ' B' ' 93' ' ' THR . 0.0 OUTLIER -103.55 85.51 2.47 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.033 177.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.699 ' HB ' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -139.99 171.25 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.202 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -176.337 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.41 ' HD3' HD22 ' A' ' 24' ' ' LEU . 11.9 ptm180 -168.6 169.63 10.12 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 58.4 m -103.93 125.7 50.51 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.518 -1.674 . . . . 0.0 109.329 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.8 mt -132.59 140.77 48.39 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 126.065 1.746 . . . . 0.0 107.419 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.09 153.43 28.74 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.007 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -37.96 -38.18 0.3 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.67 1.588 . . . . 0.0 114.759 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -54.94 -27.55 44.37 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 124.881 1.272 . . . . 0.0 112.281 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -84.18 -27.56 27.96 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.729 -0.607 . . . . 0.0 110.2 -176.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.0 mp -74.04 127.03 31.84 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 123.772 0.829 . . . . 0.0 109.479 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -94.95 -66.65 0.9 Allowed 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.577 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.6 pt-20 -157.11 147.9 21.55 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-O 121.422 0.63 . . . . 0.0 111.247 -170.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.43 ' HZ3' ' HB3' ' A' ' 102' ' ' LYS . 0.1 OUTLIER -68.65 124.48 23.74 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.34 -1.754 . . . . 0.0 109.999 173.077 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.644 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 9.0 tp -112.64 -56.74 2.37 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.128 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.644 ' OG1' ' HG ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -124.59 -169.12 1.92 Allowed 'General case' 0 N--CA 1.394 -3.231 0 C-N-CA 118.833 -1.147 . . . . 0.0 113.986 -176.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 17' ' ' GLY . 8.4 p90 -161.28 142.01 11.17 Favored 'General case' 0 CA--C 1.487 -1.463 0 C-N-CA 125.58 1.552 . . . . 0.0 109.641 -170.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.72 152.15 34.92 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.531 ' OG ' ' HE2' ' A' ' 77' ' ' LYS . 15.8 m -77.02 171.28 15.05 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.834 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 111' ' ' MET . 9.4 m-20 -64.19 -36.94 85.7 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.272 0.558 . . . . 0.0 110.679 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 15.3 t70 -64.65 -39.31 93.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.947 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' A' ' 110' ' ' LYS . 3.1 mptp? -75.84 -26.87 57.57 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.337 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.524 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -55.49 -39.94 71.07 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.851 1.26 . . . . 0.0 108.137 169.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' HE2' ' C ' ' A' ' 111' ' ' MET . 9.1 mmpt? -87.18 -1.66 58.06 Favored 'General case' 0 N--CA 1.394 -3.272 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.721 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 109' ' ' ASP . 32.7 mt-10 -90.89 -55.09 3.69 Favored 'General case' 0 N--CA 1.397 -3.113 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.63 -59.76 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-N 111.831 -2.44 . . . . 0.0 112.717 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 63.4 m-20 -62.71 -39.29 93.58 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 123.134 1.445 . . . . 0.0 111.023 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 17.7 t30 -74.01 -45.87 47.1 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 113.425 -1.716 . . . . 0.0 112.917 -172.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.68 73.35 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 12.5 tp -69.43 -40.28 77.33 Favored 'General case' 0 N--CA 1.389 -3.484 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.367 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.471 ' O ' ' HB2' ' A' ' 124' ' ' LEU . 2.5 ttp -65.2 -27.98 69.06 Favored 'General case' 0 N--CA 1.408 -2.556 0 C-N-CA 123.775 0.83 . . . . 0.0 109.817 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.3 mt -80.29 -52.9 13.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 176.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.1 t -50.39 -33.79 21.95 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.185 -1.825 . . . . 0.0 113.831 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 31.9 mt -97.5 9.35 42.63 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.006 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.51 10.73 81.35 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 115.741 1.056 . . . . 0.0 115.741 173.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 119' ' ' MET . 1.5 mm? -67.8 -54.34 19.91 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 m120 . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.037 -177.901 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -146.82 161.56 40.42 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -83.55 124.06 30.38 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.26 175.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 127.14 -15.63 6.45 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.806 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -96.73 149.52 21.73 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.678 0.751 . . . . 0.0 109.694 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' B' ' 104' ' ' THR . 51.0 t -100.68 121.74 51.84 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.253 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.439 ' O ' HG22 ' B' ' 38' ' ' VAL . 20.6 m-85 -111.83 146.25 38.0 Favored 'General case' 0 CA--C 1.456 -2.646 0 C-N-CA 124.193 0.997 . . . . 0.0 111.967 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.09 145.29 31.17 Favored 'General case' 0 C--N 1.267 -2.992 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 167.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.0 131.77 21.35 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 113.747 -1.57 . . . . 0.0 108.009 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.72 89.76 8.12 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.79 174.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.589 ' O ' HD23 ' B' ' 24' ' ' LEU 0.452 0.0 OUTLIER -108.85 59.84 0.6 Allowed 'General case' 0 N--CA 1.393 -3.295 0 CA-C-O 124.196 1.951 . . . . 0.0 112.426 177.533 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.511 ' HB3' ' HA2' ' B' ' 34' ' ' GLY . 10.9 p -111.62 62.62 0.53 Allowed Pre-proline 0 C--N 1.267 -2.992 0 CA-C-N 113.141 -1.845 . . . . 0.0 113.433 174.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.459 ' HD3' ' C ' ' B' ' 24' ' ' LEU . 22.3 Cg_endo -116.89 26.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.082 0 N-CA-C 107.692 -1.695 . . . . 0.0 107.692 158.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' B' ' 31' ' ' GLU . 18.6 m -95.01 156.39 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.87 151.74 37.56 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.535 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.04 -132.05 11.03 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -94.02 10.94 31.55 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.599 ' CB ' ' HB ' ' B' ' 27' ' ' VAL . 43.4 mt-10 -66.93 151.6 47.28 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -132.89 116.57 16.64 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -173.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . 0.401 ' HA3' HD23 ' B' ' 24' ' ' LEU . . . -149.27 -116.21 0.81 Allowed Glycine 0 N--CA 1.404 -3.494 0 C-N-CA 119.88 -1.152 . . . . 0.0 114.013 175.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.511 ' HA2' ' HB3' ' B' ' 25' ' ' SER . . . 96.63 177.83 35.36 Favored Glycine 0 N--CA 1.413 -2.886 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -171.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.74 102.87 14.08 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-O 123.167 1.46 . . . . 0.0 107.95 172.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -132.13 163.52 49.66 Favored Pre-proline 0 C--N 1.268 -2.966 0 CA-C-N 111.978 -2.374 . . . . 0.0 110.765 -172.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.416 ' HB2' HD11 ' B' ' 58' ' ' ILE . 14.0 Cg_exo -71.21 140.92 38.3 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 121.671 1.581 . . . . 0.0 109.865 165.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.439 HG22 ' O ' ' B' ' 20' ' ' TYR . 28.3 m -126.89 162.63 31.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 124.667 1.187 . . . . 0.0 108.157 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -104.72 129.66 56.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.671 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 32.1 mm -89.22 105.16 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.413 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.1 OUTLIER -100.07 -17.37 6.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.01 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.614 HE22 ' N ' ' B' ' 47' ' ' ASN . 0.6 OUTLIER -43.13 140.51 1.47 Allowed 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 127.03 2.132 . . . . 0.0 114.686 -170.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -47.89 149.55 1.31 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.331 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.584 ' HA ' ' ND2' ' B' ' 47' ' ' ASN . 30.0 t70 -71.83 -32.07 67.18 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.743 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 3.8 m -76.98 -25.07 52.31 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.127 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.62 -35.83 90.47 Favored Glycine 0 C--O 1.199 -2.048 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.614 ' N ' HE22 ' B' ' 42' ' ' GLN . 13.0 p30 -74.35 -19.09 60.57 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.339 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.491 ' HZ2' ' CG ' ' B' ' 44' ' ' ASP . 14.0 mptt -85.64 -61.59 1.72 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.203 174.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -96.58 -16.68 20.92 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 -168.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -98.62 140.75 22.01 Favored Pre-proline 0 C--N 1.302 -1.473 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.306 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.43 -11.77 11.68 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.932 1.754 . . . . 0.0 110.26 173.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -101.35 137.69 39.36 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 124.879 1.271 . . . . 0.0 111.455 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' B' ' 93' ' ' THR . 60.2 t -124.22 140.21 48.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.515 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 3.2 tp -105.69 124.74 60.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 123.455 0.702 . . . . 0.0 109.402 173.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.683 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 13.6 m -130.64 162.54 38.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.328 -175.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.468 ' HA ' HG22 ' B' ' 91' ' ' ILE . . . -118.89 132.79 56.11 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 124.27 1.028 . . . . 0.0 108.759 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.1 129.54 39.71 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' B' ' 37' ' ' PRO . 60.5 mt -86.64 133.18 30.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.202 174.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 75.1 m -127.11 133.01 50.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.24 0.543 . . . . 0.0 112.223 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 176.546 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.1 tt . . . . . 0 C--O 1.215 -0.722 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.82 -4.32 4.58 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 123.821 3.014 . . . . 0.0 116.153 -174.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 74.8 p -87.21 -18.99 29.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.407 1.098 . . . . 0.0 108.848 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . 0.431 ' CD2' HD22 ' B' ' 87' ' ' LEU . 33.5 m170 -99.83 134.8 42.2 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 170.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 5.1 p -134.24 144.98 33.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 116.979 -1.888 . . . . 0.0 112.364 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -88.62 127.88 35.57 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.25 1.02 . . . . 0.0 112.149 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.573 HG23 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -128.33 149.12 32.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 O-C-N 123.708 0.63 . . . . 0.0 112.063 175.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -64.19 131.89 48.74 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.329 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -54.62 -46.69 73.92 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 125.732 1.613 . . . . 0.0 109.813 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . 0.404 ' HZ1' ' HB3' ' B' ' 76' ' ' LYS . 6.5 mtpm? -56.29 -50.21 72.04 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.851 -175.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -78.78 -39.06 36.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.63 -170.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.573 ' CZ ' HG23 ' B' ' 73' ' ' ILE . 4.4 m-85 -84.14 -6.99 59.49 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.977 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 68.6 29.28 5.52 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.19 178.88 5.38 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.382 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -70.59 -25.0 62.86 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.422 -1.717 . . . . 0.0 111.156 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.406 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -151.68 163.52 38.94 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -176.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.37 143.92 43.42 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 22.1 t -121.3 156.83 31.69 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 119.639 -0.825 . . . . 0.0 112.257 -167.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 25.9 t -123.7 126.97 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.413 HG22 HD23 ' B' ' 88' ' ' LEU . 1.5 mp -100.24 131.33 47.93 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.158 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.431 HD22 ' CD2' ' B' ' 70' ' ' HIS . 31.8 mt -98.99 108.15 20.76 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.03 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.413 HD23 HG22 ' B' ' 86' ' ' ILE . 3.3 mm? -86.97 -0.26 56.3 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.723 0.773 . . . . 0.0 111.52 -174.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -100.15 -22.65 15.1 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 122.372 1.082 . . . . 0.0 109.928 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . 0.457 ' HA ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -104.62 85.66 2.36 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.992 177.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.683 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 0.3 OUTLIER -140.1 171.41 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.432 ' HD3' HD22 ' B' ' 24' ' ' LEU . 11.7 ptm180 -168.98 169.34 9.67 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.47 HG22 ' HA ' ' A' ' 90' ' ' GLN . 72.0 m -104.43 126.31 51.41 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.549 -177.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -132.55 142.88 49.37 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 126.069 1.748 . . . . 0.0 107.432 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -81.18 152.06 27.9 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.019 -1.473 . . . . 0.0 108.96 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -35.48 -40.01 0.15 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.891 1.676 . . . . 0.0 115.148 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -51.34 -31.79 23.26 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 125.027 1.331 . . . . 0.0 112.632 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -79.93 -27.51 39.84 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.963 0.411 . . . . 0.0 110.193 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -75.01 124.56 27.19 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 122.01 0.91 . . . . 0.0 109.563 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -95.49 -60.08 1.74 Allowed 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.902 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.2 pt-20 -161.02 148.43 15.4 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-O 121.504 0.669 . . . . 0.0 111.737 -172.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . 0.404 ' HB3' ' HZ3' ' B' ' 102' ' ' LYS . 0.1 OUTLIER -71.63 121.06 18.12 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.85 174.541 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.619 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 8.4 tp -109.37 -55.39 2.43 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.619 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 0.3 OUTLIER -124.13 -168.57 1.82 Allowed 'General case' 0 N--CA 1.391 -3.424 0 C-N-CA 118.421 -1.312 . . . . 0.0 114.497 -176.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . 0.51 ' H ' HG22 ' B' ' 104' ' ' THR . 19.9 p90 -161.48 141.69 10.68 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 125.808 1.643 . . . . 0.0 109.383 -171.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.9 150.73 36.6 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.44 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t -78.25 170.18 17.05 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.473 -175.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' B' ' 111' ' ' MET . 4.6 m-20 -60.8 -38.48 85.49 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.683 0.793 . . . . 0.0 111.121 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 27.1 t70 -64.58 -38.27 90.44 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.148 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' B' ' 110' ' ' LYS . 2.6 mptp? -75.55 -27.71 58.74 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.247 -178.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.503 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.2 OUTLIER -54.87 -40.25 69.52 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 124.912 1.285 . . . . 0.0 108.058 170.041 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.421 ' HE2' ' C ' ' B' ' 111' ' ' MET . 7.7 mmpt? -86.6 -2.43 58.49 Favored 'General case' 0 N--CA 1.384 -3.769 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.314 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' B' ' 109' ' ' ASP . 38.3 mt-10 -90.69 -55.51 3.54 Favored 'General case' 0 C--N 1.261 -3.271 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 172.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.18 -59.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 CA-C-N 111.594 -2.548 . . . . 0.0 112.786 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.539 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 56.7 m-20 -62.65 -40.24 96.42 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.14 1.448 . . . . 0.0 111.227 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.332 43.1 t30 -75.1 -42.96 55.52 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 113.531 -1.668 . . . . 0.0 112.602 -170.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.18 -31.76 73.08 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.546 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 11.2 tp -70.72 -35.09 72.56 Favored 'General case' 0 N--CA 1.39 -3.445 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.047 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.478 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 2.3 ttp -69.05 -21.49 64.09 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-O 121.686 0.755 . . . . 0.0 109.303 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 51.6 mt -87.89 -53.5 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 79.1 p -53.94 -28.48 37.33 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 26.2 mt -97.06 5.28 50.64 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.187 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.15 13.01 78.14 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 115.954 1.142 . . . . 0.0 115.954 172.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.478 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.5 mm? -68.32 -52.95 27.84 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 23.7 m120 . . . . . 0 C--O 1.241 0.65 0 CA-C-N 112.979 -1.919 . . . . 0.0 109.474 -179.375 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -146.54 156.91 43.59 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -70.36 124.91 25.32 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 169.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.14 -26.21 3.78 Favored Glycine 0 C--N 1.302 -1.359 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.093 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -97.41 167.43 11.0 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.776 0.798 . . . . 0.0 109.427 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.53 HG22 HG22 ' A' ' 104' ' ' THR . 24.7 t -122.42 139.39 49.48 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.56 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.2 m-85 -133.5 148.66 51.7 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.4 151.62 39.65 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 168.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -141.58 135.48 30.1 Favored 'General case' 0 CA--C 1.454 -2.736 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.217 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.39 93.59 9.58 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 166.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.412 HD11 ' HD3' ' A' ' 92' ' ' ARG . 1.1 pp -109.83 28.9 8.12 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.282 -1.327 . . . . 0.0 107.814 -174.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.29 62.25 0.0 OUTLIER Pre-proline 0 C--N 1.267 -3.002 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -112.87 25.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.938 0 N-CA-C 107.232 -1.872 . . . . 0.0 107.232 153.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 13.9 m -83.56 160.45 3.49 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -173.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.52 145.84 31.21 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 113.311 -1.768 . . . . 0.0 113.249 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.32 -114.21 6.65 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.602 -1.181 . . . . 0.0 114.637 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -78.34 -9.1 59.12 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 123.827 0.851 . . . . 0.0 112.963 -173.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 50.7 mt-10 -71.3 159.89 33.78 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -132.29 111.41 11.35 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -174.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.402 ' HA3' HD13 ' A' ' 24' ' ' LEU . . . -164.0 -162.54 15.11 Favored Glycine 0 N--CA 1.408 -3.23 0 C-N-CA 119.155 -1.497 . . . . 0.0 115.02 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.6 -156.81 26.45 Favored Glycine 0 N--CA 1.407 -3.283 0 N-CA-C 103.419 -3.872 . . . . 0.0 103.419 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 59.3 t -83.03 99.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.438 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 169.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -130.8 146.51 62.33 Favored Pre-proline 0 C--N 1.252 -3.652 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.277 -172.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.452 ' HB2' HD12 ' A' ' 58' ' ' ILE . 25.4 Cg_exo -62.98 137.12 60.49 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 121.702 1.601 . . . . 0.0 109.929 171.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 31.1 m -127.6 154.87 38.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 29.8 m -97.77 129.92 47.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.125 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.9 mm -91.36 107.19 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -13.82 9.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.285 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.542 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 5.0 pt20 -52.11 165.24 0.23 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 -169.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -65.51 174.43 2.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.613 -2.085 . . . . 0.0 112.118 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 9.9 t70 -72.56 -48.24 41.65 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.268 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.5 m -70.38 -30.98 68.03 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.477 0.711 . . . . 0.0 112.253 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA2' ' HB2' ' A' ' 50' ' ' SER . . . -62.32 -33.41 86.05 Favored Glycine 0 C--O 1.205 -1.67 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.691 -175.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.488 ' N ' HE22 ' A' ' 42' ' ' GLN . 10.1 p30 -84.65 -37.13 21.4 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.841 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.627 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 24.4 mmtp -67.6 -63.19 1.11 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.386 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.627 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 19.0 m-85 -102.09 -35.86 8.77 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -168.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.437 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 22.5 m -82.47 157.92 66.88 Favored Pre-proline 0 N--CA 1.422 -1.832 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.673 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 86.4 Cg_endo -86.95 -20.85 2.23 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 121.099 1.199 . . . . 0.0 111.797 174.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.402 HG22 ' HG2' ' B' ' 90' ' ' GLN . 11.3 p -99.6 135.3 41.23 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.542 ' HB ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -133.42 139.2 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.906 176.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.5 tt -81.74 126.85 39.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.964 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 34.5 m -132.97 154.98 40.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.582 174.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.5 ' CB ' HG23 ' A' ' 91' ' ' ILE . . . -115.91 133.09 56.39 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.3 136.02 56.76 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.497 HG12 ' CD1' ' A' ' 86' ' ' ILE . 49.2 mt -98.07 131.47 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.736 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 m -105.54 108.34 19.81 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.479 -178.839 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tt . . . . . 0 C--O 1.206 -1.234 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.12 -4.7 12.05 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 122.427 2.084 . . . . 0.0 115.246 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.3 p -100.09 -17.92 17.22 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.377 0.608 . . . . 0.0 111.363 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -118.55 128.45 54.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 61.0 t -111.27 134.26 54.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.208 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -99.69 124.79 45.28 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 123.744 0.653 . . . . 0.0 109.363 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.49 HG21 ' CZ ' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -116.35 153.27 18.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.209 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -54.08 129.56 34.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.058 -1.428 . . . . 0.0 112.815 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.632 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 93.1 mttt -51.98 -56.79 12.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.457 178.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -67.98 -45.84 73.03 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.193 -169.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -62.84 -33.05 74.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.016 0.436 . . . . 0.0 111.394 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.52 ' HH ' ' HG ' ' A' ' 106' ' ' LEU . 12.1 m-85 -92.9 2.31 56.85 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 123.924 0.89 . . . . 0.0 111.14 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.3 tptt 72.22 15.95 5.28 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.507 1.523 . . . . 0.0 113.562 171.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.53 175.42 6.56 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-O 122.492 1.139 . . . . 0.0 110.983 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.486 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 10.3 t70 -85.08 -27.08 26.54 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 112.944 -1.934 . . . . 0.0 110.1 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.497 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -139.31 157.09 46.5 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.42 -174.19 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.632 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 6.5 m-20 -45.89 135.44 7.15 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 124.92 1.388 . . . . 0.0 112.055 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 73' ' ' ILE . 15.4 m -103.73 121.8 43.76 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.667 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 9.8 t -107.74 136.51 42.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.497 ' CD1' HG12 ' A' ' 58' ' ' ILE . 15.9 mm -111.68 134.41 54.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.1 mt -104.91 97.42 7.29 Favored 'General case' 0 N--CA 1.416 -2.164 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.438 ' HG ' ' HB1' ' A' ' 117' ' ' ALA . 3.0 mm? -81.25 -9.42 59.77 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.497 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -95.41 -25.93 16.07 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.762 0.791 . . . . 0.0 111.292 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.592 ' O ' ' HB ' ' B' ' 93' ' ' THR . 1.1 tm0? -80.28 -60.88 2.16 Favored 'General case' 0 C--O 1.164 -3.433 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.246 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.5 HG23 ' CB ' ' A' ' 56' ' ' ALA . 1.3 pp 30.05 -174.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.529 3.475 0 C-N-CA 129.646 3.178 . . . . 0.0 116.814 175.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.412 ' HD3' HD11 ' A' ' 24' ' ' LEU . 8.7 ptm85 -176.96 159.6 1.72 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 167.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.594 ' HB ' ' O ' ' B' ' 90' ' ' GLN . 0.0 OUTLIER -114.54 108.36 16.74 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.743 1.217 . . . . 0.0 109.356 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 98' ' ' ARG . 64.9 mt -131.82 149.58 52.42 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -173.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.673 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 11.8 t70 -50.72 145.17 7.22 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 173.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 33.1 pttt -55.58 -29.74 59.6 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.589 1.556 . . . . 0.0 114.608 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.457 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 20.1 ttmm -47.56 -39.08 15.63 Favored 'General case' 0 C--N 1.274 -2.677 0 C-N-CA 126.243 1.817 . . . . 0.0 112.476 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 94' ' ' LEU . 1.7 ppt_? -73.39 -15.01 61.37 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 10.4 mp -61.75 120.6 10.98 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.912 0.885 . . . . 0.0 110.028 170.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.08 -64.27 1.08 Allowed 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.367 -177.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.4 pt-20 -156.67 145.32 19.95 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 121.786 0.803 . . . . 0.0 111.807 -172.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -60.81 120.82 10.86 Favored 'General case' 0 C--N 1.281 -2.379 0 C-N-CA 128.132 2.573 . . . . 0.0 108.814 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -114.66 -62.67 1.57 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.704 -0.798 . . . . 0.0 112.466 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.53 HG22 HG22 ' A' ' 19' ' ' VAL . 5.4 t -128.8 -160.98 1.07 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.243 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -159.39 149.25 18.77 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.052 0.941 . . . . 0.0 112.326 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.52 ' HG ' ' HH ' ' A' ' 78' ' ' TYR . 7.2 mp -107.56 135.39 49.1 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 113.853 -1.522 . . . . 0.0 112.264 -177.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.426 ' O ' ' HG2' ' A' ' 111' ' ' MET . 7.0 m -76.4 165.95 24.11 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 124.248 1.019 . . . . 0.0 110.597 176.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 111' ' ' MET . 23.3 t70 -67.71 -42.98 81.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.86 -28.86 69.28 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.737 0.78 . . . . 0.0 109.382 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HD2' ' CG2' ' A' ' 73' ' ' ILE . 71.5 mmtt -79.78 -28.78 40.3 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.684 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.8 OUTLIER -53.65 -44.55 69.69 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.153 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 10.0 mmpt? -75.13 -8.32 56.24 Favored 'General case' 0 N--CA 1.396 -3.161 0 CA-C-N 114.421 -1.263 . . . . 0.0 114.173 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -89.26 -51.56 5.51 Favored 'General case' 0 N--CA 1.397 -3.079 0 C-N-CA 116.735 -1.986 . . . . 0.0 106.264 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -53.72 -59.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 112.615 -2.084 . . . . 0.0 113.351 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 45.8 m-20 -59.73 -39.19 83.87 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 123.241 1.496 . . . . 0.0 110.989 -177.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 10.9 t30 -77.97 -40.46 39.25 Favored 'General case' 0 C--N 1.261 -3.275 0 CA-C-N 112.718 -2.037 . . . . 0.0 111.669 -173.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' HB1' ' HG ' ' A' ' 88' ' ' LEU . . . -61.69 -36.58 81.29 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 5.2 tp -70.14 -37.02 75.18 Favored 'General case' 0 N--CA 1.394 -3.24 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.2 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.447 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 1.5 ttp -66.87 -22.99 65.96 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.872 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.0 mt -88.07 -50.95 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 118' ' ' LEU . 83.5 p -59.33 -22.26 61.02 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.644 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 32.9 mt -103.73 1.28 31.58 Favored 'General case' 0 C--O 1.201 -1.486 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.501 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.35 16.86 54.71 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 117.137 1.615 . . . . 0.0 117.137 171.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.2 mm? -74.0 -52.34 13.08 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.3 m120 . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 112.47 -2.15 . . . . 0.0 112.546 -179.751 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 N--CA 1.428 -1.558 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -145.8 156.89 43.88 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -70.24 128.92 37.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.92 -26.33 4.02 Favored Glycine 0 C--N 1.307 -1.051 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.551 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -97.42 169.69 9.57 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 121.762 0.791 . . . . 0.0 109.183 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.52 HG22 HG22 ' B' ' 104' ' ' THR . 23.4 t -123.84 140.16 48.15 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.885 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.728 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 35.3 m-85 -132.9 148.96 52.29 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 124.162 0.985 . . . . 0.0 109.087 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.02 149.57 39.2 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 167.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -140.35 134.49 30.97 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.71 -175.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -86.5 93.58 9.2 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 166.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.405 HD13 ' HA3' ' B' ' 33' ' ' GLY . 1.1 pp -108.8 28.7 8.16 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.842 1.306 . . . . 0.0 108.011 -175.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.428 ' OG ' ' HA2' ' B' ' 34' ' ' GLY . 1.0 OUTLIER -90.27 62.72 0.0 OUTLIER Pre-proline 0 C--N 1.266 -3.058 0 N-CA-C 116.712 2.115 . . . . 0.0 116.712 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -113.67 25.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.981 0 N-CA-C 107.42 -1.8 . . . . 0.0 107.42 151.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 15.1 m -82.29 162.26 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -173.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.39 147.86 31.72 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.802 -1.544 . . . . 0.0 113.033 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.34 -114.53 6.79 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 114.622 -1.172 . . . . 0.0 114.323 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -75.56 -11.76 60.08 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 123.855 0.862 . . . . 0.0 113.168 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.538 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 50.3 mt-10 -71.03 158.4 36.57 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -131.91 112.6 12.58 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . 0.405 ' HA3' HD13 ' B' ' 24' ' ' LEU . . . -164.4 -161.63 13.84 Favored Glycine 0 N--CA 1.408 -3.192 0 C-N-CA 119.379 -1.391 . . . . 0.0 114.971 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.428 ' HA2' ' OG ' ' B' ' 25' ' ' SER . . . 141.6 -158.53 26.6 Favored Glycine 0 C--N 1.267 -3.279 0 N-CA-C 103.403 -3.879 . . . . 0.0 103.403 -173.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 61.8 t -82.37 98.98 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 169.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -130.72 146.78 63.4 Favored Pre-proline 0 C--N 1.253 -3.592 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.096 -172.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.49 138.03 63.07 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.766 1.644 . . . . 0.0 110.16 171.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 30.2 m -128.44 154.72 39.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.569 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.435 ' CG2' ' HB1' ' B' ' 56' ' ' ALA . 28.1 m -97.72 129.7 47.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.094 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 25.8 mm -91.31 106.27 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -14.77 9.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.25 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.561 ' OE1' ' HB3' ' B' ' 47' ' ' ASN . 0.1 OUTLIER -53.79 164.71 0.53 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -170.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -64.01 175.03 1.31 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.514 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' B' ' 48' ' ' LYS . 12.8 t70 -74.31 -47.32 35.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.866 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.9 m -70.52 -31.34 68.38 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.637 0.775 . . . . 0.0 112.199 -169.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' B' ' 50' ' ' SER . . . -62.48 -32.4 82.97 Favored Glycine 0 C--O 1.21 -1.401 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.424 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.561 ' HB3' ' OE1' ' B' ' 42' ' ' GLN . 9.7 p30 -84.65 -39.04 19.1 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.475 -0.89 . . . . 0.0 112.096 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.64 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 25.9 mmtp -65.74 -63.25 1.13 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.096 0.474 . . . . 0.0 111.726 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . 0.64 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 19.1 m-85 -102.14 -36.3 8.59 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -168.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.445 ' HB2' ' HA2' ' B' ' 46' ' ' GLY . 25.8 m -80.85 157.98 71.03 Favored Pre-proline 0 N--CA 1.418 -2.032 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.673 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 83.8 Cg_endo -87.39 -21.37 1.92 Allowed 'Trans proline' 0 N--CA 1.431 -2.162 0 C-N-CA 121.202 1.268 . . . . 0.0 111.662 173.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 9.5 p -99.41 135.12 41.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -170.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.98 138.79 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.316 175.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tt -82.3 127.39 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 124.979 1.311 . . . . 0.0 110.732 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 34.7 m -132.77 154.99 40.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.395 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.512 ' CB ' HG23 ' B' ' 91' ' ' ILE . . . -115.43 132.82 56.5 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.98 136.5 57.38 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.525 HG12 ' CD1' ' B' ' 86' ' ' ILE . 63.5 mt -97.34 132.26 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.702 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 26.3 m -106.13 106.11 16.46 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 174.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.519 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.001 -178.76 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 8.6 tt . . . . . 0 C--O 1.213 -0.847 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.84 -3.39 4.55 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 122.962 2.441 . . . . 0.0 115.301 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 66.6 p -103.37 -15.64 15.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.309 0.576 . . . . 0.0 111.19 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -119.07 129.01 54.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 52.8 t -111.38 132.99 58.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.16 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -99.58 119.8 38.64 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.355 0.662 . . . . 0.0 109.557 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.42 HG12 ' O ' ' B' ' 84' ' ' SER . 0.0 OUTLIER -111.11 153.54 12.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.536 ' OE1' ' HE3' ' B' ' 110' ' ' LYS . 1.6 mp0 -53.1 128.99 29.54 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.818 1.324 . . . . 0.0 111.956 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . 0.617 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 94.0 mttt -52.15 -56.35 15.1 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.209 0.943 . . . . 0.0 111.364 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -68.81 -43.08 76.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.845 -168.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' B' ' 77' ' ' LYS . 38.8 ttmt -64.95 -33.5 76.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.239 0.543 . . . . 0.0 110.878 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.414 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 14.7 m-85 -91.68 2.18 56.65 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.197 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 41.7 tptt 71.83 20.05 4.65 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.072 1.349 . . . . 0.0 113.074 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.71 174.05 6.41 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 122.573 1.178 . . . . 0.0 111.217 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -84.07 -26.09 29.3 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.88 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.447 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -140.97 156.75 46.0 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.385 -172.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . 0.617 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 10.9 m-20 -46.64 135.28 8.87 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.902 1.376 . . . . 0.0 112.126 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' SER . . . . . 0.42 ' O ' HG12 ' B' ' 73' ' ' ILE . 14.9 m -103.89 122.6 45.51 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.887 -177.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 8.9 t -107.88 137.16 40.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.525 ' CD1' HG12 ' B' ' 58' ' ' ILE . 16.5 mm -111.67 135.05 52.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 18.8 mt -105.38 98.72 8.38 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.03 -9.82 59.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.324 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -95.58 -26.19 15.87 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.316 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . 0.594 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -80.2 -60.7 2.23 Favored 'General case' 0 C--O 1.162 -3.534 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.138 -178.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.512 HG23 ' CB ' ' B' ' 56' ' ' ALA . 1.3 pp 30.02 -174.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 C-N-CA 129.605 3.162 . . . . 0.0 116.836 175.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.401 ' HD3' HD11 ' B' ' 24' ' ' LEU . 8.5 ptm85 -176.95 159.72 1.73 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 167.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -114.83 108.63 17.01 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.916 1.286 . . . . 0.0 109.453 179.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.488 ' HB2' ' CZ ' ' B' ' 98' ' ' ARG . 65.2 mt -131.77 150.94 51.99 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.673 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 11.7 t70 -51.9 146.12 8.84 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.32 0.509 . . . . 0.0 111.446 173.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' B' ' 99' ' ' LEU . 31.5 pttt -54.48 -33.34 59.58 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.095 1.358 . . . . 0.0 114.256 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -41.28 -40.69 1.71 Allowed 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 126.742 2.017 . . . . 0.0 113.693 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.488 ' CZ ' ' HB2' ' B' ' 94' ' ' LEU . 1.7 ppt_? -73.72 -13.95 61.05 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' B' ' 96' ' ' LYS . 10.1 mp -63.39 118.48 8.13 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 123.83 0.852 . . . . 0.0 109.81 170.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.19 -64.07 1.1 Allowed 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.304 -1.317 . . . . 0.0 112.094 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 12.2 pt-20 -156.76 145.86 20.28 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-O 121.815 0.817 . . . . 0.0 111.55 -172.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -60.39 122.57 14.91 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 128.152 2.581 . . . . 0.0 108.891 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 13.0 tp -114.97 -62.33 1.62 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 119.566 -0.853 . . . . 0.0 112.393 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.52 HG22 HG22 ' B' ' 19' ' ' VAL . 5.4 t -129.3 -160.79 1.06 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.317 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -159.31 147.76 17.86 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.262 1.025 . . . . 0.0 112.289 -169.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.79 140.52 36.95 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.0 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 15.1 t -82.91 162.41 21.55 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.074 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' B' ' 111' ' ' MET . 15.8 t70 -63.9 -44.74 92.09 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 122.73 0.412 . . . . 0.0 111.828 -175.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.7 -30.39 71.5 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.575 0.702 . . . . 0.0 110.363 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.536 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 70.0 mmtt -80.29 -27.01 38.62 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.999 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.4 OUTLIER -53.93 -44.36 70.58 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 169.131 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.414 ' HE2' ' C ' ' B' ' 111' ' ' MET . 9.7 mmpt? -75.7 -8.2 56.23 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 114.215 -1.357 . . . . 0.0 113.792 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -89.92 -50.95 5.73 Favored 'General case' 0 N--CA 1.398 -3.055 0 C-N-CA 117.215 -1.794 . . . . 0.0 106.922 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -54.26 -59.85 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-N 112.586 -2.097 . . . . 0.0 112.96 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 47.1 m-20 -58.57 -42.06 87.1 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 123.07 1.414 . . . . 0.0 111.281 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.313 14.8 t30 -74.74 -40.9 61.0 Favored 'General case' 0 C--N 1.266 -3.044 0 CA-C-N 113.059 -1.882 . . . . 0.0 111.551 -174.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.48 80.73 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 5.2 tp -69.64 -36.94 76.54 Favored 'General case' 0 N--CA 1.394 -3.272 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.789 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.463 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 1.3 ttp -67.18 -22.58 65.74 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.375 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.23 -53.92 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' SER . . . . . 0.446 ' OG ' ' HA ' ' B' ' 118' ' ' LEU . 78.1 p -55.37 -24.25 28.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.134 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 32.8 mt -101.48 0.66 37.09 Favored 'General case' 0 C--O 1.2 -1.504 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.958 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.33 16.48 55.41 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 116.98 1.552 . . . . 0.0 116.98 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.463 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.2 mm? -73.6 -51.72 15.88 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 22.2 m120 . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 112.488 -2.142 . . . . 0.0 112.252 179.811 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.524 ' HB ' ' OD1' ' A' ' 47' ' ' ASN . 60.9 mt . . . . . 0 N--CA 1.428 -1.556 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -116.38 144.68 43.97 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 172.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.537 ' HD2' ' O ' ' A' ' 41' ' ' ILE . 4.7 ttp180 -63.81 114.42 4.03 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 174.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.33 -16.52 5.43 Favored Glycine 0 N--CA 1.421 -2.35 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.78 172.02 12.91 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 122.815 1.293 . . . . 0.0 110.516 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.504 HG23 HG21 ' A' ' 104' ' ' THR . 12.6 t -132.68 128.99 58.18 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.425 0 CA-C-N 112.356 -2.202 . . . . 0.0 109.445 175.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 37.3 m-85 -126.38 147.38 49.77 Favored 'General case' 0 C--N 1.277 -2.567 0 C-N-CA 125.1 1.36 . . . . 0.0 108.325 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -82.17 161.48 22.77 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 170.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.17 133.08 13.24 Favored 'General case' 0 C--N 1.28 -2.424 0 O-C-N 123.982 0.801 . . . . 0.0 109.307 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.62 81.75 8.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 123.56 1.648 . . . . 0.0 109.258 173.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.483 ' O ' HG11 ' A' ' 27' ' ' VAL . 4.3 pp -89.27 3.66 51.32 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 113.009 -1.905 . . . . 0.0 111.95 -175.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.533 ' HB3' ' N ' ' A' ' 34' ' ' GLY . 2.3 p -89.72 60.24 0.0 OUTLIER Pre-proline 0 C--N 1.272 -2.785 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.482 ' HD3' ' C ' ' A' ' 24' ' ' LEU . 19.1 Cg_endo -118.83 30.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.582 0 N-CA-C 106.889 -2.004 . . . . 0.0 106.889 152.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.483 HG11 ' O ' ' A' ' 24' ' ' LEU . 35.3 m -71.2 176.68 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.491 -173.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.25 138.45 31.41 Favored 'General case' 0 N--CA 1.41 -2.458 0 CA-C-N 114.004 -1.453 . . . . 0.0 113.8 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.04 -133.1 11.75 Favored Glycine 0 N--CA 1.421 -2.346 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.229 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.5 m -93.76 18.5 10.17 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 47.6 mt-10 -70.36 167.92 17.11 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.541 ' HB3' HE21 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -101.21 119.08 38.22 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -174.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.27 151.93 17.55 Favored Glycine 0 CA--C 1.483 -1.914 0 N-CA-C 115.82 1.088 . . . . 0.0 115.82 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.533 ' N ' ' HB3' ' A' ' 25' ' ' SER . . . 137.18 137.28 3.6 Favored Glycine 0 C--N 1.293 -1.821 0 CA-C-N 113.313 -1.444 . . . . 0.0 111.367 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 35' ' ' VAL . 2.7 p -72.09 105.83 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 123.17 1.462 . . . . 0.0 107.752 173.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -136.08 161.18 63.98 Favored Pre-proline 0 C--N 1.253 -3.617 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.792 -172.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 18.6 Cg_exo -67.68 142.87 59.85 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.025 1.817 . . . . 0.0 110.201 170.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 20' ' ' TYR . 27.8 m -123.18 158.56 28.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 123.608 0.763 . . . . 0.0 109.325 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.436 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 33.8 m -102.03 132.4 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.704 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mm -85.16 105.94 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.537 ' O ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -103.59 -12.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.946 -178.359 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.653 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 3.4 mt-30 -42.0 157.56 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 120.706 3.595 . . . . 0.0 120.706 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -69.3 145.79 52.76 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 110.815 -2.902 . . . . 0.0 108.024 164.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 47' ' ' ASN . 20.5 t70 -62.64 -30.88 71.69 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.84 -177.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.0 m -86.87 -27.1 23.64 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.969 -1.092 . . . . 0.0 111.793 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.453 ' C ' HE22 ' A' ' 42' ' ' GLN . . . -67.59 -25.79 73.84 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 174.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.524 ' OD1' ' HB ' ' A' ' 14' ' ' ILE . 35.0 t30 -71.18 -39.39 71.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.991 -1.105 . . . . 0.0 109.77 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -74.26 -60.97 2.02 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . 0.46 16.6 p90 -128.36 2.03 5.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 119.352 3.093 . . . . 0.0 119.352 -173.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.5 m -86.86 134.21 37.72 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 172.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.403 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 34.0 Cg_exo -63.53 -29.54 70.81 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 121.606 1.538 . . . . 0.0 109.828 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -95.03 139.82 30.85 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.688 -173.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.653 ' HB ' ' OE1' ' A' ' 42' ' ' GLN . 1.1 m -131.53 157.77 43.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.7 tt -109.56 131.12 61.32 Favored 'Isoleucine or valine' 0 C--O 1.251 1.156 0 CA-C-O 121.144 0.497 . . . . 0.0 109.798 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 30.0 m -137.73 160.4 33.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.952 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.509 ' CB ' HG23 ' A' ' 91' ' ' ILE . . . -120.2 142.25 49.17 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.21 143.97 36.69 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.603 HG12 ' CD1' ' A' ' 86' ' ' ILE . 67.7 mt -97.99 140.04 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-N 113.286 -1.779 . . . . 0.0 109.251 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.7 m -137.74 116.89 12.58 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.285 0.634 . . . . 0.0 110.122 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -0.922 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.576 -178.624 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--O 1.205 -1.278 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.71 -6.73 11.26 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 122.439 2.093 . . . . 0.0 113.503 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.8 p -96.05 -18.0 20.53 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.434 0.635 . . . . 0.0 111.018 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.465 ' CD2' HD21 ' A' ' 87' ' ' LEU . 46.3 m170 -114.12 128.4 56.36 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.13 138.59 54.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 121.854 -0.529 . . . . 0.0 111.02 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.43 140.49 29.75 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.722 0.772 . . . . 0.0 111.745 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.727 HG23 ' CE1' ' A' ' 78' ' ' TYR . 3.0 mm -108.99 -176.19 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.623 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -117.69 133.76 55.6 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -173.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.644 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 73.1 mttt -44.09 -53.24 6.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.64 1.213 . . . . 0.0 110.723 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -61.12 -32.25 71.94 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.701 -1.59 . . . . 0.0 113.93 -173.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -85.2 -27.82 25.86 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.622 0.725 . . . . 0.0 109.586 -173.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.727 ' CE1' HG23 ' A' ' 73' ' ' ILE . 2.1 m-85 -97.01 0.18 48.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.735 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.8 tttp 66.42 19.43 10.94 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 121.627 0.727 . . . . 0.0 111.148 176.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 78' ' ' TYR . 7.8 mp -96.94 172.18 8.02 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-O 122.927 1.346 . . . . 0.0 112.827 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.54 -24.27 42.29 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.613 -2.539 . . . . 0.0 109.725 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.484 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -137.54 152.66 49.69 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.425 -173.191 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.644 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 11.7 p-10 -75.9 142.21 42.15 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.35 -1.296 . . . . 0.0 108.741 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -136.97 159.08 42.96 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.705 -172.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 t -110.61 153.74 12.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 124.512 1.125 . . . . 0.0 108.151 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.603 ' CD1' HG12 ' A' ' 58' ' ' ILE . 13.2 mm -117.71 140.34 41.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.465 HD21 ' CD2' ' A' ' 70' ' ' HIS . 36.7 mt -105.46 104.61 14.37 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' HB1' ' A' ' 117' ' ' ALA . 3.8 mm? -86.27 -7.18 58.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.055 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.56 -38.02 15.23 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.967 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.541 HE21 ' HB3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -98.12 77.05 2.4 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.822 -179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.509 HG23 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -108.93 179.45 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . 0.264 7.6 ptp180 -163.3 160.92 24.36 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 175.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 96.8 m -117.55 114.67 23.78 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.764 -176.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.8 mt -131.7 147.4 52.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.275 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.576 ' OD1' ' HB3' ' A' ' 97' ' ' LYS . 2.7 p30 -72.04 152.09 42.67 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.042 172.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -48.01 -26.15 1.67 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 125.735 1.614 . . . . 0.0 114.202 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.576 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . 7.0 ttpm? -73.16 -18.86 61.23 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.128 0.571 . . . . 0.0 111.228 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.514 ' HA ' ' NE ' ' A' ' 98' ' ' ARG . 2.7 mmp_? -75.9 -31.03 59.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.39 0.614 . . . . 0.0 109.593 175.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.78 130.19 39.02 Favored 'General case' 0 CA--C 1.475 -1.911 0 CA-C-O 123.07 1.414 . . . . 0.0 110.595 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.435 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 13.9 tptt -90.25 -68.31 0.79 Allowed 'General case' 0 N--CA 1.391 -3.402 0 CA-C-N 111.745 -2.48 . . . . 0.0 113.023 -171.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 8.4 pt-20 -163.67 143.58 8.43 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 121.709 0.766 . . . . 0.0 111.829 -168.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -63.39 114.86 4.12 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 128.113 2.565 . . . . 0.0 109.531 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -112.0 -62.68 1.53 Allowed 'General case' 0 N--CA 1.417 -2.098 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 19' ' ' VAL . 3.6 t -128.5 -162.5 1.19 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 117.736 -1.585 . . . . 0.0 112.912 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -160.41 140.43 11.32 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 125.228 1.411 . . . . 0.0 109.997 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 3.6 pp -108.81 157.49 18.54 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.156 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.416 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 11.8 m -89.82 174.03 7.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.323 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 111' ' ' MET . 11.0 m-20 -62.4 -32.56 73.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.202 1.001 . . . . 0.0 111.617 -177.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' OD1' ' HB2' ' A' ' 107' ' ' SER . 11.2 p-10 -70.46 -33.92 71.82 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.43 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -78.5 -28.5 46.34 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.495 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.574 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -47.47 -49.42 25.59 Favored 'General case' 0 CA--C 1.453 -2.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 168.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -76.71 -7.96 56.35 Favored 'General case' 0 N--CA 1.392 -3.372 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -175.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.4 -54.15 4.13 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 116.921 -1.911 . . . . 0.0 106.956 172.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -51.91 -59.03 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-N 112.359 -2.2 . . . . 0.0 112.968 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 118' ' ' LEU 0.261 26.0 t0 -61.41 -40.13 93.27 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.883 1.802 . . . . 0.0 109.718 -176.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -79.72 -41.99 25.57 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 112.171 -2.286 . . . . 0.0 112.009 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.456 ' HB1' ' HG ' ' A' ' 88' ' ' LEU . . . -61.77 -36.11 80.08 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 3.0 tp -64.55 -41.8 96.1 Favored 'General case' 0 N--CA 1.382 -3.86 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.98 -176.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 34.3 mtp -61.53 -34.31 75.32 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-O 120.894 0.378 . . . . 0.0 110.882 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 30.5 mt -75.07 -53.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.683 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.2 m -48.07 -34.9 10.3 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 113.254 -1.794 . . . . 0.0 113.156 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 23.2 mt -105.97 3.16 28.08 Favored 'General case' 0 C--O 1.188 -2.134 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.589 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.76 21.53 65.97 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 116.564 1.386 . . . . 0.0 116.564 172.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.74 -57.76 3.41 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 118.701 1.251 . . . . 0.0 110.022 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.9 m120 . . . . . 0 CA--C 1.559 1.324 0 CA-C-N 113.104 -1.862 . . . . 0.0 112.545 -169.05 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . 0.574 ' HB ' ' OD1' ' B' ' 47' ' ' ASN . 71.3 mt . . . . . 0 N--CA 1.433 -1.277 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -116.68 145.34 43.51 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . 0.563 ' HD2' ' O ' ' B' ' 41' ' ' ILE . 4.6 ttp180 -63.89 114.35 4.02 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 175.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.78 -18.14 5.41 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.11 171.8 11.29 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 122.888 1.328 . . . . 0.0 110.14 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.497 HG23 HG21 ' B' ' 104' ' ' THR . 10.4 t -133.35 128.65 55.6 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.576 0 CA-C-N 112.292 -2.231 . . . . 0.0 109.155 176.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 34.4 m-85 -125.86 147.02 49.57 Favored 'General case' 0 C--N 1.27 -2.865 0 C-N-CA 125.194 1.398 . . . . 0.0 108.407 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.6 mp -82.23 159.81 23.13 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 170.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.88 133.2 13.59 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.711 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.95 82.19 8.56 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 123.658 1.694 . . . . 0.0 109.666 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.474 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 4.4 pp -90.21 4.78 49.55 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.121 -174.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.557 ' HB3' ' N ' ' B' ' 34' ' ' GLY . 2.3 p -90.21 59.91 0.0 OUTLIER Pre-proline 0 C--N 1.277 -2.55 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' B' ' 24' ' ' LEU . 17.5 Cg_endo -118.59 31.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.112 0 N-CA-C 106.711 -2.073 . . . . 0.0 106.711 152.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.47 HG11 ' O ' ' B' ' 24' ' ' LEU . 33.3 m -71.14 173.05 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.39 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -142.83 120.28 11.67 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 114.8 1.408 . . . . 0.0 114.8 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.52 -131.08 10.44 Favored Glycine 0 N--CA 1.416 -2.689 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.873 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -93.79 17.03 12.7 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.458 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 41.2 mt-10 -70.46 171.62 9.79 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . 0.557 ' HB3' HE21 ' B' ' 90' ' ' GLN . 0.0 OUTLIER -103.88 125.7 50.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -175.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.43 147.84 17.03 Favored Glycine 0 CA--C 1.486 -1.748 0 N-CA-C 115.409 0.923 . . . . 0.0 115.409 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . 0.557 ' N ' ' HB3' ' B' ' 25' ' ' SER . . . 140.62 137.51 3.46 Favored Glycine 0 C--N 1.288 -2.134 0 CA-C-N 113.727 -1.236 . . . . 0.0 111.787 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.422 ' O ' HG13 ' B' ' 35' ' ' VAL . 2.5 p -73.64 104.26 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-O 122.998 1.38 . . . . 0.0 107.473 173.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -135.2 161.99 60.19 Favored Pre-proline 0 C--N 1.249 -3.784 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.08 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 19.7 Cg_exo -68.05 142.92 57.93 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 122.047 1.831 . . . . 0.0 110.173 170.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.481 HG21 ' O ' ' B' ' 20' ' ' TYR . 28.7 m -123.74 159.13 29.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 123.552 0.741 . . . . 0.0 109.273 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.429 ' CG2' ' HB1' ' B' ' 56' ' ' ALA . 32.6 m -102.0 132.3 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 120.524 0.202 . . . . 0.0 110.759 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 mm -84.93 105.89 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.563 ' O ' ' HD2' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -103.44 -12.07 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.033 -178.288 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.654 ' OE1' ' HB ' ' B' ' 53' ' ' VAL . 3.7 mt-30 -42.05 157.55 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 120.945 3.683 . . . . 0.0 120.945 -174.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -69.41 145.15 53.07 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 110.833 -2.894 . . . . 0.0 108.279 165.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' B' ' 47' ' ' ASN . 22.2 t70 -61.85 -30.14 70.65 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.673 -176.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.9 m -87.19 -28.4 22.43 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.879 -174.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.453 ' C ' HE22 ' B' ' 42' ' ' GLN . . . -66.79 -26.8 73.09 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.574 ' OD1' ' HB ' ' B' ' 14' ' ' ILE . 34.6 t30 -68.04 -39.16 83.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.738 -1.231 . . . . 0.0 110.019 176.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -76.52 -66.08 0.85 Allowed 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . 0.439 19.4 p90 -124.31 6.96 8.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 -171.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.414 ' OG ' ' HA2' ' B' ' 46' ' ' GLY . 19.6 m -92.28 131.03 35.68 Favored Pre-proline 0 N--CA 1.428 -1.573 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 171.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -63.28 -28.9 72.64 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 121.62 1.547 . . . . 0.0 110.268 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' THR . . . . . 0.409 HG21 ' HG2' ' A' ' 90' ' ' GLN . 1.8 p -94.9 138.84 32.14 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.398 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.654 ' HB ' ' OE1' ' B' ' 42' ' ' GLN . 1.2 m -130.49 158.86 42.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 9.0 tt -110.87 130.98 63.28 Favored 'Isoleucine or valine' 0 C--O 1.253 1.277 0 CA-C-O 121.269 0.557 . . . . 0.0 110.087 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 27.8 m -137.57 159.51 34.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.906 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.505 ' CB ' HG23 ' B' ' 91' ' ' ILE . . . -119.68 142.03 48.84 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.46 140.31 38.63 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.598 HG12 ' CD1' ' B' ' 86' ' ' ILE . 67.6 mt -93.89 140.43 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.253 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 90.9 m -138.12 111.95 8.34 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.388 0.675 . . . . 0.0 110.855 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.265 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 22.7 mt . . . . . 0 C--O 1.213 -0.852 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.02 -14.01 34.8 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.411 2.074 . . . . 0.0 113.855 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 67.2 p -93.88 -18.85 21.54 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.356 0.598 . . . . 0.0 111.361 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -109.26 128.75 55.32 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.02 139.01 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.662 -0.649 . . . . 0.0 110.847 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.22 143.2 26.82 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.788 0.804 . . . . 0.0 111.619 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.723 HG23 ' CE1' ' B' ' 78' ' ' TYR . 5.3 mm -112.59 166.45 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.595 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -97.56 130.55 44.6 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . 0.652 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 71.9 mttt -43.4 -52.68 5.83 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.769 1.228 . . . . 0.0 110.604 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -64.6 -25.56 68.02 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.875 1.67 . . . . 0.0 114.087 -173.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -91.36 -20.98 21.25 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.509 0.671 . . . . 0.0 109.586 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.723 ' CE1' HG23 ' B' ' 73' ' ' ILE . 2.0 m-85 -103.8 0.15 29.99 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.178 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 tttp 67.07 17.14 10.41 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.489 0.661 . . . . 0.0 111.855 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.408 HD12 ' O ' ' B' ' 78' ' ' TYR . 7.8 mp -94.46 175.1 6.81 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 123.197 1.475 . . . . 0.0 113.143 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.96 -25.99 34.36 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 111.698 -2.501 . . . . 0.0 109.489 176.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.52 153.58 50.97 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.547 -172.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . 0.652 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 8.9 p-10 -77.22 143.17 39.18 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 29.9 t -136.19 159.88 40.37 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.512 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -111.36 151.92 13.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.598 ' CD1' HG12 ' B' ' 58' ' ' ILE . 12.3 mm -116.18 139.34 43.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.5 mt -104.88 104.19 13.91 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.45 -8.86 58.82 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.124 -174.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.21 -37.68 15.91 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.373 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . 0.557 HE21 ' HB3' ' B' ' 32' ' ' GLN . 0.0 OUTLIER -98.07 77.89 2.48 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.949 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.505 HG23 ' CB ' ' B' ' 56' ' ' ALA . 2.4 pp -109.26 179.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . 0.265 8.0 ptp180 -163.28 161.56 24.79 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' B' ' 53' ' ' VAL . 90.5 m -117.85 115.13 24.34 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 113.735 -1.575 . . . . 0.0 108.534 -176.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 60.1 mt -131.79 148.25 52.55 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.957 -170.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.5 ' OD1' ' HB3' ' B' ' 97' ' ' LYS . 1.2 p30 -74.28 152.09 39.74 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.871 173.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -46.56 -28.97 1.59 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 125.693 1.597 . . . . 0.0 114.007 -175.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.5 ' HB3' ' OD1' ' B' ' 95' ' ' ASP . 7.0 ttpm? -71.77 -18.94 62.09 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 123.177 0.591 . . . . 0.0 111.517 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' B' ' 98' ' ' ARG . 2.3 mmp_? -76.29 -28.16 56.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.599 0.714 . . . . 0.0 109.695 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 7.8 mp -76.45 128.53 34.98 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 123.533 1.635 . . . . 0.0 111.037 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . 0.4 ' HB3' ' HG2' ' B' ' 101' ' ' GLU . 13.0 tptt -87.11 -67.42 0.82 Allowed 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 111.346 -2.661 . . . . 0.0 113.132 -171.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 9.1 pt-20 -166.27 146.36 6.18 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.707 0.765 . . . . 0.0 111.545 -169.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -63.98 116.2 5.63 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 128.354 2.662 . . . . 0.0 109.541 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.76 -62.72 1.55 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.755 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.497 HG21 HG23 ' B' ' 19' ' ' VAL . 4.6 t -128.63 -164.91 1.43 Allowed 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.66 -1.616 . . . . 0.0 112.153 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.32 134.79 7.48 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 124.817 1.247 . . . . 0.0 109.759 -171.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.449 ' HB3' ' CE1' ' B' ' 78' ' ' TYR . 3.6 pp -101.91 159.58 15.22 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.369 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 11.1 m -91.14 173.42 7.95 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.864 0.364 . . . . 0.0 111.112 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' B' ' 111' ' ' MET . 6.0 m-20 -64.45 -26.79 68.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.867 0.867 . . . . 0.0 112.258 -177.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.82 -38.18 67.24 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.01 -28.54 61.5 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.112 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.1 OUTLIER -47.36 -48.9 25.52 Favored 'General case' 0 CA--C 1.45 -2.881 0 CA-C-O 121.384 0.611 . . . . 0.0 109.567 167.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.43 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 9.3 mmpt? -78.63 -5.48 53.06 Favored 'General case' 0 N--CA 1.382 -3.845 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -176.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -91.16 -56.42 3.16 Favored 'General case' 0 N--CA 1.397 -3.109 0 C-N-CA 116.999 -1.88 . . . . 0.0 107.197 170.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -50.22 -59.78 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 112.203 -2.271 . . . . 0.0 113.282 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.591 ' O ' ' HB3' ' B' ' 118' ' ' LEU 0.275 17.2 t0 -60.66 -42.86 97.89 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 123.78 1.752 . . . . 0.0 109.826 -176.096 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.363 47.0 t30 -77.69 -41.68 37.16 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.095 -171.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.44 -34.17 77.66 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.591 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.1 tp -63.24 -41.69 99.11 Favored 'General case' 0 N--CA 1.381 -3.921 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.257 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 36.1 mtp -60.08 -37.89 81.26 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 120.714 0.292 . . . . 0.0 110.573 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 28.7 mt -71.06 -53.15 22.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 25.3 m -51.11 -32.64 23.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.783 178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 22.5 mt -105.63 1.79 27.62 Favored 'General case' 0 C--O 1.19 -2.074 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.495 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.45 24.99 59.8 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.492 ' HG ' ' OD1' ' A' ' 115' ' ' ASP . 7.1 mp -83.47 -58.37 2.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.778 1.289 . . . . 0.0 110.194 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 CA--C 1.562 1.424 0 CA-C-N 112.868 -1.969 . . . . 0.0 113.177 -168.92 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.425 -1.688 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -123.25 144.23 49.53 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -63.14 118.18 7.56 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.524 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.64 -19.4 5.03 Favored Glycine 0 N--CA 1.425 -2.049 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.724 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -83.13 171.47 13.67 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.353 1.073 . . . . 0.0 110.097 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.476 HG22 HG23 ' A' ' 104' ' ' THR . 13.3 t -132.38 128.03 57.79 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.373 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 24.2 m-85 -123.36 151.42 42.54 Favored 'General case' 0 C--N 1.271 -2.847 0 C-N-CA 125.274 1.43 . . . . 0.0 110.03 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.7 mp -88.63 150.17 23.17 Favored 'General case' 0 N--CA 1.396 -3.15 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -145.27 139.11 26.88 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.156 -176.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -81.86 89.95 6.38 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.533 1.158 . . . . 0.0 108.665 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.546 ' O ' HG11 ' A' ' 27' ' ' VAL . 82.2 mt -65.1 -19.45 65.99 Favored 'General case' 0 CA--C 1.481 -1.677 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.661 -178.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.43 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 10.0 m -33.75 175.0 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.322 0 C-N-CA 127.197 2.199 . . . . 0.0 114.252 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 27.32 48.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.677 0 C-N-CA 121.905 1.737 . . . . 0.0 114.588 -151.37 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 24' ' ' LEU . 1.6 m -69.88 168.22 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.002 170.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.416 ' HG3' ' CD2' ' B' ' 94' ' ' LEU . 25.2 mm-40 -99.21 107.14 19.39 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.765 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.86 -122.31 26.68 Favored Glycine 0 C--N 1.298 -1.564 0 CA-C-N 113.998 -1.455 . . . . 0.0 113.371 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.4 m -81.71 20.97 0.87 Allowed 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 46.0 mt-10 -62.24 168.26 3.54 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 117.917 -1.513 . . . . 0.0 110.32 170.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.475 HE22 ' HG3' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -70.81 107.95 4.24 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -176.276 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.76 144.3 18.81 Favored Glycine 0 CA--C 1.499 -0.95 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 157.97 10.06 Favored Glycine 0 N--CA 1.421 -2.347 0 CA-C-N 113.019 -1.59 . . . . 0.0 111.538 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -81.9 104.89 11.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 171.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.475 ' HG3' HE22 ' A' ' 32' ' ' GLN . 18.4 mmt180 -129.46 157.18 77.14 Favored Pre-proline 0 C--N 1.26 -3.29 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.58 -167.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 31.9 Cg_exo -63.22 144.88 92.79 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.211 1.941 . . . . 0.0 111.405 171.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 27.2 m -129.91 156.26 42.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 124.238 1.015 . . . . 0.0 109.067 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.476 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 32.6 m -100.22 131.99 46.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 mm -91.51 115.57 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.95 -14.25 10.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.265 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.508 HE22 ' N ' ' A' ' 47' ' ' ASN . 5.0 pt20 -53.69 163.12 0.73 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -168.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -64.94 -177.58 0.36 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.156 -2.293 . . . . 0.0 112.202 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -81.7 -42.73 19.47 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.969 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -82.69 -23.64 34.04 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -170.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.73 -32.41 74.17 Favored Glycine 0 C--O 1.204 -1.739 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.356 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.508 ' N ' HE22 ' A' ' 42' ' ' GLN . 8.3 p30 -81.52 -18.08 46.28 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.086 0.47 . . . . 0.0 111.792 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -86.65 -62.89 1.41 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.507 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -107.34 -15.26 14.68 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -168.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -91.43 141.46 26.03 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HA ' ' HE3' ' A' ' 96' ' ' LYS . 72.8 Cg_endo -81.86 -9.8 11.87 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.99 1.794 . . . . 0.0 111.381 176.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 p -109.13 135.69 49.84 Favored 'General case' 0 N--CA 1.409 -2.509 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.791 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.424 HG12 ' OE1' ' A' ' 42' ' ' GLN . 95.0 t -123.74 139.75 49.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.4 HD11 ' CD1' ' A' ' 91' ' ' ILE . 9.3 tp -97.52 128.16 49.11 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 25.9 m -140.35 164.54 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.968 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB1' ' CG2' ' A' ' 39' ' ' VAL . . . -122.32 132.93 54.64 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.7 131.66 46.46 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.514 HG12 ' CD1' ' A' ' 86' ' ' ILE . 54.3 mt -91.68 106.11 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.785 176.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.3 m -102.46 140.94 36.07 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.698 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.459 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.768 -177.771 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.9 tt . . . . . 0 N--CA 1.426 -1.63 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.5 2.56 4.41 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.632 2.221 . . . . 0.0 114.737 -174.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' ' 89' ' ' GLU . 68.0 p -103.31 -16.57 15.61 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.35 0.595 . . . . 0.0 111.483 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -109.91 129.82 55.6 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.3 p -123.01 132.71 70.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.512 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.67 130.0 34.95 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.941 0.877 . . . . 0.0 110.444 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.549 HG23 ' CZ ' ' A' ' 78' ' ' TYR . 13.1 mm -97.1 169.99 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -106.34 109.57 21.54 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 168.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.564 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -50.93 -30.7 15.49 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 125.431 1.492 . . . . 0.0 114.678 -172.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -49.37 -45.14 45.52 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 125.008 1.323 . . . . 0.0 111.508 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -79.06 -24.41 43.56 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.631 0.729 . . . . 0.0 111.678 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.549 ' CZ ' HG23 ' A' ' 73' ' ' ILE . 4.0 m-85 -97.81 6.5 47.76 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.012 -175.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.454 ' O ' HD12 ' A' ' 80' ' ' LEU 0.394 61.8 pttt 43.28 64.3 1.26 Allowed 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 119.824 3.268 . . . . 0.0 119.824 176.345 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.525 HD22 ' HZ2' ' A' ' 75' ' ' LYS . 10.3 mp -141.76 -168.27 2.63 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 169.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -113.94 -9.11 13.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 123.679 0.612 . . . . 0.0 110.821 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.428 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 50.3 mttm -115.12 112.14 22.1 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.204 -173.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -35.66 144.24 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.984 1.714 . . . . 0.0 115.388 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.7 m -123.32 132.74 54.09 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.435 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 35.4 t -120.15 138.14 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 173.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.514 ' CD1' HG12 ' A' ' 58' ' ' ILE . 23.4 mm -104.31 131.26 53.59 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.2 mt -98.6 103.51 15.47 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.505 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.57 -17.64 47.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.489 ' HG3' ' HB ' ' A' ' 69' ' ' THR . 41.3 mt-10 -86.51 -7.73 58.15 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.766 0.793 . . . . 0.0 111.231 173.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 91' ' ' ILE . 14.5 tp60 -89.27 -100.68 0.09 Allowed 'General case' 0 C--O 1.192 -1.937 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 90' ' ' GLN . 1.1 pp 57.84 179.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 C-N-CA 127.574 2.35 . . . . 0.0 110.958 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.535 ' NH2' ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -176.77 176.43 1.5 Allowed 'General case' 0 C--N 1.311 -1.108 0 O-C-N 123.897 0.748 . . . . 0.0 112.233 172.639 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 53.6 m -116.18 128.59 55.75 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.411 HD22 HH11 ' A' ' 92' ' ' ARG . 71.0 mt -131.72 141.65 49.59 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.886 -173.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.438 ' OD1' ' HG3' ' A' ' 97' ' ' LYS . 11.9 t0 -57.2 144.61 34.51 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 169.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 51' ' ' PRO . 16.8 pttp -55.41 -31.02 61.51 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.438 ' HG3' ' OD1' ' A' ' 95' ' ' ASP . 52.1 mttp -53.44 -28.82 32.27 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.919 174.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 8.9 mmp_? -74.27 -34.13 63.48 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 120.904 0.383 . . . . 0.0 110.269 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.9 mp -68.51 106.32 2.52 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.279 1.037 . . . . 0.0 110.268 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -83.74 -67.37 0.8 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.28 -1.782 . . . . 0.0 114.134 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.604 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.6 pt-20 -148.32 152.05 36.42 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-O 121.563 0.696 . . . . 0.0 110.16 -169.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 20' ' ' TYR . 30.8 mtpt -79.1 115.75 18.96 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-N 113.171 -1.831 . . . . 0.0 108.236 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 tp -104.28 -58.93 1.81 Allowed 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.288 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.476 HG23 HG22 ' A' ' 19' ' ' VAL . 5.2 t -132.54 -164.98 1.53 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 117.835 -1.546 . . . . 0.0 111.915 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.49 128.43 4.55 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 125.631 1.573 . . . . 0.0 109.876 -173.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -95.14 163.31 13.34 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.7 p -88.3 164.1 15.74 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 123.085 0.554 . . . . 0.0 112.049 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 111' ' ' MET . 22.7 t70 -61.99 -29.5 70.3 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.401 1.08 . . . . 0.0 113.37 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.13 -33.74 68.03 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -76.36 -32.25 58.51 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.496 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -52.37 -41.91 63.5 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 125.165 1.386 . . . . 0.0 110.549 175.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.609 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 2.2 mmmm -69.84 -21.73 63.34 Favored 'General case' 0 CA--C 1.465 -2.324 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.352 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -87.81 -46.56 9.33 Favored 'General case' 0 N--CA 1.398 -3.028 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 t -50.58 -54.6 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 CA-C-N 113.263 -1.79 . . . . 0.0 112.857 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 53.5 m-20 -66.24 -42.74 88.16 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 123.511 1.624 . . . . 0.0 111.946 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.609 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 3.8 t30 -74.93 -43.56 53.54 Favored 'General case' 0 C--N 1.26 -3.326 0 CA-C-N 112.76 -2.018 . . . . 0.0 112.52 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.71 -36.66 79.39 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.523 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 10.2 tp -65.33 -39.45 92.42 Favored 'General case' 0 N--CA 1.386 -3.675 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.105 -177.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.76 ' SD ' ' HA ' ' A' ' 125' ' ' ASN 0.265 7.4 ptp -74.92 -19.32 60.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 117.54 -1.664 . . . . 0.0 114.461 176.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 30.4 mt -77.03 -50.04 21.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 175.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.1 p -60.78 -30.4 70.02 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 113.111 -1.858 . . . . 0.0 112.124 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 27.4 mt -107.2 0.7 23.49 Favored 'General case' 0 C--O 1.199 -1.589 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.84 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.64 26.21 65.78 Favored Glycine 0 CA--C 1.549 2.169 0 N-CA-C 116.964 1.546 . . . . 0.0 116.964 174.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.524 ' HG ' ' CB ' ' A' ' 119' ' ' MET . 0.5 OUTLIER -113.9 15.93 18.45 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 119.263 1.531 . . . . 0.0 111.805 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.76 ' HA ' ' SD ' ' A' ' 119' ' ' MET . 2.4 t-20 . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 123.353 0.661 . . . . 0.0 112.705 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 56.8 mt . . . . . 0 N--CA 1.424 -1.766 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 24.4 mmm-85 -121.28 140.64 51.79 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -61.26 115.03 3.5 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.818 170.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.81 -16.31 5.33 Favored Glycine 0 N--CA 1.428 -1.891 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.066 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.18 172.52 11.83 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 122.266 1.032 . . . . 0.0 109.47 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.483 HG22 HG23 ' B' ' 104' ' ' THR . 12.3 t -132.88 129.09 57.66 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.174 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.265 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 23.0 m-85 -123.89 150.88 44.14 Favored 'General case' 0 C--N 1.271 -2.824 0 C-N-CA 125.322 1.449 . . . . 0.0 110.052 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 3.8 mp -87.95 150.18 23.61 Favored 'General case' 0 N--CA 1.391 -3.396 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 165.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -145.48 138.52 26.2 Favored 'General case' 0 C--N 1.26 -3.286 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.118 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.23 91.16 6.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.73 1.252 . . . . 0.0 108.477 171.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.524 ' O ' HG11 ' B' ' 27' ' ' VAL . 85.4 mt -65.83 -20.86 66.4 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-N 112.672 -2.058 . . . . 0.0 110.735 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.412 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 16.3 m -35.08 176.28 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.171 0 C-N-CA 126.97 2.108 . . . . 0.0 114.929 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 26.41 49.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.621 0 C-N-CA 121.817 1.678 . . . . 0.0 114.615 -149.432 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 1.8 m -69.99 172.9 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.337 170.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -102.52 108.71 20.1 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.055 -1.43 . . . . 0.0 110.577 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.33 -120.61 13.81 Favored Glycine 0 C--N 1.304 -1.25 0 CA-C-N 114.248 -1.342 . . . . 0.0 114.097 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.0 m -81.25 20.19 0.87 Allowed 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.529 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 46.4 mt-10 -63.87 166.24 7.59 Favored 'General case' 0 C--O 1.248 0.995 0 C-N-CA 117.695 -1.602 . . . . 0.0 109.881 169.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' GLN . . . . . 0.414 HE22 ' HG3' ' B' ' 36' ' ' ARG . 0.9 OUTLIER -71.38 108.08 4.65 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.09 146.29 19.01 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 116.069 1.187 . . . . 0.0 116.069 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.09 152.68 8.71 Favored Glycine 0 N--CA 1.417 -2.598 0 CA-C-N 113.503 -1.349 . . . . 0.0 110.722 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 p -78.38 108.65 12.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' ARG . . . . . 0.414 ' HG3' HE22 ' B' ' 32' ' ' GLN . 11.0 mmt180 -133.99 156.87 78.84 Favored Pre-proline 0 C--N 1.263 -3.191 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.042 -166.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.3 Cg_exo -63.39 144.04 89.99 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.486 2.124 . . . . 0.0 111.681 172.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 27.3 m -129.1 156.06 41.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 124.341 1.057 . . . . 0.0 109.193 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.471 ' CG2' ' HB1' ' B' ' 56' ' ' ALA . 31.8 m -99.74 131.69 46.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 30.3 mm -91.02 115.65 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.82 -14.87 10.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.241 -177.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.533 HE22 ' N ' ' B' ' 47' ' ' ASN . 4.9 pt20 -52.95 163.24 0.52 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 -168.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -65.78 -177.22 0.44 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.778 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.38 -47.94 14.89 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.7 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 20.4 m -78.17 -24.37 47.26 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -169.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -60.95 -32.35 79.68 Favored Glycine 0 C--O 1.204 -1.738 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.358 -176.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . 0.533 ' N ' HE22 ' B' ' 42' ' ' GLN . 9.9 p30 -81.49 -18.95 43.39 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.403 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -84.77 -66.66 0.87 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.015 0.436 . . . . 0.0 111.455 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -103.93 -13.71 16.25 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 19.3 m -94.72 140.03 22.44 Favored Pre-proline 0 C--N 1.295 -1.772 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.84 -6.45 11.45 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.106 1.871 . . . . 0.0 111.548 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.2 p -110.09 135.64 50.59 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.533 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . 0.444 HG12 ' OE1' ' B' ' 42' ' ' GLN . 93.1 t -123.88 139.81 49.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . 0.404 HD11 ' CD1' ' B' ' 91' ' ' ILE . 9.1 tp -97.19 128.67 48.22 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 27.4 m -140.72 164.52 21.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.035 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.471 ' HB1' ' CG2' ' B' ' 39' ' ' VAL . . . -122.38 132.82 54.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.15 130.55 43.47 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.522 HG12 ' CD1' ' B' ' 86' ' ' ILE . 56.8 mt -90.08 108.53 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.166 176.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -105.13 139.49 39.72 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.896 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.58 -178.719 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.422 -1.843 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.48 0.57 4.55 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.729 2.286 . . . . 0.0 115.098 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' THR . . . . . 0.483 ' HB ' ' HG3' ' B' ' 89' ' ' GLU . 77.7 p -103.55 -15.92 15.69 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.302 0.572 . . . . 0.0 111.789 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -110.94 129.18 55.96 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 8.6 p -122.18 132.61 70.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.521 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -84.4 136.9 33.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.282 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ILE . . . . . 0.534 HG23 ' CZ ' ' B' ' 78' ' ' TYR . 12.2 mm -108.66 157.17 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.413 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.411 ' OE2' ' HG2' ' B' ' 76' ' ' LYS . 9.2 tp10 -94.38 109.13 21.01 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 173.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' LYS . . . . . 0.571 ' HA ' ' HE3' ' B' ' 75' ' ' LYS . 0.0 OUTLIER -52.72 -30.73 34.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . 0.411 ' HG2' ' OE2' ' B' ' 74' ' ' GLU . 16.1 mmtp -50.96 -41.08 58.99 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 124.9 1.28 . . . . 0.0 112.038 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -80.25 -26.99 38.74 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.886 0.85 . . . . 0.0 111.435 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' TYR . . . . . 0.534 ' CZ ' HG23 ' B' ' 73' ' ' ILE . 4.4 m-85 -95.2 5.88 50.57 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.234 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' LYS . . . . . 0.478 ' O ' HD12 ' B' ' 80' ' ' LEU 0.399 61.6 pttt 43.62 64.66 1.18 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 119.822 3.268 . . . . 0.0 119.822 176.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' LEU . . . . . 0.507 HD22 ' HZ2' ' B' ' 75' ' ' LYS . 10.3 mp -142.69 -169.87 3.09 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 169.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -116.52 -1.75 12.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.957 0.786 . . . . 0.0 110.813 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' B' ' 75' ' ' LYS . 52.6 mttm -120.79 111.11 17.17 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.79 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -33.14 143.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 127.179 2.191 . . . . 0.0 114.526 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -124.91 133.42 53.06 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.21 -170.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 39.9 t -120.07 138.23 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 174.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.522 ' CD1' HG12 ' B' ' 58' ' ' ILE . 24.2 mm -103.95 130.39 54.61 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 51.7 mt -98.6 103.19 15.11 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 -20.32 44.25 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.619 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' GLU . . . . . 0.483 ' HG3' ' HB ' ' B' ' 69' ' ' THR . 42.9 mt-10 -84.27 -9.26 58.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.711 0.767 . . . . 0.0 111.595 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' GLN . . . . . 0.556 ' O ' HG13 ' B' ' 91' ' ' ILE . 15.0 tp60 -86.82 -100.65 0.07 Allowed 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 172.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.556 HG13 ' O ' ' B' ' 90' ' ' GLN . 1.0 OUTLIER 57.75 179.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 C-N-CA 127.63 2.372 . . . . 0.0 111.033 -179.014 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' ARG . . . . . 0.515 ' NH2' ' HA ' ' B' ' 27' ' ' VAL . 0.1 OUTLIER -176.88 177.08 1.36 Allowed 'General case' 0 C--N 1.311 -1.089 0 O-C-N 123.911 0.757 . . . . 0.0 112.297 172.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 51.9 m -116.76 128.81 55.66 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' LEU . . . . . 0.423 HD22 HH11 ' B' ' 92' ' ' ARG . 72.4 mt -131.45 142.1 49.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.058 -172.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' ASP . . . . . 0.437 ' OD1' ' HG3' ' B' ' 97' ' ' LYS . 11.0 t0 -56.6 143.92 33.91 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -57.65 -28.01 63.35 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.437 ' HG3' ' OD1' ' B' ' 95' ' ' ASP . 49.0 mttp -59.23 -22.74 61.54 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.329 174.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 8.0 mmp_? -78.15 -32.08 50.07 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.244 0.545 . . . . 0.0 109.732 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.43 105.52 2.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.475 1.131 . . . . 0.0 110.498 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.82 -64.2 1.21 Allowed 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 113.243 -1.799 . . . . 0.0 114.108 -173.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' GLU . . . . . 0.607 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -152.55 152.39 31.81 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.426 0.632 . . . . 0.0 110.362 -171.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . 0.5 ' HG2' ' CZ ' ' B' ' 20' ' ' TYR . 32.5 mtpt -78.3 115.53 18.08 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 126.06 1.744 . . . . 0.0 108.323 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 tp -103.86 -59.02 1.79 Allowed 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.721 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' THR . . . . . 0.483 HG23 HG22 ' B' ' 19' ' ' VAL . 4.7 t -132.47 -164.66 1.49 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.675 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -160.82 130.29 4.89 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 125.272 1.429 . . . . 0.0 110.226 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.73 157.31 16.36 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -175.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -80.27 166.2 21.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.976 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' B' ' 111' ' ' MET . 19.7 t70 -70.42 -23.31 62.72 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.857 0.863 . . . . 0.0 112.398 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.51 -30.16 57.09 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -78.52 -32.99 48.28 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.471 ' HA ' ' HE3' ' B' ' 111' ' ' MET . 0.2 OUTLIER -50.97 -43.6 60.48 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 125.473 1.509 . . . . 0.0 110.337 175.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.563 ' O ' ' HB3' ' B' ' 116' ' ' ASN . 0.3 OUTLIER -68.78 -20.98 64.36 Favored 'General case' 0 C--O 1.185 -2.292 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.329 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -87.4 -47.86 8.44 Favored 'General case' 0 CA--C 1.45 -2.893 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 t -49.57 -54.98 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.44 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.882 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 17.9 m-20 -64.44 -44.42 91.23 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-O 123.385 1.564 . . . . 0.0 112.074 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' ASN . . . . . 0.563 ' HB3' ' O ' ' B' ' 112' ' ' LYS 0.302 5.9 t30 -76.51 -41.33 47.25 Favored 'General case' 0 C--N 1.262 -3.212 0 C-N-CA 126.778 2.031 . . . . 0.0 112.815 -172.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.48 -33.56 76.16 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . 0.548 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 10.0 tp -65.33 -39.64 92.68 Favored 'General case' 1 N--CA 1.378 -4.059 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.773 -178.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' MET . . . . . 0.795 ' SD ' ' HA ' ' B' ' 125' ' ' ASN 0.255 6.9 ptp -73.81 -19.93 60.61 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 117.821 -1.552 . . . . 0.0 114.155 176.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 43.0 mt -75.98 -52.04 18.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 78.5 p -59.09 -28.0 66.08 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.681 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 26.9 mt -108.22 -0.45 20.9 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.922 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.81 31.78 57.82 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.52 ' HG ' ' CB ' ' B' ' 119' ' ' MET . 0.5 OUTLIER -120.95 20.09 11.61 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.821 1.31 . . . . 0.0 111.577 179.445 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.795 ' HA ' ' SD ' ' B' ' 119' ' ' MET . 13.0 m120 . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.74 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 t -154.54 104.68 2.57 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 p -75.27 97.96 3.68 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -84.32 -27.04 28.06 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -136.54 152.98 51.09 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -98.34 -172.98 2.45 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -81.38 -0.93 43.58 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -126.04 -88.14 0.59 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.586 0.231 . . . . 0.0 110.507 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -140.16 -179.42 5.97 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.2 m -63.77 -46.96 82.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 173.26 -30.0 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.441 1.496 . . . . 0.0 107.033 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.89 127.07 90.14 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.452 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.53 -25.71 17.53 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 121.542 1.495 . . . . 0.0 110.086 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.2 mt -104.97 117.48 50.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -103.38 144.33 31.52 Favored 'General case' 1 N--CA 1.374 -4.244 0 C-N-CA 123.611 0.765 . . . . 0.0 109.131 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -71.1 120.57 16.85 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 99.36 -1.16 57.2 Favored Glycine 0 C--N 1.305 -1.161 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.972 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -97.32 119.55 36.05 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.425 HG21 HG23 ' A' ' 104' ' ' THR . 87.6 t -83.81 128.26 39.0 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 C-N-CA 123.201 0.6 . . . . 0.0 112.288 -172.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 48.8 m-85 -115.29 141.38 48.11 Favored 'General case' 0 C--N 1.273 -2.721 0 C-N-CA 125.236 1.414 . . . . 0.0 111.425 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.26 148.66 39.24 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 167.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.02 149.4 34.05 Favored 'General case' 0 C--N 1.262 -3.215 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.233 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -96.91 76.68 2.74 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.532 ' O ' HG11 ' A' ' 27' ' ' VAL 0.264 3.0 tt -71.58 -18.16 62.25 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.089 -2.778 . . . . 0.0 108.437 -173.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.1 m -32.82 -178.19 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.935 0 C-N-CA 129.739 3.216 . . . . 0.0 116.384 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HB2' ' NE2' ' B' ' 28' ' ' GLN . 0.1 OUTLIER 25.95 43.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.137 0 C-N-CA 124.317 3.345 . . . . 0.0 116.648 -151.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.608 ' HB ' ' CB ' ' A' ' 31' ' ' GLU . 2.8 m -70.07 142.2 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.402 169.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.5 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 35.2 mm-40 -90.31 134.17 34.48 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 114.887 -1.052 . . . . 0.0 113.222 -172.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.84 -108.84 0.69 Allowed Glycine 0 N--CA 1.442 -0.923 0 O-C-N 124.564 1.165 . . . . 0.0 114.654 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 m -94.05 8.28 42.06 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.608 ' CB ' ' HB ' ' A' ' 27' ' ' VAL . 31.8 mt-10 -62.08 143.46 56.62 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -103.49 112.31 25.15 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.174 0.512 . . . . 0.0 110.872 -175.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.04 -178.62 40.61 Favored Glycine 0 N--CA 1.408 -3.179 0 C-N-CA 119.807 -1.187 . . . . 0.0 115.012 174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 24' ' ' LEU . . . 178.08 -160.09 26.12 Favored Glycine 0 C--N 1.266 -3.313 1 N-CA-C 101.972 -4.451 . . . . 0.0 101.972 -178.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.9 p -73.73 120.04 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.124 0 CA-C-N 120.859 2.329 . . . . 0.0 109.071 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.411 ' NH1' ' HA ' ' A' ' 59' ' ' THR . 73.2 mtt180 -152.73 166.07 16.2 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.423 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.469 ' HB2' HD13 ' A' ' 58' ' ' ILE . 11.0 Cg_exo -71.76 144.56 44.16 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.595 1.53 . . . . 0.0 109.978 169.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 28.7 m -128.19 158.26 40.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.495 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 35.9 m -101.76 130.33 51.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.832 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.9 mm -84.19 105.46 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.97 -10.19 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.035 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.664 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 2.5 tt0 -60.63 164.51 4.54 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -169.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.489 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 26.6 p-10 -68.38 -174.7 0.55 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.387 -1.733 . . . . 0.0 111.466 175.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -88.34 -38.36 15.2 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.194 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.426 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 4.0 m -81.83 -22.26 37.13 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.776 -0.578 . . . . 0.0 112.521 -171.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.63 -31.03 76.38 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -71.09 -35.31 71.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.249 0.547 . . . . 0.0 110.563 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' A' ' 45' ' ' THR . 34.4 mttp -79.63 -48.28 14.01 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -115.51 -27.79 7.03 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -172.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 61.9 m -86.12 148.33 47.41 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.992 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -81.9 -17.01 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.579 1.519 . . . . 0.0 110.221 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.2 p -91.65 151.08 20.84 Favored 'General case' 0 N--CA 1.421 -1.894 0 C-N-CA 124.635 1.174 . . . . 0.0 111.982 -174.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.664 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 61.8 t -135.12 139.02 47.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.475 HG23 ' HG3' ' A' ' 42' ' ' GLN . 10.3 tt -93.14 134.51 30.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.094 0.473 . . . . 0.0 110.196 170.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 22.1 m -139.62 164.22 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.368 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.495 ' HB1' ' CG2' ' A' ' 39' ' ' VAL . . . -122.82 138.29 54.69 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.1 132.43 45.83 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.505 HG12 HD11 ' A' ' 86' ' ' ILE . 63.3 mt -92.09 136.84 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.901 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.411 ' HA ' ' NH1' ' A' ' 36' ' ' ARG . 95.8 m -129.52 139.89 51.41 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -60.12 -75.07 0.3 Allowed Glycine 0 C--O 1.222 -0.656 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 60' ' ' GLY . 28.5 mmm180 -133.37 157.25 45.99 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.3 tp -162.29 -54.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.027 0.441 . . . . 0.0 110.243 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -172.75 144.49 1.38 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -56.43 143.84 33.33 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.294 0.996 . . . . 0.0 110.069 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.28 75.45 0.53 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.807 0.813 . . . . 0.0 110.748 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -103.13 -17.04 15.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.23 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.0 mt -101.48 140.55 21.34 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.64 1.85 3.99 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 121.951 1.767 . . . . 0.0 113.069 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.0 p -98.71 -18.8 17.84 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.394 0.616 . . . . 0.0 109.872 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -97.88 129.95 44.8 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.815 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.58 142.7 43.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -103.93 148.69 25.88 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.955 0.407 . . . . 0.0 110.969 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.2 pt -124.6 134.46 66.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.461 ' O ' ' HD1' ' A' ' 78' ' ' TYR . 2.7 mp0 -59.96 115.71 3.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.373 1.069 . . . . 0.0 113.423 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -50.56 -36.42 34.43 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.965 0.906 . . . . 0.0 112.214 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -52.35 -53.16 48.2 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 113.326 -1.761 . . . . 0.0 112.627 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -92.64 -37.65 12.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.552 0.692 . . . . 0.0 111.996 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.514 ' CE2' ' HA ' ' A' ' 106' ' ' LEU . 71.3 m-85 -75.37 -5.92 47.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.921 -172.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 75.5 24.1 1.39 Allowed 'General case' 0 C--N 1.348 0.521 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 167.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.67 179.0 4.4 Favored 'General case' 0 CA--C 1.489 -1.396 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.265 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.22 -5.29 40.74 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.485 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -140.89 150.51 43.29 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.193 -176.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -75.3 128.07 34.59 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 6.1 t -102.78 163.58 12.14 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -170.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.46 141.3 41.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.505 HD11 HG12 ' A' ' 58' ' ' ILE . 17.2 mm -107.48 133.2 52.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.9 mt -106.18 109.38 21.3 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.94 -2.68 57.02 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.509 0.671 . . . . 0.0 111.991 -175.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -97.0 -34.11 11.31 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.323 1.059 . . . . 0.0 109.677 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -94.56 80.0 3.83 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.625 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.493 ' O ' ' HB ' ' B' ' 93' ' ' THR . 2.1 pp -122.71 -177.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -173.71 -178.24 1.56 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 123.784 0.677 . . . . 0.0 112.502 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 53.9 m -123.67 126.05 45.89 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 74.7 mt -132.07 133.69 44.65 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.656 1.183 . . . . 0.0 109.784 -173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.5 p-10 -78.09 153.84 31.86 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -44.78 -21.11 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.796 1.638 . . . . 0.0 115.015 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -74.17 -17.51 60.9 Favored 'General case' 0 CA--C 1.564 1.498 0 CA-C-O 121.209 0.528 . . . . 0.0 110.604 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HD2' ' CB ' ' B' ' 28' ' ' GLN . 4.8 mmp_? -84.34 -38.52 20.25 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.073 0.549 . . . . 0.0 111.23 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.48 121.91 16.83 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 123.885 0.874 . . . . 0.0 111.1 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -92.34 -62.55 1.38 Allowed 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.784 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.1 pt-20 -159.73 143.47 14.49 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.291 0.567 . . . . 0.0 112.075 -170.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.27 123.75 20.78 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.719 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.671 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 22.1 tp -114.3 -61.92 1.67 Allowed 'General case' 0 N--CA 1.414 -2.255 0 CA-C-O 122.394 1.092 . . . . 0.0 110.435 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.671 ' OG1' ' HG ' ' A' ' 103' ' ' LEU 0.26 3.7 m -126.54 -174.8 3.22 Favored 'General case' 0 N--CA 1.401 -2.892 0 CA-C-N 113.283 -1.78 . . . . 0.0 111.93 -164.07 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.502 ' H ' ' CG2' ' A' ' 104' ' ' THR . 0.4 OUTLIER -159.73 137.17 9.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.483 1.513 . . . . 0.0 109.645 -167.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.514 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . 6.9 mt -98.22 164.02 12.49 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.775 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.8 m -98.62 159.98 14.58 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 111' ' ' MET . 21.2 m-20 -63.59 -31.61 72.83 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.314 0.578 . . . . 0.0 112.307 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.76 -41.5 83.25 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 122.077 -0.389 . . . . 0.0 109.971 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -74.57 -24.21 58.88 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.378 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.473 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -56.59 -39.75 74.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 123.819 0.847 . . . . 0.0 108.857 170.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 8.4 mmpt? -79.99 -11.09 59.81 Favored 'General case' 0 N--CA 1.39 -3.474 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.233 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -88.94 -49.42 6.8 Favored 'General case' 0 N--CA 1.39 -3.426 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -50.26 -58.77 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.199 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.78 -39.5 77.62 Favored 'General case' 0 N--CA 1.515 2.825 0 CA-C-O 123.452 1.596 . . . . 0.0 111.931 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 112' ' ' LYS 0.257 6.4 t30 -83.98 -46.62 11.87 Favored 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 112.424 -2.171 . . . . 0.0 112.77 -170.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.54 -36.16 73.44 Favored 'General case' 0 CA--C 1.47 -2.102 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 7.4 tp -62.56 -47.11 85.32 Favored 'General case' 1 N--CA 1.363 -4.782 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.104 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.622 ' SD ' ' HA ' ' A' ' 125' ' ' ASN 0.275 7.8 ptp -68.14 -22.59 64.86 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 178.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.3 mt -72.22 -51.98 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.426 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 t -55.52 -34.66 64.86 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 113.197 -1.82 . . . . 0.0 111.669 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 17.0 mt -110.38 8.4 23.28 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.769 -0.582 . . . . 0.0 111.266 -177.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.53 21.49 64.79 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 171.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.511 HD13 HD13 ' B' ' 124' ' ' LEU . 0.6 OUTLIER -99.95 13.91 32.29 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 118.56 1.18 . . . . 0.0 111.485 -176.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.622 ' HA ' ' SD ' ' A' ' 119' ' ' MET . 20.1 m120 -38.32 130.72 1.25 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 124.509 1.13 . . . . 0.0 113.357 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.99 9.16 2.6 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.679 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' A' ' 125' ' ' ASN . 42.0 t -121.51 3.47 6.31 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.292 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 76.47 133.85 0.05 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.226 1.81 . . . . 0.0 110.181 -173.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -72.26 -13.42 61.51 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.287 0.565 . . . . 0.0 111.478 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -90.07 -0.89 57.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.749 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -124.0 91.87 3.55 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.444 0.64 . . . . 0.0 110.149 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.4 m120 . . . . . 0 C--N 1.293 -1.849 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.116 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.73 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t -141.52 113.27 7.78 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -77.98 99.99 6.28 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -87.19 -22.16 25.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -141.3 159.98 41.09 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -101.3 -172.45 2.17 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.253 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -79.54 -17.53 53.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.472 . . . . 0.0 111.757 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -110.76 -84.46 0.56 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.23 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -142.71 177.57 8.23 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 m -62.08 -50.49 71.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 177.82 -34.02 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.809 1.644 . . . . 0.0 106.743 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.69 124.2 88.75 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.018 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.82 -26.13 19.39 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 121.772 1.648 . . . . 0.0 110.241 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.7 mt -104.97 116.78 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -102.78 146.1 28.76 Favored 'General case' 1 N--CA 1.377 -4.106 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.58 118.93 15.02 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 100.6 -0.66 55.51 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.971 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.43 119.39 35.87 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 86.0 t -83.72 128.51 38.75 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 123.235 0.614 . . . . 0.0 112.255 -172.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 48.7 m-85 -115.78 140.39 49.26 Favored 'General case' 0 C--N 1.272 -2.784 0 C-N-CA 125.438 1.495 . . . . 0.0 111.329 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.02 148.38 42.06 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 166.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.41 148.87 33.8 Favored 'General case' 0 C--N 1.259 -3.361 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.055 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.407 ' HB3' ' NH1' ' B' ' 98' ' ' ARG . 33.0 t70 -96.11 79.48 3.2 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.523 ' O ' HG11 ' B' ' 27' ' ' VAL 0.262 3.0 tt -74.46 -16.96 60.84 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 111.553 -2.567 . . . . 0.0 108.477 -173.251 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.405 ' CB ' ' HD2' ' B' ' 26' ' ' PRO . 3.6 m -32.68 -178.12 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.922 0 C-N-CA 130.652 3.581 . . . . 0.0 116.432 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.5 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 0.1 OUTLIER 24.91 44.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.404 3.486 0 C-N-CA 124.343 3.362 . . . . 0.0 116.373 -152.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.566 ' HB ' ' CB ' ' B' ' 31' ' ' GLU . 2.6 m -69.79 140.56 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 113.512 -1.676 . . . . 0.0 109.591 168.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 26' ' ' PRO . 33.7 mm-40 -89.83 132.83 35.05 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.766 -172.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.08 -108.61 0.68 Allowed Glycine 0 CA--C 1.501 -0.796 0 CA-C-N 114.735 -1.121 . . . . 0.0 114.81 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -93.99 6.92 46.96 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -174.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.566 ' CB ' ' HB ' ' B' ' 27' ' ' VAL . 33.7 mt-10 -63.53 140.09 58.84 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . 0.429 ' HB3' ' HG2' ' B' ' 90' ' ' GLN . 0.6 OUTLIER -101.28 119.42 38.73 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 120.828 0.347 . . . . 0.0 111.37 -176.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.72 -179.33 37.17 Favored Glycine 1 N--CA 1.393 -4.191 0 C-N-CA 118.717 -1.706 . . . . 0.0 114.785 170.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' B' ' 24' ' ' LEU . . . -177.9 -158.69 21.31 Favored Glycine 1 C--N 1.253 -4.06 1 N-CA-C 102.801 -4.12 . . . . 0.0 102.801 -178.815 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.98 108.72 8.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 120.208 2.004 . . . . 0.0 110.551 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -141.22 165.68 27.4 Favored Pre-proline 0 C--N 1.277 -2.587 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.33 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.461 ' HB2' HD13 ' B' ' 58' ' ' ILE . 11.6 Cg_exo -70.47 144.04 49.13 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.487 1.458 . . . . 0.0 109.871 169.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 29.3 m -128.02 158.7 39.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.489 ' CG2' ' HB1' ' B' ' 56' ' ' ALA . 35.1 m -102.08 130.46 51.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.891 177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 34.7 mm -84.37 105.72 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -10.66 8.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.813 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.468 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.0 OUTLIER -58.61 161.95 4.25 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 125.274 1.43 . . . . 0.0 114.723 -171.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -67.26 -172.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.771 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.451 ' CG ' ' HZ3' ' B' ' 48' ' ' LYS . 14.7 t70 -89.67 -41.28 12.02 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.204 -177.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.43 ' HA ' ' HD2' ' B' ' 48' ' ' LYS . 5.2 m -78.7 -21.91 47.46 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 -32.32 81.16 Favored Glycine 0 C--O 1.219 -0.811 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -69.76 -36.95 76.22 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.227 0.536 . . . . 0.0 110.494 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.451 ' HZ3' ' CG ' ' B' ' 44' ' ' ASP . 33.9 mttp -77.5 -50.13 13.28 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -115.4 -25.08 8.1 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -88.32 150.02 46.0 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.939 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.68 -16.4 6.69 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.506 1.471 . . . . 0.0 110.618 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -95.8 143.04 27.37 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 124.539 1.136 . . . . 0.0 112.18 -174.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.21 139.48 51.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.468 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 10.2 tt -92.14 134.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 120.948 0.404 . . . . 0.0 109.954 170.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 22.0 m -139.9 165.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 120.968 0.413 . . . . 0.0 110.255 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.489 ' HB1' ' CG2' ' B' ' 39' ' ' VAL . . . -124.15 138.83 54.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.52 134.54 47.8 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.483 HG12 ' CD1' ' B' ' 86' ' ' ILE . 64.7 mt -93.45 139.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.011 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 96.9 m -131.69 140.15 49.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' B' ' 84' ' ' SER . . . -60.33 -74.72 0.34 Allowed Glycine 0 C--O 1.219 -0.816 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' B' ' 60' ' ' GLY . 24.8 mmm180 -131.14 164.4 25.57 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 173.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 4.3 tp -167.73 -54.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 121.322 0.582 . . . . 0.0 110.326 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -170.42 147.11 2.94 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.402 ' HZ2' ' CD ' ' B' ' 72' ' ' GLU . 17.1 tppt? -59.81 145.01 46.98 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 123.922 0.764 . . . . 0.0 109.673 176.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.03 73.21 0.44 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.758 0.789 . . . . 0.0 111.159 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -100.94 -14.84 17.73 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.774 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.8 mt -103.68 141.36 22.34 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.01 0.51 4.34 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.106 1.871 . . . . 0.0 113.255 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 58.0 p -100.58 -18.83 16.42 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.32 0.581 . . . . 0.0 110.368 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -97.33 129.99 44.54 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.86 144.44 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.402 ' CD ' ' HZ2' ' B' ' 64' ' ' LYS . 33.8 mt-10 -104.9 151.36 23.96 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.931 0.396 . . . . 0.0 110.653 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . . . . . . . . . 24.7 pt -127.17 137.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.489 ' O ' ' HD1' ' B' ' 78' ' ' TYR . 27.9 mp0 -60.44 116.25 4.17 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.399 1.08 . . . . 0.0 113.217 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -50.39 -36.72 33.98 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.704 0.764 . . . . 0.0 112.627 175.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -53.58 -52.7 58.93 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 113.342 -1.754 . . . . 0.0 113.072 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -92.32 -36.78 12.99 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.592 0.711 . . . . 0.0 111.358 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.5 ' CE2' ' HA ' ' B' ' 106' ' ' LEU . 76.6 m-85 -76.08 -7.39 54.6 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.766 -173.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 74.86 28.19 1.14 Allowed 'General case' 0 C--N 1.35 0.619 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 167.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 mp -107.69 -177.51 3.36 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.687 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -91.56 -19.45 22.74 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.814 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.413 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -128.46 153.79 46.75 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.061 -173.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -75.87 128.96 36.22 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' B' ' 60' ' ' GLY . 6.8 t -102.83 164.49 11.59 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -169.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.2 t -122.42 141.25 43.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.483 ' CD1' HG12 ' B' ' 58' ' ' ILE . 14.3 mm -108.31 132.72 55.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 177.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -105.54 108.26 19.68 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.195 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.83 -3.98 55.32 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.134 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -95.87 -35.98 11.28 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.275 1.036 . . . . 0.0 109.804 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . 0.429 ' HG2' ' HB3' ' B' ' 32' ' ' GLN . 8.0 tp60 -93.05 80.6 4.55 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.63 177.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.484 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.1 pp -122.53 -177.62 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -173.17 -178.07 1.68 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.453 0.644 . . . . 0.0 112.503 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 54.1 m -124.36 126.0 45.26 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 81.6 mt -131.82 134.78 46.16 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.589 1.156 . . . . 0.0 109.816 -173.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -78.23 153.93 31.47 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -44.6 -21.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.762 1.625 . . . . 0.0 114.897 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -71.96 -18.62 61.98 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.683 0.793 . . . . 0.0 110.484 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.407 ' NH1' ' HB3' ' B' ' 23' ' ' ASP . 3.0 mmp_? -86.55 -36.38 18.96 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.174 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.79 126.06 28.56 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.791 0.805 . . . . 0.0 110.418 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -95.62 -64.48 1.05 Allowed 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.301 -1.318 . . . . 0.0 113.489 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 16.9 pt-20 -157.93 143.6 17.09 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.35 0.595 . . . . 0.0 111.558 -170.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.1 OUTLIER -66.38 123.88 21.21 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.413 -1.721 . . . . 0.0 110.706 174.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.685 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 24.9 tp -114.38 -62.14 1.64 Allowed 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.56 1.171 . . . . 0.0 110.57 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.685 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 5.1 m -125.14 -175.79 3.4 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 112.837 -1.983 . . . . 0.0 111.872 -163.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.505 ' H ' ' CG2' ' B' ' 104' ' ' THR . 0.4 OUTLIER -159.52 139.31 11.61 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 125.77 1.628 . . . . 0.0 109.384 -168.07 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.5 ' HA ' ' CE2' ' B' ' 78' ' ' TYR . 6.9 mt -101.54 159.62 15.14 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.955 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m -90.4 158.37 17.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.093 174.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' B' ' 111' ' ' MET . 8.7 m-20 -64.48 -28.48 69.69 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.513 0.673 . . . . 0.0 111.952 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.89 -33.52 64.06 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.944 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.442 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 4.6 mptp? -79.96 -22.64 42.38 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.825 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.509 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -56.59 -38.76 72.46 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 170.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.453 ' CE ' ' HA ' ' B' ' 112' ' ' LYS . 6.9 mmpt? -78.8 -12.89 60.04 Favored 'General case' 0 N--CA 1.381 -3.921 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.91 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -88.94 -50.47 6.17 Favored 'General case' 0 N--CA 1.391 -3.385 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 t -48.99 -59.6 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.224 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 5.0 m-20 -57.14 -41.87 79.9 Favored 'General case' 0 N--CA 1.514 2.726 0 CA-C-O 123.661 1.696 . . . . 0.0 112.352 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.563 ' O ' HD13 ' B' ' 120' ' ' ILE 0.345 22.0 t30 -83.64 -46.63 12.12 Favored 'General case' 0 C--N 1.251 -3.696 0 CA-C-N 112.319 -2.219 . . . . 0.0 112.285 -168.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.19 -32.52 72.28 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.563 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 7.6 tp -62.38 -46.9 86.54 Favored 'General case' 1 N--CA 1.365 -4.684 0 CA-C-N 113.514 -1.676 . . . . 0.0 109.601 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.678 ' SD ' ' HA ' ' B' ' 125' ' ' ASN 0.288 7.9 ptp -66.55 -25.42 66.64 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 177.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.563 HD13 ' O ' ' B' ' 116' ' ' ASN . 4.5 mp -72.05 -46.66 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 C-N-CA 117.756 -1.577 . . . . 0.0 108.288 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 14.9 t -58.05 -34.37 70.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.316 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 13.7 mt -110.41 7.91 23.02 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.56 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.17 20.77 67.52 Favored Glycine 0 N--CA 1.468 0.808 0 N-CA-C 116.983 1.553 . . . . 0.0 116.983 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.511 HD13 HD13 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -101.26 18.64 19.43 Favored 'General case' 0 CA--C 1.496 -1.135 0 CA-C-N 118.361 1.08 . . . . 0.0 111.309 -177.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.678 ' HA ' ' SD ' ' B' ' 119' ' ' MET . 20.3 m120 -41.35 131.74 2.77 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.175 0.922 . . . . 0.0 112.21 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.55 11.13 3.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.891 0.853 . . . . 0.0 112.679 -172.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.411 ' H ' ' C ' ' B' ' 125' ' ' ASN . 42.2 t -121.9 4.63 5.98 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 CA-C-N 114.387 -1.279 . . . . 0.0 107.812 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 75.64 135.05 0.06 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.237 1.815 . . . . 0.0 110.452 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -72.22 -13.47 61.54 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.806 -0.559 . . . . 0.0 111.741 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -92.31 3.69 54.88 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.118 0.485 . . . . 0.0 110.425 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -126.78 101.33 6.56 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.687 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 t -125.61 148.55 48.93 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -101.01 10.56 40.95 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 71.42 103.51 0.07 Allowed 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.883 1.273 . . . . 0.0 109.922 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -62.15 -54.03 46.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.388 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 176.05 -33.44 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -128.63 164.38 23.0 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.592 -2.094 . . . . 0.0 106.343 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -94.56 -60.21 1.76 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.443 ' C ' ' HG ' ' A' ' 10' ' ' SER . 19.3 p80 -119.96 -2.73 10.24 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.97 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.443 ' HG ' ' C ' ' A' ' 9' ' ' HIS . 50.4 p 61.13 -81.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.723 1.609 . . . . 0.0 113.814 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -74.86 124.87 27.64 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -80.5 148.89 67.34 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.28 156.4 10.61 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.866 2.377 . . . . 0.0 113.732 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.3 mt -66.19 133.37 31.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.253 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -102.91 121.91 43.49 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.982 -174.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -59.45 126.26 26.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.84 -7.05 44.67 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.204 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -97.56 -178.6 4.18 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 14.2 t -135.49 136.32 50.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 C-N-CA 123.679 0.792 . . . . 0.0 110.622 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 33.2 m-85 -132.2 146.24 51.88 Favored 'General case' 0 CA--C 1.466 -2.281 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.0 mp -77.84 152.73 33.28 Favored 'General case' 0 N--CA 1.395 -3.184 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.647 170.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -130.07 144.03 51.12 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.897 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.435 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 13.3 t70 -89.33 86.66 6.87 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.261 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.505 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 4.5 mm? -88.89 41.07 1.01 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.196 1.398 . . . . 0.0 112.496 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.562 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 31.7 m -73.48 174.29 4.96 Favored Pre-proline 0 C--N 1.251 -3.698 0 C-N-CA 126.123 1.769 . . . . 0.0 108.232 171.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER 4.79 51.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.41 3.81 1 C-N-CA 127.971 5.781 . . . . 0.0 118.65 -178.01 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.09 176.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.779 171.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 33.5 mm-40 -104.04 133.14 49.49 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.389 -176.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.76 -120.65 19.85 Favored Glycine 0 CA--C 1.505 -0.594 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.937 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.8 m -91.58 13.39 17.98 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -61.34 152.57 29.05 Favored 'General case' 0 C--O 1.252 1.225 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.71 177.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.509 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -71.88 120.86 18.08 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.157 -171.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -101.03 142.36 15.74 Favored Glycine 0 CA--C 1.476 -2.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.431 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 108.76 141.02 9.31 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 114.401 -0.899 . . . . 0.0 111.122 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.57 117.63 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -139.33 148.31 56.3 Favored Pre-proline 0 C--N 1.253 -3.613 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.61 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 50.0 Cg_exo -63.0 138.48 68.15 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.823 2.349 . . . . 0.0 111.654 171.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.6 m -123.93 156.22 31.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 32.9 m -100.93 132.05 47.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 120.809 0.338 . . . . 0.0 110.329 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.441 ' CG2' ' HG2' ' A' ' 42' ' ' GLN . 23.4 mm -91.59 106.66 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.413 HD11 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -104.37 -9.76 9.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.517 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.512 ' OE1' HG13 ' A' ' 53' ' ' VAL . 4.5 pt20 -51.46 162.5 0.36 Allowed 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -168.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -65.42 -177.08 0.38 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.285 -1.779 . . . . 0.0 111.765 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -73.89 -53.73 9.52 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 114.55 -1.204 . . . . 0.0 112.677 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 20.3 m -82.9 -22.39 33.95 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -166.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.58 -40.18 86.85 Favored Glycine 0 C--O 1.213 -1.219 0 O-C-N 123.059 0.224 . . . . 0.0 113.316 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.507 ' N ' HE22 ' A' ' 42' ' ' GLN . 11.0 p30 -71.05 -20.72 62.34 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 45' ' ' THR . 2.5 mptp? -86.16 -68.03 0.77 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.157 0.503 . . . . 0.0 110.517 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.35 -29.51 24.41 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -168.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 m -91.12 143.35 28.32 Favored Pre-proline 0 N--CA 1.414 -2.238 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.54 -26.45 23.91 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 120.955 1.103 . . . . 0.0 109.709 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.0 p -82.01 147.9 28.93 Favored 'General case' 0 N--CA 1.414 -2.258 0 C-N-CA 125.915 1.686 . . . . 0.0 113.619 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.512 HG13 ' OE1' ' A' ' 42' ' ' GLN . 93.3 t -132.16 140.39 47.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.454 HD12 ' O ' ' A' ' 92' ' ' ARG . 5.0 tp -103.86 124.72 58.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.416 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 25.1 m -134.02 167.92 25.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.988 -175.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.458 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . . . -126.13 139.52 53.31 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.83 137.38 41.82 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.414 HD11 ' HB2' ' A' ' 37' ' ' PRO . 60.4 mt -95.6 134.99 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-N 113.115 -1.857 . . . . 0.0 108.468 175.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 m -103.6 124.78 49.44 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.44 -10.44 79.81 Favored Glycine 0 N--CA 1.465 0.583 0 C-N-CA 121.249 -0.501 . . . . 0.0 111.984 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -117.1 170.3 8.76 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.9 mt 70.84 135.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 O-C-N 124.349 1.031 . . . . 0.0 110.557 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -142.59 32.96 1.45 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.833 0.825 . . . . 0.0 109.132 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -128.96 124.66 35.64 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.234 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.05 111.42 15.34 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 120.71 0.29 . . . . 0.0 111.152 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -97.19 -41.41 8.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.004 0.431 . . . . 0.0 111.645 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.526 HD13 ' H ' ' A' ' 67' ' ' ILE . 1.3 mp -87.28 138.95 32.06 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.94 1.18 2.01 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.677 2.251 . . . . 0.0 113.706 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.9 p -91.69 -16.26 27.23 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-O 122.301 1.048 . . . . 0.0 108.288 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -107.34 129.31 54.92 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 67.8 t -126.18 127.15 70.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.618 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.25 124.63 37.36 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.667 0.746 . . . . 0.0 109.8 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.492 HG22 ' CE1' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -108.75 156.34 9.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.297 -175.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -63.25 119.78 10.27 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 123.779 0.674 . . . . 0.0 112.619 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -46.12 -46.77 17.28 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 126.071 1.748 . . . . 0.0 110.336 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -58.2 -32.31 68.15 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 126.673 1.989 . . . . 0.0 112.826 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -91.14 -39.04 12.36 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.712 0.768 . . . . 0.0 110.792 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.492 ' CE1' HG22 ' A' ' 73' ' ' ILE . 4.2 m-85 -83.22 -9.45 59.14 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.793 -177.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 67.09 40.87 2.77 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.921 0.889 . . . . 0.0 111.096 174.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.41 -179.71 3.96 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.836 0.827 . . . . 0.0 111.073 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.8 -10.78 41.58 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.258 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -139.8 161.26 37.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.34 142.12 50.42 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.7 t -110.0 155.76 21.39 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.545 -171.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 12.6 t -117.74 128.11 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.403 HD12 ' CG1' ' A' ' 73' ' ' ILE . 1.6 mp -103.52 125.53 58.06 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.94 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 67.0 mt -100.97 110.61 22.67 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 113.228 -1.806 . . . . 0.0 110.04 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.6 mm? -83.84 3.25 34.48 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.732 -175.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -119.03 4.2 11.4 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.787 1.28 . . . . 0.0 108.39 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -122.85 35.1 4.96 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.535 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' B' ' 93' ' ' THR . 2.1 pp -85.94 -178.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.186 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.509 ' NH2' ' HB3' ' A' ' 32' ' ' GLN . 9.3 ptp85 -167.66 168.6 12.5 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 16.2 m -122.41 118.87 29.41 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.609 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 60.7 mt -131.89 140.1 48.97 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.255 -173.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.519 ' OD2' ' HB3' ' A' ' 97' ' ' LYS . 4.7 p-10 -72.89 151.26 42.01 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.635 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -45.54 -35.5 3.96 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 7.4 ttpm? -61.29 -26.1 67.56 Favored 'General case' 0 C--N 1.273 -2.753 0 C-N-CA 123.879 0.872 . . . . 0.0 112.634 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.435 ' NH1' ' HB3' ' A' ' 23' ' ' ASP . 2.3 mmp_? -75.53 -28.48 59.11 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.171 0.51 . . . . 0.0 110.813 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.05 124.22 24.5 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.492 1.117 . . . . 0.0 110.12 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -87.72 -63.64 1.27 Allowed 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.21 -1.359 . . . . 0.0 113.305 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.1 pt-20 -161.11 142.39 11.68 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 121.403 0.62 . . . . 0.0 111.969 -170.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -60.94 120.92 11.13 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 126.186 1.794 . . . . 0.0 110.731 174.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.53 -62.83 1.54 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.485 HG22 HG11 ' A' ' 19' ' ' VAL . 4.8 t -125.41 -167.0 1.62 Allowed 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.263 -1.375 . . . . 0.0 111.626 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -161.2 135.18 6.86 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 124.092 0.957 . . . . 0.0 111.831 -171.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -105.4 163.36 12.69 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.176 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.5 p -90.86 170.14 10.34 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.282 0.563 . . . . 0.0 112.459 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 111' ' ' MET . 27.6 t70 -65.82 -30.82 71.5 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.292 1.037 . . . . 0.0 112.492 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -75.44 -24.26 57.03 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 122.035 -0.415 . . . . 0.0 110.491 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.409 ' O ' HG21 ' A' ' 114' ' ' VAL . 0.7 OUTLIER -75.13 -26.65 59.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.356 174.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.497 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -55.01 -39.32 68.96 Favored 'General case' 0 CA--C 1.471 -2.085 0 CA-C-O 122.04 0.924 . . . . 0.0 109.818 172.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.497 ' HE2' ' C ' ' A' ' 111' ' ' MET . 8.3 mmpt? -74.28 -15.21 60.98 Favored 'General case' 0 N--CA 1.393 -3.292 0 CA-C-N 114.214 -1.357 . . . . 0.0 113.112 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -86.93 -56.03 3.57 Favored 'General case' 0 N--CA 1.389 -3.51 0 C-N-CA 117.649 -1.62 . . . . 0.0 109.245 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 110' ' ' LYS . 22.0 m -57.33 -47.7 84.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -174.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.403 ' HB3' ' HG ' ' B' ' 124' ' ' LEU . 44.5 m-20 -60.53 -48.02 83.6 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 123.536 1.636 . . . . 0.0 109.931 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.435 ' O ' HG13 ' A' ' 120' ' ' ILE . 12.1 t30 -76.06 -39.87 54.49 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 112.267 -2.242 . . . . 0.0 112.647 -168.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.483 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -60.25 -38.51 83.68 Favored 'General case' 0 CA--C 1.469 -2.142 0 CA-C-O 122.279 1.038 . . . . 0.0 108.605 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.0 -27.82 30.12 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.297 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.423 ' HB3' ' O ' ' A' ' 116' ' ' ASN . 3.7 ttp -60.27 -30.09 69.23 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 124.079 0.951 . . . . 0.0 108.552 172.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 116' ' ' ASN . 52.9 mt -81.22 -55.61 7.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.9 t -49.76 -43.25 47.91 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.938 1.695 . . . . 0.0 111.935 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.419 ' HG ' HG12 ' B' ' 54' ' ' ILE . 9.0 mp -82.12 5.65 18.93 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.28 5.41 76.09 Favored Glycine 0 C--N 1.341 0.857 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.436 ' HG ' ' HB3' ' B' ' 115' ' ' ASP . 3.5 mp -73.23 -42.76 62.22 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.484 1.142 . . . . 0.0 108.63 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.466 ' C ' ' H ' ' A' ' 127' ' ' VAL . 1.9 t-20 60.99 168.38 0.09 Allowed 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 126.501 1.921 . . . . 0.0 114.836 177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.44 24.28 0.57 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.104 0.954 . . . . 0.0 111.826 -173.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.466 ' H ' ' C ' ' A' ' 125' ' ' ASN . 16.4 t -103.56 -2.04 9.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-O 122.789 1.28 . . . . 0.0 108.326 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.27 9.81 39.69 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.153 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.474 ' HB3' ' O ' ' B' ' 129' ' ' HIS . 90.1 m-70 -89.75 -50.96 5.76 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.672 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -116.34 171.69 7.67 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -136.17 142.93 44.2 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 C--N 1.294 -1.84 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.505 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.858 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 38.4 t -113.24 145.83 40.35 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m -100.45 11.74 38.79 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 73.1 101.12 0.07 Allowed 'General case' 0 C--N 1.349 0.561 0 C-N-CA 124.619 1.167 . . . . 0.0 109.729 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -61.58 -53.38 57.01 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.49 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 179.6 -37.75 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -125.49 170.48 11.38 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 112.383 -2.189 . . . . 0.0 106.271 174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -98.82 -56.44 2.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -124.29 -2.35 8.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.743 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p 57.72 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.301 1.441 . . . . 0.0 113.276 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -68.48 123.17 20.08 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.15 147.38 72.91 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.71 152.64 16.42 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.364 2.71 . . . . 0.0 113.972 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 86.5 mt -59.68 134.08 24.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.195 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -104.44 122.41 45.46 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.058 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -59.55 124.97 21.81 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 120.969 0.414 . . . . 0.0 110.105 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.51 -7.42 46.47 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.501 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -97.17 179.2 4.99 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 17.4 t -134.17 137.48 51.83 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 C-N-CA 123.546 0.738 . . . . 0.0 111.031 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 27.7 m-85 -132.99 145.41 50.85 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.3 mp -76.62 151.36 36.25 Favored 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.664 170.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.63 143.83 51.0 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.341 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -87.36 84.45 7.19 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.167 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.535 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 4.4 mm? -88.17 40.93 0.98 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 123.172 1.463 . . . . 0.0 112.444 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.547 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.257 14.7 m -73.67 174.76 4.35 Favored Pre-proline 1 C--N 1.242 -4.097 0 CA-C-N 113.279 -1.782 . . . . 0.0 108.162 172.612 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 13.9 Cg_exo 3.19 53.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.406 3.571 1 C-N-CA 128.129 5.886 . . . . 0.0 118.077 -179.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 m -69.4 -178.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 113.44 -1.709 . . . . 0.0 111.836 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' B' ' 31' ' ' GLU . 33.1 mm-40 -109.79 132.7 53.91 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.624 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.87 -125.74 40.6 Favored Glycine 0 CA--C 1.499 -0.964 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.263 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 39.6 m -93.55 22.18 5.62 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.38 -0.41 . . . . 0.0 112.03 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' B' ' 28' ' ' GLN . 0.0 OUTLIER -64.24 162.46 14.61 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.388 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . 0.545 ' HB3' ' NH2' ' B' ' 92' ' ' ARG . 0.9 OUTLIER -79.92 117.42 20.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 120.87 0.367 . . . . 0.0 110.262 -173.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -98.07 145.8 17.93 Favored Glycine 0 CA--C 1.473 -2.556 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.514 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 106.54 138.96 9.24 Favored Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 114.431 -0.884 . . . . 0.0 111.18 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 t -56.93 119.42 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . 0.427 ' NH1' ' HA ' ' B' ' 59' ' ' THR . 58.7 mtt180 -140.7 148.43 52.87 Favored Pre-proline 0 C--N 1.256 -3.488 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.431 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 35.2 Cg_exo -64.1 138.49 62.2 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.707 2.271 . . . . 0.0 111.454 171.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.54 156.41 30.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.452 ' CG2' ' HB2' ' B' ' 56' ' ' ALA . 33.1 m -100.86 132.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.896 0.379 . . . . 0.0 110.439 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.46 ' CG2' ' HG2' ' B' ' 42' ' ' GLN . 24.3 mm -91.69 107.15 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.426 HD11 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -104.48 -9.99 9.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.554 ' OE1' HG12 ' B' ' 53' ' ' VAL . 4.7 pt20 -51.67 162.19 0.43 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -168.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -67.04 -179.88 1.02 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.263 -1.79 . . . . 0.0 111.852 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.25 -55.17 15.09 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.01 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.471 ' HA ' ' HD3' ' B' ' 48' ' ' LYS . 10.4 m -84.92 -22.3 29.32 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -164.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.64 -38.57 82.54 Favored Glycine 0 C--O 1.21 -1.381 0 O-C-N 123.236 0.335 . . . . 0.0 113.136 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.497 ' N ' HE22 ' B' ' 42' ' ' GLN . 10.2 p30 -71.79 -20.95 61.78 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' B' ' 45' ' ' THR . 2.8 mptp? -86.57 -67.75 0.79 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.138 0.494 . . . . 0.0 110.408 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.37 -35.78 24.86 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -169.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 18.7 m -86.09 143.31 37.06 Favored Pre-proline 0 N--CA 1.415 -2.215 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.28 -25.69 21.67 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.025 1.15 . . . . 0.0 109.309 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -82.71 145.97 29.3 Favored 'General case' 0 N--CA 1.415 -2.188 0 C-N-CA 125.545 1.538 . . . . 0.0 113.579 -173.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.554 HG12 ' OE1' ' B' ' 42' ' ' GLN . 98.0 t -130.01 140.52 48.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 176.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.466 HD12 ' O ' ' B' ' 92' ' ' ARG . 5.1 tp -103.76 124.57 58.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 121.291 0.567 . . . . 0.0 109.697 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.412 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 24.8 m -134.15 167.09 26.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.965 -175.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.452 ' HB2' ' CG2' ' B' ' 39' ' ' VAL . . . -125.53 139.54 53.52 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.49 135.78 42.23 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' B' ' 37' ' ' PRO . 59.4 mt -93.98 135.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 113.248 -1.796 . . . . 0.0 108.05 174.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' THR . . . . . 0.427 ' HA ' ' NH1' ' B' ' 36' ' ' ARG . 19.2 m -101.92 127.22 48.86 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.28 -12.23 80.98 Favored Glycine 0 N--CA 1.466 0.659 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.76 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.41 ' O ' HG22 ' B' ' 59' ' ' THR . 81.7 mtp180 -121.57 174.24 6.91 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 61.3 mt 71.53 138.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 O-C-N 124.044 0.84 . . . . 0.0 110.339 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -142.85 20.7 1.98 Allowed 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.281 -0.887 . . . . 0.0 109.755 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -118.6 124.17 46.8 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.426 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.86 112.06 17.88 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.591 0.234 . . . . 0.0 111.398 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -100.14 -35.5 9.64 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.153 0.501 . . . . 0.0 111.379 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.477 ' H ' HD13 ' B' ' 67' ' ' ILE . 0.9 OUTLIER -93.9 137.6 23.03 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 -177.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.09 3.34 1.32 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.768 2.312 . . . . 0.0 113.755 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 58.9 p -92.4 -15.9 26.62 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.455 1.121 . . . . 0.0 108.504 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -108.64 129.76 55.33 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 62.9 t -125.42 127.06 71.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 O-C-N 121.611 -0.681 . . . . 0.0 110.736 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.34 120.62 32.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.493 HG22 ' CE1' ' B' ' 78' ' ' TYR . 0.1 OUTLIER -106.6 154.28 7.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.449 -175.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -62.01 119.48 8.96 Favored 'General case' 0 C--O 1.251 1.176 0 O-C-N 124.202 0.939 . . . . 0.0 112.619 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -46.55 -46.33 19.27 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.147 1.779 . . . . 0.0 110.48 172.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -59.73 -31.33 69.52 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 126.219 1.807 . . . . 0.0 112.938 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -90.73 -39.44 12.42 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.199 0.523 . . . . 0.0 110.631 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.493 ' CE1' HG22 ' B' ' 73' ' ' ILE . 4.3 m-85 -83.29 -10.8 58.31 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.879 -177.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 tttp 70.41 34.2 2.3 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.31 1.044 . . . . 0.0 111.851 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.69 -179.79 4.07 Favored 'General case' 0 CA--C 1.492 -1.259 0 O-C-N 120.973 -1.08 . . . . 0.0 111.613 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.82 -13.41 42.24 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.785 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -140.35 161.65 37.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.98 144.8 52.21 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t -112.4 157.28 21.24 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 11.0 t -118.2 128.31 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.424 HD12 ' CG1' ' B' ' 73' ' ' ILE . 1.6 mp -103.12 124.75 57.44 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 74.5 mt -100.18 111.5 23.78 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.054 -175.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.6 mm? -84.06 2.75 37.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.614 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -119.15 4.79 11.29 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.818 1.294 . . . . 0.0 108.477 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -123.61 35.33 4.87 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.159 -1.837 . . . . 0.0 106.481 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.51 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.1 pp -85.81 -178.31 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.192 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.545 ' NH2' ' HB3' ' B' ' 32' ' ' GLN . 9.6 ptp85 -167.53 168.93 12.49 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 11.0 m -122.37 118.29 28.08 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.594 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 64.8 mt -132.0 139.86 48.76 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.403 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' B' ' 97' ' ' LYS . 6.2 p-10 -71.47 151.59 43.81 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.193 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -46.21 -37.0 6.57 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.513 ' HB3' ' OD2' ' B' ' 95' ' ' ASP . 7.0 ttpm? -61.59 -24.47 66.7 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.667 176.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -74.6 -30.11 61.56 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.481 -0.762 . . . . 0.0 110.352 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -71.31 124.93 25.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.499 1.12 . . . . 0.0 110.428 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -88.22 -64.68 1.11 Allowed 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.745 -1.571 . . . . 0.0 112.732 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 9.9 pt-20 -161.25 142.12 11.28 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 121.502 0.668 . . . . 0.0 112.523 -171.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.2 OUTLIER -60.45 121.31 11.78 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 126.491 1.916 . . . . 0.0 110.938 174.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -114.82 -63.0 1.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.345 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.489 HG22 HG11 ' B' ' 19' ' ' VAL . 3.3 t -125.25 -166.54 1.55 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.172 -1.411 . . . . 0.0 111.816 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -161.13 135.87 7.37 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.002 0.921 . . . . 0.0 112.112 -170.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 pp -108.79 157.4 18.61 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.02 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 7.1 p -86.82 175.49 8.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' B' ' 111' ' ' MET . 22.9 t70 -72.21 -29.47 64.0 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.151 0.5 . . . . 0.0 111.812 -174.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -70.2 -23.38 62.94 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.355 0.597 . . . . 0.0 109.91 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.443 ' O ' HG21 ' B' ' 114' ' ' VAL . 0.6 OUTLIER -78.8 -27.4 44.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 174.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.464 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.0 OUTLIER -55.51 -39.44 70.5 Favored 'General case' 0 CA--C 1.46 -2.487 0 CA-C-O 122.336 1.065 . . . . 0.0 109.131 172.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.464 ' HE2' ' C ' ' B' ' 111' ' ' MET . 6.9 mmpt? -71.98 -17.16 62.08 Favored 'General case' 1 N--CA 1.378 -4.053 0 CA-C-N 113.725 -1.579 . . . . 0.0 113.841 -178.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.97 -57.98 2.76 Favored 'General case' 0 N--CA 1.39 -3.436 0 C-N-CA 117.561 -1.656 . . . . 0.0 109.198 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.443 HG21 ' O ' ' B' ' 110' ' ' LYS . 22.9 m -54.85 -47.02 75.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.436 ' HB3' ' HG ' ' A' ' 124' ' ' LEU . 55.6 m-20 -61.3 -48.97 78.93 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.636 1.684 . . . . 0.0 110.535 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' B' ' 119' ' ' MET 0.349 27.0 t30 -77.13 -38.69 51.51 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.539 -167.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.418 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -62.63 -37.56 86.8 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-O 122.267 1.032 . . . . 0.0 108.812 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.66 -27.44 31.32 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.888 -174.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.439 ' HB3' ' O ' ' B' ' 116' ' ' ASN . 4.0 ttp -60.25 -31.44 70.21 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 59.6 mt -79.03 -56.39 7.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.2 t -48.64 -43.45 36.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.114 1.366 . . . . 0.0 112.235 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.434 ' HG ' HG12 ' A' ' 54' ' ' ILE . 8.6 mp -81.64 6.06 16.3 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.36 7.28 79.83 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 115.661 1.025 . . . . 0.0 115.661 172.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' B' ' 119' ' ' MET . 3.8 mp -73.59 -43.82 58.78 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 118.328 1.064 . . . . 0.0 108.422 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' B' ' 127' ' ' VAL . 1.8 t-20 61.18 169.54 0.1 Allowed 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 126.689 1.995 . . . . 0.0 114.72 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.04 27.16 0.68 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.811 0.815 . . . . 0.0 111.576 -173.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.424 ' H ' ' C ' ' B' ' 125' ' ' ASN . 16.0 t -101.75 -7.47 9.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-O 122.375 1.084 . . . . 0.0 108.38 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.43 8.59 44.67 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 113.891 -1.504 . . . . 0.0 112.407 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.474 ' O ' ' HB3' ' A' ' 129' ' ' HIS . 96.4 m-70 -87.14 -51.04 6.22 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.588 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -118.58 167.84 11.25 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -130.45 144.74 51.59 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 19.5 m120 . . . . . 0 C--N 1.286 -2.163 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 175.922 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -93.19 -51.13 5.17 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 122.614 0.366 . . . . 0.0 111.505 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 m -82.54 -42.76 17.95 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 121.554 0.692 . . . . 0.0 110.186 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -106.07 145.55 31.28 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -85.65 80.35 9.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.209 1.004 . . . . 0.0 111.048 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -124.03 116.22 22.47 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.479 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -84.85 123.9 30.99 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 173.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -76.73 102.43 6.22 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -104.14 112.94 26.16 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.901 -171.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -121.13 134.79 55.25 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.512 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -79.65 115.89 19.52 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.354 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -87.87 145.37 36.51 Favored Pre-proline 0 C--N 1.28 -2.449 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.61 101.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.503 2.135 . . . . 0.0 113.171 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.7 mt -85.82 125.45 40.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.221 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.43 ' HG2' ' OD2' ' A' ' 18' ' ' ASP . 8.4 ptp180 -121.59 157.99 29.54 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 171.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 28.6 ptt85 -69.36 113.65 6.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 168.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.481 ' HA2' ' SD ' ' A' ' 111' ' ' MET . . . 131.76 -9.07 5.51 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.875 -173.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.43 ' OD2' ' HG2' ' A' ' 15' ' ' ARG . 32.9 m-20 -96.46 173.19 7.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 122.016 0.912 . . . . 0.0 109.713 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 12.4 t -132.3 134.22 59.47 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.794 178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 50.7 m-85 -135.62 144.01 45.86 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 125.325 1.45 . . . . 0.0 108.977 176.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.9 mp -79.42 149.49 31.59 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-O 121.539 0.685 . . . . 0.0 111.097 173.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.67 134.23 33.37 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.177 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 25' ' ' SER 0.326 3.2 p-10 -81.64 104.72 12.25 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 117.931 -1.508 . . . . 0.0 111.346 176.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 5.4 mt -90.55 37.78 0.92 Allowed 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 124.92 2.295 . . . . 0.0 110.273 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.544 ' H ' ' C ' ' A' ' 23' ' ' ASP 0.282 7.3 m -63.62 171.91 2.02 Favored Pre-proline 1 C--N 1.223 -4.904 0 CA-C-N 109.364 -3.562 . . . . 0.0 107.314 167.599 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 1.0 OUTLIER 6.04 53.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.401 3.307 1 C-N-CA 126.977 5.118 . . . . 0.0 118.227 -174.73 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.32 -178.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.717 166.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -108.01 126.46 52.75 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.89 -117.9 9.82 Favored Glycine 0 N--CA 1.425 -2.058 0 CA-C-N 113.781 -1.554 . . . . 0.0 114.329 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.9 m -93.89 22.08 6.01 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.445 -0.878 . . . . 0.0 112.869 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.96 -176.36 0.68 Allowed 'General case' 0 C--O 1.247 0.948 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.934 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.8 109.11 19.9 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.56 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.18 143.27 16.45 Favored Glycine 0 CA--C 1.472 -2.636 0 CA-C-N 115.149 -0.932 . . . . 0.0 114.281 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 108.07 137.1 8.12 Favored Glycine 0 N--CA 1.418 -2.535 0 CA-C-N 113.85 -1.175 . . . . 0.0 110.811 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 p -61.93 126.71 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 122.455 1.121 . . . . 0.0 111.053 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -149.61 166.27 15.62 Favored Pre-proline 0 C--N 1.266 -3.04 0 CA-C-N 112.927 -1.942 . . . . 0.0 108.2 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 3.8 Cg_exo -75.92 143.9 26.76 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 121.903 1.735 . . . . 0.0 111.555 174.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 20' ' ' TYR . 28.6 m -118.45 158.53 19.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.517 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 34.3 m -102.36 133.05 47.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.767 0.318 . . . . 0.0 110.729 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 mm -88.72 104.9 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.429 HD13 ' C ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -104.4 -20.81 5.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.114 -178.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -54.88 165.95 0.56 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -170.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -60.66 164.03 4.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.051 -1.886 . . . . 0.0 112.527 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.08 -39.32 79.13 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.52 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 m -86.97 -26.56 23.76 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -171.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.89 -37.2 92.22 Favored Glycine 0 C--O 1.201 -1.919 0 CA-C-N 116.354 -0.385 . . . . 0.0 113.402 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.519 ' OD1' ' HD2' ' A' ' 48' ' ' LYS . 27.5 p30 -69.55 -19.69 63.68 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HD2' ' OD1' ' A' ' 47' ' ' ASN . 13.0 mptt -84.51 -61.73 1.73 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 109.901 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -89.13 -21.93 23.11 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -168.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.2 m -105.94 139.71 20.52 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.668 -0.645 . . . . 0.0 109.652 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.48 -22.26 14.17 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.437 1.425 . . . . 0.0 109.597 174.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 p -96.17 133.69 40.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.456 1.102 . . . . 0.0 111.889 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.24 145.96 34.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.3 tt -96.68 132.68 40.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.543 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.439 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 30.0 m -137.77 172.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.383 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . . . -126.0 139.55 53.33 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.53 142.76 42.75 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.45 HD12 ' HB2' ' A' ' 37' ' ' PRO . 82.7 mt -101.86 129.53 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.759 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.8 m -119.27 105.31 11.21 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.82 150.05 22.05 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.421 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 55.6 mtp180 65.94 89.88 0.09 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.099 0.96 . . . . 0.0 112.063 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 61' ' ' ARG . 0.1 OUTLIER -178.04 -48.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 174.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.441 ' OD1' ' HB2' ' A' ' 83' ' ' ASP . 2.4 m-20 60.08 -167.15 0.18 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.091 0.957 . . . . 0.0 110.394 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt 57.95 67.83 0.91 Allowed 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.68 0.612 . . . . 0.0 111.383 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.57 -61.32 2.36 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.748 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.4 tttp 69.13 -57.29 0.53 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.248 1.419 . . . . 0.0 112.539 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.5 mt -80.19 139.25 52.52 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.14 -11.29 21.33 Favored 'Trans proline' 0 CA--C 1.563 1.927 0 C-N-CA 122.199 1.933 . . . . 0.0 113.723 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.7 p -90.21 -19.02 24.67 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.353 0.597 . . . . 0.0 110.702 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -95.1 130.27 41.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.49 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.82 132.87 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.34 132.95 52.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.298 0.571 . . . . 0.0 110.909 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.481 HG13 ' CZ ' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -107.53 165.53 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.021 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -69.54 110.08 4.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 124.074 0.95 . . . . 0.0 109.828 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 20.8 pttm -58.09 -35.89 72.08 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.563 0.696 . . . . 0.0 112.115 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -51.61 -45.72 63.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.327 -1.76 . . . . 0.0 111.03 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -82.98 -34.68 26.34 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.288 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CZ ' HG13 ' A' ' 73' ' ' ILE . 1.8 m-85 -73.35 -11.52 60.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.031 -177.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.2 tptt 78.45 18.94 0.99 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.879 1.272 . . . . 0.0 111.732 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.13 179.36 4.51 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.285 1.04 . . . . 0.0 110.988 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -97.11 -24.8 15.58 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.977 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -130.33 155.25 46.66 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.108 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 4.5 m-20 -56.74 142.68 39.48 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 122.021 0.915 . . . . 0.0 113.203 -175.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.9 m -108.02 128.63 54.83 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.158 -174.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.3 t -115.82 130.22 70.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.22 129.68 60.61 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.843 0 CA-C-O 122.196 0.998 . . . . 0.0 108.575 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.0 mt -103.42 108.34 19.55 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 113.194 -1.821 . . . . 0.0 109.214 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.41 4.35 18.33 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.373 -175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.12 -38.0 6.13 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.378 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.48 53.35 2.78 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.545 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.507 HG21 ' CB ' ' A' ' 56' ' ' ALA . 2.0 pp -97.21 -176.16 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -173.96 178.11 2.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 45.4 m -121.76 129.15 52.48 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.884 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 mt -133.17 145.56 50.74 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 124.373 1.069 . . . . 0.0 109.328 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 97' ' ' LYS . 2.2 p-10 -79.73 151.16 30.57 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.284 -1.367 . . . . 0.0 110.115 173.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -39.14 -41.06 0.79 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.994 2.117 . . . . 0.0 114.521 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.468 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 7.0 ttpm? -63.65 -13.74 45.43 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 124.122 0.969 . . . . 0.0 112.401 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.5 ' HA ' ' NE ' ' A' ' 98' ' ' ARG . 3.7 mmp_? -89.73 -26.94 20.38 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.166 -0.959 . . . . 0.0 110.912 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -74.89 108.56 7.7 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-O 122.14 0.971 . . . . 0.0 109.514 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -93.83 -59.28 2.03 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -143.66 130.41 20.31 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.918 0.866 . . . . 0.0 113.232 -171.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.2 tttp -60.77 119.9 9.07 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 127.266 2.226 . . . . 0.0 108.184 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.7 tp -114.5 -62.38 1.61 Allowed 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.804 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.435 HG21 HG22 ' A' ' 19' ' ' VAL . 6.1 t -127.75 -160.49 1.02 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.238 -1.385 . . . . 0.0 112.457 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -159.37 149.97 19.42 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.371 1.868 . . . . 0.0 109.158 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -101.82 147.49 26.43 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.688 -177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -64.32 143.16 58.1 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 125.1 1.36 . . . . 0.0 108.608 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 111' ' ' MET . 7.0 p-10 -58.45 -37.39 75.34 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.29 -34.47 63.55 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.809 0.337 . . . . 0.0 110.606 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -67.67 -33.58 75.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -51.31 -46.18 62.47 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.693 173.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.685 ' HA ' ' OD2' ' A' ' 115' ' ' ASP . 0.5 OUTLIER -69.69 -17.78 63.5 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.72 -178.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -83.54 -38.67 21.41 Favored 'General case' 0 CA--C 1.442 -3.175 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.21 -42.99 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.671 0 O-C-N 126.13 2.144 . . . . 0.0 109.999 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.685 ' OD2' ' HA ' ' A' ' 112' ' ' LYS . 44.8 m-20 -57.4 -58.92 6.16 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.494 ' O ' HG13 ' A' ' 120' ' ' ILE . 1.7 m-80 -59.38 -47.39 85.63 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.3 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.09 -43.81 64.09 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 124.341 1.056 . . . . 0.0 110.852 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 tp -67.21 -45.93 75.38 Favored 'General case' 1 N--CA 1.374 -4.252 0 C-N-CA 124.336 1.054 . . . . 0.0 109.971 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.2 mtp -67.82 -20.08 65.13 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 121.477 -0.765 . . . . 0.0 112.891 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 116' ' ' ASN . 49.4 mt -77.24 -55.75 9.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 26.2 t -53.22 -42.65 66.57 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.759 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.4 mp -90.06 -1.14 57.91 Favored 'General case' 0 N--CA 1.403 -2.782 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.65 13.14 82.84 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 116.571 1.389 . . . . 0.0 116.571 170.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 5.2 mp -79.57 -59.84 2.59 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 118.624 1.212 . . . . 0.0 110.985 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 43.37 -151.28 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.65 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.3 16.49 24.74 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.061 0.934 . . . . 0.0 109.309 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.2 t -117.73 18.83 6.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.237 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 124' ' ' LEU . . . -81.11 -9.58 59.79 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.616 -0.678 . . . . 0.0 111.138 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -65.74 -52.36 51.79 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 120.925 0.393 . . . . 0.0 110.72 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -136.08 72.05 1.43 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.014 0.911 . . . . 0.0 111.118 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.488 ' HG2' HH22 ' B' ' 16' ' ' ARG . 87.2 tttt -156.31 108.03 2.5 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.429 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 p30 . . . . . 0 C--N 1.298 -1.644 0 CA-C-O 118.569 -0.729 . . . . 0.0 109.409 178.902 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.837 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -96.46 -46.0 6.54 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.246 0.545 . . . . 0.0 111.731 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -86.64 -31.86 20.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.296 0.57 . . . . 0.0 110.314 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -121.97 146.43 47.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -83.36 79.67 9.33 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 122.012 0.91 . . . . 0.0 110.315 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -125.69 112.48 16.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.726 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -80.64 122.6 27.29 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -75.52 100.9 4.68 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -105.42 119.2 38.49 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.121 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 17.2 m -127.4 145.27 50.88 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -91.89 116.17 28.68 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.04 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -83.01 146.47 51.93 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 171.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.21 114.69 0.9 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 122.186 1.924 . . . . 0.0 111.04 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 75.6 mt -99.52 120.69 49.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.058 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -117.35 159.14 23.21 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 27.0 ptt85 -70.0 113.54 7.31 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.414 ' HA2' ' SD ' ' B' ' 111' ' ' MET . . . 133.34 -15.3 4.74 Favored Glycine 0 C--N 1.305 -1.163 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.666 -173.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -89.72 171.92 9.3 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 121.946 0.879 . . . . 0.0 109.047 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.461 HG22 ' CG2' ' B' ' 104' ' ' THR . 13.3 t -131.19 132.88 63.09 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.774 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.841 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 75.6 m-85 -133.65 143.69 48.74 Favored 'General case' 0 CA--C 1.474 -1.957 0 C-N-CA 125.199 1.4 . . . . 0.0 109.463 176.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.9 mp -81.49 148.42 29.21 Favored 'General case' 0 N--CA 1.397 -3.095 0 CA-C-O 121.687 0.756 . . . . 0.0 110.99 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -136.59 134.73 37.72 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 113.177 -1.829 . . . . 0.0 107.209 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' B' ' 25' ' ' SER 0.333 3.6 p-10 -81.95 102.51 10.97 Favored 'General case' 0 C--N 1.279 -2.467 0 C-N-CA 117.975 -1.49 . . . . 0.0 111.658 175.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 4.9 mt -87.8 39.1 0.87 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 125.085 2.374 . . . . 0.0 110.396 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.547 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.287 6.6 m -64.62 171.87 2.55 Favored Pre-proline 1 C--N 1.22 -5.027 0 CA-C-N 109.363 -3.562 . . . . 0.0 107.219 167.083 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.3 OUTLIER 5.85 53.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.173 1 C-N-CA 127.153 5.235 . . . . 0.0 118.386 -174.746 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 28.5 m -69.29 -179.1 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.534 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -106.52 130.95 54.21 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.99 -117.9 7.37 Favored Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 113.751 -1.568 . . . . 0.0 113.82 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -94.18 18.08 11.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.34 -0.93 . . . . 0.0 113.188 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.52 178.1 1.04 Allowed 'General case' 0 C--O 1.249 1.063 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.942 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . 0.441 ' OE1' ' HD2' ' B' ' 36' ' ' ARG . 1.0 OUTLIER -83.52 108.81 16.89 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.522 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.79 138.52 14.11 Favored Glycine 0 CA--C 1.479 -2.212 0 CA-C-N 114.904 -1.043 . . . . 0.0 114.324 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 117.5 136.92 5.71 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 113.813 -1.193 . . . . 0.0 110.512 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 p -63.85 121.21 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 122.497 1.141 . . . . 0.0 110.9 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . 0.441 ' HD2' ' OE1' ' B' ' 32' ' ' GLN . 87.8 mtt180 -144.51 166.69 17.52 Favored Pre-proline 0 C--N 1.26 -3.319 0 CA-C-N 112.846 -1.979 . . . . 0.0 109.028 -174.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 5.4 Cg_exo -76.05 142.7 25.07 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 122.003 1.802 . . . . 0.0 111.507 174.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.496 HG21 ' O ' ' B' ' 20' ' ' TYR . 31.0 m -118.07 158.08 19.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.507 ' CG2' ' HB2' ' B' ' 56' ' ' ALA . 34.2 m -102.22 132.42 48.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.807 0.336 . . . . 0.0 110.79 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 24.0 mm -88.09 104.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.425 HD13 ' C ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -103.47 -20.8 5.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.004 -178.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -55.64 165.91 0.77 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 -170.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -59.77 163.3 4.54 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 112.709 -2.042 . . . . 0.0 112.784 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.0 -37.97 75.83 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.498 -175.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 25.8 m -87.23 -28.35 22.42 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.03 -36.06 86.65 Favored Glycine 0 C--O 1.2 -1.99 0 CA-C-O 120.077 -0.291 . . . . 0.0 113.336 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.534 ' OD1' ' HD2' ' B' ' 48' ' ' LYS . 26.6 p30 -69.21 -19.58 63.97 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.534 ' HD2' ' OD1' ' B' ' 47' ' ' ASN . 13.1 mptt -85.66 -59.44 2.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.222 0.534 . . . . 0.0 110.369 174.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -89.25 -29.75 19.0 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -169.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.7 m -99.45 138.41 20.48 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -74.7 -22.09 15.89 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.281 1.32 . . . . 0.0 109.708 173.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 3.1 p -95.43 132.7 40.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.546 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.32 146.38 34.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 4.8 tt -96.97 132.85 40.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 123.112 0.565 . . . . 0.0 110.317 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.449 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 28.3 m -138.03 171.93 14.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.556 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.507 ' HB2' ' CG2' ' B' ' 39' ' ' VAL . . . -125.05 139.8 53.47 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.12 142.03 41.77 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.468 HD12 ' HB2' ' B' ' 37' ' ' PRO . 85.2 mt -100.2 133.11 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.281 -1.781 . . . . 0.0 109.389 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 95.7 m -123.41 104.72 9.26 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.89 149.78 22.55 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.407 ' O ' ' HB ' ' B' ' 62' ' ' ILE . 47.5 mtp180 68.65 86.65 0.13 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.02 0.928 . . . . 0.0 112.844 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -176.73 -47.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . 0.548 ' OD1' ' HB2' ' B' ' 83' ' ' ASP . 2.5 m-20 58.75 -168.8 0.14 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.103 0.961 . . . . 0.0 110.777 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt 60.26 66.48 0.95 Allowed 'General case' 0 C--O 1.243 0.718 0 O-C-N 123.815 0.697 . . . . 0.0 110.403 173.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.25 -60.89 2.53 Favored 'General case' 0 C--O 1.252 1.222 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.287 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 tttp 69.41 -52.8 0.6 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.306 1.443 . . . . 0.0 112.835 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 13.2 mt -85.69 142.14 36.78 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.98 -12.69 33.35 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 122.157 1.905 . . . . 0.0 113.671 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -88.78 -19.09 26.45 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.395 0.617 . . . . 0.0 110.651 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -96.21 130.26 43.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.38 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 95.1 t -126.53 130.45 71.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 O-C-N 122.174 -0.329 . . . . 0.0 110.359 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -101.32 139.49 36.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.459 HG13 ' CZ ' ' B' ' 78' ' ' TYR . 0.7 OUTLIER -115.36 162.96 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 123.157 0.583 . . . . 0.0 111.754 -173.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -66.3 109.91 2.86 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 123.785 0.834 . . . . 0.0 110.409 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . 0.431 ' HB3' ' HA ' ' B' ' 83' ' ' ASP . 20.0 pttm -58.13 -34.98 70.82 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.873 0.844 . . . . 0.0 112.066 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -53.32 -44.19 68.21 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.177 -1.828 . . . . 0.0 110.941 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -84.51 -35.2 23.06 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.472 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.459 ' CZ ' HG13 ' B' ' 73' ' ' ILE . 1.6 m-85 -73.43 -11.49 60.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.926 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 81.59 13.81 0.61 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.222 1.409 . . . . 0.0 112.089 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.8 179.29 5.02 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 122.328 1.061 . . . . 0.0 111.189 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -96.27 -25.04 15.93 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 113.673 -1.603 . . . . 0.0 109.845 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -130.34 156.02 45.38 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . 0.548 ' HB2' ' OD1' ' B' ' 63' ' ' ASN . 2.1 m-20 -54.08 144.22 20.09 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.959 0.885 . . . . 0.0 113.239 -175.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 13.1 m -108.27 128.18 54.5 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.644 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.5 t -115.76 129.94 71.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.446 HG23 HD22 ' B' ' 88' ' ' LEU . 1.6 mp -107.4 129.88 60.55 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 mt -102.9 108.87 20.23 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 113.563 -1.653 . . . . 0.0 109.019 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.446 HD22 HG23 ' B' ' 86' ' ' ILE . 3.8 mm? -80.01 4.48 16.87 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.585 0.707 . . . . 0.0 112.451 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.15 -38.9 5.87 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.96 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -85.55 63.67 8.2 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.116 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.505 HG21 ' CB ' ' B' ' 56' ' ' ALA . 2.0 pp -108.66 -176.68 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -174.39 178.98 1.89 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 31.5 m -122.38 129.31 51.98 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.768 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 41.8 mt -133.49 145.46 50.21 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 124.513 1.125 . . . . 0.0 109.471 -174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' B' ' 97' ' ' LYS . 2.0 p30 -79.4 151.18 31.07 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 117.977 -1.489 . . . . 0.0 110.284 172.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -37.39 -42.25 0.48 Allowed 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 127.402 2.281 . . . . 0.0 114.685 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.477 ' HB3' ' HZ2' ' B' ' 97' ' ' LYS . 7.5 ttpm? -61.17 -18.05 56.14 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 124.665 1.186 . . . . 0.0 112.472 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.56 ' NE ' ' HA ' ' B' ' 98' ' ' ARG . 4.0 mmp_? -88.31 -22.45 23.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.363 -0.835 . . . . 0.0 111.622 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.31 107.83 11.2 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 121.976 0.894 . . . . 0.0 108.974 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -95.24 -57.98 2.27 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 116.823 2.156 . . . . 0.0 116.823 -173.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 12.0 pt-20 -140.15 131.93 27.47 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.979 0.895 . . . . 0.0 112.737 -171.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -63.67 119.46 9.92 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 127.151 2.18 . . . . 0.0 108.429 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.1 -63.66 1.43 Allowed 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 118.564 -1.255 . . . . 0.0 112.048 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.461 ' CG2' HG22 ' B' ' 19' ' ' VAL . 6.1 t -125.57 -160.48 0.97 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 117.645 -1.622 . . . . 0.0 112.897 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -159.75 150.89 19.54 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 126.803 2.041 . . . . 0.0 108.324 -173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.34 155.69 17.66 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -70.96 145.76 49.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' B' ' 111' ' ' MET . 2.8 p-10 -62.85 -35.43 79.93 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -176.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.0 -33.17 63.71 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.202 0.525 . . . . 0.0 109.917 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.419 ' HG2' HG21 ' B' ' 73' ' ' ILE . 16.6 tppt? -68.65 -32.96 73.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.531 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -51.83 -45.48 63.97 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.958 173.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.687 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -69.3 -16.88 63.66 Favored 'General case' 0 CA--C 1.477 -1.863 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.237 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . 0.53 ' HA ' ' ND2' ' B' ' 116' ' ' ASN . 32.6 mt-10 -85.53 -38.37 18.6 Favored 'General case' 1 N--CA 1.368 -4.55 0 C-N-CA 117.202 -1.799 . . . . 0.0 108.641 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.0 t -56.62 -44.36 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.141 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.03 172.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.634 ' OD2' ' HA ' ' B' ' 112' ' ' LYS . 25.2 m-20 -56.32 -58.1 9.41 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.557 1.17 . . . . 0.0 108.991 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.542 ' O ' HG13 ' B' ' 120' ' ' ILE . 1.3 p30 -66.34 -40.49 89.87 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.011 -1.449 . . . . 0.0 112.019 -173.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' B' ' 88' ' ' LEU . . . -59.14 -37.81 78.17 Favored 'General case' 0 CA--C 1.49 -1.364 0 O-C-N 123.636 0.585 . . . . 0.0 109.74 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.6 tp -69.56 -44.56 70.64 Favored 'General case' 1 N--CA 1.373 -4.294 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.871 -178.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 39.2 mtp -68.39 -19.92 64.65 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.643 -0.661 . . . . 0.0 112.124 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.542 HG13 ' O ' ' B' ' 116' ' ' ASN . 45.6 mt -78.18 -55.43 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 173.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 34.3 t -52.21 -43.9 64.47 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.113 1.365 . . . . 0.0 111.843 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 8.1 mp -87.74 -2.37 58.57 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.53 7.42 87.53 Favored Glycine 0 C--O 1.241 0.551 0 N-CA-C 117.116 1.606 . . . . 0.0 117.116 170.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.8 -59.19 2.86 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 118.632 1.216 . . . . 0.0 110.937 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 45.14 -151.36 0.05 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.552 -169.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.56 19.66 20.16 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.997 0.903 . . . . 0.0 109.609 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.69 7.86 6.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.663 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.02 -16.85 63.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.284 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -59.59 -53.13 61.57 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.918 -175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -134.92 71.74 1.45 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.282 1.039 . . . . 0.0 111.722 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . 0.431 ' HG2' HH22 ' A' ' 16' ' ' ARG . 87.3 tttt -160.66 108.81 1.6 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.732 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 8.4 p30 . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.287 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.5 m -87.93 95.48 10.13 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 117.447 0.624 . . . . 0.0 110.092 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 p -88.25 141.39 28.6 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.88 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -72.48 147.39 46.1 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -71.55 99.82 2.13 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.399 0.618 . . . . 0.0 111.626 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -74.15 111.07 8.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.559 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -91.84 93.5 8.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.242 0.544 . . . . 0.0 109.859 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -121.64 -15.58 7.93 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.905 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 66.99 -93.64 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -167.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.3 m 50.13 30.7 4.4 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.738 0.815 . . . . 0.0 111.519 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -94.33 81.91 4.04 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.035 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.15 123.84 89.6 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.93 100.88 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.188 1.926 . . . . 0.0 112.33 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -79.35 124.6 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -134.42 157.39 46.55 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 42' ' ' GLN . 20.3 ttt85 -67.86 130.5 43.17 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.33 173.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.34 -19.27 11.74 Favored Glycine 0 C--N 1.307 -1.034 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.158 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -93.51 176.06 6.52 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 122.112 0.958 . . . . 0.0 110.461 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.547 HG22 ' CG2' ' A' ' 104' ' ' THR . 17.4 t -128.32 135.76 61.79 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.194 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.119 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 8.0 m-85 -128.59 145.44 51.14 Favored 'General case' 0 CA--C 1.462 -2.411 0 C-N-CA 124.461 1.104 . . . . 0.0 108.996 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.3 mp -78.9 148.42 32.74 Favored 'General case' 0 N--CA 1.391 -3.411 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 168.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.1 134.48 17.3 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.397 1.06 . . . . 0.0 110.654 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.92 88.58 1.85 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.237 171.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.56 ' O ' HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -109.13 25.45 11.79 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 123.265 1.507 . . . . 0.0 109.542 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.529 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 20.2 p -94.28 62.11 0.01 OUTLIER Pre-proline 0 N--CA 1.409 -2.509 0 CA-C-N 112.95 -1.932 . . . . 0.0 116.205 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HB2' ' HB2' ' B' ' 26' ' ' PRO . 13.7 Cg_endo -113.48 29.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.556 0 N-CA-C 106.288 -2.235 . . . . 0.0 106.288 153.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 35.3 m -73.5 165.21 3.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.645 -176.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.09 141.42 30.03 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.086 -1.416 . . . . 0.0 113.307 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.83 -108.82 2.31 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.786 -1.097 . . . . 0.0 115.354 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -84.46 -5.94 59.33 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 124.264 1.025 . . . . 0.0 113.074 -173.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 71.2 mt-10 -77.4 161.65 27.84 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.417 ' HG3' ' OE1' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -125.33 156.5 38.59 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.71 -149.07 18.52 Favored Glycine 0 N--CA 1.407 -3.283 0 C-N-CA 118.462 -1.828 . . . . 0.0 114.417 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 25' ' ' SER . . . 140.55 -156.14 25.11 Favored Glycine 0 C--N 1.276 -2.772 0 N-CA-C 103.61 -3.796 . . . . 0.0 103.61 -171.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.0 100.07 10.27 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.168 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 165.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -131.63 146.45 61.92 Favored Pre-proline 0 C--N 1.258 -3.398 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.671 -167.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 47.6 Cg_exo -56.28 134.36 63.78 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.395 2.063 . . . . 0.0 111.203 171.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 29.4 m -125.28 159.11 32.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.479 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 32.9 m -97.89 130.26 46.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.55 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.8 mm -88.73 101.88 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.69 -20.36 5.54 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.863 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.571 ' HG3' HG23 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -54.86 158.91 2.5 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -170.2 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 19.0 p-10 -63.51 175.41 1.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.886 -1.507 . . . . 0.0 112.418 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -52.89 52.46 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.27 -1.786 . . . . 0.0 112.937 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -80.55 -24.17 39.47 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -163.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.69 -26.35 72.97 Favored Glycine 0 C--O 1.212 -1.23 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.991 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -73.96 -32.76 63.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.497 0.665 . . . . 0.0 110.162 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -85.45 -64.48 1.15 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.689 -173.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -96.5 -28.67 14.3 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -171.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.1 m -86.4 155.02 57.15 Favored Pre-proline 0 C--N 1.298 -1.659 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.149 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.496 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . 61.6 Cg_endo -98.26 17.05 0.51 Allowed 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 122.779 2.319 . . . . 0.0 111.425 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 p -130.56 145.8 51.95 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.415 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.563 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -146.2 139.28 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.588 0.555 . . . . 0.0 111.565 174.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.571 HG23 ' HG3' ' A' ' 42' ' ' GLN . 8.9 tt -82.2 133.71 28.59 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 CA-C-O 121.663 0.744 . . . . 0.0 111.392 175.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.406 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 29.9 m -135.85 162.56 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.712 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.513 ' CB ' HG23 ' A' ' 91' ' ' ILE . . . -123.48 139.23 54.23 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.05 134.78 47.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.467 HG12 HD12 ' A' ' 86' ' ' ILE . 54.9 mt -93.25 112.71 26.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.038 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.5 m -99.85 119.56 38.38 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.349 0.659 . . . . 0.0 109.747 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.13 17.62 53.66 Favored Glycine 0 C--O 1.221 -0.704 0 C-N-CA 120.581 -0.818 . . . . 0.0 114.992 -172.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -170.05 106.35 0.33 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.7 tt -166.52 168.46 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.487 ' OD1' ' HG2' ' A' ' 64' ' ' LYS . 28.4 t-20 -61.83 -68.55 0.31 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.532 1.06 . . . . 0.0 112.736 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' HG2' ' OD1' ' A' ' 63' ' ' ASN . 19.4 ptpt -167.8 -177.03 3.29 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 121.195 0.521 . . . . 0.0 110.721 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.97 77.05 1.29 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -95.33 -23.0 17.39 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.246 0.546 . . . . 0.0 111.261 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 tt -106.01 141.68 23.23 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.38 5.51 0.32 Allowed 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.436 2.757 . . . . 0.0 115.583 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.484 ' HA ' ' OG ' ' A' ' 121' ' ' SER . 68.4 p -96.77 -18.46 19.59 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 122.23 1.014 . . . . 0.0 109.137 176.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -102.03 129.91 48.46 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.3 p -124.62 137.55 56.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.252 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -92.92 148.13 22.27 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.166 0.507 . . . . 0.0 111.352 -176.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.413 ' O ' HD12 ' A' ' 73' ' ' ILE . 1.9 pp -124.6 148.15 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.816 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -90.55 108.82 20.04 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.676 0.75 . . . . 0.0 109.561 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.513 ' HD2' ' C ' ' A' ' 81' ' ' ASP . 37.6 pttt -45.06 -39.07 5.43 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 126.217 1.807 . . . . 0.0 115.217 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -45.89 -49.38 15.62 Favored 'General case' 0 C--N 1.267 -2.984 0 C-N-CA 126.131 1.772 . . . . 0.0 111.8 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -91.76 -41.21 10.81 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 118.805 -1.158 . . . . 0.0 112.266 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.495 ' HD1' ' O ' ' A' ' 105' ' ' TYR . 2.3 m-85 -110.8 -19.48 12.82 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -164.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -154.78 46.56 0.54 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 117.242 -1.783 . . . . 0.0 114.644 -167.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER 65.81 -131.66 0.22 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.432 0.693 . . . . 0.0 111.151 163.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.513 ' C ' ' HD2' ' A' ' 75' ' ' LYS . 23.6 t70 -88.57 -5.76 57.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.652 1.181 . . . . 0.0 109.437 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -106.67 116.33 31.75 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.4 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 5.0 p-10 -83.22 117.11 22.72 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.4 ' O ' HG13 ' A' ' 73' ' ' ILE . 13.2 t -113.65 157.93 21.51 Favored 'General case' 0 N--CA 1.406 -2.658 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.676 -166.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.01 139.16 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.467 HD12 HG12 ' A' ' 58' ' ' ILE . 17.3 mm -105.27 129.95 57.25 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 52.0 mt -101.24 110.56 22.59 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.42 HD12 HD11 ' A' ' 118' ' ' LEU . 3.2 mm? -84.01 -7.33 59.43 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 121.677 0.751 . . . . 0.0 111.168 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.546 ' O ' HG23 ' B' ' 93' ' ' THR . 10.4 pt-20 -84.74 -42.25 15.41 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.185 173.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.417 ' OE1' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -92.85 73.84 4.88 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.995 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.601 ' O ' ' HB ' ' B' ' 93' ' ' THR . 2.4 pp -117.58 179.73 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.91 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.459 ' NH1' HG13 ' A' ' 27' ' ' VAL 0.261 11.5 ptp180 -174.94 157.76 2.42 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 99.4 m -105.19 126.5 52.15 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.591 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.2 mt -131.36 150.13 52.27 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 124.137 0.898 . . . . 0.0 111.184 -169.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -51.52 141.56 15.72 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.707 0.629 . . . . 0.0 110.108 170.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 51' ' ' PRO . 44.4 mtmt -64.5 -18.82 65.15 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 120.981 0.42 . . . . 0.0 111.971 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -75.5 -9.64 58.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.11 0.481 . . . . 0.0 110.914 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.504 ' HA ' ' NE ' ' A' ' 98' ' ' ARG . 3.8 mmp_? -86.63 -36.5 18.77 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -73.39 121.74 20.96 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.616 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -106.05 -61.16 1.55 Allowed 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.2 pt-20 -143.1 130.6 21.16 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -168.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 22.0 ttmm -60.75 113.19 2.35 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 112.221 -2.263 . . . . 0.0 109.045 174.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.3 tp -112.97 -63.27 1.47 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.547 ' CG2' HG22 ' A' ' 19' ' ' VAL 0.273 5.7 t -120.89 -167.08 1.42 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 117.703 -1.599 . . . . 0.0 111.115 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.495 ' O ' ' HD1' ' A' ' 78' ' ' TYR . 13.8 p90 -160.29 142.93 13.28 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 123.687 0.795 . . . . 0.0 111.66 -169.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 32.3 mt -111.55 161.4 16.22 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.142 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' ' 111' ' ' MET . 30.2 p -92.63 167.14 12.11 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 123.906 0.882 . . . . 0.0 109.878 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.35 -31.41 72.52 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.458 0.647 . . . . 0.0 111.394 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.07 -38.51 79.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.858 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -70.86 -35.14 72.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -52.71 -49.21 65.81 Favored 'General case' 0 CA--C 1.483 -1.607 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.011 177.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.65 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 28.9 mtmm -50.08 -41.74 48.73 Favored 'General case' 0 CA--C 1.477 -1.836 0 O-C-N 124.319 1.012 . . . . 0.0 112.62 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -80.21 -32.17 38.58 Favored 'General case' 0 CA--C 1.443 -3.166 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -165.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.63 -55.64 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.761 0 CA-C-N 112.776 -2.011 . . . . 0.0 109.968 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 62.3 m-20 -57.46 -50.94 71.41 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 122.237 1.018 . . . . 0.0 110.495 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.65 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -61.6 -46.57 89.27 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.703 -178.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.409 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -58.76 -42.66 89.42 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.64 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 12.7 tp -65.56 -47.07 77.09 Favored 'General case' 0 N--CA 1.402 -2.874 0 C-N-CA 125.184 1.394 . . . . 0.0 110.299 -175.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.437 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.19 -29.46 57.94 Favored 'General case' 0 N--CA 1.414 -2.245 0 C-N-CA 124.832 1.253 . . . . 0.0 111.212 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 116' ' ' ASN . 40.6 mt -86.44 -54.0 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.484 ' OG ' ' HA ' ' A' ' 69' ' ' THR . 72.8 m -46.88 -33.56 4.64 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.516 -1.674 . . . . 0.0 112.757 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 21.7 mt -100.5 -0.29 38.17 Favored 'General case' 0 C--O 1.189 -2.113 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.999 -177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.51 7.78 71.69 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 119.591 -1.29 . . . . 0.0 116.295 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' A' ' 122' ' ' LEU . 4.9 mp -63.71 -50.17 70.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 122.7 1.238 . . . . 0.0 108.353 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.609 ' C ' HD21 ' A' ' 125' ' ' ASN 0.305 0.0 OUTLIER -137.89 90.8 2.52 Favored 'General case' 1 N--CA 1.362 -4.847 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 170.438 . . . . . . . . 5 4 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -138.17 7.75 2.67 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.881 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.7 t -106.01 -10.16 10.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 113.736 -1.575 . . . . 0.0 106.809 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.88 73.62 10.62 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 113.408 -1.724 . . . . 0.0 110.01 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -137.22 15.11 3.02 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -141.64 -57.07 0.48 Allowed 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.097 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -96.48 102.87 14.73 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 C--N 1.303 -1.426 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.16 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.274 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m -79.28 107.12 11.81 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.563 0.697 . . . . 0.0 109.685 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 9.3 p -98.94 145.16 27.32 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.284 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -79.65 149.62 31.21 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.104 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -78.81 93.92 5.06 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.59 0.709 . . . . 0.0 111.971 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . 0.49 ' HB3' ' CD2' ' B' ' 8' ' ' HIS . 80.8 m80 -67.48 113.15 5.1 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.929 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -94.83 96.07 9.1 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.268 0.556 . . . . 0.0 110.068 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.49 ' CD2' ' HB3' ' B' ' 6' ' ' HIS . 11.6 m-70 -126.95 -8.05 6.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.375 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 61.19 -95.5 0.05 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m 55.98 22.71 6.03 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.739 0.816 . . . . 0.0 111.805 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -87.43 81.96 7.67 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.816 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.31 126.42 92.51 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 173.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -60.34 100.36 0.15 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.155 1.903 . . . . 0.0 112.218 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.75 117.78 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.433 ' HE ' ' CG ' ' B' ' 18' ' ' ASP . 19.2 ptt180 -127.97 159.13 35.93 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' B' ' 42' ' ' GLN . 21.0 ttt85 -69.44 130.74 43.35 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.75 -20.34 10.08 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.002 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . 0.433 ' CG ' ' HE ' ' B' ' 15' ' ' ARG . 57.0 m-20 -93.74 175.47 6.72 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-O 122.272 1.034 . . . . 0.0 110.736 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.538 HG22 ' CG2' ' B' ' 104' ' ' THR . 12.7 t -128.38 135.95 61.28 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.0 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.601 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 5.9 m-85 -129.16 145.93 51.2 Favored 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 124.506 1.122 . . . . 0.0 109.061 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.4 mp -79.47 148.32 31.92 Favored 'General case' 0 N--CA 1.394 -3.254 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 167.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -150.83 134.75 16.66 Favored 'General case' 0 C--N 1.265 -3.099 0 O-C-N 124.361 1.038 . . . . 0.0 111.014 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.8 86.72 1.26 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 171.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.528 HD13 ' O ' ' B' ' 34' ' ' GLY 0.252 0.0 OUTLIER -104.81 23.73 12.99 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 123.156 1.455 . . . . 0.0 109.643 -179.62 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.538 ' HB3' ' HA2' ' B' ' 34' ' ' GLY . 3.5 p -94.54 62.58 0.01 OUTLIER Pre-proline 0 N--CA 1.405 -2.676 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.485 ' HB2' ' HB2' ' A' ' 26' ' ' PRO . 15.5 Cg_endo -113.72 27.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.574 0 N-CA-C 106.822 -2.03 . . . . 0.0 106.822 153.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 34.1 m -72.84 165.87 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.886 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.19 140.98 29.64 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.863 -1.517 . . . . 0.0 113.698 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.65 -108.38 2.19 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -79.41 -15.49 57.75 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 124.011 0.925 . . . . 0.0 112.5 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.533 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 71.6 mt-10 -69.65 165.92 20.2 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.63 130.98 49.91 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -172.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.35 -163.11 36.36 Favored Glycine 0 N--CA 1.408 -3.212 0 C-N-CA 117.735 -2.174 . . . . 0.0 115.278 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' B' ' 25' ' ' SER . . . 158.9 -162.05 32.33 Favored Glycine 0 C--N 1.266 -3.321 1 N-CA-C 102.664 -4.174 . . . . 0.0 102.664 -171.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.424 HG11 ' O ' ' B' ' 35' ' ' VAL . 3.4 p -89.42 99.85 9.94 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 166.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -132.44 147.19 64.68 Favored Pre-proline 0 C--N 1.257 -3.418 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.606 -167.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 51.3 Cg_exo -55.48 135.41 69.09 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.538 2.159 . . . . 0.0 112.034 173.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 28.2 m -126.21 158.65 35.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 123.849 0.86 . . . . 0.0 108.969 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.475 ' CG2' ' HB1' ' B' ' 56' ' ' ALA . 32.9 m -98.01 130.55 46.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.672 0.272 . . . . 0.0 110.666 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 18.6 mm -88.91 102.09 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.22 -20.38 5.53 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.897 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.543 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 0.0 OUTLIER -55.06 159.34 2.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -170.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.419 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 19.1 p-10 -62.47 178.95 0.37 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.491 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.72 -46.59 30.2 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.958 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -79.4 -26.49 41.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -166.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.27 -26.74 72.64 Favored Glycine 0 C--O 1.209 -1.461 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.25 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -73.69 -31.16 63.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.759 0.79 . . . . 0.0 110.263 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -85.08 -66.64 0.87 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.59 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -96.37 -27.55 14.89 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 43.5 m -86.07 154.15 57.56 Favored Pre-proline 0 C--N 1.295 -1.803 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.465 ' HA ' ' HE2' ' B' ' 96' ' ' LYS . 68.7 Cg_endo -98.52 15.01 0.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.643 2.229 . . . . 0.0 111.231 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.7 p -128.14 147.01 50.53 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.295 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.543 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -147.07 139.24 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 123.632 0.582 . . . . 0.0 111.254 174.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.536 HG23 ' HG3' ' B' ' 42' ' ' GLN . 8.5 tt -82.22 133.7 28.61 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 CA-C-O 121.73 0.776 . . . . 0.0 111.422 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 29.7 m -135.72 160.04 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.859 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.504 ' CB ' HG23 ' B' ' 91' ' ' ILE . . . -120.68 139.16 53.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.44 135.27 45.72 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.456 HG12 HD12 ' B' ' 86' ' ' ILE . 55.3 mt -90.97 113.74 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.457 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 41.1 m -101.03 110.05 22.03 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 121.769 0.795 . . . . 0.0 111.371 -175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.67 123.5 7.45 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 82.89 100.65 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.755 1.222 . . . . 0.0 112.581 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 tt -165.63 176.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -68.08 -66.87 0.51 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-N 120.436 1.471 . . . . 0.0 112.704 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -170.56 177.21 4.06 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.202 0.525 . . . . 0.0 110.778 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.19 77.71 1.83 Allowed 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -97.28 -20.39 17.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.95 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 tt -109.52 139.33 21.04 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.11 5.14 0.17 Allowed 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.489 2.793 . . . . 0.0 115.845 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' THR . . . . . 0.452 ' HA ' ' OG ' ' B' ' 121' ' ' SER . 64.7 p -98.75 -18.62 17.9 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 122.16 0.981 . . . . 0.0 109.238 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -103.5 129.56 50.7 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.91 135.38 64.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.377 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.67 143.98 26.36 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-O 121.347 0.594 . . . . 0.0 111.642 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.414 ' O ' HD12 ' B' ' 73' ' ' ILE . 2.0 pp -119.26 150.76 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.002 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -94.85 109.66 21.62 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.769 0.795 . . . . 0.0 110.565 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . 0.483 ' HD2' ' C ' ' B' ' 81' ' ' ASP . 38.6 pttt -43.67 -42.0 5.05 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.528 1.931 . . . . 0.0 115.252 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -46.0 -46.94 16.79 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 126.456 1.902 . . . . 0.0 111.736 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -92.19 -42.92 9.62 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.074 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.561 ' HD1' ' O ' ' B' ' 105' ' ' TYR . 7.1 m-85 -111.82 -18.3 12.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -164.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -156.09 47.84 0.48 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 117.756 -1.578 . . . . 0.0 114.478 -167.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' B' ' 75' ' ' LYS . 0.0 OUTLIER 63.68 -133.73 0.37 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.962 0.905 . . . . 0.0 111.203 164.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.483 ' C ' ' HD2' ' B' ' 75' ' ' LYS . 12.7 t70 -86.08 -6.71 58.97 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 125.08 1.352 . . . . 0.0 110.057 175.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -105.47 114.95 29.43 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 119.383 -0.927 . . . . 0.0 113.349 -174.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.11 117.34 20.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.4 ' O ' HG13 ' B' ' 73' ' ' ILE . 14.7 t -114.11 158.26 21.51 Favored 'General case' 0 N--CA 1.407 -2.624 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.579 -168.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 t -116.57 139.73 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.456 HD12 HG12 ' B' ' 58' ' ' ILE . 18.7 mm -104.96 129.98 56.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.27 110.32 22.55 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' B' ' 117' ' ' ALA . 3.2 mm? -84.02 -6.76 59.47 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.637 0.732 . . . . 0.0 111.013 -175.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . 0.557 ' O ' HG23 ' A' ' 93' ' ' THR . 10.5 pt-20 -86.99 -39.64 15.49 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.631 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 73.93 3.75 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.927 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.602 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.4 pp -117.76 179.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.949 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.462 ' NH1' HG13 ' B' ' 27' ' ' VAL 0.254 12.1 ptp180 -174.98 157.42 2.34 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 172.179 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 97.2 m -105.09 126.87 52.54 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.622 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 49.1 mt -131.28 150.18 52.25 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 124.246 0.966 . . . . 0.0 111.143 -169.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -50.65 140.01 15.22 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.23 0.612 . . . . 0.0 109.764 170.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' B' ' 51' ' ' PRO . 43.1 mtmt -61.45 -23.02 65.56 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 122.68 0.392 . . . . 0.0 111.622 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -70.3 -17.95 63.09 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.431 ' NE ' ' HA ' ' B' ' 98' ' ' ARG . 4.5 mmp_? -80.38 -33.32 37.27 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.827 -0.546 . . . . 0.0 109.937 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.8 mp -74.89 117.43 16.73 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.966 0.889 . . . . 0.0 109.759 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -100.64 -59.35 1.72 Allowed 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -147.28 133.95 19.94 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -170.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 21.6 ttmm -60.76 114.29 2.95 Favored 'General case' 0 C--N 1.284 -2.253 0 C-N-CA 127.458 2.303 . . . . 0.0 108.778 174.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 tp -112.78 -62.89 1.52 Allowed 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.538 ' CG2' HG22 ' B' ' 19' ' ' VAL . 5.0 t -122.1 -167.12 1.5 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.119 -1.432 . . . . 0.0 111.022 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.561 ' O ' ' HD1' ' B' ' 78' ' ' TYR . 15.7 p90 -160.21 141.3 12.24 Favored 'General case' 0 CA--C 1.488 -1.428 0 C-N-CA 123.818 0.847 . . . . 0.0 111.359 -170.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.483 ' HA ' ' CD1' ' B' ' 78' ' ' TYR . 32.1 mt -107.23 168.18 9.4 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 124.305 1.003 . . . . 0.0 108.872 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.469 ' O ' ' HG2' ' B' ' 111' ' ' MET . 39.6 p -95.69 167.62 11.17 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.151 0.58 . . . . 0.0 109.6 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -67.4 -29.7 69.28 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.897 0.856 . . . . 0.0 109.913 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.16 -39.9 78.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.231 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -71.42 -32.58 68.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' B' ' 107' ' ' SER . 0.5 OUTLIER -53.99 -48.77 70.06 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.836 177.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.704 ' O ' ' HB3' ' B' ' 116' ' ' ASN 0.271 20.1 mtmm -49.27 -43.23 42.84 Favored 'General case' 0 CA--C 1.467 -2.236 0 O-C-N 124.583 1.177 . . . . 0.0 111.96 175.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -79.44 -33.5 42.44 Favored 'General case' 0 CA--C 1.446 -3.037 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -163.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.18 -53.37 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.644 0 CA-C-N 112.548 -2.115 . . . . 0.0 110.263 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 69.3 m-20 -58.63 -52.14 66.94 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 122.437 1.113 . . . . 0.0 110.219 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.704 ' HB3' ' O ' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -67.9 -30.51 69.87 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.394 -175.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.402 ' HB2' ' HG ' ' B' ' 88' ' ' LEU . . . -71.64 -45.52 61.77 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.649 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 11.0 tp -60.03 -47.38 86.1 Favored 'General case' 0 N--CA 1.4 -2.97 0 C-N-CA 125.78 1.632 . . . . 0.0 110.416 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.43 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 0.1 OUTLIER -54.14 -33.08 57.02 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 124.567 1.147 . . . . 0.0 111.303 178.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.415 HG13 ' O ' ' B' ' 116' ' ' ASN . 56.5 mt -82.79 -53.35 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' B' ' 69' ' ' THR . 44.2 m -47.55 -33.07 6.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.724 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 20.3 mt -100.3 -1.63 35.75 Favored 'General case' 0 C--O 1.189 -2.089 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.975 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.73 8.28 70.18 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 173.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.466 ' CD1' ' HB2' ' B' ' 122' ' ' LEU . 4.9 mp -63.58 -48.08 78.89 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.693 1.235 . . . . 0.0 108.683 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.616 ' C ' HD21 ' B' ' 125' ' ' ASN 0.292 0.0 OUTLIER -139.4 92.19 2.56 Favored 'General case' 1 N--CA 1.366 -4.65 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 170.127 . . . . . . . . 5 4 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.7 10.79 2.25 Favored 'General case' 0 C--N 1.27 -2.858 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.823 175.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.37 -8.54 11.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 113.588 -1.642 . . . . 0.0 106.724 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.13 68.72 10.63 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 113.659 -1.609 . . . . 0.0 110.502 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -127.37 2.88 6.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.835 173.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -128.45 -59.44 1.15 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.822 -1.535 . . . . 0.0 107.431 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.1 102.15 14.68 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.0 m120 . . . . . 0 C--N 1.295 -1.8 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.151 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -153.82 123.33 6.64 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.0 t -137.0 110.92 8.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -82.05 118.35 22.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -102.85 114.76 29.3 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -65.27 130.74 44.42 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.409 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 26.0 m80 -75.17 -11.03 59.99 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.622 -173.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 60.29 60.1 2.13 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 122.872 1.32 . . . . 0.0 107.463 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.409 ' CD2' ' HB2' ' A' ' 7' ' ' HIS . 4.7 p80 -116.38 11.33 14.94 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.124 -175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -88.78 96.29 10.62 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.146 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -92.99 80.62 4.58 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.774 0.797 . . . . 0.0 109.092 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -74.93 132.05 78.0 Favored Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.104 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.47 160.99 40.2 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.999 2.466 . . . . 0.0 112.322 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.65 130.27 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.291 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -115.6 138.49 51.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 13.8 ptm180 -61.76 134.96 57.39 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.632 170.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.32 -12.81 36.71 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.811 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.79 166.71 22.6 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.512 1.149 . . . . 0.0 110.984 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.49 ' CG1' ' HB2' ' A' ' 103' ' ' LEU . 42.6 t -130.68 122.7 53.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.949 0 CA-C-N 112.71 -2.041 . . . . 0.0 108.994 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 88.3 m-85 -129.13 147.66 51.0 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 125.872 1.669 . . . . 0.0 110.571 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.3 mp -77.04 148.21 36.31 Favored 'General case' 0 N--CA 1.395 -3.181 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 167.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -139.97 146.6 39.33 Favored 'General case' 0 C--N 1.252 -3.662 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.904 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.551 ' O ' ' HD2' ' A' ' 98' ' ' ARG . 35.1 t70 -84.29 72.29 10.57 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 173.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.495 HD22 ' HA3' ' A' ' 33' ' ' GLY . 3.2 tt -76.79 -36.78 56.74 Favored 'General case' 0 N--CA 1.384 -3.756 0 CA-C-N 111.789 -2.459 . . . . 0.0 110.413 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.567 ' CB ' ' H ' ' A' ' 34' ' ' GLY . 71.4 m -118.5 114.75 36.03 Favored Pre-proline 0 N--CA 1.398 -3.063 1 N-CA-C 121.812 4.005 . . . . 0.0 121.812 -168.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -106.78 27.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.419 -2.902 0 C-N-CA 123.616 2.878 . . . . 0.0 106.015 152.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.579 ' C ' HE21 ' A' ' 28' ' ' GLN . 26.7 m -88.48 158.42 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 122.191 0.996 . . . . 0.0 112.816 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.716 HE21 ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -152.29 155.83 38.45 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 113.03 -1.895 . . . . 0.0 107.498 175.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.54 -130.93 10.42 Favored Glycine 0 N--CA 1.416 -2.696 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' B' ' 95' ' ' ASP . 4.7 m -93.92 -7.83 41.91 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.794 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.522 ' HG2' HH12 ' B' ' 92' ' ' ARG . 1.7 mp0 -70.87 155.98 40.14 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.624 -0.831 . . . . 0.0 110.264 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -133.75 120.63 20.79 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -171.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.495 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -155.75 -94.23 0.1 Allowed Glycine 1 N--CA 1.392 -4.292 0 C-N-CA 119.001 -1.571 . . . . 0.0 113.677 172.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.567 ' H ' ' CB ' ' A' ' 25' ' ' SER . . . 79.41 172.81 43.62 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -171.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 4.2 p -75.42 102.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 172.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -144.89 155.23 55.78 Favored Pre-proline 0 C--N 1.263 -3.177 0 CA-C-N 113.48 -1.691 . . . . 0.0 107.983 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 24.5 Cg_exo -66.39 139.33 53.93 Favored 'Trans proline' 0 C--O 1.247 0.964 0 C-N-CA 122.169 1.912 . . . . 0.0 112.803 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.1 m -127.49 163.36 30.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.123 0.969 . . . . 0.0 109.817 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.37 134.31 48.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.329 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -89.38 108.99 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -105.34 -8.07 9.95 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.701 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.64 -178.019 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.443 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -62.89 169.1 3.44 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -170.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -65.18 175.44 1.64 Allowed 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.923 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.64 -49.66 37.9 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.328 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 m -86.88 -21.3 26.42 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -169.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.16 -37.02 53.76 Favored Glycine 0 C--O 1.196 -2.273 0 CA-C-N 117.9 0.318 . . . . 0.0 112.682 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -63.62 -19.38 64.81 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -82.56 -63.82 1.3 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.039 0.536 . . . . 0.0 110.128 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -83.28 -35.36 25.35 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -172.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.1 m -83.03 136.52 43.87 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.45 -18.53 17.71 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 N-CA-C 108.34 -1.446 . . . . 0.0 108.34 170.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 11.4 p -91.4 150.67 21.16 Favored 'General case' 0 N--CA 1.415 -2.199 0 C-N-CA 125.201 1.4 . . . . 0.0 111.941 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.1 t -133.39 140.11 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 173.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.1 tt -110.23 128.7 66.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 CA-C-O 121.183 0.516 . . . . 0.0 109.929 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.499 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 32.7 m -132.39 173.18 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.941 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.423 ' CB ' HG21 ' A' ' 91' ' ' ILE . . . -128.41 143.68 51.03 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.02 132.77 41.58 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.3 mt -89.05 119.09 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.372 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.9 m -121.53 116.47 24.73 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 121.317 0.58 . . . . 0.0 110.834 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.425 ' HA3' ' HD2' ' A' ' 82' ' ' LYS . . . -97.2 171.17 26.63 Favored Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 173.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 76.88 -44.55 0.47 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.536 1.135 . . . . 0.0 112.51 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.8 mt -91.37 82.46 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.467 ' HA ' HG22 ' A' ' 85' ' ' VAL . 47.3 t-20 -100.49 94.89 6.38 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.66 0.743 . . . . 0.0 110.099 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -141.63 89.71 2.23 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.595 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.09 -145.03 0.39 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 76.72 12.35 2.45 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 122.471 1.129 . . . . 0.0 109.887 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.0 tt -128.31 132.09 24.15 Favored Pre-proline 0 C--N 1.293 -1.868 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.28 -4.22 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.64 2.894 . . . . 0.0 116.546 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.9 p -101.97 -18.84 15.48 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.913 -0.492 . . . . 0.0 111.039 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -112.24 128.92 56.39 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -117.09 133.0 65.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.727 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.1 128.57 53.41 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.288 0.566 . . . . 0.0 110.559 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.504 HG21 ' CZ ' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -124.81 154.88 32.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 123.585 0.754 . . . . 0.0 112.046 -176.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.78 141.0 53.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.764 0.792 . . . . 0.0 112.246 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -60.85 -34.58 74.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.358 -1.746 . . . . 0.0 109.2 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -55.27 -53.07 60.78 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.479 -1.691 . . . . 0.0 114.395 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -88.52 -35.83 16.75 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.094 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.504 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 6.6 m-85 -78.35 -5.15 51.36 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.727 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt 50.44 36.62 13.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.698 1.999 . . . . 0.0 115.183 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 78' ' ' TYR . 8.8 mp -87.21 -176.78 5.8 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 122.106 0.955 . . . . 0.0 110.892 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.34 -7.34 48.15 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.82 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' HD2' ' HA3' ' A' ' 60' ' ' GLY . 10.2 ptpp? -153.52 164.23 38.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -56.66 147.5 22.43 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.228 0.537 . . . . 0.0 111.001 173.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.3 m -108.09 132.51 53.5 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.744 -172.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 63' ' ' ASN . 8.3 t -118.44 124.45 73.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.417 HG22 HD22 ' A' ' 88' ' ' LEU . 1.7 mp -110.71 127.57 67.68 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.013 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.7 mt -99.91 103.64 15.23 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.241 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.417 HD22 HG22 ' A' ' 86' ' ' ILE . 3.3 mm? -86.11 70.89 10.62 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -176.83 -48.54 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.47 84.79 4.77 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 55' ' ' VAL . 2.0 pp -121.11 179.12 2.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.07 -175.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.506 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 12.1 tpt85 -152.31 146.79 25.66 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.7 m -115.5 120.11 38.43 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.506 ' HG ' ' HG3' ' A' ' 92' ' ' ARG . 29.4 mt -130.99 143.99 51.14 Favored 'General case' 0 C--O 1.198 -1.606 0 C-N-CA 125.235 1.414 . . . . 0.0 110.343 -171.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' B' ' 30' ' ' SER . 0.2 OUTLIER -77.03 152.4 35.14 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 117.075 -1.85 . . . . 0.0 110.957 170.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -42.31 -27.12 0.13 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 126.551 1.94 . . . . 0.0 115.767 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 9.5 ptpp? -71.25 -21.93 62.04 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 118.736 0.698 . . . . 0.0 111.465 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 36.2 mmt180 -68.35 -33.77 74.88 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.773 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.63 115.75 10.14 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 124.436 1.094 . . . . 0.0 110.939 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -96.89 -63.83 1.1 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.183 -1.372 . . . . 0.0 114.213 -174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.6 pt-20 -156.05 143.77 19.52 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-O 121.939 0.876 . . . . 0.0 111.665 -172.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttmm -66.82 123.61 20.62 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 112.468 -2.151 . . . . 0.0 111.558 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.49 ' HB2' ' CG1' ' A' ' 19' ' ' VAL . 3.8 mm? -93.43 -62.82 1.29 Allowed 'General case' 0 CA--C 1.472 -2.042 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.447 HG23 ' HA ' ' A' ' 78' ' ' TYR . 7.2 t -150.87 -155.66 0.64 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.038 -1.892 . . . . 0.0 111.678 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -161.37 148.3 14.69 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.974 1.71 . . . . 0.0 109.538 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.34 153.0 39.56 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.766 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.3 p -83.71 161.2 21.11 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.12 -40.38 95.72 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.036 0.922 . . . . 0.0 110.981 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.54 -16.3 62.37 Favored 'General case' 0 C--O 1.194 -1.829 0 C-N-CA 125.107 1.363 . . . . 0.0 111.282 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.449 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 67.1 mttm -91.33 -36.65 13.73 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 120.468 -1.395 . . . . 0.0 109.898 168.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.411 ' HG2' ' OD2' ' A' ' 115' ' ' ASP 0.327 38.5 ttm -64.4 -26.04 68.29 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -177.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.656 ' NZ ' ' HG3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -57.87 -14.5 6.21 Favored 'General case' 0 C--N 1.248 -3.818 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 173.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.656 ' HG3' ' NZ ' ' A' ' 112' ' ' LYS . 42.8 mt-10 -87.65 -54.44 4.26 Favored 'General case' 1 C--O 1.148 -4.254 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 171.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 t -47.05 -52.34 4.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-N 113.862 -1.517 . . . . 0.0 114.176 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.545 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 22.4 m-20 -66.05 -45.4 81.5 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 123.536 1.636 . . . . 0.0 110.838 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 112' ' ' LYS 0.256 9.3 t30 -73.83 -39.84 63.76 Favored 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 112.937 -1.938 . . . . 0.0 113.037 -171.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.4 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -58.6 -39.05 79.32 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 125.447 1.499 . . . . 0.0 108.077 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.545 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 8.8 tp -70.06 -38.12 75.71 Favored 'General case' 1 N--CA 1.373 -4.286 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.964 -175.184 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 47.7 mtp -68.51 -19.59 64.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.891 -0.505 . . . . 0.0 111.31 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.5 mt -82.22 -59.15 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.1 m -48.15 -47.69 34.67 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 125.067 1.479 . . . . 0.0 111.975 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.19 -0.39 57.04 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.84 19.11 73.1 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.0 mp -70.52 -50.29 39.26 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 118.571 1.186 . . . . 0.0 108.508 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 37.64 -136.45 0.06 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.162 -1.835 . . . . 0.0 109.613 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.29 16.26 10.6 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.988 0.899 . . . . 0.0 108.702 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.6 t -128.93 -32.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.577 -171.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 61.82 -78.99 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 125.755 1.622 . . . . 0.0 112.559 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -102.37 117.84 35.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.885 0.374 . . . . 0.0 110.018 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -88.46 104.46 16.82 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 69.64 99.26 0.06 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.129 0.966 . . . . 0.0 111.774 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.497 ' C ' HD21 ' A' ' 132' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.391 -3.395 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.319 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t -145.8 113.36 6.33 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 33.9 t -130.13 111.35 12.37 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -74.69 121.9 22.4 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.739 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -104.03 117.8 35.15 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -69.83 128.26 35.78 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -73.61 -11.98 60.6 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.855 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 62.86 45.46 5.59 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 123.168 1.461 . . . . 0.0 108.496 -175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -100.27 14.18 31.83 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.729 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -87.75 94.46 9.75 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.841 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -94.11 87.47 5.31 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -85.48 138.21 36.19 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.557 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.47 171.17 13.43 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.072 1.848 . . . . 0.0 112.232 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 69.2 mt -67.05 133.0 32.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -115.9 137.98 51.6 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.441 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 13.9 ptm180 -63.12 128.89 37.93 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.144 -1.023 . . . . 0.0 109.008 171.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.17 -11.94 26.58 Favored Glycine 0 N--CA 1.426 -2.017 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.458 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -76.42 166.99 22.65 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 122.544 1.164 . . . . 0.0 110.836 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.487 ' CG1' ' HB2' ' B' ' 103' ' ' LEU . 40.9 t -130.92 124.25 55.84 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.066 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.757 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 96.1 m-85 -131.0 148.3 52.74 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 125.79 1.636 . . . . 0.0 110.015 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 1.3 mp -77.13 147.59 36.48 Favored 'General case' 0 N--CA 1.395 -3.207 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 167.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -140.82 145.42 36.26 Favored 'General case' 0 C--N 1.248 -3.82 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.161 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.603 ' O ' ' HD2' ' B' ' 98' ' ' ARG . 35.7 t70 -85.28 78.14 9.85 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 172.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.531 ' HB3' ' O ' ' B' ' 34' ' ' GLY . 3.4 tt -79.34 -35.22 41.36 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 111.796 -2.456 . . . . 0.0 110.155 -167.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.579 ' CB ' ' H ' ' B' ' 34' ' ' GLY . 73.3 m -118.25 113.64 37.06 Favored Pre-proline 0 N--CA 1.405 -2.692 1 N-CA-C 122.231 4.16 . . . . 0.0 122.231 -168.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -103.95 24.14 0.11 Allowed 'Trans proline' 0 N--CA 1.418 -2.964 0 C-N-CA 123.056 2.504 . . . . 0.0 106.38 152.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' B' ' 25' ' ' SER . 19.3 m -85.82 165.02 2.32 Favored 'Isoleucine or valine' 0 C--N 1.373 1.624 0 CA-C-O 121.899 0.857 . . . . 0.0 112.337 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.93 159.13 34.56 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 113.187 -1.824 . . . . 0.0 106.77 174.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.96 -135.8 12.63 Favored Glycine 0 N--CA 1.421 -2.351 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 5.4 m -93.68 -0.6 55.98 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.797 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.465 ' HG2' HH12 ' A' ' 92' ' ' ARG . 1.4 mp0 -73.07 159.98 32.74 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.793 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -136.95 119.08 15.46 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -155.88 -95.16 0.11 Allowed Glycine 0 N--CA 1.4 -3.707 0 C-N-CA 118.928 -1.606 . . . . 0.0 114.095 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.579 ' H ' ' CB ' ' B' ' 25' ' ' SER . . . 80.27 -177.94 54.1 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -171.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 3.5 p -83.27 99.91 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 CA-C-O 123.586 1.66 . . . . 0.0 107.175 172.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -140.66 154.03 68.63 Favored Pre-proline 0 C--N 1.257 -3.428 0 CA-C-N 113.023 -1.899 . . . . 0.0 108.149 -168.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 25.9 Cg_exo -66.11 138.56 52.43 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 122.239 1.959 . . . . 0.0 112.504 174.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.2 163.06 28.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 123.931 0.893 . . . . 0.0 109.902 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.85 134.1 48.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.364 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 27.2 mm -89.29 109.98 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.426 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -105.59 -8.22 10.05 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.734 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.534 -178.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.473 ' OE1' HG11 ' B' ' 53' ' ' VAL . 5.4 pt20 -64.22 169.61 4.4 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -169.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -65.08 173.37 2.45 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.458 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.95 -46.35 52.9 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.623 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 8.5 m -87.79 -21.59 25.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.58 -35.82 57.69 Favored Glycine 0 C--O 1.195 -2.288 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -64.77 -19.05 65.6 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -81.91 -62.11 1.73 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 122.928 0.491 . . . . 0.0 109.701 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -83.94 -34.57 24.42 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 46.5 m -85.98 141.09 35.21 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -77.07 -19.84 13.41 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 121.222 1.281 . . . . 0.0 108.78 170.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 5.3 p -90.4 150.56 21.81 Favored 'General case' 0 N--CA 1.413 -2.298 0 C-N-CA 124.818 1.247 . . . . 0.0 112.111 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.473 HG11 ' OE1' ' B' ' 42' ' ' GLN . 94.4 t -132.28 140.06 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 tt -111.08 126.48 68.48 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-O 121.294 0.569 . . . . 0.0 110.012 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.492 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 27.1 m -131.21 173.23 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.034 -174.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.424 ' CB ' HG21 ' B' ' 91' ' ' ILE . . . -128.21 143.91 51.08 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.67 134.95 40.44 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 62.7 mt -90.75 122.39 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 113.056 -1.883 . . . . 0.0 106.727 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 98.3 m -123.51 117.04 24.2 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.461 0.648 . . . . 0.0 110.666 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.53 168.97 23.14 Favored Glycine 0 N--CA 1.412 -2.915 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 173.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 78.27 -35.57 0.19 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.006 1.322 . . . . 0.0 112.525 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 64.0 mt -98.99 81.25 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . 0.457 ' HA ' HG22 ' B' ' 85' ' ' VAL . 24.4 t-20 -95.34 96.63 9.27 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -146.2 85.38 1.67 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.99 -144.78 0.37 Allowed 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.716 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 75.38 16.35 2.67 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 122.536 1.16 . . . . 0.0 109.554 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tt -134.29 132.11 20.91 Favored Pre-proline 0 N--CA 1.421 -1.879 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.72 -18.35 12.04 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.759 2.972 . . . . 0.0 116.47 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 77.4 p -91.53 -19.13 23.1 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.079 0.399 . . . . 0.0 111.664 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -109.97 128.81 55.61 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.37 132.01 68.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.813 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.89 130.83 54.5 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.313 0.577 . . . . 0.0 110.275 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.5 HG21 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -125.24 154.64 33.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.634 -176.172 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.47 136.47 53.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.557 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -57.4 -34.22 68.65 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.385 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -55.78 -53.25 58.98 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.589 -1.641 . . . . 0.0 113.942 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -89.68 -31.86 17.3 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.052 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.5 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 6.2 m-85 -81.02 -5.68 57.89 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.735 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt 50.14 38.0 15.95 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.697 1.999 . . . . 0.0 115.151 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.428 HD12 ' O ' ' B' ' 78' ' ' TYR . 9.2 mp -88.93 -178.09 5.64 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.567 1.175 . . . . 0.0 111.032 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.84 -4.78 56.33 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.503 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -156.41 165.02 37.56 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -54.27 152.04 6.72 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.192 0.52 . . . . 0.0 110.953 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 15.9 m -111.51 131.42 55.24 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.167 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' B' ' 63' ' ' ASN . 8.0 t -117.79 124.33 72.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.409 HG22 HD22 ' B' ' 88' ' ' LEU . 1.6 mp -110.74 126.59 68.09 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 56.0 mt -98.47 102.22 13.89 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.215 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.412 ' HG ' ' HB1' ' B' ' 117' ' ' ALA . 3.6 mm? -83.95 72.06 10.46 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.753 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -178.39 -48.57 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.44 85.54 5.38 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 2.0 pp -122.19 179.05 2.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.153 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.522 HH12 ' HG2' ' A' ' 31' ' ' GLU . 12.2 tpt85 -152.41 146.76 25.57 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 86.0 m -115.92 119.49 36.1 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.51 ' HG ' ' HG3' ' B' ' 92' ' ' ARG . 22.7 mt -130.95 143.55 50.81 Favored 'General case' 0 C--O 1.196 -1.751 0 C-N-CA 125.352 1.461 . . . . 0.0 110.397 -171.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 0.3 OUTLIER -76.79 152.38 35.58 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.661 170.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -41.91 -27.51 0.12 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.416 1.886 . . . . 0.0 115.549 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -69.38 -21.84 63.76 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.697 0.681 . . . . 0.0 111.589 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.603 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 37.7 mmt180 -69.85 -35.68 74.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.105 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.19 114.47 8.37 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 124.113 0.965 . . . . 0.0 110.735 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -94.96 -65.75 0.96 Allowed 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.087 -1.415 . . . . 0.0 114.164 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.2 pt-20 -154.92 139.47 16.92 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 121.742 0.782 . . . . 0.0 111.837 -169.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 22.4 ttmm -64.56 121.28 14.07 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 127.595 2.358 . . . . 0.0 111.628 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.487 ' HB2' ' CG1' ' B' ' 19' ' ' VAL . 3.8 mm? -91.91 -63.04 1.3 Allowed 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' THR . . . . . . . . . . . . . 7.2 t -149.13 -156.27 0.71 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.827 -174.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -161.54 145.94 13.1 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 125.949 1.7 . . . . 0.0 109.886 -170.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.17 148.93 44.33 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.294 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.5 p -81.76 158.32 24.19 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.179 -0.918 . . . . 0.0 113.075 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -57.26 -42.36 81.4 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.621 1.168 . . . . 0.0 112.034 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.09 -16.51 64.0 Favored 'General case' 0 C--O 1.178 -2.681 0 C-N-CA 124.71 1.204 . . . . 0.0 111.366 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.45 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 66.3 mttm -90.63 -33.68 15.75 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.525 -1.359 . . . . 0.0 109.563 169.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.465 ' HE1' ' HB2' ' B' ' 111' ' ' MET 0.307 34.7 ttm -65.06 -25.16 67.69 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.666 ' HE3' ' N ' ' B' ' 113' ' ' GLU . 0.0 OUTLIER -58.87 -13.8 7.26 Favored 'General case' 0 C--N 1.248 -3.826 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 174.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . 0.666 ' N ' ' HE3' ' B' ' 112' ' ' LYS . 43.8 mt-10 -87.22 -54.47 4.29 Favored 'General case' 0 CA--C 1.429 -3.703 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 172.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 t -47.17 -52.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.01 -1.904 . . . . 0.0 113.93 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 16.7 m-20 -64.21 -48.48 75.73 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 123.331 1.539 . . . . 0.0 111.145 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.43 ' O ' HG13 ' B' ' 120' ' ' ILE 0.316 9.0 t30 -72.03 -39.09 69.37 Favored 'General case' 0 C--N 1.268 -2.953 0 C-N-CA 126.77 2.028 . . . . 0.0 112.795 -170.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.412 ' HB1' ' HG ' ' B' ' 88' ' ' LEU . . . -62.23 -37.97 87.45 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 124.284 1.033 . . . . 0.0 108.565 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.9 tp -69.18 -36.48 77.38 Favored 'General case' 1 N--CA 1.366 -4.627 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.682 -176.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 46.5 mtp -69.28 -19.71 63.91 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 121.997 -0.439 . . . . 0.0 110.932 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.43 HG13 ' O ' ' B' ' 116' ' ' ASN . 52.1 mt -81.88 -58.39 3.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.2 m -52.18 -44.55 64.73 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.263 0.977 . . . . 0.0 111.433 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 7.2 mp -86.72 -1.82 58.04 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.8 17.5 71.36 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 116.696 1.439 . . . . 0.0 116.696 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 6.8 mp -68.58 -49.23 61.01 Favored 'General case' 0 CA--C 1.474 -1.975 0 CA-C-N 118.735 1.267 . . . . 0.0 108.042 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 38.25 -134.79 0.1 Allowed 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.008 -1.906 . . . . 0.0 110.196 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -124.95 19.28 8.45 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.04 0.924 . . . . 0.0 108.689 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 45.5 t -134.28 -36.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.949 -173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 66.33 -78.16 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 125.989 1.716 . . . . 0.0 111.896 -174.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -98.99 117.32 33.24 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 122.212 -0.305 . . . . 0.0 110.684 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -85.19 104.55 15.17 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 66.81 93.81 0.07 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.205 0.941 . . . . 0.0 112.652 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.398 -3.033 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 179.313 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.296 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m -65.86 -38.53 89.06 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 p -104.34 159.62 15.57 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.839 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -98.96 155.64 17.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.861 0.362 . . . . 0.0 110.172 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.432 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 11.5 p80 -110.55 80.7 1.33 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.886 0.851 . . . . 0.0 112.685 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -94.86 -54.29 3.52 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -107.98 3.94 24.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.418 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.432 ' O ' ' HB2' ' A' ' 5' ' ' HIS . 39.8 m80 -94.62 111.89 23.65 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -118.81 77.65 1.2 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.163 0.506 . . . . 0.0 110.557 -177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 m -86.31 -37.99 17.95 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -104.33 96.77 6.85 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -87.84 161.77 43.41 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.7 152.52 34.27 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.607 2.205 . . . . 0.0 111.341 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.6 mt -84.31 131.47 33.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -102.3 129.4 48.73 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.58 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 1.1 ptm180 -61.99 118.08 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 128.07 -10.67 6.59 Favored Glycine 0 C--N 1.295 -1.719 0 C-N-CA 120.063 -1.065 . . . . 0.0 111.125 -172.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.427 ' CG ' ' HZ2' ' A' ' 102' ' ' LYS . 4.0 m-20 -92.72 175.33 6.85 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 122.574 1.178 . . . . 0.0 110.988 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.525 HG22 HG23 ' A' ' 104' ' ' THR . 10.8 t -133.39 134.72 56.92 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.936 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.596 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 27.6 m-85 -133.22 147.82 52.0 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 124.988 1.315 . . . . 0.0 108.11 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mp -81.01 150.69 28.77 Favored 'General case' 0 N--CA 1.408 -2.546 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.053 170.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.26 138.34 49.26 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.2 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.408 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 20.7 t70 -79.94 90.38 5.34 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.966 0.888 . . . . 0.0 109.777 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.603 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 14.9 mt -100.1 19.37 16.49 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 124.055 1.883 . . . . 0.0 109.591 -176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.49 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.266 15.0 m -61.94 167.55 4.66 Favored Pre-proline 1 C--N 1.229 -4.656 0 CA-C-N 111.41 -2.632 . . . . 0.0 108.295 169.84 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.2 OUTLIER 9.6 50.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.397 3.092 1 C-N-CA 127.367 5.378 . . . . 0.0 118.011 -175.03 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.9 m -68.74 -178.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 113.764 -1.562 . . . . 0.0 111.887 170.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 13.6 mm100 -107.44 132.14 53.52 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.565 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.74 -135.66 35.64 Favored Glycine 0 N--CA 1.425 -2.09 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.853 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -91.77 20.35 5.67 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.87 -0.665 . . . . 0.0 111.088 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 0.1 OUTLIER -65.57 152.41 44.15 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 175.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.15 110.31 13.02 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.769 -0.582 . . . . 0.0 110.786 -167.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -86.52 129.18 9.27 Favored Glycine 0 CA--C 1.49 -1.529 0 N-CA-C 116.244 1.257 . . . . 0.0 116.244 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 131.41 137.06 3.99 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 113.427 -1.387 . . . . 0.0 110.076 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.91 119.37 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 CA-C-O 122.248 1.023 . . . . 0.0 109.775 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -142.53 158.02 61.2 Favored Pre-proline 0 C--N 1.271 -2.838 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.697 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 4.6 Cg_exo -72.15 142.2 37.54 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 121.971 1.781 . . . . 0.0 111.386 174.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 20' ' ' TYR . 31.6 m -118.07 156.83 19.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.553 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.493 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 36.0 m -97.91 126.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.337 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.5 mm -87.2 103.92 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.415 HD11 ' C ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -100.7 -18.94 6.14 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.524 177.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.629 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -56.07 157.99 4.24 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -173.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 28.5 p-10 -71.19 -167.48 0.23 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.807 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -89.55 -38.69 13.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.841 -175.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.1 m -83.78 -28.22 28.3 Favored 'General case' 0 C--O 1.249 1.074 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.718 -170.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.88 -38.77 97.1 Favored Glycine 0 C--O 1.206 -1.647 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.511 ' N ' HE22 ' A' ' 42' ' ' GLN . 9.7 p30 -83.67 -20.72 33.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.237 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 4.2 mptp? -76.02 -65.24 0.94 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.811 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.527 ' CD1' ' HB3' ' A' ' 48' ' ' LYS . 85.9 m-85 -99.02 -28.2 13.51 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -171.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.5 m -93.07 154.68 41.66 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.52 -18.92 10.48 Favored 'Trans proline' 0 C--O 1.21 -0.913 0 C-N-CA 121.69 1.593 . . . . 0.0 111.603 175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 p -91.93 146.27 23.88 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.253 1.021 . . . . 0.0 113.081 -173.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.629 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -142.0 139.0 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.384 0.428 . . . . 0.0 110.491 172.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.487 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -88.43 130.25 38.26 Favored 'Isoleucine or valine' 0 C--O 1.249 1.071 0 CA-C-O 121.799 0.809 . . . . 0.0 110.334 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.37 167.55 24.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.397 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.493 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -123.5 146.43 48.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.91 136.31 36.62 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.473 HD13 ' HB2' ' A' ' 37' ' ' PRO . 19.2 mt -87.3 130.66 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.708 172.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.9 m -122.29 157.44 31.73 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.24 -174.51 10.87 Favored Glycine 0 C--O 1.241 0.563 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.078 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -74.62 88.5 2.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.931 0.872 . . . . 0.0 110.259 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.3 pt -91.46 173.15 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.104 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.508 ' OD1' ' HG3' ' A' ' 64' ' ' LYS . 9.1 p30 -104.78 165.11 11.29 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.508 ' HG3' ' OD1' ' A' ' 63' ' ' ASN . 63.0 mttp 73.74 94.34 0.07 Allowed 'General case' 0 C--O 1.248 0.987 0 C-N-CA 124.377 1.071 . . . . 0.0 112.948 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.45 102.59 5.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -71.31 -23.89 62.02 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.451 ' C ' ' H ' ' A' ' 69' ' ' THR 0.619 23.5 mm 109.84 -58.84 0.0 OUTLIER Pre-proline 0 CA--C 1.508 -0.651 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 172.016 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.36 1.94 1.09 Allowed 'Trans proline' 0 C--O 1.219 -0.433 0 CA-C-N 121.828 1.688 . . . . 0.0 114.289 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 67' ' ' ILE . 23.1 p -132.38 -10.86 3.23 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.9 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -133.82 129.11 36.06 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -174.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 p -130.51 131.71 64.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.223 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.63 124.14 28.27 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.516 HD12 ' CD2' ' A' ' 78' ' ' TYR . 13.0 pt -99.49 135.68 33.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.441 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -65.83 114.8 5.33 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.16 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -51.46 -39.42 57.42 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.637 0.732 . . . . 0.0 112.141 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -68.4 -19.05 64.59 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.308 -1.315 . . . . 0.0 113.212 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -92.46 -36.18 13.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.94 0.876 . . . . 0.0 109.4 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.516 ' CD2' HD12 ' A' ' 73' ' ' ILE . 19.1 m-85 -92.83 7.53 43.36 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.669 -1.605 . . . . 0.0 113.471 -173.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 tptm 61.23 20.38 10.95 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 121.798 0.808 . . . . 0.0 110.746 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.2 mt -98.89 175.33 5.98 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.665 0.745 . . . . 0.0 111.011 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.56 -44.76 14.29 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.619 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.423 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -129.92 158.72 38.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.552 -176.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -72.26 137.72 46.95 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.495 ' O ' HG12 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -120.76 160.51 23.22 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -172.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -111.22 139.89 33.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.55 -0.719 . . . . 0.0 109.214 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 58' ' ' ILE . 20.8 mm -104.37 135.99 39.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.8 mt -104.79 106.27 16.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.429 ' HG ' ' HB1' ' A' ' 117' ' ' ALA . 3.5 mm? -88.44 14.04 10.56 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.881 0.848 . . . . 0.0 111.505 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -112.91 -34.85 5.63 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.173 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.38 65.79 4.58 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.584 ' O ' ' HB ' ' B' ' 93' ' ' THR . 1.8 pp -102.66 173.81 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.04 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.594 ' NH1' HD23 ' A' ' 24' ' ' LEU . 10.1 ptt180 -164.29 155.45 15.61 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.585 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 52.6 m -114.73 120.65 40.79 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.0 mt -131.58 144.58 51.18 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.98 -170.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -70.54 152.45 43.95 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.009 174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -55.24 -18.34 5.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -85.36 -19.21 31.78 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.912 0.386 . . . . 0.0 110.347 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.408 ' NH1' ' HB3' ' A' ' 23' ' ' ASP . 3.0 mmp_? -70.51 -34.39 72.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 7.7 mp -74.23 121.05 20.64 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.384 173.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -95.44 -57.41 2.4 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.308 -1.315 . . . . 0.0 114.083 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.596 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.0 pt-20 -148.88 135.6 19.7 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 122.069 0.938 . . . . 0.0 113.322 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.427 ' HZ2' ' CG ' ' A' ' 18' ' ' ASP . 55.3 tttp -60.89 110.71 1.41 Allowed 'General case' 0 C--N 1.279 -2.478 0 C-N-CA 128.625 2.77 . . . . 0.0 107.564 172.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 tp -111.13 -62.6 1.52 Allowed 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.299 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.525 HG23 HG22 ' A' ' 19' ' ' VAL . 6.0 t -127.03 -161.17 1.05 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.111 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -154.03 154.41 33.67 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 124.237 1.015 . . . . 0.0 110.803 -171.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.431 HD22 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -102.79 161.95 13.32 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.977 -177.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 m -98.59 164.23 12.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 111' ' ' MET . 25.5 t70 -67.09 -33.3 75.19 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.481 0.582 . . . . 0.0 110.712 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.47 -47.43 85.71 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.612 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.601 ' O ' HG21 ' A' ' 114' ' ' VAL . 11.8 tptt -62.82 -32.97 74.27 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 173.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -51.01 -49.21 60.91 Favored 'General case' 0 CA--C 1.456 -2.662 0 CA-C-N 118.3 0.5 . . . . 0.0 109.656 169.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 9.3 mmpt? -75.17 -11.89 60.18 Favored 'General case' 0 N--CA 1.392 -3.371 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.545 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.252 30.4 mt-10 -87.48 -56.41 3.37 Favored 'General case' 0 N--CA 1.39 -3.462 0 C-N-CA 117.136 -1.826 . . . . 0.0 111.17 166.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.601 HG21 ' O ' ' A' ' 110' ' ' LYS . 35.7 m -61.18 -48.18 90.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.25 -48.13 82.87 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 123.488 1.613 . . . . 0.0 109.307 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 18.7 t30 -74.01 -42.05 60.93 Favored 'General case' 0 C--N 1.265 -3.07 0 CA-C-N 111.813 -2.449 . . . . 0.0 112.684 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.429 ' HB1' ' HG ' ' A' ' 88' ' ' LEU . . . -61.44 -40.93 96.27 Favored 'General case' 0 CA--C 1.46 -2.513 0 CA-C-O 122.365 1.079 . . . . 0.0 108.567 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.408 ' O ' HD11 ' A' ' 122' ' ' LEU . 0.6 OUTLIER -79.91 -25.44 40.56 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.939 -172.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.478 ' O ' ' HB2' ' A' ' 124' ' ' LEU . 1.6 ttp -63.8 -26.82 68.8 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-O 121.924 0.869 . . . . 0.0 108.665 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 60.9 mt -84.23 -56.94 4.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.1 t -47.2 -43.94 21.91 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.817 1.647 . . . . 0.0 112.116 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.468 ' HG ' HG21 ' B' ' 54' ' ' ILE . 8.3 mp -82.0 5.19 20.05 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.64 1.33 77.63 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 117.972 1.949 . . . . 0.0 117.972 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 119' ' ' MET . 1.2 mm? -67.28 -48.91 66.26 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 120.098 1.949 . . . . 0.0 107.804 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 54.75 -168.03 0.08 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.287 -2.233 . . . . 0.0 113.083 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.26 23.4 5.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.511 1.148 . . . . 0.0 109.306 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.5 t -90.42 -56.11 5.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.33 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 55.68 -86.74 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.779 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -110.66 129.8 55.73 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -91.75 -23.49 19.73 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -89.63 141.76 28.31 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.847 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 . . . . . 0 C--N 1.295 -1.793 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 172.475 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.232 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -68.3 -30.4 69.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.441 0.639 . . . . 0.0 109.782 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 16.7 p -109.56 150.81 27.64 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -89.58 158.85 17.47 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' B' ' 8' ' ' HIS . 10.8 p80 -113.69 65.6 0.66 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.751 0.786 . . . . 0.0 113.116 -176.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -83.37 -52.05 6.88 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -113.09 5.14 16.98 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.728 0.775 . . . . 0.0 109.861 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.409 ' O ' ' HB2' ' B' ' 5' ' ' HIS . 39.0 m80 -94.44 107.96 19.91 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -114.68 81.15 1.51 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.53 0.681 . . . . 0.0 109.308 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.8 m -88.93 -43.66 11.0 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -98.81 97.92 9.08 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -88.6 161.76 41.15 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.686 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.26 152.29 25.91 Favored 'Trans proline' 0 C--O 1.256 1.387 0 C-N-CA 122.686 2.258 . . . . 0.0 112.028 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 66.6 mt -84.9 126.63 40.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -99.73 129.06 45.82 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.589 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 0.9 OUTLIER -61.14 119.63 8.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 169.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.54 -6.65 8.51 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.469 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.35 175.36 6.46 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.206 1.003 . . . . 0.0 110.587 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.528 HG22 HG23 ' B' ' 104' ' ' THR . 16.2 t -132.98 134.33 58.13 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 113.296 -1.774 . . . . 0.0 110.355 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 32.2 m-85 -132.7 148.0 52.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 124.912 1.285 . . . . 0.0 108.314 174.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.6 mp -81.47 152.11 27.51 Favored 'General case' 0 N--CA 1.411 -2.409 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.043 170.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.33 138.21 46.26 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.703 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.429 ' HB3' ' NH1' ' B' ' 98' ' ' ARG . 27.2 t70 -78.32 89.87 4.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.984 0.897 . . . . 0.0 110.022 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.619 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 15.8 mt -98.2 17.1 19.39 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 123.895 1.807 . . . . 0.0 109.299 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.262 15.7 m -60.33 166.65 3.81 Favored Pre-proline 1 C--N 1.236 -4.338 0 CA-C-N 111.916 -2.402 . . . . 0.0 107.955 169.729 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.1 OUTLIER 10.14 50.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.458 1 C-N-CA 127.209 5.273 . . . . 0.0 118.271 -174.764 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' B' ' 31' ' ' GLU . 24.3 m -68.83 -178.69 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 113.663 -1.608 . . . . 0.0 111.68 169.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' B' ' 31' ' ' GLU . 14.5 mm100 -108.36 129.66 55.23 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.388 -1.278 . . . . 0.0 113.569 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.74 -134.75 24.17 Favored Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.612 -1.177 . . . . 0.0 112.16 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.9 m -93.48 22.1 5.64 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 122.936 0.494 . . . . 0.0 111.104 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' B' ' 28' ' ' GLN . 0.1 OUTLIER -66.43 151.94 46.14 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 174.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -77.52 110.1 12.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.867 0.365 . . . . 0.0 111.425 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . 0.619 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -86.54 139.88 16.9 Favored Glycine 0 CA--C 1.481 -2.049 0 CA-C-N 114.975 -1.011 . . . . 0.0 115.206 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 116.67 137.29 5.95 Favored Glycine 0 N--CA 1.42 -2.389 0 CA-C-N 113.652 -1.274 . . . . 0.0 110.048 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.2 124.47 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-O 121.942 0.877 . . . . 0.0 109.583 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -145.2 158.43 51.63 Favored Pre-proline 0 C--N 1.276 -2.629 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.299 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 3.7 Cg_exo -72.85 142.47 35.31 Favored 'Trans proline' 0 N--CA 1.437 -1.805 0 C-N-CA 122.053 1.835 . . . . 0.0 111.593 174.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.431 HG23 ' O ' ' B' ' 20' ' ' TYR . 29.9 m -118.34 156.7 20.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.496 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.489 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 27.3 m -97.82 126.98 50.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.416 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 20.6 mm -87.85 104.51 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.77 -18.69 6.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.364 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.613 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 0.0 OUTLIER -56.51 158.26 4.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -173.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.433 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 25.9 p-10 -71.51 -167.22 0.24 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 123.124 1.44 . . . . 0.0 112.835 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -90.65 -38.37 13.15 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.782 -2.008 . . . . 0.0 112.909 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 3.6 m -83.75 -27.51 28.86 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.127 -170.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -64.62 -37.51 94.49 Favored Glycine 0 C--O 1.202 -1.861 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.478 ' N ' HE22 ' B' ' 42' ' ' GLN . 9.9 p30 -83.82 -20.89 32.42 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.761 -0.775 . . . . 0.0 110.234 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.473 ' HB3' ' CD1' ' B' ' 49' ' ' TYR . 4.9 mptp? -76.2 -66.35 0.81 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.603 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.473 ' CD1' ' HB3' ' B' ' 48' ' ' LYS . 87.7 m-85 -95.18 -30.18 14.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.785 -171.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 23.5 m -93.45 154.35 41.29 Favored Pre-proline 0 C--N 1.292 -1.931 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.82 -16.51 8.88 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.56 1.507 . . . . 0.0 111.209 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 9.0 p -92.9 146.43 23.64 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.231 1.013 . . . . 0.0 112.868 -174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.613 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -142.34 138.79 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 123.649 0.593 . . . . 0.0 110.29 172.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.486 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -88.75 130.15 38.65 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 CA-C-O 121.742 0.782 . . . . 0.0 110.287 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.25 168.2 22.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.424 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.489 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -124.02 146.74 48.33 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.35 136.37 37.68 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -177.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.477 HD13 ' HB2' ' B' ' 37' ' ' PRO . 20.8 mt -88.49 127.25 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.14 -1.391 . . . . 0.0 107.352 172.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 60.2 m -117.77 160.33 21.53 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.28 178.76 26.32 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.984 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -68.34 101.76 1.27 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 43.9 pt -110.29 170.94 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.566 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . 0.504 ' OD1' ' HG3' ' B' ' 64' ' ' LYS . 10.0 p30 -105.16 165.76 10.87 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.504 ' HG3' ' OD1' ' B' ' 63' ' ' ASN . 62.4 mttp 75.24 80.85 0.1 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 125.018 1.327 . . . . 0.0 112.502 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.75 109.61 14.91 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -77.41 -22.22 51.89 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.5 ' C ' ' H ' ' B' ' 69' ' ' THR 0.602 24.1 mm 109.25 -58.57 0.0 OUTLIER Pre-proline 0 CA--C 1.509 -0.614 0 N-CA-C 120.24 3.422 . . . . 0.0 120.24 171.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.35 2.32 0.94 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 CA-C-N 121.691 1.64 . . . . 0.0 113.991 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' THR . . . . . 0.5 ' H ' ' C ' ' B' ' 67' ' ' ILE . 28.8 p -132.39 -11.94 3.15 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.768 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -135.48 129.21 32.8 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -173.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 p -131.35 133.17 62.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.648 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.86 125.76 29.8 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.498 HD12 ' CD2' ' B' ' 78' ' ' TYR . 12.3 pt -99.28 133.37 42.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.692 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -64.62 117.28 7.18 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 123.848 0.717 . . . . 0.0 110.39 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' B' ' 81' ' ' ASP . 21.2 pttp -53.65 -38.92 64.59 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.28 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -69.07 -19.28 64.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.546 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -91.61 -35.15 14.4 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.865 0.84 . . . . 0.0 109.106 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.498 ' CD2' HD12 ' B' ' 73' ' ' ILE . 17.1 m-85 -93.3 7.79 42.96 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.548 -173.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 23.2 tptm 61.42 23.41 13.67 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 121.802 0.81 . . . . 0.0 109.996 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 29.3 mt -100.6 177.08 5.11 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.485 0.659 . . . . 0.0 111.058 -174.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.477 ' O ' ' HD2' ' B' ' 75' ' ' LYS . 20.3 t70 -83.21 -47.74 11.23 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.913 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -128.96 159.15 36.77 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.835 -175.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.73 145.22 52.45 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.498 ' O ' HG12 ' B' ' 73' ' ' ILE . 0.3 OUTLIER -129.31 158.79 38.11 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -173.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -110.23 140.59 28.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.477 ' CD1' HG12 ' B' ' 58' ' ' ILE . 22.9 mm -105.01 136.14 40.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 35.6 mt -104.79 105.55 15.67 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.4 ' HG ' ' HB1' ' B' ' 117' ' ' ALA . 3.5 mm? -87.68 11.97 13.88 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.006 0.907 . . . . 0.0 111.324 -174.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -110.62 -34.25 6.34 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.178 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.05 66.58 3.57 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.585 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.9 pp -102.59 174.24 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.543 ' NH1' HD21 ' B' ' 24' ' ' LEU . 10.4 ptt180 -164.53 154.54 14.11 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 49.5 m -113.41 120.69 41.95 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.013 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 58.7 mt -131.43 144.47 51.21 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.825 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -71.4 152.37 43.2 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.0 174.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -50.57 -25.49 4.18 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -81.44 -18.83 43.94 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.341 0.519 . . . . 0.0 110.93 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.429 ' NH1' ' HB3' ' B' ' 23' ' ' ASP . 3.3 mmp_? -69.17 -33.89 74.09 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' B' ' 21' ' ' LEU . 7.8 mp -73.54 124.15 25.33 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.361 173.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -99.02 -53.52 3.24 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.098 -1.41 . . . . 0.0 114.68 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 13.5 pt-20 -154.92 138.78 16.26 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 122.085 0.945 . . . . 0.0 113.163 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.77 112.25 2.2 Favored 'General case' 0 C--N 1.282 -2.354 0 C-N-CA 128.66 2.784 . . . . 0.0 107.358 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -112.2 -62.77 1.52 Allowed 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.244 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.528 HG23 HG22 ' B' ' 19' ' ' VAL . 6.7 t -125.59 -157.97 0.82 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.204 -1.398 . . . . 0.0 111.486 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -156.34 152.94 28.22 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 124.311 1.044 . . . . 0.0 111.005 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.433 HD22 ' HH ' ' B' ' 78' ' ' TYR . 0.7 OUTLIER -105.1 151.54 23.88 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.289 -178.236 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 19.8 m -90.43 166.79 13.07 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' B' ' 111' ' ' MET . 33.8 t70 -67.44 -34.28 76.89 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.029 0.442 . . . . 0.0 111.23 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -62.11 -46.71 87.86 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.613 ' O ' HG21 ' B' ' 114' ' ' VAL . 11.9 tptt -62.86 -32.07 73.22 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.539 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -51.62 -47.94 63.47 Favored 'General case' 0 CA--C 1.445 -3.074 0 CA-C-O 121.245 0.545 . . . . 0.0 109.867 169.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.4 ' CE ' ' HA ' ' B' ' 112' ' ' LYS . 8.3 mmpt? -74.88 -14.06 60.62 Favored 'General case' 0 N--CA 1.384 -3.767 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . 0.252 31.6 mt-10 -87.17 -56.61 3.3 Favored 'General case' 0 N--CA 1.386 -3.633 0 C-N-CA 116.763 -1.975 . . . . 0.0 111.234 168.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.613 HG21 ' O ' ' B' ' 110' ' ' LYS . 36.0 m -60.56 -47.81 91.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.95 -50.87 71.65 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 123.365 1.555 . . . . 0.0 109.665 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.316 26.9 t30 -73.2 -40.47 64.73 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-N 112.1 -2.318 . . . . 0.0 112.792 -172.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.4 ' HB1' ' HG ' ' B' ' 88' ' ' LEU . . . -62.38 -40.04 95.15 Favored 'General case' 0 CA--C 1.46 -2.484 0 CA-C-O 122.225 1.012 . . . . 0.0 108.666 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.56 -25.28 41.65 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.739 -173.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.492 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 1.8 ttp -63.47 -27.5 69.33 Favored 'General case' 0 N--CA 1.399 -3.014 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.47 HG22 ' ND2' ' B' ' 125' ' ' ASN . 64.1 mt -83.98 -56.99 4.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 21.9 t -47.09 -43.45 20.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.216 1.406 . . . . 0.0 112.283 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.466 ' HG ' HG21 ' A' ' 54' ' ' ILE . 8.2 mp -82.2 5.36 20.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . 0.406 ' CA ' ' HB3' ' A' ' 43' ' ' ASN . . . 89.66 1.39 77.49 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 117.862 1.905 . . . . 0.0 117.862 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 119' ' ' MET . 1.1 mm? -67.41 -49.58 63.18 Favored 'General case' 0 C--O 1.249 1.048 0 CA-C-N 120.271 2.035 . . . . 0.0 107.749 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.47 ' ND2' HG22 ' B' ' 120' ' ' ILE . 1.5 t-20 53.95 -168.25 0.07 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 112.514 -2.13 . . . . 0.0 113.01 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.24 19.04 6.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.98 0.895 . . . . 0.0 110.316 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.35 -57.57 4.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.439 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 57.43 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 113.135 -1.848 . . . . 0.0 111.689 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -112.78 131.54 55.64 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -88.39 -38.61 14.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -74.85 142.92 44.09 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.029 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 . . . . . 0 C--N 1.301 -1.521 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 171.498 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.497 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -81.68 171.78 14.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 7' ' ' HIS . 23.1 t 66.73 26.08 9.62 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.455 0.702 . . . . 0.0 110.976 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -88.44 -23.92 23.16 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.139 -0.351 . . . . 0.0 111.458 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -83.92 -38.43 21.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.439 0.638 . . . . 0.0 109.767 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -155.36 141.65 18.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.41 ' HA ' ' OG ' ' A' ' 3' ' ' SER . 23.6 p80 -85.71 -31.21 22.58 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.721 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -107.68 92.33 4.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -82.41 -64.5 1.16 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 m -159.72 86.79 0.79 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.147 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -94.2 108.57 20.42 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -80.51 138.0 51.52 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.691 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.87 27.67 0.6 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.82 3.013 . . . . 0.0 112.405 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.48 ' HA ' ' HH ' ' A' ' 20' ' ' TYR . 59.3 mt -85.13 118.31 31.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.3 mmt-85 -117.22 152.75 34.16 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -64.25 122.0 15.61 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 113.33 -11.97 23.88 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.12 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -78.01 156.55 30.07 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 122.108 0.956 . . . . 0.0 110.123 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 93.3 t -116.24 118.81 60.0 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.391 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.345 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 44.2 m-85 -116.43 138.98 50.93 Favored 'General case' 0 C--O 1.181 -2.509 0 C-N-CA 126.072 1.749 . . . . 0.0 111.207 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.8 mp -82.48 147.87 28.46 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 121.392 0.615 . . . . 0.0 109.9 169.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -144.0 142.17 30.55 Favored 'General case' 0 C--N 1.274 -2.717 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.985 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.24 95.27 5.61 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 123.059 1.409 . . . . 0.0 110.256 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.804 ' O ' HG11 ' A' ' 27' ' ' VAL . 66.7 mt -88.42 -14.58 37.67 Favored 'General case' 0 C--O 1.177 -2.763 0 CA-C-N 113.214 -1.812 . . . . 0.0 112.554 -175.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.421 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 4.6 p -87.3 56.48 0.0 OUTLIER Pre-proline 0 C--N 1.256 -3.497 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -127.63 41.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 124.216 3.277 . . . . 0.0 106.709 142.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.804 HG11 ' O ' ' A' ' 24' ' ' LEU . 6.6 m -69.02 176.16 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.467 HE22 ' HB2' ' B' ' 26' ' ' PRO . 35.7 mm-40 -89.71 109.69 20.64 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.462 -1.699 . . . . 0.0 112.5 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.97 -108.56 0.56 Allowed Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.262 -1.335 . . . . 0.0 114.924 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.8 m -89.15 17.92 5.5 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 39.1 mt-10 -67.76 -175.06 0.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.969 172.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -99.09 121.17 40.63 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.78 164.29 13.9 Favored Glycine 0 CA--C 1.478 -2.252 0 CA-C-O 122.012 0.784 . . . . 0.0 114.99 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 115.68 156.71 11.07 Favored Glycine 0 N--CA 1.419 -2.48 0 CA-C-N 113.431 -1.385 . . . . 0.0 109.666 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -82.74 100.48 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.342 0 CA-C-O 123.904 1.811 . . . . 0.0 107.604 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -127.26 161.34 54.89 Favored Pre-proline 0 C--N 1.255 -3.502 0 CA-C-N 112.253 -2.249 . . . . 0.0 108.888 -170.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 5.2 Cg_exo -76.74 142.07 22.4 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 C-N-CA 121.772 1.648 . . . . 0.0 112.146 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 20' ' ' TYR . 27.6 m -119.84 156.81 22.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 124.419 1.087 . . . . 0.0 108.475 177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 m -105.57 133.82 48.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.3 mm -81.85 103.24 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -98.37 -19.22 6.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.777 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.568 HE22 ' N ' ' A' ' 47' ' ' ASN . 3.1 tt0 -57.05 163.8 1.9 Allowed 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 125.51 1.524 . . . . 0.0 114.567 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.512 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 27.4 p-10 -65.85 177.76 1.23 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.539 -1.664 . . . . 0.0 112.423 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.38 -41.56 56.06 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.556 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.8 m -85.28 -26.36 26.68 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.484 -171.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.3 -33.21 79.61 Favored Glycine 0 C--O 1.213 -1.214 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.568 ' N ' HE22 ' A' ' 42' ' ' GLN 0.262 6.7 p30 -69.63 -18.97 63.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -92.35 -68.02 0.82 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.106 0.479 . . . . 0.0 110.297 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -91.89 -16.24 26.96 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -165.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.5 m -90.73 133.83 31.74 Favored Pre-proline 0 N--CA 1.417 -2.105 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -65.68 -27.97 52.5 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 121.752 1.635 . . . . 0.0 108.698 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -94.35 137.98 32.87 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 113.333 -1.758 . . . . 0.0 112.115 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.527 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 90.4 t -122.06 140.16 46.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.523 HG21 ' CD2' ' B' ' 122' ' ' LEU . 1.5 tp -106.09 125.73 61.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-O 121.7 0.762 . . . . 0.0 110.943 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.34 171.11 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.103 -176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.483 ' CB ' HG21 ' A' ' 91' ' ' ILE . . . -124.78 142.83 51.15 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.434 ' HB1' HH11 ' A' ' 92' ' ' ARG . . . -84.18 142.53 30.26 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.564 HG12 ' CD1' ' A' ' 86' ' ' ILE . 16.2 mt -85.59 138.49 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.963 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 m -119.79 134.75 55.12 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.97 51.97 1.64 Allowed Glycine 0 N--CA 1.478 1.439 0 CA-C-O 121.36 0.422 . . . . 0.0 112.567 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . 0.262 41.5 mtp85 71.91 167.96 0.31 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 127.587 2.355 . . . . 0.0 112.415 -175.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.3 tt -155.13 -48.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.584 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -167.99 -82.04 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.185 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -170.04 170.22 7.64 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -80.37 76.49 7.18 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.474 1.131 . . . . 0.0 109.305 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -85.17 -21.19 29.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.788 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 tt -130.6 141.12 40.79 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.92 -3.61 0.71 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 124.048 3.165 . . . . 0.0 116.435 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.4 p -90.45 -18.96 24.47 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 118.921 0.782 . . . . 0.0 109.641 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -86.25 129.59 34.8 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.065 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.44 120.6 59.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -86.08 132.34 34.06 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.478 HD11 ' CG ' ' A' ' 78' ' ' TYR . 2.8 pp -84.6 157.33 3.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.987 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.453 ' HG2' ' CG ' ' A' ' 76' ' ' LYS . 19.8 tt0 -77.59 107.88 10.37 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 81' ' ' ASP . 62.7 pttt -55.22 -42.17 73.0 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.453 ' CG ' ' HG2' ' A' ' 74' ' ' GLU . 11.1 ptmm? -59.02 -32.75 70.01 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.222 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -91.39 -26.7 18.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.681 0.753 . . . . 0.0 109.84 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.478 ' CG ' HD11 ' A' ' 73' ' ' ILE . 2.8 m-85 -80.44 2.7 24.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.274 -178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 71.63 20.65 4.64 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.502 1.121 . . . . 0.0 111.068 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 mt -110.89 168.57 9.38 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.852 0.834 . . . . 0.0 111.248 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.444 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 14.7 t70 -93.2 -35.36 13.18 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.928 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -119.65 145.81 46.13 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.076 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 8.4 p-10 -76.08 147.39 38.68 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.389 0.614 . . . . 0.0 110.113 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.2 t -112.57 175.9 5.24 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.06 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 t -127.76 141.41 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.564 ' CD1' HG12 ' A' ' 58' ' ' ILE . 25.1 mm -109.36 133.36 54.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.5 mt -102.52 107.54 18.54 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.52 15.63 1.25 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.789 0.835 . . . . 0.0 112.46 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.27 -39.79 3.01 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.649 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -83.68 51.96 2.15 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 125.332 1.453 . . . . 0.0 108.237 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.483 HG21 ' CB ' ' A' ' 56' ' ' ALA . 2.0 pp -96.29 -179.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.63 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.436 ' O ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -168.0 163.13 13.62 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 18.6 m -117.77 119.93 36.39 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.414 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.2 mt -131.44 137.75 48.76 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.895 -171.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -74.35 153.16 39.42 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.445 175.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -38.99 -36.76 0.31 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 126.231 1.812 . . . . 0.0 112.837 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -64.52 -22.34 66.94 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.943 0.897 . . . . 0.0 111.54 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.7 mmp_? -79.83 -33.54 40.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.257 0.551 . . . . 0.0 109.577 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.53 101.89 4.33 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 122.601 1.191 . . . . 0.0 111.715 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -86.7 -65.09 1.05 Allowed 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 113.518 -1.674 . . . . 0.0 115.13 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 9.3 pt-20 -139.46 126.66 21.25 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 18.8 ptmt -71.45 114.07 9.14 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.319 -1.764 . . . . 0.0 110.986 171.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.6 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 24.0 tp -103.49 -56.73 2.16 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.005 -173.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.6 ' OG1' ' HG ' ' A' ' 103' ' ' LEU 0.285 3.5 m -135.42 -174.05 3.52 Favored 'General case' 0 N--CA 1.391 -3.384 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.573 -165.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.533 ' H ' ' CG2' ' A' ' 104' ' ' THR . 0.6 OUTLIER -160.64 134.93 7.24 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.489 1.516 . . . . 0.0 110.92 -166.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.59 153.4 22.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.345 0.658 . . . . 0.0 112.539 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.0 m -75.87 159.7 30.68 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.888 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 111' ' ' MET . 38.1 t70 -58.45 -51.93 67.76 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.426 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 3.5 p-10 -73.14 -26.69 61.3 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.717 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -67.41 -27.26 66.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.585 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.408 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -57.38 -39.78 76.78 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 123.527 0.731 . . . . 0.0 110.473 174.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.577 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -74.11 -19.8 60.46 Favored 'General case' 0 CA--C 1.483 -1.622 0 C-N-CA 123.245 0.618 . . . . 0.0 111.386 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.485 ' HA ' ' ND2' ' A' ' 116' ' ' ASN . 21.0 mt-10 -85.83 -36.87 19.76 Favored 'General case' 0 N--CA 1.399 -2.983 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.68 -46.77 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-N 113.153 -1.84 . . . . 0.0 109.829 170.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.468 ' OD2' ' HA ' ' A' ' 112' ' ' LYS . 37.4 m-20 -60.21 -57.74 11.49 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.88 0.848 . . . . 0.0 109.976 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.495 ' O ' HG13 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -64.88 -39.43 93.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.624 -172.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.99 -40.26 84.3 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 2.8 tp -68.36 -38.02 81.03 Favored 'General case' 1 N--CA 1.365 -4.705 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.356 -175.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 46.2 mtp -66.17 -29.67 70.0 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 121.755 -0.59 . . . . 0.0 111.261 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 116' ' ' ASN . 26.5 mt -77.33 -54.35 12.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.5 t -52.67 -36.81 57.68 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.565 -1.652 . . . . 0.0 111.358 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.522 ' HB3' ' CD1' ' B' ' 41' ' ' ILE . 42.0 mt -101.49 7.32 42.48 Favored 'General case' 0 N--CA 1.428 -1.529 0 O-C-N 121.961 -0.462 . . . . 0.0 111.512 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.91 75.24 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 116.794 1.478 . . . . 0.0 116.794 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 128' ' ' ALA . 7.2 mp -78.46 -46.94 18.51 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 118.829 1.315 . . . . 0.0 109.292 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 44.44 -148.01 0.08 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 113.274 -1.785 . . . . 0.0 110.229 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.41 15.9 9.8 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.157 -0.964 . . . . 0.0 110.16 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.5 t -92.94 -3.62 10.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.973 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 124' ' ' LEU . . . -67.8 -62.63 1.32 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.788 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -92.61 76.22 5.02 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 122.094 0.95 . . . . 0.0 111.036 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -96.13 96.29 8.74 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 173.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . 0.253 43.8 tptt -86.37 99.79 11.86 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -170.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 . . . . . 0 C--N 1.285 -2.221 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 166.875 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.425 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 21.4 m -81.73 171.66 14.3 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 122.568 0.347 . . . . 0.0 110.273 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 25.2 t 69.67 23.14 5.9 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.808 0.843 . . . . 0.0 110.37 175.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -90.02 -16.03 30.64 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.181 0.515 . . . . 0.0 111.535 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -92.41 -42.81 9.56 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -152.99 139.63 18.83 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.752 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -80.92 -35.63 32.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.391 0.615 . . . . 0.0 110.492 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -105.81 89.27 3.03 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.861 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -79.36 -67.82 0.72 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 38.8 m -155.64 91.99 1.35 Allowed 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -101.1 105.93 17.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -77.32 137.95 64.18 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.363 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.78 29.88 0.54 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.767 2.978 . . . . 0.0 111.907 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . 0.42 ' HA ' ' HH ' ' B' ' 20' ' ' TYR . 66.0 mt -87.09 119.0 34.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.9 mmt-85 -119.44 154.56 33.52 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -64.27 120.36 12.01 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 116.46 -13.93 15.53 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.998 -178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -75.67 155.05 36.14 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.33 1.062 . . . . 0.0 110.844 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 89.9 t -115.56 118.59 59.28 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.516 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.894 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.569 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 48.2 m-85 -115.52 140.44 49.15 Favored 'General case' 0 CA--C 1.455 -2.707 0 C-N-CA 125.986 1.714 . . . . 0.0 110.671 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -82.34 148.68 28.15 Favored 'General case' 0 N--CA 1.392 -3.33 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.782 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -146.07 143.6 29.5 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.733 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' B' ' 25' ' ' SER . 4.8 p-10 -75.52 93.1 2.95 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 122.325 1.059 . . . . 0.0 110.001 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.701 ' O ' HG11 ' B' ' 27' ' ' VAL . 69.5 mt -89.6 21.8 3.3 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -176.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.507 ' HB2' ' HD2' ' B' ' 26' ' ' PRO 0.264 5.4 p -79.54 -165.62 0.07 OUTLIER Pre-proline 0 N--CA 1.39 -3.427 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 176.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' B' ' 25' ' ' SER . 31.7 Cg_exo 18.39 40.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.42 1 C-N-CA 125.385 4.057 . . . . 0.0 118.193 -156.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.701 HG11 ' O ' ' B' ' 24' ' ' LEU . 7.0 m -70.56 177.8 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 122.213 1.006 . . . . 0.0 112.786 174.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -90.08 109.15 20.22 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.117 -1.401 . . . . 0.0 112.724 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.39 -108.49 0.31 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.69 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -87.28 17.65 4.25 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.0 -170.57 0.11 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 118.87 0.759 . . . . 0.0 111.292 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -103.67 118.85 37.68 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.88 167.04 16.91 Favored Glycine 0 CA--C 1.473 -2.583 0 CA-C-O 122.218 0.899 . . . . 0.0 115.306 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 113.36 154.2 11.42 Favored Glycine 0 N--CA 1.408 -3.191 0 CA-C-N 112.861 -1.669 . . . . 0.0 109.719 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.401 ' O ' HG11 ' B' ' 35' ' ' VAL . 3.1 p -80.84 103.05 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-O 123.167 1.46 . . . . 0.0 107.287 177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -130.54 161.71 59.15 Favored Pre-proline 0 C--N 1.254 -3.582 0 CA-C-N 113.267 -1.788 . . . . 0.0 108.949 -170.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 4.7 Cg_exo -75.57 141.81 25.49 Favored 'Trans proline' 0 N--CA 1.431 -2.193 0 C-N-CA 121.812 1.675 . . . . 0.0 112.33 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -120.86 156.95 24.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 124.568 1.147 . . . . 0.0 108.512 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 m -105.46 133.6 49.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.502 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 30.6 mm -81.69 102.02 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.3 -19.31 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.637 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.577 HE22 ' N ' ' B' ' 47' ' ' ASN . 2.6 tt0 -56.67 162.19 2.41 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 125.462 1.505 . . . . 0.0 114.475 -173.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.525 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 21.8 p-10 -63.8 -175.86 0.16 Allowed 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.472 -1.694 . . . . 0.0 112.492 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.76 -42.73 17.6 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.63 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 9.7 m -85.15 -26.17 27.0 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.545 -170.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.1 -34.49 84.08 Favored Glycine 0 C--O 1.217 -0.909 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.577 ' N ' HE22 ' B' ' 42' ' ' GLN 0.264 8.8 p30 -69.1 -18.77 64.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -92.65 -67.37 0.86 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.231 0.539 . . . . 0.0 110.782 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -93.43 -11.79 31.33 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -166.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 69.4 m -94.65 134.47 25.16 Favored Pre-proline 0 N--CA 1.42 -1.943 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.55 -27.51 39.09 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 121.872 1.715 . . . . 0.0 109.044 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.7 p -94.82 137.7 33.57 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.834 -174.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.504 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 89.4 t -121.86 140.21 46.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.516 HG21 ' CD2' ' A' ' 122' ' ' LEU . 1.4 tp -105.9 125.66 61.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-O 121.668 0.746 . . . . 0.0 111.257 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.32 172.44 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.994 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.492 ' CB ' HG21 ' B' ' 91' ' ' ILE . . . -127.03 142.5 51.53 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.45 ' HB1' HH11 ' B' ' 92' ' ' ARG . . . -83.3 142.95 30.71 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.576 HG12 ' CD1' ' B' ' 86' ' ' ILE . 17.2 mt -88.31 135.36 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.442 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 38.3 m -116.16 134.78 54.55 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.09 50.94 1.62 Allowed Glycine 0 N--CA 1.478 1.454 0 CA-C-O 121.732 0.629 . . . . 0.0 112.327 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 71.79 163.08 0.26 Allowed 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 127.17 2.188 . . . . 0.0 112.693 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 11.5 tt -150.34 -47.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.189 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -169.45 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.093 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.429 ' HD3' ' H ' ' B' ' 65' ' ' ALA . 16.4 tppt? -170.34 167.35 8.41 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . 0.429 ' H ' ' HD3' ' B' ' 64' ' ' LYS . . . -77.54 77.84 4.06 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.216 1.008 . . . . 0.0 108.679 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -86.12 -18.06 33.34 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.314 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 tt -134.1 142.31 42.76 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.15 -12.53 5.41 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 124.038 3.158 . . . . 0.0 116.258 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 59.2 p -83.95 -19.11 35.22 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.63 0.729 . . . . 0.0 109.829 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -85.38 129.1 34.89 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.09 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.91 121.67 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -87.77 133.5 33.86 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.487 HD11 ' CG ' ' B' ' 78' ' ' TYR . 2.8 pp -85.9 156.46 3.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.369 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.423 ' HG2' ' CG ' ' B' ' 76' ' ' LYS . 16.0 tt0 -76.26 107.45 8.51 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' B' ' 83' ' ' ASP . 62.2 pttt -56.25 -41.83 76.39 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . 0.423 ' CG ' ' HG2' ' B' ' 74' ' ' GLU . 10.8 ptmm? -59.71 -30.78 69.04 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.503 -1.226 . . . . 0.0 113.367 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -91.47 -31.18 16.08 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.561 0.696 . . . . 0.0 109.404 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.487 ' CG ' HD11 ' B' ' 73' ' ' ILE . 3.0 m-85 -76.39 1.3 16.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.442 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 74.55 12.78 3.77 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.994 1.318 . . . . 0.0 111.816 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 19.2 mt -104.46 168.48 9.06 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.873 0.844 . . . . 0.0 111.896 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -91.51 -35.85 14.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.131 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.28 147.85 44.46 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.636 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . 0.406 ' HA ' ' HB3' ' B' ' 75' ' ' LYS . 7.3 p-10 -76.84 147.97 36.81 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.157 0.503 . . . . 0.0 110.324 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -113.19 175.2 5.55 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.091 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t -126.82 141.79 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.576 ' CD1' HG12 ' B' ' 58' ' ' ILE . 25.0 mm -109.07 133.04 55.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 61.9 mt -102.22 107.07 18.01 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.994 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.01 14.02 1.56 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.821 0.849 . . . . 0.0 112.439 -174.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -116.61 -39.4 3.33 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.881 0.848 . . . . 0.0 108.944 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -84.04 52.0 2.2 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 125.229 1.412 . . . . 0.0 108.291 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.492 HG21 ' CB ' ' B' ' 56' ' ' ALA . 2.0 pp -96.46 -179.59 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.693 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.45 HH11 ' HB1' ' B' ' 57' ' ' ALA . 0.0 OUTLIER -167.92 163.12 13.8 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 17.9 m -118.1 119.59 35.21 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.48 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 51.4 mt -131.47 138.38 48.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.113 -171.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -74.03 152.9 39.89 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.707 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -38.27 -32.74 0.08 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 126.853 2.061 . . . . 0.0 113.697 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -69.31 -25.51 64.26 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.279 0.632 . . . . 0.0 110.901 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 2.1 mmp_? -76.41 -33.36 58.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -73.32 103.65 4.07 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.108 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -87.14 -61.88 1.63 Allowed 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.3 pt-20 -144.39 130.24 19.3 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.846 0.832 . . . . 0.0 113.003 -171.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.521 ' HB3' ' CZ ' ' B' ' 20' ' ' TYR . 19.4 ptmt -73.75 110.84 8.36 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.111 173.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.617 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 23.9 tp -101.48 -56.63 2.25 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.796 -172.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.617 ' OG1' ' HG ' ' B' ' 103' ' ' LEU 0.285 4.1 m -134.48 -175.0 3.73 Favored 'General case' 0 N--CA 1.387 -3.613 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.31 -166.016 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.551 ' H ' ' CG2' ' B' ' 104' ' ' THR . 0.4 OUTLIER -160.6 134.96 7.3 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.476 1.51 . . . . 0.0 110.383 -166.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 11.1 mt -85.67 157.3 20.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.523 0.729 . . . . 0.0 112.517 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 2.3 m -78.97 165.5 23.4 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.775 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' B' ' 111' ' ' MET . 27.8 t70 -61.29 -53.01 62.23 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 3.7 p-10 -72.35 -28.52 63.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.446 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -66.51 -26.9 67.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.748 0.308 . . . . 0.0 111.221 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.442 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -59.03 -40.03 83.78 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.199 0.599 . . . . 0.0 110.397 173.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.587 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -75.37 -16.91 60.34 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.056 0.455 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . 0.452 ' HA ' ' ND2' ' B' ' 116' ' ' ASN . 48.7 mt-10 -84.54 -38.32 20.15 Favored 'General case' 0 CA--C 1.443 -3.152 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.28 -48.55 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.994 0 CA-C-N 112.685 -2.052 . . . . 0.0 110.022 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.52 ' OD2' ' HA ' ' B' ' 112' ' ' LYS . 49.0 m-20 -59.56 -59.02 6.11 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.726 0.774 . . . . 0.0 110.461 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.452 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 0.5 OUTLIER -64.82 -37.55 88.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.017 -172.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.15 -39.45 86.38 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.498 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 3.0 tp -69.78 -38.26 76.64 Favored 'General case' 1 N--CA 1.366 -4.661 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.984 -175.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 48.4 mtp -65.52 -34.77 79.04 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 121.769 -0.582 . . . . 0.0 110.927 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.441 HG13 ' O ' ' B' ' 116' ' ' ASN . 23.7 mt -71.89 -53.95 18.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 20.3 t -52.76 -35.78 56.85 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.784 1.234 . . . . 0.0 111.443 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.523 ' CD2' HG21 ' A' ' 54' ' ' ILE . 39.8 mt -102.34 6.54 40.41 Favored 'General case' 0 N--CA 1.428 -1.548 0 O-C-N 121.894 -0.504 . . . . 0.0 111.508 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.26 20.69 76.88 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.48 -49.31 15.03 Favored 'General case' 0 CA--C 1.478 -1.791 0 CA-C-N 118.876 1.338 . . . . 0.0 109.056 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 44.53 -149.41 0.06 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.148 -172.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.25 14.95 9.79 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.919 -1.113 . . . . 0.0 110.651 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 36.7 t -92.35 -4.19 10.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.125 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.34 -70.01 0.26 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.608 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -83.78 79.25 9.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 122.18 0.99 . . . . 0.0 110.736 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -100.4 96.65 7.56 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -90.29 100.58 13.39 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -167.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 166.609 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.128 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.4 m -89.28 104.31 16.87 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.194 0.521 . . . . 0.0 110.021 -177.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -90.0 106.9 18.78 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -87.29 118.05 26.46 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -73.65 -29.49 62.36 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.986 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -100.8 87.85 3.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -81.4 -47.65 12.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -122.54 171.3 9.21 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.673 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -130.63 126.59 37.02 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 m -79.98 -5.3 55.46 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.305 0.574 . . . . 0.0 111.017 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -68.75 115.8 8.52 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.074 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -99.74 121.2 55.26 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.62 134.02 56.36 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 C-N-CA 122.331 2.021 . . . . 0.0 109.602 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.437 ' HB ' ' OD1' ' A' ' 47' ' ' ASN . 65.1 mt -62.08 120.35 8.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.196 0.522 . . . . 0.0 110.143 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -103.28 138.82 39.54 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -76.59 134.43 39.37 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.353 -1.339 . . . . 0.0 108.334 173.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.31 -5.53 55.42 Favored Glycine 0 C--N 1.302 -1.356 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.93 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.25 166.69 11.78 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.582 0.706 . . . . 0.0 110.114 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 37.4 t -120.05 133.7 65.95 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.422 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 44.4 m-85 -136.67 147.34 46.77 Favored 'General case' 0 CA--C 1.469 -2.165 0 C-N-CA 124.623 1.169 . . . . 0.0 107.957 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.7 mp -74.42 148.86 40.77 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.087 171.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -143.63 135.3 26.3 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.097 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.19 94.46 3.53 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.77 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.618 ' O ' HG13 ' A' ' 27' ' ' VAL . 9.2 mt -89.45 5.0 47.26 Favored 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 124.776 1.23 . . . . 0.0 110.086 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.453 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 4.6 m -52.96 -177.66 0.04 OUTLIER Pre-proline 1 C--N 1.241 -4.142 0 C-N-CA 126.817 2.047 . . . . 0.0 113.283 174.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 19.97 35.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.41 3.784 1 C-N-CA 125.716 4.277 . . . . 0.0 119.465 -157.956 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 24' ' ' LEU . 5.8 m -70.89 173.47 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.565 168.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -111.71 141.4 45.36 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.89 -111.87 1.43 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 114.786 -1.097 . . . . 0.0 115.023 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -94.16 4.4 53.94 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 123.425 0.69 . . . . 0.0 112.697 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 77.2 mt-10 -64.05 144.0 57.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.502 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 5.8 tp60 -117.73 111.47 19.16 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -170.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -126.64 -109.44 1.63 Allowed Glycine 1 N--CA 1.383 -4.844 0 C-N-CA 118.361 -1.876 . . . . 0.0 116.453 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 75.97 177.08 41.9 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 -168.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 35' ' ' VAL . 4.5 p -91.44 106.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.288 0 O-C-N 120.617 -1.519 . . . . 0.0 108.897 176.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.502 ' NH2' ' HG3' ' A' ' 32' ' ' GLN . 62.8 mtm180 -135.17 157.8 76.07 Favored Pre-proline 0 C--N 1.275 -2.672 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.648 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 31.9 Cg_exo -66.12 138.55 52.34 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.098 2.532 . . . . 0.0 112.132 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 20' ' ' TYR . 20.5 m -126.35 164.03 27.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 C-N-CA 123.5 0.72 . . . . 0.0 110.234 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 27.4 m -105.73 134.5 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.9 mm -95.01 118.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 123.093 0.557 . . . . 0.0 110.195 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -8.62 12.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.587 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.465 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 5.9 pt20 -63.42 165.66 7.49 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -167.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -75.29 -173.14 1.95 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 111.823 -2.444 . . . . 0.0 113.423 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -79.55 -43.98 22.01 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.076 -1.874 . . . . 0.0 113.411 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 m -86.19 -25.73 25.49 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -168.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.52 -20.97 78.74 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.457 ' N ' HE22 ' A' ' 42' ' ' GLN . 31.2 t-20 -72.86 -32.33 65.36 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.834 -1.183 . . . . 0.0 108.526 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -90.04 -66.73 0.9 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.534 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -98.81 -35.62 10.07 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -168.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.596 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 15.2 t -75.54 128.76 83.4 Favored Pre-proline 0 N--CA 1.435 -1.199 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.801 -174.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.548 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 61.2 Cg_endo -74.72 -11.75 22.05 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.985 1.79 . . . . 0.0 110.155 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 p -107.56 121.39 44.55 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.935 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.465 ' HB ' ' OE1' ' A' ' 42' ' ' GLN . 1.3 m -121.73 167.5 15.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.856 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.714 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 13.7 tt -108.29 125.07 65.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 123.575 0.75 . . . . 0.0 112.054 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.648 HG22 ' CD2' ' A' ' 94' ' ' LEU . 3.7 m -137.48 163.56 30.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.59 ' CA ' HG13 ' A' ' 91' ' ' ILE . . . -123.08 131.21 53.6 Favored 'General case' 0 N--CA 1.416 -2.16 0 O-C-N 123.365 0.416 . . . . 0.0 111.172 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.587 ' H ' ' CG1' ' A' ' 91' ' ' ILE . . . -66.0 130.63 43.91 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.467 HG12 ' CD1' ' A' ' 86' ' ' ILE . 56.4 mt -85.49 138.31 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 112.661 -2.063 . . . . 0.0 106.994 174.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.2 t -148.36 179.99 7.37 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.64 162.72 32.67 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 68.21 79.35 0.22 Allowed 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.437 1.095 . . . . 0.0 111.718 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 tt -142.45 -7.43 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.783 175.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 71.73 -66.42 0.3 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.436 1.495 . . . . 0.0 112.502 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -113.63 129.66 56.53 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.402 0.62 . . . . 0.0 111.799 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.9 26.39 10.55 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.106 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -80.6 62.58 4.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.757 0.789 . . . . 0.0 112.119 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -143.35 137.12 14.37 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.4 9.34 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.254 1.969 . . . . 0.0 114.145 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.0 p -118.5 -6.49 10.71 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.083 0.468 . . . . 0.0 110.613 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.464 ' CD2' HD23 ' A' ' 87' ' ' LEU . 43.4 m170 -122.6 129.32 51.76 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.2 m -122.02 139.4 49.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.618 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -94.75 129.71 41.56 Favored 'General case' 0 C--O 1.251 1.177 0 CA-C-O 121.567 0.699 . . . . 0.0 111.081 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.573 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -120.6 158.57 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.23 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -79.18 128.65 33.57 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.681 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -47.48 -48.35 27.04 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 125.369 1.468 . . . . 0.0 110.699 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -56.35 -45.0 80.63 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 126.489 1.916 . . . . 0.0 112.64 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -71.79 -34.99 69.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.98 -175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.573 ' CE1' HG21 ' A' ' 73' ' ' ILE . 3.6 m-85 -95.3 -9.89 31.77 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.192 -176.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 61.46 29.95 18.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.883 1.273 . . . . 0.0 112.863 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 7.6 mp -88.73 -179.56 6.03 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.629 1.204 . . . . 0.0 112.973 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -73.7 -26.0 60.5 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.871 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -147.83 166.87 26.28 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -59.25 141.86 53.3 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 m -103.08 137.34 41.39 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.808 -168.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.42 137.62 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' A' ' 58' ' ' ILE . 20.3 mm -116.17 138.44 46.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD23 ' CD2' ' A' ' 70' ' ' HIS . 36.6 mt -104.46 140.78 37.46 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.482 ' HG ' ' HB2' ' A' ' 117' ' ' ALA . 3.3 mm? -111.83 2.01 16.86 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 122.28 1.038 . . . . 0.0 111.27 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -99.98 -33.45 10.5 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.93 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.587 ' HB3' ' CD1' ' A' ' 91' ' ' ILE . 1.1 tm0? -80.42 -2.71 46.84 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.861 -171.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.772 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -150.91 148.22 15.15 Favored 'Isoleucine or valine' 1 CA--C 1.421 -4.01 0 CA-C-O 117.516 -1.23 . . . . 0.0 112.651 -163.538 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.772 ' HG3' ' O ' ' A' ' 91' ' ' ILE 0.264 40.0 mtm-85 179.84 -53.04 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.767 1 N-CA-C 121.934 4.05 . . . . 0.0 121.934 -174.982 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.706 ' OG1' ' HB2' ' B' ' 92' ' ' ARG . 42.2 m -123.2 101.0 7.14 Favored 'General case' 0 N--CA 1.531 3.599 0 O-C-N 121.009 -1.057 . . . . 0.0 112.994 -170.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.648 ' CD2' HG22 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -132.1 126.11 32.96 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.646 -172.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 15.7 t0 -56.25 146.3 24.04 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.46 0.704 . . . . 0.0 111.375 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.596 ' HE2' ' O ' ' A' ' 50' ' ' SER . 67.8 mttm -53.95 -33.36 56.64 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.306 1.042 . . . . 0.0 111.692 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HG3' ' OD1' ' A' ' 95' ' ' ASP . 48.1 mttp -61.73 -22.16 65.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.28 0.632 . . . . 0.0 111.102 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 34.1 mtp180 -79.3 -37.85 36.72 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.2 mp -71.25 118.25 13.81 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.284 1.033 . . . . 0.0 111.242 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -99.2 -66.92 0.87 Allowed 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.3 pt-20 -156.11 144.46 19.96 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.475 0.655 . . . . 0.0 112.561 -165.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.633 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -65.38 119.89 11.81 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 128.243 2.617 . . . . 0.0 113.656 -178.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.505 HD23 HG13 ' A' ' 19' ' ' VAL 0.295 1.7 mm? -100.42 -64.1 1.07 Allowed 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 123.402 1.572 . . . . 0.0 110.405 174.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.568 ' CG2' ' H ' ' A' ' 105' ' ' TYR . 18.4 m -127.08 -178.96 4.62 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 111.608 -2.542 . . . . 0.0 111.871 -162.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.568 ' H ' ' CG2' ' A' ' 104' ' ' THR . 12.8 p90 -160.77 131.6 5.42 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.999 1.72 . . . . 0.0 110.473 -172.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -107.22 162.19 14.1 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.295 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 p -90.22 170.5 10.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.571 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 111' ' ' MET . 6.7 p-10 -63.6 -30.83 71.88 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.789 0.836 . . . . 0.0 112.901 -173.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -69.32 -36.86 77.39 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.52 0.676 . . . . 0.0 110.157 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 114' ' ' VAL . 72.3 mmtt -78.28 -29.73 48.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.877 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.498 ' HA ' ' HE2' ' A' ' 111' ' ' MET . 0.2 OUTLIER -52.69 -42.61 64.95 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 124.122 0.969 . . . . 0.0 109.483 169.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.515 ' CE ' ' HA ' ' A' ' 112' ' ' LYS . 7.2 mmpt? -68.04 -46.74 70.32 Favored 'General case' 1 N--CA 1.377 -4.119 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.27 -34.19 76.89 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 118.661 -1.216 . . . . 0.0 111.761 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 110' ' ' LYS . 20.9 m -71.24 -45.3 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.276 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.36 -52.87 62.99 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.365 0.602 . . . . 0.0 110.153 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . 0.326 51.2 m-20 -60.86 -52.87 63.23 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.91 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.482 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -51.32 -39.8 57.71 Favored 'General case' 0 CA--C 1.461 -2.472 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.748 -174.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.685 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 1.6 tp -68.43 -46.09 70.8 Favored 'General case' 1 N--CA 1.362 -4.84 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.455 -179.24 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 43.4 mtp -64.81 -34.59 78.72 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 56.4 mt -63.45 -52.7 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.6 t -53.91 -21.48 7.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.973 -1.921 . . . . 0.0 112.735 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 34.4 mt -111.36 -5.6 14.62 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.444 ' N ' ' HB3' ' B' ' 43' ' ' ASN . . . 76.63 23.97 68.76 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.399 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.422 ' HB3' ' SD ' ' B' ' 119' ' ' MET . 58.0 mt -83.02 -59.65 2.41 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 54.7 145.69 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.15 6.43 48.02 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.121 0.963 . . . . 0.0 110.411 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.7 t -131.6 99.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.639 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.25 28.69 5.69 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -96.28 -41.48 8.64 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.22 -173.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -87.57 -25.83 23.42 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -164.22 150.38 11.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 C--N 1.291 -1.957 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 171.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.161 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -87.6 107.05 18.42 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.108 0.48 . . . . 0.0 110.266 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 10.3 t -93.92 99.27 11.64 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -79.56 122.18 26.16 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -75.33 -31.71 60.68 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.632 0.582 . . . . 0.0 110.961 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -96.44 89.24 4.97 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -83.33 -46.42 12.62 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.333 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -127.43 168.21 15.18 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.612 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -123.36 135.8 54.34 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -86.06 -6.32 59.05 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.131 0.491 . . . . 0.0 110.412 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -69.32 118.25 11.97 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.129 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -98.69 120.83 58.05 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -53.91 134.69 60.51 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.114 1.876 . . . . 0.0 109.635 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 63.6 mt -62.27 122.34 12.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 O-C-N 123.363 0.414 . . . . 0.0 110.223 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -105.0 134.46 48.06 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -74.85 123.8 25.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 118.611 -1.235 . . . . 0.0 109.165 174.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.29 -5.98 28.51 Favored Glycine 0 C--N 1.301 -1.411 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.763 -176.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.29 165.23 12.49 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 121.574 0.702 . . . . 0.0 109.679 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 35.7 t -118.48 133.0 66.7 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.523 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.636 ' O ' HG23 ' B' ' 38' ' ' VAL . 39.6 m-85 -135.82 146.5 47.6 Favored 'General case' 0 C--O 1.188 -2.165 0 C-N-CA 124.857 1.263 . . . . 0.0 108.411 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 1.8 mp -74.32 148.94 40.91 Favored 'General case' 0 N--CA 1.407 -2.61 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.989 171.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -144.42 136.21 25.93 Favored 'General case' 0 C--N 1.264 -3.133 0 O-C-N 124.416 1.073 . . . . 0.0 110.163 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.87 94.4 3.33 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.082 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 9.5 mt -89.36 4.74 47.96 Favored 'General case' 0 C--O 1.199 -1.6 0 C-N-CA 124.6 1.16 . . . . 0.0 110.222 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.446 ' CB ' ' HD2' ' B' ' 26' ' ' PRO . 4.1 m -53.96 -177.11 0.04 OUTLIER Pre-proline 1 C--N 1.241 -4.132 0 C-N-CA 126.733 2.013 . . . . 0.0 112.564 173.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' B' ' 25' ' ' SER . 0.0 OUTLIER 20.17 35.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.405 3.549 1 C-N-CA 125.942 4.428 . . . . 0.0 119.414 -157.511 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 3.7 m -71.08 172.85 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.1 167.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -112.27 135.61 52.73 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.75 -112.15 4.12 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 114.785 -1.098 . . . . 0.0 114.362 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -93.43 -0.43 56.48 Favored 'General case' 0 N--CA 1.417 -2.102 0 C-N-CA 123.405 0.682 . . . . 0.0 112.275 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 77.4 mt-10 -61.14 141.1 57.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . 0.497 ' HG3' ' NH2' ' B' ' 36' ' ' ARG . 5.3 tp60 -116.05 112.81 22.31 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -169.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -127.95 -106.77 1.36 Allowed Glycine 1 N--CA 1.378 -5.208 0 C-N-CA 118.149 -1.977 . . . . 0.0 116.688 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 74.48 175.44 34.09 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 107.663 -2.175 . . . . 0.0 107.663 -168.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 p -89.19 108.98 19.72 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.393 0 O-C-N 120.475 -1.603 . . . . 0.0 108.73 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . 0.497 ' NH2' ' HG3' ' B' ' 32' ' ' GLN . 65.1 mtm180 -137.76 157.72 72.94 Favored Pre-proline 0 C--N 1.281 -2.397 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.429 -174.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.3 Cg_exo -66.29 138.65 51.9 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.061 2.507 . . . . 0.0 111.902 173.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.636 HG23 ' O ' ' B' ' 20' ' ' TYR . 20.6 m -126.9 162.71 31.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 123.74 0.816 . . . . 0.0 110.074 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.415 ' CG2' ' HB2' ' B' ' 56' ' ' ALA . 27.1 m -104.57 134.28 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 31.9 mm -94.23 118.64 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 122.835 0.454 . . . . 0.0 110.054 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 -8.8 12.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.577 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.461 HE22 ' N ' ' B' ' 47' ' ' ASN . 6.3 pt20 -63.51 165.71 7.6 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 -167.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.444 ' HB3' ' N ' ' A' ' 123' ' ' GLY . 14.3 p-10 -77.46 -174.19 3.23 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 112.088 -2.324 . . . . 0.0 113.413 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' B' ' 47' ' ' ASN . 2.7 t70 -72.44 -47.4 49.24 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 112.837 -1.983 . . . . 0.0 113.909 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -86.65 -25.71 24.73 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -165.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.75 -21.23 77.91 Favored Glycine 0 C--O 1.218 -0.889 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.461 ' N ' HE22 ' B' ' 42' ' ' GLN . 39.1 t-20 -72.77 -32.04 65.32 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.703 -1.248 . . . . 0.0 108.259 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.407 ' HZ2' ' CG ' ' B' ' 44' ' ' ASP . 24.0 mttt -91.64 -65.38 1.01 Allowed 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -100.15 -35.56 9.62 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -168.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.577 ' O ' ' HE2' ' B' ' 96' ' ' LYS . 14.6 t -76.93 132.23 71.62 Favored Pre-proline 0 N--CA 1.433 -1.323 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 62.3 Cg_endo -77.53 -11.12 17.25 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.792 1.661 . . . . 0.0 110.154 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 1.9 p -106.38 121.83 45.03 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.745 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.45 ' HB ' ' OE1' ' B' ' 42' ' ' GLN . 1.3 m -121.82 167.96 14.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.71 ' HA ' ' O ' ' B' ' 92' ' ' ARG . 13.8 tt -109.2 125.24 66.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 123.695 0.798 . . . . 0.0 112.099 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.644 HG22 ' CD2' ' B' ' 94' ' ' LEU . 3.7 m -137.72 163.97 29.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.593 ' CA ' HG13 ' B' ' 91' ' ' ILE . . . -123.47 130.8 53.22 Favored 'General case' 0 N--CA 1.415 -2.176 0 O-C-N 123.387 0.429 . . . . 0.0 111.317 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.577 ' H ' ' CG1' ' B' ' 91' ' ' ILE . . . -65.04 132.69 49.88 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.467 HG12 ' CD1' ' B' ' 86' ' ' ILE . 57.6 mt -89.26 134.08 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 112.645 -2.07 . . . . 0.0 107.346 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -144.88 179.68 7.17 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.72 166.91 33.02 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 65.59 77.94 0.29 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.196 0.998 . . . . 0.0 112.241 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 14.1 tt -140.88 -8.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.173 -0.922 . . . . 0.0 108.753 175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 73.81 -64.81 0.38 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.509 1.523 . . . . 0.0 112.218 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -117.03 128.02 54.75 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.19 0.519 . . . . 0.0 111.541 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.53 31.31 6.23 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.112 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -84.7 61.21 6.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.858 0.837 . . . . 0.0 111.763 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp -142.11 139.75 18.45 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -69.35 9.79 0.49 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.135 1.89 . . . . 0.0 113.599 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 72.9 p -117.61 -7.85 11.0 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.079 0.466 . . . . 0.0 110.748 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.579 ' CD2' HD23 ' B' ' 87' ' ' LEU . 61.9 m170 -123.23 129.34 51.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.19 139.72 48.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.541 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -97.11 130.6 44.36 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.698 0.761 . . . . 0.0 111.439 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.573 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -123.54 154.2 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.666 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -74.77 127.04 32.21 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.197 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -45.95 -44.76 15.09 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.173 1.389 . . . . 0.0 111.5 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -59.86 -45.31 92.86 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 126.392 1.877 . . . . 0.0 112.478 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -72.41 -35.19 68.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.93 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.573 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.8 m-85 -95.78 -6.02 40.57 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.704 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 57.06 31.68 20.36 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.439 1.096 . . . . 0.0 112.864 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.476 ' CD1' ' HB3' ' B' ' 78' ' ' TYR . 6.8 mp -87.8 -178.82 6.14 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.652 1.215 . . . . 0.0 112.844 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -75.51 -25.42 57.26 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.935 -1.939 . . . . 0.0 109.735 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -148.04 168.79 21.43 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -60.34 144.42 50.72 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.098 0.475 . . . . 0.0 109.826 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 8.0 m -103.25 136.79 42.37 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.61 -168.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.29 135.87 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.467 ' CD1' HG12 ' B' ' 58' ' ' ILE . 21.0 mm -114.89 138.1 46.23 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.834 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.579 HD23 ' CD2' ' B' ' 70' ' ' HIS . 31.4 mt -104.25 141.32 36.49 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.474 ' HB3' ' HA ' ' B' ' 118' ' ' LEU . 3.4 mm? -111.59 1.42 16.82 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-O 122.173 0.987 . . . . 0.0 111.296 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -100.77 -33.44 10.25 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.021 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . 0.579 ' HB3' HD12 ' B' ' 91' ' ' ILE . 1.0 OUTLIER -81.24 -2.03 47.21 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.531 -171.016 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.764 ' O ' ' HG3' ' B' ' 92' ' ' ARG . 0.0 OUTLIER -150.8 147.68 15.59 Favored 'Isoleucine or valine' 1 CA--C 1.418 -4.103 0 CA-C-O 117.6 -1.19 . . . . 0.0 112.429 -163.715 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.764 ' HG3' ' O ' ' B' ' 91' ' ' ILE 0.273 41.2 mtm-85 179.83 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.752 1 N-CA-C 121.929 4.048 . . . . 0.0 121.929 -174.913 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.691 ' OG1' ' HB2' ' A' ' 92' ' ' ARG . 29.8 m -122.84 101.04 7.21 Favored 'General case' 0 N--CA 1.531 3.593 0 O-C-N 121.029 -1.044 . . . . 0.0 112.871 -171.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.644 ' CD2' HG22 ' B' ' 55' ' ' VAL . 0.1 OUTLIER -132.17 125.72 31.89 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.57 -173.155 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.54 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 11.0 t0 -56.94 147.47 23.71 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.439 0.696 . . . . 0.0 111.674 172.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.577 ' HE2' ' O ' ' B' ' 50' ' ' SER . 67.8 mttm -54.49 -33.0 58.99 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.455 1.102 . . . . 0.0 111.833 177.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.44 ' HG3' ' OD1' ' B' ' 95' ' ' ASP . 44.9 mttp -62.26 -23.36 66.65 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.257 0.623 . . . . 0.0 111.192 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 32.9 mtp180 -78.13 -38.51 43.64 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' B' ' 21' ' ' LEU . 8.1 mp -70.26 118.1 12.66 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 124.189 0.995 . . . . 0.0 111.121 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -97.41 -69.67 0.75 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.678 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.8 pt-20 -156.52 149.08 23.59 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.584 0.707 . . . . 0.0 112.476 -166.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.616 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 2.3 ptmt -67.71 124.74 24.11 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 127.449 2.3 . . . . 0.0 114.93 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.505 HD23 HG13 ' B' ' 19' ' ' VAL 0.287 2.0 mm? -102.27 -63.73 1.13 Allowed 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 123.389 1.566 . . . . 0.0 110.548 174.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.543 ' CG2' ' H ' ' B' ' 105' ' ' TYR . 22.8 m -131.13 -177.75 4.53 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 111.508 -2.587 . . . . 0.0 112.299 -161.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.543 ' H ' ' CG2' ' B' ' 104' ' ' THR . 13.7 p90 -160.93 132.57 5.7 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.502 1.521 . . . . 0.0 111.185 -171.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 pp -107.0 161.83 14.39 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.276 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 5.1 p -90.66 172.69 8.49 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.082 0.467 . . . . 0.0 111.857 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.39 -31.59 72.87 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.705 0.802 . . . . 0.0 112.644 -174.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -69.2 -35.68 76.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.558 0.695 . . . . 0.0 109.277 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.557 ' O ' HG23 ' B' ' 114' ' ' VAL . 73.3 mmtt -79.15 -30.27 43.51 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.178 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.497 ' HE2' ' HA ' ' B' ' 111' ' ' MET . 0.2 OUTLIER -52.23 -41.79 63.04 Favored 'General case' 0 N--CA 1.42 -1.96 0 O-C-N 124.142 0.902 . . . . 0.0 109.132 169.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.536 ' HA ' ' CE ' ' B' ' 112' ' ' LYS . 6.5 mmpt? -67.9 -47.57 68.41 Favored 'General case' 1 N--CA 1.375 -4.212 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -178.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -64.8 -38.23 90.28 Favored 'General case' 0 N--CA 1.41 -2.437 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.469 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.557 HG23 ' O ' ' B' ' 110' ' ' LYS . 25.6 m -68.93 -46.58 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.651 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -57.33 -52.91 63.45 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.12 0.486 . . . . 0.0 110.421 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.358 86.2 m-20 -59.19 -54.29 48.55 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.004 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.43 ' HB2' ' HG ' ' B' ' 88' ' ' LEU . . . -56.22 -37.29 69.48 Favored 'General case' 0 CA--C 1.46 -2.512 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.072 -171.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.689 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.6 tp -66.22 -45.36 80.95 Favored 'General case' 1 N--CA 1.358 -5.042 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.846 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' A' ' 124' ' ' LEU . 47.0 mtp -66.15 -32.61 74.16 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 53.7 mt -64.49 -54.6 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.1 t -50.52 -22.59 2.02 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.184 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.689 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 31.5 mt -111.14 -4.65 14.96 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.1 23.28 74.76 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.449 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 52.4 mt -81.37 -58.62 2.96 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 52.27 145.13 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 127.118 2.167 . . . . 0.0 116.264 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.29 10.59 29.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.805 0.812 . . . . 0.0 110.84 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 41.3 t -136.12 99.78 2.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.432 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -124.93 22.54 8.02 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.076 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -89.77 -40.97 12.14 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.865 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -88.45 -30.68 19.24 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -160.19 145.3 14.91 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 C--N 1.284 -2.278 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 172.356 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.97 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p -88.79 108.34 19.46 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.713 0.768 . . . . 0.0 112.584 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.1 m -94.48 107.17 19.15 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -132.65 119.69 20.75 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.688 0.756 . . . . 0.0 112.247 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -95.24 -24.93 16.57 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 60.73 -83.64 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.643 1.577 . . . . 0.0 112.03 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -173.25 -86.61 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 57.19 -170.18 0.1 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.893 1.277 . . . . 0.0 113.061 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -77.53 142.06 39.26 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -73.55 152.7 40.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.585 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.04 103.07 1.76 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -86.17 113.48 52.29 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.92 165.14 24.66 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.544 2.163 . . . . 0.0 112.752 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.8 mt -57.73 122.54 7.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.144 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -108.69 151.01 26.75 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -71.2 124.11 23.74 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.65 -2.91 29.1 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.479 -1.343 . . . . 0.0 112.968 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -84.84 161.1 20.04 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 104' ' ' THR . 78.4 t -121.92 108.01 21.14 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.655 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.85 174.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.56 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.2 m-85 -99.56 147.02 25.78 Favored 'General case' 0 C--N 1.255 -3.506 0 C-N-CA 124.809 1.244 . . . . 0.0 109.567 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.5 mp -83.08 146.67 28.56 Favored 'General case' 0 N--CA 1.382 -3.851 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.33 140.09 32.02 Favored 'General case' 0 C--N 1.256 -3.497 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.972 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -84.98 90.48 7.84 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.571 ' O ' HG11 ' A' ' 27' ' ' VAL . 51.3 mt -73.58 -21.67 60.27 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.966 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.432 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 4.4 m -32.91 174.46 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.738 0 C-N-CA 129.064 2.945 . . . . 0.0 115.684 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.551 ' HB2' HE22 ' B' ' 28' ' ' GLN . 0.0 OUTLIER 23.38 52.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.414 -3.199 0 C-N-CA 123.094 2.529 . . . . 0.0 114.555 -151.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.571 HG11 ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -68.33 141.48 17.53 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 CA-C-N 112.385 -2.189 . . . . 0.0 110.026 171.093 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.583 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 84.8 mm-40 -89.84 120.16 30.84 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.965 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.19 -110.7 1.64 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.061 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.4 m -94.1 10.16 34.84 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 98.3 mt-10 -61.64 143.17 56.52 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.3 118.51 31.36 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.424 -169.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.05 -171.17 23.48 Favored Glycine 0 N--CA 1.414 -2.783 0 N-CA-C 120.093 2.797 . . . . 0.0 120.093 162.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.28 -152.58 6.9 Favored Glycine 0 C--N 1.264 -3.471 1 N-CA-C 102.349 -4.301 . . . . 0.0 102.349 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.1 113.22 15.93 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-N 121.125 2.462 . . . . 0.0 109.953 176.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -143.73 162.04 43.42 Favored Pre-proline 0 C--N 1.277 -2.569 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.195 -175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 19.9 Cg_exo -72.29 143.44 39.38 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.479 2.119 . . . . 0.0 111.5 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 28.6 m -128.69 160.09 39.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 124.197 0.999 . . . . 0.0 109.531 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.0 m -104.92 131.84 53.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.608 0.242 . . . . 0.0 110.553 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.3 mm -89.85 108.44 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.404 ' C ' HD12 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -106.8 -18.34 7.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.701 178.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.618 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -52.81 156.84 1.84 Allowed 'General case' 0 C--O 1.245 0.846 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -171.151 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -56.83 155.36 7.94 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-N 113.248 -1.796 . . . . 0.0 112.075 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.18 -27.44 62.57 Favored 'General case' 0 C--N 1.264 -3.112 0 CA-C-N 113.593 -1.64 . . . . 0.0 112.386 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.3 m -83.85 -37.18 22.79 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.29 -0.256 . . . . 0.0 111.102 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.01 -27.34 73.7 Favored Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.96 -33.66 70.89 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.127 0.489 . . . . 0.0 109.859 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 10.2 mmmm -93.22 -60.69 1.73 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.956 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.512 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 71.0 m-85 -93.83 -36.14 12.39 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -165.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.6 m -80.82 138.65 50.18 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.02 -17.9 40.72 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 121.899 1.733 . . . . 0.0 111.077 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 4.7 p -98.54 158.49 15.56 Favored 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 124.856 1.263 . . . . 0.0 111.498 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.618 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -152.51 138.87 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.196 0.598 . . . . 0.0 110.454 170.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.576 HG23 ' HG3' ' A' ' 42' ' ' GLN . 8.6 tt -83.69 135.06 25.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 CA-C-O 121.4 0.619 . . . . 0.0 110.476 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 32.8 m -139.27 156.26 27.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.481 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.473 ' CB ' HG23 ' A' ' 91' ' ' ILE . . . -115.79 139.33 50.28 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 138.45 43.78 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.575 HG12 ' CD1' ' A' ' 86' ' ' ILE . 64.1 mt -96.13 134.65 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 113.129 -1.85 . . . . 0.0 107.533 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.1 t -137.29 143.53 42.2 Favored 'General case' 0 N--CA 1.414 -2.27 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.591 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.72 162.6 37.74 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 107.106 -2.398 . . . . 0.0 107.106 170.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 67.36 -164.34 0.22 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.5 mm 68.69 82.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 122.446 1.117 . . . . 0.0 108.042 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -87.12 -10.54 52.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.558 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -84.62 82.31 8.47 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -117.45 12.86 14.32 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.389 0.614 . . . . 0.0 110.94 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -83.35 68.27 9.62 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 122.626 1.203 . . . . 0.0 108.321 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 tt -165.94 140.89 3.89 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -62.05 -10.93 19.44 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.647 2.231 . . . . 0.0 115.53 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.3 p -98.22 -16.38 19.46 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -113.1 128.7 56.56 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.91 125.7 70.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.372 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -91.7 118.63 30.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.51 0.672 . . . . 0.0 109.508 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.68 HG21 ' CE1' ' A' ' 78' ' ' TYR . 3.2 mm -96.09 158.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.607 -173.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.08 120.2 14.56 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 123.743 0.817 . . . . 0.0 110.221 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 85.6 tttt -46.67 -51.27 16.33 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 126.198 1.799 . . . . 0.0 111.575 176.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -56.93 -49.48 75.48 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 126.282 1.833 . . . . 0.0 112.111 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.441 ' HD3' ' OG ' ' A' ' 107' ' ' SER . 39.4 ttmt -69.22 -33.61 73.58 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.425 0.69 . . . . 0.0 110.535 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.68 ' CE1' HG21 ' A' ' 73' ' ' ILE . 3.2 m-85 -88.63 -11.19 46.1 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.617 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.4 tttm 67.22 24.63 9.13 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.433 0.693 . . . . 0.0 111.16 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.408 HD13 ' HB3' ' A' ' 78' ' ' TYR . 7.2 mp -94.86 178.62 5.51 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-O 122.616 1.198 . . . . 0.0 112.44 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.411 ' O ' ' HE3' ' A' ' 75' ' ' LYS . 2.2 m-20 -73.54 -20.71 60.57 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 112.555 -2.111 . . . . 0.0 111.733 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 83' ' ' ASP . 11.6 ptmm? -158.48 169.97 23.25 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 9.9 p-10 -51.85 135.96 29.0 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 m -109.12 135.5 50.16 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.4 t -107.69 135.86 44.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.575 ' CD1' HG12 ' A' ' 58' ' ' ILE . 18.2 mm -112.19 135.39 51.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.0 mt -104.49 106.23 16.65 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.409 ' HG ' ' HB2' ' A' ' 117' ' ' ALA . 3.7 mm? -84.05 -5.61 59.26 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.687 -174.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -91.62 -39.56 11.81 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.986 174.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.05 79.32 4.07 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.325 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.473 HG23 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -114.73 -176.78 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -166.61 173.68 9.49 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.865 0.364 . . . . 0.0 111.57 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 67.5 m -123.34 124.32 42.69 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.2 mt -130.88 142.8 50.4 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.688 -171.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.9 p30 -74.56 152.39 39.32 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.352 174.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -47.54 -27.5 1.83 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.902 1.281 . . . . 0.0 114.31 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.3 -18.49 57.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 120.867 0.365 . . . . 0.0 111.433 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.21 -34.09 65.73 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.8 mp -76.63 126.16 30.49 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.248 1.419 . . . . 0.0 110.145 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -91.96 -67.33 0.86 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.744 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 14.6 pt-20 -153.25 152.88 31.67 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.518 -166.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.431 ' HE2' ' OH ' ' A' ' 20' ' ' TYR . 70.6 mttt -73.41 123.94 24.82 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.776 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.546 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 18.8 tp -109.38 -60.99 1.69 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 122.653 1.216 . . . . 0.0 108.438 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.546 ' OG1' ' HG ' ' A' ' 103' ' ' LEU . 2.3 m -127.36 178.72 5.87 Favored 'General case' 0 N--CA 1.381 -3.879 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.227 -166.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.43 ' N ' HG22 ' A' ' 104' ' ' THR . 2.9 p90 -160.45 139.69 10.72 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 125.121 1.368 . . . . 0.0 109.903 -169.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 pp -115.05 161.59 18.15 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.252 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.441 ' OG ' ' HD3' ' A' ' 77' ' ' LYS . 34.3 p -88.12 172.66 9.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.174 0.512 . . . . 0.0 111.628 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 111' ' ' MET . 28.3 t70 -66.14 -30.35 70.81 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.112 0.565 . . . . 0.0 111.855 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -69.47 -30.61 68.53 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.431 ' O ' HG22 ' A' ' 114' ' ' VAL . 14.4 tppt? -77.65 -30.11 51.99 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.585 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -49.04 -47.12 45.01 Favored 'General case' 0 CA--C 1.48 -1.738 0 O-C-N 123.896 0.747 . . . . 0.0 110.75 171.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.753 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -65.64 -34.58 78.56 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.807 -178.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.84 -41.68 59.4 Favored 'General case' 0 N--CA 1.4 -2.944 0 C-N-CA 118.176 -1.41 . . . . 0.0 112.121 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 110' ' ' LYS . 19.7 m -67.16 -45.35 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 118.921 -0.561 . . . . 0.0 112.103 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -54.28 -51.69 63.78 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 123.2 1.476 . . . . 0.0 109.397 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.753 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -76.31 -30.58 57.76 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 112.998 -1.91 . . . . 0.0 115.031 -172.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.409 ' HB2' ' HG ' ' A' ' 88' ' ' LEU . . . -70.68 -41.9 71.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.556 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 1.9 tp -62.33 -44.19 97.08 Favored 'General case' 0 N--CA 1.394 -3.237 0 C-N-CA 125.479 1.511 . . . . 0.0 108.741 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.657 ' CG ' ' HA ' ' A' ' 125' ' ' ASN . 21.2 ttm -48.61 -37.46 18.22 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.5 mt -82.5 -50.12 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.665 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.5 m -48.81 -35.56 14.75 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.02 -1.9 . . . . 0.0 112.722 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 23.1 mt -103.19 -3.03 26.32 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 120.055 -0.658 . . . . 0.0 112.028 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.34 29.52 58.17 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 117.359 1.704 . . . . 0.0 117.359 172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.467 HD11 HD11 ' B' ' 124' ' ' LEU . 0.2 OUTLIER -100.05 -46.02 5.47 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 118.947 1.373 . . . . 0.0 111.897 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.657 ' HA ' ' CG ' ' A' ' 119' ' ' MET . 1.6 t-20 49.29 -160.3 0.05 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.087 -168.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 128' ' ' ALA . . . -81.76 82.47 7.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.2 p 61.7 -5.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 129.19 2.996 . . . . 0.0 114.216 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 126' ' ' ALA . . . -153.08 116.55 4.68 Favored 'General case' 0 C--N 1.271 -2.828 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -77.27 -33.16 55.93 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.497 0.498 . . . . 0.0 109.948 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -109.86 137.79 47.14 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -90.47 97.54 11.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--N 1.289 -2.048 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -178.407 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.472 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p -89.21 99.06 12.13 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.122 0.487 . . . . 0.0 112.173 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 48.3 m -81.02 108.95 15.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 173.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -129.64 127.77 41.27 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.443 0.64 . . . . 0.0 112.17 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -103.3 -26.06 13.08 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 63.42 -83.07 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.717 1.607 . . . . 0.0 112.216 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -172.47 -83.06 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 54.17 -173.55 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.625 1.17 . . . . 0.0 113.963 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -77.98 132.44 37.84 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.2 m -67.62 147.48 52.67 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.628 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -61.27 113.95 2.9 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -95.13 113.72 62.11 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.71 168.08 14.1 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 122.42 2.08 . . . . 0.0 112.365 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt -61.97 122.76 13.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -108.88 145.71 34.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -66.23 125.98 27.27 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.65 -5.81 31.25 Favored Glycine 0 N--CA 1.426 -1.974 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.694 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -83.4 162.97 20.85 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.42 HG23 HG22 ' B' ' 104' ' ' THR . 75.1 t -122.53 110.14 26.02 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.766 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.732 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 30.3 m-85 -101.44 146.3 27.8 Favored 'General case' 0 C--N 1.26 -3.32 0 C-N-CA 124.875 1.27 . . . . 0.0 109.779 176.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 3.8 mp -81.13 146.14 30.7 Favored 'General case' 0 N--CA 1.388 -3.569 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 166.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.33 141.11 33.88 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.931 -173.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -85.58 89.19 7.65 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.597 ' O ' HG11 ' B' ' 27' ' ' VAL . 56.9 mt -73.03 -22.09 60.7 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.073 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 3.8 m -33.14 175.02 0.0 OUTLIER Pre-proline 0 CA--C 1.573 1.859 0 C-N-CA 129.433 3.093 . . . . 0.0 115.603 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.583 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 0.0 OUTLIER 23.8 50.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.119 0 C-N-CA 123.205 2.603 . . . . 0.0 114.998 -152.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.597 HG11 ' O ' ' B' ' 24' ' ' LEU . 0.5 OUTLIER -68.18 143.09 15.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.107 172.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . 0.551 HE22 ' HB2' ' A' ' 26' ' ' PRO . 82.8 mm-40 -89.72 118.86 29.63 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.942 -1.481 . . . . 0.0 112.301 -173.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.3 -108.72 1.4 Allowed Glycine 0 C--N 1.309 -0.935 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.584 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 43.9 m -94.71 8.67 41.69 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.491 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 98.8 mt-10 -61.56 142.59 56.99 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 173.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.84 117.65 30.38 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 122.374 -0.204 . . . . 0.0 111.351 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.36 -173.85 22.54 Favored Glycine 0 N--CA 1.412 -2.942 0 N-CA-C 120.327 2.891 . . . . 0.0 120.327 163.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . -161.28 -151.87 6.42 Favored Glycine 0 C--N 1.264 -3.459 1 N-CA-C 102.124 -4.391 . . . . 0.0 102.124 177.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.49 114.96 18.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-N 120.997 2.399 . . . . 0.0 109.867 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -145.21 161.6 41.2 Favored Pre-proline 0 C--N 1.284 -2.271 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.113 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 21.2 Cg_exo -71.91 143.15 40.35 Favored 'Trans proline' 0 CA--C 1.551 1.366 0 C-N-CA 122.599 2.199 . . . . 0.0 111.86 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 29.7 m -127.91 159.64 38.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 124.129 0.971 . . . . 0.0 109.754 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 34.1 m -103.76 132.56 49.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 CA-C-O 120.642 0.258 . . . . 0.0 110.357 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 24.4 mm -91.04 107.13 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.86 -18.89 6.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.89 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.599 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 0.0 OUTLIER -52.14 157.24 1.4 Allowed 'General case' 0 C--O 1.245 0.845 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -170.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.412 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 10.9 p-10 -56.88 158.17 5.03 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 113.182 -1.826 . . . . 0.0 112.325 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.49 -28.76 62.1 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 113.615 -1.629 . . . . 0.0 112.096 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 56.9 m -85.2 -35.24 21.76 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.175 -0.328 . . . . 0.0 111.764 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.5 -26.2 74.48 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -60.39 -32.74 71.6 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.12 0.486 . . . . 0.0 109.845 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 11.0 mmmm -93.1 -63.35 1.23 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.136 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.522 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 67.6 m-85 -91.89 -35.82 13.83 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -166.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 45.5 m -82.06 138.49 45.97 Favored Pre-proline 0 C--N 1.308 -1.212 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.66 -18.74 37.3 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 121.927 1.752 . . . . 0.0 111.178 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 3.0 p -98.81 155.64 17.26 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 124.781 1.232 . . . . 0.0 111.269 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.599 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -150.25 138.75 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 O-C-N 123.585 0.553 . . . . 0.0 110.387 171.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.544 HG23 ' HG3' ' B' ' 42' ' ' GLN . 8.8 tt -83.45 134.02 27.85 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 CA-C-O 121.46 0.647 . . . . 0.0 110.576 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 32.3 m -138.47 155.25 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.494 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.486 ' CB ' HG23 ' B' ' 91' ' ' ILE . . . -115.26 139.54 49.87 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.09 138.43 43.94 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.551 HG12 ' CD1' ' B' ' 86' ' ' ILE . 61.2 mt -96.14 134.48 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.285 -1.78 . . . . 0.0 107.422 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -137.46 141.42 41.58 Favored 'General case' 0 N--CA 1.405 -2.718 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.87 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.41 161.94 37.69 Favored Glycine 0 N--CA 1.419 -2.455 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 69.65 -168.85 0.17 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.747 0.773 . . . . 0.0 109.503 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 33.5 mm 69.36 84.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -89.87 -9.57 48.52 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.085 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -85.87 82.34 8.19 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.75 14.28 15.27 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 25.7 ttmm -84.71 68.51 10.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.397 1.094 . . . . 0.0 108.308 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 7.9 tt -165.04 138.0 3.69 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.21 -5.84 7.23 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.797 2.331 . . . . 0.0 115.538 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 80.6 p -102.05 -16.19 16.52 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.334 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.424 ' CD2' HD21 ' B' ' 87' ' ' LEU . 46.4 m170 -112.34 128.5 56.3 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -126.57 126.3 68.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.76 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -92.6 123.35 35.83 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.556 0.693 . . . . 0.0 109.373 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.66 HG21 ' CE1' ' B' ' 78' ' ' TYR . 2.8 mm -100.77 155.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.946 -173.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -64.73 119.98 11.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 123.996 0.918 . . . . 0.0 110.527 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . 0.489 ' HE3' ' O ' ' B' ' 81' ' ' ASP . 85.7 tttt -48.2 -49.08 34.23 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 126.504 1.922 . . . . 0.0 111.408 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -60.6 -45.85 92.44 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 125.871 1.668 . . . . 0.0 111.76 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -72.27 -33.78 67.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.71 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.66 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.2 m-85 -87.83 -11.1 48.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.247 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 66.44 26.34 10.09 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 121.748 0.785 . . . . 0.0 111.07 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.413 HD11 ' O ' ' B' ' 78' ' ' TYR . 6.8 mp -95.09 -178.76 4.58 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-O 122.448 1.118 . . . . 0.0 112.658 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.489 ' O ' ' HE3' ' B' ' 75' ' ' LYS . 4.9 m-20 -70.57 -28.64 65.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.104 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -154.04 171.21 19.45 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -53.69 135.66 40.68 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 7.1 m -109.44 135.49 50.39 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 t -107.73 136.55 42.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.551 ' CD1' HG12 ' B' ' 58' ' ' ILE . 13.7 mm -113.78 135.36 53.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.424 HD21 ' CD2' ' B' ' 70' ' ' HIS . 44.5 mt -104.78 104.88 14.74 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.28 -7.41 59.63 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.594 -174.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -90.99 -38.49 12.8 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.1 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.26 77.73 3.46 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.26 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.486 HG23 ' CB ' ' B' ' 56' ' ' ALA . 2.4 pp -113.45 -176.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -166.47 174.06 9.3 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 123.329 0.393 . . . . 0.0 111.55 172.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 68.8 m -123.63 124.62 43.18 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 74.7 mt -131.28 142.98 50.21 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.8 -171.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 3.9 p-10 -74.95 152.66 38.79 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.412 174.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -46.04 -30.0 1.69 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.019 1.328 . . . . 0.0 114.222 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.05 -19.75 60.52 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 120.945 0.402 . . . . 0.0 111.289 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -72.32 -34.11 67.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.407 ' HB3' ' CD2' ' B' ' 20' ' ' TYR . 7.8 mp -77.17 125.76 29.85 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.147 1.379 . . . . 0.0 110.174 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -93.3 -64.72 1.06 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.37 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -155.06 151.1 27.97 Favored 'General case' 0 N--CA 1.407 -2.587 0 CA-C-O 121.632 0.73 . . . . 0.0 111.283 -169.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.453 ' HE2' ' OH ' ' B' ' 20' ' ' TYR . 67.2 mttt -70.85 126.19 28.91 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.755 174.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.48 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 18.8 tp -112.14 -62.02 1.63 Allowed 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.731 1.253 . . . . 0.0 108.657 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.48 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 1.6 m -125.98 178.44 5.75 Favored 'General case' 0 N--CA 1.383 -3.823 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.356 -166.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.434 ' H ' ' CG2' ' B' ' 104' ' ' THR . 6.1 p90 -160.74 137.7 8.97 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.825 1.25 . . . . 0.0 109.991 -170.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -110.98 164.0 13.25 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.748 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -91.96 171.56 9.04 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.548 0.213 . . . . 0.0 111.177 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' B' ' 111' ' ' MET . 27.6 t70 -62.75 -28.69 70.14 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.232 0.539 . . . . 0.0 111.39 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -70.11 -29.11 65.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.837 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.485 ' O ' HG21 ' B' ' 114' ' ' VAL . 14.1 tppt? -81.16 -29.26 34.74 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.812 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.1 OUTLIER -47.81 -43.5 27.92 Favored 'General case' 0 CA--C 1.445 -3.078 0 O-C-N 124.173 0.921 . . . . 0.0 109.964 170.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.493 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 6.9 mmpt? -61.15 -54.02 49.66 Favored 'General case' 1 N--CA 1.37 -4.451 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.675 -178.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . 0.435 ' CD ' ' HZ3' ' B' ' 110' ' ' LYS . 29.2 mt-10 -62.41 -43.88 97.76 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.092 -177.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.485 HG21 ' O ' ' B' ' 110' ' ' LYS . 20.6 m -63.21 -43.14 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 123.67 0.606 . . . . 0.0 111.814 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -56.5 -54.85 40.96 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 123.479 0.487 . . . . 0.0 111.08 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' B' ' 119' ' ' MET 0.273 17.3 m-80 -61.7 -45.26 94.74 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.242 0.544 . . . . 0.0 110.252 -177.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.54 -43.86 97.77 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.003 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.6 tp -63.03 -46.59 86.86 Favored 'General case' 0 N--CA 1.387 -3.612 0 C-N-CA 124.287 1.035 . . . . 0.0 108.338 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.741 ' SD ' ' HA ' ' B' ' 125' ' ' ASN . 15.4 ttm -49.63 -44.08 47.15 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 29.9 mt -72.34 -50.87 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 45.8 m -49.79 -34.07 18.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.485 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 22.3 mt -102.8 -4.19 25.29 Favored 'General case' 0 C--O 1.198 -1.627 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.116 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.78 30.76 55.6 Favored Glycine 0 C--N 1.341 0.848 0 N-CA-C 117.469 1.747 . . . . 0.0 117.469 172.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -101.89 -47.27 4.64 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.696 1.248 . . . . 0.0 112.511 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.741 ' HA ' ' SD ' ' B' ' 119' ' ' MET 0.345 14.1 m120 48.16 -158.56 0.05 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.528 -167.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' B' ' 128' ' ' ALA . . . -82.7 79.62 9.05 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.932 -1.105 . . . . 0.0 110.445 -175.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.44 HG13 ' O ' ' B' ' 126' ' ' ALA . 7.3 p 65.26 -4.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 129.19 2.996 . . . . 0.0 113.024 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' B' ' 126' ' ' ALA . . . -150.02 123.23 8.91 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.355 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.416 ' HA ' ' HB2' ' B' ' 125' ' ' ASN . 41.7 t-80 -85.49 -30.07 23.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.774 0.797 . . . . 0.0 109.072 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -111.82 131.19 55.51 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -87.55 91.15 8.64 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--N 1.291 -1.954 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.913 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.3 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.6 t 73.4 18.54 3.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.892 1.277 . . . . 0.0 111.364 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 p -90.57 -3.71 57.38 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 122.133 -0.354 . . . . 0.0 111.112 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -76.53 102.04 5.9 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -87.05 -16.63 35.04 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.45 135.1 54.6 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -81.35 85.96 6.35 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.191 0.996 . . . . 0.0 110.934 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -96.98 -8.2 31.14 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.662 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -94.76 -53.3 3.91 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.8 m 48.65 80.91 0.05 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.038 1.335 . . . . 0.0 113.114 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -123.08 130.42 52.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.03 140.58 80.61 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 150.54 59.07 Favored 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 122.195 1.93 . . . . 0.0 112.212 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.34 142.04 13.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -146.77 160.72 41.9 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -77.64 122.11 24.87 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.533 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' HA2' ' SD ' ' A' ' 111' ' ' MET . . . 142.8 -30.63 2.04 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 119.395 -1.383 . . . . 0.0 113.996 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -100.43 173.87 6.37 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 118.075 0.937 . . . . 0.0 111.658 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 105' ' ' TYR . 54.0 t -110.98 138.71 38.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.836 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.516 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 92.2 m-85 -137.32 147.11 45.37 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 126.26 1.824 . . . . 0.0 108.731 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.2 mp -86.57 157.38 19.75 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 171.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.7 146.6 32.29 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.865 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -82.46 108.77 16.12 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.643 0.735 . . . . 0.0 109.63 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.578 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 15.4 mt -108.91 28.26 8.64 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 123.698 1.713 . . . . 0.0 109.073 -175.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.523 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 15.1 m -73.55 -178.62 0.75 Allowed Pre-proline 1 C--N 1.213 -5.358 0 CA-C-N 112.732 -2.031 . . . . 0.0 108.714 169.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.1 OUTLIER 17.23 42.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.148 0 C-N-CA 124.976 3.784 . . . . 0.0 118.016 -159.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 24' ' ' LEU . 5.2 m -70.2 174.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.054 0 CA-C-O 122.328 1.061 . . . . 0.0 112.234 172.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -92.49 110.56 21.97 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.005 -1.452 . . . . 0.0 114.198 -174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.65 -108.69 0.75 Allowed Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 113.918 -1.492 . . . . 0.0 114.784 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.7 m -86.58 13.85 7.85 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 36.0 mt-10 -67.4 -175.29 0.47 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.887 0.851 . . . . 0.0 112.063 173.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.58 ' NE2' ' HG3' ' A' ' 36' ' ' ARG . 12.1 tm0? -106.47 126.59 52.45 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -111.54 163.65 12.2 Favored Glycine 0 CA--C 1.498 -0.989 0 N-CA-C 116.871 1.508 . . . . 0.0 116.871 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.8 171.64 18.96 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 113.614 -1.293 . . . . 0.0 110.51 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.53 102.08 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.669 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.58 ' HG3' ' NE2' ' A' ' 32' ' ' GLN . 26.0 mmt180 -128.55 151.91 77.58 Favored Pre-proline 0 C--N 1.251 -3.715 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.88 -174.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 23.4 Cg_exo -65.46 144.92 81.32 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.839 2.359 . . . . 0.0 112.54 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 30.1 m -129.23 154.97 40.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.619 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.559 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 29.7 m -99.32 128.69 50.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.496 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.5 mm -92.24 106.44 17.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.06 -6.57 10.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.817 0.817 . . . . 0.0 109.085 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.529 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -51.15 146.64 6.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 125.853 1.661 . . . . 0.0 113.946 -170.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -60.95 -179.01 0.11 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.098 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 19.0 t70 -77.27 -48.54 17.2 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.151 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -70.25 -28.58 65.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.542 -171.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.01 -28.15 73.7 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.518 ' N ' HE22 ' A' ' 42' ' ' GLN . 87.0 m-20 -75.84 -37.59 58.88 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.278 0.561 . . . . 0.0 110.174 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HB2' ' CD2' ' A' ' 49' ' ' TYR . 49.8 mmtt -79.31 -61.6 1.95 Allowed 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.257 -176.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 55.7 m-85 -111.24 6.6 20.71 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -167.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -119.84 141.6 31.59 Favored Pre-proline 0 C--N 1.306 -1.298 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.314 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -74.17 -23.34 15.83 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.073 1.848 . . . . 0.0 110.366 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -85.17 154.71 21.82 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.813 -175.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.447 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 57.9 t -138.4 140.07 40.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.529 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 3.8 tp -99.08 125.56 52.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 171.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.447 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 21.6 m -132.68 166.54 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.743 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.559 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . . . -124.88 141.19 52.28 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.53 130.76 42.06 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.486 HG12 HD13 ' A' ' 86' ' ' ILE . 56.1 mt -90.13 120.42 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.085 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.9 m -119.3 155.47 31.76 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.79 -177.9 42.82 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 17.6 tpt180 -57.73 108.42 0.57 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 122.882 0.473 . . . . 0.0 110.836 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.9 pt -127.82 -28.58 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.422 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -160.42 147.14 15.66 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -170.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -86.73 137.74 32.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.38 80.9 0.76 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.163 0.982 . . . . 0.0 113.16 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -90.08 -38.75 13.35 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.911 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 tt -97.95 136.26 21.15 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.71 -1.1 4.47 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.198 2.599 . . . . 0.0 115.869 -175.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.1 p -91.32 -18.74 23.83 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-O 121.728 0.775 . . . . 0.0 109.432 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -101.5 129.26 47.53 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.18 127.81 69.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -99.08 131.08 45.38 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.088 0.47 . . . . 0.0 110.472 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.417 HD11 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -124.78 145.99 31.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.47 123.91 13.38 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 126.304 1.842 . . . . 0.0 113.332 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -58.67 -39.4 80.54 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.702 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -61.48 -27.76 68.8 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.974 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -91.43 -35.47 14.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.103 0.954 . . . . 0.0 109.549 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.403 ' OH ' HD22 ' A' ' 106' ' ' LEU . 32.9 m-85 -96.16 13.41 27.42 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.366 -171.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt 59.7 39.29 21.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.566 1.146 . . . . 0.0 114.064 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.86 174.31 7.62 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.792 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.0 -16.25 26.77 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.076 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -133.34 152.06 51.9 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 61' ' ' ARG . 9.6 p-10 -69.11 157.17 37.39 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.902 0.382 . . . . 0.0 110.308 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.3 t -103.41 151.79 22.36 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.388 -172.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.37 124.32 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.486 HD13 HG12 ' A' ' 58' ' ' ILE . 20.1 mm -100.95 130.36 50.45 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.662 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 76.6 mt -102.59 102.91 13.18 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.41 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -82.58 6.29 18.13 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.901 -174.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.16 -38.31 6.31 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.285 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -83.82 69.33 10.21 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.826 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.482 HG21 ' CB ' ' A' ' 56' ' ' ALA . 2.1 pp -111.44 -179.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.723 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.423 ' O ' HD11 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -167.28 165.31 15.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.2 m -118.19 118.73 32.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.1 mt -131.69 138.51 48.72 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.8 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 4.5 p-10 -73.91 152.1 40.24 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.015 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -47.69 -20.52 0.28 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.825 1.65 . . . . 0.0 115.197 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -71.39 -26.36 62.74 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.91 0.884 . . . . 0.0 110.735 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -74.26 -34.5 63.61 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.205 0.526 . . . . 0.0 110.212 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.52 124.98 26.32 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.657 1.183 . . . . 0.0 109.973 176.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -101.93 -60.17 1.58 Allowed 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -147.88 138.61 23.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.716 0.77 . . . . 0.0 112.719 -166.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 28.9 tttp -66.1 116.14 6.88 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 127.673 2.389 . . . . 0.0 107.414 174.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -110.16 -60.23 1.83 Allowed 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.76 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.479 HG21 HG22 ' A' ' 19' ' ' VAL . 10.6 t -127.64 -157.41 0.81 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.591 ' O ' HG23 ' A' ' 19' ' ' VAL . 38.0 m-85 -123.48 -89.0 0.6 Allowed 'General case' 0 C--O 1.177 -2.763 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.573 -172.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 1.5 mt 139.75 151.97 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 131.358 3.863 . . . . 0.0 105.484 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 79.0 p -97.59 154.49 17.5 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.746 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.485 ' O ' ' HD2' ' A' ' 112' ' ' LYS . 4.9 m-20 -58.54 -36.96 74.7 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 18.4 p-10 -76.74 -41.52 44.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.396 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -67.64 -25.63 65.83 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.544 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.479 ' HA ' ' HE3' ' A' ' 111' ' ' MET . 0.0 OUTLIER -53.71 -42.28 67.86 Favored 'General case' 0 N--CA 1.416 -2.146 0 C-N-CA 124.122 0.969 . . . . 0.0 110.421 171.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.65 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -71.25 -25.44 62.47 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.367 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.55 ' HA ' ' ND2' ' A' ' 116' ' ' ASN . 10.6 mt-10 -87.08 -35.19 18.85 Favored 'General case' 0 N--CA 1.394 -3.227 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.762 -171.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.75 -47.04 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.016 0 CA-C-N 112.856 -1.975 . . . . 0.0 108.501 169.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.505 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 68.5 m-20 -58.39 -52.82 63.98 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.129 0.49 . . . . 0.0 111.054 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.617 ' O ' HG13 ' A' ' 120' ' ' ILE . 3.8 p30 -64.85 -42.96 94.47 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.109 -0.637 . . . . 0.0 111.743 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.41 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.32 -38.21 71.0 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.22 0.534 . . . . 0.0 109.903 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.505 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 8.9 tp -69.94 -46.27 65.66 Favored 'General case' 0 N--CA 1.392 -3.374 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.921 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.529 ' O ' ' HB2' ' A' ' 124' ' ' LEU . 3.1 ttp -68.06 -23.48 64.96 Favored 'General case' 0 N--CA 1.408 -2.566 0 C-N-CA 124.161 0.984 . . . . 0.0 110.298 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.617 HG13 ' O ' ' A' ' 116' ' ' ASN . 49.7 mt -79.9 -54.47 11.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 174.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.5 t -47.71 -44.79 28.03 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 125.787 1.635 . . . . 0.0 112.584 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.7 mp -82.85 10.65 7.3 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.86 85.17 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 119' ' ' MET . 1.3 mm? -67.74 -63.48 1.05 Allowed 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 118.106 0.953 . . . . 0.0 109.121 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 61.08 144.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.244 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.48 11.14 27.08 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.212 1.006 . . . . 0.0 110.105 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.67 95.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.72 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 66.27 66.1 0.48 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.043 -1.435 . . . . 0.0 112.865 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -83.44 -59.98 2.28 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -103.05 135.81 44.04 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt 71.83 104.66 0.07 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.65 1.18 . . . . 0.0 111.979 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.666 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.64 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 38.7 t 70.56 11.66 7.32 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.482 1.113 . . . . 0.0 112.684 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 6.4 p -90.28 6.27 43.65 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.779 -0.576 . . . . 0.0 111.715 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -82.5 92.51 7.08 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -81.71 -16.71 50.31 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 122.297 1.046 . . . . 0.0 109.44 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -118.29 129.24 55.34 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -82.24 84.64 7.02 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.319 1.057 . . . . 0.0 110.637 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -98.38 -2.51 39.04 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.616 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -95.07 -51.31 4.7 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 46.2 m 49.72 80.45 0.07 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.521 1.128 . . . . 0.0 113.543 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -125.25 133.87 52.52 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -82.1 139.34 45.76 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.89 148.14 75.96 Favored 'Trans proline' 0 C--O 1.251 1.145 0 C-N-CA 122.289 1.993 . . . . 0.0 112.351 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 73.1 mt -91.51 140.52 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -146.03 160.45 41.86 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -76.22 125.81 29.84 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.469 ' HA2' ' SD ' ' B' ' 111' ' ' MET . . . 140.12 -34.49 2.0 Allowed Glycine 0 N--CA 1.425 -2.081 0 C-N-CA 119.507 -1.33 . . . . 0.0 113.617 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -100.11 174.21 6.27 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 118.078 0.939 . . . . 0.0 111.992 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 105' ' ' TYR . 53.5 t -110.36 139.42 33.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.115 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.573 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 89.7 m-85 -137.57 147.67 45.28 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 126.072 1.749 . . . . 0.0 109.191 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.0 mp -88.16 156.33 19.3 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.19 147.64 32.67 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.956 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -82.61 107.66 15.42 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.205 1.003 . . . . 0.0 110.346 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.647 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 10.8 mt -108.9 28.01 8.9 Favored 'General case' 0 CA--C 1.484 -1.578 0 CA-C-O 123.451 1.596 . . . . 0.0 109.206 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.526 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 15.3 m -76.45 -178.62 0.97 Allowed Pre-proline 1 C--N 1.216 -5.223 0 CA-C-N 112.785 -2.007 . . . . 0.0 107.759 170.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 17.1 43.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.393 2.873 1 C-N-CA 125.396 4.064 . . . . 0.0 118.029 -160.374 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.434 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 4.9 m -70.4 177.93 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.972 0 CA-C-O 122.171 0.986 . . . . 0.0 112.154 172.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -94.05 116.3 28.71 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.59 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.97 -108.65 0.77 Allowed Glycine 0 CA--C 1.499 -0.91 0 CA-C-N 114.622 -1.172 . . . . 0.0 114.966 172.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 10.3 m -90.97 10.55 26.08 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.544 -0.828 . . . . 0.0 113.06 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 34.9 mt-10 -62.82 -179.97 0.32 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.868 0.842 . . . . 0.0 112.777 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . 0.58 ' NE2' ' HG3' ' B' ' 36' ' ' ARG . 0.0 OUTLIER -100.2 121.71 41.88 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -106.01 155.0 16.88 Favored Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.88 176.63 15.52 Favored Glycine 0 C--N 1.307 -1.08 0 CA-C-N 113.383 -1.409 . . . . 0.0 110.19 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.97 99.67 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . 0.58 ' HG3' ' NE2' ' B' ' 32' ' ' GLN . 29.5 mmt180 -126.52 150.96 72.14 Favored Pre-proline 0 C--N 1.245 -3.974 0 CA-C-N 113.822 -1.536 . . . . 0.0 111.02 -172.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 25.1 Cg_exo -64.92 144.99 84.75 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 122.439 2.093 . . . . 0.0 112.208 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 31.0 m -129.15 155.23 41.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.453 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.555 ' CG2' ' HB2' ' B' ' 56' ' ' ALA . 30.7 m -99.87 129.01 51.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 21.7 mm -92.37 107.07 18.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.31 -7.52 10.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.679 0.752 . . . . 0.0 109.129 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.53 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.6 OUTLIER -49.82 148.68 2.97 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 126.099 1.759 . . . . 0.0 113.951 -170.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -61.83 -178.41 0.15 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.898 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' B' ' 48' ' ' LYS . 15.9 t70 -80.04 -47.56 14.7 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.483 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.6 m -69.97 -30.97 68.45 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.749 -172.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.23 -27.29 72.21 Favored Glycine 0 C--O 1.214 -1.129 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.537 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.516 ' N ' HE22 ' B' ' 42' ' ' GLN . 79.6 m-20 -78.37 -35.28 47.55 Favored 'General case' 0 CA--C 1.491 -1.318 0 O-C-N 122.554 -0.38 . . . . 0.0 110.586 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' B' ' 44' ' ' ASP . 51.7 mmtt -78.27 -60.83 2.21 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.358 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' B' ' 48' ' ' LYS . 69.1 m-85 -107.67 -11.07 15.5 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -167.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 19.1 t -106.14 143.03 26.11 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 121.711 -0.618 . . . . 0.0 109.515 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -75.79 -22.36 13.55 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.146 1.897 . . . . 0.0 110.323 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 0.8 OUTLIER -84.91 152.16 23.73 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.6 -175.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.47 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 58.9 t -136.47 140.05 44.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.53 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 4.1 tp -99.27 124.39 52.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 171.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 22.1 m -132.19 166.04 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.817 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.555 ' HB2' ' CG2' ' B' ' 39' ' ' VAL . . . -124.09 141.36 52.12 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.1 129.06 37.6 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.489 HG12 HD13 ' B' ' 86' ' ' ILE . 53.7 mt -87.61 123.02 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.915 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 25.8 m -120.42 159.6 24.77 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.13 -172.34 42.28 Favored Glycine 0 N--CA 1.435 -1.389 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.482 ' HD3' ' OD2' ' B' ' 83' ' ' ASP . 16.6 tpt180 -63.41 106.2 0.88 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.329 0.585 . . . . 0.0 110.694 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 22.2 pt -123.48 -39.76 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.637 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -155.17 139.34 16.55 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -172.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -71.84 137.99 47.94 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 123.857 0.723 . . . . 0.0 109.903 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.83 81.27 0.89 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.744 0.783 . . . . 0.0 112.952 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -90.82 -42.13 10.83 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.556 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.2 tt -94.01 134.37 26.12 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -66.54 7.89 0.36 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 123.346 2.698 . . . . 0.0 115.704 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 74.8 p -98.37 -18.83 18.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.899 0.857 . . . . 0.0 108.738 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -101.25 129.41 47.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.57 130.34 70.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -101.23 130.69 47.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.927 0.394 . . . . 0.0 110.179 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.435 HD11 HG12 ' B' ' 86' ' ' ILE . 0.0 OUTLIER -124.04 147.75 28.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.94 125.42 20.26 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 125.252 1.421 . . . . 0.0 113.287 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -61.96 -38.45 88.55 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.754 0.787 . . . . 0.0 111.234 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -61.75 -27.35 68.67 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.903 -1.499 . . . . 0.0 112.991 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -90.67 -37.1 13.97 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.976 0.893 . . . . 0.0 109.406 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.41 ' OH ' HD22 ' B' ' 106' ' ' LEU . 31.2 m-85 -94.3 12.4 27.03 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.372 -171.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt 61.0 38.43 17.36 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.549 1.139 . . . . 0.0 113.724 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 22.2 mt -123.36 174.53 7.28 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.528 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.95 -11.81 26.03 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.062 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -136.05 149.89 48.96 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . 0.482 ' OD2' ' HD3' ' B' ' 61' ' ' ARG . 8.9 p-10 -68.26 156.07 38.42 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.464 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 19.7 t -103.07 149.89 24.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.365 -171.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 41.4 t -123.58 124.81 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.288 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.489 HD13 HG12 ' B' ' 58' ' ' ILE . 19.4 mm -101.14 130.86 49.91 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.515 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 76.5 mt -102.76 102.52 12.68 Favored 'General case' 0 N--CA 1.406 -2.653 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.7 2.5 29.46 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.793 -174.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -101.79 -39.19 7.52 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.204 173.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -83.53 68.93 9.97 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.277 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.509 HG21 ' CB ' ' B' ' 56' ' ' ALA . 2.1 pp -110.23 -179.15 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.767 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.572 ' NH1' HD21 ' B' ' 24' ' ' LEU . 0.0 OUTLIER -167.25 165.03 15.47 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 50.1 m -117.8 118.66 32.64 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 62.0 mt -131.54 138.61 48.98 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.83 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 4.2 p-10 -73.87 151.82 40.37 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 118.901 -1.12 . . . . 0.0 109.825 173.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -48.28 -20.98 0.44 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.83 1.652 . . . . 0.0 114.983 -175.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -72.91 -23.87 60.76 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.458 0.703 . . . . 0.0 110.575 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -74.32 -33.49 63.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.343 0.592 . . . . 0.0 109.867 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.25 122.8 23.41 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.39 1.076 . . . . 0.0 110.73 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -99.5 -62.13 1.28 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.4 pt-20 -143.42 148.7 36.55 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 122.054 0.931 . . . . 0.0 112.551 -167.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -79.3 111.34 15.45 Favored 'General case' 0 C--N 1.276 -2.596 0 C-N-CA 127.769 2.428 . . . . 0.0 107.89 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -105.65 -61.94 1.43 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.357 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.486 HG21 HG22 ' B' ' 19' ' ' VAL . 8.3 t -125.44 -159.21 0.88 Allowed 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.53 ' O ' HG23 ' B' ' 19' ' ' VAL . 37.9 m-85 -122.73 -87.39 0.64 Allowed 'General case' 0 C--O 1.176 -2.796 0 C-N-CA 118.387 -1.325 . . . . 0.0 112.445 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' B' ' 17' ' ' GLY . 1.5 mt 137.78 155.22 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 130.962 3.705 . . . . 0.0 106.035 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 88.2 p -100.88 155.65 17.82 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.33 -0.948 . . . . 0.0 108.709 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' B' ' 111' ' ' MET . 12.9 m-20 -58.29 -40.34 81.7 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -74.23 -39.07 63.33 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.72 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -70.67 -24.96 62.78 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.433 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.484 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -54.08 -41.98 68.81 Favored 'General case' 0 N--CA 1.413 -2.283 0 C-N-CA 123.742 0.817 . . . . 0.0 110.256 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.671 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 0.6 OUTLIER -70.69 -23.98 62.58 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.285 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . 0.611 ' HA ' ' ND2' ' B' ' 116' ' ' ASN 0.263 18.5 mt-10 -86.82 -37.63 17.6 Favored 'General case' 0 N--CA 1.387 -3.587 0 C-N-CA 118.363 -1.335 . . . . 0.0 110.533 -173.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.34 -46.58 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.282 0 CA-C-N 112.79 -2.004 . . . . 0.0 108.675 169.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 66.4 m-20 -60.34 -53.56 56.22 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 111.186 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.611 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 4.0 p30 -66.36 -40.58 89.87 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.256 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.9 -35.38 74.74 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 121.217 0.532 . . . . 0.0 109.579 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.53 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 8.9 tp -71.05 -45.92 62.96 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.38 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.501 ' O ' ' HB2' ' B' ' 124' ' ' LEU . 3.0 ttp -67.23 -25.14 65.94 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.333 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.526 HG13 ' O ' ' B' ' 116' ' ' ASN . 45.7 mt -80.1 -53.35 13.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 33.8 t -47.65 -45.68 28.17 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.043 1.337 . . . . 0.0 112.248 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.435 ' HG ' HG12 ' A' ' 54' ' ' ILE . 9.6 mp -81.93 10.56 6.23 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.64 9.34 83.31 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 170.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' B' ' 119' ' ' MET . 1.4 mm? -72.49 -62.08 1.57 Allowed 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 118.284 1.042 . . . . 0.0 108.884 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.86 147.08 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.857 -173.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -111.98 14.78 20.86 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.816 0.817 . . . . 0.0 110.203 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 45.1 t -130.09 99.46 4.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.855 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 64.27 65.93 0.65 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.597 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -84.74 -58.9 2.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -103.82 136.88 42.68 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt 69.73 112.06 0.05 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.437 1.095 . . . . 0.0 110.688 -175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.298 -1.65 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.612 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 p -71.51 -21.08 61.97 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 122.412 -0.463 . . . . 0.0 111.607 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 t -87.9 -6.33 58.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.273 0.559 . . . . 0.0 109.57 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -82.88 101.98 11.36 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -92.2 -63.39 1.24 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -134.09 156.8 47.62 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.002 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 73.56 -165.68 0.1 Allowed 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.611 1.195 . . . . 0.0 110.164 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 71.9 -176.91 0.19 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.424 1.09 . . . . 0.0 110.061 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 61.29 -92.81 0.04 OUTLIER 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.997 0.919 . . . . 0.0 110.177 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.5 m -158.85 23.47 0.21 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -104.42 121.4 43.35 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.452 -170.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 10.8 t70 -111.72 120.94 41.16 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 165.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 13.4 Cg_exo -68.89 -10.81 30.2 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.308 2.006 . . . . 0.0 113.66 -176.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.454 HD12 ' HZ3' ' A' ' 96' ' ' LYS . 59.8 mt -95.89 117.32 39.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -144.4 160.62 40.74 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.545 ' HD3' ' O ' ' A' ' 41' ' ' ILE . 49.8 ttp180 -72.8 113.55 9.97 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.711 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 144.78 -27.88 1.9 Allowed Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.069 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.97 138.49 35.21 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 121.25 0.547 . . . . 0.0 111.045 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 62.8 t -89.89 121.14 39.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.706 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 23.0 m-85 -110.9 145.87 37.53 Favored 'General case' 0 C--N 1.264 -3.122 0 C-N-CA 124.135 0.974 . . . . 0.0 109.892 173.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.9 mp -84.34 151.45 24.72 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.5 154.7 36.02 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-O 121.794 0.807 . . . . 0.0 111.395 -173.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -88.99 95.14 10.2 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.495 ' O ' HG13 ' A' ' 27' ' ' VAL 0.259 1.3 tt -92.09 -11.17 36.49 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -174.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.461 ' CB ' ' HD2' ' A' ' 26' ' ' PRO . 4.5 m -33.71 -177.64 0.0 OUTLIER Pre-proline 0 CA--C 1.596 2.738 0 C-N-CA 129.589 3.156 . . . . 0.0 114.978 171.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 25' ' ' SER . 0.0 OUTLIER 31.76 37.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 123.796 2.997 . . . . 0.0 117.404 -154.272 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 24' ' ' LEU . 8.5 m -73.19 146.83 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.616 163.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -114.75 124.43 51.76 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.42 -109.08 1.94 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 114.941 -1.027 . . . . 0.0 114.659 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.6 m -64.29 -21.23 66.53 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 124.76 1.224 . . . . 0.0 112.873 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.439 ' CB ' ' HB ' ' A' ' 27' ' ' VAL . 79.2 mt-10 -69.97 142.92 52.78 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -126.73 115.58 19.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' A' ' 24' ' ' LEU . . . -160.26 -88.52 0.07 OUTLIER Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 118.958 -1.592 . . . . 0.0 114.32 173.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.99 -145.93 27.6 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 -168.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.96 122.11 54.95 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.266 0 CA-C-N 119.804 1.802 . . . . 0.0 108.486 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -146.91 163.04 30.87 Favored Pre-proline 0 C--N 1.288 -2.076 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.967 -174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 17.0 Cg_exo -70.02 138.25 36.58 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 121.74 1.627 . . . . 0.0 109.208 167.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.83 162.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.512 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 31.6 m -102.3 128.83 54.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.054 175.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.8 mm -87.14 109.56 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.545 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -105.58 -17.87 7.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.764 -177.15 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.63 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 7.1 tt0 -64.3 164.62 10.85 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -170.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.608 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 21.4 p-10 -62.63 180.0 0.3 Allowed 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.844 1.658 . . . . 0.0 111.913 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.34 -48.04 37.56 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.674 -1.603 . . . . 0.0 113.069 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.3 m -86.6 -25.22 25.07 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -162.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 50' ' ' SER . . . -63.19 -30.15 76.63 Favored Glycine 0 C--O 1.192 -2.486 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -68.23 -36.44 79.5 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.428 0.633 . . . . 0.0 110.24 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -81.99 -50.39 9.17 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.615 -172.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -97.67 -15.37 20.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -172.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 23.1 t -114.45 145.92 34.79 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.14 -3.01 10.25 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.468 2.112 . . . . 0.0 111.67 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 p -111.66 139.33 47.21 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.487 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.63 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -137.65 139.72 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 120.811 0.338 . . . . 0.0 111.549 176.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 5.1 tt -87.51 129.02 39.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.014 0 CA-C-O 121.595 0.712 . . . . 0.0 112.477 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.454 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 21.9 m -133.88 168.21 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.229 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.548 ' CB ' HG23 ' A' ' 91' ' ' ILE . . . -125.69 140.68 52.5 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.68 128.76 37.19 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.574 HG12 ' CD1' ' A' ' 86' ' ' ILE . 62.7 mt -86.85 130.34 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.486 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.5 m -128.23 114.72 17.3 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.268 0.556 . . . . 0.0 111.931 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.65 32.9 6.94 Favored Glycine 0 C--N 1.313 -0.712 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -116.28 10.45 14.81 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.174 0.988 . . . . 0.0 109.629 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.407 HG22 HG22 ' A' ' 85' ' ' VAL . 12.7 tt -147.36 152.93 12.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -129.19 169.22 15.06 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp 67.0 97.54 0.05 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.551 1.14 . . . . 0.0 112.796 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.49 100.12 11.34 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -104.38 -44.98 4.79 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 tt -70.32 130.23 89.57 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.742 176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.95 -5.05 6.92 Favored 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.979 3.119 . . . . 0.0 116.253 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.2 p -92.78 -12.3 31.59 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.857 0.836 . . . . 0.0 109.522 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -107.45 129.59 54.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.2 p -128.15 136.34 60.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.745 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -99.55 137.98 37.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.992 0.901 . . . . 0.0 112.316 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.687 HG22 ' CE1' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -119.92 160.69 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.117 -179.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.3 117.57 18.11 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 31.9 pttt -53.09 -44.6 67.7 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -52.37 -39.58 60.97 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 125.455 1.502 . . . . 0.0 111.15 177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' HD3' ' OG ' ' A' ' 107' ' ' SER . 40.2 ttmt -74.62 -35.75 62.92 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 -176.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.687 ' CE1' HG22 ' A' ' 73' ' ' ILE . 2.7 m-85 -97.51 8.86 43.83 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.645 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.3 tttm 71.81 11.32 6.29 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 125.185 1.394 . . . . 0.0 113.495 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.02 170.92 11.14 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-O 122.384 1.088 . . . . 0.0 109.948 174.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -108.39 -4.85 17.03 Favored 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.994 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -128.63 147.42 50.73 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 2.4 m-20 -52.74 134.24 36.5 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 124.045 0.84 . . . . 0.0 110.72 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 73' ' ' ILE . 13.9 m -102.14 122.96 45.16 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.163 -169.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 37.3 t -113.82 135.8 52.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.574 ' CD1' HG12 ' A' ' 58' ' ' ILE . 16.5 mm -106.14 136.64 39.83 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 N-CA-C 106.33 -1.729 . . . . 0.0 106.33 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.32 107.58 18.66 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -86.57 14.89 6.16 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.015 0.912 . . . . 0.0 111.498 -173.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -114.57 -44.34 3.09 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.158 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 80.78 6.62 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.548 HG23 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -122.95 -178.14 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.915 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . 0.254 13.5 ptp180 -175.3 167.27 3.38 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 171.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' ILE . 94.1 m -108.65 121.78 45.73 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.188 -178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.1 mt -131.1 145.61 52.06 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 124.548 1.155 . . . . 0.0 111.142 -169.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.616 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 20.1 t70 -50.94 137.07 21.72 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.632 1.173 . . . . 0.0 112.782 172.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.454 ' HZ3' HD12 ' A' ' 14' ' ' ILE . 30.0 mtpp -55.9 -29.51 60.14 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.829 0.852 . . . . 0.0 112.435 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 9.1 mtmp? -87.75 -9.58 53.58 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.888 -175.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.616 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 12.1 ptm180 -90.65 -17.19 27.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.668 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.34 127.02 31.57 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 161.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -99.0 -59.73 1.67 Allowed 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -172.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 13.3 pt-20 -147.98 131.71 16.95 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -169.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -63.67 108.94 1.53 Allowed 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 128.552 2.741 . . . . 0.0 107.118 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.686 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 57.2 tp -106.32 -63.07 1.3 Allowed 'General case' 0 N--CA 1.411 -2.4 0 CA-C-O 122.386 1.089 . . . . 0.0 111.435 -171.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.686 ' OG1' ' HG ' ' A' ' 103' ' ' LEU 0.291 19.9 m -138.32 -157.06 0.74 Allowed 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 113.76 -1.563 . . . . 0.0 111.437 -165.082 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.54 ' H ' HG22 ' A' ' 104' ' ' THR . 12.9 t80 -159.15 151.84 21.74 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 119.653 1.115 . . . . 0.0 110.513 -161.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.474 ' CG ' ' HH ' ' A' ' 78' ' ' TYR . 6.2 mp -115.1 138.37 50.96 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.37 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.465 ' OG ' ' HD3' ' A' ' 77' ' ' LYS . 19.7 m -79.79 157.33 27.1 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.534 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 111' ' ' MET . 26.1 t70 -63.61 -37.39 87.16 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.195 0.598 . . . . 0.0 112.197 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.23 -40.35 95.85 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 123.329 0.652 . . . . 0.0 110.696 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.423 ' HE3' HG23 ' A' ' 73' ' ' ILE . 14.9 tppt? -77.98 -27.42 49.12 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.957 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.527 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 1.3 mmt -50.09 -46.84 53.84 Favored 'General case' 0 CA--C 1.461 -2.447 0 CA-C-O 122.223 1.011 . . . . 0.0 109.345 171.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.414 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 8.0 mmpt? -72.94 -12.36 60.92 Favored 'General case' 0 N--CA 1.392 -3.337 0 CA-C-N 113.853 -1.521 . . . . 0.0 114.012 -177.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -90.7 -52.1 5.05 Favored 'General case' 0 N--CA 1.385 -3.709 0 C-N-CA 117.469 -1.692 . . . . 0.0 107.59 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -51.87 -59.28 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 113.217 -1.81 . . . . 0.0 113.141 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 56.7 m-20 -59.22 -39.37 82.48 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 123.534 1.635 . . . . 0.0 110.732 -177.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -80.56 -41.95 23.2 Favored 'General case' 0 C--N 1.256 -3.468 0 CA-C-N 112.442 -2.163 . . . . 0.0 112.722 -172.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.45 -35.38 73.93 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 122.191 0.996 . . . . 0.0 108.332 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 3.9 tp -68.09 -40.36 82.68 Favored 'General case' 0 N--CA 1.384 -3.757 0 CA-C-N 113.211 -1.813 . . . . 0.0 110.141 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.2 ttp -72.02 -19.94 61.78 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.33 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 54.1 mt -84.7 -52.75 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.8 t -47.93 -46.33 31.95 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.938 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.06 5.71 13.46 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.04 81.91 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 116.48 1.352 . . . . 0.0 116.48 171.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.28 -52.51 13.7 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 117.413 -1.715 . . . . 0.0 107.867 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.2 m120 56.93 149.72 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.191 -1.822 . . . . 0.0 115.149 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -102.51 89.46 3.54 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . 0.364 11.8 p 45.95 71.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 123.806 1.765 . . . . 0.0 113.926 -174.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -139.6 16.7 2.53 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 112.434 -2.167 . . . . 0.0 107.799 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -127.57 148.79 50.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 69.85 -54.48 0.61 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.355 1.062 . . . . 0.0 111.285 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -132.97 106.42 7.66 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 123.587 0.755 . . . . 0.0 109.095 175.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 C--N 1.295 -1.799 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.689 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.49 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 11.4 p -71.64 -19.42 62.1 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.194 0.521 . . . . 0.0 111.834 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 21.7 t -89.3 -2.99 58.66 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.446 0.641 . . . . 0.0 109.669 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -86.24 100.15 12.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -92.19 -51.58 5.1 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -143.68 160.66 40.29 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.474 ' HA ' ' O ' ' B' ' 11' ' ' GLN . 78.5 m-70 69.5 -164.6 0.17 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 124.324 1.015 . . . . 0.0 110.518 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 70.19 -178.67 0.22 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.033 0.933 . . . . 0.0 109.847 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 59.65 -93.67 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.734 0.813 . . . . 0.0 110.471 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 39.8 m -158.8 26.69 0.22 Allowed 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' B' ' 7' ' ' HIS . 29.0 tt0 -107.88 120.03 41.12 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.025 -173.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.02 118.1 48.75 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 166.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.8 -25.5 78.54 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.681 2.254 . . . . 0.0 113.379 -174.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . 0.421 HD13 ' NZ ' ' B' ' 96' ' ' LYS . 62.1 mt -83.67 118.19 30.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -175.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -144.87 160.73 40.82 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' B' ' 41' ' ' ILE . 50.5 ttp180 -71.39 114.4 9.41 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 143.31 -27.74 2.11 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.388 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -97.73 138.51 35.0 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.244 0.545 . . . . 0.0 111.05 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -89.76 123.44 41.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.528 174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 31.1 m-85 -113.04 146.29 39.38 Favored 'General case' 0 C--N 1.267 -3.016 0 C-N-CA 124.122 0.969 . . . . 0.0 109.806 172.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.1 mp -83.34 152.21 25.19 Favored 'General case' 0 N--CA 1.399 -2.983 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 167.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.38 156.84 40.34 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-O 121.785 0.802 . . . . 0.0 111.428 -173.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.98 93.88 8.99 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.529 ' O ' HG13 ' B' ' 27' ' ' VAL 0.25 1.6 tt -90.58 -11.24 40.59 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -174.401 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 9.2 m -33.55 -177.45 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.668 0 C-N-CA 129.497 3.119 . . . . 0.0 115.364 170.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 31.59 36.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 123.751 2.968 . . . . 0.0 117.421 -154.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.529 HG13 ' O ' ' B' ' 24' ' ' LEU . 6.9 m -73.24 148.51 8.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.61 164.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -117.48 122.51 43.93 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.75 -111.89 4.14 Favored Glycine 0 C--N 1.32 -0.344 0 CA-C-N 115.087 -0.96 . . . . 0.0 114.121 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 18.2 m -60.17 -21.86 62.19 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.651 1.18 . . . . 0.0 113.122 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.466 ' CB ' ' HB ' ' B' ' 27' ' ' VAL . 73.2 mt-10 -70.3 143.48 52.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -128.25 117.22 21.12 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . 0.434 ' HA3' HD21 ' B' ' 24' ' ' LEU . . . -160.51 -91.66 0.08 OUTLIER Glycine 0 N--CA 1.415 -2.757 0 C-N-CA 119.437 -1.363 . . . . 0.0 113.964 173.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.96 -147.45 27.66 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 105.391 -3.084 . . . . 0.0 105.391 -167.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.95 122.08 51.41 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 119.766 1.783 . . . . 0.0 108.821 172.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -145.86 162.94 33.68 Favored Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.9 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 18.4 Cg_exo -69.98 138.46 37.15 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.855 1.704 . . . . 0.0 109.008 167.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.54 161.98 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.505 ' CG2' ' HB2' ' B' ' 56' ' ' ALA . 29.1 m -101.5 129.44 52.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.186 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 33.9 mm -88.26 109.58 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.474 ' O ' ' HD3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -105.64 -18.01 7.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.734 -177.081 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.631 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 7.0 tt0 -64.92 163.73 13.9 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -170.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.622 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 13.3 p-10 -65.11 178.89 0.78 Allowed 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.876 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.05 -47.76 49.25 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 112.827 -1.988 . . . . 0.0 113.039 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 3.5 m -87.28 -24.16 24.44 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -162.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.69 -30.27 77.15 Favored Glycine 0 C--O 1.2 -1.986 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -66.29 -40.25 89.92 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 120.886 0.374 . . . . 0.0 110.624 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -78.76 -54.9 5.61 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-O 121.06 0.457 . . . . 0.0 112.04 -175.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -88.07 -25.06 23.25 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 13.9 t -107.6 144.83 30.05 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.93 -6.1 12.26 Favored 'Trans proline' 0 C--O 1.241 0.639 0 C-N-CA 122.433 2.089 . . . . 0.0 111.631 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 3.7 p -107.68 142.3 37.87 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.336 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.631 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.1 OUTLIER -140.5 139.64 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 120.803 0.335 . . . . 0.0 111.6 176.067 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' B' ' 93' ' ' THR . 4.8 tt -87.7 130.08 38.0 Favored 'Isoleucine or valine' 0 C--O 1.247 0.941 0 CA-C-O 121.611 0.72 . . . . 0.0 112.901 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.478 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 20.0 m -134.67 167.91 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.169 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.505 ' HB2' ' CG2' ' B' ' 39' ' ' VAL . . . -125.15 140.25 53.04 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.97 127.75 33.94 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.558 HG12 ' CD1' ' B' ' 86' ' ' ILE . 60.0 mt -85.54 130.81 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.535 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 91.7 m -128.26 112.76 14.83 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.43 0.633 . . . . 0.0 111.856 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.0 43.39 1.7 Allowed Glycine 0 C--N 1.307 -1.053 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 175.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -123.56 3.89 8.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.812 0.815 . . . . 0.0 109.339 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.41 HG22 HG22 ' B' ' 85' ' ' VAL . 12.3 tt -144.65 154.21 14.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -176.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -130.06 171.35 12.91 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp 68.3 96.36 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.107 0.963 . . . . 0.0 112.883 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.54 92.88 5.33 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.379 175.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . 0.42 ' HD3' ' O ' ' B' ' 66' ' ' LYS . 11.1 tmtt? -98.91 -38.74 8.89 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.8 tt -75.93 130.06 79.42 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.526 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.24 -12.99 21.95 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.854 3.036 . . . . 0.0 116.272 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 69.9 p -87.27 -13.51 43.51 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.763 0.792 . . . . 0.0 110.038 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -105.7 130.44 53.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 9.9 p -129.02 136.75 58.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.798 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -98.37 137.68 36.73 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-O 121.925 0.869 . . . . 0.0 112.025 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.67 HG22 ' CE1' ' B' ' 78' ' ' TYR . 0.3 OUTLIER -120.13 158.22 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.394 -179.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -72.95 116.19 13.16 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . 0.402 ' HB3' ' HA ' ' B' ' 83' ' ' ASP . 35.0 pttt -53.2 -43.28 67.07 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -53.22 -43.33 67.18 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 125.127 1.371 . . . . 0.0 111.011 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . 0.505 ' HD3' ' OG ' ' B' ' 107' ' ' SER . 41.0 ttmt -71.82 -34.57 69.44 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.208 -175.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.67 ' CE1' HG22 ' B' ' 73' ' ' ILE . 3.1 m-85 -96.82 7.97 45.41 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.369 0.604 . . . . 0.0 111.106 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 61.2 tttm 70.5 13.35 7.43 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.957 1.303 . . . . 0.0 113.206 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.58 167.29 13.52 Favored 'General case' 0 CA--C 1.478 -1.796 0 CA-C-O 122.212 1.006 . . . . 0.0 110.235 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -99.86 -11.74 20.47 Favored 'General case' 0 C--N 1.271 -2.825 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.041 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -126.29 149.6 49.02 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . 0.402 ' HA ' ' HB3' ' B' ' 75' ' ' LYS . 2.7 m-20 -52.45 132.96 35.48 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 124.225 0.953 . . . . 0.0 110.116 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.4 ' O ' HG12 ' B' ' 73' ' ' ILE . 10.9 m -102.39 121.99 43.41 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.826 -169.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 39.1 t -113.49 135.03 54.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.558 ' CD1' HG12 ' B' ' 58' ' ' ILE . 17.2 mm -104.94 135.91 40.9 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.853 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.4 mt -105.14 107.68 18.8 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' B' ' 118' ' ' LEU . 3.7 mm? -85.64 12.28 9.09 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.908 0.861 . . . . 0.0 111.567 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.39 -44.01 3.43 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.492 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.23 80.56 6.87 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.254 1.026 . . . . 0.0 108.252 178.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 2.2 pp -123.1 -178.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.033 -1.439 . . . . 0.0 108.192 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -175.3 167.56 3.37 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 171.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' B' ' 54' ' ' ILE . 96.0 m -108.5 121.84 45.81 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.173 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.408 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 71.7 mt -131.22 145.33 51.88 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 124.707 1.254 . . . . 0.0 110.93 -169.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.607 ' O ' ' HG2' ' B' ' 98' ' ' ARG . 27.5 t70 -52.52 136.42 32.17 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.977 0.911 . . . . 0.0 112.911 172.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.421 ' NZ ' HD13 ' B' ' 14' ' ' ILE . 29.0 mtpp -54.65 -29.85 53.53 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.115 0.966 . . . . 0.0 112.371 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.477 ' HB2' ' OD2' ' B' ' 95' ' ' ASP . 9.8 mtmp? -83.7 -17.95 39.58 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.585 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' B' ' 95' ' ' ASP . 11.8 ptm180 -86.25 -17.85 33.64 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.814 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.68 121.35 16.27 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 162.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -92.19 -60.39 1.86 Allowed 'General case' 0 C--N 1.268 -2.938 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -170.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.6 pt-20 -148.68 130.19 14.86 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-O 122.512 1.149 . . . . 0.0 114.044 -168.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -61.14 110.89 1.51 Allowed 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 128.497 2.719 . . . . 0.0 106.924 173.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.66 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 53.7 tp -107.44 -64.19 1.22 Allowed 'General case' 0 N--CA 1.402 -2.853 0 CA-C-O 121.94 0.876 . . . . 0.0 111.05 -172.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.66 ' OG1' ' HG ' ' B' ' 103' ' ' LEU 0.291 17.4 m -138.12 -157.12 0.74 Allowed 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.216 -164.2 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.529 ' H ' ' CG2' ' B' ' 104' ' ' THR . 11.9 t80 -158.32 153.63 25.78 Favored 'General case' 0 N--CA 1.402 -2.859 0 CA-C-N 119.703 1.138 . . . . 0.0 110.1 -161.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.04 138.9 50.34 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.351 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.505 ' OG ' ' HD3' ' B' ' 77' ' ' LYS . 27.7 m -82.76 156.75 23.54 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.411 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' B' ' 111' ' ' MET . 20.0 t70 -61.96 -36.78 82.46 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.42 0.629 . . . . 0.0 111.765 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -62.1 -40.95 97.61 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.623 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.485 ' HG2' ' HH ' ' B' ' 78' ' ' TYR . 13.6 tppt? -77.24 -28.74 53.75 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.175 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.5 OUTLIER -49.33 -46.17 46.46 Favored 'General case' 0 CA--C 1.459 -2.536 0 CA-C-O 122.143 0.973 . . . . 0.0 109.088 171.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.468 ' HA ' ' CE ' ' B' ' 112' ' ' LYS . 6.1 mmpt? -71.48 -16.22 62.35 Favored 'General case' 0 N--CA 1.38 -3.926 0 CA-C-N 113.841 -1.527 . . . . 0.0 114.848 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -89.89 -51.59 5.41 Favored 'General case' 0 N--CA 1.388 -3.566 0 C-N-CA 117.014 -1.874 . . . . 0.0 107.27 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.72 -59.62 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 113.36 -1.745 . . . . 0.0 113.293 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 49.1 m-20 -59.47 -40.3 86.49 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 123.713 1.721 . . . . 0.0 111.32 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.407 ' O ' HG13 ' B' ' 120' ' ' ILE 0.351 25.9 t30 -80.74 -40.38 25.34 Favored 'General case' 0 C--N 1.255 -3.54 0 CA-C-N 112.711 -2.04 . . . . 0.0 112.391 -171.397 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.58 -32.98 74.61 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 121.981 0.896 . . . . 0.0 108.681 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.8 tp -67.45 -39.67 85.35 Favored 'General case' 0 N--CA 1.38 -3.939 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.576 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 8.6 ttp -71.83 -20.37 61.84 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 123.61 0.764 . . . . 0.0 110.042 -175.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.407 HG13 ' O ' ' B' ' 116' ' ' ASN . 63.5 mt -84.3 -53.17 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.2 t -47.72 -46.09 29.32 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.993 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.401 HD12 ' O ' ' B' ' 118' ' ' LEU . 8.7 mp -79.75 5.83 12.44 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.65 9.77 79.0 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 116.195 1.238 . . . . 0.0 116.195 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 mt -71.56 -54.37 10.71 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 119.498 1.649 . . . . 0.0 107.762 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 21.3 m120 56.26 149.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 113.049 -1.887 . . . . 0.0 115.031 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -101.77 89.29 3.63 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . 0.372 10.9 p 45.69 72.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 125.993 1.717 . . . . 0.0 113.963 -173.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -139.29 19.41 2.58 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 112.99 -1.914 . . . . 0.0 107.105 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -130.47 149.84 51.96 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.481 -2.145 . . . . 0.0 105.397 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 72.19 -53.07 0.7 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.147 0.979 . . . . 0.0 110.858 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -134.58 113.31 11.63 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 124.207 1.003 . . . . 0.0 109.172 175.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 . . . . . 0 C--N 1.296 -1.752 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.24 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.743 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.8 m -79.08 85.63 4.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.736 0.779 . . . . 0.0 110.811 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m -147.61 133.77 19.39 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -89.78 114.99 26.78 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -88.77 94.02 9.77 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.358 0.599 . . . . 0.0 109.763 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -99.73 97.84 8.74 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -141.42 1.68 1.59 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -88.37 -40.29 13.67 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -109.17 162.93 13.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.8 m -150.93 130.64 13.14 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.411 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . 23.4 pt20 -86.75 82.29 7.9 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.458 1.123 . . . . 0.0 109.941 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -56.61 154.8 16.07 Favored Pre-proline 0 C--O 1.245 0.816 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.564 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.02 114.17 3.08 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.557 2.171 . . . . 0.0 109.934 173.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mt -77.22 147.75 7.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.575 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -115.6 144.36 44.01 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 19.7 ptt180 -73.87 152.3 40.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.879 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.17 -2.71 79.28 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.977 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -97.71 177.88 5.33 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 3.9 t -133.62 134.45 56.55 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 C-N-CA 122.806 0.442 . . . . 0.0 111.844 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 12.5 m-85 -131.51 144.32 51.04 Favored 'General case' 0 CA--C 1.467 -2.232 0 C-N-CA 124.46 1.104 . . . . 0.0 110.146 177.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mp -79.58 151.49 30.62 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 169.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.01 139.47 23.64 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.278 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -74.37 92.65 2.32 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.146 0.974 . . . . 0.0 109.773 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.556 ' O ' HG13 ' A' ' 27' ' ' VAL . 83.7 mt -82.19 -12.41 58.14 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-N 113.892 -1.504 . . . . 0.0 112.11 -177.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.83 61.79 0.0 OUTLIER Pre-proline 0 C--N 1.257 -3.453 0 N-CA-C 119.754 3.242 . . . . 0.0 119.754 -176.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HB2' ' O ' ' B' ' 26' ' ' PRO . 1.1 Cg_endo -117.68 22.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 N-CA-C 108.46 -1.4 . . . . 0.0 108.46 148.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 24' ' ' LEU . 14.1 m -72.81 157.97 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.943 0.878 . . . . 0.0 113.364 -172.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -124.01 156.3 36.71 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.721 -1.581 . . . . 0.0 107.163 175.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.95 -135.44 15.09 Favored Glycine 0 N--CA 1.418 -2.556 0 O-C-N 124.131 0.894 . . . . 0.0 112.068 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.6 m -94.34 6.93 47.2 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.476 -0.362 . . . . 0.0 111.686 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -71.33 153.14 42.58 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 119.374 -0.931 . . . . 0.0 112.959 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -81.85 119.15 23.55 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -171.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.4 158.97 17.19 Favored Glycine 0 CA--C 1.472 -2.651 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.495 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 111.63 137.97 7.39 Favored Glycine 0 C--N 1.276 -2.793 0 CA-C-N 113.016 -1.592 . . . . 0.0 109.972 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 p -64.6 119.13 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.124 0 CA-C-O 122.365 1.079 . . . . 0.0 109.039 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -144.93 149.22 41.77 Favored Pre-proline 0 C--N 1.267 -3.015 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.209 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 33.3 Cg_exo -58.76 136.59 74.82 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.311 2.007 . . . . 0.0 111.37 171.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 20' ' ' TYR . 29.4 m -122.51 161.68 23.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 123.933 0.893 . . . . 0.0 108.721 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.403 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 32.6 m -101.48 132.11 47.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 120.722 0.296 . . . . 0.0 110.697 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mm -86.04 105.12 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.451 HD13 ' C ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -97.39 -23.46 4.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.535 -177.081 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.586 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -64.5 168.49 5.8 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -167.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.557 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 12.9 p-10 -66.53 177.62 1.5 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.464 -1.698 . . . . 0.0 110.632 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 16.8 t70 -89.18 -29.56 19.21 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.188 -176.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.567 ' HA ' ' CD ' ' A' ' 48' ' ' LYS . 45.1 m -82.79 -26.17 32.06 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.42 -21.69 74.44 Favored Glycine 0 C--O 1.196 -2.238 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -82.12 -26.79 33.25 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.273 0.559 . . . . 0.0 109.931 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.567 ' CD ' ' HA ' ' A' ' 45' ' ' THR . 6.6 mtpp -82.94 -57.98 3.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.978 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -96.35 -35.86 11.06 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.6 m -90.84 158.74 41.71 Favored Pre-proline 0 C--N 1.29 -2.02 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -87.86 -11.45 4.69 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.38 1.387 . . . . 0.0 110.849 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 17.0 p -96.26 149.88 21.17 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.489 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -148.58 137.95 15.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.363 170.511 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.586 HG22 ' HG3' ' A' ' 42' ' ' GLN . 15.0 tt -86.47 135.32 25.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-O 121.444 0.64 . . . . 0.0 110.29 175.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.99 146.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.994 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 91' ' ' ILE . . . -109.76 135.64 50.36 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.78 145.1 48.93 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.435 HG12 HD11 ' A' ' 86' ' ' ILE . 49.1 mt -100.79 143.74 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.969 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 m -92.35 173.37 7.84 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.25 -73.23 0.9 Allowed Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 171.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 83' ' ' ASP . 78.4 ttt180 -167.86 144.51 4.14 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.9 tt -164.88 -39.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.9 m120 63.38 -178.46 0.15 Allowed 'General case' 0 C--O 1.249 1.069 0 C-N-CA 124.329 1.052 . . . . 0.0 113.119 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.5 mttm 62.66 71.73 0.51 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.175 0.99 . . . . 0.0 109.067 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 70' ' ' HIS . . . -52.35 -71.9 0.06 Allowed 'General case' 0 C--O 1.246 0.918 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.219 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt 66.63 -56.63 0.4 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.277 1.431 . . . . 0.0 113.329 175.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.69 136.84 70.5 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.0 2.44 2.14 Favored 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.101 1.867 . . . . 0.0 113.841 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 p -100.91 -18.93 16.13 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.483 0.659 . . . . 0.0 109.728 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 65' ' ' ALA . 17.5 m170 -102.03 130.09 48.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.28 136.94 52.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.568 173.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 10.2 pt-20 -101.38 146.61 27.36 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.082 0.468 . . . . 0.0 112.188 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.8 pt -112.75 146.08 17.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.11 109.0 6.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.842 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -60.32 -36.15 77.26 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.637 0.732 . . . . 0.0 112.789 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -51.4 -52.1 48.91 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.19 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -91.05 -25.62 19.57 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.361 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.57 ' CE2' ' HA ' ' A' ' 106' ' ' LEU . 1.9 m-85 -88.55 20.5 3.36 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 123.635 0.774 . . . . 0.0 111.858 -172.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 56.75 27.61 13.02 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.31 170.76 8.0 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.843 0.83 . . . . 0.0 109.718 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -99.8 -16.94 17.91 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.231 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.73 140.0 52.27 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.027 -173.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 4.4 t70 -85.81 102.8 14.0 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.0 t -103.28 172.75 6.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -165.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 37.7 t -123.9 142.97 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.435 HD11 HG12 ' A' ' 58' ' ' ILE . 20.9 mm -106.44 133.31 51.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.8 mt -105.95 107.06 17.87 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 121.462 0.648 . . . . 0.0 109.737 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.26 16.96 2.73 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.608 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.03 -40.28 3.52 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 122.13 0.967 . . . . 0.0 109.019 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.19 72.82 4.61 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.565 ' O ' ' HB ' ' B' ' 93' ' ' THR . 8.0 mt -106.62 -174.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.461 ' NH1' HD22 ' A' ' 24' ' ' LEU . 5.7 ptp180 -175.14 174.89 2.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 124.004 0.922 . . . . 0.0 109.733 166.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 68.0 m -125.27 130.05 51.26 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -132.99 143.08 49.2 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -80.54 153.05 28.32 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.876 175.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.411 ' HE2' ' HB2' ' A' ' 11' ' ' GLN . 60.2 mtpt -47.12 -18.21 0.08 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 126.523 1.929 . . . . 0.0 115.333 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -74.31 -27.15 60.58 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.317 0.58 . . . . 0.0 111.132 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -74.84 -35.73 62.38 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.449 0.7 . . . . 0.0 110.47 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mp -74.6 122.98 23.98 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.398 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.45 -59.61 1.84 Allowed 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -154.85 135.55 13.56 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.478 0.656 . . . . 0.0 112.6 -168.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.631 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -64.62 121.26 14.04 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.608 173.462 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -113.78 -61.92 1.67 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.446 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.532 HG22 HG12 ' A' ' 19' ' ' VAL . 5.2 t -126.3 -164.35 1.32 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.069 -1.452 . . . . 0.0 112.348 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -159.84 147.14 16.61 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.812 0.845 . . . . 0.0 112.651 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.57 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . 13.1 mt -98.65 155.34 17.36 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.959 -1.473 . . . . 0.0 108.476 177.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.8 m -86.36 167.86 14.37 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 111' ' ' MET . 22.2 t70 -56.58 -43.62 80.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.69 0.796 . . . . 0.0 112.381 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.13 -41.55 98.36 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -67.23 -33.66 75.83 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.512 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -55.1 -42.41 72.85 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 123.967 0.907 . . . . 0.0 110.313 175.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.64 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -76.22 -11.98 60.01 Favored 'General case' 0 CA--C 1.472 -2.046 0 C-N-CA 122.947 0.499 . . . . 0.0 111.544 179.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -86.67 -43.47 12.59 Favored 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -55.92 -58.92 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.111 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.316 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.89 -49.92 62.06 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-O 123.311 1.529 . . . . 0.0 110.344 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.633 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 1.3 t30 -68.97 -49.76 55.07 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 112.203 -2.272 . . . . 0.0 112.743 -173.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.07 -39.75 83.08 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 2.4 tp -64.32 -47.36 79.73 Favored 'General case' 1 N--CA 1.378 -4.07 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.498 -175.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.575 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 1.9 ptm -71.19 -19.74 62.36 Favored 'General case' 0 C--O 1.202 -1.424 0 O-C-N 121.568 -0.707 . . . . 0.0 112.513 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 116' ' ' ASN . 54.2 mt -76.76 -53.54 14.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -55.89 -30.94 62.35 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.236 -1.802 . . . . 0.0 111.555 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 44.2 mt -101.6 5.48 41.66 Favored 'General case' 0 N--CA 1.425 -1.696 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.527 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.38 5.36 72.53 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 117.729 1.851 . . . . 0.0 117.729 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 119' ' ' MET . 6.9 mp -71.26 -45.18 63.77 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 120.544 2.172 . . . . 0.0 108.665 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.6 m120 54.46 133.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.532 1.933 . . . . 0.0 116.006 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.48 73.66 9.47 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 122.053 0.93 . . . . 0.0 110.455 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.2 t -122.38 2.79 6.05 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.39 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 67.14 132.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.505 -1.68 . . . . 0.0 112.896 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -72.19 -41.56 66.82 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 171.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 53.11 73.09 0.38 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.783 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -77.76 90.32 4.03 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 122.194 0.997 . . . . 0.0 112.14 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 . . . . . 0 C--N 1.299 -1.61 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.714 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.264 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -82.56 92.15 7.05 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 121.747 0.784 . . . . 0.0 110.047 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 34.1 m -150.12 135.45 18.07 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -91.94 109.36 20.7 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -84.57 96.1 9.06 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -101.28 96.3 7.09 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.157 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -139.19 -3.03 1.59 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -83.31 -38.92 21.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -110.27 164.32 12.78 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.2 m -150.03 134.71 17.57 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -91.91 80.4 5.2 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.371 1.081 . . . . 0.0 109.164 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -59.11 155.41 34.11 Favored Pre-proline 0 C--O 1.243 0.739 0 CA-C-N 113.501 -1.681 . . . . 0.0 113.063 -174.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.46 113.27 2.85 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.442 2.095 . . . . 0.0 110.055 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 44.0 mt -75.91 147.44 7.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.295 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -114.5 144.83 42.72 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.548 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 19.9 ptt180 -75.31 147.4 40.2 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.777 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.02 -2.88 60.07 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.32 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -97.25 174.87 6.5 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 5.6 t -132.94 131.6 59.07 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.9 0 C-N-CA 123.596 0.759 . . . . 0.0 111.49 -176.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 8.4 m-85 -129.26 144.16 51.12 Favored 'General case' 0 CA--C 1.465 -2.296 0 C-N-CA 124.167 0.987 . . . . 0.0 110.396 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -79.94 151.1 30.27 Favored 'General case' 0 N--CA 1.4 -2.942 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.03 139.71 23.82 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.155 -175.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.64 92.29 1.95 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.048 0.928 . . . . 0.0 109.455 173.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.534 ' O ' HG13 ' B' ' 27' ' ' VAL . 90.2 mt -83.09 -9.97 58.94 Favored 'General case' 0 CA--C 1.474 -1.947 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.787 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.91 61.3 0.0 OUTLIER Pre-proline 0 C--N 1.247 -3.879 0 N-CA-C 119.262 3.06 . . . . 0.0 119.262 -176.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -117.74 21.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.255 0 N-CA-C 108.476 -1.394 . . . . 0.0 108.476 150.157 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.534 HG13 ' O ' ' B' ' 24' ' ' LEU . 15.2 m -72.62 157.91 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-O 122.085 0.945 . . . . 0.0 113.154 -171.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -124.05 155.98 37.35 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.354 -1.748 . . . . 0.0 107.679 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.26 -135.32 14.02 Favored Glycine 0 N--CA 1.421 -2.326 0 O-C-N 123.997 0.811 . . . . 0.0 112.109 173.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -94.75 8.41 42.63 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 122.661 0.384 . . . . 0.0 111.846 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.08 151.9 42.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.58 118.45 21.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 121.16 0.505 . . . . 0.0 109.857 -171.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.89 155.62 18.75 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-N 114.701 -1.136 . . . . 0.0 115.264 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 112.43 137.84 7.13 Favored Glycine 0 N--CA 1.418 -2.524 0 CA-C-N 113.023 -1.588 . . . . 0.0 110.364 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 p -63.62 119.67 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-O 122.4 1.095 . . . . 0.0 108.86 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -145.49 149.74 41.68 Favored Pre-proline 0 C--N 1.265 -3.068 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.304 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.2 Cg_exo -59.07 136.85 75.91 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.137 1.891 . . . . 0.0 111.201 171.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.494 HG21 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -122.76 161.02 24.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 123.968 0.907 . . . . 0.0 108.61 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 30.0 m -100.93 132.05 47.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 120.748 0.308 . . . . 0.0 110.723 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 26.1 mm -86.06 105.91 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.457 HD13 ' C ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -97.53 -25.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.383 -177.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.581 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.1 OUTLIER -63.12 167.85 4.65 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -167.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.56 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 14.5 p-10 -66.41 176.26 1.92 Allowed 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.083 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.98 -30.13 21.5 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.648 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' THR . . . . . 0.507 ' HA ' ' CD ' ' B' ' 48' ' ' LYS . 28.3 m -84.0 -25.52 29.89 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -170.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -68.61 -21.46 74.69 Favored Glycine 0 C--O 1.194 -2.394 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 176.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -82.88 -27.94 30.38 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.181 0.515 . . . . 0.0 110.018 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.507 ' CD ' ' HA ' ' B' ' 45' ' ' THR . 4.4 mtpp -80.74 -58.48 3.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.869 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -97.39 -35.89 10.54 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -172.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 38.5 m -88.11 156.59 51.74 Favored Pre-proline 0 C--N 1.292 -1.91 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.193 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -86.97 -12.32 5.06 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 121.22 1.28 . . . . 0.0 110.663 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 19.0 p -96.14 149.29 21.79 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.478 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.8 OUTLIER -148.1 137.87 16.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 O-C-N 123.94 0.775 . . . . 0.0 109.258 170.499 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.581 HG22 ' HG3' ' B' ' 42' ' ' GLN . 15.6 tt -86.54 135.47 25.05 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 CA-C-O 121.278 0.561 . . . . 0.0 110.277 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.67 145.65 29.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.965 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . . . . . . . . . . . -109.59 135.17 51.0 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.76 145.87 48.47 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.443 HG12 HD11 ' B' ' 86' ' ' ILE . 45.6 mt -101.91 145.22 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.859 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 5.0 m -93.6 176.85 6.21 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.62 -72.02 1.14 Allowed Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 171.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' B' ' 83' ' ' ASP . 77.8 ttt180 -168.06 144.94 4.1 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 14.2 tt -165.16 -39.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 19.1 m120 63.07 -177.22 0.15 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.479 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 61.98 68.02 0.71 Allowed 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 124.043 0.84 . . . . 0.0 109.471 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' B' ' 70' ' ' HIS . . . -49.49 -70.29 0.09 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.256 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt 64.09 -59.99 0.2 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.004 1.322 . . . . 0.0 113.847 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.0 mt -72.82 137.41 79.85 Favored Pre-proline 0 C--N 1.308 -1.229 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.05 6.86 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 122.32 2.013 . . . . 0.0 113.695 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -106.05 -18.52 14.0 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.529 0.681 . . . . 0.0 109.476 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.451 ' O ' ' HB2' ' B' ' 65' ' ' ALA . 26.7 m170 -102.43 130.18 49.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.26 137.39 50.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 8.6 pt-20 -101.08 150.67 22.68 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.998 0.428 . . . . 0.0 112.152 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . . . . . . . . . 21.0 pt -117.16 144.41 25.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.78 109.76 5.16 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.869 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.6 -38.55 85.06 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.343 0.592 . . . . 0.0 112.499 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -51.22 -51.76 50.87 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.591 -1.64 . . . . 0.0 113.55 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -88.12 -26.43 22.49 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 118.764 -1.175 . . . . 0.0 112.022 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.538 ' CE2' ' HA ' ' B' ' 106' ' ' LEU . 1.7 m-85 -89.79 19.14 4.94 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 123.722 0.809 . . . . 0.0 111.547 -171.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 60.23 23.83 13.21 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 124.542 1.137 . . . . 0.0 113.818 169.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 mt -110.59 165.84 11.48 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.058 0.933 . . . . 0.0 110.52 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.52 -14.3 25.22 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.404 -1.726 . . . . 0.0 108.853 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.68 139.16 53.79 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.005 -174.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' B' ' 61' ' ' ARG . 4.6 t70 -85.13 103.77 14.42 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 41.8 t -104.56 172.83 6.58 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -164.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' B' ' 72' ' ' GLU . 38.4 t -124.42 142.68 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.443 HD11 HG12 ' B' ' 58' ' ' ILE . 19.8 mm -106.26 133.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 80.1 mt -106.04 106.99 17.76 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.495 0.664 . . . . 0.0 109.541 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.31 16.47 3.03 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.771 0.796 . . . . 0.0 111.599 -174.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.6 -40.28 3.41 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 122.254 1.026 . . . . 0.0 109.168 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.49 74.16 5.18 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.566 ' O ' ' HB ' ' A' ' 93' ' ' THR . 8.4 mt -107.64 -174.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.496 ' NH1' ' HB3' ' B' ' 24' ' ' LEU . 5.8 ptp180 -174.48 173.76 2.87 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 123.923 0.889 . . . . 0.0 109.659 167.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 59.7 m -126.02 128.13 46.97 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -132.26 142.7 49.49 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.889 -172.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 0.8 OUTLIER -80.09 153.34 28.8 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.009 175.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -46.56 -20.78 0.13 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 126.5 1.92 . . . . 0.0 115.082 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -75.59 -22.41 56.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.023 0.439 . . . . 0.0 111.391 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -77.74 -36.82 50.33 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 122.994 0.518 . . . . 0.0 110.127 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.73 124.49 26.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 124.072 0.949 . . . . 0.0 110.547 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -96.0 -60.66 1.59 Allowed 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.3 pt-20 -154.72 135.24 13.42 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.396 0.617 . . . . 0.0 112.503 -167.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -63.94 122.6 16.89 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.837 172.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.3 tp -114.52 -62.48 1.59 Allowed 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.806 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.518 HG22 HG12 ' B' ' 19' ' ' VAL . 5.2 t -125.81 -164.68 1.33 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.702 -1.599 . . . . 0.0 112.458 -176.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -159.77 145.05 15.42 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.635 0.774 . . . . 0.0 111.866 -172.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.538 ' HA ' ' CE2' ' B' ' 78' ' ' TYR . 14.6 mt -98.22 156.43 16.7 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.526 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 49.7 m -84.08 169.22 15.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.389 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.527 ' O ' ' HB3' ' B' ' 111' ' ' MET . 12.1 t70 -59.0 -44.84 91.73 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.905 0.882 . . . . 0.0 111.875 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.31 -40.0 96.12 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.22 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -67.88 -33.11 74.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.527 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -55.08 -42.87 73.35 Favored 'General case' 0 N--CA 1.41 -2.431 0 C-N-CA 123.617 0.767 . . . . 0.0 110.205 175.068 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.705 ' O ' ' HB3' ' B' ' 116' ' ' ASN . 0.4 OUTLIER -74.94 -13.25 60.51 Favored 'General case' 0 CA--C 1.466 -2.276 0 C-N-CA 122.568 0.347 . . . . 0.0 111.738 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -86.01 -43.3 13.26 Favored 'General case' 0 N--CA 1.39 -3.435 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.78 -57.54 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.961 0 CA-C-N 112.906 -1.952 . . . . 0.0 111.922 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.7 -51.97 58.1 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 122.958 1.361 . . . . 0.0 109.56 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.705 ' HB3' ' O ' ' B' ' 112' ' ' LYS . 0.1 OUTLIER -70.06 -42.31 72.99 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 112.658 -2.065 . . . . 0.0 113.826 -171.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.91 97.0 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.512 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 2.5 tp -62.37 -45.89 91.12 Favored 'General case' 0 N--CA 1.382 -3.832 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.181 -176.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.564 ' HB2' ' HB2' ' B' ' 124' ' ' LEU . 2.0 ptm -72.14 -19.4 61.78 Favored 'General case' 0 C--O 1.205 -1.247 0 O-C-N 121.638 -0.664 . . . . 0.0 112.603 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.458 HG13 ' O ' ' B' ' 116' ' ' ASN . 59.0 mt -77.54 -53.72 13.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 173.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 9.9 t -55.37 -31.08 61.47 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.62 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 46.0 mt -101.41 5.62 42.18 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.13 10.42 71.59 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 117.419 1.727 . . . . 0.0 117.419 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.564 ' HB2' ' HB2' ' B' ' 119' ' ' MET . 7.0 mp -74.33 -44.11 53.86 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 120.402 2.101 . . . . 0.0 108.277 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 21.3 m120 51.99 129.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 126.716 2.007 . . . . 0.0 116.328 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.81 80.35 9.17 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.867 0.841 . . . . 0.0 110.64 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.87 -0.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.284 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 65.9 132.12 0.02 OUTLIER 'General case' 0 C--O 1.24 0.56 0 C-N-CA 126.183 1.793 . . . . 0.0 112.695 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -70.21 -44.15 69.21 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 56.72 78.49 0.21 Allowed 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 113.37 -1.741 . . . . 0.0 109.946 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -80.15 87.62 5.48 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.439 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 . . . . . 0 C--N 1.308 -1.196 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.365 177.822 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.743 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 p -67.21 -53.08 33.55 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.12 0.486 . . . . 0.0 110.146 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.5 m -85.93 91.0 8.24 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -72.6 106.26 4.57 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.881 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.0 m80 56.06 37.44 28.85 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.948 0.899 . . . . 0.0 111.374 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -84.29 -56.48 3.62 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -88.58 -50.06 6.51 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.585 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.23 74.24 4.61 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 122.148 0.975 . . . . 0.0 111.593 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -103.38 -75.59 0.61 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.375 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.4 p -98.2 -35.25 10.43 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.677 0.751 . . . . 0.0 109.124 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -117.98 107.05 13.58 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.486 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -77.04 139.61 65.62 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.29 99.06 0.16 Allowed 'Trans proline' 0 C--O 1.254 1.306 0 C-N-CA 121.926 1.75 . . . . 0.0 112.029 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.7 mt -79.98 128.27 38.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.25 -176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -114.97 153.87 29.8 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.52 ' HG2' ' SD ' ' A' ' 111' ' ' MET . 43.5 ttt180 -73.02 114.0 10.69 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.58 -7.54 10.35 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.478 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -81.31 172.34 13.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.153 0.978 . . . . 0.0 109.305 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.518 HG21 HG23 ' A' ' 104' ' ' THR . 19.6 t -133.07 135.14 57.25 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.129 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.457 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.1 m-85 -134.84 148.7 50.21 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -81.33 151.59 27.94 Favored 'General case' 0 N--CA 1.401 -2.906 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.455 171.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.74 133.91 47.3 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.038 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.476 ' HA ' ' HB ' ' A' ' 35' ' ' VAL 0.293 2.3 p-10 -88.47 99.71 12.49 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 117.875 -1.53 . . . . 0.0 111.282 178.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.572 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 4.5 mm? -84.84 40.22 0.79 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.788 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.292 2.7 m -67.74 170.22 7.64 Favored Pre-proline 0 C--N 1.261 -3.266 0 C-N-CA 127.835 2.454 . . . . 0.0 107.798 170.278 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.1 OUTLIER 2.23 53.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.408 3.688 1 C-N-CA 127.38 5.387 . . . . 0.0 118.051 -173.397 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.17 178.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.459 172.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -104.14 116.36 32.06 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -175.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.55 -117.69 11.71 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.297 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -94.48 19.57 9.52 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 160.41 30.09 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 173.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.575 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -75.57 119.26 19.39 Favored 'General case' 0 C--O 1.192 -1.967 0 CA-C-O 120.613 0.244 . . . . 0.0 110.705 -172.01 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -90.69 146.17 18.32 Favored Glycine 0 CA--C 1.474 -2.529 0 CA-C-O 121.636 0.576 . . . . 0.0 113.736 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.572 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 104.9 136.87 8.87 Favored Glycine 0 N--CA 1.421 -2.338 0 CA-C-N 113.511 -1.345 . . . . 0.0 111.343 176.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 1.3 p -67.76 120.01 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 CA-C-O 122.694 1.235 . . . . 0.0 110.324 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -139.68 156.77 70.95 Favored Pre-proline 0 C--N 1.266 -3.036 0 CA-C-N 112.814 -1.994 . . . . 0.0 110.434 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 34.5 Cg_exo -65.81 143.95 75.54 Favored 'Trans proline' 0 CA--C 1.555 1.531 0 C-N-CA 122.776 2.318 . . . . 0.0 112.216 172.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 20' ' ' TYR . 28.7 m -127.22 158.66 38.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.867 0.867 . . . . 0.0 109.218 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.71 134.76 45.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 O-C-N 123.154 0.284 . . . . 0.0 110.699 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 mm -82.12 96.94 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.436 HD11 ' C ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.43 -26.01 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.45 -178.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.5 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 4.5 pt20 -61.63 168.77 2.73 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 117.036 2.236 . . . . 0.0 117.036 -171.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -64.33 170.05 4.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 113.488 -1.687 . . . . 0.0 111.771 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.438 ' HA ' ' ND2' ' A' ' 47' ' ' ASN . 17.8 m-20 -81.07 -28.74 35.19 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 m -76.75 -34.93 58.03 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 122.197 -0.315 . . . . 0.0 110.607 -172.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.39 -25.68 74.64 Favored Glycine 0 C--O 1.21 -1.398 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.671 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' A' ' 44' ' ' ASP . 91.5 m-20 -63.1 -31.75 72.96 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.541 0.686 . . . . 0.0 109.983 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 20.0 mmmt -92.29 -64.21 1.14 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.947 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 54.9 m-85 -78.47 -36.19 45.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -167.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.532 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 58.9 m -93.63 133.21 28.44 Favored Pre-proline 0 N--CA 1.416 -2.13 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.363 -173.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -69.75 -21.52 33.41 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.631 1.554 . . . . 0.0 109.117 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.9 p -89.78 133.44 34.7 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.066 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.5 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 85.5 t -121.07 140.81 44.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.01 124.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 122.213 1.006 . . . . 0.0 109.911 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.441 HG11 HG11 ' A' ' 53' ' ' VAL . 24.5 m -133.59 173.03 15.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.989 -173.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.483 ' CB ' HG23 ' A' ' 91' ' ' ILE . . . -124.94 146.38 49.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.72 131.23 41.38 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.552 HG12 ' CD1' ' A' ' 86' ' ' ILE . 64.8 mt -90.07 124.66 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 113.891 -1.504 . . . . 0.0 107.356 172.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.461 ' HB ' HG23 ' A' ' 85' ' ' VAL . 64.7 m -123.07 154.24 38.82 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.23 7.86 14.26 Favored Glycine 0 N--CA 1.464 0.543 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.113 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' H ' HG23 ' A' ' 59' ' ' THR . 23.0 mmt180 -137.87 179.65 6.3 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 55.3 mt 69.39 25.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 124.112 1.911 . . . . 0.0 106.081 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.422 ' HA ' HG13 ' A' ' 85' ' ' VAL . 25.7 p-10 -79.66 85.91 5.33 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 112.965 -1.925 . . . . 0.0 111.763 -175.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -161.65 47.42 0.19 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.13 82.66 7.62 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.411 -1.268 . . . . 0.0 112.811 -169.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -113.84 1.5 14.81 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.243 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.66 138.51 21.41 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.52 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 64.7 Cg_endo -71.56 35.79 0.29 Allowed 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 121.68 1.586 . . . . 0.0 113.906 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.9 p -124.02 -19.05 5.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.032 0.92 . . . . 0.0 108.576 171.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.489 ' CD2' HD21 ' A' ' 87' ' ' LEU . 36.1 m170 -124.24 129.91 51.61 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.3 p -125.88 136.35 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.457 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.99 135.54 45.3 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.744 0.783 . . . . 0.0 111.898 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.606 ' CG2' ' HD3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -120.3 155.39 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.334 0 CA-C-N 113.877 -1.511 . . . . 0.0 112.646 -173.183 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -67.83 112.36 4.84 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 125.38 1.472 . . . . 0.0 108.871 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -44.06 -50.77 8.3 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.694 1.598 . . . . 0.0 112.68 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -66.18 -23.65 66.5 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 124.944 1.298 . . . . 0.0 114.398 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -84.86 -31.42 23.78 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.148 0.975 . . . . 0.0 109.496 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.542 ' CZ ' HG22 ' A' ' 73' ' ' ILE . 4.2 m-85 -90.42 -8.22 51.13 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.631 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 62.15 25.7 15.4 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.866 1.267 . . . . 0.0 112.599 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 7.4 mp -85.07 172.52 11.2 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-O 122.992 1.377 . . . . 0.0 113.828 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.97 -23.97 61.52 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 111.518 -2.583 . . . . 0.0 110.651 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -152.31 160.03 43.39 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.377 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -56.04 136.36 52.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 123.993 0.808 . . . . 0.0 110.991 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 m -103.28 135.03 45.67 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.376 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.461 HG23 ' HB ' ' A' ' 59' ' ' THR . 1.1 m -116.84 131.62 68.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.552 ' CD1' HG12 ' A' ' 58' ' ' ILE . 23.1 mm -107.37 127.46 63.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.489 HD21 ' CD2' ' A' ' 70' ' ' HIS . 22.7 mt -103.69 109.82 21.67 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.84 8.18 27.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.275 -172.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -110.27 -35.82 5.98 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 122.122 0.963 . . . . 0.0 108.502 172.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.409 ' OE1' HG23 ' B' ' 52' ' ' THR . 5.8 tp60 -87.22 64.33 8.28 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.181 -1.372 . . . . 0.0 107.747 175.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.483 HG23 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -108.23 -176.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.418 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.575 ' NH2' ' HB3' ' A' ' 32' ' ' GLN . 8.2 ptp85 -164.98 163.89 20.7 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 52.3 m -122.5 116.39 23.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.3 mt -131.83 141.52 49.46 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.328 1.051 . . . . 0.0 109.412 -170.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -71.12 152.05 43.84 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.109 174.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.532 ' HE3' ' O ' ' A' ' 50' ' ' SER . 94.7 mttt -44.74 -26.03 0.35 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 126.245 1.818 . . . . 0.0 114.798 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -86.97 -14.6 41.26 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -81.59 -27.66 34.14 Favored 'General case' 0 N--CA 1.395 -3.188 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.34 117.89 15.63 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 169.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -89.35 -58.85 2.38 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.0 pt-20 -151.35 133.54 15.25 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 121.845 0.831 . . . . 0.0 112.6 -170.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -60.57 115.74 3.83 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 127.485 2.314 . . . . 0.0 107.61 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -111.71 -62.77 1.51 Allowed 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.664 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.518 HG23 HG21 ' A' ' 19' ' ' VAL . 3.5 t -129.63 -163.61 1.32 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.486 -1.285 . . . . 0.0 111.794 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -160.98 147.02 14.67 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 123.976 0.91 . . . . 0.0 111.028 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -114.68 161.69 17.78 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.615 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 p -82.97 151.64 25.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.56 ' O ' ' HB3' ' A' ' 111' ' ' MET . 25.5 t70 -59.16 -36.41 75.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.09 -23.04 59.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.46 0.648 . . . . 0.0 110.82 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.606 ' HD3' ' CG2' ' A' ' 73' ' ' ILE . 15.8 ttmm -85.94 -24.58 26.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.751 0.786 . . . . 0.0 109.578 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.56 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -53.73 -33.89 57.1 Favored 'General case' 0 N--CA 1.422 -1.841 0 C-N-CA 124.462 1.105 . . . . 0.0 109.818 170.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.571 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 7.1 mmpt? -69.78 -23.3 63.33 Favored 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.398 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -84.32 -31.25 24.95 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -173.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 1.6 t -67.15 -40.29 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.267 173.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.529 ' OD1' ' HG ' ' B' ' 124' ' ' LEU . 31.4 m-20 -63.07 -31.31 72.42 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.742 1.258 . . . . 0.0 110.607 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.751 ' O ' HD13 ' A' ' 120' ' ' ILE . 10.3 m-80 -80.06 -9.02 59.67 Favored 'General case' 1 N--CA 1.569 5.487 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.514 -176.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 68' ' ' PRO 0.275 . . -99.57 -49.0 4.55 Favored 'General case' 2 N--CA 1.344 -5.732 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 175.573 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 4.2 tp -67.61 -45.65 74.83 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.532 ' SD ' ' HE1' ' B' ' 129' ' ' HIS . 3.6 ttp -66.1 -22.48 66.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.653 0.781 . . . . 0.0 109.92 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.751 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -88.18 -51.56 12.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 17.3 t -54.15 -27.6 34.62 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 126.607 1.963 . . . . 0.0 111.926 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 56.0 mt -102.23 7.11 40.87 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.594 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.54 1.66 85.5 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.511 ' HG ' ' OD1' ' B' ' 115' ' ' ASP . 3.2 mp -65.96 -52.46 49.44 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.81 1.305 . . . . 0.0 109.217 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 127' ' ' VAL . 20.7 m120 56.39 -174.1 0.06 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.789 -1.55 . . . . 0.0 113.353 178.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.04 34.88 0.62 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.142 0.972 . . . . 0.0 110.525 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' A' ' 125' ' ' ASN . 63.8 t -83.01 -16.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.298 -177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 67.31 152.1 0.08 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.09 -1.868 . . . . 0.0 112.54 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.586 ' HE1' ' SD ' ' B' ' 119' ' ' MET . 34.4 m170 -79.9 -38.88 31.61 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.811 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -112.73 87.31 2.55 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.382 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -86.89 107.66 18.45 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.658 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.5 m120 . . . . . 0 C--N 1.293 -1.862 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.951 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.544 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p -66.33 -48.68 69.51 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.083 0.468 . . . . 0.0 109.872 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 26.0 m -90.05 80.33 6.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -59.37 104.96 0.3 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.55 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.4 m80 58.12 28.97 17.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.449 1.099 . . . . 0.0 112.085 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -73.01 -53.51 10.97 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -90.11 -56.87 3.05 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.772 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.69 79.84 8.98 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.342 1.067 . . . . 0.0 111.008 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -113.3 -76.51 0.59 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.961 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 9.5 p -94.02 -33.87 13.24 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.471 0.653 . . . . 0.0 109.776 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -121.66 107.58 12.53 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.194 177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -76.66 135.59 68.13 Favored Pre-proline 0 C--N 1.295 -1.797 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.13 99.41 0.08 OUTLIER 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 122.036 1.824 . . . . 0.0 111.766 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt -82.61 130.57 35.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.358 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -117.85 149.39 40.93 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.537 ' HG2' ' SD ' ' B' ' 111' ' ' MET . 42.7 ttt180 -68.38 114.23 6.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.52 1.6 19.86 Favored Glycine 0 N--CA 1.43 -1.7 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.377 -176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -90.97 173.96 7.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.514 HG21 HG23 ' B' ' 104' ' ' THR . 22.3 t -134.18 134.34 55.29 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.096 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.55 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 28.9 m-85 -133.93 148.72 51.23 Favored 'General case' 0 CA--C 1.475 -1.912 0 C-N-CA 124.645 1.178 . . . . 0.0 107.924 177.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.455 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.4 mp -82.39 150.59 27.05 Favored 'General case' 0 N--CA 1.401 -2.881 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.485 171.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.36 134.38 48.84 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.124 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' B' ' 25' ' ' SER 0.277 3.6 p-10 -90.27 99.13 12.2 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.693 -1.603 . . . . 0.0 111.314 178.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 4.2 mm? -83.09 40.44 0.7 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.54 -1.663 . . . . 0.0 111.679 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.46 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.272 5.6 m -66.55 166.66 16.64 Favored Pre-proline 0 C--N 1.269 -2.93 0 C-N-CA 127.528 2.331 . . . . 0.0 108.299 170.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 1.1 Cg_exo 5.66 53.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.399 3.228 1 C-N-CA 127.439 5.426 . . . . 0.0 117.674 -176.012 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.16 177.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 113.594 -1.639 . . . . 0.0 111.449 171.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -103.02 116.93 33.48 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.23 -176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.68 -121.19 19.16 Favored Glycine 0 CA--C 1.488 -1.631 0 CA-C-N 114.707 -1.133 . . . . 0.0 113.744 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.1 m -93.39 21.49 6.08 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.49 163.2 23.97 Favored 'General case' 0 C--O 1.256 1.443 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 172.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . 0.584 ' HB3' ' NH2' ' B' ' 92' ' ' ARG . 0.8 OUTLIER -78.22 116.8 18.92 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 122.768 0.427 . . . . 0.0 109.989 -174.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -91.34 142.46 16.11 Favored Glycine 0 CA--C 1.465 -3.061 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.817 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 111.81 137.73 7.27 Favored Glycine 0 N--CA 1.422 -2.275 0 CA-C-N 114.299 -0.95 . . . . 0.0 111.219 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' B' ' 23' ' ' ASP . 0.8 OUTLIER -72.82 121.64 23.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-O 122.499 1.142 . . . . 0.0 109.292 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -139.74 156.32 71.01 Favored Pre-proline 0 C--N 1.262 -3.198 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.366 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.3 Cg_exo -65.6 143.93 76.84 Favored 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 122.725 2.283 . . . . 0.0 111.898 172.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.478 HG23 ' O ' ' B' ' 20' ' ' TYR . 27.9 m -127.19 158.36 38.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 123.6 0.76 . . . . 0.0 109.185 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.89 134.34 45.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.514 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.89 97.03 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.433 ' C ' HD11 ' B' ' 41' ' ' ILE . 0.0 OUTLIER -93.81 -24.74 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.376 -178.449 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.519 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 4.1 pt20 -61.52 168.01 3.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 117.287 2.328 . . . . 0.0 117.287 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -62.54 169.57 2.94 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.971 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.06 -28.82 32.2 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -75.95 -38.01 58.03 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 122.293 -0.254 . . . . 0.0 110.539 -172.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.18 -28.55 73.68 Favored Glycine 0 C--O 1.212 -1.244 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -59.18 -34.15 71.79 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.779 0.8 . . . . 0.0 110.26 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.506 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 19.8 mmmt -92.01 -61.23 1.67 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.298 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.506 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 60.3 m-85 -80.44 -35.66 34.7 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -167.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.476 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 19.6 m -94.32 134.5 25.53 Favored Pre-proline 0 C--N 1.292 -1.921 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.587 -174.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.91 -20.08 29.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.931 1.754 . . . . 0.0 109.736 173.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.409 HG23 ' OE1' ' A' ' 90' ' ' GLN . 3.0 p -92.61 136.04 33.57 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.107 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.519 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 93.3 t -121.34 140.53 45.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.01 123.97 68.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-O 122.153 0.978 . . . . 0.0 109.705 175.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.429 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 27.7 m -133.07 172.8 15.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.957 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.471 ' CB ' HG23 ' B' ' 91' ' ' ILE . . . -124.58 146.04 49.27 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.3 131.36 41.84 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.55 HG12 ' CD1' ' B' ' 86' ' ' ILE . 60.8 mt -89.84 125.76 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' THR . . . . . 0.475 ' HB ' HG23 ' B' ' 85' ' ' VAL . 41.2 m -123.55 149.58 45.09 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.81 12.75 22.6 Favored Glycine 0 N--CA 1.466 0.672 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.578 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -143.51 -179.92 6.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 68.5 mt 70.06 24.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 123.895 1.807 . . . . 0.0 106.559 -174.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . 0.411 ' HA ' HG13 ' B' ' 85' ' ' VAL . 27.4 p-10 -79.12 91.25 4.9 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.865 -175.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -163.59 45.08 0.12 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.74 83.14 7.79 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.737 -170.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -115.88 3.87 13.8 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.028 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.402 ' H ' HD13 ' B' ' 67' ' ' ILE . 2.5 mp -100.8 136.16 19.89 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . 0.404 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 59.1 Cg_endo -69.82 37.1 0.24 Allowed 'Trans proline' 0 CA--C 1.553 1.464 0 C-N-CA 122.16 1.907 . . . . 0.0 113.877 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 59.4 p -127.03 -19.11 4.46 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.54 ' CD2' HD23 ' B' ' 87' ' ' LEU . 31.9 m170 -123.49 129.94 51.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.68 136.25 61.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.171 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.13 139.82 37.24 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-O 121.294 0.569 . . . . 0.0 111.603 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.572 HG22 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -125.59 155.1 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.499 -174.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -66.74 114.78 5.9 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.033 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -45.62 -53.89 8.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.327 1.451 . . . . 0.0 112.163 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -61.45 -27.26 68.44 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -82.3 -34.25 28.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.705 0.764 . . . . 0.0 109.734 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.572 ' CZ ' HG22 ' B' ' 73' ' ' ILE . 4.1 m-85 -86.92 -7.96 57.69 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.647 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 65.22 23.14 12.22 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.982 1.313 . . . . 0.0 112.66 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.04 173.77 10.24 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 123.018 1.39 . . . . 0.0 114.051 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.74 -23.21 56.0 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 111.917 -2.401 . . . . 0.0 110.56 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -149.06 159.59 44.09 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.3 138.16 57.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 123.74 0.65 . . . . 0.0 110.464 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 11.3 m -103.11 134.2 46.93 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.079 -167.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' B' ' 59' ' ' THR . 1.1 m -116.64 131.99 67.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.55 ' CD1' HG12 ' B' ' 58' ' ' ILE . 23.6 mm -107.42 127.74 63.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 175.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.54 HD23 ' CD2' ' B' ' 70' ' ' HIS . 24.0 mt -103.06 109.22 20.7 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -177.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.83 7.7 32.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.71 0.767 . . . . 0.0 112.179 -172.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -108.76 -34.43 6.68 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-O 122.359 1.076 . . . . 0.0 108.542 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . 0.646 HE22 ' NH2' ' B' ' 92' ' ' ARG . 0.3 OUTLIER -92.79 72.85 4.91 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.477 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.3 pp -114.74 -175.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.712 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.646 ' NH2' HE22 ' B' ' 90' ' ' GLN . 8.5 ptp85 -164.91 164.67 20.74 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 53.5 m -122.58 115.52 22.3 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 68.4 mt -131.81 141.18 49.38 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.396 1.078 . . . . 0.0 109.344 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -72.16 152.68 42.12 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.301 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.476 ' HE3' ' O ' ' B' ' 50' ' ' SER . 93.3 mttt -46.65 -21.21 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.199 1.8 . . . . 0.0 115.145 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -89.0 -18.31 27.63 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -79.69 -27.34 40.73 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.71 120.53 19.43 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -91.87 -57.72 2.64 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 12.8 pt-20 -151.29 134.7 16.15 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.93 0.871 . . . . 0.0 112.728 -170.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -62.02 113.38 2.79 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 127.647 2.379 . . . . 0.0 108.8 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -109.81 -62.08 1.55 Allowed 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.769 -176.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.514 HG23 HG21 ' B' ' 19' ' ' VAL . 2.0 t -131.18 -164.48 1.44 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.45 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -161.05 145.01 13.37 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 123.838 0.855 . . . . 0.0 111.558 -171.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.78 162.37 16.39 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.542 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.8 p -83.18 149.56 26.77 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.151 0.58 . . . . 0.0 112.105 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' B' ' 111' ' ' MET . 26.9 t70 -59.55 -32.71 70.58 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.875 0.87 . . . . 0.0 113.129 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' B' ' 112' ' ' LYS . 27.2 t70 -76.81 -25.36 53.21 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.196 0.522 . . . . 0.0 110.596 178.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.56 ' HD3' ' CG2' ' B' ' 73' ' ' ILE . 15.8 ttmm -85.08 -24.62 28.02 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.877 0.846 . . . . 0.0 109.207 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.537 ' SD ' ' HG2' ' B' ' 16' ' ' ARG . 0.1 OUTLIER -52.92 -34.38 54.86 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 124.708 1.203 . . . . 0.0 109.983 169.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.554 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 7.1 mmpt? -69.78 -24.05 63.45 Favored 'General case' 0 N--CA 1.402 -2.866 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.25 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -85.21 -32.49 22.61 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.53 -42.15 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.48 0 CA-C-N 112.692 -2.049 . . . . 0.0 109.934 171.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.511 ' OD1' ' HG ' ' A' ' 124' ' ' LEU . 42.8 m-20 -60.31 -40.88 92.12 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 122.035 0.921 . . . . 0.0 109.87 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.728 ' O ' HD13 ' B' ' 120' ' ' ILE . 1.1 m-80 -64.29 -21.56 66.64 Favored 'General case' 0 N--CA 1.52 3.063 0 C-N-CA 125.362 1.465 . . . . 0.0 112.604 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' B' ' 68' ' ' PRO . . . -84.48 -53.03 5.71 Favored 'General case' 2 C--N 1.23 -4.605 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 4.1 tp -65.41 -46.76 78.73 Favored 'General case' 0 N--CA 1.4 -2.955 0 C-N-CA 124.494 1.117 . . . . 0.0 113.978 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.586 ' SD ' ' HE1' ' A' ' 129' ' ' HIS . 3.6 ttp -66.98 -24.85 66.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 123.644 0.778 . . . . 0.0 109.999 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.728 HD13 ' O ' ' B' ' 116' ' ' ASN . 2.5 mp -88.52 -45.83 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.0 t -55.18 -29.85 58.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.928 1.291 . . . . 0.0 111.359 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 58.4 mt -99.96 7.43 44.81 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 120.201 -0.599 . . . . 0.0 112.149 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.41 1.06 89.44 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 116.215 1.246 . . . . 0.0 116.215 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.529 ' HG ' ' OD1' ' A' ' 115' ' ' ASP . 3.4 mp -64.96 -51.08 63.73 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 118.832 1.316 . . . . 0.0 109.302 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m120 56.49 -169.27 0.09 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.513 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.81 29.49 1.17 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.573 0.701 . . . . 0.0 111.056 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.52 -19.93 14.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.496 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 71.01 157.71 0.18 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 126.529 1.932 . . . . 0.0 113.466 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.532 ' HE1' ' SD ' ' A' ' 119' ' ' MET . 31.4 m170 -92.94 1.1 57.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.137 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -150.77 92.97 1.89 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -96.93 97.1 8.99 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.309 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.3 m120 . . . . . 0 C--N 1.294 -1.81 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.687 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.734 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 m -93.03 88.13 6.01 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.9 t -81.12 -32.84 33.61 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -118.35 125.85 50.89 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.492 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -97.41 108.87 21.69 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -67.14 129.83 41.16 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.389 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -89.94 -175.41 4.58 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.505 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 63.46 31.71 14.8 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.672 1.225 . . . . 0.0 108.903 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -69.75 -39.47 76.71 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.6 m -81.27 89.38 6.05 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 113.764 -1.562 . . . . 0.0 106.864 171.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.48 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 97.6 mt-30 -59.05 125.21 22.67 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.132 -176.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -84.68 103.01 2.62 Favored Pre-proline 0 C--N 1.319 -0.726 0 C-N-CA 124.65 1.18 . . . . 0.0 108.646 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 11' ' ' GLN . 4.6 Cg_exo -77.06 -53.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.762 2.308 . . . . 0.0 110.341 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.9 mt -84.77 108.9 17.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 172.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -125.5 158.42 34.53 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.59 132.49 39.5 Favored 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.81 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.17 -6.17 56.14 Favored Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.165 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.43 ' CG ' ' HZ3' ' A' ' 102' ' ' LYS . 5.6 t70 -97.12 178.08 5.37 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 4.1 t -135.57 130.61 50.29 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 CA-C-O 121.491 0.662 . . . . 0.0 112.075 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 39.9 m-85 -130.49 145.53 51.87 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.316 176.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -80.31 149.83 30.17 Favored 'General case' 0 N--CA 1.395 -3.189 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 170.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.62 141.68 37.09 Favored 'General case' 0 C--N 1.257 -3.45 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.622 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.29 84.06 6.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.563 ' O ' HG11 ' A' ' 27' ' ' VAL . 91.6 mt -65.53 -27.81 68.72 Favored 'General case' 0 CA--C 1.468 -2.176 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.251 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.1 m -33.82 176.0 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.164 0 C-N-CA 128.375 2.67 . . . . 0.0 114.599 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.573 ' HB2' ' NE2' ' B' ' 28' ' ' GLN . 0.1 OUTLIER 22.92 51.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.108 0 C-N-CA 123.108 2.538 . . . . 0.0 115.554 -152.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.563 HG11 ' O ' ' A' ' 24' ' ' LEU . 14.9 m -72.02 -178.27 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.421 165.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.521 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 31.8 mm-40 -115.04 124.43 51.59 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.581 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.96 -109.1 1.67 Allowed Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 113.728 -1.578 . . . . 0.0 115.779 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -93.06 8.81 38.45 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 48.9 mt-10 -64.65 156.34 30.46 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 118.203 -1.399 . . . . 0.0 109.603 174.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.33 108.92 6.47 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -175.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.16 147.73 19.37 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 116.136 1.215 . . . . 0.0 116.136 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.48 157.19 12.38 Favored Glycine 0 N--CA 1.414 -2.83 0 CA-C-N 113.319 -1.44 . . . . 0.0 110.276 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -77.92 112.44 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 122.583 1.182 . . . . 0.0 108.283 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -134.16 158.73 74.62 Favored Pre-proline 0 C--N 1.259 -3.345 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.891 -172.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 36.0 Cg_exo -64.56 134.86 43.04 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.656 2.238 . . . . 0.0 110.984 173.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 20' ' ' TYR . 35.4 m -121.1 160.4 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.474 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 29.8 m -98.8 129.75 48.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -86.66 101.22 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.43 -20.71 5.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.636 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.493 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -55.02 158.54 2.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.232 1.413 . . . . 0.0 114.675 -170.668 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 172.28 4.89 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.322 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.21 -47.22 65.44 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.596 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -71.18 -34.17 70.67 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.919 -169.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.31 75.53 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.805 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -63.54 -35.17 79.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.187 0.517 . . . . 0.0 110.231 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -87.17 -53.39 4.88 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.301 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -96.64 -10.43 27.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -167.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.1 t -113.26 143.3 28.99 Favored Pre-proline 0 C--N 1.294 -1.83 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.191 -177.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.526 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 33.6 Cg_endo -71.39 -27.62 19.07 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.734 1.623 . . . . 0.0 109.892 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 p -97.18 142.8 28.65 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.117 -175.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.48 141.02 36.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.493 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 12.1 tt -82.02 133.79 28.44 Favored 'Isoleucine or valine' 0 C--O 1.257 1.451 0 CA-C-O 121.512 0.673 . . . . 0.0 110.739 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -136.27 155.49 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.283 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.474 ' HB1' ' CG2' ' A' ' 39' ' ' VAL . . . -121.01 141.13 51.02 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.06 129.8 38.56 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.493 HG12 ' CD1' ' A' ' 86' ' ' ILE . 57.7 mt -86.38 115.41 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 173.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.3 m -101.24 104.95 16.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.488 0.661 . . . . 0.0 110.903 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.63 49.87 0.86 Allowed Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -153.52 8.31 0.38 Allowed 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 122.895 0.478 . . . . 0.0 110.545 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.0 mt -146.23 157.2 11.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 -177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -144.19 -173.97 4.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.7 tttt 78.42 103.54 0.07 Allowed 'General case' 0 C--O 1.246 0.914 0 O-C-N 124.337 1.023 . . . . 0.0 111.287 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 67' ' ' ILE . . . -92.14 -95.31 0.14 Allowed 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.003 172.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 60.28 22.52 11.96 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.63 0.729 . . . . 0.0 111.122 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 65' ' ' ALA . 5.5 tt -160.16 136.36 6.29 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.444 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 9.3 Cg_endo -52.29 -34.07 58.23 Favored 'Trans proline' 0 C--O 1.208 -1.015 0 C-N-CA 122.832 2.355 . . . . 0.0 114.139 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 p -73.6 -18.96 60.99 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-N 118.238 0.472 . . . . 0.0 112.043 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -104.42 129.17 52.4 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 87.7 t -118.7 112.68 38.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.186 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.402 ' HG3' ' HB2' ' A' ' 65' ' ' ALA . 37.2 mt-10 -82.3 118.89 23.48 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.632 HD11 ' CE2' ' A' ' 78' ' ' TYR . 8.0 pt -101.74 133.27 45.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.268 -174.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.45 118.45 4.47 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.294 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.674 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 43.6 mttp -43.05 -48.6 6.15 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.653 1.216 . . . . 0.0 109.266 173.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -62.46 -29.13 70.3 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 112.781 -2.008 . . . . 0.0 113.28 -173.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -91.72 -29.03 17.05 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.489 0.661 . . . . 0.0 111.093 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.632 ' CE2' HD11 ' A' ' 73' ' ' ILE . 23.0 m-85 -95.84 9.58 40.04 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.256 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 tttm 61.63 27.84 17.17 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.385 1.088 . . . . 0.0 110.148 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.31 176.47 5.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.936 0.874 . . . . 0.0 109.915 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -102.79 -8.63 20.65 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.875 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.508 ' C ' ' HG2' ' A' ' 75' ' ' LYS . 9.9 ptpp? -144.1 143.56 31.19 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.674 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 34.0 m-20 -70.63 120.1 15.75 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 73' ' ' ILE . 25.3 t -104.57 174.05 6.04 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -175.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 13.3 t -122.39 139.5 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.493 ' CD1' HG12 ' A' ' 58' ' ' ILE . 19.6 mm -104.16 127.41 58.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 172.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.5 mt -102.41 104.9 15.4 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.557 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.423 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 4.0 mm? -83.06 3.33 30.88 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.653 0.74 . . . . 0.0 112.195 -175.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -97.79 -36.23 10.28 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 122.25 1.024 . . . . 0.0 108.352 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.428 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 3.1 tp60 -94.92 76.5 3.58 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.851 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.447 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -125.78 175.88 7.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -165.06 173.59 11.32 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 45.3 m -118.47 121.73 41.0 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.609 -175.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.415 ' HB3' ' HG3' ' A' ' 98' ' ' ARG . 77.0 mt -131.94 149.34 52.46 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.949 -173.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -57.55 143.64 40.17 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 170.17 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 19.0 pttm -53.8 -33.55 56.39 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.988 0.899 . . . . 0.0 112.565 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.415 ' HD3' ' HB3' ' A' ' 95' ' ' ASP . 28.9 mtpt -47.5 -31.38 4.23 Favored 'General case' 0 C--N 1.278 -2.542 0 C-N-CA 127.062 2.145 . . . . 0.0 113.436 170.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.415 ' HG3' ' HB3' ' A' ' 94' ' ' LEU . 2.4 mmp_? -69.57 -31.22 69.27 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.508 0.67 . . . . 0.0 110.323 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 7.2 mp -70.75 131.45 43.87 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.181 1.393 . . . . 0.0 110.712 175.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -99.97 -57.45 2.13 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.281 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 13.2 pt-20 -159.26 146.59 17.19 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-O 121.39 0.614 . . . . 0.0 111.377 -169.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 64.9 tttp -62.65 125.62 24.55 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 126.601 1.96 . . . . 0.0 110.559 173.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 tp -114.74 -61.75 1.7 Allowed 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.179 174.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.501 HG23 HG21 ' A' ' 19' ' ' VAL . 5.3 t -129.35 -159.84 0.99 Allowed 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.554 -1.259 . . . . 0.0 111.98 -177.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -161.05 142.29 11.7 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.258 1.423 . . . . 0.0 109.519 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -105.31 156.57 18.02 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 m -81.81 158.93 23.91 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.475 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.32 -32.33 71.13 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.866 1.267 . . . . 0.0 112.007 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 5.4 p-10 -66.91 -28.23 68.14 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.565 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -73.67 -28.76 61.93 Favored 'General case' 0 CA--C 1.483 -1.622 0 O-C-N 123.404 0.44 . . . . 0.0 111.443 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.425 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -53.06 -48.02 68.01 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-O 121.987 0.899 . . . . 0.0 108.847 174.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.425 ' HE2' ' C ' ' A' ' 111' ' ' MET . 9.0 mmpt? -79.46 -9.82 59.68 Favored 'General case' 0 N--CA 1.39 -3.444 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.655 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 109' ' ' ASP . 38.1 mt-10 -86.54 -43.73 12.49 Favored 'General case' 0 CA--C 1.471 -2.095 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 176.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.0 t -49.81 -47.17 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.037 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.411 ' CG ' ' HZ3' ' A' ' 112' ' ' LYS . 3.9 m-20 -53.87 -41.64 67.75 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.091 0.948 . . . . 0.0 111.262 176.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.612 ' O ' HD13 ' A' ' 120' ' ' ILE . 24.1 m-80 -80.41 -22.93 40.75 Favored 'General case' 0 CA--C 1.434 -3.502 0 CA-C-O 123.315 1.531 . . . . 0.0 110.21 -173.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.616 ' O ' ' HB2' ' A' ' 121' ' ' SER . . . -84.37 -37.65 21.27 Favored 'General case' 2 N--CA 1.342 -5.844 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.625 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.719 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -82.67 -55.35 4.49 Favored 'General case' 1 N--CA 1.372 -4.352 0 C-N-CA 123.124 0.57 . . . . 0.0 112.23 -175.159 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.3 mtp -56.85 -35.52 68.95 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -75.27 -45.33 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.445 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.616 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 7.7 t -62.05 -32.12 72.6 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.257 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.719 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 13.0 mt -101.17 1.51 39.18 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.434 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.5 16.24 80.54 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.3 mp -67.99 -52.15 39.05 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-N 119.413 1.606 . . . . 0.0 110.411 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 m120 45.35 115.25 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 O-C-N 125.654 1.846 . . . . 0.0 114.374 -174.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.417 ' HB1' ' CD2' ' B' ' 129' ' ' HIS . . . -68.69 88.08 0.35 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.179 -0.919 . . . . 0.0 113.332 -171.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.1 t -136.11 9.24 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.177 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.403 ' C ' ' H ' ' A' ' 130' ' ' GLN . . . -113.53 -56.47 2.4 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.157 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 72.63 -17.68 0.38 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.156 1.383 . . . . 0.0 112.405 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' A' ' 128' ' ' ALA . 24.9 pt20 -162.42 -172.74 3.28 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.46 ' HE2' ' HG2' ' B' ' 113' ' ' GLU . 28.1 tptp -64.82 126.44 27.96 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.905 0.86 . . . . 0.0 110.07 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.283 -2.305 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.102 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.5 m -87.42 82.74 7.45 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.244 0.545 . . . . 0.0 110.701 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -78.72 -29.45 45.36 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -121.38 121.74 38.29 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 175.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -93.47 114.25 26.59 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -76.27 125.36 29.04 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.464 0.478 . . . . 0.0 109.938 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -86.58 -174.65 5.1 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.528 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 64.76 30.86 12.18 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.302 1.049 . . . . 0.0 109.197 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -70.8 -37.8 73.31 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 44.7 m -82.16 90.27 6.56 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . 0.501 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 97.8 mt-30 -54.46 129.02 34.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.465 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -91.49 103.24 7.2 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' B' ' 11' ' ' GLN . 3.7 Cg_exo -75.25 -53.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.657 2.238 . . . . 0.0 110.613 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 70.2 mt -83.31 101.66 8.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 172.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -119.79 157.55 28.38 Favored 'General case' 0 C--N 1.275 -2.666 0 O-C-N 123.828 0.705 . . . . 0.0 110.061 -172.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.27 125.81 29.92 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.846 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.28 -6.86 32.28 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.835 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -97.09 177.83 5.46 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 4.8 t -134.65 130.47 53.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-O 121.411 0.624 . . . . 0.0 112.039 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 39.4 m-85 -130.12 145.17 51.68 Favored 'General case' 0 CA--C 1.472 -2.023 0 C-N-CA 124.993 1.317 . . . . 0.0 109.118 176.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' B' ' 99' ' ' LEU . 4.3 mp -79.28 151.75 30.94 Favored 'General case' 0 N--CA 1.395 -3.179 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 170.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.71 141.68 33.31 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.925 -176.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.8 83.96 6.43 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.551 ' O ' HG11 ' B' ' 27' ' ' VAL . 90.8 mt -64.92 -26.88 68.5 Favored 'General case' 0 CA--C 1.469 -2.162 0 CA-C-N 112.995 -1.911 . . . . 0.0 111.137 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.416 ' CB ' ' HD2' ' B' ' 26' ' ' PRO . 2.7 m -34.13 178.35 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.351 0 C-N-CA 128.709 2.804 . . . . 0.0 114.883 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.521 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 0.1 OUTLIER 22.44 50.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.676 0 C-N-CA 122.961 2.441 . . . . 0.0 115.277 -153.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.551 HG11 ' O ' ' B' ' 24' ' ' LEU . 11.5 m -71.3 -178.95 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.612 166.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . 0.573 ' NE2' ' HB2' ' A' ' 26' ' ' PRO . 31.1 mm-40 -115.14 128.57 56.28 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.36 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.52 -108.97 0.9 Allowed Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.152 -1.385 . . . . 0.0 115.248 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 66.8 m -93.44 7.66 43.65 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.548 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 50.1 mt-10 -62.57 159.98 14.8 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 117.852 -1.539 . . . . 0.0 109.981 175.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.61 110.23 9.84 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -176.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.04 146.93 18.62 Favored Glycine 0 CA--C 1.484 -1.879 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -174.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.85 157.54 11.69 Favored Glycine 0 N--CA 1.412 -2.9 0 CA-C-N 113.331 -1.435 . . . . 0.0 110.29 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -77.68 113.58 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 122.631 1.205 . . . . 0.0 107.78 175.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -135.63 158.77 73.57 Favored Pre-proline 0 C--N 1.259 -3.369 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.121 -171.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.2 Cg_exo -64.62 134.24 40.21 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.59 2.193 . . . . 0.0 110.925 172.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.467 HG22 ' O ' ' B' ' 20' ' ' TYR . 35.0 m -120.92 160.11 22.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 ' CG2' ' HB1' ' B' ' 56' ' ' ALA . 32.8 m -98.78 130.09 48.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -87.14 100.6 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.08 -20.99 5.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.522 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.498 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.0 OUTLIER -54.61 158.4 2.56 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -170.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.03 170.72 6.38 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.196 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.52 -44.81 70.27 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.443 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 18.7 m -72.17 -34.83 68.76 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 122.697 0.399 . . . . 0.0 111.658 -170.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.78 -30.38 76.84 Favored Glycine 0 C--O 1.219 -0.822 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.71 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -64.67 -27.23 68.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.952 0.406 . . . . 0.0 110.512 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.421 ' HB2' ' CD2' ' B' ' 49' ' ' TYR . 6.7 mmtt -93.17 -53.98 3.9 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.421 ' CD2' ' HB2' ' B' ' 48' ' ' LYS . 96.0 m-85 -100.77 1.2 40.05 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -166.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -121.16 142.05 34.22 Favored Pre-proline 0 C--N 1.292 -1.929 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.533 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.553 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 37.4 Cg_endo -71.61 -27.04 19.06 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.489 1.46 . . . . 0.0 109.539 174.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.0 146.7 24.4 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.064 -176.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.05 140.49 27.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.498 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 12.4 tt -82.13 133.41 29.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.237 0 CA-C-O 121.375 0.607 . . . . 0.0 110.677 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 36.0 m -135.59 156.33 37.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.349 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.47 ' HB1' ' CG2' ' B' ' 39' ' ' VAL . . . -121.6 140.41 52.28 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.85 128.81 36.52 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.46 HG12 ' CD1' ' B' ' 86' ' ' ILE . 55.5 mt -86.09 117.05 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 173.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.2 m -102.4 105.16 15.7 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.217 0.532 . . . . 0.0 111.077 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.5 47.99 1.03 Allowed Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -153.6 12.43 0.46 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.279 0.561 . . . . 0.0 110.81 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 62.4 mt -149.06 153.22 11.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' B' ' 64' ' ' LYS . 6.3 m120 -141.81 -172.03 3.47 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' B' ' 63' ' ' ASN . 76.6 tttt 76.32 106.87 0.08 Allowed 'General case' 0 C--O 1.244 0.797 0 O-C-N 124.244 0.965 . . . . 0.0 110.774 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.38 -94.52 0.16 Allowed 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.63 25.73 14.69 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.912 0.885 . . . . 0.0 111.162 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.8 tt -161.56 136.94 5.65 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . 0.434 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 8.5 Cg_endo -52.71 -32.1 53.7 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 122.672 2.248 . . . . 0.0 114.375 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 32.4 p -73.8 -19.33 60.79 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.082 0.468 . . . . 0.0 112.038 -172.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -104.83 129.54 53.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 96.2 t -118.68 114.11 43.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.599 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.76 117.11 22.43 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.637 HD11 ' CE2' ' B' ' 78' ' ' TYR . 8.8 pt -101.43 132.95 46.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.18 -174.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.44 119.5 6.15 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.211 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 39.9 mttp -43.19 -49.21 6.56 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.587 1.155 . . . . 0.0 109.059 173.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -61.57 -29.59 70.12 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.902 -1.954 . . . . 0.0 113.198 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -91.71 -29.72 16.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.329 0.585 . . . . 0.0 111.076 -176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.637 ' CE2' HD11 ' B' ' 73' ' ' ILE . 21.0 m-85 -95.9 7.99 44.85 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.035 -176.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 tttm 60.8 31.83 20.09 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 122.324 1.059 . . . . 0.0 109.972 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -111.86 176.29 5.08 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.495 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . 0.404 ' O ' ' HD3' ' B' ' 75' ' ' LYS . 7.3 p-10 -99.48 -9.83 22.89 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.914 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.493 ' C ' ' HG2' ' B' ' 75' ' ' LYS . 10.0 ptpp? -141.77 143.64 33.57 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.102 -174.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . 0.655 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 27.3 m-20 -71.5 119.27 15.41 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 173.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.495 ' O ' HG12 ' B' ' 73' ' ' ILE . 23.3 t -105.25 173.28 6.37 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 13.4 t -120.43 139.94 46.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.46 ' CD1' HG12 ' B' ' 58' ' ' ILE . 19.1 mm -104.18 127.68 58.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 172.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 88.0 mt -103.23 105.95 16.36 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.9 mm? -83.33 -3.98 58.02 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.039 -176.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.52 -34.48 15.53 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.256 1.027 . . . . 0.0 108.778 174.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . 0.458 ' OE1' ' HA ' ' B' ' 31' ' ' GLU . 3.5 tp60 -97.02 76.71 2.7 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.168 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.459 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.3 pp -125.13 176.6 5.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -165.43 173.83 10.66 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 47.4 m -118.8 122.23 41.91 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 64.9 mt -131.92 150.37 52.17 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.894 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.553 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 0.7 OUTLIER -58.44 142.47 48.52 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 169.581 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' B' ' 99' ' ' LEU . 18.0 pttm -51.82 -36.26 47.34 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.7 0.762 . . . . 0.0 112.435 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -44.42 -34.63 2.1 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 126.684 1.994 . . . . 0.0 113.637 171.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -67.43 -29.55 69.05 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.568 0.747 . . . . 0.0 110.71 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 96' ' ' LYS . 7.5 mp -72.48 129.63 38.78 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 125.52 1.528 . . . . 0.0 110.611 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -95.95 -58.04 2.2 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.443 -1.253 . . . . 0.0 114.097 -175.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 16.1 pt-20 -161.06 147.18 14.63 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.535 0.683 . . . . 0.0 111.847 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 64.8 tttp -61.17 124.33 20.24 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 126.974 2.11 . . . . 0.0 110.609 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.7 tp -114.57 -61.45 1.75 Allowed 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.348 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.488 HG23 HG21 ' B' ' 19' ' ' VAL . 5.8 t -129.72 -158.25 0.88 Allowed 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 118.179 -1.409 . . . . 0.0 112.063 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -160.28 148.83 16.9 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 126.063 1.745 . . . . 0.0 109.038 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.42 ' HB3' ' CZ ' ' B' ' 78' ' ' TYR . 3.8 pp -112.4 154.77 25.28 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.8 m -80.6 161.13 24.87 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.374 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.67 -32.98 73.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.87 0.868 . . . . 0.0 112.522 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.534 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 5.4 p-10 -62.4 -32.02 72.79 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -70.78 -28.85 64.97 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.441 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.1 OUTLIER -54.65 -47.78 73.11 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.462 ' HZ3' ' CG ' ' B' ' 115' ' ' ASP . 9.0 mmpt? -78.38 -12.27 59.99 Favored 'General case' 0 N--CA 1.389 -3.496 0 CA-C-N 114.508 -1.224 . . . . 0.0 113.754 -177.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' B' ' 109' ' ' ASP . 44.3 mt-10 -85.85 -41.64 14.83 Favored 'General case' 0 CA--C 1.47 -2.1 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 177.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 t -51.6 -47.02 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-N 112.911 -1.949 . . . . 0.0 110.731 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.462 ' CG ' ' HZ3' ' B' ' 112' ' ' LYS . 2.7 m-20 -53.04 -48.83 67.34 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.688 0.756 . . . . 0.0 110.276 174.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.67 ' O ' HD13 ' B' ' 120' ' ' ILE . 10.3 m-80 -69.82 -24.3 63.45 Favored 'General case' 0 N--CA 1.512 2.643 0 C-N-CA 125.004 1.322 . . . . 0.0 112.184 -176.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.446 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -83.41 -44.38 14.86 Favored 'General case' 2 C--N 1.231 -4.546 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.035 177.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.74 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.0 OUTLIER -73.51 -55.72 5.97 Favored 'General case' 1 N--CA 1.374 -4.269 0 C-N-CA 123.349 0.66 . . . . 0.0 112.162 -173.634 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 38.8 mtp -56.88 -37.88 71.97 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.67 HD13 ' O ' ' B' ' 116' ' ' ASN . 1.5 mp -77.06 -39.84 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 60.7 m -58.54 -35.87 72.97 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.625 0.726 . . . . 0.0 110.818 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.74 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 11.0 mt -101.17 -0.01 36.81 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.706 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.85 17.72 79.56 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 115.81 1.084 . . . . 0.0 115.81 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.43 -54.35 21.05 Favored 'General case' 0 CA--C 1.479 -1.753 0 CA-C-N 119.111 1.455 . . . . 0.0 110.021 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 m120 49.57 118.82 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.575 -1.648 . . . . 0.0 113.937 -173.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.6 86.29 2.11 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.749 0.785 . . . . 0.0 112.783 -172.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.3 t -132.75 6.11 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 113.888 -1.505 . . . . 0.0 107.106 173.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.72 -59.96 1.85 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.783 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.417 ' CD2' ' HB1' ' A' ' 126' ' ' ALA . 25.9 t-80 71.65 -12.8 0.61 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.919 1.287 . . . . 0.0 112.133 173.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -161.26 -175.04 4.61 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -70.43 120.7 16.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.444 0.64 . . . . 0.0 109.83 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.3 -1.547 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.663 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.573 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -92.44 -67.71 0.84 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.2 p -109.19 -3.64 17.13 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.53 0.681 . . . . 0.0 109.788 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -116.04 115.63 26.45 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -130.0 123.12 29.82 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -81.33 107.18 13.9 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -83.42 96.94 8.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.864 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.27 153.68 27.88 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -87.44 98.25 11.27 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.4 m -66.84 -26.02 66.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.346 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -150.82 136.32 17.92 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 120.844 0.354 . . . . 0.0 110.908 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.499 ' HB2' ' NH1' ' A' ' 15' ' ' ARG . 39.6 m-20 -109.43 142.71 26.25 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 173.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.22 -31.53 93.17 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 122.673 2.249 . . . . 0.0 113.922 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 55.8 mt -107.18 116.39 50.73 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.364 -173.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.499 ' NH1' ' HB2' ' A' ' 12' ' ' ASP . 32.2 mmt180 -121.45 153.55 37.73 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.456 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -75.43 139.67 42.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.799 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.13 -11.19 51.8 Favored Glycine 0 C--N 1.306 -1.101 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.007 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -97.31 173.46 7.2 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 4.6 t -130.68 130.55 64.72 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 C-N-CA 123.21 0.604 . . . . 0.0 111.763 -175.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 85.4 m-85 -127.03 143.95 51.15 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.907 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.16 147.56 40.36 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 169.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -135.86 129.42 32.32 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.706 -1.588 . . . . 0.0 107.635 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 10.1 t70 -84.99 91.08 7.98 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.351 174.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.606 HD21 ' O ' ' A' ' 24' ' ' LEU 0.432 0.0 OUTLIER -114.82 62.1 0.68 Allowed 'General case' 0 N--CA 1.385 -3.699 0 CA-C-O 124.203 1.954 . . . . 0.0 111.999 175.788 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.436 ' OG ' ' HA2' ' A' ' 34' ' ' GLY . 1.4 m -107.04 60.39 0.2 Allowed Pre-proline 0 C--N 1.266 -3.03 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.554 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -115.27 23.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.276 0 N-CA-C 108.456 -1.402 . . . . 0.0 108.456 158.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 20.1 m -88.65 158.13 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -172.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.456 ' NE2' HH22 ' B' ' 98' ' ' ARG . 0.0 OUTLIER -155.74 160.57 40.42 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 113.005 -1.907 . . . . 0.0 107.049 178.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.51 -142.82 17.47 Favored Glycine 0 C--N 1.297 -1.624 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.405 ' HB2' ' CB ' ' B' ' 95' ' ' ASP . 22.3 m -94.46 15.33 18.06 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 117.053 0.427 . . . . 0.0 110.99 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 46.3 mt-10 -70.33 157.62 37.4 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -134.99 112.87 10.95 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.42 ' HA3' HD21 ' A' ' 24' ' ' LEU . . . -145.0 -109.86 0.66 Allowed Glycine 0 N--CA 1.411 -2.975 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.545 176.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.436 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 82.95 178.11 52.24 Favored Glycine 0 N--CA 1.4 -3.76 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -172.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 1.4 p -87.45 99.36 8.47 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-O 123.556 1.646 . . . . 0.0 107.44 173.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -140.9 153.03 67.03 Favored Pre-proline 0 C--N 1.268 -2.944 0 CA-C-N 111.724 -2.489 . . . . 0.0 109.01 -168.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HB2' HD13 ' A' ' 58' ' ' ILE . 33.5 Cg_exo -60.88 141.09 93.65 Favored 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 122.623 2.216 . . . . 0.0 112.9 175.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 20' ' ' TYR . 27.4 m -126.15 157.87 36.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.491 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 34.6 m -100.1 129.86 50.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.9 mm -88.73 98.06 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -18.86 6.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.533 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.601 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -51.26 152.78 2.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -173.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -43.11 146.28 0.44 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.556 2.343 . . . . 0.0 113.23 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -66.26 -37.53 85.69 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.544 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 m -87.68 -30.67 20.22 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.374 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.07 -31.33 78.4 Favored Glycine 0 C--O 1.206 -1.626 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.478 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.538 ' N ' HE22 ' A' ' 42' ' ' GLN . 30.0 p30 -71.95 -20.85 61.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.172 0.511 . . . . 0.0 111.019 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -86.63 -51.64 6.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -85.48 -36.07 20.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -171.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.5 m -97.15 145.92 30.44 Favored Pre-proline 0 C--N 1.291 -1.975 0 O-C-N 121.988 -0.445 . . . . 0.0 110.986 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -80.27 -15.09 11.6 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.916 1.744 . . . . 0.0 109.838 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 1.9 p -96.29 146.09 25.02 Favored 'General case' 0 N--CA 1.42 -1.927 0 C-N-CA 125.007 1.323 . . . . 0.0 110.412 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.75 138.6 22.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.236 0.541 . . . . 0.0 110.746 173.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.601 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -85.34 124.64 40.2 Favored 'Isoleucine or valine' 0 C--O 1.253 1.244 0 C-N-CA 124.435 1.094 . . . . 0.0 110.19 177.059 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.67 171.11 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.419 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.491 ' HB2' ' CG2' ' A' ' 39' ' ' VAL . . . -129.65 142.76 50.67 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.97 129.68 37.27 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.49 HG12 HD13 ' A' ' 86' ' ' ILE . 59.3 mt -85.52 117.57 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.5 174.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.4 m -107.21 111.87 24.47 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.25 -31.6 77.74 Favored Glycine 0 CA--C 1.5 -0.863 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.863 -176.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -144.11 123.98 13.48 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-O 121.044 0.45 . . . . 0.0 110.728 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.5 tt -173.1 -38.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.72 -173.07 0.15 Allowed 'General case' 0 C--O 1.243 0.731 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.72 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.0 mttm 61.67 73.91 0.46 Allowed 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 124.908 1.283 . . . . 0.0 114.407 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.38 72.72 7.03 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -114.04 12.65 18.0 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 123.016 1.389 . . . . 0.0 108.508 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.2 tt -138.41 140.53 28.48 Favored Pre-proline 0 C--N 1.28 -2.442 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.596 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 12.4 Cg_endo -56.12 -28.48 70.37 Favored 'Trans proline' 0 C--O 1.2 -1.41 0 C-N-CA 122.363 2.042 . . . . 0.0 114.274 -176.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.0 p -74.08 -18.92 60.76 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.064 0.459 . . . . 0.0 111.515 -174.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.8 m170 -104.64 128.95 52.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.22 124.68 58.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -98.34 133.46 42.71 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.479 HG21 ' CZ ' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -115.53 158.37 15.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.907 -173.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.484 ' OE1' ' HE3' ' A' ' 110' ' ' LYS . 2.3 mp0 -66.3 113.58 4.71 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.093 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -52.51 -42.11 64.04 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.716 0.806 . . . . 0.0 112.556 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -61.06 -30.7 70.49 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 5.0 ttmp? -85.75 -34.99 21.05 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.716 0.769 . . . . 0.0 109.259 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.479 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 4.7 m-85 -84.71 5.29 28.87 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.937 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt 68.06 26.47 7.25 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.761 1.224 . . . . 0.0 111.227 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.8 mt -117.56 179.2 4.13 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.456 0.646 . . . . 0.0 110.759 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -108.87 -18.89 13.58 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.51 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -118.51 147.23 43.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.25 123.71 22.85 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 t -102.93 150.72 23.25 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.082 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.3 136.26 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.49 HD13 HG12 ' A' ' 58' ' ' ILE . 19.4 mm -104.49 131.14 54.12 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.967 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.8 mt -100.97 102.57 13.62 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.415 ' HG ' ' HB1' ' A' ' 117' ' ' ALA . 3.9 mm? -82.92 4.62 24.94 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.003 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.52 -42.91 7.47 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.912 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.406 ' HA ' HG23 ' B' ' 93' ' ' THR . 0.0 OUTLIER -91.01 76.71 6.17 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.668 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.428 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -117.02 178.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.479 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -173.81 163.3 4.14 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 54' ' ' ILE . 61.4 m -107.77 124.18 49.66 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.421 -178.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.2 mt -132.42 145.62 51.35 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.73 -172.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.438 ' CB ' ' HB2' ' B' ' 30' ' ' SER . 3.1 p30 -76.32 153.63 35.72 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.981 175.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -44.37 -22.14 0.06 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.463 1.905 . . . . 0.0 115.352 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.22 -18.6 60.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 118.206 0.457 . . . . 0.0 110.739 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 32.4 mmt180 -75.12 -38.81 60.95 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.6 mp -68.15 125.21 25.66 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.697 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -103.99 -64.95 1.05 Allowed 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.304 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.4 pt-20 -150.88 144.28 24.9 Favored 'General case' 0 N--CA 1.412 -2.337 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.069 -166.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -70.59 125.88 28.06 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.425 -1.716 . . . . 0.0 111.098 176.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 tp -114.57 -62.01 1.66 Allowed 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.069 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.501 HG21 HG11 ' A' ' 19' ' ' VAL . 3.8 t -127.81 -167.22 1.72 Allowed 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.639 -1.625 . . . . 0.0 111.626 -177.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -160.81 143.98 13.12 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 124.73 1.212 . . . . 0.0 109.512 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.6 pp -114.18 159.63 19.88 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.762 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.2 t -82.38 159.33 23.04 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.793 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 111' ' ' MET . 18.9 t70 -63.59 -33.31 75.33 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.439 0.638 . . . . 0.0 111.303 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.5 -28.06 65.73 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.102 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.484 ' HE3' ' OE1' ' A' ' 74' ' ' GLU . 5.7 mptp? -76.17 -29.0 57.54 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.078 0.466 . . . . 0.0 110.263 175.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.486 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -59.18 -36.31 75.11 Favored 'General case' 0 N--CA 1.416 -2.146 0 C-N-CA 123.521 0.728 . . . . 0.0 109.533 174.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.479 ' HE2' ' C ' ' A' ' 111' ' ' MET . 7.6 mmpt? -78.08 -10.99 59.88 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.34 -38.43 18.8 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.475 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 1.7 t -54.61 -39.86 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 112.432 -2.167 . . . . 0.0 110.884 173.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.44 -35.18 69.77 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 122.243 1.02 . . . . 0.0 111.801 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.472 ' O ' HD13 ' A' ' 120' ' ' ILE . 16.4 m-80 -83.89 -18.81 36.18 Favored 'General case' 0 CA--C 1.433 -3.528 0 C-N-CA 125.235 1.414 . . . . 0.0 110.083 -171.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 68' ' ' PRO . . . -84.56 -57.14 3.26 Favored 'General case' 2 N--CA 1.34 -5.952 0 CA-C-N 111.881 -2.418 . . . . 0.0 108.921 171.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 tp -67.34 -45.37 76.61 Favored 'General case' 0 N--CA 1.404 -2.727 0 C-N-CA 125.984 1.714 . . . . 0.0 113.592 -170.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 34.1 mtp -67.64 -22.06 65.34 Favored 'General case' 0 C--O 1.199 -1.575 0 O-C-N 121.704 -0.622 . . . . 0.0 111.839 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.472 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.0 OUTLIER -87.13 -45.56 16.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -178.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 10.8 t -56.31 -46.82 79.67 Favored 'General case' 0 C--N 1.277 -2.584 0 C-N-CA 126.618 1.967 . . . . 0.0 111.251 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.481 ' HG ' HG22 ' B' ' 54' ' ' ILE . 7.8 mp -89.44 3.84 51.03 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 123.149 0.579 . . . . 0.0 111.254 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.24 32.66 84.89 Favored Glycine 0 CA--C 1.539 1.583 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 175.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.422 ' N ' HD13 ' A' ' 124' ' ' LEU . 7.3 mp -78.19 -34.21 49.63 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 118.651 1.226 . . . . 0.0 109.024 175.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 25.25 124.38 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 129.216 3.006 . . . . 0.0 117.565 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.69 9.03 6.74 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.057 -1.027 . . . . 0.0 112.365 -177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.1 t -127.7 18.91 3.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -75.75 -19.82 58.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.293 1.044 . . . . 0.0 109.334 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -143.23 -179.08 6.18 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -94.24 150.93 19.84 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.706 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -54.91 120.9 7.54 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.7 m120 . . . . . 0 N--CA 1.432 -1.367 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 171.635 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.778 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -74.65 -73.44 0.24 Allowed 'General case' 0 C--O 1.246 0.885 0 CA-C-N 117.117 0.459 . . . . 0.0 110.323 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 20.7 p -114.21 16.94 17.92 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.656 0.741 . . . . 0.0 109.474 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -131.43 115.56 16.36 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . 0.413 ' HD1' ' CD2' ' B' ' 7' ' ' HIS . 19.6 t-80 -133.14 129.44 37.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -86.57 109.36 19.07 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.413 ' CD2' ' HD1' ' B' ' 5' ' ' HIS . 67.9 m80 -87.4 93.69 9.48 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.607 -175.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.47 161.62 42.08 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -93.76 99.02 11.49 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.489 0.661 . . . . 0.0 109.253 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.3 m -65.98 -27.05 67.85 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.319 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -150.0 136.13 18.76 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.078 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . 0.521 ' HB2' ' NH1' ' B' ' 15' ' ' ARG . 46.6 m-20 -108.66 142.5 25.57 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.33 -29.07 79.26 Favored 'Trans proline' 0 C--O 1.213 -0.746 0 C-N-CA 122.398 2.065 . . . . 0.0 114.153 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 53.7 mt -108.54 116.01 50.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.641 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.521 ' NH1' ' HB2' ' B' ' 12' ' ' ASP . 29.9 mmt180 -119.73 156.64 30.15 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.696 172.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -77.76 139.67 39.39 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.089 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.36 -11.94 51.25 Favored Glycine 0 C--N 1.309 -0.941 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.496 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -97.18 176.74 5.82 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 4.9 t -132.93 129.54 57.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-O 121.44 0.638 . . . . 0.0 112.209 -175.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 83.1 m-85 -126.89 143.08 51.37 Favored 'General case' 0 CA--C 1.46 -2.486 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.458 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.468 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -79.41 149.88 31.49 Favored 'General case' 0 N--CA 1.39 -3.43 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.905 170.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -136.76 131.48 33.46 Favored 'General case' 0 C--N 1.259 -3.364 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.132 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.517 ' O ' ' HD2' ' B' ' 98' ' ' ARG . 8.8 t70 -81.84 96.1 7.52 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.037 171.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.618 HD21 ' O ' ' B' ' 24' ' ' LEU 0.475 0.0 OUTLIER -118.19 60.23 0.79 Allowed 'General case' 1 N--CA 1.376 -4.175 0 CA-C-O 124.078 1.894 . . . . 0.0 111.963 172.158 . . . . . . . . 5 4 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.463 ' OG ' ' HA2' ' B' ' 34' ' ' GLY . 1.3 m -105.08 59.89 0.12 Allowed Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 113.264 -1.789 . . . . 0.0 111.687 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -116.95 24.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.594 0 N-CA-C 108.054 -1.556 . . . . 0.0 108.054 158.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 21.7 m -91.46 153.6 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . 0.627 HE21 ' N ' ' B' ' 28' ' ' GLN 0.467 0.0 OUTLIER -128.1 -64.61 0.95 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 119.336 3.087 . . . . 0.0 119.336 -177.385 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.5 -114.65 0.02 OUTLIER Glycine 0 C--N 1.313 -0.696 0 C-N-CA 120.555 -0.831 . . . . 0.0 114.076 -173.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.438 ' HB2' ' CB ' ' A' ' 95' ' ' ASP . 19.4 m -94.15 20.36 8.11 Favored 'General case' 0 C--N 1.271 -2.808 0 O-C-N 122.003 -0.704 . . . . 0.0 109.503 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.504 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 45.6 mt-10 -75.64 162.83 27.92 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -138.41 112.71 8.7 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . 0.44 ' HA3' HD21 ' B' ' 24' ' ' LEU . . . -147.18 -113.69 0.78 Allowed Glycine 0 N--CA 1.411 -2.999 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.124 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.463 ' HA2' ' OG ' ' B' ' 25' ' ' SER . . . 86.99 176.53 49.18 Favored Glycine 0 N--CA 1.399 -3.826 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 -172.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 1.6 p -84.53 99.58 6.97 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -141.46 151.17 60.15 Favored Pre-proline 0 C--N 1.262 -3.224 0 CA-C-N 112.096 -2.32 . . . . 0.0 109.26 -169.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 52.1 Cg_exo -59.0 139.69 91.99 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.825 2.35 . . . . 0.0 112.878 174.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.447 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -125.75 158.36 34.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.48 ' CG2' ' HB2' ' B' ' 56' ' ' ALA . 34.5 m -100.39 129.59 50.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 24.3 mm -88.23 98.47 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.95 -18.82 6.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.486 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.584 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.0 OUTLIER -50.81 152.07 2.23 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.29 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -41.74 145.99 0.28 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 127.69 2.396 . . . . 0.0 113.761 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.76 -39.4 93.55 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.975 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -87.73 -29.33 21.16 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.13 0.491 . . . . 0.0 110.949 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.25 -30.95 77.46 Favored Glycine 0 C--O 1.206 -1.65 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.039 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.58 ' N ' HE22 ' B' ' 42' ' ' GLN . 29.8 p30 -72.54 -20.55 61.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.064 0.459 . . . . 0.0 111.166 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.12 -53.91 4.78 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.151 0.501 . . . . 0.0 109.817 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -82.79 -35.72 26.24 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.409 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 70.1 m -94.84 143.2 25.76 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-O 120.855 0.36 . . . . 0.0 111.192 -176.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.88 -14.54 12.38 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.072 1.848 . . . . 0.0 109.524 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 1.9 p -97.18 147.93 23.59 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 125.11 1.364 . . . . 0.0 110.052 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.33 138.94 20.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.291 0.567 . . . . 0.0 110.888 173.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.584 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -85.01 124.19 39.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 C-N-CA 124.675 1.19 . . . . 0.0 109.881 177.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.78 171.15 17.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.429 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.59 ' CB ' HG23 ' B' ' 91' ' ' ILE . . . -129.82 142.97 50.6 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.0 130.31 38.21 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.485 HG12 HD13 ' B' ' 86' ' ' ILE . 57.8 mt -85.46 117.23 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.513 174.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 22.0 m -105.05 108.83 20.57 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.64 -37.68 93.85 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.067 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -142.45 125.24 16.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.969 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 tt -170.86 -42.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 67.63 -173.76 0.19 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.691 1.196 . . . . 0.0 112.646 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 62.49 71.71 0.52 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.738 1.615 . . . . 0.0 114.563 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.99 70.39 8.52 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -114.42 13.74 17.74 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 123.272 1.51 . . . . 0.0 108.622 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.4 tt -138.56 140.58 28.28 Favored Pre-proline 0 C--N 1.278 -2.509 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . 0.565 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 12.4 Cg_endo -56.72 -28.41 75.64 Favored 'Trans proline' 0 C--O 1.204 -1.18 0 C-N-CA 122.257 1.971 . . . . 0.0 114.182 -177.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 62.4 p -73.95 -19.17 60.76 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.046 0.45 . . . . 0.0 111.68 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -105.38 129.07 53.78 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 70.8 t -130.31 125.85 60.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.41 134.38 39.66 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.51 HG21 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -118.14 153.95 20.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.272 -174.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.538 ' OE1' ' HE3' ' B' ' 110' ' ' LYS . 3.7 mp0 -65.02 113.04 3.62 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.49 -178.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -50.71 -41.64 56.28 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 124.272 1.029 . . . . 0.0 112.634 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -22.04 66.17 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.252 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . 0.443 ' HZ1' ' HB2' ' B' ' 77' ' ' LYS . 4.9 ttmp? -91.36 -36.32 13.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.644 0.735 . . . . 0.0 109.071 177.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.51 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 4.5 m-85 -83.38 8.11 14.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.433 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 67.09 20.38 10.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.824 1.249 . . . . 0.0 111.757 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -111.0 179.66 3.98 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.1 0.476 . . . . 0.0 110.798 -174.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.86 -24.44 12.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.199 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -116.64 147.33 42.01 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.07 123.09 23.74 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.546 0.689 . . . . 0.0 109.237 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 22.6 t -102.88 154.11 19.53 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.72 -167.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.0 t -116.18 136.08 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.485 HD13 HG12 ' B' ' 58' ' ' ILE . 21.3 mm -104.66 131.87 52.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.932 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 66.2 mt -101.65 103.14 13.93 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.489 ' HG ' ' HB1' ' B' ' 117' ' ' ALA . 3.9 mm? -82.88 -0.41 48.17 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.535 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -94.37 -40.67 9.81 Favored 'General case' 0 N--CA 1.413 -2.294 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.94 173.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . 0.412 ' HA ' HG23 ' A' ' 93' ' ' THR . 0.0 OUTLIER -91.04 76.67 6.16 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.27 1.033 . . . . 0.0 108.59 178.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.59 HG23 ' CB ' ' B' ' 56' ' ' ALA . 2.5 pp -117.33 178.77 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.584 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -173.8 163.58 4.18 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 174.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' B' ' 54' ' ' ILE . 65.5 m -108.15 124.21 49.91 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.569 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 45.7 mt -132.34 145.85 51.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.739 -172.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 1.9 p-10 -77.8 153.5 32.77 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.412 176.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 50' ' ' SER . 99.5 mttt -44.69 -21.76 0.06 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.129 1.772 . . . . 0.0 115.446 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -73.7 -19.17 60.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.11 0.481 . . . . 0.0 110.745 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 31.5 mmt180 -74.98 -38.73 61.57 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.876 -0.515 . . . . 0.0 109.875 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.5 123.12 20.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.092 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -102.67 -65.08 1.01 Allowed 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 114.165 -1.379 . . . . 0.0 113.46 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.0 pt-20 -149.03 139.83 22.77 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.328 0.585 . . . . 0.0 111.349 -165.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.2 OUTLIER -69.76 123.5 21.57 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.754 -1.566 . . . . 0.0 111.592 176.203 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.07 -62.37 1.61 Allowed 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.249 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.51 HG21 HG11 ' B' ' 19' ' ' VAL . 3.2 t -126.91 -168.25 1.85 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 117.432 -1.707 . . . . 0.0 112.434 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -160.49 142.28 12.53 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 124.468 1.107 . . . . 0.0 110.205 -175.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -112.14 159.33 18.64 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.647 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 32.5 t -82.59 161.91 22.1 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' B' ' 111' ' ' MET . 16.7 t70 -62.1 -34.2 75.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.758 0.823 . . . . 0.0 111.373 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.01 -27.56 62.81 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.538 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 5.6 mptp? -75.0 -29.27 60.83 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 120.874 0.368 . . . . 0.0 110.02 175.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.473 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -57.54 -38.31 74.5 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.655 174.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.45 ' HE2' ' C ' ' B' ' 111' ' ' MET . 7.6 mmpt? -77.34 -13.74 59.87 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.13 -35.37 21.8 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 t -56.88 -41.36 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.568 0 CA-C-N 112.32 -2.218 . . . . 0.0 110.099 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -44.54 76.98 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.831 0.824 . . . . 0.0 110.489 174.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.736 ' O ' HD12 ' B' ' 120' ' ' ILE . 1.1 m-80 -70.61 -20.91 62.71 Favored 'General case' 0 CA--C 1.474 -1.98 0 CA-C-O 122.384 1.088 . . . . 0.0 111.135 -176.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' B' ' 68' ' ' PRO . . . -84.26 -53.85 5.2 Favored 'General case' 2 C--N 1.235 -4.405 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.291 173.35 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.67 -46.77 74.61 Favored 'General case' 0 N--CA 1.403 -2.798 0 C-N-CA 126.194 1.798 . . . . 0.0 113.471 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 38.4 mtp -66.05 -24.91 66.82 Favored 'General case' 0 C--O 1.2 -1.504 0 O-C-N 121.754 -0.591 . . . . 0.0 111.395 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.736 HD12 ' O ' ' B' ' 116' ' ' ASN . 1.3 mp -86.95 -40.77 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 70.5 m -57.12 -46.88 82.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 122.124 0.964 . . . . 0.0 111.145 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.488 ' HG ' HG22 ' A' ' 54' ' ' ILE . 7.4 mp -88.4 3.37 50.18 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.806 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.5 32.0 79.62 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.28 -37.04 63.8 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 119.041 1.421 . . . . 0.0 108.696 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.505 HD21 HG13 ' B' ' 120' ' ' ILE . 5.0 t-20 26.3 119.45 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.489 2.716 . . . . 0.0 117.443 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.49 6.62 6.72 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.429 -0.795 . . . . 0.0 112.358 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 17.2 t -122.23 15.39 5.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 122.686 1.231 . . . . 0.0 107.975 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.96 -15.22 60.68 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.254 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -148.63 173.56 13.06 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -88.25 149.44 23.82 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.154 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -54.24 123.78 13.85 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.942 0.897 . . . . 0.0 113.388 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 C--N 1.309 -1.177 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 174.17 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.095 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -124.86 -172.41 2.57 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 p 60.15 176.03 0.09 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.076 0.951 . . . . 0.0 113.246 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -90.26 -47.95 7.45 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.392 -0.817 . . . . 0.0 109.786 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -93.06 85.72 5.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.411 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -152.8 96.99 2.17 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -82.56 128.44 34.31 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -72.76 109.32 6.28 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.475 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.4 ' C ' ' H ' ' A' ' 11' ' ' GLN . 63.4 m170 -71.2 -39.88 71.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.8 m 72.54 -35.55 0.33 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.338 1.455 . . . . 0.0 111.814 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 9' ' ' HIS . 50.9 tt0 -147.83 106.67 3.83 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.487 ' HB2' ' CE ' ' A' ' 102' ' ' LYS . 4.7 m-20 -85.82 154.71 58.6 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.09 144.06 81.45 Favored 'Trans proline' 0 C--O 1.252 1.198 0 C-N-CA 122.326 2.017 . . . . 0.0 111.152 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.4 mt -71.2 114.86 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-O 121.915 0.864 . . . . 0.0 109.107 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -110.02 154.64 22.91 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.906 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -84.63 129.89 34.78 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.021 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.6 0.38 43.0 Favored Glycine 0 C--N 1.308 -0.992 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.644 -175.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -97.33 170.14 9.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 12.0 t -131.73 133.9 60.87 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 C-N-CA 124.063 0.945 . . . . 0.0 112.021 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.518 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 93.1 m-85 -132.41 145.83 51.51 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.573 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER -76.96 148.64 36.2 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 169.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.537 ' O ' HG21 ' A' ' 35' ' ' VAL . . . -143.78 149.07 36.52 Favored 'General case' 0 C--N 1.257 -3.452 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.669 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -74.45 85.78 2.02 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 124.238 1.971 . . . . 0.0 108.044 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.518 ' O ' HD12 ' A' ' 24' ' ' LEU . 2.0 tm? -87.94 13.15 11.52 Favored 'General case' 0 N--CA 1.407 -2.615 0 CA-C-N 111.198 -2.728 . . . . 0.0 111.662 -166.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 p -104.67 62.23 0.11 Allowed Pre-proline 0 N--CA 1.414 -2.236 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -113.47 23.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 121.712 1.608 . . . . 0.0 108.314 158.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 12.8 m -78.87 -179.1 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.702 -173.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.9 154.29 50.51 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.658 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.42 -108.99 1.16 Allowed Glycine 0 CA--C 1.502 -0.77 0 N-CA-C 116.271 1.268 . . . . 0.0 116.271 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 m -93.75 -6.63 45.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.236 -174.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 50.2 mt-10 -60.24 159.17 10.25 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.454 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.21 113.02 19.07 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -173.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.75 159.51 15.87 Favored Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 115.626 1.011 . . . . 0.0 115.626 -177.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 24' ' ' LEU . . . 110.43 146.31 10.89 Favored Glycine 0 N--CA 1.415 -2.764 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 22' ' ' ALA . 3.6 p -61.55 122.61 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 CA-C-O 122.507 1.146 . . . . 0.0 109.382 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -141.3 162.23 48.69 Favored Pre-proline 0 C--N 1.264 -3.124 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.753 -169.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HB2' HD11 ' A' ' 58' ' ' ILE . 1.3 Cg_endo -80.08 142.35 15.33 Favored 'Trans proline' 0 N--CA 1.427 -2.429 0 C-N-CA 121.785 1.657 . . . . 0.0 109.736 171.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 22.4 m -123.54 155.17 29.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.068 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 35.5 m -99.38 132.9 43.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.79 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.9 mm -90.97 105.2 16.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.509 HD11 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -99.56 -15.58 7.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.817 -179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.633 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 2.8 tt0 -55.47 162.65 1.5 Allowed 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 126.035 1.734 . . . . 0.0 114.518 -168.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.505 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 1.5 p30 -75.93 177.12 7.25 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.829 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.438 ' CG ' ' HZ1' ' A' ' 48' ' ' LYS . 25.3 t70 -78.24 -34.53 49.12 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 m -75.3 -24.62 57.49 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.128 0.49 . . . . 0.0 110.504 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.38 -23.06 73.35 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -83.44 -19.7 35.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.451 0.643 . . . . 0.0 109.91 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HZ1' ' CG ' ' A' ' 44' ' ' ASP . 14.6 mptt -89.93 -66.77 0.89 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.315 176.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -107.87 2.13 23.23 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.3 m -108.09 134.4 20.16 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.51 -22.92 20.68 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 121.671 1.58 . . . . 0.0 109.364 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 p -86.97 158.94 19.16 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.631 -1.622 . . . . 0.0 111.551 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.633 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 66.2 t -137.64 140.4 41.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 173.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.444 HG21 ' CD2' ' B' ' 122' ' ' LEU . 5.8 tt -105.9 127.48 60.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.516 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 34.1 m -132.01 174.65 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.263 -174.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -131.52 146.51 52.27 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.81 138.44 38.97 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 37' ' ' PRO . 81.6 mt -99.89 127.32 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.707 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -141.67 138.28 32.37 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.004 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.3 9.52 57.66 Favored Glycine 0 C--N 1.306 -1.089 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -60.44 -51.58 68.87 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.272 1.029 . . . . 0.0 112.811 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.438 HG21 HG21 ' A' ' 85' ' ' VAL . 16.3 tt -96.23 153.11 3.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -118.96 12.16 12.72 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.055 -175.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -141.71 158.42 43.84 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.37 -79.55 0.59 Allowed 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp 57.62 28.95 16.44 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.483 1.513 . . . . 0.0 111.393 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tt -155.58 147.16 16.94 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.543 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 27.0 Cg_exo -62.54 -35.04 73.29 Favored 'Trans proline' 0 C--O 1.196 -1.62 0 C-N-CA 121.431 1.421 . . . . 0.0 114.136 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.2 p -73.36 -18.59 61.16 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -114.67 128.97 56.61 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.1 127.73 75.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 118.704 0.684 . . . . 0.0 109.863 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -97.76 130.3 44.72 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.139 0.495 . . . . 0.0 110.406 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.473 HG13 ' CZ ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -110.31 169.61 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -89.04 137.17 32.56 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.385 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 82' ' ' LYS . 58.4 tttm -50.36 -42.46 53.21 Favored 'General case' 0 C--O 1.207 -1.141 0 O-C-N 124.351 1.032 . . . . 0.0 109.997 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -54.11 -49.67 68.61 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 125.623 1.569 . . . . 0.0 111.494 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.02 -40.45 38.88 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.539 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 2.4 m-85 -77.4 -8.84 58.35 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 78' ' ' TYR . 17.4 ptmt 52.74 34.0 15.22 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.571 1.549 . . . . 0.0 110.692 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.66 -173.83 2.64 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.246 -171.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.13 -29.43 67.48 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.068 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.42 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 14.4 ptmm? -166.87 168.14 14.31 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -52.4 138.46 27.11 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.48 137.98 53.44 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -169.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.438 HG21 HG21 ' A' ' 62' ' ' ILE . 21.1 t -107.97 142.05 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.478 HD11 HG12 ' A' ' 58' ' ' ILE . 16.6 mm -109.9 135.3 49.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.62 106.88 17.58 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -89.5 10.4 22.96 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.602 0.715 . . . . 0.0 111.79 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.4 -34.28 6.83 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.955 0.883 . . . . 0.0 109.662 173.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.469 ' HA ' HG22 ' B' ' 93' ' ' THR . 0.3 OUTLIER -101.2 88.39 3.48 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.687 177.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.559 ' O ' ' HD2' ' A' ' 92' ' ' ARG . 2.1 pp -121.97 178.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.943 -174.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.559 ' HD2' ' O ' ' A' ' 91' ' ' ILE . 18.2 mmm180 -136.76 172.97 12.23 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.75 0.786 . . . . 0.0 111.521 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.444 HG22 ' HA ' ' B' ' 90' ' ' GLN . 52.9 m -139.84 119.21 12.93 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 171.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 64.2 mt -134.27 145.05 48.73 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.807 0.843 . . . . 0.0 111.345 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.83 145.49 52.5 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 119.503 1.047 . . . . 0.0 109.656 165.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -49.36 -34.91 17.18 Favored 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -57.03 -23.8 49.11 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 125.374 1.469 . . . . 0.0 112.64 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 6.2 mmp_? -74.5 -27.73 60.68 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.556 0.693 . . . . 0.0 109.445 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.29 107.86 8.83 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 122.944 1.354 . . . . 0.0 110.937 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.62 -63.5 1.36 Allowed 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 113.039 -1.891 . . . . 0.0 114.875 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.5 pt-20 -158.29 150.02 21.42 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-O 121.814 0.816 . . . . 0.0 111.485 -170.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 66.2 mttm -61.3 126.44 27.37 Favored 'General case' 0 C--N 1.273 -2.738 0 C-N-CA 127.284 2.234 . . . . 0.0 111.832 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 tp -115.63 -62.45 1.59 Allowed 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.725 171.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.497 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 2.7 t -127.98 -167.16 1.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.142 -1.423 . . . . 0.0 112.33 -177.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.74 135.23 8.33 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 125.598 1.559 . . . . 0.0 110.712 -172.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 mt -87.08 157.48 19.4 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 124.098 0.959 . . . . 0.0 111.344 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.5 m -84.08 161.22 20.75 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.4 -36.52 82.59 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.538 0.735 . . . . 0.0 112.576 -176.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -79.79 -26.63 40.52 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.576 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.421 ' HG3' ' OE1' ' A' ' 113' ' ' GLU . 2.5 mptp? -70.54 -26.45 63.56 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.98 0.419 . . . . 0.0 110.687 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.479 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -57.26 -39.18 75.1 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 123.903 0.881 . . . . 0.0 109.667 172.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.515 ' HZ1' ' CG ' ' A' ' 115' ' ' ASP . 7.9 mmpt? -83.36 -11.1 58.0 Favored 'General case' 0 N--CA 1.397 -3.117 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.421 ' OE1' ' HG3' ' A' ' 110' ' ' LYS . 36.7 mt-10 -84.78 -37.16 21.14 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 117' ' ' ALA . 1.4 t -55.04 -36.91 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-N 112.835 -1.984 . . . . 0.0 110.617 172.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.515 ' CG ' ' HZ1' ' A' ' 112' ' ' LYS . 2.0 m-20 -64.56 -35.36 80.73 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.401 1.096 . . . . 0.0 111.153 174.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.669 ' O ' HD11 ' A' ' 120' ' ' ILE . 13.4 m-80 -81.13 -15.03 57.04 Favored 'General case' 1 N--CA 1.555 4.823 0 CA-C-O 124.165 1.936 . . . . 0.0 109.596 -174.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 68' ' ' PRO 0.337 . . -91.01 -51.31 5.4 Favored 'General case' 2 N--CA 1.346 -5.635 0 CA-C-N 111.867 -2.424 . . . . 0.0 105.254 175.109 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.622 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 3.3 tp -69.27 -47.47 64.53 Favored 'General case' 0 N--CA 1.393 -3.29 0 C-N-CA 124.518 1.127 . . . . 0.0 113.165 -171.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.5 mtp -64.77 -28.34 69.51 Favored 'General case' 0 C--O 1.195 -1.804 0 O-C-N 121.451 -0.78 . . . . 0.0 111.608 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.669 HD11 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -77.86 -48.67 23.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 23.1 t -56.48 -33.55 66.08 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 113.076 -1.875 . . . . 0.0 111.286 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 20.1 mt -104.48 7.32 35.34 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.021 0.439 . . . . 0.0 110.664 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.44 78.21 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.9 mp -80.51 -51.38 8.85 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 119.113 1.456 . . . . 0.0 108.927 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 50.47 -173.02 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 113.068 -1.878 . . . . 0.0 112.833 -173.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.85 103.93 5.56 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.1 p 57.24 18.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 126.664 1.986 . . . . 0.0 111.776 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 57.54 -159.46 0.26 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.628 -1.623 . . . . 0.0 109.926 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -79.0 80.12 5.36 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.668 0.747 . . . . 0.0 109.39 176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -84.93 111.15 19.42 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.214 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -130.59 97.41 4.37 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--N 1.286 -2.156 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.05 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.717 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 26.4 m -123.47 -173.52 2.75 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 23.1 m 67.41 177.8 0.24 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.916 0.886 . . . . 0.0 111.726 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -93.34 -53.09 4.23 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -88.96 86.94 7.04 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.689 0.757 . . . . 0.0 109.871 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -152.08 103.59 2.9 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -87.94 127.45 35.37 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -75.35 112.03 11.23 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . 0.443 ' C ' ' H ' ' B' ' 11' ' ' GLN . 62.4 m170 -75.44 -33.67 60.91 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.427 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 41.3 m 71.44 -35.64 0.34 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.107 1.363 . . . . 0.0 111.668 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . 0.443 ' H ' ' C ' ' B' ' 9' ' ' HIS . 50.0 tt0 -149.73 99.37 2.86 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 123.584 0.754 . . . . 0.0 109.058 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . 0.469 ' HB2' ' CE ' ' B' ' 102' ' ' LYS . 6.8 m-20 -75.7 154.6 85.35 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -56.03 148.66 57.1 Favored 'Trans proline' 0 C--O 1.252 1.219 0 C-N-CA 122.435 2.09 . . . . 0.0 111.544 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 62.8 mt -75.72 118.03 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -113.59 155.99 24.46 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.879 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.21 135.08 34.5 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.95 2.17 58.33 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.743 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -97.79 168.4 10.34 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 13.6 t -131.88 133.84 60.63 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 C-N-CA 123.805 0.842 . . . . 0.0 112.252 -176.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 89.9 m-85 -132.44 145.52 51.26 Favored 'General case' 0 CA--C 1.483 -1.628 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.417 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 0.8 OUTLIER -76.25 149.2 37.19 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 169.448 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.504 ' O ' HG23 ' B' ' 35' ' ' VAL . . . -144.35 148.66 35.02 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.891 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.5 85.64 1.54 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 124.022 1.868 . . . . 0.0 107.741 172.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.535 ' O ' HD12 ' B' ' 24' ' ' LEU . 2.1 tm? -88.8 12.95 13.66 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 111.33 -2.668 . . . . 0.0 111.769 -166.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 17.8 p -104.59 62.38 0.1 Allowed Pre-proline 0 CA--C 1.582 2.202 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -112.82 23.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 121.676 1.584 . . . . 0.0 108.316 159.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 16.1 m -78.42 -179.17 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.327 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.68 154.17 48.59 Favored 'General case' 0 C--O 1.206 -1.228 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.775 175.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.11 -112.0 3.26 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 115.307 0.883 . . . . 0.0 115.307 170.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -94.51 -2.85 50.96 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.532 0.333 . . . . 0.0 110.816 -173.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.518 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 51.7 mt-10 -60.71 158.84 11.91 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.167 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.98 112.28 18.23 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -172.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.53 156.25 17.79 Favored Glycine 0 CA--C 1.473 -2.553 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' B' ' 24' ' ' LEU . . . 114.18 149.3 10.01 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 22' ' ' ALA . 3.2 p -63.53 125.73 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-O 122.526 1.155 . . . . 0.0 108.933 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 9.7 mmt85 -142.09 160.98 53.25 Favored Pre-proline 0 C--N 1.268 -2.952 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.068 -168.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.466 ' HB2' HD11 ' B' ' 58' ' ' ILE . 0.9 OUTLIER -80.62 142.06 14.19 Favored 'Trans proline' 0 N--CA 1.426 -2.442 0 C-N-CA 121.714 1.609 . . . . 0.0 109.38 170.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 24.3 m -123.22 155.59 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.18 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 35.7 m -99.65 132.97 44.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.789 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 22.7 mm -91.52 105.42 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.5 HD11 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -99.44 -16.15 7.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.844 -179.23 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.641 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 2.8 tt0 -54.89 162.81 1.14 Allowed 'General case' 0 N--CA 1.424 -1.743 0 C-N-CA 126.369 1.868 . . . . 0.0 114.986 -167.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.504 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 2.2 p30 -74.78 175.83 7.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.934 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.465 ' CG ' ' HZ1' ' B' ' 48' ' ' LYS . 31.5 t70 -77.24 -34.78 55.81 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 21.6 m -75.39 -25.53 57.71 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.156 0.503 . . . . 0.0 110.222 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.63 -23.99 72.41 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -83.23 -20.22 34.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.986 0.422 . . . . 0.0 110.28 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.465 ' HZ1' ' CG ' ' B' ' 44' ' ' ASP . 14.4 mptt -88.87 -66.95 0.87 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.994 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -100.15 -23.4 14.86 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -167.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 15.2 m -83.85 136.17 41.94 Favored Pre-proline 0 N--CA 1.423 -1.822 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -74.27 -21.72 17.32 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 121.706 1.604 . . . . 0.0 108.754 173.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -89.18 158.11 18.02 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 113.342 -1.754 . . . . 0.0 111.276 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.641 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 60.4 t -137.82 140.29 41.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.459 HG21 ' CD2' ' A' ' 122' ' ' LEU . 5.6 tt -106.43 127.91 61.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 174.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.536 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 33.9 m -132.91 174.16 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.212 -173.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.504 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -130.74 146.71 52.28 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.53 137.43 38.62 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.491 HG12 HD11 ' B' ' 86' ' ' ILE . 82.0 mt -98.35 128.56 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 113.323 -1.762 . . . . 0.0 107.736 176.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.5 t -140.89 141.38 34.58 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 119.581 -0.847 . . . . 0.0 111.621 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.97 8.63 50.17 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -60.08 -58.84 6.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.813 0.845 . . . . 0.0 112.499 -175.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.414 HG21 HG22 ' B' ' 85' ' ' VAL . 17.9 tt -89.08 154.12 3.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -113.18 -1.22 14.41 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.672 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -134.14 151.39 51.34 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 122.197 -0.314 . . . . 0.0 110.423 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' B' ' 70' ' ' HIS . . . -108.8 -81.62 0.57 Allowed 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp 58.18 24.07 10.95 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.078 1.351 . . . . 0.0 111.332 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.2 tt -152.42 141.45 14.19 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . 0.462 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 74.9 Cg_exo -54.41 -40.57 82.52 Favored 'Trans proline' 0 C--O 1.208 -1.017 0 C-N-CA 122.187 1.924 . . . . 0.0 114.659 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 57.8 p -72.63 -18.47 61.58 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -168.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.467 ' CD2' HD21 ' B' ' 87' ' ' LEU . 53.6 m170 -113.47 128.88 56.6 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 57.3 t -121.32 130.01 75.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 O-C-N 121.545 -0.722 . . . . 0.0 109.854 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -98.53 135.72 39.67 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.114 0.483 . . . . 0.0 109.735 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' B' ' 78' ' ' TYR . 1.2 mm -112.32 174.95 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -92.99 139.08 30.9 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.223 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -51.79 -41.08 61.42 Favored 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 124.724 1.21 . . . . 0.0 109.697 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -59.21 -41.24 88.13 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 125.961 1.704 . . . . 0.0 111.686 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . 0.423 ' O ' ' HE3' ' B' ' 77' ' ' LYS . 0.2 OUTLIER -84.77 -39.05 18.89 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -176.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.555 ' O ' ' HG2' ' B' ' 79' ' ' LYS . 2.3 m-85 -79.14 -7.85 58.52 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.521 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' B' ' 78' ' ' TYR . 17.8 ptmt 52.71 33.25 13.51 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.63 1.572 . . . . 0.0 110.593 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.34 -175.89 3.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.463 -172.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.79 -29.88 70.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.93 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -165.99 165.96 17.65 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -50.91 135.31 24.59 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.08 139.38 49.93 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -169.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.414 HG22 HG21 ' B' ' 62' ' ' ILE . 21.8 t -108.09 142.6 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.491 HD11 HG12 ' B' ' 58' ' ' ILE . 16.2 mm -111.71 136.17 48.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.467 HD21 ' CD2' ' B' ' 70' ' ' HIS . 42.9 mt -106.35 106.25 16.68 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' B' ' 117' ' ' ALA . 3.8 mm? -89.07 10.39 21.9 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.714 0.769 . . . . 0.0 112.07 -175.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.67 -34.26 6.76 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.723 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . 0.444 ' HA ' HG22 ' A' ' 93' ' ' THR . 0.3 OUTLIER -100.99 87.56 3.31 Favored 'General case' 0 N--CA 1.406 -2.647 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.553 ' O ' ' HD2' ' B' ' 92' ' ' ARG . 2.1 pp -121.49 178.91 2.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.061 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.553 ' HD2' ' O ' ' B' ' 91' ' ' ILE . 18.3 mmm180 -136.8 172.46 12.97 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.73 0.776 . . . . 0.0 111.312 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 90' ' ' GLN . 54.6 m -139.82 119.35 13.09 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 170.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 65.9 mt -134.18 146.79 50.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 110.874 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -63.26 151.12 41.47 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.073 1.306 . . . . 0.0 109.668 165.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -51.22 -34.67 33.19 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -56.23 -25.42 47.51 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 125.076 1.35 . . . . 0.0 112.912 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 5.7 mmp_? -73.91 -29.17 61.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.397 0.618 . . . . 0.0 109.733 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.2 mp -75.46 107.73 7.79 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 125.045 1.338 . . . . 0.0 111.051 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.79 -65.77 0.97 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 112.882 -1.963 . . . . 0.0 114.932 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.2 pt-20 -156.32 146.34 21.25 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-O 121.504 0.669 . . . . 0.0 111.25 -169.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 67.6 mttm -60.52 126.43 27.4 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 126.639 1.976 . . . . 0.0 111.902 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -115.09 -61.92 1.68 Allowed 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.503 172.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.519 ' O ' ' HB ' ' B' ' 19' ' ' VAL . 3.4 t -127.23 -168.22 1.85 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 117.99 -1.484 . . . . 0.0 112.432 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -160.12 133.6 6.96 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 125.584 1.554 . . . . 0.0 110.456 -171.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 mt -84.29 162.67 20.01 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 124.009 0.924 . . . . 0.0 112.021 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.7 m -87.94 162.08 17.08 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.701 171.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.76 -31.79 71.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.45 -30.81 42.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.535 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -67.78 -28.91 68.0 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.011 177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.474 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.0 OUTLIER -55.46 -38.8 69.54 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 123.907 0.883 . . . . 0.0 109.988 172.61 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.561 ' HZ1' ' CG ' ' B' ' 115' ' ' ASP . 7.8 mmpt? -83.99 -13.08 54.21 Favored 'General case' 0 N--CA 1.399 -2.998 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -84.4 -33.43 23.75 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' B' ' 117' ' ' ALA . 1.4 t -58.02 -39.71 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.404 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.2 172.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.561 ' CG ' ' HZ1' ' B' ' 112' ' ' LYS . 4.3 m-20 -61.05 -42.6 98.79 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.009 0.909 . . . . 0.0 110.067 174.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.58 ' O ' HD11 ' B' ' 120' ' ' ILE . 10.4 m-80 -69.51 -21.01 63.7 Favored 'General case' 0 CA--C 1.456 -2.639 0 C-N-CA 125.01 1.324 . . . . 0.0 111.923 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' B' ' 68' ' ' PRO . . . -83.39 -50.57 8.2 Favored 'General case' 2 N--CA 1.366 -4.666 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.839 173.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 3.3 tp -71.77 -48.21 48.33 Favored 'General case' 0 N--CA 1.393 -3.296 0 C-N-CA 124.546 1.138 . . . . 0.0 113.098 -171.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 37.7 mtp -63.66 -31.35 72.5 Favored 'General case' 0 C--O 1.197 -1.662 0 O-C-N 121.451 -0.781 . . . . 0.0 111.076 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.58 HD11 ' O ' ' B' ' 116' ' ' ASN . 1.4 mp -78.78 -42.93 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -56.71 -35.48 68.57 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.028 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 19.3 mt -104.18 6.57 35.74 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.936 -0.478 . . . . 0.0 111.151 -176.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.74 23.16 78.08 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 115.891 1.117 . . . . 0.0 115.891 173.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' B' ' 122' ' ' LEU . 7.1 mp -79.55 -51.86 8.76 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 118.954 1.377 . . . . 0.0 108.361 177.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.482 ' ND2' HG13 ' B' ' 120' ' ' ILE . 1.6 t-20 52.19 -171.1 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.118 -1.855 . . . . 0.0 112.748 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.44 103.35 4.54 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p 56.54 22.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 126.358 1.863 . . . . 0.0 111.528 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 54.53 -154.3 0.28 Allowed 'General case' 0 C--O 1.249 1.052 0 CA-C-N 112.837 -1.983 . . . . 0.0 109.992 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -82.8 81.97 8.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -86.57 107.54 18.18 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.303 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -128.1 99.45 5.48 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 C--N 1.301 -1.501 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.431 178.221 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.185 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -100.71 104.15 15.43 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 117.058 0.429 . . . . 0.0 109.844 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 m -78.96 -24.45 43.88 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -66.03 103.82 1.02 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -111.95 -4.74 14.46 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.524 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -81.4 89.32 6.11 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -112.07 121.64 45.53 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -67.11 -54.33 22.39 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 54.48 -84.14 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.113 0 C-N-CA 126.113 1.765 . . . . 0.0 114.084 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.7 m -88.29 0.74 55.79 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.243 0.544 . . . . 0.0 111.565 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -107.84 73.57 0.91 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.385 0.612 . . . . 0.0 112.158 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -108.15 126.79 28.89 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.17 96.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.9 2.4 . . . . 0.0 114.341 -174.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.3 mt -77.28 128.81 37.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -146.89 161.41 40.78 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.9 ptm85 -84.05 122.03 28.23 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.823 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 130.76 -19.44 4.99 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.039 -175.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -92.42 147.31 23.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.957 0.884 . . . . 0.0 110.261 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.447 ' HB ' ' H ' ' A' ' 104' ' ' THR . 51.6 t -98.62 118.15 44.72 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.271 173.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.431 ' O ' HG22 ' A' ' 38' ' ' VAL . 19.9 m-85 -108.46 145.73 34.22 Favored 'General case' 0 CA--C 1.458 -2.562 0 C-N-CA 124.673 1.189 . . . . 0.0 112.24 176.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.7 145.58 31.51 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 166.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.92 133.12 23.05 Favored 'General case' 0 C--N 1.259 -3.343 0 CA-C-N 113.743 -1.572 . . . . 0.0 108.383 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -88.57 85.35 6.81 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-O 121.593 0.711 . . . . 0.0 109.925 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.591 ' O ' HD23 ' A' ' 24' ' ' LEU 0.459 0.0 OUTLIER -107.2 60.82 0.62 Allowed 'General case' 0 N--CA 1.393 -3.295 0 C-N-CA 116.887 -1.925 . . . . 0.0 113.121 178.557 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.508 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 25.2 p -113.59 62.48 0.95 Allowed Pre-proline 0 C--N 1.271 -2.829 0 CA-C-N 113.491 -1.686 . . . . 0.0 113.62 173.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 24' ' ' LEU . 24.4 Cg_endo -115.41 26.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.26 0 N-CA-C 107.883 -1.622 . . . . 0.0 107.883 159.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.554 ' HB ' ' CB ' ' A' ' 31' ' ' GLU . 17.4 m -94.32 159.61 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.457 -173.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.58 151.72 36.73 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.548 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.34 -132.2 11.52 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.302 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -93.85 11.94 27.61 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.554 ' CB ' ' HB ' ' A' ' 27' ' ' VAL . 42.6 mt-10 -68.09 151.51 46.92 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 170.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -131.58 114.96 15.48 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.405 ' HA3' HD23 ' A' ' 24' ' ' LEU . . . -147.72 -120.21 1.15 Allowed Glycine 0 N--CA 1.406 -3.347 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.964 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 25' ' ' SER . . . 98.54 172.79 32.17 Favored Glycine 0 N--CA 1.408 -3.175 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 -171.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.1 p -88.94 104.09 14.56 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.075 0 CA-C-O 123.033 1.396 . . . . 0.0 108.303 173.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -133.13 163.35 51.74 Favored Pre-proline 0 C--N 1.271 -2.829 0 CA-C-N 112.536 -2.12 . . . . 0.0 110.894 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HB2' HD11 ' A' ' 58' ' ' ILE . 14.5 Cg_exo -70.87 141.3 40.38 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.746 1.631 . . . . 0.0 109.749 166.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 20' ' ' TYR . 32.3 m -127.12 162.52 31.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 124.511 1.125 . . . . 0.0 108.182 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' CG2' ' HB2' ' A' ' 56' ' ' ALA . 34.8 m -104.1 128.89 57.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.671 176.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.0 mm -88.61 104.96 15.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -99.96 -16.34 7.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.588 HE22 ' N ' ' A' ' 47' ' ' ASN . 0.6 OUTLIER -43.75 139.28 2.32 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 127.168 2.187 . . . . 0.0 114.667 -170.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -46.81 145.64 1.9 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.448 ' CG ' ' HZ2' ' A' ' 48' ' ' LYS . 21.0 t70 -67.22 -32.81 74.11 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -79.11 -25.76 42.95 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.408 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.77 -33.46 80.32 Favored Glycine 0 C--O 1.199 -2.058 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.588 ' N ' HE22 ' A' ' 42' ' ' GLN 0.257 20.1 p30 -75.45 -19.68 59.3 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.366 -178.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HZ2' ' CG ' ' A' ' 44' ' ' ASP . 14.1 mptt -85.46 -59.3 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.235 172.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.52 -19.06 18.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -167.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 m -102.22 135.91 19.53 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.524 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.69 -12.55 16.59 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.066 1.844 . . . . 0.0 110.783 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.0 p -100.21 134.14 43.57 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.485 -176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 93' ' ' THR . 61.4 t -121.37 140.19 46.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.54 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 3.3 tp -105.72 125.1 61.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 123.543 0.737 . . . . 0.0 109.28 173.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.699 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 14.0 m -130.64 162.28 38.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.335 -175.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 91' ' ' ILE . . . -118.99 132.37 56.06 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.056 0.942 . . . . 0.0 108.93 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.74 128.89 38.01 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 37' ' ' PRO . 61.1 mt -85.63 132.67 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.795 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 61' ' ' ARG . 78.3 m -125.92 133.92 51.72 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.192 0.52 . . . . 0.0 111.44 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.51 36.06 3.01 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.429 ' H ' HG22 ' A' ' 59' ' ' THR . 39.4 ttm180 -115.35 -2.9 12.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.225 1.012 . . . . 0.0 108.795 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.6 tt -144.09 150.96 16.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -122.44 -27.65 4.4 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.644 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -106.73 118.58 37.04 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.204 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.95 -57.91 9.13 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.79 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 72.8 -58.17 0.61 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.589 1.555 . . . . 0.0 111.44 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.9 tt -94.31 139.49 22.46 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.71 2.12 2.24 Favored 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 123.103 2.536 . . . . 0.0 116.018 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.9 p -92.0 -19.15 22.69 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 122.497 1.141 . . . . 0.0 108.715 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.447 ' CD2' HD22 ' A' ' 87' ' ' LEU . 28.9 m170 -101.15 133.35 45.82 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 171.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 4.4 p -133.44 145.51 33.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 117.046 -1.862 . . . . 0.0 112.434 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -87.66 124.54 33.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.636 1.174 . . . . 0.0 112.88 -173.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.561 HG23 ' CZ ' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -128.54 143.97 39.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.814 0.816 . . . . 0.0 112.852 175.152 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.417 ' OE2' ' HE3' ' A' ' 110' ' ' LYS . 1.3 mp0 -60.74 133.1 55.77 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.727 -178.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 83.8 tttt -55.11 -46.44 75.58 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.751 1.62 . . . . 0.0 109.889 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.413 ' HB3' ' HZ1' ' A' ' 76' ' ' LYS . 7.6 mtpm? -58.5 -48.72 79.9 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 113.129 -1.85 . . . . 0.0 113.305 -174.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.531 ' HE2' ' OG ' ' A' ' 107' ' ' SER . 3.8 tmtm? -80.29 -38.27 31.11 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -171.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.561 ' CZ ' HG23 ' A' ' 73' ' ' ILE . 4.5 m-85 -84.3 -7.03 59.45 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.601 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 67.93 28.12 6.99 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.43 179.4 5.54 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.533 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.432 ' O ' ' HE3' ' A' ' 75' ' ' LYS . 9.9 t70 -68.82 -28.09 66.43 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.605 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.434 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -150.25 166.8 28.82 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -176.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -60.31 146.48 43.85 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.0 t -120.55 160.03 24.01 Favored 'General case' 0 N--CA 1.414 -2.247 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.558 -168.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 26.5 t -127.91 127.1 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 174.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.422 HG22 HD23 ' A' ' 88' ' ' LEU . 1.5 mp -100.96 131.62 48.27 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.447 HD22 ' CD2' ' A' ' 70' ' ' HIS . 22.6 mt -99.13 109.28 22.0 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 113.771 -1.559 . . . . 0.0 107.825 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.422 HD23 HG22 ' A' ' 86' ' ' ILE . 3.1 mm? -88.04 0.08 56.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.591 0.71 . . . . 0.0 111.313 -174.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -98.69 -24.71 14.95 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-O 122.263 1.03 . . . . 0.0 109.654 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.47 ' HA ' HG22 ' B' ' 93' ' ' THR . 0.0 OUTLIER -103.55 85.51 2.47 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.033 177.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.699 ' HB ' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -139.99 171.25 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.202 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -176.337 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.41 ' HD3' HD22 ' A' ' 24' ' ' LEU . 11.9 ptm180 -168.6 169.63 10.12 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 58.4 m -103.93 125.7 50.51 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.518 -1.674 . . . . 0.0 109.329 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.8 mt -132.59 140.77 48.39 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 126.065 1.746 . . . . 0.0 107.419 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.09 153.43 28.74 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.007 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -37.96 -38.18 0.3 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.67 1.588 . . . . 0.0 114.759 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -54.94 -27.55 44.37 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 124.881 1.272 . . . . 0.0 112.281 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -84.18 -27.56 27.96 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.729 -0.607 . . . . 0.0 110.2 -176.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.0 mp -74.04 127.03 31.84 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 123.772 0.829 . . . . 0.0 109.479 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -94.95 -66.65 0.9 Allowed 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.577 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.6 pt-20 -157.11 147.9 21.55 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-O 121.422 0.63 . . . . 0.0 111.247 -170.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.43 ' HZ3' ' HB3' ' A' ' 102' ' ' LYS . 0.1 OUTLIER -68.65 124.48 23.74 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.34 -1.754 . . . . 0.0 109.999 173.077 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.644 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 9.0 tp -112.64 -56.74 2.37 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.128 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.644 ' OG1' ' HG ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -124.59 -169.12 1.92 Allowed 'General case' 0 N--CA 1.394 -3.231 0 C-N-CA 118.833 -1.147 . . . . 0.0 113.986 -176.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 17' ' ' GLY . 8.4 p90 -161.28 142.01 11.17 Favored 'General case' 0 CA--C 1.487 -1.463 0 C-N-CA 125.58 1.552 . . . . 0.0 109.641 -170.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.72 152.15 34.92 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.531 ' OG ' ' HE2' ' A' ' 77' ' ' LYS . 15.8 m -77.02 171.28 15.05 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.834 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 111' ' ' MET . 9.4 m-20 -64.19 -36.94 85.7 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.272 0.558 . . . . 0.0 110.679 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 15.3 t70 -64.65 -39.31 93.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.947 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' A' ' 110' ' ' LYS . 3.1 mptp? -75.84 -26.87 57.57 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.337 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.524 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -55.49 -39.94 71.07 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.851 1.26 . . . . 0.0 108.137 169.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' HE2' ' C ' ' A' ' 111' ' ' MET . 9.1 mmpt? -87.18 -1.66 58.06 Favored 'General case' 0 N--CA 1.394 -3.272 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.721 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 109' ' ' ASP . 32.7 mt-10 -90.89 -55.09 3.69 Favored 'General case' 0 N--CA 1.397 -3.113 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.63 -59.76 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-N 111.831 -2.44 . . . . 0.0 112.717 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 63.4 m-20 -62.71 -39.29 93.58 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 123.134 1.445 . . . . 0.0 111.023 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 17.7 t30 -74.01 -45.87 47.1 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 113.425 -1.716 . . . . 0.0 112.917 -172.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.68 73.35 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 12.5 tp -69.43 -40.28 77.33 Favored 'General case' 0 N--CA 1.389 -3.484 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.367 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.471 ' O ' ' HB2' ' A' ' 124' ' ' LEU . 2.5 ttp -65.2 -27.98 69.06 Favored 'General case' 0 N--CA 1.408 -2.556 0 C-N-CA 123.775 0.83 . . . . 0.0 109.817 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.3 mt -80.29 -52.9 13.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 176.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.1 t -50.39 -33.79 21.95 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.185 -1.825 . . . . 0.0 113.831 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 31.9 mt -97.5 9.35 42.63 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.006 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.51 10.73 81.35 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 115.741 1.056 . . . . 0.0 115.741 173.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 119' ' ' MET . 1.5 mm? -67.8 -54.34 19.91 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.465 ' C ' ' H ' ' A' ' 127' ' ' VAL . 25.2 m120 51.57 -153.66 0.19 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.037 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.94 26.89 1.97 Allowed 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 122.257 1.027 . . . . 0.0 109.023 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.465 ' H ' ' C ' ' A' ' 125' ' ' ASN . 21.5 t -103.62 42.78 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.329 0 C-N-CA 126.044 1.738 . . . . 0.0 106.482 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.67 -16.89 52.82 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.429 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 72.35 124.24 0.03 OUTLIER 'General case' 0 C--O 1.248 1.007 0 C-N-CA 125.581 1.552 . . . . 0.0 112.35 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -83.22 139.11 33.31 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -80.21 94.87 6.13 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.67 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 C--N 1.305 -1.335 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.526 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.081 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -126.65 108.66 11.3 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m -84.44 -14.38 49.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.705 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -73.95 91.78 2.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.214 1.007 . . . . 0.0 109.454 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -99.1 -5.33 30.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.679 -1.146 . . . . 0.0 113.03 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -84.46 91.63 7.88 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.482 ' CE1' ' HB2' ' B' ' 9' ' ' HIS . 11.2 t-160 -114.81 123.47 49.29 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.563 -176.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -74.28 -55.49 5.97 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . 0.482 ' HB2' ' CE1' ' B' ' 7' ' ' HIS . 14.9 t-80 56.96 -81.97 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.463 1.505 . . . . 0.0 113.648 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.2 m -91.89 8.47 37.19 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.296 0.569 . . . . 0.0 111.039 -176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -116.16 76.44 1.02 Allowed 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.438 0.637 . . . . 0.0 111.136 177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -110.71 134.44 20.92 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.64 94.36 0.15 Allowed 'Trans proline' 0 C--O 1.239 0.567 0 C-N-CA 122.358 2.039 . . . . 0.0 113.1 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 65.1 mt -76.98 130.58 36.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -146.82 161.56 40.42 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -83.55 124.06 30.38 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.26 175.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 127.14 -15.63 6.45 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.806 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -96.73 149.52 21.73 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.678 0.751 . . . . 0.0 109.694 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' B' ' 104' ' ' THR . 51.0 t -100.68 121.74 51.84 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.253 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.439 ' O ' HG22 ' B' ' 38' ' ' VAL . 20.6 m-85 -111.83 146.25 38.0 Favored 'General case' 0 CA--C 1.456 -2.646 0 C-N-CA 124.193 0.997 . . . . 0.0 111.967 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.09 145.29 31.17 Favored 'General case' 0 C--N 1.267 -2.992 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 167.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.0 131.77 21.35 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 113.747 -1.57 . . . . 0.0 108.009 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.72 89.76 8.12 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.79 174.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.589 ' O ' HD23 ' B' ' 24' ' ' LEU 0.452 0.0 OUTLIER -108.85 59.84 0.6 Allowed 'General case' 0 N--CA 1.393 -3.295 0 CA-C-O 124.196 1.951 . . . . 0.0 112.426 177.533 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.511 ' HB3' ' HA2' ' B' ' 34' ' ' GLY . 10.9 p -111.62 62.62 0.53 Allowed Pre-proline 0 C--N 1.267 -2.992 0 CA-C-N 113.141 -1.845 . . . . 0.0 113.433 174.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.459 ' HD3' ' C ' ' B' ' 24' ' ' LEU . 22.3 Cg_endo -116.89 26.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.082 0 N-CA-C 107.692 -1.695 . . . . 0.0 107.692 158.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.599 ' HB ' ' CB ' ' B' ' 31' ' ' GLU . 18.6 m -95.01 156.39 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.87 151.74 37.56 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.535 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.04 -132.05 11.03 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -94.02 10.94 31.55 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.599 ' CB ' ' HB ' ' B' ' 27' ' ' VAL . 43.4 mt-10 -66.93 151.6 47.28 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -132.89 116.57 16.64 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -173.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . 0.401 ' HA3' HD23 ' B' ' 24' ' ' LEU . . . -149.27 -116.21 0.81 Allowed Glycine 0 N--CA 1.404 -3.494 0 C-N-CA 119.88 -1.152 . . . . 0.0 114.013 175.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.511 ' HA2' ' HB3' ' B' ' 25' ' ' SER . . . 96.63 177.83 35.36 Favored Glycine 0 N--CA 1.413 -2.886 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -171.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.74 102.87 14.08 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-O 123.167 1.46 . . . . 0.0 107.95 172.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -132.13 163.52 49.66 Favored Pre-proline 0 C--N 1.268 -2.966 0 CA-C-N 111.978 -2.374 . . . . 0.0 110.765 -172.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.416 ' HB2' HD11 ' B' ' 58' ' ' ILE . 14.0 Cg_exo -71.21 140.92 38.3 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 121.671 1.581 . . . . 0.0 109.865 165.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.439 HG22 ' O ' ' B' ' 20' ' ' TYR . 28.3 m -126.89 162.63 31.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 124.667 1.187 . . . . 0.0 108.157 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -104.72 129.66 56.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.671 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 32.1 mm -89.22 105.16 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.413 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.1 OUTLIER -100.07 -17.37 6.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.01 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.614 HE22 ' N ' ' B' ' 47' ' ' ASN . 0.6 OUTLIER -43.13 140.51 1.47 Allowed 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 127.03 2.132 . . . . 0.0 114.686 -170.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -47.89 149.55 1.31 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.331 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.584 ' HA ' ' ND2' ' B' ' 47' ' ' ASN . 30.0 t70 -71.83 -32.07 67.18 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.743 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 3.8 m -76.98 -25.07 52.31 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.127 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.62 -35.83 90.47 Favored Glycine 0 C--O 1.199 -2.048 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.614 ' N ' HE22 ' B' ' 42' ' ' GLN . 13.0 p30 -74.35 -19.09 60.57 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.339 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.491 ' HZ2' ' CG ' ' B' ' 44' ' ' ASP . 14.0 mptt -85.64 -61.59 1.72 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.203 174.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -96.58 -16.68 20.92 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 -168.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -98.62 140.75 22.01 Favored Pre-proline 0 C--N 1.302 -1.473 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.306 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.43 -11.77 11.68 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.932 1.754 . . . . 0.0 110.26 173.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -101.35 137.69 39.36 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 124.879 1.271 . . . . 0.0 111.455 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' B' ' 93' ' ' THR . 60.2 t -124.22 140.21 48.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.515 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 3.2 tp -105.69 124.74 60.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 123.455 0.702 . . . . 0.0 109.402 173.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.683 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 13.6 m -130.64 162.54 38.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.328 -175.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.468 ' HA ' HG22 ' B' ' 91' ' ' ILE . . . -118.89 132.79 56.11 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 124.27 1.028 . . . . 0.0 108.759 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.1 129.54 39.71 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' B' ' 37' ' ' PRO . 60.5 mt -86.64 133.18 30.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.202 174.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' THR . . . . . 0.407 HG22 ' H ' ' B' ' 61' ' ' ARG . 75.1 m -127.11 133.01 50.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.24 0.543 . . . . 0.0 112.223 -176.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.19 41.49 1.77 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.407 ' H ' HG22 ' B' ' 59' ' ' THR . 42.1 ttm180 -118.27 -11.43 10.07 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.938 0.875 . . . . 0.0 109.468 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 12.3 tt -138.43 145.78 27.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -116.45 -29.39 6.18 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.999 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -103.37 123.61 47.14 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.89 -59.06 4.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.403 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 61.8 tttp 72.32 -57.87 0.61 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.908 1.283 . . . . 0.0 111.655 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.1 tt -97.47 134.62 22.37 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.82 -4.32 4.58 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 123.821 3.014 . . . . 0.0 116.153 -174.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 74.8 p -87.21 -18.99 29.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.407 1.098 . . . . 0.0 108.848 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . 0.431 ' CD2' HD22 ' B' ' 87' ' ' LEU . 33.5 m170 -99.83 134.8 42.2 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 170.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 5.1 p -134.24 144.98 33.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 116.979 -1.888 . . . . 0.0 112.364 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -88.62 127.88 35.57 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.25 1.02 . . . . 0.0 112.149 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.573 HG23 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -128.33 149.12 32.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 O-C-N 123.708 0.63 . . . . 0.0 112.063 175.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -64.19 131.89 48.74 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.329 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -54.62 -46.69 73.92 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 125.732 1.613 . . . . 0.0 109.813 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . 0.404 ' HZ1' ' HB3' ' B' ' 76' ' ' LYS . 6.5 mtpm? -56.29 -50.21 72.04 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.851 -175.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -78.78 -39.06 36.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.63 -170.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.573 ' CZ ' HG23 ' B' ' 73' ' ' ILE . 4.4 m-85 -84.14 -6.99 59.49 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.977 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 68.6 29.28 5.52 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.19 178.88 5.38 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.382 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -70.59 -25.0 62.86 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.422 -1.717 . . . . 0.0 111.156 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.406 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -151.68 163.52 38.94 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -176.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.37 143.92 43.42 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 22.1 t -121.3 156.83 31.69 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 119.639 -0.825 . . . . 0.0 112.257 -167.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 25.9 t -123.7 126.97 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.413 HG22 HD23 ' B' ' 88' ' ' LEU . 1.5 mp -100.24 131.33 47.93 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.158 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.431 HD22 ' CD2' ' B' ' 70' ' ' HIS . 31.8 mt -98.99 108.15 20.76 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.03 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.413 HD23 HG22 ' B' ' 86' ' ' ILE . 3.3 mm? -86.97 -0.26 56.3 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.723 0.773 . . . . 0.0 111.52 -174.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -100.15 -22.65 15.1 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 122.372 1.082 . . . . 0.0 109.928 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . 0.457 ' HA ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -104.62 85.66 2.36 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.992 177.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.683 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 0.3 OUTLIER -140.1 171.41 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.432 ' HD3' HD22 ' B' ' 24' ' ' LEU . 11.7 ptm180 -168.98 169.34 9.67 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.47 HG22 ' HA ' ' A' ' 90' ' ' GLN . 72.0 m -104.43 126.31 51.41 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.549 -177.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -132.55 142.88 49.37 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 126.069 1.748 . . . . 0.0 107.432 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -81.18 152.06 27.9 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.019 -1.473 . . . . 0.0 108.96 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -35.48 -40.01 0.15 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.891 1.676 . . . . 0.0 115.148 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -51.34 -31.79 23.26 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 125.027 1.331 . . . . 0.0 112.632 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -79.93 -27.51 39.84 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.963 0.411 . . . . 0.0 110.193 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -75.01 124.56 27.19 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 122.01 0.91 . . . . 0.0 109.563 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -95.49 -60.08 1.74 Allowed 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.902 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.2 pt-20 -161.02 148.43 15.4 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-O 121.504 0.669 . . . . 0.0 111.737 -172.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.404 ' HB3' ' HZ3' ' B' ' 102' ' ' LYS . 0.1 OUTLIER -71.63 121.06 18.12 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.85 174.541 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.619 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 8.4 tp -109.37 -55.39 2.43 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.619 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 0.3 OUTLIER -124.13 -168.57 1.82 Allowed 'General case' 0 N--CA 1.391 -3.424 0 C-N-CA 118.421 -1.312 . . . . 0.0 114.497 -176.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.51 ' H ' HG22 ' B' ' 104' ' ' THR . 19.9 p90 -161.48 141.69 10.68 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 125.808 1.643 . . . . 0.0 109.383 -171.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.9 150.73 36.6 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.44 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t -78.25 170.18 17.05 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.473 -175.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' B' ' 111' ' ' MET . 4.6 m-20 -60.8 -38.48 85.49 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.683 0.793 . . . . 0.0 111.121 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 27.1 t70 -64.58 -38.27 90.44 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.148 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' B' ' 110' ' ' LYS . 2.6 mptp? -75.55 -27.71 58.74 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.247 -178.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.503 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.2 OUTLIER -54.87 -40.25 69.52 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 124.912 1.285 . . . . 0.0 108.058 170.041 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.421 ' HE2' ' C ' ' B' ' 111' ' ' MET . 7.7 mmpt? -86.6 -2.43 58.49 Favored 'General case' 0 N--CA 1.384 -3.769 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.314 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' B' ' 109' ' ' ASP . 38.3 mt-10 -90.69 -55.51 3.54 Favored 'General case' 0 C--N 1.261 -3.271 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 172.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.18 -59.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 CA-C-N 111.594 -2.548 . . . . 0.0 112.786 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.539 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 56.7 m-20 -62.65 -40.24 96.42 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.14 1.448 . . . . 0.0 111.227 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.332 43.1 t30 -75.1 -42.96 55.52 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 113.531 -1.668 . . . . 0.0 112.602 -170.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.18 -31.76 73.08 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.546 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 11.2 tp -70.72 -35.09 72.56 Favored 'General case' 0 N--CA 1.39 -3.445 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.047 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.478 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 2.3 ttp -69.05 -21.49 64.09 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-O 121.686 0.755 . . . . 0.0 109.303 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 51.6 mt -87.89 -53.5 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 79.1 p -53.94 -28.48 37.33 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 26.2 mt -97.06 5.28 50.64 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.187 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.15 13.01 78.14 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 115.954 1.142 . . . . 0.0 115.954 172.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.478 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.5 mm? -68.32 -52.95 27.84 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' B' ' 127' ' ' VAL . 23.7 m120 51.71 -152.85 0.21 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 112.979 -1.919 . . . . 0.0 109.474 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.69 26.24 2.09 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 122.481 1.134 . . . . 0.0 108.947 173.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' B' ' 125' ' ' ASN . 11.7 t -105.06 39.77 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.01 0 C-N-CA 125.705 1.602 . . . . 0.0 106.962 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.73 -17.48 59.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.887 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 73.04 143.03 0.06 Allowed 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.549 1.54 . . . . 0.0 110.985 -178.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -100.02 145.78 27.5 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -84.06 96.5 8.91 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 C--N 1.3 -1.551 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.526 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.971 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -83.85 -10.02 58.33 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t -114.21 103.2 10.87 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -126.02 -53.96 1.51 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 71.16 174.74 0.3 Allowed 'General case' 0 C--O 1.246 0.915 0 C-N-CA 125.1 1.36 . . . . 0.0 113.183 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -157.67 173.47 16.79 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.8 m80 74.75 -52.57 0.68 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.734 1.213 . . . . 0.0 113.703 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -45.58 -39.26 7.38 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.601 1.16 . . . . 0.0 112.34 -174.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -119.64 -33.23 4.09 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.421 175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.5 m -59.71 -47.25 86.38 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -178.2 101.09 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.78 129.91 82.45 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.17 98.99 0.33 Allowed 'Trans proline' 0 C--O 1.252 1.184 0 C-N-CA 122.406 2.07 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.8 mt -69.72 132.38 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.739 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -146.54 156.91 43.59 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -70.36 124.91 25.32 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 169.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.14 -26.21 3.78 Favored Glycine 0 C--N 1.302 -1.359 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.093 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -97.41 167.43 11.0 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.776 0.798 . . . . 0.0 109.427 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.53 HG22 HG22 ' A' ' 104' ' ' THR . 24.7 t -122.42 139.39 49.48 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.56 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.2 m-85 -133.5 148.66 51.7 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.4 151.62 39.65 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 168.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -141.58 135.48 30.1 Favored 'General case' 0 CA--C 1.454 -2.736 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.217 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.39 93.59 9.58 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 166.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.412 HD11 ' HD3' ' A' ' 92' ' ' ARG . 1.1 pp -109.83 28.9 8.12 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.282 -1.327 . . . . 0.0 107.814 -174.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.29 62.25 0.0 OUTLIER Pre-proline 0 C--N 1.267 -3.002 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -112.87 25.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.938 0 N-CA-C 107.232 -1.872 . . . . 0.0 107.232 153.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 13.9 m -83.56 160.45 3.49 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -173.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.52 145.84 31.21 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 113.311 -1.768 . . . . 0.0 113.249 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.32 -114.21 6.65 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.602 -1.181 . . . . 0.0 114.637 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -78.34 -9.1 59.12 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 123.827 0.851 . . . . 0.0 112.963 -173.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 50.7 mt-10 -71.3 159.89 33.78 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -132.29 111.41 11.35 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -174.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.402 ' HA3' HD13 ' A' ' 24' ' ' LEU . . . -164.0 -162.54 15.11 Favored Glycine 0 N--CA 1.408 -3.23 0 C-N-CA 119.155 -1.497 . . . . 0.0 115.02 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.6 -156.81 26.45 Favored Glycine 0 N--CA 1.407 -3.283 0 N-CA-C 103.419 -3.872 . . . . 0.0 103.419 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 59.3 t -83.03 99.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.438 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 169.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -130.8 146.51 62.33 Favored Pre-proline 0 C--N 1.252 -3.652 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.277 -172.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.452 ' HB2' HD12 ' A' ' 58' ' ' ILE . 25.4 Cg_exo -62.98 137.12 60.49 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 121.702 1.601 . . . . 0.0 109.929 171.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 31.1 m -127.6 154.87 38.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 29.8 m -97.77 129.92 47.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.125 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.9 mm -91.36 107.19 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -13.82 9.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.285 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.542 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 5.0 pt20 -52.11 165.24 0.23 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 -169.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -65.51 174.43 2.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.613 -2.085 . . . . 0.0 112.118 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 9.9 t70 -72.56 -48.24 41.65 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.268 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.5 m -70.38 -30.98 68.03 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.477 0.711 . . . . 0.0 112.253 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA2' ' HB2' ' A' ' 50' ' ' SER . . . -62.32 -33.41 86.05 Favored Glycine 0 C--O 1.205 -1.67 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.691 -175.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.488 ' N ' HE22 ' A' ' 42' ' ' GLN . 10.1 p30 -84.65 -37.13 21.4 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.841 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.627 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 24.4 mmtp -67.6 -63.19 1.11 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.386 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.627 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 19.0 m-85 -102.09 -35.86 8.77 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -168.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.437 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 22.5 m -82.47 157.92 66.88 Favored Pre-proline 0 N--CA 1.422 -1.832 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.673 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 86.4 Cg_endo -86.95 -20.85 2.23 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 121.099 1.199 . . . . 0.0 111.797 174.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.402 HG22 ' HG2' ' B' ' 90' ' ' GLN . 11.3 p -99.6 135.3 41.23 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.542 ' HB ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -133.42 139.2 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.906 176.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.5 tt -81.74 126.85 39.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.964 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 34.5 m -132.97 154.98 40.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.582 174.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' CB ' HG23 ' A' ' 91' ' ' ILE . . . -115.91 133.09 56.39 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.3 136.02 56.76 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.497 HG12 ' CD1' ' A' ' 86' ' ' ILE . 49.2 mt -98.07 131.47 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.736 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 m -105.54 108.34 19.81 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.27 44.98 2.95 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.479 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -162.53 172.99 14.6 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 81.2 mt 73.22 123.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.991 0 O-C-N 124.387 1.055 . . . . 0.0 111.425 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -112.79 17.95 18.62 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.41 -0.806 . . . . 0.0 110.784 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -128.8 109.87 11.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.554 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.82 -70.73 0.71 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 172.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 54.58 33.09 18.33 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.837 1.255 . . . . 0.0 112.987 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tt -151.14 139.64 13.06 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.12 -4.7 12.05 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 122.427 2.084 . . . . 0.0 115.246 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.3 p -100.09 -17.92 17.22 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.377 0.608 . . . . 0.0 111.363 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -118.55 128.45 54.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 61.0 t -111.27 134.26 54.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.208 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -99.69 124.79 45.28 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 123.744 0.653 . . . . 0.0 109.363 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.49 HG21 ' CZ ' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -116.35 153.27 18.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.209 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -54.08 129.56 34.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.058 -1.428 . . . . 0.0 112.815 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.632 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 93.1 mttt -51.98 -56.79 12.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.457 178.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -67.98 -45.84 73.03 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.193 -169.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -62.84 -33.05 74.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.016 0.436 . . . . 0.0 111.394 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.52 ' HH ' ' HG ' ' A' ' 106' ' ' LEU . 12.1 m-85 -92.9 2.31 56.85 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 123.924 0.89 . . . . 0.0 111.14 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.3 tptt 72.22 15.95 5.28 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.507 1.523 . . . . 0.0 113.562 171.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.53 175.42 6.56 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-O 122.492 1.139 . . . . 0.0 110.983 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.486 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 10.3 t70 -85.08 -27.08 26.54 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 112.944 -1.934 . . . . 0.0 110.1 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.497 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -139.31 157.09 46.5 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.42 -174.19 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.632 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 6.5 m-20 -45.89 135.44 7.15 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 124.92 1.388 . . . . 0.0 112.055 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 73' ' ' ILE . 15.4 m -103.73 121.8 43.76 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.667 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 9.8 t -107.74 136.51 42.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.497 ' CD1' HG12 ' A' ' 58' ' ' ILE . 15.9 mm -111.68 134.41 54.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.1 mt -104.91 97.42 7.29 Favored 'General case' 0 N--CA 1.416 -2.164 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.438 ' HG ' ' HB1' ' A' ' 117' ' ' ALA . 3.0 mm? -81.25 -9.42 59.77 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.497 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -95.41 -25.93 16.07 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.762 0.791 . . . . 0.0 111.292 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.592 ' O ' ' HB ' ' B' ' 93' ' ' THR . 1.1 tm0? -80.28 -60.88 2.16 Favored 'General case' 0 C--O 1.164 -3.433 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.246 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.5 HG23 ' CB ' ' A' ' 56' ' ' ALA . 1.3 pp 30.05 -174.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.529 3.475 0 C-N-CA 129.646 3.178 . . . . 0.0 116.814 175.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.412 ' HD3' HD11 ' A' ' 24' ' ' LEU . 8.7 ptm85 -176.96 159.6 1.72 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 167.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.594 ' HB ' ' O ' ' B' ' 90' ' ' GLN . 0.0 OUTLIER -114.54 108.36 16.74 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.743 1.217 . . . . 0.0 109.356 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 98' ' ' ARG . 64.9 mt -131.82 149.58 52.42 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -173.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.673 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 11.8 t70 -50.72 145.17 7.22 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 173.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 33.1 pttt -55.58 -29.74 59.6 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.589 1.556 . . . . 0.0 114.608 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.457 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 20.1 ttmm -47.56 -39.08 15.63 Favored 'General case' 0 C--N 1.274 -2.677 0 C-N-CA 126.243 1.817 . . . . 0.0 112.476 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 94' ' ' LEU . 1.7 ppt_? -73.39 -15.01 61.37 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -178.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 10.4 mp -61.75 120.6 10.98 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.912 0.885 . . . . 0.0 110.028 170.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.08 -64.27 1.08 Allowed 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.367 -177.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.4 pt-20 -156.67 145.32 19.95 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 121.786 0.803 . . . . 0.0 111.807 -172.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -60.81 120.82 10.86 Favored 'General case' 0 C--N 1.281 -2.379 0 C-N-CA 128.132 2.573 . . . . 0.0 108.814 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -114.66 -62.67 1.57 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.704 -0.798 . . . . 0.0 112.466 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.53 HG22 HG22 ' A' ' 19' ' ' VAL . 5.4 t -128.8 -160.98 1.07 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.243 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -159.39 149.25 18.77 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.052 0.941 . . . . 0.0 112.326 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.52 ' HG ' ' HH ' ' A' ' 78' ' ' TYR . 7.2 mp -107.56 135.39 49.1 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 113.853 -1.522 . . . . 0.0 112.264 -177.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.426 ' O ' ' HG2' ' A' ' 111' ' ' MET . 7.0 m -76.4 165.95 24.11 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 124.248 1.019 . . . . 0.0 110.597 176.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 111' ' ' MET . 23.3 t70 -67.71 -42.98 81.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.86 -28.86 69.28 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.737 0.78 . . . . 0.0 109.382 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HD2' ' CG2' ' A' ' 73' ' ' ILE . 71.5 mmtt -79.78 -28.78 40.3 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.684 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.8 OUTLIER -53.65 -44.55 69.69 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.153 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 10.0 mmpt? -75.13 -8.32 56.24 Favored 'General case' 0 N--CA 1.396 -3.161 0 CA-C-N 114.421 -1.263 . . . . 0.0 114.173 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -89.26 -51.56 5.51 Favored 'General case' 0 N--CA 1.397 -3.079 0 C-N-CA 116.735 -1.986 . . . . 0.0 106.264 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -53.72 -59.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 112.615 -2.084 . . . . 0.0 113.351 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 45.8 m-20 -59.73 -39.19 83.87 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 123.241 1.496 . . . . 0.0 110.989 -177.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 10.9 t30 -77.97 -40.46 39.25 Favored 'General case' 0 C--N 1.261 -3.275 0 CA-C-N 112.718 -2.037 . . . . 0.0 111.669 -173.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' HB1' ' HG ' ' A' ' 88' ' ' LEU . . . -61.69 -36.58 81.29 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 5.2 tp -70.14 -37.02 75.18 Favored 'General case' 0 N--CA 1.394 -3.24 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.2 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.447 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 1.5 ttp -66.87 -22.99 65.96 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.872 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.0 mt -88.07 -50.95 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 118' ' ' LEU . 83.5 p -59.33 -22.26 61.02 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.644 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 32.9 mt -103.73 1.28 31.58 Favored 'General case' 0 C--O 1.201 -1.486 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.501 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.35 16.86 54.71 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 117.137 1.615 . . . . 0.0 117.137 171.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.447 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.2 mm? -74.0 -52.34 13.08 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 127' ' ' VAL . 23.3 m120 58.04 -171.69 0.1 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 112.47 -2.15 . . . . 0.0 112.546 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.03 20.16 1.04 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.042 0.925 . . . . 0.0 111.098 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.491 ' H ' ' C ' ' A' ' 125' ' ' ASN . 21.9 t -88.37 79.04 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.61 142.73 32.53 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.69 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -69.34 -27.03 64.99 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.481 0.657 . . . . 0.0 110.69 -173.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -101.03 24.63 9.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.082 177.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -126.6 131.03 51.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.042 0.449 . . . . 0.0 111.109 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.4 m120 . . . . . 0 C--O 1.256 1.417 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 175.097 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.393 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -84.28 -12.11 55.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.017 0.437 . . . . 0.0 111.569 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 48.0 t -117.76 110.39 17.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -133.21 -52.31 0.89 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 66.37 170.57 0.24 Allowed 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.683 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -152.55 171.72 17.68 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 52.6 m80 77.93 -52.62 0.51 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.739 1.215 . . . . 0.0 113.272 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -44.26 -42.95 6.99 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.897 1.279 . . . . 0.0 112.112 -174.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -114.23 -37.92 4.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.385 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 5.8 m -55.12 -57.04 13.38 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.667 0.787 . . . . 0.0 112.785 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -168.23 96.0 0.41 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -175.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.39 124.21 90.51 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.43 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.59 106.85 0.45 Allowed 'Trans proline' 0 C--O 1.251 1.131 0 C-N-CA 123.024 2.482 . . . . 0.0 112.313 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -78.6 131.89 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.902 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -145.8 156.89 43.88 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -70.24 128.92 37.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.92 -26.33 4.02 Favored Glycine 0 C--N 1.307 -1.051 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.551 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -97.42 169.69 9.57 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 121.762 0.791 . . . . 0.0 109.183 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.52 HG22 HG22 ' B' ' 104' ' ' THR . 23.4 t -123.84 140.16 48.15 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.885 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.728 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 35.3 m-85 -132.9 148.96 52.29 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 124.162 0.985 . . . . 0.0 109.087 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.02 149.57 39.2 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 167.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -140.35 134.49 30.97 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.71 -175.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -86.5 93.58 9.2 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 166.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.405 HD13 ' HA3' ' B' ' 33' ' ' GLY . 1.1 pp -108.8 28.7 8.16 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.842 1.306 . . . . 0.0 108.011 -175.227 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.428 ' OG ' ' HA2' ' B' ' 34' ' ' GLY . 1.0 OUTLIER -90.27 62.72 0.0 OUTLIER Pre-proline 0 C--N 1.266 -3.058 0 N-CA-C 116.712 2.115 . . . . 0.0 116.712 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -113.67 25.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.981 0 N-CA-C 107.42 -1.8 . . . . 0.0 107.42 151.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 15.1 m -82.29 162.26 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -173.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.39 147.86 31.72 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.802 -1.544 . . . . 0.0 113.033 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.34 -114.53 6.79 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 114.622 -1.172 . . . . 0.0 114.323 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -75.56 -11.76 60.08 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 123.855 0.862 . . . . 0.0 113.168 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.538 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 50.3 mt-10 -71.03 158.4 36.57 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -131.91 112.6 12.58 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . 0.405 ' HA3' HD13 ' B' ' 24' ' ' LEU . . . -164.4 -161.63 13.84 Favored Glycine 0 N--CA 1.408 -3.192 0 C-N-CA 119.379 -1.391 . . . . 0.0 114.971 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.428 ' HA2' ' OG ' ' B' ' 25' ' ' SER . . . 141.6 -158.53 26.6 Favored Glycine 0 C--N 1.267 -3.279 0 N-CA-C 103.403 -3.879 . . . . 0.0 103.403 -173.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 61.8 t -82.37 98.98 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 169.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -130.72 146.78 63.4 Favored Pre-proline 0 C--N 1.253 -3.592 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.096 -172.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.49 138.03 63.07 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.766 1.644 . . . . 0.0 110.16 171.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 30.2 m -128.44 154.72 39.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.569 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.435 ' CG2' ' HB1' ' B' ' 56' ' ' ALA . 28.1 m -97.72 129.7 47.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.094 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 25.8 mm -91.31 106.27 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -14.77 9.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.25 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.561 ' OE1' ' HB3' ' B' ' 47' ' ' ASN . 0.1 OUTLIER -53.79 164.71 0.53 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -170.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -64.01 175.03 1.31 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.514 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' B' ' 48' ' ' LYS . 12.8 t70 -74.31 -47.32 35.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.866 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.9 m -70.52 -31.34 68.38 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.637 0.775 . . . . 0.0 112.199 -169.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' B' ' 50' ' ' SER . . . -62.48 -32.4 82.97 Favored Glycine 0 C--O 1.21 -1.401 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.424 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.561 ' HB3' ' OE1' ' B' ' 42' ' ' GLN . 9.7 p30 -84.65 -39.04 19.1 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.475 -0.89 . . . . 0.0 112.096 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.64 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 25.9 mmtp -65.74 -63.25 1.13 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.096 0.474 . . . . 0.0 111.726 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . 0.64 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 19.1 m-85 -102.14 -36.3 8.59 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -168.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.445 ' HB2' ' HA2' ' B' ' 46' ' ' GLY . 25.8 m -80.85 157.98 71.03 Favored Pre-proline 0 N--CA 1.418 -2.032 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.673 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 83.8 Cg_endo -87.39 -21.37 1.92 Allowed 'Trans proline' 0 N--CA 1.431 -2.162 0 C-N-CA 121.202 1.268 . . . . 0.0 111.662 173.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 9.5 p -99.41 135.12 41.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -170.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.98 138.79 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.316 175.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tt -82.3 127.39 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 124.979 1.311 . . . . 0.0 110.732 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 34.7 m -132.77 154.99 40.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.395 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.512 ' CB ' HG23 ' B' ' 91' ' ' ILE . . . -115.43 132.82 56.5 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.98 136.5 57.38 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.525 HG12 ' CD1' ' B' ' 86' ' ' ILE . 63.5 mt -97.34 132.26 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.702 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 26.3 m -106.13 106.11 16.46 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 174.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.24 43.98 3.25 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.001 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -163.31 172.76 14.2 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 81.9 mt 76.07 125.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 O-C-N 124.559 1.162 . . . . 0.0 111.533 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -114.15 19.16 16.61 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.542 0.686 . . . . 0.0 110.43 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -131.91 107.84 8.99 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.415 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.11 -72.57 0.64 Allowed 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 172.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 56.71 31.53 19.51 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.312 1.045 . . . . 0.0 112.719 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 8.6 tt -151.66 134.8 9.06 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.84 -3.39 4.55 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 122.962 2.441 . . . . 0.0 115.301 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 66.6 p -103.37 -15.64 15.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.309 0.576 . . . . 0.0 111.19 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -119.07 129.01 54.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 52.8 t -111.38 132.99 58.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.16 179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -99.58 119.8 38.64 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.355 0.662 . . . . 0.0 109.557 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.42 HG12 ' O ' ' B' ' 84' ' ' SER . 0.0 OUTLIER -111.11 153.54 12.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.536 ' OE1' ' HE3' ' B' ' 110' ' ' LYS . 1.6 mp0 -53.1 128.99 29.54 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.818 1.324 . . . . 0.0 111.956 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . 0.617 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 94.0 mttt -52.15 -56.35 15.1 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.209 0.943 . . . . 0.0 111.364 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -68.81 -43.08 76.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.845 -168.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' B' ' 77' ' ' LYS . 38.8 ttmt -64.95 -33.5 76.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.239 0.543 . . . . 0.0 110.878 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.414 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 14.7 m-85 -91.68 2.18 56.65 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.197 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 41.7 tptt 71.83 20.05 4.65 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.072 1.349 . . . . 0.0 113.074 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.71 174.05 6.41 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 122.573 1.178 . . . . 0.0 111.217 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -84.07 -26.09 29.3 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.88 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.447 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -140.97 156.75 46.0 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.385 -172.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . 0.617 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 10.9 m-20 -46.64 135.28 8.87 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.902 1.376 . . . . 0.0 112.126 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' SER . . . . . 0.42 ' O ' HG12 ' B' ' 73' ' ' ILE . 14.9 m -103.89 122.6 45.51 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.887 -177.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 8.9 t -107.88 137.16 40.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.525 ' CD1' HG12 ' B' ' 58' ' ' ILE . 16.5 mm -111.67 135.05 52.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 18.8 mt -105.38 98.72 8.38 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.03 -9.82 59.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.324 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -95.58 -26.19 15.87 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.316 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . 0.594 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -80.2 -60.7 2.23 Favored 'General case' 0 C--O 1.162 -3.534 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.138 -178.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.512 HG23 ' CB ' ' B' ' 56' ' ' ALA . 1.3 pp 30.02 -174.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 C-N-CA 129.605 3.162 . . . . 0.0 116.836 175.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.401 ' HD3' HD11 ' B' ' 24' ' ' LEU . 8.5 ptm85 -176.95 159.72 1.73 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 167.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -114.83 108.63 17.01 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.916 1.286 . . . . 0.0 109.453 179.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.488 ' HB2' ' CZ ' ' B' ' 98' ' ' ARG . 65.2 mt -131.77 150.94 51.99 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.673 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 11.7 t70 -51.9 146.12 8.84 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.32 0.509 . . . . 0.0 111.446 173.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' B' ' 99' ' ' LEU . 31.5 pttt -54.48 -33.34 59.58 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.095 1.358 . . . . 0.0 114.256 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -41.28 -40.69 1.71 Allowed 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 126.742 2.017 . . . . 0.0 113.693 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.488 ' CZ ' ' HB2' ' B' ' 94' ' ' LEU . 1.7 ppt_? -73.72 -13.95 61.05 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' B' ' 96' ' ' LYS . 10.1 mp -63.39 118.48 8.13 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 123.83 0.852 . . . . 0.0 109.81 170.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.19 -64.07 1.1 Allowed 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.304 -1.317 . . . . 0.0 112.094 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 12.2 pt-20 -156.76 145.86 20.28 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-O 121.815 0.817 . . . . 0.0 111.55 -172.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -60.39 122.57 14.91 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 128.152 2.581 . . . . 0.0 108.891 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 13.0 tp -114.97 -62.33 1.62 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 119.566 -0.853 . . . . 0.0 112.393 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.52 HG22 HG22 ' B' ' 19' ' ' VAL . 5.4 t -129.3 -160.79 1.06 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.317 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -159.31 147.76 17.86 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.262 1.025 . . . . 0.0 112.289 -169.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.79 140.52 36.95 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.0 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 15.1 t -82.91 162.41 21.55 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.074 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' B' ' 111' ' ' MET . 15.8 t70 -63.9 -44.74 92.09 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 122.73 0.412 . . . . 0.0 111.828 -175.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.7 -30.39 71.5 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.575 0.702 . . . . 0.0 110.363 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.536 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 70.0 mmtt -80.29 -27.01 38.62 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.999 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.4 OUTLIER -53.93 -44.36 70.58 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 169.131 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.414 ' HE2' ' C ' ' B' ' 111' ' ' MET . 9.7 mmpt? -75.7 -8.2 56.23 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 114.215 -1.357 . . . . 0.0 113.792 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -89.92 -50.95 5.73 Favored 'General case' 0 N--CA 1.398 -3.055 0 C-N-CA 117.215 -1.794 . . . . 0.0 106.922 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -54.26 -59.85 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-N 112.586 -2.097 . . . . 0.0 112.96 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 47.1 m-20 -58.57 -42.06 87.1 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 123.07 1.414 . . . . 0.0 111.281 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.313 14.8 t30 -74.74 -40.9 61.0 Favored 'General case' 0 C--N 1.266 -3.044 0 CA-C-N 113.059 -1.882 . . . . 0.0 111.551 -174.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.78 -35.48 80.73 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 5.2 tp -69.64 -36.94 76.54 Favored 'General case' 0 N--CA 1.394 -3.272 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.789 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.463 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 1.3 ttp -67.18 -22.58 65.74 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.375 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.23 -53.92 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' SER . . . . . 0.446 ' OG ' ' HA ' ' B' ' 118' ' ' LEU . 78.1 p -55.37 -24.25 28.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.134 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 32.8 mt -101.48 0.66 37.09 Favored 'General case' 0 C--O 1.2 -1.504 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.958 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.33 16.48 55.41 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 116.98 1.552 . . . . 0.0 116.98 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.463 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.2 mm? -73.6 -51.72 15.88 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' B' ' 127' ' ' VAL . 22.2 m120 58.23 -170.04 0.12 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 112.488 -2.142 . . . . 0.0 112.252 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.96 19.54 2.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.814 0.816 . . . . 0.0 111.052 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' B' ' 125' ' ' ASN . 21.4 t -86.79 68.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.212 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.62 146.93 23.65 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.179 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -71.71 -24.96 61.89 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.404 0.621 . . . . 0.0 110.298 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -101.54 14.16 32.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.058 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -116.31 127.37 54.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.302 0.572 . . . . 0.0 111.028 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 13.2 m120 . . . . . 0 C--N 1.293 -1.881 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.8 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.192 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 m -78.62 98.4 6.16 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.594 0.711 . . . . 0.0 111.461 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -78.57 126.92 31.41 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -73.66 92.4 1.96 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.485 0.659 . . . . 0.0 109.788 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -82.04 -38.36 25.1 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.371 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -125.11 170.42 11.22 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.968 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -91.54 125.43 36.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -78.57 96.15 5.39 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -74.23 -30.21 62.06 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -172.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -65.42 114.72 5.02 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 123.582 0.551 . . . . 0.0 110.104 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -86.42 -7.87 58.09 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.854 0.835 . . . . 0.0 109.074 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -96.59 113.18 62.2 Favored Pre-proline 0 N--CA 1.434 -1.228 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.203 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -91.55 3.39 4.21 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 122.578 2.185 . . . . 0.0 112.133 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.524 ' HB ' ' OD1' ' A' ' 47' ' ' ASN . 60.9 mt -105.59 131.6 54.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -116.38 144.68 43.97 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 172.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.537 ' HD2' ' O ' ' A' ' 41' ' ' ILE . 4.7 ttp180 -63.81 114.42 4.03 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 174.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.33 -16.52 5.43 Favored Glycine 0 N--CA 1.421 -2.35 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.78 172.02 12.91 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 122.815 1.293 . . . . 0.0 110.516 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.504 HG23 HG21 ' A' ' 104' ' ' THR . 12.6 t -132.68 128.99 58.18 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.425 0 CA-C-N 112.356 -2.202 . . . . 0.0 109.445 175.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 37.3 m-85 -126.38 147.38 49.77 Favored 'General case' 0 C--N 1.277 -2.567 0 C-N-CA 125.1 1.36 . . . . 0.0 108.325 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -82.17 161.48 22.77 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 170.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.17 133.08 13.24 Favored 'General case' 0 C--N 1.28 -2.424 0 O-C-N 123.982 0.801 . . . . 0.0 109.307 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.62 81.75 8.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 123.56 1.648 . . . . 0.0 109.258 173.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.483 ' O ' HG11 ' A' ' 27' ' ' VAL . 4.3 pp -89.27 3.66 51.32 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 113.009 -1.905 . . . . 0.0 111.95 -175.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.533 ' HB3' ' N ' ' A' ' 34' ' ' GLY . 2.3 p -89.72 60.24 0.0 OUTLIER Pre-proline 0 C--N 1.272 -2.785 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.482 ' HD3' ' C ' ' A' ' 24' ' ' LEU . 19.1 Cg_endo -118.83 30.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.582 0 N-CA-C 106.889 -2.004 . . . . 0.0 106.889 152.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.483 HG11 ' O ' ' A' ' 24' ' ' LEU . 35.3 m -71.2 176.68 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.491 -173.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.25 138.45 31.41 Favored 'General case' 0 N--CA 1.41 -2.458 0 CA-C-N 114.004 -1.453 . . . . 0.0 113.8 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.04 -133.1 11.75 Favored Glycine 0 N--CA 1.421 -2.346 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.229 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.5 m -93.76 18.5 10.17 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 47.6 mt-10 -70.36 167.92 17.11 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.541 ' HB3' HE21 ' A' ' 90' ' ' GLN . 0.0 OUTLIER -101.21 119.08 38.22 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -174.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.27 151.93 17.55 Favored Glycine 0 CA--C 1.483 -1.914 0 N-CA-C 115.82 1.088 . . . . 0.0 115.82 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.533 ' N ' ' HB3' ' A' ' 25' ' ' SER . . . 137.18 137.28 3.6 Favored Glycine 0 C--N 1.293 -1.821 0 CA-C-N 113.313 -1.444 . . . . 0.0 111.367 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 35' ' ' VAL . 2.7 p -72.09 105.83 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 123.17 1.462 . . . . 0.0 107.752 173.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -136.08 161.18 63.98 Favored Pre-proline 0 C--N 1.253 -3.617 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.792 -172.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 18.6 Cg_exo -67.68 142.87 59.85 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.025 1.817 . . . . 0.0 110.201 170.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 20' ' ' TYR . 27.8 m -123.18 158.56 28.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 123.608 0.763 . . . . 0.0 109.325 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.436 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 33.8 m -102.03 132.4 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.704 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mm -85.16 105.94 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.537 ' O ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -103.59 -12.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.946 -178.359 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.653 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 3.4 mt-30 -42.0 157.56 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 120.706 3.595 . . . . 0.0 120.706 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -69.3 145.79 52.76 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 110.815 -2.902 . . . . 0.0 108.024 164.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 47' ' ' ASN . 20.5 t70 -62.64 -30.88 71.69 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.84 -177.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.0 m -86.87 -27.1 23.64 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.969 -1.092 . . . . 0.0 111.793 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.453 ' C ' HE22 ' A' ' 42' ' ' GLN . . . -67.59 -25.79 73.84 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 174.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.524 ' OD1' ' HB ' ' A' ' 14' ' ' ILE . 35.0 t30 -71.18 -39.39 71.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.991 -1.105 . . . . 0.0 109.77 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -74.26 -60.97 2.02 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . 0.46 16.6 p90 -128.36 2.03 5.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 119.352 3.093 . . . . 0.0 119.352 -173.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.5 m -86.86 134.21 37.72 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 172.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.403 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 34.0 Cg_exo -63.53 -29.54 70.81 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 121.606 1.538 . . . . 0.0 109.828 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -95.03 139.82 30.85 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.688 -173.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.653 ' HB ' ' OE1' ' A' ' 42' ' ' GLN . 1.1 m -131.53 157.77 43.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.7 tt -109.56 131.12 61.32 Favored 'Isoleucine or valine' 0 C--O 1.251 1.156 0 CA-C-O 121.144 0.497 . . . . 0.0 109.798 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 30.0 m -137.73 160.4 33.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.952 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.509 ' CB ' HG23 ' A' ' 91' ' ' ILE . . . -120.2 142.25 49.17 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.21 143.97 36.69 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.603 HG12 ' CD1' ' A' ' 86' ' ' ILE . 67.7 mt -97.99 140.04 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-N 113.286 -1.779 . . . . 0.0 109.251 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.7 m -137.74 116.89 12.58 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.285 0.634 . . . . 0.0 110.122 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.64 54.44 0.58 Allowed Glycine 0 C--N 1.309 -0.922 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.576 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -124.89 2.72 8.09 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.037 0.446 . . . . 0.0 111.769 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.457 ' CG1' HG22 ' A' ' 85' ' ' VAL . 30.1 pt -140.02 164.9 22.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 174.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -101.87 -60.09 1.59 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.891 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -108.87 151.46 26.23 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.197 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.36 173.24 6.45 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.724 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -147.21 10.43 0.99 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.968 0.413 . . . . 0.0 111.121 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 mt -127.99 139.01 34.17 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.71 -6.73 11.26 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 122.439 2.093 . . . . 0.0 113.503 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.8 p -96.05 -18.0 20.53 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.434 0.635 . . . . 0.0 111.018 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.465 ' CD2' HD21 ' A' ' 87' ' ' LEU . 46.3 m170 -114.12 128.4 56.36 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.13 138.59 54.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 121.854 -0.529 . . . . 0.0 111.02 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.43 140.49 29.75 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.722 0.772 . . . . 0.0 111.745 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.727 HG23 ' CE1' ' A' ' 78' ' ' TYR . 3.0 mm -108.99 -176.19 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.623 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -117.69 133.76 55.6 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -173.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.644 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 73.1 mttt -44.09 -53.24 6.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.64 1.213 . . . . 0.0 110.723 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -61.12 -32.25 71.94 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.701 -1.59 . . . . 0.0 113.93 -173.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -85.2 -27.82 25.86 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.622 0.725 . . . . 0.0 109.586 -173.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.727 ' CE1' HG23 ' A' ' 73' ' ' ILE . 2.1 m-85 -97.01 0.18 48.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.735 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.8 tttp 66.42 19.43 10.94 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 121.627 0.727 . . . . 0.0 111.148 176.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 78' ' ' TYR . 7.8 mp -96.94 172.18 8.02 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-O 122.927 1.346 . . . . 0.0 112.827 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.54 -24.27 42.29 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.613 -2.539 . . . . 0.0 109.725 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.484 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -137.54 152.66 49.69 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.425 -173.191 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.644 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 11.7 p-10 -75.9 142.21 42.15 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.35 -1.296 . . . . 0.0 108.741 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -136.97 159.08 42.96 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.705 -172.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.457 HG22 ' CG1' ' A' ' 62' ' ' ILE . 23.4 t -110.61 153.74 12.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 124.512 1.125 . . . . 0.0 108.151 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.603 ' CD1' HG12 ' A' ' 58' ' ' ILE . 13.2 mm -117.71 140.34 41.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.465 HD21 ' CD2' ' A' ' 70' ' ' HIS . 36.7 mt -105.46 104.61 14.37 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' HB1' ' A' ' 117' ' ' ALA . 3.8 mm? -86.27 -7.18 58.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.055 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.56 -38.02 15.23 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.967 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.541 HE21 ' HB3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -98.12 77.05 2.4 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.822 -179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.509 HG23 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -108.93 179.45 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . 0.264 7.6 ptp180 -163.3 160.92 24.36 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 175.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 96.8 m -117.55 114.67 23.78 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.764 -176.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.8 mt -131.7 147.4 52.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.275 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.576 ' OD1' ' HB3' ' A' ' 97' ' ' LYS . 2.7 p30 -72.04 152.09 42.67 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.042 172.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -48.01 -26.15 1.67 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 125.735 1.614 . . . . 0.0 114.202 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.576 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . 7.0 ttpm? -73.16 -18.86 61.23 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.128 0.571 . . . . 0.0 111.228 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.514 ' HA ' ' NE ' ' A' ' 98' ' ' ARG . 2.7 mmp_? -75.9 -31.03 59.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.39 0.614 . . . . 0.0 109.593 175.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.78 130.19 39.02 Favored 'General case' 0 CA--C 1.475 -1.911 0 CA-C-O 123.07 1.414 . . . . 0.0 110.595 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.435 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 13.9 tptt -90.25 -68.31 0.79 Allowed 'General case' 0 N--CA 1.391 -3.402 0 CA-C-N 111.745 -2.48 . . . . 0.0 113.023 -171.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 8.4 pt-20 -163.67 143.58 8.43 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 121.709 0.766 . . . . 0.0 111.829 -168.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -63.39 114.86 4.12 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 128.113 2.565 . . . . 0.0 109.531 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -112.0 -62.68 1.53 Allowed 'General case' 0 N--CA 1.417 -2.098 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 19' ' ' VAL . 3.6 t -128.5 -162.5 1.19 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 117.736 -1.585 . . . . 0.0 112.912 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -160.41 140.43 11.32 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 125.228 1.411 . . . . 0.0 109.997 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 3.6 pp -108.81 157.49 18.54 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.156 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.416 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 11.8 m -89.82 174.03 7.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.323 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 111' ' ' MET . 11.0 m-20 -62.4 -32.56 73.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.202 1.001 . . . . 0.0 111.617 -177.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.416 ' OD1' ' HB2' ' A' ' 107' ' ' SER . 11.2 p-10 -70.46 -33.92 71.82 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.43 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -78.5 -28.5 46.34 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.495 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.574 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -47.47 -49.42 25.59 Favored 'General case' 0 CA--C 1.453 -2.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 168.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -76.71 -7.96 56.35 Favored 'General case' 0 N--CA 1.392 -3.372 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -175.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.4 -54.15 4.13 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 116.921 -1.911 . . . . 0.0 106.956 172.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -51.91 -59.03 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-N 112.359 -2.2 . . . . 0.0 112.968 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 118' ' ' LEU 0.261 26.0 t0 -61.41 -40.13 93.27 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.883 1.802 . . . . 0.0 109.718 -176.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -79.72 -41.99 25.57 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 112.171 -2.286 . . . . 0.0 112.009 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.456 ' HB1' ' HG ' ' A' ' 88' ' ' LEU . . . -61.77 -36.11 80.08 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 3.0 tp -64.55 -41.8 96.1 Favored 'General case' 0 N--CA 1.382 -3.86 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.98 -176.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 34.3 mtp -61.53 -34.31 75.32 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-O 120.894 0.378 . . . . 0.0 110.882 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 30.5 mt -75.07 -53.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.683 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.2 m -48.07 -34.9 10.3 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 113.254 -1.794 . . . . 0.0 113.156 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 23.2 mt -105.97 3.16 28.08 Favored 'General case' 0 C--O 1.188 -2.134 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.589 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.76 21.53 65.97 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 116.564 1.386 . . . . 0.0 116.564 172.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.74 -57.76 3.41 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 118.701 1.251 . . . . 0.0 110.022 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.9 m120 57.38 158.77 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 113.104 -1.862 . . . . 0.0 112.545 -169.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.66 11.12 9.52 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.556 -1.34 . . . . 0.0 111.811 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 t -113.08 9.09 8.03 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.885 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 58.99 31.63 21.54 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.174 -1.375 . . . . 0.0 113.062 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 70.67 115.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.752 1.221 . . . . 0.0 112.657 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -132.38 124.22 28.28 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -80.26 133.58 36.0 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 123.376 0.422 . . . . 0.0 110.963 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 . . . . . 0 CA--C 1.488 -1.434 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.678 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.614 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m -80.57 100.46 8.62 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 121.252 0.549 . . . . 0.0 111.28 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 16.6 m -84.89 129.12 34.86 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -71.47 99.89 2.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -88.88 -33.09 17.44 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.355 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -129.0 177.11 7.36 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -95.12 128.8 42.23 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -81.71 94.39 6.98 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -74.78 -24.35 58.66 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -171.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 68.1 p -71.54 120.01 16.51 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.753 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -86.66 -11.13 52.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -97.89 115.11 65.77 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.817 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -91.8 5.68 3.64 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.677 2.251 . . . . 0.0 112.07 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . 0.574 ' HB ' ' OD1' ' B' ' 47' ' ' ASN . 71.3 mt -106.47 131.63 55.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -116.68 145.34 43.51 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.563 ' HD2' ' O ' ' B' ' 41' ' ' ILE . 4.6 ttp180 -63.89 114.35 4.02 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 175.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.78 -18.14 5.41 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.11 171.8 11.29 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 122.888 1.328 . . . . 0.0 110.14 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.497 HG23 HG21 ' B' ' 104' ' ' THR . 10.4 t -133.35 128.65 55.6 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.576 0 CA-C-N 112.292 -2.231 . . . . 0.0 109.155 176.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 34.4 m-85 -125.86 147.02 49.57 Favored 'General case' 0 C--N 1.27 -2.865 0 C-N-CA 125.194 1.398 . . . . 0.0 108.407 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.6 mp -82.23 159.81 23.13 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 170.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.88 133.2 13.59 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.711 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.95 82.19 8.56 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 123.658 1.694 . . . . 0.0 109.666 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.474 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 4.4 pp -90.21 4.78 49.55 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.121 -174.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.557 ' HB3' ' N ' ' B' ' 34' ' ' GLY . 2.3 p -90.21 59.91 0.0 OUTLIER Pre-proline 0 C--N 1.277 -2.55 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' B' ' 24' ' ' LEU . 17.5 Cg_endo -118.59 31.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.112 0 N-CA-C 106.711 -2.073 . . . . 0.0 106.711 152.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.47 HG11 ' O ' ' B' ' 24' ' ' LEU . 33.3 m -71.14 173.05 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.39 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -142.83 120.28 11.67 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 114.8 1.408 . . . . 0.0 114.8 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.52 -131.08 10.44 Favored Glycine 0 N--CA 1.416 -2.689 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.873 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -93.79 17.03 12.7 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.458 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 41.2 mt-10 -70.46 171.62 9.79 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . 0.557 ' HB3' HE21 ' B' ' 90' ' ' GLN . 0.0 OUTLIER -103.88 125.7 50.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -175.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.43 147.84 17.03 Favored Glycine 0 CA--C 1.486 -1.748 0 N-CA-C 115.409 0.923 . . . . 0.0 115.409 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.557 ' N ' ' HB3' ' B' ' 25' ' ' SER . . . 140.62 137.51 3.46 Favored Glycine 0 C--N 1.288 -2.134 0 CA-C-N 113.727 -1.236 . . . . 0.0 111.787 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.422 ' O ' HG13 ' B' ' 35' ' ' VAL . 2.5 p -73.64 104.26 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-O 122.998 1.38 . . . . 0.0 107.473 173.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -135.2 161.99 60.19 Favored Pre-proline 0 C--N 1.249 -3.784 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.08 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 19.7 Cg_exo -68.05 142.92 57.93 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 122.047 1.831 . . . . 0.0 110.173 170.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.481 HG21 ' O ' ' B' ' 20' ' ' TYR . 28.7 m -123.74 159.13 29.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 123.552 0.741 . . . . 0.0 109.273 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.429 ' CG2' ' HB1' ' B' ' 56' ' ' ALA . 32.6 m -102.0 132.3 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 120.524 0.202 . . . . 0.0 110.759 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 mm -84.93 105.89 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.563 ' O ' ' HD2' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -103.44 -12.07 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.033 -178.288 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.654 ' OE1' ' HB ' ' B' ' 53' ' ' VAL . 3.7 mt-30 -42.05 157.55 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 120.945 3.683 . . . . 0.0 120.945 -174.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -69.41 145.15 53.07 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 110.833 -2.894 . . . . 0.0 108.279 165.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' B' ' 47' ' ' ASN . 22.2 t70 -61.85 -30.14 70.65 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.673 -176.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.9 m -87.19 -28.4 22.43 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.879 -174.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.453 ' C ' HE22 ' B' ' 42' ' ' GLN . . . -66.79 -26.8 73.09 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.574 ' OD1' ' HB ' ' B' ' 14' ' ' ILE . 34.6 t30 -68.04 -39.16 83.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.738 -1.231 . . . . 0.0 110.019 176.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -76.52 -66.08 0.85 Allowed 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . 0.439 19.4 p90 -124.31 6.96 8.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 -171.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.414 ' OG ' ' HA2' ' B' ' 46' ' ' GLY . 19.6 m -92.28 131.03 35.68 Favored Pre-proline 0 N--CA 1.428 -1.573 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 171.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -63.28 -28.9 72.64 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 121.62 1.547 . . . . 0.0 110.268 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.409 HG21 ' HG2' ' A' ' 90' ' ' GLN . 1.8 p -94.9 138.84 32.14 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.398 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.654 ' HB ' ' OE1' ' B' ' 42' ' ' GLN . 1.2 m -130.49 158.86 42.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 9.0 tt -110.87 130.98 63.28 Favored 'Isoleucine or valine' 0 C--O 1.253 1.277 0 CA-C-O 121.269 0.557 . . . . 0.0 110.087 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 27.8 m -137.57 159.51 34.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.906 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.505 ' CB ' HG23 ' B' ' 91' ' ' ILE . . . -119.68 142.03 48.84 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.46 140.31 38.63 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.598 HG12 ' CD1' ' B' ' 86' ' ' ILE . 67.6 mt -93.89 140.43 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.253 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 90.9 m -138.12 111.95 8.34 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.388 0.675 . . . . 0.0 110.855 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.46 63.89 0.28 Allowed Glycine 0 C--N 1.303 -1.265 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -131.44 2.72 4.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.339 0.59 . . . . 0.0 111.36 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.462 ' CG1' HG22 ' B' ' 85' ' ' VAL . 31.9 pt -139.19 170.03 16.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 174.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -105.78 -55.95 2.25 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.596 0.635 . . . . 0.0 112.307 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -114.22 151.47 32.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.473 0.654 . . . . 0.0 112.013 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.99 160.39 15.81 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.622 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -136.34 1.99 2.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.207 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 22.7 mt -115.17 142.01 27.93 Favored Pre-proline 0 C--N 1.313 -1.021 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.02 -14.01 34.8 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.411 2.074 . . . . 0.0 113.855 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 67.2 p -93.88 -18.85 21.54 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.356 0.598 . . . . 0.0 111.361 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -109.26 128.75 55.32 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.02 139.01 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.662 -0.649 . . . . 0.0 110.847 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.22 143.2 26.82 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.788 0.804 . . . . 0.0 111.619 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.723 HG23 ' CE1' ' B' ' 78' ' ' TYR . 5.3 mm -112.59 166.45 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.595 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -97.56 130.55 44.6 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . 0.652 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 71.9 mttt -43.4 -52.68 5.83 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.769 1.228 . . . . 0.0 110.604 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -64.6 -25.56 68.02 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.875 1.67 . . . . 0.0 114.087 -173.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -91.36 -20.98 21.25 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.509 0.671 . . . . 0.0 109.586 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.723 ' CE1' HG23 ' B' ' 73' ' ' ILE . 2.0 m-85 -103.8 0.15 29.99 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.178 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 tttp 67.07 17.14 10.41 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.489 0.661 . . . . 0.0 111.855 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.408 HD12 ' O ' ' B' ' 78' ' ' TYR . 7.8 mp -94.46 175.1 6.81 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 123.197 1.475 . . . . 0.0 113.143 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.96 -25.99 34.36 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 111.698 -2.501 . . . . 0.0 109.489 176.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.52 153.58 50.97 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.547 -172.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . 0.652 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 8.9 p-10 -77.22 143.17 39.18 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 29.9 t -136.19 159.88 40.37 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.512 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.462 HG22 ' CG1' ' B' ' 62' ' ' ILE . 22.9 t -111.36 151.92 13.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.598 ' CD1' HG12 ' B' ' 58' ' ' ILE . 12.3 mm -116.18 139.34 43.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.5 mt -104.88 104.19 13.91 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.45 -8.86 58.82 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.124 -174.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.21 -37.68 15.91 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.373 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . 0.557 HE21 ' HB3' ' B' ' 32' ' ' GLN . 0.0 OUTLIER -98.07 77.89 2.48 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.949 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.505 HG23 ' CB ' ' B' ' 56' ' ' ALA . 2.4 pp -109.26 179.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . 0.265 8.0 ptp180 -163.28 161.56 24.79 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' B' ' 53' ' ' VAL . 90.5 m -117.85 115.13 24.34 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 113.735 -1.575 . . . . 0.0 108.534 -176.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 60.1 mt -131.79 148.25 52.55 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.957 -170.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.5 ' OD1' ' HB3' ' B' ' 97' ' ' LYS . 1.2 p30 -74.28 152.09 39.74 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.871 173.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -46.56 -28.97 1.59 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 125.693 1.597 . . . . 0.0 114.007 -175.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.5 ' HB3' ' OD1' ' B' ' 95' ' ' ASP . 7.0 ttpm? -71.77 -18.94 62.09 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 123.177 0.591 . . . . 0.0 111.517 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' B' ' 98' ' ' ARG . 2.3 mmp_? -76.29 -28.16 56.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.599 0.714 . . . . 0.0 109.695 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 7.8 mp -76.45 128.53 34.98 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 123.533 1.635 . . . . 0.0 111.037 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . 0.4 ' HB3' ' HG2' ' B' ' 101' ' ' GLU . 13.0 tptt -87.11 -67.42 0.82 Allowed 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 111.346 -2.661 . . . . 0.0 113.132 -171.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 9.1 pt-20 -166.27 146.36 6.18 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.707 0.765 . . . . 0.0 111.545 -169.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -63.98 116.2 5.63 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 128.354 2.662 . . . . 0.0 109.541 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.76 -62.72 1.55 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.755 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.497 HG21 HG23 ' B' ' 19' ' ' VAL . 4.6 t -128.63 -164.91 1.43 Allowed 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.66 -1.616 . . . . 0.0 112.153 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.32 134.79 7.48 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 124.817 1.247 . . . . 0.0 109.759 -171.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.449 ' HB3' ' CE1' ' B' ' 78' ' ' TYR . 3.6 pp -101.91 159.58 15.22 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.369 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 11.1 m -91.14 173.42 7.95 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.864 0.364 . . . . 0.0 111.112 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' B' ' 111' ' ' MET . 6.0 m-20 -64.45 -26.79 68.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.867 0.867 . . . . 0.0 112.258 -177.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.82 -38.18 67.24 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.01 -28.54 61.5 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.112 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.1 OUTLIER -47.36 -48.9 25.52 Favored 'General case' 0 CA--C 1.45 -2.881 0 CA-C-O 121.384 0.611 . . . . 0.0 109.567 167.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.43 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 9.3 mmpt? -78.63 -5.48 53.06 Favored 'General case' 0 N--CA 1.382 -3.845 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -176.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -91.16 -56.42 3.16 Favored 'General case' 0 N--CA 1.397 -3.109 0 C-N-CA 116.999 -1.88 . . . . 0.0 107.197 170.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -50.22 -59.78 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 112.203 -2.271 . . . . 0.0 113.282 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.591 ' O ' ' HB3' ' B' ' 118' ' ' LEU 0.275 17.2 t0 -60.66 -42.86 97.89 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 123.78 1.752 . . . . 0.0 109.826 -176.096 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.363 47.0 t30 -77.69 -41.68 37.16 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.095 -171.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.44 -34.17 77.66 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.591 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.1 tp -63.24 -41.69 99.11 Favored 'General case' 0 N--CA 1.381 -3.921 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.257 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 36.1 mtp -60.08 -37.89 81.26 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 120.714 0.292 . . . . 0.0 110.573 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 28.7 mt -71.06 -53.15 22.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 25.3 m -51.11 -32.64 23.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.783 178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 22.5 mt -105.63 1.79 27.62 Favored 'General case' 0 C--O 1.19 -2.074 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.495 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.45 24.99 59.8 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.492 ' HG ' ' OD1' ' A' ' 115' ' ' ASP . 7.1 mp -83.47 -58.37 2.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.778 1.289 . . . . 0.0 110.194 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' B' ' 127' ' ' VAL . 18.1 m120 55.92 156.49 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 112.868 -1.969 . . . . 0.0 113.177 -168.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.2 12.1 3.09 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.412 -1.43 . . . . 0.0 112.151 -176.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.436 ' H ' ' C ' ' B' ' 125' ' ' ASN . 2.8 t -113.25 8.82 7.97 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.371 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 59.54 30.28 19.91 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.963 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 70.94 111.93 0.06 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.507 1.123 . . . . 0.0 112.617 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -126.89 123.86 38.22 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -83.36 132.68 34.99 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.04 0.448 . . . . 0.0 110.728 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 . . . . . 0 C--N 1.299 -1.607 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.072 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m 66.02 20.56 11.27 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.938 0.895 . . . . 0.0 111.814 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.8 m -118.9 98.16 6.06 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.385 0.612 . . . . 0.0 110.678 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -84.27 139.19 32.5 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.888 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -70.29 129.14 38.54 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -58.71 -44.04 90.24 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 123.603 0.564 . . . . 0.0 110.41 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -78.69 129.53 34.81 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 175.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -78.72 101.82 7.75 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -156.09 172.42 18.44 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.072 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -115.83 -48.64 2.75 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 176.54 124.9 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.466 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.91 107.05 16.59 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -65.5 -84.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.969 0 C-N-CA 121.582 1.522 . . . . 0.0 112.236 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.2 mt -117.85 115.69 49.3 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -123.25 144.23 49.53 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -63.14 118.18 7.56 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.524 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.64 -19.4 5.03 Favored Glycine 0 N--CA 1.425 -2.049 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.724 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -83.13 171.47 13.67 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.353 1.073 . . . . 0.0 110.097 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.476 HG22 HG23 ' A' ' 104' ' ' THR . 13.3 t -132.38 128.03 57.79 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.373 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.604 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 24.2 m-85 -123.36 151.42 42.54 Favored 'General case' 0 C--N 1.271 -2.847 0 C-N-CA 125.274 1.43 . . . . 0.0 110.03 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.7 mp -88.63 150.17 23.17 Favored 'General case' 0 N--CA 1.396 -3.15 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -145.27 139.11 26.88 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.156 -176.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -81.86 89.95 6.38 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.533 1.158 . . . . 0.0 108.665 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.546 ' O ' HG11 ' A' ' 27' ' ' VAL . 82.2 mt -65.1 -19.45 65.99 Favored 'General case' 0 CA--C 1.481 -1.677 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.661 -178.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.43 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 10.0 m -33.75 175.0 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.322 0 C-N-CA 127.197 2.199 . . . . 0.0 114.252 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 27.32 48.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.677 0 C-N-CA 121.905 1.737 . . . . 0.0 114.588 -151.37 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 24' ' ' LEU . 1.6 m -69.88 168.22 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.002 170.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.416 ' HG3' ' CD2' ' B' ' 94' ' ' LEU . 25.2 mm-40 -99.21 107.14 19.39 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.765 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.86 -122.31 26.68 Favored Glycine 0 C--N 1.298 -1.564 0 CA-C-N 113.998 -1.455 . . . . 0.0 113.371 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.4 m -81.71 20.97 0.87 Allowed 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 46.0 mt-10 -62.24 168.26 3.54 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 117.917 -1.513 . . . . 0.0 110.32 170.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.475 HE22 ' HG3' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -70.81 107.95 4.24 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -176.276 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.76 144.3 18.81 Favored Glycine 0 CA--C 1.499 -0.95 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 157.97 10.06 Favored Glycine 0 N--CA 1.421 -2.347 0 CA-C-N 113.019 -1.59 . . . . 0.0 111.538 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -81.9 104.89 11.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 171.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.475 ' HG3' HE22 ' A' ' 32' ' ' GLN . 18.4 mmt180 -129.46 157.18 77.14 Favored Pre-proline 0 C--N 1.26 -3.29 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.58 -167.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 31.9 Cg_exo -63.22 144.88 92.79 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.211 1.941 . . . . 0.0 111.405 171.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 27.2 m -129.91 156.26 42.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 124.238 1.015 . . . . 0.0 109.067 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.476 ' CG2' ' HB1' ' A' ' 56' ' ' ALA . 32.6 m -100.22 131.99 46.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 mm -91.51 115.57 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.95 -14.25 10.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.265 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.508 HE22 ' N ' ' A' ' 47' ' ' ASN . 5.0 pt20 -53.69 163.12 0.73 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -168.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -64.94 -177.58 0.36 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.156 -2.293 . . . . 0.0 112.202 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -81.7 -42.73 19.47 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.969 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -82.69 -23.64 34.04 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -170.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.73 -32.41 74.17 Favored Glycine 0 C--O 1.204 -1.739 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.356 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.508 ' N ' HE22 ' A' ' 42' ' ' GLN . 8.3 p30 -81.52 -18.08 46.28 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.086 0.47 . . . . 0.0 111.792 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -86.65 -62.89 1.41 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.507 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -107.34 -15.26 14.68 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -168.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -91.43 141.46 26.03 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HA ' ' HE3' ' A' ' 96' ' ' LYS . 72.8 Cg_endo -81.86 -9.8 11.87 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.99 1.794 . . . . 0.0 111.381 176.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 p -109.13 135.69 49.84 Favored 'General case' 0 N--CA 1.409 -2.509 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.791 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.424 HG12 ' OE1' ' A' ' 42' ' ' GLN . 95.0 t -123.74 139.75 49.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.4 HD11 ' CD1' ' A' ' 91' ' ' ILE . 9.3 tp -97.52 128.16 49.11 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 25.9 m -140.35 164.54 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.968 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB1' ' CG2' ' A' ' 39' ' ' VAL . . . -122.32 132.93 54.64 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.7 131.66 46.46 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.514 HG12 ' CD1' ' A' ' 86' ' ' ILE . 54.3 mt -91.68 106.11 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.785 176.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.3 m -102.46 140.94 36.07 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.698 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.17 129.67 9.61 Favored Glycine 0 N--CA 1.434 -1.459 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.768 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.442 ' HA ' ' OD1' ' A' ' 83' ' ' ASP . 76.9 mtm180 63.37 13.45 7.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.028 1.331 . . . . 0.0 114.585 174.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.82 109.57 28.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.937 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.5 m120 71.29 157.49 0.18 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.547 1.539 . . . . 0.0 112.592 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -109.85 163.0 13.94 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.16 84.14 7.71 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -115.54 18.28 15.97 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.9 tt -145.32 137.58 13.37 Favored Pre-proline 0 N--CA 1.426 -1.63 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.5 2.56 4.41 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.632 2.221 . . . . 0.0 114.737 -174.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' ' 89' ' ' GLU . 68.0 p -103.31 -16.57 15.61 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.35 0.595 . . . . 0.0 111.483 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -109.91 129.82 55.6 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.3 p -123.01 132.71 70.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.512 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.67 130.0 34.95 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.941 0.877 . . . . 0.0 110.444 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.549 HG23 ' CZ ' ' A' ' 78' ' ' TYR . 13.1 mm -97.1 169.99 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -106.34 109.57 21.54 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 168.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.564 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -50.93 -30.7 15.49 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 125.431 1.492 . . . . 0.0 114.678 -172.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -49.37 -45.14 45.52 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 125.008 1.323 . . . . 0.0 111.508 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -79.06 -24.41 43.56 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.631 0.729 . . . . 0.0 111.678 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.549 ' CZ ' HG23 ' A' ' 73' ' ' ILE . 4.0 m-85 -97.81 6.5 47.76 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.012 -175.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.454 ' O ' HD12 ' A' ' 80' ' ' LEU 0.394 61.8 pttt 43.28 64.3 1.26 Allowed 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 119.824 3.268 . . . . 0.0 119.824 176.345 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.525 HD22 ' HZ2' ' A' ' 75' ' ' LYS . 10.3 mp -141.76 -168.27 2.63 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 169.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -113.94 -9.11 13.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 123.679 0.612 . . . . 0.0 110.821 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.428 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 50.3 mttm -115.12 112.14 22.1 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.204 -173.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.442 ' OD1' ' HA ' ' A' ' 61' ' ' ARG . 3.6 p30 -35.66 144.24 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.984 1.714 . . . . 0.0 115.388 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.7 m -123.32 132.74 54.09 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.435 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 35.4 t -120.15 138.14 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 173.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.514 ' CD1' HG12 ' A' ' 58' ' ' ILE . 23.4 mm -104.31 131.26 53.59 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.2 mt -98.6 103.51 15.47 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.505 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.57 -17.64 47.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.489 ' HG3' ' HB ' ' A' ' 69' ' ' THR . 41.3 mt-10 -86.51 -7.73 58.15 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.766 0.793 . . . . 0.0 111.231 173.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 91' ' ' ILE . 14.5 tp60 -89.27 -100.68 0.09 Allowed 'General case' 0 C--O 1.192 -1.937 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 90' ' ' GLN . 1.1 pp 57.84 179.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 C-N-CA 127.574 2.35 . . . . 0.0 110.958 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.535 ' NH2' ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -176.77 176.43 1.5 Allowed 'General case' 0 C--N 1.311 -1.108 0 O-C-N 123.897 0.748 . . . . 0.0 112.233 172.639 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 53.6 m -116.18 128.59 55.75 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.411 HD22 HH11 ' A' ' 92' ' ' ARG . 71.0 mt -131.72 141.65 49.59 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.886 -173.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.438 ' OD1' ' HG3' ' A' ' 97' ' ' LYS . 11.9 t0 -57.2 144.61 34.51 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 169.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 51' ' ' PRO . 16.8 pttp -55.41 -31.02 61.51 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.438 ' HG3' ' OD1' ' A' ' 95' ' ' ASP . 52.1 mttp -53.44 -28.82 32.27 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.919 174.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 8.9 mmp_? -74.27 -34.13 63.48 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 120.904 0.383 . . . . 0.0 110.269 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.9 mp -68.51 106.32 2.52 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.279 1.037 . . . . 0.0 110.268 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -83.74 -67.37 0.8 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.28 -1.782 . . . . 0.0 114.134 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.604 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.6 pt-20 -148.32 152.05 36.42 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-O 121.563 0.696 . . . . 0.0 110.16 -169.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 20' ' ' TYR . 30.8 mtpt -79.1 115.75 18.96 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-N 113.171 -1.831 . . . . 0.0 108.236 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 tp -104.28 -58.93 1.81 Allowed 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.288 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.476 HG23 HG22 ' A' ' 19' ' ' VAL . 5.2 t -132.54 -164.98 1.53 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 117.835 -1.546 . . . . 0.0 111.915 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.49 128.43 4.55 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 125.631 1.573 . . . . 0.0 109.876 -173.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -95.14 163.31 13.34 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.7 p -88.3 164.1 15.74 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 123.085 0.554 . . . . 0.0 112.049 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 111' ' ' MET . 22.7 t70 -61.99 -29.5 70.3 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.401 1.08 . . . . 0.0 113.37 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.13 -33.74 68.03 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -76.36 -32.25 58.51 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.496 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -52.37 -41.91 63.5 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 125.165 1.386 . . . . 0.0 110.549 175.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.609 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 2.2 mmmm -69.84 -21.73 63.34 Favored 'General case' 0 CA--C 1.465 -2.324 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.352 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -87.81 -46.56 9.33 Favored 'General case' 0 N--CA 1.398 -3.028 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 t -50.58 -54.6 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 CA-C-N 113.263 -1.79 . . . . 0.0 112.857 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 53.5 m-20 -66.24 -42.74 88.16 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 123.511 1.624 . . . . 0.0 111.946 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.609 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 3.8 t30 -74.93 -43.56 53.54 Favored 'General case' 0 C--N 1.26 -3.326 0 CA-C-N 112.76 -2.018 . . . . 0.0 112.52 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.71 -36.66 79.39 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.523 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 10.2 tp -65.33 -39.45 92.42 Favored 'General case' 0 N--CA 1.386 -3.675 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.105 -177.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.76 ' SD ' ' HA ' ' A' ' 125' ' ' ASN 0.265 7.4 ptp -74.92 -19.32 60.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 117.54 -1.664 . . . . 0.0 114.461 176.502 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 30.4 mt -77.03 -50.04 21.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 175.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.1 p -60.78 -30.4 70.02 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 113.111 -1.858 . . . . 0.0 112.124 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 27.4 mt -107.2 0.7 23.49 Favored 'General case' 0 C--O 1.199 -1.589 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.84 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.64 26.21 65.78 Favored Glycine 0 CA--C 1.549 2.169 0 N-CA-C 116.964 1.546 . . . . 0.0 116.964 174.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.524 ' HG ' ' CB ' ' A' ' 119' ' ' MET . 0.5 OUTLIER -113.9 15.93 18.45 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 119.263 1.531 . . . . 0.0 111.805 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.76 ' HA ' ' SD ' ' A' ' 119' ' ' MET . 2.4 t-20 -43.31 124.59 3.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.353 0.661 . . . . 0.0 112.705 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.42 8.48 4.16 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -172.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 t -116.32 9.9 7.39 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 70.08 158.54 0.18 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.498 1.519 . . . . 0.0 112.21 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -105.76 156.68 18.07 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.89 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -75.9 -40.51 54.23 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -129.34 128.87 43.97 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--N 1.297 -1.678 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.618 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.954 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m 62.08 25.08 15.0 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.117 0.967 . . . . 0.0 112.399 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 20.1 m -119.15 101.68 8.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -91.11 132.43 36.05 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -64.09 134.39 54.83 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.243 -0.281 . . . . 0.0 110.243 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -64.41 -37.41 87.43 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.375 0.607 . . . . 0.0 109.812 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -85.26 130.05 34.68 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -82.57 90.47 6.8 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.142 0.496 . . . . 0.0 109.759 -178.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -146.75 158.46 43.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.852 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -97.31 -53.04 3.6 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 171.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -179.11 126.63 0.09 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.296 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.62 108.58 26.13 Favored Pre-proline 0 C--N 1.305 -1.335 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -65.05 -86.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.55 1.5 . . . . 0.0 112.482 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 56.8 mt -115.62 114.87 47.57 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 24.4 mmm-85 -121.28 140.64 51.79 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -61.26 115.03 3.5 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.818 170.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.81 -16.31 5.33 Favored Glycine 0 N--CA 1.428 -1.891 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.066 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.18 172.52 11.83 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 122.266 1.032 . . . . 0.0 109.47 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.483 HG22 HG23 ' B' ' 104' ' ' THR . 12.3 t -132.88 129.09 57.66 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.174 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.265 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 23.0 m-85 -123.89 150.88 44.14 Favored 'General case' 0 C--N 1.271 -2.824 0 C-N-CA 125.322 1.449 . . . . 0.0 110.052 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 3.8 mp -87.95 150.18 23.61 Favored 'General case' 0 N--CA 1.391 -3.396 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 165.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -145.48 138.52 26.2 Favored 'General case' 0 C--N 1.26 -3.286 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.118 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.23 91.16 6.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.73 1.252 . . . . 0.0 108.477 171.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.524 ' O ' HG11 ' B' ' 27' ' ' VAL . 85.4 mt -65.83 -20.86 66.4 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-N 112.672 -2.058 . . . . 0.0 110.735 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.412 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 16.3 m -35.08 176.28 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.171 0 C-N-CA 126.97 2.108 . . . . 0.0 114.929 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 26.41 49.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.621 0 C-N-CA 121.817 1.678 . . . . 0.0 114.615 -149.432 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 1.8 m -69.99 172.9 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.337 170.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -102.52 108.71 20.1 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.055 -1.43 . . . . 0.0 110.577 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.33 -120.61 13.81 Favored Glycine 0 C--N 1.304 -1.25 0 CA-C-N 114.248 -1.342 . . . . 0.0 114.097 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.0 m -81.25 20.19 0.87 Allowed 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.529 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 46.4 mt-10 -63.87 166.24 7.59 Favored 'General case' 0 C--O 1.248 0.995 0 C-N-CA 117.695 -1.602 . . . . 0.0 109.881 169.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' GLN . . . . . 0.414 HE22 ' HG3' ' B' ' 36' ' ' ARG . 0.9 OUTLIER -71.38 108.08 4.65 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.09 146.29 19.01 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 116.069 1.187 . . . . 0.0 116.069 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.09 152.68 8.71 Favored Glycine 0 N--CA 1.417 -2.598 0 CA-C-N 113.503 -1.349 . . . . 0.0 110.722 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 p -78.38 108.65 12.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' ARG . . . . . 0.414 ' HG3' HE22 ' B' ' 32' ' ' GLN . 11.0 mmt180 -133.99 156.87 78.84 Favored Pre-proline 0 C--N 1.263 -3.191 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.042 -166.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.3 Cg_exo -63.39 144.04 89.99 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.486 2.124 . . . . 0.0 111.681 172.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 27.3 m -129.1 156.06 41.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 124.341 1.057 . . . . 0.0 109.193 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.471 ' CG2' ' HB1' ' B' ' 56' ' ' ALA . 31.8 m -99.74 131.69 46.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 30.3 mm -91.02 115.65 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.82 -14.87 10.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.241 -177.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.533 HE22 ' N ' ' B' ' 47' ' ' ASN . 4.9 pt20 -52.95 163.24 0.52 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 -168.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -65.78 -177.22 0.44 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.778 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.38 -47.94 14.89 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.7 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 20.4 m -78.17 -24.37 47.26 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -169.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -60.95 -32.35 79.68 Favored Glycine 0 C--O 1.204 -1.738 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.358 -176.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . 0.533 ' N ' HE22 ' B' ' 42' ' ' GLN . 9.9 p30 -81.49 -18.95 43.39 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.403 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -84.77 -66.66 0.87 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.015 0.436 . . . . 0.0 111.455 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -103.93 -13.71 16.25 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 19.3 m -94.72 140.03 22.44 Favored Pre-proline 0 C--N 1.295 -1.772 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.84 -6.45 11.45 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.106 1.871 . . . . 0.0 111.548 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.2 p -110.09 135.64 50.59 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.533 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . 0.444 HG12 ' OE1' ' B' ' 42' ' ' GLN . 93.1 t -123.88 139.81 49.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . 0.404 HD11 ' CD1' ' B' ' 91' ' ' ILE . 9.1 tp -97.19 128.67 48.22 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 27.4 m -140.72 164.52 21.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.035 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.471 ' HB1' ' CG2' ' B' ' 39' ' ' VAL . . . -122.38 132.82 54.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.15 130.55 43.47 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.522 HG12 ' CD1' ' B' ' 86' ' ' ILE . 56.8 mt -90.08 108.53 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.166 176.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -105.13 139.49 39.72 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.95 130.04 9.91 Favored Glycine 0 N--CA 1.428 -1.896 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.58 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 64.09 18.19 11.09 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 174.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.403 ' O ' HG21 ' B' ' 85' ' ' VAL . 64.6 mt -110.89 105.76 19.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.617 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 13.5 m120 77.3 156.67 0.17 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.866 1.267 . . . . 0.0 113.004 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -109.08 167.44 10.09 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.81 85.23 5.55 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -174.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -112.99 8.64 18.54 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.545 1.164 . . . . 0.0 107.861 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.5 tt -132.06 134.87 25.67 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.48 0.57 4.55 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.729 2.286 . . . . 0.0 115.098 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' THR . . . . . 0.483 ' HB ' ' HG3' ' B' ' 89' ' ' GLU . 77.7 p -103.55 -15.92 15.69 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.302 0.572 . . . . 0.0 111.789 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -110.94 129.18 55.96 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 8.6 p -122.18 132.61 70.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.521 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -84.4 136.9 33.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.282 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ILE . . . . . 0.534 HG23 ' CZ ' ' B' ' 78' ' ' TYR . 12.2 mm -108.66 157.17 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.413 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.411 ' OE2' ' HG2' ' B' ' 76' ' ' LYS . 9.2 tp10 -94.38 109.13 21.01 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 173.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' LYS . . . . . 0.571 ' HA ' ' HE3' ' B' ' 75' ' ' LYS . 0.0 OUTLIER -52.72 -30.73 34.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . 0.411 ' HG2' ' OE2' ' B' ' 74' ' ' GLU . 16.1 mmtp -50.96 -41.08 58.99 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 124.9 1.28 . . . . 0.0 112.038 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -80.25 -26.99 38.74 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.886 0.85 . . . . 0.0 111.435 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.534 ' CZ ' HG23 ' B' ' 73' ' ' ILE . 4.4 m-85 -95.2 5.88 50.57 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.234 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . 0.478 ' O ' HD12 ' B' ' 80' ' ' LEU 0.399 61.6 pttt 43.62 64.66 1.18 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 119.822 3.268 . . . . 0.0 119.822 176.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.507 HD22 ' HZ2' ' B' ' 75' ' ' LYS . 10.3 mp -142.69 -169.87 3.09 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 169.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -116.52 -1.75 12.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.957 0.786 . . . . 0.0 110.813 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' B' ' 75' ' ' LYS . 52.6 mttm -120.79 111.11 17.17 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.79 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -33.14 143.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 127.179 2.191 . . . . 0.0 114.526 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -124.91 133.42 53.06 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.21 -170.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 39.9 t -120.07 138.23 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 174.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.522 ' CD1' HG12 ' B' ' 58' ' ' ILE . 24.2 mm -103.95 130.39 54.61 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 51.7 mt -98.6 103.19 15.11 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 -20.32 44.25 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.619 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' GLU . . . . . 0.483 ' HG3' ' HB ' ' B' ' 69' ' ' THR . 42.9 mt-10 -84.27 -9.26 58.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.711 0.767 . . . . 0.0 111.595 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLN . . . . . 0.556 ' O ' HG13 ' B' ' 91' ' ' ILE . 15.0 tp60 -86.82 -100.65 0.07 Allowed 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 172.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.556 HG13 ' O ' ' B' ' 90' ' ' GLN . 1.0 OUTLIER 57.75 179.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 C-N-CA 127.63 2.372 . . . . 0.0 111.033 -179.014 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' ARG . . . . . 0.515 ' NH2' ' HA ' ' B' ' 27' ' ' VAL . 0.1 OUTLIER -176.88 177.08 1.36 Allowed 'General case' 0 C--N 1.311 -1.089 0 O-C-N 123.911 0.757 . . . . 0.0 112.297 172.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 51.9 m -116.76 128.81 55.66 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' LEU . . . . . 0.423 HD22 HH11 ' B' ' 92' ' ' ARG . 72.4 mt -131.45 142.1 49.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.058 -172.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ASP . . . . . 0.437 ' OD1' ' HG3' ' B' ' 97' ' ' LYS . 11.0 t0 -56.6 143.92 33.91 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -57.65 -28.01 63.35 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.437 ' HG3' ' OD1' ' B' ' 95' ' ' ASP . 49.0 mttp -59.23 -22.74 61.54 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.329 174.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 8.0 mmp_? -78.15 -32.08 50.07 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.244 0.545 . . . . 0.0 109.732 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.43 105.52 2.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.475 1.131 . . . . 0.0 110.498 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.82 -64.2 1.21 Allowed 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 113.243 -1.799 . . . . 0.0 114.108 -173.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . 0.607 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -152.55 152.39 31.81 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.426 0.632 . . . . 0.0 110.362 -171.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.5 ' HG2' ' CZ ' ' B' ' 20' ' ' TYR . 32.5 mtpt -78.3 115.53 18.08 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 126.06 1.744 . . . . 0.0 108.323 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 tp -103.86 -59.02 1.79 Allowed 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.721 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' THR . . . . . 0.483 HG23 HG22 ' B' ' 19' ' ' VAL . 4.7 t -132.47 -164.66 1.49 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.675 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -160.82 130.29 4.89 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 125.272 1.429 . . . . 0.0 110.226 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.73 157.31 16.36 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -175.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -80.27 166.2 21.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.976 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' B' ' 111' ' ' MET . 19.7 t70 -70.42 -23.31 62.72 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.857 0.863 . . . . 0.0 112.398 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.51 -30.16 57.09 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -78.52 -32.99 48.28 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.471 ' HA ' ' HE3' ' B' ' 111' ' ' MET . 0.2 OUTLIER -50.97 -43.6 60.48 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 125.473 1.509 . . . . 0.0 110.337 175.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.563 ' O ' ' HB3' ' B' ' 116' ' ' ASN . 0.3 OUTLIER -68.78 -20.98 64.36 Favored 'General case' 0 C--O 1.185 -2.292 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.329 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -87.4 -47.86 8.44 Favored 'General case' 0 CA--C 1.45 -2.893 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 t -49.57 -54.98 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.44 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.882 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.548 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 17.9 m-20 -64.44 -44.42 91.23 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-O 123.385 1.564 . . . . 0.0 112.074 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' ASN . . . . . 0.563 ' HB3' ' O ' ' B' ' 112' ' ' LYS 0.302 5.9 t30 -76.51 -41.33 47.25 Favored 'General case' 0 C--N 1.262 -3.212 0 C-N-CA 126.778 2.031 . . . . 0.0 112.815 -172.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.48 -33.56 76.16 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . 0.548 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 10.0 tp -65.33 -39.64 92.68 Favored 'General case' 1 N--CA 1.378 -4.059 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.773 -178.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' MET . . . . . 0.795 ' SD ' ' HA ' ' B' ' 125' ' ' ASN 0.255 6.9 ptp -73.81 -19.93 60.61 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 117.821 -1.552 . . . . 0.0 114.155 176.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 43.0 mt -75.98 -52.04 18.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 78.5 p -59.09 -28.0 66.08 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.681 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 26.9 mt -108.22 -0.45 20.9 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.922 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . 0.479 ' HA2' ' CE1' ' B' ' 129' ' ' HIS . . . 74.81 31.78 57.82 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 174.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.52 ' HG ' ' CB ' ' B' ' 119' ' ' MET . 0.5 OUTLIER -120.95 20.09 11.61 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.821 1.31 . . . . 0.0 111.577 179.445 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.795 ' HA ' ' SD ' ' B' ' 119' ' ' MET . 13.0 m120 -43.88 125.3 4.18 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.93 14.0 0.94 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.828 0.823 . . . . 0.0 112.303 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.474 ' H ' ' C ' ' B' ' 125' ' ' ASN . 14.3 t -119.85 7.28 6.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 70.55 154.14 0.13 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 125.664 1.585 . . . . 0.0 112.664 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' HIS . . . . . 0.479 ' CE1' ' HA2' ' B' ' 123' ' ' GLY . 33.8 m-70 -99.83 160.61 14.17 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.332 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -79.51 -42.47 25.13 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.792 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -131.99 134.07 45.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 . . . . . 0 C--N 1.308 -1.221 0 CA-C-O 119.2 -0.428 . . . . 0.0 110.921 -178.855 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 N--CA 1.426 -1.638 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -103.38 144.33 31.52 Favored 'General case' 1 N--CA 1.374 -4.244 0 C-N-CA 123.611 0.765 . . . . 0.0 109.131 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -71.1 120.57 16.85 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 99.36 -1.16 57.2 Favored Glycine 0 C--N 1.305 -1.161 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.972 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -97.32 119.55 36.05 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.495 ' HB ' ' H ' ' A' ' 104' ' ' THR . 87.6 t -83.81 128.26 39.0 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 C-N-CA 123.201 0.6 . . . . 0.0 112.288 -172.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 48.8 m-85 -115.29 141.38 48.11 Favored 'General case' 0 C--N 1.273 -2.721 0 C-N-CA 125.236 1.414 . . . . 0.0 111.425 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER -75.26 148.66 39.24 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 167.041 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.02 149.4 34.05 Favored 'General case' 0 C--N 1.262 -3.215 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.233 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.416 ' HB2' ' HE2' ' A' ' 100' ' ' LYS . 26.0 t0 -96.91 76.68 2.74 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 27' ' ' VAL 0.264 3.0 tt -71.58 -18.16 62.25 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.089 -2.778 . . . . 0.0 108.437 -173.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.521 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 5.1 m -32.82 -178.19 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.935 0 C-N-CA 129.739 3.216 . . . . 0.0 116.384 173.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.1 OUTLIER 25.95 43.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.137 0 C-N-CA 124.317 3.345 . . . . 0.0 116.648 -151.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.728 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 2.8 m -70.07 142.2 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.402 169.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.442 ' HB3' ' HD2' ' B' ' 98' ' ' ARG . 18.2 mm100 -90.31 134.17 34.48 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 114.887 -1.052 . . . . 0.0 113.222 -172.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.84 -108.84 0.69 Allowed Glycine 0 N--CA 1.442 -0.923 0 O-C-N 124.564 1.165 . . . . 0.0 114.654 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 m -94.05 8.28 42.06 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 31.8 mt-10 -62.08 143.46 56.62 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 90' ' ' GLN . 1.1 tp-100 -103.49 112.31 25.15 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.174 0.512 . . . . 0.0 110.872 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . 166.04 -178.62 40.61 Favored Glycine 0 N--CA 1.408 -3.179 0 C-N-CA 119.807 -1.187 . . . . 0.0 115.012 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 24' ' ' LEU . . . 178.08 -160.09 26.12 Favored Glycine 0 C--N 1.266 -3.313 1 N-CA-C 101.972 -4.451 . . . . 0.0 101.972 -178.594 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.9 p -73.73 120.04 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.124 0 CA-C-N 120.859 2.329 . . . . 0.0 109.071 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.414 ' NH1' ' HA ' ' A' ' 59' ' ' THR . 73.2 mtt180 -152.73 166.07 16.2 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.423 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.655 ' HB2' HD12 ' A' ' 58' ' ' ILE . 11.0 Cg_exo -71.76 144.56 44.16 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.595 1.53 . . . . 0.0 109.978 169.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 28.7 m -128.19 158.26 40.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.507 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 35.9 m -101.76 130.33 51.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.832 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.433 HD13 HG12 ' A' ' 55' ' ' VAL . 35.9 mm -84.19 105.46 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.97 -10.19 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.035 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.666 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 2.5 tt0 -60.63 164.51 4.54 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -169.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 26.6 p-10 -68.38 -174.7 0.55 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.387 -1.733 . . . . 0.0 111.466 175.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -88.34 -38.36 15.2 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.194 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.452 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 4.0 m -81.83 -22.26 37.13 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.776 -0.578 . . . . 0.0 112.521 -171.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.63 -31.03 76.38 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -71.09 -35.31 71.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.249 0.547 . . . . 0.0 110.563 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 45' ' ' THR . 34.4 mttp -79.63 -48.28 14.01 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -115.51 -27.79 7.03 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -172.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.417 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 61.9 m -86.12 148.33 47.41 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.992 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 2.9 Cg_endo -81.9 -17.01 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.579 1.519 . . . . 0.0 110.221 174.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.2 p -91.65 151.08 20.84 Favored 'General case' 0 N--CA 1.421 -1.894 0 C-N-CA 124.635 1.174 . . . . 0.0 111.982 -174.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.666 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 61.8 t -135.12 139.02 47.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.634 HG21 HD22 ' B' ' 122' ' ' LEU . 10.3 tt -93.14 134.51 30.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.094 0.473 . . . . 0.0 110.196 170.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 94' ' ' LEU . 22.1 m -139.62 164.22 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.368 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.537 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -122.82 138.29 54.69 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.1 132.43 45.83 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 37' ' ' PRO . 63.3 mt -92.09 136.84 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.901 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.414 ' HA ' ' NH1' ' A' ' 36' ' ' ARG . 95.8 m -129.52 139.89 51.41 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . . . . . . 0 C--O 1.222 -0.656 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.0 mt . . . . . 0 N--CA 1.435 -1.212 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.64 1.85 3.99 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 121.951 1.767 . . . . 0.0 113.069 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.0 p -98.71 -18.8 17.84 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.394 0.616 . . . . 0.0 109.872 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -97.88 129.95 44.8 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.815 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.58 142.7 43.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -103.93 148.69 25.88 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.955 0.407 . . . . 0.0 110.969 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.533 HD13 HD11 ' A' ' 86' ' ' ILE . 25.2 pt -124.6 134.46 66.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.458 ' O ' ' HD1' ' A' ' 78' ' ' TYR . 2.7 mp0 -59.96 115.71 3.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.373 1.069 . . . . 0.0 113.423 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HB3' ' C ' ' A' ' 82' ' ' LYS . 22.3 pttm -50.56 -36.42 34.43 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.965 0.906 . . . . 0.0 112.214 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -52.35 -53.16 48.2 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 113.326 -1.761 . . . . 0.0 112.627 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -92.64 -37.65 12.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.552 0.692 . . . . 0.0 111.996 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.537 ' CE2' ' HA ' ' A' ' 106' ' ' LEU . 71.3 m-85 -75.37 -5.92 47.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.921 -172.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 75.5 24.1 1.39 Allowed 'General case' 0 C--N 1.348 0.521 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 167.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.67 179.0 4.4 Favored 'General case' 0 CA--C 1.489 -1.396 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.265 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.22 -5.29 40.74 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.485 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -140.89 150.51 43.29 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.193 -176.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -75.3 128.07 34.59 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 6.1 t -102.78 163.58 12.14 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -170.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.46 141.3 41.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.533 HD11 HD13 ' A' ' 73' ' ' ILE . 17.2 mm -107.48 133.2 52.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.9 mt -106.18 109.38 21.3 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.44 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -83.94 -2.68 57.02 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.509 0.671 . . . . 0.0 111.991 -175.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -97.0 -34.11 11.31 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.323 1.059 . . . . 0.0 109.677 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.428 ' HG2' ' HB3' ' A' ' 32' ' ' GLN . 9.7 tp60 -94.56 80.0 3.83 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.625 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.537 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.1 pp -122.71 -177.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -173.71 -178.24 1.56 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 123.784 0.677 . . . . 0.0 112.502 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 53.9 m -123.67 126.05 45.89 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 55' ' ' VAL . 74.7 mt -132.07 133.69 44.65 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.656 1.183 . . . . 0.0 109.784 -173.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.5 p-10 -78.09 153.84 31.86 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -44.78 -21.11 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.796 1.638 . . . . 0.0 115.015 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -74.17 -17.51 60.9 Favored 'General case' 0 CA--C 1.564 1.498 0 CA-C-O 121.209 0.528 . . . . 0.0 110.604 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.421 ' HD2' ' CB ' ' B' ' 28' ' ' GLN . 4.8 mmp_? -84.34 -38.52 20.25 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.073 0.549 . . . . 0.0 111.23 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.48 121.91 16.83 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 123.885 0.874 . . . . 0.0 111.1 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 23' ' ' ASP . 68.2 mttm -92.34 -62.55 1.38 Allowed 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.784 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.1 pt-20 -159.73 143.47 14.49 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.291 0.567 . . . . 0.0 112.075 -170.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.27 123.75 20.78 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.719 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.712 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 22.1 tp -114.3 -61.92 1.67 Allowed 'General case' 0 N--CA 1.414 -2.255 0 CA-C-O 122.394 1.092 . . . . 0.0 110.435 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.712 ' OG1' ' HG ' ' A' ' 103' ' ' LEU 0.26 3.7 m -126.54 -174.8 3.22 Favored 'General case' 0 N--CA 1.401 -2.892 0 CA-C-N 113.283 -1.78 . . . . 0.0 111.93 -164.07 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.432 ' H ' ' CG2' ' A' ' 104' ' ' THR . 0.4 OUTLIER -159.73 137.17 9.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.483 1.513 . . . . 0.0 109.645 -167.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.537 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . 6.9 mt -98.22 164.02 12.49 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.775 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.8 m -98.62 159.98 14.58 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 111' ' ' MET . 21.2 m-20 -63.59 -31.61 72.83 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.314 0.578 . . . . 0.0 112.307 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.76 -41.5 83.25 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 122.077 -0.389 . . . . 0.0 109.971 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -74.57 -24.21 58.88 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.378 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.482 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -56.59 -39.75 74.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 123.819 0.847 . . . . 0.0 108.857 170.84 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 8.4 mmpt? -79.99 -11.09 59.81 Favored 'General case' 0 N--CA 1.39 -3.474 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.233 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -88.94 -49.42 6.8 Favored 'General case' 0 N--CA 1.39 -3.426 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -50.26 -58.77 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.199 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.78 -39.5 77.62 Favored 'General case' 0 N--CA 1.515 2.825 0 CA-C-O 123.452 1.596 . . . . 0.0 111.931 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.511 ' HB3' ' O ' ' A' ' 112' ' ' LYS 0.257 6.4 t30 -83.98 -46.62 11.87 Favored 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 112.424 -2.171 . . . . 0.0 112.77 -170.078 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.54 -36.16 73.44 Favored 'General case' 0 CA--C 1.47 -2.102 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.546 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 7.4 tp -62.56 -47.11 85.32 Favored 'General case' 1 N--CA 1.363 -4.782 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.104 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.633 ' SD ' ' HA ' ' A' ' 125' ' ' ASN 0.275 7.8 ptp -68.14 -22.59 64.86 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 178.006 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.3 mt -72.22 -51.98 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.426 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 t -55.52 -34.66 64.86 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 113.197 -1.82 . . . . 0.0 111.669 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.632 HD22 HG21 ' B' ' 54' ' ' ILE . 17.0 mt -110.38 8.4 23.28 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.769 -0.582 . . . . 0.0 111.266 -177.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.53 21.49 64.79 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 171.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.782 HD11 HD11 ' B' ' 124' ' ' LEU . 0.6 OUTLIER -99.95 13.91 32.29 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 118.56 1.18 . . . . 0.0 111.485 -176.435 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.633 ' HA ' ' SD ' ' A' ' 119' ' ' MET . 20.1 m120 . . . . . 0 N--CA 1.482 1.133 0 O-C-N 124.509 1.13 . . . . 0.0 113.357 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.7 mt . . . . . 0 N--CA 1.424 -1.775 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -102.78 146.1 28.76 Favored 'General case' 1 N--CA 1.377 -4.106 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.58 118.93 15.02 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 100.6 -0.66 55.51 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.971 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.43 119.39 35.87 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.493 ' HB ' ' H ' ' B' ' 104' ' ' THR . 86.0 t -83.72 128.51 38.75 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 123.235 0.614 . . . . 0.0 112.255 -172.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 48.7 m-85 -115.78 140.39 49.26 Favored 'General case' 0 C--N 1.272 -2.784 0 C-N-CA 125.438 1.495 . . . . 0.0 111.329 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.514 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 0.8 OUTLIER -74.02 148.38 42.06 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 166.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -145.41 148.87 33.8 Favored 'General case' 0 C--N 1.259 -3.361 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.055 -176.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -96.11 79.48 3.2 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.549 ' O ' HG13 ' B' ' 27' ' ' VAL 0.262 3.0 tt -74.46 -16.96 60.84 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 111.553 -2.567 . . . . 0.0 108.477 -173.251 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.501 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 3.6 m -32.68 -178.12 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.922 0 C-N-CA 130.652 3.581 . . . . 0.0 116.432 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.1 OUTLIER 24.91 44.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.404 3.486 0 C-N-CA 124.343 3.362 . . . . 0.0 116.373 -152.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.716 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 2.6 m -69.79 140.56 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 113.512 -1.676 . . . . 0.0 109.591 168.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLN . . . . . 0.421 ' CB ' ' HD2' ' A' ' 98' ' ' ARG . 17.1 mm100 -89.83 132.83 35.05 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.766 -172.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.08 -108.61 0.68 Allowed Glycine 0 CA--C 1.501 -0.796 0 CA-C-N 114.735 -1.121 . . . . 0.0 114.81 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -93.99 6.92 46.96 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -174.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.716 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 33.7 mt-10 -63.53 140.09 58.84 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.469 ' HB3' ' HG2' ' B' ' 90' ' ' GLN . 0.3 OUTLIER -101.28 119.42 38.73 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 120.828 0.347 . . . . 0.0 111.37 -176.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.416 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . 161.72 -179.33 37.17 Favored Glycine 1 N--CA 1.393 -4.191 0 C-N-CA 118.717 -1.706 . . . . 0.0 114.785 170.231 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' B' ' 24' ' ' LEU . . . -177.9 -158.69 21.31 Favored Glycine 1 C--N 1.253 -4.06 1 N-CA-C 102.801 -4.12 . . . . 0.0 102.801 -178.815 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 7.2 p -75.98 108.72 8.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 120.208 2.004 . . . . 0.0 110.551 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -141.22 165.68 27.4 Favored Pre-proline 0 C--N 1.277 -2.587 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.33 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.649 ' HB2' HD12 ' B' ' 58' ' ' ILE . 11.6 Cg_exo -70.47 144.04 49.13 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.487 1.458 . . . . 0.0 109.871 169.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 29.3 m -128.02 158.7 39.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 35.1 m -102.08 130.46 51.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.891 177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.419 HD13 HG12 ' B' ' 55' ' ' VAL . 34.7 mm -84.37 105.72 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -10.66 8.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.813 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.527 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.0 OUTLIER -58.61 161.95 4.25 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 125.274 1.43 . . . . 0.0 114.723 -171.283 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -67.26 -172.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.771 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -89.67 -41.28 12.02 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.204 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.455 ' HA ' ' HD2' ' B' ' 48' ' ' LYS . 5.2 m -78.7 -21.91 47.46 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 -32.32 81.16 Favored Glycine 0 C--O 1.219 -0.811 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -69.76 -36.95 76.22 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.227 0.536 . . . . 0.0 110.494 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.455 ' HD2' ' HA ' ' B' ' 45' ' ' THR . 33.9 mttp -77.5 -50.13 13.28 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -115.4 -25.08 8.1 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -88.32 150.02 46.0 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.939 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.68 -16.4 6.69 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.506 1.471 . . . . 0.0 110.618 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.5 p -95.8 143.04 27.37 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 124.539 1.136 . . . . 0.0 112.18 -174.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.21 139.48 51.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.632 HG21 HD22 ' A' ' 122' ' ' LEU . 10.2 tt -92.14 134.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 120.948 0.404 . . . . 0.0 109.954 170.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.485 HG21 HD12 ' B' ' 94' ' ' LEU . 22.0 m -139.9 165.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 120.968 0.413 . . . . 0.0 110.255 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.541 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -124.15 138.83 54.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.52 134.54 47.8 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.649 HD12 ' HB2' ' B' ' 37' ' ' PRO . 64.7 mt -93.45 139.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.011 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 96.9 m -131.69 140.15 49.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' B' ' 84' ' ' SER . . . . . . . . 0 C--O 1.219 -0.816 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.8 mt . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.01 0.51 4.34 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.106 1.871 . . . . 0.0 113.255 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 58.0 p -100.58 -18.83 16.42 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.32 0.581 . . . . 0.0 110.368 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -97.33 129.99 44.54 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.86 144.44 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -104.9 151.36 23.96 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.931 0.396 . . . . 0.0 110.653 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.506 HD13 HD11 ' B' ' 86' ' ' ILE . 24.7 pt -127.17 137.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.487 ' O ' ' HD1' ' B' ' 78' ' ' TYR . 27.9 mp0 -60.44 116.25 4.17 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.399 1.08 . . . . 0.0 113.217 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' LYS . . . . . 0.448 ' HB3' ' C ' ' B' ' 82' ' ' LYS . 22.1 pttm -50.39 -36.72 33.98 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.704 0.764 . . . . 0.0 112.627 175.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -53.58 -52.7 58.93 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 113.342 -1.754 . . . . 0.0 113.072 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -92.32 -36.78 12.99 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.592 0.711 . . . . 0.0 111.358 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' B' ' 106' ' ' LEU . 76.6 m-85 -76.08 -7.39 54.6 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.766 -173.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 74.86 28.19 1.14 Allowed 'General case' 0 C--N 1.35 0.619 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 167.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 mp -107.69 -177.51 3.36 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.687 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -91.56 -19.45 22.74 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.814 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.448 ' C ' ' HB3' ' B' ' 75' ' ' LYS . 0.2 OUTLIER -128.46 153.79 46.75 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.061 -173.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -75.87 128.96 36.22 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.501 ' HB3' HD11 ' B' ' 73' ' ' ILE . 6.8 t -102.83 164.49 11.59 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -169.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.2 t -122.42 141.25 43.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.51 HD12 HG12 ' B' ' 58' ' ' ILE . 14.3 mm -108.31 132.72 55.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 177.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -105.54 108.26 19.68 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.195 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.83 -3.98 55.32 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.134 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -95.87 -35.98 11.28 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.275 1.036 . . . . 0.0 109.804 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLN . . . . . 0.469 ' HG2' ' HB3' ' B' ' 32' ' ' GLN . 8.0 tp60 -93.05 80.6 4.55 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.63 177.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.541 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.1 pp -122.53 -177.62 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -173.17 -178.07 1.68 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.453 0.644 . . . . 0.0 112.503 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 54.1 m -124.36 126.0 45.26 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.485 HD12 HG21 ' B' ' 55' ' ' VAL . 81.6 mt -131.82 134.78 46.16 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.589 1.156 . . . . 0.0 109.816 -173.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 2.9 p-10 -78.23 153.93 31.47 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -44.6 -21.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.762 1.625 . . . . 0.0 114.897 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -71.96 -18.62 61.98 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.683 0.793 . . . . 0.0 110.484 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.442 ' HD2' ' HB3' ' A' ' 28' ' ' GLN . 3.0 mmp_? -86.55 -36.38 18.96 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.174 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.79 126.06 28.56 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.791 0.805 . . . . 0.0 110.418 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -95.62 -64.48 1.05 Allowed 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.301 -1.318 . . . . 0.0 113.489 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 16.9 pt-20 -157.93 143.6 17.09 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.35 0.595 . . . . 0.0 111.558 -170.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.1 OUTLIER -66.38 123.88 21.21 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.413 -1.721 . . . . 0.0 110.706 174.411 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.721 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 24.9 tp -114.38 -62.14 1.64 Allowed 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.56 1.171 . . . . 0.0 110.57 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.721 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 5.1 m -125.14 -175.79 3.4 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 112.837 -1.983 . . . . 0.0 111.872 -163.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.435 ' H ' ' CG2' ' B' ' 104' ' ' THR . 0.4 OUTLIER -159.52 139.31 11.61 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 125.77 1.628 . . . . 0.0 109.384 -168.07 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.523 ' HA ' ' CE2' ' B' ' 78' ' ' TYR . 6.9 mt -101.54 159.62 15.14 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.955 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m -90.4 158.37 17.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.093 174.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' B' ' 111' ' ' MET . 8.7 m-20 -64.48 -28.48 69.69 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.513 0.673 . . . . 0.0 111.952 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.89 -33.52 64.06 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.944 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.451 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 4.6 mptp? -79.96 -22.64 42.38 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.825 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.518 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -56.59 -38.76 72.46 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 170.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.575 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 6.9 mmpt? -78.8 -12.89 60.04 Favored 'General case' 0 N--CA 1.381 -3.921 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.91 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -88.94 -50.47 6.17 Favored 'General case' 0 N--CA 1.391 -3.385 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 t -48.99 -59.6 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.224 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 5.0 m-20 -57.14 -41.87 79.9 Favored 'General case' 0 N--CA 1.514 2.726 0 CA-C-O 123.661 1.696 . . . . 0.0 112.352 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.586 ' O ' HD12 ' B' ' 120' ' ' ILE 0.345 22.0 t30 -83.64 -46.63 12.12 Favored 'General case' 0 C--N 1.251 -3.696 0 CA-C-N 112.319 -2.219 . . . . 0.0 112.285 -168.143 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.19 -32.52 72.28 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.545 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 7.6 tp -62.38 -46.9 86.54 Favored 'General case' 1 N--CA 1.365 -4.684 0 CA-C-N 113.514 -1.676 . . . . 0.0 109.601 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.686 ' SD ' ' HA ' ' B' ' 125' ' ' ASN 0.288 7.9 ptp -66.55 -25.42 66.64 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 177.198 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.586 HD12 ' O ' ' B' ' 116' ' ' ASN . 4.5 mp -72.05 -46.66 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 C-N-CA 117.756 -1.577 . . . . 0.0 108.288 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 14.9 t -58.05 -34.37 70.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.316 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.634 HD22 HG21 ' A' ' 54' ' ' ILE . 13.7 mt -110.41 7.91 23.02 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.56 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.17 20.77 67.52 Favored Glycine 0 N--CA 1.468 0.808 0 N-CA-C 116.983 1.553 . . . . 0.0 116.983 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.782 HD11 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -101.26 18.64 19.43 Favored 'General case' 0 CA--C 1.496 -1.135 0 CA-C-N 118.361 1.08 . . . . 0.0 111.309 -177.4 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.686 ' HA ' ' SD ' ' B' ' 119' ' ' MET . 20.3 m120 . . . . . 0 N--CA 1.475 0.815 0 O-C-N 124.175 0.922 . . . . 0.0 112.21 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -102.91 121.91 43.49 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.982 -174.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -59.45 126.26 26.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.84 -7.05 44.67 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.204 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -97.56 -178.6 4.18 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 14.2 t -135.49 136.32 50.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 C-N-CA 123.679 0.792 . . . . 0.0 110.622 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 33.2 m-85 -132.2 146.24 51.88 Favored 'General case' 0 CA--C 1.466 -2.281 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.0 mp -77.84 152.73 33.28 Favored 'General case' 0 N--CA 1.395 -3.184 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.647 170.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -130.07 144.03 51.12 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.897 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 13.3 t70 -89.33 86.66 6.87 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.261 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 4.5 mm? -88.89 41.07 1.01 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.196 1.398 . . . . 0.0 112.496 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.615 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 31.7 m -73.48 174.29 4.96 Favored Pre-proline 0 C--N 1.251 -3.698 0 C-N-CA 126.123 1.769 . . . . 0.0 108.232 171.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.615 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER 4.79 51.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.41 3.81 1 C-N-CA 127.971 5.781 . . . . 0.0 118.65 -178.01 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 27.8 m -69.09 176.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.779 171.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 33.5 mm-40 -104.04 133.14 49.49 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.389 -176.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.76 -120.65 19.85 Favored Glycine 0 CA--C 1.505 -0.594 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.937 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.8 m -91.58 13.39 17.98 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -61.34 152.57 29.05 Favored 'General case' 0 C--O 1.252 1.225 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.71 177.312 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.527 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -71.88 120.86 18.08 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.157 -171.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -101.03 142.36 15.74 Favored Glycine 0 CA--C 1.476 -2.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.431 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 108.76 141.02 9.31 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 114.401 -0.899 . . . . 0.0 111.122 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.57 117.63 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -139.33 148.31 56.3 Favored Pre-proline 0 C--N 1.253 -3.613 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.61 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 50.0 Cg_exo -63.0 138.48 68.15 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.823 2.349 . . . . 0.0 111.654 171.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 20' ' ' TYR . 30.6 m -123.93 156.22 31.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.486 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.9 m -100.93 132.05 47.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 120.809 0.338 . . . . 0.0 110.329 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.466 ' CG2' ' HG2' ' A' ' 42' ' ' GLN . 23.4 mm -91.59 106.66 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -104.37 -9.76 9.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.517 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.56 HE22 ' N ' ' A' ' 47' ' ' ASN . 4.5 pt20 -51.46 162.5 0.36 Allowed 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -168.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -65.42 -177.08 0.38 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.285 -1.779 . . . . 0.0 111.765 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -73.89 -53.73 9.52 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 114.55 -1.204 . . . . 0.0 112.677 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.525 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 20.3 m -82.9 -22.39 33.95 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -166.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.58 -40.18 86.85 Favored Glycine 0 C--O 1.213 -1.219 0 O-C-N 123.059 0.224 . . . . 0.0 113.316 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.56 ' N ' HE22 ' A' ' 42' ' ' GLN . 11.0 p30 -71.05 -20.72 62.34 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 45' ' ' THR . 2.5 mptp? -86.16 -68.03 0.77 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.157 0.503 . . . . 0.0 110.517 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.35 -29.51 24.41 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -168.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 m -91.12 143.35 28.32 Favored Pre-proline 0 N--CA 1.414 -2.238 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.54 -26.45 23.91 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 120.955 1.103 . . . . 0.0 109.709 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.0 p -82.01 147.9 28.93 Favored 'General case' 0 N--CA 1.414 -2.258 0 C-N-CA 125.915 1.686 . . . . 0.0 113.619 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.541 HG13 ' OE1' ' A' ' 42' ' ' GLN . 93.3 t -132.16 140.39 47.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.701 HD11 HD13 ' A' ' 91' ' ' ILE . 5.0 tp -103.86 124.72 58.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.426 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 25.1 m -134.02 167.92 25.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.988 -175.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.503 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -126.13 139.52 53.31 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.83 137.38 41.82 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' A' ' 37' ' ' PRO . 60.4 mt -95.6 134.99 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-N 113.115 -1.857 . . . . 0.0 108.468 175.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 m -103.6 124.78 49.44 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.583 0 C-N-CA 121.249 -0.501 . . . . 0.0 111.984 -176.555 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.218 -0.577 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.94 1.18 2.01 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.677 2.251 . . . . 0.0 113.706 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.9 p -91.69 -16.26 27.23 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-O 122.301 1.048 . . . . 0.0 108.288 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -107.34 129.31 54.92 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 73' ' ' ILE . 67.8 t -126.18 127.15 70.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.618 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.25 124.63 37.36 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.667 0.746 . . . . 0.0 109.8 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.679 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -108.75 156.34 9.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.297 -175.147 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -63.25 119.78 10.27 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 123.779 0.674 . . . . 0.0 112.619 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -46.12 -46.77 17.28 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 126.071 1.748 . . . . 0.0 110.336 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -58.2 -32.31 68.15 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 126.673 1.989 . . . . 0.0 112.826 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -91.14 -39.04 12.36 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.712 0.768 . . . . 0.0 110.792 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.679 ' CE1' HG21 ' A' ' 73' ' ' ILE . 4.2 m-85 -83.22 -9.45 59.14 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.793 -177.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 67.09 40.87 2.77 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.921 0.889 . . . . 0.0 111.096 174.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.41 -179.71 3.96 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.836 0.827 . . . . 0.0 111.073 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.8 -10.78 41.58 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.258 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -139.8 161.26 37.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.34 142.12 50.42 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.7 t -110.0 155.76 21.39 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.545 -171.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 12.6 t -117.74 128.11 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.483 HD13 HG13 ' A' ' 73' ' ' ILE . 1.6 mp -103.52 125.53 58.06 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.94 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 90' ' ' GLN . 67.0 mt -100.97 110.61 22.67 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 113.228 -1.806 . . . . 0.0 110.04 -175.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.56 HD12 HD23 ' A' ' 118' ' ' LEU . 3.6 mm? -83.84 3.25 34.48 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.732 -175.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -119.03 4.2 11.4 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.787 1.28 . . . . 0.0 108.39 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 8.5 tp60 -122.85 35.1 4.96 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.535 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.701 HD13 HD11 ' A' ' 54' ' ' ILE . 2.1 pp -85.94 -178.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.186 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.527 ' NH2' ' HB3' ' A' ' 32' ' ' GLN . 9.3 ptp85 -167.66 168.6 12.5 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 16.2 m -122.41 118.87 29.41 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.609 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 60.7 mt -131.89 140.1 48.97 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.255 -173.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.534 ' OD2' ' HB3' ' A' ' 97' ' ' LYS . 4.7 p-10 -72.89 151.26 42.01 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.635 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -45.54 -35.5 3.96 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.534 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 7.4 ttpm? -61.29 -26.1 67.56 Favored 'General case' 0 C--N 1.273 -2.753 0 C-N-CA 123.879 0.872 . . . . 0.0 112.634 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.441 ' NH1' ' HB3' ' A' ' 23' ' ' ASP . 2.3 mmp_? -75.53 -28.48 59.11 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.171 0.51 . . . . 0.0 110.813 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.05 124.22 24.5 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.492 1.117 . . . . 0.0 110.12 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -87.72 -63.64 1.27 Allowed 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.21 -1.359 . . . . 0.0 113.305 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.1 pt-20 -161.11 142.39 11.68 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 121.403 0.62 . . . . 0.0 111.969 -170.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -60.94 120.92 11.13 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 126.186 1.794 . . . . 0.0 110.731 174.408 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.53 -62.83 1.54 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.518 HG22 HG11 ' A' ' 19' ' ' VAL . 4.8 t -125.41 -167.0 1.62 Allowed 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.263 -1.375 . . . . 0.0 111.626 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -161.2 135.18 6.86 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 124.092 0.957 . . . . 0.0 111.831 -171.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -105.4 163.36 12.69 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.176 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.5 p -90.86 170.14 10.34 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.282 0.563 . . . . 0.0 112.459 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 111' ' ' MET . 27.6 t70 -65.82 -30.82 71.5 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.292 1.037 . . . . 0.0 112.492 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -75.44 -24.26 57.03 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 122.035 -0.415 . . . . 0.0 110.491 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.7 OUTLIER -75.13 -26.65 59.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.356 174.417 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.486 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -55.01 -39.32 68.96 Favored 'General case' 0 CA--C 1.471 -2.085 0 CA-C-O 122.04 0.924 . . . . 0.0 109.818 172.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.494 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 8.3 mmpt? -74.28 -15.21 60.98 Favored 'General case' 0 N--CA 1.393 -3.292 0 CA-C-N 114.214 -1.357 . . . . 0.0 113.112 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -86.93 -56.03 3.57 Favored 'General case' 0 N--CA 1.389 -3.51 0 C-N-CA 117.649 -1.62 . . . . 0.0 109.245 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 110' ' ' LYS . 22.0 m -57.33 -47.7 84.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -174.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.5 ' HB3' ' HG ' ' B' ' 124' ' ' LEU . 44.5 m-20 -60.53 -48.02 83.6 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 123.536 1.636 . . . . 0.0 109.931 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 12.1 t30 -76.06 -39.87 54.49 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 112.267 -2.242 . . . . 0.0 112.647 -168.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.513 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -60.25 -38.51 83.68 Favored 'General case' 0 CA--C 1.469 -2.142 0 CA-C-O 122.279 1.038 . . . . 0.0 108.605 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.56 HD23 HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -83.0 -27.82 30.12 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.297 -173.28 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.435 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 3.7 ttp -60.27 -30.09 69.23 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 124.079 0.951 . . . . 0.0 108.552 172.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 116' ' ' ASN . 52.9 mt -81.22 -55.61 7.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.9 t -49.76 -43.25 47.91 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.938 1.695 . . . . 0.0 111.935 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.485 ' HG ' HG12 ' B' ' 54' ' ' ILE . 9.0 mp -82.12 5.65 18.93 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.28 5.41 76.09 Favored Glycine 0 C--N 1.341 0.857 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' B' ' 115' ' ' ASP . 3.5 mp -73.23 -42.76 62.22 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.484 1.142 . . . . 0.0 108.63 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.6 t30 . . . . . 0 N--CA 1.435 -1.218 0 C-N-CA 126.501 1.921 . . . . 0.0 114.836 177.933 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--O 1.244 0.766 0 CA-C-O 121.296 0.569 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -104.44 122.41 45.46 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.058 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -59.55 124.97 21.81 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 120.969 0.414 . . . . 0.0 110.105 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.51 -7.42 46.47 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.501 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -97.17 179.2 4.99 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 17.4 t -134.17 137.48 51.83 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 C-N-CA 123.546 0.738 . . . . 0.0 111.031 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 27.7 m-85 -132.99 145.41 50.85 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.3 mp -76.62 151.36 36.25 Favored 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.664 170.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.63 143.83 51.0 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.341 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -87.36 84.45 7.19 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.167 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.517 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 4.4 mm? -88.17 40.93 0.98 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 123.172 1.463 . . . . 0.0 112.444 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.591 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.257 14.7 m -73.67 174.76 4.35 Favored Pre-proline 1 C--N 1.242 -4.097 0 CA-C-N 113.279 -1.782 . . . . 0.0 108.162 172.612 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 13.9 Cg_exo 3.19 53.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.406 3.571 1 C-N-CA 128.129 5.886 . . . . 0.0 118.077 -179.294 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 m -69.4 -178.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 113.44 -1.709 . . . . 0.0 111.836 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' B' ' 31' ' ' GLU . 33.1 mm-40 -109.79 132.7 53.91 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.624 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.87 -125.74 40.6 Favored Glycine 0 CA--C 1.499 -0.964 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.263 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 39.6 m -93.55 22.18 5.62 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.38 -0.41 . . . . 0.0 112.03 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' B' ' 28' ' ' GLN . 0.0 OUTLIER -64.24 162.46 14.61 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.388 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.565 ' HB3' ' NH2' ' B' ' 92' ' ' ARG . 0.9 OUTLIER -79.92 117.42 20.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 120.87 0.367 . . . . 0.0 110.262 -173.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -98.07 145.8 17.93 Favored Glycine 0 CA--C 1.473 -2.556 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.514 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 106.54 138.96 9.24 Favored Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 114.431 -0.884 . . . . 0.0 111.18 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 t -56.93 119.42 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ARG . . . . . 0.431 ' NH1' ' HA ' ' B' ' 59' ' ' THR . 58.7 mtt180 -140.7 148.43 52.87 Favored Pre-proline 0 C--N 1.256 -3.488 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.431 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.534 ' HB2' HD12 ' B' ' 58' ' ' ILE . 35.2 Cg_exo -64.1 138.49 62.2 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.707 2.271 . . . . 0.0 111.454 171.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.42 HG22 ' O ' ' B' ' 20' ' ' TYR . 31.5 m -123.54 156.41 30.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 33.1 m -100.86 132.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.896 0.379 . . . . 0.0 110.439 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.477 ' CG2' ' HG2' ' B' ' 42' ' ' GLN . 24.3 mm -91.69 107.15 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.417 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -104.48 -9.99 9.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.571 ' OE1' HG13 ' B' ' 53' ' ' VAL . 4.7 pt20 -51.67 162.19 0.43 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -168.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -67.04 -179.88 1.02 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.263 -1.79 . . . . 0.0 111.852 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.25 -55.17 15.09 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.01 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.549 ' HA ' ' HD3' ' B' ' 48' ' ' LYS . 10.4 m -84.92 -22.3 29.32 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -164.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.64 -38.57 82.54 Favored Glycine 0 C--O 1.21 -1.381 0 O-C-N 123.236 0.335 . . . . 0.0 113.136 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.549 ' N ' HE22 ' B' ' 42' ' ' GLN . 10.2 p30 -71.79 -20.95 61.78 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.549 ' HD3' ' HA ' ' B' ' 45' ' ' THR . 2.8 mptp? -86.57 -67.75 0.79 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.138 0.494 . . . . 0.0 110.408 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.37 -35.78 24.86 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -169.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 18.7 m -86.09 143.31 37.06 Favored Pre-proline 0 N--CA 1.415 -2.215 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.28 -25.69 21.67 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.025 1.15 . . . . 0.0 109.309 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.4 p -82.71 145.97 29.3 Favored 'General case' 0 N--CA 1.415 -2.188 0 C-N-CA 125.545 1.538 . . . . 0.0 113.579 -173.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.571 HG13 ' OE1' ' B' ' 42' ' ' GLN . 98.0 t -130.01 140.52 48.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 176.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.702 HD11 HD13 ' B' ' 91' ' ' ILE . 5.1 tp -103.76 124.57 58.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 121.291 0.567 . . . . 0.0 109.697 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.418 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 24.8 m -134.15 167.09 26.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.965 -175.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.506 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -125.53 139.54 53.52 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.49 135.78 42.23 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' B' ' 37' ' ' PRO . 59.4 mt -93.98 135.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 113.248 -1.796 . . . . 0.0 108.05 174.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' THR . . . . . 0.431 ' HA ' ' NH1' ' B' ' 36' ' ' ARG . 19.2 m -101.92 127.22 48.86 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.659 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.76 -176.104 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.218 -0.575 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.09 3.34 1.32 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.768 2.312 . . . . 0.0 113.755 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 58.9 p -92.4 -15.9 26.62 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.455 1.121 . . . . 0.0 108.504 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -108.64 129.76 55.33 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 175.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.518 HG12 HD13 ' B' ' 73' ' ' ILE . 62.9 t -125.42 127.06 71.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 O-C-N 121.611 -0.681 . . . . 0.0 110.736 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.34 120.62 32.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.663 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.1 OUTLIER -106.6 154.28 7.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.449 -175.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -62.01 119.48 8.96 Favored 'General case' 0 C--O 1.251 1.176 0 O-C-N 124.202 0.939 . . . . 0.0 112.619 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -46.55 -46.33 19.27 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.147 1.779 . . . . 0.0 110.48 172.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -59.73 -31.33 69.52 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 126.219 1.807 . . . . 0.0 112.938 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -90.73 -39.44 12.42 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.199 0.523 . . . . 0.0 110.631 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.663 ' CE1' HG21 ' B' ' 73' ' ' ILE . 4.3 m-85 -83.29 -10.8 58.31 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.879 -177.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 tttp 70.41 34.2 2.3 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.31 1.044 . . . . 0.0 111.851 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.69 -179.79 4.07 Favored 'General case' 0 CA--C 1.492 -1.259 0 O-C-N 120.973 -1.08 . . . . 0.0 111.613 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.82 -13.41 42.24 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.785 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -140.35 161.65 37.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.98 144.8 52.21 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t -112.4 157.28 21.24 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 11.0 t -118.2 128.31 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.511 HD13 HG13 ' B' ' 73' ' ' ILE . 1.6 mp -103.12 124.75 57.44 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' B' ' 90' ' ' GLN . 74.5 mt -100.18 111.5 23.78 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.054 -175.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.54 HD12 HD23 ' B' ' 118' ' ' LEU . 3.6 mm? -84.06 2.75 37.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.614 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -119.15 4.79 11.29 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.818 1.294 . . . . 0.0 108.477 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 8.3 tp60 -123.61 35.33 4.87 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.159 -1.837 . . . . 0.0 106.481 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.702 HD13 HD11 ' B' ' 54' ' ' ILE . 2.1 pp -85.81 -178.31 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.192 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.565 ' NH2' ' HB3' ' B' ' 32' ' ' GLN . 9.6 ptp85 -167.53 168.93 12.49 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 11.0 m -122.37 118.29 28.08 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.594 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 64.8 mt -132.0 139.86 48.76 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.403 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.531 ' OD2' ' HB3' ' B' ' 97' ' ' LYS . 6.2 p-10 -71.47 151.59 43.81 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.193 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -46.21 -37.0 6.57 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.531 ' HB3' ' OD2' ' B' ' 95' ' ' ASP . 7.0 ttpm? -61.59 -24.47 66.7 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.667 176.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -74.6 -30.11 61.56 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.481 -0.762 . . . . 0.0 110.352 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -71.31 124.93 25.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.499 1.12 . . . . 0.0 110.428 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -88.22 -64.68 1.11 Allowed 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.745 -1.571 . . . . 0.0 112.732 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 9.9 pt-20 -161.25 142.12 11.28 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 121.502 0.668 . . . . 0.0 112.523 -171.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.2 OUTLIER -60.45 121.31 11.78 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 126.491 1.916 . . . . 0.0 110.938 174.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -114.82 -63.0 1.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.345 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.496 HG22 HG11 ' B' ' 19' ' ' VAL . 3.3 t -125.25 -166.54 1.55 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.172 -1.411 . . . . 0.0 111.816 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -161.13 135.87 7.37 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.002 0.921 . . . . 0.0 112.112 -170.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 pp -108.79 157.4 18.61 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.02 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 7.1 p -86.82 175.49 8.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' B' ' 111' ' ' MET . 22.9 t70 -72.21 -29.47 64.0 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.151 0.5 . . . . 0.0 111.812 -174.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -70.2 -23.38 62.94 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.355 0.597 . . . . 0.0 109.91 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.441 ' O ' HG22 ' B' ' 114' ' ' VAL . 0.6 OUTLIER -78.8 -27.4 44.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 174.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.466 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.0 OUTLIER -55.51 -39.44 70.5 Favored 'General case' 0 CA--C 1.46 -2.487 0 CA-C-O 122.336 1.065 . . . . 0.0 109.131 172.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.516 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 6.9 mmpt? -71.98 -17.16 62.08 Favored 'General case' 1 N--CA 1.378 -4.053 0 CA-C-N 113.725 -1.579 . . . . 0.0 113.841 -178.095 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.97 -57.98 2.76 Favored 'General case' 0 N--CA 1.39 -3.436 0 C-N-CA 117.561 -1.656 . . . . 0.0 109.198 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 110' ' ' LYS . 22.9 m -54.85 -47.02 75.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.519 ' HB3' ' HG ' ' A' ' 124' ' ' LEU . 55.6 m-20 -61.3 -48.97 78.93 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.636 1.684 . . . . 0.0 110.535 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' B' ' 119' ' ' MET 0.349 27.0 t30 -77.13 -38.69 51.51 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.539 -167.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.425 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -62.63 -37.56 86.8 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-O 122.267 1.032 . . . . 0.0 108.812 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.54 HD23 HD12 ' B' ' 88' ' ' LEU . 0.7 OUTLIER -82.66 -27.44 31.32 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.888 -174.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' B' ' 116' ' ' ASN . 4.0 ttp -60.25 -31.44 70.21 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 59.6 mt -79.03 -56.39 7.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.2 t -48.64 -43.45 36.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.114 1.366 . . . . 0.0 112.235 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.49 ' HG ' HG12 ' A' ' 54' ' ' ILE . 8.6 mp -81.64 6.06 16.3 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.36 7.28 79.83 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 115.661 1.025 . . . . 0.0 115.661 172.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 115' ' ' ASP . 3.8 mp -73.59 -43.82 58.78 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 118.328 1.064 . . . . 0.0 108.422 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 . . . . . 0 N--CA 1.432 -1.355 0 C-N-CA 126.689 1.995 . . . . 0.0 114.72 178.522 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.7 mt . . . . . 0 N--CA 1.444 -0.766 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.445 ' HG2' ' OD2' ' A' ' 18' ' ' ASP . 8.4 ptp180 -121.59 157.99 29.54 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 171.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 28.6 ptt85 -69.36 113.65 6.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 168.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.495 ' HA2' ' SD ' ' A' ' 111' ' ' MET . . . 131.76 -9.07 5.51 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.875 -173.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD2' ' HG2' ' A' ' 15' ' ' ARG . 32.9 m-20 -96.46 173.19 7.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 122.016 0.912 . . . . 0.0 109.713 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 12.4 t -132.3 134.22 59.47 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.794 178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.466 ' O ' HG22 ' A' ' 38' ' ' VAL . 50.7 m-85 -135.62 144.01 45.86 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 125.325 1.45 . . . . 0.0 108.977 176.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.637 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.9 mp -79.42 149.49 31.59 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-O 121.539 0.685 . . . . 0.0 111.097 173.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.67 134.23 33.37 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.177 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.553 ' HA ' ' HB ' ' A' ' 35' ' ' VAL 0.326 3.2 p-10 -81.64 104.72 12.25 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 117.931 -1.508 . . . . 0.0 111.346 176.278 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 5.4 mt -90.55 37.78 0.92 Allowed 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 124.92 2.295 . . . . 0.0 110.273 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.576 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.282 7.3 m -63.62 171.91 2.02 Favored Pre-proline 1 C--N 1.223 -4.904 0 CA-C-N 109.364 -3.562 . . . . 0.0 107.314 167.599 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 1.0 OUTLIER 6.04 53.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.401 3.307 1 C-N-CA 126.977 5.118 . . . . 0.0 118.227 -174.73 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.32 -178.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.717 166.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -108.01 126.46 52.75 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.89 -117.9 9.82 Favored Glycine 0 N--CA 1.425 -2.058 0 CA-C-N 113.781 -1.554 . . . . 0.0 114.329 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.9 m -93.89 22.08 6.01 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.445 -0.878 . . . . 0.0 112.869 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.96 -176.36 0.68 Allowed 'General case' 0 C--O 1.247 0.948 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.934 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.412 ' OE1' ' HD2' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -88.8 109.11 19.9 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.56 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.18 143.27 16.45 Favored Glycine 0 CA--C 1.472 -2.636 0 CA-C-N 115.149 -0.932 . . . . 0.0 114.281 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 108.07 137.1 8.12 Favored Glycine 0 N--CA 1.418 -2.535 0 CA-C-N 113.85 -1.175 . . . . 0.0 110.811 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 2.0 p -61.93 126.71 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 122.455 1.121 . . . . 0.0 111.053 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 84.4 mtt180 -149.61 166.27 15.62 Favored Pre-proline 0 C--N 1.266 -3.04 0 CA-C-N 112.927 -1.942 . . . . 0.0 108.2 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 3.8 Cg_exo -75.92 143.9 26.76 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 121.903 1.735 . . . . 0.0 111.555 174.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 20' ' ' TYR . 28.6 m -118.45 158.53 19.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 34.3 m -102.36 133.05 47.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.767 0.318 . . . . 0.0 110.729 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 mm -88.72 104.9 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.403 HD13 ' C ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -104.4 -20.81 5.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.114 -178.622 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -54.88 165.95 0.56 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -170.737 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -60.66 164.03 4.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.051 -1.886 . . . . 0.0 112.527 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.08 -39.32 79.13 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.52 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 m -86.97 -26.56 23.76 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -171.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.89 -37.2 92.22 Favored Glycine 0 C--O 1.201 -1.919 0 CA-C-N 116.354 -0.385 . . . . 0.0 113.402 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.535 ' OD1' ' HD2' ' A' ' 48' ' ' LYS . 27.5 p30 -69.55 -19.69 63.68 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HD2' ' OD1' ' A' ' 47' ' ' ASN . 13.0 mptt -84.51 -61.73 1.73 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 109.901 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -89.13 -21.93 23.11 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -168.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.2 m -105.94 139.71 20.52 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.668 -0.645 . . . . 0.0 109.652 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.48 -22.26 14.17 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.437 1.425 . . . . 0.0 109.597 174.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 3.7 p -96.17 133.69 40.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.456 1.102 . . . . 0.0 111.889 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.24 145.96 34.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.3 tt -96.68 132.68 40.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.543 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.453 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 30.0 m -137.77 172.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.383 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.558 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -126.0 139.55 53.33 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.53 142.76 42.75 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.622 HD12 ' HB2' ' A' ' 37' ' ' PRO . 82.7 mt -101.86 129.53 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.759 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.8 m -119.27 105.31 11.21 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.428 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.178 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.4 HD12 ' CE1' ' A' ' 70' ' ' HIS . 12.5 mt . . . . . 0 N--CA 1.437 -1.087 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.14 -11.29 21.33 Favored 'Trans proline' 0 CA--C 1.563 1.927 0 C-N-CA 122.199 1.933 . . . . 0.0 113.723 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.7 p -90.21 -19.02 24.67 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.353 0.597 . . . . 0.0 110.702 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.4 ' CE1' HD12 ' A' ' 67' ' ' ILE . 26.1 m170 -95.1 130.27 41.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.49 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.82 132.87 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.34 132.95 52.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.298 0.571 . . . . 0.0 110.909 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.805 HG23 ' HG2' ' A' ' 110' ' ' LYS . 0.7 OUTLIER -107.53 165.53 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.021 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.475 ' H ' HG22 ' A' ' 73' ' ' ILE . 1.3 mp0 -69.54 110.08 4.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 124.074 0.95 . . . . 0.0 109.828 176.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 20.8 pttm -58.09 -35.89 72.08 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.563 0.696 . . . . 0.0 112.115 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -51.61 -45.72 63.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.327 -1.76 . . . . 0.0 111.03 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -82.98 -34.68 26.34 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.288 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.661 ' CE1' HG21 ' A' ' 73' ' ' ILE . 1.8 m-85 -73.35 -11.52 60.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.031 -177.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.2 tptt 78.45 18.94 0.99 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.879 1.272 . . . . 0.0 111.732 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.13 179.36 4.51 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.285 1.04 . . . . 0.0 110.988 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -97.11 -24.8 15.58 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.977 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -130.33 155.25 46.66 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.108 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.467 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 4.5 m-20 -56.74 142.68 39.48 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 122.021 0.915 . . . . 0.0 113.203 -175.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.9 m -108.02 128.63 54.83 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.158 -174.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.3 t -115.82 130.22 70.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 HD22 ' A' ' 88' ' ' LEU . 1.6 mp -107.22 129.68 60.61 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.843 0 CA-C-O 122.196 0.998 . . . . 0.0 108.575 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.0 mt -103.42 108.34 19.55 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 113.194 -1.821 . . . . 0.0 109.214 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.519 HD22 HG22 ' A' ' 86' ' ' ILE . 3.9 mm? -80.41 4.35 18.33 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.373 -175.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.12 -38.0 6.13 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.378 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.48 53.35 2.78 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.545 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.558 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.0 pp -97.21 -176.16 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -173.96 178.11 2.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 45.4 m -121.76 129.15 52.48 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.884 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 mt -133.17 145.56 50.74 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 124.373 1.069 . . . . 0.0 109.328 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.486 ' OD2' ' HB3' ' A' ' 97' ' ' LYS . 2.2 p-10 -79.73 151.16 30.57 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.284 -1.367 . . . . 0.0 110.115 173.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -39.14 -41.06 0.79 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.994 2.117 . . . . 0.0 114.521 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.486 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 7.0 ttpm? -63.65 -13.74 45.43 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 124.122 0.969 . . . . 0.0 112.401 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' A' ' 98' ' ' ARG . 3.7 mmp_? -89.73 -26.94 20.38 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.166 -0.959 . . . . 0.0 110.912 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -74.89 108.56 7.7 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-O 122.14 0.971 . . . . 0.0 109.514 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -93.83 -59.28 2.03 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -143.66 130.41 20.31 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.918 0.866 . . . . 0.0 113.232 -171.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.2 tttp -60.77 119.9 9.07 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 127.266 2.226 . . . . 0.0 108.184 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.7 tp -114.5 -62.38 1.61 Allowed 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.804 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 78' ' ' TYR . 6.1 t -127.75 -160.49 1.02 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.238 -1.385 . . . . 0.0 112.457 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -159.37 149.97 19.42 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.371 1.868 . . . . 0.0 109.158 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -101.82 147.49 26.43 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.688 -177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -64.32 143.16 58.1 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 125.1 1.36 . . . . 0.0 108.608 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 111' ' ' MET . 7.0 p-10 -58.45 -37.39 75.34 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.29 -34.47 63.55 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.809 0.337 . . . . 0.0 110.606 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.805 ' HG2' HG23 ' A' ' 73' ' ' ILE . 16.7 tppt? -67.67 -33.58 75.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.495 ' SD ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -51.31 -46.18 62.47 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.693 173.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.696 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -69.69 -17.78 63.5 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.72 -178.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -83.54 -38.67 21.41 Favored 'General case' 0 CA--C 1.442 -3.175 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.21 -42.99 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.671 0 O-C-N 126.13 2.144 . . . . 0.0 109.999 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.693 ' OD2' ' HA ' ' A' ' 112' ' ' LYS . 44.8 m-20 -57.4 -58.92 6.16 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.53 ' O ' HG13 ' A' ' 120' ' ' ILE . 2.5 m120 -59.38 -47.39 85.63 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.3 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.515 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -52.09 -43.81 64.09 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 124.341 1.056 . . . . 0.0 110.852 -178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 tp -67.21 -45.93 75.38 Favored 'General case' 1 N--CA 1.374 -4.252 0 C-N-CA 124.336 1.054 . . . . 0.0 109.971 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.2 mtp -67.82 -20.08 65.13 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 121.477 -0.765 . . . . 0.0 112.891 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 116' ' ' ASN . 49.4 mt -77.24 -55.75 9.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 26.2 t -53.22 -42.65 66.57 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.759 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.4 mp -90.06 -1.14 57.91 Favored 'General case' 0 N--CA 1.403 -2.782 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.65 13.14 82.84 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 116.571 1.389 . . . . 0.0 116.571 170.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.57 -59.84 2.59 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 118.624 1.212 . . . . 0.0 110.985 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 CA--C 1.568 1.649 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.65 -168.468 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -117.35 159.14 23.21 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 27.0 ptt85 -70.0 113.54 7.31 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.427 ' HA2' ' SD ' ' B' ' 111' ' ' MET . . . 133.34 -15.3 4.74 Favored Glycine 0 C--N 1.305 -1.163 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.666 -173.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -89.72 171.92 9.3 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 121.946 0.879 . . . . 0.0 109.047 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.408 HG11 HG22 ' B' ' 104' ' ' THR . 13.3 t -131.19 132.88 63.09 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.774 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.841 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.492 ' O ' HG22 ' B' ' 38' ' ' VAL . 75.6 m-85 -133.65 143.69 48.74 Favored 'General case' 0 CA--C 1.474 -1.957 0 C-N-CA 125.199 1.4 . . . . 0.0 109.463 176.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.652 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.9 mp -81.49 148.42 29.21 Favored 'General case' 0 N--CA 1.397 -3.095 0 CA-C-O 121.687 0.756 . . . . 0.0 110.99 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -136.59 134.73 37.72 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 113.177 -1.829 . . . . 0.0 107.209 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' B' ' 35' ' ' VAL 0.333 3.6 p-10 -81.95 102.51 10.97 Favored 'General case' 0 C--N 1.279 -2.467 0 C-N-CA 117.975 -1.49 . . . . 0.0 111.658 175.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 4.9 mt -87.8 39.1 0.87 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 125.085 2.374 . . . . 0.0 110.396 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.572 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.287 6.6 m -64.62 171.87 2.55 Favored Pre-proline 1 C--N 1.22 -5.027 0 CA-C-N 109.363 -3.562 . . . . 0.0 107.219 167.083 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.3 OUTLIER 5.85 53.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.173 1 C-N-CA 127.153 5.235 . . . . 0.0 118.386 -174.746 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 28.5 m -69.29 -179.1 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.534 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -106.52 130.95 54.21 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.99 -117.9 7.37 Favored Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 113.751 -1.568 . . . . 0.0 113.82 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -94.18 18.08 11.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.34 -0.93 . . . . 0.0 113.188 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.52 178.1 1.04 Allowed 'General case' 0 C--O 1.249 1.063 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.942 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.457 ' OE1' ' HD2' ' B' ' 36' ' ' ARG . 1.0 OUTLIER -83.52 108.81 16.89 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.522 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.79 138.52 14.11 Favored Glycine 0 CA--C 1.479 -2.212 0 CA-C-N 114.904 -1.043 . . . . 0.0 114.324 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 117.5 136.92 5.71 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 113.813 -1.193 . . . . 0.0 110.512 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' B' ' 23' ' ' ASP . 1.5 p -63.85 121.21 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 122.497 1.141 . . . . 0.0 110.9 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ARG . . . . . 0.457 ' HD2' ' OE1' ' B' ' 32' ' ' GLN . 87.8 mtt180 -144.51 166.69 17.52 Favored Pre-proline 0 C--N 1.26 -3.319 0 CA-C-N 112.846 -1.979 . . . . 0.0 109.028 -174.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 5.4 Cg_exo -76.05 142.7 25.07 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 122.003 1.802 . . . . 0.0 111.507 174.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.492 HG22 ' O ' ' B' ' 20' ' ' TYR . 31.0 m -118.07 158.08 19.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.2 m -102.22 132.42 48.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.807 0.336 . . . . 0.0 110.79 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 24.0 mm -88.09 104.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.47 -20.8 5.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.004 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -55.64 165.91 0.77 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 -170.478 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -59.77 163.3 4.54 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 112.709 -2.042 . . . . 0.0 112.784 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.0 -37.97 75.83 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.498 -175.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 25.8 m -87.23 -28.35 22.42 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.03 -36.06 86.65 Favored Glycine 0 C--O 1.2 -1.99 0 CA-C-O 120.077 -0.291 . . . . 0.0 113.336 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.548 ' OD1' ' HD2' ' B' ' 48' ' ' LYS . 26.6 p30 -69.21 -19.58 63.97 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.548 ' HD2' ' OD1' ' B' ' 47' ' ' ASN . 13.1 mptt -85.66 -59.44 2.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.222 0.534 . . . . 0.0 110.369 174.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -89.25 -29.75 19.0 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -169.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.7 m -99.45 138.41 20.48 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -74.7 -22.09 15.89 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.281 1.32 . . . . 0.0 109.708 173.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 3.1 p -95.43 132.7 40.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.546 -176.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.32 146.38 34.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.42 ' CD1' HD11 ' A' ' 91' ' ' ILE . 4.8 tt -96.97 132.85 40.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 123.112 0.565 . . . . 0.0 110.317 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.462 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 28.3 m -138.03 171.93 14.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.556 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.558 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -125.05 139.8 53.47 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.12 142.03 41.77 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.631 HD12 ' HB2' ' B' ' 37' ' ' PRO . 85.2 mt -100.2 133.11 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.281 -1.781 . . . . 0.0 109.389 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 95.7 m -123.41 104.72 9.26 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.601 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.249 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 13.2 mt . . . . . 0 N--CA 1.437 -1.119 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.98 -12.69 33.35 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 122.157 1.905 . . . . 0.0 113.671 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -88.78 -19.09 26.45 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.395 0.617 . . . . 0.0 110.651 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -96.21 130.26 43.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.38 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 95.1 t -126.53 130.45 71.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 O-C-N 122.174 -0.329 . . . . 0.0 110.359 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -101.32 139.49 36.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.78 HG23 ' HG2' ' B' ' 110' ' ' LYS . 0.7 OUTLIER -115.36 162.96 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 123.157 0.583 . . . . 0.0 111.754 -173.653 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.415 ' H ' HG22 ' B' ' 73' ' ' ILE . 1.3 mp0 -66.3 109.91 2.86 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 123.785 0.834 . . . . 0.0 110.409 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' LYS . . . . . 0.451 ' HB3' ' HA ' ' B' ' 83' ' ' ASP . 20.0 pttm -58.13 -34.98 70.82 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.873 0.844 . . . . 0.0 112.066 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -53.32 -44.19 68.21 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.177 -1.828 . . . . 0.0 110.941 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -84.51 -35.2 23.06 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.472 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.636 ' CE1' HG21 ' B' ' 73' ' ' ILE . 1.6 m-85 -73.43 -11.49 60.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.926 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 81.59 13.81 0.61 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.222 1.409 . . . . 0.0 112.089 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.8 179.29 5.02 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 122.328 1.061 . . . . 0.0 111.189 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -96.27 -25.04 15.93 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 113.673 -1.603 . . . . 0.0 109.845 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -130.34 156.02 45.38 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.451 ' HA ' ' HB3' ' B' ' 75' ' ' LYS . 2.1 m-20 -54.08 144.22 20.09 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.959 0.885 . . . . 0.0 113.239 -175.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 13.1 m -108.27 128.18 54.5 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.644 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.5 t -115.76 129.94 71.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.481 HG22 HD22 ' B' ' 88' ' ' LEU . 1.6 mp -107.4 129.88 60.55 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 mt -102.9 108.87 20.23 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 113.563 -1.653 . . . . 0.0 109.019 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.481 HD22 HG22 ' B' ' 86' ' ' ILE . 3.8 mm? -80.01 4.48 16.87 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.585 0.707 . . . . 0.0 112.451 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.15 -38.9 5.87 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.96 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -85.55 63.67 8.2 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.116 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.558 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.0 pp -108.66 -176.68 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -174.39 178.98 1.89 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 31.5 m -122.38 129.31 51.98 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.768 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 41.8 mt -133.49 145.46 50.21 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 124.513 1.125 . . . . 0.0 109.471 -174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' B' ' 97' ' ' LYS . 2.0 p30 -79.4 151.18 31.07 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 117.977 -1.489 . . . . 0.0 110.284 172.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -37.39 -42.25 0.48 Allowed 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 127.402 2.281 . . . . 0.0 114.685 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.468 ' HB3' ' OD2' ' B' ' 95' ' ' ASP . 7.5 ttpm? -61.17 -18.05 56.14 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 124.665 1.186 . . . . 0.0 112.472 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.589 ' NE ' ' HA ' ' B' ' 98' ' ' ARG . 4.0 mmp_? -88.31 -22.45 23.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.363 -0.835 . . . . 0.0 111.622 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.31 107.83 11.2 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 121.976 0.894 . . . . 0.0 108.974 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -95.24 -57.98 2.27 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 116.823 2.156 . . . . 0.0 116.823 -173.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.525 ' HG3' HD13 ' B' ' 21' ' ' LEU . 12.0 pt-20 -140.15 131.93 27.47 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.979 0.895 . . . . 0.0 112.737 -171.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -63.67 119.46 9.92 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 127.151 2.18 . . . . 0.0 108.429 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.1 -63.66 1.43 Allowed 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 118.564 -1.255 . . . . 0.0 112.048 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.408 HG22 HG11 ' B' ' 19' ' ' VAL . 6.1 t -125.57 -160.48 0.97 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 117.645 -1.622 . . . . 0.0 112.897 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -159.75 150.89 19.54 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 126.803 2.041 . . . . 0.0 108.324 -173.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.34 155.69 17.66 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -70.96 145.76 49.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' B' ' 111' ' ' MET . 2.8 p-10 -62.85 -35.43 79.93 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -176.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.0 -33.17 63.71 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.202 0.525 . . . . 0.0 109.917 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.78 ' HG2' HG23 ' B' ' 73' ' ' ILE . 16.6 tppt? -68.65 -32.96 73.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.531 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -51.83 -45.48 63.97 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.958 173.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.704 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -69.3 -16.88 63.66 Favored 'General case' 0 CA--C 1.477 -1.863 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.237 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 113' ' ' GLU . . . . . 0.588 ' HA ' ' ND2' ' B' ' 116' ' ' ASN . 32.6 mt-10 -85.53 -38.37 18.6 Favored 'General case' 1 N--CA 1.368 -4.55 0 C-N-CA 117.202 -1.799 . . . . 0.0 108.641 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.0 t -56.62 -44.36 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.141 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.03 172.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.639 ' OD2' ' HA ' ' B' ' 112' ' ' LYS . 25.2 m-20 -56.32 -58.1 9.41 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.557 1.17 . . . . 0.0 108.991 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.588 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 1.3 p30 -66.34 -40.49 89.87 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.011 -1.449 . . . . 0.0 112.019 -173.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -59.14 -37.81 78.17 Favored 'General case' 0 CA--C 1.49 -1.364 0 O-C-N 123.636 0.585 . . . . 0.0 109.74 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.48 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.6 tp -69.56 -44.56 70.64 Favored 'General case' 1 N--CA 1.373 -4.294 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.871 -178.24 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 39.2 mtp -68.39 -19.92 64.65 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.643 -0.661 . . . . 0.0 112.124 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' B' ' 117' ' ' ALA . 45.6 mt -78.18 -55.43 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 173.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 34.3 t -52.21 -43.9 64.47 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.113 1.365 . . . . 0.0 111.843 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 8.1 mp -87.74 -2.37 58.57 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.53 7.42 87.53 Favored Glycine 0 C--O 1.241 0.551 0 N-CA-C 117.116 1.606 . . . . 0.0 117.116 170.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.8 -59.19 2.86 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 118.632 1.216 . . . . 0.0 110.937 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 C--N 1.3 -1.559 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.552 -169.616 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -134.42 157.39 46.55 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 42' ' ' GLN . 20.3 ttt85 -67.86 130.5 43.17 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.33 173.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.34 -19.27 11.74 Favored Glycine 0 C--N 1.307 -1.034 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.158 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -93.51 176.06 6.52 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 122.112 0.958 . . . . 0.0 110.461 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 17.4 t -128.32 135.76 61.79 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.194 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.119 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 8.0 m-85 -128.59 145.44 51.14 Favored 'General case' 0 CA--C 1.462 -2.411 0 C-N-CA 124.461 1.104 . . . . 0.0 108.996 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.3 mp -78.9 148.42 32.74 Favored 'General case' 0 N--CA 1.391 -3.411 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 168.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.1 134.48 17.3 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.397 1.06 . . . . 0.0 110.654 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.92 88.58 1.85 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.237 171.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.532 HD22 ' O ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -109.13 25.45 11.79 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 123.265 1.507 . . . . 0.0 109.542 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.663 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 20.2 p -94.28 62.11 0.01 OUTLIER Pre-proline 0 N--CA 1.409 -2.509 0 CA-C-N 112.95 -1.932 . . . . 0.0 116.205 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HB2' ' HB2' ' B' ' 26' ' ' PRO . 13.7 Cg_endo -113.48 29.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.556 0 N-CA-C 106.288 -2.235 . . . . 0.0 106.288 153.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.673 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 35.3 m -73.5 165.21 3.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.645 -176.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.09 141.42 30.03 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.086 -1.416 . . . . 0.0 113.307 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.83 -108.82 2.31 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.786 -1.097 . . . . 0.0 115.354 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -84.46 -5.94 59.33 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 124.264 1.025 . . . . 0.0 113.074 -173.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.673 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 71.2 mt-10 -77.4 161.65 27.84 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.458 ' HG3' ' OE1' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -125.33 156.5 38.59 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.133 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.71 -149.07 18.52 Favored Glycine 0 N--CA 1.407 -3.283 0 C-N-CA 118.462 -1.828 . . . . 0.0 114.417 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.663 ' HA2' ' HB3' ' A' ' 25' ' ' SER . . . 140.55 -156.14 25.11 Favored Glycine 0 C--N 1.276 -2.772 0 N-CA-C 103.61 -3.796 . . . . 0.0 103.61 -171.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.0 100.07 10.27 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.168 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 165.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -131.63 146.45 61.92 Favored Pre-proline 0 C--N 1.258 -3.398 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.671 -167.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 47.6 Cg_exo -56.28 134.36 63.78 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.395 2.063 . . . . 0.0 111.203 171.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 29.4 m -125.28 159.11 32.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.493 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.9 m -97.89 130.26 46.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.55 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.8 mm -88.73 101.88 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.69 -20.36 5.54 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.863 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.681 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -54.86 158.91 2.5 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -170.2 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.458 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 19.0 p-10 -63.51 175.41 1.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.886 -1.507 . . . . 0.0 112.418 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -52.89 52.46 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.27 -1.786 . . . . 0.0 112.937 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -80.55 -24.17 39.47 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -163.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.69 -26.35 72.97 Favored Glycine 0 C--O 1.212 -1.23 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.991 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -73.96 -32.76 63.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.497 0.665 . . . . 0.0 110.162 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -85.45 -64.48 1.15 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.689 -173.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -96.5 -28.67 14.3 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -171.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.1 m -86.4 155.02 57.15 Favored Pre-proline 0 C--N 1.298 -1.659 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.149 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.561 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . 61.6 Cg_endo -98.26 17.05 0.51 Allowed 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 122.779 2.319 . . . . 0.0 111.425 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 p -130.56 145.8 51.95 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.415 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.572 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -146.2 139.28 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.588 0.555 . . . . 0.0 111.565 174.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.681 HG22 ' HG3' ' A' ' 42' ' ' GLN . 8.9 tt -82.2 133.71 28.59 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 CA-C-O 121.663 0.744 . . . . 0.0 111.392 175.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 29.9 m -135.85 162.56 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.712 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.557 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -123.48 139.23 54.23 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.05 134.78 47.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.577 HG12 HD12 ' A' ' 86' ' ' ILE . 54.9 mt -93.25 112.71 26.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.038 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.5 m -99.85 119.56 38.38 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.349 0.659 . . . . 0.0 109.747 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.704 0 C-N-CA 120.581 -0.818 . . . . 0.0 114.992 -172.742 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 N--CA 1.443 -0.78 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.38 5.51 0.32 Allowed 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.436 2.757 . . . . 0.0 115.583 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.524 ' HA ' ' OG ' ' A' ' 121' ' ' SER . 68.4 p -96.77 -18.46 19.59 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 122.23 1.014 . . . . 0.0 109.137 176.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.03 129.91 48.46 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.3 p -124.62 137.55 56.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.252 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -92.92 148.13 22.27 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.166 0.507 . . . . 0.0 111.352 -176.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 84' ' ' SER . 1.9 pp -124.6 148.15 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.816 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -90.55 108.82 20.04 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.676 0.75 . . . . 0.0 109.561 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HD2' ' C ' ' A' ' 81' ' ' ASP . 37.6 pttt -45.06 -39.07 5.43 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 126.217 1.807 . . . . 0.0 115.217 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -45.89 -49.38 15.62 Favored 'General case' 0 C--N 1.267 -2.984 0 C-N-CA 126.131 1.772 . . . . 0.0 111.8 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -91.76 -41.21 10.81 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 118.805 -1.158 . . . . 0.0 112.266 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.495 ' HD1' ' O ' ' A' ' 105' ' ' TYR . 2.3 m-85 -110.8 -19.48 12.82 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -164.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.453 ' HG2' ' HB2' ' A' ' 84' ' ' SER . 56.8 tptt -154.78 46.56 0.54 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 117.242 -1.783 . . . . 0.0 114.644 -167.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 65.81 -131.66 0.22 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.432 0.693 . . . . 0.0 111.151 163.493 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.51 ' C ' ' HD2' ' A' ' 75' ' ' LYS . 23.6 t70 -88.57 -5.76 57.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.652 1.181 . . . . 0.0 109.437 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -106.67 116.33 31.75 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.436 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 5.0 p-10 -83.22 117.11 22.72 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.453 ' HB2' ' HG2' ' A' ' 79' ' ' LYS . 13.2 t -113.65 157.93 21.51 Favored 'General case' 0 N--CA 1.406 -2.658 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.676 -166.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.01 139.16 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.577 HD12 HG12 ' A' ' 58' ' ' ILE . 17.3 mm -105.27 129.95 57.25 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 52.0 mt -101.24 110.56 22.59 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.478 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.2 mm? -84.01 -7.33 59.43 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 121.677 0.751 . . . . 0.0 111.168 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.546 ' O ' HG21 ' B' ' 93' ' ' THR . 10.4 pt-20 -84.74 -42.25 15.41 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.185 173.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.458 ' OE1' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -92.85 73.84 4.88 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.995 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.609 ' O ' ' HB ' ' B' ' 93' ' ' THR . 2.4 pp -117.58 179.73 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.91 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.524 ' NH1' HG12 ' A' ' 27' ' ' VAL 0.261 11.5 ptp180 -174.94 157.76 2.42 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 99.4 m -105.19 126.5 52.15 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.591 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.2 mt -131.36 150.13 52.27 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 124.137 0.898 . . . . 0.0 111.184 -169.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -51.52 141.56 15.72 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.707 0.629 . . . . 0.0 110.108 170.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 51' ' ' PRO . 44.4 mtmt -64.5 -18.82 65.15 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 120.981 0.42 . . . . 0.0 111.971 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -75.5 -9.64 58.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.11 0.481 . . . . 0.0 110.914 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.542 ' HA ' ' NE ' ' A' ' 98' ' ' ARG . 3.8 mmp_? -86.63 -36.5 18.77 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -73.39 121.74 20.96 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.616 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -106.05 -61.16 1.55 Allowed 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.2 pt-20 -143.1 130.6 21.16 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -168.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 22.0 ttmm -60.75 113.19 2.35 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 112.221 -2.263 . . . . 0.0 109.045 174.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.3 tp -112.97 -63.27 1.47 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.495 ' H ' ' HB ' ' A' ' 19' ' ' VAL 0.273 5.7 t -120.89 -167.08 1.42 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 117.703 -1.599 . . . . 0.0 111.115 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.495 ' O ' ' HD1' ' A' ' 78' ' ' TYR . 13.8 p90 -160.29 142.93 13.28 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 123.687 0.795 . . . . 0.0 111.66 -169.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.413 ' HA ' ' CD1' ' A' ' 78' ' ' TYR . 32.3 mt -111.55 161.4 16.22 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.142 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 111' ' ' MET . 30.2 p -92.63 167.14 12.11 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 123.906 0.882 . . . . 0.0 109.878 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.35 -31.41 72.52 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.458 0.647 . . . . 0.0 111.394 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.07 -38.51 79.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.858 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -70.86 -35.14 72.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -52.71 -49.21 65.81 Favored 'General case' 0 CA--C 1.483 -1.607 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.011 177.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 28.9 mtmm -50.08 -41.74 48.73 Favored 'General case' 0 CA--C 1.477 -1.836 0 O-C-N 124.319 1.012 . . . . 0.0 112.62 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -80.21 -32.17 38.58 Favored 'General case' 0 CA--C 1.443 -3.166 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -165.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.63 -55.64 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.761 0 CA-C-N 112.776 -2.011 . . . . 0.0 109.968 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 62.3 m-20 -57.46 -50.94 71.41 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 122.237 1.018 . . . . 0.0 110.495 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.672 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -61.6 -46.57 89.27 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.703 -178.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.478 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.76 -42.66 89.42 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 12.7 tp -65.56 -47.07 77.09 Favored 'General case' 0 N--CA 1.402 -2.874 0 C-N-CA 125.184 1.394 . . . . 0.0 110.299 -175.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.512 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.19 -29.46 57.94 Favored 'General case' 0 N--CA 1.414 -2.245 0 C-N-CA 124.832 1.253 . . . . 0.0 111.212 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 116' ' ' ASN . 40.6 mt -86.44 -54.0 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.524 ' OG ' ' HA ' ' A' ' 69' ' ' THR . 72.8 m -46.88 -33.56 4.64 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.516 -1.674 . . . . 0.0 112.757 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 21.7 mt -100.5 -0.29 38.17 Favored 'General case' 0 C--O 1.189 -2.113 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.999 -177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.51 7.78 71.69 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 119.591 -1.29 . . . . 0.0 116.295 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.512 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 4.9 mp -63.71 -50.17 70.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 122.7 1.238 . . . . 0.0 108.353 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . 0.305 0.1 OUTLIER . . . . . 1 N--CA 1.362 -4.847 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 170.438 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 58.8 mt . . . . . 0 N--CA 1.418 -2.056 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' B' ' 18' ' ' ASP . 19.2 ptt180 -127.97 159.13 35.93 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' B' ' 42' ' ' GLN . 21.0 ttt85 -69.44 130.74 43.35 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.75 -20.34 10.08 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.002 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ASP . . . . . 0.437 ' CG ' ' HE ' ' B' ' 15' ' ' ARG . 57.0 m-20 -93.74 175.47 6.72 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-O 122.272 1.034 . . . . 0.0 110.736 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 12.7 t -128.38 135.95 61.28 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.0 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 5.9 m-85 -129.16 145.93 51.2 Favored 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 124.506 1.122 . . . . 0.0 109.061 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.517 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.4 mp -79.47 148.32 31.92 Favored 'General case' 0 N--CA 1.394 -3.254 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 167.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -150.83 134.75 16.66 Favored 'General case' 0 C--N 1.265 -3.099 0 O-C-N 124.361 1.038 . . . . 0.0 111.014 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.8 86.72 1.26 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 171.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.476 ' C ' ' HD3' ' B' ' 26' ' ' PRO 0.252 0.0 OUTLIER -104.81 23.73 12.99 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 123.156 1.455 . . . . 0.0 109.643 -179.62 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.662 ' HB3' ' HA2' ' B' ' 34' ' ' GLY . 3.5 p -94.54 62.58 0.01 OUTLIER Pre-proline 0 N--CA 1.405 -2.676 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.565 ' HB2' ' HB2' ' A' ' 26' ' ' PRO . 15.5 Cg_endo -113.72 27.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.574 0 N-CA-C 106.822 -2.03 . . . . 0.0 106.822 153.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.666 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 34.1 m -72.84 165.87 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.886 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.19 140.98 29.64 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.863 -1.517 . . . . 0.0 113.698 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.65 -108.38 2.19 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -79.41 -15.49 57.75 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 124.011 0.925 . . . . 0.0 112.5 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.666 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 71.6 mt-10 -69.65 165.92 20.2 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.63 130.98 49.91 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -172.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.35 -163.11 36.36 Favored Glycine 0 N--CA 1.408 -3.212 0 C-N-CA 117.735 -2.174 . . . . 0.0 115.278 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.662 ' HA2' ' HB3' ' B' ' 25' ' ' SER . . . 158.9 -162.05 32.33 Favored Glycine 0 C--N 1.266 -3.321 1 N-CA-C 102.664 -4.174 . . . . 0.0 102.664 -171.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.42 99.85 9.94 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 166.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -132.44 147.19 64.68 Favored Pre-proline 0 C--N 1.257 -3.418 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.606 -167.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 51.3 Cg_exo -55.48 135.41 69.09 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.538 2.159 . . . . 0.0 112.034 173.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 28.2 m -126.21 158.65 35.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 123.849 0.86 . . . . 0.0 108.969 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.495 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 32.9 m -98.01 130.55 46.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.672 0.272 . . . . 0.0 110.666 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 18.6 mm -88.91 102.09 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.22 -20.38 5.53 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.897 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.661 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -55.06 159.34 2.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -170.275 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.433 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 19.1 p-10 -62.47 178.95 0.37 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.491 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.72 -46.59 30.2 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.958 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -79.4 -26.49 41.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -166.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.27 -26.74 72.64 Favored Glycine 0 C--O 1.209 -1.461 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.25 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -73.69 -31.16 63.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.759 0.79 . . . . 0.0 110.263 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -85.08 -66.64 0.87 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.59 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -96.37 -27.55 14.89 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 43.5 m -86.07 154.15 57.56 Favored Pre-proline 0 C--N 1.295 -1.803 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.533 ' HA ' ' HE2' ' B' ' 96' ' ' LYS . 68.7 Cg_endo -98.52 15.01 0.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.643 2.229 . . . . 0.0 111.231 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.7 p -128.14 147.01 50.53 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.295 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.558 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -147.07 139.24 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 123.632 0.582 . . . . 0.0 111.254 174.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.661 HG22 ' HG3' ' B' ' 42' ' ' GLN . 8.5 tt -82.22 133.7 28.61 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 CA-C-O 121.73 0.776 . . . . 0.0 111.422 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 29.7 m -135.72 160.04 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.859 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.551 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -120.68 139.16 53.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.44 135.27 45.72 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.557 HG12 HD12 ' B' ' 86' ' ' ILE . 55.3 mt -90.97 113.74 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.457 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 41.1 m -101.03 110.05 22.03 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 121.769 0.795 . . . . 0.0 111.371 -175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.488 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 172.697 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 tt . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.11 5.14 0.17 Allowed 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.489 2.793 . . . . 0.0 115.845 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' THR . . . . . 0.482 ' HA ' ' OG ' ' B' ' 121' ' ' SER . 64.7 p -98.75 -18.62 17.9 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 122.16 0.981 . . . . 0.0 109.238 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -103.5 129.56 50.7 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.91 135.38 64.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.377 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.67 143.98 26.36 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-O 121.347 0.594 . . . . 0.0 111.642 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 84' ' ' SER . 2.0 pp -119.26 150.76 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.002 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -94.85 109.66 21.62 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.769 0.795 . . . . 0.0 110.565 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' B' ' 80' ' ' LEU . 38.6 pttt -43.67 -42.0 5.05 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.528 1.931 . . . . 0.0 115.252 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -46.0 -46.94 16.79 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 126.456 1.902 . . . . 0.0 111.736 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -92.19 -42.92 9.62 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.074 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.564 ' HD1' ' O ' ' B' ' 105' ' ' TYR . 7.1 m-85 -111.82 -18.3 12.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -164.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -156.09 47.84 0.48 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 117.756 -1.578 . . . . 0.0 114.478 -167.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' B' ' 75' ' ' LYS . 0.0 OUTLIER 63.68 -133.73 0.37 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.962 0.905 . . . . 0.0 111.203 164.176 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.481 ' O ' ' HD2' ' B' ' 75' ' ' LYS . 12.7 t70 -86.08 -6.71 58.97 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 125.08 1.352 . . . . 0.0 110.057 175.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -105.47 114.95 29.43 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 119.383 -0.927 . . . . 0.0 113.349 -174.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.44 ' N ' ' HD3' ' B' ' 75' ' ' LYS . 7.2 p-10 -80.11 117.34 20.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.459 ' O ' HG13 ' B' ' 73' ' ' ILE . 14.7 t -114.11 158.26 21.51 Favored 'General case' 0 N--CA 1.407 -2.624 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.579 -168.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 t -116.57 139.73 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.557 HD12 HG12 ' B' ' 58' ' ' ILE . 18.7 mm -104.96 129.98 56.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.27 110.32 22.55 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.2 mm? -84.02 -6.76 59.47 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.637 0.732 . . . . 0.0 111.013 -175.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' GLU . . . . . 0.561 ' O ' HG21 ' A' ' 93' ' ' THR . 10.5 pt-20 -86.99 -39.64 15.49 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.631 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 73.93 3.75 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.927 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.604 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.4 pp -117.76 179.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.949 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.524 ' NH1' HG12 ' B' ' 27' ' ' VAL 0.254 12.1 ptp180 -174.98 157.42 2.34 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 172.179 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.609 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 97.2 m -105.09 126.87 52.54 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.622 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 49.1 mt -131.28 150.18 52.25 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 124.246 0.966 . . . . 0.0 111.143 -169.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -50.65 140.01 15.22 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.23 0.612 . . . . 0.0 109.764 170.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' B' ' 51' ' ' PRO . 43.1 mtmt -61.45 -23.02 65.56 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 122.68 0.392 . . . . 0.0 111.622 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -70.3 -17.95 63.09 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' B' ' 98' ' ' ARG . 4.5 mmp_? -80.38 -33.32 37.27 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.827 -0.546 . . . . 0.0 109.937 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.8 mp -74.89 117.43 16.73 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.966 0.889 . . . . 0.0 109.759 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -100.64 -59.35 1.72 Allowed 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -147.28 133.95 19.94 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -170.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 21.6 ttmm -60.76 114.29 2.95 Favored 'General case' 0 C--N 1.284 -2.253 0 C-N-CA 127.458 2.303 . . . . 0.0 108.778 174.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 tp -112.78 -62.89 1.52 Allowed 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.505 HG22 HG11 ' B' ' 19' ' ' VAL . 5.0 t -122.1 -167.12 1.5 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.119 -1.432 . . . . 0.0 111.022 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.564 ' O ' ' HD1' ' B' ' 78' ' ' TYR . 15.7 p90 -160.21 141.3 12.24 Favored 'General case' 0 CA--C 1.488 -1.428 0 C-N-CA 123.818 0.847 . . . . 0.0 111.359 -170.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.504 ' HA ' ' CD1' ' B' ' 78' ' ' TYR . 32.1 mt -107.23 168.18 9.4 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 124.305 1.003 . . . . 0.0 108.872 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' B' ' 111' ' ' MET . 39.6 p -95.69 167.62 11.17 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.151 0.58 . . . . 0.0 109.6 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' B' ' 111' ' ' MET . 33.5 t70 -67.4 -29.7 69.28 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.897 0.856 . . . . 0.0 109.913 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.16 -39.9 78.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.231 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -71.42 -32.58 68.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 107' ' ' SER . 0.5 OUTLIER -53.99 -48.77 70.06 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.836 177.257 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.738 ' O ' ' HB3' ' B' ' 116' ' ' ASN 0.271 20.1 mtmm -49.27 -43.23 42.84 Favored 'General case' 0 CA--C 1.467 -2.236 0 O-C-N 124.583 1.177 . . . . 0.0 111.96 175.642 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -79.44 -33.5 42.44 Favored 'General case' 0 CA--C 1.446 -3.037 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -163.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.18 -53.37 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.644 0 CA-C-N 112.548 -2.115 . . . . 0.0 110.263 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 69.3 m-20 -58.63 -52.14 66.94 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 122.437 1.113 . . . . 0.0 110.219 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.738 ' HB3' ' O ' ' B' ' 112' ' ' LYS . 0.4 OUTLIER -67.9 -30.51 69.87 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.394 -175.01 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.447 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -71.64 -45.52 61.77 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.631 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 11.0 tp -60.03 -47.38 86.1 Favored 'General case' 0 N--CA 1.4 -2.97 0 C-N-CA 125.78 1.632 . . . . 0.0 110.416 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.535 ' HE2' HG13 ' B' ' 120' ' ' ILE . 0.1 OUTLIER -54.14 -33.08 57.02 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 124.567 1.147 . . . . 0.0 111.303 178.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.535 HG13 ' HE2' ' B' ' 119' ' ' MET . 56.5 mt -82.79 -53.35 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' B' ' 69' ' ' THR . 44.2 m -47.55 -33.07 6.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.724 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 20.3 mt -100.3 -1.63 35.75 Favored 'General case' 0 C--O 1.189 -2.089 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.975 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.73 8.28 70.18 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 173.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.504 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 4.9 mp -63.58 -48.08 78.89 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.693 1.235 . . . . 0.0 108.683 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . 0.292 0.1 OUTLIER . . . . . 1 N--CA 1.366 -4.65 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 170.127 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.241 0.643 0 CA-C-O 120.807 0.337 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -115.6 138.49 51.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 13.8 ptm180 -61.76 134.96 57.39 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.632 170.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.32 -12.81 36.71 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.811 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.79 166.71 22.6 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.512 1.149 . . . . 0.0 110.984 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.673 HG12 ' HB2' ' A' ' 103' ' ' LEU . 42.6 t -130.68 122.7 53.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.949 0 CA-C-N 112.71 -2.041 . . . . 0.0 108.994 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 88.3 m-85 -129.13 147.66 51.0 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 125.872 1.669 . . . . 0.0 110.571 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.3 mp -77.04 148.21 36.31 Favored 'General case' 0 N--CA 1.395 -3.181 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 167.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -139.97 146.6 39.33 Favored 'General case' 0 C--N 1.252 -3.662 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.904 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.551 ' O ' ' HD2' ' A' ' 98' ' ' ARG . 35.1 t70 -84.29 72.29 10.57 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 173.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.711 HD22 ' HA3' ' A' ' 33' ' ' GLY . 3.2 tt -76.79 -36.78 56.74 Favored 'General case' 0 N--CA 1.384 -3.756 0 CA-C-N 111.789 -2.459 . . . . 0.0 110.413 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.659 ' CB ' ' H ' ' A' ' 34' ' ' GLY . 71.4 m -118.5 114.75 36.03 Favored Pre-proline 0 N--CA 1.398 -3.063 1 N-CA-C 121.812 4.005 . . . . 0.0 121.812 -168.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -106.78 27.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.419 -2.902 0 C-N-CA 123.616 2.878 . . . . 0.0 106.015 152.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' A' ' 25' ' ' SER . 26.7 m -88.48 158.42 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 122.191 0.996 . . . . 0.0 112.816 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -152.29 155.83 38.45 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 113.03 -1.895 . . . . 0.0 107.498 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.54 -130.93 10.42 Favored Glycine 0 N--CA 1.416 -2.696 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' B' ' 95' ' ' ASP . 4.7 m -93.92 -7.83 41.91 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.794 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.535 ' HG2' HH12 ' B' ' 92' ' ' ARG . 1.7 mp0 -70.87 155.98 40.14 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.624 -0.831 . . . . 0.0 110.264 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -133.75 120.63 20.79 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -171.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.711 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -155.75 -94.23 0.1 Allowed Glycine 1 N--CA 1.392 -4.292 0 C-N-CA 119.001 -1.571 . . . . 0.0 113.677 172.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.659 ' H ' ' CB ' ' A' ' 25' ' ' SER . . . 79.41 172.81 43.62 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -171.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 4.2 p -75.42 102.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 172.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -144.89 155.23 55.78 Favored Pre-proline 0 C--N 1.263 -3.177 0 CA-C-N 113.48 -1.691 . . . . 0.0 107.983 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 24.5 Cg_exo -66.39 139.33 53.93 Favored 'Trans proline' 0 C--O 1.247 0.964 0 C-N-CA 122.169 1.912 . . . . 0.0 112.803 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.1 m -127.49 163.36 30.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.123 0.969 . . . . 0.0 109.817 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.37 134.31 48.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.329 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -89.38 108.99 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.455 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -105.34 -8.07 9.95 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.701 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.64 -178.019 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.455 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -62.89 169.1 3.44 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -170.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -65.18 175.44 1.64 Allowed 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.923 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.64 -49.66 37.9 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.328 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.402 HG22 ' CD2' ' A' ' 49' ' ' TYR . 7.1 m -86.88 -21.3 26.42 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -169.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.16 -37.02 53.76 Favored Glycine 0 C--O 1.196 -2.273 0 CA-C-N 117.9 0.318 . . . . 0.0 112.682 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.448 ' N ' HE22 ' A' ' 42' ' ' GLN . 8.4 p30 -63.62 -19.38 64.81 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -82.56 -63.82 1.3 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.039 0.536 . . . . 0.0 110.128 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.402 ' CD2' HG22 ' A' ' 45' ' ' THR . 38.2 p90 -83.28 -35.36 25.35 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -172.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.1 m -83.03 136.52 43.87 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.45 -18.53 17.71 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 N-CA-C 108.34 -1.446 . . . . 0.0 108.34 170.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 11.4 p -91.4 150.67 21.16 Favored 'General case' 0 N--CA 1.415 -2.199 0 C-N-CA 125.201 1.4 . . . . 0.0 111.941 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.1 t -133.39 140.11 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 173.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.1 tt -110.23 128.7 66.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 CA-C-O 121.183 0.516 . . . . 0.0 109.929 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.516 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 32.7 m -132.39 173.18 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.941 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -128.41 143.68 51.03 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.02 132.77 41.58 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.3 mt -89.05 119.09 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.372 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.9 m -121.53 116.47 24.73 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 121.317 0.58 . . . . 0.0 110.834 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.481 ' HA3' ' HD2' ' A' ' 82' ' ' LYS . . . . . . . . 0 N--CA 1.422 -2.288 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.0 tt . . . . . 0 N--CA 1.425 -1.685 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.28 -4.22 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.64 2.894 . . . . 0.0 116.546 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.9 p -101.97 -18.84 15.48 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.913 -0.492 . . . . 0.0 111.039 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -112.24 128.92 56.39 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -117.09 133.0 65.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.727 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.1 128.57 53.41 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.288 0.566 . . . . 0.0 110.559 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.491 HG21 ' CZ ' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -124.81 154.88 32.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 123.585 0.754 . . . . 0.0 112.046 -176.5 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.78 141.0 53.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.764 0.792 . . . . 0.0 112.246 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -60.85 -34.58 74.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.358 -1.746 . . . . 0.0 109.2 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -55.27 -53.07 60.78 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.479 -1.691 . . . . 0.0 114.395 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -88.52 -35.83 16.75 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.094 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.491 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 6.6 m-85 -78.35 -5.15 51.36 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.727 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt 50.44 36.62 13.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.698 1.999 . . . . 0.0 115.183 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 78' ' ' TYR . 8.8 mp -87.21 -176.78 5.8 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 122.106 0.955 . . . . 0.0 110.892 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.34 -7.34 48.15 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.82 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HD2' ' HA3' ' A' ' 60' ' ' GLY . 10.2 ptpp? -153.52 164.23 38.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -56.66 147.5 22.43 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.228 0.537 . . . . 0.0 111.001 173.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.3 m -108.09 132.51 53.5 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.744 -172.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.3 t -118.44 124.45 73.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 HD22 ' A' ' 88' ' ' LEU . 1.7 mp -110.71 127.57 67.68 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.013 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.7 mt -99.91 103.64 15.23 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.241 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.519 HD22 HG22 ' A' ' 86' ' ' ILE . 3.3 mm? -86.11 70.89 10.62 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -176.83 -48.54 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.47 84.79 4.77 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 55' ' ' VAL . 2.0 pp -121.11 179.12 2.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.07 -175.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.567 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 12.1 tpt85 -152.31 146.79 25.66 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.7 m -115.5 120.11 38.43 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.567 ' HG ' ' HG3' ' A' ' 92' ' ' ARG . 29.4 mt -130.99 143.99 51.14 Favored 'General case' 0 C--O 1.198 -1.606 0 C-N-CA 125.235 1.414 . . . . 0.0 110.343 -171.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -77.03 152.4 35.14 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 117.075 -1.85 . . . . 0.0 110.957 170.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -42.31 -27.12 0.13 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 126.551 1.94 . . . . 0.0 115.767 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.434 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 9.5 ptpp? -71.25 -21.93 62.04 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 118.736 0.698 . . . . 0.0 111.465 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 36.2 mmt180 -68.35 -33.77 74.88 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.773 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.63 115.75 10.14 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 124.436 1.094 . . . . 0.0 110.939 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -96.89 -63.83 1.1 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.183 -1.372 . . . . 0.0 114.213 -174.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.6 pt-20 -156.05 143.77 19.52 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-O 121.939 0.876 . . . . 0.0 111.665 -172.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttmm -66.82 123.61 20.62 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 112.468 -2.151 . . . . 0.0 111.558 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.673 ' HB2' HG12 ' A' ' 19' ' ' VAL . 3.8 mm? -93.43 -62.82 1.29 Allowed 'General case' 0 CA--C 1.472 -2.042 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 78' ' ' TYR . 7.2 t -150.87 -155.66 0.64 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.038 -1.892 . . . . 0.0 111.678 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -161.37 148.3 14.69 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.974 1.71 . . . . 0.0 109.538 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.34 153.0 39.56 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.766 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.3 p -83.71 161.2 21.11 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.12 -40.38 95.72 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.036 0.922 . . . . 0.0 110.981 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.54 -16.3 62.37 Favored 'General case' 0 C--O 1.194 -1.829 0 C-N-CA 125.107 1.363 . . . . 0.0 111.282 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.412 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 67.1 mttm -91.33 -36.65 13.73 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 120.468 -1.395 . . . . 0.0 109.898 168.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.444 ' HG2' ' OD2' ' A' ' 115' ' ' ASP 0.327 38.5 ttm -64.4 -26.04 68.29 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -177.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.719 ' HE3' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -57.87 -14.5 6.21 Favored 'General case' 0 C--N 1.248 -3.818 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 173.378 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.719 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 42.8 mt-10 -87.65 -54.44 4.26 Favored 'General case' 1 C--O 1.148 -4.254 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 171.602 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 111' ' ' MET . 2.1 t -47.05 -52.34 4.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-N 113.862 -1.517 . . . . 0.0 114.176 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 22.4 m-20 -66.05 -45.4 81.5 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 123.536 1.636 . . . . 0.0 110.838 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 112' ' ' LYS 0.256 9.3 t30 -73.83 -39.84 63.76 Favored 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 112.937 -1.938 . . . . 0.0 113.037 -171.622 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.6 -39.05 79.32 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 125.447 1.499 . . . . 0.0 108.077 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.55 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 8.8 tp -70.06 -38.12 75.71 Favored 'General case' 1 N--CA 1.373 -4.286 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.964 -175.184 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 47.7 mtp -68.51 -19.59 64.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.891 -0.505 . . . . 0.0 111.31 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 117' ' ' ALA . 49.5 mt -82.22 -59.15 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.1 m -48.15 -47.69 34.67 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 125.067 1.479 . . . . 0.0 111.975 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.19 -0.39 57.04 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.84 19.11 73.1 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.421 ' HG ' ' OD1' ' B' ' 115' ' ' ASP . 7.0 mp -70.52 -50.29 39.26 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 118.571 1.186 . . . . 0.0 108.508 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.435 -1.224 0 CA-C-N 113.162 -1.835 . . . . 0.0 109.613 -174.113 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 69.2 mt . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -115.9 137.98 51.6 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 13.9 ptm180 -63.12 128.89 37.93 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.144 -1.023 . . . . 0.0 109.008 171.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.17 -11.94 26.58 Favored Glycine 0 N--CA 1.426 -2.017 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.458 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -76.42 166.99 22.65 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 122.544 1.164 . . . . 0.0 110.836 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.685 HG12 ' HB2' ' B' ' 103' ' ' LEU . 40.9 t -130.92 124.25 55.84 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.066 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.757 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -131.0 148.3 52.74 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 125.79 1.636 . . . . 0.0 110.015 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 1.3 mp -77.13 147.59 36.48 Favored 'General case' 0 N--CA 1.395 -3.207 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 167.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -140.82 145.42 36.26 Favored 'General case' 0 C--N 1.248 -3.82 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.161 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.606 ' O ' ' HD2' ' B' ' 98' ' ' ARG . 35.7 t70 -85.28 78.14 9.85 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 172.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.648 HD22 ' HA3' ' B' ' 33' ' ' GLY . 3.4 tt -79.34 -35.22 41.36 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 111.796 -2.456 . . . . 0.0 110.155 -167.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.655 ' CB ' ' H ' ' B' ' 34' ' ' GLY . 73.3 m -118.25 113.64 37.06 Favored Pre-proline 0 N--CA 1.405 -2.692 1 N-CA-C 122.231 4.16 . . . . 0.0 122.231 -168.242 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -103.95 24.14 0.11 Allowed 'Trans proline' 0 N--CA 1.418 -2.964 0 C-N-CA 123.056 2.504 . . . . 0.0 106.38 152.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' B' ' 25' ' ' SER . 19.3 m -85.82 165.02 2.32 Favored 'Isoleucine or valine' 0 C--N 1.373 1.624 0 CA-C-O 121.899 0.857 . . . . 0.0 112.337 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -158.93 159.13 34.56 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 113.187 -1.824 . . . . 0.0 106.77 174.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.96 -135.8 12.63 Favored Glycine 0 N--CA 1.421 -2.351 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 5.4 m -93.68 -0.6 55.98 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.797 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.478 ' HG2' HH12 ' A' ' 92' ' ' ARG . 1.4 mp0 -73.07 159.98 32.74 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.793 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -136.95 119.08 15.46 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.648 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -155.88 -95.16 0.11 Allowed Glycine 0 N--CA 1.4 -3.707 0 C-N-CA 118.928 -1.606 . . . . 0.0 114.095 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.655 ' H ' ' CB ' ' B' ' 25' ' ' SER . . . 80.27 -177.94 54.1 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -171.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 3.5 p -83.27 99.91 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 CA-C-O 123.586 1.66 . . . . 0.0 107.175 172.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -140.66 154.03 68.63 Favored Pre-proline 0 C--N 1.257 -3.428 0 CA-C-N 113.023 -1.899 . . . . 0.0 108.149 -168.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 25.9 Cg_exo -66.11 138.56 52.43 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 122.239 1.959 . . . . 0.0 112.504 174.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.2 163.06 28.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 123.931 0.893 . . . . 0.0 109.902 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.85 134.1 48.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.364 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.408 HD13 HG12 ' B' ' 55' ' ' VAL . 27.2 mm -89.29 109.98 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.451 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -105.59 -8.22 10.05 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.734 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.534 -178.19 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.486 ' OE1' HG13 ' B' ' 53' ' ' VAL . 5.4 pt20 -64.22 169.61 4.4 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -169.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -65.08 173.37 2.45 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.458 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.95 -46.35 52.9 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.623 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.41 HG22 ' CD2' ' B' ' 49' ' ' TYR . 8.5 m -87.79 -21.59 25.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.58 -35.82 57.69 Favored Glycine 0 C--O 1.195 -2.288 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -64.77 -19.05 65.6 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -81.91 -62.11 1.73 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 122.928 0.491 . . . . 0.0 109.701 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' B' ' 45' ' ' THR . 34.9 p90 -83.94 -34.57 24.42 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 46.5 m -85.98 141.09 35.21 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -77.07 -19.84 13.41 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 121.222 1.281 . . . . 0.0 108.78 170.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 5.3 p -90.4 150.56 21.81 Favored 'General case' 0 N--CA 1.413 -2.298 0 C-N-CA 124.818 1.247 . . . . 0.0 112.111 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.486 HG13 ' OE1' ' B' ' 42' ' ' GLN . 94.4 t -132.28 140.06 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 tt -111.08 126.48 68.48 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-O 121.294 0.569 . . . . 0.0 110.012 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.531 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 27.1 m -131.21 173.23 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.034 -174.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.455 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -128.21 143.91 51.08 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.67 134.95 40.44 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 62.7 mt -90.75 122.39 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 113.056 -1.883 . . . . 0.0 106.727 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 98.3 m -123.51 117.04 24.2 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.461 0.648 . . . . 0.0 110.666 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.434 ' HA3' ' HD2' ' B' ' 82' ' ' LYS . . . . . . . . 0 N--CA 1.412 -2.915 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 173.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tt . . . . . 0 N--CA 1.421 -1.879 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.72 -18.35 12.04 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.759 2.972 . . . . 0.0 116.47 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 77.4 p -91.53 -19.13 23.1 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.079 0.399 . . . . 0.0 111.664 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -109.97 128.81 55.61 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.37 132.01 68.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.813 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.89 130.83 54.5 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.313 0.577 . . . . 0.0 110.275 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.496 HG21 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -125.24 154.64 33.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.634 -176.172 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.47 136.47 53.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.557 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -57.4 -34.22 68.65 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.385 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -55.78 -53.25 58.98 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.589 -1.641 . . . . 0.0 113.942 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -89.68 -31.86 17.3 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.052 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.496 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 6.2 m-85 -81.02 -5.68 57.89 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.735 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt 50.14 38.0 15.95 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.697 1.999 . . . . 0.0 115.151 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.43 HD12 ' O ' ' B' ' 78' ' ' TYR . 9.2 mp -88.93 -178.09 5.64 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.567 1.175 . . . . 0.0 111.032 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.84 -4.78 56.33 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.503 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.434 ' HD2' ' HA3' ' B' ' 60' ' ' GLY . 10.1 ptpp? -156.41 165.02 37.56 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -177.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -54.27 152.04 6.72 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.192 0.52 . . . . 0.0 110.953 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 15.9 m -111.51 131.42 55.24 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.167 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 8.0 t -117.79 124.33 72.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.508 HG22 HD22 ' B' ' 88' ' ' LEU . 1.6 mp -110.74 126.59 68.09 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 56.0 mt -98.47 102.22 13.89 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.215 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.508 HD22 HG22 ' B' ' 86' ' ' ILE . 3.6 mm? -83.95 72.06 10.46 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.753 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -178.39 -48.57 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.44 85.54 5.38 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 2.0 pp -122.19 179.05 2.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.153 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.575 ' HG3' ' HG ' ' B' ' 94' ' ' LEU . 12.2 tpt85 -152.41 146.76 25.57 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 86.0 m -115.92 119.49 36.1 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.575 ' HG ' ' HG3' ' B' ' 92' ' ' ARG . 22.7 mt -130.95 143.55 50.81 Favored 'General case' 0 C--O 1.196 -1.751 0 C-N-CA 125.352 1.461 . . . . 0.0 110.397 -171.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 0.3 OUTLIER -76.79 152.38 35.58 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.661 170.777 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -41.91 -27.51 0.12 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.416 1.886 . . . . 0.0 115.549 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -69.38 -21.84 63.76 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.697 0.681 . . . . 0.0 111.589 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 37.7 mmt180 -69.85 -35.68 74.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.105 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.19 114.47 8.37 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 124.113 0.965 . . . . 0.0 110.735 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -94.96 -65.75 0.96 Allowed 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.087 -1.415 . . . . 0.0 114.164 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.92 139.47 16.92 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 121.742 0.782 . . . . 0.0 111.837 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 22.4 ttmm -64.56 121.28 14.07 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 127.595 2.358 . . . . 0.0 111.628 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.685 ' HB2' HG12 ' B' ' 19' ' ' VAL . 3.8 mm? -91.91 -63.04 1.3 Allowed 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.401 ' H ' ' HB ' ' B' ' 19' ' ' VAL . 7.2 t -149.13 -156.27 0.71 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.827 -174.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -161.54 145.94 13.1 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 125.949 1.7 . . . . 0.0 109.886 -170.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.17 148.93 44.33 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.294 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.5 p -81.76 158.32 24.19 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.179 -0.918 . . . . 0.0 113.075 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -57.26 -42.36 81.4 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.621 1.168 . . . . 0.0 112.034 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.09 -16.51 64.0 Favored 'General case' 0 C--O 1.178 -2.681 0 C-N-CA 124.71 1.204 . . . . 0.0 111.366 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.419 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 66.3 mttm -90.63 -33.68 15.75 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.525 -1.359 . . . . 0.0 109.563 169.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.445 ' HG2' ' OD2' ' B' ' 115' ' ' ASP 0.307 34.7 ttm -65.06 -25.16 67.69 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.742 ' HE3' ' N ' ' B' ' 113' ' ' GLU . 0.0 OUTLIER -58.87 -13.8 7.26 Favored 'General case' 0 C--N 1.248 -3.826 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 174.129 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 113' ' ' GLU . . . . . 0.742 ' N ' ' HE3' ' B' ' 112' ' ' LYS . 43.8 mt-10 -87.22 -54.47 4.29 Favored 'General case' 0 CA--C 1.429 -3.703 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 172.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' B' ' 111' ' ' MET . 2.1 t -47.17 -52.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.01 -1.904 . . . . 0.0 113.93 -177.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 16.7 m-20 -64.21 -48.48 75.73 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 123.331 1.539 . . . . 0.0 111.145 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.435 ' O ' HG13 ' B' ' 120' ' ' ILE 0.316 9.0 t30 -72.03 -39.09 69.37 Favored 'General case' 0 C--N 1.268 -2.953 0 C-N-CA 126.77 2.028 . . . . 0.0 112.795 -170.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.477 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -62.23 -37.97 87.45 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 124.284 1.033 . . . . 0.0 108.565 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.507 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.9 tp -69.18 -36.48 77.38 Favored 'General case' 1 N--CA 1.366 -4.627 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.682 -176.44 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 46.5 mtp -69.28 -19.71 63.91 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 121.997 -0.439 . . . . 0.0 110.932 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' B' ' 117' ' ' ALA . 52.1 mt -81.88 -58.39 3.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.2 m -52.18 -44.55 64.73 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.263 0.977 . . . . 0.0 111.433 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 7.2 mp -86.72 -1.82 58.04 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.8 17.5 71.36 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 116.696 1.439 . . . . 0.0 116.696 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.548 HD21 HD23 ' A' ' 118' ' ' LEU . 6.8 mp -68.58 -49.23 61.01 Favored 'General case' 0 CA--C 1.474 -1.975 0 CA-C-N 118.735 1.267 . . . . 0.0 108.042 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 N--CA 1.425 -1.702 0 CA-C-N 113.008 -1.906 . . . . 0.0 110.196 -175.76 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.443 HG22 HG21 ' A' ' 40' ' ' ILE . 67.6 mt . . . . . 0 N--CA 1.424 -1.729 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -102.3 129.4 48.73 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.586 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 1.1 ptm180 -61.99 118.08 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 128.07 -10.67 6.59 Favored Glycine 0 C--N 1.295 -1.719 0 C-N-CA 120.063 -1.065 . . . . 0.0 111.125 -172.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.72 175.33 6.85 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 122.574 1.178 . . . . 0.0 110.988 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.479 HG11 HG22 ' A' ' 104' ' ' THR . 10.8 t -133.39 134.72 56.92 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.936 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 27.6 m-85 -133.22 147.82 52.0 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 124.988 1.315 . . . . 0.0 108.11 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mp -81.01 150.69 28.77 Favored 'General case' 0 N--CA 1.408 -2.546 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.053 170.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.26 138.34 49.26 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.2 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.41 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 20.7 t70 -79.94 90.38 5.34 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.966 0.888 . . . . 0.0 109.777 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.604 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 14.9 mt -100.1 19.37 16.49 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 124.055 1.883 . . . . 0.0 109.591 -176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.52 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.266 15.0 m -61.94 167.55 4.66 Favored Pre-proline 1 C--N 1.229 -4.656 0 CA-C-N 111.41 -2.632 . . . . 0.0 108.295 169.84 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.2 OUTLIER 9.6 50.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.397 3.092 1 C-N-CA 127.367 5.378 . . . . 0.0 118.011 -175.03 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.9 m -68.74 -178.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 113.764 -1.562 . . . . 0.0 111.887 170.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 13.6 mm100 -107.44 132.14 53.52 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.565 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.74 -135.66 35.64 Favored Glycine 0 N--CA 1.425 -2.09 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.853 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -91.77 20.35 5.67 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.87 -0.665 . . . . 0.0 111.088 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 0.1 OUTLIER -65.57 152.41 44.15 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 175.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.407 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -78.15 110.31 13.02 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.769 -0.582 . . . . 0.0 110.786 -167.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -86.52 129.18 9.27 Favored Glycine 0 CA--C 1.49 -1.529 0 N-CA-C 116.244 1.257 . . . . 0.0 116.244 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 131.41 137.06 3.99 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 113.427 -1.387 . . . . 0.0 110.076 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.91 119.37 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 CA-C-O 122.248 1.023 . . . . 0.0 109.775 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -142.53 158.02 61.2 Favored Pre-proline 0 C--N 1.271 -2.838 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.697 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 4.6 Cg_exo -72.15 142.2 37.54 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 121.971 1.781 . . . . 0.0 111.386 174.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 20' ' ' TYR . 31.6 m -118.07 156.83 19.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.553 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 36.0 m -97.91 126.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.337 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.443 HG21 HG22 ' A' ' 14' ' ' ILE . 24.5 mm -87.2 103.92 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.7 -18.94 6.14 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.524 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.812 ' HG3' HG22 ' A' ' 54' ' ' ILE . 3.6 tt0 -56.07 157.99 4.24 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -173.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 28.5 p-10 -71.19 -167.48 0.23 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.807 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -89.55 -38.69 13.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.841 -175.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.1 m -83.78 -28.22 28.3 Favored 'General case' 0 C--O 1.249 1.074 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.718 -170.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.88 -38.77 97.1 Favored Glycine 0 C--O 1.206 -1.647 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -83.67 -20.72 33.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.237 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 4.2 mptp? -76.02 -65.24 0.94 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.811 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.537 ' CD1' ' HB3' ' A' ' 48' ' ' LYS . 85.9 m-85 -99.02 -28.2 13.51 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -171.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.5 m -93.07 154.68 41.66 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . 59.4 Cg_endo -79.52 -18.92 10.48 Favored 'Trans proline' 0 C--O 1.21 -0.913 0 C-N-CA 121.69 1.593 . . . . 0.0 111.603 175.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 4.2 p -91.93 146.27 23.88 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.253 1.021 . . . . 0.0 113.081 -173.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.807 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -142.0 139.0 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.384 0.428 . . . . 0.0 110.491 172.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.812 HG22 ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -88.43 130.25 38.26 Favored 'Isoleucine or valine' 0 C--O 1.249 1.071 0 CA-C-O 121.799 0.809 . . . . 0.0 110.334 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.37 167.55 24.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.397 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.513 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -123.5 146.43 48.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.446 ' HB2' HH21 ' A' ' 92' ' ' ARG . . . -79.91 136.31 36.62 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.63 HD12 ' HB2' ' A' ' 37' ' ' PRO . 19.2 mt -87.3 130.66 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.708 172.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.9 m -122.29 157.44 31.73 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.563 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.078 179.815 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 67' ' ' ILE 0.619 23.5 mm . . . . . 0 CA--C 1.508 -0.651 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.36 1.94 1.09 Allowed 'Trans proline' 0 C--O 1.219 -0.433 0 CA-C-N 121.828 1.688 . . . . 0.0 114.289 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 p -132.38 -10.86 3.23 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.9 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -133.82 129.11 36.06 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -174.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 p -130.51 131.71 64.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.223 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.63 124.14 28.27 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.606 HD13 HD11 ' A' ' 86' ' ' ILE . 13.0 pt -99.49 135.68 33.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.441 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -65.83 114.8 5.33 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.16 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.412 ' HD2' ' O ' ' A' ' 81' ' ' ASP . 20.9 pttp -51.46 -39.42 57.42 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.637 0.732 . . . . 0.0 112.141 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -68.4 -19.05 64.59 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.308 -1.315 . . . . 0.0 113.212 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -92.46 -36.18 13.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.94 0.876 . . . . 0.0 109.4 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.572 ' CD2' HD12 ' A' ' 73' ' ' ILE . 19.1 m-85 -92.83 7.53 43.36 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.669 -1.605 . . . . 0.0 113.471 -173.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 tptm 61.23 20.38 10.95 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 121.798 0.808 . . . . 0.0 110.746 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.2 mt -98.89 175.33 5.98 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.665 0.745 . . . . 0.0 111.011 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.412 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 11.2 t70 -83.56 -44.76 14.29 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.619 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -129.92 158.72 38.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.552 -176.023 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -72.26 137.72 46.95 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.546 ' O ' HG12 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -120.76 160.51 23.22 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -172.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -111.22 139.89 33.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.55 -0.719 . . . . 0.0 109.214 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.606 HD11 HD13 ' A' ' 73' ' ' ILE . 20.8 mm -104.37 135.99 39.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.8 mt -104.79 106.27 16.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.491 HD12 HD23 ' A' ' 118' ' ' LEU . 3.5 mm? -88.44 14.04 10.56 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.881 0.848 . . . . 0.0 111.505 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -112.91 -34.85 5.63 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.173 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.38 65.79 4.58 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.551 ' O ' ' HB ' ' B' ' 93' ' ' THR . 1.8 pp -102.66 173.81 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.04 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.598 ' NH1' HD22 ' A' ' 24' ' ' LEU . 10.1 ptt180 -164.29 155.45 15.61 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 52.6 m -114.73 120.65 40.79 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.0 mt -131.58 144.58 51.18 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.98 -170.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 2.6 p30 -70.54 152.45 43.95 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.009 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 51' ' ' PRO . 56.8 mtmt -55.24 -18.34 5.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -176.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -85.36 -19.21 31.78 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.912 0.386 . . . . 0.0 110.347 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.415 ' HA ' ' NE ' ' A' ' 98' ' ' ARG . 3.0 mmp_? -70.51 -34.39 72.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.23 121.05 20.64 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.384 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -95.44 -57.41 2.4 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.308 -1.315 . . . . 0.0 114.083 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.0 pt-20 -148.88 135.6 19.7 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 122.069 0.938 . . . . 0.0 113.322 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 55.3 tttp -60.89 110.71 1.41 Allowed 'General case' 0 C--N 1.279 -2.478 0 C-N-CA 128.625 2.77 . . . . 0.0 107.564 172.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 tp -111.13 -62.6 1.52 Allowed 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.299 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.479 HG22 HG11 ' A' ' 19' ' ' VAL . 6.0 t -127.03 -161.17 1.05 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.111 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -154.03 154.41 33.67 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 124.237 1.015 . . . . 0.0 110.803 -171.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.79 161.95 13.32 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.977 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 m -98.59 164.23 12.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 111' ' ' MET . 25.5 t70 -67.09 -33.3 75.19 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.481 0.582 . . . . 0.0 110.712 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.47 -47.43 85.71 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.612 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.597 ' O ' HG22 ' A' ' 114' ' ' VAL . 11.8 tptt -62.82 -32.97 74.27 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 173.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.537 ' HA ' ' CE ' ' A' ' 111' ' ' MET . 0.0 OUTLIER -51.01 -49.21 60.91 Favored 'General case' 0 CA--C 1.456 -2.662 0 CA-C-N 118.3 0.5 . . . . 0.0 109.656 169.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 9.3 mmpt? -75.17 -11.89 60.18 Favored 'General case' 0 N--CA 1.392 -3.371 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.545 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.252 30.4 mt-10 -87.48 -56.41 3.37 Favored 'General case' 0 N--CA 1.39 -3.462 0 C-N-CA 117.136 -1.826 . . . . 0.0 111.17 166.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 110' ' ' LYS . 35.7 m -61.18 -48.18 90.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.25 -48.13 82.87 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 123.488 1.613 . . . . 0.0 109.307 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 18.7 t30 -74.01 -42.05 60.93 Favored 'General case' 0 C--N 1.265 -3.07 0 CA-C-N 111.813 -2.449 . . . . 0.0 112.684 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.488 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.44 -40.93 96.27 Favored 'General case' 0 CA--C 1.46 -2.513 0 CA-C-O 122.365 1.079 . . . . 0.0 108.567 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.491 HD23 HD12 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -79.91 -25.44 40.56 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.939 -172.003 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.525 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 1.6 ttp -63.8 -26.82 68.8 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-O 121.924 0.869 . . . . 0.0 108.665 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 60.9 mt -84.23 -56.94 4.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 118' ' ' LEU . 15.1 t -47.2 -43.94 21.91 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.817 1.647 . . . . 0.0 112.116 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.773 ' HG ' HG21 ' B' ' 54' ' ' ILE . 8.3 mp -82.0 5.19 20.05 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.411 ' CA ' ' HB3' ' B' ' 43' ' ' ASN . . . 89.64 1.33 77.63 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 117.972 1.949 . . . . 0.0 117.972 176.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.525 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.2 mm? -67.28 -48.91 66.26 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 120.098 1.949 . . . . 0.0 107.804 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 N--CA 1.429 -1.491 0 CA-C-N 112.287 -2.233 . . . . 0.0 113.083 179.15 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.458 HG22 HG21 ' B' ' 40' ' ' ILE . 66.6 mt . . . . . 0 N--CA 1.419 -2.012 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -99.73 129.06 45.82 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.597 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 0.9 OUTLIER -61.14 119.63 8.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 169.478 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.54 -6.65 8.51 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.469 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.35 175.36 6.46 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.206 1.003 . . . . 0.0 110.587 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.463 HG11 HG22 ' B' ' 104' ' ' THR . 16.2 t -132.98 134.33 58.13 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 113.296 -1.774 . . . . 0.0 110.355 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 32.2 m-85 -132.7 148.0 52.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 124.912 1.285 . . . . 0.0 108.314 174.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.647 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.6 mp -81.47 152.11 27.51 Favored 'General case' 0 N--CA 1.411 -2.409 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.043 170.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.33 138.21 46.26 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.703 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.434 ' HB3' ' NH1' ' B' ' 98' ' ' ARG . 27.2 t70 -78.32 89.87 4.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.984 0.897 . . . . 0.0 110.022 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.623 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 15.8 mt -98.2 17.1 19.39 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 123.895 1.807 . . . . 0.0 109.299 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.534 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.262 15.7 m -60.33 166.65 3.81 Favored Pre-proline 1 C--N 1.236 -4.338 0 CA-C-N 111.916 -2.402 . . . . 0.0 107.955 169.729 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.1 OUTLIER 10.14 50.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.458 1 C-N-CA 127.209 5.273 . . . . 0.0 118.271 -174.764 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' B' ' 31' ' ' GLU . 24.3 m -68.83 -178.69 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 113.663 -1.608 . . . . 0.0 111.68 169.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' B' ' 31' ' ' GLU . 14.5 mm100 -108.36 129.66 55.23 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.388 -1.278 . . . . 0.0 113.569 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.74 -134.75 24.17 Favored Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.612 -1.177 . . . . 0.0 112.16 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.9 m -93.48 22.1 5.64 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 122.936 0.494 . . . . 0.0 111.104 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' B' ' 28' ' ' GLN . 0.1 OUTLIER -66.43 151.94 46.14 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 174.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -77.52 110.1 12.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.867 0.365 . . . . 0.0 111.425 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -86.54 139.88 16.9 Favored Glycine 0 CA--C 1.481 -2.049 0 CA-C-N 114.975 -1.011 . . . . 0.0 115.206 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 116.67 137.29 5.95 Favored Glycine 0 N--CA 1.42 -2.389 0 CA-C-N 113.652 -1.274 . . . . 0.0 110.048 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.2 124.47 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-O 121.942 0.877 . . . . 0.0 109.583 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -145.2 158.43 51.63 Favored Pre-proline 0 C--N 1.276 -2.629 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.299 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 3.7 Cg_exo -72.85 142.47 35.31 Favored 'Trans proline' 0 N--CA 1.437 -1.805 0 C-N-CA 122.053 1.835 . . . . 0.0 111.593 174.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.439 HG22 ' O ' ' B' ' 20' ' ' TYR . 29.9 m -118.34 156.7 20.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.496 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.514 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 27.3 m -97.82 126.98 50.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.416 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.458 HG21 HG22 ' B' ' 14' ' ' ILE . 20.6 mm -87.85 104.51 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.77 -18.69 6.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.364 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.835 ' HG3' HG22 ' B' ' 54' ' ' ILE . 3.6 tt0 -56.51 158.26 4.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -173.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.433 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 25.9 p-10 -71.51 -167.22 0.24 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 123.124 1.44 . . . . 0.0 112.835 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -90.65 -38.37 13.15 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.782 -2.008 . . . . 0.0 112.909 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 3.6 m -83.75 -27.51 28.86 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.127 -170.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -64.62 -37.51 94.49 Favored Glycine 0 C--O 1.202 -1.861 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -83.82 -20.89 32.42 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.761 -0.775 . . . . 0.0 110.234 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.485 ' HB3' ' CD1' ' B' ' 49' ' ' TYR . 4.9 mptp? -76.2 -66.35 0.81 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.603 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' B' ' 48' ' ' LYS . 87.7 m-85 -95.18 -30.18 14.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.785 -171.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 23.5 m -93.45 154.35 41.29 Favored Pre-proline 0 C--N 1.292 -1.931 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.82 -16.51 8.88 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.56 1.507 . . . . 0.0 111.209 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 9.0 p -92.9 146.43 23.64 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.231 1.013 . . . . 0.0 112.868 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.786 ' HA ' ' NE2' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -142.34 138.79 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 123.649 0.593 . . . . 0.0 110.29 172.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.835 HG22 ' HG3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -88.75 130.15 38.65 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 CA-C-O 121.742 0.782 . . . . 0.0 110.287 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.25 168.2 22.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.424 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.539 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -124.02 146.74 48.33 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.515 ' HB2' HH21 ' B' ' 92' ' ' ARG . . . -78.35 136.37 37.68 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' B' ' 37' ' ' PRO . 20.8 mt -88.49 127.25 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.14 -1.391 . . . . 0.0 107.352 172.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 60.2 m -117.77 160.33 21.53 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.911 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.984 179.481 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' B' ' 67' ' ' ILE 0.602 24.1 mm . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 120.24 3.422 . . . . 0.0 120.24 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.35 2.32 0.94 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 CA-C-N 121.691 1.64 . . . . 0.0 113.991 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 28.8 p -132.39 -11.94 3.15 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.768 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -135.48 129.21 32.8 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -173.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 p -131.35 133.17 62.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.648 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.86 125.76 29.8 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.631 HD13 HD11 ' B' ' 86' ' ' ILE . 12.3 pt -99.28 133.37 42.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.692 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -64.62 117.28 7.18 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 123.848 0.717 . . . . 0.0 110.39 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' B' ' 81' ' ' ASP . 21.2 pttp -53.65 -38.92 64.59 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.28 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -69.07 -19.28 64.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.546 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -91.61 -35.15 14.4 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.865 0.84 . . . . 0.0 109.106 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.574 ' CD2' HD12 ' B' ' 73' ' ' ILE . 17.1 m-85 -93.3 7.79 42.96 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.548 -173.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 23.2 tptm 61.42 23.41 13.67 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 121.802 0.81 . . . . 0.0 109.996 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 29.3 mt -100.6 177.08 5.11 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.485 0.659 . . . . 0.0 111.058 -174.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' B' ' 75' ' ' LYS . 20.3 t70 -83.21 -47.74 11.23 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.913 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -128.96 159.15 36.77 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.835 -175.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.73 145.22 52.45 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.549 ' O ' HG12 ' B' ' 73' ' ' ILE . 0.3 OUTLIER -129.31 158.79 38.11 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -173.019 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -110.23 140.59 28.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.631 HD11 HD13 ' B' ' 73' ' ' ILE . 22.9 mm -105.01 136.14 40.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 35.6 mt -104.79 105.55 15.67 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.491 HD12 HD23 ' B' ' 118' ' ' LEU . 3.5 mm? -87.68 11.97 13.88 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.006 0.907 . . . . 0.0 111.324 -174.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -110.62 -34.25 6.34 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.178 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.05 66.58 3.57 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.551 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.9 pp -102.59 174.24 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.554 ' NH1' HD22 ' B' ' 24' ' ' LEU . 10.4 ptt180 -164.53 154.54 14.11 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 49.5 m -113.41 120.69 41.95 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.013 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 58.7 mt -131.43 144.47 51.21 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.825 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 1.9 p30 -71.4 152.37 43.2 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.0 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -50.57 -25.49 4.18 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -81.44 -18.83 43.94 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.341 0.519 . . . . 0.0 110.93 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.434 ' NH1' ' HB3' ' B' ' 23' ' ' ASP . 3.3 mmp_? -69.17 -33.89 74.09 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' B' ' 21' ' ' LEU . 7.8 mp -73.54 124.15 25.33 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.361 173.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -99.02 -53.52 3.24 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.098 -1.41 . . . . 0.0 114.68 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 13.5 pt-20 -154.92 138.78 16.26 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 122.085 0.945 . . . . 0.0 113.163 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.77 112.25 2.2 Favored 'General case' 0 C--N 1.282 -2.354 0 C-N-CA 128.66 2.784 . . . . 0.0 107.358 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -112.2 -62.77 1.52 Allowed 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.244 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.463 HG22 HG11 ' B' ' 19' ' ' VAL . 6.7 t -125.59 -157.97 0.82 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.204 -1.398 . . . . 0.0 111.486 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -156.34 152.94 28.22 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 124.311 1.044 . . . . 0.0 111.005 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.1 151.54 23.88 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.289 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 19.8 m -90.43 166.79 13.07 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' B' ' 111' ' ' MET . 33.8 t70 -67.44 -34.28 76.89 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.029 0.442 . . . . 0.0 111.23 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -62.11 -46.71 87.86 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.616 ' O ' HG22 ' B' ' 114' ' ' VAL . 11.9 tptt -62.86 -32.07 73.22 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.539 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -51.62 -47.94 63.47 Favored 'General case' 0 CA--C 1.445 -3.074 0 CA-C-O 121.245 0.545 . . . . 0.0 109.867 169.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 8.3 mmpt? -74.88 -14.06 60.62 Favored 'General case' 0 N--CA 1.384 -3.767 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . 0.252 31.6 mt-10 -87.17 -56.61 3.3 Favored 'General case' 0 N--CA 1.386 -3.633 0 C-N-CA 116.763 -1.975 . . . . 0.0 111.234 168.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' VAL . . . . . 0.616 HG22 ' O ' ' B' ' 110' ' ' LYS . 36.0 m -60.56 -47.81 91.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.95 -50.87 71.65 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 123.365 1.555 . . . . 0.0 109.665 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.316 26.9 t30 -73.2 -40.47 64.73 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-N 112.1 -2.318 . . . . 0.0 112.792 -172.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.444 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -62.38 -40.04 95.15 Favored 'General case' 0 CA--C 1.46 -2.484 0 CA-C-O 122.225 1.012 . . . . 0.0 108.666 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.491 HD23 HD12 ' B' ' 88' ' ' LEU . 0.6 OUTLIER -79.56 -25.28 41.65 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.739 -173.303 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.529 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 1.8 ttp -63.47 -27.5 69.33 Favored 'General case' 0 N--CA 1.399 -3.014 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 64.1 mt -83.98 -56.99 4.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' SER . . . . . 0.447 ' HB3' ' HA ' ' B' ' 118' ' ' LEU . 21.9 t -47.09 -43.45 20.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.216 1.406 . . . . 0.0 112.283 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.79 ' HG ' HG21 ' A' ' 54' ' ' ILE . 8.2 mp -82.2 5.36 20.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' GLY . . . . . 0.424 ' CA ' ' HB3' ' A' ' 43' ' ' ASN . . . 89.66 1.39 77.49 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 117.862 1.905 . . . . 0.0 117.862 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.529 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.1 mm? -67.41 -49.58 63.18 Favored 'General case' 0 C--O 1.249 1.048 0 CA-C-N 120.271 2.035 . . . . 0.0 107.749 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 N--CA 1.439 -1.016 0 CA-C-N 112.514 -2.13 . . . . 0.0 113.01 179.34 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 47' ' ' ASN . 59.3 mt . . . . . 0 N--CA 1.438 -1.029 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.3 mmt-85 -117.22 152.75 34.16 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -64.25 122.0 15.61 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 113.33 -11.97 23.88 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.12 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -78.01 156.55 30.07 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 122.108 0.956 . . . . 0.0 110.123 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.463 ' HB ' ' H ' ' A' ' 104' ' ' THR . 93.3 t -116.24 118.81 60.0 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.391 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.345 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 44.2 m-85 -116.43 138.98 50.93 Favored 'General case' 0 C--O 1.181 -2.509 0 C-N-CA 126.072 1.749 . . . . 0.0 111.207 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.8 mp -82.48 147.87 28.46 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 121.392 0.615 . . . . 0.0 109.9 169.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -144.0 142.17 30.55 Favored 'General case' 0 C--N 1.274 -2.717 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.985 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.24 95.27 5.61 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 123.059 1.409 . . . . 0.0 110.256 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.823 ' O ' HG13 ' A' ' 27' ' ' VAL . 66.7 mt -88.42 -14.58 37.67 Favored 'General case' 0 C--O 1.177 -2.763 0 CA-C-N 113.214 -1.812 . . . . 0.0 112.554 -175.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 4.6 p -87.3 56.48 0.0 OUTLIER Pre-proline 0 C--N 1.256 -3.497 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -127.63 41.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 124.216 3.277 . . . . 0.0 106.709 142.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 24' ' ' LEU . 6.6 m -69.02 176.16 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -89.71 109.69 20.64 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.462 -1.699 . . . . 0.0 112.5 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.97 -108.56 0.56 Allowed Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.262 -1.335 . . . . 0.0 114.924 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.8 m -89.15 17.92 5.5 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 39.1 mt-10 -67.76 -175.06 0.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.969 172.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.414 ' NE2' ' HG3' ' A' ' 36' ' ' ARG . 13.1 tm0? -99.09 121.17 40.63 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.78 164.29 13.9 Favored Glycine 0 CA--C 1.478 -2.252 0 CA-C-O 122.012 0.784 . . . . 0.0 114.99 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.507 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . 115.68 156.71 11.07 Favored Glycine 0 N--CA 1.419 -2.48 0 CA-C-N 113.431 -1.385 . . . . 0.0 109.666 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -82.74 100.48 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.342 0 CA-C-O 123.904 1.811 . . . . 0.0 107.604 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.414 ' HG3' ' NE2' ' A' ' 32' ' ' GLN . 28.4 mmt180 -127.26 161.34 54.89 Favored Pre-proline 0 C--N 1.255 -3.502 0 CA-C-N 112.253 -2.249 . . . . 0.0 108.888 -170.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.7 ' HB2' HD12 ' A' ' 58' ' ' ILE . 5.2 Cg_exo -76.74 142.07 22.4 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 C-N-CA 121.772 1.648 . . . . 0.0 112.146 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 20' ' ' TYR . 27.6 m -119.84 156.81 22.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 124.419 1.087 . . . . 0.0 108.475 177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 21.2 m -105.57 133.82 48.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.3 mm -81.85 103.24 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -98.37 -19.22 6.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.777 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.547 HE22 ' N ' ' A' ' 47' ' ' ASN . 3.1 tt0 -57.05 163.8 1.9 Allowed 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 125.51 1.524 . . . . 0.0 114.567 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 27.4 p-10 -65.85 177.76 1.23 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.539 -1.664 . . . . 0.0 112.423 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.38 -41.56 56.06 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.556 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.8 m -85.28 -26.36 26.68 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.484 -171.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.3 -33.21 79.61 Favored Glycine 0 C--O 1.213 -1.214 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.547 ' N ' HE22 ' A' ' 42' ' ' GLN 0.262 6.7 p30 -69.63 -18.97 63.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -92.35 -68.02 0.82 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.106 0.479 . . . . 0.0 110.297 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -91.89 -16.24 26.96 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -165.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.5 m -90.73 133.83 31.74 Favored Pre-proline 0 N--CA 1.417 -2.105 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -65.68 -27.97 52.5 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 121.752 1.635 . . . . 0.0 108.698 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.4 p -94.35 137.98 32.87 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 113.333 -1.758 . . . . 0.0 112.115 -175.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.542 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 90.4 t -122.06 140.16 46.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.701 HD13 HD11 ' B' ' 91' ' ' ILE . 1.5 tp -106.09 125.73 61.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-O 121.7 0.762 . . . . 0.0 110.943 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.34 171.11 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.103 -176.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.52 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -124.78 142.83 51.15 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.508 ' HB2' HH11 ' A' ' 92' ' ' ARG . . . -84.18 142.53 30.26 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 ' HB2' ' A' ' 37' ' ' PRO . 16.2 mt -85.59 138.49 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.963 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 m -119.79 134.75 55.12 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.439 0 CA-C-O 121.36 0.422 . . . . 0.0 112.567 -179.484 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 tt . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.92 -3.61 0.71 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 124.048 3.165 . . . . 0.0 116.435 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.4 p -90.45 -18.96 24.47 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 118.921 0.782 . . . . 0.0 109.641 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -86.25 129.59 34.8 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.065 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.44 120.6 59.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -86.08 132.34 34.06 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.481 HD13 ' CG ' ' A' ' 78' ' ' TYR . 2.8 pp -84.6 157.33 3.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.987 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HG2' ' CG ' ' A' ' 76' ' ' LYS . 19.8 tt0 -77.59 107.88 10.37 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 62.7 pttt -55.22 -42.17 73.0 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.459 ' CG ' ' HG2' ' A' ' 74' ' ' GLU . 11.1 ptmm? -59.02 -32.75 70.01 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.222 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -91.39 -26.7 18.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.681 0.753 . . . . 0.0 109.84 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CG ' HD13 ' A' ' 73' ' ' ILE . 2.8 m-85 -80.44 2.7 24.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.274 -178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 71.63 20.65 4.64 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.502 1.121 . . . . 0.0 111.068 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 mt -110.89 168.57 9.38 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.852 0.834 . . . . 0.0 111.248 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.481 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 14.7 t70 -93.2 -35.36 13.18 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.928 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -119.65 145.81 46.13 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.076 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 8.4 p-10 -76.08 147.39 38.68 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.389 0.614 . . . . 0.0 110.113 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.2 t -112.57 175.9 5.24 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.06 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 t -127.76 141.41 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.575 ' CD1' HG12 ' A' ' 58' ' ' ILE . 25.1 mm -109.36 133.36 54.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.5 mt -102.52 107.54 18.54 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -79.52 15.63 1.25 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.789 0.835 . . . . 0.0 112.46 -174.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.27 -39.79 3.01 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.649 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -83.68 51.96 2.15 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 125.332 1.453 . . . . 0.0 108.237 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.709 HD11 HD13 ' B' ' 54' ' ' ILE . 2.0 pp -96.29 -179.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.63 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.508 HH11 ' HB2' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -168.0 163.13 13.62 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.6 m -117.77 119.93 36.39 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.414 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.2 mt -131.44 137.75 48.76 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.895 -171.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 2.8 p-10 -74.35 153.16 39.42 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.445 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -38.99 -36.76 0.31 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 126.231 1.812 . . . . 0.0 112.837 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -64.52 -22.34 66.94 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.943 0.897 . . . . 0.0 111.54 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.7 mmp_? -79.83 -33.54 40.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.257 0.551 . . . . 0.0 109.577 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.53 101.89 4.33 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 122.601 1.191 . . . . 0.0 111.715 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -86.7 -65.09 1.05 Allowed 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 113.518 -1.674 . . . . 0.0 115.13 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 9.3 pt-20 -139.46 126.66 21.25 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 18.8 ptmt -71.45 114.07 9.14 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.319 -1.764 . . . . 0.0 110.986 171.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.631 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 24.0 tp -103.49 -56.73 2.16 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.005 -173.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.631 ' OG1' ' HG ' ' A' ' 103' ' ' LEU 0.285 3.5 m -135.42 -174.05 3.52 Favored 'General case' 0 N--CA 1.391 -3.384 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.573 -165.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.472 ' H ' ' CG2' ' A' ' 104' ' ' THR . 0.6 OUTLIER -160.64 134.93 7.24 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.489 1.516 . . . . 0.0 110.92 -166.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.59 153.4 22.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.345 0.658 . . . . 0.0 112.539 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.432 ' HB2' ' HD3' ' A' ' 110' ' ' LYS . 2.0 m -75.87 159.7 30.68 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.888 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 111' ' ' MET . 38.1 t70 -58.45 -51.93 67.76 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 3.5 p-10 -73.14 -26.69 61.3 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.717 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.432 ' HD3' ' HB2' ' A' ' 107' ' ' SER . 2.0 mptp? -67.41 -27.26 66.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.585 176.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.412 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -57.38 -39.78 76.78 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 123.527 0.731 . . . . 0.0 110.473 174.114 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.604 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -74.11 -19.8 60.46 Favored 'General case' 0 CA--C 1.483 -1.622 0 C-N-CA 123.245 0.618 . . . . 0.0 111.386 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.489 ' HA ' ' ND2' ' A' ' 116' ' ' ASN . 21.0 mt-10 -85.83 -36.87 19.76 Favored 'General case' 0 N--CA 1.399 -2.983 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.68 -46.77 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-N 113.153 -1.84 . . . . 0.0 109.829 170.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 112' ' ' LYS . 37.4 m-20 -60.21 -57.74 11.49 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.88 0.848 . . . . 0.0 109.976 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 113' ' ' GLU . 0.4 OUTLIER -64.88 -39.43 93.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.624 -172.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.487 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.99 -40.26 84.3 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 2.8 tp -68.36 -38.02 81.03 Favored 'General case' 1 N--CA 1.365 -4.705 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.356 -175.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 46.2 mtp -66.17 -29.67 70.0 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 121.755 -0.59 . . . . 0.0 111.261 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 116' ' ' ASN . 26.5 mt -77.33 -54.35 12.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.5 t -52.67 -36.81 57.68 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.565 -1.652 . . . . 0.0 111.358 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.533 ' HB3' ' CD1' ' B' ' 41' ' ' ILE . 42.0 mt -101.49 7.32 42.48 Favored 'General case' 0 N--CA 1.428 -1.529 0 O-C-N 121.961 -0.462 . . . . 0.0 111.512 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.91 75.24 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 116.794 1.478 . . . . 0.0 116.794 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -78.46 -46.94 18.51 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 118.829 1.315 . . . . 0.0 109.292 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.438 -1.053 0 CA-C-N 113.274 -1.785 . . . . 0.0 110.229 -172.241 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 66.0 mt . . . . . 0 N--CA 1.445 -0.716 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.9 mmt-85 -119.44 154.56 33.52 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -64.27 120.36 12.01 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 116.46 -13.93 15.53 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.998 -178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ASP . . . . . 0.413 ' O ' HG12 ' B' ' 40' ' ' ILE . 14.1 m-20 -75.67 155.05 36.14 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.33 1.062 . . . . 0.0 110.844 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.477 ' HB ' ' H ' ' B' ' 104' ' ' THR . 89.9 t -115.56 118.59 59.28 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.516 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.894 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.532 ' CZ ' ' HB3' ' B' ' 102' ' ' LYS . 48.2 m-85 -115.52 140.44 49.15 Favored 'General case' 0 CA--C 1.455 -2.707 0 C-N-CA 125.986 1.714 . . . . 0.0 110.671 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -82.34 148.68 28.15 Favored 'General case' 0 N--CA 1.392 -3.33 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.782 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -146.07 143.6 29.5 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.733 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' B' ' 25' ' ' SER . 4.8 p-10 -75.52 93.1 2.95 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 122.325 1.059 . . . . 0.0 110.001 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.746 ' O ' HG13 ' B' ' 27' ' ' VAL . 69.5 mt -89.6 21.8 3.3 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -176.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.639 ' HB2' ' HD2' ' B' ' 26' ' ' PRO 0.264 5.4 p -79.54 -165.62 0.07 OUTLIER Pre-proline 0 N--CA 1.39 -3.427 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 176.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.639 ' HD2' ' HB2' ' B' ' 25' ' ' SER . 31.7 Cg_exo 18.39 40.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.42 1 C-N-CA 125.385 4.057 . . . . 0.0 118.193 -156.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.746 HG13 ' O ' ' B' ' 24' ' ' LEU . 7.0 m -70.56 177.8 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 122.213 1.006 . . . . 0.0 112.786 174.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -90.08 109.15 20.22 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.117 -1.401 . . . . 0.0 112.724 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.39 -108.49 0.31 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.69 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -87.28 17.65 4.25 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.0 -170.57 0.11 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 118.87 0.759 . . . . 0.0 111.292 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -103.67 118.85 37.68 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.88 167.04 16.91 Favored Glycine 0 CA--C 1.473 -2.583 0 CA-C-O 122.218 0.899 . . . . 0.0 115.306 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 113.36 154.2 11.42 Favored Glycine 0 N--CA 1.408 -3.191 0 CA-C-N 112.861 -1.669 . . . . 0.0 109.719 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -80.84 103.05 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-O 123.167 1.46 . . . . 0.0 107.287 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -130.54 161.71 59.15 Favored Pre-proline 0 C--N 1.254 -3.582 0 CA-C-N 113.267 -1.788 . . . . 0.0 108.949 -170.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.674 ' HB2' HD12 ' B' ' 58' ' ' ILE . 4.7 Cg_exo -75.57 141.81 25.49 Favored 'Trans proline' 0 N--CA 1.431 -2.193 0 C-N-CA 121.812 1.675 . . . . 0.0 112.33 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -120.86 156.95 24.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 124.568 1.147 . . . . 0.0 108.512 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 21.8 m -105.46 133.6 49.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.502 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.413 HG12 ' O ' ' B' ' 18' ' ' ASP . 30.6 mm -81.69 102.02 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.3 -19.31 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.637 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.535 HE22 ' N ' ' B' ' 47' ' ' ASN . 2.6 tt0 -56.67 162.19 2.41 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 125.462 1.505 . . . . 0.0 114.475 -173.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.525 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 21.8 p-10 -63.8 -175.86 0.16 Allowed 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.472 -1.694 . . . . 0.0 112.492 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.76 -42.73 17.6 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.63 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 9.7 m -85.15 -26.17 27.0 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.545 -170.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.1 -34.49 84.08 Favored Glycine 0 C--O 1.217 -0.909 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.535 ' N ' HE22 ' B' ' 42' ' ' GLN 0.264 8.8 p30 -69.1 -18.77 64.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.365 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -92.65 -67.37 0.86 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.231 0.539 . . . . 0.0 110.782 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -93.43 -11.79 31.33 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -166.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 69.4 m -94.65 134.47 25.16 Favored Pre-proline 0 N--CA 1.42 -1.943 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.55 -27.51 39.09 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 121.872 1.715 . . . . 0.0 109.044 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.7 p -94.82 137.7 33.57 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.834 -174.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.518 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 89.4 t -121.86 140.21 46.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.709 HD13 HD11 ' A' ' 91' ' ' ILE . 1.4 tp -105.9 125.66 61.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-O 121.668 0.746 . . . . 0.0 111.257 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.406 HG12 HD13 ' B' ' 40' ' ' ILE . 34.1 m -133.32 172.44 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.994 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.524 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -127.03 142.5 51.53 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.525 ' HB2' HH11 ' B' ' 92' ' ' ARG . . . -83.3 142.95 30.71 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' B' ' 37' ' ' PRO . 17.2 mt -88.31 135.36 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.442 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 38.3 m -116.16 134.78 54.55 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.454 0 CA-C-O 121.732 0.629 . . . . 0.0 112.327 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.15 -12.53 5.41 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 124.038 3.158 . . . . 0.0 116.258 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 59.2 p -83.95 -19.11 35.22 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.63 0.729 . . . . 0.0 109.829 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -85.38 129.1 34.89 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.09 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.91 121.67 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -87.77 133.5 33.86 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.491 HD13 ' CG ' ' B' ' 78' ' ' TYR . 2.8 pp -85.9 156.46 3.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.369 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.434 ' HG2' ' CG ' ' B' ' 76' ' ' LYS . 16.0 tt0 -76.26 107.45 8.51 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' B' ' 83' ' ' ASP . 62.2 pttt -56.25 -41.83 76.39 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' LYS . . . . . 0.434 ' CG ' ' HG2' ' B' ' 74' ' ' GLU . 10.8 ptmm? -59.71 -30.78 69.04 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.503 -1.226 . . . . 0.0 113.367 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -91.47 -31.18 16.08 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.561 0.696 . . . . 0.0 109.404 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.491 ' CG ' HD13 ' B' ' 73' ' ' ILE . 3.0 m-85 -76.39 1.3 16.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.442 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 74.55 12.78 3.77 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.994 1.318 . . . . 0.0 111.816 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 19.2 mt -104.46 168.48 9.06 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.873 0.844 . . . . 0.0 111.896 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' B' ' 75' ' ' LYS . 18.3 t70 -91.51 -35.85 14.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.131 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.28 147.85 44.46 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.636 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' B' ' 75' ' ' LYS . 7.3 p-10 -76.84 147.97 36.81 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.157 0.503 . . . . 0.0 110.324 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -113.19 175.2 5.55 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.091 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t -126.82 141.79 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.587 ' CD1' HG12 ' B' ' 58' ' ' ILE . 25.0 mm -109.07 133.04 55.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 61.9 mt -102.22 107.07 18.01 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.994 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.7 mm? -79.01 14.02 1.56 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.821 0.849 . . . . 0.0 112.439 -174.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -116.61 -39.4 3.33 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.881 0.848 . . . . 0.0 108.944 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -84.04 52.0 2.2 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 125.229 1.412 . . . . 0.0 108.291 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.701 HD11 HD13 ' A' ' 54' ' ' ILE . 2.0 pp -96.46 -179.59 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.693 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.525 HH11 ' HB2' ' B' ' 57' ' ' ALA . 0.0 OUTLIER -167.92 163.12 13.8 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 17.9 m -118.1 119.59 35.21 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.48 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 51.4 mt -131.47 138.38 48.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.113 -171.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 3.7 p-10 -74.03 152.9 39.89 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.707 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -38.27 -32.74 0.08 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 126.853 2.061 . . . . 0.0 113.697 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -69.31 -25.51 64.26 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.279 0.632 . . . . 0.0 110.901 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 2.1 mmp_? -76.41 -33.36 58.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -73.32 103.65 4.07 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.108 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -87.14 -61.88 1.63 Allowed 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.3 pt-20 -144.39 130.24 19.3 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.846 0.832 . . . . 0.0 113.003 -171.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' LYS . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 20' ' ' TYR . 19.4 ptmt -73.75 110.84 8.36 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.111 173.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.641 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 23.9 tp -101.48 -56.63 2.25 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.796 -172.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.641 ' OG1' ' HG ' ' B' ' 103' ' ' LEU 0.285 4.1 m -134.48 -175.0 3.73 Favored 'General case' 0 N--CA 1.387 -3.613 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.31 -166.016 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.48 ' H ' ' CG2' ' B' ' 104' ' ' THR . 0.4 OUTLIER -160.6 134.96 7.3 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.476 1.51 . . . . 0.0 110.383 -166.566 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 11.1 mt -85.67 157.3 20.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.523 0.729 . . . . 0.0 112.517 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' SER . . . . . 0.416 ' HB2' ' HD3' ' B' ' 110' ' ' LYS . 2.3 m -78.97 165.5 23.4 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.775 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' B' ' 111' ' ' MET . 27.8 t70 -61.29 -53.01 62.23 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 3.7 p-10 -72.35 -28.52 63.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.446 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.416 ' HD3' ' HB2' ' B' ' 107' ' ' SER . 2.2 mptp? -66.51 -26.9 67.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.748 0.308 . . . . 0.0 111.221 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.448 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -59.03 -40.03 83.78 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.199 0.599 . . . . 0.0 110.397 173.542 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.609 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -75.37 -16.91 60.34 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.056 0.455 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 113' ' ' GLU . . . . . 0.443 ' HA ' ' ND2' ' B' ' 116' ' ' ASN . 48.7 mt-10 -84.54 -38.32 20.15 Favored 'General case' 0 CA--C 1.443 -3.152 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.28 -48.55 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.994 0 CA-C-N 112.685 -2.052 . . . . 0.0 110.022 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' B' ' 112' ' ' LYS . 49.0 m-20 -59.56 -59.02 6.11 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.726 0.774 . . . . 0.0 110.461 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 0.5 OUTLIER -64.82 -37.55 88.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.017 -172.647 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.456 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -60.15 -39.45 86.38 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 3.0 tp -69.78 -38.26 76.64 Favored 'General case' 1 N--CA 1.366 -4.661 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.984 -175.538 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 48.4 mtp -65.52 -34.77 79.04 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 121.769 -0.582 . . . . 0.0 110.927 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' B' ' 117' ' ' ALA . 23.7 mt -71.89 -53.95 18.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 20.3 t -52.76 -35.78 56.85 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.784 1.234 . . . . 0.0 111.443 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.534 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 39.8 mt -102.34 6.54 40.41 Favored 'General case' 0 N--CA 1.428 -1.548 0 O-C-N 121.894 -0.504 . . . . 0.0 111.508 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.26 20.69 76.88 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.48 -49.31 15.03 Favored 'General case' 0 CA--C 1.478 -1.791 0 CA-C-N 118.876 1.338 . . . . 0.0 109.056 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.437 -1.083 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.148 -172.108 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.448 ' HB ' ' OD1' ' A' ' 47' ' ' ASN . 65.1 mt . . . . . 0 N--CA 1.444 -0.761 0 CA-C-O 121.196 0.522 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -103.28 138.82 39.54 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -76.59 134.43 39.37 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.353 -1.339 . . . . 0.0 108.334 173.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.31 -5.53 55.42 Favored Glycine 0 C--N 1.302 -1.356 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.93 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.25 166.69 11.78 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.582 0.706 . . . . 0.0 110.114 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 37.4 t -120.05 133.7 65.95 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.422 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.595 ' O ' HG22 ' A' ' 38' ' ' VAL . 44.4 m-85 -136.67 147.34 46.77 Favored 'General case' 0 CA--C 1.469 -2.165 0 C-N-CA 124.623 1.169 . . . . 0.0 107.957 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.7 mp -74.42 148.86 40.77 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.087 171.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -143.63 135.3 26.3 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.097 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.19 94.46 3.53 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.77 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 9.2 mt -89.45 5.0 47.26 Favored 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 124.776 1.23 . . . . 0.0 110.086 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.609 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 4.6 m -52.96 -177.66 0.04 OUTLIER Pre-proline 1 C--N 1.241 -4.142 0 C-N-CA 126.817 2.047 . . . . 0.0 113.283 174.172 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 19.97 35.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.41 3.784 1 C-N-CA 125.716 4.277 . . . . 0.0 119.465 -157.956 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 5.8 m -70.89 173.47 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.565 168.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -111.71 141.4 45.36 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.89 -111.87 1.43 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 114.786 -1.097 . . . . 0.0 115.023 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -94.16 4.4 53.94 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 123.425 0.69 . . . . 0.0 112.697 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 77.2 mt-10 -64.05 144.0 57.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.524 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 5.8 tp60 -117.73 111.47 19.16 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -170.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -126.64 -109.44 1.63 Allowed Glycine 1 N--CA 1.383 -4.844 0 C-N-CA 118.361 -1.876 . . . . 0.0 116.453 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 75.97 177.08 41.9 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 -168.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.5 p -91.44 106.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.288 0 O-C-N 120.617 -1.519 . . . . 0.0 108.897 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.524 ' NH2' ' HG3' ' A' ' 32' ' ' GLN . 62.8 mtm180 -135.17 157.8 76.07 Favored Pre-proline 0 C--N 1.275 -2.672 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.648 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 31.9 Cg_exo -66.12 138.55 52.34 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.098 2.532 . . . . 0.0 112.132 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 20' ' ' TYR . 20.5 m -126.35 164.03 27.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 C-N-CA 123.5 0.72 . . . . 0.0 110.234 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 27.4 m -105.73 134.5 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.9 mm -95.01 118.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 123.093 0.557 . . . . 0.0 110.195 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -8.62 12.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.587 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.567 ' NE2' ' HB ' ' A' ' 53' ' ' VAL . 5.5 pt20 -63.42 165.66 7.49 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -167.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.458 ' HB3' ' N ' ' B' ' 123' ' ' GLY . 18.4 p-10 -75.29 -173.14 1.95 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 111.823 -2.444 . . . . 0.0 113.423 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -79.55 -43.98 22.01 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.076 -1.874 . . . . 0.0 113.411 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 m -86.19 -25.73 25.49 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -168.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 50' ' ' SER . . . -71.52 -20.97 78.74 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.448 ' OD1' ' HB ' ' A' ' 14' ' ' ILE . 31.2 t-20 -72.86 -32.33 65.36 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.834 -1.183 . . . . 0.0 108.526 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -90.04 -66.73 0.9 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.534 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -98.81 -35.62 10.07 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -168.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.598 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 15.2 t -75.54 128.76 83.4 Favored Pre-proline 0 N--CA 1.435 -1.199 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.801 -174.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.545 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 61.2 Cg_endo -74.72 -11.75 22.05 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.985 1.79 . . . . 0.0 110.155 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 p -107.56 121.39 44.55 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.935 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.567 ' HB ' ' NE2' ' A' ' 42' ' ' GLN . 1.3 m -121.73 167.5 15.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.856 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.727 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 13.7 tt -108.29 125.07 65.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 123.575 0.75 . . . . 0.0 112.054 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.67 HG22 ' CD2' ' A' ' 94' ' ' LEU . 3.7 m -137.48 163.56 30.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.715 ' HA ' HG13 ' A' ' 91' ' ' ILE . . . -123.08 131.21 53.6 Favored 'General case' 0 N--CA 1.416 -2.16 0 O-C-N 123.365 0.416 . . . . 0.0 111.172 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.656 ' N ' HG21 ' A' ' 91' ' ' ILE . . . -66.0 130.63 43.91 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.539 HG12 HD12 ' A' ' 86' ' ' ILE . 56.4 mt -85.49 138.31 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 112.661 -2.063 . . . . 0.0 106.994 174.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.2 t -148.36 179.99 7.37 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.469 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.376 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.441 -0.899 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.4 9.34 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.254 1.969 . . . . 0.0 114.145 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.0 p -118.5 -6.49 10.71 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.083 0.468 . . . . 0.0 110.613 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.471 ' CD2' HD22 ' A' ' 87' ' ' LEU . 43.4 m170 -122.6 129.32 51.76 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.2 m -122.02 139.4 49.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.618 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -94.75 129.71 41.56 Favored 'General case' 0 C--O 1.251 1.177 0 CA-C-O 121.567 0.699 . . . . 0.0 111.081 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.724 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -120.6 158.57 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.23 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -79.18 128.65 33.57 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.681 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -47.48 -48.35 27.04 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 125.369 1.468 . . . . 0.0 110.699 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -56.35 -45.0 80.63 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 126.489 1.916 . . . . 0.0 112.64 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -71.79 -34.99 69.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.98 -175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.724 ' CE1' HG21 ' A' ' 73' ' ' ILE . 3.6 m-85 -95.3 -9.89 31.77 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.192 -176.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 61.46 29.95 18.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.883 1.273 . . . . 0.0 112.863 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 7.6 mp -88.73 -179.56 6.03 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.629 1.204 . . . . 0.0 112.973 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -73.7 -26.0 60.5 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.871 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -147.83 166.87 26.28 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -59.25 141.86 53.3 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 m -103.08 137.34 41.39 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.808 -168.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.42 137.62 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.539 HD12 HG12 ' A' ' 58' ' ' ILE . 20.3 mm -116.17 138.44 46.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.528 ' O ' HD11 ' A' ' 91' ' ' ILE . 36.6 mt -104.46 140.78 37.46 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.551 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.3 mm? -111.83 2.01 16.86 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 122.28 1.038 . . . . 0.0 111.27 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -99.98 -33.45 10.5 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.93 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.802 ' HB3' HD13 ' A' ' 91' ' ' ILE . 1.1 tm0? -80.42 -2.71 46.84 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.861 -171.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.802 HD13 ' HB3' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -150.91 148.22 15.15 Favored 'Isoleucine or valine' 1 CA--C 1.421 -4.01 0 CA-C-O 117.516 -1.23 . . . . 0.0 112.651 -163.538 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.896 ' HB3' ' HB3' ' B' ' 92' ' ' ARG 0.264 40.0 mtm-85 179.84 -53.04 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.767 1 N-CA-C 121.934 4.05 . . . . 0.0 121.934 -174.982 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.724 ' OG1' ' HB2' ' B' ' 92' ' ' ARG . 42.2 m -123.2 101.0 7.14 Favored 'General case' 0 N--CA 1.531 3.599 0 O-C-N 121.009 -1.057 . . . . 0.0 112.994 -170.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.67 ' CD2' HG22 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -132.1 126.11 32.96 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.646 -172.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 15.7 t0 -56.25 146.3 24.04 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.46 0.704 . . . . 0.0 111.375 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.598 ' HE2' ' O ' ' A' ' 50' ' ' SER . 67.8 mttm -53.95 -33.36 56.64 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.306 1.042 . . . . 0.0 111.692 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HG3' ' OD1' ' A' ' 95' ' ' ASP . 48.1 mttp -61.73 -22.16 65.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.28 0.632 . . . . 0.0 111.102 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 34.1 mtp180 -79.3 -37.85 36.72 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.2 mp -71.25 118.25 13.81 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.284 1.033 . . . . 0.0 111.242 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -99.2 -66.92 0.87 Allowed 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.3 pt-20 -156.11 144.46 19.96 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.475 0.655 . . . . 0.0 112.561 -165.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -65.38 119.89 11.81 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 128.243 2.617 . . . . 0.0 113.656 -178.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.575 HD23 HG12 ' A' ' 19' ' ' VAL 0.295 1.7 mm? -100.42 -64.1 1.07 Allowed 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 123.402 1.572 . . . . 0.0 110.405 174.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.576 ' H ' ' HB ' ' A' ' 19' ' ' VAL . 18.4 m -127.08 -178.96 4.62 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 111.608 -2.542 . . . . 0.0 111.871 -162.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.451 ' H ' ' CG2' ' A' ' 104' ' ' THR . 12.8 p90 -160.77 131.6 5.42 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.999 1.72 . . . . 0.0 110.473 -172.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -107.22 162.19 14.1 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.295 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 p -90.22 170.5 10.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.571 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 111' ' ' MET . 6.7 p-10 -63.6 -30.83 71.88 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.789 0.836 . . . . 0.0 112.901 -173.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -69.32 -36.86 77.39 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.52 0.676 . . . . 0.0 110.157 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.528 ' O ' HG22 ' A' ' 114' ' ' VAL . 72.3 mmtt -78.28 -29.73 48.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.877 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.481 ' HA ' ' CE ' ' A' ' 111' ' ' MET . 0.2 OUTLIER -52.69 -42.61 64.95 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 124.122 0.969 . . . . 0.0 109.483 169.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.598 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 7.2 mmpt? -68.04 -46.74 70.32 Favored 'General case' 1 N--CA 1.377 -4.119 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.27 -34.19 76.89 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 118.661 -1.216 . . . . 0.0 111.761 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 110' ' ' LYS . 20.9 m -71.24 -45.3 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.276 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.36 -52.87 62.99 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.365 0.602 . . . . 0.0 110.153 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . 0.326 51.2 m-20 -60.86 -52.87 63.23 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.91 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.551 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -51.32 -39.8 57.71 Favored 'General case' 0 CA--C 1.461 -2.472 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.748 -174.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.695 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 1.6 tp -68.43 -46.09 70.8 Favored 'General case' 1 N--CA 1.362 -4.84 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.455 -179.24 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 43.4 mtp -64.81 -34.59 78.72 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 117' ' ' ALA . 56.4 mt -63.45 -52.7 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 175.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.6 t -53.91 -21.48 7.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.973 -1.921 . . . . 0.0 112.735 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 34.4 mt -111.36 -5.6 14.62 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.494 ' N ' ' HB3' ' B' ' 43' ' ' ASN . . . 76.63 23.97 68.76 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.399 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.434 ' HB3' ' SD ' ' B' ' 119' ' ' MET . 58.0 mt -83.02 -59.65 2.41 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.833 0.349 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -105.0 134.46 48.06 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -74.85 123.8 25.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 118.611 -1.235 . . . . 0.0 109.165 174.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.29 -5.98 28.51 Favored Glycine 0 C--N 1.301 -1.411 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.763 -176.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.29 165.23 12.49 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 121.574 0.702 . . . . 0.0 109.679 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 35.7 t -118.48 133.0 66.7 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.523 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.622 ' O ' HG22 ' B' ' 38' ' ' VAL . 39.6 m-85 -135.82 146.5 47.6 Favored 'General case' 0 C--O 1.188 -2.165 0 C-N-CA 124.857 1.263 . . . . 0.0 108.411 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 1.8 mp -74.32 148.94 40.91 Favored 'General case' 0 N--CA 1.407 -2.61 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.989 171.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -144.42 136.21 25.93 Favored 'General case' 0 C--N 1.264 -3.133 0 O-C-N 124.416 1.073 . . . . 0.0 110.163 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.87 94.4 3.33 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.082 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 9.5 mt -89.36 4.74 47.96 Favored 'General case' 0 C--O 1.199 -1.6 0 C-N-CA 124.6 1.16 . . . . 0.0 110.222 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.583 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 4.1 m -53.96 -177.11 0.04 OUTLIER Pre-proline 1 C--N 1.241 -4.132 0 C-N-CA 126.733 2.013 . . . . 0.0 112.564 173.542 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 20.17 35.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.405 3.549 1 C-N-CA 125.942 4.428 . . . . 0.0 119.414 -157.511 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.605 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 3.7 m -71.08 172.85 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.1 167.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -112.27 135.61 52.73 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.75 -112.15 4.12 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 114.785 -1.098 . . . . 0.0 114.362 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -93.43 -0.43 56.48 Favored 'General case' 0 N--CA 1.417 -2.102 0 C-N-CA 123.405 0.682 . . . . 0.0 112.275 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.605 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 77.4 mt-10 -61.14 141.1 57.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.511 ' HG3' ' NH2' ' B' ' 36' ' ' ARG . 5.3 tp60 -116.05 112.81 22.31 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -169.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.404 ' CA ' ' HB3' ' B' ' 24' ' ' LEU . . . -127.95 -106.77 1.36 Allowed Glycine 1 N--CA 1.378 -5.208 0 C-N-CA 118.149 -1.977 . . . . 0.0 116.688 -177.152 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 74.48 175.44 34.09 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 107.663 -2.175 . . . . 0.0 107.663 -168.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 p -89.19 108.98 19.72 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.393 0 O-C-N 120.475 -1.603 . . . . 0.0 108.73 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ARG . . . . . 0.511 ' NH2' ' HG3' ' B' ' 32' ' ' GLN . 65.1 mtm180 -137.76 157.72 72.94 Favored Pre-proline 0 C--N 1.281 -2.397 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.429 -174.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.3 Cg_exo -66.29 138.65 51.9 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.061 2.507 . . . . 0.0 111.902 173.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.622 HG22 ' O ' ' B' ' 20' ' ' TYR . 20.6 m -126.9 162.71 31.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 123.74 0.816 . . . . 0.0 110.074 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 27.1 m -104.57 134.28 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 31.9 mm -94.23 118.64 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 122.835 0.454 . . . . 0.0 110.054 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 -8.8 12.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.577 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.544 ' NE2' ' HB ' ' B' ' 53' ' ' VAL . 5.7 pt20 -63.51 165.71 7.6 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 -167.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.494 ' HB3' ' N ' ' A' ' 123' ' ' GLY . 14.3 p-10 -77.46 -174.19 3.23 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 112.088 -2.324 . . . . 0.0 113.413 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' B' ' 47' ' ' ASN . 2.7 t70 -72.44 -47.4 49.24 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 112.837 -1.983 . . . . 0.0 113.909 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -86.65 -25.71 24.73 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -165.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' B' ' 50' ' ' SER . . . -70.75 -21.23 77.91 Favored Glycine 0 C--O 1.218 -0.889 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' B' ' 44' ' ' ASP . 39.1 t-20 -72.77 -32.04 65.32 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.703 -1.248 . . . . 0.0 108.259 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -91.64 -65.38 1.01 Allowed 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -100.15 -35.56 9.62 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -168.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.583 ' O ' ' HE2' ' B' ' 96' ' ' LYS . 14.6 t -76.93 132.23 71.62 Favored Pre-proline 0 N--CA 1.433 -1.323 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.551 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 62.3 Cg_endo -77.53 -11.12 17.25 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.792 1.661 . . . . 0.0 110.154 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 1.9 p -106.38 121.83 45.03 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.745 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.544 ' HB ' ' NE2' ' B' ' 42' ' ' GLN . 1.3 m -121.82 167.96 14.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' B' ' 92' ' ' ARG . 13.8 tt -109.2 125.24 66.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 123.695 0.798 . . . . 0.0 112.099 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.663 HG22 ' CD2' ' B' ' 94' ' ' LEU . 3.7 m -137.72 163.97 29.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.694 ' HA ' HG13 ' B' ' 91' ' ' ILE . . . -123.47 130.8 53.22 Favored 'General case' 0 N--CA 1.415 -2.176 0 O-C-N 123.387 0.429 . . . . 0.0 111.317 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.669 ' H ' HG21 ' B' ' 91' ' ' ILE . . . -65.04 132.69 49.88 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.559 HG12 HD12 ' B' ' 86' ' ' ILE . 57.6 mt -89.26 134.08 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 112.645 -2.07 . . . . 0.0 107.346 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -144.88 179.68 7.17 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.887 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.567 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -69.35 9.79 0.49 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.135 1.89 . . . . 0.0 113.599 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 72.9 p -117.61 -7.85 11.0 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.079 0.466 . . . . 0.0 110.748 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' HIS . . . . . 0.587 ' CD2' HD22 ' B' ' 87' ' ' LEU . 61.9 m170 -123.23 129.34 51.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.428 HG23 HD11 ' B' ' 73' ' ' ILE . 32.9 m -122.19 139.72 48.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.541 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -97.11 130.6 44.36 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.698 0.761 . . . . 0.0 111.439 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.728 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -123.54 154.2 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.666 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -74.77 127.04 32.21 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.197 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -45.95 -44.76 15.09 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.173 1.389 . . . . 0.0 111.5 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -59.86 -45.31 92.86 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 126.392 1.877 . . . . 0.0 112.478 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -72.41 -35.19 68.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.93 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.728 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.8 m-85 -95.78 -6.02 40.57 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.704 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 57.06 31.68 20.36 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.439 1.096 . . . . 0.0 112.864 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' B' ' 78' ' ' TYR . 6.8 mp -87.8 -178.82 6.14 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.652 1.215 . . . . 0.0 112.844 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -75.51 -25.42 57.26 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.935 -1.939 . . . . 0.0 109.735 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -148.04 168.79 21.43 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -60.34 144.42 50.72 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.098 0.475 . . . . 0.0 109.826 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 8.0 m -103.25 136.79 42.37 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.61 -168.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.29 135.87 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.559 HD12 HG12 ' B' ' 58' ' ' ILE . 21.0 mm -114.89 138.1 46.23 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.834 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.587 HD22 ' CD2' ' B' ' 70' ' ' HIS . 31.4 mt -104.25 141.32 36.49 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' B' ' 118' ' ' LEU . 3.4 mm? -111.59 1.42 16.82 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-O 122.173 0.987 . . . . 0.0 111.296 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' GLU . . . . . 0.417 ' HA ' HH12 ' B' ' 92' ' ' ARG . 8.7 pt-20 -100.77 -33.44 10.25 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.021 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLN . . . . . 0.796 ' HB3' HD13 ' B' ' 91' ' ' ILE . 1.0 OUTLIER -81.24 -2.03 47.21 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.531 -171.016 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.796 HD13 ' HB3' ' B' ' 90' ' ' GLN . 0.0 OUTLIER -150.8 147.68 15.59 Favored 'Isoleucine or valine' 1 CA--C 1.418 -4.103 0 CA-C-O 117.6 -1.19 . . . . 0.0 112.429 -163.715 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.896 ' HB3' ' HB3' ' A' ' 92' ' ' ARG 0.273 41.2 mtm-85 179.83 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.752 1 N-CA-C 121.929 4.048 . . . . 0.0 121.929 -174.913 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.722 ' OG1' ' HB2' ' A' ' 92' ' ' ARG . 29.8 m -122.84 101.04 7.21 Favored 'General case' 0 N--CA 1.531 3.593 0 O-C-N 121.029 -1.044 . . . . 0.0 112.871 -171.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.663 ' CD2' HG22 ' B' ' 55' ' ' VAL . 0.1 OUTLIER -132.17 125.72 31.89 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.57 -173.155 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 11.0 t0 -56.94 147.47 23.71 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.439 0.696 . . . . 0.0 111.674 172.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.583 ' HE2' ' O ' ' B' ' 50' ' ' SER . 67.8 mttm -54.49 -33.0 58.99 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.455 1.102 . . . . 0.0 111.833 177.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.444 ' HZ3' ' CG ' ' B' ' 95' ' ' ASP . 44.9 mttp -62.26 -23.36 66.65 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.257 0.623 . . . . 0.0 111.192 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 32.9 mtp180 -78.13 -38.51 43.64 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.26 118.1 12.66 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 124.189 0.995 . . . . 0.0 111.121 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -97.41 -69.67 0.75 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.678 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.8 pt-20 -156.52 149.08 23.59 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.584 0.707 . . . . 0.0 112.476 -166.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 2.3 ptmt -67.71 124.74 24.11 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 127.449 2.3 . . . . 0.0 114.93 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.574 HD23 HG12 ' B' ' 19' ' ' VAL 0.287 2.0 mm? -102.27 -63.73 1.13 Allowed 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 123.389 1.566 . . . . 0.0 110.548 174.428 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.513 ' H ' ' HB ' ' B' ' 19' ' ' VAL . 22.8 m -131.13 -177.75 4.53 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 111.508 -2.587 . . . . 0.0 112.299 -161.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.42 ' H ' ' CG2' ' B' ' 104' ' ' THR . 13.7 p90 -160.93 132.57 5.7 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.502 1.521 . . . . 0.0 111.185 -171.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 pp -107.0 161.83 14.39 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.276 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 5.1 p -90.66 172.69 8.49 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.082 0.467 . . . . 0.0 111.857 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.39 -31.59 72.87 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.705 0.802 . . . . 0.0 112.644 -174.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -69.2 -35.68 76.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.558 0.695 . . . . 0.0 109.277 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.556 ' O ' HG22 ' B' ' 114' ' ' VAL . 73.3 mmtt -79.15 -30.27 43.51 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.178 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.492 ' HA ' ' HE3' ' B' ' 111' ' ' MET . 0.2 OUTLIER -52.23 -41.79 63.04 Favored 'General case' 0 N--CA 1.42 -1.96 0 O-C-N 124.142 0.902 . . . . 0.0 109.132 169.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.614 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 6.5 mmpt? -67.9 -47.57 68.41 Favored 'General case' 1 N--CA 1.375 -4.212 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -178.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -64.8 -38.23 90.28 Favored 'General case' 0 N--CA 1.41 -2.437 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.469 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' VAL . . . . . 0.556 HG22 ' O ' ' B' ' 110' ' ' LYS . 25.6 m -68.93 -46.58 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.651 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -57.33 -52.91 63.45 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.12 0.486 . . . . 0.0 110.421 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.358 86.2 m-20 -59.19 -54.29 48.55 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.004 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.411 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -56.22 -37.29 69.48 Favored 'General case' 0 CA--C 1.46 -2.512 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.072 -171.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.703 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.6 tp -66.22 -45.36 80.95 Favored 'General case' 1 N--CA 1.358 -5.042 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.846 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.434 ' SD ' ' HB3' ' A' ' 124' ' ' LEU . 47.0 mtp -66.15 -32.61 74.16 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' B' ' 117' ' ' ALA . 53.7 mt -64.49 -54.6 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.1 t -50.52 -22.59 2.02 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.184 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 31.5 mt -111.14 -4.65 14.96 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' GLY . . . . . 0.458 ' N ' ' HB3' ' A' ' 43' ' ' ASN . . . 75.1 23.28 74.76 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.449 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 52.4 mt -81.37 -58.62 2.96 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 CA--C 1.554 1.098 0 C-N-CA 127.118 2.167 . . . . 0.0 116.264 -179.667 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.8 mt . . . . . 0 C--O 1.242 0.662 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -108.69 151.01 26.75 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -71.2 124.11 23.74 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.65 -2.91 29.1 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.479 -1.343 . . . . 0.0 112.968 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -84.84 161.1 20.04 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.451 HG21 HG22 ' A' ' 104' ' ' THR . 78.4 t -121.92 108.01 21.14 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.655 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.85 174.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.2 m-85 -99.56 147.02 25.78 Favored 'General case' 0 C--N 1.255 -3.506 0 C-N-CA 124.809 1.244 . . . . 0.0 109.567 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.5 mp -83.08 146.67 28.56 Favored 'General case' 0 N--CA 1.382 -3.851 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.33 140.09 32.02 Favored 'General case' 0 C--N 1.256 -3.497 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.972 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -84.98 90.48 7.84 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.594 ' O ' HG13 ' A' ' 27' ' ' VAL . 51.3 mt -73.58 -21.67 60.27 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.966 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.589 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 4.4 m -32.91 174.46 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.738 0 C-N-CA 129.064 2.945 . . . . 0.0 115.684 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 23.38 52.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.414 -3.199 0 C-N-CA 123.094 2.529 . . . . 0.0 114.555 -151.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -68.33 141.48 17.53 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 CA-C-N 112.385 -2.189 . . . . 0.0 110.026 171.093 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.458 ' OE1' ' HB2' ' B' ' 26' ' ' PRO . 18.0 mm100 -89.84 120.16 30.84 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.965 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.19 -110.7 1.64 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.061 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' B' ' 95' ' ' ASP . 33.4 m -94.1 10.16 34.84 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 98.3 mt-10 -61.64 143.17 56.52 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.3 118.51 31.36 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.424 -169.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.05 -171.17 23.48 Favored Glycine 0 N--CA 1.414 -2.783 0 N-CA-C 120.093 2.797 . . . . 0.0 120.093 162.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.28 -152.58 6.9 Favored Glycine 0 C--N 1.264 -3.471 1 N-CA-C 102.349 -4.301 . . . . 0.0 102.349 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.1 113.22 15.93 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-N 121.125 2.462 . . . . 0.0 109.953 176.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -143.73 162.04 43.42 Favored Pre-proline 0 C--N 1.277 -2.569 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.195 -175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.557 ' HB2' HD12 ' A' ' 58' ' ' ILE . 19.9 Cg_exo -72.29 143.44 39.38 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.479 2.119 . . . . 0.0 111.5 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 28.6 m -128.69 160.09 39.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 124.197 0.999 . . . . 0.0 109.531 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.0 m -104.92 131.84 53.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.608 0.242 . . . . 0.0 110.553 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.403 HD13 HG12 ' A' ' 55' ' ' VAL . 24.3 mm -89.85 108.44 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.8 -18.34 7.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.701 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.791 ' NE2' ' HA ' ' A' ' 53' ' ' VAL . 2.6 tt0 -52.81 156.84 1.84 Allowed 'General case' 0 C--O 1.245 0.846 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -171.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.429 ' HA ' ' HA3' ' B' ' 123' ' ' GLY . 13.1 p-10 -56.83 155.36 7.94 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-N 113.248 -1.796 . . . . 0.0 112.075 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.18 -27.44 62.57 Favored 'General case' 0 C--N 1.264 -3.112 0 CA-C-N 113.593 -1.64 . . . . 0.0 112.386 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.3 m -83.85 -37.18 22.79 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.29 -0.256 . . . . 0.0 111.102 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.01 -27.34 73.7 Favored Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.96 -33.66 70.89 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.127 0.489 . . . . 0.0 109.859 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.529 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 10.2 mmmm -93.22 -60.69 1.73 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.956 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.529 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 71.0 m-85 -93.83 -36.14 12.39 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -165.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.6 m -80.82 138.65 50.18 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.02 -17.9 40.72 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 121.899 1.733 . . . . 0.0 111.077 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 4.7 p -98.54 158.49 15.56 Favored 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 124.856 1.263 . . . . 0.0 111.498 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.791 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -152.51 138.87 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.196 0.598 . . . . 0.0 110.454 170.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.667 HG22 ' HG3' ' A' ' 42' ' ' GLN . 8.6 tt -83.69 135.06 25.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 CA-C-O 121.4 0.619 . . . . 0.0 110.476 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 32.8 m -139.27 156.26 27.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.481 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.534 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -115.79 139.33 50.28 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 138.45 43.78 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.585 HG12 HD12 ' A' ' 86' ' ' ILE . 64.1 mt -96.13 134.65 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 113.129 -1.85 . . . . 0.0 107.533 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.1 t -137.29 143.53 42.2 Favored 'General case' 0 N--CA 1.414 -2.27 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.591 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.372 0 N-CA-C 107.106 -2.398 . . . . 0.0 107.106 170.385 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 N--CA 1.434 -1.241 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -62.05 -10.93 19.44 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.647 2.231 . . . . 0.0 115.53 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.3 p -98.22 -16.38 19.46 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -113.1 128.7 56.56 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.91 125.7 70.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.372 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -91.7 118.63 30.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.51 0.672 . . . . 0.0 109.508 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.889 HG21 ' CE1' ' A' ' 78' ' ' TYR . 3.2 mm -96.09 158.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.607 -173.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.08 120.2 14.56 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 123.743 0.817 . . . . 0.0 110.221 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 85.6 tttt -46.67 -51.27 16.33 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 126.198 1.799 . . . . 0.0 111.575 176.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -56.93 -49.48 75.48 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 126.282 1.833 . . . . 0.0 112.111 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.445 ' HD3' ' OG ' ' A' ' 107' ' ' SER . 39.4 ttmt -69.22 -33.61 73.58 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.425 0.69 . . . . 0.0 110.535 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.889 ' CE1' HG21 ' A' ' 73' ' ' ILE . 3.2 m-85 -88.63 -11.19 46.1 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.617 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.4 tttm 67.22 24.63 9.13 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.433 0.693 . . . . 0.0 111.16 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 78' ' ' TYR . 7.2 mp -94.86 178.62 5.51 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-O 122.616 1.198 . . . . 0.0 112.44 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.413 ' O ' ' HE3' ' A' ' 75' ' ' LYS . 2.2 m-20 -73.54 -20.71 60.57 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 112.555 -2.111 . . . . 0.0 111.733 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 83' ' ' ASP . 11.6 ptmm? -158.48 169.97 23.25 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 9.9 p-10 -51.85 135.96 29.0 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 m -109.12 135.5 50.16 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.4 t -107.69 135.86 44.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.585 HD12 HG12 ' A' ' 58' ' ' ILE . 18.2 mm -112.19 135.39 51.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.0 mt -104.49 106.23 16.65 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -84.05 -5.61 59.26 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.687 -174.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -91.62 -39.56 11.81 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.986 174.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.05 79.32 4.07 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.325 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.534 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -114.73 -176.78 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -166.61 173.68 9.49 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.865 0.364 . . . . 0.0 111.57 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 67.5 m -123.34 124.32 42.69 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.2 mt -130.88 142.8 50.4 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.688 -171.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.9 p30 -74.56 152.39 39.32 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.352 174.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -47.54 -27.5 1.83 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.902 1.281 . . . . 0.0 114.31 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.3 -18.49 57.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 120.867 0.365 . . . . 0.0 111.433 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.21 -34.09 65.73 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.41 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 7.8 mp -76.63 126.16 30.49 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.248 1.419 . . . . 0.0 110.145 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -91.96 -67.33 0.86 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.744 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 14.6 pt-20 -153.25 152.88 31.67 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.518 -166.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.452 ' HE2' ' OH ' ' A' ' 20' ' ' TYR . 70.6 mttt -73.41 123.94 24.82 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.776 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.574 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 18.8 tp -109.38 -60.99 1.69 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 122.653 1.216 . . . . 0.0 108.438 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.574 ' OG1' ' HG ' ' A' ' 103' ' ' LEU . 2.3 m -127.36 178.72 5.87 Favored 'General case' 0 N--CA 1.381 -3.879 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.227 -166.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -160.45 139.69 10.72 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 125.121 1.368 . . . . 0.0 109.903 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 pp -115.05 161.59 18.15 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.252 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.445 ' OG ' ' HD3' ' A' ' 77' ' ' LYS . 34.3 p -88.12 172.66 9.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.174 0.512 . . . . 0.0 111.628 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 111' ' ' MET . 28.3 t70 -66.14 -30.35 70.81 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.112 0.565 . . . . 0.0 111.855 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -69.47 -30.61 68.53 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 114' ' ' VAL . 14.4 tppt? -77.65 -30.11 51.99 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.585 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -49.04 -47.12 45.01 Favored 'General case' 0 CA--C 1.48 -1.738 0 O-C-N 123.896 0.747 . . . . 0.0 110.75 171.129 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.754 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -65.64 -34.58 78.56 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.807 -178.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.84 -41.68 59.4 Favored 'General case' 0 N--CA 1.4 -2.944 0 C-N-CA 118.176 -1.41 . . . . 0.0 112.121 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 110' ' ' LYS . 19.7 m -67.16 -45.35 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 118.921 -0.561 . . . . 0.0 112.103 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -54.28 -51.69 63.78 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 123.2 1.476 . . . . 0.0 109.397 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.754 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -76.31 -30.58 57.76 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 112.998 -1.91 . . . . 0.0 115.031 -172.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.502 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -70.68 -41.9 71.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 1.9 tp -62.33 -44.19 97.08 Favored 'General case' 0 N--CA 1.394 -3.237 0 C-N-CA 125.479 1.511 . . . . 0.0 108.741 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.646 ' CG ' ' HA ' ' A' ' 125' ' ' ASN . 21.2 ttm -48.61 -37.46 18.22 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.5 mt -82.5 -50.12 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.665 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.5 m -48.81 -35.56 14.75 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.02 -1.9 . . . . 0.0 112.722 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.553 HD22 HG21 ' B' ' 54' ' ' ILE . 23.1 mt -103.19 -3.03 26.32 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 120.055 -0.658 . . . . 0.0 112.028 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' B' ' 43' ' ' ASN . . . 76.34 29.52 58.17 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 117.359 1.704 . . . . 0.0 117.359 172.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.645 HD11 HD11 ' B' ' 124' ' ' LEU . 0.2 OUTLIER -100.05 -46.02 5.47 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 118.947 1.373 . . . . 0.0 111.897 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.646 ' HA ' ' CG ' ' A' ' 119' ' ' MET . 1.6 t-20 . . . . . 0 C--N 1.296 -1.737 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.087 -168.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -108.88 145.71 34.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -66.23 125.98 27.27 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.65 -5.81 31.25 Favored Glycine 0 N--CA 1.426 -1.974 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.694 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -83.4 162.97 20.85 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.482 HG21 HG22 ' B' ' 104' ' ' THR . 75.1 t -122.53 110.14 26.02 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.766 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.732 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 30.3 m-85 -101.44 146.3 27.8 Favored 'General case' 0 C--N 1.26 -3.32 0 C-N-CA 124.875 1.27 . . . . 0.0 109.779 176.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 3.8 mp -81.13 146.14 30.7 Favored 'General case' 0 N--CA 1.388 -3.569 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 166.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.33 141.11 33.88 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.931 -173.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -85.58 89.19 7.65 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.616 ' O ' HG13 ' B' ' 27' ' ' VAL . 56.9 mt -73.03 -22.09 60.7 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.073 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.603 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 3.8 m -33.14 175.02 0.0 OUTLIER Pre-proline 0 CA--C 1.573 1.859 0 C-N-CA 129.433 3.093 . . . . 0.0 115.603 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 23.8 50.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.119 0 C-N-CA 123.205 2.603 . . . . 0.0 114.998 -152.241 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.616 HG13 ' O ' ' B' ' 24' ' ' LEU . 0.5 OUTLIER -68.18 143.09 15.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.107 172.397 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -89.72 118.86 29.63 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.942 -1.481 . . . . 0.0 112.301 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.3 -108.72 1.4 Allowed Glycine 0 C--N 1.309 -0.935 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.584 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 43.9 m -94.71 8.67 41.69 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.583 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 98.8 mt-10 -61.56 142.59 56.99 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 173.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.84 117.65 30.38 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 122.374 -0.204 . . . . 0.0 111.351 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.36 -173.85 22.54 Favored Glycine 0 N--CA 1.412 -2.942 0 N-CA-C 120.327 2.891 . . . . 0.0 120.327 163.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.28 -151.87 6.42 Favored Glycine 0 C--N 1.264 -3.459 1 N-CA-C 102.124 -4.391 . . . . 0.0 102.124 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.49 114.96 18.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-N 120.997 2.399 . . . . 0.0 109.867 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -145.21 161.6 41.2 Favored Pre-proline 0 C--N 1.284 -2.271 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.113 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 21.2 Cg_exo -71.91 143.15 40.35 Favored 'Trans proline' 0 CA--C 1.551 1.366 0 C-N-CA 122.599 2.199 . . . . 0.0 111.86 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 29.7 m -127.91 159.64 38.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 124.129 0.971 . . . . 0.0 109.754 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.1 m -103.76 132.56 49.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 CA-C-O 120.642 0.258 . . . . 0.0 110.357 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.4 HD13 HG12 ' B' ' 55' ' ' VAL . 24.4 mm -91.04 107.13 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.86 -18.89 6.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.89 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.769 ' NE2' ' HA ' ' B' ' 53' ' ' VAL . 2.4 tt0 -52.14 157.24 1.4 Allowed 'General case' 0 C--O 1.245 0.845 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -170.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 10.9 p-10 -56.88 158.17 5.03 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 113.182 -1.826 . . . . 0.0 112.325 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.49 -28.76 62.1 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 113.615 -1.629 . . . . 0.0 112.096 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 56.9 m -85.2 -35.24 21.76 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.175 -0.328 . . . . 0.0 111.764 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.5 -26.2 74.48 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -60.39 -32.74 71.6 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.12 0.486 . . . . 0.0 109.845 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.535 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 11.0 mmmm -93.1 -63.35 1.23 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.136 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.535 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 67.6 m-85 -91.89 -35.82 13.83 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -166.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 45.5 m -82.06 138.49 45.97 Favored Pre-proline 0 C--N 1.308 -1.212 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.66 -18.74 37.3 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 121.927 1.752 . . . . 0.0 111.178 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 3.0 p -98.81 155.64 17.26 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 124.781 1.232 . . . . 0.0 111.269 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.769 ' HA ' ' NE2' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -150.25 138.75 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 O-C-N 123.585 0.553 . . . . 0.0 110.387 171.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.649 HG22 ' HG3' ' B' ' 42' ' ' GLN . 8.8 tt -83.45 134.02 27.85 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 CA-C-O 121.46 0.647 . . . . 0.0 110.576 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 32.3 m -138.47 155.25 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.494 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.531 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -115.26 139.54 49.87 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.09 138.43 43.94 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.576 HG12 HD12 ' B' ' 86' ' ' ILE . 61.2 mt -96.14 134.48 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.285 -1.78 . . . . 0.0 107.422 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -137.46 141.42 41.58 Favored 'General case' 0 N--CA 1.405 -2.718 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.87 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.455 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 169.296 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 7.9 tt . . . . . 0 N--CA 1.431 -1.382 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.21 -5.84 7.23 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.797 2.331 . . . . 0.0 115.538 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 80.6 p -102.05 -16.19 16.52 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.334 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -112.34 128.5 56.3 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -126.57 126.3 68.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.76 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -92.6 123.35 35.83 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.556 0.693 . . . . 0.0 109.373 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.871 HG21 ' CE1' ' B' ' 78' ' ' TYR . 2.8 mm -100.77 155.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.946 -173.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.433 ' CD ' ' HZ1' ' B' ' 110' ' ' LYS . 2.4 mp0 -64.73 119.98 11.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 123.996 0.918 . . . . 0.0 110.527 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' LYS . . . . . 0.496 ' HE3' ' O ' ' B' ' 81' ' ' ASP . 85.7 tttt -48.2 -49.08 34.23 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 126.504 1.922 . . . . 0.0 111.408 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -60.6 -45.85 92.44 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 125.871 1.668 . . . . 0.0 111.76 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -72.27 -33.78 67.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.71 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.871 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.2 m-85 -87.83 -11.1 48.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.247 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 66.44 26.34 10.09 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 121.748 0.785 . . . . 0.0 111.07 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' B' ' 78' ' ' TYR . 6.8 mp -95.09 -178.76 4.58 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-O 122.448 1.118 . . . . 0.0 112.658 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.496 ' O ' ' HE3' ' B' ' 75' ' ' LYS . 4.9 m-20 -70.57 -28.64 65.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.104 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -154.04 171.21 19.45 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -53.69 135.66 40.68 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 7.1 m -109.44 135.49 50.39 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 t -107.73 136.55 42.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.576 HD12 HG12 ' B' ' 58' ' ' ILE . 13.7 mm -113.78 135.36 53.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 44.5 mt -104.78 104.88 14.74 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.28 -7.41 59.63 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.594 -174.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -90.99 -38.49 12.8 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.1 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.26 77.73 3.46 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.26 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.531 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.4 pp -113.45 -176.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.401 ' NH1' HG12 ' B' ' 27' ' ' VAL . 14.1 ptm180 -166.47 174.06 9.3 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 123.329 0.393 . . . . 0.0 111.55 172.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 68.8 m -123.63 124.62 43.18 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 74.7 mt -131.28 142.98 50.21 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.8 -171.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 3.9 p-10 -74.95 152.66 38.79 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.412 174.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -46.04 -30.0 1.69 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.019 1.328 . . . . 0.0 114.222 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.05 -19.75 60.52 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 120.945 0.402 . . . . 0.0 111.289 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -72.32 -34.11 67.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.417 ' HB3' ' CD2' ' B' ' 20' ' ' TYR . 7.8 mp -77.17 125.76 29.85 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.147 1.379 . . . . 0.0 110.174 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -93.3 -64.72 1.06 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.37 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -155.06 151.1 27.97 Favored 'General case' 0 N--CA 1.407 -2.587 0 CA-C-O 121.632 0.73 . . . . 0.0 111.283 -169.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' LYS . . . . . 0.473 ' HE2' ' OH ' ' B' ' 20' ' ' TYR . 67.2 mttt -70.85 126.19 28.91 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.755 174.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.506 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 18.8 tp -112.14 -62.02 1.63 Allowed 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.731 1.253 . . . . 0.0 108.657 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.506 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 1.6 m -125.98 178.44 5.75 Favored 'General case' 0 N--CA 1.383 -3.823 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.356 -166.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -160.74 137.7 8.97 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.825 1.25 . . . . 0.0 109.991 -170.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -110.98 164.0 13.25 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.748 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -91.96 171.56 9.04 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.548 0.213 . . . . 0.0 111.177 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' B' ' 111' ' ' MET . 27.6 t70 -62.75 -28.69 70.14 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.232 0.539 . . . . 0.0 111.39 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -70.11 -29.11 65.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.837 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.509 ' O ' HG22 ' B' ' 114' ' ' VAL . 14.1 tppt? -81.16 -29.26 34.74 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.812 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.486 ' CE ' ' HA ' ' B' ' 111' ' ' MET . 0.1 OUTLIER -47.81 -43.5 27.92 Favored 'General case' 0 CA--C 1.445 -3.078 0 O-C-N 124.173 0.921 . . . . 0.0 109.964 170.27 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.518 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 6.9 mmpt? -61.15 -54.02 49.66 Favored 'General case' 1 N--CA 1.37 -4.451 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.675 -178.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -62.41 -43.88 97.76 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.092 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' VAL . . . . . 0.509 HG22 ' O ' ' B' ' 110' ' ' LYS . 20.6 m -63.21 -43.14 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 123.67 0.606 . . . . 0.0 111.814 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -56.5 -54.85 40.96 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 123.479 0.487 . . . . 0.0 111.08 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' B' ' 119' ' ' MET 0.273 13.2 m120 -61.7 -45.26 94.74 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.242 0.544 . . . . 0.0 110.252 -177.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.54 -43.86 97.77 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.003 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.602 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.6 tp -63.03 -46.59 86.86 Favored 'General case' 0 N--CA 1.387 -3.612 0 C-N-CA 124.287 1.035 . . . . 0.0 108.338 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.74 ' SD ' ' HA ' ' B' ' 125' ' ' ASN . 15.4 ttm -49.63 -44.08 47.15 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 29.9 mt -72.34 -50.87 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 45.8 m -49.79 -34.07 18.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.485 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 22.3 mt -102.8 -4.19 25.29 Favored 'General case' 0 C--O 1.198 -1.627 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.116 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 43' ' ' ASN . . . 76.78 30.76 55.6 Favored Glycine 0 C--N 1.341 0.848 0 N-CA-C 117.469 1.747 . . . . 0.0 117.469 172.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.645 HD11 HD11 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -101.89 -47.27 4.64 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.696 1.248 . . . . 0.0 112.511 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.74 ' HA ' ' SD ' ' B' ' 119' ' ' MET 0.345 14.1 m120 . . . . . 0 C--N 1.302 -1.476 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.528 -167.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.5 mt . . . . . 0 N--CA 1.419 -1.985 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -146.77 160.72 41.9 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -77.64 122.11 24.87 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.533 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.432 ' HA2' ' SD ' ' A' ' 111' ' ' MET . . . 142.8 -30.63 2.04 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 119.395 -1.383 . . . . 0.0 113.996 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -100.43 173.87 6.37 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 118.075 0.937 . . . . 0.0 111.658 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 105' ' ' TYR . 54.0 t -110.98 138.71 38.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.836 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 92.2 m-85 -137.32 147.11 45.37 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 126.26 1.824 . . . . 0.0 108.731 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.2 mp -86.57 157.38 19.75 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 171.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.7 146.6 32.29 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.865 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -82.46 108.77 16.12 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.643 0.735 . . . . 0.0 109.63 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.606 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 15.4 mt -108.91 28.26 8.64 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 123.698 1.713 . . . . 0.0 109.073 -175.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.671 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 15.1 m -73.55 -178.62 0.75 Allowed Pre-proline 1 C--N 1.213 -5.358 0 CA-C-N 112.732 -2.031 . . . . 0.0 108.714 169.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.1 OUTLIER 17.23 42.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.148 0 C-N-CA 124.976 3.784 . . . . 0.0 118.016 -159.739 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 24' ' ' LEU . 5.2 m -70.2 174.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.054 0 CA-C-O 122.328 1.061 . . . . 0.0 112.234 172.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -92.49 110.56 21.97 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.005 -1.452 . . . . 0.0 114.198 -174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.65 -108.69 0.75 Allowed Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 113.918 -1.492 . . . . 0.0 114.784 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.7 m -86.58 13.85 7.85 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 36.0 mt-10 -67.4 -175.29 0.47 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.887 0.851 . . . . 0.0 112.063 173.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.594 ' NE2' ' HG3' ' A' ' 36' ' ' ARG . 12.1 tm0? -106.47 126.59 52.45 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -111.54 163.65 12.2 Favored Glycine 0 CA--C 1.498 -0.989 0 N-CA-C 116.871 1.508 . . . . 0.0 116.871 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.8 171.64 18.96 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 113.614 -1.293 . . . . 0.0 110.51 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.53 102.08 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.669 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.594 ' HG3' ' NE2' ' A' ' 32' ' ' GLN . 26.0 mmt180 -128.55 151.91 77.58 Favored Pre-proline 0 C--N 1.251 -3.715 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.88 -174.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 23.4 Cg_exo -65.46 144.92 81.32 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.839 2.359 . . . . 0.0 112.54 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 30.1 m -129.23 154.97 40.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.619 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 29.7 m -99.32 128.69 50.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.496 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.5 mm -92.24 106.44 17.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.06 -6.57 10.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.817 0.817 . . . . 0.0 109.085 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.593 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -51.15 146.64 6.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 125.853 1.661 . . . . 0.0 113.946 -170.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -60.95 -179.01 0.11 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.098 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 19.0 t70 -77.27 -48.54 17.2 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.151 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -70.25 -28.58 65.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.542 -171.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.01 -28.15 73.7 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.525 ' N ' HE22 ' A' ' 42' ' ' GLN . 87.0 m-20 -75.84 -37.59 58.88 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.278 0.561 . . . . 0.0 110.174 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 49' ' ' TYR . 49.8 mmtt -79.31 -61.6 1.95 Allowed 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.257 -176.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 55.7 m-85 -111.24 6.6 20.71 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -167.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 22.7 t -119.84 141.6 31.59 Favored Pre-proline 0 C--N 1.306 -1.298 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.314 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 10.2 Cg_exo -74.17 -23.34 15.83 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.073 1.848 . . . . 0.0 110.366 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -85.17 154.71 21.82 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.813 -175.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.46 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 57.9 t -138.4 140.07 40.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.713 HD11 HD13 ' A' ' 91' ' ' ILE . 3.8 tp -99.08 125.56 52.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 171.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 21.6 m -132.68 166.54 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.743 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.583 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -124.88 141.19 52.28 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.53 130.76 42.06 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.622 HG12 HD12 ' A' ' 86' ' ' ILE . 56.1 mt -90.13 120.42 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.085 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.9 m -119.3 155.47 31.76 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 175.224 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 tt . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.71 -1.1 4.47 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.198 2.599 . . . . 0.0 115.869 -175.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.1 p -91.32 -18.74 23.83 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-O 121.728 0.775 . . . . 0.0 109.432 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -101.5 129.26 47.53 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.18 127.81 69.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 84' ' ' SER . 12.8 pt-20 -99.08 131.08 45.38 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.088 0.47 . . . . 0.0 110.472 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.508 HD11 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -124.78 145.99 31.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.47 123.91 13.38 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 126.304 1.842 . . . . 0.0 113.332 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -58.67 -39.4 80.54 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.702 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 51.2 pttt -61.48 -27.76 68.8 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.974 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -91.43 -35.47 14.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.103 0.954 . . . . 0.0 109.549 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.401 ' OH ' HD23 ' A' ' 106' ' ' LEU . 32.9 m-85 -96.16 13.41 27.42 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.366 -171.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt 59.7 39.29 21.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.566 1.146 . . . . 0.0 114.064 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.86 174.31 7.62 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.792 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.0 -16.25 26.77 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.076 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -133.34 152.06 51.9 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.11 157.17 37.39 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.902 0.382 . . . . 0.0 110.308 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 72' ' ' GLU . 21.3 t -103.41 151.79 22.36 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.388 -172.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.37 124.32 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.622 HD12 HG12 ' A' ' 58' ' ' ILE . 20.1 mm -100.95 130.36 50.45 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.662 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 76.6 mt -102.59 102.91 13.18 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -82.58 6.29 18.13 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.901 -174.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.16 -38.31 6.31 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.285 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.412 ' HA ' HG21 ' B' ' 93' ' ' THR . 4.6 tp60 -83.82 69.33 10.21 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.826 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 54' ' ' ILE . 2.1 pp -111.44 -179.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.723 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.446 ' O ' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -167.28 165.31 15.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.2 m -118.19 118.73 32.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.1 mt -131.69 138.51 48.72 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.8 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 4.5 p-10 -73.91 152.1 40.24 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.015 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -47.69 -20.52 0.28 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.825 1.65 . . . . 0.0 115.197 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -71.39 -26.36 62.74 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.91 0.884 . . . . 0.0 110.735 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -74.26 -34.5 63.61 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.205 0.526 . . . . 0.0 110.212 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.52 124.98 26.32 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.657 1.183 . . . . 0.0 109.973 176.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -101.93 -60.17 1.58 Allowed 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -147.88 138.61 23.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.716 0.77 . . . . 0.0 112.719 -166.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 28.9 tttp -66.1 116.14 6.88 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 127.673 2.389 . . . . 0.0 107.414 174.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -110.16 -60.23 1.83 Allowed 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.76 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.414 ' CG2' HG21 ' A' ' 19' ' ' VAL . 10.6 t -127.64 -157.41 0.81 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.637 ' O ' HG23 ' A' ' 19' ' ' VAL . 38.0 m-85 -123.48 -89.0 0.6 Allowed 'General case' 0 C--O 1.177 -2.763 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.573 -172.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 1.5 mt 139.75 151.97 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 131.358 3.863 . . . . 0.0 105.484 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 79.0 p -97.59 154.49 17.5 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.746 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.511 ' O ' ' HD2' ' A' ' 112' ' ' LYS . 4.9 m-20 -58.54 -36.96 74.7 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 18.4 p-10 -76.74 -41.52 44.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.396 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -67.64 -25.63 65.83 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.544 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.465 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -53.71 -42.28 67.86 Favored 'General case' 0 N--CA 1.416 -2.146 0 C-N-CA 124.122 0.969 . . . . 0.0 110.421 171.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.672 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -71.25 -25.44 62.47 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.367 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.606 ' HA ' ' ND2' ' A' ' 116' ' ' ASN . 10.6 mt-10 -87.08 -35.19 18.85 Favored 'General case' 0 N--CA 1.394 -3.227 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.762 -171.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.75 -47.04 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.016 0 CA-C-N 112.856 -1.975 . . . . 0.0 108.501 169.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 68.5 m-20 -58.39 -52.82 63.98 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.129 0.49 . . . . 0.0 111.054 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.606 ' ND2' ' HA ' ' A' ' 113' ' ' GLU . 3.8 p30 -64.85 -42.96 94.47 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.109 -0.637 . . . . 0.0 111.743 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.519 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.32 -38.21 71.0 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.22 0.534 . . . . 0.0 109.903 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 8.9 tp -69.94 -46.27 65.66 Favored 'General case' 0 N--CA 1.392 -3.374 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.921 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.516 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 3.1 ttp -68.06 -23.48 64.96 Favored 'General case' 0 N--CA 1.408 -2.566 0 C-N-CA 124.161 0.984 . . . . 0.0 110.298 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 116' ' ' ASN . 49.7 mt -79.9 -54.47 11.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 174.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.5 t -47.71 -44.79 28.03 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 125.787 1.635 . . . . 0.0 112.584 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.458 ' HG ' HG12 ' B' ' 54' ' ' ILE . 9.7 mp -82.85 10.65 7.3 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.86 85.17 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.516 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.3 mm? -67.74 -63.48 1.05 Allowed 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 118.106 0.953 . . . . 0.0 109.121 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--N 1.305 -1.359 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.244 -173.281 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.426 -1.659 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -146.03 160.45 41.86 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -76.22 125.81 29.84 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.476 ' HA2' ' SD ' ' B' ' 111' ' ' MET . . . 140.12 -34.49 2.0 Allowed Glycine 0 N--CA 1.425 -2.081 0 C-N-CA 119.507 -1.33 . . . . 0.0 113.617 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -100.11 174.21 6.27 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 118.078 0.939 . . . . 0.0 111.992 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 105' ' ' TYR . 53.5 t -110.36 139.42 33.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.115 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 89.7 m-85 -137.57 147.67 45.28 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 126.072 1.749 . . . . 0.0 109.191 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.535 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.0 mp -88.16 156.33 19.3 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.19 147.64 32.67 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.956 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -82.61 107.66 15.42 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.205 1.003 . . . . 0.0 110.346 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.677 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 10.8 mt -108.9 28.01 8.9 Favored 'General case' 0 CA--C 1.484 -1.578 0 CA-C-O 123.451 1.596 . . . . 0.0 109.206 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.666 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 15.3 m -76.45 -178.62 0.97 Allowed Pre-proline 1 C--N 1.216 -5.223 0 CA-C-N 112.785 -2.007 . . . . 0.0 107.759 170.075 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.666 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 17.1 43.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.393 2.873 1 C-N-CA 125.396 4.064 . . . . 0.0 118.029 -160.374 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.495 HG13 ' O ' ' B' ' 24' ' ' LEU . 4.9 m -70.4 177.93 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.972 0 CA-C-O 122.171 0.986 . . . . 0.0 112.154 172.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -94.05 116.3 28.71 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.59 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.97 -108.65 0.77 Allowed Glycine 0 CA--C 1.499 -0.91 0 CA-C-N 114.622 -1.172 . . . . 0.0 114.966 172.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 10.3 m -90.97 10.55 26.08 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.544 -0.828 . . . . 0.0 113.06 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.483 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 34.9 mt-10 -62.82 -179.97 0.32 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.868 0.842 . . . . 0.0 112.777 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.446 ' OE1' ' HG3' ' B' ' 36' ' ' ARG . 0.0 OUTLIER -100.2 121.71 41.88 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.0 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.677 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -106.01 155.0 16.88 Favored Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.88 176.63 15.52 Favored Glycine 0 C--N 1.307 -1.08 0 CA-C-N 113.383 -1.409 . . . . 0.0 110.19 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.97 99.67 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ARG . . . . . 0.446 ' HG3' ' OE1' ' B' ' 32' ' ' GLN . 29.5 mmt180 -126.52 150.96 72.14 Favored Pre-proline 0 C--N 1.245 -3.974 0 CA-C-N 113.822 -1.536 . . . . 0.0 111.02 -172.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 25.1 Cg_exo -64.92 144.99 84.75 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 122.439 2.093 . . . . 0.0 112.208 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 31.0 m -129.15 155.23 41.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.453 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.582 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 30.7 m -99.87 129.01 51.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 21.7 mm -92.37 107.07 18.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.31 -7.52 10.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.679 0.752 . . . . 0.0 109.129 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.576 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.6 OUTLIER -49.82 148.68 2.97 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 126.099 1.759 . . . . 0.0 113.951 -170.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -61.83 -178.41 0.15 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.898 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' B' ' 48' ' ' LYS . 15.9 t70 -80.04 -47.56 14.7 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.483 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.6 m -69.97 -30.97 68.45 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.749 -172.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.23 -27.29 72.21 Favored Glycine 0 C--O 1.214 -1.129 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.537 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.516 ' N ' HE22 ' B' ' 42' ' ' GLN . 79.6 m-20 -78.37 -35.28 47.55 Favored 'General case' 0 CA--C 1.491 -1.318 0 O-C-N 122.554 -0.38 . . . . 0.0 110.586 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' B' ' 44' ' ' ASP . 51.7 mmtt -78.27 -60.83 2.21 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.358 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.436 ' CD2' ' HB2' ' B' ' 48' ' ' LYS . 69.1 m-85 -107.67 -11.07 15.5 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -167.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 19.1 t -106.14 143.03 26.11 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 121.711 -0.618 . . . . 0.0 109.515 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -75.79 -22.36 13.55 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.146 1.897 . . . . 0.0 110.323 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 0.8 OUTLIER -84.91 152.16 23.73 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.6 -175.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.478 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 58.9 t -136.47 140.05 44.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.706 HD11 HD13 ' B' ' 91' ' ' ILE . 4.1 tp -99.27 124.39 52.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 171.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 22.1 m -132.19 166.04 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.817 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.582 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -124.09 141.36 52.12 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.1 129.06 37.6 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.611 HG12 HD12 ' B' ' 86' ' ' ILE . 53.7 mt -87.61 123.02 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.915 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 25.8 m -120.42 159.6 24.77 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.389 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 176.97 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.2 tt . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -66.54 7.89 0.36 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 123.346 2.698 . . . . 0.0 115.704 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 74.8 p -98.37 -18.83 18.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.899 0.857 . . . . 0.0 108.738 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -101.25 129.41 47.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.57 130.34 70.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' B' ' 84' ' ' SER . 12.1 pt-20 -101.23 130.69 47.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.927 0.394 . . . . 0.0 110.179 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.517 HD11 HG12 ' B' ' 86' ' ' ILE . 0.0 OUTLIER -124.04 147.75 28.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.94 125.42 20.26 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 125.252 1.421 . . . . 0.0 113.287 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -61.96 -38.45 88.55 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.754 0.787 . . . . 0.0 111.234 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -61.75 -27.35 68.67 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.903 -1.499 . . . . 0.0 112.991 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -90.67 -37.1 13.97 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.976 0.893 . . . . 0.0 109.406 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.42 ' OH ' HD23 ' B' ' 106' ' ' LEU . 31.2 m-85 -94.3 12.4 27.03 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.372 -171.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt 61.0 38.43 17.36 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.549 1.139 . . . . 0.0 113.724 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 22.2 mt -123.36 174.53 7.28 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.528 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.95 -11.81 26.03 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.062 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -136.05 149.89 48.96 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -68.26 156.07 38.42 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.464 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' B' ' 72' ' ' GLU . 19.7 t -103.07 149.89 24.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.365 -171.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 41.4 t -123.58 124.81 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.288 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.611 HD12 HG12 ' B' ' 58' ' ' ILE . 19.4 mm -101.14 130.86 49.91 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.515 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 76.5 mt -102.76 102.52 12.68 Favored 'General case' 0 N--CA 1.406 -2.653 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.8 mm? -81.7 2.5 29.46 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.793 -174.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -101.79 -39.19 7.52 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.204 173.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -83.53 68.93 9.97 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.277 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.706 HD13 HD11 ' B' ' 54' ' ' ILE . 2.1 pp -110.23 -179.15 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.767 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.575 ' NH1' HD22 ' B' ' 24' ' ' LEU . 0.0 OUTLIER -167.25 165.03 15.47 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 90' ' ' GLN . 50.1 m -117.8 118.66 32.64 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 62.0 mt -131.54 138.61 48.98 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.83 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 4.2 p-10 -73.87 151.82 40.37 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 118.901 -1.12 . . . . 0.0 109.825 173.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -48.28 -20.98 0.44 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.83 1.652 . . . . 0.0 114.983 -175.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -72.91 -23.87 60.76 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.458 0.703 . . . . 0.0 110.575 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -74.32 -33.49 63.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.343 0.592 . . . . 0.0 109.867 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.25 122.8 23.41 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.39 1.076 . . . . 0.0 110.73 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -99.5 -62.13 1.28 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.4 pt-20 -143.42 148.7 36.55 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 122.054 0.931 . . . . 0.0 112.551 -167.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -79.3 111.34 15.45 Favored 'General case' 0 C--N 1.276 -2.596 0 C-N-CA 127.769 2.428 . . . . 0.0 107.89 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -105.65 -61.94 1.43 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.357 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.443 ' CG2' HG21 ' B' ' 19' ' ' VAL . 8.3 t -125.44 -159.21 0.88 Allowed 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.577 ' O ' HG23 ' B' ' 19' ' ' VAL . 37.9 m-85 -122.73 -87.39 0.64 Allowed 'General case' 0 C--O 1.176 -2.796 0 C-N-CA 118.387 -1.325 . . . . 0.0 112.445 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' B' ' 17' ' ' GLY . 1.5 mt 137.78 155.22 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 130.962 3.705 . . . . 0.0 106.035 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 88.2 p -100.88 155.65 17.82 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.33 -0.948 . . . . 0.0 108.709 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' B' ' 111' ' ' MET . 12.9 m-20 -58.29 -40.34 81.7 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -74.23 -39.07 63.33 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.72 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -70.67 -24.96 62.78 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.433 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -54.08 -41.98 68.81 Favored 'General case' 0 N--CA 1.413 -2.283 0 C-N-CA 123.742 0.817 . . . . 0.0 110.256 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.705 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 0.6 OUTLIER -70.69 -23.98 62.58 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.285 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 113' ' ' GLU . . . . . 0.648 ' HA ' ' ND2' ' B' ' 116' ' ' ASN 0.263 18.5 mt-10 -86.82 -37.63 17.6 Favored 'General case' 0 N--CA 1.387 -3.587 0 C-N-CA 118.363 -1.335 . . . . 0.0 110.533 -173.318 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.34 -46.58 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.282 0 CA-C-N 112.79 -2.004 . . . . 0.0 108.675 169.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 66.4 m-20 -60.34 -53.56 56.22 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 111.186 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.648 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 4.0 p30 -66.36 -40.58 89.87 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.256 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.464 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -59.9 -35.38 74.74 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 121.217 0.532 . . . . 0.0 109.579 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 8.9 tp -71.05 -45.92 62.96 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.38 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.511 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 3.0 ttp -67.23 -25.14 65.94 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.333 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.515 HG13 ' O ' ' B' ' 116' ' ' ASN . 45.7 mt -80.1 -53.35 13.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 33.8 t -47.65 -45.68 28.17 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.043 1.337 . . . . 0.0 112.248 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.502 ' HG ' HG12 ' A' ' 54' ' ' ILE . 9.6 mp -81.93 10.56 6.23 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.64 9.34 83.31 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 170.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.511 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.4 mm? -72.49 -62.08 1.57 Allowed 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 118.284 1.042 . . . . 0.0 108.884 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 C--N 1.303 -1.43 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.857 -173.529 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.465 HD12 ' NZ ' ' A' ' 96' ' ' LYS . 59.8 mt . . . . . 0 N--CA 1.424 -1.734 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -144.4 160.62 40.74 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.549 ' HD3' ' O ' ' A' ' 41' ' ' ILE . 49.8 ttp180 -72.8 113.55 9.97 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.711 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 144.78 -27.88 1.9 Allowed Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.069 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.97 138.49 35.21 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 121.25 0.547 . . . . 0.0 111.045 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 104' ' ' THR . 62.8 t -89.89 121.14 39.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.706 174.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 23.0 m-85 -110.9 145.87 37.53 Favored 'General case' 0 C--N 1.264 -3.122 0 C-N-CA 124.135 0.974 . . . . 0.0 109.892 173.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.9 mp -84.34 151.45 24.72 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.5 154.7 36.02 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-O 121.794 0.807 . . . . 0.0 111.395 -173.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 98' ' ' ARG . 22.2 t70 -88.99 95.14 10.2 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.556 HD23 ' HD2' ' A' ' 92' ' ' ARG 0.259 1.3 tt -92.09 -11.17 36.49 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -174.524 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.569 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 4.5 m -33.71 -177.64 0.0 OUTLIER Pre-proline 0 CA--C 1.596 2.738 0 C-N-CA 129.589 3.156 . . . . 0.0 114.978 171.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 31.76 37.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 123.796 2.997 . . . . 0.0 117.404 -154.272 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 8.5 m -73.19 146.83 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.616 163.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -114.75 124.43 51.76 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.42 -109.08 1.94 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 114.941 -1.027 . . . . 0.0 114.659 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.6 m -64.29 -21.23 66.53 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 124.76 1.224 . . . . 0.0 112.873 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 79.2 mt-10 -69.97 142.92 52.78 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -126.73 115.58 19.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.541 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -160.26 -88.52 0.07 OUTLIER Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 118.958 -1.592 . . . . 0.0 114.32 173.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.99 -145.93 27.6 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 -168.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.96 122.11 54.95 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.266 0 CA-C-N 119.804 1.802 . . . . 0.0 108.486 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -146.91 163.04 30.87 Favored Pre-proline 0 C--N 1.288 -2.076 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.967 -174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 17.0 Cg_exo -70.02 138.25 36.58 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 121.74 1.627 . . . . 0.0 109.208 167.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.83 162.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.532 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 31.6 m -102.3 128.83 54.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.054 175.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.8 mm -87.14 109.56 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -105.58 -17.87 7.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.764 -177.15 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.655 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 7.1 tt0 -64.3 164.62 10.85 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -170.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.627 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 21.4 p-10 -62.63 180.0 0.3 Allowed 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.844 1.658 . . . . 0.0 111.913 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.34 -48.04 37.56 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.674 -1.603 . . . . 0.0 113.069 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.3 m -86.6 -25.22 25.07 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -162.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 50' ' ' SER . . . -63.19 -30.15 76.63 Favored Glycine 0 C--O 1.192 -2.486 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -68.23 -36.44 79.5 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.428 0.633 . . . . 0.0 110.24 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -81.99 -50.39 9.17 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.615 -172.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -97.67 -15.37 20.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -172.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 23.1 t -114.45 145.92 34.79 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.14 -3.01 10.25 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.468 2.112 . . . . 0.0 111.67 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 p -111.66 139.33 47.21 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.487 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.655 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -137.65 139.72 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 120.811 0.338 . . . . 0.0 111.549 176.017 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 5.1 tt -87.51 129.02 39.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.014 0 CA-C-O 121.595 0.712 . . . . 0.0 112.477 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 21.9 m -133.88 168.21 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.229 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.532 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -125.69 140.68 52.5 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.68 128.76 37.19 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.578 HG12 ' CD1' ' A' ' 86' ' ' ILE . 62.7 mt -86.85 130.34 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.486 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.5 m -128.23 114.72 17.3 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.268 0.556 . . . . 0.0 111.931 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.712 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 176.043 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 tt . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.95 -5.05 6.92 Favored 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.979 3.119 . . . . 0.0 116.253 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.2 p -92.78 -12.3 31.59 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.857 0.836 . . . . 0.0 109.522 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -107.45 129.59 54.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.2 p -128.15 136.34 60.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.745 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -99.55 137.98 37.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.992 0.901 . . . . 0.0 112.316 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.725 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -119.92 160.69 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.117 -179.229 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.3 117.57 18.11 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -53.09 -44.6 67.7 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -52.37 -39.58 60.97 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 125.455 1.502 . . . . 0.0 111.15 177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.468 ' HD3' ' OG ' ' A' ' 107' ' ' SER . 40.2 ttmt -74.62 -35.75 62.92 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 -176.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 73' ' ' ILE . 2.7 m-85 -97.51 8.86 43.83 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.645 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.3 tttm 71.81 11.32 6.29 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 125.185 1.394 . . . . 0.0 113.495 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.02 170.92 11.14 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-O 122.384 1.088 . . . . 0.0 109.948 174.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -108.39 -4.85 17.03 Favored 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.994 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -128.63 147.42 50.73 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -52.74 134.24 36.5 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 124.045 0.84 . . . . 0.0 110.72 -177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.44 ' O ' HG12 ' A' ' 73' ' ' ILE . 13.9 m -102.14 122.96 45.16 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.163 -169.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 37.3 t -113.82 135.8 52.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.578 ' CD1' HG12 ' A' ' 58' ' ' ILE . 16.5 mm -106.14 136.64 39.83 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 N-CA-C 106.33 -1.729 . . . . 0.0 106.33 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.32 107.58 18.66 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.6 mm? -86.57 14.89 6.16 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.015 0.912 . . . . 0.0 111.498 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -114.57 -44.34 3.09 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.158 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 80.78 6.62 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.528 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -122.95 -178.14 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.915 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.556 ' HD2' HD23 ' A' ' 24' ' ' LEU 0.254 13.5 ptp180 -175.3 167.27 3.38 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 171.148 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 54' ' ' ILE . 94.1 m -108.65 121.78 45.73 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.188 -178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.1 mt -131.1 145.61 52.06 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 124.548 1.155 . . . . 0.0 111.142 -169.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 20.1 t70 -50.94 137.07 21.72 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.632 1.173 . . . . 0.0 112.782 172.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.465 ' NZ ' HD12 ' A' ' 14' ' ' ILE . 30.0 mtpp -55.9 -29.51 60.14 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.829 0.852 . . . . 0.0 112.435 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 9.1 mtmp? -87.75 -9.58 53.58 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.888 -175.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 12.1 ptm180 -90.65 -17.19 27.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.668 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.34 127.02 31.57 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 161.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -99.0 -59.73 1.67 Allowed 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -172.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 13.3 pt-20 -147.98 131.71 16.95 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -169.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -63.67 108.94 1.53 Allowed 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 128.552 2.741 . . . . 0.0 107.118 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.713 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 57.2 tp -106.32 -63.07 1.3 Allowed 'General case' 0 N--CA 1.411 -2.4 0 CA-C-O 122.386 1.089 . . . . 0.0 111.435 -171.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.769 HG22 ' H ' ' A' ' 105' ' ' TYR 0.291 19.9 m -138.32 -157.06 0.74 Allowed 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 113.76 -1.563 . . . . 0.0 111.437 -165.082 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.769 ' H ' HG22 ' A' ' 104' ' ' THR . 12.9 t80 -159.15 151.84 21.74 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 119.653 1.115 . . . . 0.0 110.513 -161.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -115.1 138.37 50.96 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.37 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.468 ' OG ' ' HD3' ' A' ' 77' ' ' LYS . 19.7 m -79.79 157.33 27.1 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.534 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 111' ' ' MET . 26.1 t70 -63.61 -37.39 87.16 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.195 0.598 . . . . 0.0 112.197 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.23 -40.35 95.85 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 123.329 0.652 . . . . 0.0 110.696 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HE3' HG23 ' A' ' 73' ' ' ILE . 14.9 tppt? -77.98 -27.42 49.12 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.957 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.528 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 1.3 mmt -50.09 -46.84 53.84 Favored 'General case' 0 CA--C 1.461 -2.447 0 CA-C-O 122.223 1.011 . . . . 0.0 109.345 171.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 8.0 mmpt? -72.94 -12.36 60.92 Favored 'General case' 0 N--CA 1.392 -3.337 0 CA-C-N 113.853 -1.521 . . . . 0.0 114.012 -177.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -90.7 -52.1 5.05 Favored 'General case' 0 N--CA 1.385 -3.709 0 C-N-CA 117.469 -1.692 . . . . 0.0 107.59 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -51.87 -59.28 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 113.217 -1.81 . . . . 0.0 113.141 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 56.7 m-20 -59.22 -39.37 82.48 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 123.534 1.635 . . . . 0.0 110.732 -177.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -80.56 -41.95 23.2 Favored 'General case' 0 C--N 1.256 -3.468 0 CA-C-N 112.442 -2.163 . . . . 0.0 112.722 -172.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.453 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.45 -35.38 73.93 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 122.191 0.996 . . . . 0.0 108.332 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 3.9 tp -68.09 -40.36 82.68 Favored 'General case' 0 N--CA 1.384 -3.757 0 CA-C-N 113.211 -1.813 . . . . 0.0 110.141 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.2 ttp -72.02 -19.94 61.78 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.33 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 117' ' ' ALA . 54.1 mt -84.7 -52.75 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.8 t -47.93 -46.33 31.95 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.938 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.06 5.71 13.46 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.04 81.91 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 116.48 1.352 . . . . 0.0 116.48 171.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' B' ' 115' ' ' ASP . 5.9 mt -73.28 -52.51 13.7 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 117.413 -1.715 . . . . 0.0 107.867 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 . . . . . 0 C--N 1.313 -1.019 0 CA-C-N 113.191 -1.822 . . . . 0.0 115.149 -178.721 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.458 HD12 ' NZ ' ' B' ' 96' ' ' LYS . 62.1 mt . . . . . 0 N--CA 1.43 -1.426 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -144.87 160.73 40.82 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' B' ' 41' ' ' ILE . 50.5 ttp180 -71.39 114.4 9.41 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 143.31 -27.74 2.11 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.388 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -97.73 138.51 35.0 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.244 0.545 . . . . 0.0 111.05 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.427 ' HB ' ' H ' ' B' ' 104' ' ' THR . 64.7 t -89.76 123.44 41.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.528 174.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -113.04 146.29 39.38 Favored 'General case' 0 C--N 1.267 -3.016 0 C-N-CA 124.122 0.969 . . . . 0.0 109.806 172.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.602 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.1 mp -83.34 152.21 25.19 Favored 'General case' 0 N--CA 1.399 -2.983 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 167.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.38 156.84 40.34 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-O 121.785 0.802 . . . . 0.0 111.428 -173.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.98 93.88 8.99 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.556 HD22 ' HA3' ' B' ' 33' ' ' GLY 0.25 1.6 tt -90.58 -11.24 40.59 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -174.401 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.622 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 9.2 m -33.55 -177.45 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.668 0 C-N-CA 129.497 3.119 . . . . 0.0 115.364 170.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 31.59 36.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 123.751 2.968 . . . . 0.0 117.421 -154.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.542 HG13 ' O ' ' B' ' 24' ' ' LEU . 6.9 m -73.24 148.51 8.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.61 164.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -117.48 122.51 43.93 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.75 -111.89 4.14 Favored Glycine 0 C--N 1.32 -0.344 0 CA-C-N 115.087 -0.96 . . . . 0.0 114.121 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 18.2 m -60.17 -21.86 62.19 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.651 1.18 . . . . 0.0 113.122 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.517 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 73.2 mt-10 -70.3 143.48 52.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -128.25 117.22 21.12 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.556 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -160.51 -91.66 0.08 OUTLIER Glycine 0 N--CA 1.415 -2.757 0 C-N-CA 119.437 -1.363 . . . . 0.0 113.964 173.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.96 -147.45 27.66 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 105.391 -3.084 . . . . 0.0 105.391 -167.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.95 122.08 51.41 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 119.766 1.783 . . . . 0.0 108.821 172.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -145.86 162.94 33.68 Favored Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.9 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 18.4 Cg_exo -69.98 138.46 37.15 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.855 1.704 . . . . 0.0 109.008 167.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.54 161.98 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 29.1 m -101.5 129.44 52.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.186 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 33.9 mm -88.26 109.58 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.479 ' O ' ' HD3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -105.64 -18.01 7.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.734 -177.081 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.665 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 7.0 tt0 -64.92 163.73 13.9 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -170.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.63 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 13.3 p-10 -65.11 178.89 0.78 Allowed 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.876 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.05 -47.76 49.25 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 112.827 -1.988 . . . . 0.0 113.039 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.426 ' HA ' ' HD2' ' B' ' 48' ' ' LYS . 3.5 m -87.28 -24.16 24.44 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -162.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' B' ' 50' ' ' SER . . . -63.69 -30.27 77.15 Favored Glycine 0 C--O 1.2 -1.986 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -66.29 -40.25 89.92 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 120.886 0.374 . . . . 0.0 110.624 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' B' ' 45' ' ' THR . 28.5 mttt -78.76 -54.9 5.61 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-O 121.06 0.457 . . . . 0.0 112.04 -175.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -88.07 -25.06 23.25 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' B' ' 46' ' ' GLY . 13.9 t -107.6 144.83 30.05 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.93 -6.1 12.26 Favored 'Trans proline' 0 C--O 1.241 0.639 0 C-N-CA 122.433 2.089 . . . . 0.0 111.631 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 3.7 p -107.68 142.3 37.87 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.336 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.665 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.1 OUTLIER -140.5 139.64 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 120.803 0.335 . . . . 0.0 111.6 176.067 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' B' ' 93' ' ' THR . 4.8 tt -87.7 130.08 38.0 Favored 'Isoleucine or valine' 0 C--O 1.247 0.941 0 CA-C-O 121.611 0.72 . . . . 0.0 112.901 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.492 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 20.0 m -134.67 167.91 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.169 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.525 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -125.15 140.25 53.04 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.97 127.75 33.94 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.57 HG12 ' CD1' ' B' ' 86' ' ' ILE . 60.0 mt -85.54 130.81 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.535 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 91.7 m -128.26 112.76 14.83 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.43 0.633 . . . . 0.0 111.856 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.053 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 175.52 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.8 tt . . . . . 0 CA--C 1.548 0.894 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.24 -12.99 21.95 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.854 3.036 . . . . 0.0 116.272 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 69.9 p -87.27 -13.51 43.51 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.763 0.792 . . . . 0.0 110.038 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -105.7 130.44 53.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 9.9 p -129.02 136.75 58.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.798 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -98.37 137.68 36.73 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-O 121.925 0.869 . . . . 0.0 112.025 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.715 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.3 OUTLIER -120.13 158.22 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.394 -179.365 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -72.95 116.19 13.16 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -53.2 -43.28 67.07 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -53.22 -43.33 67.18 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 125.127 1.371 . . . . 0.0 111.011 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' LYS . . . . . 0.513 ' HD3' ' OG ' ' B' ' 107' ' ' SER . 41.0 ttmt -71.82 -34.57 69.44 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.208 -175.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.715 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.1 m-85 -96.82 7.97 45.41 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.369 0.604 . . . . 0.0 111.106 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 61.2 tttm 70.5 13.35 7.43 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.957 1.303 . . . . 0.0 113.206 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.58 167.29 13.52 Favored 'General case' 0 CA--C 1.478 -1.796 0 CA-C-O 122.212 1.006 . . . . 0.0 110.235 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -99.86 -11.74 20.47 Favored 'General case' 0 C--N 1.271 -2.825 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.041 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -126.29 149.6 49.02 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.45 132.96 35.48 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 124.225 0.953 . . . . 0.0 110.116 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.419 ' O ' HG12 ' B' ' 73' ' ' ILE . 10.9 m -102.39 121.99 43.41 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.826 -169.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 39.1 t -113.49 135.03 54.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.57 ' CD1' HG12 ' B' ' 58' ' ' ILE . 17.2 mm -104.94 135.91 40.9 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.853 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.4 mt -105.14 107.68 18.8 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' B' ' 118' ' ' LEU . 3.7 mm? -85.64 12.28 9.09 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.908 0.861 . . . . 0.0 111.567 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.39 -44.01 3.43 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.492 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.23 80.56 6.87 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.254 1.026 . . . . 0.0 108.252 178.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.525 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.2 pp -123.1 -178.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.033 -1.439 . . . . 0.0 108.192 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.524 ' HD2' HD23 ' B' ' 24' ' ' LEU . 13.6 ptp180 -175.3 167.56 3.37 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 171.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' B' ' 54' ' ' ILE . 96.0 m -108.5 121.84 45.81 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.173 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.444 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 71.7 mt -131.22 145.33 51.88 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 124.707 1.254 . . . . 0.0 110.93 -169.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.621 ' O ' ' HG2' ' B' ' 98' ' ' ARG . 27.5 t70 -52.52 136.42 32.17 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.977 0.911 . . . . 0.0 112.911 172.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.458 ' NZ ' HD12 ' B' ' 14' ' ' ILE . 29.0 mtpp -54.65 -29.85 53.53 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.115 0.966 . . . . 0.0 112.371 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.48 ' HB2' ' OD2' ' B' ' 95' ' ' ASP . 9.8 mtmp? -83.7 -17.95 39.58 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.585 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.621 ' HG2' ' O ' ' B' ' 95' ' ' ASP . 11.8 ptm180 -86.25 -17.85 33.64 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.814 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.68 121.35 16.27 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 162.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -92.19 -60.39 1.86 Allowed 'General case' 0 C--N 1.268 -2.938 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -170.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.449 ' HG3' HD13 ' B' ' 21' ' ' LEU . 10.6 pt-20 -148.68 130.19 14.86 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-O 122.512 1.149 . . . . 0.0 114.044 -168.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -61.14 110.89 1.51 Allowed 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 128.497 2.719 . . . . 0.0 106.924 173.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.679 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 53.7 tp -107.44 -64.19 1.22 Allowed 'General case' 0 N--CA 1.402 -2.853 0 CA-C-O 121.94 0.876 . . . . 0.0 111.05 -172.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.734 HG22 ' H ' ' B' ' 105' ' ' TYR 0.291 17.4 m -138.12 -157.12 0.74 Allowed 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.216 -164.2 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.734 ' H ' HG22 ' B' ' 104' ' ' THR . 11.9 t80 -158.32 153.63 25.78 Favored 'General case' 0 N--CA 1.402 -2.859 0 CA-C-N 119.703 1.138 . . . . 0.0 110.1 -161.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.04 138.9 50.34 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.351 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' SER . . . . . 0.513 ' OG ' ' HD3' ' B' ' 77' ' ' LYS . 27.7 m -82.76 156.75 23.54 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.411 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' B' ' 111' ' ' MET . 20.0 t70 -61.96 -36.78 82.46 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.42 0.629 . . . . 0.0 111.765 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -62.1 -40.95 97.61 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.623 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.457 ' HE3' HG23 ' B' ' 73' ' ' ILE . 13.6 tppt? -77.24 -28.74 53.75 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.175 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.5 OUTLIER -49.33 -46.17 46.46 Favored 'General case' 0 CA--C 1.459 -2.536 0 CA-C-O 122.143 0.973 . . . . 0.0 109.088 171.198 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.563 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 6.1 mmpt? -71.48 -16.22 62.35 Favored 'General case' 0 N--CA 1.38 -3.926 0 CA-C-N 113.841 -1.527 . . . . 0.0 114.848 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -89.89 -51.59 5.41 Favored 'General case' 0 N--CA 1.388 -3.566 0 C-N-CA 117.014 -1.874 . . . . 0.0 107.27 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.72 -59.62 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 113.36 -1.745 . . . . 0.0 113.293 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 49.1 m-20 -59.47 -40.3 86.49 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 123.713 1.721 . . . . 0.0 111.32 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.406 ' O ' HG13 ' B' ' 120' ' ' ILE 0.351 25.9 t30 -80.74 -40.38 25.34 Favored 'General case' 0 C--N 1.255 -3.54 0 CA-C-N 112.711 -2.04 . . . . 0.0 112.391 -171.397 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -63.58 -32.98 74.61 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 121.981 0.896 . . . . 0.0 108.681 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.8 tp -67.45 -39.67 85.35 Favored 'General case' 0 N--CA 1.38 -3.939 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.576 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 8.6 ttp -71.83 -20.37 61.84 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 123.61 0.764 . . . . 0.0 110.042 -175.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' B' ' 117' ' ' ALA . 63.5 mt -84.3 -53.17 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.2 t -47.72 -46.09 29.32 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.993 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 8.7 mp -79.75 5.83 12.44 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.65 9.77 79.0 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 116.195 1.238 . . . . 0.0 116.195 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.424 HD22 ' HB3' ' A' ' 115' ' ' ASP . 6.2 mt -71.56 -54.37 10.71 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 119.498 1.649 . . . . 0.0 107.762 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 . . . . . 0 C--N 1.312 -1.045 0 CA-C-N 113.049 -1.887 . . . . 0.0 115.031 -177.645 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mt . . . . . 0 N--CA 1.438 -1.037 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -115.6 144.36 44.01 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 19.7 ptt180 -73.87 152.3 40.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.879 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.17 -2.71 79.28 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.977 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -97.71 177.88 5.33 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 3.9 t -133.62 134.45 56.55 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 C-N-CA 122.806 0.442 . . . . 0.0 111.844 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.486 ' O ' HG22 ' A' ' 38' ' ' VAL . 12.5 m-85 -131.51 144.32 51.04 Favored 'General case' 0 CA--C 1.467 -2.232 0 C-N-CA 124.46 1.104 . . . . 0.0 110.146 177.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mp -79.58 151.49 30.62 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 169.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.01 139.47 23.64 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.278 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -74.37 92.65 2.32 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.146 0.974 . . . . 0.0 109.773 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.587 ' O ' HG13 ' A' ' 27' ' ' VAL . 83.7 mt -82.19 -12.41 58.14 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-N 113.892 -1.504 . . . . 0.0 112.11 -177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -90.83 61.79 0.0 OUTLIER Pre-proline 0 C--N 1.257 -3.453 0 N-CA-C 119.754 3.242 . . . . 0.0 119.754 -176.201 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' B' ' 26' ' ' PRO . 1.1 Cg_endo -117.68 22.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 N-CA-C 108.46 -1.4 . . . . 0.0 108.46 148.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 24' ' ' LEU . 14.1 m -72.81 157.97 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.943 0.878 . . . . 0.0 113.364 -172.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -124.01 156.3 36.71 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.721 -1.581 . . . . 0.0 107.163 175.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.95 -135.44 15.09 Favored Glycine 0 N--CA 1.418 -2.556 0 O-C-N 124.131 0.894 . . . . 0.0 112.068 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.6 m -94.34 6.93 47.2 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.476 -0.362 . . . . 0.0 111.686 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 7.1 mm-40 -71.33 153.14 42.58 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 119.374 -0.931 . . . . 0.0 112.959 -176.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -81.85 119.15 23.55 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -171.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.4 158.97 17.19 Favored Glycine 0 CA--C 1.472 -2.651 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.495 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . 111.63 137.97 7.39 Favored Glycine 0 C--N 1.276 -2.793 0 CA-C-N 113.016 -1.592 . . . . 0.0 109.972 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 p -64.6 119.13 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.124 0 CA-C-O 122.365 1.079 . . . . 0.0 109.039 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -144.93 149.22 41.77 Favored Pre-proline 0 C--N 1.267 -3.015 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.209 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 33.3 Cg_exo -58.76 136.59 74.82 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.311 2.007 . . . . 0.0 111.37 171.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 20' ' ' TYR . 29.4 m -122.51 161.68 23.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 123.933 0.893 . . . . 0.0 108.721 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.6 m -101.48 132.11 47.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 120.722 0.296 . . . . 0.0 110.697 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mm -86.04 105.12 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -97.39 -23.46 4.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.535 -177.081 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.65 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -64.5 168.49 5.8 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -167.781 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.58 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 12.9 p-10 -66.53 177.62 1.5 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.464 -1.698 . . . . 0.0 110.632 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 16.8 t70 -89.18 -29.56 19.21 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.188 -176.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.586 ' HA ' ' CD ' ' A' ' 48' ' ' LYS . 45.1 m -82.79 -26.17 32.06 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.42 -21.69 74.44 Favored Glycine 0 C--O 1.196 -2.238 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -82.12 -26.79 33.25 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.273 0.559 . . . . 0.0 109.931 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.586 ' CD ' ' HA ' ' A' ' 45' ' ' THR . 6.6 mtpp -82.94 -57.98 3.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.978 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -96.35 -35.86 11.06 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.6 m -90.84 158.74 41.71 Favored Pre-proline 0 C--N 1.29 -2.02 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -87.86 -11.45 4.69 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.38 1.387 . . . . 0.0 110.849 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 17.0 p -96.26 149.88 21.17 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.504 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -148.58 137.95 15.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.363 170.511 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.65 HG22 ' HG3' ' A' ' 42' ' ' GLN . 15.0 tt -86.47 135.32 25.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-O 121.444 0.64 . . . . 0.0 110.29 175.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.99 146.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.994 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 91' ' ' ILE . . . -109.76 135.64 50.36 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.78 145.1 48.93 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.44 HG12 HD12 ' A' ' 86' ' ' ILE . 49.1 mt -100.79 143.74 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.969 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 m -92.35 173.37 7.84 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.888 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 171.082 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 mt . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.0 2.44 2.14 Favored 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.101 1.867 . . . . 0.0 113.841 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 p -100.91 -18.93 16.13 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.483 0.659 . . . . 0.0 109.728 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -102.03 130.09 48.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.28 136.94 52.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.568 173.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 10.2 pt-20 -101.38 146.61 27.36 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.082 0.468 . . . . 0.0 112.188 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.8 pt -112.75 146.08 17.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.11 109.0 6.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.842 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -60.32 -36.15 77.26 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.637 0.732 . . . . 0.0 112.789 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -51.4 -52.1 48.91 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.19 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -91.05 -25.62 19.57 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.361 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' A' ' 106' ' ' LEU . 1.9 m-85 -88.55 20.5 3.36 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 123.635 0.774 . . . . 0.0 111.858 -172.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 56.75 27.61 13.02 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.31 170.76 8.0 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.843 0.83 . . . . 0.0 109.718 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -99.8 -16.94 17.91 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.231 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.73 140.0 52.27 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.027 -173.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.81 102.8 14.0 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.0 t -103.28 172.75 6.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -165.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 37.7 t -123.9 142.97 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.44 HD12 HG12 ' A' ' 58' ' ' ILE . 20.9 mm -106.44 133.31 51.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.8 mt -105.95 107.06 17.87 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 121.462 0.648 . . . . 0.0 109.737 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.6 mm? -84.26 16.96 2.73 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.608 -175.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.03 -40.28 3.52 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 122.13 0.967 . . . . 0.0 109.019 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.19 72.82 4.61 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.56 ' O ' ' HB ' ' B' ' 93' ' ' THR . 8.0 mt -106.62 -174.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.533 ' H ' HG22 ' A' ' 91' ' ' ILE . 5.7 ptp180 -175.14 174.89 2.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 124.004 0.922 . . . . 0.0 109.733 166.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.559 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 68.0 m -125.27 130.05 51.26 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -132.99 143.08 49.2 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -80.54 153.05 28.32 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.876 175.543 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -47.12 -18.21 0.08 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 126.523 1.929 . . . . 0.0 115.333 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -74.31 -27.15 60.58 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.317 0.58 . . . . 0.0 111.132 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -74.84 -35.73 62.38 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.449 0.7 . . . . 0.0 110.47 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mp -74.6 122.98 23.98 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.398 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.45 -59.61 1.84 Allowed 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -154.85 135.55 13.56 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.478 0.656 . . . . 0.0 112.6 -168.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -64.62 121.26 14.04 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.608 173.462 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -113.78 -61.92 1.67 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.446 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.516 HG22 HG11 ' A' ' 19' ' ' VAL . 5.2 t -126.3 -164.35 1.32 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.069 -1.452 . . . . 0.0 112.348 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -159.84 147.14 16.61 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.812 0.845 . . . . 0.0 112.651 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.586 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . 13.1 mt -98.65 155.34 17.36 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.959 -1.473 . . . . 0.0 108.476 177.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.8 m -86.36 167.86 14.37 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 111' ' ' MET . 22.2 t70 -56.58 -43.62 80.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.69 0.796 . . . . 0.0 112.381 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.13 -41.55 98.36 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -67.23 -33.66 75.83 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.513 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -55.1 -42.41 72.85 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 123.967 0.907 . . . . 0.0 110.313 175.431 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.668 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -76.22 -11.98 60.01 Favored 'General case' 0 CA--C 1.472 -2.046 0 C-N-CA 122.947 0.499 . . . . 0.0 111.544 179.482 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -86.67 -43.47 12.59 Favored 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -55.92 -58.92 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.111 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.316 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.89 -49.92 62.06 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-O 123.311 1.529 . . . . 0.0 110.344 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.665 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 1.3 t30 -68.97 -49.76 55.07 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 112.203 -2.272 . . . . 0.0 112.743 -173.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.45 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.07 -39.75 83.08 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 2.4 tp -64.32 -47.36 79.73 Favored 'General case' 1 N--CA 1.378 -4.07 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.498 -175.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.685 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 1.9 ptm -71.19 -19.74 62.36 Favored 'General case' 0 C--O 1.202 -1.424 0 O-C-N 121.568 -0.707 . . . . 0.0 112.513 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 116' ' ' ASN . 54.2 mt -76.76 -53.54 14.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -55.89 -30.94 62.35 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.236 -1.802 . . . . 0.0 111.555 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.573 HD22 HG21 ' B' ' 54' ' ' ILE . 44.2 mt -101.6 5.48 41.66 Favored 'General case' 0 N--CA 1.425 -1.696 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.527 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.38 5.36 72.53 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 117.729 1.851 . . . . 0.0 117.729 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.685 ' HB2' ' HB2' ' A' ' 119' ' ' MET . 6.9 mp -71.26 -45.18 63.77 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 120.544 2.172 . . . . 0.0 108.665 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 126.532 1.933 . . . . 0.0 116.006 177.08 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -114.5 144.83 42.72 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.558 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 19.9 ptt180 -75.31 147.4 40.2 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.777 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.02 -2.88 60.07 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.32 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -97.25 174.87 6.5 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 5.6 t -132.94 131.6 59.07 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.9 0 C-N-CA 123.596 0.759 . . . . 0.0 111.49 -176.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.5 ' O ' HG22 ' B' ' 38' ' ' VAL . 8.4 m-85 -129.26 144.16 51.12 Favored 'General case' 0 CA--C 1.465 -2.296 0 C-N-CA 124.167 0.987 . . . . 0.0 110.396 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -79.94 151.1 30.27 Favored 'General case' 0 N--CA 1.4 -2.942 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.03 139.71 23.82 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.155 -175.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.64 92.29 1.95 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.048 0.928 . . . . 0.0 109.455 173.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.572 ' O ' HG13 ' B' ' 27' ' ' VAL . 90.2 mt -83.09 -9.97 58.94 Favored 'General case' 0 CA--C 1.474 -1.947 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.787 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.434 ' HB3' ' H ' ' B' ' 34' ' ' GLY . 0.1 OUTLIER -91.91 61.3 0.0 OUTLIER Pre-proline 0 C--N 1.247 -3.879 0 N-CA-C 119.262 3.06 . . . . 0.0 119.262 -176.439 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.429 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -117.74 21.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.255 0 N-CA-C 108.476 -1.394 . . . . 0.0 108.476 150.157 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.572 HG13 ' O ' ' B' ' 24' ' ' LEU . 15.2 m -72.62 157.91 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-O 122.085 0.945 . . . . 0.0 113.154 -171.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -124.05 155.98 37.35 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.354 -1.748 . . . . 0.0 107.679 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.26 -135.32 14.02 Favored Glycine 0 N--CA 1.421 -2.326 0 O-C-N 123.997 0.811 . . . . 0.0 112.109 173.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -94.75 8.41 42.63 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 122.661 0.384 . . . . 0.0 111.846 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.08 151.9 42.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.58 118.45 21.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 121.16 0.505 . . . . 0.0 109.857 -171.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.89 155.62 18.75 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-N 114.701 -1.136 . . . . 0.0 115.264 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.434 ' H ' ' HB3' ' B' ' 25' ' ' SER . . . 112.43 137.84 7.13 Favored Glycine 0 N--CA 1.418 -2.524 0 CA-C-N 113.023 -1.588 . . . . 0.0 110.364 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 p -63.62 119.67 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-O 122.4 1.095 . . . . 0.0 108.86 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -145.49 149.74 41.68 Favored Pre-proline 0 C--N 1.265 -3.068 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.304 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.2 Cg_exo -59.07 136.85 75.91 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.137 1.891 . . . . 0.0 111.201 171.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -122.76 161.02 24.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 123.968 0.907 . . . . 0.0 108.61 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 30.0 m -100.93 132.05 47.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 120.748 0.308 . . . . 0.0 110.723 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 26.1 mm -86.06 105.91 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.43 HG23 HG23 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -97.53 -25.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.383 -177.565 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.641 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.1 OUTLIER -63.12 167.85 4.65 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -167.7 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.575 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 14.5 p-10 -66.41 176.26 1.92 Allowed 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.083 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.98 -30.13 21.5 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.648 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' THR . . . . . 0.522 ' HA ' ' CD ' ' B' ' 48' ' ' LYS . 28.3 m -84.0 -25.52 29.89 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -170.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -68.61 -21.46 74.69 Favored Glycine 0 C--O 1.194 -2.394 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 176.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -82.88 -27.94 30.38 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.181 0.515 . . . . 0.0 110.018 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.522 ' CD ' ' HA ' ' B' ' 45' ' ' THR . 4.4 mtpp -80.74 -58.48 3.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.869 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -97.39 -35.89 10.54 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -172.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 38.5 m -88.11 156.59 51.74 Favored Pre-proline 0 C--N 1.292 -1.91 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.193 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -86.97 -12.32 5.06 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 121.22 1.28 . . . . 0.0 110.663 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 19.0 p -96.14 149.29 21.79 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.479 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.8 OUTLIER -148.1 137.87 16.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 O-C-N 123.94 0.775 . . . . 0.0 109.258 170.499 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.641 HG22 ' HG3' ' B' ' 42' ' ' GLN . 15.6 tt -86.54 135.47 25.05 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 CA-C-O 121.278 0.561 . . . . 0.0 110.277 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.67 145.65 29.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.965 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' B' ' 91' ' ' ILE . . . -109.59 135.17 51.0 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.76 145.87 48.47 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.439 HG12 HD12 ' B' ' 86' ' ' ILE . 45.6 mt -101.91 145.22 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.859 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 5.0 m -93.6 176.85 6.21 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.074 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 171.37 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.0 mt . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.05 6.86 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 122.32 2.013 . . . . 0.0 113.695 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -106.05 -18.52 14.0 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.529 0.681 . . . . 0.0 109.476 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -102.43 130.18 49.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.26 137.39 50.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 8.6 pt-20 -101.08 150.67 22.68 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.998 0.428 . . . . 0.0 112.152 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ILE . . . . . . . . . . . . . 21.0 pt -117.16 144.41 25.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.78 109.76 5.16 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.869 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.6 -38.55 85.06 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.343 0.592 . . . . 0.0 112.499 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -51.22 -51.76 50.87 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.591 -1.64 . . . . 0.0 113.55 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -88.12 -26.43 22.49 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 118.764 -1.175 . . . . 0.0 112.022 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' B' ' 106' ' ' LEU . 1.7 m-85 -89.79 19.14 4.94 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 123.722 0.809 . . . . 0.0 111.547 -171.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 60.23 23.83 13.21 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 124.542 1.137 . . . . 0.0 113.818 169.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 mt -110.59 165.84 11.48 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.058 0.933 . . . . 0.0 110.52 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.52 -14.3 25.22 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.404 -1.726 . . . . 0.0 108.853 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.68 139.16 53.79 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.005 -174.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -85.13 103.77 14.42 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 41.8 t -104.56 172.83 6.58 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -164.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' B' ' 72' ' ' GLU . 38.4 t -124.42 142.68 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.439 HD12 HG12 ' B' ' 58' ' ' ILE . 19.8 mm -106.26 133.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 80.1 mt -106.04 106.99 17.76 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.495 0.664 . . . . 0.0 109.541 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.7 mm? -84.31 16.47 3.03 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.771 0.796 . . . . 0.0 111.599 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.6 -40.28 3.41 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 122.254 1.026 . . . . 0.0 109.168 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.49 74.16 5.18 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.559 ' O ' ' HB ' ' A' ' 93' ' ' THR . 8.4 mt -107.64 -174.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.522 ' NH1' ' HB3' ' B' ' 24' ' ' LEU . 5.8 ptp180 -174.48 173.76 2.87 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 123.923 0.889 . . . . 0.0 109.659 167.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 59.7 m -126.02 128.13 46.97 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -132.26 142.7 49.49 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.889 -172.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 0.8 OUTLIER -80.09 153.34 28.8 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.009 175.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -46.56 -20.78 0.13 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 126.5 1.92 . . . . 0.0 115.082 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -75.59 -22.41 56.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.023 0.439 . . . . 0.0 111.391 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -77.74 -36.82 50.33 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 122.994 0.518 . . . . 0.0 110.127 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.73 124.49 26.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 124.072 0.949 . . . . 0.0 110.547 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -96.0 -60.66 1.59 Allowed 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.3 pt-20 -154.72 135.24 13.42 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.396 0.617 . . . . 0.0 112.503 -167.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 102' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -63.94 122.6 16.89 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.837 172.67 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.3 tp -114.52 -62.48 1.59 Allowed 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.806 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.519 HG22 HG11 ' B' ' 19' ' ' VAL . 5.2 t -125.81 -164.68 1.33 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.702 -1.599 . . . . 0.0 112.458 -176.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -159.77 145.05 15.42 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.635 0.774 . . . . 0.0 111.866 -172.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.548 ' HA ' ' CE2' ' B' ' 78' ' ' TYR . 14.6 mt -98.22 156.43 16.7 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.526 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 49.7 m -84.08 169.22 15.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.389 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' B' ' 111' ' ' MET . 12.1 t70 -59.0 -44.84 91.73 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.905 0.882 . . . . 0.0 111.875 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.31 -40.0 96.12 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.22 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -67.88 -33.11 74.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -55.08 -42.87 73.35 Favored 'General case' 0 N--CA 1.41 -2.431 0 C-N-CA 123.617 0.767 . . . . 0.0 110.205 175.068 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.707 ' O ' ' HB3' ' B' ' 116' ' ' ASN . 0.4 OUTLIER -74.94 -13.25 60.51 Favored 'General case' 0 CA--C 1.466 -2.276 0 C-N-CA 122.568 0.347 . . . . 0.0 111.738 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -86.01 -43.3 13.26 Favored 'General case' 0 N--CA 1.39 -3.435 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.78 -57.54 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.961 0 CA-C-N 112.906 -1.952 . . . . 0.0 111.922 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.7 -51.97 58.1 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 122.958 1.361 . . . . 0.0 109.56 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.707 ' HB3' ' O ' ' B' ' 112' ' ' LYS . 0.0 OUTLIER -70.06 -42.31 72.99 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 112.658 -2.065 . . . . 0.0 113.826 -171.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.42 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -64.25 -40.91 97.0 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 2.5 tp -62.37 -45.89 91.12 Favored 'General case' 0 N--CA 1.382 -3.832 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.181 -176.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.695 ' HB2' ' HB2' ' B' ' 124' ' ' LEU . 2.0 ptm -72.14 -19.4 61.78 Favored 'General case' 0 C--O 1.205 -1.247 0 O-C-N 121.638 -0.664 . . . . 0.0 112.603 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 116' ' ' ASN . 59.0 mt -77.54 -53.72 13.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 173.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 9.9 t -55.37 -31.08 61.47 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.62 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.619 HD22 HG21 ' A' ' 54' ' ' ILE . 46.0 mt -101.41 5.62 42.18 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.13 10.42 71.59 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 117.419 1.727 . . . . 0.0 117.419 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' B' ' 119' ' ' MET . 7.0 mp -74.33 -44.11 53.86 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 120.402 2.101 . . . . 0.0 108.277 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 . . . . . 0 N--CA 1.488 1.454 0 C-N-CA 126.716 2.007 . . . . 0.0 116.328 176.84 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.7 mt . . . . . 0 C--O 1.241 0.635 0 CA-C-O 120.882 0.372 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -114.97 153.87 29.8 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.523 ' HG2' ' SD ' ' A' ' 111' ' ' MET . 43.5 ttt180 -73.02 114.0 10.69 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.58 -7.54 10.35 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.478 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -81.31 172.34 13.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.153 0.978 . . . . 0.0 109.305 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.509 HG11 HG22 ' A' ' 104' ' ' THR . 19.6 t -133.07 135.14 57.25 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.129 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.457 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.1 m-85 -134.84 148.7 50.21 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -81.33 151.59 27.94 Favored 'General case' 0 N--CA 1.401 -2.906 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.455 171.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -129.74 133.91 47.3 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.038 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.631 ' HA ' ' HB ' ' A' ' 35' ' ' VAL 0.293 2.3 p-10 -88.47 99.71 12.49 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 117.875 -1.53 . . . . 0.0 111.282 178.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 4.5 mm? -84.84 40.22 0.79 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.788 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.539 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.292 2.7 m -67.74 170.22 7.64 Favored Pre-proline 0 C--N 1.261 -3.266 0 C-N-CA 127.835 2.454 . . . . 0.0 107.798 170.278 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.1 OUTLIER 2.23 53.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.408 3.688 1 C-N-CA 127.38 5.387 . . . . 0.0 118.051 -173.397 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.17 178.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.459 172.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -104.14 116.36 32.06 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -175.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.55 -117.69 11.71 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.297 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -94.48 19.57 9.52 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 160.41 30.09 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 173.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.605 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -75.57 119.26 19.39 Favored 'General case' 0 C--O 1.192 -1.967 0 CA-C-O 120.613 0.244 . . . . 0.0 110.705 -172.01 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -90.69 146.17 18.32 Favored Glycine 0 CA--C 1.474 -2.529 0 CA-C-O 121.636 0.576 . . . . 0.0 113.736 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 104.9 136.87 8.87 Favored Glycine 0 N--CA 1.421 -2.338 0 CA-C-N 113.511 -1.345 . . . . 0.0 111.343 176.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 1.3 p -67.76 120.01 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 CA-C-O 122.694 1.235 . . . . 0.0 110.324 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -139.68 156.77 70.95 Favored Pre-proline 0 C--N 1.266 -3.036 0 CA-C-N 112.814 -1.994 . . . . 0.0 110.434 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.609 ' HB2' HD12 ' A' ' 58' ' ' ILE . 34.5 Cg_exo -65.81 143.95 75.54 Favored 'Trans proline' 0 CA--C 1.555 1.531 0 C-N-CA 122.776 2.318 . . . . 0.0 112.216 172.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 20' ' ' TYR . 28.7 m -127.22 158.66 38.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.867 0.867 . . . . 0.0 109.218 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.71 134.76 45.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 O-C-N 123.154 0.284 . . . . 0.0 110.699 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 mm -82.12 96.94 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.423 HD13 ' C ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.43 -26.01 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.45 -178.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.521 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 4.5 pt20 -61.63 168.77 2.73 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 117.036 2.236 . . . . 0.0 117.036 -171.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -64.33 170.05 4.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 113.488 -1.687 . . . . 0.0 111.771 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.45 ' HA ' ' ND2' ' A' ' 47' ' ' ASN . 17.8 m-20 -81.07 -28.74 35.19 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 m -76.75 -34.93 58.03 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 122.197 -0.315 . . . . 0.0 110.607 -172.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.39 -25.68 74.64 Favored Glycine 0 C--O 1.21 -1.398 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.671 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.45 ' ND2' ' HA ' ' A' ' 44' ' ' ASP . 91.5 m-20 -63.1 -31.75 72.96 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.541 0.686 . . . . 0.0 109.983 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.505 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 20.0 mmmt -92.29 -64.21 1.14 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.947 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 54.9 m-85 -78.47 -36.19 45.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -167.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.531 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 58.9 m -93.63 133.21 28.44 Favored Pre-proline 0 N--CA 1.416 -2.13 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.363 -173.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -69.75 -21.52 33.41 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.631 1.554 . . . . 0.0 109.117 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 6.9 p -89.78 133.44 34.7 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.066 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.521 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 85.5 t -121.07 140.81 44.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.438 HG23 ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -113.01 124.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 122.213 1.006 . . . . 0.0 109.911 175.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.454 HG13 HG12 ' A' ' 53' ' ' VAL . 24.5 m -133.59 173.03 15.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.989 -173.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.515 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -124.94 146.38 49.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.72 131.23 41.38 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 37' ' ' PRO . 64.8 mt -90.07 124.66 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 113.891 -1.504 . . . . 0.0 107.356 172.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.673 ' HB ' HG23 ' A' ' 85' ' ' VAL . 64.7 m -123.07 154.24 38.82 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.543 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.113 -178.372 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.592 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 64.7 Cg_endo -71.56 35.79 0.29 Allowed 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 121.68 1.586 . . . . 0.0 113.906 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.9 p -124.02 -19.05 5.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.032 0.92 . . . . 0.0 108.576 171.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -124.24 129.91 51.61 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.3 p -125.88 136.35 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.457 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.99 135.54 45.3 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.744 0.783 . . . . 0.0 111.898 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.679 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -120.3 155.39 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.334 0 CA-C-N 113.877 -1.511 . . . . 0.0 112.646 -173.183 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -67.83 112.36 4.84 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 125.38 1.472 . . . . 0.0 108.871 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -44.06 -50.77 8.3 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.694 1.598 . . . . 0.0 112.68 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -66.18 -23.65 66.5 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 124.944 1.298 . . . . 0.0 114.398 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -84.86 -31.42 23.78 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.148 0.975 . . . . 0.0 109.496 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.679 ' CE1' HG21 ' A' ' 73' ' ' ILE . 4.2 m-85 -90.42 -8.22 51.13 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.631 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 62.15 25.7 15.4 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.866 1.267 . . . . 0.0 112.599 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 7.4 mp -85.07 172.52 11.2 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-O 122.992 1.377 . . . . 0.0 113.828 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.97 -23.97 61.52 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 111.518 -2.583 . . . . 0.0 110.651 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -152.31 160.03 43.39 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.377 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -56.04 136.36 52.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 123.993 0.808 . . . . 0.0 110.991 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 m -103.28 135.03 45.67 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.376 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.673 HG23 ' HB ' ' A' ' 59' ' ' THR . 1.1 m -116.84 131.62 68.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.572 ' CD1' HG12 ' A' ' 58' ' ' ILE . 23.1 mm -107.37 127.46 63.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 90' ' ' GLN . 22.7 mt -103.69 109.82 21.67 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.565 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -87.84 8.18 27.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.275 -172.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -110.27 -35.82 5.98 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 122.122 0.963 . . . . 0.0 108.502 172.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 5.8 tp60 -87.22 64.33 8.28 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.181 -1.372 . . . . 0.0 107.747 175.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.515 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -108.23 -176.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.418 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.605 ' NH2' ' HB3' ' A' ' 32' ' ' GLN . 8.2 ptp85 -164.98 163.89 20.7 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 52.3 m -122.5 116.39 23.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.3 mt -131.83 141.52 49.46 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.328 1.051 . . . . 0.0 109.412 -170.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.7 p30 -71.12 152.05 43.84 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.109 174.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 50' ' ' SER . 94.7 mttt -44.74 -26.03 0.35 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 126.245 1.818 . . . . 0.0 114.798 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -86.97 -14.6 41.26 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -81.59 -27.66 34.14 Favored 'General case' 0 N--CA 1.395 -3.188 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.34 117.89 15.63 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 169.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -89.35 -58.85 2.38 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.0 pt-20 -151.35 133.54 15.25 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 121.845 0.831 . . . . 0.0 112.6 -170.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -60.57 115.74 3.83 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 127.485 2.314 . . . . 0.0 107.61 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -111.71 -62.77 1.51 Allowed 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.664 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.509 HG22 HG11 ' A' ' 19' ' ' VAL . 3.5 t -129.63 -163.61 1.32 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.486 -1.285 . . . . 0.0 111.794 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -160.98 147.02 14.67 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 123.976 0.91 . . . . 0.0 111.028 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -114.68 161.69 17.78 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.615 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 p -82.97 151.64 25.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 111' ' ' MET . 25.5 t70 -59.16 -36.41 75.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.09 -23.04 59.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.46 0.648 . . . . 0.0 110.82 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.625 ' HD3' ' CG2' ' A' ' 73' ' ' ILE . 15.8 ttmm -85.94 -24.58 26.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.751 0.786 . . . . 0.0 109.578 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.566 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -53.73 -33.89 57.1 Favored 'General case' 0 N--CA 1.422 -1.841 0 C-N-CA 124.462 1.105 . . . . 0.0 109.818 170.406 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.599 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 7.1 mmpt? -69.78 -23.3 63.33 Favored 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.398 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -84.32 -31.25 24.95 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -173.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.421 HG13 HD11 ' A' ' 88' ' ' LEU . 1.6 t -67.15 -40.29 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.267 173.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.563 ' OD1' ' HG ' ' B' ' 124' ' ' LEU . 31.4 m-20 -63.07 -31.31 72.42 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.742 1.258 . . . . 0.0 110.607 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.71 ' O ' HD13 ' A' ' 120' ' ' ILE . 10.3 m-80 -80.06 -9.02 59.67 Favored 'General case' 1 N--CA 1.569 5.487 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.514 -176.627 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 68' ' ' PRO 0.275 . . -99.57 -49.0 4.55 Favored 'General case' 2 N--CA 1.344 -5.732 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 175.573 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 4.2 tp -67.61 -45.65 74.83 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.524 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 3.6 ttp -66.1 -22.48 66.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.653 0.781 . . . . 0.0 109.92 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -88.18 -51.56 12.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 t -54.15 -27.6 34.62 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 126.607 1.963 . . . . 0.0 111.926 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 56.0 mt -102.23 7.11 40.87 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.594 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.54 1.66 85.5 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 124' ' ' LEU . 3.2 mp -65.96 -52.46 49.44 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.81 1.305 . . . . 0.0 109.217 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.7 m120 . . . . . 0 C--N 1.311 -1.088 0 CA-C-N 113.789 -1.55 . . . . 0.0 113.353 178.251 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt . . . . . 0 C--O 1.241 0.648 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -117.85 149.39 40.93 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.542 ' HG2' ' SD ' ' B' ' 111' ' ' MET . 42.7 ttt180 -68.38 114.23 6.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.52 1.6 19.86 Favored Glycine 0 N--CA 1.43 -1.7 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.377 -176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -90.97 173.96 7.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.482 HG11 HG22 ' B' ' 104' ' ' THR . 22.3 t -134.18 134.34 55.29 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.096 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.55 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 28.9 m-85 -133.93 148.72 51.23 Favored 'General case' 0 CA--C 1.475 -1.912 0 C-N-CA 124.645 1.178 . . . . 0.0 107.924 177.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.548 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.4 mp -82.39 150.59 27.05 Favored 'General case' 0 N--CA 1.401 -2.881 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.485 171.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.36 134.38 48.84 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.124 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.608 ' HA ' ' HB ' ' B' ' 35' ' ' VAL 0.277 3.6 p-10 -90.27 99.13 12.2 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.693 -1.603 . . . . 0.0 111.314 178.646 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.631 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 4.2 mm? -83.09 40.44 0.7 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.54 -1.663 . . . . 0.0 111.679 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.48 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.272 5.6 m -66.55 166.66 16.64 Favored Pre-proline 0 C--N 1.269 -2.93 0 C-N-CA 127.528 2.331 . . . . 0.0 108.299 170.697 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 1.1 Cg_exo 5.66 53.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.399 3.228 1 C-N-CA 127.439 5.426 . . . . 0.0 117.674 -176.012 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.16 177.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 113.594 -1.639 . . . . 0.0 111.449 171.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -103.02 116.93 33.48 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.23 -176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.68 -121.19 19.16 Favored Glycine 0 CA--C 1.488 -1.631 0 CA-C-N 114.707 -1.133 . . . . 0.0 113.744 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.1 m -93.39 21.49 6.08 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.49 163.2 23.97 Favored 'General case' 0 C--O 1.256 1.443 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 172.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.612 ' HB3' HH22 ' B' ' 92' ' ' ARG . 0.8 OUTLIER -78.22 116.8 18.92 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 122.768 0.427 . . . . 0.0 109.989 -174.41 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -91.34 142.46 16.11 Favored Glycine 0 CA--C 1.465 -3.061 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.817 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 111.81 137.73 7.27 Favored Glycine 0 N--CA 1.422 -2.275 0 CA-C-N 114.299 -0.95 . . . . 0.0 111.219 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.608 ' HB ' ' HA ' ' B' ' 23' ' ' ASP . 0.8 OUTLIER -72.82 121.64 23.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-O 122.499 1.142 . . . . 0.0 109.292 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -139.74 156.32 71.01 Favored Pre-proline 0 C--N 1.262 -3.198 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.366 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.64 ' HB2' HD12 ' B' ' 58' ' ' ILE . 31.3 Cg_exo -65.6 143.93 76.84 Favored 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 122.725 2.283 . . . . 0.0 111.898 172.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.479 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.9 m -127.19 158.36 38.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 123.6 0.76 . . . . 0.0 109.185 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.89 134.34 45.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.514 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.89 97.03 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.416 HD13 ' C ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -93.81 -24.74 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.376 -178.449 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.534 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 4.1 pt20 -61.52 168.01 3.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 117.287 2.328 . . . . 0.0 117.287 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -62.54 169.57 2.94 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.971 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.06 -28.82 32.2 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -75.95 -38.01 58.03 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 122.293 -0.254 . . . . 0.0 110.539 -172.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.18 -28.55 73.68 Favored Glycine 0 C--O 1.212 -1.244 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -59.18 -34.15 71.79 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.779 0.8 . . . . 0.0 110.26 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.517 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 19.8 mmmt -92.01 -61.23 1.67 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.298 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 60.3 m-85 -80.44 -35.66 34.7 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -167.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.478 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 19.6 m -94.32 134.5 25.53 Favored Pre-proline 0 C--N 1.292 -1.921 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.587 -174.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.91 -20.08 29.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.931 1.754 . . . . 0.0 109.736 173.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 3.0 p -92.61 136.04 33.57 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.107 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.534 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 93.3 t -121.34 140.53 45.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -112.01 123.97 68.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-O 122.153 0.978 . . . . 0.0 109.705 175.698 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.479 HG13 HG12 ' B' ' 53' ' ' VAL . 27.7 m -133.07 172.8 15.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.957 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.52 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -124.58 146.04 49.27 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.3 131.36 41.84 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' B' ' 37' ' ' PRO . 60.8 mt -89.84 125.76 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' THR . . . . . 0.713 ' HB ' HG23 ' B' ' 85' ' ' VAL . 41.2 m -123.55 149.58 45.09 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.672 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.578 179.933 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 mp . . . . . 0 CA--C 1.494 -1.176 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 68' ' ' PRO . . . . . 0.451 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 59.1 Cg_endo -69.82 37.1 0.24 Allowed 'Trans proline' 0 CA--C 1.553 1.464 0 C-N-CA 122.16 1.907 . . . . 0.0 113.877 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 59.4 p -127.03 -19.11 4.46 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -123.49 129.94 51.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.68 136.25 61.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.171 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.13 139.82 37.24 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-O 121.294 0.569 . . . . 0.0 111.603 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.657 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -125.59 155.1 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.499 -174.087 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -66.74 114.78 5.9 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.033 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -45.62 -53.89 8.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.327 1.451 . . . . 0.0 112.163 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -61.45 -27.26 68.44 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -82.3 -34.25 28.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.705 0.764 . . . . 0.0 109.734 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.657 ' CE1' HG21 ' B' ' 73' ' ' ILE . 4.1 m-85 -86.92 -7.96 57.69 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.647 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 65.22 23.14 12.22 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.982 1.313 . . . . 0.0 112.66 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.04 173.77 10.24 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 123.018 1.39 . . . . 0.0 114.051 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.74 -23.21 56.0 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 111.917 -2.401 . . . . 0.0 110.56 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -149.06 159.59 44.09 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.3 138.16 57.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 123.74 0.65 . . . . 0.0 110.464 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 11.3 m -103.11 134.2 46.93 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.079 -167.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.713 HG23 ' HB ' ' B' ' 59' ' ' THR . 1.1 m -116.64 131.99 67.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.565 ' CD1' HG12 ' B' ' 58' ' ' ILE . 23.6 mm -107.42 127.74 63.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 175.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 24.0 mt -103.06 109.22 20.7 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.5 mm? -88.83 7.7 32.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.71 0.767 . . . . 0.0 112.179 -172.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -108.76 -34.43 6.68 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-O 122.359 1.076 . . . . 0.0 108.542 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLN . . . . . 0.447 HE22 HH22 ' B' ' 92' ' ' ARG . 0.1 OUTLIER -92.79 72.85 4.91 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.795 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.52 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.3 pp -114.74 -175.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.712 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.612 HH22 ' HB3' ' B' ' 32' ' ' GLN . 8.5 ptp85 -164.91 164.67 20.74 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 53.5 m -122.58 115.52 22.3 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 68.4 mt -131.81 141.18 49.38 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.396 1.078 . . . . 0.0 109.344 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 3.5 p-10 -72.16 152.68 42.12 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.301 174.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.478 ' HE3' ' O ' ' B' ' 50' ' ' SER . 93.3 mttt -46.65 -21.21 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.199 1.8 . . . . 0.0 115.145 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -89.0 -18.31 27.63 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -79.69 -27.34 40.73 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.71 120.53 19.43 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -91.87 -57.72 2.64 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 12.8 pt-20 -151.29 134.7 16.15 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.93 0.871 . . . . 0.0 112.728 -170.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -62.02 113.38 2.79 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 127.647 2.379 . . . . 0.0 108.8 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -109.81 -62.08 1.55 Allowed 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.769 -176.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.482 HG22 HG11 ' B' ' 19' ' ' VAL . 2.0 t -131.18 -164.48 1.44 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.45 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -161.05 145.01 13.37 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 123.838 0.855 . . . . 0.0 111.558 -171.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.78 162.37 16.39 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.542 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.8 p -83.18 149.56 26.77 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.151 0.58 . . . . 0.0 112.105 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' B' ' 111' ' ' MET . 26.9 t70 -59.55 -32.71 70.58 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.875 0.87 . . . . 0.0 113.129 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -76.81 -25.36 53.21 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.196 0.522 . . . . 0.0 110.596 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.579 ' HD3' ' CG2' ' B' ' 73' ' ' ILE . 15.8 ttmm -85.08 -24.62 28.02 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.877 0.846 . . . . 0.0 109.207 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.542 ' SD ' ' HG2' ' B' ' 16' ' ' ARG . 0.1 OUTLIER -52.92 -34.38 54.86 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 124.708 1.203 . . . . 0.0 109.983 169.694 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.574 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 7.1 mmpt? -69.78 -24.05 63.45 Favored 'General case' 0 N--CA 1.402 -2.866 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.25 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -85.21 -32.49 22.61 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 114' ' ' VAL . . . . . 0.44 HG13 HD11 ' B' ' 88' ' ' LEU . 1.8 t -63.53 -42.15 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.48 0 CA-C-N 112.692 -2.049 . . . . 0.0 109.934 171.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.537 ' OD1' ' HG ' ' A' ' 124' ' ' LEU . 42.8 m-20 -60.31 -40.88 92.12 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 122.035 0.921 . . . . 0.0 109.87 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.748 ' O ' HD13 ' B' ' 120' ' ' ILE . 3.1 m120 -64.29 -21.56 66.64 Favored 'General case' 0 N--CA 1.52 3.063 0 C-N-CA 125.362 1.465 . . . . 0.0 112.604 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.556 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -84.48 -53.03 5.71 Favored 'General case' 2 C--N 1.23 -4.605 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.787 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 4.1 tp -65.41 -46.76 78.73 Favored 'General case' 0 N--CA 1.4 -2.955 0 C-N-CA 124.494 1.117 . . . . 0.0 113.978 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.481 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 3.6 ttp -66.98 -24.85 66.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 123.644 0.778 . . . . 0.0 109.999 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.748 HD13 ' O ' ' B' ' 116' ' ' ASN . 2.5 mp -88.52 -45.83 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.0 t -55.18 -29.85 58.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.928 1.291 . . . . 0.0 111.359 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 58.4 mt -99.96 7.43 44.81 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 120.201 -0.599 . . . . 0.0 112.149 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.41 1.06 89.44 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 116.215 1.246 . . . . 0.0 116.215 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.578 ' H ' HD12 ' B' ' 124' ' ' LEU . 3.4 mp -64.96 -51.08 63.73 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 118.832 1.316 . . . . 0.0 109.302 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 . . . . . 0 C--N 1.309 -1.179 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.513 179.211 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.414 -2.227 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.454 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 35.6 ptt180 -125.5 158.42 34.53 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -173.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.59 132.49 39.5 Favored 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.81 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.17 -6.17 56.14 Favored Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.165 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.454 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 5.6 t70 -97.12 178.08 5.37 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 4.1 t -135.57 130.61 50.29 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 CA-C-O 121.491 0.662 . . . . 0.0 112.075 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 39.9 m-85 -130.49 145.53 51.87 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.316 176.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -80.31 149.83 30.17 Favored 'General case' 0 N--CA 1.395 -3.189 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 170.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.62 141.68 37.09 Favored 'General case' 0 C--N 1.257 -3.45 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.622 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.29 84.06 6.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.536 ' O ' HG13 ' A' ' 27' ' ' VAL . 91.6 mt -65.53 -27.81 68.72 Favored 'General case' 0 CA--C 1.468 -2.176 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.251 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.514 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 2.1 m -33.82 176.0 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.164 0 C-N-CA 128.375 2.67 . . . . 0.0 114.599 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.585 ' HB2' ' NE2' ' B' ' 28' ' ' GLN . 0.1 OUTLIER 22.92 51.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.108 0 C-N-CA 123.108 2.538 . . . . 0.0 115.554 -152.615 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 14.9 m -72.02 -178.27 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.421 165.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.535 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 31.8 mm-40 -115.04 124.43 51.59 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.581 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.96 -109.1 1.67 Allowed Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 113.728 -1.578 . . . . 0.0 115.779 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -93.06 8.81 38.45 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.669 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 48.9 mt-10 -64.65 156.34 30.46 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 118.203 -1.399 . . . . 0.0 109.603 174.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.41 HE22 ' HG3' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -73.33 108.92 6.47 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -175.703 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.16 147.73 19.37 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 116.136 1.215 . . . . 0.0 116.136 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.48 157.19 12.38 Favored Glycine 0 N--CA 1.414 -2.83 0 CA-C-N 113.319 -1.44 . . . . 0.0 110.276 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -77.92 112.44 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 122.583 1.182 . . . . 0.0 108.283 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.41 ' HG3' HE22 ' A' ' 32' ' ' GLN . 17.5 mmt180 -134.16 158.73 74.62 Favored Pre-proline 0 C--N 1.259 -3.345 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.891 -172.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 36.0 Cg_exo -64.56 134.86 43.04 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.656 2.238 . . . . 0.0 110.984 173.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 20' ' ' TYR . 35.4 m -121.1 160.4 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 29.8 m -98.8 129.75 48.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -86.66 101.22 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.43 -20.71 5.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.636 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -55.02 158.54 2.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.232 1.413 . . . . 0.0 114.675 -170.668 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 172.28 4.89 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.322 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.21 -47.22 65.44 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.596 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -71.18 -34.17 70.67 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.919 -169.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.31 75.53 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.805 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -63.54 -35.17 79.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.187 0.517 . . . . 0.0 110.231 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -87.17 -53.39 4.88 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.301 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -96.64 -10.43 27.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -167.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.1 t -113.26 143.3 28.99 Favored Pre-proline 0 C--N 1.294 -1.83 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.191 -177.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 33.6 Cg_endo -71.39 -27.62 19.07 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.734 1.623 . . . . 0.0 109.892 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 p -97.18 142.8 28.65 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.117 -175.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.48 141.02 36.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.758 HG21 HD22 ' B' ' 122' ' ' LEU . 12.1 tt -82.02 133.79 28.44 Favored 'Isoleucine or valine' 0 C--O 1.257 1.451 0 CA-C-O 121.512 0.673 . . . . 0.0 110.739 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -136.27 155.49 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.283 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.525 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -121.01 141.13 51.02 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.06 129.8 38.56 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.51 HD12 ' HB2' ' A' ' 37' ' ' PRO . 57.7 mt -86.38 115.41 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 173.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.3 m -101.24 104.95 16.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.488 0.661 . . . . 0.0 110.903 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.855 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.66 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.5 tt . . . . . 0 N--CA 1.439 -1.004 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 9.3 Cg_endo -52.29 -34.07 58.23 Favored 'Trans proline' 0 C--O 1.208 -1.015 0 C-N-CA 122.832 2.355 . . . . 0.0 114.139 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 p -73.6 -18.96 60.99 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-N 118.238 0.472 . . . . 0.0 112.043 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -104.42 129.17 52.4 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 87.7 t -118.7 112.68 38.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.186 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -82.3 118.89 23.48 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.642 HD12 ' CD2' ' A' ' 78' ' ' TYR . 8.0 pt -101.74 133.27 45.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.268 -174.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.45 118.45 4.47 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.294 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.687 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 43.6 mttp -43.05 -48.6 6.15 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.653 1.216 . . . . 0.0 109.266 173.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -62.46 -29.13 70.3 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 112.781 -2.008 . . . . 0.0 113.28 -173.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -91.72 -29.03 17.05 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.489 0.661 . . . . 0.0 111.093 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.642 ' CD2' HD12 ' A' ' 73' ' ' ILE . 23.0 m-85 -95.84 9.58 40.04 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.256 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 tttm 61.63 27.84 17.17 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.385 1.088 . . . . 0.0 110.148 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.31 176.47 5.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.936 0.874 . . . . 0.0 109.915 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -102.79 -8.63 20.65 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.875 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.503 ' C ' ' HG2' ' A' ' 75' ' ' LYS . 9.9 ptpp? -144.1 143.56 31.19 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.687 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 34.0 m-20 -70.63 120.1 15.75 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.499 ' HB3' HD11 ' A' ' 73' ' ' ILE . 25.3 t -104.57 174.05 6.04 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -175.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 13.3 t -122.39 139.5 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.498 ' CD1' HG12 ' A' ' 58' ' ' ILE . 19.6 mm -104.16 127.41 58.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 172.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.5 mt -102.41 104.9 15.4 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.557 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 4.0 mm? -83.06 3.33 30.88 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.653 0.74 . . . . 0.0 112.195 -175.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -97.79 -36.23 10.28 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 122.25 1.024 . . . . 0.0 108.352 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.438 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 3.1 tp60 -94.92 76.5 3.58 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.851 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.525 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -125.78 175.88 7.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -165.06 173.59 11.32 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.3 m -118.47 121.73 41.0 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.609 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.49 ' HB3' ' HG3' ' A' ' 98' ' ' ARG . 77.0 mt -131.94 149.34 52.46 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.949 -173.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -57.55 143.64 40.17 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 170.17 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 19.0 pttm -53.8 -33.55 56.39 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.988 0.899 . . . . 0.0 112.565 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.494 ' HD3' ' HB3' ' A' ' 95' ' ' ASP . 28.9 mtpt -47.5 -31.38 4.23 Favored 'General case' 0 C--N 1.278 -2.542 0 C-N-CA 127.062 2.145 . . . . 0.0 113.436 170.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.49 ' HG3' ' HB3' ' A' ' 94' ' ' LEU . 2.4 mmp_? -69.57 -31.22 69.27 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.508 0.67 . . . . 0.0 110.323 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 7.2 mp -70.75 131.45 43.87 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.181 1.393 . . . . 0.0 110.712 175.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -99.97 -57.45 2.13 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.281 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 13.2 pt-20 -159.26 146.59 17.19 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-O 121.39 0.614 . . . . 0.0 111.377 -169.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 64.9 tttp -62.65 125.62 24.55 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 126.601 1.96 . . . . 0.0 110.559 173.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 tp -114.74 -61.75 1.7 Allowed 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.179 174.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.469 HG22 HG11 ' A' ' 19' ' ' VAL . 5.3 t -129.35 -159.84 0.99 Allowed 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.554 -1.259 . . . . 0.0 111.98 -177.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -161.05 142.29 11.7 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.258 1.423 . . . . 0.0 109.519 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -105.31 156.57 18.02 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 m -81.81 158.93 23.91 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.475 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.32 -32.33 71.13 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.866 1.267 . . . . 0.0 112.007 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 5.4 p-10 -66.91 -28.23 68.14 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.565 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -73.67 -28.76 61.93 Favored 'General case' 0 CA--C 1.483 -1.622 0 O-C-N 123.404 0.44 . . . . 0.0 111.443 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.42 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -53.06 -48.02 68.01 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-O 121.987 0.899 . . . . 0.0 108.847 174.117 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.42 ' HE2' ' C ' ' A' ' 111' ' ' MET . 9.0 mmpt? -79.46 -9.82 59.68 Favored 'General case' 0 N--CA 1.39 -3.444 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.655 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 109' ' ' ASP . 38.1 mt-10 -86.54 -43.73 12.49 Favored 'General case' 0 CA--C 1.471 -2.095 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 176.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.0 t -49.81 -47.17 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.037 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -53.87 -41.64 67.75 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.091 0.948 . . . . 0.0 111.262 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.658 ' O ' HD13 ' A' ' 120' ' ' ILE . 24.1 m-80 -80.41 -22.93 40.75 Favored 'General case' 0 CA--C 1.434 -3.502 0 CA-C-O 123.315 1.531 . . . . 0.0 110.21 -173.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 121' ' ' SER . . . -84.37 -37.65 21.27 Favored 'General case' 2 N--CA 1.342 -5.844 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.625 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.711 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -82.67 -55.35 4.49 Favored 'General case' 1 N--CA 1.372 -4.352 0 C-N-CA 123.124 0.57 . . . . 0.0 112.23 -175.159 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.3 mtp -56.85 -35.52 68.95 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -75.27 -45.33 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.445 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.613 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 7.7 t -62.05 -32.12 72.6 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.257 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.762 HD22 HG21 ' B' ' 54' ' ' ILE . 13.0 mt -101.17 1.51 39.18 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.434 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.5 16.24 80.54 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.3 mp -67.99 -52.15 39.05 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-N 119.413 1.606 . . . . 0.0 110.411 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 m120 . . . . . 0 C--N 1.313 -0.984 0 O-C-N 125.654 1.846 . . . . 0.0 114.374 -174.633 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 70.2 mt . . . . . 0 N--CA 1.422 -1.873 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.42 ' HG3' ' HB2' ' B' ' 18' ' ' ASP . 34.9 ptt180 -119.79 157.55 28.38 Favored 'General case' 0 C--N 1.275 -2.666 0 O-C-N 123.828 0.705 . . . . 0.0 110.061 -172.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.27 125.81 29.92 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.846 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.28 -6.86 32.28 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.835 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' ASP . . . . . 0.454 ' CG ' ' HZ3' ' B' ' 102' ' ' LYS . 5.3 t70 -97.09 177.83 5.46 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 4.8 t -134.65 130.47 53.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-O 121.411 0.624 . . . . 0.0 112.039 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.467 ' O ' HG22 ' B' ' 38' ' ' VAL . 39.4 m-85 -130.12 145.17 51.68 Favored 'General case' 0 CA--C 1.472 -2.023 0 C-N-CA 124.993 1.317 . . . . 0.0 109.118 176.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.3 mp -79.28 151.75 30.94 Favored 'General case' 0 N--CA 1.395 -3.179 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 170.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.71 141.68 33.31 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.925 -176.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.8 83.96 6.43 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.537 ' O ' HG13 ' B' ' 27' ' ' VAL . 90.8 mt -64.92 -26.88 68.5 Favored 'General case' 0 CA--C 1.469 -2.162 0 CA-C-N 112.995 -1.911 . . . . 0.0 111.137 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 2.7 m -34.13 178.35 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.351 0 C-N-CA 128.709 2.804 . . . . 0.0 114.883 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.535 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 0.1 OUTLIER 22.44 50.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.676 0 C-N-CA 122.961 2.441 . . . . 0.0 115.277 -153.246 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 11.5 m -71.3 -178.95 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.612 166.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 26' ' ' PRO . 31.1 mm-40 -115.14 128.57 56.28 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.36 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.52 -108.97 0.9 Allowed Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.152 -1.385 . . . . 0.0 115.248 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 66.8 m -93.44 7.66 43.65 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.636 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 50.1 mt-10 -62.57 159.98 14.8 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 117.852 -1.539 . . . . 0.0 109.981 175.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.428 HE22 ' HG3' ' B' ' 36' ' ' ARG . 1.0 OUTLIER -75.61 110.23 9.84 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -176.025 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.04 146.93 18.62 Favored Glycine 0 CA--C 1.484 -1.879 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -174.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.85 157.54 11.69 Favored Glycine 0 N--CA 1.412 -2.9 0 CA-C-N 113.331 -1.435 . . . . 0.0 110.29 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -77.68 113.58 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 122.631 1.205 . . . . 0.0 107.78 175.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' ARG . . . . . 0.428 ' HG3' HE22 ' B' ' 32' ' ' GLN . 19.5 mmt180 -135.63 158.77 73.57 Favored Pre-proline 0 C--N 1.259 -3.369 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.121 -171.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.2 Cg_exo -64.62 134.24 40.21 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.59 2.193 . . . . 0.0 110.925 172.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.467 HG22 ' O ' ' B' ' 20' ' ' TYR . 35.0 m -120.92 160.11 22.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 32.8 m -98.78 130.09 48.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -87.14 100.6 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.08 -20.99 5.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.522 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.586 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -54.61 158.4 2.56 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -170.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.03 170.72 6.38 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.196 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.52 -44.81 70.27 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.443 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 18.7 m -72.17 -34.83 68.76 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 122.697 0.399 . . . . 0.0 111.658 -170.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.78 -30.38 76.84 Favored Glycine 0 C--O 1.219 -0.822 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.71 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -64.67 -27.23 68.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.952 0.406 . . . . 0.0 110.512 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.427 ' HB2' ' CD2' ' B' ' 49' ' ' TYR . 6.7 mmtt -93.17 -53.98 3.9 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' B' ' 48' ' ' LYS . 96.0 m-85 -100.77 1.2 40.05 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -166.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -121.16 142.05 34.22 Favored Pre-proline 0 C--N 1.292 -1.929 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.533 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 37.4 Cg_endo -71.61 -27.04 19.06 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.489 1.46 . . . . 0.0 109.539 174.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.0 146.7 24.4 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.064 -176.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.425 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.4 OUTLIER -143.05 140.49 27.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.762 HG21 HD22 ' A' ' 122' ' ' LEU . 12.4 tt -82.13 133.41 29.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.237 0 CA-C-O 121.375 0.607 . . . . 0.0 110.677 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 36.0 m -135.59 156.33 37.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.349 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.537 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -121.6 140.41 52.28 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.85 128.81 36.52 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' B' ' 37' ' ' PRO . 55.5 mt -86.09 117.05 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 173.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.2 m -102.4 105.16 15.7 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.217 0.532 . . . . 0.0 111.077 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.439 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.802 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.435 -1.176 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 68' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 8.5 Cg_endo -52.71 -32.1 53.7 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 122.672 2.248 . . . . 0.0 114.375 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 32.4 p -73.8 -19.33 60.79 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.082 0.468 . . . . 0.0 112.038 -172.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -104.83 129.54 53.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 96.2 t -118.68 114.11 43.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.599 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.76 117.11 22.43 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.648 HD12 ' CD2' ' B' ' 78' ' ' TYR . 8.8 pt -101.43 132.95 46.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.18 -174.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.44 119.5 6.15 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.211 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' LYS . . . . . 0.672 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 39.9 mttp -43.19 -49.21 6.56 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.587 1.155 . . . . 0.0 109.059 173.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -61.57 -29.59 70.12 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.902 -1.954 . . . . 0.0 113.198 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' LYS . . . . . 0.408 ' HD2' ' HE2' ' B' ' 110' ' ' LYS . 94.7 mttt -91.71 -29.72 16.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.329 0.585 . . . . 0.0 111.076 -176.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.648 ' CD2' HD12 ' B' ' 73' ' ' ILE . 21.0 m-85 -95.9 7.99 44.85 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.035 -176.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 tttm 60.8 31.83 20.09 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 122.324 1.059 . . . . 0.0 109.972 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -111.86 176.29 5.08 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.495 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' B' ' 75' ' ' LYS . 7.3 p-10 -99.48 -9.83 22.89 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.914 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.488 ' C ' ' HG2' ' B' ' 75' ' ' LYS . 10.0 ptpp? -141.77 143.64 33.57 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.102 -174.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.672 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 27.3 m-20 -71.5 119.27 15.41 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 173.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.529 ' O ' HG12 ' B' ' 73' ' ' ILE . 23.3 t -105.25 173.28 6.37 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 13.4 t -120.43 139.94 46.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.479 HD12 HG12 ' B' ' 58' ' ' ILE . 19.1 mm -104.18 127.68 58.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 172.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 88.0 mt -103.23 105.95 16.36 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.6 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.9 mm? -83.33 -3.98 58.02 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.039 -176.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.52 -34.48 15.53 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.256 1.027 . . . . 0.0 108.778 174.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLN . . . . . 0.465 ' OE1' ' HA ' ' B' ' 31' ' ' GLU . 3.5 tp60 -97.02 76.71 2.7 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.168 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.537 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.3 pp -125.13 176.6 5.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -165.43 173.83 10.66 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 47.4 m -118.8 122.23 41.91 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 64.9 mt -131.92 150.37 52.17 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.894 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.505 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 0.7 OUTLIER -58.44 142.47 48.52 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 169.581 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' B' ' 99' ' ' LEU . 18.0 pttm -51.82 -36.26 47.34 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.7 0.762 . . . . 0.0 112.435 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.481 ' HD3' ' HB3' ' B' ' 95' ' ' ASP . 28.3 mtpt -44.42 -34.63 2.1 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 126.684 1.994 . . . . 0.0 113.637 171.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -67.43 -29.55 69.05 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.568 0.747 . . . . 0.0 110.71 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' B' ' 96' ' ' LYS . 7.5 mp -72.48 129.63 38.78 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 125.52 1.528 . . . . 0.0 110.611 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -95.95 -58.04 2.2 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.443 -1.253 . . . . 0.0 114.097 -175.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 16.1 pt-20 -161.06 147.18 14.63 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.535 0.683 . . . . 0.0 111.847 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 102' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 64.8 tttp -61.17 124.33 20.24 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 126.974 2.11 . . . . 0.0 110.609 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.7 tp -114.57 -61.45 1.75 Allowed 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.348 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.473 HG22 HG11 ' B' ' 19' ' ' VAL . 5.8 t -129.72 -158.25 0.88 Allowed 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 118.179 -1.409 . . . . 0.0 112.063 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -160.28 148.83 16.9 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 126.063 1.745 . . . . 0.0 109.038 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.427 ' HB3' ' CZ ' ' B' ' 78' ' ' TYR . 3.8 pp -112.4 154.77 25.28 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.8 m -80.6 161.13 24.87 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.374 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.67 -32.98 73.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.87 0.868 . . . . 0.0 112.522 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.541 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 5.4 p-10 -62.4 -32.02 72.79 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.408 ' HE2' ' HD2' ' B' ' 77' ' ' LYS . 2.8 mptp? -70.78 -28.85 64.97 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.433 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.1 OUTLIER -54.65 -47.78 73.11 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.275 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.433 ' HE2' ' C ' ' B' ' 111' ' ' MET . 9.0 mmpt? -78.38 -12.27 59.99 Favored 'General case' 0 N--CA 1.389 -3.496 0 CA-C-N 114.508 -1.224 . . . . 0.0 113.754 -177.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 113' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' B' ' 109' ' ' ASP . 44.3 mt-10 -85.85 -41.64 14.83 Favored 'General case' 0 CA--C 1.47 -2.1 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 177.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 t -51.6 -47.02 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-N 112.911 -1.949 . . . . 0.0 110.731 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -53.04 -48.83 67.34 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.688 0.756 . . . . 0.0 110.276 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.702 ' O ' HD13 ' B' ' 120' ' ' ILE . 10.3 m-80 -69.82 -24.3 63.45 Favored 'General case' 0 N--CA 1.512 2.643 0 C-N-CA 125.004 1.322 . . . . 0.0 112.184 -176.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.6 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -83.41 -44.38 14.86 Favored 'General case' 2 C--N 1.231 -4.546 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.035 177.917 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.732 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.0 OUTLIER -73.51 -55.72 5.97 Favored 'General case' 1 N--CA 1.374 -4.269 0 C-N-CA 123.349 0.66 . . . . 0.0 112.162 -173.634 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 38.8 mtp -56.88 -37.88 71.97 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.702 HD13 ' O ' ' B' ' 116' ' ' ASN . 1.5 mp -77.06 -39.84 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 60.7 m -58.54 -35.87 72.97 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.625 0.726 . . . . 0.0 110.818 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.758 HD22 HG21 ' A' ' 54' ' ' ILE . 11.0 mt -101.17 -0.01 36.81 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.706 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.85 17.72 79.56 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 115.81 1.084 . . . . 0.0 115.81 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.43 -54.35 21.05 Favored 'General case' 0 CA--C 1.479 -1.753 0 CA-C-N 119.111 1.455 . . . . 0.0 110.021 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 m120 . . . . . 0 C--N 1.305 -1.364 0 CA-C-N 113.575 -1.648 . . . . 0.0 113.937 -173.831 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.433 -1.284 0 CA-C-O 120.76 0.315 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -121.45 153.55 37.73 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.456 172.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -75.43 139.67 42.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.799 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.13 -11.19 51.8 Favored Glycine 0 C--N 1.306 -1.101 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.007 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -97.31 173.46 7.2 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 4.6 t -130.68 130.55 64.72 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 C-N-CA 123.21 0.604 . . . . 0.0 111.763 -175.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 85.4 m-85 -127.03 143.95 51.15 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.907 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -75.16 147.56 40.36 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 169.083 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -135.86 129.42 32.32 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.706 -1.588 . . . . 0.0 107.635 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 10.1 t70 -84.99 91.08 7.98 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.351 174.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.582 HD22 ' O ' ' A' ' 24' ' ' LEU 0.432 0.0 OUTLIER -114.82 62.1 0.68 Allowed 'General case' 0 N--CA 1.385 -3.699 0 CA-C-O 124.203 1.954 . . . . 0.0 111.999 175.788 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.435 ' OG ' ' HA2' ' A' ' 34' ' ' GLY . 1.4 m -107.04 60.39 0.2 Allowed Pre-proline 0 C--N 1.266 -3.03 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.554 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.473 ' HB3' HE22 ' B' ' 28' ' ' GLN . 22.7 Cg_endo -115.27 23.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.276 0 N-CA-C 108.456 -1.402 . . . . 0.0 108.456 158.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.623 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 20.1 m -88.65 158.13 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -172.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -155.74 160.57 40.42 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 113.005 -1.907 . . . . 0.0 107.049 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.51 -142.82 17.47 Favored Glycine 0 C--N 1.297 -1.624 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.411 ' HB2' ' CB ' ' B' ' 95' ' ' ASP . 22.3 m -94.46 15.33 18.06 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 117.053 0.427 . . . . 0.0 110.99 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.623 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 46.3 mt-10 -70.33 157.62 37.4 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -134.99 112.87 10.95 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.494 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -145.0 -109.86 0.66 Allowed Glycine 0 N--CA 1.411 -2.975 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.545 176.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 82.95 178.11 52.24 Favored Glycine 0 N--CA 1.4 -3.76 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -172.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 23' ' ' ASP . 1.4 p -87.45 99.36 8.47 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-O 123.556 1.646 . . . . 0.0 107.44 173.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -140.9 153.03 67.03 Favored Pre-proline 0 C--N 1.268 -2.944 0 CA-C-N 111.724 -2.489 . . . . 0.0 109.01 -168.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.58 ' HB2' HD12 ' A' ' 58' ' ' ILE . 33.5 Cg_exo -60.88 141.09 93.65 Favored 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 122.623 2.216 . . . . 0.0 112.9 175.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 20' ' ' TYR . 27.4 m -126.15 157.87 36.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 34.6 m -100.1 129.86 50.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.9 mm -88.73 98.06 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -18.86 6.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.533 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.69 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 1.2 tt0 -51.26 152.78 2.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -173.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -43.11 146.28 0.44 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.556 2.343 . . . . 0.0 113.23 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -66.26 -37.53 85.69 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.544 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 m -87.68 -30.67 20.22 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.374 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.07 -31.33 78.4 Favored Glycine 0 C--O 1.206 -1.626 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.478 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -71.95 -20.85 61.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.172 0.511 . . . . 0.0 111.019 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -86.63 -51.64 6.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -85.48 -36.07 20.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -171.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.5 m -97.15 145.92 30.44 Favored Pre-proline 0 C--N 1.291 -1.975 0 O-C-N 121.988 -0.445 . . . . 0.0 110.986 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -80.27 -15.09 11.6 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.916 1.744 . . . . 0.0 109.838 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 1.9 p -96.29 146.09 25.02 Favored 'General case' 0 N--CA 1.42 -1.927 0 C-N-CA 125.007 1.323 . . . . 0.0 110.412 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.49 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.2 OUTLIER -144.75 138.6 22.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.236 0.541 . . . . 0.0 110.746 173.603 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.69 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -85.34 124.64 40.2 Favored 'Isoleucine or valine' 0 C--O 1.253 1.244 0 C-N-CA 124.435 1.094 . . . . 0.0 110.19 177.059 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.67 171.11 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.419 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.584 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -129.65 142.76 50.67 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.97 129.68 37.27 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.639 HG12 HD12 ' A' ' 86' ' ' ILE . 59.3 mt -85.52 117.57 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.5 174.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.4 m -107.21 111.87 24.47 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.863 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.863 -176.203 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.2 tt . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.575 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 12.4 Cg_endo -56.12 -28.48 70.37 Favored 'Trans proline' 0 C--O 1.2 -1.41 0 C-N-CA 122.363 2.042 . . . . 0.0 114.274 -176.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.0 p -74.08 -18.92 60.76 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.064 0.459 . . . . 0.0 111.515 -174.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.8 m170 -104.64 128.95 52.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.401 HG12 HD13 ' A' ' 73' ' ' ILE . 59.1 t -130.22 124.68 58.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -98.34 133.46 42.71 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.625 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -115.53 158.37 15.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.907 -173.214 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.502 ' OE1' ' HE3' ' A' ' 110' ' ' LYS . 2.3 mp0 -66.3 113.58 4.71 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.093 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -52.51 -42.11 64.04 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.716 0.806 . . . . 0.0 112.556 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.463 ' HD3' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -61.06 -30.7 70.49 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.463 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 5.0 ttmp? -85.75 -34.99 21.05 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.716 0.769 . . . . 0.0 109.259 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.625 ' CE1' HG21 ' A' ' 73' ' ' ILE . 4.7 m-85 -84.71 5.29 28.87 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.937 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt 68.06 26.47 7.25 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.761 1.224 . . . . 0.0 111.227 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.8 mt -117.56 179.2 4.13 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.456 0.646 . . . . 0.0 110.759 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -108.87 -18.89 13.58 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.51 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -118.51 147.23 43.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.25 123.71 22.85 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 t -102.93 150.72 23.25 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.082 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.3 136.26 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.639 HD12 HG12 ' A' ' 58' ' ' ILE . 19.4 mm -104.49 131.14 54.12 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.967 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.8 mt -100.97 102.57 13.62 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.9 mm? -82.92 4.62 24.94 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.003 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.52 -42.91 7.47 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.912 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.457 ' HA ' HG21 ' B' ' 93' ' ' THR . 0.0 OUTLIER -91.01 76.71 6.17 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.668 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.584 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -117.02 178.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.479 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.417 ' HD2' HD23 ' A' ' 24' ' ' LEU . 15.6 ptp180 -173.81 163.3 4.14 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.475 HG21 ' HA ' ' B' ' 90' ' ' GLN . 61.4 m -107.77 124.18 49.66 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.421 -178.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.405 ' HB3' ' HG3' ' A' ' 98' ' ' ARG . 43.2 mt -132.42 145.62 51.35 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.73 -172.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.1 p30 -76.32 153.63 35.72 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.981 175.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -44.37 -22.14 0.06 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.463 1.905 . . . . 0.0 115.352 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.22 -18.6 60.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 118.206 0.457 . . . . 0.0 110.739 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 32.4 mmt180 -75.12 -38.81 60.95 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.6 mp -68.15 125.21 25.66 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.697 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 23' ' ' ASP . 67.9 mttm -103.99 -64.95 1.05 Allowed 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.304 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.4 pt-20 -150.88 144.28 24.9 Favored 'General case' 0 N--CA 1.412 -2.337 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.069 -166.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -70.59 125.88 28.06 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.425 -1.716 . . . . 0.0 111.098 176.935 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 tp -114.57 -62.01 1.66 Allowed 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.069 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.499 HG22 HG11 ' A' ' 19' ' ' VAL . 3.8 t -127.81 -167.22 1.72 Allowed 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.639 -1.625 . . . . 0.0 111.626 -177.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -160.81 143.98 13.12 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 124.73 1.212 . . . . 0.0 109.512 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.6 pp -114.18 159.63 19.88 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.762 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.2 t -82.38 159.33 23.04 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.793 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 111' ' ' MET . 18.9 t70 -63.59 -33.31 75.33 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.439 0.638 . . . . 0.0 111.303 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.5 -28.06 65.73 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.102 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.502 ' HE3' ' OE1' ' A' ' 74' ' ' GLU . 5.7 mptp? -76.17 -29.0 57.54 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.078 0.466 . . . . 0.0 110.263 175.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -59.18 -36.31 75.11 Favored 'General case' 0 N--CA 1.416 -2.146 0 C-N-CA 123.521 0.728 . . . . 0.0 109.533 174.662 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.485 ' HE2' ' C ' ' A' ' 111' ' ' MET . 7.6 mmpt? -78.08 -10.99 59.88 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.34 -38.43 18.8 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 1.7 t -54.61 -39.86 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 112.432 -2.167 . . . . 0.0 110.884 173.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.44 -35.18 69.77 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 122.243 1.02 . . . . 0.0 111.801 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.553 ' O ' HD13 ' A' ' 120' ' ' ILE . 16.4 m-80 -83.89 -18.81 36.18 Favored 'General case' 0 CA--C 1.433 -3.528 0 C-N-CA 125.235 1.414 . . . . 0.0 110.083 -171.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 68' ' ' PRO . . . -84.56 -57.14 3.26 Favored 'General case' 2 N--CA 1.34 -5.952 0 CA-C-N 111.881 -2.418 . . . . 0.0 108.921 171.271 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 tp -67.34 -45.37 76.61 Favored 'General case' 0 N--CA 1.404 -2.727 0 C-N-CA 125.984 1.714 . . . . 0.0 113.592 -170.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 34.1 mtp -67.64 -22.06 65.34 Favored 'General case' 0 C--O 1.199 -1.575 0 O-C-N 121.704 -0.622 . . . . 0.0 111.839 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.0 OUTLIER -87.13 -45.56 16.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -178.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 10.8 t -56.31 -46.82 79.67 Favored 'General case' 0 C--N 1.277 -2.584 0 C-N-CA 126.618 1.967 . . . . 0.0 111.251 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.614 ' HG ' HG21 ' B' ' 54' ' ' ILE . 7.8 mp -89.44 3.84 51.03 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 123.149 0.579 . . . . 0.0 111.254 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.24 32.66 84.89 Favored Glycine 0 CA--C 1.539 1.583 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 175.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.3 mp -78.19 -34.21 49.63 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 118.651 1.226 . . . . 0.0 109.024 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.2 t30 . . . . . 0 CA--C 1.549 0.929 0 C-N-CA 129.216 3.006 . . . . 0.0 117.565 179.597 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 53.7 mt . . . . . 0 N--CA 1.441 -0.901 0 CA-C-O 120.685 0.279 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -119.73 156.64 30.15 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.696 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -77.76 139.67 39.39 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.089 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.36 -11.94 51.25 Favored Glycine 0 C--N 1.309 -0.941 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.496 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -97.18 176.74 5.82 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 4.9 t -132.93 129.54 57.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-O 121.44 0.638 . . . . 0.0 112.209 -175.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.449 ' O ' HG22 ' B' ' 38' ' ' VAL . 83.1 m-85 -126.89 143.08 51.37 Favored 'General case' 0 CA--C 1.46 -2.486 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.458 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.592 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -79.41 149.88 31.49 Favored 'General case' 0 N--CA 1.39 -3.43 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.905 170.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -136.76 131.48 33.46 Favored 'General case' 0 C--N 1.259 -3.364 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.132 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' B' ' 35' ' ' VAL . 8.8 t70 -81.84 96.1 7.52 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.037 171.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.582 ' O ' HD22 ' B' ' 24' ' ' LEU 0.475 0.0 OUTLIER -118.19 60.23 0.79 Allowed 'General case' 1 N--CA 1.376 -4.175 0 CA-C-O 124.078 1.894 . . . . 0.0 111.963 172.158 . . . . . . . . 5 4 . 1 . 015 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HA2' ' B' ' 34' ' ' GLY . 1.3 m -105.08 59.89 0.12 Allowed Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 113.264 -1.789 . . . . 0.0 111.687 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.462 ' HD2' HG13 ' B' ' 27' ' ' VAL . 27.9 Cg_endo -116.95 24.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.594 0 N-CA-C 108.054 -1.556 . . . . 0.0 108.054 158.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.663 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 21.7 m -91.46 153.6 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' GLN . . . . . 0.473 HE22 ' HB3' ' A' ' 26' ' ' PRO 0.467 11.7 pm0 -128.1 -64.61 0.95 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 119.336 3.087 . . . . 0.0 119.336 -177.385 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.5 -114.65 0.02 OUTLIER Glycine 0 C--N 1.313 -0.696 0 C-N-CA 120.555 -0.831 . . . . 0.0 114.076 -173.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.443 ' HB2' ' CB ' ' A' ' 95' ' ' ASP . 19.4 m -94.15 20.36 8.11 Favored 'General case' 0 C--N 1.271 -2.808 0 O-C-N 122.003 -0.704 . . . . 0.0 109.503 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.663 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 45.6 mt-10 -75.64 162.83 27.92 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -138.41 112.71 8.7 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.515 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -147.18 -113.69 0.78 Allowed Glycine 0 N--CA 1.411 -2.999 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.124 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.459 ' HA2' ' OG ' ' B' ' 25' ' ' SER . . . 86.99 176.53 49.18 Favored Glycine 0 N--CA 1.399 -3.826 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 -172.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' B' ' 23' ' ' ASP . 1.6 p -84.53 99.58 6.97 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -141.46 151.17 60.15 Favored Pre-proline 0 C--N 1.262 -3.224 0 CA-C-N 112.096 -2.32 . . . . 0.0 109.26 -169.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 52.1 Cg_exo -59.0 139.69 91.99 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.825 2.35 . . . . 0.0 112.878 174.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.449 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -125.75 158.36 34.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.5 m -100.39 129.59 50.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 24.3 mm -88.23 98.47 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.95 -18.82 6.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.486 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.681 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 1.2 tt0 -50.81 152.07 2.23 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -41.74 145.99 0.28 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 127.69 2.396 . . . . 0.0 113.761 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.76 -39.4 93.55 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.975 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -87.73 -29.33 21.16 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.13 0.491 . . . . 0.0 110.949 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.25 -30.95 77.46 Favored Glycine 0 C--O 1.206 -1.65 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.039 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -72.54 -20.55 61.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.064 0.459 . . . . 0.0 111.166 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.12 -53.91 4.78 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.151 0.501 . . . . 0.0 109.817 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -82.79 -35.72 26.24 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.409 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 70.1 m -94.84 143.2 25.76 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-O 120.855 0.36 . . . . 0.0 111.192 -176.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.88 -14.54 12.38 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.072 1.848 . . . . 0.0 109.524 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 1.9 p -97.18 147.93 23.59 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 125.11 1.364 . . . . 0.0 110.052 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.49 ' HA ' HE21 ' B' ' 42' ' ' GLN . 0.2 OUTLIER -146.33 138.94 20.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.291 0.567 . . . . 0.0 110.888 173.217 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.681 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -85.01 124.19 39.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 C-N-CA 124.675 1.19 . . . . 0.0 109.881 177.342 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.78 171.15 17.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.429 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.59 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -129.82 142.97 50.6 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.0 130.31 38.21 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.655 HG12 HD12 ' B' ' 86' ' ' ILE . 57.8 mt -85.46 117.23 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.513 174.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 22.0 m -105.05 108.83 20.57 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.067 -177.241 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.4 tt . . . . . 0 N--CA 1.416 -2.164 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 68' ' ' PRO . . . . . 0.563 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 12.4 Cg_endo -56.72 -28.41 75.64 Favored 'Trans proline' 0 C--O 1.204 -1.18 0 C-N-CA 122.257 1.971 . . . . 0.0 114.182 -177.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 62.4 p -73.95 -19.17 60.76 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.046 0.45 . . . . 0.0 111.68 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -105.38 129.07 53.78 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.404 ' CG2' ' HB2' ' B' ' 117' ' ' ALA . 70.8 t -130.31 125.85 60.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.41 134.38 39.66 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.608 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -118.14 153.95 20.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.272 -174.413 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.55 ' OE1' ' HE3' ' B' ' 110' ' ' LYS . 3.7 mp0 -65.02 113.04 3.62 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.49 -178.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -50.71 -41.64 56.28 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 124.272 1.029 . . . . 0.0 112.634 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -22.04 66.17 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.252 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -91.36 -36.32 13.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.644 0.735 . . . . 0.0 109.071 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.608 ' CE1' HG21 ' B' ' 73' ' ' ILE . 4.5 m-85 -83.38 8.11 14.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.433 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 67.09 20.38 10.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.824 1.249 . . . . 0.0 111.757 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -111.0 179.66 3.98 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.1 0.476 . . . . 0.0 110.798 -174.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.86 -24.44 12.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.199 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -116.64 147.33 42.01 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.07 123.09 23.74 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.546 0.689 . . . . 0.0 109.237 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 22.6 t -102.88 154.11 19.53 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.72 -167.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.0 t -116.18 136.08 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.655 HD12 HG12 ' B' ' 58' ' ' ILE . 21.3 mm -104.66 131.87 52.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.932 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 66.2 mt -101.65 103.14 13.93 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.574 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.9 mm? -82.88 -0.41 48.17 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.535 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -94.37 -40.67 9.81 Favored 'General case' 0 N--CA 1.413 -2.294 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.94 173.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLN . . . . . 0.475 ' HA ' HG21 ' A' ' 93' ' ' THR . 0.0 OUTLIER -91.04 76.67 6.16 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.27 1.033 . . . . 0.0 108.59 178.755 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.59 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.5 pp -117.33 178.77 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.584 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.418 ' HD2' HD23 ' B' ' 24' ' ' LEU . 15.5 ptp180 -173.8 163.58 4.18 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 90' ' ' GLN . 65.5 m -108.15 124.21 49.91 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.569 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.44 ' HB3' ' HG3' ' B' ' 98' ' ' ARG . 45.7 mt -132.34 145.85 51.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.739 -172.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 1.9 p-10 -77.8 153.5 32.77 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.412 176.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 50' ' ' SER . 99.5 mttt -44.69 -21.76 0.06 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.129 1.772 . . . . 0.0 115.446 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -73.7 -19.17 60.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.11 0.481 . . . . 0.0 110.745 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.534 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 31.5 mmt180 -74.98 -38.73 61.57 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.876 -0.515 . . . . 0.0 109.875 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.5 123.12 20.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.092 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -102.67 -65.08 1.01 Allowed 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 114.165 -1.379 . . . . 0.0 113.46 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.0 pt-20 -149.03 139.83 22.77 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.328 0.585 . . . . 0.0 111.349 -165.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 102' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.2 OUTLIER -69.76 123.5 21.57 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.754 -1.566 . . . . 0.0 111.592 176.203 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.07 -62.37 1.61 Allowed 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.249 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.532 HG22 HG11 ' B' ' 19' ' ' VAL . 3.2 t -126.91 -168.25 1.85 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 117.432 -1.707 . . . . 0.0 112.434 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -160.49 142.28 12.53 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 124.468 1.107 . . . . 0.0 110.205 -175.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -112.14 159.33 18.64 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.647 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 32.5 t -82.59 161.91 22.1 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' B' ' 111' ' ' MET . 16.7 t70 -62.1 -34.2 75.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.758 0.823 . . . . 0.0 111.373 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.01 -27.56 62.81 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.55 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 5.6 mptp? -75.0 -29.27 60.83 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 120.874 0.368 . . . . 0.0 110.02 175.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.481 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -57.54 -38.31 74.5 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.655 174.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.45 ' HE2' ' C ' ' B' ' 111' ' ' MET . 7.6 mmpt? -77.34 -13.74 59.87 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.13 -35.37 21.8 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 t -56.88 -41.36 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.568 0 CA-C-N 112.32 -2.218 . . . . 0.0 110.099 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -44.54 76.98 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.831 0.824 . . . . 0.0 110.489 174.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.732 ' O ' HD13 ' B' ' 120' ' ' ILE . 3.2 m120 -70.61 -20.91 62.71 Favored 'General case' 0 CA--C 1.474 -1.98 0 CA-C-O 122.384 1.088 . . . . 0.0 111.135 -176.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.574 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -84.26 -53.85 5.2 Favored 'General case' 2 C--N 1.235 -4.405 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.291 173.35 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.67 -46.77 74.61 Favored 'General case' 0 N--CA 1.403 -2.798 0 C-N-CA 126.194 1.798 . . . . 0.0 113.471 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 38.4 mtp -66.05 -24.91 66.82 Favored 'General case' 0 C--O 1.2 -1.504 0 O-C-N 121.754 -0.591 . . . . 0.0 111.395 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.732 HD13 ' O ' ' B' ' 116' ' ' ASN . 1.3 mp -86.95 -40.77 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 70.5 m -57.12 -46.88 82.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 122.124 0.964 . . . . 0.0 111.145 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.598 ' HG ' HG21 ' A' ' 54' ' ' ILE . 7.4 mp -88.4 3.37 50.18 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.806 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.5 32.0 79.62 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.28 -37.04 63.8 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 119.041 1.421 . . . . 0.0 108.696 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 7.4 t30 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 128.489 2.716 . . . . 0.0 117.443 179.485 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 N--CA 1.429 -1.512 0 CA-C-O 121.915 0.864 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -110.02 154.64 22.91 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.906 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -84.63 129.89 34.78 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.021 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.6 0.38 43.0 Favored Glycine 0 C--N 1.308 -0.992 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.644 -175.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -97.33 170.14 9.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 104' ' ' THR . 12.0 t -131.73 133.9 60.87 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 C-N-CA 124.063 0.945 . . . . 0.0 112.021 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 93.1 m-85 -132.41 145.83 51.51 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.573 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER -76.96 148.64 36.2 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 169.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -143.78 149.07 36.52 Favored 'General case' 0 C--N 1.257 -3.452 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.669 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -74.45 85.78 2.02 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 124.238 1.971 . . . . 0.0 108.044 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.505 ' O ' HD13 ' A' ' 24' ' ' LEU . 2.0 tm? -87.94 13.15 11.52 Favored 'General case' 0 N--CA 1.407 -2.615 0 CA-C-N 111.198 -2.728 . . . . 0.0 111.662 -166.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 p -104.67 62.23 0.11 Allowed Pre-proline 0 N--CA 1.414 -2.236 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -113.47 23.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 121.712 1.608 . . . . 0.0 108.314 158.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.65 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 12.8 m -78.87 -179.1 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.702 -173.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.9 154.29 50.51 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.658 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.42 -108.99 1.16 Allowed Glycine 0 CA--C 1.502 -0.77 0 N-CA-C 116.271 1.268 . . . . 0.0 116.271 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 m -93.75 -6.63 45.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.236 -174.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 50.2 mt-10 -60.24 159.17 10.25 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.454 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.433 HE22 ' HG3' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -81.21 113.02 19.07 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -173.045 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.75 159.51 15.87 Favored Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 115.626 1.011 . . . . 0.0 115.626 -177.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 24' ' ' LEU . . . 110.43 146.31 10.89 Favored Glycine 0 N--CA 1.415 -2.764 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 22' ' ' ALA . 3.6 p -61.55 122.61 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 CA-C-O 122.507 1.146 . . . . 0.0 109.382 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.433 ' HG3' HE22 ' A' ' 32' ' ' GLN . 14.4 mmt85 -141.3 162.23 48.69 Favored Pre-proline 0 C--N 1.264 -3.124 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.753 -169.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HB2' HD12 ' A' ' 58' ' ' ILE . 1.3 Cg_endo -80.08 142.35 15.33 Favored 'Trans proline' 0 N--CA 1.427 -2.429 0 C-N-CA 121.785 1.657 . . . . 0.0 109.736 171.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 22.4 m -123.54 155.17 29.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.068 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.518 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 35.5 m -99.38 132.9 43.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.79 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.459 HD13 HG12 ' A' ' 55' ' ' VAL . 22.9 mm -90.97 105.2 16.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -99.56 -15.58 7.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.817 -179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.641 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 2.8 tt0 -55.47 162.65 1.5 Allowed 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 126.035 1.734 . . . . 0.0 114.518 -168.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.512 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 1.5 p30 -75.93 177.12 7.25 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.829 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.24 -34.53 49.12 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 m -75.3 -24.62 57.49 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.128 0.49 . . . . 0.0 110.504 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.38 -23.06 73.35 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -83.44 -19.7 35.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.451 0.643 . . . . 0.0 109.91 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -89.93 -66.77 0.89 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.315 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -107.87 2.13 23.23 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.3 m -108.09 134.4 20.16 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.51 -22.92 20.68 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 121.671 1.58 . . . . 0.0 109.364 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 p -86.97 158.94 19.16 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.631 -1.622 . . . . 0.0 111.551 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.641 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 66.2 t -137.64 140.4 41.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 173.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.451 HD13 ' CD2' ' B' ' 122' ' ' LEU . 5.8 tt -105.9 127.48 60.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.548 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 34.1 m -132.01 174.65 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.263 -174.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -131.52 146.51 52.27 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.81 138.44 38.97 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 37' ' ' PRO . 81.6 mt -99.89 127.32 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.707 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -141.67 138.28 32.37 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.004 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.089 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 176.879 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tt . . . . . 0 N--CA 1.432 -1.359 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 27.0 Cg_exo -62.54 -35.04 73.29 Favored 'Trans proline' 0 C--O 1.196 -1.62 0 C-N-CA 121.431 1.421 . . . . 0.0 114.136 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.2 p -73.36 -18.59 61.16 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -114.67 128.97 56.61 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.1 127.73 75.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 118.704 0.684 . . . . 0.0 109.863 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -97.76 130.3 44.72 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.139 0.495 . . . . 0.0 110.406 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.505 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -110.31 169.61 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.4 ' H ' HG22 ' A' ' 73' ' ' ILE . 44.4 mt-10 -89.04 137.17 32.56 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.385 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 82' ' ' LYS . 58.4 tttm -50.36 -42.46 53.21 Favored 'General case' 0 C--O 1.207 -1.141 0 O-C-N 124.351 1.032 . . . . 0.0 109.997 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.435 ' HG3' ' H ' ' A' ' 76' ' ' LYS . 46.5 mttp -54.11 -49.67 68.61 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 125.623 1.569 . . . . 0.0 111.494 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.02 -40.45 38.88 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 2.4 m-85 -77.4 -8.84 58.35 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 78' ' ' TYR . 17.4 ptmt 52.74 34.0 15.22 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.571 1.549 . . . . 0.0 110.692 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.66 -173.83 2.64 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.246 -171.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.13 -29.43 67.48 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.068 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 14.4 ptmm? -166.87 168.14 14.31 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -52.4 138.46 27.11 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.48 137.98 53.44 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -169.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 t -107.97 142.05 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.597 HD12 HG12 ' A' ' 58' ' ' ILE . 16.6 mm -109.9 135.3 49.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.62 106.88 17.58 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -89.5 10.4 22.96 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.602 0.715 . . . . 0.0 111.79 -175.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.4 -34.28 6.83 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.955 0.883 . . . . 0.0 109.662 173.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.578 ' HA ' HG21 ' B' ' 93' ' ' THR . 0.3 OUTLIER -101.2 88.39 3.48 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.687 177.927 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.562 ' O ' ' HD2' ' A' ' 92' ' ' ARG . 2.1 pp -121.97 178.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.943 -174.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.562 ' HD2' ' O ' ' A' ' 91' ' ' ILE . 18.2 mmm180 -136.76 172.97 12.23 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.75 0.786 . . . . 0.0 111.521 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.578 HG21 ' HA ' ' B' ' 90' ' ' GLN . 52.9 m -139.84 119.21 12.93 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 171.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 64.2 mt -134.27 145.05 48.73 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.807 0.843 . . . . 0.0 111.345 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.83 145.49 52.5 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 119.503 1.047 . . . . 0.0 109.656 165.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -49.36 -34.91 17.18 Favored 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -57.03 -23.8 49.11 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 125.374 1.469 . . . . 0.0 112.64 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 6.2 mmp_? -74.5 -27.73 60.68 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.556 0.693 . . . . 0.0 109.445 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.29 107.86 8.83 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 122.944 1.354 . . . . 0.0 110.937 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.62 -63.5 1.36 Allowed 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 113.039 -1.891 . . . . 0.0 114.875 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.5 pt-20 -158.29 150.02 21.42 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-O 121.814 0.816 . . . . 0.0 111.485 -170.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 66.2 mttm -61.3 126.44 27.37 Favored 'General case' 0 C--N 1.273 -2.738 0 C-N-CA 127.284 2.234 . . . . 0.0 111.832 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 tp -115.63 -62.45 1.59 Allowed 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.725 171.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.53 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 2.7 t -127.98 -167.16 1.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.142 -1.423 . . . . 0.0 112.33 -177.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.74 135.23 8.33 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 125.598 1.559 . . . . 0.0 110.712 -172.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 mt -87.08 157.48 19.4 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 124.098 0.959 . . . . 0.0 111.344 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.466 ' HB2' ' HD3' ' A' ' 110' ' ' LYS . 7.5 m -84.08 161.22 20.75 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 111' ' ' MET . 4.9 m-20 -62.4 -36.52 82.59 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.538 0.735 . . . . 0.0 112.576 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -79.79 -26.63 40.52 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.576 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.466 ' HD3' ' HB2' ' A' ' 107' ' ' SER . 2.5 mptp? -70.54 -26.45 63.56 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.98 0.419 . . . . 0.0 110.687 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.468 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -57.26 -39.18 75.1 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 123.903 0.881 . . . . 0.0 109.667 172.742 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.468 ' HE2' ' C ' ' A' ' 111' ' ' MET . 7.9 mmpt? -83.36 -11.1 58.0 Favored 'General case' 0 N--CA 1.397 -3.117 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.426 ' OE1' ' HG3' ' A' ' 110' ' ' LYS . 36.7 mt-10 -84.78 -37.16 21.14 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 1.4 t -55.04 -36.91 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-N 112.835 -1.984 . . . . 0.0 110.617 172.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.56 -35.36 80.73 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.401 1.096 . . . . 0.0 111.153 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.659 ' O ' HD13 ' A' ' 120' ' ' ILE . 13.4 m-80 -81.13 -15.03 57.04 Favored 'General case' 1 N--CA 1.555 4.823 0 CA-C-O 124.165 1.936 . . . . 0.0 109.596 -174.579 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.555 ' HB3' ' HG ' ' A' ' 88' ' ' LEU 0.337 . . -91.01 -51.31 5.4 Favored 'General case' 2 N--CA 1.346 -5.635 0 CA-C-N 111.867 -2.424 . . . . 0.0 105.254 175.109 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.621 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 3.3 tp -69.27 -47.47 64.53 Favored 'General case' 0 N--CA 1.393 -3.29 0 C-N-CA 124.518 1.127 . . . . 0.0 113.165 -171.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.5 mtp -64.77 -28.34 69.51 Favored 'General case' 0 C--O 1.195 -1.804 0 O-C-N 121.451 -0.78 . . . . 0.0 111.608 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.659 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -77.86 -48.67 23.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 23.1 t -56.48 -33.55 66.08 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 113.076 -1.875 . . . . 0.0 111.286 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 20.1 mt -104.48 7.32 35.34 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.021 0.439 . . . . 0.0 110.664 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.44 78.21 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.413 ' CD1' ' HB2' ' A' ' 122' ' ' LEU . 6.9 mp -80.51 -51.38 8.85 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 119.113 1.456 . . . . 0.0 108.927 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 CA--C 1.557 1.215 0 CA-C-N 113.068 -1.878 . . . . 0.0 112.833 -173.215 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.432 -1.341 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -113.59 155.99 24.46 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.879 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.21 135.08 34.5 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.95 2.17 58.33 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.743 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' ASP . . . . . 0.411 ' CG ' ' HZ2' ' B' ' 102' ' ' LYS . 10.1 t70 -97.79 168.4 10.34 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 13.6 t -131.88 133.84 60.63 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 C-N-CA 123.805 0.842 . . . . 0.0 112.252 -176.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 89.9 m-85 -132.44 145.52 51.26 Favored 'General case' 0 CA--C 1.483 -1.628 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.417 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 0.8 OUTLIER -76.25 149.2 37.19 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 169.448 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.482 ' O ' HG23 ' B' ' 35' ' ' VAL . . . -144.35 148.66 35.02 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.891 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.5 85.64 1.54 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 124.022 1.868 . . . . 0.0 107.741 172.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.52 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.1 tm? -88.8 12.95 13.66 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 111.33 -2.668 . . . . 0.0 111.769 -166.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 17.8 p -104.59 62.38 0.1 Allowed Pre-proline 0 CA--C 1.582 2.202 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -112.82 23.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 121.676 1.584 . . . . 0.0 108.316 159.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 16.1 m -78.42 -179.17 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.327 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.68 154.17 48.59 Favored 'General case' 0 C--O 1.206 -1.228 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.775 175.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.11 -112.0 3.26 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 115.307 0.883 . . . . 0.0 115.307 170.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -94.51 -2.85 50.96 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.532 0.333 . . . . 0.0 110.816 -173.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.67 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 51.7 mt-10 -60.71 158.84 11.91 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.167 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.413 HE22 ' HG3' ' B' ' 36' ' ' ARG . 0.9 OUTLIER -80.98 112.28 18.23 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -172.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.53 156.25 17.79 Favored Glycine 0 CA--C 1.473 -2.553 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' B' ' 24' ' ' LEU . . . 114.18 149.3 10.01 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 22' ' ' ALA . 3.2 p -63.53 125.73 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-O 122.526 1.155 . . . . 0.0 108.933 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' ARG . . . . . 0.413 ' HG3' HE22 ' B' ' 32' ' ' GLN . 9.7 mmt85 -142.09 160.98 53.25 Favored Pre-proline 0 C--N 1.268 -2.952 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.068 -168.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.617 ' HB2' HD12 ' B' ' 58' ' ' ILE . 0.9 OUTLIER -80.62 142.06 14.19 Favored 'Trans proline' 0 N--CA 1.426 -2.442 0 C-N-CA 121.714 1.609 . . . . 0.0 109.38 170.356 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 24.3 m -123.22 155.59 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.18 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.518 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 35.7 m -99.65 132.97 44.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.789 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.441 HD13 HG12 ' B' ' 55' ' ' VAL . 22.7 mm -91.52 105.42 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.501 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -99.44 -16.15 7.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.844 -179.23 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.652 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 2.8 tt0 -54.89 162.81 1.14 Allowed 'General case' 0 N--CA 1.424 -1.743 0 C-N-CA 126.369 1.868 . . . . 0.0 114.986 -167.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.502 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 2.2 p30 -74.78 175.83 7.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.934 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -77.24 -34.78 55.81 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 21.6 m -75.39 -25.53 57.71 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.156 0.503 . . . . 0.0 110.222 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.63 -23.99 72.41 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -83.23 -20.22 34.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.986 0.422 . . . . 0.0 110.28 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -88.87 -66.95 0.87 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.994 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -100.15 -23.4 14.86 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -167.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' B' ' 51' ' ' PRO . 15.2 m -83.85 136.17 41.94 Favored Pre-proline 0 N--CA 1.423 -1.822 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 50' ' ' SER . 8.0 Cg_exo -74.27 -21.72 17.32 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 121.706 1.604 . . . . 0.0 108.754 173.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -89.18 158.11 18.02 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 113.342 -1.754 . . . . 0.0 111.276 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.652 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 60.4 t -137.82 140.29 41.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.457 HD13 ' CD2' ' A' ' 122' ' ' LEU . 5.6 tt -106.43 127.91 61.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 174.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.56 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 33.9 m -132.91 174.16 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.212 -173.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.518 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -130.74 146.71 52.28 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.53 137.43 38.62 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' B' ' 37' ' ' PRO . 82.0 mt -98.35 128.56 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 113.323 -1.762 . . . . 0.0 107.736 176.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.5 t -140.89 141.38 34.58 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 119.581 -0.847 . . . . 0.0 111.621 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.242 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.149 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.2 tt . . . . . 0 N--CA 1.44 -0.973 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 68' ' ' PRO . . . . . 0.455 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 74.9 Cg_exo -54.41 -40.57 82.52 Favored 'Trans proline' 0 C--O 1.208 -1.017 0 C-N-CA 122.187 1.924 . . . . 0.0 114.659 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 57.8 p -72.63 -18.47 61.58 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -168.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -113.47 128.88 56.6 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' B' ' 117' ' ' ALA . 57.3 t -121.32 130.01 75.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 O-C-N 121.545 -0.722 . . . . 0.0 109.854 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -98.53 135.72 39.67 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.114 0.483 . . . . 0.0 109.735 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.517 HG21 ' CE1' ' B' ' 78' ' ' TYR . 1.2 mm -112.32 174.95 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.427 ' H ' HG22 ' B' ' 73' ' ' ILE . 41.0 mt-10 -92.99 139.08 30.9 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.223 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -51.79 -41.08 61.42 Favored 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 124.724 1.21 . . . . 0.0 109.697 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -59.21 -41.24 88.13 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 125.961 1.704 . . . . 0.0 111.686 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' LYS . . . . . 0.433 ' O ' ' HE3' ' B' ' 77' ' ' LYS . 0.2 OUTLIER -84.77 -39.05 18.89 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -176.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.569 ' O ' ' HG2' ' B' ' 79' ' ' LYS . 2.3 m-85 -79.14 -7.85 58.52 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.521 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' B' ' 78' ' ' TYR . 17.8 ptmt 52.71 33.25 13.51 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.63 1.572 . . . . 0.0 110.593 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.34 -175.89 3.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.463 -172.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.79 -29.88 70.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.93 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -165.99 165.96 17.65 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -50.91 135.31 24.59 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.08 139.38 49.93 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -169.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.09 142.6 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.594 HD12 HG12 ' B' ' 58' ' ' ILE . 16.2 mm -111.71 136.17 48.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 42.9 mt -106.35 106.25 16.68 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.605 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.8 mm? -89.07 10.39 21.9 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.714 0.769 . . . . 0.0 112.07 -175.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.67 -34.26 6.76 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.723 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 90' ' ' GLN . . . . . 0.578 ' HA ' HG21 ' A' ' 93' ' ' THR . 0.3 OUTLIER -100.99 87.56 3.31 Favored 'General case' 0 N--CA 1.406 -2.647 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 2.1 pp -121.49 178.91 2.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.061 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' B' ' 91' ' ' ILE . 18.3 mmm180 -136.8 172.46 12.97 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.73 0.776 . . . . 0.0 111.312 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 90' ' ' GLN . 54.6 m -139.82 119.35 13.09 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 170.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 65.9 mt -134.18 146.79 50.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 110.874 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -63.26 151.12 41.47 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.073 1.306 . . . . 0.0 109.668 165.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -51.22 -34.67 33.19 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -56.23 -25.42 47.51 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 125.076 1.35 . . . . 0.0 112.912 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 5.7 mmp_? -73.91 -29.17 61.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.397 0.618 . . . . 0.0 109.733 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.2 mp -75.46 107.73 7.79 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 125.045 1.338 . . . . 0.0 111.051 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.79 -65.77 0.97 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 112.882 -1.963 . . . . 0.0 114.932 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.2 pt-20 -156.32 146.34 21.25 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-O 121.504 0.669 . . . . 0.0 111.25 -169.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 102' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 67.6 mttm -60.52 126.43 27.4 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 126.639 1.976 . . . . 0.0 111.902 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -115.09 -61.92 1.68 Allowed 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.503 172.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.545 ' O ' ' HB ' ' B' ' 19' ' ' VAL . 3.4 t -127.23 -168.22 1.85 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 117.99 -1.484 . . . . 0.0 112.432 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -160.12 133.6 6.96 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 125.584 1.554 . . . . 0.0 110.456 -171.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 mt -84.29 162.67 20.01 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 124.009 0.924 . . . . 0.0 112.021 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 107' ' ' SER . . . . . 0.431 ' HB2' ' HD3' ' B' ' 110' ' ' LYS . 3.7 m -87.94 162.08 17.08 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.701 171.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.76 -31.79 71.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.45 -30.81 42.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.535 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.467 ' HG2' HG23 ' B' ' 73' ' ' ILE . 2.6 mptp? -67.78 -28.91 68.0 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.011 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.464 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.0 OUTLIER -55.46 -38.8 69.54 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 123.907 0.883 . . . . 0.0 109.988 172.61 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.464 ' HE2' ' C ' ' B' ' 111' ' ' MET . 7.8 mmpt? -83.99 -13.08 54.21 Favored 'General case' 0 N--CA 1.399 -2.998 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -84.4 -33.43 23.75 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.4 t -58.02 -39.71 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.404 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.2 172.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.05 -42.6 98.79 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.009 0.909 . . . . 0.0 110.067 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.624 ' O ' HD13 ' B' ' 120' ' ' ILE . 10.4 m-80 -69.51 -21.01 63.7 Favored 'General case' 0 CA--C 1.456 -2.639 0 C-N-CA 125.01 1.324 . . . . 0.0 111.923 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.605 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -83.39 -50.57 8.2 Favored 'General case' 2 N--CA 1.366 -4.666 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.839 173.53 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 3.3 tp -71.77 -48.21 48.33 Favored 'General case' 0 N--CA 1.393 -3.296 0 C-N-CA 124.546 1.138 . . . . 0.0 113.098 -171.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 37.7 mtp -63.66 -31.35 72.5 Favored 'General case' 0 C--O 1.197 -1.662 0 O-C-N 121.451 -0.781 . . . . 0.0 111.076 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.624 HD13 ' O ' ' B' ' 116' ' ' ASN . 1.4 mp -78.78 -42.93 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -56.71 -35.48 68.57 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.028 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 19.3 mt -104.18 6.57 35.74 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.936 -0.478 . . . . 0.0 111.151 -176.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.74 23.16 78.08 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 115.891 1.117 . . . . 0.0 115.891 173.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' B' ' 122' ' ' LEU . 7.1 mp -79.55 -51.86 8.76 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 118.954 1.377 . . . . 0.0 108.361 177.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 C--N 1.306 -1.312 0 CA-C-N 113.118 -1.855 . . . . 0.0 112.748 -173.315 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.246 0.885 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -146.89 161.41 40.78 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.9 ptm85 -84.05 122.03 28.23 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.823 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 130.76 -19.44 4.99 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.039 -175.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -92.42 147.31 23.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.957 0.884 . . . . 0.0 110.261 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.623 ' HB ' ' H ' ' A' ' 104' ' ' THR . 51.6 t -98.62 118.15 44.72 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.271 173.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.432 ' O ' HG22 ' A' ' 38' ' ' VAL . 19.9 m-85 -108.46 145.73 34.22 Favored 'General case' 0 CA--C 1.458 -2.562 0 C-N-CA 124.673 1.189 . . . . 0.0 112.24 176.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -80.7 145.58 31.51 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 166.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -143.92 133.12 23.05 Favored 'General case' 0 C--N 1.259 -3.343 0 CA-C-N 113.743 -1.572 . . . . 0.0 108.383 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HA ' ' HB ' ' A' ' 35' ' ' VAL . 6.8 p-10 -88.57 85.35 6.81 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-O 121.593 0.711 . . . . 0.0 109.925 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.537 HD22 ' O ' ' A' ' 24' ' ' LEU 0.459 0.0 OUTLIER -107.2 60.82 0.62 Allowed 'General case' 0 N--CA 1.393 -3.295 0 C-N-CA 116.887 -1.925 . . . . 0.0 113.121 178.557 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.581 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 25.2 p -113.59 62.48 0.95 Allowed Pre-proline 0 C--N 1.271 -2.829 0 CA-C-N 113.491 -1.686 . . . . 0.0 113.62 173.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.457 ' HD3' ' C ' ' A' ' 24' ' ' LEU . 24.4 Cg_endo -115.41 26.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.26 0 N-CA-C 107.883 -1.622 . . . . 0.0 107.883 159.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 17.4 m -94.32 159.61 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.457 -173.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.58 151.72 36.73 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.548 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.34 -132.2 11.52 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.302 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -93.85 11.94 27.61 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.652 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 42.6 mt-10 -68.09 151.51 46.92 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 170.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -131.58 114.96 15.48 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.495 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -147.72 -120.21 1.15 Allowed Glycine 0 N--CA 1.406 -3.347 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.964 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.581 ' HA2' ' HB3' ' A' ' 25' ' ' SER . . . 98.54 172.79 32.17 Favored Glycine 0 N--CA 1.408 -3.175 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 -171.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 1.1 p -88.94 104.09 14.56 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.075 0 CA-C-O 123.033 1.396 . . . . 0.0 108.303 173.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -133.13 163.35 51.74 Favored Pre-proline 0 C--N 1.271 -2.829 0 CA-C-N 112.536 -2.12 . . . . 0.0 110.894 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.542 ' HB2' HD12 ' A' ' 58' ' ' ILE . 14.5 Cg_exo -70.87 141.3 40.38 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.746 1.631 . . . . 0.0 109.749 166.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 20' ' ' TYR . 32.3 m -127.12 162.52 31.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 124.511 1.125 . . . . 0.0 108.182 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 34.8 m -104.1 128.89 57.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.671 176.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.423 HD13 HG12 ' A' ' 55' ' ' VAL . 33.0 mm -88.61 104.96 15.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -99.96 -16.34 7.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.873 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.594 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -43.75 139.28 2.32 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 127.168 2.187 . . . . 0.0 114.667 -170.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -46.81 145.64 1.9 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.22 -32.81 74.11 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -79.11 -25.76 42.95 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.408 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.77 -33.46 80.32 Favored Glycine 0 C--O 1.199 -2.058 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.553 ' N ' HE22 ' A' ' 42' ' ' GLN 0.257 20.1 p30 -75.45 -19.68 59.3 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.366 -178.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -85.46 -59.3 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.235 172.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.52 -19.06 18.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -167.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 m -102.22 135.91 19.53 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.524 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.69 -12.55 16.59 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.066 1.844 . . . . 0.0 110.783 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 3.0 p -100.21 134.14 43.57 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.485 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 93' ' ' THR . 61.4 t -121.37 140.19 46.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.594 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 3.3 tp -105.72 125.1 61.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 123.543 0.737 . . . . 0.0 109.28 173.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.736 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 14.0 m -130.64 162.28 38.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.335 -175.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.553 ' HA ' HG22 ' A' ' 91' ' ' ILE . . . -118.99 132.37 56.06 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.056 0.942 . . . . 0.0 108.93 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.74 128.89 38.01 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.542 HD12 ' HB2' ' A' ' 37' ' ' PRO . 61.1 mt -85.63 132.67 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.795 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.3 m -125.92 133.92 51.72 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.192 0.52 . . . . 0.0 111.44 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 177.047 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.9 tt . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.71 2.12 2.24 Favored 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 123.103 2.536 . . . . 0.0 116.018 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 121' ' ' SER . 51.9 p -92.0 -19.15 22.69 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 122.497 1.141 . . . . 0.0 108.715 176.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -101.15 133.35 45.82 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 171.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 4.4 p -133.44 145.51 33.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 117.046 -1.862 . . . . 0.0 112.434 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -87.66 124.54 33.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.636 1.174 . . . . 0.0 112.88 -173.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.555 HG21 ' CZ ' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -128.54 143.97 39.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.814 0.816 . . . . 0.0 112.852 175.152 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.432 ' OE2' ' HE3' ' A' ' 110' ' ' LYS . 1.3 mp0 -60.74 133.1 55.77 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.727 -178.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 83.8 tttt -55.11 -46.44 75.58 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.751 1.62 . . . . 0.0 109.889 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -58.5 -48.72 79.9 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 113.129 -1.85 . . . . 0.0 113.305 -174.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.535 ' HE2' ' OG ' ' A' ' 107' ' ' SER . 3.8 tmtm? -80.29 -38.27 31.11 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -171.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.555 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 4.5 m-85 -84.3 -7.03 59.45 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.601 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 67.93 28.12 6.99 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.43 179.4 5.54 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.533 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HE3' ' A' ' 75' ' ' LYS . 9.9 t70 -68.82 -28.09 66.43 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.605 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.449 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -150.25 166.8 28.82 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -176.484 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -60.31 146.48 43.85 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.0 t -120.55 160.03 24.01 Favored 'General case' 0 N--CA 1.414 -2.247 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.558 -168.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 26.5 t -127.91 127.1 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 174.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.481 HG22 HD22 ' A' ' 88' ' ' LEU . 1.5 mp -100.96 131.62 48.27 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.6 mt -99.13 109.28 22.0 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 113.771 -1.559 . . . . 0.0 107.825 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.481 HD22 HG22 ' A' ' 86' ' ' ILE . 3.1 mm? -88.04 0.08 56.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.591 0.71 . . . . 0.0 111.313 -174.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -98.69 -24.71 14.95 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-O 122.263 1.03 . . . . 0.0 109.654 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.504 ' HA ' HG21 ' B' ' 93' ' ' THR . 0.0 OUTLIER -103.55 85.51 2.47 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.033 177.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.736 ' HB ' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -139.99 171.25 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.202 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -176.337 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.451 ' HD3' HD23 ' A' ' 24' ' ' LEU . 11.9 ptm180 -168.6 169.63 10.12 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.499 HG21 ' HA ' ' B' ' 90' ' ' GLN . 58.4 m -103.93 125.7 50.51 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.518 -1.674 . . . . 0.0 109.329 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.8 mt -132.59 140.77 48.39 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 126.065 1.746 . . . . 0.0 107.419 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.8 OUTLIER -80.09 153.43 28.74 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.007 175.77 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -37.96 -38.18 0.3 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.67 1.588 . . . . 0.0 114.759 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -54.94 -27.55 44.37 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 124.881 1.272 . . . . 0.0 112.281 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -84.18 -27.56 27.96 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.729 -0.607 . . . . 0.0 110.2 -176.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.0 mp -74.04 127.03 31.84 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 123.772 0.829 . . . . 0.0 109.479 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 23' ' ' ASP . 68.3 mttm -94.95 -66.65 0.9 Allowed 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.577 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.11 147.9 21.55 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-O 121.422 0.63 . . . . 0.0 111.247 -170.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 124.48 23.74 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.34 -1.754 . . . . 0.0 109.999 173.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.646 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 9.0 tp -112.64 -56.74 2.37 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.128 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.646 ' OG1' ' HG ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -124.59 -169.12 1.92 Allowed 'General case' 0 N--CA 1.394 -3.231 0 C-N-CA 118.833 -1.147 . . . . 0.0 113.986 -176.106 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 17' ' ' GLY . 8.4 p90 -161.28 142.01 11.17 Favored 'General case' 0 CA--C 1.487 -1.463 0 C-N-CA 125.58 1.552 . . . . 0.0 109.641 -170.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.72 152.15 34.92 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.535 ' OG ' ' HE2' ' A' ' 77' ' ' LYS . 15.8 m -77.02 171.28 15.05 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.834 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 111' ' ' MET . 9.4 m-20 -64.19 -36.94 85.7 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.272 0.558 . . . . 0.0 110.679 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 15.3 t70 -64.65 -39.31 93.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.947 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 110' ' ' LYS . 3.1 mptp? -75.84 -26.87 57.57 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.337 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.528 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -55.49 -39.94 71.07 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.851 1.26 . . . . 0.0 108.137 169.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 9.1 mmpt? -87.18 -1.66 58.06 Favored 'General case' 0 N--CA 1.394 -3.272 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.721 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 109' ' ' ASP . 32.7 mt-10 -90.89 -55.09 3.69 Favored 'General case' 0 N--CA 1.397 -3.113 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.63 -59.76 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-N 111.831 -2.44 . . . . 0.0 112.717 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 63.4 m-20 -62.71 -39.29 93.58 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 123.134 1.445 . . . . 0.0 111.023 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 17.7 t30 -74.01 -45.87 47.1 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 113.425 -1.716 . . . . 0.0 112.917 -172.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.68 73.35 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 12.5 tp -69.43 -40.28 77.33 Favored 'General case' 0 N--CA 1.389 -3.484 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.367 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.542 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 2.5 ttp -65.2 -27.98 69.06 Favored 'General case' 0 N--CA 1.408 -2.556 0 C-N-CA 123.775 0.83 . . . . 0.0 109.817 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.3 mt -80.29 -52.9 13.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 176.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.441 ' HA ' HG22 ' A' ' 69' ' ' THR . 38.1 t -50.39 -33.79 21.95 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.185 -1.825 . . . . 0.0 113.831 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 31.9 mt -97.5 9.35 42.63 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.006 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.51 10.73 81.35 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 115.741 1.056 . . . . 0.0 115.741 173.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.542 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.5 mm? -67.8 -54.34 19.91 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.037 -177.901 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -146.82 161.56 40.42 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -83.55 124.06 30.38 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.26 175.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 127.14 -15.63 6.45 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.806 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -96.73 149.52 21.73 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.678 0.751 . . . . 0.0 109.694 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.599 ' HB ' ' H ' ' B' ' 104' ' ' THR . 51.0 t -100.68 121.74 51.84 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.253 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.435 ' O ' HG22 ' B' ' 38' ' ' VAL . 20.6 m-85 -111.83 146.25 38.0 Favored 'General case' 0 CA--C 1.456 -2.646 0 C-N-CA 124.193 0.997 . . . . 0.0 111.967 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.09 145.29 31.17 Favored 'General case' 0 C--N 1.267 -2.992 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 167.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -144.0 131.77 21.35 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 113.747 -1.57 . . . . 0.0 108.009 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.447 ' HA ' ' HB ' ' B' ' 35' ' ' VAL . 6.1 p-10 -87.72 89.76 8.12 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.79 174.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.551 ' O ' HD22 ' B' ' 24' ' ' LEU 0.452 0.0 OUTLIER -108.85 59.84 0.6 Allowed 'General case' 0 N--CA 1.393 -3.295 0 CA-C-O 124.196 1.951 . . . . 0.0 112.426 177.533 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.588 ' HB3' ' HA2' ' B' ' 34' ' ' GLY . 10.9 p -111.62 62.62 0.53 Allowed Pre-proline 0 C--N 1.267 -2.992 0 CA-C-N 113.141 -1.845 . . . . 0.0 113.433 174.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.502 ' HD3' ' C ' ' B' ' 24' ' ' LEU . 22.3 Cg_endo -116.89 26.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.082 0 N-CA-C 107.692 -1.695 . . . . 0.0 107.692 158.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 18.6 m -95.01 156.39 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.87 151.74 37.56 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.535 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.04 -132.05 11.03 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -94.02 10.94 31.55 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.641 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 43.4 mt-10 -66.93 151.6 47.28 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -132.89 116.57 16.64 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -173.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLY . . . . . 0.514 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -149.27 -116.21 0.81 Allowed Glycine 0 N--CA 1.404 -3.494 0 C-N-CA 119.88 -1.152 . . . . 0.0 114.013 175.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.588 ' HA2' ' HB3' ' B' ' 25' ' ' SER . . . 96.63 177.83 35.36 Favored Glycine 0 N--CA 1.413 -2.886 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -171.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' B' ' 23' ' ' ASP . 1.0 OUTLIER -93.74 102.87 14.08 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-O 123.167 1.46 . . . . 0.0 107.95 172.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -132.13 163.52 49.66 Favored Pre-proline 0 C--N 1.268 -2.966 0 CA-C-N 111.978 -2.374 . . . . 0.0 110.765 -172.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.512 ' HB2' HD12 ' B' ' 58' ' ' ILE . 14.0 Cg_exo -71.21 140.92 38.3 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 121.671 1.581 . . . . 0.0 109.865 165.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.435 HG22 ' O ' ' B' ' 20' ' ' TYR . 28.3 m -126.89 162.63 31.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 124.667 1.187 . . . . 0.0 108.157 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.6 m -104.72 129.66 56.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.671 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 32.1 mm -89.22 105.16 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.41 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.1 OUTLIER -100.07 -17.37 6.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.01 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.596 HE22 ' N ' ' B' ' 47' ' ' ASN . 0.6 OUTLIER -43.13 140.51 1.47 Allowed 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 127.03 2.132 . . . . 0.0 114.686 -170.749 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -47.89 149.55 1.31 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.331 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.576 ' HA ' ' ND2' ' B' ' 47' ' ' ASN . 30.0 t70 -71.83 -32.07 67.18 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.743 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 3.8 m -76.98 -25.07 52.31 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.127 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.62 -35.83 90.47 Favored Glycine 0 C--O 1.199 -2.048 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.596 ' N ' HE22 ' B' ' 42' ' ' GLN . 13.0 p30 -74.35 -19.09 60.57 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.339 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' B' ' 44' ' ' ASP . 14.0 mptt -85.64 -61.59 1.72 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.203 174.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -96.58 -16.68 20.92 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 -168.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -98.62 140.75 22.01 Favored Pre-proline 0 C--N 1.302 -1.473 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.306 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.43 -11.77 11.68 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.932 1.754 . . . . 0.0 110.26 173.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.4 p -101.35 137.69 39.36 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 124.879 1.271 . . . . 0.0 111.455 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' B' ' 93' ' ' THR . 60.2 t -124.22 140.21 48.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.564 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 3.2 tp -105.69 124.74 60.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 123.455 0.702 . . . . 0.0 109.402 173.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.721 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 13.6 m -130.64 162.54 38.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.328 -175.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' B' ' 91' ' ' ILE . . . -118.89 132.79 56.11 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 124.27 1.028 . . . . 0.0 108.759 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.1 129.54 39.71 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' B' ' 37' ' ' PRO . 60.5 mt -86.64 133.18 30.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.202 174.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 75.1 m -127.11 133.01 50.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.24 0.543 . . . . 0.0 112.223 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 176.546 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.1 tt . . . . . 0 C--O 1.215 -0.722 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.82 -4.32 4.58 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 123.821 3.014 . . . . 0.0 116.153 -174.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 74.8 p -87.21 -18.99 29.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.407 1.098 . . . . 0.0 108.848 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -99.83 134.8 42.2 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 170.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 5.1 p -134.24 144.98 33.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 116.979 -1.888 . . . . 0.0 112.364 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -88.62 127.88 35.57 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.25 1.02 . . . . 0.0 112.149 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.575 HG21 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -128.33 149.12 32.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 O-C-N 123.708 0.63 . . . . 0.0 112.063 175.168 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -64.19 131.89 48.74 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.329 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -54.62 -46.69 73.92 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 125.732 1.613 . . . . 0.0 109.813 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -56.29 -50.21 72.04 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.851 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -78.78 -39.06 36.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.63 -170.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.575 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 4.4 m-85 -84.14 -6.99 59.49 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.977 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 68.6 29.28 5.52 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.19 178.88 5.38 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.382 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -70.59 -25.0 62.86 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.422 -1.717 . . . . 0.0 111.156 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.411 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -151.68 163.52 38.94 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -176.669 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.37 143.92 43.42 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 22.1 t -121.3 156.83 31.69 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 119.639 -0.825 . . . . 0.0 112.257 -167.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 25.9 t -123.7 126.97 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.46 HG22 HD22 ' B' ' 88' ' ' LEU . 1.5 mp -100.24 131.33 47.93 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.158 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 31.8 mt -98.99 108.15 20.76 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.03 -177.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.46 HD22 HG22 ' B' ' 86' ' ' ILE . 3.3 mm? -86.97 -0.26 56.3 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.723 0.773 . . . . 0.0 111.52 -174.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -100.15 -22.65 15.1 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 122.372 1.082 . . . . 0.0 109.928 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 90' ' ' GLN . . . . . 0.499 ' HA ' HG21 ' A' ' 93' ' ' THR . 0.0 OUTLIER -104.62 85.66 2.36 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.992 177.448 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.721 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 0.3 OUTLIER -140.1 171.41 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.494 ' HD3' HD23 ' B' ' 24' ' ' LEU . 11.7 ptm180 -168.98 169.34 9.67 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 90' ' ' GLN . 72.0 m -104.43 126.31 51.41 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.549 -177.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -132.55 142.88 49.37 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 126.069 1.748 . . . . 0.0 107.432 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 1.7 p-10 -81.18 152.06 27.9 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.019 -1.473 . . . . 0.0 108.96 175.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -35.48 -40.01 0.15 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.891 1.676 . . . . 0.0 115.148 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -51.34 -31.79 23.26 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 125.027 1.331 . . . . 0.0 112.632 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -79.93 -27.51 39.84 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.963 0.411 . . . . 0.0 110.193 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -75.01 124.56 27.19 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 122.01 0.91 . . . . 0.0 109.563 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -95.49 -60.08 1.74 Allowed 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.902 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -161.02 148.43 15.4 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-O 121.504 0.669 . . . . 0.0 111.737 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.63 121.06 18.12 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.85 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.628 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 8.4 tp -109.37 -55.39 2.43 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.628 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 0.3 OUTLIER -124.13 -168.57 1.82 Allowed 'General case' 0 N--CA 1.391 -3.424 0 C-N-CA 118.421 -1.312 . . . . 0.0 114.497 -176.724 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 105' ' ' TYR . . . . . 0.493 ' H ' HG22 ' B' ' 104' ' ' THR . 19.9 p90 -161.48 141.69 10.68 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 125.808 1.643 . . . . 0.0 109.383 -171.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.9 150.73 36.6 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.44 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t -78.25 170.18 17.05 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.473 -175.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.508 ' O ' ' HB3' ' B' ' 111' ' ' MET . 4.6 m-20 -60.8 -38.48 85.49 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.683 0.793 . . . . 0.0 111.121 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 27.1 t70 -64.58 -38.27 90.44 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.148 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.495 ' HD2' ' N ' ' B' ' 110' ' ' LYS . 2.6 mptp? -75.55 -27.71 58.74 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.247 -178.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.508 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.2 OUTLIER -54.87 -40.25 69.52 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 124.912 1.285 . . . . 0.0 108.058 170.041 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.535 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 7.7 mmpt? -86.6 -2.43 58.49 Favored 'General case' 0 N--CA 1.384 -3.769 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.314 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 113' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' B' ' 109' ' ' ASP . 38.3 mt-10 -90.69 -55.51 3.54 Favored 'General case' 0 C--N 1.261 -3.271 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 172.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.18 -59.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 CA-C-N 111.594 -2.548 . . . . 0.0 112.786 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 56.7 m-20 -62.65 -40.24 96.42 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.14 1.448 . . . . 0.0 111.227 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.332 43.1 t30 -75.1 -42.96 55.52 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 113.531 -1.668 . . . . 0.0 112.602 -170.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -64.18 -31.76 73.08 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 11.2 tp -70.72 -35.09 72.56 Favored 'General case' 0 N--CA 1.39 -3.445 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.047 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.554 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 2.3 ttp -69.05 -21.49 64.09 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-O 121.686 0.755 . . . . 0.0 109.303 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' B' ' 117' ' ' ALA . 51.6 mt -87.89 -53.5 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' B' ' 118' ' ' LEU . 79.1 p -53.94 -28.48 37.33 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 26.2 mt -97.06 5.28 50.64 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.187 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.15 13.01 78.14 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 115.954 1.142 . . . . 0.0 115.954 172.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.554 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.5 mm? -68.32 -52.95 27.84 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 23.7 m120 . . . . . 0 C--O 1.241 0.65 0 CA-C-N 112.979 -1.919 . . . . 0.0 109.474 -179.375 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -146.54 156.91 43.59 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -70.36 124.91 25.32 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 169.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.14 -26.21 3.78 Favored Glycine 0 C--N 1.302 -1.359 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.093 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -97.41 167.43 11.0 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.776 0.798 . . . . 0.0 109.427 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.472 HG11 HG22 ' A' ' 104' ' ' THR . 24.7 t -122.42 139.39 49.48 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.56 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.516 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.2 m-85 -133.5 148.66 51.7 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.4 151.62 39.65 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 168.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -141.58 135.48 30.1 Favored 'General case' 0 CA--C 1.454 -2.736 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.217 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.39 93.59 9.58 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 166.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.471 HD13 ' HD3' ' A' ' 92' ' ' ARG . 1.1 pp -109.83 28.9 8.12 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.282 -1.327 . . . . 0.0 107.814 -174.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.29 62.25 0.0 OUTLIER Pre-proline 0 C--N 1.267 -3.002 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -112.87 25.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.938 0 N-CA-C 107.232 -1.872 . . . . 0.0 107.232 153.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.695 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 13.9 m -83.56 160.45 3.49 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -173.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.52 145.84 31.21 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 113.311 -1.768 . . . . 0.0 113.249 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.32 -114.21 6.65 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.602 -1.181 . . . . 0.0 114.637 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -78.34 -9.1 59.12 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 123.827 0.851 . . . . 0.0 112.963 -173.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.695 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 50.7 mt-10 -71.3 159.89 33.78 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -132.29 111.41 11.35 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -174.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.0 -162.54 15.11 Favored Glycine 0 N--CA 1.408 -3.23 0 C-N-CA 119.155 -1.497 . . . . 0.0 115.02 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.6 -156.81 26.45 Favored Glycine 0 N--CA 1.407 -3.283 0 N-CA-C 103.419 -3.872 . . . . 0.0 103.419 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 59.3 t -83.03 99.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.438 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 169.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -130.8 146.51 62.33 Favored Pre-proline 0 C--N 1.252 -3.652 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.277 -172.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HB2' HD12 ' A' ' 58' ' ' ILE . 25.4 Cg_exo -62.98 137.12 60.49 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 121.702 1.601 . . . . 0.0 109.929 171.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 31.1 m -127.6 154.87 38.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 29.8 m -97.77 129.92 47.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.125 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.415 HD13 HG12 ' A' ' 55' ' ' VAL . 25.9 mm -91.36 107.19 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -13.82 9.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.285 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.533 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 5.0 pt20 -52.11 165.24 0.23 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 -169.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -65.51 174.43 2.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.613 -2.085 . . . . 0.0 112.118 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 9.9 t70 -72.56 -48.24 41.65 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.268 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.5 m -70.38 -30.98 68.03 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.477 0.711 . . . . 0.0 112.253 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 50' ' ' SER . . . -62.32 -33.41 86.05 Favored Glycine 0 C--O 1.205 -1.67 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.691 -175.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.52 ' N ' HE22 ' A' ' 42' ' ' GLN . 10.1 p30 -84.65 -37.13 21.4 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.841 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.645 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 24.4 mmtp -67.6 -63.19 1.11 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.386 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.645 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 19.0 m-85 -102.09 -35.86 8.77 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -168.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.477 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 22.5 m -82.47 157.92 66.88 Favored Pre-proline 0 N--CA 1.422 -1.832 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.677 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 86.4 Cg_endo -86.95 -20.85 2.23 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 121.099 1.199 . . . . 0.0 111.797 174.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.483 HG21 ' HG2' ' B' ' 90' ' ' GLN . 11.3 p -99.6 135.3 41.23 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.533 ' HB ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -133.42 139.2 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.906 176.074 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.5 tt -81.74 126.85 39.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.964 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 34.5 m -132.97 154.98 40.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.582 174.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.586 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -115.91 133.09 56.39 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.3 136.02 56.76 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.521 HG12 HD12 ' A' ' 86' ' ' ILE . 49.2 mt -98.07 131.47 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.736 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 m -105.54 108.34 19.81 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.479 -178.839 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tt . . . . . 0 C--O 1.206 -1.234 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.12 -4.7 12.05 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 122.427 2.084 . . . . 0.0 115.246 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.3 p -100.09 -17.92 17.22 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.377 0.608 . . . . 0.0 111.363 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -118.55 128.45 54.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.411 HG12 HD13 ' A' ' 73' ' ' ILE . 61.0 t -111.27 134.26 54.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.208 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -99.69 124.79 45.28 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 123.744 0.653 . . . . 0.0 109.363 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.521 HD11 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -116.35 153.27 18.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.209 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -54.08 129.56 34.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.058 -1.428 . . . . 0.0 112.815 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.644 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 93.1 mttt -51.98 -56.79 12.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.457 178.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -67.98 -45.84 73.03 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.193 -169.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -62.84 -33.05 74.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.016 0.436 . . . . 0.0 111.394 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.492 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 12.1 m-85 -92.9 2.31 56.85 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 123.924 0.89 . . . . 0.0 111.14 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.3 tptt 72.22 15.95 5.28 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.507 1.523 . . . . 0.0 113.562 171.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.53 175.42 6.56 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-O 122.492 1.139 . . . . 0.0 110.983 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.495 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 10.3 t70 -85.08 -27.08 26.54 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 112.944 -1.934 . . . . 0.0 110.1 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.499 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -139.31 157.09 46.5 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.42 -174.19 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.644 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 6.5 m-20 -45.89 135.44 7.15 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 124.92 1.388 . . . . 0.0 112.055 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 73' ' ' ILE . 15.4 m -103.73 121.8 43.76 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.667 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.8 t -107.74 136.51 42.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.521 HG12 HD11 ' A' ' 73' ' ' ILE . 15.9 mm -111.68 134.41 54.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.1 mt -104.91 97.42 7.29 Favored 'General case' 0 N--CA 1.416 -2.164 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.0 mm? -81.25 -9.42 59.77 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.497 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -95.41 -25.93 16.07 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.762 0.791 . . . . 0.0 111.292 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' B' ' 93' ' ' THR . 1.1 tm0? -80.28 -60.88 2.16 Favored 'General case' 0 C--O 1.164 -3.433 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.246 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.586 HG22 ' CB ' ' A' ' 56' ' ' ALA . 1.3 pp 30.05 -174.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.529 3.475 0 C-N-CA 129.646 3.178 . . . . 0.0 116.814 175.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.471 ' HD3' HD13 ' A' ' 24' ' ' LEU . 8.7 ptm85 -176.96 159.6 1.72 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 167.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' B' ' 90' ' ' GLN . 0.0 OUTLIER -114.54 108.36 16.74 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.743 1.217 . . . . 0.0 109.356 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.535 ' HB2' ' CZ ' ' A' ' 98' ' ' ARG . 64.9 mt -131.82 149.58 52.42 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -173.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.677 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 11.8 t70 -50.72 145.17 7.22 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 173.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 33.1 pttt -55.58 -29.74 59.6 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.589 1.556 . . . . 0.0 114.608 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 20.1 ttmm -47.56 -39.08 15.63 Favored 'General case' 0 C--N 1.274 -2.677 0 C-N-CA 126.243 1.817 . . . . 0.0 112.476 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.535 ' CZ ' ' HB2' ' A' ' 94' ' ' LEU . 1.7 ppt_? -73.39 -15.01 61.37 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 10.4 mp -61.75 120.6 10.98 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.912 0.885 . . . . 0.0 110.028 170.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.08 -64.27 1.08 Allowed 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.367 -177.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.4 pt-20 -156.67 145.32 19.95 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 121.786 0.803 . . . . 0.0 111.807 -172.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -60.81 120.82 10.86 Favored 'General case' 0 C--N 1.281 -2.379 0 C-N-CA 128.132 2.573 . . . . 0.0 108.814 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -114.66 -62.67 1.57 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.704 -0.798 . . . . 0.0 112.466 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.472 HG22 HG11 ' A' ' 19' ' ' VAL . 5.4 t -128.8 -160.98 1.07 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.243 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -159.39 149.25 18.77 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.052 0.941 . . . . 0.0 112.326 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.56 135.39 49.1 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 113.853 -1.522 . . . . 0.0 112.264 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 111' ' ' MET . 7.0 m -76.4 165.95 24.11 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 124.248 1.019 . . . . 0.0 110.597 176.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 111' ' ' MET . 23.3 t70 -67.71 -42.98 81.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.86 -28.86 69.28 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.737 0.78 . . . . 0.0 109.382 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 110' ' ' LYS . 71.5 mmtt -79.78 -28.78 40.3 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.684 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.8 OUTLIER -53.65 -44.55 69.69 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.153 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 10.0 mmpt? -75.13 -8.32 56.24 Favored 'General case' 0 N--CA 1.396 -3.161 0 CA-C-N 114.421 -1.263 . . . . 0.0 114.173 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -89.26 -51.56 5.51 Favored 'General case' 0 N--CA 1.397 -3.079 0 C-N-CA 116.735 -1.986 . . . . 0.0 106.264 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -53.72 -59.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 112.615 -2.084 . . . . 0.0 113.351 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 45.8 m-20 -59.73 -39.19 83.87 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 123.241 1.496 . . . . 0.0 110.989 -177.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 10.9 t30 -77.97 -40.46 39.25 Favored 'General case' 0 C--N 1.261 -3.275 0 CA-C-N 112.718 -2.037 . . . . 0.0 111.669 -173.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.525 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.69 -36.58 81.29 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.505 ' HA ' ' OG ' ' A' ' 121' ' ' SER . 5.2 tp -70.14 -37.02 75.18 Favored 'General case' 0 N--CA 1.394 -3.24 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.2 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.504 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 1.5 ttp -66.87 -22.99 65.96 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.872 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 117' ' ' ALA . 45.0 mt -88.07 -50.95 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 118' ' ' LEU . 83.5 p -59.33 -22.26 61.02 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.644 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 32.9 mt -103.73 1.28 31.58 Favored 'General case' 0 C--O 1.201 -1.486 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.501 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.35 16.86 54.71 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 117.137 1.615 . . . . 0.0 117.137 171.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.504 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.2 mm? -74.0 -52.34 13.08 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 112.47 -2.15 . . . . 0.0 112.546 -179.751 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 N--CA 1.428 -1.558 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -145.8 156.89 43.88 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -70.24 128.92 37.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.92 -26.33 4.02 Favored Glycine 0 C--N 1.307 -1.051 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.551 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -97.42 169.69 9.57 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 121.762 0.791 . . . . 0.0 109.183 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.468 ' HB ' ' H ' ' B' ' 104' ' ' THR . 23.4 t -123.84 140.16 48.15 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.885 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.728 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 35.3 m-85 -132.9 148.96 52.29 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 124.162 0.985 . . . . 0.0 109.087 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.02 149.57 39.2 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 167.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -140.35 134.49 30.97 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.71 -175.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -86.5 93.58 9.2 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 166.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.462 HD13 ' HD3' ' B' ' 92' ' ' ARG . 1.1 pp -108.8 28.7 8.16 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.842 1.306 . . . . 0.0 108.011 -175.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.416 ' OG ' ' HA2' ' B' ' 34' ' ' GLY . 1.0 OUTLIER -90.27 62.72 0.0 OUTLIER Pre-proline 0 C--N 1.266 -3.058 0 N-CA-C 116.712 2.115 . . . . 0.0 116.712 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -113.67 25.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.981 0 N-CA-C 107.42 -1.8 . . . . 0.0 107.42 151.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.692 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 15.1 m -82.29 162.26 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -173.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.39 147.86 31.72 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.802 -1.544 . . . . 0.0 113.033 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.34 -114.53 6.79 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 114.622 -1.172 . . . . 0.0 114.323 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -75.56 -11.76 60.08 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 123.855 0.862 . . . . 0.0 113.168 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.692 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 50.3 mt-10 -71.03 158.4 36.57 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -131.91 112.6 12.58 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.4 -161.63 13.84 Favored Glycine 0 N--CA 1.408 -3.192 0 C-N-CA 119.379 -1.391 . . . . 0.0 114.971 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.416 ' HA2' ' OG ' ' B' ' 25' ' ' SER . . . 141.6 -158.53 26.6 Favored Glycine 0 C--N 1.267 -3.279 0 N-CA-C 103.403 -3.879 . . . . 0.0 103.403 -173.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 61.8 t -82.37 98.98 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 169.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -130.72 146.78 63.4 Favored Pre-proline 0 C--N 1.253 -3.592 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.096 -172.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.562 ' HB2' HD12 ' B' ' 58' ' ' ILE . 27.2 Cg_exo -63.49 138.03 63.07 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.766 1.644 . . . . 0.0 110.16 171.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 30.2 m -128.44 154.72 39.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.569 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 28.1 m -97.72 129.7 47.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.094 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 25.8 mm -91.31 106.27 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -14.77 9.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.25 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.575 ' OE1' ' HB3' ' B' ' 47' ' ' ASN . 0.1 OUTLIER -53.79 164.71 0.53 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -170.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -64.01 175.03 1.31 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.514 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' B' ' 48' ' ' LYS . 12.8 t70 -74.31 -47.32 35.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.866 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.9 m -70.52 -31.34 68.38 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.637 0.775 . . . . 0.0 112.199 -169.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' B' ' 50' ' ' SER . . . -62.48 -32.4 82.97 Favored Glycine 0 C--O 1.21 -1.401 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.424 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.575 ' HB3' ' OE1' ' B' ' 42' ' ' GLN . 9.7 p30 -84.65 -39.04 19.1 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.475 -0.89 . . . . 0.0 112.096 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.656 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 25.9 mmtp -65.74 -63.25 1.13 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.096 0.474 . . . . 0.0 111.726 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' TYR . . . . . 0.656 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 19.1 m-85 -102.14 -36.3 8.59 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -168.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.487 ' HB2' ' HA2' ' B' ' 46' ' ' GLY . 25.8 m -80.85 157.98 71.03 Favored Pre-proline 0 N--CA 1.418 -2.032 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.671 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 83.8 Cg_endo -87.39 -21.37 1.92 Allowed 'Trans proline' 0 N--CA 1.431 -2.162 0 C-N-CA 121.202 1.268 . . . . 0.0 111.662 173.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.457 HG21 ' HG2' ' A' ' 90' ' ' GLN . 9.5 p -99.41 135.12 41.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -170.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.98 138.79 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.316 175.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tt -82.3 127.39 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 124.979 1.311 . . . . 0.0 110.732 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 34.7 m -132.77 154.99 40.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.395 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.592 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -115.43 132.82 56.5 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.98 136.5 57.38 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.562 HD12 ' HB2' ' B' ' 37' ' ' PRO . 63.5 mt -97.34 132.26 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.702 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' B' ' 85' ' ' VAL . 26.3 m -106.13 106.11 16.46 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 174.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.519 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.001 -178.76 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 8.6 tt . . . . . 0 C--O 1.213 -0.847 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.84 -3.39 4.55 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 122.962 2.441 . . . . 0.0 115.301 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 66.6 p -103.37 -15.64 15.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.309 0.576 . . . . 0.0 111.19 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -119.07 129.01 54.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 52.8 t -111.38 132.99 58.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.16 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -99.58 119.8 38.64 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.355 0.662 . . . . 0.0 109.557 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.526 HD11 HG12 ' B' ' 86' ' ' ILE . 0.0 OUTLIER -111.11 153.54 12.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.624 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.545 ' OE1' ' HE3' ' B' ' 110' ' ' LYS . 1.6 mp0 -53.1 128.99 29.54 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.818 1.324 . . . . 0.0 111.956 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 75' ' ' LYS . . . . . 0.634 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 94.0 mttt -52.15 -56.35 15.1 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.209 0.943 . . . . 0.0 111.364 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -68.81 -43.08 76.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.845 -168.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 77' ' ' LYS . . . . . 0.437 ' HB2' ' HE3' ' B' ' 77' ' ' LYS . 38.8 ttmt -64.95 -33.5 76.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.239 0.543 . . . . 0.0 110.878 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.422 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 14.7 m-85 -91.68 2.18 56.65 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.197 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 41.7 tptt 71.83 20.05 4.65 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.072 1.349 . . . . 0.0 113.074 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.71 174.05 6.41 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 122.573 1.178 . . . . 0.0 111.217 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -84.07 -26.09 29.3 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.88 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.443 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -140.97 156.75 46.0 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.385 -172.791 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.634 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 10.9 m-20 -46.64 135.28 8.87 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.902 1.376 . . . . 0.0 112.126 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 84' ' ' SER . . . . . 0.429 ' O ' HG12 ' B' ' 73' ' ' ILE . 14.9 m -103.89 122.6 45.51 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.887 -177.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' B' ' 59' ' ' THR . 8.9 t -107.88 137.16 40.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.539 ' CD1' HG12 ' B' ' 58' ' ' ILE . 16.5 mm -111.67 135.05 52.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 18.8 mt -105.38 98.72 8.38 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.1 mm? -82.03 -9.82 59.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.324 -172.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -95.58 -26.19 15.87 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.316 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 90' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -80.2 -60.7 2.23 Favored 'General case' 0 C--O 1.162 -3.534 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.138 -178.403 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.592 HG22 ' CB ' ' B' ' 56' ' ' ALA . 1.3 pp 30.02 -174.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 C-N-CA 129.605 3.162 . . . . 0.0 116.836 175.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.464 ' HE ' HD21 ' B' ' 94' ' ' LEU . 8.5 ptm85 -176.95 159.72 1.73 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 167.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -114.83 108.63 17.01 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.916 1.286 . . . . 0.0 109.453 179.549 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.53 ' HB2' ' CZ ' ' B' ' 98' ' ' ARG . 65.2 mt -131.77 150.94 51.99 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 11.7 t70 -51.9 146.12 8.84 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.32 0.509 . . . . 0.0 111.446 173.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' B' ' 99' ' ' LEU . 31.5 pttt -54.48 -33.34 59.58 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.095 1.358 . . . . 0.0 114.256 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -41.28 -40.69 1.71 Allowed 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 126.742 2.017 . . . . 0.0 113.693 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.53 ' CZ ' ' HB2' ' B' ' 94' ' ' LEU . 1.7 ppt_? -73.72 -13.95 61.05 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' B' ' 96' ' ' LYS . 10.1 mp -63.39 118.48 8.13 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 123.83 0.852 . . . . 0.0 109.81 170.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.19 -64.07 1.1 Allowed 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.304 -1.317 . . . . 0.0 112.094 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 12.2 pt-20 -156.76 145.86 20.28 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-O 121.815 0.817 . . . . 0.0 111.55 -172.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -60.39 122.57 14.91 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 128.152 2.581 . . . . 0.0 108.891 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 13.0 tp -114.97 -62.33 1.62 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 119.566 -0.853 . . . . 0.0 112.393 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.468 ' H ' ' HB ' ' B' ' 19' ' ' VAL . 5.4 t -129.3 -160.79 1.06 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.317 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -159.31 147.76 17.86 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.262 1.025 . . . . 0.0 112.289 -169.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.79 140.52 36.95 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.0 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 15.1 t -82.91 162.41 21.55 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.074 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' B' ' 111' ' ' MET . 15.8 t70 -63.9 -44.74 92.09 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 122.73 0.412 . . . . 0.0 111.828 -175.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.7 -30.39 71.5 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.575 0.702 . . . . 0.0 110.363 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.545 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 70.0 mmtt -80.29 -27.01 38.62 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.999 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.4 OUTLIER -53.93 -44.36 70.58 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 169.131 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.42 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 9.7 mmpt? -75.7 -8.2 56.23 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 114.215 -1.357 . . . . 0.0 113.792 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -89.92 -50.95 5.73 Favored 'General case' 0 N--CA 1.398 -3.055 0 C-N-CA 117.215 -1.794 . . . . 0.0 106.922 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -54.26 -59.85 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-N 112.586 -2.097 . . . . 0.0 112.96 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 47.1 m-20 -58.57 -42.06 87.1 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 123.07 1.414 . . . . 0.0 111.281 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.313 14.8 t30 -74.74 -40.9 61.0 Favored 'General case' 0 C--N 1.266 -3.044 0 CA-C-N 113.059 -1.882 . . . . 0.0 111.551 -174.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.428 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -63.78 -35.48 80.73 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.516 ' HA ' ' OG ' ' B' ' 121' ' ' SER . 5.2 tp -69.64 -36.94 76.54 Favored 'General case' 0 N--CA 1.394 -3.272 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.789 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.529 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 1.3 ttp -67.18 -22.58 65.74 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.375 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' B' ' 117' ' ' ALA . 60.3 mt -87.23 -53.92 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 121' ' ' SER . . . . . 0.516 ' OG ' ' HA ' ' B' ' 118' ' ' LEU . 78.1 p -55.37 -24.25 28.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.134 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 32.8 mt -101.48 0.66 37.09 Favored 'General case' 0 C--O 1.2 -1.504 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.958 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.33 16.48 55.41 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 116.98 1.552 . . . . 0.0 116.98 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.529 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.2 mm? -73.6 -51.72 15.88 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 22.2 m120 . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 112.488 -2.142 . . . . 0.0 112.252 179.811 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.534 ' HB ' ' OD1' ' A' ' 47' ' ' ASN . 60.9 mt . . . . . 0 N--CA 1.428 -1.556 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -116.38 144.68 43.97 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 172.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 41' ' ' ILE . 4.7 ttp180 -63.81 114.42 4.03 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 174.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.33 -16.52 5.43 Favored Glycine 0 N--CA 1.421 -2.35 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.78 172.02 12.91 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 122.815 1.293 . . . . 0.0 110.516 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.424 HG11 HG22 ' A' ' 104' ' ' THR . 12.6 t -132.68 128.99 58.18 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.425 0 CA-C-N 112.356 -2.202 . . . . 0.0 109.445 175.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 37.3 m-85 -126.38 147.38 49.77 Favored 'General case' 0 C--N 1.277 -2.567 0 C-N-CA 125.1 1.36 . . . . 0.0 108.325 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -82.17 161.48 22.77 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 170.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.17 133.08 13.24 Favored 'General case' 0 C--N 1.28 -2.424 0 O-C-N 123.982 0.801 . . . . 0.0 109.307 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.62 81.75 8.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 123.56 1.648 . . . . 0.0 109.258 173.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.519 ' C ' ' HD3' ' A' ' 26' ' ' PRO . 4.3 pp -89.27 3.66 51.32 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 113.009 -1.905 . . . . 0.0 111.95 -175.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.587 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 2.3 p -89.72 60.24 0.0 OUTLIER Pre-proline 0 C--N 1.272 -2.785 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.519 ' HD3' ' C ' ' A' ' 24' ' ' LEU . 19.1 Cg_endo -118.83 30.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.582 0 N-CA-C 106.889 -2.004 . . . . 0.0 106.889 152.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 24' ' ' LEU . 35.3 m -71.2 176.68 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.491 -173.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.25 138.45 31.41 Favored 'General case' 0 N--CA 1.41 -2.458 0 CA-C-N 114.004 -1.453 . . . . 0.0 113.8 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.04 -133.1 11.75 Favored Glycine 0 N--CA 1.421 -2.346 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.229 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.5 m -93.76 18.5 10.17 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 47.6 mt-10 -70.36 167.92 17.11 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.519 ' HB3' HE21 ' A' ' 90' ' ' GLN . 1.1 tm0? -101.21 119.08 38.22 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -174.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.27 151.93 17.55 Favored Glycine 0 CA--C 1.483 -1.914 0 N-CA-C 115.82 1.088 . . . . 0.0 115.82 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.587 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . 137.18 137.28 3.6 Favored Glycine 0 C--N 1.293 -1.821 0 CA-C-N 113.313 -1.444 . . . . 0.0 111.367 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 35' ' ' VAL . 2.7 p -72.09 105.83 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 123.17 1.462 . . . . 0.0 107.752 173.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -136.08 161.18 63.98 Favored Pre-proline 0 C--N 1.253 -3.617 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.792 -172.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 18.6 Cg_exo -67.68 142.87 59.85 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.025 1.817 . . . . 0.0 110.201 170.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 20' ' ' TYR . 27.8 m -123.18 158.56 28.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 123.608 0.763 . . . . 0.0 109.325 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 33.8 m -102.03 132.4 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.704 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mm -85.16 105.94 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.546 ' O ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -103.59 -12.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.946 -178.359 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.786 ' NE2' ' HB ' ' A' ' 53' ' ' VAL . 3.6 mt-30 -42.0 157.56 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 120.706 3.595 . . . . 0.0 120.706 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -69.3 145.79 52.76 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 110.815 -2.902 . . . . 0.0 108.024 164.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 47' ' ' ASN . 20.5 t70 -62.64 -30.88 71.69 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.84 -177.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.0 m -86.87 -27.1 23.64 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.969 -1.092 . . . . 0.0 111.793 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.59 -25.79 73.84 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 174.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.534 ' OD1' ' HB ' ' A' ' 14' ' ' ILE . 35.0 t30 -71.18 -39.39 71.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.991 -1.105 . . . . 0.0 109.77 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -74.26 -60.97 2.02 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . 0.46 16.6 p90 -128.36 2.03 5.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 119.352 3.093 . . . . 0.0 119.352 -173.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.5 m -86.86 134.21 37.72 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 172.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 34.0 Cg_exo -63.53 -29.54 70.81 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 121.606 1.538 . . . . 0.0 109.828 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.427 HG21 ' HG2' ' B' ' 90' ' ' GLN . 2.5 p -95.03 139.82 30.85 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.688 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.786 ' HB ' ' NE2' ' A' ' 42' ' ' GLN . 1.1 m -131.53 157.77 43.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.462 HG21 HD22 ' B' ' 122' ' ' LEU . 8.7 tt -109.56 131.12 61.32 Favored 'Isoleucine or valine' 0 C--O 1.251 1.156 0 CA-C-O 121.144 0.497 . . . . 0.0 109.798 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.455 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 30.0 m -137.73 160.4 33.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.952 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -120.2 142.25 49.17 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.21 143.97 36.69 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.616 HG12 ' CD1' ' A' ' 86' ' ' ILE . 67.7 mt -97.99 140.04 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-N 113.286 -1.779 . . . . 0.0 109.251 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.7 m -137.74 116.89 12.58 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.285 0.634 . . . . 0.0 110.122 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -0.922 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.576 -178.624 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--O 1.205 -1.278 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.71 -6.73 11.26 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 122.439 2.093 . . . . 0.0 113.503 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.8 p -96.05 -18.0 20.53 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.434 0.635 . . . . 0.0 111.018 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.444 ' CD2' HD22 ' A' ' 87' ' ' LEU . 46.3 m170 -114.12 128.4 56.36 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.13 138.59 54.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 121.854 -0.529 . . . . 0.0 111.02 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.43 140.49 29.75 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.722 0.772 . . . . 0.0 111.745 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.895 HG21 ' CE1' ' A' ' 78' ' ' TYR . 3.0 mm -108.99 -176.19 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.623 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 73' ' ' ILE . 5.5 mm-40 -117.69 133.76 55.6 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -173.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.649 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 73.1 mttt -44.09 -53.24 6.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.64 1.213 . . . . 0.0 110.723 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -61.12 -32.25 71.94 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.701 -1.59 . . . . 0.0 113.93 -173.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -85.2 -27.82 25.86 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.622 0.725 . . . . 0.0 109.586 -173.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.895 ' CE1' HG21 ' A' ' 73' ' ' ILE . 2.1 m-85 -97.01 0.18 48.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.735 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.8 tttp 66.42 19.43 10.94 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 121.627 0.727 . . . . 0.0 111.148 176.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.455 ' HB3' ' H ' ' A' ' 82' ' ' LYS . 7.8 mp -96.94 172.18 8.02 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-O 122.927 1.346 . . . . 0.0 112.827 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.54 -24.27 42.29 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.613 -2.539 . . . . 0.0 109.725 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.489 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -137.54 152.66 49.69 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.425 -173.191 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.649 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 11.7 p-10 -75.9 142.21 42.15 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.35 -1.296 . . . . 0.0 108.741 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -136.97 159.08 42.96 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.705 -172.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 t -110.61 153.74 12.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 124.512 1.125 . . . . 0.0 108.151 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.616 ' CD1' HG12 ' A' ' 58' ' ' ILE . 13.2 mm -117.71 140.34 41.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.444 HD22 ' CD2' ' A' ' 70' ' ' HIS . 36.7 mt -105.46 104.61 14.37 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -86.27 -7.18 58.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.055 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.56 -38.02 15.23 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.967 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.519 HE21 ' HB3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -98.12 77.05 2.4 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.822 -179.594 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.552 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -108.93 179.45 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . 0.264 7.6 ptp180 -163.3 160.92 24.36 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 175.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 96.8 m -117.55 114.67 23.78 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.764 -176.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.8 mt -131.7 147.4 52.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.275 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.59 ' OD1' ' HB3' ' A' ' 97' ' ' LYS . 2.7 p30 -72.04 152.09 42.67 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.042 172.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -48.01 -26.15 1.67 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 125.735 1.614 . . . . 0.0 114.202 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.59 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . 7.0 ttpm? -73.16 -18.86 61.23 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.128 0.571 . . . . 0.0 111.228 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.536 ' HA ' ' NE ' ' A' ' 98' ' ' ARG . 2.7 mmp_? -75.9 -31.03 59.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.39 0.614 . . . . 0.0 109.593 175.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.78 130.19 39.02 Favored 'General case' 0 CA--C 1.475 -1.911 0 CA-C-O 123.07 1.414 . . . . 0.0 110.595 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 13.9 tptt -90.25 -68.31 0.79 Allowed 'General case' 0 N--CA 1.391 -3.402 0 CA-C-N 111.745 -2.48 . . . . 0.0 113.023 -171.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 8.4 pt-20 -163.67 143.58 8.43 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 121.709 0.766 . . . . 0.0 111.829 -168.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -63.39 114.86 4.12 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 128.113 2.565 . . . . 0.0 109.531 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -112.0 -62.68 1.53 Allowed 'General case' 0 N--CA 1.417 -2.098 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.424 HG22 HG11 ' A' ' 19' ' ' VAL . 3.6 t -128.5 -162.5 1.19 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 117.736 -1.585 . . . . 0.0 112.912 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -160.41 140.43 11.32 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 125.228 1.411 . . . . 0.0 109.997 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.432 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 3.6 pp -108.81 157.49 18.54 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.156 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.432 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 11.8 m -89.82 174.03 7.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.323 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 111' ' ' MET . 11.0 m-20 -62.4 -32.56 73.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.202 1.001 . . . . 0.0 111.617 -177.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' A' ' 107' ' ' SER . 11.2 p-10 -70.46 -33.92 71.82 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.43 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -78.5 -28.5 46.34 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.495 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.578 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -47.47 -49.42 25.59 Favored 'General case' 0 CA--C 1.453 -2.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 168.122 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 9.9 mmpt? -76.71 -7.96 56.35 Favored 'General case' 0 N--CA 1.392 -3.372 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.4 -54.15 4.13 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 116.921 -1.911 . . . . 0.0 106.956 172.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -51.91 -59.03 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-N 112.359 -2.2 . . . . 0.0 112.968 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.554 ' O ' ' HB3' ' A' ' 118' ' ' LEU 0.261 26.0 t0 -61.41 -40.13 93.27 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.883 1.802 . . . . 0.0 109.718 -176.16 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 14.6 t30 -79.72 -41.99 25.57 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 112.171 -2.286 . . . . 0.0 112.009 -172.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.547 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.77 -36.11 80.08 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.554 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 3.0 tp -64.55 -41.8 96.1 Favored 'General case' 0 N--CA 1.382 -3.86 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.98 -176.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 34.3 mtp -61.53 -34.31 75.32 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-O 120.894 0.378 . . . . 0.0 110.882 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 117' ' ' ALA . 30.5 mt -75.07 -53.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.683 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.2 m -48.07 -34.9 10.3 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 113.254 -1.794 . . . . 0.0 113.156 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 23.2 mt -105.97 3.16 28.08 Favored 'General case' 0 C--O 1.188 -2.134 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.589 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.76 21.53 65.97 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 116.564 1.386 . . . . 0.0 116.564 172.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.74 -57.76 3.41 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 118.701 1.251 . . . . 0.0 110.022 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.9 m120 . . . . . 0 CA--C 1.559 1.324 0 CA-C-N 113.104 -1.862 . . . . 0.0 112.545 -169.05 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 14' ' ' ILE . . . . . 0.582 ' HB ' ' OD1' ' B' ' 47' ' ' ASN . 71.3 mt . . . . . 0 N--CA 1.433 -1.277 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -116.68 145.34 43.51 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ARG . . . . . 0.568 ' HD2' ' O ' ' B' ' 41' ' ' ILE . 4.6 ttp180 -63.89 114.35 4.02 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 175.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.78 -18.14 5.41 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.11 171.8 11.29 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 122.888 1.328 . . . . 0.0 110.14 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.444 HG11 HG22 ' B' ' 104' ' ' THR . 10.4 t -133.35 128.65 55.6 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.576 0 CA-C-N 112.292 -2.231 . . . . 0.0 109.155 176.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.528 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 34.4 m-85 -125.86 147.02 49.57 Favored 'General case' 0 C--N 1.27 -2.865 0 C-N-CA 125.194 1.398 . . . . 0.0 108.407 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.607 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.6 mp -82.23 159.81 23.13 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 170.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.88 133.2 13.59 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.711 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.95 82.19 8.56 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 123.658 1.694 . . . . 0.0 109.666 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.511 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 4.4 pp -90.21 4.78 49.55 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.121 -174.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.572 ' HB3' ' N ' ' B' ' 34' ' ' GLY . 2.3 p -90.21 59.91 0.0 OUTLIER Pre-proline 0 C--N 1.277 -2.55 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.511 ' HD3' ' C ' ' B' ' 24' ' ' LEU . 17.5 Cg_endo -118.59 31.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.112 0 N-CA-C 106.711 -2.073 . . . . 0.0 106.711 152.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 33.3 m -71.14 173.05 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.39 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -142.83 120.28 11.67 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 114.8 1.408 . . . . 0.0 114.8 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.52 -131.08 10.44 Favored Glycine 0 N--CA 1.416 -2.689 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.873 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -93.79 17.03 12.7 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.525 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 41.2 mt-10 -70.46 171.62 9.79 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' GLN . . . . . 0.401 ' HB3' HE21 ' B' ' 90' ' ' GLN . 0.0 OUTLIER -103.88 125.7 50.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -175.346 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.43 147.84 17.03 Favored Glycine 0 CA--C 1.486 -1.748 0 N-CA-C 115.409 0.923 . . . . 0.0 115.409 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' GLY . . . . . 0.572 ' N ' ' HB3' ' B' ' 25' ' ' SER . . . 140.62 137.51 3.46 Favored Glycine 0 C--N 1.288 -2.134 0 CA-C-N 113.727 -1.236 . . . . 0.0 111.787 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -73.64 104.26 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-O 122.998 1.38 . . . . 0.0 107.473 173.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -135.2 161.99 60.19 Favored Pre-proline 0 C--N 1.249 -3.784 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.08 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 19.7 Cg_exo -68.05 142.92 57.93 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 122.047 1.831 . . . . 0.0 110.173 170.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 20' ' ' TYR . 28.7 m -123.74 159.13 29.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 123.552 0.741 . . . . 0.0 109.273 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 32.6 m -102.0 132.3 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 120.524 0.202 . . . . 0.0 110.759 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 mm -84.93 105.89 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.568 ' O ' ' HD2' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -103.44 -12.07 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.033 -178.288 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.797 ' NE2' ' HB ' ' B' ' 53' ' ' VAL . 4.0 mt-30 -42.05 157.55 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 120.945 3.683 . . . . 0.0 120.945 -174.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -69.41 145.15 53.07 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 110.833 -2.894 . . . . 0.0 108.279 165.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' B' ' 47' ' ' ASN . 22.2 t70 -61.85 -30.14 70.65 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.673 -176.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.9 m -87.19 -28.4 22.43 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.879 -174.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.436 ' HA2' ' OG ' ' B' ' 50' ' ' SER . . . -66.79 -26.8 73.09 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ASN . . . . . 0.582 ' OD1' ' HB ' ' B' ' 14' ' ' ILE . 34.6 t30 -68.04 -39.16 83.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.738 -1.231 . . . . 0.0 110.019 176.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -76.52 -66.08 0.85 Allowed 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . 0.439 19.4 p90 -124.31 6.96 8.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 -171.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.436 ' OG ' ' HA2' ' B' ' 46' ' ' GLY . 19.6 m -92.28 131.03 35.68 Favored Pre-proline 0 N--CA 1.428 -1.573 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 171.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.4 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 27.3 Cg_exo -63.28 -28.9 72.64 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 121.62 1.547 . . . . 0.0 110.268 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 52' ' ' THR . . . . . 0.467 HG21 ' HG2' ' A' ' 90' ' ' GLN . 1.8 p -94.9 138.84 32.14 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.398 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.797 ' HB ' ' NE2' ' B' ' 42' ' ' GLN . 1.2 m -130.49 158.86 42.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.466 HG21 HD22 ' A' ' 122' ' ' LEU . 9.0 tt -110.87 130.98 63.28 Favored 'Isoleucine or valine' 0 C--O 1.253 1.277 0 CA-C-O 121.269 0.557 . . . . 0.0 110.087 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 27.8 m -137.57 159.51 34.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.906 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.547 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -119.68 142.03 48.84 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.46 140.31 38.63 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.613 HG12 ' CD1' ' B' ' 86' ' ' ILE . 67.6 mt -93.89 140.43 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.253 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 90.9 m -138.12 111.95 8.34 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.388 0.675 . . . . 0.0 110.855 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.265 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 22.7 mt . . . . . 0 C--O 1.213 -0.852 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.02 -14.01 34.8 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.411 2.074 . . . . 0.0 113.855 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 67.2 p -93.88 -18.85 21.54 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.356 0.598 . . . . 0.0 111.361 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -109.26 128.75 55.32 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.02 139.01 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.662 -0.649 . . . . 0.0 110.847 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.22 143.2 26.82 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.788 0.804 . . . . 0.0 111.619 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.862 HG21 ' CE1' ' B' ' 78' ' ' TYR . 5.3 mm -112.59 166.45 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.595 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.56 ' H ' HG22 ' B' ' 73' ' ' ILE . 2.5 mm-40 -97.56 130.55 44.6 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 75' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 71.9 mttt -43.4 -52.68 5.83 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.769 1.228 . . . . 0.0 110.604 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -64.6 -25.56 68.02 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.875 1.67 . . . . 0.0 114.087 -173.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -91.36 -20.98 21.25 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.509 0.671 . . . . 0.0 109.586 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.862 ' CE1' HG21 ' B' ' 73' ' ' ILE . 2.0 m-85 -103.8 0.15 29.99 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.178 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 tttp 67.07 17.14 10.41 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.489 0.661 . . . . 0.0 111.855 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' B' ' 78' ' ' TYR . 7.8 mp -94.46 175.1 6.81 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 123.197 1.475 . . . . 0.0 113.143 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.96 -25.99 34.36 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 111.698 -2.501 . . . . 0.0 109.489 176.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.421 ' H ' ' HB3' ' B' ' 80' ' ' LEU . 0.3 OUTLIER -136.52 153.58 50.97 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.547 -172.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.655 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 8.9 p-10 -77.22 143.17 39.18 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 29.9 t -136.19 159.88 40.37 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.512 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -111.36 151.92 13.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.613 ' CD1' HG12 ' B' ' 58' ' ' ILE . 12.3 mm -116.18 139.34 43.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.5 mt -104.88 104.19 13.91 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.427 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.9 mm? -84.45 -8.86 58.82 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.124 -174.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.21 -37.68 15.91 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.373 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 90' ' ' GLN . . . . . 0.427 ' HG2' HG21 ' A' ' 52' ' ' THR . 0.0 OUTLIER -98.07 77.89 2.48 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.949 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.547 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.4 pp -109.26 179.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . 0.265 8.0 ptp180 -163.28 161.56 24.79 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' B' ' 53' ' ' VAL . 90.5 m -117.85 115.13 24.34 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 113.735 -1.575 . . . . 0.0 108.534 -176.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 60.1 mt -131.79 148.25 52.55 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.957 -170.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.513 ' OD1' ' HB3' ' B' ' 97' ' ' LYS . 1.2 p30 -74.28 152.09 39.74 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.871 173.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -46.56 -28.97 1.59 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 125.693 1.597 . . . . 0.0 114.007 -175.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.513 ' HB3' ' OD1' ' B' ' 95' ' ' ASP . 7.0 ttpm? -71.77 -18.94 62.09 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 123.177 0.591 . . . . 0.0 111.517 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.537 ' NE ' ' HA ' ' B' ' 98' ' ' ARG . 2.3 mmp_? -76.29 -28.16 56.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.599 0.714 . . . . 0.0 109.695 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 7.8 mp -76.45 128.53 34.98 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 123.533 1.635 . . . . 0.0 111.037 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 100' ' ' LYS . . . . . 0.409 ' HB3' ' HG2' ' B' ' 101' ' ' GLU . 13.0 tptt -87.11 -67.42 0.82 Allowed 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 111.346 -2.661 . . . . 0.0 113.132 -171.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 9.1 pt-20 -166.27 146.36 6.18 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.707 0.765 . . . . 0.0 111.545 -169.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -63.98 116.2 5.63 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 128.354 2.662 . . . . 0.0 109.541 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.76 -62.72 1.55 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.755 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.444 HG22 HG11 ' B' ' 19' ' ' VAL . 4.6 t -128.63 -164.91 1.43 Allowed 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.66 -1.616 . . . . 0.0 112.153 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.32 134.79 7.48 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 124.817 1.247 . . . . 0.0 109.759 -171.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.466 ' HB3' ' CE1' ' B' ' 78' ' ' TYR . 3.6 pp -101.91 159.58 15.22 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.369 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 11.1 m -91.14 173.42 7.95 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.864 0.364 . . . . 0.0 111.112 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' B' ' 111' ' ' MET . 6.0 m-20 -64.45 -26.79 68.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.867 0.867 . . . . 0.0 112.258 -177.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.82 -38.18 67.24 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.01 -28.54 61.5 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.112 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.1 OUTLIER -47.36 -48.9 25.52 Favored 'General case' 0 CA--C 1.45 -2.881 0 CA-C-O 121.384 0.611 . . . . 0.0 109.567 167.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.547 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 9.3 mmpt? -78.63 -5.48 53.06 Favored 'General case' 0 N--CA 1.382 -3.845 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -176.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -91.16 -56.42 3.16 Favored 'General case' 0 N--CA 1.397 -3.109 0 C-N-CA 116.999 -1.88 . . . . 0.0 107.197 170.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -50.22 -59.78 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 112.203 -2.271 . . . . 0.0 113.282 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.598 ' O ' ' HB3' ' B' ' 118' ' ' LEU 0.275 17.2 t0 -60.66 -42.86 97.89 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 123.78 1.752 . . . . 0.0 109.826 -176.096 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.363 47.0 t30 -77.69 -41.68 37.16 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.095 -171.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -65.44 -34.17 77.66 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.598 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.1 tp -63.24 -41.69 99.11 Favored 'General case' 0 N--CA 1.381 -3.921 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.257 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 36.1 mtp -60.08 -37.89 81.26 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 120.714 0.292 . . . . 0.0 110.573 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' B' ' 117' ' ' ALA . 28.7 mt -71.06 -53.15 22.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 25.3 m -51.11 -32.64 23.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.783 178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 22.5 mt -105.63 1.79 27.62 Favored 'General case' 0 C--O 1.19 -2.074 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.495 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.45 24.99 59.8 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.506 ' HG ' ' OD1' ' A' ' 115' ' ' ASP . 7.1 mp -83.47 -58.37 2.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.778 1.289 . . . . 0.0 110.194 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 CA--C 1.562 1.424 0 CA-C-N 112.868 -1.969 . . . . 0.0 113.177 -168.92 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.425 -1.688 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -123.25 144.23 49.53 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -63.14 118.18 7.56 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.524 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.64 -19.4 5.03 Favored Glycine 0 N--CA 1.425 -2.049 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.724 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -83.13 171.47 13.67 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.353 1.073 . . . . 0.0 110.097 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.441 HG11 HG22 ' A' ' 104' ' ' THR . 13.3 t -132.38 128.03 57.79 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.373 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 24.2 m-85 -123.36 151.42 42.54 Favored 'General case' 0 C--N 1.271 -2.847 0 C-N-CA 125.274 1.43 . . . . 0.0 110.03 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.7 mp -88.63 150.17 23.17 Favored 'General case' 0 N--CA 1.396 -3.15 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -145.27 139.11 26.88 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.156 -176.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -81.86 89.95 6.38 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.533 1.158 . . . . 0.0 108.665 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.601 ' O ' HG13 ' A' ' 27' ' ' VAL . 82.2 mt -65.1 -19.45 65.99 Favored 'General case' 0 CA--C 1.481 -1.677 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.661 -178.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.569 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 10.0 m -33.75 175.0 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.322 0 C-N-CA 127.197 2.199 . . . . 0.0 114.252 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 27.32 48.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.677 0 C-N-CA 121.905 1.737 . . . . 0.0 114.588 -151.37 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 24' ' ' LEU . 1.6 m -69.88 168.22 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.002 170.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.489 ' HG3' HD23 ' B' ' 94' ' ' LEU . 12.1 mm100 -99.21 107.14 19.39 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.765 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.86 -122.31 26.68 Favored Glycine 0 C--N 1.298 -1.564 0 CA-C-N 113.998 -1.455 . . . . 0.0 113.371 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.4 m -81.71 20.97 0.87 Allowed 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.601 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 46.0 mt-10 -62.24 168.26 3.54 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 117.917 -1.513 . . . . 0.0 110.32 170.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.533 HE22 ' HG3' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -70.81 107.95 4.24 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -176.276 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.76 144.3 18.81 Favored Glycine 0 CA--C 1.499 -0.95 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 157.97 10.06 Favored Glycine 0 N--CA 1.421 -2.347 0 CA-C-N 113.019 -1.59 . . . . 0.0 111.538 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -81.9 104.89 11.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 171.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.533 ' HG3' HE22 ' A' ' 32' ' ' GLN . 18.4 mmt180 -129.46 157.18 77.14 Favored Pre-proline 0 C--N 1.26 -3.29 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.58 -167.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HB2' HD12 ' A' ' 58' ' ' ILE . 31.9 Cg_exo -63.22 144.88 92.79 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.211 1.941 . . . . 0.0 111.405 171.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 27.2 m -129.91 156.26 42.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 124.238 1.015 . . . . 0.0 109.067 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.6 m -100.22 131.99 46.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 mm -91.51 115.57 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.95 -14.25 10.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.265 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.621 HE21 HG13 ' A' ' 53' ' ' VAL . 5.0 pt20 -53.69 163.12 0.73 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -168.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -64.94 -177.58 0.36 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.156 -2.293 . . . . 0.0 112.202 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -81.7 -42.73 19.47 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.969 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -82.69 -23.64 34.04 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -170.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.73 -32.41 74.17 Favored Glycine 0 C--O 1.204 -1.739 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.356 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -81.52 -18.08 46.28 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.086 0.47 . . . . 0.0 111.792 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -86.65 -62.89 1.41 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.507 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -107.34 -15.26 14.68 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -168.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -91.43 141.46 26.03 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HA ' ' HE3' ' A' ' 96' ' ' LYS . 72.8 Cg_endo -81.86 -9.8 11.87 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.99 1.794 . . . . 0.0 111.381 176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 p -109.13 135.69 49.84 Favored 'General case' 0 N--CA 1.409 -2.509 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.791 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.621 HG13 HE21 ' A' ' 42' ' ' GLN . 95.0 t -123.74 139.75 49.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.567 HG21 HD22 ' B' ' 122' ' ' LEU . 9.3 tp -97.52 128.16 49.11 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 25.9 m -140.35 164.54 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.968 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -122.32 132.93 54.64 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.7 131.66 46.46 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.539 HD12 ' HB2' ' A' ' 37' ' ' PRO . 54.3 mt -91.68 106.11 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.785 176.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.3 m -102.46 140.94 36.07 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.698 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.459 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.768 -177.771 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.9 tt . . . . . 0 N--CA 1.426 -1.63 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.58 ' HB2' HD13 ' A' ' 120' ' ' ILE . 61.2 Cg_endo -71.5 2.56 4.41 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.632 2.221 . . . . 0.0 114.737 -174.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.506 ' HB ' ' HG3' ' A' ' 89' ' ' GLU . 68.0 p -103.31 -16.57 15.61 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.35 0.595 . . . . 0.0 111.483 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -109.91 129.82 55.6 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 176.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.3 p -123.01 132.71 70.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.512 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.67 130.0 34.95 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.941 0.877 . . . . 0.0 110.444 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.56 HD11 HG12 ' A' ' 86' ' ' ILE . 13.1 mm -97.1 169.99 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.458 ' N ' HG22 ' A' ' 73' ' ' ILE . 7.4 tp10 -106.34 109.57 21.54 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 168.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.605 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -50.93 -30.7 15.49 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 125.431 1.492 . . . . 0.0 114.678 -172.701 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.401 ' HG2' ' OE1' ' A' ' 74' ' ' GLU . 42.5 mmtm -49.37 -45.14 45.52 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 125.008 1.323 . . . . 0.0 111.508 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -79.06 -24.41 43.56 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.631 0.729 . . . . 0.0 111.678 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.538 ' HB2' ' HE3' ' A' ' 75' ' ' LYS . 4.0 m-85 -97.81 6.5 47.76 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.012 -175.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.466 ' O ' HD12 ' A' ' 80' ' ' LEU 0.394 61.8 pttt 43.28 64.3 1.26 Allowed 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 119.824 3.268 . . . . 0.0 119.824 176.345 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.597 HD22 ' HZ3' ' A' ' 75' ' ' LYS . 10.3 mp -141.76 -168.27 2.63 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 169.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -113.94 -9.11 13.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 123.679 0.612 . . . . 0.0 110.821 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 50.3 mttm -115.12 112.14 22.1 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.204 -173.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -35.66 144.24 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.984 1.714 . . . . 0.0 115.388 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.7 m -123.32 132.74 54.09 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.435 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 35.4 t -120.15 138.14 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 173.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.56 HG12 HD11 ' A' ' 73' ' ' ILE . 23.4 mm -104.31 131.26 53.59 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.2 mt -98.6 103.51 15.47 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.505 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -81.57 -17.64 47.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.506 ' HG3' ' HB ' ' A' ' 69' ' ' THR . 41.3 mt-10 -86.51 -7.73 58.15 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.766 0.793 . . . . 0.0 111.231 173.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 91' ' ' ILE . 14.5 tp60 -89.27 -100.68 0.09 Allowed 'General case' 0 C--O 1.192 -1.937 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 90' ' ' GLN . 1.1 pp 57.84 179.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 C-N-CA 127.574 2.35 . . . . 0.0 110.958 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.515 ' NH2' ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -176.77 176.43 1.5 Allowed 'General case' 0 C--N 1.311 -1.108 0 O-C-N 123.897 0.748 . . . . 0.0 112.233 172.639 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.449 HG21 ' O ' ' B' ' 90' ' ' GLN . 53.6 m -116.18 128.59 55.75 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.477 HD23 ' HG3' ' B' ' 28' ' ' GLN . 71.0 mt -131.72 141.65 49.59 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.886 -173.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.425 ' OD1' ' HG3' ' A' ' 97' ' ' LYS . 11.9 t0 -57.2 144.61 34.51 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 169.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 51' ' ' PRO . 16.8 pttp -55.41 -31.02 61.51 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.425 ' HG3' ' OD1' ' A' ' 95' ' ' ASP . 52.1 mttp -53.44 -28.82 32.27 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.919 174.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 8.9 mmp_? -74.27 -34.13 63.48 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 120.904 0.383 . . . . 0.0 110.269 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.9 mp -68.51 106.32 2.52 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.279 1.037 . . . . 0.0 110.268 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -83.74 -67.37 0.8 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.28 -1.782 . . . . 0.0 114.134 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.587 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.6 pt-20 -148.32 152.05 36.42 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-O 121.563 0.696 . . . . 0.0 110.16 -169.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 20' ' ' TYR . 30.8 mtpt -79.1 115.75 18.96 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-N 113.171 -1.831 . . . . 0.0 108.236 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 tp -104.28 -58.93 1.81 Allowed 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.288 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.441 HG22 HG11 ' A' ' 19' ' ' VAL . 5.2 t -132.54 -164.98 1.53 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 117.835 -1.546 . . . . 0.0 111.915 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.49 128.43 4.55 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 125.631 1.573 . . . . 0.0 109.876 -173.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.423 HD11 ' HE3' ' A' ' 111' ' ' MET . 3.7 pp -95.14 163.31 13.34 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.7 p -88.3 164.1 15.74 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 123.085 0.554 . . . . 0.0 112.049 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 111' ' ' MET . 22.7 t70 -61.99 -29.5 70.3 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.401 1.08 . . . . 0.0 113.37 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.13 -33.74 68.03 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -76.36 -32.25 58.51 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.502 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -52.37 -41.91 63.5 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 125.165 1.386 . . . . 0.0 110.549 175.779 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.657 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 2.2 mmmm -69.84 -21.73 63.34 Favored 'General case' 0 CA--C 1.465 -2.324 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.352 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -87.81 -46.56 9.33 Favored 'General case' 0 N--CA 1.398 -3.028 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 t -50.58 -54.6 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 CA-C-N 113.263 -1.79 . . . . 0.0 112.857 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 53.5 m-20 -66.24 -42.74 88.16 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 123.511 1.624 . . . . 0.0 111.946 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.657 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 3.8 t30 -74.93 -43.56 53.54 Favored 'General case' 0 C--N 1.26 -3.326 0 CA-C-N 112.76 -2.018 . . . . 0.0 112.52 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -60.71 -36.66 79.39 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.528 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 10.2 tp -65.33 -39.45 92.42 Favored 'General case' 0 N--CA 1.386 -3.675 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.105 -177.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.775 ' SD ' ' HA ' ' A' ' 125' ' ' ASN 0.265 7.4 ptp -74.92 -19.32 60.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 117.54 -1.664 . . . . 0.0 114.461 176.502 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 68' ' ' PRO . 30.4 mt -77.03 -50.04 21.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 175.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.1 p -60.78 -30.4 70.02 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 113.111 -1.858 . . . . 0.0 112.124 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.554 HD22 HG21 ' B' ' 54' ' ' ILE . 27.4 mt -107.2 0.7 23.49 Favored 'General case' 0 C--O 1.199 -1.589 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.84 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.64 26.21 65.78 Favored Glycine 0 CA--C 1.549 2.169 0 N-CA-C 116.964 1.546 . . . . 0.0 116.964 174.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.557 HD11 HD11 ' B' ' 124' ' ' LEU . 0.5 OUTLIER -113.9 15.93 18.45 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 119.263 1.531 . . . . 0.0 111.805 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.775 ' HA ' ' SD ' ' A' ' 119' ' ' MET . 2.4 t-20 . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 123.353 0.661 . . . . 0.0 112.705 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 56.8 mt . . . . . 0 N--CA 1.424 -1.766 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 24.4 mmm-85 -121.28 140.64 51.79 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -61.26 115.03 3.5 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.818 170.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.81 -16.31 5.33 Favored Glycine 0 N--CA 1.428 -1.891 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.066 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.18 172.52 11.83 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 122.266 1.032 . . . . 0.0 109.47 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.461 HG11 HG22 ' B' ' 104' ' ' THR . 12.3 t -132.88 129.09 57.66 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.174 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.265 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 23.0 m-85 -123.89 150.88 44.14 Favored 'General case' 0 C--N 1.271 -2.824 0 C-N-CA 125.322 1.449 . . . . 0.0 110.052 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 3.8 mp -87.95 150.18 23.61 Favored 'General case' 0 N--CA 1.391 -3.396 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 165.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -145.48 138.52 26.2 Favored 'General case' 0 C--N 1.26 -3.286 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.118 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.23 91.16 6.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.73 1.252 . . . . 0.0 108.477 171.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.572 ' O ' HG13 ' B' ' 27' ' ' VAL . 85.4 mt -65.83 -20.86 66.4 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-N 112.672 -2.058 . . . . 0.0 110.735 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.532 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 16.3 m -35.08 176.28 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.171 0 C-N-CA 126.97 2.108 . . . . 0.0 114.929 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 26.41 49.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.621 0 C-N-CA 121.817 1.678 . . . . 0.0 114.615 -149.432 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.594 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 1.8 m -69.99 172.9 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.337 170.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' GLN . . . . . 0.477 ' HG3' HD23 ' A' ' 94' ' ' LEU . 10.9 mm100 -102.52 108.71 20.1 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.055 -1.43 . . . . 0.0 110.577 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.33 -120.61 13.81 Favored Glycine 0 C--N 1.304 -1.25 0 CA-C-N 114.248 -1.342 . . . . 0.0 114.097 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.0 m -81.25 20.19 0.87 Allowed 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.594 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 46.4 mt-10 -63.87 166.24 7.59 Favored 'General case' 0 C--O 1.248 0.995 0 C-N-CA 117.695 -1.602 . . . . 0.0 109.881 169.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.38 108.08 4.65 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -175.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.09 146.29 19.01 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 116.069 1.187 . . . . 0.0 116.069 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.09 152.68 8.71 Favored Glycine 0 N--CA 1.417 -2.598 0 CA-C-N 113.503 -1.349 . . . . 0.0 110.722 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 p -78.38 108.65 12.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -133.99 156.87 78.84 Favored Pre-proline 0 C--N 1.263 -3.191 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.042 -166.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' PRO . . . . . 0.557 ' HB2' HD12 ' B' ' 58' ' ' ILE . 31.3 Cg_exo -63.39 144.04 89.99 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.486 2.124 . . . . 0.0 111.681 172.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 27.3 m -129.1 156.06 41.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 124.341 1.057 . . . . 0.0 109.193 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.5 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 31.8 m -99.74 131.69 46.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 30.3 mm -91.02 115.65 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.82 -14.87 10.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.241 -177.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.666 HE21 HG13 ' B' ' 53' ' ' VAL . 4.8 pt20 -52.95 163.24 0.52 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 -168.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -65.78 -177.22 0.44 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.778 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.38 -47.94 14.89 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.7 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 20.4 m -78.17 -24.37 47.26 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -169.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -60.95 -32.35 79.68 Favored Glycine 0 C--O 1.204 -1.738 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.358 -176.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -81.49 -18.95 43.39 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.403 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -84.77 -66.66 0.87 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.015 0.436 . . . . 0.0 111.455 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -103.93 -13.71 16.25 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 19.3 m -94.72 140.03 22.44 Favored Pre-proline 0 C--N 1.295 -1.772 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.84 -6.45 11.45 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.106 1.871 . . . . 0.0 111.548 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.2 p -110.09 135.64 50.59 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.533 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.666 HG13 HE21 ' B' ' 42' ' ' GLN . 93.1 t -123.88 139.81 49.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.554 HG21 HD22 ' A' ' 122' ' ' LEU . 9.1 tp -97.19 128.67 48.22 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 27.4 m -140.72 164.52 21.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.035 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.5 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -122.38 132.82 54.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.15 130.55 43.47 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.557 HD12 ' HB2' ' B' ' 37' ' ' PRO . 56.8 mt -90.08 108.53 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.166 176.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -105.13 139.49 39.72 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.896 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.58 -178.719 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.422 -1.843 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 68' ' ' PRO . . . . . 0.474 ' HB2' HD13 ' B' ' 120' ' ' ILE . 49.2 Cg_endo -68.48 0.57 4.55 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.729 2.286 . . . . 0.0 115.098 -175.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' THR . . . . . 0.509 ' HB ' ' HG3' ' B' ' 89' ' ' GLU . 77.7 p -103.55 -15.92 15.69 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.302 0.572 . . . . 0.0 111.789 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -110.94 129.18 55.96 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 8.6 p -122.18 132.61 70.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.521 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -84.4 136.9 33.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.282 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ILE . . . . . 0.56 HD11 HG12 ' B' ' 86' ' ' ILE . 12.2 mm -108.66 157.17 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.413 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.444 ' N ' HG22 ' B' ' 73' ' ' ILE . 9.2 tp10 -94.38 109.13 21.01 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 173.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 75' ' ' LYS . . . . . 0.621 ' HZ3' HD22 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -52.72 -30.73 34.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.742 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 76' ' ' LYS . . . . . 0.438 ' H ' ' HG2' ' B' ' 76' ' ' LYS . 16.1 mmtp -50.96 -41.08 58.99 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 124.9 1.28 . . . . 0.0 112.038 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -80.25 -26.99 38.74 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.886 0.85 . . . . 0.0 111.435 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' TYR . . . . . 0.541 ' HB2' ' HE3' ' B' ' 75' ' ' LYS . 4.4 m-85 -95.2 5.88 50.57 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.234 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' LYS . . . . . 0.49 ' O ' HD12 ' B' ' 80' ' ' LEU 0.399 61.6 pttt 43.62 64.66 1.18 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 119.822 3.268 . . . . 0.0 119.822 176.305 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 80' ' ' LEU . . . . . 0.621 HD22 ' HZ3' ' B' ' 75' ' ' LYS . 10.3 mp -142.69 -169.87 3.09 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 169.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -116.52 -1.75 12.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.957 0.786 . . . . 0.0 110.813 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' LYS . . . . . 0.432 ' O ' ' HD3' ' B' ' 75' ' ' LYS . 52.6 mttm -120.79 111.11 17.17 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.79 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -33.14 143.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 127.179 2.191 . . . . 0.0 114.526 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -124.91 133.42 53.06 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.21 -170.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 39.9 t -120.07 138.23 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 174.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.56 HG12 HD11 ' B' ' 73' ' ' ILE . 24.2 mm -103.95 130.39 54.61 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 51.7 mt -98.6 103.19 15.11 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 -20.32 44.25 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.619 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' GLU . . . . . 0.509 ' HG3' ' HB ' ' B' ' 69' ' ' THR . 42.9 mt-10 -84.27 -9.26 58.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.711 0.767 . . . . 0.0 111.595 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' GLN . . . . . 0.555 ' O ' HG13 ' B' ' 91' ' ' ILE . 15.0 tp60 -86.82 -100.65 0.07 Allowed 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 172.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.555 HG13 ' O ' ' B' ' 90' ' ' GLN . 1.0 OUTLIER 57.75 179.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 C-N-CA 127.63 2.372 . . . . 0.0 111.033 -179.014 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 92' ' ' ARG . . . . . 0.484 ' NH2' ' HA ' ' B' ' 27' ' ' VAL . 0.1 OUTLIER -176.88 177.08 1.36 Allowed 'General case' 0 C--N 1.311 -1.089 0 O-C-N 123.911 0.757 . . . . 0.0 112.297 172.485 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 93' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 90' ' ' GLN . 51.9 m -116.76 128.81 55.66 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 94' ' ' LEU . . . . . 0.489 HD23 ' HG3' ' A' ' 28' ' ' GLN . 72.4 mt -131.45 142.1 49.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.058 -172.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 95' ' ' ASP . . . . . 0.43 ' OD1' ' HG3' ' B' ' 97' ' ' LYS . 11.0 t0 -56.6 143.92 33.91 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -57.65 -28.01 63.35 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.43 ' HG3' ' OD1' ' B' ' 95' ' ' ASP . 49.0 mttp -59.23 -22.74 61.54 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.329 174.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 98' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 8.0 mmp_? -78.15 -32.08 50.07 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.244 0.545 . . . . 0.0 109.732 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.43 105.52 2.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.475 1.131 . . . . 0.0 110.498 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.82 -64.2 1.21 Allowed 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 113.243 -1.799 . . . . 0.0 114.108 -173.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -152.55 152.39 31.81 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.426 0.632 . . . . 0.0 110.362 -171.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 102' ' ' LYS . . . . . 0.516 ' HG2' ' CZ ' ' B' ' 20' ' ' TYR . 32.5 mtpt -78.3 115.53 18.08 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 126.06 1.744 . . . . 0.0 108.323 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 tp -103.86 -59.02 1.79 Allowed 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.721 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 104' ' ' THR . . . . . 0.461 HG22 HG11 ' B' ' 19' ' ' VAL . 4.7 t -132.47 -164.66 1.49 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.675 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -160.82 130.29 4.89 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 125.272 1.429 . . . . 0.0 110.226 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.73 157.31 16.36 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -175.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -80.27 166.2 21.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.976 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 108' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' B' ' 111' ' ' MET . 19.7 t70 -70.42 -23.31 62.72 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.857 0.863 . . . . 0.0 112.398 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.51 -30.16 57.09 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -78.52 -32.99 48.28 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.458 ' HA ' ' HE3' ' B' ' 111' ' ' MET . 0.2 OUTLIER -50.97 -43.6 60.48 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 125.473 1.509 . . . . 0.0 110.337 175.738 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' B' ' 116' ' ' ASN . 0.3 OUTLIER -68.78 -20.98 64.36 Favored 'General case' 0 C--O 1.185 -2.292 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.329 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -87.4 -47.86 8.44 Favored 'General case' 0 CA--C 1.45 -2.893 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 t -49.57 -54.98 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.44 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.882 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.559 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 17.9 m-20 -64.44 -44.42 91.23 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-O 123.385 1.564 . . . . 0.0 112.074 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 116' ' ' ASN . . . . . 0.61 ' HB3' ' O ' ' B' ' 112' ' ' LYS 0.302 5.9 t30 -76.51 -41.33 47.25 Favored 'General case' 0 C--N 1.262 -3.212 0 C-N-CA 126.778 2.031 . . . . 0.0 112.815 -172.631 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.59 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -64.48 -33.56 76.16 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 10.0 tp -65.33 -39.64 92.68 Favored 'General case' 1 N--CA 1.378 -4.059 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.773 -178.107 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 119' ' ' MET . . . . . 0.8 ' SD ' ' HA ' ' B' ' 125' ' ' ASN 0.255 6.9 ptp -73.81 -19.93 60.61 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 117.821 -1.552 . . . . 0.0 114.155 176.36 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' B' ' 117' ' ' ALA . 43.0 mt -75.98 -52.04 18.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 78.5 p -59.09 -28.0 66.08 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.681 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.567 HD22 HG21 ' A' ' 54' ' ' ILE . 26.9 mt -108.22 -0.45 20.9 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.922 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.81 31.78 57.82 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.557 HD11 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -120.95 20.09 11.61 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.821 1.31 . . . . 0.0 111.577 179.445 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.8 ' HA ' ' SD ' ' B' ' 119' ' ' MET . 13.0 m120 . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.74 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 t -154.54 104.68 2.57 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 p -75.27 97.96 3.68 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -84.32 -27.04 28.06 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -136.54 152.98 51.09 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -98.34 -172.98 2.45 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -81.38 -0.93 43.58 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -126.04 -88.14 0.59 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.586 0.231 . . . . 0.0 110.507 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -140.16 -179.42 5.97 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.2 m -63.77 -46.96 82.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 173.26 -30.0 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.441 1.496 . . . . 0.0 107.033 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.89 127.07 90.14 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.452 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.53 -25.71 17.53 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 121.542 1.495 . . . . 0.0 110.086 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.2 mt -104.97 117.48 50.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -103.38 144.33 31.52 Favored 'General case' 1 N--CA 1.374 -4.244 0 C-N-CA 123.611 0.765 . . . . 0.0 109.131 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -71.1 120.57 16.85 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 99.36 -1.16 57.2 Favored Glycine 0 C--N 1.305 -1.161 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.972 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -97.32 119.55 36.05 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.495 ' HB ' ' H ' ' A' ' 104' ' ' THR . 87.6 t -83.81 128.26 39.0 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 C-N-CA 123.201 0.6 . . . . 0.0 112.288 -172.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 48.8 m-85 -115.29 141.38 48.11 Favored 'General case' 0 C--N 1.273 -2.721 0 C-N-CA 125.236 1.414 . . . . 0.0 111.425 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER -75.26 148.66 39.24 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 167.041 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.02 149.4 34.05 Favored 'General case' 0 C--N 1.262 -3.215 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.233 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.416 ' HB2' ' HE2' ' A' ' 100' ' ' LYS . 26.0 t0 -96.91 76.68 2.74 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 27' ' ' VAL 0.264 3.0 tt -71.58 -18.16 62.25 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.089 -2.778 . . . . 0.0 108.437 -173.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.521 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 5.1 m -32.82 -178.19 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.935 0 C-N-CA 129.739 3.216 . . . . 0.0 116.384 173.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.1 OUTLIER 25.95 43.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.137 0 C-N-CA 124.317 3.345 . . . . 0.0 116.648 -151.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.728 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 2.8 m -70.07 142.2 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.402 169.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.442 ' HB3' ' HD2' ' B' ' 98' ' ' ARG . 18.2 mm100 -90.31 134.17 34.48 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 114.887 -1.052 . . . . 0.0 113.222 -172.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.84 -108.84 0.69 Allowed Glycine 0 N--CA 1.442 -0.923 0 O-C-N 124.564 1.165 . . . . 0.0 114.654 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 m -94.05 8.28 42.06 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 31.8 mt-10 -62.08 143.46 56.62 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 90' ' ' GLN . 1.1 tp-100 -103.49 112.31 25.15 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.174 0.512 . . . . 0.0 110.872 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . 166.04 -178.62 40.61 Favored Glycine 0 N--CA 1.408 -3.179 0 C-N-CA 119.807 -1.187 . . . . 0.0 115.012 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 24' ' ' LEU . . . 178.08 -160.09 26.12 Favored Glycine 0 C--N 1.266 -3.313 1 N-CA-C 101.972 -4.451 . . . . 0.0 101.972 -178.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.9 p -73.73 120.04 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.124 0 CA-C-N 120.859 2.329 . . . . 0.0 109.071 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.414 ' NH1' ' HA ' ' A' ' 59' ' ' THR . 73.2 mtt180 -152.73 166.07 16.2 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.423 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.655 ' HB2' HD12 ' A' ' 58' ' ' ILE . 11.0 Cg_exo -71.76 144.56 44.16 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.595 1.53 . . . . 0.0 109.978 169.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 28.7 m -128.19 158.26 40.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.507 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 35.9 m -101.76 130.33 51.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.832 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.433 HD13 HG12 ' A' ' 55' ' ' VAL . 35.9 mm -84.19 105.46 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.97 -10.19 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.035 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.666 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 2.5 tt0 -60.63 164.51 4.54 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -169.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 26.6 p-10 -68.38 -174.7 0.55 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.387 -1.733 . . . . 0.0 111.466 175.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -88.34 -38.36 15.2 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.194 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.452 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 4.0 m -81.83 -22.26 37.13 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.776 -0.578 . . . . 0.0 112.521 -171.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.63 -31.03 76.38 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -71.09 -35.31 71.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.249 0.547 . . . . 0.0 110.563 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 45' ' ' THR . 34.4 mttp -79.63 -48.28 14.01 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -115.51 -27.79 7.03 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -172.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.417 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 61.9 m -86.12 148.33 47.41 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.992 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 2.9 Cg_endo -81.9 -17.01 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.579 1.519 . . . . 0.0 110.221 174.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.2 p -91.65 151.08 20.84 Favored 'General case' 0 N--CA 1.421 -1.894 0 C-N-CA 124.635 1.174 . . . . 0.0 111.982 -174.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.666 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 61.8 t -135.12 139.02 47.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.634 HG21 HD22 ' B' ' 122' ' ' LEU . 10.3 tt -93.14 134.51 30.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.094 0.473 . . . . 0.0 110.196 170.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 94' ' ' LEU . 22.1 m -139.62 164.22 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.368 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.537 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -122.82 138.29 54.69 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.1 132.43 45.83 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 37' ' ' PRO . 63.3 mt -92.09 136.84 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.901 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.414 ' HA ' ' NH1' ' A' ' 36' ' ' ARG . 95.8 m -129.52 139.89 51.41 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -60.12 -75.07 0.3 Allowed Glycine 0 C--O 1.222 -0.656 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 60' ' ' GLY . 28.5 mmm180 -133.37 157.25 45.99 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.3 tp -162.29 -54.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.027 0.441 . . . . 0.0 110.243 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -172.75 144.49 1.38 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -56.43 143.84 33.33 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.294 0.996 . . . . 0.0 110.069 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.28 75.45 0.53 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.807 0.813 . . . . 0.0 110.748 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -103.13 -17.04 15.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.23 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.0 mt -101.48 140.55 21.34 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.64 1.85 3.99 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 121.951 1.767 . . . . 0.0 113.069 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.0 p -98.71 -18.8 17.84 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.394 0.616 . . . . 0.0 109.872 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -97.88 129.95 44.8 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.815 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.58 142.7 43.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -103.93 148.69 25.88 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.955 0.407 . . . . 0.0 110.969 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.533 HD13 HD11 ' A' ' 86' ' ' ILE . 25.2 pt -124.6 134.46 66.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' O ' ' HD1' ' A' ' 78' ' ' TYR . 2.7 mp0 -59.96 115.71 3.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.373 1.069 . . . . 0.0 113.423 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HB3' ' C ' ' A' ' 82' ' ' LYS . 22.3 pttm -50.56 -36.42 34.43 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.965 0.906 . . . . 0.0 112.214 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -52.35 -53.16 48.2 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 113.326 -1.761 . . . . 0.0 112.627 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -92.64 -37.65 12.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.552 0.692 . . . . 0.0 111.996 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.537 ' CE2' ' HA ' ' A' ' 106' ' ' LEU . 71.3 m-85 -75.37 -5.92 47.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.921 -172.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 75.5 24.1 1.39 Allowed 'General case' 0 C--N 1.348 0.521 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 167.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.67 179.0 4.4 Favored 'General case' 0 CA--C 1.489 -1.396 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.265 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.22 -5.29 40.74 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.485 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -140.89 150.51 43.29 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.193 -176.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -75.3 128.07 34.59 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 6.1 t -102.78 163.58 12.14 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -170.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.46 141.3 41.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.533 HD11 HD13 ' A' ' 73' ' ' ILE . 17.2 mm -107.48 133.2 52.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.9 mt -106.18 109.38 21.3 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.44 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -83.94 -2.68 57.02 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.509 0.671 . . . . 0.0 111.991 -175.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -97.0 -34.11 11.31 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.323 1.059 . . . . 0.0 109.677 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.428 ' HG2' ' HB3' ' A' ' 32' ' ' GLN . 9.7 tp60 -94.56 80.0 3.83 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.625 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.537 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.1 pp -122.71 -177.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -173.71 -178.24 1.56 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 123.784 0.677 . . . . 0.0 112.502 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 53.9 m -123.67 126.05 45.89 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 55' ' ' VAL . 74.7 mt -132.07 133.69 44.65 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.656 1.183 . . . . 0.0 109.784 -173.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.5 p-10 -78.09 153.84 31.86 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -44.78 -21.11 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.796 1.638 . . . . 0.0 115.015 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -74.17 -17.51 60.9 Favored 'General case' 0 CA--C 1.564 1.498 0 CA-C-O 121.209 0.528 . . . . 0.0 110.604 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.421 ' HD2' ' CB ' ' B' ' 28' ' ' GLN . 4.8 mmp_? -84.34 -38.52 20.25 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.073 0.549 . . . . 0.0 111.23 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.48 121.91 16.83 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 123.885 0.874 . . . . 0.0 111.1 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 23' ' ' ASP . 68.2 mttm -92.34 -62.55 1.38 Allowed 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.784 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.1 pt-20 -159.73 143.47 14.49 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.291 0.567 . . . . 0.0 112.075 -170.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.27 123.75 20.78 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.719 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.712 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 22.1 tp -114.3 -61.92 1.67 Allowed 'General case' 0 N--CA 1.414 -2.255 0 CA-C-O 122.394 1.092 . . . . 0.0 110.435 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.712 ' OG1' ' HG ' ' A' ' 103' ' ' LEU 0.26 3.7 m -126.54 -174.8 3.22 Favored 'General case' 0 N--CA 1.401 -2.892 0 CA-C-N 113.283 -1.78 . . . . 0.0 111.93 -164.07 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.432 ' H ' ' CG2' ' A' ' 104' ' ' THR . 0.4 OUTLIER -159.73 137.17 9.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.483 1.513 . . . . 0.0 109.645 -167.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.537 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . 6.9 mt -98.22 164.02 12.49 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.775 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.8 m -98.62 159.98 14.58 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 111' ' ' MET . 21.2 m-20 -63.59 -31.61 72.83 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.314 0.578 . . . . 0.0 112.307 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.76 -41.5 83.25 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 122.077 -0.389 . . . . 0.0 109.971 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -74.57 -24.21 58.88 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.378 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.482 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -56.59 -39.75 74.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 123.819 0.847 . . . . 0.0 108.857 170.84 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 8.4 mmpt? -79.99 -11.09 59.81 Favored 'General case' 0 N--CA 1.39 -3.474 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.233 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -88.94 -49.42 6.8 Favored 'General case' 0 N--CA 1.39 -3.426 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -50.26 -58.77 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.199 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.78 -39.5 77.62 Favored 'General case' 0 N--CA 1.515 2.825 0 CA-C-O 123.452 1.596 . . . . 0.0 111.931 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.511 ' HB3' ' O ' ' A' ' 112' ' ' LYS 0.257 6.4 t30 -83.98 -46.62 11.87 Favored 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 112.424 -2.171 . . . . 0.0 112.77 -170.078 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.54 -36.16 73.44 Favored 'General case' 0 CA--C 1.47 -2.102 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.546 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 7.4 tp -62.56 -47.11 85.32 Favored 'General case' 1 N--CA 1.363 -4.782 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.104 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.633 ' SD ' ' HA ' ' A' ' 125' ' ' ASN 0.275 7.8 ptp -68.14 -22.59 64.86 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 178.006 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.3 mt -72.22 -51.98 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.426 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 t -55.52 -34.66 64.86 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 113.197 -1.82 . . . . 0.0 111.669 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.632 HD22 HG21 ' B' ' 54' ' ' ILE . 17.0 mt -110.38 8.4 23.28 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.769 -0.582 . . . . 0.0 111.266 -177.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.53 21.49 64.79 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 171.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.782 HD11 HD11 ' B' ' 124' ' ' LEU . 0.6 OUTLIER -99.95 13.91 32.29 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 118.56 1.18 . . . . 0.0 111.485 -176.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.633 ' HA ' ' SD ' ' A' ' 119' ' ' MET . 20.1 m120 -38.32 130.72 1.25 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 124.509 1.13 . . . . 0.0 113.357 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.99 9.16 2.6 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.679 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.51 3.47 6.31 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.292 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 76.47 133.85 0.05 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.226 1.81 . . . . 0.0 110.181 -173.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -72.26 -13.42 61.51 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.287 0.565 . . . . 0.0 111.478 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -90.07 -0.89 57.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.749 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -124.0 91.87 3.55 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.444 0.64 . . . . 0.0 110.149 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 . . . . . 0 C--N 1.293 -1.849 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.116 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.73 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t -141.52 113.27 7.78 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -77.98 99.99 6.28 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -87.19 -22.16 25.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -141.3 159.98 41.09 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -101.3 -172.45 2.17 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.253 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -79.54 -17.53 53.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.472 . . . . 0.0 111.757 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -110.76 -84.46 0.56 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.23 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -142.71 177.57 8.23 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 m -62.08 -50.49 71.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 177.82 -34.02 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.809 1.644 . . . . 0.0 106.743 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.69 124.2 88.75 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.018 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.82 -26.13 19.39 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 121.772 1.648 . . . . 0.0 110.241 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.7 mt -104.97 116.78 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -102.78 146.1 28.76 Favored 'General case' 1 N--CA 1.377 -4.106 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.58 118.93 15.02 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 100.6 -0.66 55.51 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.971 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.43 119.39 35.87 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.493 ' HB ' ' H ' ' B' ' 104' ' ' THR . 86.0 t -83.72 128.51 38.75 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 123.235 0.614 . . . . 0.0 112.255 -172.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 48.7 m-85 -115.78 140.39 49.26 Favored 'General case' 0 C--N 1.272 -2.784 0 C-N-CA 125.438 1.495 . . . . 0.0 111.329 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.514 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 0.8 OUTLIER -74.02 148.38 42.06 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 166.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -145.41 148.87 33.8 Favored 'General case' 0 C--N 1.259 -3.361 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.055 -176.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -96.11 79.48 3.2 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.549 ' O ' HG13 ' B' ' 27' ' ' VAL 0.262 3.0 tt -74.46 -16.96 60.84 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 111.553 -2.567 . . . . 0.0 108.477 -173.251 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.501 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 3.6 m -32.68 -178.12 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.922 0 C-N-CA 130.652 3.581 . . . . 0.0 116.432 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.1 OUTLIER 24.91 44.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.404 3.486 0 C-N-CA 124.343 3.362 . . . . 0.0 116.373 -152.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.716 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 2.6 m -69.79 140.56 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 113.512 -1.676 . . . . 0.0 109.591 168.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLN . . . . . 0.421 ' CB ' ' HD2' ' A' ' 98' ' ' ARG . 17.1 mm100 -89.83 132.83 35.05 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.766 -172.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.08 -108.61 0.68 Allowed Glycine 0 CA--C 1.501 -0.796 0 CA-C-N 114.735 -1.121 . . . . 0.0 114.81 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -93.99 6.92 46.96 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -174.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.716 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 33.7 mt-10 -63.53 140.09 58.84 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.469 ' HB3' ' HG2' ' B' ' 90' ' ' GLN . 0.3 OUTLIER -101.28 119.42 38.73 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 120.828 0.347 . . . . 0.0 111.37 -176.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.416 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . 161.72 -179.33 37.17 Favored Glycine 1 N--CA 1.393 -4.191 0 C-N-CA 118.717 -1.706 . . . . 0.0 114.785 170.231 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' B' ' 24' ' ' LEU . . . -177.9 -158.69 21.31 Favored Glycine 1 C--N 1.253 -4.06 1 N-CA-C 102.801 -4.12 . . . . 0.0 102.801 -178.815 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 7.2 p -75.98 108.72 8.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 120.208 2.004 . . . . 0.0 110.551 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -141.22 165.68 27.4 Favored Pre-proline 0 C--N 1.277 -2.587 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.33 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.649 ' HB2' HD12 ' B' ' 58' ' ' ILE . 11.6 Cg_exo -70.47 144.04 49.13 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.487 1.458 . . . . 0.0 109.871 169.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 29.3 m -128.02 158.7 39.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 35.1 m -102.08 130.46 51.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.891 177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.419 HD13 HG12 ' B' ' 55' ' ' VAL . 34.7 mm -84.37 105.72 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -10.66 8.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.813 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.527 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.0 OUTLIER -58.61 161.95 4.25 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 125.274 1.43 . . . . 0.0 114.723 -171.283 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -67.26 -172.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.771 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -89.67 -41.28 12.02 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.204 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.455 ' HA ' ' HD2' ' B' ' 48' ' ' LYS . 5.2 m -78.7 -21.91 47.46 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 -32.32 81.16 Favored Glycine 0 C--O 1.219 -0.811 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -69.76 -36.95 76.22 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.227 0.536 . . . . 0.0 110.494 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.455 ' HD2' ' HA ' ' B' ' 45' ' ' THR . 33.9 mttp -77.5 -50.13 13.28 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -115.4 -25.08 8.1 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -88.32 150.02 46.0 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.939 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.68 -16.4 6.69 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.506 1.471 . . . . 0.0 110.618 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.5 p -95.8 143.04 27.37 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 124.539 1.136 . . . . 0.0 112.18 -174.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.21 139.48 51.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.632 HG21 HD22 ' A' ' 122' ' ' LEU . 10.2 tt -92.14 134.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 120.948 0.404 . . . . 0.0 109.954 170.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.485 HG21 HD12 ' B' ' 94' ' ' LEU . 22.0 m -139.9 165.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 120.968 0.413 . . . . 0.0 110.255 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.541 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -124.15 138.83 54.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.52 134.54 47.8 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.649 HD12 ' HB2' ' B' ' 37' ' ' PRO . 64.7 mt -93.45 139.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.011 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 96.9 m -131.69 140.15 49.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' B' ' 84' ' ' SER . . . -60.33 -74.72 0.34 Allowed Glycine 0 C--O 1.219 -0.816 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' B' ' 60' ' ' GLY . 24.8 mmm180 -131.14 164.4 25.57 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 173.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 4.3 tp -167.73 -54.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 121.322 0.582 . . . . 0.0 110.326 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -170.42 147.11 2.94 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -59.81 145.01 46.98 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 123.922 0.764 . . . . 0.0 109.673 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.03 73.21 0.44 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.758 0.789 . . . . 0.0 111.159 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -100.94 -14.84 17.73 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.774 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.8 mt -103.68 141.36 22.34 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.01 0.51 4.34 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.106 1.871 . . . . 0.0 113.255 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 58.0 p -100.58 -18.83 16.42 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.32 0.581 . . . . 0.0 110.368 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -97.33 129.99 44.54 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.86 144.44 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -104.9 151.36 23.96 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.931 0.396 . . . . 0.0 110.653 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.506 HD13 HD11 ' B' ' 86' ' ' ILE . 24.7 pt -127.17 137.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.487 ' O ' ' HD1' ' B' ' 78' ' ' TYR . 27.9 mp0 -60.44 116.25 4.17 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.399 1.08 . . . . 0.0 113.217 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' LYS . . . . . 0.448 ' HB3' ' C ' ' B' ' 82' ' ' LYS . 22.1 pttm -50.39 -36.72 33.98 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.704 0.764 . . . . 0.0 112.627 175.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -53.58 -52.7 58.93 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 113.342 -1.754 . . . . 0.0 113.072 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -92.32 -36.78 12.99 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.592 0.711 . . . . 0.0 111.358 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' B' ' 106' ' ' LEU . 76.6 m-85 -76.08 -7.39 54.6 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.766 -173.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 74.86 28.19 1.14 Allowed 'General case' 0 C--N 1.35 0.619 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 167.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 mp -107.69 -177.51 3.36 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.687 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -91.56 -19.45 22.74 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.814 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.448 ' C ' ' HB3' ' B' ' 75' ' ' LYS . 0.2 OUTLIER -128.46 153.79 46.75 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.061 -173.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -75.87 128.96 36.22 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.501 ' HB3' HD11 ' B' ' 73' ' ' ILE . 6.8 t -102.83 164.49 11.59 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -169.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.2 t -122.42 141.25 43.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.51 HD12 HG12 ' B' ' 58' ' ' ILE . 14.3 mm -108.31 132.72 55.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 177.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -105.54 108.26 19.68 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.195 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.83 -3.98 55.32 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.134 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -95.87 -35.98 11.28 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.275 1.036 . . . . 0.0 109.804 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLN . . . . . 0.469 ' HG2' ' HB3' ' B' ' 32' ' ' GLN . 8.0 tp60 -93.05 80.6 4.55 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.63 177.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.541 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.1 pp -122.53 -177.62 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -173.17 -178.07 1.68 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.453 0.644 . . . . 0.0 112.503 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 54.1 m -124.36 126.0 45.26 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.485 HD12 HG21 ' B' ' 55' ' ' VAL . 81.6 mt -131.82 134.78 46.16 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.589 1.156 . . . . 0.0 109.816 -173.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 2.9 p-10 -78.23 153.93 31.47 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -44.6 -21.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.762 1.625 . . . . 0.0 114.897 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -71.96 -18.62 61.98 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.683 0.793 . . . . 0.0 110.484 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.442 ' HD2' ' HB3' ' A' ' 28' ' ' GLN . 3.0 mmp_? -86.55 -36.38 18.96 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.174 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.79 126.06 28.56 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.791 0.805 . . . . 0.0 110.418 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -95.62 -64.48 1.05 Allowed 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.301 -1.318 . . . . 0.0 113.489 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 16.9 pt-20 -157.93 143.6 17.09 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.35 0.595 . . . . 0.0 111.558 -170.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.1 OUTLIER -66.38 123.88 21.21 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.413 -1.721 . . . . 0.0 110.706 174.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.721 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 24.9 tp -114.38 -62.14 1.64 Allowed 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.56 1.171 . . . . 0.0 110.57 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.721 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 5.1 m -125.14 -175.79 3.4 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 112.837 -1.983 . . . . 0.0 111.872 -163.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.435 ' H ' ' CG2' ' B' ' 104' ' ' THR . 0.4 OUTLIER -159.52 139.31 11.61 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 125.77 1.628 . . . . 0.0 109.384 -168.07 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.523 ' HA ' ' CE2' ' B' ' 78' ' ' TYR . 6.9 mt -101.54 159.62 15.14 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.955 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m -90.4 158.37 17.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.093 174.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' B' ' 111' ' ' MET . 8.7 m-20 -64.48 -28.48 69.69 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.513 0.673 . . . . 0.0 111.952 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.89 -33.52 64.06 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.944 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.451 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 4.6 mptp? -79.96 -22.64 42.38 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.825 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.518 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -56.59 -38.76 72.46 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 170.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.575 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 6.9 mmpt? -78.8 -12.89 60.04 Favored 'General case' 0 N--CA 1.381 -3.921 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.91 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -88.94 -50.47 6.17 Favored 'General case' 0 N--CA 1.391 -3.385 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 t -48.99 -59.6 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.224 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 5.0 m-20 -57.14 -41.87 79.9 Favored 'General case' 0 N--CA 1.514 2.726 0 CA-C-O 123.661 1.696 . . . . 0.0 112.352 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.586 ' O ' HD12 ' B' ' 120' ' ' ILE 0.345 22.0 t30 -83.64 -46.63 12.12 Favored 'General case' 0 C--N 1.251 -3.696 0 CA-C-N 112.319 -2.219 . . . . 0.0 112.285 -168.143 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.19 -32.52 72.28 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.545 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 7.6 tp -62.38 -46.9 86.54 Favored 'General case' 1 N--CA 1.365 -4.684 0 CA-C-N 113.514 -1.676 . . . . 0.0 109.601 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.686 ' SD ' ' HA ' ' B' ' 125' ' ' ASN 0.288 7.9 ptp -66.55 -25.42 66.64 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 177.198 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.586 HD12 ' O ' ' B' ' 116' ' ' ASN . 4.5 mp -72.05 -46.66 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 C-N-CA 117.756 -1.577 . . . . 0.0 108.288 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 14.9 t -58.05 -34.37 70.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.316 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.634 HD22 HG21 ' A' ' 54' ' ' ILE . 13.7 mt -110.41 7.91 23.02 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.56 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.17 20.77 67.52 Favored Glycine 0 N--CA 1.468 0.808 0 N-CA-C 116.983 1.553 . . . . 0.0 116.983 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.782 HD11 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -101.26 18.64 19.43 Favored 'General case' 0 CA--C 1.496 -1.135 0 CA-C-N 118.361 1.08 . . . . 0.0 111.309 -177.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.686 ' HA ' ' SD ' ' B' ' 119' ' ' MET . 20.3 m120 -41.35 131.74 2.77 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.175 0.922 . . . . 0.0 112.21 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.55 11.13 3.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.891 0.853 . . . . 0.0 112.679 -172.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 42.2 t -121.9 4.63 5.98 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 CA-C-N 114.387 -1.279 . . . . 0.0 107.812 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 75.64 135.05 0.06 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.237 1.815 . . . . 0.0 110.452 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -72.22 -13.47 61.54 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.806 -0.559 . . . . 0.0 111.741 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -92.31 3.69 54.88 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.118 0.485 . . . . 0.0 110.425 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -126.78 101.33 6.56 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.605 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.687 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 t -125.61 148.55 48.93 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -101.01 10.56 40.95 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 71.42 103.51 0.07 Allowed 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.883 1.273 . . . . 0.0 109.922 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -62.15 -54.03 46.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.388 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 176.05 -33.44 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -128.63 164.38 23.0 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.592 -2.094 . . . . 0.0 106.343 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -94.56 -60.21 1.76 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.431 ' C ' ' HG ' ' A' ' 10' ' ' SER . 19.3 p80 -119.96 -2.73 10.24 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.97 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.431 ' HG ' ' C ' ' A' ' 9' ' ' HIS . 50.4 p 61.13 -81.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.723 1.609 . . . . 0.0 113.814 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -74.86 124.87 27.64 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -80.5 148.89 67.34 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.28 156.4 10.61 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.866 2.377 . . . . 0.0 113.732 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.3 mt -66.19 133.37 31.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.253 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -102.91 121.91 43.49 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.982 -174.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -59.45 126.26 26.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.84 -7.05 44.67 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.204 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -97.56 -178.6 4.18 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 14.2 t -135.49 136.32 50.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 C-N-CA 123.679 0.792 . . . . 0.0 110.622 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 33.2 m-85 -132.2 146.24 51.88 Favored 'General case' 0 CA--C 1.466 -2.281 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.0 mp -77.84 152.73 33.28 Favored 'General case' 0 N--CA 1.395 -3.184 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.647 170.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -130.07 144.03 51.12 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.897 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 13.3 t70 -89.33 86.66 6.87 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.261 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 4.5 mm? -88.89 41.07 1.01 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.196 1.398 . . . . 0.0 112.496 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.615 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 31.7 m -73.48 174.29 4.96 Favored Pre-proline 0 C--N 1.251 -3.698 0 C-N-CA 126.123 1.769 . . . . 0.0 108.232 171.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.615 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER 4.79 51.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.41 3.81 1 C-N-CA 127.971 5.781 . . . . 0.0 118.65 -178.01 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 27.8 m -69.09 176.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.779 171.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 33.5 mm-40 -104.04 133.14 49.49 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.389 -176.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.76 -120.65 19.85 Favored Glycine 0 CA--C 1.505 -0.594 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.937 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.8 m -91.58 13.39 17.98 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -61.34 152.57 29.05 Favored 'General case' 0 C--O 1.252 1.225 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.71 177.312 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.527 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -71.88 120.86 18.08 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.157 -171.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -101.03 142.36 15.74 Favored Glycine 0 CA--C 1.476 -2.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.431 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 108.76 141.02 9.31 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 114.401 -0.899 . . . . 0.0 111.122 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.57 117.63 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -139.33 148.31 56.3 Favored Pre-proline 0 C--N 1.253 -3.613 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.61 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 50.0 Cg_exo -63.0 138.48 68.15 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.823 2.349 . . . . 0.0 111.654 171.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 20' ' ' TYR . 30.6 m -123.93 156.22 31.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.486 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.9 m -100.93 132.05 47.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 120.809 0.338 . . . . 0.0 110.329 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.466 ' CG2' ' HG2' ' A' ' 42' ' ' GLN . 23.4 mm -91.59 106.66 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -104.37 -9.76 9.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.517 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.56 HE22 ' N ' ' A' ' 47' ' ' ASN . 4.5 pt20 -51.46 162.5 0.36 Allowed 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -168.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -65.42 -177.08 0.38 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.285 -1.779 . . . . 0.0 111.765 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -73.89 -53.73 9.52 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 114.55 -1.204 . . . . 0.0 112.677 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.525 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 20.3 m -82.9 -22.39 33.95 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -166.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.58 -40.18 86.85 Favored Glycine 0 C--O 1.213 -1.219 0 O-C-N 123.059 0.224 . . . . 0.0 113.316 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.56 ' N ' HE22 ' A' ' 42' ' ' GLN . 11.0 p30 -71.05 -20.72 62.34 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 45' ' ' THR . 2.5 mptp? -86.16 -68.03 0.77 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.157 0.503 . . . . 0.0 110.517 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.35 -29.51 24.41 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -168.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 m -91.12 143.35 28.32 Favored Pre-proline 0 N--CA 1.414 -2.238 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.54 -26.45 23.91 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 120.955 1.103 . . . . 0.0 109.709 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.0 p -82.01 147.9 28.93 Favored 'General case' 0 N--CA 1.414 -2.258 0 C-N-CA 125.915 1.686 . . . . 0.0 113.619 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.541 HG13 ' OE1' ' A' ' 42' ' ' GLN . 93.3 t -132.16 140.39 47.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.701 HD11 HD13 ' A' ' 91' ' ' ILE . 5.0 tp -103.86 124.72 58.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.426 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 25.1 m -134.02 167.92 25.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.988 -175.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -126.13 139.52 53.31 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.83 137.38 41.82 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' A' ' 37' ' ' PRO . 60.4 mt -95.6 134.99 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-N 113.115 -1.857 . . . . 0.0 108.468 175.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 m -103.6 124.78 49.44 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.44 -10.44 79.81 Favored Glycine 0 N--CA 1.465 0.583 0 C-N-CA 121.249 -0.501 . . . . 0.0 111.984 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -117.1 170.3 8.76 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.448 HG22 HG21 ' A' ' 85' ' ' VAL . 61.9 mt 70.84 135.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 O-C-N 124.349 1.031 . . . . 0.0 110.557 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -142.59 32.96 1.45 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.833 0.825 . . . . 0.0 109.132 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -128.96 124.66 35.64 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.234 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.05 111.42 15.34 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 120.71 0.29 . . . . 0.0 111.152 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -97.19 -41.41 8.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.004 0.431 . . . . 0.0 111.645 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.681 HD12 ' H ' ' A' ' 67' ' ' ILE . 1.3 mp -87.28 138.95 32.06 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.94 1.18 2.01 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.677 2.251 . . . . 0.0 113.706 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.9 p -91.69 -16.26 27.23 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-O 122.301 1.048 . . . . 0.0 108.288 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -107.34 129.31 54.92 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 73' ' ' ILE . 67.8 t -126.18 127.15 70.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.618 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.25 124.63 37.36 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.667 0.746 . . . . 0.0 109.8 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.679 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -108.75 156.34 9.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.297 -175.147 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -63.25 119.78 10.27 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 123.779 0.674 . . . . 0.0 112.619 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -46.12 -46.77 17.28 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 126.071 1.748 . . . . 0.0 110.336 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -58.2 -32.31 68.15 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 126.673 1.989 . . . . 0.0 112.826 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -91.14 -39.04 12.36 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.712 0.768 . . . . 0.0 110.792 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.679 ' CE1' HG21 ' A' ' 73' ' ' ILE . 4.2 m-85 -83.22 -9.45 59.14 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.793 -177.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 67.09 40.87 2.77 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.921 0.889 . . . . 0.0 111.096 174.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.41 -179.71 3.96 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.836 0.827 . . . . 0.0 111.073 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.8 -10.78 41.58 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.258 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -139.8 161.26 37.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.34 142.12 50.42 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.7 t -110.0 155.76 21.39 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.545 -171.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.448 HG21 HG22 ' A' ' 62' ' ' ILE . 12.6 t -117.74 128.11 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.483 HD13 HG13 ' A' ' 73' ' ' ILE . 1.6 mp -103.52 125.53 58.06 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.94 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 90' ' ' GLN . 67.0 mt -100.97 110.61 22.67 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 113.228 -1.806 . . . . 0.0 110.04 -175.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.56 HD12 HD23 ' A' ' 118' ' ' LEU . 3.6 mm? -83.84 3.25 34.48 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.732 -175.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -119.03 4.2 11.4 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.787 1.28 . . . . 0.0 108.39 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 8.5 tp60 -122.85 35.1 4.96 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.535 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.701 HD13 HD11 ' A' ' 54' ' ' ILE . 2.1 pp -85.94 -178.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.186 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.527 ' NH2' ' HB3' ' A' ' 32' ' ' GLN . 9.3 ptp85 -167.66 168.6 12.5 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 16.2 m -122.41 118.87 29.41 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.609 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 60.7 mt -131.89 140.1 48.97 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.255 -173.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.534 ' OD2' ' HB3' ' A' ' 97' ' ' LYS . 4.7 p-10 -72.89 151.26 42.01 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.635 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -45.54 -35.5 3.96 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.534 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 7.4 ttpm? -61.29 -26.1 67.56 Favored 'General case' 0 C--N 1.273 -2.753 0 C-N-CA 123.879 0.872 . . . . 0.0 112.634 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.441 ' NH1' ' HB3' ' A' ' 23' ' ' ASP . 2.3 mmp_? -75.53 -28.48 59.11 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.171 0.51 . . . . 0.0 110.813 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.05 124.22 24.5 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.492 1.117 . . . . 0.0 110.12 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -87.72 -63.64 1.27 Allowed 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.21 -1.359 . . . . 0.0 113.305 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.1 pt-20 -161.11 142.39 11.68 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 121.403 0.62 . . . . 0.0 111.969 -170.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -60.94 120.92 11.13 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 126.186 1.794 . . . . 0.0 110.731 174.408 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.53 -62.83 1.54 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.518 HG22 HG11 ' A' ' 19' ' ' VAL . 4.8 t -125.41 -167.0 1.62 Allowed 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.263 -1.375 . . . . 0.0 111.626 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -161.2 135.18 6.86 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 124.092 0.957 . . . . 0.0 111.831 -171.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -105.4 163.36 12.69 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.176 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.5 p -90.86 170.14 10.34 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.282 0.563 . . . . 0.0 112.459 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 111' ' ' MET . 27.6 t70 -65.82 -30.82 71.5 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.292 1.037 . . . . 0.0 112.492 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -75.44 -24.26 57.03 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 122.035 -0.415 . . . . 0.0 110.491 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.7 OUTLIER -75.13 -26.65 59.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.356 174.417 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.486 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -55.01 -39.32 68.96 Favored 'General case' 0 CA--C 1.471 -2.085 0 CA-C-O 122.04 0.924 . . . . 0.0 109.818 172.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.494 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 8.3 mmpt? -74.28 -15.21 60.98 Favored 'General case' 0 N--CA 1.393 -3.292 0 CA-C-N 114.214 -1.357 . . . . 0.0 113.112 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -86.93 -56.03 3.57 Favored 'General case' 0 N--CA 1.389 -3.51 0 C-N-CA 117.649 -1.62 . . . . 0.0 109.245 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 110' ' ' LYS . 22.0 m -57.33 -47.7 84.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -174.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.5 ' HB3' ' HG ' ' B' ' 124' ' ' LEU . 44.5 m-20 -60.53 -48.02 83.6 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 123.536 1.636 . . . . 0.0 109.931 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 12.1 t30 -76.06 -39.87 54.49 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 112.267 -2.242 . . . . 0.0 112.647 -168.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.513 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -60.25 -38.51 83.68 Favored 'General case' 0 CA--C 1.469 -2.142 0 CA-C-O 122.279 1.038 . . . . 0.0 108.605 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.56 HD23 HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -83.0 -27.82 30.12 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.297 -173.28 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.435 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 3.7 ttp -60.27 -30.09 69.23 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 124.079 0.951 . . . . 0.0 108.552 172.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 116' ' ' ASN . 52.9 mt -81.22 -55.61 7.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.9 t -49.76 -43.25 47.91 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.938 1.695 . . . . 0.0 111.935 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.485 ' HG ' HG12 ' B' ' 54' ' ' ILE . 9.0 mp -82.12 5.65 18.93 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.28 5.41 76.09 Favored Glycine 0 C--N 1.341 0.857 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' B' ' 115' ' ' ASP . 3.5 mp -73.23 -42.76 62.22 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.484 1.142 . . . . 0.0 108.63 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 60.99 168.38 0.09 Allowed 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 126.501 1.921 . . . . 0.0 114.836 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.44 24.28 0.57 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.104 0.954 . . . . 0.0 111.826 -173.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.56 -2.04 9.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-O 122.789 1.28 . . . . 0.0 108.326 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.27 9.81 39.69 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.153 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.485 ' HB3' ' O ' ' B' ' 129' ' ' HIS . 90.1 m-70 -89.75 -50.96 5.76 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.672 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -116.34 171.69 7.67 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -136.17 142.93 44.2 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 . . . . . 0 C--N 1.294 -1.84 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.505 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.858 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 38.4 t -113.24 145.83 40.35 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m -100.45 11.74 38.79 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 73.1 101.12 0.07 Allowed 'General case' 0 C--N 1.349 0.561 0 C-N-CA 124.619 1.167 . . . . 0.0 109.729 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -61.58 -53.38 57.01 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.49 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 179.6 -37.75 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -125.49 170.48 11.38 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 112.383 -2.189 . . . . 0.0 106.271 174.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -98.82 -56.44 2.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -124.29 -2.35 8.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.743 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p 57.72 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.301 1.441 . . . . 0.0 113.276 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -68.48 123.17 20.08 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.15 147.38 72.91 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.71 152.64 16.42 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.364 2.71 . . . . 0.0 113.972 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 86.5 mt -59.68 134.08 24.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.195 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -104.44 122.41 45.46 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.058 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -59.55 124.97 21.81 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 120.969 0.414 . . . . 0.0 110.105 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.51 -7.42 46.47 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.501 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -97.17 179.2 4.99 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 17.4 t -134.17 137.48 51.83 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 C-N-CA 123.546 0.738 . . . . 0.0 111.031 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 27.7 m-85 -132.99 145.41 50.85 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.3 mp -76.62 151.36 36.25 Favored 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.664 170.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.63 143.83 51.0 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.341 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -87.36 84.45 7.19 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.167 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.517 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 4.4 mm? -88.17 40.93 0.98 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 123.172 1.463 . . . . 0.0 112.444 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.591 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.257 14.7 m -73.67 174.76 4.35 Favored Pre-proline 1 C--N 1.242 -4.097 0 CA-C-N 113.279 -1.782 . . . . 0.0 108.162 172.612 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 13.9 Cg_exo 3.19 53.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.406 3.571 1 C-N-CA 128.129 5.886 . . . . 0.0 118.077 -179.294 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 m -69.4 -178.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 113.44 -1.709 . . . . 0.0 111.836 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' B' ' 31' ' ' GLU . 33.1 mm-40 -109.79 132.7 53.91 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.624 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.87 -125.74 40.6 Favored Glycine 0 CA--C 1.499 -0.964 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.263 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 39.6 m -93.55 22.18 5.62 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.38 -0.41 . . . . 0.0 112.03 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' B' ' 28' ' ' GLN . 0.0 OUTLIER -64.24 162.46 14.61 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.388 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.565 ' HB3' ' NH2' ' B' ' 92' ' ' ARG . 0.9 OUTLIER -79.92 117.42 20.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 120.87 0.367 . . . . 0.0 110.262 -173.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -98.07 145.8 17.93 Favored Glycine 0 CA--C 1.473 -2.556 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.514 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 106.54 138.96 9.24 Favored Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 114.431 -0.884 . . . . 0.0 111.18 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 t -56.93 119.42 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ARG . . . . . 0.431 ' NH1' ' HA ' ' B' ' 59' ' ' THR . 58.7 mtt180 -140.7 148.43 52.87 Favored Pre-proline 0 C--N 1.256 -3.488 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.431 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.534 ' HB2' HD12 ' B' ' 58' ' ' ILE . 35.2 Cg_exo -64.1 138.49 62.2 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.707 2.271 . . . . 0.0 111.454 171.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.42 HG22 ' O ' ' B' ' 20' ' ' TYR . 31.5 m -123.54 156.41 30.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 33.1 m -100.86 132.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.896 0.379 . . . . 0.0 110.439 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.477 ' CG2' ' HG2' ' B' ' 42' ' ' GLN . 24.3 mm -91.69 107.15 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.417 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -104.48 -9.99 9.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.571 ' OE1' HG13 ' B' ' 53' ' ' VAL . 4.7 pt20 -51.67 162.19 0.43 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -168.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -67.04 -179.88 1.02 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.263 -1.79 . . . . 0.0 111.852 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.25 -55.17 15.09 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.01 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.549 ' HA ' ' HD3' ' B' ' 48' ' ' LYS . 10.4 m -84.92 -22.3 29.32 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -164.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.64 -38.57 82.54 Favored Glycine 0 C--O 1.21 -1.381 0 O-C-N 123.236 0.335 . . . . 0.0 113.136 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.549 ' N ' HE22 ' B' ' 42' ' ' GLN . 10.2 p30 -71.79 -20.95 61.78 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.549 ' HD3' ' HA ' ' B' ' 45' ' ' THR . 2.8 mptp? -86.57 -67.75 0.79 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.138 0.494 . . . . 0.0 110.408 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.37 -35.78 24.86 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -169.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 18.7 m -86.09 143.31 37.06 Favored Pre-proline 0 N--CA 1.415 -2.215 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.28 -25.69 21.67 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.025 1.15 . . . . 0.0 109.309 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.4 p -82.71 145.97 29.3 Favored 'General case' 0 N--CA 1.415 -2.188 0 C-N-CA 125.545 1.538 . . . . 0.0 113.579 -173.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.571 HG13 ' OE1' ' B' ' 42' ' ' GLN . 98.0 t -130.01 140.52 48.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 176.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.702 HD11 HD13 ' B' ' 91' ' ' ILE . 5.1 tp -103.76 124.57 58.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 121.291 0.567 . . . . 0.0 109.697 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.418 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 24.8 m -134.15 167.09 26.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.965 -175.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.506 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -125.53 139.54 53.52 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.49 135.78 42.23 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' B' ' 37' ' ' PRO . 59.4 mt -93.98 135.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 113.248 -1.796 . . . . 0.0 108.05 174.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' THR . . . . . 0.431 ' HA ' ' NH1' ' B' ' 36' ' ' ARG . 19.2 m -101.92 127.22 48.86 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.28 -12.23 80.98 Favored Glycine 0 N--CA 1.466 0.659 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.76 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -121.57 174.24 6.91 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.449 HG22 HG21 ' B' ' 85' ' ' VAL . 61.3 mt 71.53 138.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 O-C-N 124.044 0.84 . . . . 0.0 110.339 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -142.85 20.7 1.98 Allowed 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.281 -0.887 . . . . 0.0 109.755 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -118.6 124.17 46.8 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.426 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.86 112.06 17.88 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.591 0.234 . . . . 0.0 111.398 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -100.14 -35.5 9.64 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.153 0.501 . . . . 0.0 111.379 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.64 ' H ' HD12 ' B' ' 67' ' ' ILE . 0.9 OUTLIER -93.9 137.6 23.03 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 -177.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.09 3.34 1.32 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.768 2.312 . . . . 0.0 113.755 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 58.9 p -92.4 -15.9 26.62 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.455 1.121 . . . . 0.0 108.504 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -108.64 129.76 55.33 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 175.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.518 HG12 HD13 ' B' ' 73' ' ' ILE . 62.9 t -125.42 127.06 71.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 O-C-N 121.611 -0.681 . . . . 0.0 110.736 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.34 120.62 32.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.663 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.1 OUTLIER -106.6 154.28 7.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.449 -175.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -62.01 119.48 8.96 Favored 'General case' 0 C--O 1.251 1.176 0 O-C-N 124.202 0.939 . . . . 0.0 112.619 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -46.55 -46.33 19.27 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.147 1.779 . . . . 0.0 110.48 172.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -59.73 -31.33 69.52 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 126.219 1.807 . . . . 0.0 112.938 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -90.73 -39.44 12.42 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.199 0.523 . . . . 0.0 110.631 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.663 ' CE1' HG21 ' B' ' 73' ' ' ILE . 4.3 m-85 -83.29 -10.8 58.31 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.879 -177.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 tttp 70.41 34.2 2.3 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.31 1.044 . . . . 0.0 111.851 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.69 -179.79 4.07 Favored 'General case' 0 CA--C 1.492 -1.259 0 O-C-N 120.973 -1.08 . . . . 0.0 111.613 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.82 -13.41 42.24 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.785 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -140.35 161.65 37.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.98 144.8 52.21 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t -112.4 157.28 21.24 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.449 HG21 HG22 ' B' ' 62' ' ' ILE . 11.0 t -118.2 128.31 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.511 HD13 HG13 ' B' ' 73' ' ' ILE . 1.6 mp -103.12 124.75 57.44 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' B' ' 90' ' ' GLN . 74.5 mt -100.18 111.5 23.78 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.054 -175.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.54 HD12 HD23 ' B' ' 118' ' ' LEU . 3.6 mm? -84.06 2.75 37.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.614 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -119.15 4.79 11.29 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.818 1.294 . . . . 0.0 108.477 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 8.3 tp60 -123.61 35.33 4.87 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.159 -1.837 . . . . 0.0 106.481 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.702 HD13 HD11 ' B' ' 54' ' ' ILE . 2.1 pp -85.81 -178.31 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.192 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.565 ' NH2' ' HB3' ' B' ' 32' ' ' GLN . 9.6 ptp85 -167.53 168.93 12.49 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 11.0 m -122.37 118.29 28.08 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.594 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 64.8 mt -132.0 139.86 48.76 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.403 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.531 ' OD2' ' HB3' ' B' ' 97' ' ' LYS . 6.2 p-10 -71.47 151.59 43.81 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.193 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -46.21 -37.0 6.57 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.531 ' HB3' ' OD2' ' B' ' 95' ' ' ASP . 7.0 ttpm? -61.59 -24.47 66.7 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.667 176.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -74.6 -30.11 61.56 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.481 -0.762 . . . . 0.0 110.352 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -71.31 124.93 25.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.499 1.12 . . . . 0.0 110.428 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -88.22 -64.68 1.11 Allowed 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.745 -1.571 . . . . 0.0 112.732 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 9.9 pt-20 -161.25 142.12 11.28 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 121.502 0.668 . . . . 0.0 112.523 -171.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.2 OUTLIER -60.45 121.31 11.78 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 126.491 1.916 . . . . 0.0 110.938 174.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -114.82 -63.0 1.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.345 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.496 HG22 HG11 ' B' ' 19' ' ' VAL . 3.3 t -125.25 -166.54 1.55 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.172 -1.411 . . . . 0.0 111.816 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -161.13 135.87 7.37 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.002 0.921 . . . . 0.0 112.112 -170.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 pp -108.79 157.4 18.61 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.02 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 7.1 p -86.82 175.49 8.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' B' ' 111' ' ' MET . 22.9 t70 -72.21 -29.47 64.0 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.151 0.5 . . . . 0.0 111.812 -174.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -70.2 -23.38 62.94 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.355 0.597 . . . . 0.0 109.91 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.441 ' O ' HG22 ' B' ' 114' ' ' VAL . 0.6 OUTLIER -78.8 -27.4 44.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 174.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.466 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.0 OUTLIER -55.51 -39.44 70.5 Favored 'General case' 0 CA--C 1.46 -2.487 0 CA-C-O 122.336 1.065 . . . . 0.0 109.131 172.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.516 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 6.9 mmpt? -71.98 -17.16 62.08 Favored 'General case' 1 N--CA 1.378 -4.053 0 CA-C-N 113.725 -1.579 . . . . 0.0 113.841 -178.095 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.97 -57.98 2.76 Favored 'General case' 0 N--CA 1.39 -3.436 0 C-N-CA 117.561 -1.656 . . . . 0.0 109.198 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 110' ' ' LYS . 22.9 m -54.85 -47.02 75.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.519 ' HB3' ' HG ' ' A' ' 124' ' ' LEU . 55.6 m-20 -61.3 -48.97 78.93 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.636 1.684 . . . . 0.0 110.535 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' B' ' 119' ' ' MET 0.349 27.0 t30 -77.13 -38.69 51.51 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.539 -167.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.425 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -62.63 -37.56 86.8 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-O 122.267 1.032 . . . . 0.0 108.812 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.54 HD23 HD12 ' B' ' 88' ' ' LEU . 0.7 OUTLIER -82.66 -27.44 31.32 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.888 -174.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' B' ' 116' ' ' ASN . 4.0 ttp -60.25 -31.44 70.21 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 59.6 mt -79.03 -56.39 7.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.2 t -48.64 -43.45 36.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.114 1.366 . . . . 0.0 112.235 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.49 ' HG ' HG12 ' A' ' 54' ' ' ILE . 8.6 mp -81.64 6.06 16.3 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.36 7.28 79.83 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 115.661 1.025 . . . . 0.0 115.661 172.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 115' ' ' ASP . 3.8 mp -73.59 -43.82 58.78 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 118.328 1.064 . . . . 0.0 108.422 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 61.18 169.54 0.1 Allowed 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 126.689 1.995 . . . . 0.0 114.72 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.04 27.16 0.68 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.811 0.815 . . . . 0.0 111.576 -173.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 16.0 t -101.75 -7.47 9.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-O 122.375 1.084 . . . . 0.0 108.38 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.43 8.59 44.67 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 113.891 -1.504 . . . . 0.0 112.407 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.485 ' O ' ' HB3' ' A' ' 129' ' ' HIS . 96.4 m-70 -87.14 -51.04 6.22 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.588 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -118.58 167.84 11.25 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -130.45 144.74 51.59 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 19.5 m120 . . . . . 0 C--N 1.286 -2.163 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 175.922 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -93.19 -51.13 5.17 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 122.614 0.366 . . . . 0.0 111.505 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 m -82.54 -42.76 17.95 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 121.554 0.692 . . . . 0.0 110.186 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -106.07 145.55 31.28 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -85.65 80.35 9.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.209 1.004 . . . . 0.0 111.048 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -124.03 116.22 22.47 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.479 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -84.85 123.9 30.99 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 173.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -76.73 102.43 6.22 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -104.14 112.94 26.16 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.901 -171.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -121.13 134.79 55.25 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.512 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -79.65 115.89 19.52 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.354 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' O ' HG13 ' A' ' 14' ' ' ILE . 16.0 t70 -87.87 145.37 36.51 Favored Pre-proline 0 C--N 1.28 -2.449 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.61 101.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.503 2.135 . . . . 0.0 113.171 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 12' ' ' ASP . 62.7 mt -85.82 125.45 40.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.221 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.445 ' HG2' ' OD2' ' A' ' 18' ' ' ASP . 8.4 ptp180 -121.59 157.99 29.54 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 171.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.535 HH22 ' HG2' ' B' ' 131' ' ' LYS . 28.6 ptt85 -69.36 113.65 6.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 168.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.495 ' HA2' ' SD ' ' A' ' 111' ' ' MET . . . 131.76 -9.07 5.51 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.875 -173.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD2' ' HG2' ' A' ' 15' ' ' ARG . 32.9 m-20 -96.46 173.19 7.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 122.016 0.912 . . . . 0.0 109.713 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 12.4 t -132.3 134.22 59.47 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.794 178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.466 ' O ' HG22 ' A' ' 38' ' ' VAL . 50.7 m-85 -135.62 144.01 45.86 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 125.325 1.45 . . . . 0.0 108.977 176.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.637 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.9 mp -79.42 149.49 31.59 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-O 121.539 0.685 . . . . 0.0 111.097 173.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.67 134.23 33.37 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.177 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.553 ' HA ' ' HB ' ' A' ' 35' ' ' VAL 0.326 3.2 p-10 -81.64 104.72 12.25 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 117.931 -1.508 . . . . 0.0 111.346 176.278 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 5.4 mt -90.55 37.78 0.92 Allowed 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 124.92 2.295 . . . . 0.0 110.273 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.576 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.282 7.3 m -63.62 171.91 2.02 Favored Pre-proline 1 C--N 1.223 -4.904 0 CA-C-N 109.364 -3.562 . . . . 0.0 107.314 167.599 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 1.0 OUTLIER 6.04 53.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.401 3.307 1 C-N-CA 126.977 5.118 . . . . 0.0 118.227 -174.73 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.32 -178.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.717 166.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -108.01 126.46 52.75 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.89 -117.9 9.82 Favored Glycine 0 N--CA 1.425 -2.058 0 CA-C-N 113.781 -1.554 . . . . 0.0 114.329 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.9 m -93.89 22.08 6.01 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.445 -0.878 . . . . 0.0 112.869 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.96 -176.36 0.68 Allowed 'General case' 0 C--O 1.247 0.948 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.934 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.412 ' OE1' ' HD2' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -88.8 109.11 19.9 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.56 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.18 143.27 16.45 Favored Glycine 0 CA--C 1.472 -2.636 0 CA-C-N 115.149 -0.932 . . . . 0.0 114.281 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 108.07 137.1 8.12 Favored Glycine 0 N--CA 1.418 -2.535 0 CA-C-N 113.85 -1.175 . . . . 0.0 110.811 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 2.0 p -61.93 126.71 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 122.455 1.121 . . . . 0.0 111.053 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 84.4 mtt180 -149.61 166.27 15.62 Favored Pre-proline 0 C--N 1.266 -3.04 0 CA-C-N 112.927 -1.942 . . . . 0.0 108.2 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 3.8 Cg_exo -75.92 143.9 26.76 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 121.903 1.735 . . . . 0.0 111.555 174.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 20' ' ' TYR . 28.6 m -118.45 158.53 19.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 34.3 m -102.36 133.05 47.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.767 0.318 . . . . 0.0 110.729 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 mm -88.72 104.9 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.403 HD13 ' C ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -104.4 -20.81 5.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.114 -178.622 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -54.88 165.95 0.56 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -170.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -60.66 164.03 4.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.051 -1.886 . . . . 0.0 112.527 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.08 -39.32 79.13 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.52 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 m -86.97 -26.56 23.76 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -171.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.89 -37.2 92.22 Favored Glycine 0 C--O 1.201 -1.919 0 CA-C-N 116.354 -0.385 . . . . 0.0 113.402 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.535 ' OD1' ' HD2' ' A' ' 48' ' ' LYS . 27.5 p30 -69.55 -19.69 63.68 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HD2' ' OD1' ' A' ' 47' ' ' ASN . 13.0 mptt -84.51 -61.73 1.73 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 109.901 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -89.13 -21.93 23.11 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -168.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.2 m -105.94 139.71 20.52 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.668 -0.645 . . . . 0.0 109.652 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.48 -22.26 14.17 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.437 1.425 . . . . 0.0 109.597 174.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 3.7 p -96.17 133.69 40.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.456 1.102 . . . . 0.0 111.889 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.24 145.96 34.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.3 tt -96.68 132.68 40.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.543 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.453 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 30.0 m -137.77 172.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.383 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.558 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -126.0 139.55 53.33 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.53 142.76 42.75 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.622 HD12 ' HB2' ' A' ' 37' ' ' PRO . 82.7 mt -101.86 129.53 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.759 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.8 m -119.27 105.31 11.21 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.82 150.05 22.05 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 55.6 mtp180 65.94 89.88 0.09 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.099 0.96 . . . . 0.0 112.063 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 61' ' ' ARG . 0.1 OUTLIER -178.04 -48.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 174.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 83' ' ' ASP . 2.4 m-20 60.08 -167.15 0.18 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.091 0.957 . . . . 0.0 110.394 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt 57.95 67.83 0.91 Allowed 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.68 0.612 . . . . 0.0 111.383 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.57 -61.32 2.36 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.748 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.4 tttp 69.13 -57.29 0.53 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.248 1.419 . . . . 0.0 112.539 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.4 HD12 ' CE1' ' A' ' 70' ' ' HIS . 12.5 mt -80.19 139.25 52.52 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.14 -11.29 21.33 Favored 'Trans proline' 0 CA--C 1.563 1.927 0 C-N-CA 122.199 1.933 . . . . 0.0 113.723 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.7 p -90.21 -19.02 24.67 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.353 0.597 . . . . 0.0 110.702 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.4 ' CE1' HD12 ' A' ' 67' ' ' ILE . 26.1 m170 -95.1 130.27 41.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.49 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.82 132.87 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.34 132.95 52.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.298 0.571 . . . . 0.0 110.909 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.805 HG23 ' HG2' ' A' ' 110' ' ' LYS . 0.7 OUTLIER -107.53 165.53 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.021 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.475 ' H ' HG22 ' A' ' 73' ' ' ILE . 1.3 mp0 -69.54 110.08 4.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 124.074 0.95 . . . . 0.0 109.828 176.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 20.8 pttm -58.09 -35.89 72.08 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.563 0.696 . . . . 0.0 112.115 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -51.61 -45.72 63.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.327 -1.76 . . . . 0.0 111.03 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -82.98 -34.68 26.34 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.288 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.661 ' CE1' HG21 ' A' ' 73' ' ' ILE . 1.8 m-85 -73.35 -11.52 60.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.031 -177.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.2 tptt 78.45 18.94 0.99 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.879 1.272 . . . . 0.0 111.732 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.13 179.36 4.51 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.285 1.04 . . . . 0.0 110.988 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -97.11 -24.8 15.58 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.977 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -130.33 155.25 46.66 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.108 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.467 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 4.5 m-20 -56.74 142.68 39.48 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 122.021 0.915 . . . . 0.0 113.203 -175.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.9 m -108.02 128.63 54.83 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.158 -174.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.3 t -115.82 130.22 70.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 HD22 ' A' ' 88' ' ' LEU . 1.6 mp -107.22 129.68 60.61 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.843 0 CA-C-O 122.196 0.998 . . . . 0.0 108.575 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.0 mt -103.42 108.34 19.55 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 113.194 -1.821 . . . . 0.0 109.214 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.519 HD22 HG22 ' A' ' 86' ' ' ILE . 3.9 mm? -80.41 4.35 18.33 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.373 -175.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.12 -38.0 6.13 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.378 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.48 53.35 2.78 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.545 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.558 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.0 pp -97.21 -176.16 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -173.96 178.11 2.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 45.4 m -121.76 129.15 52.48 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.884 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 mt -133.17 145.56 50.74 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 124.373 1.069 . . . . 0.0 109.328 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.486 ' OD2' ' HB3' ' A' ' 97' ' ' LYS . 2.2 p-10 -79.73 151.16 30.57 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.284 -1.367 . . . . 0.0 110.115 173.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -39.14 -41.06 0.79 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.994 2.117 . . . . 0.0 114.521 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.486 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 7.0 ttpm? -63.65 -13.74 45.43 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 124.122 0.969 . . . . 0.0 112.401 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' A' ' 98' ' ' ARG . 3.7 mmp_? -89.73 -26.94 20.38 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.166 -0.959 . . . . 0.0 110.912 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -74.89 108.56 7.7 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-O 122.14 0.971 . . . . 0.0 109.514 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -93.83 -59.28 2.03 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -143.66 130.41 20.31 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.918 0.866 . . . . 0.0 113.232 -171.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.2 tttp -60.77 119.9 9.07 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 127.266 2.226 . . . . 0.0 108.184 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.7 tp -114.5 -62.38 1.61 Allowed 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.804 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 78' ' ' TYR . 6.1 t -127.75 -160.49 1.02 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.238 -1.385 . . . . 0.0 112.457 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -159.37 149.97 19.42 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.371 1.868 . . . . 0.0 109.158 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -101.82 147.49 26.43 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.688 -177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -64.32 143.16 58.1 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 125.1 1.36 . . . . 0.0 108.608 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 111' ' ' MET . 7.0 p-10 -58.45 -37.39 75.34 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.29 -34.47 63.55 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.809 0.337 . . . . 0.0 110.606 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.805 ' HG2' HG23 ' A' ' 73' ' ' ILE . 16.7 tppt? -67.67 -33.58 75.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.495 ' SD ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -51.31 -46.18 62.47 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.693 173.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.696 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -69.69 -17.78 63.5 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.72 -178.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -83.54 -38.67 21.41 Favored 'General case' 0 CA--C 1.442 -3.175 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.21 -42.99 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.671 0 O-C-N 126.13 2.144 . . . . 0.0 109.999 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.693 ' OD2' ' HA ' ' A' ' 112' ' ' LYS . 44.8 m-20 -57.4 -58.92 6.16 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.53 ' O ' HG13 ' A' ' 120' ' ' ILE . 2.5 m120 -59.38 -47.39 85.63 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.3 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.515 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -52.09 -43.81 64.09 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 124.341 1.056 . . . . 0.0 110.852 -178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 tp -67.21 -45.93 75.38 Favored 'General case' 1 N--CA 1.374 -4.252 0 C-N-CA 124.336 1.054 . . . . 0.0 109.971 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.2 mtp -67.82 -20.08 65.13 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 121.477 -0.765 . . . . 0.0 112.891 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 116' ' ' ASN . 49.4 mt -77.24 -55.75 9.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 26.2 t -53.22 -42.65 66.57 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.759 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.4 mp -90.06 -1.14 57.91 Favored 'General case' 0 N--CA 1.403 -2.782 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.65 13.14 82.84 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 116.571 1.389 . . . . 0.0 116.571 170.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 5.2 mp -79.57 -59.84 2.59 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 118.624 1.212 . . . . 0.0 110.985 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 43.37 -151.28 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.65 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.3 16.49 24.74 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.061 0.934 . . . . 0.0 109.309 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.2 t -117.73 18.83 6.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.237 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 124' ' ' LEU . . . -81.11 -9.58 59.79 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.616 -0.678 . . . . 0.0 111.138 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -65.74 -52.36 51.79 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 120.925 0.393 . . . . 0.0 110.72 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -136.08 72.05 1.43 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.014 0.911 . . . . 0.0 111.118 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.551 ' HG2' HH22 ' B' ' 16' ' ' ARG . 87.2 tttt -156.31 108.03 2.5 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.429 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 p30 . . . . . 0 C--N 1.298 -1.644 0 CA-C-O 118.569 -0.729 . . . . 0.0 109.409 178.902 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.837 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -96.46 -46.0 6.54 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.246 0.545 . . . . 0.0 111.731 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -86.64 -31.86 20.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.296 0.57 . . . . 0.0 110.314 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -121.97 146.43 47.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -83.36 79.67 9.33 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 122.012 0.91 . . . . 0.0 110.315 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -125.69 112.48 16.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.726 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -80.64 122.6 27.29 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -75.52 100.9 4.68 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -105.42 119.2 38.49 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.121 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 17.2 m -127.4 145.27 50.88 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -91.89 116.17 28.68 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.04 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -83.01 146.47 51.93 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 171.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.21 114.69 0.9 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 122.186 1.924 . . . . 0.0 111.04 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 75.6 mt -99.52 120.69 49.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.058 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -117.35 159.14 23.21 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.551 HH22 ' HG2' ' A' ' 131' ' ' LYS . 27.0 ptt85 -70.0 113.54 7.31 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.427 ' HA2' ' SD ' ' B' ' 111' ' ' MET . . . 133.34 -15.3 4.74 Favored Glycine 0 C--N 1.305 -1.163 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.666 -173.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -89.72 171.92 9.3 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 121.946 0.879 . . . . 0.0 109.047 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.408 HG11 HG22 ' B' ' 104' ' ' THR . 13.3 t -131.19 132.88 63.09 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.774 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.841 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.492 ' O ' HG22 ' B' ' 38' ' ' VAL . 75.6 m-85 -133.65 143.69 48.74 Favored 'General case' 0 CA--C 1.474 -1.957 0 C-N-CA 125.199 1.4 . . . . 0.0 109.463 176.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.652 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.9 mp -81.49 148.42 29.21 Favored 'General case' 0 N--CA 1.397 -3.095 0 CA-C-O 121.687 0.756 . . . . 0.0 110.99 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -136.59 134.73 37.72 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 113.177 -1.829 . . . . 0.0 107.209 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' B' ' 35' ' ' VAL 0.333 3.6 p-10 -81.95 102.51 10.97 Favored 'General case' 0 C--N 1.279 -2.467 0 C-N-CA 117.975 -1.49 . . . . 0.0 111.658 175.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 4.9 mt -87.8 39.1 0.87 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 125.085 2.374 . . . . 0.0 110.396 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.572 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.287 6.6 m -64.62 171.87 2.55 Favored Pre-proline 1 C--N 1.22 -5.027 0 CA-C-N 109.363 -3.562 . . . . 0.0 107.219 167.083 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.3 OUTLIER 5.85 53.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.173 1 C-N-CA 127.153 5.235 . . . . 0.0 118.386 -174.746 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 28.5 m -69.29 -179.1 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.534 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -106.52 130.95 54.21 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.99 -117.9 7.37 Favored Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 113.751 -1.568 . . . . 0.0 113.82 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -94.18 18.08 11.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.34 -0.93 . . . . 0.0 113.188 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.52 178.1 1.04 Allowed 'General case' 0 C--O 1.249 1.063 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.942 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.457 ' OE1' ' HD2' ' B' ' 36' ' ' ARG . 1.0 OUTLIER -83.52 108.81 16.89 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.522 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.79 138.52 14.11 Favored Glycine 0 CA--C 1.479 -2.212 0 CA-C-N 114.904 -1.043 . . . . 0.0 114.324 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 117.5 136.92 5.71 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 113.813 -1.193 . . . . 0.0 110.512 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' B' ' 23' ' ' ASP . 1.5 p -63.85 121.21 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 122.497 1.141 . . . . 0.0 110.9 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ARG . . . . . 0.457 ' HD2' ' OE1' ' B' ' 32' ' ' GLN . 87.8 mtt180 -144.51 166.69 17.52 Favored Pre-proline 0 C--N 1.26 -3.319 0 CA-C-N 112.846 -1.979 . . . . 0.0 109.028 -174.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 5.4 Cg_exo -76.05 142.7 25.07 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 122.003 1.802 . . . . 0.0 111.507 174.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.492 HG22 ' O ' ' B' ' 20' ' ' TYR . 31.0 m -118.07 158.08 19.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.2 m -102.22 132.42 48.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.807 0.336 . . . . 0.0 110.79 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 24.0 mm -88.09 104.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.47 -20.8 5.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.004 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -55.64 165.91 0.77 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 -170.478 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -59.77 163.3 4.54 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 112.709 -2.042 . . . . 0.0 112.784 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.0 -37.97 75.83 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.498 -175.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 25.8 m -87.23 -28.35 22.42 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.03 -36.06 86.65 Favored Glycine 0 C--O 1.2 -1.99 0 CA-C-O 120.077 -0.291 . . . . 0.0 113.336 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.548 ' OD1' ' HD2' ' B' ' 48' ' ' LYS . 26.6 p30 -69.21 -19.58 63.97 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.548 ' HD2' ' OD1' ' B' ' 47' ' ' ASN . 13.1 mptt -85.66 -59.44 2.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.222 0.534 . . . . 0.0 110.369 174.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -89.25 -29.75 19.0 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -169.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.7 m -99.45 138.41 20.48 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -74.7 -22.09 15.89 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.281 1.32 . . . . 0.0 109.708 173.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 3.1 p -95.43 132.7 40.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.546 -176.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.32 146.38 34.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.42 ' CD1' HD11 ' A' ' 91' ' ' ILE . 4.8 tt -96.97 132.85 40.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 123.112 0.565 . . . . 0.0 110.317 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.462 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 28.3 m -138.03 171.93 14.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.556 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.558 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -125.05 139.8 53.47 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.12 142.03 41.77 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.631 HD12 ' HB2' ' B' ' 37' ' ' PRO . 85.2 mt -100.2 133.11 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.281 -1.781 . . . . 0.0 109.389 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 95.7 m -123.41 104.72 9.26 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.89 149.78 22.55 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.437 ' O ' ' HB ' ' B' ' 62' ' ' ILE . 47.5 mtp180 68.65 86.65 0.13 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.02 0.928 . . . . 0.0 112.844 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -176.73 -47.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.294 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ASN . . . . . 0.559 ' OD1' ' HB2' ' B' ' 83' ' ' ASP . 2.5 m-20 58.75 -168.8 0.14 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.103 0.961 . . . . 0.0 110.777 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt 60.26 66.48 0.95 Allowed 'General case' 0 C--O 1.243 0.718 0 O-C-N 123.815 0.697 . . . . 0.0 110.403 173.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.25 -60.89 2.53 Favored 'General case' 0 C--O 1.252 1.222 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.287 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 tttp 69.41 -52.8 0.6 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.306 1.443 . . . . 0.0 112.835 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 13.2 mt -85.69 142.14 36.78 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.98 -12.69 33.35 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 122.157 1.905 . . . . 0.0 113.671 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -88.78 -19.09 26.45 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.395 0.617 . . . . 0.0 110.651 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -96.21 130.26 43.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.38 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 95.1 t -126.53 130.45 71.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 O-C-N 122.174 -0.329 . . . . 0.0 110.359 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -101.32 139.49 36.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.78 HG23 ' HG2' ' B' ' 110' ' ' LYS . 0.7 OUTLIER -115.36 162.96 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 123.157 0.583 . . . . 0.0 111.754 -173.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.415 ' H ' HG22 ' B' ' 73' ' ' ILE . 1.3 mp0 -66.3 109.91 2.86 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 123.785 0.834 . . . . 0.0 110.409 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' LYS . . . . . 0.451 ' HB3' ' HA ' ' B' ' 83' ' ' ASP . 20.0 pttm -58.13 -34.98 70.82 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.873 0.844 . . . . 0.0 112.066 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -53.32 -44.19 68.21 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.177 -1.828 . . . . 0.0 110.941 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -84.51 -35.2 23.06 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.472 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.636 ' CE1' HG21 ' B' ' 73' ' ' ILE . 1.6 m-85 -73.43 -11.49 60.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.926 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 81.59 13.81 0.61 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.222 1.409 . . . . 0.0 112.089 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.8 179.29 5.02 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 122.328 1.061 . . . . 0.0 111.189 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -96.27 -25.04 15.93 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 113.673 -1.603 . . . . 0.0 109.845 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -130.34 156.02 45.38 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.559 ' HB2' ' OD1' ' B' ' 63' ' ' ASN . 2.1 m-20 -54.08 144.22 20.09 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.959 0.885 . . . . 0.0 113.239 -175.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 13.1 m -108.27 128.18 54.5 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.644 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.5 t -115.76 129.94 71.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.481 HG22 HD22 ' B' ' 88' ' ' LEU . 1.6 mp -107.4 129.88 60.55 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 mt -102.9 108.87 20.23 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 113.563 -1.653 . . . . 0.0 109.019 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.481 HD22 HG22 ' B' ' 86' ' ' ILE . 3.8 mm? -80.01 4.48 16.87 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.585 0.707 . . . . 0.0 112.451 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.15 -38.9 5.87 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.96 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -85.55 63.67 8.2 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.116 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.558 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.0 pp -108.66 -176.68 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -174.39 178.98 1.89 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 31.5 m -122.38 129.31 51.98 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.768 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 41.8 mt -133.49 145.46 50.21 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 124.513 1.125 . . . . 0.0 109.471 -174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' B' ' 97' ' ' LYS . 2.0 p30 -79.4 151.18 31.07 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 117.977 -1.489 . . . . 0.0 110.284 172.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -37.39 -42.25 0.48 Allowed 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 127.402 2.281 . . . . 0.0 114.685 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.468 ' HB3' ' OD2' ' B' ' 95' ' ' ASP . 7.5 ttpm? -61.17 -18.05 56.14 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 124.665 1.186 . . . . 0.0 112.472 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.589 ' NE ' ' HA ' ' B' ' 98' ' ' ARG . 4.0 mmp_? -88.31 -22.45 23.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.363 -0.835 . . . . 0.0 111.622 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.31 107.83 11.2 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 121.976 0.894 . . . . 0.0 108.974 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -95.24 -57.98 2.27 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 116.823 2.156 . . . . 0.0 116.823 -173.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.525 ' HG3' HD13 ' B' ' 21' ' ' LEU . 12.0 pt-20 -140.15 131.93 27.47 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.979 0.895 . . . . 0.0 112.737 -171.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -63.67 119.46 9.92 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 127.151 2.18 . . . . 0.0 108.429 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.1 -63.66 1.43 Allowed 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 118.564 -1.255 . . . . 0.0 112.048 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.408 HG22 HG11 ' B' ' 19' ' ' VAL . 6.1 t -125.57 -160.48 0.97 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 117.645 -1.622 . . . . 0.0 112.897 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -159.75 150.89 19.54 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 126.803 2.041 . . . . 0.0 108.324 -173.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.34 155.69 17.66 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -70.96 145.76 49.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' B' ' 111' ' ' MET . 2.8 p-10 -62.85 -35.43 79.93 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -176.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.0 -33.17 63.71 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.202 0.525 . . . . 0.0 109.917 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.78 ' HG2' HG23 ' B' ' 73' ' ' ILE . 16.6 tppt? -68.65 -32.96 73.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.531 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -51.83 -45.48 63.97 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.958 173.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.704 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -69.3 -16.88 63.66 Favored 'General case' 0 CA--C 1.477 -1.863 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.237 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 113' ' ' GLU . . . . . 0.588 ' HA ' ' ND2' ' B' ' 116' ' ' ASN . 32.6 mt-10 -85.53 -38.37 18.6 Favored 'General case' 1 N--CA 1.368 -4.55 0 C-N-CA 117.202 -1.799 . . . . 0.0 108.641 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.0 t -56.62 -44.36 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.141 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.03 172.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.639 ' OD2' ' HA ' ' B' ' 112' ' ' LYS . 25.2 m-20 -56.32 -58.1 9.41 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.557 1.17 . . . . 0.0 108.991 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.588 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 1.3 p30 -66.34 -40.49 89.87 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.011 -1.449 . . . . 0.0 112.019 -173.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -59.14 -37.81 78.17 Favored 'General case' 0 CA--C 1.49 -1.364 0 O-C-N 123.636 0.585 . . . . 0.0 109.74 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.48 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.6 tp -69.56 -44.56 70.64 Favored 'General case' 1 N--CA 1.373 -4.294 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.871 -178.24 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 39.2 mtp -68.39 -19.92 64.65 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.643 -0.661 . . . . 0.0 112.124 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' B' ' 117' ' ' ALA . 45.6 mt -78.18 -55.43 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 173.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 34.3 t -52.21 -43.9 64.47 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.113 1.365 . . . . 0.0 111.843 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 8.1 mp -87.74 -2.37 58.57 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.53 7.42 87.53 Favored Glycine 0 C--O 1.241 0.551 0 N-CA-C 117.116 1.606 . . . . 0.0 117.116 170.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.8 -59.19 2.86 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 118.632 1.216 . . . . 0.0 110.937 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 45.14 -151.36 0.05 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.552 -169.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.56 19.66 20.16 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.997 0.903 . . . . 0.0 109.609 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.69 7.86 6.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.663 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.02 -16.85 63.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.284 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -59.59 -53.13 61.57 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.918 -175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -134.92 71.74 1.45 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.282 1.039 . . . . 0.0 111.722 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' LYS . . . . . 0.535 ' HG2' HH22 ' A' ' 16' ' ' ARG . 87.3 tttt -160.66 108.81 1.6 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.732 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 8.4 p30 . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.287 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.5 m -87.93 95.48 10.13 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 117.447 0.624 . . . . 0.0 110.092 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 p -88.25 141.39 28.6 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.88 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -72.48 147.39 46.1 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -71.55 99.82 2.13 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.399 0.618 . . . . 0.0 111.626 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -74.15 111.07 8.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.559 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -91.84 93.5 8.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.242 0.544 . . . . 0.0 109.859 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -121.64 -15.58 7.93 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.905 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 66.99 -93.64 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -167.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.3 m 50.13 30.7 4.4 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.738 0.815 . . . . 0.0 111.519 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -94.33 81.91 4.04 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.035 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.15 123.84 89.6 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.93 100.88 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.188 1.926 . . . . 0.0 112.33 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -79.35 124.6 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -134.42 157.39 46.55 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 42' ' ' GLN . 20.3 ttt85 -67.86 130.5 43.17 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.33 173.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.34 -19.27 11.74 Favored Glycine 0 C--N 1.307 -1.034 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.158 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -93.51 176.06 6.52 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 122.112 0.958 . . . . 0.0 110.461 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 17.4 t -128.32 135.76 61.79 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.194 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.119 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 8.0 m-85 -128.59 145.44 51.14 Favored 'General case' 0 CA--C 1.462 -2.411 0 C-N-CA 124.461 1.104 . . . . 0.0 108.996 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.3 mp -78.9 148.42 32.74 Favored 'General case' 0 N--CA 1.391 -3.411 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 168.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.1 134.48 17.3 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.397 1.06 . . . . 0.0 110.654 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.92 88.58 1.85 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.237 171.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.532 HD22 ' O ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -109.13 25.45 11.79 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 123.265 1.507 . . . . 0.0 109.542 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.663 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 20.2 p -94.28 62.11 0.01 OUTLIER Pre-proline 0 N--CA 1.409 -2.509 0 CA-C-N 112.95 -1.932 . . . . 0.0 116.205 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HB2' ' HB2' ' B' ' 26' ' ' PRO . 13.7 Cg_endo -113.48 29.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.556 0 N-CA-C 106.288 -2.235 . . . . 0.0 106.288 153.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.673 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 35.3 m -73.5 165.21 3.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.645 -176.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.09 141.42 30.03 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.086 -1.416 . . . . 0.0 113.307 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.83 -108.82 2.31 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.786 -1.097 . . . . 0.0 115.354 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -84.46 -5.94 59.33 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 124.264 1.025 . . . . 0.0 113.074 -173.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.673 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 71.2 mt-10 -77.4 161.65 27.84 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.458 ' HG3' ' OE1' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -125.33 156.5 38.59 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.133 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.71 -149.07 18.52 Favored Glycine 0 N--CA 1.407 -3.283 0 C-N-CA 118.462 -1.828 . . . . 0.0 114.417 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.663 ' HA2' ' HB3' ' A' ' 25' ' ' SER . . . 140.55 -156.14 25.11 Favored Glycine 0 C--N 1.276 -2.772 0 N-CA-C 103.61 -3.796 . . . . 0.0 103.61 -171.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.0 100.07 10.27 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.168 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 165.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -131.63 146.45 61.92 Favored Pre-proline 0 C--N 1.258 -3.398 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.671 -167.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 47.6 Cg_exo -56.28 134.36 63.78 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.395 2.063 . . . . 0.0 111.203 171.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 29.4 m -125.28 159.11 32.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.493 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.9 m -97.89 130.26 46.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.55 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.8 mm -88.73 101.88 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.69 -20.36 5.54 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.863 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.681 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -54.86 158.91 2.5 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -170.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.458 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 19.0 p-10 -63.51 175.41 1.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.886 -1.507 . . . . 0.0 112.418 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -52.89 52.46 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.27 -1.786 . . . . 0.0 112.937 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -80.55 -24.17 39.47 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -163.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.69 -26.35 72.97 Favored Glycine 0 C--O 1.212 -1.23 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.991 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -73.96 -32.76 63.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.497 0.665 . . . . 0.0 110.162 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -85.45 -64.48 1.15 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.689 -173.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -96.5 -28.67 14.3 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -171.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.1 m -86.4 155.02 57.15 Favored Pre-proline 0 C--N 1.298 -1.659 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.149 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.561 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . 61.6 Cg_endo -98.26 17.05 0.51 Allowed 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 122.779 2.319 . . . . 0.0 111.425 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 p -130.56 145.8 51.95 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.415 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.572 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -146.2 139.28 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.588 0.555 . . . . 0.0 111.565 174.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.681 HG22 ' HG3' ' A' ' 42' ' ' GLN . 8.9 tt -82.2 133.71 28.59 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 CA-C-O 121.663 0.744 . . . . 0.0 111.392 175.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 29.9 m -135.85 162.56 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.712 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.557 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -123.48 139.23 54.23 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.05 134.78 47.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.577 HG12 HD12 ' A' ' 86' ' ' ILE . 54.9 mt -93.25 112.71 26.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.038 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.5 m -99.85 119.56 38.38 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.349 0.659 . . . . 0.0 109.747 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.13 17.62 53.66 Favored Glycine 0 C--O 1.221 -0.704 0 C-N-CA 120.581 -0.818 . . . . 0.0 114.992 -172.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -170.05 106.35 0.33 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.7 tt -166.52 168.46 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.484 ' OD1' ' HG2' ' A' ' 64' ' ' LYS . 28.4 t-20 -61.83 -68.55 0.31 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.532 1.06 . . . . 0.0 112.736 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.484 ' HG2' ' OD1' ' A' ' 63' ' ' ASN . 19.4 ptpt -167.8 -177.03 3.29 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 121.195 0.521 . . . . 0.0 110.721 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.97 77.05 1.29 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -95.33 -23.0 17.39 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.246 0.546 . . . . 0.0 111.261 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 tt -106.01 141.68 23.23 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.38 5.51 0.32 Allowed 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.436 2.757 . . . . 0.0 115.583 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.524 ' HA ' ' OG ' ' A' ' 121' ' ' SER . 68.4 p -96.77 -18.46 19.59 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 122.23 1.014 . . . . 0.0 109.137 176.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -102.03 129.91 48.46 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.3 p -124.62 137.55 56.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.252 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -92.92 148.13 22.27 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.166 0.507 . . . . 0.0 111.352 -176.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 84' ' ' SER . 1.9 pp -124.6 148.15 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.816 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -90.55 108.82 20.04 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.676 0.75 . . . . 0.0 109.561 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HD2' ' C ' ' A' ' 81' ' ' ASP . 37.6 pttt -45.06 -39.07 5.43 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 126.217 1.807 . . . . 0.0 115.217 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -45.89 -49.38 15.62 Favored 'General case' 0 C--N 1.267 -2.984 0 C-N-CA 126.131 1.772 . . . . 0.0 111.8 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -91.76 -41.21 10.81 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 118.805 -1.158 . . . . 0.0 112.266 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.495 ' HD1' ' O ' ' A' ' 105' ' ' TYR . 2.3 m-85 -110.8 -19.48 12.82 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -164.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.453 ' HG2' ' HB2' ' A' ' 84' ' ' SER . 56.8 tptt -154.78 46.56 0.54 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 117.242 -1.783 . . . . 0.0 114.644 -167.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 65.81 -131.66 0.22 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.432 0.693 . . . . 0.0 111.151 163.493 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.51 ' C ' ' HD2' ' A' ' 75' ' ' LYS . 23.6 t70 -88.57 -5.76 57.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.652 1.181 . . . . 0.0 109.437 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -106.67 116.33 31.75 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.436 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 5.0 p-10 -83.22 117.11 22.72 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.453 ' HB2' ' HG2' ' A' ' 79' ' ' LYS . 13.2 t -113.65 157.93 21.51 Favored 'General case' 0 N--CA 1.406 -2.658 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.676 -166.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.01 139.16 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.577 HD12 HG12 ' A' ' 58' ' ' ILE . 17.3 mm -105.27 129.95 57.25 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 52.0 mt -101.24 110.56 22.59 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.478 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.2 mm? -84.01 -7.33 59.43 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 121.677 0.751 . . . . 0.0 111.168 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.546 ' O ' HG21 ' B' ' 93' ' ' THR . 10.4 pt-20 -84.74 -42.25 15.41 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.185 173.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.458 ' OE1' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -92.85 73.84 4.88 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.995 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.609 ' O ' ' HB ' ' B' ' 93' ' ' THR . 2.4 pp -117.58 179.73 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.91 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.524 ' NH1' HG12 ' A' ' 27' ' ' VAL 0.261 11.5 ptp180 -174.94 157.76 2.42 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 99.4 m -105.19 126.5 52.15 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.591 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.2 mt -131.36 150.13 52.27 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 124.137 0.898 . . . . 0.0 111.184 -169.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -51.52 141.56 15.72 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.707 0.629 . . . . 0.0 110.108 170.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 51' ' ' PRO . 44.4 mtmt -64.5 -18.82 65.15 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 120.981 0.42 . . . . 0.0 111.971 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -75.5 -9.64 58.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.11 0.481 . . . . 0.0 110.914 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.542 ' HA ' ' NE ' ' A' ' 98' ' ' ARG . 3.8 mmp_? -86.63 -36.5 18.77 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -73.39 121.74 20.96 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.616 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -106.05 -61.16 1.55 Allowed 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.2 pt-20 -143.1 130.6 21.16 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -168.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 22.0 ttmm -60.75 113.19 2.35 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 112.221 -2.263 . . . . 0.0 109.045 174.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.3 tp -112.97 -63.27 1.47 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.495 ' H ' ' HB ' ' A' ' 19' ' ' VAL 0.273 5.7 t -120.89 -167.08 1.42 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 117.703 -1.599 . . . . 0.0 111.115 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.495 ' O ' ' HD1' ' A' ' 78' ' ' TYR . 13.8 p90 -160.29 142.93 13.28 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 123.687 0.795 . . . . 0.0 111.66 -169.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.413 ' HA ' ' CD1' ' A' ' 78' ' ' TYR . 32.3 mt -111.55 161.4 16.22 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.142 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 111' ' ' MET . 30.2 p -92.63 167.14 12.11 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 123.906 0.882 . . . . 0.0 109.878 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.35 -31.41 72.52 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.458 0.647 . . . . 0.0 111.394 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.07 -38.51 79.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.858 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -70.86 -35.14 72.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -52.71 -49.21 65.81 Favored 'General case' 0 CA--C 1.483 -1.607 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.011 177.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 28.9 mtmm -50.08 -41.74 48.73 Favored 'General case' 0 CA--C 1.477 -1.836 0 O-C-N 124.319 1.012 . . . . 0.0 112.62 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -80.21 -32.17 38.58 Favored 'General case' 0 CA--C 1.443 -3.166 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -165.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.63 -55.64 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.761 0 CA-C-N 112.776 -2.011 . . . . 0.0 109.968 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 62.3 m-20 -57.46 -50.94 71.41 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 122.237 1.018 . . . . 0.0 110.495 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.672 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -61.6 -46.57 89.27 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.703 -178.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.478 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.76 -42.66 89.42 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 12.7 tp -65.56 -47.07 77.09 Favored 'General case' 0 N--CA 1.402 -2.874 0 C-N-CA 125.184 1.394 . . . . 0.0 110.299 -175.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.512 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.19 -29.46 57.94 Favored 'General case' 0 N--CA 1.414 -2.245 0 C-N-CA 124.832 1.253 . . . . 0.0 111.212 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 116' ' ' ASN . 40.6 mt -86.44 -54.0 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.524 ' OG ' ' HA ' ' A' ' 69' ' ' THR . 72.8 m -46.88 -33.56 4.64 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.516 -1.674 . . . . 0.0 112.757 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 21.7 mt -100.5 -0.29 38.17 Favored 'General case' 0 C--O 1.189 -2.113 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.999 -177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.51 7.78 71.69 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 119.591 -1.29 . . . . 0.0 116.295 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.512 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 4.9 mp -63.71 -50.17 70.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 122.7 1.238 . . . . 0.0 108.353 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . 0.305 0.1 OUTLIER -137.89 90.8 2.52 Favored 'General case' 1 N--CA 1.362 -4.847 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 170.438 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -138.17 7.75 2.67 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.881 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.7 t -106.01 -10.16 10.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 113.736 -1.575 . . . . 0.0 106.809 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.88 73.62 10.62 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 113.408 -1.724 . . . . 0.0 110.01 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -137.22 15.11 3.02 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -141.64 -57.07 0.48 Allowed 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.097 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -96.48 102.87 14.73 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 C--N 1.303 -1.426 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.16 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.274 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m -79.28 107.12 11.81 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.563 0.697 . . . . 0.0 109.685 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 9.3 p -98.94 145.16 27.32 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.284 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -79.65 149.62 31.21 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.104 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -78.81 93.92 5.06 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.59 0.709 . . . . 0.0 111.971 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' HIS . . . . . 0.505 ' HB3' ' CD2' ' B' ' 8' ' ' HIS . 80.8 m80 -67.48 113.15 5.1 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.929 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -94.83 96.07 9.1 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.268 0.556 . . . . 0.0 110.068 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.505 ' CD2' ' HB3' ' B' ' 6' ' ' HIS . 11.6 m-70 -126.95 -8.05 6.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.375 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 61.19 -95.5 0.05 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m 55.98 22.71 6.03 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.739 0.816 . . . . 0.0 111.805 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -87.43 81.96 7.67 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.816 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.31 126.42 92.51 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 173.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -60.34 100.36 0.15 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.155 1.903 . . . . 0.0 112.218 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.75 117.78 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' B' ' 18' ' ' ASP . 19.2 ptt180 -127.97 159.13 35.93 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' B' ' 42' ' ' GLN . 21.0 ttt85 -69.44 130.74 43.35 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.75 -20.34 10.08 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.002 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ASP . . . . . 0.437 ' CG ' ' HE ' ' B' ' 15' ' ' ARG . 57.0 m-20 -93.74 175.47 6.72 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-O 122.272 1.034 . . . . 0.0 110.736 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 12.7 t -128.38 135.95 61.28 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.0 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 5.9 m-85 -129.16 145.93 51.2 Favored 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 124.506 1.122 . . . . 0.0 109.061 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.517 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.4 mp -79.47 148.32 31.92 Favored 'General case' 0 N--CA 1.394 -3.254 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 167.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -150.83 134.75 16.66 Favored 'General case' 0 C--N 1.265 -3.099 0 O-C-N 124.361 1.038 . . . . 0.0 111.014 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.8 86.72 1.26 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 171.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.476 ' C ' ' HD3' ' B' ' 26' ' ' PRO 0.252 0.0 OUTLIER -104.81 23.73 12.99 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 123.156 1.455 . . . . 0.0 109.643 -179.62 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.662 ' HB3' ' HA2' ' B' ' 34' ' ' GLY . 3.5 p -94.54 62.58 0.01 OUTLIER Pre-proline 0 N--CA 1.405 -2.676 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.565 ' HB2' ' HB2' ' A' ' 26' ' ' PRO . 15.5 Cg_endo -113.72 27.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.574 0 N-CA-C 106.822 -2.03 . . . . 0.0 106.822 153.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.666 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 34.1 m -72.84 165.87 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.886 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.19 140.98 29.64 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.863 -1.517 . . . . 0.0 113.698 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.65 -108.38 2.19 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -79.41 -15.49 57.75 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 124.011 0.925 . . . . 0.0 112.5 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.666 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 71.6 mt-10 -69.65 165.92 20.2 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.63 130.98 49.91 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -172.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.35 -163.11 36.36 Favored Glycine 0 N--CA 1.408 -3.212 0 C-N-CA 117.735 -2.174 . . . . 0.0 115.278 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.662 ' HA2' ' HB3' ' B' ' 25' ' ' SER . . . 158.9 -162.05 32.33 Favored Glycine 0 C--N 1.266 -3.321 1 N-CA-C 102.664 -4.174 . . . . 0.0 102.664 -171.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.42 99.85 9.94 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 166.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -132.44 147.19 64.68 Favored Pre-proline 0 C--N 1.257 -3.418 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.606 -167.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 51.3 Cg_exo -55.48 135.41 69.09 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.538 2.159 . . . . 0.0 112.034 173.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 28.2 m -126.21 158.65 35.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 123.849 0.86 . . . . 0.0 108.969 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.495 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 32.9 m -98.01 130.55 46.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.672 0.272 . . . . 0.0 110.666 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 18.6 mm -88.91 102.09 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.22 -20.38 5.53 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.897 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.661 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -55.06 159.34 2.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -170.275 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.433 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 19.1 p-10 -62.47 178.95 0.37 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.491 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.72 -46.59 30.2 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.958 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -79.4 -26.49 41.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -166.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.27 -26.74 72.64 Favored Glycine 0 C--O 1.209 -1.461 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.25 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -73.69 -31.16 63.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.759 0.79 . . . . 0.0 110.263 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -85.08 -66.64 0.87 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.59 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -96.37 -27.55 14.89 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 43.5 m -86.07 154.15 57.56 Favored Pre-proline 0 C--N 1.295 -1.803 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.533 ' HA ' ' HE2' ' B' ' 96' ' ' LYS . 68.7 Cg_endo -98.52 15.01 0.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.643 2.229 . . . . 0.0 111.231 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.7 p -128.14 147.01 50.53 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.295 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.558 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -147.07 139.24 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 123.632 0.582 . . . . 0.0 111.254 174.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.661 HG22 ' HG3' ' B' ' 42' ' ' GLN . 8.5 tt -82.22 133.7 28.61 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 CA-C-O 121.73 0.776 . . . . 0.0 111.422 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 29.7 m -135.72 160.04 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.859 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.551 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -120.68 139.16 53.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.44 135.27 45.72 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.557 HG12 HD12 ' B' ' 86' ' ' ILE . 55.3 mt -90.97 113.74 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.457 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 41.1 m -101.03 110.05 22.03 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 121.769 0.795 . . . . 0.0 111.371 -175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.67 123.5 7.45 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 82.89 100.65 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.755 1.222 . . . . 0.0 112.581 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 tt -165.63 176.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -68.08 -66.87 0.51 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-N 120.436 1.471 . . . . 0.0 112.704 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -170.56 177.21 4.06 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.202 0.525 . . . . 0.0 110.778 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.19 77.71 1.83 Allowed 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -97.28 -20.39 17.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.95 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 tt -109.52 139.33 21.04 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.11 5.14 0.17 Allowed 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.489 2.793 . . . . 0.0 115.845 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' THR . . . . . 0.482 ' HA ' ' OG ' ' B' ' 121' ' ' SER . 64.7 p -98.75 -18.62 17.9 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 122.16 0.981 . . . . 0.0 109.238 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -103.5 129.56 50.7 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.91 135.38 64.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.377 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.67 143.98 26.36 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-O 121.347 0.594 . . . . 0.0 111.642 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 84' ' ' SER . 2.0 pp -119.26 150.76 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.002 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -94.85 109.66 21.62 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.769 0.795 . . . . 0.0 110.565 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' B' ' 80' ' ' LEU . 38.6 pttt -43.67 -42.0 5.05 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.528 1.931 . . . . 0.0 115.252 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -46.0 -46.94 16.79 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 126.456 1.902 . . . . 0.0 111.736 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -92.19 -42.92 9.62 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.074 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.564 ' HD1' ' O ' ' B' ' 105' ' ' TYR . 7.1 m-85 -111.82 -18.3 12.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -164.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -156.09 47.84 0.48 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 117.756 -1.578 . . . . 0.0 114.478 -167.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' B' ' 75' ' ' LYS . 0.0 OUTLIER 63.68 -133.73 0.37 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.962 0.905 . . . . 0.0 111.203 164.176 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.481 ' O ' ' HD2' ' B' ' 75' ' ' LYS . 12.7 t70 -86.08 -6.71 58.97 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 125.08 1.352 . . . . 0.0 110.057 175.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -105.47 114.95 29.43 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 119.383 -0.927 . . . . 0.0 113.349 -174.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.44 ' N ' ' HD3' ' B' ' 75' ' ' LYS . 7.2 p-10 -80.11 117.34 20.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.459 ' O ' HG13 ' B' ' 73' ' ' ILE . 14.7 t -114.11 158.26 21.51 Favored 'General case' 0 N--CA 1.407 -2.624 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.579 -168.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 t -116.57 139.73 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.557 HD12 HG12 ' B' ' 58' ' ' ILE . 18.7 mm -104.96 129.98 56.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.27 110.32 22.55 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.2 mm? -84.02 -6.76 59.47 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.637 0.732 . . . . 0.0 111.013 -175.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' GLU . . . . . 0.561 ' O ' HG21 ' A' ' 93' ' ' THR . 10.5 pt-20 -86.99 -39.64 15.49 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.631 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 73.93 3.75 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.927 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.604 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.4 pp -117.76 179.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.949 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.524 ' NH1' HG12 ' B' ' 27' ' ' VAL 0.254 12.1 ptp180 -174.98 157.42 2.34 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 172.179 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.609 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 97.2 m -105.09 126.87 52.54 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.622 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 49.1 mt -131.28 150.18 52.25 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 124.246 0.966 . . . . 0.0 111.143 -169.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -50.65 140.01 15.22 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.23 0.612 . . . . 0.0 109.764 170.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' B' ' 51' ' ' PRO . 43.1 mtmt -61.45 -23.02 65.56 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 122.68 0.392 . . . . 0.0 111.622 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -70.3 -17.95 63.09 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' B' ' 98' ' ' ARG . 4.5 mmp_? -80.38 -33.32 37.27 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.827 -0.546 . . . . 0.0 109.937 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.8 mp -74.89 117.43 16.73 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.966 0.889 . . . . 0.0 109.759 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -100.64 -59.35 1.72 Allowed 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -147.28 133.95 19.94 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -170.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 21.6 ttmm -60.76 114.29 2.95 Favored 'General case' 0 C--N 1.284 -2.253 0 C-N-CA 127.458 2.303 . . . . 0.0 108.778 174.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 tp -112.78 -62.89 1.52 Allowed 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.505 HG22 HG11 ' B' ' 19' ' ' VAL . 5.0 t -122.1 -167.12 1.5 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.119 -1.432 . . . . 0.0 111.022 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.564 ' O ' ' HD1' ' B' ' 78' ' ' TYR . 15.7 p90 -160.21 141.3 12.24 Favored 'General case' 0 CA--C 1.488 -1.428 0 C-N-CA 123.818 0.847 . . . . 0.0 111.359 -170.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.504 ' HA ' ' CD1' ' B' ' 78' ' ' TYR . 32.1 mt -107.23 168.18 9.4 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 124.305 1.003 . . . . 0.0 108.872 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' B' ' 111' ' ' MET . 39.6 p -95.69 167.62 11.17 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.151 0.58 . . . . 0.0 109.6 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' B' ' 111' ' ' MET . 33.5 t70 -67.4 -29.7 69.28 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.897 0.856 . . . . 0.0 109.913 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.16 -39.9 78.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.231 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -71.42 -32.58 68.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 107' ' ' SER . 0.5 OUTLIER -53.99 -48.77 70.06 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.836 177.257 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.738 ' O ' ' HB3' ' B' ' 116' ' ' ASN 0.271 20.1 mtmm -49.27 -43.23 42.84 Favored 'General case' 0 CA--C 1.467 -2.236 0 O-C-N 124.583 1.177 . . . . 0.0 111.96 175.642 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -79.44 -33.5 42.44 Favored 'General case' 0 CA--C 1.446 -3.037 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -163.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.18 -53.37 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.644 0 CA-C-N 112.548 -2.115 . . . . 0.0 110.263 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 69.3 m-20 -58.63 -52.14 66.94 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 122.437 1.113 . . . . 0.0 110.219 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.738 ' HB3' ' O ' ' B' ' 112' ' ' LYS . 0.4 OUTLIER -67.9 -30.51 69.87 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.394 -175.01 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.447 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -71.64 -45.52 61.77 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.631 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 11.0 tp -60.03 -47.38 86.1 Favored 'General case' 0 N--CA 1.4 -2.97 0 C-N-CA 125.78 1.632 . . . . 0.0 110.416 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.535 ' HE2' HG13 ' B' ' 120' ' ' ILE . 0.1 OUTLIER -54.14 -33.08 57.02 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 124.567 1.147 . . . . 0.0 111.303 178.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.535 HG13 ' HE2' ' B' ' 119' ' ' MET . 56.5 mt -82.79 -53.35 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' B' ' 69' ' ' THR . 44.2 m -47.55 -33.07 6.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.724 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 20.3 mt -100.3 -1.63 35.75 Favored 'General case' 0 C--O 1.189 -2.089 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.975 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' B' ' 126' ' ' ALA . . . 88.73 8.28 70.18 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.504 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 4.9 mp -63.58 -48.08 78.89 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.693 1.235 . . . . 0.0 108.683 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . 0.292 0.1 OUTLIER -139.4 92.19 2.56 Favored 'General case' 1 N--CA 1.366 -4.65 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 170.127 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.407 ' HB3' ' HA2' ' B' ' 123' ' ' GLY . . . -140.7 10.79 2.25 Favored 'General case' 0 C--N 1.27 -2.858 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.823 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.37 -8.54 11.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 113.588 -1.642 . . . . 0.0 106.724 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.13 68.72 10.63 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 113.659 -1.609 . . . . 0.0 110.502 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -127.37 2.88 6.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.835 173.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -128.45 -59.44 1.15 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.822 -1.535 . . . . 0.0 107.431 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.1 102.15 14.68 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.0 m120 . . . . . 0 C--N 1.295 -1.8 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.975 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.151 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -153.82 123.33 6.64 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.0 t -137.0 110.92 8.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -82.05 118.35 22.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -102.85 114.76 29.3 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.458 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 85.4 t60 -65.27 130.74 44.42 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -75.17 -11.03 59.99 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.622 -173.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.458 ' H ' ' CD2' ' A' ' 6' ' ' HIS . 24.9 t-80 60.29 60.1 2.13 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 122.872 1.32 . . . . 0.0 107.463 -173.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -116.38 11.33 14.94 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.124 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -88.78 96.29 10.62 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.146 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -92.99 80.62 4.58 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.774 0.797 . . . . 0.0 109.092 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -74.93 132.05 78.0 Favored Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.104 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.47 160.99 40.2 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.999 2.466 . . . . 0.0 112.322 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.65 130.27 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.291 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -115.6 138.49 51.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 13.8 ptm180 -61.76 134.96 57.39 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.632 170.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.32 -12.81 36.71 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.811 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.79 166.71 22.6 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.512 1.149 . . . . 0.0 110.984 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.673 HG12 ' HB2' ' A' ' 103' ' ' LEU . 42.6 t -130.68 122.7 53.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.949 0 CA-C-N 112.71 -2.041 . . . . 0.0 108.994 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 88.3 m-85 -129.13 147.66 51.0 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 125.872 1.669 . . . . 0.0 110.571 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.3 mp -77.04 148.21 36.31 Favored 'General case' 0 N--CA 1.395 -3.181 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 167.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -139.97 146.6 39.33 Favored 'General case' 0 C--N 1.252 -3.662 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.904 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.551 ' O ' ' HD2' ' A' ' 98' ' ' ARG . 35.1 t70 -84.29 72.29 10.57 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 173.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.711 HD22 ' HA3' ' A' ' 33' ' ' GLY . 3.2 tt -76.79 -36.78 56.74 Favored 'General case' 0 N--CA 1.384 -3.756 0 CA-C-N 111.789 -2.459 . . . . 0.0 110.413 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.659 ' CB ' ' H ' ' A' ' 34' ' ' GLY . 71.4 m -118.5 114.75 36.03 Favored Pre-proline 0 N--CA 1.398 -3.063 1 N-CA-C 121.812 4.005 . . . . 0.0 121.812 -168.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -106.78 27.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.419 -2.902 0 C-N-CA 123.616 2.878 . . . . 0.0 106.015 152.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' A' ' 25' ' ' SER . 26.7 m -88.48 158.42 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 122.191 0.996 . . . . 0.0 112.816 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -152.29 155.83 38.45 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 113.03 -1.895 . . . . 0.0 107.498 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.54 -130.93 10.42 Favored Glycine 0 N--CA 1.416 -2.696 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' B' ' 95' ' ' ASP . 4.7 m -93.92 -7.83 41.91 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.794 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.535 ' HG2' HH12 ' B' ' 92' ' ' ARG . 1.7 mp0 -70.87 155.98 40.14 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.624 -0.831 . . . . 0.0 110.264 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -133.75 120.63 20.79 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -171.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.711 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -155.75 -94.23 0.1 Allowed Glycine 1 N--CA 1.392 -4.292 0 C-N-CA 119.001 -1.571 . . . . 0.0 113.677 172.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.659 ' H ' ' CB ' ' A' ' 25' ' ' SER . . . 79.41 172.81 43.62 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -171.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 4.2 p -75.42 102.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 172.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -144.89 155.23 55.78 Favored Pre-proline 0 C--N 1.263 -3.177 0 CA-C-N 113.48 -1.691 . . . . 0.0 107.983 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 24.5 Cg_exo -66.39 139.33 53.93 Favored 'Trans proline' 0 C--O 1.247 0.964 0 C-N-CA 122.169 1.912 . . . . 0.0 112.803 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.1 m -127.49 163.36 30.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.123 0.969 . . . . 0.0 109.817 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.37 134.31 48.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.329 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -89.38 108.99 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.455 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -105.34 -8.07 9.95 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.701 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.64 -178.019 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.455 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -62.89 169.1 3.44 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -170.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -65.18 175.44 1.64 Allowed 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.923 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.64 -49.66 37.9 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.328 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.402 HG22 ' CD2' ' A' ' 49' ' ' TYR . 7.1 m -86.88 -21.3 26.42 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -169.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.16 -37.02 53.76 Favored Glycine 0 C--O 1.196 -2.273 0 CA-C-N 117.9 0.318 . . . . 0.0 112.682 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.448 ' N ' HE22 ' A' ' 42' ' ' GLN . 8.4 p30 -63.62 -19.38 64.81 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -82.56 -63.82 1.3 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.039 0.536 . . . . 0.0 110.128 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.402 ' CD2' HG22 ' A' ' 45' ' ' THR . 38.2 p90 -83.28 -35.36 25.35 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -172.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.1 m -83.03 136.52 43.87 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.45 -18.53 17.71 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 N-CA-C 108.34 -1.446 . . . . 0.0 108.34 170.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 11.4 p -91.4 150.67 21.16 Favored 'General case' 0 N--CA 1.415 -2.199 0 C-N-CA 125.201 1.4 . . . . 0.0 111.941 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.1 t -133.39 140.11 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 173.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.1 tt -110.23 128.7 66.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 CA-C-O 121.183 0.516 . . . . 0.0 109.929 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.516 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 32.7 m -132.39 173.18 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.941 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -128.41 143.68 51.03 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.02 132.77 41.58 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.3 mt -89.05 119.09 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.372 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.9 m -121.53 116.47 24.73 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 121.317 0.58 . . . . 0.0 110.834 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.481 ' HA3' ' HD2' ' A' ' 82' ' ' LYS . . . -97.2 171.17 26.63 Favored Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 173.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 76.88 -44.55 0.47 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.536 1.135 . . . . 0.0 112.51 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.8 mt -91.37 82.46 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.641 ' HA ' HG21 ' A' ' 85' ' ' VAL . 47.3 t-20 -100.49 94.89 6.38 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.66 0.743 . . . . 0.0 110.099 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -141.63 89.71 2.23 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.595 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.09 -145.03 0.39 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 76.72 12.35 2.45 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 122.471 1.129 . . . . 0.0 109.887 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.0 tt -128.31 132.09 24.15 Favored Pre-proline 0 C--N 1.293 -1.868 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.28 -4.22 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.64 2.894 . . . . 0.0 116.546 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.9 p -101.97 -18.84 15.48 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.913 -0.492 . . . . 0.0 111.039 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -112.24 128.92 56.39 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -117.09 133.0 65.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.727 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.1 128.57 53.41 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.288 0.566 . . . . 0.0 110.559 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.491 HG21 ' CZ ' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -124.81 154.88 32.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 123.585 0.754 . . . . 0.0 112.046 -176.5 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.78 141.0 53.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.764 0.792 . . . . 0.0 112.246 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -60.85 -34.58 74.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.358 -1.746 . . . . 0.0 109.2 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -55.27 -53.07 60.78 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.479 -1.691 . . . . 0.0 114.395 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -88.52 -35.83 16.75 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.094 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.491 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 6.6 m-85 -78.35 -5.15 51.36 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.727 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt 50.44 36.62 13.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.698 1.999 . . . . 0.0 115.183 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 78' ' ' TYR . 8.8 mp -87.21 -176.78 5.8 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 122.106 0.955 . . . . 0.0 110.892 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.34 -7.34 48.15 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.82 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HD2' ' HA3' ' A' ' 60' ' ' GLY . 10.2 ptpp? -153.52 164.23 38.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -56.66 147.5 22.43 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.228 0.537 . . . . 0.0 111.001 173.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.3 m -108.09 132.51 53.5 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.744 -172.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 63' ' ' ASN . 8.3 t -118.44 124.45 73.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 HD22 ' A' ' 88' ' ' LEU . 1.7 mp -110.71 127.57 67.68 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.013 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.7 mt -99.91 103.64 15.23 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.241 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.519 HD22 HG22 ' A' ' 86' ' ' ILE . 3.3 mm? -86.11 70.89 10.62 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -176.83 -48.54 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.47 84.79 4.77 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 55' ' ' VAL . 2.0 pp -121.11 179.12 2.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.07 -175.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.567 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 12.1 tpt85 -152.31 146.79 25.66 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.7 m -115.5 120.11 38.43 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.567 ' HG ' ' HG3' ' A' ' 92' ' ' ARG . 29.4 mt -130.99 143.99 51.14 Favored 'General case' 0 C--O 1.198 -1.606 0 C-N-CA 125.235 1.414 . . . . 0.0 110.343 -171.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -77.03 152.4 35.14 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 117.075 -1.85 . . . . 0.0 110.957 170.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -42.31 -27.12 0.13 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 126.551 1.94 . . . . 0.0 115.767 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 9.5 ptpp? -71.25 -21.93 62.04 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 118.736 0.698 . . . . 0.0 111.465 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 36.2 mmt180 -68.35 -33.77 74.88 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.773 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.63 115.75 10.14 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 124.436 1.094 . . . . 0.0 110.939 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -96.89 -63.83 1.1 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.183 -1.372 . . . . 0.0 114.213 -174.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.6 pt-20 -156.05 143.77 19.52 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-O 121.939 0.876 . . . . 0.0 111.665 -172.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttmm -66.82 123.61 20.62 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 112.468 -2.151 . . . . 0.0 111.558 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.673 ' HB2' HG12 ' A' ' 19' ' ' VAL . 3.8 mm? -93.43 -62.82 1.29 Allowed 'General case' 0 CA--C 1.472 -2.042 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 78' ' ' TYR . 7.2 t -150.87 -155.66 0.64 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.038 -1.892 . . . . 0.0 111.678 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -161.37 148.3 14.69 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.974 1.71 . . . . 0.0 109.538 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.34 153.0 39.56 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.766 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.3 p -83.71 161.2 21.11 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.12 -40.38 95.72 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.036 0.922 . . . . 0.0 110.981 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.54 -16.3 62.37 Favored 'General case' 0 C--O 1.194 -1.829 0 C-N-CA 125.107 1.363 . . . . 0.0 111.282 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.412 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 67.1 mttm -91.33 -36.65 13.73 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 120.468 -1.395 . . . . 0.0 109.898 168.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.444 ' HG2' ' OD2' ' A' ' 115' ' ' ASP 0.327 38.5 ttm -64.4 -26.04 68.29 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -177.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.719 ' HE3' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -57.87 -14.5 6.21 Favored 'General case' 0 C--N 1.248 -3.818 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 173.378 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.719 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 42.8 mt-10 -87.65 -54.44 4.26 Favored 'General case' 1 C--O 1.148 -4.254 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 171.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 111' ' ' MET . 2.1 t -47.05 -52.34 4.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-N 113.862 -1.517 . . . . 0.0 114.176 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 22.4 m-20 -66.05 -45.4 81.5 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 123.536 1.636 . . . . 0.0 110.838 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 112' ' ' LYS 0.256 9.3 t30 -73.83 -39.84 63.76 Favored 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 112.937 -1.938 . . . . 0.0 113.037 -171.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.6 -39.05 79.32 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 125.447 1.499 . . . . 0.0 108.077 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.55 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 8.8 tp -70.06 -38.12 75.71 Favored 'General case' 1 N--CA 1.373 -4.286 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.964 -175.184 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 47.7 mtp -68.51 -19.59 64.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.891 -0.505 . . . . 0.0 111.31 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 117' ' ' ALA . 49.5 mt -82.22 -59.15 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.1 m -48.15 -47.69 34.67 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 125.067 1.479 . . . . 0.0 111.975 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.19 -0.39 57.04 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.84 19.11 73.1 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.421 ' HG ' ' OD1' ' B' ' 115' ' ' ASP . 7.0 mp -70.52 -50.29 39.26 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 118.571 1.186 . . . . 0.0 108.508 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 37.64 -136.45 0.06 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.162 -1.835 . . . . 0.0 109.613 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.29 16.26 10.6 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.988 0.899 . . . . 0.0 108.702 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.6 t -128.93 -32.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.577 -171.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 61.82 -78.99 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 125.755 1.622 . . . . 0.0 112.559 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -102.37 117.84 35.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.885 0.374 . . . . 0.0 110.018 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -88.46 104.46 16.82 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 69.64 99.26 0.06 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.129 0.966 . . . . 0.0 111.774 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 . . . . . 0 N--CA 1.391 -3.395 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 178.836 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.319 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t -145.8 113.36 6.33 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 33.9 t -130.13 111.35 12.37 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -74.69 121.9 22.4 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.739 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -104.03 117.8 35.15 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' HIS . . . . . 0.466 ' CD2' ' H ' ' B' ' 8' ' ' HIS . 79.1 t60 -69.83 128.26 35.78 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -73.61 -11.98 60.6 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.855 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.466 ' H ' ' CD2' ' B' ' 6' ' ' HIS . 27.6 t-80 62.86 45.46 5.59 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 123.168 1.461 . . . . 0.0 108.496 -175.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -100.27 14.18 31.83 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.729 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -87.75 94.46 9.75 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.841 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -94.11 87.47 5.31 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -85.48 138.21 36.19 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.557 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.47 171.17 13.43 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.072 1.848 . . . . 0.0 112.232 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 69.2 mt -67.05 133.0 32.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -115.9 137.98 51.6 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 13.9 ptm180 -63.12 128.89 37.93 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.144 -1.023 . . . . 0.0 109.008 171.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.17 -11.94 26.58 Favored Glycine 0 N--CA 1.426 -2.017 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.458 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -76.42 166.99 22.65 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 122.544 1.164 . . . . 0.0 110.836 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.685 HG12 ' HB2' ' B' ' 103' ' ' LEU . 40.9 t -130.92 124.25 55.84 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.066 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.757 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -131.0 148.3 52.74 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 125.79 1.636 . . . . 0.0 110.015 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 1.3 mp -77.13 147.59 36.48 Favored 'General case' 0 N--CA 1.395 -3.207 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 167.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -140.82 145.42 36.26 Favored 'General case' 0 C--N 1.248 -3.82 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.161 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.606 ' O ' ' HD2' ' B' ' 98' ' ' ARG . 35.7 t70 -85.28 78.14 9.85 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 172.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.648 HD22 ' HA3' ' B' ' 33' ' ' GLY . 3.4 tt -79.34 -35.22 41.36 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 111.796 -2.456 . . . . 0.0 110.155 -167.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.655 ' CB ' ' H ' ' B' ' 34' ' ' GLY . 73.3 m -118.25 113.64 37.06 Favored Pre-proline 0 N--CA 1.405 -2.692 1 N-CA-C 122.231 4.16 . . . . 0.0 122.231 -168.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -103.95 24.14 0.11 Allowed 'Trans proline' 0 N--CA 1.418 -2.964 0 C-N-CA 123.056 2.504 . . . . 0.0 106.38 152.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' B' ' 25' ' ' SER . 19.3 m -85.82 165.02 2.32 Favored 'Isoleucine or valine' 0 C--N 1.373 1.624 0 CA-C-O 121.899 0.857 . . . . 0.0 112.337 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -158.93 159.13 34.56 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 113.187 -1.824 . . . . 0.0 106.77 174.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.96 -135.8 12.63 Favored Glycine 0 N--CA 1.421 -2.351 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 5.4 m -93.68 -0.6 55.98 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.797 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.478 ' HG2' HH12 ' A' ' 92' ' ' ARG . 1.4 mp0 -73.07 159.98 32.74 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.793 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -136.95 119.08 15.46 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.648 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -155.88 -95.16 0.11 Allowed Glycine 0 N--CA 1.4 -3.707 0 C-N-CA 118.928 -1.606 . . . . 0.0 114.095 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.655 ' H ' ' CB ' ' B' ' 25' ' ' SER . . . 80.27 -177.94 54.1 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -171.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 3.5 p -83.27 99.91 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 CA-C-O 123.586 1.66 . . . . 0.0 107.175 172.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -140.66 154.03 68.63 Favored Pre-proline 0 C--N 1.257 -3.428 0 CA-C-N 113.023 -1.899 . . . . 0.0 108.149 -168.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 25.9 Cg_exo -66.11 138.56 52.43 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 122.239 1.959 . . . . 0.0 112.504 174.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.2 163.06 28.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 123.931 0.893 . . . . 0.0 109.902 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.85 134.1 48.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.364 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.408 HD13 HG12 ' B' ' 55' ' ' VAL . 27.2 mm -89.29 109.98 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.451 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -105.59 -8.22 10.05 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.734 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.534 -178.19 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.486 ' OE1' HG13 ' B' ' 53' ' ' VAL . 5.4 pt20 -64.22 169.61 4.4 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -169.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -65.08 173.37 2.45 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.458 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.95 -46.35 52.9 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.623 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.41 HG22 ' CD2' ' B' ' 49' ' ' TYR . 8.5 m -87.79 -21.59 25.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.58 -35.82 57.69 Favored Glycine 0 C--O 1.195 -2.288 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -64.77 -19.05 65.6 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -81.91 -62.11 1.73 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 122.928 0.491 . . . . 0.0 109.701 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' B' ' 45' ' ' THR . 34.9 p90 -83.94 -34.57 24.42 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 46.5 m -85.98 141.09 35.21 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -77.07 -19.84 13.41 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 121.222 1.281 . . . . 0.0 108.78 170.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 5.3 p -90.4 150.56 21.81 Favored 'General case' 0 N--CA 1.413 -2.298 0 C-N-CA 124.818 1.247 . . . . 0.0 112.111 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.486 HG13 ' OE1' ' B' ' 42' ' ' GLN . 94.4 t -132.28 140.06 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 tt -111.08 126.48 68.48 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-O 121.294 0.569 . . . . 0.0 110.012 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.531 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 27.1 m -131.21 173.23 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.034 -174.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.455 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -128.21 143.91 51.08 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.67 134.95 40.44 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 62.7 mt -90.75 122.39 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 113.056 -1.883 . . . . 0.0 106.727 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 98.3 m -123.51 117.04 24.2 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.461 0.648 . . . . 0.0 110.666 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.434 ' HA3' ' HD2' ' B' ' 82' ' ' LYS . . . -98.53 168.97 23.14 Favored Glycine 0 N--CA 1.412 -2.915 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 173.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 78.27 -35.57 0.19 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.006 1.322 . . . . 0.0 112.525 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 64.0 mt -98.99 81.25 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ASN . . . . . 0.629 ' HA ' HG21 ' B' ' 85' ' ' VAL . 24.4 t-20 -95.34 96.63 9.27 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -146.2 85.38 1.67 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.99 -144.78 0.37 Allowed 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.716 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 75.38 16.35 2.67 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 122.536 1.16 . . . . 0.0 109.554 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tt -134.29 132.11 20.91 Favored Pre-proline 0 N--CA 1.421 -1.879 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.72 -18.35 12.04 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.759 2.972 . . . . 0.0 116.47 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 77.4 p -91.53 -19.13 23.1 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.079 0.399 . . . . 0.0 111.664 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -109.97 128.81 55.61 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.37 132.01 68.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.813 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.89 130.83 54.5 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.313 0.577 . . . . 0.0 110.275 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.496 HG21 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -125.24 154.64 33.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.634 -176.172 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.47 136.47 53.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.557 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -57.4 -34.22 68.65 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.385 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -55.78 -53.25 58.98 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.589 -1.641 . . . . 0.0 113.942 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -89.68 -31.86 17.3 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.052 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.496 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 6.2 m-85 -81.02 -5.68 57.89 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.735 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt 50.14 38.0 15.95 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.697 1.999 . . . . 0.0 115.151 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.43 HD12 ' O ' ' B' ' 78' ' ' TYR . 9.2 mp -88.93 -178.09 5.64 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.567 1.175 . . . . 0.0 111.032 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.84 -4.78 56.33 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.503 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.434 ' HD2' ' HA3' ' B' ' 60' ' ' GLY . 10.1 ptpp? -156.41 165.02 37.56 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -177.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -54.27 152.04 6.72 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.192 0.52 . . . . 0.0 110.953 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 15.9 m -111.51 131.42 55.24 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.167 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.629 HG21 ' HA ' ' B' ' 63' ' ' ASN . 8.0 t -117.79 124.33 72.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.508 HG22 HD22 ' B' ' 88' ' ' LEU . 1.6 mp -110.74 126.59 68.09 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 56.0 mt -98.47 102.22 13.89 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.215 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.508 HD22 HG22 ' B' ' 86' ' ' ILE . 3.6 mm? -83.95 72.06 10.46 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.753 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -178.39 -48.57 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.44 85.54 5.38 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 2.0 pp -122.19 179.05 2.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.153 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.575 ' HG3' ' HG ' ' B' ' 94' ' ' LEU . 12.2 tpt85 -152.41 146.76 25.57 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 86.0 m -115.92 119.49 36.1 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.575 ' HG ' ' HG3' ' B' ' 92' ' ' ARG . 22.7 mt -130.95 143.55 50.81 Favored 'General case' 0 C--O 1.196 -1.751 0 C-N-CA 125.352 1.461 . . . . 0.0 110.397 -171.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 0.3 OUTLIER -76.79 152.38 35.58 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.661 170.777 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -41.91 -27.51 0.12 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.416 1.886 . . . . 0.0 115.549 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -69.38 -21.84 63.76 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.697 0.681 . . . . 0.0 111.589 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 37.7 mmt180 -69.85 -35.68 74.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.105 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.19 114.47 8.37 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 124.113 0.965 . . . . 0.0 110.735 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -94.96 -65.75 0.96 Allowed 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.087 -1.415 . . . . 0.0 114.164 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.92 139.47 16.92 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 121.742 0.782 . . . . 0.0 111.837 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 22.4 ttmm -64.56 121.28 14.07 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 127.595 2.358 . . . . 0.0 111.628 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.685 ' HB2' HG12 ' B' ' 19' ' ' VAL . 3.8 mm? -91.91 -63.04 1.3 Allowed 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.401 ' H ' ' HB ' ' B' ' 19' ' ' VAL . 7.2 t -149.13 -156.27 0.71 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.827 -174.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -161.54 145.94 13.1 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 125.949 1.7 . . . . 0.0 109.886 -170.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.17 148.93 44.33 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.294 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.5 p -81.76 158.32 24.19 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.179 -0.918 . . . . 0.0 113.075 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -57.26 -42.36 81.4 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.621 1.168 . . . . 0.0 112.034 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.09 -16.51 64.0 Favored 'General case' 0 C--O 1.178 -2.681 0 C-N-CA 124.71 1.204 . . . . 0.0 111.366 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.419 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 66.3 mttm -90.63 -33.68 15.75 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.525 -1.359 . . . . 0.0 109.563 169.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.445 ' HG2' ' OD2' ' B' ' 115' ' ' ASP 0.307 34.7 ttm -65.06 -25.16 67.69 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.742 ' HE3' ' N ' ' B' ' 113' ' ' GLU . 0.0 OUTLIER -58.87 -13.8 7.26 Favored 'General case' 0 C--N 1.248 -3.826 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 174.129 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 113' ' ' GLU . . . . . 0.742 ' N ' ' HE3' ' B' ' 112' ' ' LYS . 43.8 mt-10 -87.22 -54.47 4.29 Favored 'General case' 0 CA--C 1.429 -3.703 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 172.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' B' ' 111' ' ' MET . 2.1 t -47.17 -52.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.01 -1.904 . . . . 0.0 113.93 -177.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 16.7 m-20 -64.21 -48.48 75.73 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 123.331 1.539 . . . . 0.0 111.145 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.435 ' O ' HG13 ' B' ' 120' ' ' ILE 0.316 9.0 t30 -72.03 -39.09 69.37 Favored 'General case' 0 C--N 1.268 -2.953 0 C-N-CA 126.77 2.028 . . . . 0.0 112.795 -170.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.477 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -62.23 -37.97 87.45 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 124.284 1.033 . . . . 0.0 108.565 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.507 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.9 tp -69.18 -36.48 77.38 Favored 'General case' 1 N--CA 1.366 -4.627 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.682 -176.44 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 46.5 mtp -69.28 -19.71 63.91 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 121.997 -0.439 . . . . 0.0 110.932 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' B' ' 117' ' ' ALA . 52.1 mt -81.88 -58.39 3.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.2 m -52.18 -44.55 64.73 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.263 0.977 . . . . 0.0 111.433 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 7.2 mp -86.72 -1.82 58.04 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.8 17.5 71.36 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 116.696 1.439 . . . . 0.0 116.696 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.548 HD21 HD23 ' A' ' 118' ' ' LEU . 6.8 mp -68.58 -49.23 61.01 Favored 'General case' 0 CA--C 1.474 -1.975 0 CA-C-N 118.735 1.267 . . . . 0.0 108.042 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 38.25 -134.79 0.1 Allowed 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.008 -1.906 . . . . 0.0 110.196 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -124.95 19.28 8.45 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.04 0.924 . . . . 0.0 108.689 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 45.5 t -134.28 -36.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.949 -173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 66.33 -78.16 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 125.989 1.716 . . . . 0.0 111.896 -174.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -98.99 117.32 33.24 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 122.212 -0.305 . . . . 0.0 110.684 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -85.19 104.55 15.17 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 66.81 93.81 0.07 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.205 0.941 . . . . 0.0 112.652 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 21.6 t30 . . . . . 0 N--CA 1.398 -3.033 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 179.313 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.296 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m -65.86 -38.53 89.06 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 p -104.34 159.62 15.57 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.839 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -98.96 155.64 17.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.861 0.362 . . . . 0.0 110.172 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 11.5 p80 -110.55 80.7 1.33 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.886 0.851 . . . . 0.0 112.685 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -94.86 -54.29 3.52 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -107.98 3.94 24.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.418 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 5' ' ' HIS . 39.8 m80 -94.62 111.89 23.65 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -118.81 77.65 1.2 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.163 0.506 . . . . 0.0 110.557 -177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 m -86.31 -37.99 17.95 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -104.33 96.77 6.85 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -87.84 161.77 43.41 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.7 152.52 34.27 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.607 2.205 . . . . 0.0 111.341 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.443 HG22 HG21 ' A' ' 40' ' ' ILE . 67.6 mt -84.31 131.47 33.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -102.3 129.4 48.73 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.586 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 1.1 ptm180 -61.99 118.08 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 128.07 -10.67 6.59 Favored Glycine 0 C--N 1.295 -1.719 0 C-N-CA 120.063 -1.065 . . . . 0.0 111.125 -172.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.72 175.33 6.85 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 122.574 1.178 . . . . 0.0 110.988 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.479 HG11 HG22 ' A' ' 104' ' ' THR . 10.8 t -133.39 134.72 56.92 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.936 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 27.6 m-85 -133.22 147.82 52.0 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 124.988 1.315 . . . . 0.0 108.11 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mp -81.01 150.69 28.77 Favored 'General case' 0 N--CA 1.408 -2.546 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.053 170.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.26 138.34 49.26 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.2 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.41 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 20.7 t70 -79.94 90.38 5.34 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.966 0.888 . . . . 0.0 109.777 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.604 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 14.9 mt -100.1 19.37 16.49 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 124.055 1.883 . . . . 0.0 109.591 -176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.52 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.266 15.0 m -61.94 167.55 4.66 Favored Pre-proline 1 C--N 1.229 -4.656 0 CA-C-N 111.41 -2.632 . . . . 0.0 108.295 169.84 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.2 OUTLIER 9.6 50.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.397 3.092 1 C-N-CA 127.367 5.378 . . . . 0.0 118.011 -175.03 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.9 m -68.74 -178.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 113.764 -1.562 . . . . 0.0 111.887 170.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 13.6 mm100 -107.44 132.14 53.52 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.565 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.74 -135.66 35.64 Favored Glycine 0 N--CA 1.425 -2.09 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.853 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -91.77 20.35 5.67 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.87 -0.665 . . . . 0.0 111.088 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 0.1 OUTLIER -65.57 152.41 44.15 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 175.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.407 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -78.15 110.31 13.02 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.769 -0.582 . . . . 0.0 110.786 -167.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -86.52 129.18 9.27 Favored Glycine 0 CA--C 1.49 -1.529 0 N-CA-C 116.244 1.257 . . . . 0.0 116.244 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 131.41 137.06 3.99 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 113.427 -1.387 . . . . 0.0 110.076 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.91 119.37 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 CA-C-O 122.248 1.023 . . . . 0.0 109.775 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -142.53 158.02 61.2 Favored Pre-proline 0 C--N 1.271 -2.838 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.697 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 4.6 Cg_exo -72.15 142.2 37.54 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 121.971 1.781 . . . . 0.0 111.386 174.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 20' ' ' TYR . 31.6 m -118.07 156.83 19.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.553 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 36.0 m -97.91 126.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.337 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.443 HG21 HG22 ' A' ' 14' ' ' ILE . 24.5 mm -87.2 103.92 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.7 -18.94 6.14 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.524 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.812 ' HG3' HG22 ' A' ' 54' ' ' ILE . 3.6 tt0 -56.07 157.99 4.24 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -173.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 28.5 p-10 -71.19 -167.48 0.23 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.807 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -89.55 -38.69 13.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.841 -175.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.1 m -83.78 -28.22 28.3 Favored 'General case' 0 C--O 1.249 1.074 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.718 -170.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.88 -38.77 97.1 Favored Glycine 0 C--O 1.206 -1.647 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -83.67 -20.72 33.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.237 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 4.2 mptp? -76.02 -65.24 0.94 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.811 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.537 ' CD1' ' HB3' ' A' ' 48' ' ' LYS . 85.9 m-85 -99.02 -28.2 13.51 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -171.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.5 m -93.07 154.68 41.66 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . 59.4 Cg_endo -79.52 -18.92 10.48 Favored 'Trans proline' 0 C--O 1.21 -0.913 0 C-N-CA 121.69 1.593 . . . . 0.0 111.603 175.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 4.2 p -91.93 146.27 23.88 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.253 1.021 . . . . 0.0 113.081 -173.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.807 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -142.0 139.0 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.384 0.428 . . . . 0.0 110.491 172.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.812 HG22 ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -88.43 130.25 38.26 Favored 'Isoleucine or valine' 0 C--O 1.249 1.071 0 CA-C-O 121.799 0.809 . . . . 0.0 110.334 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.37 167.55 24.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.397 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.513 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -123.5 146.43 48.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.446 ' HB2' HH21 ' A' ' 92' ' ' ARG . . . -79.91 136.31 36.62 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.63 HD12 ' HB2' ' A' ' 37' ' ' PRO . 19.2 mt -87.3 130.66 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.708 172.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.9 m -122.29 157.44 31.73 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.24 -174.51 10.87 Favored Glycine 0 C--O 1.241 0.563 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.078 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -74.62 88.5 2.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.931 0.872 . . . . 0.0 110.259 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.3 pt -91.46 173.15 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.104 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.512 ' OD1' ' HG3' ' A' ' 64' ' ' LYS . 9.1 p30 -104.78 165.11 11.29 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HG3' ' OD1' ' A' ' 63' ' ' ASN . 63.0 mttp 73.74 94.34 0.07 Allowed 'General case' 0 C--O 1.248 0.987 0 C-N-CA 124.377 1.071 . . . . 0.0 112.948 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.45 102.59 5.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -71.31 -23.89 62.02 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 67' ' ' ILE 0.619 23.5 mm 109.84 -58.84 0.0 OUTLIER Pre-proline 0 CA--C 1.508 -0.651 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 172.016 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.36 1.94 1.09 Allowed 'Trans proline' 0 C--O 1.219 -0.433 0 CA-C-N 121.828 1.688 . . . . 0.0 114.289 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 p -132.38 -10.86 3.23 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.9 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -133.82 129.11 36.06 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -174.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 p -130.51 131.71 64.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.223 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.63 124.14 28.27 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.606 HD13 HD11 ' A' ' 86' ' ' ILE . 13.0 pt -99.49 135.68 33.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.441 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -65.83 114.8 5.33 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.16 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.412 ' HD2' ' O ' ' A' ' 81' ' ' ASP . 20.9 pttp -51.46 -39.42 57.42 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.637 0.732 . . . . 0.0 112.141 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -68.4 -19.05 64.59 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.308 -1.315 . . . . 0.0 113.212 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -92.46 -36.18 13.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.94 0.876 . . . . 0.0 109.4 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.572 ' CD2' HD12 ' A' ' 73' ' ' ILE . 19.1 m-85 -92.83 7.53 43.36 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.669 -1.605 . . . . 0.0 113.471 -173.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 tptm 61.23 20.38 10.95 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 121.798 0.808 . . . . 0.0 110.746 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.2 mt -98.89 175.33 5.98 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.665 0.745 . . . . 0.0 111.011 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.412 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 11.2 t70 -83.56 -44.76 14.29 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.619 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -129.92 158.72 38.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.552 -176.023 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -72.26 137.72 46.95 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.546 ' O ' HG12 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -120.76 160.51 23.22 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -172.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -111.22 139.89 33.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.55 -0.719 . . . . 0.0 109.214 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.606 HD11 HD13 ' A' ' 73' ' ' ILE . 20.8 mm -104.37 135.99 39.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.8 mt -104.79 106.27 16.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.491 HD12 HD23 ' A' ' 118' ' ' LEU . 3.5 mm? -88.44 14.04 10.56 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.881 0.848 . . . . 0.0 111.505 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -112.91 -34.85 5.63 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.173 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.38 65.79 4.58 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.551 ' O ' ' HB ' ' B' ' 93' ' ' THR . 1.8 pp -102.66 173.81 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.04 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.598 ' NH1' HD22 ' A' ' 24' ' ' LEU . 10.1 ptt180 -164.29 155.45 15.61 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 52.6 m -114.73 120.65 40.79 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.0 mt -131.58 144.58 51.18 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.98 -170.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 2.6 p30 -70.54 152.45 43.95 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.009 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 51' ' ' PRO . 56.8 mtmt -55.24 -18.34 5.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -176.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -85.36 -19.21 31.78 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.912 0.386 . . . . 0.0 110.347 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.415 ' HA ' ' NE ' ' A' ' 98' ' ' ARG . 3.0 mmp_? -70.51 -34.39 72.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.23 121.05 20.64 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.384 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -95.44 -57.41 2.4 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.308 -1.315 . . . . 0.0 114.083 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.0 pt-20 -148.88 135.6 19.7 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 122.069 0.938 . . . . 0.0 113.322 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 55.3 tttp -60.89 110.71 1.41 Allowed 'General case' 0 C--N 1.279 -2.478 0 C-N-CA 128.625 2.77 . . . . 0.0 107.564 172.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 tp -111.13 -62.6 1.52 Allowed 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.299 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.479 HG22 HG11 ' A' ' 19' ' ' VAL . 6.0 t -127.03 -161.17 1.05 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.111 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -154.03 154.41 33.67 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 124.237 1.015 . . . . 0.0 110.803 -171.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.79 161.95 13.32 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.977 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 m -98.59 164.23 12.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 111' ' ' MET . 25.5 t70 -67.09 -33.3 75.19 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.481 0.582 . . . . 0.0 110.712 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.47 -47.43 85.71 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.612 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.597 ' O ' HG22 ' A' ' 114' ' ' VAL . 11.8 tptt -62.82 -32.97 74.27 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 173.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.537 ' HA ' ' CE ' ' A' ' 111' ' ' MET . 0.0 OUTLIER -51.01 -49.21 60.91 Favored 'General case' 0 CA--C 1.456 -2.662 0 CA-C-N 118.3 0.5 . . . . 0.0 109.656 169.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 9.3 mmpt? -75.17 -11.89 60.18 Favored 'General case' 0 N--CA 1.392 -3.371 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.545 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.252 30.4 mt-10 -87.48 -56.41 3.37 Favored 'General case' 0 N--CA 1.39 -3.462 0 C-N-CA 117.136 -1.826 . . . . 0.0 111.17 166.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 110' ' ' LYS . 35.7 m -61.18 -48.18 90.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.25 -48.13 82.87 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 123.488 1.613 . . . . 0.0 109.307 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 18.7 t30 -74.01 -42.05 60.93 Favored 'General case' 0 C--N 1.265 -3.07 0 CA-C-N 111.813 -2.449 . . . . 0.0 112.684 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.488 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.44 -40.93 96.27 Favored 'General case' 0 CA--C 1.46 -2.513 0 CA-C-O 122.365 1.079 . . . . 0.0 108.567 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.491 HD23 HD12 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -79.91 -25.44 40.56 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.939 -172.003 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.525 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 1.6 ttp -63.8 -26.82 68.8 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-O 121.924 0.869 . . . . 0.0 108.665 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 60.9 mt -84.23 -56.94 4.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 118' ' ' LEU . 15.1 t -47.2 -43.94 21.91 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.817 1.647 . . . . 0.0 112.116 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.773 ' HG ' HG21 ' B' ' 54' ' ' ILE . 8.3 mp -82.0 5.19 20.05 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.411 ' CA ' ' HB3' ' B' ' 43' ' ' ASN . . . 89.64 1.33 77.63 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 117.972 1.949 . . . . 0.0 117.972 176.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.525 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.2 mm? -67.28 -48.91 66.26 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 120.098 1.949 . . . . 0.0 107.804 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 54.75 -168.03 0.08 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.287 -2.233 . . . . 0.0 113.083 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.26 23.4 5.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.511 1.148 . . . . 0.0 109.306 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.5 t -90.42 -56.11 5.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.33 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 55.68 -86.74 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.779 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -110.66 129.8 55.73 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -91.75 -23.49 19.73 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -89.63 141.76 28.31 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.847 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 . . . . . 0 C--N 1.295 -1.793 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 172.475 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.232 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -68.3 -30.4 69.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.441 0.639 . . . . 0.0 109.782 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 16.7 p -109.56 150.81 27.64 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -89.58 158.85 17.47 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' B' ' 8' ' ' HIS . 10.8 p80 -113.69 65.6 0.66 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.751 0.786 . . . . 0.0 113.116 -176.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -83.37 -52.05 6.88 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -113.09 5.14 16.98 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.728 0.775 . . . . 0.0 109.861 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' B' ' 5' ' ' HIS . 39.0 m80 -94.44 107.96 19.91 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -114.68 81.15 1.51 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.53 0.681 . . . . 0.0 109.308 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.8 m -88.93 -43.66 11.0 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -98.81 97.92 9.08 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -88.6 161.76 41.15 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.686 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.26 152.29 25.91 Favored 'Trans proline' 0 C--O 1.256 1.387 0 C-N-CA 122.686 2.258 . . . . 0.0 112.028 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.458 HG22 HG21 ' B' ' 40' ' ' ILE . 66.6 mt -84.9 126.63 40.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -99.73 129.06 45.82 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.597 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 0.9 OUTLIER -61.14 119.63 8.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 169.478 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.54 -6.65 8.51 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.469 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.35 175.36 6.46 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.206 1.003 . . . . 0.0 110.587 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.463 HG11 HG22 ' B' ' 104' ' ' THR . 16.2 t -132.98 134.33 58.13 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 113.296 -1.774 . . . . 0.0 110.355 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 32.2 m-85 -132.7 148.0 52.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 124.912 1.285 . . . . 0.0 108.314 174.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.647 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.6 mp -81.47 152.11 27.51 Favored 'General case' 0 N--CA 1.411 -2.409 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.043 170.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.33 138.21 46.26 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.703 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.434 ' HB3' ' NH1' ' B' ' 98' ' ' ARG . 27.2 t70 -78.32 89.87 4.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.984 0.897 . . . . 0.0 110.022 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.623 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 15.8 mt -98.2 17.1 19.39 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 123.895 1.807 . . . . 0.0 109.299 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.534 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.262 15.7 m -60.33 166.65 3.81 Favored Pre-proline 1 C--N 1.236 -4.338 0 CA-C-N 111.916 -2.402 . . . . 0.0 107.955 169.729 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.1 OUTLIER 10.14 50.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.458 1 C-N-CA 127.209 5.273 . . . . 0.0 118.271 -174.764 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' B' ' 31' ' ' GLU . 24.3 m -68.83 -178.69 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 113.663 -1.608 . . . . 0.0 111.68 169.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' B' ' 31' ' ' GLU . 14.5 mm100 -108.36 129.66 55.23 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.388 -1.278 . . . . 0.0 113.569 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.74 -134.75 24.17 Favored Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.612 -1.177 . . . . 0.0 112.16 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.9 m -93.48 22.1 5.64 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 122.936 0.494 . . . . 0.0 111.104 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' B' ' 28' ' ' GLN . 0.1 OUTLIER -66.43 151.94 46.14 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 174.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -77.52 110.1 12.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.867 0.365 . . . . 0.0 111.425 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -86.54 139.88 16.9 Favored Glycine 0 CA--C 1.481 -2.049 0 CA-C-N 114.975 -1.011 . . . . 0.0 115.206 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 116.67 137.29 5.95 Favored Glycine 0 N--CA 1.42 -2.389 0 CA-C-N 113.652 -1.274 . . . . 0.0 110.048 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.2 124.47 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-O 121.942 0.877 . . . . 0.0 109.583 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -145.2 158.43 51.63 Favored Pre-proline 0 C--N 1.276 -2.629 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.299 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 3.7 Cg_exo -72.85 142.47 35.31 Favored 'Trans proline' 0 N--CA 1.437 -1.805 0 C-N-CA 122.053 1.835 . . . . 0.0 111.593 174.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.439 HG22 ' O ' ' B' ' 20' ' ' TYR . 29.9 m -118.34 156.7 20.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.496 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.514 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 27.3 m -97.82 126.98 50.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.416 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.458 HG21 HG22 ' B' ' 14' ' ' ILE . 20.6 mm -87.85 104.51 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.77 -18.69 6.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.364 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.835 ' HG3' HG22 ' B' ' 54' ' ' ILE . 3.6 tt0 -56.51 158.26 4.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -173.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.433 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 25.9 p-10 -71.51 -167.22 0.24 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 123.124 1.44 . . . . 0.0 112.835 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -90.65 -38.37 13.15 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.782 -2.008 . . . . 0.0 112.909 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 3.6 m -83.75 -27.51 28.86 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.127 -170.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -64.62 -37.51 94.49 Favored Glycine 0 C--O 1.202 -1.861 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -83.82 -20.89 32.42 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.761 -0.775 . . . . 0.0 110.234 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.485 ' HB3' ' CD1' ' B' ' 49' ' ' TYR . 4.9 mptp? -76.2 -66.35 0.81 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.603 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' B' ' 48' ' ' LYS . 87.7 m-85 -95.18 -30.18 14.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.785 -171.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 23.5 m -93.45 154.35 41.29 Favored Pre-proline 0 C--N 1.292 -1.931 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.82 -16.51 8.88 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.56 1.507 . . . . 0.0 111.209 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 9.0 p -92.9 146.43 23.64 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.231 1.013 . . . . 0.0 112.868 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.786 ' HA ' ' NE2' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -142.34 138.79 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 123.649 0.593 . . . . 0.0 110.29 172.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.835 HG22 ' HG3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -88.75 130.15 38.65 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 CA-C-O 121.742 0.782 . . . . 0.0 110.287 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.25 168.2 22.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.424 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.539 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -124.02 146.74 48.33 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.515 ' HB2' HH21 ' B' ' 92' ' ' ARG . . . -78.35 136.37 37.68 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' B' ' 37' ' ' PRO . 20.8 mt -88.49 127.25 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.14 -1.391 . . . . 0.0 107.352 172.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 60.2 m -117.77 160.33 21.53 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.28 178.76 26.32 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.984 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -68.34 101.76 1.27 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 43.9 pt -110.29 170.94 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.566 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ASN . . . . . 0.509 ' OD1' ' HG3' ' B' ' 64' ' ' LYS . 10.0 p30 -105.16 165.76 10.87 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.509 ' HG3' ' OD1' ' B' ' 63' ' ' ASN . 62.4 mttp 75.24 80.85 0.1 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 125.018 1.327 . . . . 0.0 112.502 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.75 109.61 14.91 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -77.41 -22.22 51.89 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' B' ' 67' ' ' ILE 0.602 24.1 mm 109.25 -58.57 0.0 OUTLIER Pre-proline 0 CA--C 1.509 -0.614 0 N-CA-C 120.24 3.422 . . . . 0.0 120.24 171.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.35 2.32 0.94 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 CA-C-N 121.691 1.64 . . . . 0.0 113.991 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 28.8 p -132.39 -11.94 3.15 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.768 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -135.48 129.21 32.8 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -173.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 p -131.35 133.17 62.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.648 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.86 125.76 29.8 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.631 HD13 HD11 ' B' ' 86' ' ' ILE . 12.3 pt -99.28 133.37 42.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.692 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -64.62 117.28 7.18 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 123.848 0.717 . . . . 0.0 110.39 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' B' ' 81' ' ' ASP . 21.2 pttp -53.65 -38.92 64.59 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.28 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -69.07 -19.28 64.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.546 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -91.61 -35.15 14.4 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.865 0.84 . . . . 0.0 109.106 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.574 ' CD2' HD12 ' B' ' 73' ' ' ILE . 17.1 m-85 -93.3 7.79 42.96 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.548 -173.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 23.2 tptm 61.42 23.41 13.67 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 121.802 0.81 . . . . 0.0 109.996 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 29.3 mt -100.6 177.08 5.11 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.485 0.659 . . . . 0.0 111.058 -174.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' B' ' 75' ' ' LYS . 20.3 t70 -83.21 -47.74 11.23 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.913 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -128.96 159.15 36.77 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.835 -175.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.73 145.22 52.45 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.549 ' O ' HG12 ' B' ' 73' ' ' ILE . 0.3 OUTLIER -129.31 158.79 38.11 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -173.019 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -110.23 140.59 28.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.631 HD11 HD13 ' B' ' 73' ' ' ILE . 22.9 mm -105.01 136.14 40.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 35.6 mt -104.79 105.55 15.67 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.491 HD12 HD23 ' B' ' 118' ' ' LEU . 3.5 mm? -87.68 11.97 13.88 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.006 0.907 . . . . 0.0 111.324 -174.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -110.62 -34.25 6.34 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.178 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.05 66.58 3.57 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.551 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.9 pp -102.59 174.24 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.554 ' NH1' HD22 ' B' ' 24' ' ' LEU . 10.4 ptt180 -164.53 154.54 14.11 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 49.5 m -113.41 120.69 41.95 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.013 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 58.7 mt -131.43 144.47 51.21 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.825 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 1.9 p30 -71.4 152.37 43.2 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.0 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -50.57 -25.49 4.18 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -81.44 -18.83 43.94 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.341 0.519 . . . . 0.0 110.93 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.434 ' NH1' ' HB3' ' B' ' 23' ' ' ASP . 3.3 mmp_? -69.17 -33.89 74.09 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' B' ' 21' ' ' LEU . 7.8 mp -73.54 124.15 25.33 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.361 173.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -99.02 -53.52 3.24 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.098 -1.41 . . . . 0.0 114.68 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 13.5 pt-20 -154.92 138.78 16.26 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 122.085 0.945 . . . . 0.0 113.163 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.77 112.25 2.2 Favored 'General case' 0 C--N 1.282 -2.354 0 C-N-CA 128.66 2.784 . . . . 0.0 107.358 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -112.2 -62.77 1.52 Allowed 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.244 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.463 HG22 HG11 ' B' ' 19' ' ' VAL . 6.7 t -125.59 -157.97 0.82 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.204 -1.398 . . . . 0.0 111.486 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -156.34 152.94 28.22 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 124.311 1.044 . . . . 0.0 111.005 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.1 151.54 23.88 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.289 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 19.8 m -90.43 166.79 13.07 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' B' ' 111' ' ' MET . 33.8 t70 -67.44 -34.28 76.89 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.029 0.442 . . . . 0.0 111.23 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -62.11 -46.71 87.86 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.616 ' O ' HG22 ' B' ' 114' ' ' VAL . 11.9 tptt -62.86 -32.07 73.22 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.539 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -51.62 -47.94 63.47 Favored 'General case' 0 CA--C 1.445 -3.074 0 CA-C-O 121.245 0.545 . . . . 0.0 109.867 169.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 8.3 mmpt? -74.88 -14.06 60.62 Favored 'General case' 0 N--CA 1.384 -3.767 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . 0.252 31.6 mt-10 -87.17 -56.61 3.3 Favored 'General case' 0 N--CA 1.386 -3.633 0 C-N-CA 116.763 -1.975 . . . . 0.0 111.234 168.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' VAL . . . . . 0.616 HG22 ' O ' ' B' ' 110' ' ' LYS . 36.0 m -60.56 -47.81 91.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.95 -50.87 71.65 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 123.365 1.555 . . . . 0.0 109.665 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.316 26.9 t30 -73.2 -40.47 64.73 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-N 112.1 -2.318 . . . . 0.0 112.792 -172.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.444 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -62.38 -40.04 95.15 Favored 'General case' 0 CA--C 1.46 -2.484 0 CA-C-O 122.225 1.012 . . . . 0.0 108.666 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.491 HD23 HD12 ' B' ' 88' ' ' LEU . 0.6 OUTLIER -79.56 -25.28 41.65 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.739 -173.303 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.529 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 1.8 ttp -63.47 -27.5 69.33 Favored 'General case' 0 N--CA 1.399 -3.014 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.496 HG23 ' ND2' ' B' ' 125' ' ' ASN . 64.1 mt -83.98 -56.99 4.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' SER . . . . . 0.447 ' HB3' ' HA ' ' B' ' 118' ' ' LEU . 21.9 t -47.09 -43.45 20.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.216 1.406 . . . . 0.0 112.283 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.79 ' HG ' HG21 ' A' ' 54' ' ' ILE . 8.2 mp -82.2 5.36 20.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.424 ' CA ' ' HB3' ' A' ' 43' ' ' ASN . . . 89.66 1.39 77.49 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 117.862 1.905 . . . . 0.0 117.862 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.529 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.1 mm? -67.41 -49.58 63.18 Favored 'General case' 0 C--O 1.249 1.048 0 CA-C-N 120.271 2.035 . . . . 0.0 107.749 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.496 ' ND2' HG23 ' B' ' 120' ' ' ILE . 1.5 t-20 53.95 -168.25 0.07 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 112.514 -2.13 . . . . 0.0 113.01 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.24 19.04 6.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.98 0.895 . . . . 0.0 110.316 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.35 -57.57 4.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.439 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 57.43 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 113.135 -1.848 . . . . 0.0 111.689 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -112.78 131.54 55.64 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -88.39 -38.61 14.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -74.85 142.92 44.09 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.029 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 . . . . . 0 C--N 1.301 -1.521 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 171.498 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.497 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -81.68 171.78 14.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.428 ' OG ' ' HA ' ' A' ' 7' ' ' HIS . 23.1 t 66.73 26.08 9.62 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.455 0.702 . . . . 0.0 110.976 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -88.44 -23.92 23.16 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.139 -0.351 . . . . 0.0 111.458 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -83.92 -38.43 21.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.439 0.638 . . . . 0.0 109.767 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -155.36 141.65 18.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.428 ' HA ' ' OG ' ' A' ' 3' ' ' SER . 23.6 p80 -85.71 -31.21 22.58 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.721 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -107.68 92.33 4.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -82.41 -64.5 1.16 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 m -159.72 86.79 0.79 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.147 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -94.2 108.57 20.42 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -80.51 138.0 51.52 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.691 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.87 27.67 0.6 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.82 3.013 . . . . 0.0 112.405 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 47' ' ' ASN . 59.3 mt -85.13 118.31 31.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.3 mmt-85 -117.22 152.75 34.16 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -64.25 122.0 15.61 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 113.33 -11.97 23.88 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.12 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -78.01 156.55 30.07 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 122.108 0.956 . . . . 0.0 110.123 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.463 ' HB ' ' H ' ' A' ' 104' ' ' THR . 93.3 t -116.24 118.81 60.0 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.391 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.345 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 44.2 m-85 -116.43 138.98 50.93 Favored 'General case' 0 C--O 1.181 -2.509 0 C-N-CA 126.072 1.749 . . . . 0.0 111.207 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.8 mp -82.48 147.87 28.46 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 121.392 0.615 . . . . 0.0 109.9 169.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -144.0 142.17 30.55 Favored 'General case' 0 C--N 1.274 -2.717 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.985 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.24 95.27 5.61 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 123.059 1.409 . . . . 0.0 110.256 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.823 ' O ' HG13 ' A' ' 27' ' ' VAL . 66.7 mt -88.42 -14.58 37.67 Favored 'General case' 0 C--O 1.177 -2.763 0 CA-C-N 113.214 -1.812 . . . . 0.0 112.554 -175.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 4.6 p -87.3 56.48 0.0 OUTLIER Pre-proline 0 C--N 1.256 -3.497 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -127.63 41.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 124.216 3.277 . . . . 0.0 106.709 142.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 24' ' ' LEU . 6.6 m -69.02 176.16 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -89.71 109.69 20.64 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.462 -1.699 . . . . 0.0 112.5 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.97 -108.56 0.56 Allowed Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.262 -1.335 . . . . 0.0 114.924 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.8 m -89.15 17.92 5.5 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 39.1 mt-10 -67.76 -175.06 0.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.969 172.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.414 ' NE2' ' HG3' ' A' ' 36' ' ' ARG . 13.1 tm0? -99.09 121.17 40.63 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.78 164.29 13.9 Favored Glycine 0 CA--C 1.478 -2.252 0 CA-C-O 122.012 0.784 . . . . 0.0 114.99 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.507 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . 115.68 156.71 11.07 Favored Glycine 0 N--CA 1.419 -2.48 0 CA-C-N 113.431 -1.385 . . . . 0.0 109.666 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -82.74 100.48 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.342 0 CA-C-O 123.904 1.811 . . . . 0.0 107.604 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.414 ' HG3' ' NE2' ' A' ' 32' ' ' GLN . 28.4 mmt180 -127.26 161.34 54.89 Favored Pre-proline 0 C--N 1.255 -3.502 0 CA-C-N 112.253 -2.249 . . . . 0.0 108.888 -170.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.7 ' HB2' HD12 ' A' ' 58' ' ' ILE . 5.2 Cg_exo -76.74 142.07 22.4 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 C-N-CA 121.772 1.648 . . . . 0.0 112.146 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 20' ' ' TYR . 27.6 m -119.84 156.81 22.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 124.419 1.087 . . . . 0.0 108.475 177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 21.2 m -105.57 133.82 48.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.3 mm -81.85 103.24 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -98.37 -19.22 6.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.777 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.547 HE22 ' N ' ' A' ' 47' ' ' ASN . 3.1 tt0 -57.05 163.8 1.9 Allowed 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 125.51 1.524 . . . . 0.0 114.567 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 27.4 p-10 -65.85 177.76 1.23 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.539 -1.664 . . . . 0.0 112.423 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.38 -41.56 56.06 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.556 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.8 m -85.28 -26.36 26.68 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.484 -171.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.3 -33.21 79.61 Favored Glycine 0 C--O 1.213 -1.214 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.547 ' N ' HE22 ' A' ' 42' ' ' GLN 0.262 6.7 p30 -69.63 -18.97 63.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -92.35 -68.02 0.82 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.106 0.479 . . . . 0.0 110.297 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -91.89 -16.24 26.96 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -165.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.5 m -90.73 133.83 31.74 Favored Pre-proline 0 N--CA 1.417 -2.105 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -65.68 -27.97 52.5 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 121.752 1.635 . . . . 0.0 108.698 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.4 p -94.35 137.98 32.87 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 113.333 -1.758 . . . . 0.0 112.115 -175.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.542 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 90.4 t -122.06 140.16 46.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.701 HD13 HD11 ' B' ' 91' ' ' ILE . 1.5 tp -106.09 125.73 61.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-O 121.7 0.762 . . . . 0.0 110.943 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.34 171.11 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.103 -176.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.52 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -124.78 142.83 51.15 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.508 ' HB2' HH11 ' A' ' 92' ' ' ARG . . . -84.18 142.53 30.26 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 ' HB2' ' A' ' 37' ' ' PRO . 16.2 mt -85.59 138.49 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.963 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 m -119.79 134.75 55.12 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.97 51.97 1.64 Allowed Glycine 0 N--CA 1.478 1.439 0 CA-C-O 121.36 0.422 . . . . 0.0 112.567 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . 0.262 41.5 mtp85 71.91 167.96 0.31 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 127.587 2.355 . . . . 0.0 112.415 -175.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.3 tt -155.13 -48.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.584 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -167.99 -82.04 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.185 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -170.04 170.22 7.64 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.408 ' HB2' ' HG3' ' A' ' 72' ' ' GLU . . . -80.37 76.49 7.18 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.474 1.131 . . . . 0.0 109.305 175.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -85.17 -21.19 29.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.788 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 tt -130.6 141.12 40.79 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.92 -3.61 0.71 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 124.048 3.165 . . . . 0.0 116.435 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.4 p -90.45 -18.96 24.47 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 118.921 0.782 . . . . 0.0 109.641 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -86.25 129.59 34.8 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.065 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.44 120.6 59.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.408 ' HG3' ' HB2' ' A' ' 65' ' ' ALA . 26.2 mt-10 -86.08 132.34 34.06 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.481 HD13 ' CG ' ' A' ' 78' ' ' TYR . 2.8 pp -84.6 157.33 3.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.987 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HG2' ' CG ' ' A' ' 76' ' ' LYS . 19.8 tt0 -77.59 107.88 10.37 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 62.7 pttt -55.22 -42.17 73.0 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.459 ' CG ' ' HG2' ' A' ' 74' ' ' GLU . 11.1 ptmm? -59.02 -32.75 70.01 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.222 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -91.39 -26.7 18.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.681 0.753 . . . . 0.0 109.84 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CG ' HD13 ' A' ' 73' ' ' ILE . 2.8 m-85 -80.44 2.7 24.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.274 -178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 71.63 20.65 4.64 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.502 1.121 . . . . 0.0 111.068 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 mt -110.89 168.57 9.38 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.852 0.834 . . . . 0.0 111.248 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.481 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 14.7 t70 -93.2 -35.36 13.18 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.928 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -119.65 145.81 46.13 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.076 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 8.4 p-10 -76.08 147.39 38.68 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.389 0.614 . . . . 0.0 110.113 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.2 t -112.57 175.9 5.24 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.06 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 t -127.76 141.41 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.575 ' CD1' HG12 ' A' ' 58' ' ' ILE . 25.1 mm -109.36 133.36 54.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.5 mt -102.52 107.54 18.54 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -79.52 15.63 1.25 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.789 0.835 . . . . 0.0 112.46 -174.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.27 -39.79 3.01 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.649 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -83.68 51.96 2.15 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 125.332 1.453 . . . . 0.0 108.237 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.709 HD11 HD13 ' B' ' 54' ' ' ILE . 2.0 pp -96.29 -179.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.63 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.508 HH11 ' HB2' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -168.0 163.13 13.62 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.6 m -117.77 119.93 36.39 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.414 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.2 mt -131.44 137.75 48.76 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.895 -171.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 2.8 p-10 -74.35 153.16 39.42 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.445 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -38.99 -36.76 0.31 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 126.231 1.812 . . . . 0.0 112.837 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -64.52 -22.34 66.94 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.943 0.897 . . . . 0.0 111.54 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.7 mmp_? -79.83 -33.54 40.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.257 0.551 . . . . 0.0 109.577 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.53 101.89 4.33 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 122.601 1.191 . . . . 0.0 111.715 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -86.7 -65.09 1.05 Allowed 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 113.518 -1.674 . . . . 0.0 115.13 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 9.3 pt-20 -139.46 126.66 21.25 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 18.8 ptmt -71.45 114.07 9.14 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.319 -1.764 . . . . 0.0 110.986 171.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.631 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 24.0 tp -103.49 -56.73 2.16 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.005 -173.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.631 ' OG1' ' HG ' ' A' ' 103' ' ' LEU 0.285 3.5 m -135.42 -174.05 3.52 Favored 'General case' 0 N--CA 1.391 -3.384 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.573 -165.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.472 ' H ' ' CG2' ' A' ' 104' ' ' THR . 0.6 OUTLIER -160.64 134.93 7.24 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.489 1.516 . . . . 0.0 110.92 -166.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.59 153.4 22.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.345 0.658 . . . . 0.0 112.539 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.432 ' HB2' ' HD3' ' A' ' 110' ' ' LYS . 2.0 m -75.87 159.7 30.68 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.888 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 111' ' ' MET . 38.1 t70 -58.45 -51.93 67.76 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 3.5 p-10 -73.14 -26.69 61.3 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.717 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.432 ' HD3' ' HB2' ' A' ' 107' ' ' SER . 2.0 mptp? -67.41 -27.26 66.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.585 176.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.412 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -57.38 -39.78 76.78 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 123.527 0.731 . . . . 0.0 110.473 174.114 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.604 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -74.11 -19.8 60.46 Favored 'General case' 0 CA--C 1.483 -1.622 0 C-N-CA 123.245 0.618 . . . . 0.0 111.386 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.489 ' HA ' ' ND2' ' A' ' 116' ' ' ASN . 21.0 mt-10 -85.83 -36.87 19.76 Favored 'General case' 0 N--CA 1.399 -2.983 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.68 -46.77 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-N 113.153 -1.84 . . . . 0.0 109.829 170.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 112' ' ' LYS . 37.4 m-20 -60.21 -57.74 11.49 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.88 0.848 . . . . 0.0 109.976 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 113' ' ' GLU . 0.4 OUTLIER -64.88 -39.43 93.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.624 -172.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.487 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.99 -40.26 84.3 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 2.8 tp -68.36 -38.02 81.03 Favored 'General case' 1 N--CA 1.365 -4.705 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.356 -175.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 46.2 mtp -66.17 -29.67 70.0 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 121.755 -0.59 . . . . 0.0 111.261 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 116' ' ' ASN . 26.5 mt -77.33 -54.35 12.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.5 t -52.67 -36.81 57.68 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.565 -1.652 . . . . 0.0 111.358 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.533 ' HB3' ' CD1' ' B' ' 41' ' ' ILE . 42.0 mt -101.49 7.32 42.48 Favored 'General case' 0 N--CA 1.428 -1.529 0 O-C-N 121.961 -0.462 . . . . 0.0 111.512 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.91 75.24 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 116.794 1.478 . . . . 0.0 116.794 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 128' ' ' ALA . 7.2 mp -78.46 -46.94 18.51 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 118.829 1.315 . . . . 0.0 109.292 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 44.44 -148.01 0.08 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 113.274 -1.785 . . . . 0.0 110.229 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.41 15.9 9.8 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.157 -0.964 . . . . 0.0 110.16 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.5 t -92.94 -3.62 10.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.973 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 124' ' ' LEU . . . -67.8 -62.63 1.32 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.788 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -92.61 76.22 5.02 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 122.094 0.95 . . . . 0.0 111.036 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -96.13 96.29 8.74 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 173.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . 0.253 43.8 tptt -86.37 99.79 11.86 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -170.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 . . . . . 0 C--N 1.285 -2.221 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 166.875 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.425 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 21.4 m -81.73 171.66 14.3 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 122.568 0.347 . . . . 0.0 110.273 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 25.2 t 69.67 23.14 5.9 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.808 0.843 . . . . 0.0 110.37 175.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -90.02 -16.03 30.64 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.181 0.515 . . . . 0.0 111.535 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -92.41 -42.81 9.56 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -152.99 139.63 18.83 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.752 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -80.92 -35.63 32.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.391 0.615 . . . . 0.0 110.492 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -105.81 89.27 3.03 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.861 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -79.36 -67.82 0.72 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 38.8 m -155.64 91.99 1.35 Allowed 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -101.1 105.93 17.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -77.32 137.95 64.18 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.363 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.78 29.88 0.54 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.767 2.978 . . . . 0.0 111.907 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 66.0 mt -87.09 119.0 34.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.9 mmt-85 -119.44 154.56 33.52 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -64.27 120.36 12.01 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 116.46 -13.93 15.53 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.998 -178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ASP . . . . . 0.413 ' O ' HG12 ' B' ' 40' ' ' ILE . 14.1 m-20 -75.67 155.05 36.14 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.33 1.062 . . . . 0.0 110.844 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.477 ' HB ' ' H ' ' B' ' 104' ' ' THR . 89.9 t -115.56 118.59 59.28 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.516 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.894 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.532 ' CZ ' ' HB3' ' B' ' 102' ' ' LYS . 48.2 m-85 -115.52 140.44 49.15 Favored 'General case' 0 CA--C 1.455 -2.707 0 C-N-CA 125.986 1.714 . . . . 0.0 110.671 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -82.34 148.68 28.15 Favored 'General case' 0 N--CA 1.392 -3.33 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.782 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -146.07 143.6 29.5 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.733 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' B' ' 25' ' ' SER . 4.8 p-10 -75.52 93.1 2.95 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 122.325 1.059 . . . . 0.0 110.001 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.746 ' O ' HG13 ' B' ' 27' ' ' VAL . 69.5 mt -89.6 21.8 3.3 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -176.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.639 ' HB2' ' HD2' ' B' ' 26' ' ' PRO 0.264 5.4 p -79.54 -165.62 0.07 OUTLIER Pre-proline 0 N--CA 1.39 -3.427 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 176.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.639 ' HD2' ' HB2' ' B' ' 25' ' ' SER . 31.7 Cg_exo 18.39 40.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.42 1 C-N-CA 125.385 4.057 . . . . 0.0 118.193 -156.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.746 HG13 ' O ' ' B' ' 24' ' ' LEU . 7.0 m -70.56 177.8 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 122.213 1.006 . . . . 0.0 112.786 174.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -90.08 109.15 20.22 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.117 -1.401 . . . . 0.0 112.724 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.39 -108.49 0.31 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.69 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -87.28 17.65 4.25 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.0 -170.57 0.11 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 118.87 0.759 . . . . 0.0 111.292 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -103.67 118.85 37.68 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.88 167.04 16.91 Favored Glycine 0 CA--C 1.473 -2.583 0 CA-C-O 122.218 0.899 . . . . 0.0 115.306 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 113.36 154.2 11.42 Favored Glycine 0 N--CA 1.408 -3.191 0 CA-C-N 112.861 -1.669 . . . . 0.0 109.719 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -80.84 103.05 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-O 123.167 1.46 . . . . 0.0 107.287 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -130.54 161.71 59.15 Favored Pre-proline 0 C--N 1.254 -3.582 0 CA-C-N 113.267 -1.788 . . . . 0.0 108.949 -170.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.674 ' HB2' HD12 ' B' ' 58' ' ' ILE . 4.7 Cg_exo -75.57 141.81 25.49 Favored 'Trans proline' 0 N--CA 1.431 -2.193 0 C-N-CA 121.812 1.675 . . . . 0.0 112.33 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -120.86 156.95 24.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 124.568 1.147 . . . . 0.0 108.512 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 21.8 m -105.46 133.6 49.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.502 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.413 HG12 ' O ' ' B' ' 18' ' ' ASP . 30.6 mm -81.69 102.02 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.3 -19.31 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.637 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.535 HE22 ' N ' ' B' ' 47' ' ' ASN . 2.6 tt0 -56.67 162.19 2.41 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 125.462 1.505 . . . . 0.0 114.475 -173.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.525 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 21.8 p-10 -63.8 -175.86 0.16 Allowed 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.472 -1.694 . . . . 0.0 112.492 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.76 -42.73 17.6 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.63 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 9.7 m -85.15 -26.17 27.0 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.545 -170.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.1 -34.49 84.08 Favored Glycine 0 C--O 1.217 -0.909 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.535 ' N ' HE22 ' B' ' 42' ' ' GLN 0.264 8.8 p30 -69.1 -18.77 64.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.365 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -92.65 -67.37 0.86 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.231 0.539 . . . . 0.0 110.782 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -93.43 -11.79 31.33 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -166.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 69.4 m -94.65 134.47 25.16 Favored Pre-proline 0 N--CA 1.42 -1.943 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.55 -27.51 39.09 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 121.872 1.715 . . . . 0.0 109.044 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.7 p -94.82 137.7 33.57 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.834 -174.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.518 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 89.4 t -121.86 140.21 46.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.709 HD13 HD11 ' A' ' 91' ' ' ILE . 1.4 tp -105.9 125.66 61.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-O 121.668 0.746 . . . . 0.0 111.257 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.406 HG12 HD13 ' B' ' 40' ' ' ILE . 34.1 m -133.32 172.44 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.994 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.524 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -127.03 142.5 51.53 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.525 ' HB2' HH11 ' B' ' 92' ' ' ARG . . . -83.3 142.95 30.71 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' B' ' 37' ' ' PRO . 17.2 mt -88.31 135.36 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.442 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 38.3 m -116.16 134.78 54.55 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.09 50.94 1.62 Allowed Glycine 0 N--CA 1.478 1.454 0 CA-C-O 121.732 0.629 . . . . 0.0 112.327 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 71.79 163.08 0.26 Allowed 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 127.17 2.188 . . . . 0.0 112.693 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 11.5 tt -150.34 -47.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.189 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -169.45 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.093 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' B' ' 65' ' ' ALA . 16.4 tppt? -170.34 167.35 8.41 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.444 ' H ' ' HD3' ' B' ' 64' ' ' LYS . . . -77.54 77.84 4.06 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.216 1.008 . . . . 0.0 108.679 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -86.12 -18.06 33.34 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.314 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 tt -134.1 142.31 42.76 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.15 -12.53 5.41 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 124.038 3.158 . . . . 0.0 116.258 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 59.2 p -83.95 -19.11 35.22 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.63 0.729 . . . . 0.0 109.829 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -85.38 129.1 34.89 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.09 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.91 121.67 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -87.77 133.5 33.86 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.491 HD13 ' CG ' ' B' ' 78' ' ' TYR . 2.8 pp -85.9 156.46 3.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.369 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.434 ' HG2' ' CG ' ' B' ' 76' ' ' LYS . 16.0 tt0 -76.26 107.45 8.51 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' B' ' 83' ' ' ASP . 62.2 pttt -56.25 -41.83 76.39 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' LYS . . . . . 0.434 ' CG ' ' HG2' ' B' ' 74' ' ' GLU . 10.8 ptmm? -59.71 -30.78 69.04 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.503 -1.226 . . . . 0.0 113.367 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -91.47 -31.18 16.08 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.561 0.696 . . . . 0.0 109.404 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.491 ' CG ' HD13 ' B' ' 73' ' ' ILE . 3.0 m-85 -76.39 1.3 16.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.442 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 74.55 12.78 3.77 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.994 1.318 . . . . 0.0 111.816 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 19.2 mt -104.46 168.48 9.06 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.873 0.844 . . . . 0.0 111.896 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' B' ' 75' ' ' LYS . 18.3 t70 -91.51 -35.85 14.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.131 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.28 147.85 44.46 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.636 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' B' ' 75' ' ' LYS . 7.3 p-10 -76.84 147.97 36.81 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.157 0.503 . . . . 0.0 110.324 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -113.19 175.2 5.55 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.091 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t -126.82 141.79 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.587 ' CD1' HG12 ' B' ' 58' ' ' ILE . 25.0 mm -109.07 133.04 55.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 61.9 mt -102.22 107.07 18.01 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.994 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.7 mm? -79.01 14.02 1.56 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.821 0.849 . . . . 0.0 112.439 -174.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -116.61 -39.4 3.33 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.881 0.848 . . . . 0.0 108.944 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -84.04 52.0 2.2 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 125.229 1.412 . . . . 0.0 108.291 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.701 HD11 HD13 ' A' ' 54' ' ' ILE . 2.0 pp -96.46 -179.59 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.693 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.525 HH11 ' HB2' ' B' ' 57' ' ' ALA . 0.0 OUTLIER -167.92 163.12 13.8 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 17.9 m -118.1 119.59 35.21 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.48 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 51.4 mt -131.47 138.38 48.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.113 -171.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 3.7 p-10 -74.03 152.9 39.89 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.707 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -38.27 -32.74 0.08 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 126.853 2.061 . . . . 0.0 113.697 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -69.31 -25.51 64.26 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.279 0.632 . . . . 0.0 110.901 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 2.1 mmp_? -76.41 -33.36 58.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -73.32 103.65 4.07 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.108 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -87.14 -61.88 1.63 Allowed 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.3 pt-20 -144.39 130.24 19.3 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.846 0.832 . . . . 0.0 113.003 -171.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 20' ' ' TYR . 19.4 ptmt -73.75 110.84 8.36 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.111 173.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.641 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 23.9 tp -101.48 -56.63 2.25 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.796 -172.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.641 ' OG1' ' HG ' ' B' ' 103' ' ' LEU 0.285 4.1 m -134.48 -175.0 3.73 Favored 'General case' 0 N--CA 1.387 -3.613 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.31 -166.016 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.48 ' H ' ' CG2' ' B' ' 104' ' ' THR . 0.4 OUTLIER -160.6 134.96 7.3 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.476 1.51 . . . . 0.0 110.383 -166.566 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 11.1 mt -85.67 157.3 20.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.523 0.729 . . . . 0.0 112.517 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.416 ' HB2' ' HD3' ' B' ' 110' ' ' LYS . 2.3 m -78.97 165.5 23.4 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.775 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' B' ' 111' ' ' MET . 27.8 t70 -61.29 -53.01 62.23 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 3.7 p-10 -72.35 -28.52 63.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.446 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.416 ' HD3' ' HB2' ' B' ' 107' ' ' SER . 2.2 mptp? -66.51 -26.9 67.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.748 0.308 . . . . 0.0 111.221 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.448 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -59.03 -40.03 83.78 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.199 0.599 . . . . 0.0 110.397 173.542 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.609 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -75.37 -16.91 60.34 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.056 0.455 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 113' ' ' GLU . . . . . 0.443 ' HA ' ' ND2' ' B' ' 116' ' ' ASN . 48.7 mt-10 -84.54 -38.32 20.15 Favored 'General case' 0 CA--C 1.443 -3.152 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.28 -48.55 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.994 0 CA-C-N 112.685 -2.052 . . . . 0.0 110.022 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' B' ' 112' ' ' LYS . 49.0 m-20 -59.56 -59.02 6.11 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.726 0.774 . . . . 0.0 110.461 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 0.5 OUTLIER -64.82 -37.55 88.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.017 -172.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.456 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -60.15 -39.45 86.38 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 3.0 tp -69.78 -38.26 76.64 Favored 'General case' 1 N--CA 1.366 -4.661 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.984 -175.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 48.4 mtp -65.52 -34.77 79.04 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 121.769 -0.582 . . . . 0.0 110.927 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' B' ' 117' ' ' ALA . 23.7 mt -71.89 -53.95 18.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 20.3 t -52.76 -35.78 56.85 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.784 1.234 . . . . 0.0 111.443 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.534 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 39.8 mt -102.34 6.54 40.41 Favored 'General case' 0 N--CA 1.428 -1.548 0 O-C-N 121.894 -0.504 . . . . 0.0 111.508 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.26 20.69 76.88 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 7.1 mp -77.48 -49.31 15.03 Favored 'General case' 0 CA--C 1.478 -1.791 0 CA-C-N 118.876 1.338 . . . . 0.0 109.056 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 44.53 -149.41 0.06 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.148 -172.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.25 14.95 9.79 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.919 -1.113 . . . . 0.0 110.651 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 36.7 t -92.35 -4.19 10.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.125 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' B' ' 124' ' ' LEU . . . -65.34 -70.01 0.26 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.608 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -83.78 79.25 9.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 122.18 0.99 . . . . 0.0 110.736 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -100.4 96.65 7.56 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -90.29 100.58 13.39 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -167.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 166.609 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.128 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.4 m -89.28 104.31 16.87 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.194 0.521 . . . . 0.0 110.021 -177.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -90.0 106.9 18.78 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -87.29 118.05 26.46 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -73.65 -29.49 62.36 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.986 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -100.8 87.85 3.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -81.4 -47.65 12.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -122.54 171.3 9.21 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.673 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -130.63 126.59 37.02 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 m -79.98 -5.3 55.46 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.305 0.574 . . . . 0.0 111.017 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -68.75 115.8 8.52 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.074 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -99.74 121.2 55.26 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.62 134.02 56.36 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 C-N-CA 122.331 2.021 . . . . 0.0 109.602 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.448 ' HB ' ' OD1' ' A' ' 47' ' ' ASN . 65.1 mt -62.08 120.35 8.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.196 0.522 . . . . 0.0 110.143 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -103.28 138.82 39.54 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -76.59 134.43 39.37 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.353 -1.339 . . . . 0.0 108.334 173.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.31 -5.53 55.42 Favored Glycine 0 C--N 1.302 -1.356 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.93 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.25 166.69 11.78 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.582 0.706 . . . . 0.0 110.114 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 37.4 t -120.05 133.7 65.95 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.422 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.595 ' O ' HG22 ' A' ' 38' ' ' VAL . 44.4 m-85 -136.67 147.34 46.77 Favored 'General case' 0 CA--C 1.469 -2.165 0 C-N-CA 124.623 1.169 . . . . 0.0 107.957 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.7 mp -74.42 148.86 40.77 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.087 171.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -143.63 135.3 26.3 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.097 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.19 94.46 3.53 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.77 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 9.2 mt -89.45 5.0 47.26 Favored 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 124.776 1.23 . . . . 0.0 110.086 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.609 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 4.6 m -52.96 -177.66 0.04 OUTLIER Pre-proline 1 C--N 1.241 -4.142 0 C-N-CA 126.817 2.047 . . . . 0.0 113.283 174.172 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 19.97 35.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.41 3.784 1 C-N-CA 125.716 4.277 . . . . 0.0 119.465 -157.956 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 5.8 m -70.89 173.47 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.565 168.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -111.71 141.4 45.36 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.89 -111.87 1.43 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 114.786 -1.097 . . . . 0.0 115.023 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -94.16 4.4 53.94 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 123.425 0.69 . . . . 0.0 112.697 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 77.2 mt-10 -64.05 144.0 57.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.524 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 5.8 tp60 -117.73 111.47 19.16 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -170.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -126.64 -109.44 1.63 Allowed Glycine 1 N--CA 1.383 -4.844 0 C-N-CA 118.361 -1.876 . . . . 0.0 116.453 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 75.97 177.08 41.9 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 -168.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.5 p -91.44 106.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.288 0 O-C-N 120.617 -1.519 . . . . 0.0 108.897 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.524 ' NH2' ' HG3' ' A' ' 32' ' ' GLN . 62.8 mtm180 -135.17 157.8 76.07 Favored Pre-proline 0 C--N 1.275 -2.672 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.648 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 31.9 Cg_exo -66.12 138.55 52.34 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.098 2.532 . . . . 0.0 112.132 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 20' ' ' TYR . 20.5 m -126.35 164.03 27.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 C-N-CA 123.5 0.72 . . . . 0.0 110.234 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 27.4 m -105.73 134.5 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.9 mm -95.01 118.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 123.093 0.557 . . . . 0.0 110.195 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -8.62 12.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.587 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.567 ' NE2' ' HB ' ' A' ' 53' ' ' VAL . 5.5 pt20 -63.42 165.66 7.49 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -167.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.458 ' HB3' ' N ' ' B' ' 123' ' ' GLY . 18.4 p-10 -75.29 -173.14 1.95 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 111.823 -2.444 . . . . 0.0 113.423 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -79.55 -43.98 22.01 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.076 -1.874 . . . . 0.0 113.411 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 m -86.19 -25.73 25.49 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -168.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 50' ' ' SER . . . -71.52 -20.97 78.74 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.448 ' OD1' ' HB ' ' A' ' 14' ' ' ILE . 31.2 t-20 -72.86 -32.33 65.36 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.834 -1.183 . . . . 0.0 108.526 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -90.04 -66.73 0.9 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.534 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -98.81 -35.62 10.07 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -168.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.598 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 15.2 t -75.54 128.76 83.4 Favored Pre-proline 0 N--CA 1.435 -1.199 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.801 -174.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.545 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 61.2 Cg_endo -74.72 -11.75 22.05 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.985 1.79 . . . . 0.0 110.155 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 p -107.56 121.39 44.55 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.935 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.567 ' HB ' ' NE2' ' A' ' 42' ' ' GLN . 1.3 m -121.73 167.5 15.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.856 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.727 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 13.7 tt -108.29 125.07 65.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 123.575 0.75 . . . . 0.0 112.054 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.67 HG22 ' CD2' ' A' ' 94' ' ' LEU . 3.7 m -137.48 163.56 30.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.715 ' HA ' HG13 ' A' ' 91' ' ' ILE . . . -123.08 131.21 53.6 Favored 'General case' 0 N--CA 1.416 -2.16 0 O-C-N 123.365 0.416 . . . . 0.0 111.172 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.656 ' N ' HG21 ' A' ' 91' ' ' ILE . . . -66.0 130.63 43.91 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.539 HG12 HD12 ' A' ' 86' ' ' ILE . 56.4 mt -85.49 138.31 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 112.661 -2.063 . . . . 0.0 106.994 174.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.2 t -148.36 179.99 7.37 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.64 162.72 32.67 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 68.21 79.35 0.22 Allowed 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.437 1.095 . . . . 0.0 111.718 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.403 ' H ' ' H ' ' A' ' 63' ' ' ASN . 15.2 tt -142.45 -7.43 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.783 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.403 ' H ' ' H ' ' A' ' 62' ' ' ILE . 61.2 m-80 71.73 -66.42 0.3 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.436 1.495 . . . . 0.0 112.502 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -113.63 129.66 56.53 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.402 0.62 . . . . 0.0 111.799 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.9 26.39 10.55 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.106 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -80.6 62.58 4.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.757 0.789 . . . . 0.0 112.119 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -143.35 137.12 14.37 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.4 9.34 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.254 1.969 . . . . 0.0 114.145 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.0 p -118.5 -6.49 10.71 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.083 0.468 . . . . 0.0 110.613 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.471 ' CD2' HD22 ' A' ' 87' ' ' LEU . 43.4 m170 -122.6 129.32 51.76 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.2 m -122.02 139.4 49.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.618 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -94.75 129.71 41.56 Favored 'General case' 0 C--O 1.251 1.177 0 CA-C-O 121.567 0.699 . . . . 0.0 111.081 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.724 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -120.6 158.57 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.23 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -79.18 128.65 33.57 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.681 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -47.48 -48.35 27.04 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 125.369 1.468 . . . . 0.0 110.699 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -56.35 -45.0 80.63 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 126.489 1.916 . . . . 0.0 112.64 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -71.79 -34.99 69.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.98 -175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.724 ' CE1' HG21 ' A' ' 73' ' ' ILE . 3.6 m-85 -95.3 -9.89 31.77 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.192 -176.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 61.46 29.95 18.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.883 1.273 . . . . 0.0 112.863 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 7.6 mp -88.73 -179.56 6.03 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.629 1.204 . . . . 0.0 112.973 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -73.7 -26.0 60.5 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.871 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -147.83 166.87 26.28 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -59.25 141.86 53.3 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 m -103.08 137.34 41.39 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.808 -168.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.42 137.62 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.539 HD12 HG12 ' A' ' 58' ' ' ILE . 20.3 mm -116.17 138.44 46.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.528 ' O ' HD11 ' A' ' 91' ' ' ILE . 36.6 mt -104.46 140.78 37.46 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.551 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.3 mm? -111.83 2.01 16.86 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 122.28 1.038 . . . . 0.0 111.27 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -99.98 -33.45 10.5 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.93 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.802 ' HB3' HD13 ' A' ' 91' ' ' ILE . 1.1 tm0? -80.42 -2.71 46.84 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.861 -171.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.802 HD13 ' HB3' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -150.91 148.22 15.15 Favored 'Isoleucine or valine' 1 CA--C 1.421 -4.01 0 CA-C-O 117.516 -1.23 . . . . 0.0 112.651 -163.538 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.896 ' HB3' ' HB3' ' B' ' 92' ' ' ARG 0.264 40.0 mtm-85 179.84 -53.04 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.767 1 N-CA-C 121.934 4.05 . . . . 0.0 121.934 -174.982 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.724 ' OG1' ' HB2' ' B' ' 92' ' ' ARG . 42.2 m -123.2 101.0 7.14 Favored 'General case' 0 N--CA 1.531 3.599 0 O-C-N 121.009 -1.057 . . . . 0.0 112.994 -170.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.67 ' CD2' HG22 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -132.1 126.11 32.96 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.646 -172.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 15.7 t0 -56.25 146.3 24.04 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.46 0.704 . . . . 0.0 111.375 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.598 ' HE2' ' O ' ' A' ' 50' ' ' SER . 67.8 mttm -53.95 -33.36 56.64 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.306 1.042 . . . . 0.0 111.692 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HG3' ' OD1' ' A' ' 95' ' ' ASP . 48.1 mttp -61.73 -22.16 65.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.28 0.632 . . . . 0.0 111.102 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 34.1 mtp180 -79.3 -37.85 36.72 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.2 mp -71.25 118.25 13.81 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.284 1.033 . . . . 0.0 111.242 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -99.2 -66.92 0.87 Allowed 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.3 pt-20 -156.11 144.46 19.96 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.475 0.655 . . . . 0.0 112.561 -165.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -65.38 119.89 11.81 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 128.243 2.617 . . . . 0.0 113.656 -178.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.575 HD23 HG12 ' A' ' 19' ' ' VAL 0.295 1.7 mm? -100.42 -64.1 1.07 Allowed 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 123.402 1.572 . . . . 0.0 110.405 174.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.576 ' H ' ' HB ' ' A' ' 19' ' ' VAL . 18.4 m -127.08 -178.96 4.62 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 111.608 -2.542 . . . . 0.0 111.871 -162.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.451 ' H ' ' CG2' ' A' ' 104' ' ' THR . 12.8 p90 -160.77 131.6 5.42 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.999 1.72 . . . . 0.0 110.473 -172.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -107.22 162.19 14.1 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.295 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 p -90.22 170.5 10.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.571 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 111' ' ' MET . 6.7 p-10 -63.6 -30.83 71.88 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.789 0.836 . . . . 0.0 112.901 -173.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -69.32 -36.86 77.39 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.52 0.676 . . . . 0.0 110.157 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.528 ' O ' HG22 ' A' ' 114' ' ' VAL . 72.3 mmtt -78.28 -29.73 48.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.877 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.481 ' HA ' ' CE ' ' A' ' 111' ' ' MET . 0.2 OUTLIER -52.69 -42.61 64.95 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 124.122 0.969 . . . . 0.0 109.483 169.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.598 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 7.2 mmpt? -68.04 -46.74 70.32 Favored 'General case' 1 N--CA 1.377 -4.119 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.27 -34.19 76.89 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 118.661 -1.216 . . . . 0.0 111.761 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 110' ' ' LYS . 20.9 m -71.24 -45.3 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.276 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.36 -52.87 62.99 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.365 0.602 . . . . 0.0 110.153 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . 0.326 51.2 m-20 -60.86 -52.87 63.23 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.91 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.551 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -51.32 -39.8 57.71 Favored 'General case' 0 CA--C 1.461 -2.472 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.748 -174.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.695 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 1.6 tp -68.43 -46.09 70.8 Favored 'General case' 1 N--CA 1.362 -4.84 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.455 -179.24 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 43.4 mtp -64.81 -34.59 78.72 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 117' ' ' ALA . 56.4 mt -63.45 -52.7 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 175.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.6 t -53.91 -21.48 7.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.973 -1.921 . . . . 0.0 112.735 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 34.4 mt -111.36 -5.6 14.62 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.494 ' N ' ' HB3' ' B' ' 43' ' ' ASN . . . 76.63 23.97 68.76 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.399 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.434 ' HB3' ' SD ' ' B' ' 119' ' ' MET . 58.0 mt -83.02 -59.65 2.41 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 54.7 145.69 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.15 6.43 48.02 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.121 0.963 . . . . 0.0 110.411 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.7 t -131.6 99.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.639 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.25 28.69 5.69 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -96.28 -41.48 8.64 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.22 -173.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -87.57 -25.83 23.42 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -164.22 150.38 11.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 . . . . . 0 C--N 1.291 -1.957 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 171.994 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.161 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -87.6 107.05 18.42 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.108 0.48 . . . . 0.0 110.266 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 10.3 t -93.92 99.27 11.64 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -79.56 122.18 26.16 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -75.33 -31.71 60.68 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.632 0.582 . . . . 0.0 110.961 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -96.44 89.24 4.97 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -83.33 -46.42 12.62 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.333 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -127.43 168.21 15.18 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.612 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -123.36 135.8 54.34 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -86.06 -6.32 59.05 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.131 0.491 . . . . 0.0 110.412 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -69.32 118.25 11.97 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.129 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -98.69 120.83 58.05 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -53.91 134.69 60.51 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.114 1.876 . . . . 0.0 109.635 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 63.6 mt -62.27 122.34 12.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 O-C-N 123.363 0.414 . . . . 0.0 110.223 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -105.0 134.46 48.06 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -74.85 123.8 25.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 118.611 -1.235 . . . . 0.0 109.165 174.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.29 -5.98 28.51 Favored Glycine 0 C--N 1.301 -1.411 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.763 -176.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.29 165.23 12.49 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 121.574 0.702 . . . . 0.0 109.679 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 35.7 t -118.48 133.0 66.7 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.523 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.622 ' O ' HG22 ' B' ' 38' ' ' VAL . 39.6 m-85 -135.82 146.5 47.6 Favored 'General case' 0 C--O 1.188 -2.165 0 C-N-CA 124.857 1.263 . . . . 0.0 108.411 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 1.8 mp -74.32 148.94 40.91 Favored 'General case' 0 N--CA 1.407 -2.61 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.989 171.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -144.42 136.21 25.93 Favored 'General case' 0 C--N 1.264 -3.133 0 O-C-N 124.416 1.073 . . . . 0.0 110.163 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.87 94.4 3.33 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.082 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 9.5 mt -89.36 4.74 47.96 Favored 'General case' 0 C--O 1.199 -1.6 0 C-N-CA 124.6 1.16 . . . . 0.0 110.222 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.583 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 4.1 m -53.96 -177.11 0.04 OUTLIER Pre-proline 1 C--N 1.241 -4.132 0 C-N-CA 126.733 2.013 . . . . 0.0 112.564 173.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 20.17 35.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.405 3.549 1 C-N-CA 125.942 4.428 . . . . 0.0 119.414 -157.511 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.605 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 3.7 m -71.08 172.85 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.1 167.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -112.27 135.61 52.73 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.75 -112.15 4.12 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 114.785 -1.098 . . . . 0.0 114.362 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -93.43 -0.43 56.48 Favored 'General case' 0 N--CA 1.417 -2.102 0 C-N-CA 123.405 0.682 . . . . 0.0 112.275 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.605 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 77.4 mt-10 -61.14 141.1 57.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.511 ' HG3' ' NH2' ' B' ' 36' ' ' ARG . 5.3 tp60 -116.05 112.81 22.31 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -169.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.404 ' CA ' ' HB3' ' B' ' 24' ' ' LEU . . . -127.95 -106.77 1.36 Allowed Glycine 1 N--CA 1.378 -5.208 0 C-N-CA 118.149 -1.977 . . . . 0.0 116.688 -177.152 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 74.48 175.44 34.09 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 107.663 -2.175 . . . . 0.0 107.663 -168.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 p -89.19 108.98 19.72 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.393 0 O-C-N 120.475 -1.603 . . . . 0.0 108.73 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ARG . . . . . 0.511 ' NH2' ' HG3' ' B' ' 32' ' ' GLN . 65.1 mtm180 -137.76 157.72 72.94 Favored Pre-proline 0 C--N 1.281 -2.397 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.429 -174.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.3 Cg_exo -66.29 138.65 51.9 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.061 2.507 . . . . 0.0 111.902 173.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.622 HG22 ' O ' ' B' ' 20' ' ' TYR . 20.6 m -126.9 162.71 31.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 123.74 0.816 . . . . 0.0 110.074 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 27.1 m -104.57 134.28 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 31.9 mm -94.23 118.64 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 122.835 0.454 . . . . 0.0 110.054 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 -8.8 12.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.577 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.544 ' NE2' ' HB ' ' B' ' 53' ' ' VAL . 5.7 pt20 -63.51 165.71 7.6 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 -167.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.494 ' HB3' ' N ' ' A' ' 123' ' ' GLY . 14.3 p-10 -77.46 -174.19 3.23 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 112.088 -2.324 . . . . 0.0 113.413 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' B' ' 47' ' ' ASN . 2.7 t70 -72.44 -47.4 49.24 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 112.837 -1.983 . . . . 0.0 113.909 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -86.65 -25.71 24.73 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -165.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' B' ' 50' ' ' SER . . . -70.75 -21.23 77.91 Favored Glycine 0 C--O 1.218 -0.889 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' B' ' 44' ' ' ASP . 39.1 t-20 -72.77 -32.04 65.32 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.703 -1.248 . . . . 0.0 108.259 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -91.64 -65.38 1.01 Allowed 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -100.15 -35.56 9.62 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -168.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.583 ' O ' ' HE2' ' B' ' 96' ' ' LYS . 14.6 t -76.93 132.23 71.62 Favored Pre-proline 0 N--CA 1.433 -1.323 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.551 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 62.3 Cg_endo -77.53 -11.12 17.25 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.792 1.661 . . . . 0.0 110.154 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 1.9 p -106.38 121.83 45.03 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.745 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.544 ' HB ' ' NE2' ' B' ' 42' ' ' GLN . 1.3 m -121.82 167.96 14.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' B' ' 92' ' ' ARG . 13.8 tt -109.2 125.24 66.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 123.695 0.798 . . . . 0.0 112.099 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.663 HG22 ' CD2' ' B' ' 94' ' ' LEU . 3.7 m -137.72 163.97 29.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.694 ' HA ' HG13 ' B' ' 91' ' ' ILE . . . -123.47 130.8 53.22 Favored 'General case' 0 N--CA 1.415 -2.176 0 O-C-N 123.387 0.429 . . . . 0.0 111.317 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.669 ' H ' HG21 ' B' ' 91' ' ' ILE . . . -65.04 132.69 49.88 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.559 HG12 HD12 ' B' ' 86' ' ' ILE . 57.6 mt -89.26 134.08 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 112.645 -2.07 . . . . 0.0 107.346 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -144.88 179.68 7.17 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.72 166.91 33.02 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 65.59 77.94 0.29 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.196 0.998 . . . . 0.0 112.241 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.438 HG22 HG21 ' B' ' 85' ' ' VAL . 14.1 tt -140.88 -8.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.173 -0.922 . . . . 0.0 108.753 175.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 73.81 -64.81 0.38 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.509 1.523 . . . . 0.0 112.218 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -117.03 128.02 54.75 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.19 0.519 . . . . 0.0 111.541 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.53 31.31 6.23 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.112 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -84.7 61.21 6.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.858 0.837 . . . . 0.0 111.763 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp -142.11 139.75 18.45 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -69.35 9.79 0.49 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.135 1.89 . . . . 0.0 113.599 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 72.9 p -117.61 -7.85 11.0 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.079 0.466 . . . . 0.0 110.748 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.587 ' CD2' HD22 ' B' ' 87' ' ' LEU . 61.9 m170 -123.23 129.34 51.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.428 HG23 HD11 ' B' ' 73' ' ' ILE . 32.9 m -122.19 139.72 48.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.541 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -97.11 130.6 44.36 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.698 0.761 . . . . 0.0 111.439 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.728 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -123.54 154.2 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.666 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -74.77 127.04 32.21 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.197 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -45.95 -44.76 15.09 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.173 1.389 . . . . 0.0 111.5 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -59.86 -45.31 92.86 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 126.392 1.877 . . . . 0.0 112.478 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -72.41 -35.19 68.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.93 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.728 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.8 m-85 -95.78 -6.02 40.57 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.704 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 57.06 31.68 20.36 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.439 1.096 . . . . 0.0 112.864 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' B' ' 78' ' ' TYR . 6.8 mp -87.8 -178.82 6.14 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.652 1.215 . . . . 0.0 112.844 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -75.51 -25.42 57.26 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.935 -1.939 . . . . 0.0 109.735 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -148.04 168.79 21.43 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -60.34 144.42 50.72 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.098 0.475 . . . . 0.0 109.826 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 8.0 m -103.25 136.79 42.37 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.61 -168.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.438 HG21 HG22 ' B' ' 62' ' ' ILE . 21.8 t -120.29 135.87 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.559 HD12 HG12 ' B' ' 58' ' ' ILE . 21.0 mm -114.89 138.1 46.23 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.834 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.587 HD22 ' CD2' ' B' ' 70' ' ' HIS . 31.4 mt -104.25 141.32 36.49 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' B' ' 118' ' ' LEU . 3.4 mm? -111.59 1.42 16.82 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-O 122.173 0.987 . . . . 0.0 111.296 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' GLU . . . . . 0.417 ' HA ' HH12 ' B' ' 92' ' ' ARG . 8.7 pt-20 -100.77 -33.44 10.25 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.021 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLN . . . . . 0.796 ' HB3' HD13 ' B' ' 91' ' ' ILE . 1.0 OUTLIER -81.24 -2.03 47.21 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.531 -171.016 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.796 HD13 ' HB3' ' B' ' 90' ' ' GLN . 0.0 OUTLIER -150.8 147.68 15.59 Favored 'Isoleucine or valine' 1 CA--C 1.418 -4.103 0 CA-C-O 117.6 -1.19 . . . . 0.0 112.429 -163.715 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.896 ' HB3' ' HB3' ' A' ' 92' ' ' ARG 0.273 41.2 mtm-85 179.83 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.752 1 N-CA-C 121.929 4.048 . . . . 0.0 121.929 -174.913 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.722 ' OG1' ' HB2' ' A' ' 92' ' ' ARG . 29.8 m -122.84 101.04 7.21 Favored 'General case' 0 N--CA 1.531 3.593 0 O-C-N 121.029 -1.044 . . . . 0.0 112.871 -171.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.663 ' CD2' HG22 ' B' ' 55' ' ' VAL . 0.1 OUTLIER -132.17 125.72 31.89 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.57 -173.155 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 11.0 t0 -56.94 147.47 23.71 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.439 0.696 . . . . 0.0 111.674 172.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.583 ' HE2' ' O ' ' B' ' 50' ' ' SER . 67.8 mttm -54.49 -33.0 58.99 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.455 1.102 . . . . 0.0 111.833 177.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.444 ' HZ3' ' CG ' ' B' ' 95' ' ' ASP . 44.9 mttp -62.26 -23.36 66.65 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.257 0.623 . . . . 0.0 111.192 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 32.9 mtp180 -78.13 -38.51 43.64 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.26 118.1 12.66 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 124.189 0.995 . . . . 0.0 111.121 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -97.41 -69.67 0.75 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.678 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.8 pt-20 -156.52 149.08 23.59 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.584 0.707 . . . . 0.0 112.476 -166.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 2.3 ptmt -67.71 124.74 24.11 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 127.449 2.3 . . . . 0.0 114.93 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.574 HD23 HG12 ' B' ' 19' ' ' VAL 0.287 2.0 mm? -102.27 -63.73 1.13 Allowed 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 123.389 1.566 . . . . 0.0 110.548 174.428 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.513 ' H ' ' HB ' ' B' ' 19' ' ' VAL . 22.8 m -131.13 -177.75 4.53 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 111.508 -2.587 . . . . 0.0 112.299 -161.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.42 ' H ' ' CG2' ' B' ' 104' ' ' THR . 13.7 p90 -160.93 132.57 5.7 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.502 1.521 . . . . 0.0 111.185 -171.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 pp -107.0 161.83 14.39 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.276 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 5.1 p -90.66 172.69 8.49 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.082 0.467 . . . . 0.0 111.857 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.39 -31.59 72.87 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.705 0.802 . . . . 0.0 112.644 -174.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -69.2 -35.68 76.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.558 0.695 . . . . 0.0 109.277 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.556 ' O ' HG22 ' B' ' 114' ' ' VAL . 73.3 mmtt -79.15 -30.27 43.51 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.178 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.492 ' HA ' ' HE3' ' B' ' 111' ' ' MET . 0.2 OUTLIER -52.23 -41.79 63.04 Favored 'General case' 0 N--CA 1.42 -1.96 0 O-C-N 124.142 0.902 . . . . 0.0 109.132 169.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.614 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 6.5 mmpt? -67.9 -47.57 68.41 Favored 'General case' 1 N--CA 1.375 -4.212 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -178.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -64.8 -38.23 90.28 Favored 'General case' 0 N--CA 1.41 -2.437 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.469 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' VAL . . . . . 0.556 HG22 ' O ' ' B' ' 110' ' ' LYS . 25.6 m -68.93 -46.58 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.651 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -57.33 -52.91 63.45 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.12 0.486 . . . . 0.0 110.421 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.358 86.2 m-20 -59.19 -54.29 48.55 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.004 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.411 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -56.22 -37.29 69.48 Favored 'General case' 0 CA--C 1.46 -2.512 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.072 -171.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.703 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.6 tp -66.22 -45.36 80.95 Favored 'General case' 1 N--CA 1.358 -5.042 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.846 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.434 ' SD ' ' HB3' ' A' ' 124' ' ' LEU . 47.0 mtp -66.15 -32.61 74.16 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' B' ' 117' ' ' ALA . 53.7 mt -64.49 -54.6 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.1 t -50.52 -22.59 2.02 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.184 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 31.5 mt -111.14 -4.65 14.96 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.458 ' N ' ' HB3' ' A' ' 43' ' ' ASN . . . 75.1 23.28 74.76 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.449 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 52.4 mt -81.37 -58.62 2.96 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 52.27 145.13 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 127.118 2.167 . . . . 0.0 116.264 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.29 10.59 29.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.805 0.812 . . . . 0.0 110.84 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 41.3 t -136.12 99.78 2.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.432 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -124.93 22.54 8.02 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.076 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -89.77 -40.97 12.14 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.865 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -88.45 -30.68 19.24 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -160.19 145.3 14.91 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 . . . . . 0 C--N 1.284 -2.278 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 172.356 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.97 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p -88.79 108.34 19.46 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.713 0.768 . . . . 0.0 112.584 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.1 m -94.48 107.17 19.15 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -132.65 119.69 20.75 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.688 0.756 . . . . 0.0 112.247 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -95.24 -24.93 16.57 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 60.73 -83.64 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.643 1.577 . . . . 0.0 112.03 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -173.25 -86.61 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 57.19 -170.18 0.1 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.893 1.277 . . . . 0.0 113.061 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -77.53 142.06 39.26 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -73.55 152.7 40.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.585 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.04 103.07 1.76 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -86.17 113.48 52.29 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.92 165.14 24.66 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.544 2.163 . . . . 0.0 112.752 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.8 mt -57.73 122.54 7.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.144 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -108.69 151.01 26.75 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -71.2 124.11 23.74 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.65 -2.91 29.1 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.479 -1.343 . . . . 0.0 112.968 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -84.84 161.1 20.04 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.451 HG21 HG22 ' A' ' 104' ' ' THR . 78.4 t -121.92 108.01 21.14 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.655 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.85 174.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.2 m-85 -99.56 147.02 25.78 Favored 'General case' 0 C--N 1.255 -3.506 0 C-N-CA 124.809 1.244 . . . . 0.0 109.567 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.5 mp -83.08 146.67 28.56 Favored 'General case' 0 N--CA 1.382 -3.851 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.33 140.09 32.02 Favored 'General case' 0 C--N 1.256 -3.497 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.972 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -84.98 90.48 7.84 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.594 ' O ' HG13 ' A' ' 27' ' ' VAL . 51.3 mt -73.58 -21.67 60.27 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.966 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.589 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 4.4 m -32.91 174.46 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.738 0 C-N-CA 129.064 2.945 . . . . 0.0 115.684 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 23.38 52.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.414 -3.199 0 C-N-CA 123.094 2.529 . . . . 0.0 114.555 -151.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -68.33 141.48 17.53 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 CA-C-N 112.385 -2.189 . . . . 0.0 110.026 171.093 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.458 ' OE1' ' HB2' ' B' ' 26' ' ' PRO . 18.0 mm100 -89.84 120.16 30.84 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.965 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.19 -110.7 1.64 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.061 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' B' ' 95' ' ' ASP . 33.4 m -94.1 10.16 34.84 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 98.3 mt-10 -61.64 143.17 56.52 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.3 118.51 31.36 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.424 -169.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.05 -171.17 23.48 Favored Glycine 0 N--CA 1.414 -2.783 0 N-CA-C 120.093 2.797 . . . . 0.0 120.093 162.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.28 -152.58 6.9 Favored Glycine 0 C--N 1.264 -3.471 1 N-CA-C 102.349 -4.301 . . . . 0.0 102.349 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.1 113.22 15.93 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-N 121.125 2.462 . . . . 0.0 109.953 176.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -143.73 162.04 43.42 Favored Pre-proline 0 C--N 1.277 -2.569 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.195 -175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.557 ' HB2' HD12 ' A' ' 58' ' ' ILE . 19.9 Cg_exo -72.29 143.44 39.38 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.479 2.119 . . . . 0.0 111.5 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 28.6 m -128.69 160.09 39.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 124.197 0.999 . . . . 0.0 109.531 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.0 m -104.92 131.84 53.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.608 0.242 . . . . 0.0 110.553 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.403 HD13 HG12 ' A' ' 55' ' ' VAL . 24.3 mm -89.85 108.44 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.8 -18.34 7.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.701 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.791 ' NE2' ' HA ' ' A' ' 53' ' ' VAL . 2.6 tt0 -52.81 156.84 1.84 Allowed 'General case' 0 C--O 1.245 0.846 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -171.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.429 ' HA ' ' HA3' ' B' ' 123' ' ' GLY . 13.1 p-10 -56.83 155.36 7.94 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-N 113.248 -1.796 . . . . 0.0 112.075 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.18 -27.44 62.57 Favored 'General case' 0 C--N 1.264 -3.112 0 CA-C-N 113.593 -1.64 . . . . 0.0 112.386 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.3 m -83.85 -37.18 22.79 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.29 -0.256 . . . . 0.0 111.102 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.01 -27.34 73.7 Favored Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.96 -33.66 70.89 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.127 0.489 . . . . 0.0 109.859 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.529 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 10.2 mmmm -93.22 -60.69 1.73 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.956 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.529 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 71.0 m-85 -93.83 -36.14 12.39 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -165.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.6 m -80.82 138.65 50.18 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.02 -17.9 40.72 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 121.899 1.733 . . . . 0.0 111.077 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 4.7 p -98.54 158.49 15.56 Favored 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 124.856 1.263 . . . . 0.0 111.498 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.791 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -152.51 138.87 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.196 0.598 . . . . 0.0 110.454 170.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.667 HG22 ' HG3' ' A' ' 42' ' ' GLN . 8.6 tt -83.69 135.06 25.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 CA-C-O 121.4 0.619 . . . . 0.0 110.476 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 32.8 m -139.27 156.26 27.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.481 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.534 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -115.79 139.33 50.28 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 138.45 43.78 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.585 HG12 HD12 ' A' ' 86' ' ' ILE . 64.1 mt -96.13 134.65 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 113.129 -1.85 . . . . 0.0 107.533 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.1 t -137.29 143.53 42.2 Favored 'General case' 0 N--CA 1.414 -2.27 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.591 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.72 162.6 37.74 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 107.106 -2.398 . . . . 0.0 107.106 170.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 67.36 -164.34 0.22 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.5 mm 68.69 82.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 122.446 1.117 . . . . 0.0 108.042 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -87.12 -10.54 52.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.558 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -84.62 82.31 8.47 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.438 ' HA ' ' HB2' ' A' ' 70' ' ' HIS . . . -117.45 12.86 14.32 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.389 0.614 . . . . 0.0 110.94 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -83.35 68.27 9.62 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 122.626 1.203 . . . . 0.0 108.321 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 tt -165.94 140.89 3.89 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -62.05 -10.93 19.44 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.647 2.231 . . . . 0.0 115.53 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.3 p -98.22 -16.38 19.46 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 65' ' ' ALA . 48.1 m170 -113.1 128.7 56.56 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.91 125.7 70.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.372 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -91.7 118.63 30.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.51 0.672 . . . . 0.0 109.508 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.889 HG21 ' CE1' ' A' ' 78' ' ' TYR . 3.2 mm -96.09 158.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.607 -173.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.08 120.2 14.56 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 123.743 0.817 . . . . 0.0 110.221 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 85.6 tttt -46.67 -51.27 16.33 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 126.198 1.799 . . . . 0.0 111.575 176.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -56.93 -49.48 75.48 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 126.282 1.833 . . . . 0.0 112.111 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.445 ' HD3' ' OG ' ' A' ' 107' ' ' SER . 39.4 ttmt -69.22 -33.61 73.58 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.425 0.69 . . . . 0.0 110.535 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.889 ' CE1' HG21 ' A' ' 73' ' ' ILE . 3.2 m-85 -88.63 -11.19 46.1 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.617 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.4 tttm 67.22 24.63 9.13 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.433 0.693 . . . . 0.0 111.16 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 78' ' ' TYR . 7.2 mp -94.86 178.62 5.51 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-O 122.616 1.198 . . . . 0.0 112.44 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.413 ' O ' ' HE3' ' A' ' 75' ' ' LYS . 2.2 m-20 -73.54 -20.71 60.57 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 112.555 -2.111 . . . . 0.0 111.733 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 83' ' ' ASP . 11.6 ptmm? -158.48 169.97 23.25 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 9.9 p-10 -51.85 135.96 29.0 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 m -109.12 135.5 50.16 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.4 t -107.69 135.86 44.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.585 HD12 HG12 ' A' ' 58' ' ' ILE . 18.2 mm -112.19 135.39 51.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.0 mt -104.49 106.23 16.65 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -84.05 -5.61 59.26 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.687 -174.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -91.62 -39.56 11.81 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.986 174.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.05 79.32 4.07 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.325 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.534 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -114.73 -176.78 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -166.61 173.68 9.49 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.865 0.364 . . . . 0.0 111.57 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 67.5 m -123.34 124.32 42.69 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.2 mt -130.88 142.8 50.4 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.688 -171.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.9 p30 -74.56 152.39 39.32 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.352 174.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -47.54 -27.5 1.83 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.902 1.281 . . . . 0.0 114.31 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.3 -18.49 57.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 120.867 0.365 . . . . 0.0 111.433 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.21 -34.09 65.73 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.41 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 7.8 mp -76.63 126.16 30.49 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.248 1.419 . . . . 0.0 110.145 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -91.96 -67.33 0.86 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.744 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 14.6 pt-20 -153.25 152.88 31.67 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.518 -166.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.452 ' HE2' ' OH ' ' A' ' 20' ' ' TYR . 70.6 mttt -73.41 123.94 24.82 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.776 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.574 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 18.8 tp -109.38 -60.99 1.69 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 122.653 1.216 . . . . 0.0 108.438 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.574 ' OG1' ' HG ' ' A' ' 103' ' ' LEU . 2.3 m -127.36 178.72 5.87 Favored 'General case' 0 N--CA 1.381 -3.879 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.227 -166.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -160.45 139.69 10.72 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 125.121 1.368 . . . . 0.0 109.903 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 pp -115.05 161.59 18.15 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.252 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.445 ' OG ' ' HD3' ' A' ' 77' ' ' LYS . 34.3 p -88.12 172.66 9.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.174 0.512 . . . . 0.0 111.628 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 111' ' ' MET . 28.3 t70 -66.14 -30.35 70.81 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.112 0.565 . . . . 0.0 111.855 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -69.47 -30.61 68.53 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 114' ' ' VAL . 14.4 tppt? -77.65 -30.11 51.99 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.585 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -49.04 -47.12 45.01 Favored 'General case' 0 CA--C 1.48 -1.738 0 O-C-N 123.896 0.747 . . . . 0.0 110.75 171.129 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.754 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -65.64 -34.58 78.56 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.807 -178.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.84 -41.68 59.4 Favored 'General case' 0 N--CA 1.4 -2.944 0 C-N-CA 118.176 -1.41 . . . . 0.0 112.121 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 110' ' ' LYS . 19.7 m -67.16 -45.35 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 118.921 -0.561 . . . . 0.0 112.103 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -54.28 -51.69 63.78 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 123.2 1.476 . . . . 0.0 109.397 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.754 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -76.31 -30.58 57.76 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 112.998 -1.91 . . . . 0.0 115.031 -172.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.502 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -70.68 -41.9 71.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 1.9 tp -62.33 -44.19 97.08 Favored 'General case' 0 N--CA 1.394 -3.237 0 C-N-CA 125.479 1.511 . . . . 0.0 108.741 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.646 ' CG ' ' HA ' ' A' ' 125' ' ' ASN . 21.2 ttm -48.61 -37.46 18.22 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.5 mt -82.5 -50.12 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.665 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.5 m -48.81 -35.56 14.75 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.02 -1.9 . . . . 0.0 112.722 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.553 HD22 HG21 ' B' ' 54' ' ' ILE . 23.1 mt -103.19 -3.03 26.32 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 120.055 -0.658 . . . . 0.0 112.028 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' B' ' 43' ' ' ASN . . . 76.34 29.52 58.17 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 117.359 1.704 . . . . 0.0 117.359 172.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.645 HD11 HD11 ' B' ' 124' ' ' LEU . 0.2 OUTLIER -100.05 -46.02 5.47 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 118.947 1.373 . . . . 0.0 111.897 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.646 ' HA ' ' CG ' ' A' ' 119' ' ' MET . 1.6 t-20 49.29 -160.3 0.05 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.087 -168.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.76 82.47 7.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.2 p 61.7 -5.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 129.19 2.996 . . . . 0.0 114.216 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.08 116.55 4.68 Favored 'General case' 0 C--N 1.271 -2.828 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -77.27 -33.16 55.93 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.497 0.498 . . . . 0.0 109.948 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -109.86 137.79 47.14 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -90.47 97.54 11.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--N 1.289 -2.048 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -178.407 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.472 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p -89.21 99.06 12.13 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.122 0.487 . . . . 0.0 112.173 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 48.3 m -81.02 108.95 15.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 173.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -129.64 127.77 41.27 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.443 0.64 . . . . 0.0 112.17 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -103.3 -26.06 13.08 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 63.42 -83.07 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.717 1.607 . . . . 0.0 112.216 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -172.47 -83.06 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 54.17 -173.55 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.625 1.17 . . . . 0.0 113.963 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -77.98 132.44 37.84 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.2 m -67.62 147.48 52.67 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.628 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -61.27 113.95 2.9 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -95.13 113.72 62.11 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.71 168.08 14.1 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 122.42 2.08 . . . . 0.0 112.365 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt -61.97 122.76 13.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -108.88 145.71 34.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -66.23 125.98 27.27 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.65 -5.81 31.25 Favored Glycine 0 N--CA 1.426 -1.974 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.694 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -83.4 162.97 20.85 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.482 HG21 HG22 ' B' ' 104' ' ' THR . 75.1 t -122.53 110.14 26.02 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.766 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.732 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 30.3 m-85 -101.44 146.3 27.8 Favored 'General case' 0 C--N 1.26 -3.32 0 C-N-CA 124.875 1.27 . . . . 0.0 109.779 176.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 3.8 mp -81.13 146.14 30.7 Favored 'General case' 0 N--CA 1.388 -3.569 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 166.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.33 141.11 33.88 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.931 -173.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -85.58 89.19 7.65 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.616 ' O ' HG13 ' B' ' 27' ' ' VAL . 56.9 mt -73.03 -22.09 60.7 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.073 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.603 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 3.8 m -33.14 175.02 0.0 OUTLIER Pre-proline 0 CA--C 1.573 1.859 0 C-N-CA 129.433 3.093 . . . . 0.0 115.603 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 23.8 50.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.119 0 C-N-CA 123.205 2.603 . . . . 0.0 114.998 -152.241 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.616 HG13 ' O ' ' B' ' 24' ' ' LEU . 0.5 OUTLIER -68.18 143.09 15.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.107 172.397 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -89.72 118.86 29.63 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.942 -1.481 . . . . 0.0 112.301 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.3 -108.72 1.4 Allowed Glycine 0 C--N 1.309 -0.935 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.584 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 43.9 m -94.71 8.67 41.69 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.583 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 98.8 mt-10 -61.56 142.59 56.99 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 173.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.84 117.65 30.38 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 122.374 -0.204 . . . . 0.0 111.351 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.36 -173.85 22.54 Favored Glycine 0 N--CA 1.412 -2.942 0 N-CA-C 120.327 2.891 . . . . 0.0 120.327 163.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.28 -151.87 6.42 Favored Glycine 0 C--N 1.264 -3.459 1 N-CA-C 102.124 -4.391 . . . . 0.0 102.124 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.49 114.96 18.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-N 120.997 2.399 . . . . 0.0 109.867 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -145.21 161.6 41.2 Favored Pre-proline 0 C--N 1.284 -2.271 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.113 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 21.2 Cg_exo -71.91 143.15 40.35 Favored 'Trans proline' 0 CA--C 1.551 1.366 0 C-N-CA 122.599 2.199 . . . . 0.0 111.86 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 29.7 m -127.91 159.64 38.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 124.129 0.971 . . . . 0.0 109.754 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.1 m -103.76 132.56 49.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 CA-C-O 120.642 0.258 . . . . 0.0 110.357 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.4 HD13 HG12 ' B' ' 55' ' ' VAL . 24.4 mm -91.04 107.13 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.86 -18.89 6.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.89 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.769 ' NE2' ' HA ' ' B' ' 53' ' ' VAL . 2.4 tt0 -52.14 157.24 1.4 Allowed 'General case' 0 C--O 1.245 0.845 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -170.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 10.9 p-10 -56.88 158.17 5.03 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 113.182 -1.826 . . . . 0.0 112.325 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.49 -28.76 62.1 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 113.615 -1.629 . . . . 0.0 112.096 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 56.9 m -85.2 -35.24 21.76 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.175 -0.328 . . . . 0.0 111.764 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.5 -26.2 74.48 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -60.39 -32.74 71.6 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.12 0.486 . . . . 0.0 109.845 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.535 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 11.0 mmmm -93.1 -63.35 1.23 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.136 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.535 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 67.6 m-85 -91.89 -35.82 13.83 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -166.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 45.5 m -82.06 138.49 45.97 Favored Pre-proline 0 C--N 1.308 -1.212 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.66 -18.74 37.3 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 121.927 1.752 . . . . 0.0 111.178 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 3.0 p -98.81 155.64 17.26 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 124.781 1.232 . . . . 0.0 111.269 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.769 ' HA ' ' NE2' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -150.25 138.75 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 O-C-N 123.585 0.553 . . . . 0.0 110.387 171.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.649 HG22 ' HG3' ' B' ' 42' ' ' GLN . 8.8 tt -83.45 134.02 27.85 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 CA-C-O 121.46 0.647 . . . . 0.0 110.576 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 32.3 m -138.47 155.25 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.494 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.531 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -115.26 139.54 49.87 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.09 138.43 43.94 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.576 HG12 HD12 ' B' ' 86' ' ' ILE . 61.2 mt -96.14 134.48 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.285 -1.78 . . . . 0.0 107.422 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -137.46 141.42 41.58 Favored 'General case' 0 N--CA 1.405 -2.718 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.87 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.41 161.94 37.69 Favored Glycine 0 N--CA 1.419 -2.455 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 69.65 -168.85 0.17 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.747 0.773 . . . . 0.0 109.503 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 33.5 mm 69.36 84.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -89.87 -9.57 48.52 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.085 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -85.87 82.34 8.19 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' B' ' 70' ' ' HIS . . . -116.75 14.28 15.27 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.906 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 25.7 ttmm -84.71 68.51 10.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.397 1.094 . . . . 0.0 108.308 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 7.9 tt -165.04 138.0 3.69 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.21 -5.84 7.23 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.797 2.331 . . . . 0.0 115.538 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 80.6 p -102.05 -16.19 16.52 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.334 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.431 ' HB2' ' HA ' ' B' ' 65' ' ' ALA . 46.4 m170 -112.34 128.5 56.3 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -126.57 126.3 68.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.76 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -92.6 123.35 35.83 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.556 0.693 . . . . 0.0 109.373 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.871 HG21 ' CE1' ' B' ' 78' ' ' TYR . 2.8 mm -100.77 155.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.946 -173.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.433 ' CD ' ' HZ1' ' B' ' 110' ' ' LYS . 2.4 mp0 -64.73 119.98 11.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 123.996 0.918 . . . . 0.0 110.527 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' LYS . . . . . 0.496 ' HE3' ' O ' ' B' ' 81' ' ' ASP . 85.7 tttt -48.2 -49.08 34.23 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 126.504 1.922 . . . . 0.0 111.408 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -60.6 -45.85 92.44 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 125.871 1.668 . . . . 0.0 111.76 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -72.27 -33.78 67.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.71 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.871 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.2 m-85 -87.83 -11.1 48.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.247 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 66.44 26.34 10.09 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 121.748 0.785 . . . . 0.0 111.07 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' B' ' 78' ' ' TYR . 6.8 mp -95.09 -178.76 4.58 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-O 122.448 1.118 . . . . 0.0 112.658 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.496 ' O ' ' HE3' ' B' ' 75' ' ' LYS . 4.9 m-20 -70.57 -28.64 65.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.104 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -154.04 171.21 19.45 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -53.69 135.66 40.68 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 7.1 m -109.44 135.49 50.39 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 t -107.73 136.55 42.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.576 HD12 HG12 ' B' ' 58' ' ' ILE . 13.7 mm -113.78 135.36 53.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' B' ' 70' ' ' HIS . 44.5 mt -104.78 104.88 14.74 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.28 -7.41 59.63 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.594 -174.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -90.99 -38.49 12.8 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.1 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.26 77.73 3.46 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.26 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.531 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.4 pp -113.45 -176.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.401 ' NH1' HG12 ' B' ' 27' ' ' VAL . 14.1 ptm180 -166.47 174.06 9.3 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 123.329 0.393 . . . . 0.0 111.55 172.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 68.8 m -123.63 124.62 43.18 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 74.7 mt -131.28 142.98 50.21 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.8 -171.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 3.9 p-10 -74.95 152.66 38.79 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.412 174.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -46.04 -30.0 1.69 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.019 1.328 . . . . 0.0 114.222 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.05 -19.75 60.52 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 120.945 0.402 . . . . 0.0 111.289 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -72.32 -34.11 67.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.417 ' HB3' ' CD2' ' B' ' 20' ' ' TYR . 7.8 mp -77.17 125.76 29.85 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.147 1.379 . . . . 0.0 110.174 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -93.3 -64.72 1.06 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.37 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -155.06 151.1 27.97 Favored 'General case' 0 N--CA 1.407 -2.587 0 CA-C-O 121.632 0.73 . . . . 0.0 111.283 -169.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.473 ' HE2' ' OH ' ' B' ' 20' ' ' TYR . 67.2 mttt -70.85 126.19 28.91 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.755 174.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.506 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 18.8 tp -112.14 -62.02 1.63 Allowed 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.731 1.253 . . . . 0.0 108.657 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.506 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 1.6 m -125.98 178.44 5.75 Favored 'General case' 0 N--CA 1.383 -3.823 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.356 -166.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -160.74 137.7 8.97 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.825 1.25 . . . . 0.0 109.991 -170.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -110.98 164.0 13.25 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.748 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -91.96 171.56 9.04 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.548 0.213 . . . . 0.0 111.177 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' B' ' 111' ' ' MET . 27.6 t70 -62.75 -28.69 70.14 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.232 0.539 . . . . 0.0 111.39 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -70.11 -29.11 65.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.837 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.509 ' O ' HG22 ' B' ' 114' ' ' VAL . 14.1 tppt? -81.16 -29.26 34.74 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.812 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.486 ' CE ' ' HA ' ' B' ' 111' ' ' MET . 0.1 OUTLIER -47.81 -43.5 27.92 Favored 'General case' 0 CA--C 1.445 -3.078 0 O-C-N 124.173 0.921 . . . . 0.0 109.964 170.27 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.518 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 6.9 mmpt? -61.15 -54.02 49.66 Favored 'General case' 1 N--CA 1.37 -4.451 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.675 -178.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -62.41 -43.88 97.76 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.092 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' VAL . . . . . 0.509 HG22 ' O ' ' B' ' 110' ' ' LYS . 20.6 m -63.21 -43.14 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 123.67 0.606 . . . . 0.0 111.814 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -56.5 -54.85 40.96 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 123.479 0.487 . . . . 0.0 111.08 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' B' ' 119' ' ' MET 0.273 13.2 m120 -61.7 -45.26 94.74 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.242 0.544 . . . . 0.0 110.252 -177.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.54 -43.86 97.77 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.003 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.602 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.6 tp -63.03 -46.59 86.86 Favored 'General case' 0 N--CA 1.387 -3.612 0 C-N-CA 124.287 1.035 . . . . 0.0 108.338 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.74 ' SD ' ' HA ' ' B' ' 125' ' ' ASN . 15.4 ttm -49.63 -44.08 47.15 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 29.9 mt -72.34 -50.87 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 45.8 m -49.79 -34.07 18.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.485 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 22.3 mt -102.8 -4.19 25.29 Favored 'General case' 0 C--O 1.198 -1.627 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.116 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 43' ' ' ASN . . . 76.78 30.76 55.6 Favored Glycine 0 C--N 1.341 0.848 0 N-CA-C 117.469 1.747 . . . . 0.0 117.469 172.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.645 HD11 HD11 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -101.89 -47.27 4.64 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.696 1.248 . . . . 0.0 112.511 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.74 ' HA ' ' SD ' ' B' ' 119' ' ' MET 0.345 49.5 m-80 48.16 -158.56 0.05 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.528 -167.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ALA . . . . . 0.402 ' O ' HG12 ' B' ' 127' ' ' VAL . . . -82.7 79.62 9.05 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.932 -1.105 . . . . 0.0 110.445 -175.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.402 HG12 ' O ' ' B' ' 126' ' ' ALA . 7.3 p 65.26 -4.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 129.19 2.996 . . . . 0.0 113.024 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -150.02 123.23 8.91 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.355 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.46 ' HA ' ' HB2' ' B' ' 125' ' ' ASN . 81.5 t60 -85.49 -30.07 23.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.774 0.797 . . . . 0.0 109.072 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -111.82 131.19 55.51 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -87.55 91.15 8.64 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--N 1.291 -1.954 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.913 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.3 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.6 t 73.4 18.54 3.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.892 1.277 . . . . 0.0 111.364 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 p -90.57 -3.71 57.38 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 122.133 -0.354 . . . . 0.0 111.112 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -76.53 102.04 5.9 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -87.05 -16.63 35.04 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.45 135.1 54.6 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -81.35 85.96 6.35 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.191 0.996 . . . . 0.0 110.934 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -96.98 -8.2 31.14 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.662 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -94.76 -53.3 3.91 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.8 m 48.65 80.91 0.05 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.038 1.335 . . . . 0.0 113.114 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -123.08 130.42 52.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.03 140.58 80.61 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 150.54 59.07 Favored 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 122.195 1.93 . . . . 0.0 112.212 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.34 142.04 13.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -146.77 160.72 41.9 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -77.64 122.11 24.87 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.533 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.432 ' HA2' ' SD ' ' A' ' 111' ' ' MET . . . 142.8 -30.63 2.04 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 119.395 -1.383 . . . . 0.0 113.996 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -100.43 173.87 6.37 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 118.075 0.937 . . . . 0.0 111.658 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 105' ' ' TYR . 54.0 t -110.98 138.71 38.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.836 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 92.2 m-85 -137.32 147.11 45.37 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 126.26 1.824 . . . . 0.0 108.731 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.2 mp -86.57 157.38 19.75 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 171.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.7 146.6 32.29 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.865 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -82.46 108.77 16.12 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.643 0.735 . . . . 0.0 109.63 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.606 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 15.4 mt -108.91 28.26 8.64 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 123.698 1.713 . . . . 0.0 109.073 -175.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.671 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 15.1 m -73.55 -178.62 0.75 Allowed Pre-proline 1 C--N 1.213 -5.358 0 CA-C-N 112.732 -2.031 . . . . 0.0 108.714 169.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.1 OUTLIER 17.23 42.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.148 0 C-N-CA 124.976 3.784 . . . . 0.0 118.016 -159.739 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 24' ' ' LEU . 5.2 m -70.2 174.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.054 0 CA-C-O 122.328 1.061 . . . . 0.0 112.234 172.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -92.49 110.56 21.97 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.005 -1.452 . . . . 0.0 114.198 -174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.65 -108.69 0.75 Allowed Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 113.918 -1.492 . . . . 0.0 114.784 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.7 m -86.58 13.85 7.85 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 36.0 mt-10 -67.4 -175.29 0.47 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.887 0.851 . . . . 0.0 112.063 173.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.594 ' NE2' ' HG3' ' A' ' 36' ' ' ARG . 12.1 tm0? -106.47 126.59 52.45 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -111.54 163.65 12.2 Favored Glycine 0 CA--C 1.498 -0.989 0 N-CA-C 116.871 1.508 . . . . 0.0 116.871 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.8 171.64 18.96 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 113.614 -1.293 . . . . 0.0 110.51 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.53 102.08 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.669 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.594 ' HG3' ' NE2' ' A' ' 32' ' ' GLN . 26.0 mmt180 -128.55 151.91 77.58 Favored Pre-proline 0 C--N 1.251 -3.715 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.88 -174.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 23.4 Cg_exo -65.46 144.92 81.32 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.839 2.359 . . . . 0.0 112.54 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 30.1 m -129.23 154.97 40.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.619 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 29.7 m -99.32 128.69 50.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.496 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.5 mm -92.24 106.44 17.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.06 -6.57 10.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.817 0.817 . . . . 0.0 109.085 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.593 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -51.15 146.64 6.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 125.853 1.661 . . . . 0.0 113.946 -170.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -60.95 -179.01 0.11 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.098 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 19.0 t70 -77.27 -48.54 17.2 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.151 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -70.25 -28.58 65.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.542 -171.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.01 -28.15 73.7 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.525 ' N ' HE22 ' A' ' 42' ' ' GLN . 87.0 m-20 -75.84 -37.59 58.88 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.278 0.561 . . . . 0.0 110.174 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 49' ' ' TYR . 49.8 mmtt -79.31 -61.6 1.95 Allowed 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.257 -176.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 55.7 m-85 -111.24 6.6 20.71 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -167.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 22.7 t -119.84 141.6 31.59 Favored Pre-proline 0 C--N 1.306 -1.298 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.314 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 10.2 Cg_exo -74.17 -23.34 15.83 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.073 1.848 . . . . 0.0 110.366 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -85.17 154.71 21.82 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.813 -175.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.46 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 57.9 t -138.4 140.07 40.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.713 HD11 HD13 ' A' ' 91' ' ' ILE . 3.8 tp -99.08 125.56 52.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 171.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 21.6 m -132.68 166.54 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.743 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.583 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -124.88 141.19 52.28 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.53 130.76 42.06 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.622 HG12 HD12 ' A' ' 86' ' ' ILE . 56.1 mt -90.13 120.42 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.085 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.482 HG21 HD13 ' A' ' 62' ' ' ILE . 22.9 m -119.3 155.47 31.76 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.79 -177.9 42.82 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.486 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 17.6 tpt180 -57.73 108.42 0.57 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 122.882 0.473 . . . . 0.0 110.836 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.482 HD13 HG21 ' A' ' 59' ' ' THR . 20.9 pt -127.82 -28.58 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.422 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -160.42 147.14 15.66 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -170.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -86.73 137.74 32.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.38 80.9 0.76 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.163 0.982 . . . . 0.0 113.16 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -90.08 -38.75 13.35 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.911 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 tt -97.95 136.26 21.15 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.71 -1.1 4.47 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.198 2.599 . . . . 0.0 115.869 -175.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.1 p -91.32 -18.74 23.83 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-O 121.728 0.775 . . . . 0.0 109.432 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -101.5 129.26 47.53 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.18 127.81 69.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 84' ' ' SER . 12.8 pt-20 -99.08 131.08 45.38 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.088 0.47 . . . . 0.0 110.472 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.508 HD11 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -124.78 145.99 31.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.47 123.91 13.38 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 126.304 1.842 . . . . 0.0 113.332 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -58.67 -39.4 80.54 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.702 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 51.2 pttt -61.48 -27.76 68.8 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.974 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -91.43 -35.47 14.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.103 0.954 . . . . 0.0 109.549 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.401 ' OH ' HD23 ' A' ' 106' ' ' LEU . 32.9 m-85 -96.16 13.41 27.42 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.366 -171.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt 59.7 39.29 21.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.566 1.146 . . . . 0.0 114.064 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.86 174.31 7.62 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.792 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.0 -16.25 26.77 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.076 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -133.34 152.06 51.9 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.486 ' OD2' ' HD3' ' A' ' 61' ' ' ARG . 9.6 p-10 -69.11 157.17 37.39 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.902 0.382 . . . . 0.0 110.308 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 72' ' ' GLU . 21.3 t -103.41 151.79 22.36 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.388 -172.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.37 124.32 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.622 HD12 HG12 ' A' ' 58' ' ' ILE . 20.1 mm -100.95 130.36 50.45 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.662 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 76.6 mt -102.59 102.91 13.18 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -82.58 6.29 18.13 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.901 -174.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.16 -38.31 6.31 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.285 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.412 ' HA ' HG21 ' B' ' 93' ' ' THR . 4.6 tp60 -83.82 69.33 10.21 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.826 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 54' ' ' ILE . 2.1 pp -111.44 -179.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.723 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.446 ' O ' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -167.28 165.31 15.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.2 m -118.19 118.73 32.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.1 mt -131.69 138.51 48.72 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.8 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 4.5 p-10 -73.91 152.1 40.24 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.015 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -47.69 -20.52 0.28 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.825 1.65 . . . . 0.0 115.197 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -71.39 -26.36 62.74 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.91 0.884 . . . . 0.0 110.735 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -74.26 -34.5 63.61 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.205 0.526 . . . . 0.0 110.212 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.52 124.98 26.32 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.657 1.183 . . . . 0.0 109.973 176.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -101.93 -60.17 1.58 Allowed 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -147.88 138.61 23.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.716 0.77 . . . . 0.0 112.719 -166.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 28.9 tttp -66.1 116.14 6.88 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 127.673 2.389 . . . . 0.0 107.414 174.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -110.16 -60.23 1.83 Allowed 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.76 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.414 ' CG2' HG21 ' A' ' 19' ' ' VAL . 10.6 t -127.64 -157.41 0.81 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.637 ' O ' HG23 ' A' ' 19' ' ' VAL . 38.0 m-85 -123.48 -89.0 0.6 Allowed 'General case' 0 C--O 1.177 -2.763 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.573 -172.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 1.5 mt 139.75 151.97 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 131.358 3.863 . . . . 0.0 105.484 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 79.0 p -97.59 154.49 17.5 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.746 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.511 ' O ' ' HD2' ' A' ' 112' ' ' LYS . 4.9 m-20 -58.54 -36.96 74.7 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 18.4 p-10 -76.74 -41.52 44.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.396 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -67.64 -25.63 65.83 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.544 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.465 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -53.71 -42.28 67.86 Favored 'General case' 0 N--CA 1.416 -2.146 0 C-N-CA 124.122 0.969 . . . . 0.0 110.421 171.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.672 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -71.25 -25.44 62.47 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.367 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.606 ' HA ' ' ND2' ' A' ' 116' ' ' ASN . 10.6 mt-10 -87.08 -35.19 18.85 Favored 'General case' 0 N--CA 1.394 -3.227 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.762 -171.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.75 -47.04 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.016 0 CA-C-N 112.856 -1.975 . . . . 0.0 108.501 169.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 68.5 m-20 -58.39 -52.82 63.98 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.129 0.49 . . . . 0.0 111.054 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.606 ' ND2' ' HA ' ' A' ' 113' ' ' GLU . 3.8 p30 -64.85 -42.96 94.47 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.109 -0.637 . . . . 0.0 111.743 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.32 -38.21 71.0 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.22 0.534 . . . . 0.0 109.903 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 8.9 tp -69.94 -46.27 65.66 Favored 'General case' 0 N--CA 1.392 -3.374 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.921 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.516 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 3.1 ttp -68.06 -23.48 64.96 Favored 'General case' 0 N--CA 1.408 -2.566 0 C-N-CA 124.161 0.984 . . . . 0.0 110.298 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 116' ' ' ASN . 49.7 mt -79.9 -54.47 11.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 174.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.5 t -47.71 -44.79 28.03 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 125.787 1.635 . . . . 0.0 112.584 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.458 ' HG ' HG12 ' B' ' 54' ' ' ILE . 9.7 mp -82.85 10.65 7.3 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.86 85.17 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.516 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.3 mm? -67.74 -63.48 1.05 Allowed 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 118.106 0.953 . . . . 0.0 109.121 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 61.08 144.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.244 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.48 11.14 27.08 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.212 1.006 . . . . 0.0 110.105 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.67 95.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.72 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 66.27 66.1 0.48 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.043 -1.435 . . . . 0.0 112.865 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -83.44 -59.98 2.28 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -103.05 135.81 44.04 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt 71.83 104.66 0.07 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.65 1.18 . . . . 0.0 111.979 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.666 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.64 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 38.7 t 70.56 11.66 7.32 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.482 1.113 . . . . 0.0 112.684 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 6.4 p -90.28 6.27 43.65 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.779 -0.576 . . . . 0.0 111.715 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -82.5 92.51 7.08 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -81.71 -16.71 50.31 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 122.297 1.046 . . . . 0.0 109.44 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -118.29 129.24 55.34 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -82.24 84.64 7.02 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.319 1.057 . . . . 0.0 110.637 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -98.38 -2.51 39.04 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.616 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -95.07 -51.31 4.7 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 46.2 m 49.72 80.45 0.07 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.521 1.128 . . . . 0.0 113.543 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -125.25 133.87 52.52 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -82.1 139.34 45.76 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.89 148.14 75.96 Favored 'Trans proline' 0 C--O 1.251 1.145 0 C-N-CA 122.289 1.993 . . . . 0.0 112.351 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 73.1 mt -91.51 140.52 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -146.03 160.45 41.86 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -76.22 125.81 29.84 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.476 ' HA2' ' SD ' ' B' ' 111' ' ' MET . . . 140.12 -34.49 2.0 Allowed Glycine 0 N--CA 1.425 -2.081 0 C-N-CA 119.507 -1.33 . . . . 0.0 113.617 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -100.11 174.21 6.27 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 118.078 0.939 . . . . 0.0 111.992 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 105' ' ' TYR . 53.5 t -110.36 139.42 33.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.115 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 89.7 m-85 -137.57 147.67 45.28 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 126.072 1.749 . . . . 0.0 109.191 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.535 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.0 mp -88.16 156.33 19.3 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.19 147.64 32.67 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.956 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -82.61 107.66 15.42 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.205 1.003 . . . . 0.0 110.346 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.677 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 10.8 mt -108.9 28.01 8.9 Favored 'General case' 0 CA--C 1.484 -1.578 0 CA-C-O 123.451 1.596 . . . . 0.0 109.206 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.666 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 15.3 m -76.45 -178.62 0.97 Allowed Pre-proline 1 C--N 1.216 -5.223 0 CA-C-N 112.785 -2.007 . . . . 0.0 107.759 170.075 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.666 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 17.1 43.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.393 2.873 1 C-N-CA 125.396 4.064 . . . . 0.0 118.029 -160.374 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.495 HG13 ' O ' ' B' ' 24' ' ' LEU . 4.9 m -70.4 177.93 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.972 0 CA-C-O 122.171 0.986 . . . . 0.0 112.154 172.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -94.05 116.3 28.71 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.59 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.97 -108.65 0.77 Allowed Glycine 0 CA--C 1.499 -0.91 0 CA-C-N 114.622 -1.172 . . . . 0.0 114.966 172.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 10.3 m -90.97 10.55 26.08 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.544 -0.828 . . . . 0.0 113.06 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.483 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 34.9 mt-10 -62.82 -179.97 0.32 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.868 0.842 . . . . 0.0 112.777 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.446 ' OE1' ' HG3' ' B' ' 36' ' ' ARG . 0.0 OUTLIER -100.2 121.71 41.88 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.677 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -106.01 155.0 16.88 Favored Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.88 176.63 15.52 Favored Glycine 0 C--N 1.307 -1.08 0 CA-C-N 113.383 -1.409 . . . . 0.0 110.19 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.97 99.67 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ARG . . . . . 0.446 ' HG3' ' OE1' ' B' ' 32' ' ' GLN . 29.5 mmt180 -126.52 150.96 72.14 Favored Pre-proline 0 C--N 1.245 -3.974 0 CA-C-N 113.822 -1.536 . . . . 0.0 111.02 -172.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 25.1 Cg_exo -64.92 144.99 84.75 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 122.439 2.093 . . . . 0.0 112.208 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 31.0 m -129.15 155.23 41.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.453 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.582 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 30.7 m -99.87 129.01 51.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 21.7 mm -92.37 107.07 18.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.31 -7.52 10.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.679 0.752 . . . . 0.0 109.129 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.576 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.6 OUTLIER -49.82 148.68 2.97 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 126.099 1.759 . . . . 0.0 113.951 -170.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -61.83 -178.41 0.15 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.898 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' B' ' 48' ' ' LYS . 15.9 t70 -80.04 -47.56 14.7 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.483 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.6 m -69.97 -30.97 68.45 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.749 -172.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.23 -27.29 72.21 Favored Glycine 0 C--O 1.214 -1.129 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.537 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.516 ' N ' HE22 ' B' ' 42' ' ' GLN . 79.6 m-20 -78.37 -35.28 47.55 Favored 'General case' 0 CA--C 1.491 -1.318 0 O-C-N 122.554 -0.38 . . . . 0.0 110.586 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' B' ' 44' ' ' ASP . 51.7 mmtt -78.27 -60.83 2.21 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.358 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.436 ' CD2' ' HB2' ' B' ' 48' ' ' LYS . 69.1 m-85 -107.67 -11.07 15.5 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -167.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 19.1 t -106.14 143.03 26.11 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 121.711 -0.618 . . . . 0.0 109.515 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -75.79 -22.36 13.55 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.146 1.897 . . . . 0.0 110.323 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 0.8 OUTLIER -84.91 152.16 23.73 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.6 -175.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.478 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 58.9 t -136.47 140.05 44.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.706 HD11 HD13 ' B' ' 91' ' ' ILE . 4.1 tp -99.27 124.39 52.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 171.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 22.1 m -132.19 166.04 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.817 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.582 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -124.09 141.36 52.12 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.1 129.06 37.6 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.611 HG12 HD12 ' B' ' 86' ' ' ILE . 53.7 mt -87.61 123.02 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.915 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' THR . . . . . 0.486 HG21 HD13 ' B' ' 62' ' ' ILE . 25.8 m -120.42 159.6 24.77 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.13 -172.34 42.28 Favored Glycine 0 N--CA 1.435 -1.389 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.498 ' HD3' ' OD2' ' B' ' 83' ' ' ASP . 16.6 tpt180 -63.41 106.2 0.88 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.329 0.585 . . . . 0.0 110.694 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.486 HD13 HG21 ' B' ' 59' ' ' THR . 22.2 pt -123.48 -39.76 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.637 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -155.17 139.34 16.55 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -172.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -71.84 137.99 47.94 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 123.857 0.723 . . . . 0.0 109.903 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.83 81.27 0.89 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.744 0.783 . . . . 0.0 112.952 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -90.82 -42.13 10.83 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.556 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.2 tt -94.01 134.37 26.12 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -66.54 7.89 0.36 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 123.346 2.698 . . . . 0.0 115.704 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 74.8 p -98.37 -18.83 18.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.899 0.857 . . . . 0.0 108.738 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -101.25 129.41 47.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.57 130.34 70.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' B' ' 84' ' ' SER . 12.1 pt-20 -101.23 130.69 47.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.927 0.394 . . . . 0.0 110.179 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.517 HD11 HG12 ' B' ' 86' ' ' ILE . 0.0 OUTLIER -124.04 147.75 28.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.94 125.42 20.26 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 125.252 1.421 . . . . 0.0 113.287 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -61.96 -38.45 88.55 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.754 0.787 . . . . 0.0 111.234 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -61.75 -27.35 68.67 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.903 -1.499 . . . . 0.0 112.991 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -90.67 -37.1 13.97 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.976 0.893 . . . . 0.0 109.406 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.42 ' OH ' HD23 ' B' ' 106' ' ' LEU . 31.2 m-85 -94.3 12.4 27.03 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.372 -171.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt 61.0 38.43 17.36 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.549 1.139 . . . . 0.0 113.724 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 22.2 mt -123.36 174.53 7.28 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.528 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.95 -11.81 26.03 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.062 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -136.05 149.89 48.96 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.498 ' OD2' ' HD3' ' B' ' 61' ' ' ARG . 8.9 p-10 -68.26 156.07 38.42 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.464 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' B' ' 72' ' ' GLU . 19.7 t -103.07 149.89 24.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.365 -171.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 41.4 t -123.58 124.81 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.288 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.611 HD12 HG12 ' B' ' 58' ' ' ILE . 19.4 mm -101.14 130.86 49.91 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.515 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.431 HD21 HD11 ' B' ' 62' ' ' ILE . 76.5 mt -102.76 102.52 12.68 Favored 'General case' 0 N--CA 1.406 -2.653 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.8 mm? -81.7 2.5 29.46 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.793 -174.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -101.79 -39.19 7.52 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.204 173.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -83.53 68.93 9.97 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.277 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.706 HD13 HD11 ' B' ' 54' ' ' ILE . 2.1 pp -110.23 -179.15 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.767 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.575 ' NH1' HD22 ' B' ' 24' ' ' LEU . 0.0 OUTLIER -167.25 165.03 15.47 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 90' ' ' GLN . 50.1 m -117.8 118.66 32.64 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 62.0 mt -131.54 138.61 48.98 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.83 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 4.2 p-10 -73.87 151.82 40.37 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 118.901 -1.12 . . . . 0.0 109.825 173.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -48.28 -20.98 0.44 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.83 1.652 . . . . 0.0 114.983 -175.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -72.91 -23.87 60.76 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.458 0.703 . . . . 0.0 110.575 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -74.32 -33.49 63.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.343 0.592 . . . . 0.0 109.867 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.25 122.8 23.41 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.39 1.076 . . . . 0.0 110.73 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -99.5 -62.13 1.28 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.4 pt-20 -143.42 148.7 36.55 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 122.054 0.931 . . . . 0.0 112.551 -167.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -79.3 111.34 15.45 Favored 'General case' 0 C--N 1.276 -2.596 0 C-N-CA 127.769 2.428 . . . . 0.0 107.89 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -105.65 -61.94 1.43 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.357 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.443 ' CG2' HG21 ' B' ' 19' ' ' VAL . 8.3 t -125.44 -159.21 0.88 Allowed 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.577 ' O ' HG23 ' B' ' 19' ' ' VAL . 37.9 m-85 -122.73 -87.39 0.64 Allowed 'General case' 0 C--O 1.176 -2.796 0 C-N-CA 118.387 -1.325 . . . . 0.0 112.445 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' B' ' 17' ' ' GLY . 1.5 mt 137.78 155.22 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 130.962 3.705 . . . . 0.0 106.035 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 88.2 p -100.88 155.65 17.82 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.33 -0.948 . . . . 0.0 108.709 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' B' ' 111' ' ' MET . 12.9 m-20 -58.29 -40.34 81.7 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -74.23 -39.07 63.33 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.72 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -70.67 -24.96 62.78 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.433 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -54.08 -41.98 68.81 Favored 'General case' 0 N--CA 1.413 -2.283 0 C-N-CA 123.742 0.817 . . . . 0.0 110.256 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.705 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 0.6 OUTLIER -70.69 -23.98 62.58 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.285 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 113' ' ' GLU . . . . . 0.648 ' HA ' ' ND2' ' B' ' 116' ' ' ASN 0.263 18.5 mt-10 -86.82 -37.63 17.6 Favored 'General case' 0 N--CA 1.387 -3.587 0 C-N-CA 118.363 -1.335 . . . . 0.0 110.533 -173.318 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.34 -46.58 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.282 0 CA-C-N 112.79 -2.004 . . . . 0.0 108.675 169.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 66.4 m-20 -60.34 -53.56 56.22 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 111.186 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.648 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 4.0 p30 -66.36 -40.58 89.87 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.256 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.464 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -59.9 -35.38 74.74 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 121.217 0.532 . . . . 0.0 109.579 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 8.9 tp -71.05 -45.92 62.96 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.38 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.511 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 3.0 ttp -67.23 -25.14 65.94 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.333 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.515 HG13 ' O ' ' B' ' 116' ' ' ASN . 45.7 mt -80.1 -53.35 13.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 33.8 t -47.65 -45.68 28.17 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.043 1.337 . . . . 0.0 112.248 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.502 ' HG ' HG12 ' A' ' 54' ' ' ILE . 9.6 mp -81.93 10.56 6.23 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.64 9.34 83.31 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 170.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.511 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.4 mm? -72.49 -62.08 1.57 Allowed 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 118.284 1.042 . . . . 0.0 108.884 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.86 147.08 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.857 -173.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -111.98 14.78 20.86 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.816 0.817 . . . . 0.0 110.203 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 45.1 t -130.09 99.46 4.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.855 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 64.27 65.93 0.65 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.597 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -84.74 -58.9 2.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -103.82 136.88 42.68 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt 69.73 112.06 0.05 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.437 1.095 . . . . 0.0 110.688 -175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 C--N 1.298 -1.65 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.939 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.612 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 p -71.51 -21.08 61.97 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 122.412 -0.463 . . . . 0.0 111.607 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 t -87.9 -6.33 58.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.273 0.559 . . . . 0.0 109.57 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -82.88 101.98 11.36 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -92.2 -63.39 1.24 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -134.09 156.8 47.62 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.002 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 73.56 -165.68 0.1 Allowed 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.611 1.195 . . . . 0.0 110.164 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 71.9 -176.91 0.19 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.424 1.09 . . . . 0.0 110.061 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 61.29 -92.81 0.04 OUTLIER 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.997 0.919 . . . . 0.0 110.177 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.5 m -158.85 23.47 0.21 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -104.42 121.4 43.35 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.452 -170.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -111.72 120.94 41.16 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 165.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.89 -10.81 30.2 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.308 2.006 . . . . 0.0 113.66 -176.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.465 HD12 ' NZ ' ' A' ' 96' ' ' LYS . 59.8 mt -95.89 117.32 39.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -144.4 160.62 40.74 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.549 ' HD3' ' O ' ' A' ' 41' ' ' ILE . 49.8 ttp180 -72.8 113.55 9.97 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.711 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 144.78 -27.88 1.9 Allowed Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.069 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.97 138.49 35.21 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 121.25 0.547 . . . . 0.0 111.045 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 104' ' ' THR . 62.8 t -89.89 121.14 39.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.706 174.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 23.0 m-85 -110.9 145.87 37.53 Favored 'General case' 0 C--N 1.264 -3.122 0 C-N-CA 124.135 0.974 . . . . 0.0 109.892 173.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.9 mp -84.34 151.45 24.72 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.5 154.7 36.02 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-O 121.794 0.807 . . . . 0.0 111.395 -173.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 98' ' ' ARG . 22.2 t70 -88.99 95.14 10.2 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.556 HD23 ' HD2' ' A' ' 92' ' ' ARG 0.259 1.3 tt -92.09 -11.17 36.49 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -174.524 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.569 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 4.5 m -33.71 -177.64 0.0 OUTLIER Pre-proline 0 CA--C 1.596 2.738 0 C-N-CA 129.589 3.156 . . . . 0.0 114.978 171.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 31.76 37.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 123.796 2.997 . . . . 0.0 117.404 -154.272 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 8.5 m -73.19 146.83 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.616 163.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -114.75 124.43 51.76 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.42 -109.08 1.94 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 114.941 -1.027 . . . . 0.0 114.659 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.6 m -64.29 -21.23 66.53 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 124.76 1.224 . . . . 0.0 112.873 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 79.2 mt-10 -69.97 142.92 52.78 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -126.73 115.58 19.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.541 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -160.26 -88.52 0.07 OUTLIER Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 118.958 -1.592 . . . . 0.0 114.32 173.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.99 -145.93 27.6 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 -168.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.96 122.11 54.95 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.266 0 CA-C-N 119.804 1.802 . . . . 0.0 108.486 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -146.91 163.04 30.87 Favored Pre-proline 0 C--N 1.288 -2.076 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.967 -174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 17.0 Cg_exo -70.02 138.25 36.58 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 121.74 1.627 . . . . 0.0 109.208 167.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.83 162.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.532 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 31.6 m -102.3 128.83 54.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.054 175.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.8 mm -87.14 109.56 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -105.58 -17.87 7.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.764 -177.15 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.655 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 7.1 tt0 -64.3 164.62 10.85 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -170.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.627 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 21.4 p-10 -62.63 180.0 0.3 Allowed 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.844 1.658 . . . . 0.0 111.913 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.34 -48.04 37.56 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.674 -1.603 . . . . 0.0 113.069 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.3 m -86.6 -25.22 25.07 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -162.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 50' ' ' SER . . . -63.19 -30.15 76.63 Favored Glycine 0 C--O 1.192 -2.486 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -68.23 -36.44 79.5 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.428 0.633 . . . . 0.0 110.24 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -81.99 -50.39 9.17 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.615 -172.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -97.67 -15.37 20.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -172.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 23.1 t -114.45 145.92 34.79 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.14 -3.01 10.25 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.468 2.112 . . . . 0.0 111.67 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 p -111.66 139.33 47.21 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.487 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.655 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -137.65 139.72 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 120.811 0.338 . . . . 0.0 111.549 176.017 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 5.1 tt -87.51 129.02 39.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.014 0 CA-C-O 121.595 0.712 . . . . 0.0 112.477 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 21.9 m -133.88 168.21 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.229 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.532 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -125.69 140.68 52.5 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.68 128.76 37.19 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.578 HG12 ' CD1' ' A' ' 86' ' ' ILE . 62.7 mt -86.85 130.34 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.486 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 61' ' ' ARG . 88.5 m -128.23 114.72 17.3 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.268 0.556 . . . . 0.0 111.931 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.65 32.9 6.94 Favored Glycine 0 C--N 1.313 -0.712 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.463 ' H ' HG22 ' A' ' 59' ' ' THR . 41.8 ttm180 -116.28 10.45 14.81 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.174 0.988 . . . . 0.0 109.629 -177.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.455 HG23 HG21 ' A' ' 85' ' ' VAL . 12.7 tt -147.36 152.93 12.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -129.19 169.22 15.06 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp 67.0 97.54 0.05 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.551 1.14 . . . . 0.0 112.796 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.436 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . . . -98.49 100.12 11.34 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -104.38 -44.98 4.79 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 tt -70.32 130.23 89.57 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.742 176.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.95 -5.05 6.92 Favored 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.979 3.119 . . . . 0.0 116.253 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.2 p -92.78 -12.3 31.59 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.857 0.836 . . . . 0.0 109.522 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -107.45 129.59 54.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.2 p -128.15 136.34 60.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.745 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 65' ' ' ALA . 8.4 pt-20 -99.55 137.98 37.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.992 0.901 . . . . 0.0 112.316 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.725 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -119.92 160.69 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.117 -179.229 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.3 117.57 18.11 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -53.09 -44.6 67.7 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -52.37 -39.58 60.97 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 125.455 1.502 . . . . 0.0 111.15 177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.468 ' HD3' ' OG ' ' A' ' 107' ' ' SER . 40.2 ttmt -74.62 -35.75 62.92 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 -176.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 73' ' ' ILE . 2.7 m-85 -97.51 8.86 43.83 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.645 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.3 tttm 71.81 11.32 6.29 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 125.185 1.394 . . . . 0.0 113.495 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.02 170.92 11.14 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-O 122.384 1.088 . . . . 0.0 109.948 174.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -108.39 -4.85 17.03 Favored 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.994 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -128.63 147.42 50.73 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -52.74 134.24 36.5 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 124.045 0.84 . . . . 0.0 110.72 -177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.44 ' O ' HG12 ' A' ' 73' ' ' ILE . 13.9 m -102.14 122.96 45.16 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.163 -169.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 37.3 t -113.82 135.8 52.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.578 ' CD1' HG12 ' A' ' 58' ' ' ILE . 16.5 mm -106.14 136.64 39.83 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 N-CA-C 106.33 -1.729 . . . . 0.0 106.33 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.32 107.58 18.66 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.6 mm? -86.57 14.89 6.16 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.015 0.912 . . . . 0.0 111.498 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -114.57 -44.34 3.09 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.158 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 80.78 6.62 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.528 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -122.95 -178.14 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.915 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.556 ' HD2' HD23 ' A' ' 24' ' ' LEU 0.254 13.5 ptp180 -175.3 167.27 3.38 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 171.148 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 54' ' ' ILE . 94.1 m -108.65 121.78 45.73 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.188 -178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.1 mt -131.1 145.61 52.06 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 124.548 1.155 . . . . 0.0 111.142 -169.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 20.1 t70 -50.94 137.07 21.72 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.632 1.173 . . . . 0.0 112.782 172.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.465 ' NZ ' HD12 ' A' ' 14' ' ' ILE . 30.0 mtpp -55.9 -29.51 60.14 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.829 0.852 . . . . 0.0 112.435 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 9.1 mtmp? -87.75 -9.58 53.58 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.888 -175.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 12.1 ptm180 -90.65 -17.19 27.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.668 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.34 127.02 31.57 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 161.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -99.0 -59.73 1.67 Allowed 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -172.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 13.3 pt-20 -147.98 131.71 16.95 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -169.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -63.67 108.94 1.53 Allowed 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 128.552 2.741 . . . . 0.0 107.118 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.713 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 57.2 tp -106.32 -63.07 1.3 Allowed 'General case' 0 N--CA 1.411 -2.4 0 CA-C-O 122.386 1.089 . . . . 0.0 111.435 -171.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.769 HG22 ' H ' ' A' ' 105' ' ' TYR 0.291 19.9 m -138.32 -157.06 0.74 Allowed 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 113.76 -1.563 . . . . 0.0 111.437 -165.082 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.769 ' H ' HG22 ' A' ' 104' ' ' THR . 12.9 t80 -159.15 151.84 21.74 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 119.653 1.115 . . . . 0.0 110.513 -161.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -115.1 138.37 50.96 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.37 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.468 ' OG ' ' HD3' ' A' ' 77' ' ' LYS . 19.7 m -79.79 157.33 27.1 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.534 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 111' ' ' MET . 26.1 t70 -63.61 -37.39 87.16 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.195 0.598 . . . . 0.0 112.197 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.23 -40.35 95.85 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 123.329 0.652 . . . . 0.0 110.696 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HE3' HG23 ' A' ' 73' ' ' ILE . 14.9 tppt? -77.98 -27.42 49.12 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.957 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.528 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 1.3 mmt -50.09 -46.84 53.84 Favored 'General case' 0 CA--C 1.461 -2.447 0 CA-C-O 122.223 1.011 . . . . 0.0 109.345 171.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 8.0 mmpt? -72.94 -12.36 60.92 Favored 'General case' 0 N--CA 1.392 -3.337 0 CA-C-N 113.853 -1.521 . . . . 0.0 114.012 -177.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -90.7 -52.1 5.05 Favored 'General case' 0 N--CA 1.385 -3.709 0 C-N-CA 117.469 -1.692 . . . . 0.0 107.59 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -51.87 -59.28 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 113.217 -1.81 . . . . 0.0 113.141 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 56.7 m-20 -59.22 -39.37 82.48 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 123.534 1.635 . . . . 0.0 110.732 -177.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -80.56 -41.95 23.2 Favored 'General case' 0 C--N 1.256 -3.468 0 CA-C-N 112.442 -2.163 . . . . 0.0 112.722 -172.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.453 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.45 -35.38 73.93 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 122.191 0.996 . . . . 0.0 108.332 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 3.9 tp -68.09 -40.36 82.68 Favored 'General case' 0 N--CA 1.384 -3.757 0 CA-C-N 113.211 -1.813 . . . . 0.0 110.141 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.2 ttp -72.02 -19.94 61.78 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.33 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 117' ' ' ALA . 54.1 mt -84.7 -52.75 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.8 t -47.93 -46.33 31.95 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.938 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.06 5.71 13.46 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.04 81.91 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 116.48 1.352 . . . . 0.0 116.48 171.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' B' ' 115' ' ' ASP . 5.9 mt -73.28 -52.51 13.7 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 117.413 -1.715 . . . . 0.0 107.867 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.49 ' HB3' ' HB3' ' A' ' 128' ' ' ALA . 50.7 m-80 56.93 149.72 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.191 -1.822 . . . . 0.0 115.149 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -102.51 89.46 3.54 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . 0.364 11.8 p 45.95 71.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 123.806 1.765 . . . . 0.0 113.926 -174.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 125' ' ' ASN . . . -139.6 16.7 2.53 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 112.434 -2.167 . . . . 0.0 107.799 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -127.57 148.79 50.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 69.85 -54.48 0.61 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.355 1.062 . . . . 0.0 111.285 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -132.97 106.42 7.66 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 123.587 0.755 . . . . 0.0 109.095 175.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 C--N 1.295 -1.799 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.689 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.49 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 11.4 p -71.64 -19.42 62.1 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.194 0.521 . . . . 0.0 111.834 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 21.7 t -89.3 -2.99 58.66 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.446 0.641 . . . . 0.0 109.669 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -86.24 100.15 12.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -92.19 -51.58 5.1 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -143.68 160.66 40.29 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.465 ' HA ' ' O ' ' B' ' 11' ' ' GLN . 78.5 m-70 69.5 -164.6 0.17 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 124.324 1.015 . . . . 0.0 110.518 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 70.19 -178.67 0.22 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.033 0.933 . . . . 0.0 109.847 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 59.65 -93.67 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.734 0.813 . . . . 0.0 110.471 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 39.8 m -158.8 26.69 0.22 Allowed 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' B' ' 7' ' ' HIS . 29.0 tt0 -107.88 120.03 41.12 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.025 -173.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.02 118.1 48.75 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 166.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.8 -25.5 78.54 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.681 2.254 . . . . 0.0 113.379 -174.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.458 HD12 ' NZ ' ' B' ' 96' ' ' LYS . 62.1 mt -83.67 118.19 30.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -175.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -144.87 160.73 40.82 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' B' ' 41' ' ' ILE . 50.5 ttp180 -71.39 114.4 9.41 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 143.31 -27.74 2.11 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.388 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -97.73 138.51 35.0 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.244 0.545 . . . . 0.0 111.05 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.427 ' HB ' ' H ' ' B' ' 104' ' ' THR . 64.7 t -89.76 123.44 41.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.528 174.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -113.04 146.29 39.38 Favored 'General case' 0 C--N 1.267 -3.016 0 C-N-CA 124.122 0.969 . . . . 0.0 109.806 172.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.602 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.1 mp -83.34 152.21 25.19 Favored 'General case' 0 N--CA 1.399 -2.983 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 167.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.38 156.84 40.34 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-O 121.785 0.802 . . . . 0.0 111.428 -173.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.98 93.88 8.99 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.556 HD22 ' HA3' ' B' ' 33' ' ' GLY 0.25 1.6 tt -90.58 -11.24 40.59 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -174.401 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.622 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 9.2 m -33.55 -177.45 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.668 0 C-N-CA 129.497 3.119 . . . . 0.0 115.364 170.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 31.59 36.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 123.751 2.968 . . . . 0.0 117.421 -154.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.542 HG13 ' O ' ' B' ' 24' ' ' LEU . 6.9 m -73.24 148.51 8.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.61 164.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -117.48 122.51 43.93 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.75 -111.89 4.14 Favored Glycine 0 C--N 1.32 -0.344 0 CA-C-N 115.087 -0.96 . . . . 0.0 114.121 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 18.2 m -60.17 -21.86 62.19 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.651 1.18 . . . . 0.0 113.122 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.517 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 73.2 mt-10 -70.3 143.48 52.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -128.25 117.22 21.12 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.556 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -160.51 -91.66 0.08 OUTLIER Glycine 0 N--CA 1.415 -2.757 0 C-N-CA 119.437 -1.363 . . . . 0.0 113.964 173.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.96 -147.45 27.66 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 105.391 -3.084 . . . . 0.0 105.391 -167.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.95 122.08 51.41 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 119.766 1.783 . . . . 0.0 108.821 172.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -145.86 162.94 33.68 Favored Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.9 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 18.4 Cg_exo -69.98 138.46 37.15 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.855 1.704 . . . . 0.0 109.008 167.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.54 161.98 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 29.1 m -101.5 129.44 52.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.186 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 33.9 mm -88.26 109.58 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.479 ' O ' ' HD3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -105.64 -18.01 7.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.734 -177.081 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.665 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 7.0 tt0 -64.92 163.73 13.9 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -170.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.63 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 13.3 p-10 -65.11 178.89 0.78 Allowed 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.876 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.05 -47.76 49.25 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 112.827 -1.988 . . . . 0.0 113.039 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.426 ' HA ' ' HD2' ' B' ' 48' ' ' LYS . 3.5 m -87.28 -24.16 24.44 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -162.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' B' ' 50' ' ' SER . . . -63.69 -30.27 77.15 Favored Glycine 0 C--O 1.2 -1.986 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -66.29 -40.25 89.92 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 120.886 0.374 . . . . 0.0 110.624 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' B' ' 45' ' ' THR . 28.5 mttt -78.76 -54.9 5.61 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-O 121.06 0.457 . . . . 0.0 112.04 -175.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -88.07 -25.06 23.25 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' B' ' 46' ' ' GLY . 13.9 t -107.6 144.83 30.05 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.93 -6.1 12.26 Favored 'Trans proline' 0 C--O 1.241 0.639 0 C-N-CA 122.433 2.089 . . . . 0.0 111.631 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 3.7 p -107.68 142.3 37.87 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.336 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.665 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.1 OUTLIER -140.5 139.64 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 120.803 0.335 . . . . 0.0 111.6 176.067 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' B' ' 93' ' ' THR . 4.8 tt -87.7 130.08 38.0 Favored 'Isoleucine or valine' 0 C--O 1.247 0.941 0 CA-C-O 121.611 0.72 . . . . 0.0 112.901 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.492 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 20.0 m -134.67 167.91 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.169 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.525 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -125.15 140.25 53.04 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.97 127.75 33.94 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.57 HG12 ' CD1' ' B' ' 86' ' ' ILE . 60.0 mt -85.54 130.81 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.535 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' THR . . . . . 0.41 HG22 ' H ' ' B' ' 61' ' ' ARG . 91.7 m -128.26 112.76 14.83 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.43 0.633 . . . . 0.0 111.856 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.0 43.39 1.7 Allowed Glycine 0 C--N 1.307 -1.053 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 175.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.41 ' H ' HG22 ' B' ' 59' ' ' THR . 43.5 ttm180 -123.56 3.89 8.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.812 0.815 . . . . 0.0 109.339 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.467 HG23 HG21 ' B' ' 85' ' ' VAL . 12.3 tt -144.65 154.21 14.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -176.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -130.06 171.35 12.91 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp 68.3 96.36 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.107 0.963 . . . . 0.0 112.883 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.54 92.88 5.33 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.379 175.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' B' ' 66' ' ' LYS . 11.1 tmtt? -98.91 -38.74 8.89 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.8 tt -75.93 130.06 79.42 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.526 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.24 -12.99 21.95 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.854 3.036 . . . . 0.0 116.272 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 69.9 p -87.27 -13.51 43.51 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.763 0.792 . . . . 0.0 110.038 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -105.7 130.44 53.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 9.9 p -129.02 136.75 58.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.798 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -98.37 137.68 36.73 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-O 121.925 0.869 . . . . 0.0 112.025 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.715 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.3 OUTLIER -120.13 158.22 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.394 -179.365 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -72.95 116.19 13.16 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -53.2 -43.28 67.07 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -53.22 -43.33 67.18 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 125.127 1.371 . . . . 0.0 111.011 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' LYS . . . . . 0.513 ' HD3' ' OG ' ' B' ' 107' ' ' SER . 41.0 ttmt -71.82 -34.57 69.44 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.208 -175.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.715 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.1 m-85 -96.82 7.97 45.41 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.369 0.604 . . . . 0.0 111.106 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 61.2 tttm 70.5 13.35 7.43 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.957 1.303 . . . . 0.0 113.206 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.58 167.29 13.52 Favored 'General case' 0 CA--C 1.478 -1.796 0 CA-C-O 122.212 1.006 . . . . 0.0 110.235 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -99.86 -11.74 20.47 Favored 'General case' 0 C--N 1.271 -2.825 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.041 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -126.29 149.6 49.02 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.45 132.96 35.48 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 124.225 0.953 . . . . 0.0 110.116 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.419 ' O ' HG12 ' B' ' 73' ' ' ILE . 10.9 m -102.39 121.99 43.41 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.826 -169.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.467 HG21 HG23 ' B' ' 62' ' ' ILE . 39.1 t -113.49 135.03 54.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.57 ' CD1' HG12 ' B' ' 58' ' ' ILE . 17.2 mm -104.94 135.91 40.9 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.853 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.4 mt -105.14 107.68 18.8 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' B' ' 118' ' ' LEU . 3.7 mm? -85.64 12.28 9.09 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.908 0.861 . . . . 0.0 111.567 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.39 -44.01 3.43 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.492 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.23 80.56 6.87 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.254 1.026 . . . . 0.0 108.252 178.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.525 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.2 pp -123.1 -178.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.033 -1.439 . . . . 0.0 108.192 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.524 ' HD2' HD23 ' B' ' 24' ' ' LEU . 13.6 ptp180 -175.3 167.56 3.37 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 171.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' B' ' 54' ' ' ILE . 96.0 m -108.5 121.84 45.81 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.173 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.444 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 71.7 mt -131.22 145.33 51.88 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 124.707 1.254 . . . . 0.0 110.93 -169.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.621 ' O ' ' HG2' ' B' ' 98' ' ' ARG . 27.5 t70 -52.52 136.42 32.17 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.977 0.911 . . . . 0.0 112.911 172.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.458 ' NZ ' HD12 ' B' ' 14' ' ' ILE . 29.0 mtpp -54.65 -29.85 53.53 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.115 0.966 . . . . 0.0 112.371 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.48 ' HB2' ' OD2' ' B' ' 95' ' ' ASP . 9.8 mtmp? -83.7 -17.95 39.58 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.585 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.621 ' HG2' ' O ' ' B' ' 95' ' ' ASP . 11.8 ptm180 -86.25 -17.85 33.64 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.814 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.68 121.35 16.27 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 162.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -92.19 -60.39 1.86 Allowed 'General case' 0 C--N 1.268 -2.938 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -170.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.449 ' HG3' HD13 ' B' ' 21' ' ' LEU . 10.6 pt-20 -148.68 130.19 14.86 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-O 122.512 1.149 . . . . 0.0 114.044 -168.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -61.14 110.89 1.51 Allowed 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 128.497 2.719 . . . . 0.0 106.924 173.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.679 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 53.7 tp -107.44 -64.19 1.22 Allowed 'General case' 0 N--CA 1.402 -2.853 0 CA-C-O 121.94 0.876 . . . . 0.0 111.05 -172.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.734 HG22 ' H ' ' B' ' 105' ' ' TYR 0.291 17.4 m -138.12 -157.12 0.74 Allowed 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.216 -164.2 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.734 ' H ' HG22 ' B' ' 104' ' ' THR . 11.9 t80 -158.32 153.63 25.78 Favored 'General case' 0 N--CA 1.402 -2.859 0 CA-C-N 119.703 1.138 . . . . 0.0 110.1 -161.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.04 138.9 50.34 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.351 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.513 ' OG ' ' HD3' ' B' ' 77' ' ' LYS . 27.7 m -82.76 156.75 23.54 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.411 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' B' ' 111' ' ' MET . 20.0 t70 -61.96 -36.78 82.46 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.42 0.629 . . . . 0.0 111.765 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -62.1 -40.95 97.61 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.623 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.457 ' HE3' HG23 ' B' ' 73' ' ' ILE . 13.6 tppt? -77.24 -28.74 53.75 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.175 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.5 OUTLIER -49.33 -46.17 46.46 Favored 'General case' 0 CA--C 1.459 -2.536 0 CA-C-O 122.143 0.973 . . . . 0.0 109.088 171.198 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.563 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 6.1 mmpt? -71.48 -16.22 62.35 Favored 'General case' 0 N--CA 1.38 -3.926 0 CA-C-N 113.841 -1.527 . . . . 0.0 114.848 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -89.89 -51.59 5.41 Favored 'General case' 0 N--CA 1.388 -3.566 0 C-N-CA 117.014 -1.874 . . . . 0.0 107.27 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.72 -59.62 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 113.36 -1.745 . . . . 0.0 113.293 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 49.1 m-20 -59.47 -40.3 86.49 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 123.713 1.721 . . . . 0.0 111.32 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.406 ' O ' HG13 ' B' ' 120' ' ' ILE 0.351 25.9 t30 -80.74 -40.38 25.34 Favored 'General case' 0 C--N 1.255 -3.54 0 CA-C-N 112.711 -2.04 . . . . 0.0 112.391 -171.397 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -63.58 -32.98 74.61 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 121.981 0.896 . . . . 0.0 108.681 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.8 tp -67.45 -39.67 85.35 Favored 'General case' 0 N--CA 1.38 -3.939 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.576 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 8.6 ttp -71.83 -20.37 61.84 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 123.61 0.764 . . . . 0.0 110.042 -175.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' B' ' 117' ' ' ALA . 63.5 mt -84.3 -53.17 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.2 t -47.72 -46.09 29.32 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.993 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 8.7 mp -79.75 5.83 12.44 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.65 9.77 79.0 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 116.195 1.238 . . . . 0.0 116.195 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.424 HD22 ' HB3' ' A' ' 115' ' ' ASP . 6.2 mt -71.56 -54.37 10.71 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 119.498 1.649 . . . . 0.0 107.762 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' B' ' 128' ' ' ALA . 53.9 m-80 56.26 149.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 113.049 -1.887 . . . . 0.0 115.031 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -101.77 89.29 3.63 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . 0.372 10.9 p 45.69 72.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 125.993 1.717 . . . . 0.0 113.963 -173.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 128' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' B' ' 125' ' ' ASN . . . -139.29 19.41 2.58 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 112.99 -1.914 . . . . 0.0 107.105 176.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -130.47 149.84 51.96 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.481 -2.145 . . . . 0.0 105.397 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 72.19 -53.07 0.7 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.147 0.979 . . . . 0.0 110.858 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -134.58 113.31 11.63 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 124.207 1.003 . . . . 0.0 109.172 175.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 . . . . . 0 C--N 1.296 -1.752 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.24 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.743 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.8 m -79.08 85.63 4.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.736 0.779 . . . . 0.0 110.811 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m -147.61 133.77 19.39 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -89.78 114.99 26.78 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -88.77 94.02 9.77 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.358 0.599 . . . . 0.0 109.763 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -99.73 97.84 8.74 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -141.42 1.68 1.59 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -88.37 -40.29 13.67 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -109.17 162.93 13.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.8 m -150.93 130.64 13.14 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.447 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . 23.4 pt20 -86.75 82.29 7.9 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.458 1.123 . . . . 0.0 109.941 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -56.61 154.8 16.07 Favored Pre-proline 0 C--O 1.245 0.816 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.564 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.02 114.17 3.08 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.557 2.171 . . . . 0.0 109.934 173.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mt -77.22 147.75 7.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.575 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -115.6 144.36 44.01 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 19.7 ptt180 -73.87 152.3 40.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.879 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.17 -2.71 79.28 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.977 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -97.71 177.88 5.33 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 3.9 t -133.62 134.45 56.55 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 C-N-CA 122.806 0.442 . . . . 0.0 111.844 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.486 ' O ' HG22 ' A' ' 38' ' ' VAL . 12.5 m-85 -131.51 144.32 51.04 Favored 'General case' 0 CA--C 1.467 -2.232 0 C-N-CA 124.46 1.104 . . . . 0.0 110.146 177.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mp -79.58 151.49 30.62 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 169.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.01 139.47 23.64 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.278 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -74.37 92.65 2.32 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.146 0.974 . . . . 0.0 109.773 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.587 ' O ' HG13 ' A' ' 27' ' ' VAL . 83.7 mt -82.19 -12.41 58.14 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-N 113.892 -1.504 . . . . 0.0 112.11 -177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -90.83 61.79 0.0 OUTLIER Pre-proline 0 C--N 1.257 -3.453 0 N-CA-C 119.754 3.242 . . . . 0.0 119.754 -176.201 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' B' ' 26' ' ' PRO . 1.1 Cg_endo -117.68 22.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 N-CA-C 108.46 -1.4 . . . . 0.0 108.46 148.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 24' ' ' LEU . 14.1 m -72.81 157.97 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.943 0.878 . . . . 0.0 113.364 -172.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -124.01 156.3 36.71 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.721 -1.581 . . . . 0.0 107.163 175.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.95 -135.44 15.09 Favored Glycine 0 N--CA 1.418 -2.556 0 O-C-N 124.131 0.894 . . . . 0.0 112.068 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.6 m -94.34 6.93 47.2 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.476 -0.362 . . . . 0.0 111.686 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 7.1 mm-40 -71.33 153.14 42.58 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 119.374 -0.931 . . . . 0.0 112.959 -176.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -81.85 119.15 23.55 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -171.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.4 158.97 17.19 Favored Glycine 0 CA--C 1.472 -2.651 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.495 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . 111.63 137.97 7.39 Favored Glycine 0 C--N 1.276 -2.793 0 CA-C-N 113.016 -1.592 . . . . 0.0 109.972 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 p -64.6 119.13 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.124 0 CA-C-O 122.365 1.079 . . . . 0.0 109.039 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -144.93 149.22 41.77 Favored Pre-proline 0 C--N 1.267 -3.015 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.209 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 33.3 Cg_exo -58.76 136.59 74.82 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.311 2.007 . . . . 0.0 111.37 171.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 20' ' ' TYR . 29.4 m -122.51 161.68 23.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 123.933 0.893 . . . . 0.0 108.721 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.6 m -101.48 132.11 47.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 120.722 0.296 . . . . 0.0 110.697 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mm -86.04 105.12 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -97.39 -23.46 4.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.535 -177.081 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.65 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -64.5 168.49 5.8 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -167.781 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.58 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 12.9 p-10 -66.53 177.62 1.5 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.464 -1.698 . . . . 0.0 110.632 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 16.8 t70 -89.18 -29.56 19.21 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.188 -176.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.586 ' HA ' ' CD ' ' A' ' 48' ' ' LYS . 45.1 m -82.79 -26.17 32.06 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.42 -21.69 74.44 Favored Glycine 0 C--O 1.196 -2.238 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -82.12 -26.79 33.25 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.273 0.559 . . . . 0.0 109.931 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.586 ' CD ' ' HA ' ' A' ' 45' ' ' THR . 6.6 mtpp -82.94 -57.98 3.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.978 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -96.35 -35.86 11.06 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.6 m -90.84 158.74 41.71 Favored Pre-proline 0 C--N 1.29 -2.02 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -87.86 -11.45 4.69 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.38 1.387 . . . . 0.0 110.849 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 17.0 p -96.26 149.88 21.17 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.504 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -148.58 137.95 15.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.363 170.511 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.65 HG22 ' HG3' ' A' ' 42' ' ' GLN . 15.0 tt -86.47 135.32 25.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-O 121.444 0.64 . . . . 0.0 110.29 175.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.99 146.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.994 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 91' ' ' ILE . . . -109.76 135.64 50.36 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.78 145.1 48.93 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.44 HG12 HD12 ' A' ' 86' ' ' ILE . 49.1 mt -100.79 143.74 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.969 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 m -92.35 173.37 7.84 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.25 -73.23 0.9 Allowed Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 171.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 83' ' ' ASP . 78.4 ttt180 -167.86 144.51 4.14 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.9 tt -164.88 -39.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.9 m120 63.38 -178.46 0.15 Allowed 'General case' 0 C--O 1.249 1.069 0 C-N-CA 124.329 1.052 . . . . 0.0 113.119 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.5 mttm 62.66 71.73 0.51 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.175 0.99 . . . . 0.0 109.067 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 70' ' ' HIS . . . -52.35 -71.9 0.06 Allowed 'General case' 0 C--O 1.246 0.918 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.219 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt 66.63 -56.63 0.4 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.277 1.431 . . . . 0.0 113.329 175.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.69 136.84 70.5 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.0 2.44 2.14 Favored 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.101 1.867 . . . . 0.0 113.841 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 p -100.91 -18.93 16.13 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.483 0.659 . . . . 0.0 109.728 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.432 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 17.5 m170 -102.03 130.09 48.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.28 136.94 52.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.568 173.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 10.2 pt-20 -101.38 146.61 27.36 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.082 0.468 . . . . 0.0 112.188 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.8 pt -112.75 146.08 17.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.11 109.0 6.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.842 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -60.32 -36.15 77.26 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.637 0.732 . . . . 0.0 112.789 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -51.4 -52.1 48.91 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.19 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -91.05 -25.62 19.57 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.361 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' A' ' 106' ' ' LEU . 1.9 m-85 -88.55 20.5 3.36 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 123.635 0.774 . . . . 0.0 111.858 -172.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 56.75 27.61 13.02 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.31 170.76 8.0 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.843 0.83 . . . . 0.0 109.718 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -99.8 -16.94 17.91 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.231 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.73 140.0 52.27 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.027 -173.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.528 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 4.4 t70 -85.81 102.8 14.0 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.0 t -103.28 172.75 6.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -165.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 37.7 t -123.9 142.97 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.44 HD12 HG12 ' A' ' 58' ' ' ILE . 20.9 mm -106.44 133.31 51.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.8 mt -105.95 107.06 17.87 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 121.462 0.648 . . . . 0.0 109.737 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.6 mm? -84.26 16.96 2.73 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.608 -175.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.03 -40.28 3.52 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 122.13 0.967 . . . . 0.0 109.019 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.19 72.82 4.61 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.56 ' O ' ' HB ' ' B' ' 93' ' ' THR . 8.0 mt -106.62 -174.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.533 ' H ' HG22 ' A' ' 91' ' ' ILE . 5.7 ptp180 -175.14 174.89 2.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 124.004 0.922 . . . . 0.0 109.733 166.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.559 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 68.0 m -125.27 130.05 51.26 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -132.99 143.08 49.2 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -80.54 153.05 28.32 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.876 175.543 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 11' ' ' GLN . 60.2 mtpt -47.12 -18.21 0.08 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 126.523 1.929 . . . . 0.0 115.333 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -74.31 -27.15 60.58 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.317 0.58 . . . . 0.0 111.132 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -74.84 -35.73 62.38 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.449 0.7 . . . . 0.0 110.47 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mp -74.6 122.98 23.98 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.398 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.45 -59.61 1.84 Allowed 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -154.85 135.55 13.56 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.478 0.656 . . . . 0.0 112.6 -168.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -64.62 121.26 14.04 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.608 173.462 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -113.78 -61.92 1.67 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.446 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.516 HG22 HG11 ' A' ' 19' ' ' VAL . 5.2 t -126.3 -164.35 1.32 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.069 -1.452 . . . . 0.0 112.348 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -159.84 147.14 16.61 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.812 0.845 . . . . 0.0 112.651 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.586 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . 13.1 mt -98.65 155.34 17.36 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.959 -1.473 . . . . 0.0 108.476 177.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.8 m -86.36 167.86 14.37 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 111' ' ' MET . 22.2 t70 -56.58 -43.62 80.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.69 0.796 . . . . 0.0 112.381 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.13 -41.55 98.36 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -67.23 -33.66 75.83 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.513 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -55.1 -42.41 72.85 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 123.967 0.907 . . . . 0.0 110.313 175.431 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.668 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -76.22 -11.98 60.01 Favored 'General case' 0 CA--C 1.472 -2.046 0 C-N-CA 122.947 0.499 . . . . 0.0 111.544 179.482 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -86.67 -43.47 12.59 Favored 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -55.92 -58.92 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.111 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.316 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.89 -49.92 62.06 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-O 123.311 1.529 . . . . 0.0 110.344 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.665 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 1.3 t30 -68.97 -49.76 55.07 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 112.203 -2.272 . . . . 0.0 112.743 -173.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.45 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.07 -39.75 83.08 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 2.4 tp -64.32 -47.36 79.73 Favored 'General case' 1 N--CA 1.378 -4.07 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.498 -175.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.685 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 1.9 ptm -71.19 -19.74 62.36 Favored 'General case' 0 C--O 1.202 -1.424 0 O-C-N 121.568 -0.707 . . . . 0.0 112.513 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 116' ' ' ASN . 54.2 mt -76.76 -53.54 14.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -55.89 -30.94 62.35 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.236 -1.802 . . . . 0.0 111.555 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.573 HD22 HG21 ' B' ' 54' ' ' ILE . 44.2 mt -101.6 5.48 41.66 Favored 'General case' 0 N--CA 1.425 -1.696 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.527 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.38 5.36 72.53 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 117.729 1.851 . . . . 0.0 117.729 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.685 ' HB2' ' HB2' ' A' ' 119' ' ' MET . 6.9 mp -71.26 -45.18 63.77 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 120.544 2.172 . . . . 0.0 108.665 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 54.46 133.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.532 1.933 . . . . 0.0 116.006 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.48 73.66 9.47 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 122.053 0.93 . . . . 0.0 110.455 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.2 t -122.38 2.79 6.05 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.39 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 67.14 132.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.505 -1.68 . . . . 0.0 112.896 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -72.19 -41.56 66.82 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 171.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 53.11 73.09 0.38 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.783 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -77.76 90.32 4.03 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 122.194 0.997 . . . . 0.0 112.14 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 . . . . . 0 C--N 1.299 -1.61 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.714 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.264 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -82.56 92.15 7.05 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 121.747 0.784 . . . . 0.0 110.047 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 34.1 m -150.12 135.45 18.07 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -91.94 109.36 20.7 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -84.57 96.1 9.06 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -101.28 96.3 7.09 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.157 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -139.19 -3.03 1.59 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -83.31 -38.92 21.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -110.27 164.32 12.78 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.2 m -150.03 134.71 17.57 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -91.91 80.4 5.2 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.371 1.081 . . . . 0.0 109.164 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -59.11 155.41 34.11 Favored Pre-proline 0 C--O 1.243 0.739 0 CA-C-N 113.501 -1.681 . . . . 0.0 113.063 -174.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.46 113.27 2.85 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.442 2.095 . . . . 0.0 110.055 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 44.0 mt -75.91 147.44 7.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.295 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -114.5 144.83 42.72 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.558 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 19.9 ptt180 -75.31 147.4 40.2 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.777 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.02 -2.88 60.07 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.32 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -97.25 174.87 6.5 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 5.6 t -132.94 131.6 59.07 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.9 0 C-N-CA 123.596 0.759 . . . . 0.0 111.49 -176.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.5 ' O ' HG22 ' B' ' 38' ' ' VAL . 8.4 m-85 -129.26 144.16 51.12 Favored 'General case' 0 CA--C 1.465 -2.296 0 C-N-CA 124.167 0.987 . . . . 0.0 110.396 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -79.94 151.1 30.27 Favored 'General case' 0 N--CA 1.4 -2.942 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.03 139.71 23.82 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.155 -175.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.64 92.29 1.95 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.048 0.928 . . . . 0.0 109.455 173.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.572 ' O ' HG13 ' B' ' 27' ' ' VAL . 90.2 mt -83.09 -9.97 58.94 Favored 'General case' 0 CA--C 1.474 -1.947 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.787 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.434 ' HB3' ' H ' ' B' ' 34' ' ' GLY . 0.1 OUTLIER -91.91 61.3 0.0 OUTLIER Pre-proline 0 C--N 1.247 -3.879 0 N-CA-C 119.262 3.06 . . . . 0.0 119.262 -176.439 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.429 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -117.74 21.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.255 0 N-CA-C 108.476 -1.394 . . . . 0.0 108.476 150.157 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.572 HG13 ' O ' ' B' ' 24' ' ' LEU . 15.2 m -72.62 157.91 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-O 122.085 0.945 . . . . 0.0 113.154 -171.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -124.05 155.98 37.35 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.354 -1.748 . . . . 0.0 107.679 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.26 -135.32 14.02 Favored Glycine 0 N--CA 1.421 -2.326 0 O-C-N 123.997 0.811 . . . . 0.0 112.109 173.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -94.75 8.41 42.63 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 122.661 0.384 . . . . 0.0 111.846 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.08 151.9 42.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.58 118.45 21.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 121.16 0.505 . . . . 0.0 109.857 -171.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.89 155.62 18.75 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-N 114.701 -1.136 . . . . 0.0 115.264 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.434 ' H ' ' HB3' ' B' ' 25' ' ' SER . . . 112.43 137.84 7.13 Favored Glycine 0 N--CA 1.418 -2.524 0 CA-C-N 113.023 -1.588 . . . . 0.0 110.364 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 p -63.62 119.67 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-O 122.4 1.095 . . . . 0.0 108.86 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -145.49 149.74 41.68 Favored Pre-proline 0 C--N 1.265 -3.068 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.304 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.2 Cg_exo -59.07 136.85 75.91 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.137 1.891 . . . . 0.0 111.201 171.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -122.76 161.02 24.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 123.968 0.907 . . . . 0.0 108.61 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 30.0 m -100.93 132.05 47.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 120.748 0.308 . . . . 0.0 110.723 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 26.1 mm -86.06 105.91 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.43 HG23 HG23 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -97.53 -25.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.383 -177.565 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.641 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.1 OUTLIER -63.12 167.85 4.65 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -167.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.575 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 14.5 p-10 -66.41 176.26 1.92 Allowed 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.083 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.98 -30.13 21.5 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.648 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' THR . . . . . 0.522 ' HA ' ' CD ' ' B' ' 48' ' ' LYS . 28.3 m -84.0 -25.52 29.89 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -170.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -68.61 -21.46 74.69 Favored Glycine 0 C--O 1.194 -2.394 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 176.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -82.88 -27.94 30.38 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.181 0.515 . . . . 0.0 110.018 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.522 ' CD ' ' HA ' ' B' ' 45' ' ' THR . 4.4 mtpp -80.74 -58.48 3.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.869 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -97.39 -35.89 10.54 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -172.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 38.5 m -88.11 156.59 51.74 Favored Pre-proline 0 C--N 1.292 -1.91 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.193 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -86.97 -12.32 5.06 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 121.22 1.28 . . . . 0.0 110.663 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 19.0 p -96.14 149.29 21.79 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.479 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.8 OUTLIER -148.1 137.87 16.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 O-C-N 123.94 0.775 . . . . 0.0 109.258 170.499 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.641 HG22 ' HG3' ' B' ' 42' ' ' GLN . 15.6 tt -86.54 135.47 25.05 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 CA-C-O 121.278 0.561 . . . . 0.0 110.277 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.67 145.65 29.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.965 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' B' ' 91' ' ' ILE . . . -109.59 135.17 51.0 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.76 145.87 48.47 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.439 HG12 HD12 ' B' ' 86' ' ' ILE . 45.6 mt -101.91 145.22 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.859 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 5.0 m -93.6 176.85 6.21 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.62 -72.02 1.14 Allowed Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 171.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' B' ' 83' ' ' ASP . 77.8 ttt180 -168.06 144.94 4.1 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 14.2 tt -165.16 -39.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 19.1 m120 63.07 -177.22 0.15 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.479 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 61.98 68.02 0.71 Allowed 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 124.043 0.84 . . . . 0.0 109.471 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' B' ' 70' ' ' HIS . . . -49.49 -70.29 0.09 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.256 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt 64.09 -59.99 0.2 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.004 1.322 . . . . 0.0 113.847 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.0 mt -72.82 137.41 79.85 Favored Pre-proline 0 C--N 1.308 -1.229 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.05 6.86 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 122.32 2.013 . . . . 0.0 113.695 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -106.05 -18.52 14.0 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.529 0.681 . . . . 0.0 109.476 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.444 ' O ' ' HB1' ' B' ' 65' ' ' ALA . 26.7 m170 -102.43 130.18 49.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.26 137.39 50.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 8.6 pt-20 -101.08 150.67 22.68 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.998 0.428 . . . . 0.0 112.152 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ILE . . . . . . . . . . . . . 21.0 pt -117.16 144.41 25.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.78 109.76 5.16 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.869 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.6 -38.55 85.06 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.343 0.592 . . . . 0.0 112.499 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -51.22 -51.76 50.87 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.591 -1.64 . . . . 0.0 113.55 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -88.12 -26.43 22.49 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 118.764 -1.175 . . . . 0.0 112.022 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' B' ' 106' ' ' LEU . 1.7 m-85 -89.79 19.14 4.94 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 123.722 0.809 . . . . 0.0 111.547 -171.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 60.23 23.83 13.21 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 124.542 1.137 . . . . 0.0 113.818 169.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 mt -110.59 165.84 11.48 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.058 0.933 . . . . 0.0 110.52 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.52 -14.3 25.22 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.404 -1.726 . . . . 0.0 108.853 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.68 139.16 53.79 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.005 -174.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' B' ' 61' ' ' ARG . 4.6 t70 -85.13 103.77 14.42 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 41.8 t -104.56 172.83 6.58 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -164.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' B' ' 72' ' ' GLU . 38.4 t -124.42 142.68 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.439 HD12 HG12 ' B' ' 58' ' ' ILE . 19.8 mm -106.26 133.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 80.1 mt -106.04 106.99 17.76 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.495 0.664 . . . . 0.0 109.541 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.7 mm? -84.31 16.47 3.03 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.771 0.796 . . . . 0.0 111.599 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.6 -40.28 3.41 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 122.254 1.026 . . . . 0.0 109.168 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.49 74.16 5.18 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.559 ' O ' ' HB ' ' A' ' 93' ' ' THR . 8.4 mt -107.64 -174.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.522 ' NH1' ' HB3' ' B' ' 24' ' ' LEU . 5.8 ptp180 -174.48 173.76 2.87 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 123.923 0.889 . . . . 0.0 109.659 167.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 59.7 m -126.02 128.13 46.97 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -132.26 142.7 49.49 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.889 -172.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 0.8 OUTLIER -80.09 153.34 28.8 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.009 175.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -46.56 -20.78 0.13 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 126.5 1.92 . . . . 0.0 115.082 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -75.59 -22.41 56.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.023 0.439 . . . . 0.0 111.391 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -77.74 -36.82 50.33 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 122.994 0.518 . . . . 0.0 110.127 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.73 124.49 26.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 124.072 0.949 . . . . 0.0 110.547 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -96.0 -60.66 1.59 Allowed 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.3 pt-20 -154.72 135.24 13.42 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.396 0.617 . . . . 0.0 112.503 -167.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -63.94 122.6 16.89 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.837 172.67 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.3 tp -114.52 -62.48 1.59 Allowed 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.806 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.519 HG22 HG11 ' B' ' 19' ' ' VAL . 5.2 t -125.81 -164.68 1.33 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.702 -1.599 . . . . 0.0 112.458 -176.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -159.77 145.05 15.42 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.635 0.774 . . . . 0.0 111.866 -172.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.548 ' HA ' ' CE2' ' B' ' 78' ' ' TYR . 14.6 mt -98.22 156.43 16.7 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.526 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 49.7 m -84.08 169.22 15.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.389 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' B' ' 111' ' ' MET . 12.1 t70 -59.0 -44.84 91.73 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.905 0.882 . . . . 0.0 111.875 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.31 -40.0 96.12 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.22 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -67.88 -33.11 74.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -55.08 -42.87 73.35 Favored 'General case' 0 N--CA 1.41 -2.431 0 C-N-CA 123.617 0.767 . . . . 0.0 110.205 175.068 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.707 ' O ' ' HB3' ' B' ' 116' ' ' ASN . 0.4 OUTLIER -74.94 -13.25 60.51 Favored 'General case' 0 CA--C 1.466 -2.276 0 C-N-CA 122.568 0.347 . . . . 0.0 111.738 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -86.01 -43.3 13.26 Favored 'General case' 0 N--CA 1.39 -3.435 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.78 -57.54 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.961 0 CA-C-N 112.906 -1.952 . . . . 0.0 111.922 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.7 -51.97 58.1 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 122.958 1.361 . . . . 0.0 109.56 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.707 ' HB3' ' O ' ' B' ' 112' ' ' LYS . 0.0 OUTLIER -70.06 -42.31 72.99 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 112.658 -2.065 . . . . 0.0 113.826 -171.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.42 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -64.25 -40.91 97.0 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 2.5 tp -62.37 -45.89 91.12 Favored 'General case' 0 N--CA 1.382 -3.832 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.181 -176.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.695 ' HB2' ' HB2' ' B' ' 124' ' ' LEU . 2.0 ptm -72.14 -19.4 61.78 Favored 'General case' 0 C--O 1.205 -1.247 0 O-C-N 121.638 -0.664 . . . . 0.0 112.603 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 116' ' ' ASN . 59.0 mt -77.54 -53.72 13.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 173.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 9.9 t -55.37 -31.08 61.47 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.62 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.619 HD22 HG21 ' A' ' 54' ' ' ILE . 46.0 mt -101.41 5.62 42.18 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.13 10.42 71.59 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 117.419 1.727 . . . . 0.0 117.419 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' B' ' 119' ' ' MET . 7.0 mp -74.33 -44.11 53.86 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 120.402 2.101 . . . . 0.0 108.277 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 51.99 129.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 126.716 2.007 . . . . 0.0 116.328 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.81 80.35 9.17 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.867 0.841 . . . . 0.0 110.64 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.87 -0.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.284 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 65.9 132.12 0.02 OUTLIER 'General case' 0 C--O 1.24 0.56 0 C-N-CA 126.183 1.793 . . . . 0.0 112.695 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -70.21 -44.15 69.21 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 56.72 78.49 0.21 Allowed 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 113.37 -1.741 . . . . 0.0 109.946 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -80.15 87.62 5.48 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.439 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 . . . . . 0 C--N 1.308 -1.196 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.365 177.822 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.743 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 p -67.21 -53.08 33.55 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.12 0.486 . . . . 0.0 110.146 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.5 m -85.93 91.0 8.24 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -72.6 106.26 4.57 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.881 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.0 m80 56.06 37.44 28.85 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.948 0.899 . . . . 0.0 111.374 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -84.29 -56.48 3.62 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -88.58 -50.06 6.51 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.585 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.23 74.24 4.61 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 122.148 0.975 . . . . 0.0 111.593 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -103.38 -75.59 0.61 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.375 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.4 p -98.2 -35.25 10.43 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.677 0.751 . . . . 0.0 109.124 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -117.98 107.05 13.58 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.486 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -77.04 139.61 65.62 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.29 99.06 0.16 Allowed 'Trans proline' 0 C--O 1.254 1.306 0 C-N-CA 121.926 1.75 . . . . 0.0 112.029 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.7 mt -79.98 128.27 38.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.25 -176.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -114.97 153.87 29.8 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.523 ' HG2' ' SD ' ' A' ' 111' ' ' MET . 43.5 ttt180 -73.02 114.0 10.69 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.58 -7.54 10.35 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.478 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -81.31 172.34 13.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.153 0.978 . . . . 0.0 109.305 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.509 HG11 HG22 ' A' ' 104' ' ' THR . 19.6 t -133.07 135.14 57.25 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.129 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.457 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.1 m-85 -134.84 148.7 50.21 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -81.33 151.59 27.94 Favored 'General case' 0 N--CA 1.401 -2.906 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.455 171.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -129.74 133.91 47.3 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.038 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.631 ' HA ' ' HB ' ' A' ' 35' ' ' VAL 0.293 2.3 p-10 -88.47 99.71 12.49 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 117.875 -1.53 . . . . 0.0 111.282 178.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 4.5 mm? -84.84 40.22 0.79 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.788 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.539 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.292 2.7 m -67.74 170.22 7.64 Favored Pre-proline 0 C--N 1.261 -3.266 0 C-N-CA 127.835 2.454 . . . . 0.0 107.798 170.278 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.1 OUTLIER 2.23 53.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.408 3.688 1 C-N-CA 127.38 5.387 . . . . 0.0 118.051 -173.397 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.17 178.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.459 172.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -104.14 116.36 32.06 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -175.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.55 -117.69 11.71 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.297 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -94.48 19.57 9.52 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 160.41 30.09 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 173.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.605 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -75.57 119.26 19.39 Favored 'General case' 0 C--O 1.192 -1.967 0 CA-C-O 120.613 0.244 . . . . 0.0 110.705 -172.01 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -90.69 146.17 18.32 Favored Glycine 0 CA--C 1.474 -2.529 0 CA-C-O 121.636 0.576 . . . . 0.0 113.736 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 104.9 136.87 8.87 Favored Glycine 0 N--CA 1.421 -2.338 0 CA-C-N 113.511 -1.345 . . . . 0.0 111.343 176.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 1.3 p -67.76 120.01 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 CA-C-O 122.694 1.235 . . . . 0.0 110.324 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -139.68 156.77 70.95 Favored Pre-proline 0 C--N 1.266 -3.036 0 CA-C-N 112.814 -1.994 . . . . 0.0 110.434 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.609 ' HB2' HD12 ' A' ' 58' ' ' ILE . 34.5 Cg_exo -65.81 143.95 75.54 Favored 'Trans proline' 0 CA--C 1.555 1.531 0 C-N-CA 122.776 2.318 . . . . 0.0 112.216 172.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 20' ' ' TYR . 28.7 m -127.22 158.66 38.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.867 0.867 . . . . 0.0 109.218 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.71 134.76 45.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 O-C-N 123.154 0.284 . . . . 0.0 110.699 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 mm -82.12 96.94 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.423 HD13 ' C ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.43 -26.01 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.45 -178.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.521 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 4.5 pt20 -61.63 168.77 2.73 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 117.036 2.236 . . . . 0.0 117.036 -171.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -64.33 170.05 4.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 113.488 -1.687 . . . . 0.0 111.771 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.45 ' HA ' ' ND2' ' A' ' 47' ' ' ASN . 17.8 m-20 -81.07 -28.74 35.19 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 m -76.75 -34.93 58.03 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 122.197 -0.315 . . . . 0.0 110.607 -172.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.39 -25.68 74.64 Favored Glycine 0 C--O 1.21 -1.398 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.671 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.45 ' ND2' ' HA ' ' A' ' 44' ' ' ASP . 91.5 m-20 -63.1 -31.75 72.96 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.541 0.686 . . . . 0.0 109.983 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.505 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 20.0 mmmt -92.29 -64.21 1.14 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.947 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 54.9 m-85 -78.47 -36.19 45.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -167.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.531 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 58.9 m -93.63 133.21 28.44 Favored Pre-proline 0 N--CA 1.416 -2.13 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.363 -173.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -69.75 -21.52 33.41 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.631 1.554 . . . . 0.0 109.117 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 6.9 p -89.78 133.44 34.7 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.066 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.521 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 85.5 t -121.07 140.81 44.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.438 HG23 ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -113.01 124.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 122.213 1.006 . . . . 0.0 109.911 175.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.454 HG13 HG12 ' A' ' 53' ' ' VAL . 24.5 m -133.59 173.03 15.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.989 -173.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.515 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -124.94 146.38 49.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.72 131.23 41.38 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 37' ' ' PRO . 64.8 mt -90.07 124.66 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 113.891 -1.504 . . . . 0.0 107.356 172.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.673 ' HB ' HG23 ' A' ' 85' ' ' VAL . 64.7 m -123.07 154.24 38.82 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.23 7.86 14.26 Favored Glycine 0 N--CA 1.464 0.543 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.113 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.476 ' H ' HG22 ' A' ' 59' ' ' THR . 23.0 mmt180 -137.87 179.65 6.3 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 55.3 mt 69.39 25.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 124.112 1.911 . . . . 0.0 106.081 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.401 ' HA ' HG11 ' A' ' 85' ' ' VAL . 25.7 p-10 -79.66 85.91 5.33 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 112.965 -1.925 . . . . 0.0 111.763 -175.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -161.65 47.42 0.19 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.13 82.66 7.62 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.411 -1.268 . . . . 0.0 112.811 -169.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -113.84 1.5 14.81 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.243 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.557 HD12 ' H ' ' A' ' 67' ' ' ILE . 1.9 mp -96.66 138.51 21.41 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.592 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 64.7 Cg_endo -71.56 35.79 0.29 Allowed 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 121.68 1.586 . . . . 0.0 113.906 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.9 p -124.02 -19.05 5.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.032 0.92 . . . . 0.0 108.576 171.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -124.24 129.91 51.61 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.3 p -125.88 136.35 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.457 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.99 135.54 45.3 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.744 0.783 . . . . 0.0 111.898 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.679 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -120.3 155.39 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.334 0 CA-C-N 113.877 -1.511 . . . . 0.0 112.646 -173.183 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -67.83 112.36 4.84 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 125.38 1.472 . . . . 0.0 108.871 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -44.06 -50.77 8.3 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.694 1.598 . . . . 0.0 112.68 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -66.18 -23.65 66.5 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 124.944 1.298 . . . . 0.0 114.398 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -84.86 -31.42 23.78 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.148 0.975 . . . . 0.0 109.496 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.679 ' CE1' HG21 ' A' ' 73' ' ' ILE . 4.2 m-85 -90.42 -8.22 51.13 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.631 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 62.15 25.7 15.4 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.866 1.267 . . . . 0.0 112.599 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 7.4 mp -85.07 172.52 11.2 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-O 122.992 1.377 . . . . 0.0 113.828 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.97 -23.97 61.52 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 111.518 -2.583 . . . . 0.0 110.651 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -152.31 160.03 43.39 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.377 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -56.04 136.36 52.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 123.993 0.808 . . . . 0.0 110.991 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 m -103.28 135.03 45.67 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.376 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.673 HG23 ' HB ' ' A' ' 59' ' ' THR . 1.1 m -116.84 131.62 68.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.572 ' CD1' HG12 ' A' ' 58' ' ' ILE . 23.1 mm -107.37 127.46 63.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 90' ' ' GLN . 22.7 mt -103.69 109.82 21.67 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.565 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -87.84 8.18 27.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.275 -172.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -110.27 -35.82 5.98 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 122.122 0.963 . . . . 0.0 108.502 172.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 5.8 tp60 -87.22 64.33 8.28 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.181 -1.372 . . . . 0.0 107.747 175.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.515 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -108.23 -176.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.418 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.605 ' NH2' ' HB3' ' A' ' 32' ' ' GLN . 8.2 ptp85 -164.98 163.89 20.7 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 52.3 m -122.5 116.39 23.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.3 mt -131.83 141.52 49.46 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.328 1.051 . . . . 0.0 109.412 -170.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.7 p30 -71.12 152.05 43.84 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.109 174.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 50' ' ' SER . 94.7 mttt -44.74 -26.03 0.35 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 126.245 1.818 . . . . 0.0 114.798 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -86.97 -14.6 41.26 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -81.59 -27.66 34.14 Favored 'General case' 0 N--CA 1.395 -3.188 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.34 117.89 15.63 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 169.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -89.35 -58.85 2.38 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.0 pt-20 -151.35 133.54 15.25 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 121.845 0.831 . . . . 0.0 112.6 -170.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -60.57 115.74 3.83 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 127.485 2.314 . . . . 0.0 107.61 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -111.71 -62.77 1.51 Allowed 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.664 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.509 HG22 HG11 ' A' ' 19' ' ' VAL . 3.5 t -129.63 -163.61 1.32 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.486 -1.285 . . . . 0.0 111.794 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -160.98 147.02 14.67 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 123.976 0.91 . . . . 0.0 111.028 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -114.68 161.69 17.78 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.615 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 p -82.97 151.64 25.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 111' ' ' MET . 25.5 t70 -59.16 -36.41 75.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.09 -23.04 59.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.46 0.648 . . . . 0.0 110.82 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.625 ' HD3' ' CG2' ' A' ' 73' ' ' ILE . 15.8 ttmm -85.94 -24.58 26.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.751 0.786 . . . . 0.0 109.578 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.566 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -53.73 -33.89 57.1 Favored 'General case' 0 N--CA 1.422 -1.841 0 C-N-CA 124.462 1.105 . . . . 0.0 109.818 170.406 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.599 ' N ' ' HE2' ' A' ' 112' ' ' LYS . 7.1 mmpt? -69.78 -23.3 63.33 Favored 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.398 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -84.32 -31.25 24.95 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -173.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.421 HG13 HD11 ' A' ' 88' ' ' LEU . 1.6 t -67.15 -40.29 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.267 173.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.569 ' HB3' ' CE1' ' B' ' 129' ' ' HIS . 31.4 m-20 -63.07 -31.31 72.42 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.742 1.258 . . . . 0.0 110.607 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.71 ' O ' HD13 ' A' ' 120' ' ' ILE . 10.3 m-80 -80.06 -9.02 59.67 Favored 'General case' 1 N--CA 1.569 5.487 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.514 -176.627 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 68' ' ' PRO 0.275 . . -99.57 -49.0 4.55 Favored 'General case' 2 N--CA 1.344 -5.732 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 175.573 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 4.2 tp -67.61 -45.65 74.83 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.524 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 3.6 ttp -66.1 -22.48 66.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.653 0.781 . . . . 0.0 109.92 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -88.18 -51.56 12.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 t -54.15 -27.6 34.62 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 126.607 1.963 . . . . 0.0 111.926 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 56.0 mt -102.23 7.11 40.87 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.594 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.54 1.66 85.5 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 124' ' ' LEU . 3.2 mp -65.96 -52.46 49.44 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.81 1.305 . . . . 0.0 109.217 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.7 m120 56.39 -174.1 0.06 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.789 -1.55 . . . . 0.0 113.353 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.04 34.88 0.62 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.142 0.972 . . . . 0.0 110.525 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 63.8 t -83.01 -16.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.298 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 67.31 152.1 0.08 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.09 -1.868 . . . . 0.0 112.54 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.565 ' HE1' ' HB3' ' B' ' 115' ' ' ASP . 64.0 m-70 -79.9 -38.88 31.61 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.811 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -112.73 87.31 2.55 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.382 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -86.89 107.66 18.45 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.658 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.5 m120 . . . . . 0 C--N 1.293 -1.862 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.951 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.544 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p -66.33 -48.68 69.51 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.083 0.468 . . . . 0.0 109.872 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 26.0 m -90.05 80.33 6.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -59.37 104.96 0.3 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.55 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.411 ' O ' ' HB2' ' B' ' 9' ' ' HIS . 34.4 m80 58.12 28.97 17.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.449 1.099 . . . . 0.0 112.085 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -73.01 -53.51 10.97 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -90.11 -56.87 3.05 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.772 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -82.69 79.84 8.98 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.342 1.067 . . . . 0.0 111.008 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' B' ' 5' ' ' HIS . 20.4 t-80 -113.3 -76.51 0.59 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.961 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 9.5 p -94.02 -33.87 13.24 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.471 0.653 . . . . 0.0 109.776 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -121.66 107.58 12.53 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.194 177.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -76.66 135.59 68.13 Favored Pre-proline 0 C--N 1.295 -1.797 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.13 99.41 0.08 OUTLIER 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 122.036 1.824 . . . . 0.0 111.766 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt -82.61 130.57 35.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.358 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -117.85 149.39 40.93 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.542 ' HG2' ' SD ' ' B' ' 111' ' ' MET . 42.7 ttt180 -68.38 114.23 6.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.52 1.6 19.86 Favored Glycine 0 N--CA 1.43 -1.7 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.377 -176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -90.97 173.96 7.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.482 HG11 HG22 ' B' ' 104' ' ' THR . 22.3 t -134.18 134.34 55.29 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.096 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.55 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 28.9 m-85 -133.93 148.72 51.23 Favored 'General case' 0 CA--C 1.475 -1.912 0 C-N-CA 124.645 1.178 . . . . 0.0 107.924 177.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.548 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.4 mp -82.39 150.59 27.05 Favored 'General case' 0 N--CA 1.401 -2.881 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.485 171.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.36 134.38 48.84 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.124 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.608 ' HA ' ' HB ' ' B' ' 35' ' ' VAL 0.277 3.6 p-10 -90.27 99.13 12.2 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.693 -1.603 . . . . 0.0 111.314 178.646 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.631 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 4.2 mm? -83.09 40.44 0.7 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.54 -1.663 . . . . 0.0 111.679 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.48 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.272 5.6 m -66.55 166.66 16.64 Favored Pre-proline 0 C--N 1.269 -2.93 0 C-N-CA 127.528 2.331 . . . . 0.0 108.299 170.697 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 1.1 Cg_exo 5.66 53.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.399 3.228 1 C-N-CA 127.439 5.426 . . . . 0.0 117.674 -176.012 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.16 177.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 113.594 -1.639 . . . . 0.0 111.449 171.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -103.02 116.93 33.48 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.23 -176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.68 -121.19 19.16 Favored Glycine 0 CA--C 1.488 -1.631 0 CA-C-N 114.707 -1.133 . . . . 0.0 113.744 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.1 m -93.39 21.49 6.08 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.49 163.2 23.97 Favored 'General case' 0 C--O 1.256 1.443 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 172.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.612 ' HB3' HH22 ' B' ' 92' ' ' ARG . 0.8 OUTLIER -78.22 116.8 18.92 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 122.768 0.427 . . . . 0.0 109.989 -174.41 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -91.34 142.46 16.11 Favored Glycine 0 CA--C 1.465 -3.061 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.817 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 111.81 137.73 7.27 Favored Glycine 0 N--CA 1.422 -2.275 0 CA-C-N 114.299 -0.95 . . . . 0.0 111.219 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.608 ' HB ' ' HA ' ' B' ' 23' ' ' ASP . 0.8 OUTLIER -72.82 121.64 23.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-O 122.499 1.142 . . . . 0.0 109.292 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -139.74 156.32 71.01 Favored Pre-proline 0 C--N 1.262 -3.198 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.366 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.64 ' HB2' HD12 ' B' ' 58' ' ' ILE . 31.3 Cg_exo -65.6 143.93 76.84 Favored 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 122.725 2.283 . . . . 0.0 111.898 172.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.479 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.9 m -127.19 158.36 38.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 123.6 0.76 . . . . 0.0 109.185 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.89 134.34 45.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.514 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.89 97.03 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.416 HD13 ' C ' ' B' ' 41' ' ' ILE . 0.0 OUTLIER -93.81 -24.74 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.376 -178.449 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.534 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 4.1 pt20 -61.52 168.01 3.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 117.287 2.328 . . . . 0.0 117.287 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -62.54 169.57 2.94 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.971 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.06 -28.82 32.2 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -75.95 -38.01 58.03 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 122.293 -0.254 . . . . 0.0 110.539 -172.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.18 -28.55 73.68 Favored Glycine 0 C--O 1.212 -1.244 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -59.18 -34.15 71.79 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.779 0.8 . . . . 0.0 110.26 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.517 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 19.8 mmmt -92.01 -61.23 1.67 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.298 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 60.3 m-85 -80.44 -35.66 34.7 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -167.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.478 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 19.6 m -94.32 134.5 25.53 Favored Pre-proline 0 C--N 1.292 -1.921 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.587 -174.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.91 -20.08 29.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.931 1.754 . . . . 0.0 109.736 173.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 3.0 p -92.61 136.04 33.57 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.107 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.534 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 93.3 t -121.34 140.53 45.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -112.01 123.97 68.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-O 122.153 0.978 . . . . 0.0 109.705 175.698 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.479 HG13 HG12 ' B' ' 53' ' ' VAL . 27.7 m -133.07 172.8 15.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.957 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.52 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -124.58 146.04 49.27 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.3 131.36 41.84 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' B' ' 37' ' ' PRO . 60.8 mt -89.84 125.76 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' THR . . . . . 0.713 ' HB ' HG23 ' B' ' 85' ' ' VAL . 41.2 m -123.55 149.58 45.09 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.81 12.75 22.6 Favored Glycine 0 N--CA 1.466 0.672 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.578 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.469 ' H ' HG22 ' B' ' 59' ' ' THR . 29.0 mmt180 -143.51 -179.92 6.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' B' ' 61' ' ' ARG . 68.5 mt 70.06 24.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 123.895 1.807 . . . . 0.0 106.559 -174.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ASN . . . . . 0.422 ' HA ' HG11 ' B' ' 85' ' ' VAL . 27.4 p-10 -79.12 91.25 4.9 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.865 -175.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -163.59 45.08 0.12 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.74 83.14 7.79 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.737 -170.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -115.88 3.87 13.8 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.028 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.484 ' H ' HD12 ' B' ' 67' ' ' ILE . 2.5 mp -100.8 136.16 19.89 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' PRO . . . . . 0.451 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 59.1 Cg_endo -69.82 37.1 0.24 Allowed 'Trans proline' 0 CA--C 1.553 1.464 0 C-N-CA 122.16 1.907 . . . . 0.0 113.877 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 59.4 p -127.03 -19.11 4.46 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -123.49 129.94 51.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.68 136.25 61.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.171 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.13 139.82 37.24 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-O 121.294 0.569 . . . . 0.0 111.603 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.657 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -125.59 155.1 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.499 -174.087 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -66.74 114.78 5.9 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.033 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -45.62 -53.89 8.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.327 1.451 . . . . 0.0 112.163 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -61.45 -27.26 68.44 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -82.3 -34.25 28.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.705 0.764 . . . . 0.0 109.734 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.657 ' CE1' HG21 ' B' ' 73' ' ' ILE . 4.1 m-85 -86.92 -7.96 57.69 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.647 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 65.22 23.14 12.22 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.982 1.313 . . . . 0.0 112.66 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.04 173.77 10.24 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 123.018 1.39 . . . . 0.0 114.051 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.74 -23.21 56.0 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 111.917 -2.401 . . . . 0.0 110.56 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -149.06 159.59 44.09 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.3 138.16 57.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 123.74 0.65 . . . . 0.0 110.464 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 11.3 m -103.11 134.2 46.93 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.079 -167.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.713 HG23 ' HB ' ' B' ' 59' ' ' THR . 1.1 m -116.64 131.99 67.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.565 ' CD1' HG12 ' B' ' 58' ' ' ILE . 23.6 mm -107.42 127.74 63.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 175.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 24.0 mt -103.06 109.22 20.7 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.5 mm? -88.83 7.7 32.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.71 0.767 . . . . 0.0 112.179 -172.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -108.76 -34.43 6.68 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-O 122.359 1.076 . . . . 0.0 108.542 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLN . . . . . 0.447 HE22 HH22 ' B' ' 92' ' ' ARG . 0.1 OUTLIER -92.79 72.85 4.91 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.795 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.52 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.3 pp -114.74 -175.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.712 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.612 HH22 ' HB3' ' B' ' 32' ' ' GLN . 8.5 ptp85 -164.91 164.67 20.74 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 53.5 m -122.58 115.52 22.3 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 68.4 mt -131.81 141.18 49.38 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.396 1.078 . . . . 0.0 109.344 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 3.5 p-10 -72.16 152.68 42.12 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.301 174.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.478 ' HE3' ' O ' ' B' ' 50' ' ' SER . 93.3 mttt -46.65 -21.21 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.199 1.8 . . . . 0.0 115.145 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -89.0 -18.31 27.63 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -79.69 -27.34 40.73 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.71 120.53 19.43 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -91.87 -57.72 2.64 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 12.8 pt-20 -151.29 134.7 16.15 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.93 0.871 . . . . 0.0 112.728 -170.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -62.02 113.38 2.79 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 127.647 2.379 . . . . 0.0 108.8 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -109.81 -62.08 1.55 Allowed 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.769 -176.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.482 HG22 HG11 ' B' ' 19' ' ' VAL . 2.0 t -131.18 -164.48 1.44 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.45 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -161.05 145.01 13.37 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 123.838 0.855 . . . . 0.0 111.558 -171.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.78 162.37 16.39 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.542 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.8 p -83.18 149.56 26.77 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.151 0.58 . . . . 0.0 112.105 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' B' ' 111' ' ' MET . 26.9 t70 -59.55 -32.71 70.58 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.875 0.87 . . . . 0.0 113.129 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -76.81 -25.36 53.21 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.196 0.522 . . . . 0.0 110.596 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.579 ' HD3' ' CG2' ' B' ' 73' ' ' ILE . 15.8 ttmm -85.08 -24.62 28.02 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.877 0.846 . . . . 0.0 109.207 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.542 ' SD ' ' HG2' ' B' ' 16' ' ' ARG . 0.1 OUTLIER -52.92 -34.38 54.86 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 124.708 1.203 . . . . 0.0 109.983 169.694 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.574 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 7.1 mmpt? -69.78 -24.05 63.45 Favored 'General case' 0 N--CA 1.402 -2.866 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.25 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -85.21 -32.49 22.61 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 114' ' ' VAL . . . . . 0.44 HG13 HD11 ' B' ' 88' ' ' LEU . 1.8 t -63.53 -42.15 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.48 0 CA-C-N 112.692 -2.049 . . . . 0.0 109.934 171.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.565 ' HB3' ' HE1' ' A' ' 129' ' ' HIS . 42.8 m-20 -60.31 -40.88 92.12 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 122.035 0.921 . . . . 0.0 109.87 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.748 ' O ' HD13 ' B' ' 120' ' ' ILE . 3.1 m120 -64.29 -21.56 66.64 Favored 'General case' 0 N--CA 1.52 3.063 0 C-N-CA 125.362 1.465 . . . . 0.0 112.604 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.556 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -84.48 -53.03 5.71 Favored 'General case' 2 C--N 1.23 -4.605 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.787 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 4.1 tp -65.41 -46.76 78.73 Favored 'General case' 0 N--CA 1.4 -2.955 0 C-N-CA 124.494 1.117 . . . . 0.0 113.978 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.481 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 3.6 ttp -66.98 -24.85 66.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 123.644 0.778 . . . . 0.0 109.999 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.748 HD13 ' O ' ' B' ' 116' ' ' ASN . 2.5 mp -88.52 -45.83 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.0 t -55.18 -29.85 58.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.928 1.291 . . . . 0.0 111.359 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 58.4 mt -99.96 7.43 44.81 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 120.201 -0.599 . . . . 0.0 112.149 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.41 1.06 89.44 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 116.215 1.246 . . . . 0.0 116.215 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.578 ' H ' HD12 ' B' ' 124' ' ' LEU . 3.4 mp -64.96 -51.08 63.73 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 118.832 1.316 . . . . 0.0 109.302 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 56.49 -169.27 0.09 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.513 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.81 29.49 1.17 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.573 0.701 . . . . 0.0 111.056 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.52 -19.93 14.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.496 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 71.01 157.71 0.18 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 126.529 1.932 . . . . 0.0 113.466 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.569 ' CE1' ' HB3' ' A' ' 115' ' ' ASP . 46.0 m-70 -92.94 1.1 57.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.137 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -150.77 92.97 1.89 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -96.93 97.1 8.99 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.309 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.3 m120 . . . . . 0 C--N 1.294 -1.81 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.687 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.734 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 m -93.03 88.13 6.01 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.9 t -81.12 -32.84 33.61 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -118.35 125.85 50.89 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.492 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -97.41 108.87 21.69 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -67.14 129.83 41.16 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.389 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -89.94 -175.41 4.58 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.505 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 63.46 31.71 14.8 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.672 1.225 . . . . 0.0 108.903 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -69.75 -39.47 76.71 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.6 m -81.27 89.38 6.05 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 113.764 -1.562 . . . . 0.0 106.864 171.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.464 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 97.6 mt-30 -59.05 125.21 22.67 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.132 -176.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -84.68 103.01 2.62 Favored Pre-proline 0 C--N 1.319 -0.726 0 C-N-CA 124.65 1.18 . . . . 0.0 108.646 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 11' ' ' GLN . 4.6 Cg_exo -77.06 -53.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.762 2.308 . . . . 0.0 110.341 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.9 mt -84.77 108.9 17.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 172.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.454 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 35.6 ptt180 -125.5 158.42 34.53 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -173.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.59 132.49 39.5 Favored 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.81 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.17 -6.17 56.14 Favored Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.165 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.454 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 5.6 t70 -97.12 178.08 5.37 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 4.1 t -135.57 130.61 50.29 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 CA-C-O 121.491 0.662 . . . . 0.0 112.075 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 39.9 m-85 -130.49 145.53 51.87 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.316 176.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -80.31 149.83 30.17 Favored 'General case' 0 N--CA 1.395 -3.189 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 170.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.62 141.68 37.09 Favored 'General case' 0 C--N 1.257 -3.45 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.622 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.29 84.06 6.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.536 ' O ' HG13 ' A' ' 27' ' ' VAL . 91.6 mt -65.53 -27.81 68.72 Favored 'General case' 0 CA--C 1.468 -2.176 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.251 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.514 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 2.1 m -33.82 176.0 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.164 0 C-N-CA 128.375 2.67 . . . . 0.0 114.599 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.585 ' HB2' ' NE2' ' B' ' 28' ' ' GLN . 0.1 OUTLIER 22.92 51.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.108 0 C-N-CA 123.108 2.538 . . . . 0.0 115.554 -152.615 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 14.9 m -72.02 -178.27 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.421 165.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.535 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 31.8 mm-40 -115.04 124.43 51.59 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.581 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.96 -109.1 1.67 Allowed Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 113.728 -1.578 . . . . 0.0 115.779 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -93.06 8.81 38.45 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.669 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 48.9 mt-10 -64.65 156.34 30.46 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 118.203 -1.399 . . . . 0.0 109.603 174.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.41 HE22 ' HG3' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -73.33 108.92 6.47 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -175.703 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.16 147.73 19.37 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 116.136 1.215 . . . . 0.0 116.136 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.48 157.19 12.38 Favored Glycine 0 N--CA 1.414 -2.83 0 CA-C-N 113.319 -1.44 . . . . 0.0 110.276 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -77.92 112.44 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 122.583 1.182 . . . . 0.0 108.283 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.41 ' HG3' HE22 ' A' ' 32' ' ' GLN . 17.5 mmt180 -134.16 158.73 74.62 Favored Pre-proline 0 C--N 1.259 -3.345 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.891 -172.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 36.0 Cg_exo -64.56 134.86 43.04 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.656 2.238 . . . . 0.0 110.984 173.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 20' ' ' TYR . 35.4 m -121.1 160.4 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 29.8 m -98.8 129.75 48.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -86.66 101.22 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.43 -20.71 5.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.636 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -55.02 158.54 2.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.232 1.413 . . . . 0.0 114.675 -170.668 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 172.28 4.89 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.322 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.21 -47.22 65.44 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.596 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -71.18 -34.17 70.67 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.919 -169.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.31 75.53 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.805 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -63.54 -35.17 79.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.187 0.517 . . . . 0.0 110.231 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -87.17 -53.39 4.88 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.301 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -96.64 -10.43 27.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -167.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.1 t -113.26 143.3 28.99 Favored Pre-proline 0 C--N 1.294 -1.83 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.191 -177.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 33.6 Cg_endo -71.39 -27.62 19.07 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.734 1.623 . . . . 0.0 109.892 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 p -97.18 142.8 28.65 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.117 -175.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.48 141.02 36.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.758 HG21 HD22 ' B' ' 122' ' ' LEU . 12.1 tt -82.02 133.79 28.44 Favored 'Isoleucine or valine' 0 C--O 1.257 1.451 0 CA-C-O 121.512 0.673 . . . . 0.0 110.739 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -136.27 155.49 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.283 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.525 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -121.01 141.13 51.02 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.06 129.8 38.56 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.51 HD12 ' HB2' ' A' ' 37' ' ' PRO . 57.7 mt -86.38 115.41 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 173.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.3 m -101.24 104.95 16.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.488 0.661 . . . . 0.0 110.903 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.63 49.87 0.86 Allowed Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -153.52 8.31 0.38 Allowed 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 122.895 0.478 . . . . 0.0 110.545 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.0 mt -146.23 157.2 11.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 -177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -144.19 -173.97 4.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.7 tttt 78.42 103.54 0.07 Allowed 'General case' 0 C--O 1.246 0.914 0 O-C-N 124.337 1.023 . . . . 0.0 111.287 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.537 ' HB2' ' HG3' ' A' ' 72' ' ' GLU . . . -92.14 -95.31 0.14 Allowed 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.003 172.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 60.28 22.52 11.96 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.63 0.729 . . . . 0.0 111.122 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 65' ' ' ALA . 5.5 tt -160.16 136.36 6.29 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 9.3 Cg_endo -52.29 -34.07 58.23 Favored 'Trans proline' 0 C--O 1.208 -1.015 0 C-N-CA 122.832 2.355 . . . . 0.0 114.139 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 p -73.6 -18.96 60.99 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-N 118.238 0.472 . . . . 0.0 112.043 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -104.42 129.17 52.4 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 87.7 t -118.7 112.68 38.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.186 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.537 ' HG3' ' HB2' ' A' ' 65' ' ' ALA . 37.2 mt-10 -82.3 118.89 23.48 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.642 HD12 ' CD2' ' A' ' 78' ' ' TYR . 8.0 pt -101.74 133.27 45.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.268 -174.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.45 118.45 4.47 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.294 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.687 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 43.6 mttp -43.05 -48.6 6.15 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.653 1.216 . . . . 0.0 109.266 173.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -62.46 -29.13 70.3 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 112.781 -2.008 . . . . 0.0 113.28 -173.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -91.72 -29.03 17.05 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.489 0.661 . . . . 0.0 111.093 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.642 ' CD2' HD12 ' A' ' 73' ' ' ILE . 23.0 m-85 -95.84 9.58 40.04 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.256 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 tttm 61.63 27.84 17.17 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.385 1.088 . . . . 0.0 110.148 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.31 176.47 5.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.936 0.874 . . . . 0.0 109.915 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -102.79 -8.63 20.65 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.875 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.503 ' C ' ' HG2' ' A' ' 75' ' ' LYS . 9.9 ptpp? -144.1 143.56 31.19 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.687 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 34.0 m-20 -70.63 120.1 15.75 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.499 ' HB3' HD11 ' A' ' 73' ' ' ILE . 25.3 t -104.57 174.05 6.04 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -175.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 13.3 t -122.39 139.5 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.498 ' CD1' HG12 ' A' ' 58' ' ' ILE . 19.6 mm -104.16 127.41 58.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 172.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.5 mt -102.41 104.9 15.4 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.557 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 4.0 mm? -83.06 3.33 30.88 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.653 0.74 . . . . 0.0 112.195 -175.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -97.79 -36.23 10.28 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 122.25 1.024 . . . . 0.0 108.352 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.438 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 3.1 tp60 -94.92 76.5 3.58 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.851 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.525 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -125.78 175.88 7.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -165.06 173.59 11.32 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.3 m -118.47 121.73 41.0 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.609 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.49 ' HB3' ' HG3' ' A' ' 98' ' ' ARG . 77.0 mt -131.94 149.34 52.46 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.949 -173.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -57.55 143.64 40.17 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 170.17 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 19.0 pttm -53.8 -33.55 56.39 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.988 0.899 . . . . 0.0 112.565 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.494 ' HD3' ' HB3' ' A' ' 95' ' ' ASP . 28.9 mtpt -47.5 -31.38 4.23 Favored 'General case' 0 C--N 1.278 -2.542 0 C-N-CA 127.062 2.145 . . . . 0.0 113.436 170.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.49 ' HG3' ' HB3' ' A' ' 94' ' ' LEU . 2.4 mmp_? -69.57 -31.22 69.27 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.508 0.67 . . . . 0.0 110.323 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 7.2 mp -70.75 131.45 43.87 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.181 1.393 . . . . 0.0 110.712 175.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -99.97 -57.45 2.13 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.281 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 13.2 pt-20 -159.26 146.59 17.19 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-O 121.39 0.614 . . . . 0.0 111.377 -169.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 64.9 tttp -62.65 125.62 24.55 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 126.601 1.96 . . . . 0.0 110.559 173.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 tp -114.74 -61.75 1.7 Allowed 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.179 174.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.469 HG22 HG11 ' A' ' 19' ' ' VAL . 5.3 t -129.35 -159.84 0.99 Allowed 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.554 -1.259 . . . . 0.0 111.98 -177.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -161.05 142.29 11.7 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.258 1.423 . . . . 0.0 109.519 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -105.31 156.57 18.02 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 m -81.81 158.93 23.91 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.475 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.32 -32.33 71.13 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.866 1.267 . . . . 0.0 112.007 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 5.4 p-10 -66.91 -28.23 68.14 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.565 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -73.67 -28.76 61.93 Favored 'General case' 0 CA--C 1.483 -1.622 0 O-C-N 123.404 0.44 . . . . 0.0 111.443 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.42 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -53.06 -48.02 68.01 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-O 121.987 0.899 . . . . 0.0 108.847 174.117 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.42 ' HE2' ' C ' ' A' ' 111' ' ' MET . 9.0 mmpt? -79.46 -9.82 59.68 Favored 'General case' 0 N--CA 1.39 -3.444 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.655 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 109' ' ' ASP . 38.1 mt-10 -86.54 -43.73 12.49 Favored 'General case' 0 CA--C 1.471 -2.095 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 176.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.0 t -49.81 -47.17 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.037 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -53.87 -41.64 67.75 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.091 0.948 . . . . 0.0 111.262 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.658 ' O ' HD13 ' A' ' 120' ' ' ILE . 24.1 m-80 -80.41 -22.93 40.75 Favored 'General case' 0 CA--C 1.434 -3.502 0 CA-C-O 123.315 1.531 . . . . 0.0 110.21 -173.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 121' ' ' SER . . . -84.37 -37.65 21.27 Favored 'General case' 2 N--CA 1.342 -5.844 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.625 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.711 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -82.67 -55.35 4.49 Favored 'General case' 1 N--CA 1.372 -4.352 0 C-N-CA 123.124 0.57 . . . . 0.0 112.23 -175.159 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.3 mtp -56.85 -35.52 68.95 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -75.27 -45.33 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.445 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.613 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 7.7 t -62.05 -32.12 72.6 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.257 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.762 HD22 HG21 ' B' ' 54' ' ' ILE . 13.0 mt -101.17 1.51 39.18 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.434 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.5 16.24 80.54 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.3 mp -67.99 -52.15 39.05 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-N 119.413 1.606 . . . . 0.0 110.411 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 m120 45.35 115.25 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 O-C-N 125.654 1.846 . . . . 0.0 114.374 -174.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.69 88.08 0.35 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.179 -0.919 . . . . 0.0 113.332 -171.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.1 t -136.11 9.24 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.177 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.53 -56.47 2.4 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.157 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 46.9 t60 72.63 -17.68 0.38 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.156 1.383 . . . . 0.0 112.405 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -162.42 -172.74 3.28 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.577 ' HE2' ' HG2' ' B' ' 113' ' ' GLU . 28.1 tptp -64.82 126.44 27.96 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.905 0.86 . . . . 0.0 110.07 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.283 -2.305 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.102 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.5 m -87.42 82.74 7.45 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.244 0.545 . . . . 0.0 110.701 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -78.72 -29.45 45.36 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -121.38 121.74 38.29 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 175.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -93.47 114.25 26.59 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -76.27 125.36 29.04 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.464 0.478 . . . . 0.0 109.938 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -86.58 -174.65 5.1 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.528 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 64.76 30.86 12.18 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.302 1.049 . . . . 0.0 109.197 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -70.8 -37.8 73.31 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 44.7 m -82.16 90.27 6.56 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.489 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 97.8 mt-30 -54.46 129.02 34.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.465 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -91.49 103.24 7.2 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' B' ' 11' ' ' GLN . 3.7 Cg_exo -75.25 -53.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.657 2.238 . . . . 0.0 110.613 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 70.2 mt -83.31 101.66 8.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 172.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.42 ' HG3' ' HB2' ' B' ' 18' ' ' ASP . 34.9 ptt180 -119.79 157.55 28.38 Favored 'General case' 0 C--N 1.275 -2.666 0 O-C-N 123.828 0.705 . . . . 0.0 110.061 -172.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.27 125.81 29.92 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.846 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.28 -6.86 32.28 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.835 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' ASP . . . . . 0.454 ' CG ' ' HZ3' ' B' ' 102' ' ' LYS . 5.3 t70 -97.09 177.83 5.46 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 4.8 t -134.65 130.47 53.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-O 121.411 0.624 . . . . 0.0 112.039 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.467 ' O ' HG22 ' B' ' 38' ' ' VAL . 39.4 m-85 -130.12 145.17 51.68 Favored 'General case' 0 CA--C 1.472 -2.023 0 C-N-CA 124.993 1.317 . . . . 0.0 109.118 176.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.3 mp -79.28 151.75 30.94 Favored 'General case' 0 N--CA 1.395 -3.179 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 170.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.71 141.68 33.31 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.925 -176.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.8 83.96 6.43 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.537 ' O ' HG13 ' B' ' 27' ' ' VAL . 90.8 mt -64.92 -26.88 68.5 Favored 'General case' 0 CA--C 1.469 -2.162 0 CA-C-N 112.995 -1.911 . . . . 0.0 111.137 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 2.7 m -34.13 178.35 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.351 0 C-N-CA 128.709 2.804 . . . . 0.0 114.883 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.535 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 0.1 OUTLIER 22.44 50.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.676 0 C-N-CA 122.961 2.441 . . . . 0.0 115.277 -153.246 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 11.5 m -71.3 -178.95 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.612 166.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 26' ' ' PRO . 31.1 mm-40 -115.14 128.57 56.28 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.36 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.52 -108.97 0.9 Allowed Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.152 -1.385 . . . . 0.0 115.248 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 66.8 m -93.44 7.66 43.65 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.636 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 50.1 mt-10 -62.57 159.98 14.8 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 117.852 -1.539 . . . . 0.0 109.981 175.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.428 HE22 ' HG3' ' B' ' 36' ' ' ARG . 1.0 OUTLIER -75.61 110.23 9.84 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -176.025 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.04 146.93 18.62 Favored Glycine 0 CA--C 1.484 -1.879 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -174.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.85 157.54 11.69 Favored Glycine 0 N--CA 1.412 -2.9 0 CA-C-N 113.331 -1.435 . . . . 0.0 110.29 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -77.68 113.58 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 122.631 1.205 . . . . 0.0 107.78 175.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' ARG . . . . . 0.428 ' HG3' HE22 ' B' ' 32' ' ' GLN . 19.5 mmt180 -135.63 158.77 73.57 Favored Pre-proline 0 C--N 1.259 -3.369 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.121 -171.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.2 Cg_exo -64.62 134.24 40.21 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.59 2.193 . . . . 0.0 110.925 172.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.467 HG22 ' O ' ' B' ' 20' ' ' TYR . 35.0 m -120.92 160.11 22.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 32.8 m -98.78 130.09 48.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -87.14 100.6 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.08 -20.99 5.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.522 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.586 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -54.61 158.4 2.56 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -170.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.03 170.72 6.38 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.196 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.52 -44.81 70.27 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.443 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 18.7 m -72.17 -34.83 68.76 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 122.697 0.399 . . . . 0.0 111.658 -170.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.78 -30.38 76.84 Favored Glycine 0 C--O 1.219 -0.822 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.71 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -64.67 -27.23 68.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.952 0.406 . . . . 0.0 110.512 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.427 ' HB2' ' CD2' ' B' ' 49' ' ' TYR . 6.7 mmtt -93.17 -53.98 3.9 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' B' ' 48' ' ' LYS . 96.0 m-85 -100.77 1.2 40.05 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -166.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -121.16 142.05 34.22 Favored Pre-proline 0 C--N 1.292 -1.929 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.533 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 37.4 Cg_endo -71.61 -27.04 19.06 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.489 1.46 . . . . 0.0 109.539 174.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.0 146.7 24.4 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.064 -176.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.425 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.4 OUTLIER -143.05 140.49 27.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.762 HG21 HD22 ' A' ' 122' ' ' LEU . 12.4 tt -82.13 133.41 29.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.237 0 CA-C-O 121.375 0.607 . . . . 0.0 110.677 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 36.0 m -135.59 156.33 37.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.349 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.537 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -121.6 140.41 52.28 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.85 128.81 36.52 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' B' ' 37' ' ' PRO . 55.5 mt -86.09 117.05 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 173.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.2 m -102.4 105.16 15.7 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.217 0.532 . . . . 0.0 111.077 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.5 47.99 1.03 Allowed Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -153.6 12.43 0.46 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.279 0.561 . . . . 0.0 110.81 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 62.4 mt -149.06 153.22 11.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' B' ' 64' ' ' LYS . 6.3 m120 -141.81 -172.03 3.47 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' B' ' 63' ' ' ASN . 76.6 tttt 76.32 106.87 0.08 Allowed 'General case' 0 C--O 1.244 0.797 0 O-C-N 124.244 0.965 . . . . 0.0 110.774 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' B' ' 72' ' ' GLU . . . -93.38 -94.52 0.16 Allowed 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.63 25.73 14.69 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.912 0.885 . . . . 0.0 111.162 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.405 HG22 ' O ' ' B' ' 65' ' ' ALA . 5.8 tt -161.56 136.94 5.65 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 8.5 Cg_endo -52.71 -32.1 53.7 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 122.672 2.248 . . . . 0.0 114.375 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 32.4 p -73.8 -19.33 60.79 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.082 0.468 . . . . 0.0 112.038 -172.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -104.83 129.54 53.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 96.2 t -118.68 114.11 43.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.599 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' B' ' 65' ' ' ALA . 45.5 mt-10 -82.76 117.11 22.43 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 174.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.648 HD12 ' CD2' ' B' ' 78' ' ' TYR . 8.8 pt -101.43 132.95 46.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.18 -174.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.44 119.5 6.15 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.211 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' LYS . . . . . 0.672 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 39.9 mttp -43.19 -49.21 6.56 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.587 1.155 . . . . 0.0 109.059 173.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -61.57 -29.59 70.12 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.902 -1.954 . . . . 0.0 113.198 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' LYS . . . . . 0.408 ' HD2' ' HE2' ' B' ' 110' ' ' LYS . 94.7 mttt -91.71 -29.72 16.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.329 0.585 . . . . 0.0 111.076 -176.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.648 ' CD2' HD12 ' B' ' 73' ' ' ILE . 21.0 m-85 -95.9 7.99 44.85 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.035 -176.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 tttm 60.8 31.83 20.09 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 122.324 1.059 . . . . 0.0 109.972 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -111.86 176.29 5.08 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.495 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' B' ' 75' ' ' LYS . 7.3 p-10 -99.48 -9.83 22.89 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.914 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.488 ' C ' ' HG2' ' B' ' 75' ' ' LYS . 10.0 ptpp? -141.77 143.64 33.57 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.102 -174.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.672 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 27.3 m-20 -71.5 119.27 15.41 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 173.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.529 ' O ' HG12 ' B' ' 73' ' ' ILE . 23.3 t -105.25 173.28 6.37 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 13.4 t -120.43 139.94 46.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.479 HD12 HG12 ' B' ' 58' ' ' ILE . 19.1 mm -104.18 127.68 58.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 172.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 88.0 mt -103.23 105.95 16.36 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.6 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.9 mm? -83.33 -3.98 58.02 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.039 -176.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.52 -34.48 15.53 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.256 1.027 . . . . 0.0 108.778 174.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLN . . . . . 0.465 ' OE1' ' HA ' ' B' ' 31' ' ' GLU . 3.5 tp60 -97.02 76.71 2.7 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.168 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.537 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.3 pp -125.13 176.6 5.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -165.43 173.83 10.66 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 47.4 m -118.8 122.23 41.91 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 64.9 mt -131.92 150.37 52.17 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.894 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.505 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 0.7 OUTLIER -58.44 142.47 48.52 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 169.581 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' B' ' 99' ' ' LEU . 18.0 pttm -51.82 -36.26 47.34 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.7 0.762 . . . . 0.0 112.435 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.481 ' HD3' ' HB3' ' B' ' 95' ' ' ASP . 28.3 mtpt -44.42 -34.63 2.1 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 126.684 1.994 . . . . 0.0 113.637 171.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -67.43 -29.55 69.05 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.568 0.747 . . . . 0.0 110.71 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' B' ' 96' ' ' LYS . 7.5 mp -72.48 129.63 38.78 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 125.52 1.528 . . . . 0.0 110.611 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -95.95 -58.04 2.2 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.443 -1.253 . . . . 0.0 114.097 -175.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 16.1 pt-20 -161.06 147.18 14.63 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.535 0.683 . . . . 0.0 111.847 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 64.8 tttp -61.17 124.33 20.24 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 126.974 2.11 . . . . 0.0 110.609 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.7 tp -114.57 -61.45 1.75 Allowed 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.348 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.473 HG22 HG11 ' B' ' 19' ' ' VAL . 5.8 t -129.72 -158.25 0.88 Allowed 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 118.179 -1.409 . . . . 0.0 112.063 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -160.28 148.83 16.9 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 126.063 1.745 . . . . 0.0 109.038 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.427 ' HB3' ' CZ ' ' B' ' 78' ' ' TYR . 3.8 pp -112.4 154.77 25.28 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.8 m -80.6 161.13 24.87 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.374 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.67 -32.98 73.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.87 0.868 . . . . 0.0 112.522 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.541 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 5.4 p-10 -62.4 -32.02 72.79 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.408 ' HE2' ' HD2' ' B' ' 77' ' ' LYS . 2.8 mptp? -70.78 -28.85 64.97 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.433 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.1 OUTLIER -54.65 -47.78 73.11 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.275 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.433 ' HE2' ' C ' ' B' ' 111' ' ' MET . 9.0 mmpt? -78.38 -12.27 59.99 Favored 'General case' 0 N--CA 1.389 -3.496 0 CA-C-N 114.508 -1.224 . . . . 0.0 113.754 -177.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 113' ' ' GLU . . . . . 0.577 ' HG2' ' HE2' ' A' ' 131' ' ' LYS . 44.3 mt-10 -85.85 -41.64 14.83 Favored 'General case' 0 CA--C 1.47 -2.1 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 177.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 t -51.6 -47.02 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-N 112.911 -1.949 . . . . 0.0 110.731 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -53.04 -48.83 67.34 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.688 0.756 . . . . 0.0 110.276 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.702 ' O ' HD13 ' B' ' 120' ' ' ILE . 10.3 m-80 -69.82 -24.3 63.45 Favored 'General case' 0 N--CA 1.512 2.643 0 C-N-CA 125.004 1.322 . . . . 0.0 112.184 -176.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.6 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -83.41 -44.38 14.86 Favored 'General case' 2 C--N 1.231 -4.546 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.035 177.917 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.732 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.0 OUTLIER -73.51 -55.72 5.97 Favored 'General case' 1 N--CA 1.374 -4.269 0 C-N-CA 123.349 0.66 . . . . 0.0 112.162 -173.634 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 38.8 mtp -56.88 -37.88 71.97 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.702 HD13 ' O ' ' B' ' 116' ' ' ASN . 1.5 mp -77.06 -39.84 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 60.7 m -58.54 -35.87 72.97 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.625 0.726 . . . . 0.0 110.818 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.758 HD22 HG21 ' A' ' 54' ' ' ILE . 11.0 mt -101.17 -0.01 36.81 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.706 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.85 17.72 79.56 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 115.81 1.084 . . . . 0.0 115.81 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.43 -54.35 21.05 Favored 'General case' 0 CA--C 1.479 -1.753 0 CA-C-N 119.111 1.455 . . . . 0.0 110.021 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 m120 49.57 118.82 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.575 -1.648 . . . . 0.0 113.937 -173.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.6 86.29 2.11 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.749 0.785 . . . . 0.0 112.783 -172.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.3 t -132.75 6.11 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 113.888 -1.505 . . . . 0.0 107.106 173.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.72 -59.96 1.85 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.783 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 36.0 t60 71.65 -12.8 0.61 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.919 1.287 . . . . 0.0 112.133 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -161.26 -175.04 4.61 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -70.43 120.7 16.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.444 0.64 . . . . 0.0 109.83 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.3 -1.547 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.663 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.573 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -92.44 -67.71 0.84 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.2 p -109.19 -3.64 17.13 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.53 0.681 . . . . 0.0 109.788 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -116.04 115.63 26.45 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -130.0 123.12 29.82 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -81.33 107.18 13.9 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -83.42 96.94 8.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.864 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.27 153.68 27.88 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.404 ' H ' ' CD2' ' A' ' 9' ' ' HIS . 1.7 p80 -87.44 98.25 11.27 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 174.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.4 m -66.84 -26.02 66.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.346 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -150.82 136.32 17.92 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 120.844 0.354 . . . . 0.0 110.908 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.502 ' HB2' ' NH1' ' A' ' 15' ' ' ARG . 39.6 m-20 -109.43 142.71 26.25 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 173.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.22 -31.53 93.17 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 122.673 2.249 . . . . 0.0 113.922 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 55.8 mt -107.18 116.39 50.73 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.364 -173.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.502 ' NH1' ' HB2' ' A' ' 12' ' ' ASP . 32.2 mmt180 -121.45 153.55 37.73 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.456 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -75.43 139.67 42.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.799 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.13 -11.19 51.8 Favored Glycine 0 C--N 1.306 -1.101 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.007 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -97.31 173.46 7.2 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 4.6 t -130.68 130.55 64.72 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 C-N-CA 123.21 0.604 . . . . 0.0 111.763 -175.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 85.4 m-85 -127.03 143.95 51.15 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.907 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -75.16 147.56 40.36 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 169.083 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -135.86 129.42 32.32 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.706 -1.588 . . . . 0.0 107.635 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 10.1 t70 -84.99 91.08 7.98 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.351 174.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.582 HD22 ' O ' ' A' ' 24' ' ' LEU 0.432 0.0 OUTLIER -114.82 62.1 0.68 Allowed 'General case' 0 N--CA 1.385 -3.699 0 CA-C-O 124.203 1.954 . . . . 0.0 111.999 175.788 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.435 ' OG ' ' HA2' ' A' ' 34' ' ' GLY . 1.4 m -107.04 60.39 0.2 Allowed Pre-proline 0 C--N 1.266 -3.03 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.554 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.473 ' HB3' HE22 ' B' ' 28' ' ' GLN . 22.7 Cg_endo -115.27 23.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.276 0 N-CA-C 108.456 -1.402 . . . . 0.0 108.456 158.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.623 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 20.1 m -88.65 158.13 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -172.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -155.74 160.57 40.42 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 113.005 -1.907 . . . . 0.0 107.049 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.51 -142.82 17.47 Favored Glycine 0 C--N 1.297 -1.624 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.411 ' HB2' ' CB ' ' B' ' 95' ' ' ASP . 22.3 m -94.46 15.33 18.06 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 117.053 0.427 . . . . 0.0 110.99 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.623 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 46.3 mt-10 -70.33 157.62 37.4 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -134.99 112.87 10.95 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.494 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -145.0 -109.86 0.66 Allowed Glycine 0 N--CA 1.411 -2.975 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.545 176.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 82.95 178.11 52.24 Favored Glycine 0 N--CA 1.4 -3.76 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -172.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 23' ' ' ASP . 1.4 p -87.45 99.36 8.47 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-O 123.556 1.646 . . . . 0.0 107.44 173.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -140.9 153.03 67.03 Favored Pre-proline 0 C--N 1.268 -2.944 0 CA-C-N 111.724 -2.489 . . . . 0.0 109.01 -168.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.58 ' HB2' HD12 ' A' ' 58' ' ' ILE . 33.5 Cg_exo -60.88 141.09 93.65 Favored 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 122.623 2.216 . . . . 0.0 112.9 175.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 20' ' ' TYR . 27.4 m -126.15 157.87 36.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 34.6 m -100.1 129.86 50.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.9 mm -88.73 98.06 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -18.86 6.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.533 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.69 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 1.2 tt0 -51.26 152.78 2.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -173.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -43.11 146.28 0.44 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.556 2.343 . . . . 0.0 113.23 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -66.26 -37.53 85.69 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.544 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 m -87.68 -30.67 20.22 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.374 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.07 -31.33 78.4 Favored Glycine 0 C--O 1.206 -1.626 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.478 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 30.0 p30 -71.95 -20.85 61.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.172 0.511 . . . . 0.0 111.019 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -86.63 -51.64 6.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -85.48 -36.07 20.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -171.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.5 m -97.15 145.92 30.44 Favored Pre-proline 0 C--N 1.291 -1.975 0 O-C-N 121.988 -0.445 . . . . 0.0 110.986 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -80.27 -15.09 11.6 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.916 1.744 . . . . 0.0 109.838 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 1.9 p -96.29 146.09 25.02 Favored 'General case' 0 N--CA 1.42 -1.927 0 C-N-CA 125.007 1.323 . . . . 0.0 110.412 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.49 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.2 OUTLIER -144.75 138.6 22.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.236 0.541 . . . . 0.0 110.746 173.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.69 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -85.34 124.64 40.2 Favored 'Isoleucine or valine' 0 C--O 1.253 1.244 0 C-N-CA 124.435 1.094 . . . . 0.0 110.19 177.059 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.67 171.11 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.419 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.584 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -129.65 142.76 50.67 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.97 129.68 37.27 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.639 HG12 HD12 ' A' ' 86' ' ' ILE . 59.3 mt -85.52 117.57 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.5 174.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.4 m -107.21 111.87 24.47 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.25 -31.6 77.74 Favored Glycine 0 CA--C 1.5 -0.863 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.863 -176.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -144.11 123.98 13.48 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-O 121.044 0.45 . . . . 0.0 110.728 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.5 tt -173.1 -38.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.72 -173.07 0.15 Allowed 'General case' 0 C--O 1.243 0.731 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.72 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.0 mttm 61.67 73.91 0.46 Allowed 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 124.908 1.283 . . . . 0.0 114.407 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.38 72.72 7.03 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -114.04 12.65 18.0 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 123.016 1.389 . . . . 0.0 108.508 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.2 tt -138.41 140.53 28.48 Favored Pre-proline 0 C--N 1.28 -2.442 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.575 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 12.4 Cg_endo -56.12 -28.48 70.37 Favored 'Trans proline' 0 C--O 1.2 -1.41 0 C-N-CA 122.363 2.042 . . . . 0.0 114.274 -176.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.0 p -74.08 -18.92 60.76 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.064 0.459 . . . . 0.0 111.515 -174.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.8 m170 -104.64 128.95 52.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.401 HG12 HD13 ' A' ' 73' ' ' ILE . 59.1 t -130.22 124.68 58.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -98.34 133.46 42.71 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.625 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -115.53 158.37 15.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.907 -173.214 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.502 ' OE1' ' HE3' ' A' ' 110' ' ' LYS . 2.3 mp0 -66.3 113.58 4.71 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.093 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -52.51 -42.11 64.04 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.716 0.806 . . . . 0.0 112.556 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.463 ' HD3' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -61.06 -30.7 70.49 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.463 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 5.0 ttmp? -85.75 -34.99 21.05 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.716 0.769 . . . . 0.0 109.259 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.625 ' CE1' HG21 ' A' ' 73' ' ' ILE . 4.7 m-85 -84.71 5.29 28.87 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.937 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt 68.06 26.47 7.25 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.761 1.224 . . . . 0.0 111.227 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.8 mt -117.56 179.2 4.13 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.456 0.646 . . . . 0.0 110.759 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -108.87 -18.89 13.58 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.51 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -118.51 147.23 43.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.25 123.71 22.85 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 t -102.93 150.72 23.25 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.082 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.3 136.26 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.639 HD12 HG12 ' A' ' 58' ' ' ILE . 19.4 mm -104.49 131.14 54.12 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.967 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.8 mt -100.97 102.57 13.62 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.9 mm? -82.92 4.62 24.94 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.003 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.52 -42.91 7.47 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.912 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.457 ' HA ' HG21 ' B' ' 93' ' ' THR . 0.0 OUTLIER -91.01 76.71 6.17 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.668 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.584 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -117.02 178.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.479 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.417 ' HD2' HD23 ' A' ' 24' ' ' LEU . 15.6 ptp180 -173.81 163.3 4.14 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.475 HG21 ' HA ' ' B' ' 90' ' ' GLN . 61.4 m -107.77 124.18 49.66 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.421 -178.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.405 ' HB3' ' HG3' ' A' ' 98' ' ' ARG . 43.2 mt -132.42 145.62 51.35 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.73 -172.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.1 p30 -76.32 153.63 35.72 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.981 175.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -44.37 -22.14 0.06 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.463 1.905 . . . . 0.0 115.352 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.22 -18.6 60.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 118.206 0.457 . . . . 0.0 110.739 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 32.4 mmt180 -75.12 -38.81 60.95 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.6 mp -68.15 125.21 25.66 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.697 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 23' ' ' ASP . 67.9 mttm -103.99 -64.95 1.05 Allowed 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.304 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.4 pt-20 -150.88 144.28 24.9 Favored 'General case' 0 N--CA 1.412 -2.337 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.069 -166.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -70.59 125.88 28.06 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.425 -1.716 . . . . 0.0 111.098 176.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 tp -114.57 -62.01 1.66 Allowed 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.069 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.499 HG22 HG11 ' A' ' 19' ' ' VAL . 3.8 t -127.81 -167.22 1.72 Allowed 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.639 -1.625 . . . . 0.0 111.626 -177.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -160.81 143.98 13.12 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 124.73 1.212 . . . . 0.0 109.512 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.6 pp -114.18 159.63 19.88 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.762 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.2 t -82.38 159.33 23.04 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.793 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 111' ' ' MET . 18.9 t70 -63.59 -33.31 75.33 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.439 0.638 . . . . 0.0 111.303 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.5 -28.06 65.73 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.102 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.502 ' HE3' ' OE1' ' A' ' 74' ' ' GLU . 5.7 mptp? -76.17 -29.0 57.54 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.078 0.466 . . . . 0.0 110.263 175.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -59.18 -36.31 75.11 Favored 'General case' 0 N--CA 1.416 -2.146 0 C-N-CA 123.521 0.728 . . . . 0.0 109.533 174.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.485 ' HE2' ' C ' ' A' ' 111' ' ' MET . 7.6 mmpt? -78.08 -10.99 59.88 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.34 -38.43 18.8 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 1.7 t -54.61 -39.86 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 112.432 -2.167 . . . . 0.0 110.884 173.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.44 -35.18 69.77 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 122.243 1.02 . . . . 0.0 111.801 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.553 ' O ' HD13 ' A' ' 120' ' ' ILE . 16.4 m-80 -83.89 -18.81 36.18 Favored 'General case' 0 CA--C 1.433 -3.528 0 C-N-CA 125.235 1.414 . . . . 0.0 110.083 -171.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 68' ' ' PRO . . . -84.56 -57.14 3.26 Favored 'General case' 2 N--CA 1.34 -5.952 0 CA-C-N 111.881 -2.418 . . . . 0.0 108.921 171.271 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 tp -67.34 -45.37 76.61 Favored 'General case' 0 N--CA 1.404 -2.727 0 C-N-CA 125.984 1.714 . . . . 0.0 113.592 -170.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 34.1 mtp -67.64 -22.06 65.34 Favored 'General case' 0 C--O 1.199 -1.575 0 O-C-N 121.704 -0.622 . . . . 0.0 111.839 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.0 OUTLIER -87.13 -45.56 16.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -178.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 10.8 t -56.31 -46.82 79.67 Favored 'General case' 0 C--N 1.277 -2.584 0 C-N-CA 126.618 1.967 . . . . 0.0 111.251 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.614 ' HG ' HG21 ' B' ' 54' ' ' ILE . 7.8 mp -89.44 3.84 51.03 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 123.149 0.579 . . . . 0.0 111.254 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.24 32.66 84.89 Favored Glycine 0 CA--C 1.539 1.583 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 175.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.3 mp -78.19 -34.21 49.63 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 118.651 1.226 . . . . 0.0 109.024 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 25.25 124.38 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 129.216 3.006 . . . . 0.0 117.565 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.69 9.03 6.74 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.057 -1.027 . . . . 0.0 112.365 -177.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.1 t -127.7 18.91 3.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -75.75 -19.82 58.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.293 1.044 . . . . 0.0 109.334 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -143.23 -179.08 6.18 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -94.24 150.93 19.84 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.706 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -54.91 120.9 7.54 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.7 m120 . . . . . 0 N--CA 1.432 -1.367 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 171.635 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.778 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -74.65 -73.44 0.24 Allowed 'General case' 0 C--O 1.246 0.885 0 CA-C-N 117.117 0.459 . . . . 0.0 110.323 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 20.7 p -114.21 16.94 17.92 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.656 0.741 . . . . 0.0 109.474 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -131.43 115.56 16.36 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -133.14 129.44 37.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -86.57 109.36 19.07 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -87.4 93.69 9.48 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.607 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.47 161.62 42.08 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -93.76 99.02 11.49 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.489 0.661 . . . . 0.0 109.253 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.3 m -65.98 -27.05 67.85 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.319 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -150.0 136.13 18.76 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.078 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ASP . . . . . 0.52 ' HB2' ' NH1' ' B' ' 15' ' ' ARG . 46.6 m-20 -108.66 142.5 25.57 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.33 -29.07 79.26 Favored 'Trans proline' 0 C--O 1.213 -0.746 0 C-N-CA 122.398 2.065 . . . . 0.0 114.153 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 53.7 mt -108.54 116.01 50.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.641 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.52 ' NH1' ' HB2' ' B' ' 12' ' ' ASP . 29.9 mmt180 -119.73 156.64 30.15 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.696 172.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -77.76 139.67 39.39 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.089 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.36 -11.94 51.25 Favored Glycine 0 C--N 1.309 -0.941 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.496 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -97.18 176.74 5.82 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 4.9 t -132.93 129.54 57.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-O 121.44 0.638 . . . . 0.0 112.209 -175.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.449 ' O ' HG22 ' B' ' 38' ' ' VAL . 83.1 m-85 -126.89 143.08 51.37 Favored 'General case' 0 CA--C 1.46 -2.486 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.458 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.592 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -79.41 149.88 31.49 Favored 'General case' 0 N--CA 1.39 -3.43 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.905 170.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -136.76 131.48 33.46 Favored 'General case' 0 C--N 1.259 -3.364 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.132 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' B' ' 35' ' ' VAL . 8.8 t70 -81.84 96.1 7.52 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.037 171.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.582 ' O ' HD22 ' B' ' 24' ' ' LEU 0.475 0.0 OUTLIER -118.19 60.23 0.79 Allowed 'General case' 1 N--CA 1.376 -4.175 0 CA-C-O 124.078 1.894 . . . . 0.0 111.963 172.158 . . . . . . . . 5 4 . 1 . 015 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HA2' ' B' ' 34' ' ' GLY . 1.3 m -105.08 59.89 0.12 Allowed Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 113.264 -1.789 . . . . 0.0 111.687 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.462 ' HD2' HG13 ' B' ' 27' ' ' VAL . 27.9 Cg_endo -116.95 24.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.594 0 N-CA-C 108.054 -1.556 . . . . 0.0 108.054 158.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.663 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 21.7 m -91.46 153.6 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' GLN . . . . . 0.473 HE22 ' HB3' ' A' ' 26' ' ' PRO 0.467 11.7 pm0 -128.1 -64.61 0.95 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 119.336 3.087 . . . . 0.0 119.336 -177.385 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.5 -114.65 0.02 OUTLIER Glycine 0 C--N 1.313 -0.696 0 C-N-CA 120.555 -0.831 . . . . 0.0 114.076 -173.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.443 ' HB2' ' CB ' ' A' ' 95' ' ' ASP . 19.4 m -94.15 20.36 8.11 Favored 'General case' 0 C--N 1.271 -2.808 0 O-C-N 122.003 -0.704 . . . . 0.0 109.503 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.663 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 45.6 mt-10 -75.64 162.83 27.92 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -138.41 112.71 8.7 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.515 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -147.18 -113.69 0.78 Allowed Glycine 0 N--CA 1.411 -2.999 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.124 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.459 ' HA2' ' OG ' ' B' ' 25' ' ' SER . . . 86.99 176.53 49.18 Favored Glycine 0 N--CA 1.399 -3.826 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 -172.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' B' ' 23' ' ' ASP . 1.6 p -84.53 99.58 6.97 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -141.46 151.17 60.15 Favored Pre-proline 0 C--N 1.262 -3.224 0 CA-C-N 112.096 -2.32 . . . . 0.0 109.26 -169.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 52.1 Cg_exo -59.0 139.69 91.99 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.825 2.35 . . . . 0.0 112.878 174.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.449 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -125.75 158.36 34.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.5 m -100.39 129.59 50.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 24.3 mm -88.23 98.47 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.95 -18.82 6.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.486 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.681 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 1.2 tt0 -50.81 152.07 2.23 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -41.74 145.99 0.28 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 127.69 2.396 . . . . 0.0 113.761 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.76 -39.4 93.55 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.975 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -87.73 -29.33 21.16 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.13 0.491 . . . . 0.0 110.949 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.25 -30.95 77.46 Favored Glycine 0 C--O 1.206 -1.65 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.039 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -72.54 -20.55 61.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.064 0.459 . . . . 0.0 111.166 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.12 -53.91 4.78 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.151 0.501 . . . . 0.0 109.817 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -82.79 -35.72 26.24 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.409 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 70.1 m -94.84 143.2 25.76 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-O 120.855 0.36 . . . . 0.0 111.192 -176.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.88 -14.54 12.38 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.072 1.848 . . . . 0.0 109.524 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 1.9 p -97.18 147.93 23.59 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 125.11 1.364 . . . . 0.0 110.052 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.49 ' HA ' HE21 ' B' ' 42' ' ' GLN . 0.2 OUTLIER -146.33 138.94 20.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.291 0.567 . . . . 0.0 110.888 173.217 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.681 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -85.01 124.19 39.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 C-N-CA 124.675 1.19 . . . . 0.0 109.881 177.342 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.78 171.15 17.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.429 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.59 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -129.82 142.97 50.6 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.0 130.31 38.21 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.655 HG12 HD12 ' B' ' 86' ' ' ILE . 57.8 mt -85.46 117.23 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.513 174.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 22.0 m -105.05 108.83 20.57 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.64 -37.68 93.85 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.067 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -142.45 125.24 16.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.969 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 tt -170.86 -42.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 67.63 -173.76 0.19 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.691 1.196 . . . . 0.0 112.646 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 62.49 71.71 0.52 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.738 1.615 . . . . 0.0 114.563 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.99 70.39 8.52 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -114.42 13.74 17.74 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 123.272 1.51 . . . . 0.0 108.622 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.4 tt -138.56 140.58 28.28 Favored Pre-proline 0 C--N 1.278 -2.509 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' PRO . . . . . 0.563 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 12.4 Cg_endo -56.72 -28.41 75.64 Favored 'Trans proline' 0 C--O 1.204 -1.18 0 C-N-CA 122.257 1.971 . . . . 0.0 114.182 -177.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 62.4 p -73.95 -19.17 60.76 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.046 0.45 . . . . 0.0 111.68 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -105.38 129.07 53.78 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.404 ' CG2' ' HB2' ' B' ' 117' ' ' ALA . 70.8 t -130.31 125.85 60.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.41 134.38 39.66 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.608 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -118.14 153.95 20.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.272 -174.413 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.55 ' OE1' ' HE3' ' B' ' 110' ' ' LYS . 3.7 mp0 -65.02 113.04 3.62 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.49 -178.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -50.71 -41.64 56.28 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 124.272 1.029 . . . . 0.0 112.634 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -22.04 66.17 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.252 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -91.36 -36.32 13.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.644 0.735 . . . . 0.0 109.071 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.608 ' CE1' HG21 ' B' ' 73' ' ' ILE . 4.5 m-85 -83.38 8.11 14.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.433 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 67.09 20.38 10.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.824 1.249 . . . . 0.0 111.757 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -111.0 179.66 3.98 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.1 0.476 . . . . 0.0 110.798 -174.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.86 -24.44 12.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.199 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -116.64 147.33 42.01 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.07 123.09 23.74 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.546 0.689 . . . . 0.0 109.237 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 22.6 t -102.88 154.11 19.53 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.72 -167.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.0 t -116.18 136.08 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.655 HD12 HG12 ' B' ' 58' ' ' ILE . 21.3 mm -104.66 131.87 52.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.932 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 66.2 mt -101.65 103.14 13.93 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.574 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.9 mm? -82.88 -0.41 48.17 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.535 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -94.37 -40.67 9.81 Favored 'General case' 0 N--CA 1.413 -2.294 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.94 173.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLN . . . . . 0.475 ' HA ' HG21 ' A' ' 93' ' ' THR . 0.0 OUTLIER -91.04 76.67 6.16 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.27 1.033 . . . . 0.0 108.59 178.755 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.59 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.5 pp -117.33 178.77 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.584 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.418 ' HD2' HD23 ' B' ' 24' ' ' LEU . 15.5 ptp180 -173.8 163.58 4.18 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 90' ' ' GLN . 65.5 m -108.15 124.21 49.91 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.569 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.44 ' HB3' ' HG3' ' B' ' 98' ' ' ARG . 45.7 mt -132.34 145.85 51.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.739 -172.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 1.9 p-10 -77.8 153.5 32.77 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.412 176.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 50' ' ' SER . 99.5 mttt -44.69 -21.76 0.06 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.129 1.772 . . . . 0.0 115.446 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -73.7 -19.17 60.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.11 0.481 . . . . 0.0 110.745 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.534 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 31.5 mmt180 -74.98 -38.73 61.57 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.876 -0.515 . . . . 0.0 109.875 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.5 123.12 20.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.092 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -102.67 -65.08 1.01 Allowed 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 114.165 -1.379 . . . . 0.0 113.46 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.0 pt-20 -149.03 139.83 22.77 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.328 0.585 . . . . 0.0 111.349 -165.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.2 OUTLIER -69.76 123.5 21.57 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.754 -1.566 . . . . 0.0 111.592 176.203 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.07 -62.37 1.61 Allowed 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.249 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.532 HG22 HG11 ' B' ' 19' ' ' VAL . 3.2 t -126.91 -168.25 1.85 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 117.432 -1.707 . . . . 0.0 112.434 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -160.49 142.28 12.53 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 124.468 1.107 . . . . 0.0 110.205 -175.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -112.14 159.33 18.64 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.647 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 32.5 t -82.59 161.91 22.1 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' B' ' 111' ' ' MET . 16.7 t70 -62.1 -34.2 75.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.758 0.823 . . . . 0.0 111.373 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.01 -27.56 62.81 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.55 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 5.6 mptp? -75.0 -29.27 60.83 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 120.874 0.368 . . . . 0.0 110.02 175.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.481 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -57.54 -38.31 74.5 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.655 174.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.45 ' HE2' ' C ' ' B' ' 111' ' ' MET . 7.6 mmpt? -77.34 -13.74 59.87 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.13 -35.37 21.8 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 t -56.88 -41.36 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.568 0 CA-C-N 112.32 -2.218 . . . . 0.0 110.099 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -44.54 76.98 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.831 0.824 . . . . 0.0 110.489 174.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.732 ' O ' HD13 ' B' ' 120' ' ' ILE . 3.2 m120 -70.61 -20.91 62.71 Favored 'General case' 0 CA--C 1.474 -1.98 0 CA-C-O 122.384 1.088 . . . . 0.0 111.135 -176.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.574 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -84.26 -53.85 5.2 Favored 'General case' 2 C--N 1.235 -4.405 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.291 173.35 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.67 -46.77 74.61 Favored 'General case' 0 N--CA 1.403 -2.798 0 C-N-CA 126.194 1.798 . . . . 0.0 113.471 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 38.4 mtp -66.05 -24.91 66.82 Favored 'General case' 0 C--O 1.2 -1.504 0 O-C-N 121.754 -0.591 . . . . 0.0 111.395 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.732 HD13 ' O ' ' B' ' 116' ' ' ASN . 1.3 mp -86.95 -40.77 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 70.5 m -57.12 -46.88 82.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 122.124 0.964 . . . . 0.0 111.145 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.598 ' HG ' HG21 ' A' ' 54' ' ' ILE . 7.4 mp -88.4 3.37 50.18 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.806 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.5 32.0 79.62 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.28 -37.04 63.8 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 119.041 1.421 . . . . 0.0 108.696 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.588 HD22 HG13 ' B' ' 120' ' ' ILE . 5.0 t-20 26.3 119.45 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.489 2.716 . . . . 0.0 117.443 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.49 6.62 6.72 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.429 -0.795 . . . . 0.0 112.358 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 17.2 t -122.23 15.39 5.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 122.686 1.231 . . . . 0.0 107.975 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.96 -15.22 60.68 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.254 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -148.63 173.56 13.06 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -88.25 149.44 23.82 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.154 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -54.24 123.78 13.85 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.942 0.897 . . . . 0.0 113.388 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 C--N 1.309 -1.177 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 174.17 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.095 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -124.86 -172.41 2.57 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 p 60.15 176.03 0.09 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.076 0.951 . . . . 0.0 113.246 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -90.26 -47.95 7.45 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.392 -0.817 . . . . 0.0 109.786 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -93.06 85.72 5.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.411 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -152.8 96.99 2.17 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -82.56 128.44 34.31 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -72.76 109.32 6.28 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.475 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 63.4 m170 -71.2 -39.88 71.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.8 m 72.54 -35.55 0.33 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.338 1.455 . . . . 0.0 111.814 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -147.83 106.67 3.83 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HB2' ' CE ' ' A' ' 102' ' ' LYS . 4.7 m-20 -85.82 154.71 58.6 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.09 144.06 81.45 Favored 'Trans proline' 0 C--O 1.252 1.198 0 C-N-CA 122.326 2.017 . . . . 0.0 111.152 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.4 mt -71.2 114.86 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-O 121.915 0.864 . . . . 0.0 109.107 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -110.02 154.64 22.91 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.906 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -84.63 129.89 34.78 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.021 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.6 0.38 43.0 Favored Glycine 0 C--N 1.308 -0.992 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.644 -175.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -97.33 170.14 9.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 104' ' ' THR . 12.0 t -131.73 133.9 60.87 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 C-N-CA 124.063 0.945 . . . . 0.0 112.021 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 93.1 m-85 -132.41 145.83 51.51 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.573 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER -76.96 148.64 36.2 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 169.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -143.78 149.07 36.52 Favored 'General case' 0 C--N 1.257 -3.452 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.669 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -74.45 85.78 2.02 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 124.238 1.971 . . . . 0.0 108.044 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.505 ' O ' HD13 ' A' ' 24' ' ' LEU . 2.0 tm? -87.94 13.15 11.52 Favored 'General case' 0 N--CA 1.407 -2.615 0 CA-C-N 111.198 -2.728 . . . . 0.0 111.662 -166.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 p -104.67 62.23 0.11 Allowed Pre-proline 0 N--CA 1.414 -2.236 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -113.47 23.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 121.712 1.608 . . . . 0.0 108.314 158.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.65 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 12.8 m -78.87 -179.1 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.702 -173.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.9 154.29 50.51 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.658 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.42 -108.99 1.16 Allowed Glycine 0 CA--C 1.502 -0.77 0 N-CA-C 116.271 1.268 . . . . 0.0 116.271 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 m -93.75 -6.63 45.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.236 -174.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 50.2 mt-10 -60.24 159.17 10.25 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.454 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.433 HE22 ' HG3' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -81.21 113.02 19.07 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -173.045 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.75 159.51 15.87 Favored Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 115.626 1.011 . . . . 0.0 115.626 -177.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 24' ' ' LEU . . . 110.43 146.31 10.89 Favored Glycine 0 N--CA 1.415 -2.764 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 22' ' ' ALA . 3.6 p -61.55 122.61 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 CA-C-O 122.507 1.146 . . . . 0.0 109.382 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.433 ' HG3' HE22 ' A' ' 32' ' ' GLN . 14.4 mmt85 -141.3 162.23 48.69 Favored Pre-proline 0 C--N 1.264 -3.124 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.753 -169.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HB2' HD12 ' A' ' 58' ' ' ILE . 1.3 Cg_endo -80.08 142.35 15.33 Favored 'Trans proline' 0 N--CA 1.427 -2.429 0 C-N-CA 121.785 1.657 . . . . 0.0 109.736 171.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 22.4 m -123.54 155.17 29.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.068 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.518 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 35.5 m -99.38 132.9 43.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.79 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.459 HD13 HG12 ' A' ' 55' ' ' VAL . 22.9 mm -90.97 105.2 16.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -99.56 -15.58 7.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.817 -179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.641 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 2.8 tt0 -55.47 162.65 1.5 Allowed 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 126.035 1.734 . . . . 0.0 114.518 -168.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.512 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 1.5 p30 -75.93 177.12 7.25 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.829 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.24 -34.53 49.12 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 m -75.3 -24.62 57.49 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.128 0.49 . . . . 0.0 110.504 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.38 -23.06 73.35 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -83.44 -19.7 35.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.451 0.643 . . . . 0.0 109.91 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -89.93 -66.77 0.89 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.315 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -107.87 2.13 23.23 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.3 m -108.09 134.4 20.16 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.51 -22.92 20.68 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 121.671 1.58 . . . . 0.0 109.364 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 p -86.97 158.94 19.16 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.631 -1.622 . . . . 0.0 111.551 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.641 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 66.2 t -137.64 140.4 41.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 173.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.451 HD13 ' CD2' ' B' ' 122' ' ' LEU . 5.8 tt -105.9 127.48 60.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.548 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 34.1 m -132.01 174.65 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.263 -174.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -131.52 146.51 52.27 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.81 138.44 38.97 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 37' ' ' PRO . 81.6 mt -99.89 127.32 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.707 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -141.67 138.28 32.37 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.004 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.3 9.52 57.66 Favored Glycine 0 C--N 1.306 -1.089 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -60.44 -51.58 68.87 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.272 1.029 . . . . 0.0 112.811 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.655 HG23 HG21 ' A' ' 85' ' ' VAL . 16.3 tt -96.23 153.11 3.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -118.96 12.16 12.72 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.055 -175.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' H ' HG12 ' A' ' 62' ' ' ILE . 59.6 mttp -141.71 158.42 43.84 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.37 -79.55 0.59 Allowed 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp 57.62 28.95 16.44 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.483 1.513 . . . . 0.0 111.393 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tt -155.58 147.16 16.94 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 27.0 Cg_exo -62.54 -35.04 73.29 Favored 'Trans proline' 0 C--O 1.196 -1.62 0 C-N-CA 121.431 1.421 . . . . 0.0 114.136 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.2 p -73.36 -18.59 61.16 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -114.67 128.97 56.61 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.1 127.73 75.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 118.704 0.684 . . . . 0.0 109.863 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -97.76 130.3 44.72 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.139 0.495 . . . . 0.0 110.406 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.505 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -110.31 169.61 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.4 ' H ' HG22 ' A' ' 73' ' ' ILE . 44.4 mt-10 -89.04 137.17 32.56 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.385 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 82' ' ' LYS . 58.4 tttm -50.36 -42.46 53.21 Favored 'General case' 0 C--O 1.207 -1.141 0 O-C-N 124.351 1.032 . . . . 0.0 109.997 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.435 ' HG3' ' H ' ' A' ' 76' ' ' LYS . 46.5 mttp -54.11 -49.67 68.61 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 125.623 1.569 . . . . 0.0 111.494 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.02 -40.45 38.88 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 2.4 m-85 -77.4 -8.84 58.35 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 78' ' ' TYR . 17.4 ptmt 52.74 34.0 15.22 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.571 1.549 . . . . 0.0 110.692 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.66 -173.83 2.64 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.246 -171.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.13 -29.43 67.48 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.068 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 14.4 ptmm? -166.87 168.14 14.31 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -52.4 138.46 27.11 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.48 137.98 53.44 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -169.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.655 HG21 HG23 ' A' ' 62' ' ' ILE . 21.1 t -107.97 142.05 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.597 HD12 HG12 ' A' ' 58' ' ' ILE . 16.6 mm -109.9 135.3 49.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.62 106.88 17.58 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -89.5 10.4 22.96 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.602 0.715 . . . . 0.0 111.79 -175.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.4 -34.28 6.83 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.955 0.883 . . . . 0.0 109.662 173.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.578 ' HA ' HG21 ' B' ' 93' ' ' THR . 0.3 OUTLIER -101.2 88.39 3.48 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.687 177.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.562 ' O ' ' HD2' ' A' ' 92' ' ' ARG . 2.1 pp -121.97 178.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.943 -174.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.562 ' HD2' ' O ' ' A' ' 91' ' ' ILE . 18.2 mmm180 -136.76 172.97 12.23 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.75 0.786 . . . . 0.0 111.521 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.578 HG21 ' HA ' ' B' ' 90' ' ' GLN . 52.9 m -139.84 119.21 12.93 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 171.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 64.2 mt -134.27 145.05 48.73 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.807 0.843 . . . . 0.0 111.345 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.83 145.49 52.5 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 119.503 1.047 . . . . 0.0 109.656 165.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -49.36 -34.91 17.18 Favored 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -57.03 -23.8 49.11 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 125.374 1.469 . . . . 0.0 112.64 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 6.2 mmp_? -74.5 -27.73 60.68 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.556 0.693 . . . . 0.0 109.445 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.29 107.86 8.83 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 122.944 1.354 . . . . 0.0 110.937 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.62 -63.5 1.36 Allowed 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 113.039 -1.891 . . . . 0.0 114.875 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.5 pt-20 -158.29 150.02 21.42 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-O 121.814 0.816 . . . . 0.0 111.485 -170.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 66.2 mttm -61.3 126.44 27.37 Favored 'General case' 0 C--N 1.273 -2.738 0 C-N-CA 127.284 2.234 . . . . 0.0 111.832 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 tp -115.63 -62.45 1.59 Allowed 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.725 171.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.53 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 2.7 t -127.98 -167.16 1.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.142 -1.423 . . . . 0.0 112.33 -177.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.74 135.23 8.33 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 125.598 1.559 . . . . 0.0 110.712 -172.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 mt -87.08 157.48 19.4 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 124.098 0.959 . . . . 0.0 111.344 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.466 ' HB2' ' HD3' ' A' ' 110' ' ' LYS . 7.5 m -84.08 161.22 20.75 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 111' ' ' MET . 4.9 m-20 -62.4 -36.52 82.59 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.538 0.735 . . . . 0.0 112.576 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -79.79 -26.63 40.52 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.576 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.466 ' HD3' ' HB2' ' A' ' 107' ' ' SER . 2.5 mptp? -70.54 -26.45 63.56 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.98 0.419 . . . . 0.0 110.687 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.468 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -57.26 -39.18 75.1 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 123.903 0.881 . . . . 0.0 109.667 172.742 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.468 ' HE2' ' C ' ' A' ' 111' ' ' MET . 7.9 mmpt? -83.36 -11.1 58.0 Favored 'General case' 0 N--CA 1.397 -3.117 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.426 ' OE1' ' HG3' ' A' ' 110' ' ' LYS . 36.7 mt-10 -84.78 -37.16 21.14 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 1.4 t -55.04 -36.91 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-N 112.835 -1.984 . . . . 0.0 110.617 172.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.56 -35.36 80.73 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.401 1.096 . . . . 0.0 111.153 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.659 ' O ' HD13 ' A' ' 120' ' ' ILE . 13.4 m-80 -81.13 -15.03 57.04 Favored 'General case' 1 N--CA 1.555 4.823 0 CA-C-O 124.165 1.936 . . . . 0.0 109.596 -174.579 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.555 ' HB3' ' HG ' ' A' ' 88' ' ' LEU 0.337 . . -91.01 -51.31 5.4 Favored 'General case' 2 N--CA 1.346 -5.635 0 CA-C-N 111.867 -2.424 . . . . 0.0 105.254 175.109 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.621 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 3.3 tp -69.27 -47.47 64.53 Favored 'General case' 0 N--CA 1.393 -3.29 0 C-N-CA 124.518 1.127 . . . . 0.0 113.165 -171.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.5 mtp -64.77 -28.34 69.51 Favored 'General case' 0 C--O 1.195 -1.804 0 O-C-N 121.451 -0.78 . . . . 0.0 111.608 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.659 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -77.86 -48.67 23.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 23.1 t -56.48 -33.55 66.08 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 113.076 -1.875 . . . . 0.0 111.286 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 20.1 mt -104.48 7.32 35.34 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.021 0.439 . . . . 0.0 110.664 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.44 78.21 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.413 ' CD1' ' HB2' ' A' ' 122' ' ' LEU . 6.9 mp -80.51 -51.38 8.85 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 119.113 1.456 . . . . 0.0 108.927 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 50.47 -173.02 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 113.068 -1.878 . . . . 0.0 112.833 -173.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.85 103.93 5.56 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.1 p 57.24 18.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 126.664 1.986 . . . . 0.0 111.776 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 57.54 -159.46 0.26 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.628 -1.623 . . . . 0.0 109.926 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -79.0 80.12 5.36 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.668 0.747 . . . . 0.0 109.39 176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -84.93 111.15 19.42 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.214 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -130.59 97.41 4.37 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--N 1.286 -2.156 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.05 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.717 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 26.4 m -123.47 -173.52 2.75 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 23.1 m 67.41 177.8 0.24 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.916 0.886 . . . . 0.0 111.726 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -93.34 -53.09 4.23 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -88.96 86.94 7.04 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.689 0.757 . . . . 0.0 109.871 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -152.08 103.59 2.9 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -87.94 127.45 35.37 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -75.35 112.03 11.23 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' HIS . . . . . 0.416 ' C ' ' H ' ' B' ' 11' ' ' GLN . 62.4 m170 -75.44 -33.67 60.91 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.427 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 41.3 m 71.44 -35.64 0.34 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.107 1.363 . . . . 0.0 111.668 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' GLN . . . . . 0.416 ' H ' ' C ' ' B' ' 9' ' ' HIS . 50.0 tt0 -149.73 99.37 2.86 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 123.584 0.754 . . . . 0.0 109.058 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ASP . . . . . 0.486 ' HB2' ' CE ' ' B' ' 102' ' ' LYS . 6.8 m-20 -75.7 154.6 85.35 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -56.03 148.66 57.1 Favored 'Trans proline' 0 C--O 1.252 1.219 0 C-N-CA 122.435 2.09 . . . . 0.0 111.544 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 62.8 mt -75.72 118.03 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -113.59 155.99 24.46 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.879 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.21 135.08 34.5 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.95 2.17 58.33 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.743 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' ASP . . . . . 0.411 ' CG ' ' HZ2' ' B' ' 102' ' ' LYS . 10.1 t70 -97.79 168.4 10.34 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 13.6 t -131.88 133.84 60.63 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 C-N-CA 123.805 0.842 . . . . 0.0 112.252 -176.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 89.9 m-85 -132.44 145.52 51.26 Favored 'General case' 0 CA--C 1.483 -1.628 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.417 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 0.8 OUTLIER -76.25 149.2 37.19 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 169.448 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.482 ' O ' HG23 ' B' ' 35' ' ' VAL . . . -144.35 148.66 35.02 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.891 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.5 85.64 1.54 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 124.022 1.868 . . . . 0.0 107.741 172.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.52 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.1 tm? -88.8 12.95 13.66 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 111.33 -2.668 . . . . 0.0 111.769 -166.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 17.8 p -104.59 62.38 0.1 Allowed Pre-proline 0 CA--C 1.582 2.202 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -112.82 23.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 121.676 1.584 . . . . 0.0 108.316 159.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 16.1 m -78.42 -179.17 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.327 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.68 154.17 48.59 Favored 'General case' 0 C--O 1.206 -1.228 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.775 175.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.11 -112.0 3.26 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 115.307 0.883 . . . . 0.0 115.307 170.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -94.51 -2.85 50.96 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.532 0.333 . . . . 0.0 110.816 -173.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.67 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 51.7 mt-10 -60.71 158.84 11.91 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.167 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.413 HE22 ' HG3' ' B' ' 36' ' ' ARG . 0.9 OUTLIER -80.98 112.28 18.23 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -172.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.53 156.25 17.79 Favored Glycine 0 CA--C 1.473 -2.553 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' B' ' 24' ' ' LEU . . . 114.18 149.3 10.01 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 22' ' ' ALA . 3.2 p -63.53 125.73 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-O 122.526 1.155 . . . . 0.0 108.933 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' ARG . . . . . 0.413 ' HG3' HE22 ' B' ' 32' ' ' GLN . 9.7 mmt85 -142.09 160.98 53.25 Favored Pre-proline 0 C--N 1.268 -2.952 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.068 -168.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.617 ' HB2' HD12 ' B' ' 58' ' ' ILE . 0.9 OUTLIER -80.62 142.06 14.19 Favored 'Trans proline' 0 N--CA 1.426 -2.442 0 C-N-CA 121.714 1.609 . . . . 0.0 109.38 170.356 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 24.3 m -123.22 155.59 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.18 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.518 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 35.7 m -99.65 132.97 44.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.789 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.441 HD13 HG12 ' B' ' 55' ' ' VAL . 22.7 mm -91.52 105.42 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.501 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -99.44 -16.15 7.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.844 -179.23 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.652 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 2.8 tt0 -54.89 162.81 1.14 Allowed 'General case' 0 N--CA 1.424 -1.743 0 C-N-CA 126.369 1.868 . . . . 0.0 114.986 -167.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.502 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 2.2 p30 -74.78 175.83 7.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.934 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -77.24 -34.78 55.81 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 21.6 m -75.39 -25.53 57.71 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.156 0.503 . . . . 0.0 110.222 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.63 -23.99 72.41 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -83.23 -20.22 34.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.986 0.422 . . . . 0.0 110.28 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -88.87 -66.95 0.87 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.994 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -100.15 -23.4 14.86 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -167.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' B' ' 51' ' ' PRO . 15.2 m -83.85 136.17 41.94 Favored Pre-proline 0 N--CA 1.423 -1.822 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 50' ' ' SER . 8.0 Cg_exo -74.27 -21.72 17.32 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 121.706 1.604 . . . . 0.0 108.754 173.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -89.18 158.11 18.02 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 113.342 -1.754 . . . . 0.0 111.276 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.652 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 60.4 t -137.82 140.29 41.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.457 HD13 ' CD2' ' A' ' 122' ' ' LEU . 5.6 tt -106.43 127.91 61.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 174.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.56 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 33.9 m -132.91 174.16 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.212 -173.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.518 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -130.74 146.71 52.28 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.53 137.43 38.62 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' B' ' 37' ' ' PRO . 82.0 mt -98.35 128.56 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 113.323 -1.762 . . . . 0.0 107.736 176.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.5 t -140.89 141.38 34.58 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 119.581 -0.847 . . . . 0.0 111.621 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.97 8.63 50.17 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -60.08 -58.84 6.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.813 0.845 . . . . 0.0 112.499 -175.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.52 HG23 HG21 ' B' ' 85' ' ' VAL . 17.9 tt -89.08 154.12 3.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -113.18 -1.22 14.41 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.672 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.424 ' H ' HG12 ' B' ' 62' ' ' ILE . 62.7 mttp -134.14 151.39 51.34 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 122.197 -0.314 . . . . 0.0 110.423 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' B' ' 70' ' ' HIS . . . -108.8 -81.62 0.57 Allowed 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp 58.18 24.07 10.95 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.078 1.351 . . . . 0.0 111.332 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.2 tt -152.42 141.45 14.19 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' PRO . . . . . 0.455 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 74.9 Cg_exo -54.41 -40.57 82.52 Favored 'Trans proline' 0 C--O 1.208 -1.017 0 C-N-CA 122.187 1.924 . . . . 0.0 114.659 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 57.8 p -72.63 -18.47 61.58 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -168.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.405 ' O ' ' HB1' ' B' ' 65' ' ' ALA . 4.6 m-70 -113.47 128.88 56.6 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' B' ' 117' ' ' ALA . 57.3 t -121.32 130.01 75.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 O-C-N 121.545 -0.722 . . . . 0.0 109.854 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -98.53 135.72 39.67 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.114 0.483 . . . . 0.0 109.735 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.517 HG21 ' CE1' ' B' ' 78' ' ' TYR . 1.2 mm -112.32 174.95 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.427 ' H ' HG22 ' B' ' 73' ' ' ILE . 41.0 mt-10 -92.99 139.08 30.9 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.223 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -51.79 -41.08 61.42 Favored 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 124.724 1.21 . . . . 0.0 109.697 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -59.21 -41.24 88.13 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 125.961 1.704 . . . . 0.0 111.686 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' LYS . . . . . 0.433 ' O ' ' HE3' ' B' ' 77' ' ' LYS . 0.2 OUTLIER -84.77 -39.05 18.89 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -176.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.569 ' O ' ' HG2' ' B' ' 79' ' ' LYS . 2.3 m-85 -79.14 -7.85 58.52 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.521 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' B' ' 78' ' ' TYR . 17.8 ptmt 52.71 33.25 13.51 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.63 1.572 . . . . 0.0 110.593 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.34 -175.89 3.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.463 -172.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.79 -29.88 70.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.93 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -165.99 165.96 17.65 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -50.91 135.31 24.59 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.08 139.38 49.93 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -169.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.52 HG21 HG23 ' B' ' 62' ' ' ILE . 21.8 t -108.09 142.6 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.594 HD12 HG12 ' B' ' 58' ' ' ILE . 16.2 mm -111.71 136.17 48.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 42.9 mt -106.35 106.25 16.68 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.605 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.8 mm? -89.07 10.39 21.9 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.714 0.769 . . . . 0.0 112.07 -175.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.67 -34.26 6.76 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.723 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLN . . . . . 0.578 ' HA ' HG21 ' A' ' 93' ' ' THR . 0.3 OUTLIER -100.99 87.56 3.31 Favored 'General case' 0 N--CA 1.406 -2.647 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 2.1 pp -121.49 178.91 2.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.061 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' B' ' 91' ' ' ILE . 18.3 mmm180 -136.8 172.46 12.97 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.73 0.776 . . . . 0.0 111.312 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 90' ' ' GLN . 54.6 m -139.82 119.35 13.09 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 170.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 65.9 mt -134.18 146.79 50.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 110.874 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -63.26 151.12 41.47 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.073 1.306 . . . . 0.0 109.668 165.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -51.22 -34.67 33.19 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -56.23 -25.42 47.51 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 125.076 1.35 . . . . 0.0 112.912 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 5.7 mmp_? -73.91 -29.17 61.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.397 0.618 . . . . 0.0 109.733 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.2 mp -75.46 107.73 7.79 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 125.045 1.338 . . . . 0.0 111.051 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.79 -65.77 0.97 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 112.882 -1.963 . . . . 0.0 114.932 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.2 pt-20 -156.32 146.34 21.25 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-O 121.504 0.669 . . . . 0.0 111.25 -169.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 67.6 mttm -60.52 126.43 27.4 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 126.639 1.976 . . . . 0.0 111.902 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -115.09 -61.92 1.68 Allowed 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.503 172.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.545 ' O ' ' HB ' ' B' ' 19' ' ' VAL . 3.4 t -127.23 -168.22 1.85 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 117.99 -1.484 . . . . 0.0 112.432 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -160.12 133.6 6.96 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 125.584 1.554 . . . . 0.0 110.456 -171.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 mt -84.29 162.67 20.01 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 124.009 0.924 . . . . 0.0 112.021 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.431 ' HB2' ' HD3' ' B' ' 110' ' ' LYS . 3.7 m -87.94 162.08 17.08 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.701 171.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.76 -31.79 71.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.45 -30.81 42.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.535 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.467 ' HG2' HG23 ' B' ' 73' ' ' ILE . 2.6 mptp? -67.78 -28.91 68.0 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.011 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.464 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.0 OUTLIER -55.46 -38.8 69.54 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 123.907 0.883 . . . . 0.0 109.988 172.61 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.464 ' HE2' ' C ' ' B' ' 111' ' ' MET . 7.8 mmpt? -83.99 -13.08 54.21 Favored 'General case' 0 N--CA 1.399 -2.998 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -84.4 -33.43 23.75 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.4 t -58.02 -39.71 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.404 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.2 172.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.05 -42.6 98.79 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.009 0.909 . . . . 0.0 110.067 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.624 ' O ' HD13 ' B' ' 120' ' ' ILE . 10.4 m-80 -69.51 -21.01 63.7 Favored 'General case' 0 CA--C 1.456 -2.639 0 C-N-CA 125.01 1.324 . . . . 0.0 111.923 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.605 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -83.39 -50.57 8.2 Favored 'General case' 2 N--CA 1.366 -4.666 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.839 173.53 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 3.3 tp -71.77 -48.21 48.33 Favored 'General case' 0 N--CA 1.393 -3.296 0 C-N-CA 124.546 1.138 . . . . 0.0 113.098 -171.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 37.7 mtp -63.66 -31.35 72.5 Favored 'General case' 0 C--O 1.197 -1.662 0 O-C-N 121.451 -0.781 . . . . 0.0 111.076 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.624 HD13 ' O ' ' B' ' 116' ' ' ASN . 1.4 mp -78.78 -42.93 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -56.71 -35.48 68.57 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.028 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 19.3 mt -104.18 6.57 35.74 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.936 -0.478 . . . . 0.0 111.151 -176.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.74 23.16 78.08 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 115.891 1.117 . . . . 0.0 115.891 173.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' B' ' 122' ' ' LEU . 7.1 mp -79.55 -51.86 8.76 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 118.954 1.377 . . . . 0.0 108.361 177.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.492 ' ND2' HG13 ' B' ' 120' ' ' ILE . 1.6 t-20 52.19 -171.1 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.118 -1.855 . . . . 0.0 112.748 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.44 103.35 4.54 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p 56.54 22.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 126.358 1.863 . . . . 0.0 111.528 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 54.53 -154.3 0.28 Allowed 'General case' 0 C--O 1.249 1.052 0 CA-C-N 112.837 -1.983 . . . . 0.0 109.992 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -82.8 81.97 8.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -86.57 107.54 18.18 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.303 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -128.1 99.45 5.48 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 C--N 1.301 -1.501 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.431 178.221 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.185 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -100.71 104.15 15.43 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 117.058 0.429 . . . . 0.0 109.844 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 m -78.96 -24.45 43.88 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -66.03 103.82 1.02 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -111.95 -4.74 14.46 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.524 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -81.4 89.32 6.11 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -112.07 121.64 45.53 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -67.11 -54.33 22.39 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 54.48 -84.14 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.113 0 C-N-CA 126.113 1.765 . . . . 0.0 114.084 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.7 m -88.29 0.74 55.79 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.243 0.544 . . . . 0.0 111.565 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -107.84 73.57 0.91 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.385 0.612 . . . . 0.0 112.158 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -108.15 126.79 28.89 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.17 96.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.9 2.4 . . . . 0.0 114.341 -174.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.3 mt -77.28 128.81 37.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -146.89 161.41 40.78 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.9 ptm85 -84.05 122.03 28.23 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.823 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 130.76 -19.44 4.99 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.039 -175.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -92.42 147.31 23.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.957 0.884 . . . . 0.0 110.261 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.623 ' HB ' ' H ' ' A' ' 104' ' ' THR . 51.6 t -98.62 118.15 44.72 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.271 173.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.432 ' O ' HG22 ' A' ' 38' ' ' VAL . 19.9 m-85 -108.46 145.73 34.22 Favored 'General case' 0 CA--C 1.458 -2.562 0 C-N-CA 124.673 1.189 . . . . 0.0 112.24 176.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -80.7 145.58 31.51 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 166.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -143.92 133.12 23.05 Favored 'General case' 0 C--N 1.259 -3.343 0 CA-C-N 113.743 -1.572 . . . . 0.0 108.383 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HA ' ' HB ' ' A' ' 35' ' ' VAL . 6.8 p-10 -88.57 85.35 6.81 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-O 121.593 0.711 . . . . 0.0 109.925 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.537 HD22 ' O ' ' A' ' 24' ' ' LEU 0.459 0.0 OUTLIER -107.2 60.82 0.62 Allowed 'General case' 0 N--CA 1.393 -3.295 0 C-N-CA 116.887 -1.925 . . . . 0.0 113.121 178.557 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.581 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 25.2 p -113.59 62.48 0.95 Allowed Pre-proline 0 C--N 1.271 -2.829 0 CA-C-N 113.491 -1.686 . . . . 0.0 113.62 173.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.457 ' HD3' ' C ' ' A' ' 24' ' ' LEU . 24.4 Cg_endo -115.41 26.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.26 0 N-CA-C 107.883 -1.622 . . . . 0.0 107.883 159.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 17.4 m -94.32 159.61 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.457 -173.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.58 151.72 36.73 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.548 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.34 -132.2 11.52 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.302 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -93.85 11.94 27.61 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.652 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 42.6 mt-10 -68.09 151.51 46.92 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 170.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -131.58 114.96 15.48 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.495 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -147.72 -120.21 1.15 Allowed Glycine 0 N--CA 1.406 -3.347 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.964 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.581 ' HA2' ' HB3' ' A' ' 25' ' ' SER . . . 98.54 172.79 32.17 Favored Glycine 0 N--CA 1.408 -3.175 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 -171.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 1.1 p -88.94 104.09 14.56 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.075 0 CA-C-O 123.033 1.396 . . . . 0.0 108.303 173.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -133.13 163.35 51.74 Favored Pre-proline 0 C--N 1.271 -2.829 0 CA-C-N 112.536 -2.12 . . . . 0.0 110.894 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.542 ' HB2' HD12 ' A' ' 58' ' ' ILE . 14.5 Cg_exo -70.87 141.3 40.38 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.746 1.631 . . . . 0.0 109.749 166.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 20' ' ' TYR . 32.3 m -127.12 162.52 31.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 124.511 1.125 . . . . 0.0 108.182 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 34.8 m -104.1 128.89 57.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.671 176.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.423 HD13 HG12 ' A' ' 55' ' ' VAL . 33.0 mm -88.61 104.96 15.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -99.96 -16.34 7.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.594 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -43.75 139.28 2.32 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 127.168 2.187 . . . . 0.0 114.667 -170.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -46.81 145.64 1.9 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.22 -32.81 74.11 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -79.11 -25.76 42.95 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.408 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.77 -33.46 80.32 Favored Glycine 0 C--O 1.199 -2.058 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.553 ' N ' HE22 ' A' ' 42' ' ' GLN 0.257 20.1 p30 -75.45 -19.68 59.3 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.366 -178.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -85.46 -59.3 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.235 172.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.52 -19.06 18.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -167.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 m -102.22 135.91 19.53 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.524 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.69 -12.55 16.59 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.066 1.844 . . . . 0.0 110.783 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 3.0 p -100.21 134.14 43.57 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.485 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 93' ' ' THR . 61.4 t -121.37 140.19 46.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.594 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 3.3 tp -105.72 125.1 61.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 123.543 0.737 . . . . 0.0 109.28 173.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.736 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 14.0 m -130.64 162.28 38.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.335 -175.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.553 ' HA ' HG22 ' A' ' 91' ' ' ILE . . . -118.99 132.37 56.06 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.056 0.942 . . . . 0.0 108.93 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.74 128.89 38.01 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.542 HD12 ' HB2' ' A' ' 37' ' ' PRO . 61.1 mt -85.63 132.67 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.795 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 61' ' ' ARG . 78.3 m -125.92 133.92 51.72 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.192 0.52 . . . . 0.0 111.44 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.51 36.06 3.01 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.516 ' H ' HG22 ' A' ' 59' ' ' THR . 39.4 ttm180 -115.35 -2.9 12.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.225 1.012 . . . . 0.0 108.795 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.6 tt -144.09 150.96 16.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -122.44 -27.65 4.4 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.644 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -106.73 118.58 37.04 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.204 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.478 ' HB2' ' HG3' ' A' ' 72' ' ' GLU . . . -62.95 -57.91 9.13 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.79 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 72.8 -58.17 0.61 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.589 1.555 . . . . 0.0 111.44 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.9 tt -94.31 139.49 22.46 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.71 2.12 2.24 Favored 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 123.103 2.536 . . . . 0.0 116.018 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 121' ' ' SER . 51.9 p -92.0 -19.15 22.69 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 122.497 1.141 . . . . 0.0 108.715 176.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.441 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 1.0 OUTLIER -101.15 133.35 45.82 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 171.311 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 4.4 p -133.44 145.51 33.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 117.046 -1.862 . . . . 0.0 112.434 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.478 ' HG3' ' HB2' ' A' ' 65' ' ' ALA . 21.4 mt-10 -87.66 124.54 33.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.636 1.174 . . . . 0.0 112.88 -173.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.555 HG21 ' CZ ' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -128.54 143.97 39.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.814 0.816 . . . . 0.0 112.852 175.152 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' OE2' ' HE3' ' A' ' 110' ' ' LYS . 1.3 mp0 -60.74 133.1 55.77 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.727 -178.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 83.8 tttt -55.11 -46.44 75.58 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.751 1.62 . . . . 0.0 109.889 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -58.5 -48.72 79.9 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 113.129 -1.85 . . . . 0.0 113.305 -174.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.535 ' HE2' ' OG ' ' A' ' 107' ' ' SER . 3.8 tmtm? -80.29 -38.27 31.11 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -171.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.555 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 4.5 m-85 -84.3 -7.03 59.45 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.601 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 67.93 28.12 6.99 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.43 179.4 5.54 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.533 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HE3' ' A' ' 75' ' ' LYS . 9.9 t70 -68.82 -28.09 66.43 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.605 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.449 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -150.25 166.8 28.82 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -176.484 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -60.31 146.48 43.85 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.0 t -120.55 160.03 24.01 Favored 'General case' 0 N--CA 1.414 -2.247 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.558 -168.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 26.5 t -127.91 127.1 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 174.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.481 HG22 HD22 ' A' ' 88' ' ' LEU . 1.5 mp -100.96 131.62 48.27 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.6 mt -99.13 109.28 22.0 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 113.771 -1.559 . . . . 0.0 107.825 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.481 HD22 HG22 ' A' ' 86' ' ' ILE . 3.1 mm? -88.04 0.08 56.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.591 0.71 . . . . 0.0 111.313 -174.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -98.69 -24.71 14.95 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-O 122.263 1.03 . . . . 0.0 109.654 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.504 ' HA ' HG21 ' B' ' 93' ' ' THR . 0.0 OUTLIER -103.55 85.51 2.47 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.033 177.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.736 ' HB ' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -139.99 171.25 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.202 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -176.337 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.451 ' HD3' HD23 ' A' ' 24' ' ' LEU . 11.9 ptm180 -168.6 169.63 10.12 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.499 HG21 ' HA ' ' B' ' 90' ' ' GLN . 58.4 m -103.93 125.7 50.51 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.518 -1.674 . . . . 0.0 109.329 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.8 mt -132.59 140.77 48.39 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 126.065 1.746 . . . . 0.0 107.419 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.8 OUTLIER -80.09 153.43 28.74 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.007 175.77 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -37.96 -38.18 0.3 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.67 1.588 . . . . 0.0 114.759 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -54.94 -27.55 44.37 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 124.881 1.272 . . . . 0.0 112.281 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -84.18 -27.56 27.96 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.729 -0.607 . . . . 0.0 110.2 -176.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.0 mp -74.04 127.03 31.84 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 123.772 0.829 . . . . 0.0 109.479 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 23' ' ' ASP . 68.3 mttm -94.95 -66.65 0.9 Allowed 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.577 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.11 147.9 21.55 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-O 121.422 0.63 . . . . 0.0 111.247 -170.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 124.48 23.74 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.34 -1.754 . . . . 0.0 109.999 173.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.646 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 9.0 tp -112.64 -56.74 2.37 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.128 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.646 ' OG1' ' HG ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -124.59 -169.12 1.92 Allowed 'General case' 0 N--CA 1.394 -3.231 0 C-N-CA 118.833 -1.147 . . . . 0.0 113.986 -176.106 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 17' ' ' GLY . 8.4 p90 -161.28 142.01 11.17 Favored 'General case' 0 CA--C 1.487 -1.463 0 C-N-CA 125.58 1.552 . . . . 0.0 109.641 -170.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.72 152.15 34.92 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.535 ' OG ' ' HE2' ' A' ' 77' ' ' LYS . 15.8 m -77.02 171.28 15.05 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.834 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 111' ' ' MET . 9.4 m-20 -64.19 -36.94 85.7 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.272 0.558 . . . . 0.0 110.679 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 15.3 t70 -64.65 -39.31 93.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.947 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 110' ' ' LYS . 3.1 mptp? -75.84 -26.87 57.57 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.337 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.528 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -55.49 -39.94 71.07 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.851 1.26 . . . . 0.0 108.137 169.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 9.1 mmpt? -87.18 -1.66 58.06 Favored 'General case' 0 N--CA 1.394 -3.272 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.721 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 109' ' ' ASP . 32.7 mt-10 -90.89 -55.09 3.69 Favored 'General case' 0 N--CA 1.397 -3.113 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.63 -59.76 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-N 111.831 -2.44 . . . . 0.0 112.717 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 63.4 m-20 -62.71 -39.29 93.58 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 123.134 1.445 . . . . 0.0 111.023 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 17.7 t30 -74.01 -45.87 47.1 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 113.425 -1.716 . . . . 0.0 112.917 -172.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.68 73.35 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 12.5 tp -69.43 -40.28 77.33 Favored 'General case' 0 N--CA 1.389 -3.484 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.367 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.542 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 2.5 ttp -65.2 -27.98 69.06 Favored 'General case' 0 N--CA 1.408 -2.556 0 C-N-CA 123.775 0.83 . . . . 0.0 109.817 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.3 mt -80.29 -52.9 13.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 176.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.441 ' HA ' HG22 ' A' ' 69' ' ' THR . 38.1 t -50.39 -33.79 21.95 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.185 -1.825 . . . . 0.0 113.831 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 31.9 mt -97.5 9.35 42.63 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.006 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.51 10.73 81.35 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 115.741 1.056 . . . . 0.0 115.741 173.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.542 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.5 mm? -67.8 -54.34 19.91 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 51.57 -153.66 0.19 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.037 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.94 26.89 1.97 Allowed 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 122.257 1.027 . . . . 0.0 109.023 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.62 42.78 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.329 0 C-N-CA 126.044 1.738 . . . . 0.0 106.482 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.67 -16.89 52.82 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.429 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 30.4 m80 72.35 124.24 0.03 OUTLIER 'General case' 0 C--O 1.248 1.007 0 C-N-CA 125.581 1.552 . . . . 0.0 112.35 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -83.22 139.11 33.31 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -80.21 94.87 6.13 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.67 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 C--N 1.305 -1.335 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.526 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.081 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -126.65 108.66 11.3 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m -84.44 -14.38 49.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.705 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -73.95 91.78 2.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.214 1.007 . . . . 0.0 109.454 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -99.1 -5.33 30.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.679 -1.146 . . . . 0.0 113.03 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -84.46 91.63 7.88 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.481 ' CE1' ' HB2' ' B' ' 9' ' ' HIS . 11.2 t-160 -114.81 123.47 49.29 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.563 -176.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -74.28 -55.49 5.97 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' HIS . . . . . 0.481 ' HB2' ' CE1' ' B' ' 7' ' ' HIS . 14.9 t-80 56.96 -81.97 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.463 1.505 . . . . 0.0 113.648 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.2 m -91.89 8.47 37.19 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.296 0.569 . . . . 0.0 111.039 -176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -116.16 76.44 1.02 Allowed 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.438 0.637 . . . . 0.0 111.136 177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -110.71 134.44 20.92 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.64 94.36 0.15 Allowed 'Trans proline' 0 C--O 1.239 0.567 0 C-N-CA 122.358 2.039 . . . . 0.0 113.1 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 65.1 mt -76.98 130.58 36.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -146.82 161.56 40.42 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -83.55 124.06 30.38 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.26 175.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 127.14 -15.63 6.45 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.806 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -96.73 149.52 21.73 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.678 0.751 . . . . 0.0 109.694 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.599 ' HB ' ' H ' ' B' ' 104' ' ' THR . 51.0 t -100.68 121.74 51.84 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.253 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.435 ' O ' HG22 ' B' ' 38' ' ' VAL . 20.6 m-85 -111.83 146.25 38.0 Favored 'General case' 0 CA--C 1.456 -2.646 0 C-N-CA 124.193 0.997 . . . . 0.0 111.967 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.09 145.29 31.17 Favored 'General case' 0 C--N 1.267 -2.992 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 167.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -144.0 131.77 21.35 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 113.747 -1.57 . . . . 0.0 108.009 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.447 ' HA ' ' HB ' ' B' ' 35' ' ' VAL . 6.1 p-10 -87.72 89.76 8.12 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.79 174.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.551 ' O ' HD22 ' B' ' 24' ' ' LEU 0.452 0.0 OUTLIER -108.85 59.84 0.6 Allowed 'General case' 0 N--CA 1.393 -3.295 0 CA-C-O 124.196 1.951 . . . . 0.0 112.426 177.533 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.588 ' HB3' ' HA2' ' B' ' 34' ' ' GLY . 10.9 p -111.62 62.62 0.53 Allowed Pre-proline 0 C--N 1.267 -2.992 0 CA-C-N 113.141 -1.845 . . . . 0.0 113.433 174.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.502 ' HD3' ' C ' ' B' ' 24' ' ' LEU . 22.3 Cg_endo -116.89 26.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.082 0 N-CA-C 107.692 -1.695 . . . . 0.0 107.692 158.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 18.6 m -95.01 156.39 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.87 151.74 37.56 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.535 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.04 -132.05 11.03 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -94.02 10.94 31.55 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.641 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 43.4 mt-10 -66.93 151.6 47.28 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -132.89 116.57 16.64 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -173.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLY . . . . . 0.514 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -149.27 -116.21 0.81 Allowed Glycine 0 N--CA 1.404 -3.494 0 C-N-CA 119.88 -1.152 . . . . 0.0 114.013 175.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.588 ' HA2' ' HB3' ' B' ' 25' ' ' SER . . . 96.63 177.83 35.36 Favored Glycine 0 N--CA 1.413 -2.886 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -171.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' B' ' 23' ' ' ASP . 1.0 OUTLIER -93.74 102.87 14.08 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-O 123.167 1.46 . . . . 0.0 107.95 172.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -132.13 163.52 49.66 Favored Pre-proline 0 C--N 1.268 -2.966 0 CA-C-N 111.978 -2.374 . . . . 0.0 110.765 -172.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.512 ' HB2' HD12 ' B' ' 58' ' ' ILE . 14.0 Cg_exo -71.21 140.92 38.3 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 121.671 1.581 . . . . 0.0 109.865 165.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.435 HG22 ' O ' ' B' ' 20' ' ' TYR . 28.3 m -126.89 162.63 31.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 124.667 1.187 . . . . 0.0 108.157 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.6 m -104.72 129.66 56.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.671 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 32.1 mm -89.22 105.16 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.41 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.1 OUTLIER -100.07 -17.37 6.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.01 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.596 HE22 ' N ' ' B' ' 47' ' ' ASN . 0.6 OUTLIER -43.13 140.51 1.47 Allowed 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 127.03 2.132 . . . . 0.0 114.686 -170.749 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -47.89 149.55 1.31 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.331 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.576 ' HA ' ' ND2' ' B' ' 47' ' ' ASN . 30.0 t70 -71.83 -32.07 67.18 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.743 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 3.8 m -76.98 -25.07 52.31 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.127 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.62 -35.83 90.47 Favored Glycine 0 C--O 1.199 -2.048 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.596 ' N ' HE22 ' B' ' 42' ' ' GLN . 13.0 p30 -74.35 -19.09 60.57 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.339 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' B' ' 44' ' ' ASP . 14.0 mptt -85.64 -61.59 1.72 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.203 174.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -96.58 -16.68 20.92 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 -168.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -98.62 140.75 22.01 Favored Pre-proline 0 C--N 1.302 -1.473 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.306 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.43 -11.77 11.68 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.932 1.754 . . . . 0.0 110.26 173.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.4 p -101.35 137.69 39.36 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 124.879 1.271 . . . . 0.0 111.455 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' B' ' 93' ' ' THR . 60.2 t -124.22 140.21 48.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.564 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 3.2 tp -105.69 124.74 60.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 123.455 0.702 . . . . 0.0 109.402 173.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.721 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 13.6 m -130.64 162.54 38.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.328 -175.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' B' ' 91' ' ' ILE . . . -118.89 132.79 56.11 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 124.27 1.028 . . . . 0.0 108.759 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.1 129.54 39.71 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' B' ' 37' ' ' PRO . 60.5 mt -86.64 133.18 30.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.202 174.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 59' ' ' THR . . . . . 0.497 HG22 ' H ' ' B' ' 61' ' ' ARG . 75.1 m -127.11 133.01 50.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.24 0.543 . . . . 0.0 112.223 -176.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.19 41.49 1.77 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.497 ' H ' HG22 ' B' ' 59' ' ' THR . 42.1 ttm180 -118.27 -11.43 10.07 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.938 0.875 . . . . 0.0 109.468 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 12.3 tt -138.43 145.78 27.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -116.45 -29.39 6.18 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.999 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -103.37 123.61 47.14 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' ALA . . . . . 0.553 ' HB2' ' HG3' ' B' ' 72' ' ' GLU . . . -64.89 -59.06 4.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.403 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 61.8 tttp 72.32 -57.87 0.61 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.908 1.283 . . . . 0.0 111.655 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.1 tt -97.47 134.62 22.37 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.82 -4.32 4.58 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 123.821 3.014 . . . . 0.0 116.153 -174.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 74.8 p -87.21 -18.99 29.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.407 1.098 . . . . 0.0 108.848 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' HIS . . . . . 0.411 ' O ' ' HB1' ' B' ' 65' ' ' ALA . 1.4 m-70 -99.83 134.8 42.2 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 170.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 5.1 p -134.24 144.98 33.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 116.979 -1.888 . . . . 0.0 112.364 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.553 ' HG3' ' HB2' ' B' ' 65' ' ' ALA . 31.2 mt-10 -88.62 127.88 35.57 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.25 1.02 . . . . 0.0 112.149 -175.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.575 HG21 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -128.33 149.12 32.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 O-C-N 123.708 0.63 . . . . 0.0 112.063 175.168 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -64.19 131.89 48.74 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.329 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -54.62 -46.69 73.92 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 125.732 1.613 . . . . 0.0 109.813 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -56.29 -50.21 72.04 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.851 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -78.78 -39.06 36.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.63 -170.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.575 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 4.4 m-85 -84.14 -6.99 59.49 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.977 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 68.6 29.28 5.52 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.19 178.88 5.38 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.382 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -70.59 -25.0 62.86 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.422 -1.717 . . . . 0.0 111.156 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.411 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -151.68 163.52 38.94 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -176.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.37 143.92 43.42 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 22.1 t -121.3 156.83 31.69 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 119.639 -0.825 . . . . 0.0 112.257 -167.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 25.9 t -123.7 126.97 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.46 HG22 HD22 ' B' ' 88' ' ' LEU . 1.5 mp -100.24 131.33 47.93 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.158 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 31.8 mt -98.99 108.15 20.76 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.03 -177.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.46 HD22 HG22 ' B' ' 86' ' ' ILE . 3.3 mm? -86.97 -0.26 56.3 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.723 0.773 . . . . 0.0 111.52 -174.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -100.15 -22.65 15.1 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 122.372 1.082 . . . . 0.0 109.928 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLN . . . . . 0.499 ' HA ' HG21 ' A' ' 93' ' ' THR . 0.0 OUTLIER -104.62 85.66 2.36 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.992 177.448 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.721 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 0.3 OUTLIER -140.1 171.41 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.494 ' HD3' HD23 ' B' ' 24' ' ' LEU . 11.7 ptm180 -168.98 169.34 9.67 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 90' ' ' GLN . 72.0 m -104.43 126.31 51.41 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.549 -177.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -132.55 142.88 49.37 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 126.069 1.748 . . . . 0.0 107.432 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 1.7 p-10 -81.18 152.06 27.9 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.019 -1.473 . . . . 0.0 108.96 175.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -35.48 -40.01 0.15 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.891 1.676 . . . . 0.0 115.148 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -51.34 -31.79 23.26 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 125.027 1.331 . . . . 0.0 112.632 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -79.93 -27.51 39.84 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.963 0.411 . . . . 0.0 110.193 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -75.01 124.56 27.19 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 122.01 0.91 . . . . 0.0 109.563 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -95.49 -60.08 1.74 Allowed 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.902 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -161.02 148.43 15.4 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-O 121.504 0.669 . . . . 0.0 111.737 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.63 121.06 18.12 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.85 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.628 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 8.4 tp -109.37 -55.39 2.43 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.628 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 0.3 OUTLIER -124.13 -168.57 1.82 Allowed 'General case' 0 N--CA 1.391 -3.424 0 C-N-CA 118.421 -1.312 . . . . 0.0 114.497 -176.724 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.493 ' H ' HG22 ' B' ' 104' ' ' THR . 19.9 p90 -161.48 141.69 10.68 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 125.808 1.643 . . . . 0.0 109.383 -171.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.9 150.73 36.6 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.44 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t -78.25 170.18 17.05 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.473 -175.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.508 ' O ' ' HB3' ' B' ' 111' ' ' MET . 4.6 m-20 -60.8 -38.48 85.49 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.683 0.793 . . . . 0.0 111.121 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 27.1 t70 -64.58 -38.27 90.44 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.148 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.495 ' HD2' ' N ' ' B' ' 110' ' ' LYS . 2.6 mptp? -75.55 -27.71 58.74 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.247 -178.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.508 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.2 OUTLIER -54.87 -40.25 69.52 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 124.912 1.285 . . . . 0.0 108.058 170.041 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.535 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 7.7 mmpt? -86.6 -2.43 58.49 Favored 'General case' 0 N--CA 1.384 -3.769 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.314 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 113' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' B' ' 109' ' ' ASP . 38.3 mt-10 -90.69 -55.51 3.54 Favored 'General case' 0 C--N 1.261 -3.271 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 172.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.18 -59.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 CA-C-N 111.594 -2.548 . . . . 0.0 112.786 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 56.7 m-20 -62.65 -40.24 96.42 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.14 1.448 . . . . 0.0 111.227 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.332 43.1 t30 -75.1 -42.96 55.52 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 113.531 -1.668 . . . . 0.0 112.602 -170.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -64.18 -31.76 73.08 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 11.2 tp -70.72 -35.09 72.56 Favored 'General case' 0 N--CA 1.39 -3.445 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.047 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.554 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 2.3 ttp -69.05 -21.49 64.09 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-O 121.686 0.755 . . . . 0.0 109.303 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' B' ' 117' ' ' ALA . 51.6 mt -87.89 -53.5 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' B' ' 118' ' ' LEU . 79.1 p -53.94 -28.48 37.33 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 26.2 mt -97.06 5.28 50.64 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.187 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.15 13.01 78.14 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 115.954 1.142 . . . . 0.0 115.954 172.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.554 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.5 mm? -68.32 -52.95 27.84 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 23.7 m120 51.71 -152.85 0.21 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 112.979 -1.919 . . . . 0.0 109.474 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.69 26.24 2.09 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 122.481 1.134 . . . . 0.0 108.947 173.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.06 39.77 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.01 0 C-N-CA 125.705 1.602 . . . . 0.0 106.962 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.73 -17.48 59.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.887 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 22.8 m80 73.04 143.03 0.06 Allowed 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.549 1.54 . . . . 0.0 110.985 -178.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -100.02 145.78 27.5 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -84.06 96.5 8.91 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 C--N 1.3 -1.551 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.526 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.971 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -83.85 -10.02 58.33 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t -114.21 103.2 10.87 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -126.02 -53.96 1.51 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 71.16 174.74 0.3 Allowed 'General case' 0 C--O 1.246 0.915 0 C-N-CA 125.1 1.36 . . . . 0.0 113.183 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -157.67 173.47 16.79 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.8 m80 74.75 -52.57 0.68 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.734 1.213 . . . . 0.0 113.703 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -45.58 -39.26 7.38 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.601 1.16 . . . . 0.0 112.34 -174.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -119.64 -33.23 4.09 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.421 175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.5 m -59.71 -47.25 86.38 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -178.2 101.09 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.78 129.91 82.45 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.17 98.99 0.33 Allowed 'Trans proline' 0 C--O 1.252 1.184 0 C-N-CA 122.406 2.07 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.8 mt -69.72 132.38 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.739 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -146.54 156.91 43.59 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -70.36 124.91 25.32 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 169.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.14 -26.21 3.78 Favored Glycine 0 C--N 1.302 -1.359 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.093 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -97.41 167.43 11.0 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.776 0.798 . . . . 0.0 109.427 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.472 HG11 HG22 ' A' ' 104' ' ' THR . 24.7 t -122.42 139.39 49.48 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.56 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.516 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.2 m-85 -133.5 148.66 51.7 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.4 151.62 39.65 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 168.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -141.58 135.48 30.1 Favored 'General case' 0 CA--C 1.454 -2.736 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.217 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.39 93.59 9.58 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 166.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.471 HD13 ' HD3' ' A' ' 92' ' ' ARG . 1.1 pp -109.83 28.9 8.12 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.282 -1.327 . . . . 0.0 107.814 -174.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.29 62.25 0.0 OUTLIER Pre-proline 0 C--N 1.267 -3.002 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -112.87 25.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.938 0 N-CA-C 107.232 -1.872 . . . . 0.0 107.232 153.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.695 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 13.9 m -83.56 160.45 3.49 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -173.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.52 145.84 31.21 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 113.311 -1.768 . . . . 0.0 113.249 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.32 -114.21 6.65 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.602 -1.181 . . . . 0.0 114.637 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -78.34 -9.1 59.12 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 123.827 0.851 . . . . 0.0 112.963 -173.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.695 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 50.7 mt-10 -71.3 159.89 33.78 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -132.29 111.41 11.35 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -174.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.0 -162.54 15.11 Favored Glycine 0 N--CA 1.408 -3.23 0 C-N-CA 119.155 -1.497 . . . . 0.0 115.02 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.6 -156.81 26.45 Favored Glycine 0 N--CA 1.407 -3.283 0 N-CA-C 103.419 -3.872 . . . . 0.0 103.419 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 59.3 t -83.03 99.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.438 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 169.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -130.8 146.51 62.33 Favored Pre-proline 0 C--N 1.252 -3.652 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.277 -172.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HB2' HD12 ' A' ' 58' ' ' ILE . 25.4 Cg_exo -62.98 137.12 60.49 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 121.702 1.601 . . . . 0.0 109.929 171.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 31.1 m -127.6 154.87 38.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 29.8 m -97.77 129.92 47.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.125 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.415 HD13 HG12 ' A' ' 55' ' ' VAL . 25.9 mm -91.36 107.19 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -13.82 9.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.285 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.533 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 5.0 pt20 -52.11 165.24 0.23 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 -169.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -65.51 174.43 2.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.613 -2.085 . . . . 0.0 112.118 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 9.9 t70 -72.56 -48.24 41.65 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.268 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.5 m -70.38 -30.98 68.03 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.477 0.711 . . . . 0.0 112.253 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 50' ' ' SER . . . -62.32 -33.41 86.05 Favored Glycine 0 C--O 1.205 -1.67 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.691 -175.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.52 ' N ' HE22 ' A' ' 42' ' ' GLN . 10.1 p30 -84.65 -37.13 21.4 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.841 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.645 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 24.4 mmtp -67.6 -63.19 1.11 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.386 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.645 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 19.0 m-85 -102.09 -35.86 8.77 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -168.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.477 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 22.5 m -82.47 157.92 66.88 Favored Pre-proline 0 N--CA 1.422 -1.832 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.677 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 86.4 Cg_endo -86.95 -20.85 2.23 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 121.099 1.199 . . . . 0.0 111.797 174.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.483 HG21 ' HG2' ' B' ' 90' ' ' GLN . 11.3 p -99.6 135.3 41.23 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.533 ' HB ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -133.42 139.2 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.906 176.074 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.5 tt -81.74 126.85 39.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.964 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 34.5 m -132.97 154.98 40.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.582 174.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.586 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -115.91 133.09 56.39 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.3 136.02 56.76 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.521 HG12 HD12 ' A' ' 86' ' ' ILE . 49.2 mt -98.07 131.47 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.736 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 m -105.54 108.34 19.81 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.27 44.98 2.95 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.479 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -162.53 172.99 14.6 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 81.2 mt 73.22 123.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.991 0 O-C-N 124.387 1.055 . . . . 0.0 111.425 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -112.79 17.95 18.62 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.41 -0.806 . . . . 0.0 110.784 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -128.8 109.87 11.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.554 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.82 -70.73 0.71 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 172.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 54.58 33.09 18.33 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.837 1.255 . . . . 0.0 112.987 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tt -151.14 139.64 13.06 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.12 -4.7 12.05 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 122.427 2.084 . . . . 0.0 115.246 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.3 p -100.09 -17.92 17.22 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.377 0.608 . . . . 0.0 111.363 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -118.55 128.45 54.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.411 HG12 HD13 ' A' ' 73' ' ' ILE . 61.0 t -111.27 134.26 54.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.208 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -99.69 124.79 45.28 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 123.744 0.653 . . . . 0.0 109.363 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.521 HD11 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -116.35 153.27 18.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.209 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -54.08 129.56 34.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.058 -1.428 . . . . 0.0 112.815 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.644 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 93.1 mttt -51.98 -56.79 12.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.457 178.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -67.98 -45.84 73.03 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.193 -169.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -62.84 -33.05 74.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.016 0.436 . . . . 0.0 111.394 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.492 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 12.1 m-85 -92.9 2.31 56.85 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 123.924 0.89 . . . . 0.0 111.14 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.3 tptt 72.22 15.95 5.28 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.507 1.523 . . . . 0.0 113.562 171.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.53 175.42 6.56 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-O 122.492 1.139 . . . . 0.0 110.983 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.495 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 10.3 t70 -85.08 -27.08 26.54 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 112.944 -1.934 . . . . 0.0 110.1 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.499 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -139.31 157.09 46.5 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.42 -174.19 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.644 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 6.5 m-20 -45.89 135.44 7.15 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 124.92 1.388 . . . . 0.0 112.055 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 73' ' ' ILE . 15.4 m -103.73 121.8 43.76 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.667 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.8 t -107.74 136.51 42.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.521 HG12 HD11 ' A' ' 73' ' ' ILE . 15.9 mm -111.68 134.41 54.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.1 mt -104.91 97.42 7.29 Favored 'General case' 0 N--CA 1.416 -2.164 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.0 mm? -81.25 -9.42 59.77 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.497 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -95.41 -25.93 16.07 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.762 0.791 . . . . 0.0 111.292 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' B' ' 93' ' ' THR . 1.1 tm0? -80.28 -60.88 2.16 Favored 'General case' 0 C--O 1.164 -3.433 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.246 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.586 HG22 ' CB ' ' A' ' 56' ' ' ALA . 1.3 pp 30.05 -174.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.529 3.475 0 C-N-CA 129.646 3.178 . . . . 0.0 116.814 175.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.471 ' HD3' HD13 ' A' ' 24' ' ' LEU . 8.7 ptm85 -176.96 159.6 1.72 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 167.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' B' ' 90' ' ' GLN . 0.0 OUTLIER -114.54 108.36 16.74 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.743 1.217 . . . . 0.0 109.356 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.535 ' HB2' ' CZ ' ' A' ' 98' ' ' ARG . 64.9 mt -131.82 149.58 52.42 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -173.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.677 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 11.8 t70 -50.72 145.17 7.22 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 173.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 33.1 pttt -55.58 -29.74 59.6 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.589 1.556 . . . . 0.0 114.608 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 20.1 ttmm -47.56 -39.08 15.63 Favored 'General case' 0 C--N 1.274 -2.677 0 C-N-CA 126.243 1.817 . . . . 0.0 112.476 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.535 ' CZ ' ' HB2' ' A' ' 94' ' ' LEU . 1.7 ppt_? -73.39 -15.01 61.37 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -178.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 10.4 mp -61.75 120.6 10.98 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.912 0.885 . . . . 0.0 110.028 170.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.08 -64.27 1.08 Allowed 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.367 -177.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.4 pt-20 -156.67 145.32 19.95 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 121.786 0.803 . . . . 0.0 111.807 -172.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -60.81 120.82 10.86 Favored 'General case' 0 C--N 1.281 -2.379 0 C-N-CA 128.132 2.573 . . . . 0.0 108.814 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -114.66 -62.67 1.57 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.704 -0.798 . . . . 0.0 112.466 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.472 HG22 HG11 ' A' ' 19' ' ' VAL . 5.4 t -128.8 -160.98 1.07 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.243 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -159.39 149.25 18.77 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.052 0.941 . . . . 0.0 112.326 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.56 135.39 49.1 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 113.853 -1.522 . . . . 0.0 112.264 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 111' ' ' MET . 7.0 m -76.4 165.95 24.11 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 124.248 1.019 . . . . 0.0 110.597 176.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 111' ' ' MET . 23.3 t70 -67.71 -42.98 81.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.86 -28.86 69.28 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.737 0.78 . . . . 0.0 109.382 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 110' ' ' LYS . 71.5 mmtt -79.78 -28.78 40.3 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.684 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.8 OUTLIER -53.65 -44.55 69.69 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.153 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 10.0 mmpt? -75.13 -8.32 56.24 Favored 'General case' 0 N--CA 1.396 -3.161 0 CA-C-N 114.421 -1.263 . . . . 0.0 114.173 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -89.26 -51.56 5.51 Favored 'General case' 0 N--CA 1.397 -3.079 0 C-N-CA 116.735 -1.986 . . . . 0.0 106.264 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -53.72 -59.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 112.615 -2.084 . . . . 0.0 113.351 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 45.8 m-20 -59.73 -39.19 83.87 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 123.241 1.496 . . . . 0.0 110.989 -177.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 10.9 t30 -77.97 -40.46 39.25 Favored 'General case' 0 C--N 1.261 -3.275 0 CA-C-N 112.718 -2.037 . . . . 0.0 111.669 -173.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.525 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.69 -36.58 81.29 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.505 ' HA ' ' OG ' ' A' ' 121' ' ' SER . 5.2 tp -70.14 -37.02 75.18 Favored 'General case' 0 N--CA 1.394 -3.24 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.2 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.504 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 1.5 ttp -66.87 -22.99 65.96 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.872 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 117' ' ' ALA . 45.0 mt -88.07 -50.95 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 118' ' ' LEU . 83.5 p -59.33 -22.26 61.02 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.644 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 32.9 mt -103.73 1.28 31.58 Favored 'General case' 0 C--O 1.201 -1.486 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.501 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.35 16.86 54.71 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 117.137 1.615 . . . . 0.0 117.137 171.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.504 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.2 mm? -74.0 -52.34 13.08 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 58.04 -171.69 0.1 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 112.47 -2.15 . . . . 0.0 112.546 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.03 20.16 1.04 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.042 0.925 . . . . 0.0 111.098 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.37 79.04 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.61 142.73 32.53 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.69 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -69.34 -27.03 64.99 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.481 0.657 . . . . 0.0 110.69 -173.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -101.03 24.63 9.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.082 177.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -126.6 131.03 51.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.042 0.449 . . . . 0.0 111.109 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 . . . . . 0 C--O 1.256 1.417 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 175.097 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.393 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -84.28 -12.11 55.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.017 0.437 . . . . 0.0 111.569 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 48.0 t -117.76 110.39 17.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -133.21 -52.31 0.89 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 66.37 170.57 0.24 Allowed 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.683 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -152.55 171.72 17.68 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 52.6 m80 77.93 -52.62 0.51 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.739 1.215 . . . . 0.0 113.272 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -44.26 -42.95 6.99 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.897 1.279 . . . . 0.0 112.112 -174.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -114.23 -37.92 4.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.385 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 5.8 m -55.12 -57.04 13.38 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.667 0.787 . . . . 0.0 112.785 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -168.23 96.0 0.41 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -175.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.39 124.21 90.51 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.43 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.59 106.85 0.45 Allowed 'Trans proline' 0 C--O 1.251 1.131 0 C-N-CA 123.024 2.482 . . . . 0.0 112.313 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -78.6 131.89 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.902 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -145.8 156.89 43.88 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -70.24 128.92 37.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.92 -26.33 4.02 Favored Glycine 0 C--N 1.307 -1.051 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.551 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -97.42 169.69 9.57 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 121.762 0.791 . . . . 0.0 109.183 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.468 ' HB ' ' H ' ' B' ' 104' ' ' THR . 23.4 t -123.84 140.16 48.15 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.885 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.728 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 35.3 m-85 -132.9 148.96 52.29 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 124.162 0.985 . . . . 0.0 109.087 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.02 149.57 39.2 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 167.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -140.35 134.49 30.97 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.71 -175.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -86.5 93.58 9.2 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 166.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.462 HD13 ' HD3' ' B' ' 92' ' ' ARG . 1.1 pp -108.8 28.7 8.16 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.842 1.306 . . . . 0.0 108.011 -175.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.416 ' OG ' ' HA2' ' B' ' 34' ' ' GLY . 1.0 OUTLIER -90.27 62.72 0.0 OUTLIER Pre-proline 0 C--N 1.266 -3.058 0 N-CA-C 116.712 2.115 . . . . 0.0 116.712 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -113.67 25.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.981 0 N-CA-C 107.42 -1.8 . . . . 0.0 107.42 151.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.692 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 15.1 m -82.29 162.26 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -173.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.39 147.86 31.72 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.802 -1.544 . . . . 0.0 113.033 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.34 -114.53 6.79 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 114.622 -1.172 . . . . 0.0 114.323 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -75.56 -11.76 60.08 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 123.855 0.862 . . . . 0.0 113.168 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.692 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 50.3 mt-10 -71.03 158.4 36.57 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -131.91 112.6 12.58 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.4 -161.63 13.84 Favored Glycine 0 N--CA 1.408 -3.192 0 C-N-CA 119.379 -1.391 . . . . 0.0 114.971 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.416 ' HA2' ' OG ' ' B' ' 25' ' ' SER . . . 141.6 -158.53 26.6 Favored Glycine 0 C--N 1.267 -3.279 0 N-CA-C 103.403 -3.879 . . . . 0.0 103.403 -173.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 61.8 t -82.37 98.98 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 169.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -130.72 146.78 63.4 Favored Pre-proline 0 C--N 1.253 -3.592 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.096 -172.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.562 ' HB2' HD12 ' B' ' 58' ' ' ILE . 27.2 Cg_exo -63.49 138.03 63.07 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.766 1.644 . . . . 0.0 110.16 171.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 30.2 m -128.44 154.72 39.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.569 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 28.1 m -97.72 129.7 47.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.094 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 25.8 mm -91.31 106.27 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -14.77 9.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.25 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.575 ' OE1' ' HB3' ' B' ' 47' ' ' ASN . 0.1 OUTLIER -53.79 164.71 0.53 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -170.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -64.01 175.03 1.31 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.514 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' B' ' 48' ' ' LYS . 12.8 t70 -74.31 -47.32 35.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.866 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.9 m -70.52 -31.34 68.38 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.637 0.775 . . . . 0.0 112.199 -169.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' B' ' 50' ' ' SER . . . -62.48 -32.4 82.97 Favored Glycine 0 C--O 1.21 -1.401 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.424 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.575 ' HB3' ' OE1' ' B' ' 42' ' ' GLN . 9.7 p30 -84.65 -39.04 19.1 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.475 -0.89 . . . . 0.0 112.096 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.656 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 25.9 mmtp -65.74 -63.25 1.13 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.096 0.474 . . . . 0.0 111.726 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' TYR . . . . . 0.656 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 19.1 m-85 -102.14 -36.3 8.59 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -168.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.487 ' HB2' ' HA2' ' B' ' 46' ' ' GLY . 25.8 m -80.85 157.98 71.03 Favored Pre-proline 0 N--CA 1.418 -2.032 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.671 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 83.8 Cg_endo -87.39 -21.37 1.92 Allowed 'Trans proline' 0 N--CA 1.431 -2.162 0 C-N-CA 121.202 1.268 . . . . 0.0 111.662 173.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.457 HG21 ' HG2' ' A' ' 90' ' ' GLN . 9.5 p -99.41 135.12 41.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -170.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.98 138.79 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.316 175.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tt -82.3 127.39 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 124.979 1.311 . . . . 0.0 110.732 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 34.7 m -132.77 154.99 40.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.395 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.592 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -115.43 132.82 56.5 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.98 136.5 57.38 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.562 HD12 ' HB2' ' B' ' 37' ' ' PRO . 63.5 mt -97.34 132.26 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.702 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' B' ' 85' ' ' VAL . 26.3 m -106.13 106.11 16.46 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 174.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.24 43.98 3.25 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.001 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -163.31 172.76 14.2 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 81.9 mt 76.07 125.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 O-C-N 124.559 1.162 . . . . 0.0 111.533 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -114.15 19.16 16.61 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.542 0.686 . . . . 0.0 110.43 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -131.91 107.84 8.99 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.415 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.11 -72.57 0.64 Allowed 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 172.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 56.71 31.53 19.51 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.312 1.045 . . . . 0.0 112.719 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 8.6 tt -151.66 134.8 9.06 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.84 -3.39 4.55 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 122.962 2.441 . . . . 0.0 115.301 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 66.6 p -103.37 -15.64 15.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.309 0.576 . . . . 0.0 111.19 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -119.07 129.01 54.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 52.8 t -111.38 132.99 58.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.16 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -99.58 119.8 38.64 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.355 0.662 . . . . 0.0 109.557 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.526 HD11 HG12 ' B' ' 86' ' ' ILE . 0.0 OUTLIER -111.11 153.54 12.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.624 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.545 ' OE1' ' HE3' ' B' ' 110' ' ' LYS . 1.6 mp0 -53.1 128.99 29.54 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.818 1.324 . . . . 0.0 111.956 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 75' ' ' LYS . . . . . 0.634 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 94.0 mttt -52.15 -56.35 15.1 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.209 0.943 . . . . 0.0 111.364 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -68.81 -43.08 76.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.845 -168.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' LYS . . . . . 0.437 ' HB2' ' HE3' ' B' ' 77' ' ' LYS . 38.8 ttmt -64.95 -33.5 76.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.239 0.543 . . . . 0.0 110.878 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.422 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 14.7 m-85 -91.68 2.18 56.65 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.197 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 41.7 tptt 71.83 20.05 4.65 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.072 1.349 . . . . 0.0 113.074 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.71 174.05 6.41 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 122.573 1.178 . . . . 0.0 111.217 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -84.07 -26.09 29.3 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.88 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.443 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -140.97 156.75 46.0 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.385 -172.791 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.634 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 10.9 m-20 -46.64 135.28 8.87 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.902 1.376 . . . . 0.0 112.126 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 84' ' ' SER . . . . . 0.429 ' O ' HG12 ' B' ' 73' ' ' ILE . 14.9 m -103.89 122.6 45.51 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.887 -177.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' B' ' 59' ' ' THR . 8.9 t -107.88 137.16 40.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.539 ' CD1' HG12 ' B' ' 58' ' ' ILE . 16.5 mm -111.67 135.05 52.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 18.8 mt -105.38 98.72 8.38 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.1 mm? -82.03 -9.82 59.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.324 -172.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -95.58 -26.19 15.87 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.316 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -80.2 -60.7 2.23 Favored 'General case' 0 C--O 1.162 -3.534 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.138 -178.403 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.592 HG22 ' CB ' ' B' ' 56' ' ' ALA . 1.3 pp 30.02 -174.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 C-N-CA 129.605 3.162 . . . . 0.0 116.836 175.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.464 ' HE ' HD21 ' B' ' 94' ' ' LEU . 8.5 ptm85 -176.95 159.72 1.73 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 167.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -114.83 108.63 17.01 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.916 1.286 . . . . 0.0 109.453 179.549 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.53 ' HB2' ' CZ ' ' B' ' 98' ' ' ARG . 65.2 mt -131.77 150.94 51.99 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 11.7 t70 -51.9 146.12 8.84 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.32 0.509 . . . . 0.0 111.446 173.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' B' ' 99' ' ' LEU . 31.5 pttt -54.48 -33.34 59.58 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.095 1.358 . . . . 0.0 114.256 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -41.28 -40.69 1.71 Allowed 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 126.742 2.017 . . . . 0.0 113.693 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.53 ' CZ ' ' HB2' ' B' ' 94' ' ' LEU . 1.7 ppt_? -73.72 -13.95 61.05 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' B' ' 96' ' ' LYS . 10.1 mp -63.39 118.48 8.13 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 123.83 0.852 . . . . 0.0 109.81 170.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.19 -64.07 1.1 Allowed 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.304 -1.317 . . . . 0.0 112.094 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 12.2 pt-20 -156.76 145.86 20.28 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-O 121.815 0.817 . . . . 0.0 111.55 -172.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -60.39 122.57 14.91 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 128.152 2.581 . . . . 0.0 108.891 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 13.0 tp -114.97 -62.33 1.62 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 119.566 -0.853 . . . . 0.0 112.393 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.468 ' H ' ' HB ' ' B' ' 19' ' ' VAL . 5.4 t -129.3 -160.79 1.06 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.317 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -159.31 147.76 17.86 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.262 1.025 . . . . 0.0 112.289 -169.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.79 140.52 36.95 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.0 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 15.1 t -82.91 162.41 21.55 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.074 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' B' ' 111' ' ' MET . 15.8 t70 -63.9 -44.74 92.09 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 122.73 0.412 . . . . 0.0 111.828 -175.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.7 -30.39 71.5 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.575 0.702 . . . . 0.0 110.363 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.545 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 70.0 mmtt -80.29 -27.01 38.62 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.999 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.4 OUTLIER -53.93 -44.36 70.58 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 169.131 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.42 ' N ' ' HE2' ' B' ' 112' ' ' LYS . 9.7 mmpt? -75.7 -8.2 56.23 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 114.215 -1.357 . . . . 0.0 113.792 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -89.92 -50.95 5.73 Favored 'General case' 0 N--CA 1.398 -3.055 0 C-N-CA 117.215 -1.794 . . . . 0.0 106.922 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -54.26 -59.85 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-N 112.586 -2.097 . . . . 0.0 112.96 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 47.1 m-20 -58.57 -42.06 87.1 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 123.07 1.414 . . . . 0.0 111.281 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.313 14.8 t30 -74.74 -40.9 61.0 Favored 'General case' 0 C--N 1.266 -3.044 0 CA-C-N 113.059 -1.882 . . . . 0.0 111.551 -174.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.428 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -63.78 -35.48 80.73 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.516 ' HA ' ' OG ' ' B' ' 121' ' ' SER . 5.2 tp -69.64 -36.94 76.54 Favored 'General case' 0 N--CA 1.394 -3.272 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.789 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.529 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 1.3 ttp -67.18 -22.58 65.74 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.375 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' B' ' 117' ' ' ALA . 60.3 mt -87.23 -53.92 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 121' ' ' SER . . . . . 0.516 ' OG ' ' HA ' ' B' ' 118' ' ' LEU . 78.1 p -55.37 -24.25 28.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.134 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 32.8 mt -101.48 0.66 37.09 Favored 'General case' 0 C--O 1.2 -1.504 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.958 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.33 16.48 55.41 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 116.98 1.552 . . . . 0.0 116.98 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.529 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.2 mm? -73.6 -51.72 15.88 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 22.2 m120 58.23 -170.04 0.12 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 112.488 -2.142 . . . . 0.0 112.252 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.96 19.54 2.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.814 0.816 . . . . 0.0 111.052 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.79 68.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.212 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.62 146.93 23.65 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.179 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -71.71 -24.96 61.89 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.404 0.621 . . . . 0.0 110.298 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -101.54 14.16 32.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.058 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -116.31 127.37 54.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.302 0.572 . . . . 0.0 111.028 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 . . . . . 0 C--N 1.293 -1.881 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.8 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.192 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 m -78.62 98.4 6.16 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.594 0.711 . . . . 0.0 111.461 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -78.57 126.92 31.41 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -73.66 92.4 1.96 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.485 0.659 . . . . 0.0 109.788 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -82.04 -38.36 25.1 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.371 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -125.11 170.42 11.22 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.968 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -91.54 125.43 36.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -78.57 96.15 5.39 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -74.23 -30.21 62.06 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -172.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -65.42 114.72 5.02 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 123.582 0.551 . . . . 0.0 110.104 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -86.42 -7.87 58.09 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.854 0.835 . . . . 0.0 109.074 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -96.59 113.18 62.2 Favored Pre-proline 0 N--CA 1.434 -1.228 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.203 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -91.55 3.39 4.21 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 122.578 2.185 . . . . 0.0 112.133 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.534 ' HB ' ' OD1' ' A' ' 47' ' ' ASN . 60.9 mt -105.59 131.6 54.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -116.38 144.68 43.97 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 172.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 41' ' ' ILE . 4.7 ttp180 -63.81 114.42 4.03 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 174.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.33 -16.52 5.43 Favored Glycine 0 N--CA 1.421 -2.35 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.78 172.02 12.91 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 122.815 1.293 . . . . 0.0 110.516 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.424 HG11 HG22 ' A' ' 104' ' ' THR . 12.6 t -132.68 128.99 58.18 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.425 0 CA-C-N 112.356 -2.202 . . . . 0.0 109.445 175.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 37.3 m-85 -126.38 147.38 49.77 Favored 'General case' 0 C--N 1.277 -2.567 0 C-N-CA 125.1 1.36 . . . . 0.0 108.325 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -82.17 161.48 22.77 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 170.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.17 133.08 13.24 Favored 'General case' 0 C--N 1.28 -2.424 0 O-C-N 123.982 0.801 . . . . 0.0 109.307 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.62 81.75 8.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 123.56 1.648 . . . . 0.0 109.258 173.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.519 ' C ' ' HD3' ' A' ' 26' ' ' PRO . 4.3 pp -89.27 3.66 51.32 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 113.009 -1.905 . . . . 0.0 111.95 -175.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.587 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 2.3 p -89.72 60.24 0.0 OUTLIER Pre-proline 0 C--N 1.272 -2.785 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.519 ' HD3' ' C ' ' A' ' 24' ' ' LEU . 19.1 Cg_endo -118.83 30.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.582 0 N-CA-C 106.889 -2.004 . . . . 0.0 106.889 152.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 24' ' ' LEU . 35.3 m -71.2 176.68 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.491 -173.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.25 138.45 31.41 Favored 'General case' 0 N--CA 1.41 -2.458 0 CA-C-N 114.004 -1.453 . . . . 0.0 113.8 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.04 -133.1 11.75 Favored Glycine 0 N--CA 1.421 -2.346 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.229 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.5 m -93.76 18.5 10.17 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 47.6 mt-10 -70.36 167.92 17.11 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.519 ' HB3' HE21 ' A' ' 90' ' ' GLN . 1.1 tm0? -101.21 119.08 38.22 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -174.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.27 151.93 17.55 Favored Glycine 0 CA--C 1.483 -1.914 0 N-CA-C 115.82 1.088 . . . . 0.0 115.82 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.587 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . 137.18 137.28 3.6 Favored Glycine 0 C--N 1.293 -1.821 0 CA-C-N 113.313 -1.444 . . . . 0.0 111.367 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 35' ' ' VAL . 2.7 p -72.09 105.83 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 123.17 1.462 . . . . 0.0 107.752 173.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -136.08 161.18 63.98 Favored Pre-proline 0 C--N 1.253 -3.617 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.792 -172.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 18.6 Cg_exo -67.68 142.87 59.85 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.025 1.817 . . . . 0.0 110.201 170.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 20' ' ' TYR . 27.8 m -123.18 158.56 28.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 123.608 0.763 . . . . 0.0 109.325 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 33.8 m -102.03 132.4 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.704 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mm -85.16 105.94 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.546 ' O ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -103.59 -12.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.946 -178.359 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.786 ' NE2' ' HB ' ' A' ' 53' ' ' VAL . 3.6 mt-30 -42.0 157.56 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 120.706 3.595 . . . . 0.0 120.706 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -69.3 145.79 52.76 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 110.815 -2.902 . . . . 0.0 108.024 164.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 47' ' ' ASN . 20.5 t70 -62.64 -30.88 71.69 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.84 -177.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.0 m -86.87 -27.1 23.64 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.969 -1.092 . . . . 0.0 111.793 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.59 -25.79 73.84 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 174.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.534 ' OD1' ' HB ' ' A' ' 14' ' ' ILE . 35.0 t30 -71.18 -39.39 71.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.991 -1.105 . . . . 0.0 109.77 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -74.26 -60.97 2.02 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . 0.46 16.6 p90 -128.36 2.03 5.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 119.352 3.093 . . . . 0.0 119.352 -173.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.5 m -86.86 134.21 37.72 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 172.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 34.0 Cg_exo -63.53 -29.54 70.81 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 121.606 1.538 . . . . 0.0 109.828 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.427 HG21 ' HG2' ' B' ' 90' ' ' GLN . 2.5 p -95.03 139.82 30.85 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.688 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.786 ' HB ' ' NE2' ' A' ' 42' ' ' GLN . 1.1 m -131.53 157.77 43.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.462 HG21 HD22 ' B' ' 122' ' ' LEU . 8.7 tt -109.56 131.12 61.32 Favored 'Isoleucine or valine' 0 C--O 1.251 1.156 0 CA-C-O 121.144 0.497 . . . . 0.0 109.798 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.455 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 30.0 m -137.73 160.4 33.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.952 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -120.2 142.25 49.17 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.21 143.97 36.69 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.616 HG12 ' CD1' ' A' ' 86' ' ' ILE . 67.7 mt -97.99 140.04 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-N 113.286 -1.779 . . . . 0.0 109.251 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.7 m -137.74 116.89 12.58 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.285 0.634 . . . . 0.0 110.122 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.64 54.44 0.58 Allowed Glycine 0 C--N 1.309 -0.922 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.576 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -124.89 2.72 8.09 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.037 0.446 . . . . 0.0 111.769 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.449 ' CG1' HG21 ' A' ' 85' ' ' VAL . 30.1 pt -140.02 164.9 22.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 174.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -101.87 -60.09 1.59 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.891 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -108.87 151.46 26.23 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.197 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.36 173.24 6.45 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.724 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -147.21 10.43 0.99 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.968 0.413 . . . . 0.0 111.121 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 mt -127.99 139.01 34.17 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.71 -6.73 11.26 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 122.439 2.093 . . . . 0.0 113.503 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.8 p -96.05 -18.0 20.53 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.434 0.635 . . . . 0.0 111.018 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.444 ' CD2' HD22 ' A' ' 87' ' ' LEU . 46.3 m170 -114.12 128.4 56.36 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.13 138.59 54.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 121.854 -0.529 . . . . 0.0 111.02 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.43 140.49 29.75 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.722 0.772 . . . . 0.0 111.745 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.895 HG21 ' CE1' ' A' ' 78' ' ' TYR . 3.0 mm -108.99 -176.19 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.623 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 73' ' ' ILE . 5.5 mm-40 -117.69 133.76 55.6 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -173.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.649 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 73.1 mttt -44.09 -53.24 6.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.64 1.213 . . . . 0.0 110.723 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -61.12 -32.25 71.94 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.701 -1.59 . . . . 0.0 113.93 -173.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -85.2 -27.82 25.86 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.622 0.725 . . . . 0.0 109.586 -173.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.895 ' CE1' HG21 ' A' ' 73' ' ' ILE . 2.1 m-85 -97.01 0.18 48.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.735 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.8 tttp 66.42 19.43 10.94 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 121.627 0.727 . . . . 0.0 111.148 176.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.455 ' HB3' ' H ' ' A' ' 82' ' ' LYS . 7.8 mp -96.94 172.18 8.02 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-O 122.927 1.346 . . . . 0.0 112.827 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.54 -24.27 42.29 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.613 -2.539 . . . . 0.0 109.725 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' NZ ' ' HB3' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -137.54 152.66 49.69 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.425 -173.191 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.649 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 11.7 p-10 -75.9 142.21 42.15 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.35 -1.296 . . . . 0.0 108.741 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -136.97 159.08 42.96 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.705 -172.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.449 HG21 ' CG1' ' A' ' 62' ' ' ILE . 23.4 t -110.61 153.74 12.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 124.512 1.125 . . . . 0.0 108.151 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.616 ' CD1' HG12 ' A' ' 58' ' ' ILE . 13.2 mm -117.71 140.34 41.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.444 HD22 ' CD2' ' A' ' 70' ' ' HIS . 36.7 mt -105.46 104.61 14.37 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -86.27 -7.18 58.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.055 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.56 -38.02 15.23 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.967 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.519 HE21 ' HB3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -98.12 77.05 2.4 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.822 -179.594 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.552 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -108.93 179.45 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . 0.264 7.6 ptp180 -163.3 160.92 24.36 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 175.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 96.8 m -117.55 114.67 23.78 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.764 -176.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.8 mt -131.7 147.4 52.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.275 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.59 ' OD1' ' HB3' ' A' ' 97' ' ' LYS . 2.7 p30 -72.04 152.09 42.67 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.042 172.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -48.01 -26.15 1.67 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 125.735 1.614 . . . . 0.0 114.202 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.59 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . 7.0 ttpm? -73.16 -18.86 61.23 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.128 0.571 . . . . 0.0 111.228 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.536 ' HA ' ' NE ' ' A' ' 98' ' ' ARG . 2.7 mmp_? -75.9 -31.03 59.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.39 0.614 . . . . 0.0 109.593 175.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.78 130.19 39.02 Favored 'General case' 0 CA--C 1.475 -1.911 0 CA-C-O 123.07 1.414 . . . . 0.0 110.595 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 13.9 tptt -90.25 -68.31 0.79 Allowed 'General case' 0 N--CA 1.391 -3.402 0 CA-C-N 111.745 -2.48 . . . . 0.0 113.023 -171.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 8.4 pt-20 -163.67 143.58 8.43 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 121.709 0.766 . . . . 0.0 111.829 -168.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -63.39 114.86 4.12 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 128.113 2.565 . . . . 0.0 109.531 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -112.0 -62.68 1.53 Allowed 'General case' 0 N--CA 1.417 -2.098 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.424 HG22 HG11 ' A' ' 19' ' ' VAL . 3.6 t -128.5 -162.5 1.19 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 117.736 -1.585 . . . . 0.0 112.912 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -160.41 140.43 11.32 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 125.228 1.411 . . . . 0.0 109.997 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.432 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 3.6 pp -108.81 157.49 18.54 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.156 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.432 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 11.8 m -89.82 174.03 7.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.323 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 111' ' ' MET . 11.0 m-20 -62.4 -32.56 73.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.202 1.001 . . . . 0.0 111.617 -177.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' A' ' 107' ' ' SER . 11.2 p-10 -70.46 -33.92 71.82 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.43 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -78.5 -28.5 46.34 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.495 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.578 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -47.47 -49.42 25.59 Favored 'General case' 0 CA--C 1.453 -2.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 168.122 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 9.9 mmpt? -76.71 -7.96 56.35 Favored 'General case' 0 N--CA 1.392 -3.372 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.4 -54.15 4.13 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 116.921 -1.911 . . . . 0.0 106.956 172.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -51.91 -59.03 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-N 112.359 -2.2 . . . . 0.0 112.968 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.554 ' O ' ' HB3' ' A' ' 118' ' ' LEU 0.261 26.0 t0 -61.41 -40.13 93.27 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.883 1.802 . . . . 0.0 109.718 -176.16 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 14.6 t30 -79.72 -41.99 25.57 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 112.171 -2.286 . . . . 0.0 112.009 -172.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.547 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.77 -36.11 80.08 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.554 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 3.0 tp -64.55 -41.8 96.1 Favored 'General case' 0 N--CA 1.382 -3.86 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.98 -176.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 34.3 mtp -61.53 -34.31 75.32 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-O 120.894 0.378 . . . . 0.0 110.882 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 117' ' ' ALA . 30.5 mt -75.07 -53.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.683 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.2 m -48.07 -34.9 10.3 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 113.254 -1.794 . . . . 0.0 113.156 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 23.2 mt -105.97 3.16 28.08 Favored 'General case' 0 C--O 1.188 -2.134 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.589 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.76 21.53 65.97 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 116.564 1.386 . . . . 0.0 116.564 172.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.74 -57.76 3.41 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 118.701 1.251 . . . . 0.0 110.022 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.9 m120 57.38 158.77 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 113.104 -1.862 . . . . 0.0 112.545 -169.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.66 11.12 9.52 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.556 -1.34 . . . . 0.0 111.811 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 t -113.08 9.09 8.03 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.885 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 58.99 31.63 21.54 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.174 -1.375 . . . . 0.0 113.062 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 70.67 115.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.752 1.221 . . . . 0.0 112.657 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -132.38 124.22 28.28 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -80.26 133.58 36.0 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 123.376 0.422 . . . . 0.0 110.963 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 . . . . . 0 CA--C 1.488 -1.434 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.678 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.614 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m -80.57 100.46 8.62 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 121.252 0.549 . . . . 0.0 111.28 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 16.6 m -84.89 129.12 34.86 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -71.47 99.89 2.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -88.88 -33.09 17.44 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.355 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -129.0 177.11 7.36 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -95.12 128.8 42.23 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -81.71 94.39 6.98 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -74.78 -24.35 58.66 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -171.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 68.1 p -71.54 120.01 16.51 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.753 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -86.66 -11.13 52.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -97.89 115.11 65.77 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.817 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -91.8 5.68 3.64 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.677 2.251 . . . . 0.0 112.07 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.582 ' HB ' ' OD1' ' B' ' 47' ' ' ASN . 71.3 mt -106.47 131.63 55.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -116.68 145.34 43.51 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.568 ' HD2' ' O ' ' B' ' 41' ' ' ILE . 4.6 ttp180 -63.89 114.35 4.02 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 175.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.78 -18.14 5.41 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.11 171.8 11.29 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 122.888 1.328 . . . . 0.0 110.14 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.444 HG11 HG22 ' B' ' 104' ' ' THR . 10.4 t -133.35 128.65 55.6 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.576 0 CA-C-N 112.292 -2.231 . . . . 0.0 109.155 176.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.528 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 34.4 m-85 -125.86 147.02 49.57 Favored 'General case' 0 C--N 1.27 -2.865 0 C-N-CA 125.194 1.398 . . . . 0.0 108.407 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.607 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.6 mp -82.23 159.81 23.13 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 170.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.88 133.2 13.59 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.711 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.95 82.19 8.56 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 123.658 1.694 . . . . 0.0 109.666 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.511 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 4.4 pp -90.21 4.78 49.55 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.121 -174.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.572 ' HB3' ' N ' ' B' ' 34' ' ' GLY . 2.3 p -90.21 59.91 0.0 OUTLIER Pre-proline 0 C--N 1.277 -2.55 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.511 ' HD3' ' C ' ' B' ' 24' ' ' LEU . 17.5 Cg_endo -118.59 31.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.112 0 N-CA-C 106.711 -2.073 . . . . 0.0 106.711 152.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 33.3 m -71.14 173.05 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.39 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -142.83 120.28 11.67 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 114.8 1.408 . . . . 0.0 114.8 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.52 -131.08 10.44 Favored Glycine 0 N--CA 1.416 -2.689 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.873 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -93.79 17.03 12.7 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.525 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 41.2 mt-10 -70.46 171.62 9.79 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' GLN . . . . . 0.401 ' HB3' HE21 ' B' ' 90' ' ' GLN . 0.0 OUTLIER -103.88 125.7 50.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -175.346 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.43 147.84 17.03 Favored Glycine 0 CA--C 1.486 -1.748 0 N-CA-C 115.409 0.923 . . . . 0.0 115.409 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.572 ' N ' ' HB3' ' B' ' 25' ' ' SER . . . 140.62 137.51 3.46 Favored Glycine 0 C--N 1.288 -2.134 0 CA-C-N 113.727 -1.236 . . . . 0.0 111.787 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -73.64 104.26 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-O 122.998 1.38 . . . . 0.0 107.473 173.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -135.2 161.99 60.19 Favored Pre-proline 0 C--N 1.249 -3.784 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.08 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 19.7 Cg_exo -68.05 142.92 57.93 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 122.047 1.831 . . . . 0.0 110.173 170.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 20' ' ' TYR . 28.7 m -123.74 159.13 29.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 123.552 0.741 . . . . 0.0 109.273 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 32.6 m -102.0 132.3 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 120.524 0.202 . . . . 0.0 110.759 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 mm -84.93 105.89 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.568 ' O ' ' HD2' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -103.44 -12.07 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.033 -178.288 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.797 ' NE2' ' HB ' ' B' ' 53' ' ' VAL . 4.0 mt-30 -42.05 157.55 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 120.945 3.683 . . . . 0.0 120.945 -174.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -69.41 145.15 53.07 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 110.833 -2.894 . . . . 0.0 108.279 165.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' B' ' 47' ' ' ASN . 22.2 t70 -61.85 -30.14 70.65 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.673 -176.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.9 m -87.19 -28.4 22.43 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.879 -174.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.436 ' HA2' ' OG ' ' B' ' 50' ' ' SER . . . -66.79 -26.8 73.09 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ASN . . . . . 0.582 ' OD1' ' HB ' ' B' ' 14' ' ' ILE . 34.6 t30 -68.04 -39.16 83.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.738 -1.231 . . . . 0.0 110.019 176.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -76.52 -66.08 0.85 Allowed 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . 0.439 19.4 p90 -124.31 6.96 8.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 -171.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.436 ' OG ' ' HA2' ' B' ' 46' ' ' GLY . 19.6 m -92.28 131.03 35.68 Favored Pre-proline 0 N--CA 1.428 -1.573 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 171.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.4 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 27.3 Cg_exo -63.28 -28.9 72.64 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 121.62 1.547 . . . . 0.0 110.268 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.467 HG21 ' HG2' ' A' ' 90' ' ' GLN . 1.8 p -94.9 138.84 32.14 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.398 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.797 ' HB ' ' NE2' ' B' ' 42' ' ' GLN . 1.2 m -130.49 158.86 42.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.466 HG21 HD22 ' A' ' 122' ' ' LEU . 9.0 tt -110.87 130.98 63.28 Favored 'Isoleucine or valine' 0 C--O 1.253 1.277 0 CA-C-O 121.269 0.557 . . . . 0.0 110.087 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 27.8 m -137.57 159.51 34.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.906 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.547 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -119.68 142.03 48.84 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.46 140.31 38.63 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.613 HG12 ' CD1' ' B' ' 86' ' ' ILE . 67.6 mt -93.89 140.43 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.253 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 90.9 m -138.12 111.95 8.34 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.388 0.675 . . . . 0.0 110.855 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.46 63.89 0.28 Allowed Glycine 0 C--N 1.303 -1.265 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -131.44 2.72 4.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.339 0.59 . . . . 0.0 111.36 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.45 ' CG1' HG21 ' B' ' 85' ' ' VAL . 31.9 pt -139.19 170.03 16.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 174.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -105.78 -55.95 2.25 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.596 0.635 . . . . 0.0 112.307 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -114.22 151.47 32.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.473 0.654 . . . . 0.0 112.013 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.99 160.39 15.81 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.622 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -136.34 1.99 2.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.207 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 22.7 mt -115.17 142.01 27.93 Favored Pre-proline 0 C--N 1.313 -1.021 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.02 -14.01 34.8 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.411 2.074 . . . . 0.0 113.855 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 67.2 p -93.88 -18.85 21.54 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.356 0.598 . . . . 0.0 111.361 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -109.26 128.75 55.32 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.02 139.01 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.662 -0.649 . . . . 0.0 110.847 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.22 143.2 26.82 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.788 0.804 . . . . 0.0 111.619 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.862 HG21 ' CE1' ' B' ' 78' ' ' TYR . 5.3 mm -112.59 166.45 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.595 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.56 ' H ' HG22 ' B' ' 73' ' ' ILE . 2.5 mm-40 -97.56 130.55 44.6 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 75' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 71.9 mttt -43.4 -52.68 5.83 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.769 1.228 . . . . 0.0 110.604 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -64.6 -25.56 68.02 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.875 1.67 . . . . 0.0 114.087 -173.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -91.36 -20.98 21.25 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.509 0.671 . . . . 0.0 109.586 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.862 ' CE1' HG21 ' B' ' 73' ' ' ILE . 2.0 m-85 -103.8 0.15 29.99 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.178 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 tttp 67.07 17.14 10.41 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.489 0.661 . . . . 0.0 111.855 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' B' ' 78' ' ' TYR . 7.8 mp -94.46 175.1 6.81 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 123.197 1.475 . . . . 0.0 113.143 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.96 -25.99 34.36 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 111.698 -2.501 . . . . 0.0 109.489 176.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.421 ' H ' ' HB3' ' B' ' 80' ' ' LEU . 0.3 OUTLIER -136.52 153.58 50.97 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.547 -172.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.655 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 8.9 p-10 -77.22 143.17 39.18 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 29.9 t -136.19 159.88 40.37 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.512 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.45 HG21 ' CG1' ' B' ' 62' ' ' ILE . 22.9 t -111.36 151.92 13.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.613 ' CD1' HG12 ' B' ' 58' ' ' ILE . 12.3 mm -116.18 139.34 43.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.5 mt -104.88 104.19 13.91 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.427 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.9 mm? -84.45 -8.86 58.82 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.124 -174.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.21 -37.68 15.91 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.373 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLN . . . . . 0.427 ' HG2' HG21 ' A' ' 52' ' ' THR . 0.0 OUTLIER -98.07 77.89 2.48 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.949 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.547 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.4 pp -109.26 179.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . 0.265 8.0 ptp180 -163.28 161.56 24.79 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' B' ' 53' ' ' VAL . 90.5 m -117.85 115.13 24.34 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 113.735 -1.575 . . . . 0.0 108.534 -176.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 60.1 mt -131.79 148.25 52.55 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.957 -170.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.513 ' OD1' ' HB3' ' B' ' 97' ' ' LYS . 1.2 p30 -74.28 152.09 39.74 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.871 173.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -46.56 -28.97 1.59 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 125.693 1.597 . . . . 0.0 114.007 -175.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.513 ' HB3' ' OD1' ' B' ' 95' ' ' ASP . 7.0 ttpm? -71.77 -18.94 62.09 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 123.177 0.591 . . . . 0.0 111.517 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.537 ' NE ' ' HA ' ' B' ' 98' ' ' ARG . 2.3 mmp_? -76.29 -28.16 56.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.599 0.714 . . . . 0.0 109.695 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 7.8 mp -76.45 128.53 34.98 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 123.533 1.635 . . . . 0.0 111.037 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' LYS . . . . . 0.409 ' HB3' ' HG2' ' B' ' 101' ' ' GLU . 13.0 tptt -87.11 -67.42 0.82 Allowed 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 111.346 -2.661 . . . . 0.0 113.132 -171.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 9.1 pt-20 -166.27 146.36 6.18 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.707 0.765 . . . . 0.0 111.545 -169.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -63.98 116.2 5.63 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 128.354 2.662 . . . . 0.0 109.541 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.76 -62.72 1.55 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.755 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.444 HG22 HG11 ' B' ' 19' ' ' VAL . 4.6 t -128.63 -164.91 1.43 Allowed 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.66 -1.616 . . . . 0.0 112.153 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.32 134.79 7.48 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 124.817 1.247 . . . . 0.0 109.759 -171.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.466 ' HB3' ' CE1' ' B' ' 78' ' ' TYR . 3.6 pp -101.91 159.58 15.22 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.369 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 11.1 m -91.14 173.42 7.95 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.864 0.364 . . . . 0.0 111.112 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' B' ' 111' ' ' MET . 6.0 m-20 -64.45 -26.79 68.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.867 0.867 . . . . 0.0 112.258 -177.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.82 -38.18 67.24 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.01 -28.54 61.5 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.112 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.1 OUTLIER -47.36 -48.9 25.52 Favored 'General case' 0 CA--C 1.45 -2.881 0 CA-C-O 121.384 0.611 . . . . 0.0 109.567 167.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.547 ' HA ' ' HE2' ' B' ' 112' ' ' LYS . 9.3 mmpt? -78.63 -5.48 53.06 Favored 'General case' 0 N--CA 1.382 -3.845 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -176.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -91.16 -56.42 3.16 Favored 'General case' 0 N--CA 1.397 -3.109 0 C-N-CA 116.999 -1.88 . . . . 0.0 107.197 170.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -50.22 -59.78 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 112.203 -2.271 . . . . 0.0 113.282 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.598 ' O ' ' HB3' ' B' ' 118' ' ' LEU 0.275 17.2 t0 -60.66 -42.86 97.89 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 123.78 1.752 . . . . 0.0 109.826 -176.096 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.363 47.0 t30 -77.69 -41.68 37.16 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.095 -171.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -65.44 -34.17 77.66 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.598 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.1 tp -63.24 -41.69 99.11 Favored 'General case' 0 N--CA 1.381 -3.921 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.257 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 36.1 mtp -60.08 -37.89 81.26 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 120.714 0.292 . . . . 0.0 110.573 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' B' ' 117' ' ' ALA . 28.7 mt -71.06 -53.15 22.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 25.3 m -51.11 -32.64 23.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.783 178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 22.5 mt -105.63 1.79 27.62 Favored 'General case' 0 C--O 1.19 -2.074 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.495 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.45 24.99 59.8 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.506 ' HG ' ' OD1' ' A' ' 115' ' ' ASP . 7.1 mp -83.47 -58.37 2.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.778 1.289 . . . . 0.0 110.194 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 18.1 m120 55.92 156.49 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 112.868 -1.969 . . . . 0.0 113.177 -168.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.2 12.1 3.09 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.412 -1.43 . . . . 0.0 112.151 -176.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.25 8.82 7.97 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.371 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 59.54 30.28 19.91 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.963 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 70.94 111.93 0.06 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.507 1.123 . . . . 0.0 112.617 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -126.89 123.86 38.22 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -83.36 132.68 34.99 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.04 0.448 . . . . 0.0 110.728 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 . . . . . 0 C--N 1.299 -1.607 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.072 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m 66.02 20.56 11.27 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.938 0.895 . . . . 0.0 111.814 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.8 m -118.9 98.16 6.06 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.385 0.612 . . . . 0.0 110.678 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -84.27 139.19 32.5 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.888 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -70.29 129.14 38.54 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -58.71 -44.04 90.24 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 123.603 0.564 . . . . 0.0 110.41 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -78.69 129.53 34.81 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 175.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -78.72 101.82 7.75 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -156.09 172.42 18.44 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.072 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -115.83 -48.64 2.75 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 176.54 124.9 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.466 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.91 107.05 16.59 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -65.5 -84.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.969 0 C-N-CA 121.582 1.522 . . . . 0.0 112.236 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.2 mt -117.85 115.69 49.3 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -123.25 144.23 49.53 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -63.14 118.18 7.56 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.524 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.64 -19.4 5.03 Favored Glycine 0 N--CA 1.425 -2.049 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.724 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -83.13 171.47 13.67 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.353 1.073 . . . . 0.0 110.097 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.441 HG11 HG22 ' A' ' 104' ' ' THR . 13.3 t -132.38 128.03 57.79 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.373 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 24.2 m-85 -123.36 151.42 42.54 Favored 'General case' 0 C--N 1.271 -2.847 0 C-N-CA 125.274 1.43 . . . . 0.0 110.03 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.7 mp -88.63 150.17 23.17 Favored 'General case' 0 N--CA 1.396 -3.15 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -145.27 139.11 26.88 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.156 -176.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -81.86 89.95 6.38 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.533 1.158 . . . . 0.0 108.665 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.601 ' O ' HG13 ' A' ' 27' ' ' VAL . 82.2 mt -65.1 -19.45 65.99 Favored 'General case' 0 CA--C 1.481 -1.677 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.661 -178.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.569 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 10.0 m -33.75 175.0 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.322 0 C-N-CA 127.197 2.199 . . . . 0.0 114.252 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 27.32 48.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.677 0 C-N-CA 121.905 1.737 . . . . 0.0 114.588 -151.37 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 24' ' ' LEU . 1.6 m -69.88 168.22 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.002 170.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.489 ' HG3' HD23 ' B' ' 94' ' ' LEU . 12.1 mm100 -99.21 107.14 19.39 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.765 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.86 -122.31 26.68 Favored Glycine 0 C--N 1.298 -1.564 0 CA-C-N 113.998 -1.455 . . . . 0.0 113.371 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.4 m -81.71 20.97 0.87 Allowed 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.601 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 46.0 mt-10 -62.24 168.26 3.54 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 117.917 -1.513 . . . . 0.0 110.32 170.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.533 HE22 ' HG3' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -70.81 107.95 4.24 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -176.276 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.76 144.3 18.81 Favored Glycine 0 CA--C 1.499 -0.95 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 157.97 10.06 Favored Glycine 0 N--CA 1.421 -2.347 0 CA-C-N 113.019 -1.59 . . . . 0.0 111.538 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -81.9 104.89 11.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 171.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.533 ' HG3' HE22 ' A' ' 32' ' ' GLN . 18.4 mmt180 -129.46 157.18 77.14 Favored Pre-proline 0 C--N 1.26 -3.29 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.58 -167.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HB2' HD12 ' A' ' 58' ' ' ILE . 31.9 Cg_exo -63.22 144.88 92.79 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.211 1.941 . . . . 0.0 111.405 171.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 27.2 m -129.91 156.26 42.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 124.238 1.015 . . . . 0.0 109.067 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.6 m -100.22 131.99 46.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 mm -91.51 115.57 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.95 -14.25 10.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.265 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.621 HE21 HG13 ' A' ' 53' ' ' VAL . 5.0 pt20 -53.69 163.12 0.73 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -168.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -64.94 -177.58 0.36 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.156 -2.293 . . . . 0.0 112.202 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -81.7 -42.73 19.47 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.969 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -82.69 -23.64 34.04 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -170.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.73 -32.41 74.17 Favored Glycine 0 C--O 1.204 -1.739 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.356 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -81.52 -18.08 46.28 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.086 0.47 . . . . 0.0 111.792 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -86.65 -62.89 1.41 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.507 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -107.34 -15.26 14.68 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -168.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -91.43 141.46 26.03 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HA ' ' HE3' ' A' ' 96' ' ' LYS . 72.8 Cg_endo -81.86 -9.8 11.87 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.99 1.794 . . . . 0.0 111.381 176.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 p -109.13 135.69 49.84 Favored 'General case' 0 N--CA 1.409 -2.509 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.791 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.621 HG13 HE21 ' A' ' 42' ' ' GLN . 95.0 t -123.74 139.75 49.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.567 HG21 HD22 ' B' ' 122' ' ' LEU . 9.3 tp -97.52 128.16 49.11 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 25.9 m -140.35 164.54 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.968 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -122.32 132.93 54.64 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.7 131.66 46.46 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.539 HD12 ' HB2' ' A' ' 37' ' ' PRO . 54.3 mt -91.68 106.11 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.785 176.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.3 m -102.46 140.94 36.07 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.698 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.17 129.67 9.61 Favored Glycine 0 N--CA 1.434 -1.459 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.768 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.46 ' HA ' ' OD1' ' A' ' 83' ' ' ASP . 76.9 mtm180 63.37 13.45 7.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.028 1.331 . . . . 0.0 114.585 174.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.82 109.57 28.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.937 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.5 m120 71.29 157.49 0.18 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.547 1.539 . . . . 0.0 112.592 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -109.85 163.0 13.94 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.16 84.14 7.71 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -115.54 18.28 15.97 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.9 tt -145.32 137.58 13.37 Favored Pre-proline 0 N--CA 1.426 -1.63 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.58 ' HB2' HD13 ' A' ' 120' ' ' ILE . 61.2 Cg_endo -71.5 2.56 4.41 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.632 2.221 . . . . 0.0 114.737 -174.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.506 ' HB ' ' HG3' ' A' ' 89' ' ' GLU . 68.0 p -103.31 -16.57 15.61 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.35 0.595 . . . . 0.0 111.483 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -109.91 129.82 55.6 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.3 p -123.01 132.71 70.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.512 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.67 130.0 34.95 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.941 0.877 . . . . 0.0 110.444 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.56 HD11 HG12 ' A' ' 86' ' ' ILE . 13.1 mm -97.1 169.99 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' N ' HG22 ' A' ' 73' ' ' ILE . 7.4 tp10 -106.34 109.57 21.54 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 168.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.605 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -50.93 -30.7 15.49 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 125.431 1.492 . . . . 0.0 114.678 -172.701 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.401 ' HG2' ' OE1' ' A' ' 74' ' ' GLU . 42.5 mmtm -49.37 -45.14 45.52 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 125.008 1.323 . . . . 0.0 111.508 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -79.06 -24.41 43.56 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.631 0.729 . . . . 0.0 111.678 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.538 ' HB2' ' HE3' ' A' ' 75' ' ' LYS . 4.0 m-85 -97.81 6.5 47.76 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.012 -175.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.466 ' O ' HD12 ' A' ' 80' ' ' LEU 0.394 61.8 pttt 43.28 64.3 1.26 Allowed 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 119.824 3.268 . . . . 0.0 119.824 176.345 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.597 HD22 ' HZ3' ' A' ' 75' ' ' LYS . 10.3 mp -141.76 -168.27 2.63 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 169.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -113.94 -9.11 13.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 123.679 0.612 . . . . 0.0 110.821 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 50.3 mttm -115.12 112.14 22.1 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.204 -173.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.46 ' OD1' ' HA ' ' A' ' 61' ' ' ARG . 3.6 p30 -35.66 144.24 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.984 1.714 . . . . 0.0 115.388 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.7 m -123.32 132.74 54.09 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.435 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 35.4 t -120.15 138.14 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 173.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.56 HG12 HD11 ' A' ' 73' ' ' ILE . 23.4 mm -104.31 131.26 53.59 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.2 mt -98.6 103.51 15.47 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.505 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -81.57 -17.64 47.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.506 ' HG3' ' HB ' ' A' ' 69' ' ' THR . 41.3 mt-10 -86.51 -7.73 58.15 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.766 0.793 . . . . 0.0 111.231 173.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 91' ' ' ILE . 14.5 tp60 -89.27 -100.68 0.09 Allowed 'General case' 0 C--O 1.192 -1.937 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 90' ' ' GLN . 1.1 pp 57.84 179.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 C-N-CA 127.574 2.35 . . . . 0.0 110.958 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.515 ' NH2' ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -176.77 176.43 1.5 Allowed 'General case' 0 C--N 1.311 -1.108 0 O-C-N 123.897 0.748 . . . . 0.0 112.233 172.639 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.449 HG21 ' O ' ' B' ' 90' ' ' GLN . 53.6 m -116.18 128.59 55.75 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.477 HD23 ' HG3' ' B' ' 28' ' ' GLN . 71.0 mt -131.72 141.65 49.59 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.886 -173.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.425 ' OD1' ' HG3' ' A' ' 97' ' ' LYS . 11.9 t0 -57.2 144.61 34.51 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 169.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 51' ' ' PRO . 16.8 pttp -55.41 -31.02 61.51 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.425 ' HG3' ' OD1' ' A' ' 95' ' ' ASP . 52.1 mttp -53.44 -28.82 32.27 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.919 174.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 8.9 mmp_? -74.27 -34.13 63.48 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 120.904 0.383 . . . . 0.0 110.269 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.9 mp -68.51 106.32 2.52 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.279 1.037 . . . . 0.0 110.268 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -83.74 -67.37 0.8 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.28 -1.782 . . . . 0.0 114.134 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.587 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.6 pt-20 -148.32 152.05 36.42 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-O 121.563 0.696 . . . . 0.0 110.16 -169.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 20' ' ' TYR . 30.8 mtpt -79.1 115.75 18.96 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-N 113.171 -1.831 . . . . 0.0 108.236 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 tp -104.28 -58.93 1.81 Allowed 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.288 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.441 HG22 HG11 ' A' ' 19' ' ' VAL . 5.2 t -132.54 -164.98 1.53 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 117.835 -1.546 . . . . 0.0 111.915 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.49 128.43 4.55 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 125.631 1.573 . . . . 0.0 109.876 -173.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.423 HD11 ' HE3' ' A' ' 111' ' ' MET . 3.7 pp -95.14 163.31 13.34 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.7 p -88.3 164.1 15.74 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 123.085 0.554 . . . . 0.0 112.049 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 111' ' ' MET . 22.7 t70 -61.99 -29.5 70.3 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.401 1.08 . . . . 0.0 113.37 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.13 -33.74 68.03 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -76.36 -32.25 58.51 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.502 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -52.37 -41.91 63.5 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 125.165 1.386 . . . . 0.0 110.549 175.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.657 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 2.2 mmmm -69.84 -21.73 63.34 Favored 'General case' 0 CA--C 1.465 -2.324 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.352 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -87.81 -46.56 9.33 Favored 'General case' 0 N--CA 1.398 -3.028 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 t -50.58 -54.6 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 CA-C-N 113.263 -1.79 . . . . 0.0 112.857 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 53.5 m-20 -66.24 -42.74 88.16 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 123.511 1.624 . . . . 0.0 111.946 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.657 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 3.8 t30 -74.93 -43.56 53.54 Favored 'General case' 0 C--N 1.26 -3.326 0 CA-C-N 112.76 -2.018 . . . . 0.0 112.52 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -60.71 -36.66 79.39 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.528 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 10.2 tp -65.33 -39.45 92.42 Favored 'General case' 0 N--CA 1.386 -3.675 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.105 -177.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.775 ' SD ' ' HA ' ' A' ' 125' ' ' ASN 0.265 7.4 ptp -74.92 -19.32 60.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 117.54 -1.664 . . . . 0.0 114.461 176.502 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 68' ' ' PRO . 30.4 mt -77.03 -50.04 21.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 175.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.1 p -60.78 -30.4 70.02 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 113.111 -1.858 . . . . 0.0 112.124 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.554 HD22 HG21 ' B' ' 54' ' ' ILE . 27.4 mt -107.2 0.7 23.49 Favored 'General case' 0 C--O 1.199 -1.589 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.84 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.406 ' HA2' ' CE1' ' A' ' 129' ' ' HIS . . . 75.64 26.21 65.78 Favored Glycine 0 CA--C 1.549 2.169 0 N-CA-C 116.964 1.546 . . . . 0.0 116.964 174.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.557 HD11 HD11 ' B' ' 124' ' ' LEU . 0.5 OUTLIER -113.9 15.93 18.45 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 119.263 1.531 . . . . 0.0 111.805 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.775 ' HA ' ' SD ' ' A' ' 119' ' ' MET . 2.4 t-20 -43.31 124.59 3.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.353 0.661 . . . . 0.0 112.705 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.42 8.48 4.16 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -172.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 t -116.32 9.9 7.39 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 70.08 158.54 0.18 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.498 1.519 . . . . 0.0 112.21 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.406 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 37.4 m-70 -105.76 156.68 18.07 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.89 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -75.9 -40.51 54.23 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -129.34 128.87 43.97 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--N 1.297 -1.678 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.618 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.954 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m 62.08 25.08 15.0 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.117 0.967 . . . . 0.0 112.399 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 20.1 m -119.15 101.68 8.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -91.11 132.43 36.05 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -64.09 134.39 54.83 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.243 -0.281 . . . . 0.0 110.243 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -64.41 -37.41 87.43 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.375 0.607 . . . . 0.0 109.812 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -85.26 130.05 34.68 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -82.57 90.47 6.8 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.142 0.496 . . . . 0.0 109.759 -178.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -146.75 158.46 43.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.852 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -97.31 -53.04 3.6 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 171.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -179.11 126.63 0.09 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.296 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.62 108.58 26.13 Favored Pre-proline 0 C--N 1.305 -1.335 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -65.05 -86.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.55 1.5 . . . . 0.0 112.482 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 56.8 mt -115.62 114.87 47.57 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 24.4 mmm-85 -121.28 140.64 51.79 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -61.26 115.03 3.5 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.818 170.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.81 -16.31 5.33 Favored Glycine 0 N--CA 1.428 -1.891 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.066 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.18 172.52 11.83 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 122.266 1.032 . . . . 0.0 109.47 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.461 HG11 HG22 ' B' ' 104' ' ' THR . 12.3 t -132.88 129.09 57.66 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.174 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.265 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 23.0 m-85 -123.89 150.88 44.14 Favored 'General case' 0 C--N 1.271 -2.824 0 C-N-CA 125.322 1.449 . . . . 0.0 110.052 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 3.8 mp -87.95 150.18 23.61 Favored 'General case' 0 N--CA 1.391 -3.396 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 165.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -145.48 138.52 26.2 Favored 'General case' 0 C--N 1.26 -3.286 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.118 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.23 91.16 6.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.73 1.252 . . . . 0.0 108.477 171.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.572 ' O ' HG13 ' B' ' 27' ' ' VAL . 85.4 mt -65.83 -20.86 66.4 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-N 112.672 -2.058 . . . . 0.0 110.735 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.532 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 16.3 m -35.08 176.28 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.171 0 C-N-CA 126.97 2.108 . . . . 0.0 114.929 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 26.41 49.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.621 0 C-N-CA 121.817 1.678 . . . . 0.0 114.615 -149.432 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.594 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 1.8 m -69.99 172.9 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.337 170.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' GLN . . . . . 0.477 ' HG3' HD23 ' A' ' 94' ' ' LEU . 10.9 mm100 -102.52 108.71 20.1 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.055 -1.43 . . . . 0.0 110.577 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.33 -120.61 13.81 Favored Glycine 0 C--N 1.304 -1.25 0 CA-C-N 114.248 -1.342 . . . . 0.0 114.097 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.0 m -81.25 20.19 0.87 Allowed 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.594 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 46.4 mt-10 -63.87 166.24 7.59 Favored 'General case' 0 C--O 1.248 0.995 0 C-N-CA 117.695 -1.602 . . . . 0.0 109.881 169.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.38 108.08 4.65 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -175.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.09 146.29 19.01 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 116.069 1.187 . . . . 0.0 116.069 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.09 152.68 8.71 Favored Glycine 0 N--CA 1.417 -2.598 0 CA-C-N 113.503 -1.349 . . . . 0.0 110.722 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 p -78.38 108.65 12.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -133.99 156.87 78.84 Favored Pre-proline 0 C--N 1.263 -3.191 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.042 -166.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' PRO . . . . . 0.557 ' HB2' HD12 ' B' ' 58' ' ' ILE . 31.3 Cg_exo -63.39 144.04 89.99 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.486 2.124 . . . . 0.0 111.681 172.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 27.3 m -129.1 156.06 41.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 124.341 1.057 . . . . 0.0 109.193 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.5 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 31.8 m -99.74 131.69 46.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 30.3 mm -91.02 115.65 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.82 -14.87 10.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.241 -177.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.666 HE21 HG13 ' B' ' 53' ' ' VAL . 4.8 pt20 -52.95 163.24 0.52 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 -168.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -65.78 -177.22 0.44 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.778 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.38 -47.94 14.89 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.7 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 20.4 m -78.17 -24.37 47.26 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -169.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -60.95 -32.35 79.68 Favored Glycine 0 C--O 1.204 -1.738 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.358 -176.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -81.49 -18.95 43.39 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.403 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -84.77 -66.66 0.87 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.015 0.436 . . . . 0.0 111.455 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -103.93 -13.71 16.25 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 19.3 m -94.72 140.03 22.44 Favored Pre-proline 0 C--N 1.295 -1.772 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.84 -6.45 11.45 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.106 1.871 . . . . 0.0 111.548 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.2 p -110.09 135.64 50.59 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.533 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.666 HG13 HE21 ' B' ' 42' ' ' GLN . 93.1 t -123.88 139.81 49.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.554 HG21 HD22 ' A' ' 122' ' ' LEU . 9.1 tp -97.19 128.67 48.22 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 27.4 m -140.72 164.52 21.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.035 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.5 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -122.38 132.82 54.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.15 130.55 43.47 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.557 HD12 ' HB2' ' B' ' 37' ' ' PRO . 56.8 mt -90.08 108.53 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.166 176.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -105.13 139.49 39.72 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.95 130.04 9.91 Favored Glycine 0 N--CA 1.428 -1.896 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.58 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 64.09 18.19 11.09 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 174.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 64.6 mt -110.89 105.76 19.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.617 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 13.5 m120 77.3 156.67 0.17 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.866 1.267 . . . . 0.0 113.004 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -109.08 167.44 10.09 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.81 85.23 5.55 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -174.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -112.99 8.64 18.54 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.545 1.164 . . . . 0.0 107.861 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.5 tt -132.06 134.87 25.67 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' PRO . . . . . 0.474 ' HB2' HD13 ' B' ' 120' ' ' ILE . 49.2 Cg_endo -68.48 0.57 4.55 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.729 2.286 . . . . 0.0 115.098 -175.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' THR . . . . . 0.509 ' HB ' ' HG3' ' B' ' 89' ' ' GLU . 77.7 p -103.55 -15.92 15.69 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.302 0.572 . . . . 0.0 111.789 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -110.94 129.18 55.96 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 8.6 p -122.18 132.61 70.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.521 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -84.4 136.9 33.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.282 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ILE . . . . . 0.56 HD11 HG12 ' B' ' 86' ' ' ILE . 12.2 mm -108.66 157.17 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.413 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.444 ' N ' HG22 ' B' ' 73' ' ' ILE . 9.2 tp10 -94.38 109.13 21.01 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 173.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' LYS . . . . . 0.621 ' HZ3' HD22 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -52.72 -30.73 34.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 76' ' ' LYS . . . . . 0.438 ' H ' ' HG2' ' B' ' 76' ' ' LYS . 16.1 mmtp -50.96 -41.08 58.99 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 124.9 1.28 . . . . 0.0 112.038 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -80.25 -26.99 38.74 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.886 0.85 . . . . 0.0 111.435 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.541 ' HB2' ' HE3' ' B' ' 75' ' ' LYS . 4.4 m-85 -95.2 5.88 50.57 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.234 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.49 ' O ' HD12 ' B' ' 80' ' ' LEU 0.399 61.6 pttt 43.62 64.66 1.18 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 119.822 3.268 . . . . 0.0 119.822 176.305 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.621 HD22 ' HZ3' ' B' ' 75' ' ' LYS . 10.3 mp -142.69 -169.87 3.09 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 169.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -116.52 -1.75 12.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.957 0.786 . . . . 0.0 110.813 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' LYS . . . . . 0.432 ' O ' ' HD3' ' B' ' 75' ' ' LYS . 52.6 mttm -120.79 111.11 17.17 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.79 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -33.14 143.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 127.179 2.191 . . . . 0.0 114.526 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -124.91 133.42 53.06 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.21 -170.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 39.9 t -120.07 138.23 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 174.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.56 HG12 HD11 ' B' ' 73' ' ' ILE . 24.2 mm -103.95 130.39 54.61 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 51.7 mt -98.6 103.19 15.11 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 -20.32 44.25 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.619 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' GLU . . . . . 0.509 ' HG3' ' HB ' ' B' ' 69' ' ' THR . 42.9 mt-10 -84.27 -9.26 58.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.711 0.767 . . . . 0.0 111.595 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLN . . . . . 0.555 ' O ' HG13 ' B' ' 91' ' ' ILE . 15.0 tp60 -86.82 -100.65 0.07 Allowed 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 172.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.555 HG13 ' O ' ' B' ' 90' ' ' GLN . 1.0 OUTLIER 57.75 179.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 C-N-CA 127.63 2.372 . . . . 0.0 111.033 -179.014 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 92' ' ' ARG . . . . . 0.484 ' NH2' ' HA ' ' B' ' 27' ' ' VAL . 0.1 OUTLIER -176.88 177.08 1.36 Allowed 'General case' 0 C--N 1.311 -1.089 0 O-C-N 123.911 0.757 . . . . 0.0 112.297 172.485 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 93' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 90' ' ' GLN . 51.9 m -116.76 128.81 55.66 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 94' ' ' LEU . . . . . 0.489 HD23 ' HG3' ' A' ' 28' ' ' GLN . 72.4 mt -131.45 142.1 49.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.058 -172.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ASP . . . . . 0.43 ' OD1' ' HG3' ' B' ' 97' ' ' LYS . 11.0 t0 -56.6 143.92 33.91 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -57.65 -28.01 63.35 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.43 ' HG3' ' OD1' ' B' ' 95' ' ' ASP . 49.0 mttp -59.23 -22.74 61.54 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.329 174.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 98' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 8.0 mmp_? -78.15 -32.08 50.07 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.244 0.545 . . . . 0.0 109.732 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.43 105.52 2.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.475 1.131 . . . . 0.0 110.498 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.82 -64.2 1.21 Allowed 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 113.243 -1.799 . . . . 0.0 114.108 -173.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -152.55 152.39 31.81 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.426 0.632 . . . . 0.0 110.362 -171.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.516 ' HG2' ' CZ ' ' B' ' 20' ' ' TYR . 32.5 mtpt -78.3 115.53 18.08 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 126.06 1.744 . . . . 0.0 108.323 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 tp -103.86 -59.02 1.79 Allowed 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.721 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 104' ' ' THR . . . . . 0.461 HG22 HG11 ' B' ' 19' ' ' VAL . 4.7 t -132.47 -164.66 1.49 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.675 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -160.82 130.29 4.89 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 125.272 1.429 . . . . 0.0 110.226 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.73 157.31 16.36 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -175.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -80.27 166.2 21.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.976 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 108' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' B' ' 111' ' ' MET . 19.7 t70 -70.42 -23.31 62.72 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.857 0.863 . . . . 0.0 112.398 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.51 -30.16 57.09 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -78.52 -32.99 48.28 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.458 ' HA ' ' HE3' ' B' ' 111' ' ' MET . 0.2 OUTLIER -50.97 -43.6 60.48 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 125.473 1.509 . . . . 0.0 110.337 175.738 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' B' ' 116' ' ' ASN . 0.3 OUTLIER -68.78 -20.98 64.36 Favored 'General case' 0 C--O 1.185 -2.292 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.329 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -87.4 -47.86 8.44 Favored 'General case' 0 CA--C 1.45 -2.893 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 t -49.57 -54.98 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.44 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.882 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.559 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 17.9 m-20 -64.44 -44.42 91.23 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-O 123.385 1.564 . . . . 0.0 112.074 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' ASN . . . . . 0.61 ' HB3' ' O ' ' B' ' 112' ' ' LYS 0.302 5.9 t30 -76.51 -41.33 47.25 Favored 'General case' 0 C--N 1.262 -3.212 0 C-N-CA 126.778 2.031 . . . . 0.0 112.815 -172.631 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.59 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -64.48 -33.56 76.16 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 10.0 tp -65.33 -39.64 92.68 Favored 'General case' 1 N--CA 1.378 -4.059 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.773 -178.107 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 119' ' ' MET . . . . . 0.8 ' SD ' ' HA ' ' B' ' 125' ' ' ASN 0.255 6.9 ptp -73.81 -19.93 60.61 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 117.821 -1.552 . . . . 0.0 114.155 176.36 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' B' ' 117' ' ' ALA . 43.0 mt -75.98 -52.04 18.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 78.5 p -59.09 -28.0 66.08 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.681 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.567 HD22 HG21 ' A' ' 54' ' ' ILE . 26.9 mt -108.22 -0.45 20.9 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.922 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' GLY . . . . . 0.496 ' HA2' ' CE1' ' B' ' 129' ' ' HIS . . . 74.81 31.78 57.82 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 174.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.557 HD11 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -120.95 20.09 11.61 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.821 1.31 . . . . 0.0 111.577 179.445 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.8 ' HA ' ' SD ' ' B' ' 119' ' ' MET . 13.0 m120 -43.88 125.3 4.18 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.93 14.0 0.94 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.828 0.823 . . . . 0.0 112.303 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 14.3 t -119.85 7.28 6.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 70.55 154.14 0.13 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 125.664 1.585 . . . . 0.0 112.664 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 129' ' ' HIS . . . . . 0.496 ' CE1' ' HA2' ' B' ' 123' ' ' GLY . 33.8 m-70 -99.83 160.61 14.17 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.332 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -79.51 -42.47 25.13 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.792 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -131.99 134.07 45.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 . . . . . 0 C--N 1.308 -1.221 0 CA-C-O 119.2 -0.428 . . . . 0.0 110.921 -178.855 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.2 mt . . . . . 0 N--CA 1.426 -1.638 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -103.38 144.33 31.52 Favored 'General case' 1 N--CA 1.374 -4.244 0 C-N-CA 123.611 0.765 . . . . 0.0 109.131 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -71.1 120.57 16.85 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 99.36 -1.16 57.2 Favored Glycine 0 C--N 1.305 -1.161 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.972 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -97.32 119.55 36.05 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.495 ' HB ' ' H ' ' A' ' 104' ' ' THR . 87.6 t -83.81 128.26 39.0 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 C-N-CA 123.201 0.6 . . . . 0.0 112.288 -172.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 48.8 m-85 -115.29 141.38 48.11 Favored 'General case' 0 C--N 1.273 -2.721 0 C-N-CA 125.236 1.414 . . . . 0.0 111.425 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER -75.26 148.66 39.24 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 167.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.02 149.4 34.05 Favored 'General case' 0 C--N 1.262 -3.215 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.233 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.416 ' HB2' ' HE2' ' A' ' 100' ' ' LYS . 26.0 t0 -96.91 76.68 2.74 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 27' ' ' VAL 0.264 3.0 tt -71.58 -18.16 62.25 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.089 -2.778 . . . . 0.0 108.437 -173.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.521 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 5.1 m -32.82 -178.19 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.935 0 C-N-CA 129.739 3.216 . . . . 0.0 116.384 173.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.558 ' HB2' ' NE2' ' B' ' 28' ' ' GLN . 0.1 OUTLIER 25.95 43.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.137 0 C-N-CA 124.317 3.345 . . . . 0.0 116.648 -151.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.728 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 2.8 m -70.07 142.2 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.402 169.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.533 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 35.2 mm-40 -90.31 134.17 34.48 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 114.887 -1.052 . . . . 0.0 113.222 -172.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.84 -108.84 0.69 Allowed Glycine 0 N--CA 1.442 -0.923 0 O-C-N 124.564 1.165 . . . . 0.0 114.654 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 m -94.05 8.28 42.06 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 31.8 mt-10 -62.08 143.46 56.62 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 90' ' ' GLN . 2.1 tp60 -103.49 112.31 25.15 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.174 0.512 . . . . 0.0 110.872 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . 166.04 -178.62 40.61 Favored Glycine 0 N--CA 1.408 -3.179 0 C-N-CA 119.807 -1.187 . . . . 0.0 115.012 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 24' ' ' LEU . . . 178.08 -160.09 26.12 Favored Glycine 0 C--N 1.266 -3.313 1 N-CA-C 101.972 -4.451 . . . . 0.0 101.972 -178.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.9 p -73.73 120.04 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.124 0 CA-C-N 120.859 2.329 . . . . 0.0 109.071 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.414 ' NH1' ' HA ' ' A' ' 59' ' ' THR . 73.2 mtt180 -152.73 166.07 16.2 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.423 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.655 ' HB2' HD12 ' A' ' 58' ' ' ILE . 11.0 Cg_exo -71.76 144.56 44.16 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.595 1.53 . . . . 0.0 109.978 169.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 28.7 m -128.19 158.26 40.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.507 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 35.9 m -101.76 130.33 51.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.832 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.433 HD13 HG12 ' A' ' 55' ' ' VAL . 35.9 mm -84.19 105.46 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.97 -10.19 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.035 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.666 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 2.5 tt0 -60.63 164.51 4.54 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -169.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 26.6 p-10 -68.38 -174.7 0.55 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.387 -1.733 . . . . 0.0 111.466 175.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -88.34 -38.36 15.2 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.194 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.452 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 4.0 m -81.83 -22.26 37.13 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.776 -0.578 . . . . 0.0 112.521 -171.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.63 -31.03 76.38 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -71.09 -35.31 71.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.249 0.547 . . . . 0.0 110.563 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 45' ' ' THR . 34.4 mttp -79.63 -48.28 14.01 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -115.51 -27.79 7.03 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -172.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.417 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 61.9 m -86.12 148.33 47.41 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.992 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 2.9 Cg_endo -81.9 -17.01 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.579 1.519 . . . . 0.0 110.221 174.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.2 p -91.65 151.08 20.84 Favored 'General case' 0 N--CA 1.421 -1.894 0 C-N-CA 124.635 1.174 . . . . 0.0 111.982 -174.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.666 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 61.8 t -135.12 139.02 47.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.634 HG21 HD22 ' B' ' 122' ' ' LEU . 10.3 tt -93.14 134.51 30.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.094 0.473 . . . . 0.0 110.196 170.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 94' ' ' LEU . 22.1 m -139.62 164.22 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.368 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.537 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -122.82 138.29 54.69 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.1 132.43 45.83 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 37' ' ' PRO . 63.3 mt -92.09 136.84 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.901 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.414 ' HA ' ' NH1' ' A' ' 36' ' ' ARG . 95.8 m -129.52 139.89 51.41 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . . . . . . 0 C--O 1.222 -0.656 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.0 mt . . . . . 0 N--CA 1.435 -1.212 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.64 1.85 3.99 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 121.951 1.767 . . . . 0.0 113.069 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.0 p -98.71 -18.8 17.84 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.394 0.616 . . . . 0.0 109.872 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -97.88 129.95 44.8 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.815 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.58 142.7 43.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -103.93 148.69 25.88 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.955 0.407 . . . . 0.0 110.969 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.533 HD13 HD11 ' A' ' 86' ' ' ILE . 25.2 pt -124.6 134.46 66.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.458 ' O ' ' HD1' ' A' ' 78' ' ' TYR . 2.7 mp0 -59.96 115.71 3.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.373 1.069 . . . . 0.0 113.423 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HB3' ' C ' ' A' ' 82' ' ' LYS . 22.3 pttm -50.56 -36.42 34.43 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.965 0.906 . . . . 0.0 112.214 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -52.35 -53.16 48.2 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 113.326 -1.761 . . . . 0.0 112.627 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -92.64 -37.65 12.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.552 0.692 . . . . 0.0 111.996 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.537 ' CE2' ' HA ' ' A' ' 106' ' ' LEU . 71.3 m-85 -75.37 -5.92 47.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.921 -172.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 75.5 24.1 1.39 Allowed 'General case' 0 C--N 1.348 0.521 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 167.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.67 179.0 4.4 Favored 'General case' 0 CA--C 1.489 -1.396 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.265 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.22 -5.29 40.74 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.485 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -140.89 150.51 43.29 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.193 -176.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -75.3 128.07 34.59 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 6.1 t -102.78 163.58 12.14 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -170.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.46 141.3 41.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.533 HD11 HD13 ' A' ' 73' ' ' ILE . 17.2 mm -107.48 133.2 52.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.9 mt -106.18 109.38 21.3 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.44 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -83.94 -2.68 57.02 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.509 0.671 . . . . 0.0 111.991 -175.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -97.0 -34.11 11.31 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.323 1.059 . . . . 0.0 109.677 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.428 ' HG2' ' HB3' ' A' ' 32' ' ' GLN . 9.7 tp60 -94.56 80.0 3.83 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.625 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.537 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.1 pp -122.71 -177.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -173.71 -178.24 1.56 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 123.784 0.677 . . . . 0.0 112.502 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 53.9 m -123.67 126.05 45.89 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 55' ' ' VAL . 74.7 mt -132.07 133.69 44.65 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.656 1.183 . . . . 0.0 109.784 -173.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.5 p-10 -78.09 153.84 31.86 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -44.78 -21.11 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.796 1.638 . . . . 0.0 115.015 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -74.17 -17.51 60.9 Favored 'General case' 0 CA--C 1.564 1.498 0 CA-C-O 121.209 0.528 . . . . 0.0 110.604 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.421 ' HD2' ' CB ' ' B' ' 28' ' ' GLN . 4.8 mmp_? -84.34 -38.52 20.25 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.073 0.549 . . . . 0.0 111.23 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.48 121.91 16.83 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 123.885 0.874 . . . . 0.0 111.1 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 23' ' ' ASP . 68.2 mttm -92.34 -62.55 1.38 Allowed 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.784 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.1 pt-20 -159.73 143.47 14.49 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.291 0.567 . . . . 0.0 112.075 -170.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.27 123.75 20.78 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.719 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.712 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 22.1 tp -114.3 -61.92 1.67 Allowed 'General case' 0 N--CA 1.414 -2.255 0 CA-C-O 122.394 1.092 . . . . 0.0 110.435 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.712 ' OG1' ' HG ' ' A' ' 103' ' ' LEU 0.26 3.7 m -126.54 -174.8 3.22 Favored 'General case' 0 N--CA 1.401 -2.892 0 CA-C-N 113.283 -1.78 . . . . 0.0 111.93 -164.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.432 ' H ' ' CG2' ' A' ' 104' ' ' THR . 0.4 OUTLIER -159.73 137.17 9.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.483 1.513 . . . . 0.0 109.645 -167.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.537 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . 6.9 mt -98.22 164.02 12.49 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.775 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.8 m -98.62 159.98 14.58 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 111' ' ' MET . 21.2 m-20 -63.59 -31.61 72.83 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.314 0.578 . . . . 0.0 112.307 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.76 -41.5 83.25 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 122.077 -0.389 . . . . 0.0 109.971 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -74.57 -24.21 58.88 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.378 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.482 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -56.59 -39.75 74.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 123.819 0.847 . . . . 0.0 108.857 170.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 8.4 mmpt? -79.99 -11.09 59.81 Favored 'General case' 0 N--CA 1.39 -3.474 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.233 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -88.94 -49.42 6.8 Favored 'General case' 0 N--CA 1.39 -3.426 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -50.26 -58.77 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.199 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.78 -39.5 77.62 Favored 'General case' 0 N--CA 1.515 2.825 0 CA-C-O 123.452 1.596 . . . . 0.0 111.931 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.511 ' HB3' ' O ' ' A' ' 112' ' ' LYS 0.257 6.4 t30 -83.98 -46.62 11.87 Favored 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 112.424 -2.171 . . . . 0.0 112.77 -170.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.54 -36.16 73.44 Favored 'General case' 0 CA--C 1.47 -2.102 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.546 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 7.4 tp -62.56 -47.11 85.32 Favored 'General case' 1 N--CA 1.363 -4.782 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.104 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.633 ' SD ' ' HA ' ' A' ' 125' ' ' ASN 0.275 7.8 ptp -68.14 -22.59 64.86 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 178.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.3 mt -72.22 -51.98 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.426 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 t -55.52 -34.66 64.86 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 113.197 -1.82 . . . . 0.0 111.669 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.632 HD22 HG21 ' B' ' 54' ' ' ILE . 17.0 mt -110.38 8.4 23.28 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.769 -0.582 . . . . 0.0 111.266 -177.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.53 21.49 64.79 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 171.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.782 HD11 HD11 ' B' ' 124' ' ' LEU . 0.6 OUTLIER -99.95 13.91 32.29 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 118.56 1.18 . . . . 0.0 111.485 -176.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.633 ' HA ' ' SD ' ' A' ' 119' ' ' MET . 20.1 m120 . . . . . 0 N--CA 1.482 1.133 0 O-C-N 124.509 1.13 . . . . 0.0 113.357 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.7 mt . . . . . 0 N--CA 1.424 -1.775 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -102.78 146.1 28.76 Favored 'General case' 1 N--CA 1.377 -4.106 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.58 118.93 15.02 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 100.6 -0.66 55.51 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.971 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.43 119.39 35.87 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.493 ' HB ' ' H ' ' B' ' 104' ' ' THR . 86.0 t -83.72 128.51 38.75 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 123.235 0.614 . . . . 0.0 112.255 -172.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 48.7 m-85 -115.78 140.39 49.26 Favored 'General case' 0 C--N 1.272 -2.784 0 C-N-CA 125.438 1.495 . . . . 0.0 111.329 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.514 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 0.8 OUTLIER -74.02 148.38 42.06 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 166.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -145.41 148.87 33.8 Favored 'General case' 0 C--N 1.259 -3.361 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.055 -176.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -96.11 79.48 3.2 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.549 ' O ' HG13 ' B' ' 27' ' ' VAL 0.262 3.0 tt -74.46 -16.96 60.84 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 111.553 -2.567 . . . . 0.0 108.477 -173.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.501 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 3.6 m -32.68 -178.12 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.922 0 C-N-CA 130.652 3.581 . . . . 0.0 116.432 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.533 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 0.1 OUTLIER 24.91 44.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.404 3.486 0 C-N-CA 124.343 3.362 . . . . 0.0 116.373 -152.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.716 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 2.6 m -69.79 140.56 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 113.512 -1.676 . . . . 0.0 109.591 168.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . 0.558 ' NE2' ' HB2' ' A' ' 26' ' ' PRO . 33.7 mm-40 -89.83 132.83 35.05 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.766 -172.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.08 -108.61 0.68 Allowed Glycine 0 CA--C 1.501 -0.796 0 CA-C-N 114.735 -1.121 . . . . 0.0 114.81 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -93.99 6.92 46.96 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -174.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.716 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 33.7 mt-10 -63.53 140.09 58.84 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.469 ' HB3' ' HG2' ' B' ' 90' ' ' GLN . 0.6 OUTLIER -101.28 119.42 38.73 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 120.828 0.347 . . . . 0.0 111.37 -176.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.416 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . 161.72 -179.33 37.17 Favored Glycine 1 N--CA 1.393 -4.191 0 C-N-CA 118.717 -1.706 . . . . 0.0 114.785 170.231 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' B' ' 24' ' ' LEU . . . -177.9 -158.69 21.31 Favored Glycine 1 C--N 1.253 -4.06 1 N-CA-C 102.801 -4.12 . . . . 0.0 102.801 -178.815 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 7.2 p -75.98 108.72 8.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 120.208 2.004 . . . . 0.0 110.551 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -141.22 165.68 27.4 Favored Pre-proline 0 C--N 1.277 -2.587 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.33 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.649 ' HB2' HD12 ' B' ' 58' ' ' ILE . 11.6 Cg_exo -70.47 144.04 49.13 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.487 1.458 . . . . 0.0 109.871 169.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 29.3 m -128.02 158.7 39.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 35.1 m -102.08 130.46 51.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.891 177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.419 HD13 HG12 ' B' ' 55' ' ' VAL . 34.7 mm -84.37 105.72 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -10.66 8.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.813 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.527 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.0 OUTLIER -58.61 161.95 4.25 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 125.274 1.43 . . . . 0.0 114.723 -171.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -67.26 -172.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.771 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -89.67 -41.28 12.02 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.204 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.455 ' HA ' ' HD2' ' B' ' 48' ' ' LYS . 5.2 m -78.7 -21.91 47.46 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 -32.32 81.16 Favored Glycine 0 C--O 1.219 -0.811 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -69.76 -36.95 76.22 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.227 0.536 . . . . 0.0 110.494 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.455 ' HD2' ' HA ' ' B' ' 45' ' ' THR . 33.9 mttp -77.5 -50.13 13.28 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -115.4 -25.08 8.1 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -88.32 150.02 46.0 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.939 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.68 -16.4 6.69 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.506 1.471 . . . . 0.0 110.618 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.5 p -95.8 143.04 27.37 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 124.539 1.136 . . . . 0.0 112.18 -174.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.21 139.48 51.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.632 HG21 HD22 ' A' ' 122' ' ' LEU . 10.2 tt -92.14 134.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 120.948 0.404 . . . . 0.0 109.954 170.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.485 HG21 HD12 ' B' ' 94' ' ' LEU . 22.0 m -139.9 165.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 120.968 0.413 . . . . 0.0 110.255 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.541 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -124.15 138.83 54.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.52 134.54 47.8 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.649 HD12 ' HB2' ' B' ' 37' ' ' PRO . 64.7 mt -93.45 139.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.011 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 96.9 m -131.69 140.15 49.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' B' ' 84' ' ' SER . . . . . . . . 0 C--O 1.219 -0.816 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.8 mt . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.01 0.51 4.34 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.106 1.871 . . . . 0.0 113.255 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 58.0 p -100.58 -18.83 16.42 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.32 0.581 . . . . 0.0 110.368 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -97.33 129.99 44.54 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.86 144.44 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -104.9 151.36 23.96 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.931 0.396 . . . . 0.0 110.653 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.506 HD13 HD11 ' B' ' 86' ' ' ILE . 24.7 pt -127.17 137.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.487 ' O ' ' HD1' ' B' ' 78' ' ' TYR . 27.9 mp0 -60.44 116.25 4.17 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.399 1.08 . . . . 0.0 113.217 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . 0.448 ' HB3' ' C ' ' B' ' 82' ' ' LYS . 22.1 pttm -50.39 -36.72 33.98 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.704 0.764 . . . . 0.0 112.627 175.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -53.58 -52.7 58.93 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 113.342 -1.754 . . . . 0.0 113.072 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -92.32 -36.78 12.99 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.592 0.711 . . . . 0.0 111.358 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' B' ' 106' ' ' LEU . 76.6 m-85 -76.08 -7.39 54.6 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.766 -173.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 74.86 28.19 1.14 Allowed 'General case' 0 C--N 1.35 0.619 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 167.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 mp -107.69 -177.51 3.36 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.687 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -91.56 -19.45 22.74 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.814 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.448 ' C ' ' HB3' ' B' ' 75' ' ' LYS . 0.2 OUTLIER -128.46 153.79 46.75 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.061 -173.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -75.87 128.96 36.22 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.501 ' HB3' HD11 ' B' ' 73' ' ' ILE . 6.8 t -102.83 164.49 11.59 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -169.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.2 t -122.42 141.25 43.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.51 HD12 HG12 ' B' ' 58' ' ' ILE . 14.3 mm -108.31 132.72 55.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 177.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -105.54 108.26 19.68 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.195 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.83 -3.98 55.32 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.134 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -95.87 -35.98 11.28 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.275 1.036 . . . . 0.0 109.804 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . 0.469 ' HG2' ' HB3' ' B' ' 32' ' ' GLN . 8.0 tp60 -93.05 80.6 4.55 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.63 177.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.541 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.1 pp -122.53 -177.62 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -173.17 -178.07 1.68 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.453 0.644 . . . . 0.0 112.503 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 54.1 m -124.36 126.0 45.26 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.485 HD12 HG21 ' B' ' 55' ' ' VAL . 81.6 mt -131.82 134.78 46.16 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.589 1.156 . . . . 0.0 109.816 -173.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 2.9 p-10 -78.23 153.93 31.47 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -44.6 -21.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.762 1.625 . . . . 0.0 114.897 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -71.96 -18.62 61.98 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.683 0.793 . . . . 0.0 110.484 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.442 ' HD2' ' HB3' ' A' ' 28' ' ' GLN . 3.0 mmp_? -86.55 -36.38 18.96 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.174 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.79 126.06 28.56 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.791 0.805 . . . . 0.0 110.418 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -95.62 -64.48 1.05 Allowed 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.301 -1.318 . . . . 0.0 113.489 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 16.9 pt-20 -157.93 143.6 17.09 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.35 0.595 . . . . 0.0 111.558 -170.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.1 OUTLIER -66.38 123.88 21.21 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.413 -1.721 . . . . 0.0 110.706 174.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.721 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 24.9 tp -114.38 -62.14 1.64 Allowed 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.56 1.171 . . . . 0.0 110.57 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.721 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 5.1 m -125.14 -175.79 3.4 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 112.837 -1.983 . . . . 0.0 111.872 -163.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.435 ' H ' ' CG2' ' B' ' 104' ' ' THR . 0.4 OUTLIER -159.52 139.31 11.61 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 125.77 1.628 . . . . 0.0 109.384 -168.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.523 ' HA ' ' CE2' ' B' ' 78' ' ' TYR . 6.9 mt -101.54 159.62 15.14 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.955 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m -90.4 158.37 17.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.093 174.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' B' ' 111' ' ' MET . 8.7 m-20 -64.48 -28.48 69.69 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.513 0.673 . . . . 0.0 111.952 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.89 -33.52 64.06 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.944 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.451 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 4.6 mptp? -79.96 -22.64 42.38 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.825 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.518 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -56.59 -38.76 72.46 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 170.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' B' ' 112' ' ' LYS . 6.9 mmpt? -78.8 -12.89 60.04 Favored 'General case' 0 N--CA 1.381 -3.921 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.91 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -88.94 -50.47 6.17 Favored 'General case' 0 N--CA 1.391 -3.385 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 t -48.99 -59.6 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.224 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 5.0 m-20 -57.14 -41.87 79.9 Favored 'General case' 0 N--CA 1.514 2.726 0 CA-C-O 123.661 1.696 . . . . 0.0 112.352 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.586 ' O ' HD12 ' B' ' 120' ' ' ILE 0.345 22.0 t30 -83.64 -46.63 12.12 Favored 'General case' 0 C--N 1.251 -3.696 0 CA-C-N 112.319 -2.219 . . . . 0.0 112.285 -168.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.19 -32.52 72.28 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.545 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 7.6 tp -62.38 -46.9 86.54 Favored 'General case' 1 N--CA 1.365 -4.684 0 CA-C-N 113.514 -1.676 . . . . 0.0 109.601 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.686 ' SD ' ' HA ' ' B' ' 125' ' ' ASN 0.288 7.9 ptp -66.55 -25.42 66.64 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 177.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.586 HD12 ' O ' ' B' ' 116' ' ' ASN . 4.5 mp -72.05 -46.66 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 C-N-CA 117.756 -1.577 . . . . 0.0 108.288 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 14.9 t -58.05 -34.37 70.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.316 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.634 HD22 HG21 ' A' ' 54' ' ' ILE . 13.7 mt -110.41 7.91 23.02 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.56 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.17 20.77 67.52 Favored Glycine 0 N--CA 1.468 0.808 0 N-CA-C 116.983 1.553 . . . . 0.0 116.983 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.782 HD11 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -101.26 18.64 19.43 Favored 'General case' 0 CA--C 1.496 -1.135 0 CA-C-N 118.361 1.08 . . . . 0.0 111.309 -177.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.686 ' HA ' ' SD ' ' B' ' 119' ' ' MET . 20.3 m120 . . . . . 0 N--CA 1.475 0.815 0 O-C-N 124.175 0.922 . . . . 0.0 112.21 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.3 mt . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -102.91 121.91 43.49 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.982 -174.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -59.45 126.26 26.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.84 -7.05 44.67 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.204 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -97.56 -178.6 4.18 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 14.2 t -135.49 136.32 50.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 C-N-CA 123.679 0.792 . . . . 0.0 110.622 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 33.2 m-85 -132.2 146.24 51.88 Favored 'General case' 0 CA--C 1.466 -2.281 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.0 mp -77.84 152.73 33.28 Favored 'General case' 0 N--CA 1.395 -3.184 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.647 170.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -130.07 144.03 51.12 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.897 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 13.3 t70 -89.33 86.66 6.87 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.261 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 4.5 mm? -88.89 41.07 1.01 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.196 1.398 . . . . 0.0 112.496 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.615 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 31.7 m -73.48 174.29 4.96 Favored Pre-proline 0 C--N 1.251 -3.698 0 C-N-CA 126.123 1.769 . . . . 0.0 108.232 171.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.615 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER 4.79 51.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.41 3.81 1 C-N-CA 127.971 5.781 . . . . 0.0 118.65 -178.01 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 27.8 m -69.09 176.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.779 171.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 33.5 mm-40 -104.04 133.14 49.49 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.389 -176.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.76 -120.65 19.85 Favored Glycine 0 CA--C 1.505 -0.594 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.937 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.8 m -91.58 13.39 17.98 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -61.34 152.57 29.05 Favored 'General case' 0 C--O 1.252 1.225 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.71 177.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.527 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -71.88 120.86 18.08 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.157 -171.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -101.03 142.36 15.74 Favored Glycine 0 CA--C 1.476 -2.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.431 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 108.76 141.02 9.31 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 114.401 -0.899 . . . . 0.0 111.122 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.57 117.63 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -139.33 148.31 56.3 Favored Pre-proline 0 C--N 1.253 -3.613 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.61 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 50.0 Cg_exo -63.0 138.48 68.15 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.823 2.349 . . . . 0.0 111.654 171.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 20' ' ' TYR . 30.6 m -123.93 156.22 31.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.486 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.9 m -100.93 132.05 47.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 120.809 0.338 . . . . 0.0 110.329 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.466 ' CG2' ' HG2' ' A' ' 42' ' ' GLN . 23.4 mm -91.59 106.66 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -104.37 -9.76 9.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.517 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.56 HE22 ' N ' ' A' ' 47' ' ' ASN . 4.5 pt20 -51.46 162.5 0.36 Allowed 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -168.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -65.42 -177.08 0.38 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.285 -1.779 . . . . 0.0 111.765 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -73.89 -53.73 9.52 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 114.55 -1.204 . . . . 0.0 112.677 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.525 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 20.3 m -82.9 -22.39 33.95 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -166.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.58 -40.18 86.85 Favored Glycine 0 C--O 1.213 -1.219 0 O-C-N 123.059 0.224 . . . . 0.0 113.316 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.56 ' N ' HE22 ' A' ' 42' ' ' GLN . 11.0 p30 -71.05 -20.72 62.34 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 45' ' ' THR . 2.5 mptp? -86.16 -68.03 0.77 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.157 0.503 . . . . 0.0 110.517 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.35 -29.51 24.41 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -168.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 m -91.12 143.35 28.32 Favored Pre-proline 0 N--CA 1.414 -2.238 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.54 -26.45 23.91 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 120.955 1.103 . . . . 0.0 109.709 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.0 p -82.01 147.9 28.93 Favored 'General case' 0 N--CA 1.414 -2.258 0 C-N-CA 125.915 1.686 . . . . 0.0 113.619 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.541 HG13 ' OE1' ' A' ' 42' ' ' GLN . 93.3 t -132.16 140.39 47.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.701 HD11 HD13 ' A' ' 91' ' ' ILE . 5.0 tp -103.86 124.72 58.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.426 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 25.1 m -134.02 167.92 25.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.988 -175.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.503 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -126.13 139.52 53.31 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.83 137.38 41.82 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' A' ' 37' ' ' PRO . 60.4 mt -95.6 134.99 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-N 113.115 -1.857 . . . . 0.0 108.468 175.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 m -103.6 124.78 49.44 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.583 0 C-N-CA 121.249 -0.501 . . . . 0.0 111.984 -176.555 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.218 -0.577 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.94 1.18 2.01 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.677 2.251 . . . . 0.0 113.706 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.9 p -91.69 -16.26 27.23 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-O 122.301 1.048 . . . . 0.0 108.288 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -107.34 129.31 54.92 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 73' ' ' ILE . 67.8 t -126.18 127.15 70.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.618 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.25 124.63 37.36 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.667 0.746 . . . . 0.0 109.8 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.679 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -108.75 156.34 9.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.297 -175.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -63.25 119.78 10.27 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 123.779 0.674 . . . . 0.0 112.619 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -46.12 -46.77 17.28 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 126.071 1.748 . . . . 0.0 110.336 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -58.2 -32.31 68.15 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 126.673 1.989 . . . . 0.0 112.826 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -91.14 -39.04 12.36 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.712 0.768 . . . . 0.0 110.792 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.679 ' CE1' HG21 ' A' ' 73' ' ' ILE . 4.2 m-85 -83.22 -9.45 59.14 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.793 -177.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 67.09 40.87 2.77 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.921 0.889 . . . . 0.0 111.096 174.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.41 -179.71 3.96 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.836 0.827 . . . . 0.0 111.073 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.8 -10.78 41.58 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.258 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -139.8 161.26 37.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.34 142.12 50.42 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.7 t -110.0 155.76 21.39 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.545 -171.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 12.6 t -117.74 128.11 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.483 HD13 HG13 ' A' ' 73' ' ' ILE . 1.6 mp -103.52 125.53 58.06 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.94 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 90' ' ' GLN . 67.0 mt -100.97 110.61 22.67 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 113.228 -1.806 . . . . 0.0 110.04 -175.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.56 HD12 HD23 ' A' ' 118' ' ' LEU . 3.6 mm? -83.84 3.25 34.48 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.732 -175.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -119.03 4.2 11.4 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.787 1.28 . . . . 0.0 108.39 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 8.5 tp60 -122.85 35.1 4.96 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.535 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.701 HD13 HD11 ' A' ' 54' ' ' ILE . 2.1 pp -85.94 -178.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.186 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.527 ' NH2' ' HB3' ' A' ' 32' ' ' GLN . 9.3 ptp85 -167.66 168.6 12.5 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 16.2 m -122.41 118.87 29.41 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.609 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 60.7 mt -131.89 140.1 48.97 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.255 -173.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.534 ' OD2' ' HB3' ' A' ' 97' ' ' LYS . 4.7 p-10 -72.89 151.26 42.01 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.635 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -45.54 -35.5 3.96 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.534 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 7.4 ttpm? -61.29 -26.1 67.56 Favored 'General case' 0 C--N 1.273 -2.753 0 C-N-CA 123.879 0.872 . . . . 0.0 112.634 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.441 ' NH1' ' HB3' ' A' ' 23' ' ' ASP . 2.3 mmp_? -75.53 -28.48 59.11 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.171 0.51 . . . . 0.0 110.813 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.05 124.22 24.5 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.492 1.117 . . . . 0.0 110.12 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -87.72 -63.64 1.27 Allowed 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.21 -1.359 . . . . 0.0 113.305 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.1 pt-20 -161.11 142.39 11.68 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 121.403 0.62 . . . . 0.0 111.969 -170.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -60.94 120.92 11.13 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 126.186 1.794 . . . . 0.0 110.731 174.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.53 -62.83 1.54 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.518 HG22 HG11 ' A' ' 19' ' ' VAL . 4.8 t -125.41 -167.0 1.62 Allowed 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.263 -1.375 . . . . 0.0 111.626 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -161.2 135.18 6.86 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 124.092 0.957 . . . . 0.0 111.831 -171.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -105.4 163.36 12.69 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.176 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.5 p -90.86 170.14 10.34 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.282 0.563 . . . . 0.0 112.459 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 111' ' ' MET . 27.6 t70 -65.82 -30.82 71.5 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.292 1.037 . . . . 0.0 112.492 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -75.44 -24.26 57.03 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 122.035 -0.415 . . . . 0.0 110.491 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.7 OUTLIER -75.13 -26.65 59.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.356 174.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.486 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -55.01 -39.32 68.96 Favored 'General case' 0 CA--C 1.471 -2.085 0 CA-C-O 122.04 0.924 . . . . 0.0 109.818 172.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.494 ' HE2' ' N ' ' A' ' 112' ' ' LYS . 8.3 mmpt? -74.28 -15.21 60.98 Favored 'General case' 0 N--CA 1.393 -3.292 0 CA-C-N 114.214 -1.357 . . . . 0.0 113.112 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -86.93 -56.03 3.57 Favored 'General case' 0 N--CA 1.389 -3.51 0 C-N-CA 117.649 -1.62 . . . . 0.0 109.245 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 110' ' ' LYS . 22.0 m -57.33 -47.7 84.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -174.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.5 ' HB3' ' HG ' ' B' ' 124' ' ' LEU . 44.5 m-20 -60.53 -48.02 83.6 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 123.536 1.636 . . . . 0.0 109.931 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 12.1 t30 -76.06 -39.87 54.49 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 112.267 -2.242 . . . . 0.0 112.647 -168.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.513 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -60.25 -38.51 83.68 Favored 'General case' 0 CA--C 1.469 -2.142 0 CA-C-O 122.279 1.038 . . . . 0.0 108.605 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.56 HD23 HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -83.0 -27.82 30.12 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.297 -173.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.435 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 3.7 ttp -60.27 -30.09 69.23 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 124.079 0.951 . . . . 0.0 108.552 172.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 116' ' ' ASN . 52.9 mt -81.22 -55.61 7.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.9 t -49.76 -43.25 47.91 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.938 1.695 . . . . 0.0 111.935 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.485 ' HG ' HG12 ' B' ' 54' ' ' ILE . 9.0 mp -82.12 5.65 18.93 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.28 5.41 76.09 Favored Glycine 0 C--N 1.341 0.857 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' B' ' 115' ' ' ASP . 3.5 mp -73.23 -42.76 62.22 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.484 1.142 . . . . 0.0 108.63 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.435 -1.218 0 C-N-CA 126.501 1.921 . . . . 0.0 114.836 177.933 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 86.5 mt . . . . . 0 C--O 1.244 0.766 0 CA-C-O 121.296 0.569 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -104.44 122.41 45.46 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.058 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -59.55 124.97 21.81 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 120.969 0.414 . . . . 0.0 110.105 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.51 -7.42 46.47 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.501 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -97.17 179.2 4.99 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 17.4 t -134.17 137.48 51.83 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 C-N-CA 123.546 0.738 . . . . 0.0 111.031 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 27.7 m-85 -132.99 145.41 50.85 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.3 mp -76.62 151.36 36.25 Favored 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.664 170.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.63 143.83 51.0 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.341 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -87.36 84.45 7.19 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.167 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.517 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 4.4 mm? -88.17 40.93 0.98 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 123.172 1.463 . . . . 0.0 112.444 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.591 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.257 14.7 m -73.67 174.76 4.35 Favored Pre-proline 1 C--N 1.242 -4.097 0 CA-C-N 113.279 -1.782 . . . . 0.0 108.162 172.612 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 13.9 Cg_exo 3.19 53.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.406 3.571 1 C-N-CA 128.129 5.886 . . . . 0.0 118.077 -179.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 m -69.4 -178.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 113.44 -1.709 . . . . 0.0 111.836 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' B' ' 31' ' ' GLU . 33.1 mm-40 -109.79 132.7 53.91 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.624 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.87 -125.74 40.6 Favored Glycine 0 CA--C 1.499 -0.964 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.263 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 39.6 m -93.55 22.18 5.62 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.38 -0.41 . . . . 0.0 112.03 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' B' ' 28' ' ' GLN . 0.0 OUTLIER -64.24 162.46 14.61 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.388 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.565 ' HB3' ' NH2' ' B' ' 92' ' ' ARG . 0.9 OUTLIER -79.92 117.42 20.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 120.87 0.367 . . . . 0.0 110.262 -173.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -98.07 145.8 17.93 Favored Glycine 0 CA--C 1.473 -2.556 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.514 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 106.54 138.96 9.24 Favored Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 114.431 -0.884 . . . . 0.0 111.18 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 t -56.93 119.42 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . 0.431 ' NH1' ' HA ' ' B' ' 59' ' ' THR . 58.7 mtt180 -140.7 148.43 52.87 Favored Pre-proline 0 C--N 1.256 -3.488 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.431 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.534 ' HB2' HD12 ' B' ' 58' ' ' ILE . 35.2 Cg_exo -64.1 138.49 62.2 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.707 2.271 . . . . 0.0 111.454 171.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.42 HG22 ' O ' ' B' ' 20' ' ' TYR . 31.5 m -123.54 156.41 30.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 33.1 m -100.86 132.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.896 0.379 . . . . 0.0 110.439 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.477 ' CG2' ' HG2' ' B' ' 42' ' ' GLN . 24.3 mm -91.69 107.15 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.417 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -104.48 -9.99 9.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.571 ' OE1' HG13 ' B' ' 53' ' ' VAL . 4.7 pt20 -51.67 162.19 0.43 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -168.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -67.04 -179.88 1.02 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.263 -1.79 . . . . 0.0 111.852 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.25 -55.17 15.09 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.01 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.549 ' HA ' ' HD3' ' B' ' 48' ' ' LYS . 10.4 m -84.92 -22.3 29.32 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -164.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.64 -38.57 82.54 Favored Glycine 0 C--O 1.21 -1.381 0 O-C-N 123.236 0.335 . . . . 0.0 113.136 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.549 ' N ' HE22 ' B' ' 42' ' ' GLN . 10.2 p30 -71.79 -20.95 61.78 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.549 ' HD3' ' HA ' ' B' ' 45' ' ' THR . 2.8 mptp? -86.57 -67.75 0.79 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.138 0.494 . . . . 0.0 110.408 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.37 -35.78 24.86 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -169.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 18.7 m -86.09 143.31 37.06 Favored Pre-proline 0 N--CA 1.415 -2.215 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.28 -25.69 21.67 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.025 1.15 . . . . 0.0 109.309 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.4 p -82.71 145.97 29.3 Favored 'General case' 0 N--CA 1.415 -2.188 0 C-N-CA 125.545 1.538 . . . . 0.0 113.579 -173.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.571 HG13 ' OE1' ' B' ' 42' ' ' GLN . 98.0 t -130.01 140.52 48.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 176.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.702 HD11 HD13 ' B' ' 91' ' ' ILE . 5.1 tp -103.76 124.57 58.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 121.291 0.567 . . . . 0.0 109.697 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.418 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 24.8 m -134.15 167.09 26.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.965 -175.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.506 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -125.53 139.54 53.52 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.49 135.78 42.23 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' B' ' 37' ' ' PRO . 59.4 mt -93.98 135.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 113.248 -1.796 . . . . 0.0 108.05 174.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . 0.431 ' HA ' ' NH1' ' B' ' 36' ' ' ARG . 19.2 m -101.92 127.22 48.86 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.659 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.76 -176.104 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.218 -0.575 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.09 3.34 1.32 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.768 2.312 . . . . 0.0 113.755 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 58.9 p -92.4 -15.9 26.62 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.455 1.121 . . . . 0.0 108.504 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -108.64 129.76 55.33 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.518 HG12 HD13 ' B' ' 73' ' ' ILE . 62.9 t -125.42 127.06 71.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 O-C-N 121.611 -0.681 . . . . 0.0 110.736 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.34 120.62 32.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.663 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.1 OUTLIER -106.6 154.28 7.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.449 -175.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -62.01 119.48 8.96 Favored 'General case' 0 C--O 1.251 1.176 0 O-C-N 124.202 0.939 . . . . 0.0 112.619 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -46.55 -46.33 19.27 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.147 1.779 . . . . 0.0 110.48 172.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -59.73 -31.33 69.52 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 126.219 1.807 . . . . 0.0 112.938 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -90.73 -39.44 12.42 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.199 0.523 . . . . 0.0 110.631 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.663 ' CE1' HG21 ' B' ' 73' ' ' ILE . 4.3 m-85 -83.29 -10.8 58.31 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.879 -177.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 tttp 70.41 34.2 2.3 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.31 1.044 . . . . 0.0 111.851 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.69 -179.79 4.07 Favored 'General case' 0 CA--C 1.492 -1.259 0 O-C-N 120.973 -1.08 . . . . 0.0 111.613 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.82 -13.41 42.24 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.785 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -140.35 161.65 37.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.98 144.8 52.21 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t -112.4 157.28 21.24 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 11.0 t -118.2 128.31 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.511 HD13 HG13 ' B' ' 73' ' ' ILE . 1.6 mp -103.12 124.75 57.44 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' B' ' 90' ' ' GLN . 74.5 mt -100.18 111.5 23.78 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.054 -175.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.54 HD12 HD23 ' B' ' 118' ' ' LEU . 3.6 mm? -84.06 2.75 37.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.614 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -119.15 4.79 11.29 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.818 1.294 . . . . 0.0 108.477 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 8.3 tp60 -123.61 35.33 4.87 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.159 -1.837 . . . . 0.0 106.481 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.702 HD13 HD11 ' B' ' 54' ' ' ILE . 2.1 pp -85.81 -178.31 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.192 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.565 ' NH2' ' HB3' ' B' ' 32' ' ' GLN . 9.6 ptp85 -167.53 168.93 12.49 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 11.0 m -122.37 118.29 28.08 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.594 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 64.8 mt -132.0 139.86 48.76 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.403 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.531 ' OD2' ' HB3' ' B' ' 97' ' ' LYS . 6.2 p-10 -71.47 151.59 43.81 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.193 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -46.21 -37.0 6.57 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.531 ' HB3' ' OD2' ' B' ' 95' ' ' ASP . 7.0 ttpm? -61.59 -24.47 66.7 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.667 176.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -74.6 -30.11 61.56 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.481 -0.762 . . . . 0.0 110.352 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -71.31 124.93 25.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.499 1.12 . . . . 0.0 110.428 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -88.22 -64.68 1.11 Allowed 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.745 -1.571 . . . . 0.0 112.732 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 9.9 pt-20 -161.25 142.12 11.28 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 121.502 0.668 . . . . 0.0 112.523 -171.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.2 OUTLIER -60.45 121.31 11.78 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 126.491 1.916 . . . . 0.0 110.938 174.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -114.82 -63.0 1.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.345 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.496 HG22 HG11 ' B' ' 19' ' ' VAL . 3.3 t -125.25 -166.54 1.55 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.172 -1.411 . . . . 0.0 111.816 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -161.13 135.87 7.37 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.002 0.921 . . . . 0.0 112.112 -170.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 pp -108.79 157.4 18.61 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.02 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 7.1 p -86.82 175.49 8.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' B' ' 111' ' ' MET . 22.9 t70 -72.21 -29.47 64.0 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.151 0.5 . . . . 0.0 111.812 -174.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -70.2 -23.38 62.94 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.355 0.597 . . . . 0.0 109.91 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.441 ' O ' HG22 ' B' ' 114' ' ' VAL . 0.6 OUTLIER -78.8 -27.4 44.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 174.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.466 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.0 OUTLIER -55.51 -39.44 70.5 Favored 'General case' 0 CA--C 1.46 -2.487 0 CA-C-O 122.336 1.065 . . . . 0.0 109.131 172.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' B' ' 112' ' ' LYS . 6.9 mmpt? -71.98 -17.16 62.08 Favored 'General case' 1 N--CA 1.378 -4.053 0 CA-C-N 113.725 -1.579 . . . . 0.0 113.841 -178.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.97 -57.98 2.76 Favored 'General case' 0 N--CA 1.39 -3.436 0 C-N-CA 117.561 -1.656 . . . . 0.0 109.198 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 110' ' ' LYS . 22.9 m -54.85 -47.02 75.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.519 ' HB3' ' HG ' ' A' ' 124' ' ' LEU . 55.6 m-20 -61.3 -48.97 78.93 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.636 1.684 . . . . 0.0 110.535 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' B' ' 119' ' ' MET 0.349 27.0 t30 -77.13 -38.69 51.51 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.539 -167.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.425 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -62.63 -37.56 86.8 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-O 122.267 1.032 . . . . 0.0 108.812 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.54 HD23 HD12 ' B' ' 88' ' ' LEU . 0.7 OUTLIER -82.66 -27.44 31.32 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.888 -174.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' B' ' 116' ' ' ASN . 4.0 ttp -60.25 -31.44 70.21 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 59.6 mt -79.03 -56.39 7.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.2 t -48.64 -43.45 36.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.114 1.366 . . . . 0.0 112.235 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.49 ' HG ' HG12 ' A' ' 54' ' ' ILE . 8.6 mp -81.64 6.06 16.3 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.36 7.28 79.83 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 115.661 1.025 . . . . 0.0 115.661 172.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 115' ' ' ASP . 3.8 mp -73.59 -43.82 58.78 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 118.328 1.064 . . . . 0.0 108.422 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 . . . . . 0 N--CA 1.432 -1.355 0 C-N-CA 126.689 1.995 . . . . 0.0 114.72 178.522 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 62.7 mt . . . . . 0 N--CA 1.444 -0.766 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.445 ' HG2' ' OD2' ' A' ' 18' ' ' ASP . 8.4 ptp180 -121.59 157.99 29.54 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 171.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 28.6 ptt85 -69.36 113.65 6.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 168.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.495 ' HA2' ' SD ' ' A' ' 111' ' ' MET . . . 131.76 -9.07 5.51 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.875 -173.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD2' ' HG2' ' A' ' 15' ' ' ARG . 32.9 m-20 -96.46 173.19 7.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 122.016 0.912 . . . . 0.0 109.713 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 12.4 t -132.3 134.22 59.47 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.794 178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.466 ' O ' HG22 ' A' ' 38' ' ' VAL . 50.7 m-85 -135.62 144.01 45.86 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 125.325 1.45 . . . . 0.0 108.977 176.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.637 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.9 mp -79.42 149.49 31.59 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-O 121.539 0.685 . . . . 0.0 111.097 173.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.67 134.23 33.37 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.177 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.553 ' HA ' ' HB ' ' A' ' 35' ' ' VAL 0.326 3.2 p-10 -81.64 104.72 12.25 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 117.931 -1.508 . . . . 0.0 111.346 176.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 5.4 mt -90.55 37.78 0.92 Allowed 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 124.92 2.295 . . . . 0.0 110.273 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.576 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.282 7.3 m -63.62 171.91 2.02 Favored Pre-proline 1 C--N 1.223 -4.904 0 CA-C-N 109.364 -3.562 . . . . 0.0 107.314 167.599 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 1.0 OUTLIER 6.04 53.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.401 3.307 1 C-N-CA 126.977 5.118 . . . . 0.0 118.227 -174.73 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.32 -178.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.717 166.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.416 HE22 ' HB2' ' B' ' 26' ' ' PRO . 31.5 mm-40 -108.01 126.46 52.75 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.89 -117.9 9.82 Favored Glycine 0 N--CA 1.425 -2.058 0 CA-C-N 113.781 -1.554 . . . . 0.0 114.329 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.9 m -93.89 22.08 6.01 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.445 -0.878 . . . . 0.0 112.869 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.96 -176.36 0.68 Allowed 'General case' 0 C--O 1.247 0.948 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.934 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.412 ' OE1' ' HD2' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -88.8 109.11 19.9 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.56 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.18 143.27 16.45 Favored Glycine 0 CA--C 1.472 -2.636 0 CA-C-N 115.149 -0.932 . . . . 0.0 114.281 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 108.07 137.1 8.12 Favored Glycine 0 N--CA 1.418 -2.535 0 CA-C-N 113.85 -1.175 . . . . 0.0 110.811 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 2.0 p -61.93 126.71 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 122.455 1.121 . . . . 0.0 111.053 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 84.4 mtt180 -149.61 166.27 15.62 Favored Pre-proline 0 C--N 1.266 -3.04 0 CA-C-N 112.927 -1.942 . . . . 0.0 108.2 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 3.8 Cg_exo -75.92 143.9 26.76 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 121.903 1.735 . . . . 0.0 111.555 174.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 20' ' ' TYR . 28.6 m -118.45 158.53 19.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 34.3 m -102.36 133.05 47.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.767 0.318 . . . . 0.0 110.729 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 mm -88.72 104.9 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.403 ' C ' HD13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -104.4 -20.81 5.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.114 -178.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -54.88 165.95 0.56 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -170.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -60.66 164.03 4.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.051 -1.886 . . . . 0.0 112.527 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.08 -39.32 79.13 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.52 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 m -86.97 -26.56 23.76 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -171.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.89 -37.2 92.22 Favored Glycine 0 C--O 1.201 -1.919 0 CA-C-N 116.354 -0.385 . . . . 0.0 113.402 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.535 ' OD1' ' HD2' ' A' ' 48' ' ' LYS . 27.5 p30 -69.55 -19.69 63.68 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HD2' ' OD1' ' A' ' 47' ' ' ASN . 13.0 mptt -84.51 -61.73 1.73 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 109.901 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -89.13 -21.93 23.11 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -168.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.2 m -105.94 139.71 20.52 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.668 -0.645 . . . . 0.0 109.652 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.48 -22.26 14.17 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.437 1.425 . . . . 0.0 109.597 174.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 3.7 p -96.17 133.69 40.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.456 1.102 . . . . 0.0 111.889 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.24 145.96 34.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.3 tt -96.68 132.68 40.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.543 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.453 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 30.0 m -137.77 172.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.383 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.558 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -126.0 139.55 53.33 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.53 142.76 42.75 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.622 HD12 ' HB2' ' A' ' 37' ' ' PRO . 82.7 mt -101.86 129.53 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.759 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.8 m -119.27 105.31 11.21 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.428 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.178 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.4 HD12 ' CE1' ' A' ' 70' ' ' HIS . 12.5 mt . . . . . 0 N--CA 1.437 -1.087 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.14 -11.29 21.33 Favored 'Trans proline' 0 CA--C 1.563 1.927 0 C-N-CA 122.199 1.933 . . . . 0.0 113.723 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.7 p -90.21 -19.02 24.67 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.353 0.597 . . . . 0.0 110.702 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.4 ' CE1' HD12 ' A' ' 67' ' ' ILE . 26.1 m170 -95.1 130.27 41.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.49 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.82 132.87 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.34 132.95 52.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.298 0.571 . . . . 0.0 110.909 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.805 HG23 ' HG2' ' A' ' 110' ' ' LYS . 0.7 OUTLIER -107.53 165.53 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.021 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.475 ' H ' HG22 ' A' ' 73' ' ' ILE . 1.3 mp0 -69.54 110.08 4.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 124.074 0.95 . . . . 0.0 109.828 176.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 20.8 pttm -58.09 -35.89 72.08 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.563 0.696 . . . . 0.0 112.115 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -51.61 -45.72 63.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.327 -1.76 . . . . 0.0 111.03 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -82.98 -34.68 26.34 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.288 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.661 ' CE1' HG21 ' A' ' 73' ' ' ILE . 1.8 m-85 -73.35 -11.52 60.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.031 -177.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.2 tptt 78.45 18.94 0.99 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.879 1.272 . . . . 0.0 111.732 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.13 179.36 4.51 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.285 1.04 . . . . 0.0 110.988 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -97.11 -24.8 15.58 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.977 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -130.33 155.25 46.66 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.108 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.467 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 4.5 m-20 -56.74 142.68 39.48 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 122.021 0.915 . . . . 0.0 113.203 -175.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.9 m -108.02 128.63 54.83 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.158 -174.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.3 t -115.82 130.22 70.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 HD22 ' A' ' 88' ' ' LEU . 1.6 mp -107.22 129.68 60.61 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.843 0 CA-C-O 122.196 0.998 . . . . 0.0 108.575 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.0 mt -103.42 108.34 19.55 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 113.194 -1.821 . . . . 0.0 109.214 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.519 HD22 HG22 ' A' ' 86' ' ' ILE . 3.9 mm? -80.41 4.35 18.33 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.373 -175.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.12 -38.0 6.13 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.378 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.48 53.35 2.78 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.545 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.558 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.0 pp -97.21 -176.16 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -173.96 178.11 2.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 45.4 m -121.76 129.15 52.48 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.884 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 mt -133.17 145.56 50.74 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 124.373 1.069 . . . . 0.0 109.328 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.486 ' OD2' ' HB3' ' A' ' 97' ' ' LYS . 2.2 p-10 -79.73 151.16 30.57 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.284 -1.367 . . . . 0.0 110.115 173.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -39.14 -41.06 0.79 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.994 2.117 . . . . 0.0 114.521 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.486 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 7.0 ttpm? -63.65 -13.74 45.43 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 124.122 0.969 . . . . 0.0 112.401 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.534 ' NE ' ' HA ' ' A' ' 98' ' ' ARG . 3.7 mmp_? -89.73 -26.94 20.38 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.166 -0.959 . . . . 0.0 110.912 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -74.89 108.56 7.7 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-O 122.14 0.971 . . . . 0.0 109.514 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -93.83 -59.28 2.03 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -143.66 130.41 20.31 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.918 0.866 . . . . 0.0 113.232 -171.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.2 tttp -60.77 119.9 9.07 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 127.266 2.226 . . . . 0.0 108.184 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.7 tp -114.5 -62.38 1.61 Allowed 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.804 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 78' ' ' TYR . 6.1 t -127.75 -160.49 1.02 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.238 -1.385 . . . . 0.0 112.457 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -159.37 149.97 19.42 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.371 1.868 . . . . 0.0 109.158 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -101.82 147.49 26.43 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.688 -177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -64.32 143.16 58.1 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 125.1 1.36 . . . . 0.0 108.608 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 111' ' ' MET . 7.0 p-10 -58.45 -37.39 75.34 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.29 -34.47 63.55 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.809 0.337 . . . . 0.0 110.606 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.805 ' HG2' HG23 ' A' ' 73' ' ' ILE . 16.7 tppt? -67.67 -33.58 75.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.495 ' SD ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -51.31 -46.18 62.47 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.693 173.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.696 ' HE2' ' N ' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -69.69 -17.78 63.5 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.72 -178.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -83.54 -38.67 21.41 Favored 'General case' 0 CA--C 1.442 -3.175 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.21 -42.99 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.671 0 O-C-N 126.13 2.144 . . . . 0.0 109.999 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.693 ' OD2' ' HA ' ' A' ' 112' ' ' LYS . 44.8 m-20 -57.4 -58.92 6.16 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.53 ' O ' HG13 ' A' ' 120' ' ' ILE . 1.7 m-80 -59.38 -47.39 85.63 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.3 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.515 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -52.09 -43.81 64.09 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 124.341 1.056 . . . . 0.0 110.852 -178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 tp -67.21 -45.93 75.38 Favored 'General case' 1 N--CA 1.374 -4.252 0 C-N-CA 124.336 1.054 . . . . 0.0 109.971 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.2 mtp -67.82 -20.08 65.13 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 121.477 -0.765 . . . . 0.0 112.891 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 116' ' ' ASN . 49.4 mt -77.24 -55.75 9.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 26.2 t -53.22 -42.65 66.57 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.759 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.4 mp -90.06 -1.14 57.91 Favored 'General case' 0 N--CA 1.403 -2.782 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.65 13.14 82.84 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 116.571 1.389 . . . . 0.0 116.571 170.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.2 mp -79.57 -59.84 2.59 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 118.624 1.212 . . . . 0.0 110.985 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 CA--C 1.568 1.649 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.65 -168.468 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.448 -0.559 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -117.35 159.14 23.21 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 27.0 ptt85 -70.0 113.54 7.31 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.427 ' HA2' ' SD ' ' B' ' 111' ' ' MET . . . 133.34 -15.3 4.74 Favored Glycine 0 C--N 1.305 -1.163 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.666 -173.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -89.72 171.92 9.3 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 121.946 0.879 . . . . 0.0 109.047 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.408 HG11 HG22 ' B' ' 104' ' ' THR . 13.3 t -131.19 132.88 63.09 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.774 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.841 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.492 ' O ' HG22 ' B' ' 38' ' ' VAL . 75.6 m-85 -133.65 143.69 48.74 Favored 'General case' 0 CA--C 1.474 -1.957 0 C-N-CA 125.199 1.4 . . . . 0.0 109.463 176.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.652 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.9 mp -81.49 148.42 29.21 Favored 'General case' 0 N--CA 1.397 -3.095 0 CA-C-O 121.687 0.756 . . . . 0.0 110.99 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -136.59 134.73 37.72 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 113.177 -1.829 . . . . 0.0 107.209 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' B' ' 35' ' ' VAL 0.333 3.6 p-10 -81.95 102.51 10.97 Favored 'General case' 0 C--N 1.279 -2.467 0 C-N-CA 117.975 -1.49 . . . . 0.0 111.658 175.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 4.9 mt -87.8 39.1 0.87 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 125.085 2.374 . . . . 0.0 110.396 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.572 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.287 6.6 m -64.62 171.87 2.55 Favored Pre-proline 1 C--N 1.22 -5.027 0 CA-C-N 109.363 -3.562 . . . . 0.0 107.219 167.083 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.3 OUTLIER 5.85 53.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.173 1 C-N-CA 127.153 5.235 . . . . 0.0 118.386 -174.746 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 28.5 m -69.29 -179.1 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.534 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . 0.419 HE22 ' HB2' ' A' ' 26' ' ' PRO . 32.1 mm-40 -106.52 130.95 54.21 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -176.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.99 -117.9 7.37 Favored Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 113.751 -1.568 . . . . 0.0 113.82 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -94.18 18.08 11.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.34 -0.93 . . . . 0.0 113.188 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.52 178.1 1.04 Allowed 'General case' 0 C--O 1.249 1.063 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.942 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.457 ' OE1' ' HD2' ' B' ' 36' ' ' ARG . 1.0 OUTLIER -83.52 108.81 16.89 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.522 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.79 138.52 14.11 Favored Glycine 0 CA--C 1.479 -2.212 0 CA-C-N 114.904 -1.043 . . . . 0.0 114.324 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 117.5 136.92 5.71 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 113.813 -1.193 . . . . 0.0 110.512 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' B' ' 23' ' ' ASP . 1.5 p -63.85 121.21 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 122.497 1.141 . . . . 0.0 110.9 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . 0.457 ' HD2' ' OE1' ' B' ' 32' ' ' GLN . 87.8 mtt180 -144.51 166.69 17.52 Favored Pre-proline 0 C--N 1.26 -3.319 0 CA-C-N 112.846 -1.979 . . . . 0.0 109.028 -174.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 5.4 Cg_exo -76.05 142.7 25.07 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 122.003 1.802 . . . . 0.0 111.507 174.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.492 HG22 ' O ' ' B' ' 20' ' ' TYR . 31.0 m -118.07 158.08 19.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.2 m -102.22 132.42 48.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.807 0.336 . . . . 0.0 110.79 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 24.0 mm -88.09 104.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.47 -20.8 5.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.004 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -55.64 165.91 0.77 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 -170.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -59.77 163.3 4.54 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 112.709 -2.042 . . . . 0.0 112.784 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.0 -37.97 75.83 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.498 -175.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 25.8 m -87.23 -28.35 22.42 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.03 -36.06 86.65 Favored Glycine 0 C--O 1.2 -1.99 0 CA-C-O 120.077 -0.291 . . . . 0.0 113.336 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.548 ' OD1' ' HD2' ' B' ' 48' ' ' LYS . 26.6 p30 -69.21 -19.58 63.97 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.548 ' HD2' ' OD1' ' B' ' 47' ' ' ASN . 13.1 mptt -85.66 -59.44 2.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.222 0.534 . . . . 0.0 110.369 174.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -89.25 -29.75 19.0 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -169.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.7 m -99.45 138.41 20.48 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -74.7 -22.09 15.89 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.281 1.32 . . . . 0.0 109.708 173.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 3.1 p -95.43 132.7 40.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.546 -176.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.32 146.38 34.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.42 ' CD1' HD11 ' A' ' 91' ' ' ILE . 4.8 tt -96.97 132.85 40.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 123.112 0.565 . . . . 0.0 110.317 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.462 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 28.3 m -138.03 171.93 14.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.556 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.558 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -125.05 139.8 53.47 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.12 142.03 41.77 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.631 HD12 ' HB2' ' B' ' 37' ' ' PRO . 85.2 mt -100.2 133.11 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.281 -1.781 . . . . 0.0 109.389 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 95.7 m -123.41 104.72 9.26 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.601 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.249 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 13.2 mt . . . . . 0 N--CA 1.437 -1.119 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.98 -12.69 33.35 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 122.157 1.905 . . . . 0.0 113.671 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -88.78 -19.09 26.45 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.395 0.617 . . . . 0.0 110.651 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -96.21 130.26 43.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.38 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 95.1 t -126.53 130.45 71.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 O-C-N 122.174 -0.329 . . . . 0.0 110.359 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -101.32 139.49 36.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.78 HG23 ' HG2' ' B' ' 110' ' ' LYS . 0.7 OUTLIER -115.36 162.96 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 123.157 0.583 . . . . 0.0 111.754 -173.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.415 ' H ' HG22 ' B' ' 73' ' ' ILE . 1.3 mp0 -66.3 109.91 2.86 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 123.785 0.834 . . . . 0.0 110.409 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . 0.451 ' HB3' ' HA ' ' B' ' 83' ' ' ASP . 20.0 pttm -58.13 -34.98 70.82 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.873 0.844 . . . . 0.0 112.066 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -53.32 -44.19 68.21 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.177 -1.828 . . . . 0.0 110.941 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -84.51 -35.2 23.06 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.472 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.636 ' CE1' HG21 ' B' ' 73' ' ' ILE . 1.6 m-85 -73.43 -11.49 60.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.926 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 81.59 13.81 0.61 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.222 1.409 . . . . 0.0 112.089 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.8 179.29 5.02 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 122.328 1.061 . . . . 0.0 111.189 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -96.27 -25.04 15.93 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 113.673 -1.603 . . . . 0.0 109.845 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -130.34 156.02 45.38 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.451 ' HA ' ' HB3' ' B' ' 75' ' ' LYS . 2.1 m-20 -54.08 144.22 20.09 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.959 0.885 . . . . 0.0 113.239 -175.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 13.1 m -108.27 128.18 54.5 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.644 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.5 t -115.76 129.94 71.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.481 HG22 HD22 ' B' ' 88' ' ' LEU . 1.6 mp -107.4 129.88 60.55 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 mt -102.9 108.87 20.23 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 113.563 -1.653 . . . . 0.0 109.019 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.481 HD22 HG22 ' B' ' 86' ' ' ILE . 3.8 mm? -80.01 4.48 16.87 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.585 0.707 . . . . 0.0 112.451 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.15 -38.9 5.87 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.96 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -85.55 63.67 8.2 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.116 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.558 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.0 pp -108.66 -176.68 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -174.39 178.98 1.89 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 31.5 m -122.38 129.31 51.98 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.768 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 41.8 mt -133.49 145.46 50.21 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 124.513 1.125 . . . . 0.0 109.471 -174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' B' ' 97' ' ' LYS . 2.0 p30 -79.4 151.18 31.07 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 117.977 -1.489 . . . . 0.0 110.284 172.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -37.39 -42.25 0.48 Allowed 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 127.402 2.281 . . . . 0.0 114.685 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.468 ' HB3' ' OD2' ' B' ' 95' ' ' ASP . 7.5 ttpm? -61.17 -18.05 56.14 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 124.665 1.186 . . . . 0.0 112.472 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.589 ' HA ' ' NE ' ' B' ' 98' ' ' ARG . 4.0 mmp_? -88.31 -22.45 23.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.363 -0.835 . . . . 0.0 111.622 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.31 107.83 11.2 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 121.976 0.894 . . . . 0.0 108.974 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -95.24 -57.98 2.27 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 116.823 2.156 . . . . 0.0 116.823 -173.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.525 ' HG3' HD13 ' B' ' 21' ' ' LEU . 12.0 pt-20 -140.15 131.93 27.47 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.979 0.895 . . . . 0.0 112.737 -171.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -63.67 119.46 9.92 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 127.151 2.18 . . . . 0.0 108.429 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.1 -63.66 1.43 Allowed 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 118.564 -1.255 . . . . 0.0 112.048 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.408 HG22 HG11 ' B' ' 19' ' ' VAL . 6.1 t -125.57 -160.48 0.97 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 117.645 -1.622 . . . . 0.0 112.897 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -159.75 150.89 19.54 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 126.803 2.041 . . . . 0.0 108.324 -173.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.34 155.69 17.66 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -70.96 145.76 49.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' B' ' 111' ' ' MET . 2.8 p-10 -62.85 -35.43 79.93 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -176.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.0 -33.17 63.71 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.202 0.525 . . . . 0.0 109.917 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.78 ' HG2' HG23 ' B' ' 73' ' ' ILE . 16.6 tppt? -68.65 -32.96 73.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.531 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -51.83 -45.48 63.97 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.958 173.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.704 ' HE2' ' N ' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -69.3 -16.88 63.66 Favored 'General case' 0 CA--C 1.477 -1.863 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.237 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . 0.588 ' HA ' ' ND2' ' B' ' 116' ' ' ASN . 32.6 mt-10 -85.53 -38.37 18.6 Favored 'General case' 1 N--CA 1.368 -4.55 0 C-N-CA 117.202 -1.799 . . . . 0.0 108.641 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.0 t -56.62 -44.36 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.141 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.03 172.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.639 ' OD2' ' HA ' ' B' ' 112' ' ' LYS . 25.2 m-20 -56.32 -58.1 9.41 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.557 1.17 . . . . 0.0 108.991 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.588 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 1.3 p30 -66.34 -40.49 89.87 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.011 -1.449 . . . . 0.0 112.019 -173.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -59.14 -37.81 78.17 Favored 'General case' 0 CA--C 1.49 -1.364 0 O-C-N 123.636 0.585 . . . . 0.0 109.74 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.48 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.6 tp -69.56 -44.56 70.64 Favored 'General case' 1 N--CA 1.373 -4.294 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.871 -178.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 39.2 mtp -68.39 -19.92 64.65 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.643 -0.661 . . . . 0.0 112.124 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' B' ' 117' ' ' ALA . 45.6 mt -78.18 -55.43 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 173.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 34.3 t -52.21 -43.9 64.47 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.113 1.365 . . . . 0.0 111.843 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 8.1 mp -87.74 -2.37 58.57 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.53 7.42 87.53 Favored Glycine 0 C--O 1.241 0.551 0 N-CA-C 117.116 1.606 . . . . 0.0 117.116 170.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.8 -59.19 2.86 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 118.632 1.216 . . . . 0.0 110.937 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 C--N 1.3 -1.559 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.552 -169.616 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -134.42 157.39 46.55 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 42' ' ' GLN . 20.3 ttt85 -67.86 130.5 43.17 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.33 173.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.34 -19.27 11.74 Favored Glycine 0 C--N 1.307 -1.034 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.158 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -93.51 176.06 6.52 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 122.112 0.958 . . . . 0.0 110.461 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 17.4 t -128.32 135.76 61.79 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.194 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.119 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 8.0 m-85 -128.59 145.44 51.14 Favored 'General case' 0 CA--C 1.462 -2.411 0 C-N-CA 124.461 1.104 . . . . 0.0 108.996 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.3 mp -78.9 148.42 32.74 Favored 'General case' 0 N--CA 1.391 -3.411 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 168.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.1 134.48 17.3 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.397 1.06 . . . . 0.0 110.654 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.92 88.58 1.85 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.237 171.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.532 ' O ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -109.13 25.45 11.79 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 123.265 1.507 . . . . 0.0 109.542 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.663 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 20.2 p -94.28 62.11 0.01 OUTLIER Pre-proline 0 N--CA 1.409 -2.509 0 CA-C-N 112.95 -1.932 . . . . 0.0 116.205 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HB2' ' HB2' ' B' ' 26' ' ' PRO . 13.7 Cg_endo -113.48 29.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.556 0 N-CA-C 106.288 -2.235 . . . . 0.0 106.288 153.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.673 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 35.3 m -73.5 165.21 3.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.645 -176.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.09 141.42 30.03 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.086 -1.416 . . . . 0.0 113.307 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.83 -108.82 2.31 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.786 -1.097 . . . . 0.0 115.354 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -84.46 -5.94 59.33 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 124.264 1.025 . . . . 0.0 113.074 -173.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.673 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 71.2 mt-10 -77.4 161.65 27.84 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.458 ' HG3' ' OE1' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -125.33 156.5 38.59 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.71 -149.07 18.52 Favored Glycine 0 N--CA 1.407 -3.283 0 C-N-CA 118.462 -1.828 . . . . 0.0 114.417 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.663 ' HA2' ' HB3' ' A' ' 25' ' ' SER . . . 140.55 -156.14 25.11 Favored Glycine 0 C--N 1.276 -2.772 0 N-CA-C 103.61 -3.796 . . . . 0.0 103.61 -171.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.0 100.07 10.27 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.168 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 165.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -131.63 146.45 61.92 Favored Pre-proline 0 C--N 1.258 -3.398 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.671 -167.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 47.6 Cg_exo -56.28 134.36 63.78 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.395 2.063 . . . . 0.0 111.203 171.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 29.4 m -125.28 159.11 32.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.493 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.9 m -97.89 130.26 46.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.55 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.8 mm -88.73 101.88 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.69 -20.36 5.54 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.863 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.681 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -54.86 158.91 2.5 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -170.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.458 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 19.0 p-10 -63.51 175.41 1.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.886 -1.507 . . . . 0.0 112.418 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -52.89 52.46 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.27 -1.786 . . . . 0.0 112.937 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -80.55 -24.17 39.47 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -163.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.69 -26.35 72.97 Favored Glycine 0 C--O 1.212 -1.23 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.991 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -73.96 -32.76 63.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.497 0.665 . . . . 0.0 110.162 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -85.45 -64.48 1.15 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.689 -173.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -96.5 -28.67 14.3 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -171.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.1 m -86.4 155.02 57.15 Favored Pre-proline 0 C--N 1.298 -1.659 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.149 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.561 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . 61.6 Cg_endo -98.26 17.05 0.51 Allowed 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 122.779 2.319 . . . . 0.0 111.425 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 p -130.56 145.8 51.95 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.415 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.572 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -146.2 139.28 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.588 0.555 . . . . 0.0 111.565 174.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.681 HG22 ' HG3' ' A' ' 42' ' ' GLN . 8.9 tt -82.2 133.71 28.59 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 CA-C-O 121.663 0.744 . . . . 0.0 111.392 175.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 29.9 m -135.85 162.56 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.712 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.557 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -123.48 139.23 54.23 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.05 134.78 47.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.577 HG12 HD12 ' A' ' 86' ' ' ILE . 54.9 mt -93.25 112.71 26.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.038 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.5 m -99.85 119.56 38.38 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.349 0.659 . . . . 0.0 109.747 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.704 0 C-N-CA 120.581 -0.818 . . . . 0.0 114.992 -172.742 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 N--CA 1.443 -0.78 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.38 5.51 0.32 Allowed 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.436 2.757 . . . . 0.0 115.583 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.524 ' HA ' ' OG ' ' A' ' 121' ' ' SER . 68.4 p -96.77 -18.46 19.59 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 122.23 1.014 . . . . 0.0 109.137 176.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -102.03 129.91 48.46 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.3 p -124.62 137.55 56.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.252 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -92.92 148.13 22.27 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.166 0.507 . . . . 0.0 111.352 -176.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 84' ' ' SER . 1.9 pp -124.6 148.15 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.816 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -90.55 108.82 20.04 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.676 0.75 . . . . 0.0 109.561 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HD2' ' C ' ' A' ' 81' ' ' ASP . 37.6 pttt -45.06 -39.07 5.43 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 126.217 1.807 . . . . 0.0 115.217 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -45.89 -49.38 15.62 Favored 'General case' 0 C--N 1.267 -2.984 0 C-N-CA 126.131 1.772 . . . . 0.0 111.8 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -91.76 -41.21 10.81 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 118.805 -1.158 . . . . 0.0 112.266 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.495 ' HD1' ' O ' ' A' ' 105' ' ' TYR . 2.3 m-85 -110.8 -19.48 12.82 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -164.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.453 ' HG2' ' HB2' ' A' ' 84' ' ' SER . 56.8 tptt -154.78 46.56 0.54 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 117.242 -1.783 . . . . 0.0 114.644 -167.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 65.81 -131.66 0.22 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.432 0.693 . . . . 0.0 111.151 163.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.51 ' C ' ' HD2' ' A' ' 75' ' ' LYS . 23.6 t70 -88.57 -5.76 57.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.652 1.181 . . . . 0.0 109.437 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -106.67 116.33 31.75 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.436 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 5.0 p-10 -83.22 117.11 22.72 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.453 ' HB2' ' HG2' ' A' ' 79' ' ' LYS . 13.2 t -113.65 157.93 21.51 Favored 'General case' 0 N--CA 1.406 -2.658 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.676 -166.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.01 139.16 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.577 HD12 HG12 ' A' ' 58' ' ' ILE . 17.3 mm -105.27 129.95 57.25 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 52.0 mt -101.24 110.56 22.59 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.478 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.2 mm? -84.01 -7.33 59.43 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 121.677 0.751 . . . . 0.0 111.168 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.546 ' O ' HG21 ' B' ' 93' ' ' THR . 10.4 pt-20 -84.74 -42.25 15.41 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.185 173.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.458 ' OE1' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -92.85 73.84 4.88 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.995 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.609 ' O ' ' HB ' ' B' ' 93' ' ' THR . 2.4 pp -117.58 179.73 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.91 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.524 ' NH1' HG12 ' A' ' 27' ' ' VAL 0.261 11.5 ptp180 -174.94 157.76 2.42 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 99.4 m -105.19 126.5 52.15 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.591 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.2 mt -131.36 150.13 52.27 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 124.137 0.898 . . . . 0.0 111.184 -169.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -51.52 141.56 15.72 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.707 0.629 . . . . 0.0 110.108 170.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 51' ' ' PRO . 44.4 mtmt -64.5 -18.82 65.15 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 120.981 0.42 . . . . 0.0 111.971 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -75.5 -9.64 58.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.11 0.481 . . . . 0.0 110.914 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.542 ' NE ' ' HA ' ' A' ' 98' ' ' ARG . 3.8 mmp_? -86.63 -36.5 18.77 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -73.39 121.74 20.96 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.616 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -106.05 -61.16 1.55 Allowed 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.2 pt-20 -143.1 130.6 21.16 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -168.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 22.0 ttmm -60.75 113.19 2.35 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 112.221 -2.263 . . . . 0.0 109.045 174.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.3 tp -112.97 -63.27 1.47 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.495 ' H ' ' HB ' ' A' ' 19' ' ' VAL 0.273 5.7 t -120.89 -167.08 1.42 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 117.703 -1.599 . . . . 0.0 111.115 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.495 ' O ' ' HD1' ' A' ' 78' ' ' TYR . 13.8 p90 -160.29 142.93 13.28 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 123.687 0.795 . . . . 0.0 111.66 -169.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.413 ' HA ' ' CD1' ' A' ' 78' ' ' TYR . 32.3 mt -111.55 161.4 16.22 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.142 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 111' ' ' MET . 30.2 p -92.63 167.14 12.11 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 123.906 0.882 . . . . 0.0 109.878 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.35 -31.41 72.52 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.458 0.647 . . . . 0.0 111.394 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.07 -38.51 79.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.858 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -70.86 -35.14 72.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -52.71 -49.21 65.81 Favored 'General case' 0 CA--C 1.483 -1.607 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.011 177.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 28.9 mtmm -50.08 -41.74 48.73 Favored 'General case' 0 CA--C 1.477 -1.836 0 O-C-N 124.319 1.012 . . . . 0.0 112.62 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -80.21 -32.17 38.58 Favored 'General case' 0 CA--C 1.443 -3.166 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -165.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.63 -55.64 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.761 0 CA-C-N 112.776 -2.011 . . . . 0.0 109.968 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 62.3 m-20 -57.46 -50.94 71.41 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 122.237 1.018 . . . . 0.0 110.495 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.672 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -61.6 -46.57 89.27 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.703 -178.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.478 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.76 -42.66 89.42 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 12.7 tp -65.56 -47.07 77.09 Favored 'General case' 0 N--CA 1.402 -2.874 0 C-N-CA 125.184 1.394 . . . . 0.0 110.299 -175.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.512 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.19 -29.46 57.94 Favored 'General case' 0 N--CA 1.414 -2.245 0 C-N-CA 124.832 1.253 . . . . 0.0 111.212 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 116' ' ' ASN . 40.6 mt -86.44 -54.0 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.524 ' OG ' ' HA ' ' A' ' 69' ' ' THR . 72.8 m -46.88 -33.56 4.64 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.516 -1.674 . . . . 0.0 112.757 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 21.7 mt -100.5 -0.29 38.17 Favored 'General case' 0 C--O 1.189 -2.113 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.999 -177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.51 7.78 71.69 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 119.591 -1.29 . . . . 0.0 116.295 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.512 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 4.9 mp -63.71 -50.17 70.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 122.7 1.238 . . . . 0.0 108.353 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.609 ' C ' HD22 ' A' ' 125' ' ' ASN 0.305 0.0 OUTLIER . . . . . 1 N--CA 1.362 -4.847 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 170.438 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 58.8 mt . . . . . 0 N--CA 1.418 -2.056 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' B' ' 18' ' ' ASP . 19.2 ptt180 -127.97 159.13 35.93 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' B' ' 42' ' ' GLN . 21.0 ttt85 -69.44 130.74 43.35 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.75 -20.34 10.08 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.002 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . 0.437 ' CG ' ' HE ' ' B' ' 15' ' ' ARG . 57.0 m-20 -93.74 175.47 6.72 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-O 122.272 1.034 . . . . 0.0 110.736 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 12.7 t -128.38 135.95 61.28 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.0 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 5.9 m-85 -129.16 145.93 51.2 Favored 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 124.506 1.122 . . . . 0.0 109.061 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.517 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.4 mp -79.47 148.32 31.92 Favored 'General case' 0 N--CA 1.394 -3.254 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 167.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -150.83 134.75 16.66 Favored 'General case' 0 C--N 1.265 -3.099 0 O-C-N 124.361 1.038 . . . . 0.0 111.014 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.8 86.72 1.26 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 171.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.476 ' C ' ' HD3' ' B' ' 26' ' ' PRO 0.252 0.0 OUTLIER -104.81 23.73 12.99 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 123.156 1.455 . . . . 0.0 109.643 -179.62 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.662 ' HB3' ' HA2' ' B' ' 34' ' ' GLY . 3.5 p -94.54 62.58 0.01 OUTLIER Pre-proline 0 N--CA 1.405 -2.676 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.565 ' HB2' ' HB2' ' A' ' 26' ' ' PRO . 15.5 Cg_endo -113.72 27.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.574 0 N-CA-C 106.822 -2.03 . . . . 0.0 106.822 153.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.666 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 34.1 m -72.84 165.87 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.886 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.19 140.98 29.64 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.863 -1.517 . . . . 0.0 113.698 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.65 -108.38 2.19 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -79.41 -15.49 57.75 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 124.011 0.925 . . . . 0.0 112.5 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.666 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 71.6 mt-10 -69.65 165.92 20.2 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.63 130.98 49.91 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -172.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.35 -163.11 36.36 Favored Glycine 0 N--CA 1.408 -3.212 0 C-N-CA 117.735 -2.174 . . . . 0.0 115.278 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.662 ' HA2' ' HB3' ' B' ' 25' ' ' SER . . . 158.9 -162.05 32.33 Favored Glycine 0 C--N 1.266 -3.321 1 N-CA-C 102.664 -4.174 . . . . 0.0 102.664 -171.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.42 99.85 9.94 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 166.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -132.44 147.19 64.68 Favored Pre-proline 0 C--N 1.257 -3.418 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.606 -167.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 51.3 Cg_exo -55.48 135.41 69.09 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.538 2.159 . . . . 0.0 112.034 173.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 28.2 m -126.21 158.65 35.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 123.849 0.86 . . . . 0.0 108.969 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.495 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 32.9 m -98.01 130.55 46.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.672 0.272 . . . . 0.0 110.666 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 18.6 mm -88.91 102.09 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.22 -20.38 5.53 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.897 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.661 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -55.06 159.34 2.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -170.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.433 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 19.1 p-10 -62.47 178.95 0.37 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.491 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.72 -46.59 30.2 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.958 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -79.4 -26.49 41.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -166.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.27 -26.74 72.64 Favored Glycine 0 C--O 1.209 -1.461 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.25 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -73.69 -31.16 63.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.759 0.79 . . . . 0.0 110.263 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -85.08 -66.64 0.87 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.59 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -96.37 -27.55 14.89 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 43.5 m -86.07 154.15 57.56 Favored Pre-proline 0 C--N 1.295 -1.803 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.533 ' HA ' ' HE2' ' B' ' 96' ' ' LYS . 68.7 Cg_endo -98.52 15.01 0.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.643 2.229 . . . . 0.0 111.231 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.7 p -128.14 147.01 50.53 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.295 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.558 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -147.07 139.24 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 123.632 0.582 . . . . 0.0 111.254 174.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.661 HG22 ' HG3' ' B' ' 42' ' ' GLN . 8.5 tt -82.22 133.7 28.61 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 CA-C-O 121.73 0.776 . . . . 0.0 111.422 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 29.7 m -135.72 160.04 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.859 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.551 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -120.68 139.16 53.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.44 135.27 45.72 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.557 HG12 HD12 ' B' ' 86' ' ' ILE . 55.3 mt -90.97 113.74 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.457 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 41.1 m -101.03 110.05 22.03 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 121.769 0.795 . . . . 0.0 111.371 -175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.488 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 172.697 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 tt . . . . . 0 N--CA 1.433 -1.301 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.11 5.14 0.17 Allowed 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.489 2.793 . . . . 0.0 115.845 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . 0.482 ' HA ' ' OG ' ' B' ' 121' ' ' SER . 64.7 p -98.75 -18.62 17.9 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 122.16 0.981 . . . . 0.0 109.238 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -103.5 129.56 50.7 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.91 135.38 64.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.377 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.67 143.98 26.36 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-O 121.347 0.594 . . . . 0.0 111.642 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 84' ' ' SER . 2.0 pp -119.26 150.76 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.002 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -94.85 109.66 21.62 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.769 0.795 . . . . 0.0 110.565 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' B' ' 80' ' ' LEU . 38.6 pttt -43.67 -42.0 5.05 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.528 1.931 . . . . 0.0 115.252 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -46.0 -46.94 16.79 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 126.456 1.902 . . . . 0.0 111.736 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -92.19 -42.92 9.62 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.074 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.564 ' HD1' ' O ' ' B' ' 105' ' ' TYR . 7.1 m-85 -111.82 -18.3 12.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -164.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -156.09 47.84 0.48 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 117.756 -1.578 . . . . 0.0 114.478 -167.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' B' ' 75' ' ' LYS . 0.0 OUTLIER 63.68 -133.73 0.37 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.962 0.905 . . . . 0.0 111.203 164.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.481 ' O ' ' HD2' ' B' ' 75' ' ' LYS . 12.7 t70 -86.08 -6.71 58.97 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 125.08 1.352 . . . . 0.0 110.057 175.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -105.47 114.95 29.43 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 119.383 -0.927 . . . . 0.0 113.349 -174.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.44 ' N ' ' HD3' ' B' ' 75' ' ' LYS . 7.2 p-10 -80.11 117.34 20.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.459 ' O ' HG13 ' B' ' 73' ' ' ILE . 14.7 t -114.11 158.26 21.51 Favored 'General case' 0 N--CA 1.407 -2.624 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.579 -168.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 t -116.57 139.73 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.557 HD12 HG12 ' B' ' 58' ' ' ILE . 18.7 mm -104.96 129.98 56.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.27 110.32 22.55 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.2 mm? -84.02 -6.76 59.47 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.637 0.732 . . . . 0.0 111.013 -175.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . 0.561 ' O ' HG21 ' A' ' 93' ' ' THR . 10.5 pt-20 -86.99 -39.64 15.49 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.631 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 73.93 3.75 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.927 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.604 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.4 pp -117.76 179.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.949 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.524 ' NH1' HG12 ' B' ' 27' ' ' VAL 0.254 12.1 ptp180 -174.98 157.42 2.34 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 172.179 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.609 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 97.2 m -105.09 126.87 52.54 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.622 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 49.1 mt -131.28 150.18 52.25 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 124.246 0.966 . . . . 0.0 111.143 -169.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -50.65 140.01 15.22 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.23 0.612 . . . . 0.0 109.764 170.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' B' ' 51' ' ' PRO . 43.1 mtmt -61.45 -23.02 65.56 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 122.68 0.392 . . . . 0.0 111.622 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -70.3 -17.95 63.09 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' B' ' 98' ' ' ARG . 4.5 mmp_? -80.38 -33.32 37.27 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.827 -0.546 . . . . 0.0 109.937 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.8 mp -74.89 117.43 16.73 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.966 0.889 . . . . 0.0 109.759 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -100.64 -59.35 1.72 Allowed 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -147.28 133.95 19.94 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -170.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 21.6 ttmm -60.76 114.29 2.95 Favored 'General case' 0 C--N 1.284 -2.253 0 C-N-CA 127.458 2.303 . . . . 0.0 108.778 174.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 tp -112.78 -62.89 1.52 Allowed 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.505 HG22 HG11 ' B' ' 19' ' ' VAL . 5.0 t -122.1 -167.12 1.5 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.119 -1.432 . . . . 0.0 111.022 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.564 ' O ' ' HD1' ' B' ' 78' ' ' TYR . 15.7 p90 -160.21 141.3 12.24 Favored 'General case' 0 CA--C 1.488 -1.428 0 C-N-CA 123.818 0.847 . . . . 0.0 111.359 -170.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.504 ' HA ' ' CD1' ' B' ' 78' ' ' TYR . 32.1 mt -107.23 168.18 9.4 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 124.305 1.003 . . . . 0.0 108.872 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' B' ' 111' ' ' MET . 39.6 p -95.69 167.62 11.17 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.151 0.58 . . . . 0.0 109.6 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' B' ' 111' ' ' MET . 33.5 t70 -67.4 -29.7 69.28 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.897 0.856 . . . . 0.0 109.913 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.16 -39.9 78.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.231 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -71.42 -32.58 68.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 107' ' ' SER . 0.5 OUTLIER -53.99 -48.77 70.06 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.836 177.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.738 ' O ' ' HB3' ' B' ' 116' ' ' ASN 0.271 20.1 mtmm -49.27 -43.23 42.84 Favored 'General case' 0 CA--C 1.467 -2.236 0 O-C-N 124.583 1.177 . . . . 0.0 111.96 175.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -79.44 -33.5 42.44 Favored 'General case' 0 CA--C 1.446 -3.037 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -163.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.18 -53.37 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.644 0 CA-C-N 112.548 -2.115 . . . . 0.0 110.263 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 69.3 m-20 -58.63 -52.14 66.94 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 122.437 1.113 . . . . 0.0 110.219 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.738 ' HB3' ' O ' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -67.9 -30.51 69.87 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.394 -175.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.447 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -71.64 -45.52 61.77 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.631 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 11.0 tp -60.03 -47.38 86.1 Favored 'General case' 0 N--CA 1.4 -2.97 0 C-N-CA 125.78 1.632 . . . . 0.0 110.416 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.531 ' HE2' HG13 ' B' ' 120' ' ' ILE . 0.1 OUTLIER -54.14 -33.08 57.02 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 124.567 1.147 . . . . 0.0 111.303 178.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.531 HG13 ' HE2' ' B' ' 119' ' ' MET . 56.5 mt -82.79 -53.35 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' B' ' 69' ' ' THR . 44.2 m -47.55 -33.07 6.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.724 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 20.3 mt -100.3 -1.63 35.75 Favored 'General case' 0 C--O 1.189 -2.089 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.975 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.73 8.28 70.18 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 173.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.504 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 4.9 mp -63.58 -48.08 78.89 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.693 1.235 . . . . 0.0 108.683 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.62 ' C ' HD22 ' B' ' 125' ' ' ASN 0.292 0.0 OUTLIER . . . . . 1 N--CA 1.366 -4.65 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 170.127 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.241 0.643 0 CA-C-O 120.807 0.337 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -115.6 138.49 51.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 13.8 ptm180 -61.76 134.96 57.39 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.632 170.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.32 -12.81 36.71 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.811 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.79 166.71 22.6 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.512 1.149 . . . . 0.0 110.984 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.673 HG12 ' HB2' ' A' ' 103' ' ' LEU . 42.6 t -130.68 122.7 53.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.949 0 CA-C-N 112.71 -2.041 . . . . 0.0 108.994 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 88.3 m-85 -129.13 147.66 51.0 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 125.872 1.669 . . . . 0.0 110.571 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.3 mp -77.04 148.21 36.31 Favored 'General case' 0 N--CA 1.395 -3.181 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 167.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -139.97 146.6 39.33 Favored 'General case' 0 C--N 1.252 -3.662 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.904 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.551 ' O ' ' HD2' ' A' ' 98' ' ' ARG . 35.1 t70 -84.29 72.29 10.57 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 173.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.711 HD22 ' HA3' ' A' ' 33' ' ' GLY . 3.2 tt -76.79 -36.78 56.74 Favored 'General case' 0 N--CA 1.384 -3.756 0 CA-C-N 111.789 -2.459 . . . . 0.0 110.413 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.659 ' CB ' ' H ' ' A' ' 34' ' ' GLY . 71.4 m -118.5 114.75 36.03 Favored Pre-proline 0 N--CA 1.398 -3.063 1 N-CA-C 121.812 4.005 . . . . 0.0 121.812 -168.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -106.78 27.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.419 -2.902 0 C-N-CA 123.616 2.878 . . . . 0.0 106.015 152.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.67 ' C ' HE21 ' A' ' 28' ' ' GLN . 26.7 m -88.48 158.42 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 122.191 0.996 . . . . 0.0 112.816 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.732 ' N ' HE21 ' A' ' 28' ' ' GLN . 0.0 OUTLIER -152.29 155.83 38.45 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 113.03 -1.895 . . . . 0.0 107.498 175.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.54 -130.93 10.42 Favored Glycine 0 N--CA 1.416 -2.696 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' B' ' 95' ' ' ASP . 4.7 m -93.92 -7.83 41.91 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.794 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.535 ' HG2' HH12 ' B' ' 92' ' ' ARG . 1.7 mp0 -70.87 155.98 40.14 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.624 -0.831 . . . . 0.0 110.264 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -133.75 120.63 20.79 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -171.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.711 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -155.75 -94.23 0.1 Allowed Glycine 1 N--CA 1.392 -4.292 0 C-N-CA 119.001 -1.571 . . . . 0.0 113.677 172.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.659 ' H ' ' CB ' ' A' ' 25' ' ' SER . . . 79.41 172.81 43.62 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -171.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 4.2 p -75.42 102.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 172.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -144.89 155.23 55.78 Favored Pre-proline 0 C--N 1.263 -3.177 0 CA-C-N 113.48 -1.691 . . . . 0.0 107.983 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 24.5 Cg_exo -66.39 139.33 53.93 Favored 'Trans proline' 0 C--O 1.247 0.964 0 C-N-CA 122.169 1.912 . . . . 0.0 112.803 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.1 m -127.49 163.36 30.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.123 0.969 . . . . 0.0 109.817 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.37 134.31 48.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.329 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -89.38 108.99 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.455 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -105.34 -8.07 9.95 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.701 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.64 -178.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.455 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -62.89 169.1 3.44 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -170.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -65.18 175.44 1.64 Allowed 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.923 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.64 -49.66 37.9 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.328 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.402 HG22 ' CD2' ' A' ' 49' ' ' TYR . 7.1 m -86.88 -21.3 26.42 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -169.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.16 -37.02 53.76 Favored Glycine 0 C--O 1.196 -2.273 0 CA-C-N 117.9 0.318 . . . . 0.0 112.682 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.448 ' N ' HE22 ' A' ' 42' ' ' GLN . 8.4 p30 -63.62 -19.38 64.81 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -82.56 -63.82 1.3 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.039 0.536 . . . . 0.0 110.128 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.402 ' CD2' HG22 ' A' ' 45' ' ' THR . 38.2 p90 -83.28 -35.36 25.35 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -172.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.1 m -83.03 136.52 43.87 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.45 -18.53 17.71 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 N-CA-C 108.34 -1.446 . . . . 0.0 108.34 170.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 11.4 p -91.4 150.67 21.16 Favored 'General case' 0 N--CA 1.415 -2.199 0 C-N-CA 125.201 1.4 . . . . 0.0 111.941 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.1 t -133.39 140.11 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 173.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.1 tt -110.23 128.7 66.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 CA-C-O 121.183 0.516 . . . . 0.0 109.929 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.516 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 32.7 m -132.39 173.18 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.941 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -128.41 143.68 51.03 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.02 132.77 41.58 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.3 mt -89.05 119.09 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.372 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.9 m -121.53 116.47 24.73 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 121.317 0.58 . . . . 0.0 110.834 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.481 ' HA3' ' HD2' ' A' ' 82' ' ' LYS . . . . . . . . 0 N--CA 1.422 -2.288 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.0 tt . . . . . 0 N--CA 1.425 -1.685 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.28 -4.22 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.64 2.894 . . . . 0.0 116.546 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.9 p -101.97 -18.84 15.48 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.913 -0.492 . . . . 0.0 111.039 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -112.24 128.92 56.39 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -117.09 133.0 65.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.727 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.1 128.57 53.41 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.288 0.566 . . . . 0.0 110.559 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.491 HG21 ' CZ ' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -124.81 154.88 32.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 123.585 0.754 . . . . 0.0 112.046 -176.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.78 141.0 53.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.764 0.792 . . . . 0.0 112.246 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -60.85 -34.58 74.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.358 -1.746 . . . . 0.0 109.2 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -55.27 -53.07 60.78 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.479 -1.691 . . . . 0.0 114.395 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -88.52 -35.83 16.75 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.094 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.491 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 6.6 m-85 -78.35 -5.15 51.36 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.727 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt 50.44 36.62 13.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.698 1.999 . . . . 0.0 115.183 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 78' ' ' TYR . 8.8 mp -87.21 -176.78 5.8 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 122.106 0.955 . . . . 0.0 110.892 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.34 -7.34 48.15 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.82 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HD2' ' HA3' ' A' ' 60' ' ' GLY . 10.2 ptpp? -153.52 164.23 38.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -56.66 147.5 22.43 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.228 0.537 . . . . 0.0 111.001 173.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.3 m -108.09 132.51 53.5 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.744 -172.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.3 t -118.44 124.45 73.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 HD22 ' A' ' 88' ' ' LEU . 1.7 mp -110.71 127.57 67.68 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.013 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.7 mt -99.91 103.64 15.23 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.241 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.519 HD22 HG22 ' A' ' 86' ' ' ILE . 3.3 mm? -86.11 70.89 10.62 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -176.83 -48.54 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.47 84.79 4.77 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 55' ' ' VAL . 2.0 pp -121.11 179.12 2.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.07 -175.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.567 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 12.1 tpt85 -152.31 146.79 25.66 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.7 m -115.5 120.11 38.43 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.567 ' HG ' ' HG3' ' A' ' 92' ' ' ARG . 29.4 mt -130.99 143.99 51.14 Favored 'General case' 0 C--O 1.198 -1.606 0 C-N-CA 125.235 1.414 . . . . 0.0 110.343 -171.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -77.03 152.4 35.14 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 117.075 -1.85 . . . . 0.0 110.957 170.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -42.31 -27.12 0.13 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 126.551 1.94 . . . . 0.0 115.767 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.434 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 9.5 ptpp? -71.25 -21.93 62.04 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 118.736 0.698 . . . . 0.0 111.465 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 36.2 mmt180 -68.35 -33.77 74.88 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.773 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.63 115.75 10.14 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 124.436 1.094 . . . . 0.0 110.939 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -96.89 -63.83 1.1 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.183 -1.372 . . . . 0.0 114.213 -174.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.6 pt-20 -156.05 143.77 19.52 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-O 121.939 0.876 . . . . 0.0 111.665 -172.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttmm -66.82 123.61 20.62 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 112.468 -2.151 . . . . 0.0 111.558 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.673 ' HB2' HG12 ' A' ' 19' ' ' VAL . 3.8 mm? -93.43 -62.82 1.29 Allowed 'General case' 0 CA--C 1.472 -2.042 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 78' ' ' TYR . 7.2 t -150.87 -155.66 0.64 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.038 -1.892 . . . . 0.0 111.678 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -161.37 148.3 14.69 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.974 1.71 . . . . 0.0 109.538 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.34 153.0 39.56 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.766 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.3 p -83.71 161.2 21.11 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.12 -40.38 95.72 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.036 0.922 . . . . 0.0 110.981 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.54 -16.3 62.37 Favored 'General case' 0 C--O 1.194 -1.829 0 C-N-CA 125.107 1.363 . . . . 0.0 111.282 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.412 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 67.1 mttm -91.33 -36.65 13.73 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 120.468 -1.395 . . . . 0.0 109.898 168.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.444 ' HG2' ' OD2' ' A' ' 115' ' ' ASP 0.327 38.5 ttm -64.4 -26.04 68.29 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -177.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.719 ' HE3' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -57.87 -14.5 6.21 Favored 'General case' 0 C--N 1.248 -3.818 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 173.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.719 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 42.8 mt-10 -87.65 -54.44 4.26 Favored 'General case' 1 C--O 1.148 -4.254 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 171.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 111' ' ' MET . 2.1 t -47.05 -52.34 4.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-N 113.862 -1.517 . . . . 0.0 114.176 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 22.4 m-20 -66.05 -45.4 81.5 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 123.536 1.636 . . . . 0.0 110.838 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 112' ' ' LYS 0.256 9.3 t30 -73.83 -39.84 63.76 Favored 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 112.937 -1.938 . . . . 0.0 113.037 -171.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.6 -39.05 79.32 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 125.447 1.499 . . . . 0.0 108.077 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.55 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 8.8 tp -70.06 -38.12 75.71 Favored 'General case' 1 N--CA 1.373 -4.286 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.964 -175.184 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 47.7 mtp -68.51 -19.59 64.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.891 -0.505 . . . . 0.0 111.31 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 117' ' ' ALA . 49.5 mt -82.22 -59.15 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.1 m -48.15 -47.69 34.67 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 125.067 1.479 . . . . 0.0 111.975 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.19 -0.39 57.04 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.84 19.11 73.1 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.421 ' HG ' ' OD1' ' B' ' 115' ' ' ASP . 7.0 mp -70.52 -50.29 39.26 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 118.571 1.186 . . . . 0.0 108.508 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 N--CA 1.435 -1.224 0 CA-C-N 113.162 -1.835 . . . . 0.0 109.613 -174.113 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 69.2 mt . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -115.9 137.98 51.6 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 13.9 ptm180 -63.12 128.89 37.93 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.144 -1.023 . . . . 0.0 109.008 171.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.17 -11.94 26.58 Favored Glycine 0 N--CA 1.426 -2.017 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.458 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -76.42 166.99 22.65 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 122.544 1.164 . . . . 0.0 110.836 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.685 HG12 ' HB2' ' B' ' 103' ' ' LEU . 40.9 t -130.92 124.25 55.84 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.066 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.757 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -131.0 148.3 52.74 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 125.79 1.636 . . . . 0.0 110.015 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 1.3 mp -77.13 147.59 36.48 Favored 'General case' 0 N--CA 1.395 -3.207 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 167.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -140.82 145.42 36.26 Favored 'General case' 0 C--N 1.248 -3.82 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.161 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.606 ' O ' ' HD2' ' B' ' 98' ' ' ARG . 35.7 t70 -85.28 78.14 9.85 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 172.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.648 HD22 ' HA3' ' B' ' 33' ' ' GLY . 3.4 tt -79.34 -35.22 41.36 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 111.796 -2.456 . . . . 0.0 110.155 -167.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.655 ' CB ' ' H ' ' B' ' 34' ' ' GLY . 73.3 m -118.25 113.64 37.06 Favored Pre-proline 0 N--CA 1.405 -2.692 1 N-CA-C 122.231 4.16 . . . . 0.0 122.231 -168.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -103.95 24.14 0.11 Allowed 'Trans proline' 0 N--CA 1.418 -2.964 0 C-N-CA 123.056 2.504 . . . . 0.0 106.38 152.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' B' ' 25' ' ' SER . 19.3 m -85.82 165.02 2.32 Favored 'Isoleucine or valine' 0 C--N 1.373 1.624 0 CA-C-O 121.899 0.857 . . . . 0.0 112.337 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.93 159.13 34.56 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 113.187 -1.824 . . . . 0.0 106.77 174.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.96 -135.8 12.63 Favored Glycine 0 N--CA 1.421 -2.351 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 5.4 m -93.68 -0.6 55.98 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.797 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.478 ' HG2' HH12 ' A' ' 92' ' ' ARG . 1.4 mp0 -73.07 159.98 32.74 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.793 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -136.95 119.08 15.46 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.648 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -155.88 -95.16 0.11 Allowed Glycine 0 N--CA 1.4 -3.707 0 C-N-CA 118.928 -1.606 . . . . 0.0 114.095 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.655 ' H ' ' CB ' ' B' ' 25' ' ' SER . . . 80.27 -177.94 54.1 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -171.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 3.5 p -83.27 99.91 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 CA-C-O 123.586 1.66 . . . . 0.0 107.175 172.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -140.66 154.03 68.63 Favored Pre-proline 0 C--N 1.257 -3.428 0 CA-C-N 113.023 -1.899 . . . . 0.0 108.149 -168.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 25.9 Cg_exo -66.11 138.56 52.43 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 122.239 1.959 . . . . 0.0 112.504 174.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.2 163.06 28.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 123.931 0.893 . . . . 0.0 109.902 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.85 134.1 48.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.364 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.408 HD13 HG12 ' B' ' 55' ' ' VAL . 27.2 mm -89.29 109.98 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.451 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -105.59 -8.22 10.05 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.734 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.534 -178.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.486 ' OE1' HG13 ' B' ' 53' ' ' VAL . 5.4 pt20 -64.22 169.61 4.4 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -169.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -65.08 173.37 2.45 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.458 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.95 -46.35 52.9 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.623 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.41 HG22 ' CD2' ' B' ' 49' ' ' TYR . 8.5 m -87.79 -21.59 25.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.58 -35.82 57.69 Favored Glycine 0 C--O 1.195 -2.288 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -64.77 -19.05 65.6 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -81.91 -62.11 1.73 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 122.928 0.491 . . . . 0.0 109.701 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' B' ' 45' ' ' THR . 34.9 p90 -83.94 -34.57 24.42 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 46.5 m -85.98 141.09 35.21 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -77.07 -19.84 13.41 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 121.222 1.281 . . . . 0.0 108.78 170.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 5.3 p -90.4 150.56 21.81 Favored 'General case' 0 N--CA 1.413 -2.298 0 C-N-CA 124.818 1.247 . . . . 0.0 112.111 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.486 HG13 ' OE1' ' B' ' 42' ' ' GLN . 94.4 t -132.28 140.06 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 tt -111.08 126.48 68.48 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-O 121.294 0.569 . . . . 0.0 110.012 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.531 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 27.1 m -131.21 173.23 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.034 -174.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.455 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -128.21 143.91 51.08 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.67 134.95 40.44 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 62.7 mt -90.75 122.39 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 113.056 -1.883 . . . . 0.0 106.727 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 98.3 m -123.51 117.04 24.2 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.461 0.648 . . . . 0.0 110.666 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.434 ' HA3' ' HD2' ' B' ' 82' ' ' LYS . . . . . . . . 0 N--CA 1.412 -2.915 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 173.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tt . . . . . 0 N--CA 1.421 -1.879 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.72 -18.35 12.04 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.759 2.972 . . . . 0.0 116.47 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 77.4 p -91.53 -19.13 23.1 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.079 0.399 . . . . 0.0 111.664 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -109.97 128.81 55.61 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.37 132.01 68.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.813 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.89 130.83 54.5 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.313 0.577 . . . . 0.0 110.275 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.496 HG21 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -125.24 154.64 33.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.634 -176.172 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.47 136.47 53.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.557 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -57.4 -34.22 68.65 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.385 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -55.78 -53.25 58.98 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.589 -1.641 . . . . 0.0 113.942 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -89.68 -31.86 17.3 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.052 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.496 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 6.2 m-85 -81.02 -5.68 57.89 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.735 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt 50.14 38.0 15.95 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.697 1.999 . . . . 0.0 115.151 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.43 HD12 ' O ' ' B' ' 78' ' ' TYR . 9.2 mp -88.93 -178.09 5.64 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.567 1.175 . . . . 0.0 111.032 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.84 -4.78 56.33 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.503 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.434 ' HD2' ' HA3' ' B' ' 60' ' ' GLY . 10.1 ptpp? -156.41 165.02 37.56 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -177.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -54.27 152.04 6.72 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.192 0.52 . . . . 0.0 110.953 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 15.9 m -111.51 131.42 55.24 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.167 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 8.0 t -117.79 124.33 72.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.508 HG22 HD22 ' B' ' 88' ' ' LEU . 1.6 mp -110.74 126.59 68.09 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 56.0 mt -98.47 102.22 13.89 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.215 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.508 HD22 HG22 ' B' ' 86' ' ' ILE . 3.6 mm? -83.95 72.06 10.46 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.753 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -178.39 -48.57 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.44 85.54 5.38 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 2.0 pp -122.19 179.05 2.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.153 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.575 ' HG3' ' HG ' ' B' ' 94' ' ' LEU . 12.2 tpt85 -152.41 146.76 25.57 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 86.0 m -115.92 119.49 36.1 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.575 ' HG ' ' HG3' ' B' ' 92' ' ' ARG . 22.7 mt -130.95 143.55 50.81 Favored 'General case' 0 C--O 1.196 -1.751 0 C-N-CA 125.352 1.461 . . . . 0.0 110.397 -171.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 0.3 OUTLIER -76.79 152.38 35.58 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.661 170.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -41.91 -27.51 0.12 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.416 1.886 . . . . 0.0 115.549 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -69.38 -21.84 63.76 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.697 0.681 . . . . 0.0 111.589 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 37.7 mmt180 -69.85 -35.68 74.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.105 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.19 114.47 8.37 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 124.113 0.965 . . . . 0.0 110.735 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -94.96 -65.75 0.96 Allowed 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.087 -1.415 . . . . 0.0 114.164 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.92 139.47 16.92 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 121.742 0.782 . . . . 0.0 111.837 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 22.4 ttmm -64.56 121.28 14.07 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 127.595 2.358 . . . . 0.0 111.628 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.685 ' HB2' HG12 ' B' ' 19' ' ' VAL . 3.8 mm? -91.91 -63.04 1.3 Allowed 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.401 ' H ' ' HB ' ' B' ' 19' ' ' VAL . 7.2 t -149.13 -156.27 0.71 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.827 -174.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -161.54 145.94 13.1 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 125.949 1.7 . . . . 0.0 109.886 -170.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.17 148.93 44.33 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.294 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.5 p -81.76 158.32 24.19 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.179 -0.918 . . . . 0.0 113.075 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -57.26 -42.36 81.4 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.621 1.168 . . . . 0.0 112.034 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.09 -16.51 64.0 Favored 'General case' 0 C--O 1.178 -2.681 0 C-N-CA 124.71 1.204 . . . . 0.0 111.366 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.419 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 66.3 mttm -90.63 -33.68 15.75 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.525 -1.359 . . . . 0.0 109.563 169.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.445 ' HG2' ' OD2' ' B' ' 115' ' ' ASP 0.307 34.7 ttm -65.06 -25.16 67.69 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.742 ' HE3' ' N ' ' B' ' 113' ' ' GLU . 0.0 OUTLIER -58.87 -13.8 7.26 Favored 'General case' 0 C--N 1.248 -3.826 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 174.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . 0.742 ' N ' ' HE3' ' B' ' 112' ' ' LYS . 43.8 mt-10 -87.22 -54.47 4.29 Favored 'General case' 0 CA--C 1.429 -3.703 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 172.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' B' ' 111' ' ' MET . 2.1 t -47.17 -52.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.01 -1.904 . . . . 0.0 113.93 -177.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 16.7 m-20 -64.21 -48.48 75.73 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 123.331 1.539 . . . . 0.0 111.145 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.435 ' O ' HG13 ' B' ' 120' ' ' ILE 0.316 9.0 t30 -72.03 -39.09 69.37 Favored 'General case' 0 C--N 1.268 -2.953 0 C-N-CA 126.77 2.028 . . . . 0.0 112.795 -170.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.477 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -62.23 -37.97 87.45 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 124.284 1.033 . . . . 0.0 108.565 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.507 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.9 tp -69.18 -36.48 77.38 Favored 'General case' 1 N--CA 1.366 -4.627 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.682 -176.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 46.5 mtp -69.28 -19.71 63.91 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 121.997 -0.439 . . . . 0.0 110.932 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' B' ' 117' ' ' ALA . 52.1 mt -81.88 -58.39 3.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.2 m -52.18 -44.55 64.73 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.263 0.977 . . . . 0.0 111.433 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 7.2 mp -86.72 -1.82 58.04 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.8 17.5 71.36 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 116.696 1.439 . . . . 0.0 116.696 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.548 HD21 HD23 ' A' ' 118' ' ' LEU . 6.8 mp -68.58 -49.23 61.01 Favored 'General case' 0 CA--C 1.474 -1.975 0 CA-C-N 118.735 1.267 . . . . 0.0 108.042 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 . . . . . 0 N--CA 1.425 -1.702 0 CA-C-N 113.008 -1.906 . . . . 0.0 110.196 -175.76 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.443 HG22 HG21 ' A' ' 40' ' ' ILE . 67.6 mt . . . . . 0 N--CA 1.424 -1.729 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -102.3 129.4 48.73 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.586 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 1.1 ptm180 -61.99 118.08 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 128.07 -10.67 6.59 Favored Glycine 0 C--N 1.295 -1.719 0 C-N-CA 120.063 -1.065 . . . . 0.0 111.125 -172.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.72 175.33 6.85 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 122.574 1.178 . . . . 0.0 110.988 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.479 HG11 HG22 ' A' ' 104' ' ' THR . 10.8 t -133.39 134.72 56.92 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.936 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 27.6 m-85 -133.22 147.82 52.0 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 124.988 1.315 . . . . 0.0 108.11 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mp -81.01 150.69 28.77 Favored 'General case' 0 N--CA 1.408 -2.546 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.053 170.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.26 138.34 49.26 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.2 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.41 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 20.7 t70 -79.94 90.38 5.34 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.966 0.888 . . . . 0.0 109.777 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.604 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 14.9 mt -100.1 19.37 16.49 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 124.055 1.883 . . . . 0.0 109.591 -176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.52 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.266 15.0 m -61.94 167.55 4.66 Favored Pre-proline 1 C--N 1.229 -4.656 0 CA-C-N 111.41 -2.632 . . . . 0.0 108.295 169.84 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.2 OUTLIER 9.6 50.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.397 3.092 1 C-N-CA 127.367 5.378 . . . . 0.0 118.011 -175.03 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.9 m -68.74 -178.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 113.764 -1.562 . . . . 0.0 111.887 170.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 13.6 mm100 -107.44 132.14 53.52 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.565 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.74 -135.66 35.64 Favored Glycine 0 N--CA 1.425 -2.09 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.853 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -91.77 20.35 5.67 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.87 -0.665 . . . . 0.0 111.088 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 0.1 OUTLIER -65.57 152.41 44.15 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 175.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.407 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -78.15 110.31 13.02 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.769 -0.582 . . . . 0.0 110.786 -167.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -86.52 129.18 9.27 Favored Glycine 0 CA--C 1.49 -1.529 0 N-CA-C 116.244 1.257 . . . . 0.0 116.244 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 131.41 137.06 3.99 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 113.427 -1.387 . . . . 0.0 110.076 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.91 119.37 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 CA-C-O 122.248 1.023 . . . . 0.0 109.775 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -142.53 158.02 61.2 Favored Pre-proline 0 C--N 1.271 -2.838 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.697 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 4.6 Cg_exo -72.15 142.2 37.54 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 121.971 1.781 . . . . 0.0 111.386 174.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 20' ' ' TYR . 31.6 m -118.07 156.83 19.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.553 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 36.0 m -97.91 126.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.337 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.443 HG21 HG22 ' A' ' 14' ' ' ILE . 24.5 mm -87.2 103.92 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.7 -18.94 6.14 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.524 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.812 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -56.07 157.99 4.24 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -173.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 28.5 p-10 -71.19 -167.48 0.23 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.807 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -89.55 -38.69 13.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.841 -175.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.1 m -83.78 -28.22 28.3 Favored 'General case' 0 C--O 1.249 1.074 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.718 -170.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.88 -38.77 97.1 Favored Glycine 0 C--O 1.206 -1.647 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.602 ' N ' HE22 ' A' ' 42' ' ' GLN . 9.7 p30 -83.67 -20.72 33.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.237 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 4.2 mptp? -76.02 -65.24 0.94 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.811 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.537 ' CD1' ' HB3' ' A' ' 48' ' ' LYS . 85.9 m-85 -99.02 -28.2 13.51 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -171.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.5 m -93.07 154.68 41.66 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . 59.4 Cg_endo -79.52 -18.92 10.48 Favored 'Trans proline' 0 C--O 1.21 -0.913 0 C-N-CA 121.69 1.593 . . . . 0.0 111.603 175.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 4.2 p -91.93 146.27 23.88 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.253 1.021 . . . . 0.0 113.081 -173.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.657 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -142.0 139.0 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.384 0.428 . . . . 0.0 110.491 172.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.812 HG22 ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -88.43 130.25 38.26 Favored 'Isoleucine or valine' 0 C--O 1.249 1.071 0 CA-C-O 121.799 0.809 . . . . 0.0 110.334 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.37 167.55 24.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.397 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.513 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -123.5 146.43 48.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.446 ' HB2' HH21 ' A' ' 92' ' ' ARG . . . -79.91 136.31 36.62 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.63 HD12 ' HB2' ' A' ' 37' ' ' PRO . 19.2 mt -87.3 130.66 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.708 172.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.9 m -122.29 157.44 31.73 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.563 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.078 179.815 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 67' ' ' ILE 0.619 23.5 mm . . . . . 0 CA--C 1.508 -0.651 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.36 1.94 1.09 Allowed 'Trans proline' 0 C--O 1.219 -0.433 0 CA-C-N 121.828 1.688 . . . . 0.0 114.289 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 p -132.38 -10.86 3.23 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.9 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -133.82 129.11 36.06 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -174.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 p -130.51 131.71 64.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.223 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.63 124.14 28.27 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.606 HD13 HD11 ' A' ' 86' ' ' ILE . 13.0 pt -99.49 135.68 33.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.441 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -65.83 114.8 5.33 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.16 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.412 ' HD2' ' O ' ' A' ' 81' ' ' ASP . 20.9 pttp -51.46 -39.42 57.42 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.637 0.732 . . . . 0.0 112.141 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -68.4 -19.05 64.59 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.308 -1.315 . . . . 0.0 113.212 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -92.46 -36.18 13.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.94 0.876 . . . . 0.0 109.4 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.572 ' CD2' HD12 ' A' ' 73' ' ' ILE . 19.1 m-85 -92.83 7.53 43.36 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.669 -1.605 . . . . 0.0 113.471 -173.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 tptm 61.23 20.38 10.95 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 121.798 0.808 . . . . 0.0 110.746 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.2 mt -98.89 175.33 5.98 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.665 0.745 . . . . 0.0 111.011 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.412 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 11.2 t70 -83.56 -44.76 14.29 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.619 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.421 ' HB3' ' NZ ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -129.92 158.72 38.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.552 -176.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -72.26 137.72 46.95 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.546 ' O ' HG12 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -120.76 160.51 23.22 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -172.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -111.22 139.89 33.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.55 -0.719 . . . . 0.0 109.214 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.606 HD11 HD13 ' A' ' 73' ' ' ILE . 20.8 mm -104.37 135.99 39.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.8 mt -104.79 106.27 16.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.491 HD12 HD23 ' A' ' 118' ' ' LEU . 3.5 mm? -88.44 14.04 10.56 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.881 0.848 . . . . 0.0 111.505 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -112.91 -34.85 5.63 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.173 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.38 65.79 4.58 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.551 ' O ' ' HB ' ' B' ' 93' ' ' THR . 1.8 pp -102.66 173.81 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.04 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.598 ' NH1' HD22 ' A' ' 24' ' ' LEU . 10.1 ptt180 -164.29 155.45 15.61 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 52.6 m -114.73 120.65 40.79 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.0 mt -131.58 144.58 51.18 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.98 -170.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 2.6 p30 -70.54 152.45 43.95 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.009 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 51' ' ' PRO . 56.8 mtmt -55.24 -18.34 5.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -176.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -85.36 -19.21 31.78 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.912 0.386 . . . . 0.0 110.347 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.415 ' NE ' ' HA ' ' A' ' 98' ' ' ARG . 3.0 mmp_? -70.51 -34.39 72.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.23 121.05 20.64 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.384 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -95.44 -57.41 2.4 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.308 -1.315 . . . . 0.0 114.083 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.0 pt-20 -148.88 135.6 19.7 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 122.069 0.938 . . . . 0.0 113.322 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 55.3 tttp -60.89 110.71 1.41 Allowed 'General case' 0 C--N 1.279 -2.478 0 C-N-CA 128.625 2.77 . . . . 0.0 107.564 172.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 tp -111.13 -62.6 1.52 Allowed 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.299 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.479 HG22 HG11 ' A' ' 19' ' ' VAL . 6.0 t -127.03 -161.17 1.05 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.111 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -154.03 154.41 33.67 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 124.237 1.015 . . . . 0.0 110.803 -171.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.79 161.95 13.32 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.977 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 m -98.59 164.23 12.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 111' ' ' MET . 25.5 t70 -67.09 -33.3 75.19 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.481 0.582 . . . . 0.0 110.712 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.47 -47.43 85.71 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.612 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.597 ' O ' HG22 ' A' ' 114' ' ' VAL . 11.8 tptt -62.82 -32.97 74.27 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 173.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.537 ' CE ' ' HA ' ' A' ' 111' ' ' MET . 0.0 OUTLIER -51.01 -49.21 60.91 Favored 'General case' 0 CA--C 1.456 -2.662 0 CA-C-N 118.3 0.5 . . . . 0.0 109.656 169.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 9.3 mmpt? -75.17 -11.89 60.18 Favored 'General case' 0 N--CA 1.392 -3.371 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.545 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.252 30.4 mt-10 -87.48 -56.41 3.37 Favored 'General case' 0 N--CA 1.39 -3.462 0 C-N-CA 117.136 -1.826 . . . . 0.0 111.17 166.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 110' ' ' LYS . 35.7 m -61.18 -48.18 90.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.25 -48.13 82.87 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 123.488 1.613 . . . . 0.0 109.307 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 18.7 t30 -74.01 -42.05 60.93 Favored 'General case' 0 C--N 1.265 -3.07 0 CA-C-N 111.813 -2.449 . . . . 0.0 112.684 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.488 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.44 -40.93 96.27 Favored 'General case' 0 CA--C 1.46 -2.513 0 CA-C-O 122.365 1.079 . . . . 0.0 108.567 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.491 HD23 HD12 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -79.91 -25.44 40.56 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.939 -172.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.525 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 1.6 ttp -63.8 -26.82 68.8 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-O 121.924 0.869 . . . . 0.0 108.665 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 60.9 mt -84.23 -56.94 4.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 118' ' ' LEU . 15.1 t -47.2 -43.94 21.91 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.817 1.647 . . . . 0.0 112.116 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.773 ' HG ' HG21 ' B' ' 54' ' ' ILE . 8.3 mp -82.0 5.19 20.05 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.411 ' CA ' ' HB3' ' B' ' 43' ' ' ASN . . . 89.64 1.33 77.63 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 117.972 1.949 . . . . 0.0 117.972 176.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.525 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.2 mm? -67.28 -48.91 66.26 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 120.098 1.949 . . . . 0.0 107.804 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 N--CA 1.429 -1.491 0 CA-C-N 112.287 -2.233 . . . . 0.0 113.083 179.15 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.458 HG22 HG21 ' B' ' 40' ' ' ILE . 66.6 mt . . . . . 0 N--CA 1.419 -2.012 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -99.73 129.06 45.82 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.597 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 0.9 OUTLIER -61.14 119.63 8.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 169.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.54 -6.65 8.51 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.469 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.35 175.36 6.46 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.206 1.003 . . . . 0.0 110.587 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.463 HG11 HG22 ' B' ' 104' ' ' THR . 16.2 t -132.98 134.33 58.13 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 113.296 -1.774 . . . . 0.0 110.355 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 32.2 m-85 -132.7 148.0 52.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 124.912 1.285 . . . . 0.0 108.314 174.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.647 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.6 mp -81.47 152.11 27.51 Favored 'General case' 0 N--CA 1.411 -2.409 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.043 170.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.33 138.21 46.26 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.703 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.434 ' HB3' ' NH1' ' B' ' 98' ' ' ARG . 27.2 t70 -78.32 89.87 4.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.984 0.897 . . . . 0.0 110.022 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.623 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 15.8 mt -98.2 17.1 19.39 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 123.895 1.807 . . . . 0.0 109.299 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.534 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.262 15.7 m -60.33 166.65 3.81 Favored Pre-proline 1 C--N 1.236 -4.338 0 CA-C-N 111.916 -2.402 . . . . 0.0 107.955 169.729 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.1 OUTLIER 10.14 50.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.458 1 C-N-CA 127.209 5.273 . . . . 0.0 118.271 -174.764 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' B' ' 31' ' ' GLU . 24.3 m -68.83 -178.69 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 113.663 -1.608 . . . . 0.0 111.68 169.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' B' ' 31' ' ' GLU . 14.5 mm100 -108.36 129.66 55.23 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.388 -1.278 . . . . 0.0 113.569 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.74 -134.75 24.17 Favored Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.612 -1.177 . . . . 0.0 112.16 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.9 m -93.48 22.1 5.64 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 122.936 0.494 . . . . 0.0 111.104 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' B' ' 28' ' ' GLN . 0.1 OUTLIER -66.43 151.94 46.14 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 174.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -77.52 110.1 12.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.867 0.365 . . . . 0.0 111.425 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -86.54 139.88 16.9 Favored Glycine 0 CA--C 1.481 -2.049 0 CA-C-N 114.975 -1.011 . . . . 0.0 115.206 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 116.67 137.29 5.95 Favored Glycine 0 N--CA 1.42 -2.389 0 CA-C-N 113.652 -1.274 . . . . 0.0 110.048 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.2 124.47 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-O 121.942 0.877 . . . . 0.0 109.583 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -145.2 158.43 51.63 Favored Pre-proline 0 C--N 1.276 -2.629 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.299 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 3.7 Cg_exo -72.85 142.47 35.31 Favored 'Trans proline' 0 N--CA 1.437 -1.805 0 C-N-CA 122.053 1.835 . . . . 0.0 111.593 174.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.439 HG22 ' O ' ' B' ' 20' ' ' TYR . 29.9 m -118.34 156.7 20.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.496 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.514 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 27.3 m -97.82 126.98 50.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.416 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.458 HG21 HG22 ' B' ' 14' ' ' ILE . 20.6 mm -87.85 104.51 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.77 -18.69 6.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.364 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.835 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -56.51 158.26 4.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -173.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.433 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 25.9 p-10 -71.51 -167.22 0.24 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 123.124 1.44 . . . . 0.0 112.835 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -90.65 -38.37 13.15 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.782 -2.008 . . . . 0.0 112.909 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 3.6 m -83.75 -27.51 28.86 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.127 -170.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -64.62 -37.51 94.49 Favored Glycine 0 C--O 1.202 -1.861 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.613 ' N ' HE22 ' B' ' 42' ' ' GLN . 9.9 p30 -83.82 -20.89 32.42 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.761 -0.775 . . . . 0.0 110.234 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.485 ' HB3' ' CD1' ' B' ' 49' ' ' TYR . 4.9 mptp? -76.2 -66.35 0.81 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.603 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' B' ' 48' ' ' LYS . 87.7 m-85 -95.18 -30.18 14.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.785 -171.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 23.5 m -93.45 154.35 41.29 Favored Pre-proline 0 C--N 1.292 -1.931 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.82 -16.51 8.88 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.56 1.507 . . . . 0.0 111.209 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 9.0 p -92.9 146.43 23.64 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.231 1.013 . . . . 0.0 112.868 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.636 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -142.34 138.79 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 123.649 0.593 . . . . 0.0 110.29 172.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.835 HG22 ' HG3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -88.75 130.15 38.65 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 CA-C-O 121.742 0.782 . . . . 0.0 110.287 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.25 168.2 22.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.424 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.539 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -124.02 146.74 48.33 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.515 ' HB2' HH21 ' B' ' 92' ' ' ARG . . . -78.35 136.37 37.68 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' B' ' 37' ' ' PRO . 20.8 mt -88.49 127.25 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.14 -1.391 . . . . 0.0 107.352 172.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 60.2 m -117.77 160.33 21.53 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.911 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.984 179.481 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' B' ' 67' ' ' ILE 0.602 24.1 mm . . . . . 0 CA--C 1.509 -0.614 0 N-CA-C 120.24 3.422 . . . . 0.0 120.24 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.35 2.32 0.94 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 CA-C-N 121.691 1.64 . . . . 0.0 113.991 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 28.8 p -132.39 -11.94 3.15 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.768 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -135.48 129.21 32.8 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -173.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 p -131.35 133.17 62.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.648 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.86 125.76 29.8 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.631 HD13 HD11 ' B' ' 86' ' ' ILE . 12.3 pt -99.28 133.37 42.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.692 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -64.62 117.28 7.18 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 123.848 0.717 . . . . 0.0 110.39 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' B' ' 81' ' ' ASP . 21.2 pttp -53.65 -38.92 64.59 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.28 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -69.07 -19.28 64.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.546 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -91.61 -35.15 14.4 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.865 0.84 . . . . 0.0 109.106 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.574 ' CD2' HD12 ' B' ' 73' ' ' ILE . 17.1 m-85 -93.3 7.79 42.96 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.548 -173.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 23.2 tptm 61.42 23.41 13.67 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 121.802 0.81 . . . . 0.0 109.996 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 29.3 mt -100.6 177.08 5.11 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.485 0.659 . . . . 0.0 111.058 -174.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' B' ' 75' ' ' LYS . 20.3 t70 -83.21 -47.74 11.23 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.913 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -128.96 159.15 36.77 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.835 -175.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.73 145.22 52.45 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.549 ' O ' HG12 ' B' ' 73' ' ' ILE . 0.3 OUTLIER -129.31 158.79 38.11 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -173.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -110.23 140.59 28.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.631 HD11 HD13 ' B' ' 73' ' ' ILE . 22.9 mm -105.01 136.14 40.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 35.6 mt -104.79 105.55 15.67 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.491 HD12 HD23 ' B' ' 118' ' ' LEU . 3.5 mm? -87.68 11.97 13.88 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.006 0.907 . . . . 0.0 111.324 -174.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -110.62 -34.25 6.34 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.178 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.05 66.58 3.57 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.551 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.9 pp -102.59 174.24 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.554 ' NH1' HD22 ' B' ' 24' ' ' LEU . 10.4 ptt180 -164.53 154.54 14.11 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 49.5 m -113.41 120.69 41.95 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.013 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 58.7 mt -131.43 144.47 51.21 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.825 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 1.9 p30 -71.4 152.37 43.2 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.0 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -50.57 -25.49 4.18 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -81.44 -18.83 43.94 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.341 0.519 . . . . 0.0 110.93 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.434 ' NH1' ' HB3' ' B' ' 23' ' ' ASP . 3.3 mmp_? -69.17 -33.89 74.09 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' B' ' 21' ' ' LEU . 7.8 mp -73.54 124.15 25.33 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.361 173.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -99.02 -53.52 3.24 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.098 -1.41 . . . . 0.0 114.68 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 13.5 pt-20 -154.92 138.78 16.26 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 122.085 0.945 . . . . 0.0 113.163 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.77 112.25 2.2 Favored 'General case' 0 C--N 1.282 -2.354 0 C-N-CA 128.66 2.784 . . . . 0.0 107.358 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -112.2 -62.77 1.52 Allowed 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.244 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.463 HG22 HG11 ' B' ' 19' ' ' VAL . 6.7 t -125.59 -157.97 0.82 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.204 -1.398 . . . . 0.0 111.486 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -156.34 152.94 28.22 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 124.311 1.044 . . . . 0.0 111.005 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.1 151.54 23.88 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.289 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 19.8 m -90.43 166.79 13.07 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' B' ' 111' ' ' MET . 33.8 t70 -67.44 -34.28 76.89 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.029 0.442 . . . . 0.0 111.23 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -62.11 -46.71 87.86 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.616 ' O ' HG22 ' B' ' 114' ' ' VAL . 11.9 tptt -62.86 -32.07 73.22 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.539 ' HA ' ' CE ' ' B' ' 111' ' ' MET . 0.0 OUTLIER -51.62 -47.94 63.47 Favored 'General case' 0 CA--C 1.445 -3.074 0 CA-C-O 121.245 0.545 . . . . 0.0 109.867 169.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' B' ' 112' ' ' LYS . 8.3 mmpt? -74.88 -14.06 60.62 Favored 'General case' 0 N--CA 1.384 -3.767 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . 0.252 31.6 mt-10 -87.17 -56.61 3.3 Favored 'General case' 0 N--CA 1.386 -3.633 0 C-N-CA 116.763 -1.975 . . . . 0.0 111.234 168.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . 0.616 HG22 ' O ' ' B' ' 110' ' ' LYS . 36.0 m -60.56 -47.81 91.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.95 -50.87 71.65 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 123.365 1.555 . . . . 0.0 109.665 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.316 26.9 t30 -73.2 -40.47 64.73 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-N 112.1 -2.318 . . . . 0.0 112.792 -172.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.444 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -62.38 -40.04 95.15 Favored 'General case' 0 CA--C 1.46 -2.484 0 CA-C-O 122.225 1.012 . . . . 0.0 108.666 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.491 HD23 HD12 ' B' ' 88' ' ' LEU . 0.6 OUTLIER -79.56 -25.28 41.65 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.739 -173.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.529 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 1.8 ttp -63.47 -27.5 69.33 Favored 'General case' 0 N--CA 1.399 -3.014 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.496 HG23 ' ND2' ' B' ' 125' ' ' ASN . 64.1 mt -83.98 -56.99 4.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . 0.447 ' HB3' ' HA ' ' B' ' 118' ' ' LEU . 21.9 t -47.09 -43.45 20.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.216 1.406 . . . . 0.0 112.283 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.79 ' HG ' HG21 ' A' ' 54' ' ' ILE . 8.2 mp -82.2 5.36 20.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . 0.424 ' CA ' ' HB3' ' A' ' 43' ' ' ASN . . . 89.66 1.39 77.49 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 117.862 1.905 . . . . 0.0 117.862 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.529 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.1 mm? -67.41 -49.58 63.18 Favored 'General case' 0 C--O 1.249 1.048 0 CA-C-N 120.271 2.035 . . . . 0.0 107.749 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.496 ' ND2' HG23 ' B' ' 120' ' ' ILE . 1.5 t-20 . . . . . 0 N--CA 1.439 -1.016 0 CA-C-N 112.514 -2.13 . . . . 0.0 113.01 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 47' ' ' ASN . 59.3 mt . . . . . 0 N--CA 1.438 -1.029 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.3 mmt-85 -117.22 152.75 34.16 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -64.25 122.0 15.61 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 113.33 -11.97 23.88 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.12 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -78.01 156.55 30.07 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 122.108 0.956 . . . . 0.0 110.123 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.463 ' HB ' ' H ' ' A' ' 104' ' ' THR . 93.3 t -116.24 118.81 60.0 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.391 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.345 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 44.2 m-85 -116.43 138.98 50.93 Favored 'General case' 0 C--O 1.181 -2.509 0 C-N-CA 126.072 1.749 . . . . 0.0 111.207 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.8 mp -82.48 147.87 28.46 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 121.392 0.615 . . . . 0.0 109.9 169.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -144.0 142.17 30.55 Favored 'General case' 0 C--N 1.274 -2.717 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.985 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.24 95.27 5.61 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 123.059 1.409 . . . . 0.0 110.256 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.823 ' O ' HG13 ' A' ' 27' ' ' VAL . 66.7 mt -88.42 -14.58 37.67 Favored 'General case' 0 C--O 1.177 -2.763 0 CA-C-N 113.214 -1.812 . . . . 0.0 112.554 -175.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 4.6 p -87.3 56.48 0.0 OUTLIER Pre-proline 0 C--N 1.256 -3.497 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -127.63 41.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 124.216 3.277 . . . . 0.0 106.709 142.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 24' ' ' LEU . 6.6 m -69.02 176.16 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.526 HE22 ' HB2' ' B' ' 26' ' ' PRO . 35.7 mm-40 -89.71 109.69 20.64 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.462 -1.699 . . . . 0.0 112.5 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.97 -108.56 0.56 Allowed Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.262 -1.335 . . . . 0.0 114.924 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.8 m -89.15 17.92 5.5 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 39.1 mt-10 -67.76 -175.06 0.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.969 172.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.414 ' NE2' ' HG3' ' A' ' 36' ' ' ARG . 13.1 tm0? -99.09 121.17 40.63 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.78 164.29 13.9 Favored Glycine 0 CA--C 1.478 -2.252 0 CA-C-O 122.012 0.784 . . . . 0.0 114.99 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.507 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . 115.68 156.71 11.07 Favored Glycine 0 N--CA 1.419 -2.48 0 CA-C-N 113.431 -1.385 . . . . 0.0 109.666 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -82.74 100.48 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.342 0 CA-C-O 123.904 1.811 . . . . 0.0 107.604 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.414 ' HG3' ' NE2' ' A' ' 32' ' ' GLN . 28.4 mmt180 -127.26 161.34 54.89 Favored Pre-proline 0 C--N 1.255 -3.502 0 CA-C-N 112.253 -2.249 . . . . 0.0 108.888 -170.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.7 ' HB2' HD12 ' A' ' 58' ' ' ILE . 5.2 Cg_exo -76.74 142.07 22.4 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 C-N-CA 121.772 1.648 . . . . 0.0 112.146 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 20' ' ' TYR . 27.6 m -119.84 156.81 22.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 124.419 1.087 . . . . 0.0 108.475 177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 21.2 m -105.57 133.82 48.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.3 mm -81.85 103.24 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -98.37 -19.22 6.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.777 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.547 HE22 ' N ' ' A' ' 47' ' ' ASN . 3.1 tt0 -57.05 163.8 1.9 Allowed 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 125.51 1.524 . . . . 0.0 114.567 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 27.4 p-10 -65.85 177.76 1.23 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.539 -1.664 . . . . 0.0 112.423 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.38 -41.56 56.06 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.556 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.8 m -85.28 -26.36 26.68 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.484 -171.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.3 -33.21 79.61 Favored Glycine 0 C--O 1.213 -1.214 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.547 ' N ' HE22 ' A' ' 42' ' ' GLN 0.262 6.7 p30 -69.63 -18.97 63.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -92.35 -68.02 0.82 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.106 0.479 . . . . 0.0 110.297 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -91.89 -16.24 26.96 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -165.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.5 m -90.73 133.83 31.74 Favored Pre-proline 0 N--CA 1.417 -2.105 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -65.68 -27.97 52.5 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 121.752 1.635 . . . . 0.0 108.698 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.4 p -94.35 137.98 32.87 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 113.333 -1.758 . . . . 0.0 112.115 -175.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.542 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 90.4 t -122.06 140.16 46.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.701 HD13 HD11 ' B' ' 91' ' ' ILE . 1.5 tp -106.09 125.73 61.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-O 121.7 0.762 . . . . 0.0 110.943 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.34 171.11 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.103 -176.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.52 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -124.78 142.83 51.15 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.508 ' HB2' HH11 ' A' ' 92' ' ' ARG . . . -84.18 142.53 30.26 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 ' HB2' ' A' ' 37' ' ' PRO . 16.2 mt -85.59 138.49 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.963 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 m -119.79 134.75 55.12 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.439 0 CA-C-O 121.36 0.422 . . . . 0.0 112.567 -179.484 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 tt . . . . . 0 N--CA 1.432 -1.344 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.92 -3.61 0.71 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 124.048 3.165 . . . . 0.0 116.435 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.4 p -90.45 -18.96 24.47 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 118.921 0.782 . . . . 0.0 109.641 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -86.25 129.59 34.8 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.065 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.44 120.6 59.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -86.08 132.34 34.06 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.481 HD13 ' CG ' ' A' ' 78' ' ' TYR . 2.8 pp -84.6 157.33 3.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.987 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HG2' ' CG ' ' A' ' 76' ' ' LYS . 19.8 tt0 -77.59 107.88 10.37 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 62.7 pttt -55.22 -42.17 73.0 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.459 ' CG ' ' HG2' ' A' ' 74' ' ' GLU . 11.1 ptmm? -59.02 -32.75 70.01 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.222 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -91.39 -26.7 18.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.681 0.753 . . . . 0.0 109.84 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CG ' HD13 ' A' ' 73' ' ' ILE . 2.8 m-85 -80.44 2.7 24.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.274 -178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 71.63 20.65 4.64 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.502 1.121 . . . . 0.0 111.068 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 mt -110.89 168.57 9.38 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.852 0.834 . . . . 0.0 111.248 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.481 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 14.7 t70 -93.2 -35.36 13.18 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.928 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -119.65 145.81 46.13 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.076 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 8.4 p-10 -76.08 147.39 38.68 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.389 0.614 . . . . 0.0 110.113 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.2 t -112.57 175.9 5.24 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.06 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 t -127.76 141.41 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.575 ' CD1' HG12 ' A' ' 58' ' ' ILE . 25.1 mm -109.36 133.36 54.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.5 mt -102.52 107.54 18.54 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -79.52 15.63 1.25 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.789 0.835 . . . . 0.0 112.46 -174.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.27 -39.79 3.01 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.649 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -83.68 51.96 2.15 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 125.332 1.453 . . . . 0.0 108.237 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.709 HD11 HD13 ' B' ' 54' ' ' ILE . 2.0 pp -96.29 -179.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.63 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.508 HH11 ' HB2' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -168.0 163.13 13.62 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.6 m -117.77 119.93 36.39 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.414 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.2 mt -131.44 137.75 48.76 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.895 -171.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 2.8 p-10 -74.35 153.16 39.42 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.445 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -38.99 -36.76 0.31 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 126.231 1.812 . . . . 0.0 112.837 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -64.52 -22.34 66.94 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.943 0.897 . . . . 0.0 111.54 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.7 mmp_? -79.83 -33.54 40.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.257 0.551 . . . . 0.0 109.577 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.53 101.89 4.33 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 122.601 1.191 . . . . 0.0 111.715 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -86.7 -65.09 1.05 Allowed 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 113.518 -1.674 . . . . 0.0 115.13 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 9.3 pt-20 -139.46 126.66 21.25 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 18.8 ptmt -71.45 114.07 9.14 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.319 -1.764 . . . . 0.0 110.986 171.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.631 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 24.0 tp -103.49 -56.73 2.16 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.005 -173.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.631 ' OG1' ' HG ' ' A' ' 103' ' ' LEU 0.285 3.5 m -135.42 -174.05 3.52 Favored 'General case' 0 N--CA 1.391 -3.384 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.573 -165.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.472 ' H ' ' CG2' ' A' ' 104' ' ' THR . 0.6 OUTLIER -160.64 134.93 7.24 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.489 1.516 . . . . 0.0 110.92 -166.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.59 153.4 22.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.345 0.658 . . . . 0.0 112.539 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.432 ' HB2' ' HD3' ' A' ' 110' ' ' LYS . 2.0 m -75.87 159.7 30.68 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.888 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 111' ' ' MET . 38.1 t70 -58.45 -51.93 67.76 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 3.5 p-10 -73.14 -26.69 61.3 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.717 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.432 ' HD3' ' HB2' ' A' ' 107' ' ' SER . 2.0 mptp? -67.41 -27.26 66.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.585 176.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.412 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -57.38 -39.78 76.78 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 123.527 0.731 . . . . 0.0 110.473 174.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.604 ' HE2' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -74.11 -19.8 60.46 Favored 'General case' 0 CA--C 1.483 -1.622 0 C-N-CA 123.245 0.618 . . . . 0.0 111.386 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.489 ' HA ' ' ND2' ' A' ' 116' ' ' ASN . 21.0 mt-10 -85.83 -36.87 19.76 Favored 'General case' 0 N--CA 1.399 -2.983 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.68 -46.77 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-N 113.153 -1.84 . . . . 0.0 109.829 170.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 112' ' ' LYS . 37.4 m-20 -60.21 -57.74 11.49 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.88 0.848 . . . . 0.0 109.976 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 113' ' ' GLU . 0.4 OUTLIER -64.88 -39.43 93.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.624 -172.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.487 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.99 -40.26 84.3 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 2.8 tp -68.36 -38.02 81.03 Favored 'General case' 1 N--CA 1.365 -4.705 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.356 -175.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 46.2 mtp -66.17 -29.67 70.0 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 121.755 -0.59 . . . . 0.0 111.261 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 116' ' ' ASN . 26.5 mt -77.33 -54.35 12.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.5 t -52.67 -36.81 57.68 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.565 -1.652 . . . . 0.0 111.358 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.533 ' HB3' ' CD1' ' B' ' 41' ' ' ILE . 42.0 mt -101.49 7.32 42.48 Favored 'General case' 0 N--CA 1.428 -1.529 0 O-C-N 121.961 -0.462 . . . . 0.0 111.512 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.91 75.24 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 116.794 1.478 . . . . 0.0 116.794 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 mp -78.46 -46.94 18.51 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 118.829 1.315 . . . . 0.0 109.292 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.438 -1.053 0 CA-C-N 113.274 -1.785 . . . . 0.0 110.229 -172.241 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 66.0 mt . . . . . 0 N--CA 1.445 -0.716 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.9 mmt-85 -119.44 154.56 33.52 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -64.27 120.36 12.01 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 116.46 -13.93 15.53 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.998 -178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . 0.413 ' O ' HG12 ' B' ' 40' ' ' ILE . 14.1 m-20 -75.67 155.05 36.14 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.33 1.062 . . . . 0.0 110.844 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.477 ' HB ' ' H ' ' B' ' 104' ' ' THR . 89.9 t -115.56 118.59 59.28 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.516 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.894 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.532 ' CZ ' ' HB3' ' B' ' 102' ' ' LYS . 48.2 m-85 -115.52 140.44 49.15 Favored 'General case' 0 CA--C 1.455 -2.707 0 C-N-CA 125.986 1.714 . . . . 0.0 110.671 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -82.34 148.68 28.15 Favored 'General case' 0 N--CA 1.392 -3.33 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.782 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -146.07 143.6 29.5 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.733 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' B' ' 25' ' ' SER . 4.8 p-10 -75.52 93.1 2.95 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 122.325 1.059 . . . . 0.0 110.001 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.746 ' O ' HG13 ' B' ' 27' ' ' VAL . 69.5 mt -89.6 21.8 3.3 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -176.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.639 ' HB2' ' HD2' ' B' ' 26' ' ' PRO 0.264 5.4 p -79.54 -165.62 0.07 OUTLIER Pre-proline 0 N--CA 1.39 -3.427 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 176.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.639 ' HD2' ' HB2' ' B' ' 25' ' ' SER . 31.7 Cg_exo 18.39 40.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.42 1 C-N-CA 125.385 4.057 . . . . 0.0 118.193 -156.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.746 HG13 ' O ' ' B' ' 24' ' ' LEU . 7.0 m -70.56 177.8 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 122.213 1.006 . . . . 0.0 112.786 174.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -90.08 109.15 20.22 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.117 -1.401 . . . . 0.0 112.724 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.39 -108.49 0.31 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.69 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -87.28 17.65 4.25 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.0 -170.57 0.11 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 118.87 0.759 . . . . 0.0 111.292 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -103.67 118.85 37.68 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.88 167.04 16.91 Favored Glycine 0 CA--C 1.473 -2.583 0 CA-C-O 122.218 0.899 . . . . 0.0 115.306 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 113.36 154.2 11.42 Favored Glycine 0 N--CA 1.408 -3.191 0 CA-C-N 112.861 -1.669 . . . . 0.0 109.719 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -80.84 103.05 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-O 123.167 1.46 . . . . 0.0 107.287 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -130.54 161.71 59.15 Favored Pre-proline 0 C--N 1.254 -3.582 0 CA-C-N 113.267 -1.788 . . . . 0.0 108.949 -170.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.674 ' HB2' HD12 ' B' ' 58' ' ' ILE . 4.7 Cg_exo -75.57 141.81 25.49 Favored 'Trans proline' 0 N--CA 1.431 -2.193 0 C-N-CA 121.812 1.675 . . . . 0.0 112.33 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -120.86 156.95 24.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 124.568 1.147 . . . . 0.0 108.512 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 21.8 m -105.46 133.6 49.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.502 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.413 HG12 ' O ' ' B' ' 18' ' ' ASP . 30.6 mm -81.69 102.02 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.3 -19.31 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.637 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.535 HE22 ' N ' ' B' ' 47' ' ' ASN . 2.6 tt0 -56.67 162.19 2.41 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 125.462 1.505 . . . . 0.0 114.475 -173.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.525 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 21.8 p-10 -63.8 -175.86 0.16 Allowed 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.472 -1.694 . . . . 0.0 112.492 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.76 -42.73 17.6 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.63 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 9.7 m -85.15 -26.17 27.0 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.545 -170.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.1 -34.49 84.08 Favored Glycine 0 C--O 1.217 -0.909 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.535 ' N ' HE22 ' B' ' 42' ' ' GLN 0.264 8.8 p30 -69.1 -18.77 64.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -92.65 -67.37 0.86 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.231 0.539 . . . . 0.0 110.782 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -93.43 -11.79 31.33 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -166.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 69.4 m -94.65 134.47 25.16 Favored Pre-proline 0 N--CA 1.42 -1.943 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.55 -27.51 39.09 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 121.872 1.715 . . . . 0.0 109.044 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.7 p -94.82 137.7 33.57 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.834 -174.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.518 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 89.4 t -121.86 140.21 46.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.709 HD13 HD11 ' A' ' 91' ' ' ILE . 1.4 tp -105.9 125.66 61.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-O 121.668 0.746 . . . . 0.0 111.257 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.406 HG12 HD13 ' B' ' 40' ' ' ILE . 34.1 m -133.32 172.44 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.994 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.524 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -127.03 142.5 51.53 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.525 ' HB2' HH11 ' B' ' 92' ' ' ARG . . . -83.3 142.95 30.71 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' B' ' 37' ' ' PRO . 17.2 mt -88.31 135.36 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.442 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 38.3 m -116.16 134.78 54.55 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.454 0 CA-C-O 121.732 0.629 . . . . 0.0 112.327 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.15 -12.53 5.41 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 124.038 3.158 . . . . 0.0 116.258 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 59.2 p -83.95 -19.11 35.22 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.63 0.729 . . . . 0.0 109.829 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -85.38 129.1 34.89 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.09 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.91 121.67 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -87.77 133.5 33.86 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.491 HD13 ' CG ' ' B' ' 78' ' ' TYR . 2.8 pp -85.9 156.46 3.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.369 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.434 ' HG2' ' CG ' ' B' ' 76' ' ' LYS . 16.0 tt0 -76.26 107.45 8.51 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' B' ' 83' ' ' ASP . 62.2 pttt -56.25 -41.83 76.39 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . 0.434 ' CG ' ' HG2' ' B' ' 74' ' ' GLU . 10.8 ptmm? -59.71 -30.78 69.04 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.503 -1.226 . . . . 0.0 113.367 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -91.47 -31.18 16.08 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.561 0.696 . . . . 0.0 109.404 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.491 ' CG ' HD13 ' B' ' 73' ' ' ILE . 3.0 m-85 -76.39 1.3 16.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.442 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 74.55 12.78 3.77 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.994 1.318 . . . . 0.0 111.816 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 19.2 mt -104.46 168.48 9.06 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.873 0.844 . . . . 0.0 111.896 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' B' ' 75' ' ' LYS . 18.3 t70 -91.51 -35.85 14.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.131 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.28 147.85 44.46 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.636 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' B' ' 75' ' ' LYS . 7.3 p-10 -76.84 147.97 36.81 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.157 0.503 . . . . 0.0 110.324 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -113.19 175.2 5.55 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.091 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t -126.82 141.79 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.587 ' CD1' HG12 ' B' ' 58' ' ' ILE . 25.0 mm -109.07 133.04 55.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 61.9 mt -102.22 107.07 18.01 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.994 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.7 mm? -79.01 14.02 1.56 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.821 0.849 . . . . 0.0 112.439 -174.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -116.61 -39.4 3.33 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.881 0.848 . . . . 0.0 108.944 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -84.04 52.0 2.2 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 125.229 1.412 . . . . 0.0 108.291 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.701 HD11 HD13 ' A' ' 54' ' ' ILE . 2.0 pp -96.46 -179.59 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.693 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.525 HH11 ' HB2' ' B' ' 57' ' ' ALA . 0.0 OUTLIER -167.92 163.12 13.8 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 17.9 m -118.1 119.59 35.21 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.48 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 51.4 mt -131.47 138.38 48.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.113 -171.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 3.7 p-10 -74.03 152.9 39.89 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.707 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -38.27 -32.74 0.08 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 126.853 2.061 . . . . 0.0 113.697 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -69.31 -25.51 64.26 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.279 0.632 . . . . 0.0 110.901 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 2.1 mmp_? -76.41 -33.36 58.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -73.32 103.65 4.07 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.108 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -87.14 -61.88 1.63 Allowed 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.3 pt-20 -144.39 130.24 19.3 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.846 0.832 . . . . 0.0 113.003 -171.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 20' ' ' TYR . 19.4 ptmt -73.75 110.84 8.36 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.111 173.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.641 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 23.9 tp -101.48 -56.63 2.25 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.796 -172.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.641 ' OG1' ' HG ' ' B' ' 103' ' ' LEU 0.285 4.1 m -134.48 -175.0 3.73 Favored 'General case' 0 N--CA 1.387 -3.613 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.31 -166.016 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.48 ' H ' ' CG2' ' B' ' 104' ' ' THR . 0.4 OUTLIER -160.6 134.96 7.3 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.476 1.51 . . . . 0.0 110.383 -166.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 11.1 mt -85.67 157.3 20.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.523 0.729 . . . . 0.0 112.517 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . 0.416 ' HB2' ' HD3' ' B' ' 110' ' ' LYS . 2.3 m -78.97 165.5 23.4 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.775 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' B' ' 111' ' ' MET . 27.8 t70 -61.29 -53.01 62.23 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 3.7 p-10 -72.35 -28.52 63.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.446 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.416 ' HD3' ' HB2' ' B' ' 107' ' ' SER . 2.2 mptp? -66.51 -26.9 67.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.748 0.308 . . . . 0.0 111.221 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.448 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -59.03 -40.03 83.78 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.199 0.599 . . . . 0.0 110.397 173.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.609 ' HE2' ' N ' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -75.37 -16.91 60.34 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.056 0.455 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . 0.443 ' HA ' ' ND2' ' B' ' 116' ' ' ASN . 48.7 mt-10 -84.54 -38.32 20.15 Favored 'General case' 0 CA--C 1.443 -3.152 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.28 -48.55 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.994 0 CA-C-N 112.685 -2.052 . . . . 0.0 110.022 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' B' ' 112' ' ' LYS . 49.0 m-20 -59.56 -59.02 6.11 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.726 0.774 . . . . 0.0 110.461 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 0.5 OUTLIER -64.82 -37.55 88.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.017 -172.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.456 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -60.15 -39.45 86.38 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 3.0 tp -69.78 -38.26 76.64 Favored 'General case' 1 N--CA 1.366 -4.661 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.984 -175.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 48.4 mtp -65.52 -34.77 79.04 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 121.769 -0.582 . . . . 0.0 110.927 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' B' ' 117' ' ' ALA . 23.7 mt -71.89 -53.95 18.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 20.3 t -52.76 -35.78 56.85 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.784 1.234 . . . . 0.0 111.443 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.534 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 39.8 mt -102.34 6.54 40.41 Favored 'General case' 0 N--CA 1.428 -1.548 0 O-C-N 121.894 -0.504 . . . . 0.0 111.508 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.26 20.69 76.88 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.48 -49.31 15.03 Favored 'General case' 0 CA--C 1.478 -1.791 0 CA-C-N 118.876 1.338 . . . . 0.0 109.056 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.437 -1.083 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.148 -172.108 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.448 ' HB ' ' OD1' ' A' ' 47' ' ' ASN . 65.1 mt . . . . . 0 N--CA 1.444 -0.761 0 CA-C-O 121.196 0.522 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -103.28 138.82 39.54 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -76.59 134.43 39.37 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.353 -1.339 . . . . 0.0 108.334 173.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.31 -5.53 55.42 Favored Glycine 0 C--N 1.302 -1.356 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.93 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.25 166.69 11.78 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.582 0.706 . . . . 0.0 110.114 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 37.4 t -120.05 133.7 65.95 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.422 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.595 ' O ' HG22 ' A' ' 38' ' ' VAL . 44.4 m-85 -136.67 147.34 46.77 Favored 'General case' 0 CA--C 1.469 -2.165 0 C-N-CA 124.623 1.169 . . . . 0.0 107.957 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.7 mp -74.42 148.86 40.77 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.087 171.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -143.63 135.3 26.3 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.097 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.19 94.46 3.53 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.77 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 9.2 mt -89.45 5.0 47.26 Favored 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 124.776 1.23 . . . . 0.0 110.086 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.609 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 4.6 m -52.96 -177.66 0.04 OUTLIER Pre-proline 1 C--N 1.241 -4.142 0 C-N-CA 126.817 2.047 . . . . 0.0 113.283 174.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 19.97 35.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.41 3.784 1 C-N-CA 125.716 4.277 . . . . 0.0 119.465 -157.956 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 5.8 m -70.89 173.47 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.565 168.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.41 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 33.8 mm-40 -111.71 141.4 45.36 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.89 -111.87 1.43 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 114.786 -1.097 . . . . 0.0 115.023 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -94.16 4.4 53.94 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 123.425 0.69 . . . . 0.0 112.697 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 77.2 mt-10 -64.05 144.0 57.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.524 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 5.8 tp60 -117.73 111.47 19.16 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -170.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -126.64 -109.44 1.63 Allowed Glycine 1 N--CA 1.383 -4.844 0 C-N-CA 118.361 -1.876 . . . . 0.0 116.453 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 75.97 177.08 41.9 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 -168.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.5 p -91.44 106.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.288 0 O-C-N 120.617 -1.519 . . . . 0.0 108.897 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.524 ' NH2' ' HG3' ' A' ' 32' ' ' GLN . 62.8 mtm180 -135.17 157.8 76.07 Favored Pre-proline 0 C--N 1.275 -2.672 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.648 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 31.9 Cg_exo -66.12 138.55 52.34 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.098 2.532 . . . . 0.0 112.132 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 20' ' ' TYR . 20.5 m -126.35 164.03 27.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 C-N-CA 123.5 0.72 . . . . 0.0 110.234 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 27.4 m -105.73 134.5 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.9 mm -95.01 118.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 123.093 0.557 . . . . 0.0 110.195 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -8.62 12.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.587 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.412 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 5.9 pt20 -63.42 165.66 7.49 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -167.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.458 ' HB3' ' N ' ' B' ' 123' ' ' GLY . 18.4 p-10 -75.29 -173.14 1.95 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 111.823 -2.444 . . . . 0.0 113.423 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -79.55 -43.98 22.01 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.076 -1.874 . . . . 0.0 113.411 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 m -86.19 -25.73 25.49 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -168.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 50' ' ' SER . . . -71.52 -20.97 78.74 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.448 ' OD1' ' HB ' ' A' ' 14' ' ' ILE . 31.2 t-20 -72.86 -32.33 65.36 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.834 -1.183 . . . . 0.0 108.526 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -90.04 -66.73 0.9 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.534 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -98.81 -35.62 10.07 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -168.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.598 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 15.2 t -75.54 128.76 83.4 Favored Pre-proline 0 N--CA 1.435 -1.199 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.801 -174.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.545 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 61.2 Cg_endo -74.72 -11.75 22.05 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.985 1.79 . . . . 0.0 110.155 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 p -107.56 121.39 44.55 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.935 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.412 ' HB ' ' OE1' ' A' ' 42' ' ' GLN . 1.3 m -121.73 167.5 15.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.856 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.727 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 13.7 tt -108.29 125.07 65.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 123.575 0.75 . . . . 0.0 112.054 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.67 HG22 ' CD2' ' A' ' 94' ' ' LEU . 3.7 m -137.48 163.56 30.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.715 ' HA ' HG13 ' A' ' 91' ' ' ILE . . . -123.08 131.21 53.6 Favored 'General case' 0 N--CA 1.416 -2.16 0 O-C-N 123.365 0.416 . . . . 0.0 111.172 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.656 ' N ' HG21 ' A' ' 91' ' ' ILE . . . -66.0 130.63 43.91 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.539 HG12 HD12 ' A' ' 86' ' ' ILE . 56.4 mt -85.49 138.31 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 112.661 -2.063 . . . . 0.0 106.994 174.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.2 t -148.36 179.99 7.37 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.469 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.376 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 N--CA 1.441 -0.899 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.4 9.34 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.254 1.969 . . . . 0.0 114.145 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.0 p -118.5 -6.49 10.71 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.083 0.468 . . . . 0.0 110.613 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.471 ' CD2' HD22 ' A' ' 87' ' ' LEU . 43.4 m170 -122.6 129.32 51.76 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.2 m -122.02 139.4 49.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.618 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -94.75 129.71 41.56 Favored 'General case' 0 C--O 1.251 1.177 0 CA-C-O 121.567 0.699 . . . . 0.0 111.081 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.724 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -120.6 158.57 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.23 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -79.18 128.65 33.57 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.681 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -47.48 -48.35 27.04 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 125.369 1.468 . . . . 0.0 110.699 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -56.35 -45.0 80.63 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 126.489 1.916 . . . . 0.0 112.64 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -71.79 -34.99 69.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.98 -175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.724 ' CE1' HG21 ' A' ' 73' ' ' ILE . 3.6 m-85 -95.3 -9.89 31.77 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.192 -176.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 61.46 29.95 18.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.883 1.273 . . . . 0.0 112.863 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 7.6 mp -88.73 -179.56 6.03 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.629 1.204 . . . . 0.0 112.973 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -73.7 -26.0 60.5 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.871 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -147.83 166.87 26.28 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -59.25 141.86 53.3 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 m -103.08 137.34 41.39 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.808 -168.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.42 137.62 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.539 HD12 HG12 ' A' ' 58' ' ' ILE . 20.3 mm -116.17 138.44 46.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.528 ' O ' HD11 ' A' ' 91' ' ' ILE . 36.6 mt -104.46 140.78 37.46 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.551 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.3 mm? -111.83 2.01 16.86 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 122.28 1.038 . . . . 0.0 111.27 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -99.98 -33.45 10.5 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.93 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.802 ' HB3' HD13 ' A' ' 91' ' ' ILE . 1.1 tm0? -80.42 -2.71 46.84 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.861 -171.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.802 HD13 ' HB3' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -150.91 148.22 15.15 Favored 'Isoleucine or valine' 1 CA--C 1.421 -4.01 0 CA-C-O 117.516 -1.23 . . . . 0.0 112.651 -163.538 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.896 ' HB3' ' HB3' ' B' ' 92' ' ' ARG 0.264 40.0 mtm-85 179.84 -53.04 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.767 1 N-CA-C 121.934 4.05 . . . . 0.0 121.934 -174.982 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.724 ' OG1' ' HB2' ' B' ' 92' ' ' ARG . 42.2 m -123.2 101.0 7.14 Favored 'General case' 0 N--CA 1.531 3.599 0 O-C-N 121.009 -1.057 . . . . 0.0 112.994 -170.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.67 ' CD2' HG22 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -132.1 126.11 32.96 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.646 -172.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 15.7 t0 -56.25 146.3 24.04 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.46 0.704 . . . . 0.0 111.375 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.598 ' HE2' ' O ' ' A' ' 50' ' ' SER . 67.8 mttm -53.95 -33.36 56.64 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.306 1.042 . . . . 0.0 111.692 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HG3' ' OD1' ' A' ' 95' ' ' ASP . 48.1 mttp -61.73 -22.16 65.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.28 0.632 . . . . 0.0 111.102 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 34.1 mtp180 -79.3 -37.85 36.72 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.2 mp -71.25 118.25 13.81 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.284 1.033 . . . . 0.0 111.242 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -99.2 -66.92 0.87 Allowed 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.3 pt-20 -156.11 144.46 19.96 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.475 0.655 . . . . 0.0 112.561 -165.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -65.38 119.89 11.81 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 128.243 2.617 . . . . 0.0 113.656 -178.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.575 HD23 HG12 ' A' ' 19' ' ' VAL 0.295 1.7 mm? -100.42 -64.1 1.07 Allowed 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 123.402 1.572 . . . . 0.0 110.405 174.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.576 ' H ' ' HB ' ' A' ' 19' ' ' VAL . 18.4 m -127.08 -178.96 4.62 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 111.608 -2.542 . . . . 0.0 111.871 -162.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.451 ' H ' ' CG2' ' A' ' 104' ' ' THR . 12.8 p90 -160.77 131.6 5.42 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.999 1.72 . . . . 0.0 110.473 -172.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -107.22 162.19 14.1 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.295 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 p -90.22 170.5 10.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.571 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 111' ' ' MET . 6.7 p-10 -63.6 -30.83 71.88 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.789 0.836 . . . . 0.0 112.901 -173.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -69.32 -36.86 77.39 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.52 0.676 . . . . 0.0 110.157 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.528 ' O ' HG22 ' A' ' 114' ' ' VAL . 72.3 mmtt -78.28 -29.73 48.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.877 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.481 ' CE ' ' HA ' ' A' ' 111' ' ' MET . 0.2 OUTLIER -52.69 -42.61 64.95 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 124.122 0.969 . . . . 0.0 109.483 169.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.598 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 7.2 mmpt? -68.04 -46.74 70.32 Favored 'General case' 1 N--CA 1.377 -4.119 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.27 -34.19 76.89 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 118.661 -1.216 . . . . 0.0 111.761 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 110' ' ' LYS . 20.9 m -71.24 -45.3 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.276 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.36 -52.87 62.99 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.365 0.602 . . . . 0.0 110.153 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . 0.326 51.2 m-20 -60.86 -52.87 63.23 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.91 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.551 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -51.32 -39.8 57.71 Favored 'General case' 0 CA--C 1.461 -2.472 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.748 -174.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.695 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 1.6 tp -68.43 -46.09 70.8 Favored 'General case' 1 N--CA 1.362 -4.84 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.455 -179.24 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 43.4 mtp -64.81 -34.59 78.72 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 117' ' ' ALA . 56.4 mt -63.45 -52.7 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 175.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.6 t -53.91 -21.48 7.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.973 -1.921 . . . . 0.0 112.735 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 34.4 mt -111.36 -5.6 14.62 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.494 ' N ' ' HB3' ' B' ' 43' ' ' ASN . . . 76.63 23.97 68.76 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.399 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.434 ' HB3' ' SD ' ' B' ' 119' ' ' MET . 58.0 mt -83.02 -59.65 2.41 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.833 0.349 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -105.0 134.46 48.06 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -74.85 123.8 25.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 118.611 -1.235 . . . . 0.0 109.165 174.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.29 -5.98 28.51 Favored Glycine 0 C--N 1.301 -1.411 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.763 -176.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.29 165.23 12.49 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 121.574 0.702 . . . . 0.0 109.679 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 35.7 t -118.48 133.0 66.7 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.523 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.622 ' O ' HG22 ' B' ' 38' ' ' VAL . 39.6 m-85 -135.82 146.5 47.6 Favored 'General case' 0 C--O 1.188 -2.165 0 C-N-CA 124.857 1.263 . . . . 0.0 108.411 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 1.8 mp -74.32 148.94 40.91 Favored 'General case' 0 N--CA 1.407 -2.61 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.989 171.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -144.42 136.21 25.93 Favored 'General case' 0 C--N 1.264 -3.133 0 O-C-N 124.416 1.073 . . . . 0.0 110.163 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.87 94.4 3.33 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.082 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 9.5 mt -89.36 4.74 47.96 Favored 'General case' 0 C--O 1.199 -1.6 0 C-N-CA 124.6 1.16 . . . . 0.0 110.222 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.583 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 4.1 m -53.96 -177.11 0.04 OUTLIER Pre-proline 1 C--N 1.241 -4.132 0 C-N-CA 126.733 2.013 . . . . 0.0 112.564 173.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 20.17 35.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.405 3.549 1 C-N-CA 125.942 4.428 . . . . 0.0 119.414 -157.511 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.605 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 3.7 m -71.08 172.85 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.1 167.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . 0.4 ' NE2' ' HB2' ' A' ' 26' ' ' PRO . 33.0 mm-40 -112.27 135.61 52.73 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.75 -112.15 4.12 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 114.785 -1.098 . . . . 0.0 114.362 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -93.43 -0.43 56.48 Favored 'General case' 0 N--CA 1.417 -2.102 0 C-N-CA 123.405 0.682 . . . . 0.0 112.275 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.605 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 77.4 mt-10 -61.14 141.1 57.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.511 ' HG3' ' NH2' ' B' ' 36' ' ' ARG . 5.3 tp60 -116.05 112.81 22.31 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -169.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.404 ' CA ' ' HB3' ' B' ' 24' ' ' LEU . . . -127.95 -106.77 1.36 Allowed Glycine 1 N--CA 1.378 -5.208 0 C-N-CA 118.149 -1.977 . . . . 0.0 116.688 -177.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 74.48 175.44 34.09 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 107.663 -2.175 . . . . 0.0 107.663 -168.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 p -89.19 108.98 19.72 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.393 0 O-C-N 120.475 -1.603 . . . . 0.0 108.73 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . 0.511 ' NH2' ' HG3' ' B' ' 32' ' ' GLN . 65.1 mtm180 -137.76 157.72 72.94 Favored Pre-proline 0 C--N 1.281 -2.397 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.429 -174.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.3 Cg_exo -66.29 138.65 51.9 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.061 2.507 . . . . 0.0 111.902 173.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.622 HG22 ' O ' ' B' ' 20' ' ' TYR . 20.6 m -126.9 162.71 31.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 123.74 0.816 . . . . 0.0 110.074 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 27.1 m -104.57 134.28 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 31.9 mm -94.23 118.64 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 122.835 0.454 . . . . 0.0 110.054 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 -8.8 12.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.577 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.416 HE22 ' N ' ' B' ' 47' ' ' ASN . 6.3 pt20 -63.51 165.71 7.6 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 -167.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.494 ' HB3' ' N ' ' A' ' 123' ' ' GLY . 14.3 p-10 -77.46 -174.19 3.23 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 112.088 -2.324 . . . . 0.0 113.413 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' B' ' 47' ' ' ASN . 2.7 t70 -72.44 -47.4 49.24 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 112.837 -1.983 . . . . 0.0 113.909 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -86.65 -25.71 24.73 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -165.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' B' ' 50' ' ' SER . . . -70.75 -21.23 77.91 Favored Glycine 0 C--O 1.218 -0.889 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' B' ' 44' ' ' ASP . 39.1 t-20 -72.77 -32.04 65.32 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.703 -1.248 . . . . 0.0 108.259 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -91.64 -65.38 1.01 Allowed 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -100.15 -35.56 9.62 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -168.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.583 ' O ' ' HE2' ' B' ' 96' ' ' LYS . 14.6 t -76.93 132.23 71.62 Favored Pre-proline 0 N--CA 1.433 -1.323 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.551 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 62.3 Cg_endo -77.53 -11.12 17.25 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.792 1.661 . . . . 0.0 110.154 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 1.9 p -106.38 121.83 45.03 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.745 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 1.3 m -121.82 167.96 14.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' B' ' 92' ' ' ARG . 13.8 tt -109.2 125.24 66.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 123.695 0.798 . . . . 0.0 112.099 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.663 HG22 ' CD2' ' B' ' 94' ' ' LEU . 3.7 m -137.72 163.97 29.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.694 ' HA ' HG13 ' B' ' 91' ' ' ILE . . . -123.47 130.8 53.22 Favored 'General case' 0 N--CA 1.415 -2.176 0 O-C-N 123.387 0.429 . . . . 0.0 111.317 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.669 ' H ' HG21 ' B' ' 91' ' ' ILE . . . -65.04 132.69 49.88 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.559 HG12 HD12 ' B' ' 86' ' ' ILE . 57.6 mt -89.26 134.08 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 112.645 -2.07 . . . . 0.0 107.346 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -144.88 179.68 7.17 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.887 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.567 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.442 -0.865 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -69.35 9.79 0.49 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.135 1.89 . . . . 0.0 113.599 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 72.9 p -117.61 -7.85 11.0 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.079 0.466 . . . . 0.0 110.748 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . 0.587 ' CD2' HD22 ' B' ' 87' ' ' LEU . 61.9 m170 -123.23 129.34 51.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.428 HG23 HD11 ' B' ' 73' ' ' ILE . 32.9 m -122.19 139.72 48.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.541 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -97.11 130.6 44.36 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.698 0.761 . . . . 0.0 111.439 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.728 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -123.54 154.2 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.666 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -74.77 127.04 32.21 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.197 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -45.95 -44.76 15.09 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.173 1.389 . . . . 0.0 111.5 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -59.86 -45.31 92.86 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 126.392 1.877 . . . . 0.0 112.478 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -72.41 -35.19 68.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.93 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.728 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.8 m-85 -95.78 -6.02 40.57 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.704 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 57.06 31.68 20.36 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.439 1.096 . . . . 0.0 112.864 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' B' ' 78' ' ' TYR . 6.8 mp -87.8 -178.82 6.14 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.652 1.215 . . . . 0.0 112.844 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -75.51 -25.42 57.26 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.935 -1.939 . . . . 0.0 109.735 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -148.04 168.79 21.43 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -60.34 144.42 50.72 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.098 0.475 . . . . 0.0 109.826 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 8.0 m -103.25 136.79 42.37 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.61 -168.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -120.29 135.87 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.559 HD12 HG12 ' B' ' 58' ' ' ILE . 21.0 mm -114.89 138.1 46.23 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.834 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.587 HD22 ' CD2' ' B' ' 70' ' ' HIS . 31.4 mt -104.25 141.32 36.49 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' B' ' 118' ' ' LEU . 3.4 mm? -111.59 1.42 16.82 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-O 122.173 0.987 . . . . 0.0 111.296 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . 0.417 ' HA ' HH12 ' B' ' 92' ' ' ARG . 8.7 pt-20 -100.77 -33.44 10.25 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.021 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . 0.796 ' HB3' HD13 ' B' ' 91' ' ' ILE . 1.0 OUTLIER -81.24 -2.03 47.21 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.531 -171.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.796 HD13 ' HB3' ' B' ' 90' ' ' GLN . 0.0 OUTLIER -150.8 147.68 15.59 Favored 'Isoleucine or valine' 1 CA--C 1.418 -4.103 0 CA-C-O 117.6 -1.19 . . . . 0.0 112.429 -163.715 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.896 ' HB3' ' HB3' ' A' ' 92' ' ' ARG 0.273 41.2 mtm-85 179.83 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.752 1 N-CA-C 121.929 4.048 . . . . 0.0 121.929 -174.913 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.722 ' OG1' ' HB2' ' A' ' 92' ' ' ARG . 29.8 m -122.84 101.04 7.21 Favored 'General case' 0 N--CA 1.531 3.593 0 O-C-N 121.029 -1.044 . . . . 0.0 112.871 -171.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.663 ' CD2' HG22 ' B' ' 55' ' ' VAL . 0.1 OUTLIER -132.17 125.72 31.89 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.57 -173.155 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 11.0 t0 -56.94 147.47 23.71 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.439 0.696 . . . . 0.0 111.674 172.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.583 ' HE2' ' O ' ' B' ' 50' ' ' SER . 67.8 mttm -54.49 -33.0 58.99 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.455 1.102 . . . . 0.0 111.833 177.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.444 ' HZ3' ' CG ' ' B' ' 95' ' ' ASP . 44.9 mttp -62.26 -23.36 66.65 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.257 0.623 . . . . 0.0 111.192 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 32.9 mtp180 -78.13 -38.51 43.64 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.26 118.1 12.66 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 124.189 0.995 . . . . 0.0 111.121 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -97.41 -69.67 0.75 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.678 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.8 pt-20 -156.52 149.08 23.59 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.584 0.707 . . . . 0.0 112.476 -166.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 2.3 ptmt -67.71 124.74 24.11 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 127.449 2.3 . . . . 0.0 114.93 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.574 HD23 HG12 ' B' ' 19' ' ' VAL 0.287 2.0 mm? -102.27 -63.73 1.13 Allowed 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 123.389 1.566 . . . . 0.0 110.548 174.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.513 ' H ' ' HB ' ' B' ' 19' ' ' VAL . 22.8 m -131.13 -177.75 4.53 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 111.508 -2.587 . . . . 0.0 112.299 -161.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.42 ' H ' ' CG2' ' B' ' 104' ' ' THR . 13.7 p90 -160.93 132.57 5.7 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.502 1.521 . . . . 0.0 111.185 -171.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 pp -107.0 161.83 14.39 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.276 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 5.1 p -90.66 172.69 8.49 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.082 0.467 . . . . 0.0 111.857 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.39 -31.59 72.87 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.705 0.802 . . . . 0.0 112.644 -174.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -69.2 -35.68 76.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.558 0.695 . . . . 0.0 109.277 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.556 ' O ' HG22 ' B' ' 114' ' ' VAL . 73.3 mmtt -79.15 -30.27 43.51 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.178 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.492 ' HA ' ' HE3' ' B' ' 111' ' ' MET . 0.2 OUTLIER -52.23 -41.79 63.04 Favored 'General case' 0 N--CA 1.42 -1.96 0 O-C-N 124.142 0.902 . . . . 0.0 109.132 169.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' B' ' 112' ' ' LYS . 6.5 mmpt? -67.9 -47.57 68.41 Favored 'General case' 1 N--CA 1.375 -4.212 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -178.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -64.8 -38.23 90.28 Favored 'General case' 0 N--CA 1.41 -2.437 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.469 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . 0.556 HG22 ' O ' ' B' ' 110' ' ' LYS . 25.6 m -68.93 -46.58 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.651 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -57.33 -52.91 63.45 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.12 0.486 . . . . 0.0 110.421 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.358 86.2 m-20 -59.19 -54.29 48.55 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.004 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.411 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -56.22 -37.29 69.48 Favored 'General case' 0 CA--C 1.46 -2.512 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.072 -171.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.703 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.6 tp -66.22 -45.36 80.95 Favored 'General case' 1 N--CA 1.358 -5.042 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.846 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.434 ' SD ' ' HB3' ' A' ' 124' ' ' LEU . 47.0 mtp -66.15 -32.61 74.16 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' B' ' 117' ' ' ALA . 53.7 mt -64.49 -54.6 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.1 t -50.52 -22.59 2.02 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.184 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 31.5 mt -111.14 -4.65 14.96 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . 0.458 ' N ' ' HB3' ' A' ' 43' ' ' ASN . . . 75.1 23.28 74.76 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.449 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 52.4 mt -81.37 -58.62 2.96 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 CA--C 1.554 1.098 0 C-N-CA 127.118 2.167 . . . . 0.0 116.264 -179.667 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.8 mt . . . . . 0 C--O 1.242 0.662 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -108.69 151.01 26.75 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -71.2 124.11 23.74 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.65 -2.91 29.1 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.479 -1.343 . . . . 0.0 112.968 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -84.84 161.1 20.04 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.451 HG21 HG22 ' A' ' 104' ' ' THR . 78.4 t -121.92 108.01 21.14 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.655 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.85 174.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.2 m-85 -99.56 147.02 25.78 Favored 'General case' 0 C--N 1.255 -3.506 0 C-N-CA 124.809 1.244 . . . . 0.0 109.567 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.5 mp -83.08 146.67 28.56 Favored 'General case' 0 N--CA 1.382 -3.851 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.33 140.09 32.02 Favored 'General case' 0 C--N 1.256 -3.497 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.972 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -84.98 90.48 7.84 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.594 ' O ' HG13 ' A' ' 27' ' ' VAL . 51.3 mt -73.58 -21.67 60.27 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.966 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.589 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 4.4 m -32.91 174.46 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.738 0 C-N-CA 129.064 2.945 . . . . 0.0 115.684 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.66 ' HB2' HE22 ' B' ' 28' ' ' GLN . 0.0 OUTLIER 23.38 52.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.414 -3.199 0 C-N-CA 123.094 2.529 . . . . 0.0 114.555 -151.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -68.33 141.48 17.53 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 CA-C-N 112.385 -2.189 . . . . 0.0 110.026 171.093 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.604 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 84.8 mm-40 -89.84 120.16 30.84 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.965 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.19 -110.7 1.64 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.061 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' B' ' 95' ' ' ASP . 33.4 m -94.1 10.16 34.84 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 98.3 mt-10 -61.64 143.17 56.52 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.3 118.51 31.36 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.424 -169.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.05 -171.17 23.48 Favored Glycine 0 N--CA 1.414 -2.783 0 N-CA-C 120.093 2.797 . . . . 0.0 120.093 162.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.28 -152.58 6.9 Favored Glycine 0 C--N 1.264 -3.471 1 N-CA-C 102.349 -4.301 . . . . 0.0 102.349 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.1 113.22 15.93 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-N 121.125 2.462 . . . . 0.0 109.953 176.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -143.73 162.04 43.42 Favored Pre-proline 0 C--N 1.277 -2.569 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.195 -175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.557 ' HB2' HD12 ' A' ' 58' ' ' ILE . 19.9 Cg_exo -72.29 143.44 39.38 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.479 2.119 . . . . 0.0 111.5 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 28.6 m -128.69 160.09 39.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 124.197 0.999 . . . . 0.0 109.531 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.0 m -104.92 131.84 53.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.608 0.242 . . . . 0.0 110.553 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.403 HD13 HG12 ' A' ' 55' ' ' VAL . 24.3 mm -89.85 108.44 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.8 -18.34 7.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.701 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.667 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -52.81 156.84 1.84 Allowed 'General case' 0 C--O 1.245 0.846 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -171.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.429 ' HA ' ' HA3' ' B' ' 123' ' ' GLY . 13.1 p-10 -56.83 155.36 7.94 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-N 113.248 -1.796 . . . . 0.0 112.075 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.18 -27.44 62.57 Favored 'General case' 0 C--N 1.264 -3.112 0 CA-C-N 113.593 -1.64 . . . . 0.0 112.386 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.3 m -83.85 -37.18 22.79 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.29 -0.256 . . . . 0.0 111.102 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.01 -27.34 73.7 Favored Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.439 ' N ' HE22 ' A' ' 42' ' ' GLN . 94.8 m-20 -58.96 -33.66 70.89 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.127 0.489 . . . . 0.0 109.859 176.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.529 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 10.2 mmmm -93.22 -60.69 1.73 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.956 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.529 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 71.0 m-85 -93.83 -36.14 12.39 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -165.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.6 m -80.82 138.65 50.18 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.02 -17.9 40.72 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 121.899 1.733 . . . . 0.0 111.077 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 4.7 p -98.54 158.49 15.56 Favored 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 124.856 1.263 . . . . 0.0 111.498 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.634 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -152.51 138.87 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.196 0.598 . . . . 0.0 110.454 170.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.667 HG22 ' HG3' ' A' ' 42' ' ' GLN . 8.6 tt -83.69 135.06 25.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 CA-C-O 121.4 0.619 . . . . 0.0 110.476 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 32.8 m -139.27 156.26 27.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.481 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.534 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -115.79 139.33 50.28 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 138.45 43.78 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.585 HG12 HD12 ' A' ' 86' ' ' ILE . 64.1 mt -96.13 134.65 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 113.129 -1.85 . . . . 0.0 107.533 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.1 t -137.29 143.53 42.2 Favored 'General case' 0 N--CA 1.414 -2.27 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.591 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.372 0 N-CA-C 107.106 -2.398 . . . . 0.0 107.106 170.385 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 N--CA 1.434 -1.241 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -62.05 -10.93 19.44 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.647 2.231 . . . . 0.0 115.53 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.3 p -98.22 -16.38 19.46 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 48.1 m170 -113.1 128.7 56.56 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.91 125.7 70.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.372 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -91.7 118.63 30.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.51 0.672 . . . . 0.0 109.508 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.889 HG21 ' CE1' ' A' ' 78' ' ' TYR . 3.2 mm -96.09 158.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.607 -173.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.08 120.2 14.56 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 123.743 0.817 . . . . 0.0 110.221 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 85.6 tttt -46.67 -51.27 16.33 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 126.198 1.799 . . . . 0.0 111.575 176.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -56.93 -49.48 75.48 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 126.282 1.833 . . . . 0.0 112.111 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.445 ' HD3' ' OG ' ' A' ' 107' ' ' SER . 39.4 ttmt -69.22 -33.61 73.58 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.425 0.69 . . . . 0.0 110.535 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.889 ' CE1' HG21 ' A' ' 73' ' ' ILE . 3.2 m-85 -88.63 -11.19 46.1 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.617 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.4 tttm 67.22 24.63 9.13 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.433 0.693 . . . . 0.0 111.16 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 78' ' ' TYR . 7.2 mp -94.86 178.62 5.51 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-O 122.616 1.198 . . . . 0.0 112.44 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.413 ' O ' ' HE3' ' A' ' 75' ' ' LYS . 2.2 m-20 -73.54 -20.71 60.57 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 112.555 -2.111 . . . . 0.0 111.733 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 83' ' ' ASP . 11.6 ptmm? -158.48 169.97 23.25 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 9.9 p-10 -51.85 135.96 29.0 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 m -109.12 135.5 50.16 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.4 t -107.69 135.86 44.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.585 HD12 HG12 ' A' ' 58' ' ' ILE . 18.2 mm -112.19 135.39 51.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.0 mt -104.49 106.23 16.65 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -84.05 -5.61 59.26 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.687 -174.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -91.62 -39.56 11.81 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.986 174.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.05 79.32 4.07 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.325 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.534 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -114.73 -176.78 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -166.61 173.68 9.49 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.865 0.364 . . . . 0.0 111.57 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 67.5 m -123.34 124.32 42.69 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.2 mt -130.88 142.8 50.4 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.688 -171.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.9 p30 -74.56 152.39 39.32 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.352 174.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -47.54 -27.5 1.83 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.902 1.281 . . . . 0.0 114.31 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.3 -18.49 57.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 120.867 0.365 . . . . 0.0 111.433 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.21 -34.09 65.73 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.41 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 7.8 mp -76.63 126.16 30.49 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.248 1.419 . . . . 0.0 110.145 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -91.96 -67.33 0.86 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.744 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 14.6 pt-20 -153.25 152.88 31.67 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.518 -166.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.452 ' HE2' ' OH ' ' A' ' 20' ' ' TYR . 70.6 mttt -73.41 123.94 24.82 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.776 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.574 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 18.8 tp -109.38 -60.99 1.69 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 122.653 1.216 . . . . 0.0 108.438 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.574 ' OG1' ' HG ' ' A' ' 103' ' ' LEU . 2.3 m -127.36 178.72 5.87 Favored 'General case' 0 N--CA 1.381 -3.879 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.227 -166.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -160.45 139.69 10.72 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 125.121 1.368 . . . . 0.0 109.903 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 pp -115.05 161.59 18.15 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.252 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.445 ' OG ' ' HD3' ' A' ' 77' ' ' LYS . 34.3 p -88.12 172.66 9.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.174 0.512 . . . . 0.0 111.628 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 111' ' ' MET . 28.3 t70 -66.14 -30.35 70.81 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.112 0.565 . . . . 0.0 111.855 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -69.47 -30.61 68.53 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 114' ' ' VAL . 14.4 tppt? -77.65 -30.11 51.99 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.585 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -49.04 -47.12 45.01 Favored 'General case' 0 CA--C 1.48 -1.738 0 O-C-N 123.896 0.747 . . . . 0.0 110.75 171.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.754 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -65.64 -34.58 78.56 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.807 -178.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.84 -41.68 59.4 Favored 'General case' 0 N--CA 1.4 -2.944 0 C-N-CA 118.176 -1.41 . . . . 0.0 112.121 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 110' ' ' LYS . 19.7 m -67.16 -45.35 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 118.921 -0.561 . . . . 0.0 112.103 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -54.28 -51.69 63.78 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 123.2 1.476 . . . . 0.0 109.397 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.754 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -76.31 -30.58 57.76 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 112.998 -1.91 . . . . 0.0 115.031 -172.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.502 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -70.68 -41.9 71.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 1.9 tp -62.33 -44.19 97.08 Favored 'General case' 0 N--CA 1.394 -3.237 0 C-N-CA 125.479 1.511 . . . . 0.0 108.741 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.646 ' CG ' ' HA ' ' A' ' 125' ' ' ASN . 21.2 ttm -48.61 -37.46 18.22 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.5 mt -82.5 -50.12 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.665 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.5 m -48.81 -35.56 14.75 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.02 -1.9 . . . . 0.0 112.722 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.553 HD22 HG21 ' B' ' 54' ' ' ILE . 23.1 mt -103.19 -3.03 26.32 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 120.055 -0.658 . . . . 0.0 112.028 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' B' ' 43' ' ' ASN . . . 76.34 29.52 58.17 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 117.359 1.704 . . . . 0.0 117.359 172.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.645 HD11 HD11 ' B' ' 124' ' ' LEU . 0.2 OUTLIER -100.05 -46.02 5.47 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 118.947 1.373 . . . . 0.0 111.897 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.646 ' HA ' ' CG ' ' A' ' 119' ' ' MET . 1.6 t-20 . . . . . 0 C--N 1.296 -1.737 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.087 -168.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -108.88 145.71 34.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -66.23 125.98 27.27 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.65 -5.81 31.25 Favored Glycine 0 N--CA 1.426 -1.974 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.694 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -83.4 162.97 20.85 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.482 HG21 HG22 ' B' ' 104' ' ' THR . 75.1 t -122.53 110.14 26.02 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.766 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.732 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 30.3 m-85 -101.44 146.3 27.8 Favored 'General case' 0 C--N 1.26 -3.32 0 C-N-CA 124.875 1.27 . . . . 0.0 109.779 176.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 3.8 mp -81.13 146.14 30.7 Favored 'General case' 0 N--CA 1.388 -3.569 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 166.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.33 141.11 33.88 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.931 -173.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -85.58 89.19 7.65 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.616 ' O ' HG13 ' B' ' 27' ' ' VAL . 56.9 mt -73.03 -22.09 60.7 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.073 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.603 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 3.8 m -33.14 175.02 0.0 OUTLIER Pre-proline 0 CA--C 1.573 1.859 0 C-N-CA 129.433 3.093 . . . . 0.0 115.603 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.604 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 0.0 OUTLIER 23.8 50.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.119 0 C-N-CA 123.205 2.603 . . . . 0.0 114.998 -152.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.616 HG13 ' O ' ' B' ' 24' ' ' LEU . 0.5 OUTLIER -68.18 143.09 15.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.107 172.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . 0.66 HE22 ' HB2' ' A' ' 26' ' ' PRO . 82.8 mm-40 -89.72 118.86 29.63 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.942 -1.481 . . . . 0.0 112.301 -173.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.3 -108.72 1.4 Allowed Glycine 0 C--N 1.309 -0.935 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.584 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 43.9 m -94.71 8.67 41.69 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.583 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 98.8 mt-10 -61.56 142.59 56.99 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 173.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.84 117.65 30.38 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 122.374 -0.204 . . . . 0.0 111.351 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.36 -173.85 22.54 Favored Glycine 0 N--CA 1.412 -2.942 0 N-CA-C 120.327 2.891 . . . . 0.0 120.327 163.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.28 -151.87 6.42 Favored Glycine 0 C--N 1.264 -3.459 1 N-CA-C 102.124 -4.391 . . . . 0.0 102.124 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.49 114.96 18.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-N 120.997 2.399 . . . . 0.0 109.867 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -145.21 161.6 41.2 Favored Pre-proline 0 C--N 1.284 -2.271 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.113 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 21.2 Cg_exo -71.91 143.15 40.35 Favored 'Trans proline' 0 CA--C 1.551 1.366 0 C-N-CA 122.599 2.199 . . . . 0.0 111.86 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 29.7 m -127.91 159.64 38.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 124.129 0.971 . . . . 0.0 109.754 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.1 m -103.76 132.56 49.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 CA-C-O 120.642 0.258 . . . . 0.0 110.357 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.4 HD13 HG12 ' B' ' 55' ' ' VAL . 24.4 mm -91.04 107.13 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.86 -18.89 6.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.89 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.649 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -52.14 157.24 1.4 Allowed 'General case' 0 C--O 1.245 0.845 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -170.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 10.9 p-10 -56.88 158.17 5.03 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 113.182 -1.826 . . . . 0.0 112.325 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.49 -28.76 62.1 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 113.615 -1.629 . . . . 0.0 112.096 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 56.9 m -85.2 -35.24 21.76 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.175 -0.328 . . . . 0.0 111.764 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.421 ' C ' HE22 ' B' ' 42' ' ' GLN . . . -68.5 -26.2 74.48 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.459 ' N ' HE22 ' B' ' 42' ' ' GLN . 94.6 m-20 -60.39 -32.74 71.6 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.12 0.486 . . . . 0.0 109.845 176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.535 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 11.0 mmmm -93.1 -63.35 1.23 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.136 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.535 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 67.6 m-85 -91.89 -35.82 13.83 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -166.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 45.5 m -82.06 138.49 45.97 Favored Pre-proline 0 C--N 1.308 -1.212 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.66 -18.74 37.3 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 121.927 1.752 . . . . 0.0 111.178 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 3.0 p -98.81 155.64 17.26 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 124.781 1.232 . . . . 0.0 111.269 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.619 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -150.25 138.75 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 O-C-N 123.585 0.553 . . . . 0.0 110.387 171.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.649 HG22 ' HG3' ' B' ' 42' ' ' GLN . 8.8 tt -83.45 134.02 27.85 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 CA-C-O 121.46 0.647 . . . . 0.0 110.576 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 32.3 m -138.47 155.25 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.494 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.531 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -115.26 139.54 49.87 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.09 138.43 43.94 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.576 HG12 HD12 ' B' ' 86' ' ' ILE . 61.2 mt -96.14 134.48 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.285 -1.78 . . . . 0.0 107.422 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -137.46 141.42 41.58 Favored 'General case' 0 N--CA 1.405 -2.718 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.87 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.455 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 169.296 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 7.9 tt . . . . . 0 N--CA 1.431 -1.382 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.21 -5.84 7.23 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.797 2.331 . . . . 0.0 115.538 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 80.6 p -102.05 -16.19 16.52 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.334 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . 0.43 ' CD2' HD22 ' B' ' 87' ' ' LEU . 46.4 m170 -112.34 128.5 56.3 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -126.57 126.3 68.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.76 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -92.6 123.35 35.83 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.556 0.693 . . . . 0.0 109.373 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.871 HG21 ' CE1' ' B' ' 78' ' ' TYR . 2.8 mm -100.77 155.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.946 -173.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.433 ' CD ' ' HZ1' ' B' ' 110' ' ' LYS . 2.4 mp0 -64.73 119.98 11.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 123.996 0.918 . . . . 0.0 110.527 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . 0.496 ' HE3' ' O ' ' B' ' 81' ' ' ASP . 85.7 tttt -48.2 -49.08 34.23 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 126.504 1.922 . . . . 0.0 111.408 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -60.6 -45.85 92.44 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 125.871 1.668 . . . . 0.0 111.76 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -72.27 -33.78 67.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.71 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.871 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.2 m-85 -87.83 -11.1 48.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.247 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 66.44 26.34 10.09 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 121.748 0.785 . . . . 0.0 111.07 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' B' ' 78' ' ' TYR . 6.8 mp -95.09 -178.76 4.58 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-O 122.448 1.118 . . . . 0.0 112.658 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.496 ' O ' ' HE3' ' B' ' 75' ' ' LYS . 4.9 m-20 -70.57 -28.64 65.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.104 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -154.04 171.21 19.45 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -53.69 135.66 40.68 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 7.1 m -109.44 135.49 50.39 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 t -107.73 136.55 42.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.576 HD12 HG12 ' B' ' 58' ' ' ILE . 13.7 mm -113.78 135.36 53.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' B' ' 70' ' ' HIS . 44.5 mt -104.78 104.88 14.74 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.28 -7.41 59.63 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.594 -174.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -90.99 -38.49 12.8 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.1 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.26 77.73 3.46 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.26 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.531 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.4 pp -113.45 -176.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.401 ' NH1' HG12 ' B' ' 27' ' ' VAL . 14.1 ptm180 -166.47 174.06 9.3 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 123.329 0.393 . . . . 0.0 111.55 172.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 68.8 m -123.63 124.62 43.18 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 74.7 mt -131.28 142.98 50.21 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.8 -171.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 3.9 p-10 -74.95 152.66 38.79 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.412 174.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -46.04 -30.0 1.69 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.019 1.328 . . . . 0.0 114.222 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.05 -19.75 60.52 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 120.945 0.402 . . . . 0.0 111.289 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -72.32 -34.11 67.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.417 ' HB3' ' CD2' ' B' ' 20' ' ' TYR . 7.8 mp -77.17 125.76 29.85 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.147 1.379 . . . . 0.0 110.174 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -93.3 -64.72 1.06 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.37 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -155.06 151.1 27.97 Favored 'General case' 0 N--CA 1.407 -2.587 0 CA-C-O 121.632 0.73 . . . . 0.0 111.283 -169.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . 0.473 ' HE2' ' OH ' ' B' ' 20' ' ' TYR . 67.2 mttt -70.85 126.19 28.91 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.755 174.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.506 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 18.8 tp -112.14 -62.02 1.63 Allowed 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.731 1.253 . . . . 0.0 108.657 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.506 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 1.6 m -125.98 178.44 5.75 Favored 'General case' 0 N--CA 1.383 -3.823 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.356 -166.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -160.74 137.7 8.97 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.825 1.25 . . . . 0.0 109.991 -170.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -110.98 164.0 13.25 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.748 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -91.96 171.56 9.04 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.548 0.213 . . . . 0.0 111.177 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' B' ' 111' ' ' MET . 27.6 t70 -62.75 -28.69 70.14 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.232 0.539 . . . . 0.0 111.39 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -70.11 -29.11 65.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.837 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.509 ' O ' HG22 ' B' ' 114' ' ' VAL . 14.1 tppt? -81.16 -29.26 34.74 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.812 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.486 ' HA ' ' CE ' ' B' ' 111' ' ' MET . 0.1 OUTLIER -47.81 -43.5 27.92 Favored 'General case' 0 CA--C 1.445 -3.078 0 O-C-N 124.173 0.921 . . . . 0.0 109.964 170.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.518 ' HE2' ' N ' ' B' ' 112' ' ' LYS . 6.9 mmpt? -61.15 -54.02 49.66 Favored 'General case' 1 N--CA 1.37 -4.451 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.675 -178.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -62.41 -43.88 97.76 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.092 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . 0.509 HG22 ' O ' ' B' ' 110' ' ' LYS . 20.6 m -63.21 -43.14 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 123.67 0.606 . . . . 0.0 111.814 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -56.5 -54.85 40.96 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 123.479 0.487 . . . . 0.0 111.08 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' B' ' 119' ' ' MET 0.273 17.3 m-80 -61.7 -45.26 94.74 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.242 0.544 . . . . 0.0 110.252 -177.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.54 -43.86 97.77 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.003 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.602 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.6 tp -63.03 -46.59 86.86 Favored 'General case' 0 N--CA 1.387 -3.612 0 C-N-CA 124.287 1.035 . . . . 0.0 108.338 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.74 ' SD ' ' HA ' ' B' ' 125' ' ' ASN . 15.4 ttm -49.63 -44.08 47.15 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 29.9 mt -72.34 -50.87 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 45.8 m -49.79 -34.07 18.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.485 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 22.3 mt -102.8 -4.19 25.29 Favored 'General case' 0 C--O 1.198 -1.627 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.116 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 43' ' ' ASN . . . 76.78 30.76 55.6 Favored Glycine 0 C--N 1.341 0.848 0 N-CA-C 117.469 1.747 . . . . 0.0 117.469 172.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.645 HD11 HD11 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -101.89 -47.27 4.64 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.696 1.248 . . . . 0.0 112.511 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.74 ' HA ' ' SD ' ' B' ' 119' ' ' MET 0.345 14.1 m120 . . . . . 0 C--N 1.302 -1.476 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.528 -167.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.5 mt . . . . . 0 N--CA 1.419 -1.985 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -146.77 160.72 41.9 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -77.64 122.11 24.87 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.533 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.432 ' HA2' ' SD ' ' A' ' 111' ' ' MET . . . 142.8 -30.63 2.04 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 119.395 -1.383 . . . . 0.0 113.996 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -100.43 173.87 6.37 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 118.075 0.937 . . . . 0.0 111.658 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 105' ' ' TYR . 54.0 t -110.98 138.71 38.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.836 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 92.2 m-85 -137.32 147.11 45.37 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 126.26 1.824 . . . . 0.0 108.731 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.2 mp -86.57 157.38 19.75 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 171.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.7 146.6 32.29 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.865 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -82.46 108.77 16.12 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.643 0.735 . . . . 0.0 109.63 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.606 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 15.4 mt -108.91 28.26 8.64 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 123.698 1.713 . . . . 0.0 109.073 -175.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.671 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 15.1 m -73.55 -178.62 0.75 Allowed Pre-proline 1 C--N 1.213 -5.358 0 CA-C-N 112.732 -2.031 . . . . 0.0 108.714 169.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.1 OUTLIER 17.23 42.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.148 0 C-N-CA 124.976 3.784 . . . . 0.0 118.016 -159.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 24' ' ' LEU . 5.2 m -70.2 174.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.054 0 CA-C-O 122.328 1.061 . . . . 0.0 112.234 172.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -92.49 110.56 21.97 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.005 -1.452 . . . . 0.0 114.198 -174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.65 -108.69 0.75 Allowed Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 113.918 -1.492 . . . . 0.0 114.784 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.7 m -86.58 13.85 7.85 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 36.0 mt-10 -67.4 -175.29 0.47 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.887 0.851 . . . . 0.0 112.063 173.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.594 ' NE2' ' HG3' ' A' ' 36' ' ' ARG . 12.1 tm0? -106.47 126.59 52.45 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -111.54 163.65 12.2 Favored Glycine 0 CA--C 1.498 -0.989 0 N-CA-C 116.871 1.508 . . . . 0.0 116.871 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.8 171.64 18.96 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 113.614 -1.293 . . . . 0.0 110.51 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.53 102.08 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.669 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.594 ' HG3' ' NE2' ' A' ' 32' ' ' GLN . 26.0 mmt180 -128.55 151.91 77.58 Favored Pre-proline 0 C--N 1.251 -3.715 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.88 -174.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 23.4 Cg_exo -65.46 144.92 81.32 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.839 2.359 . . . . 0.0 112.54 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 30.1 m -129.23 154.97 40.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.619 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 29.7 m -99.32 128.69 50.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.496 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.5 mm -92.24 106.44 17.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.06 -6.57 10.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.817 0.817 . . . . 0.0 109.085 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.593 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -51.15 146.64 6.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 125.853 1.661 . . . . 0.0 113.946 -170.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -60.95 -179.01 0.11 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.098 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 19.0 t70 -77.27 -48.54 17.2 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.151 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -70.25 -28.58 65.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.542 -171.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.01 -28.15 73.7 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.525 ' N ' HE22 ' A' ' 42' ' ' GLN . 87.0 m-20 -75.84 -37.59 58.88 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.278 0.561 . . . . 0.0 110.174 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 49' ' ' TYR . 49.8 mmtt -79.31 -61.6 1.95 Allowed 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.257 -176.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 55.7 m-85 -111.24 6.6 20.71 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -167.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 22.7 t -119.84 141.6 31.59 Favored Pre-proline 0 C--N 1.306 -1.298 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.314 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 10.2 Cg_exo -74.17 -23.34 15.83 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.073 1.848 . . . . 0.0 110.366 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -85.17 154.71 21.82 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.813 -175.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.46 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 57.9 t -138.4 140.07 40.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.713 HD11 HD13 ' A' ' 91' ' ' ILE . 3.8 tp -99.08 125.56 52.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 171.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 21.6 m -132.68 166.54 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.743 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.583 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -124.88 141.19 52.28 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.53 130.76 42.06 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.622 HG12 HD12 ' A' ' 86' ' ' ILE . 56.1 mt -90.13 120.42 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.085 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.9 m -119.3 155.47 31.76 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.004 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 175.224 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 tt . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.71 -1.1 4.47 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.198 2.599 . . . . 0.0 115.869 -175.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.1 p -91.32 -18.74 23.83 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-O 121.728 0.775 . . . . 0.0 109.432 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -101.5 129.26 47.53 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.18 127.81 69.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 84' ' ' SER . 12.8 pt-20 -99.08 131.08 45.38 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.088 0.47 . . . . 0.0 110.472 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.508 HD11 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -124.78 145.99 31.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.47 123.91 13.38 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 126.304 1.842 . . . . 0.0 113.332 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -58.67 -39.4 80.54 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.702 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 51.2 pttt -61.48 -27.76 68.8 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.974 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -91.43 -35.47 14.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.103 0.954 . . . . 0.0 109.549 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.401 ' OH ' HD23 ' A' ' 106' ' ' LEU . 32.9 m-85 -96.16 13.41 27.42 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.366 -171.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt 59.7 39.29 21.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.566 1.146 . . . . 0.0 114.064 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.86 174.31 7.62 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.792 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.0 -16.25 26.77 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.076 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -133.34 152.06 51.9 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.11 157.17 37.39 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.902 0.382 . . . . 0.0 110.308 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 72' ' ' GLU . 21.3 t -103.41 151.79 22.36 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.388 -172.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.37 124.32 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.622 HD12 HG12 ' A' ' 58' ' ' ILE . 20.1 mm -100.95 130.36 50.45 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.662 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 76.6 mt -102.59 102.91 13.18 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -82.58 6.29 18.13 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.901 -174.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.16 -38.31 6.31 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.285 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.412 ' HA ' HG21 ' B' ' 93' ' ' THR . 4.6 tp60 -83.82 69.33 10.21 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.826 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 54' ' ' ILE . 2.1 pp -111.44 -179.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.723 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.446 ' O ' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -167.28 165.31 15.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.2 m -118.19 118.73 32.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.1 mt -131.69 138.51 48.72 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.8 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 4.5 p-10 -73.91 152.1 40.24 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.015 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -47.69 -20.52 0.28 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.825 1.65 . . . . 0.0 115.197 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -71.39 -26.36 62.74 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.91 0.884 . . . . 0.0 110.735 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -74.26 -34.5 63.61 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.205 0.526 . . . . 0.0 110.212 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.52 124.98 26.32 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.657 1.183 . . . . 0.0 109.973 176.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -101.93 -60.17 1.58 Allowed 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -147.88 138.61 23.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.716 0.77 . . . . 0.0 112.719 -166.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 28.9 tttp -66.1 116.14 6.88 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 127.673 2.389 . . . . 0.0 107.414 174.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -110.16 -60.23 1.83 Allowed 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.76 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.414 ' CG2' HG21 ' A' ' 19' ' ' VAL . 10.6 t -127.64 -157.41 0.81 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.637 ' O ' HG23 ' A' ' 19' ' ' VAL . 38.0 m-85 -123.48 -89.0 0.6 Allowed 'General case' 0 C--O 1.177 -2.763 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.573 -172.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 1.5 mt 139.75 151.97 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 131.358 3.863 . . . . 0.0 105.484 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 79.0 p -97.59 154.49 17.5 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.746 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.511 ' O ' ' HD2' ' A' ' 112' ' ' LYS . 4.9 m-20 -58.54 -36.96 74.7 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 18.4 p-10 -76.74 -41.52 44.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.396 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -67.64 -25.63 65.83 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.544 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.465 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -53.71 -42.28 67.86 Favored 'General case' 0 N--CA 1.416 -2.146 0 C-N-CA 124.122 0.969 . . . . 0.0 110.421 171.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.672 ' HE2' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -71.25 -25.44 62.47 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.367 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.606 ' HA ' ' ND2' ' A' ' 116' ' ' ASN . 10.6 mt-10 -87.08 -35.19 18.85 Favored 'General case' 0 N--CA 1.394 -3.227 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.762 -171.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.75 -47.04 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.016 0 CA-C-N 112.856 -1.975 . . . . 0.0 108.501 169.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 68.5 m-20 -58.39 -52.82 63.98 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.129 0.49 . . . . 0.0 111.054 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.606 ' ND2' ' HA ' ' A' ' 113' ' ' GLU . 3.8 p30 -64.85 -42.96 94.47 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.109 -0.637 . . . . 0.0 111.743 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.519 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.32 -38.21 71.0 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.22 0.534 . . . . 0.0 109.903 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 8.9 tp -69.94 -46.27 65.66 Favored 'General case' 0 N--CA 1.392 -3.374 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.921 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.516 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 3.1 ttp -68.06 -23.48 64.96 Favored 'General case' 0 N--CA 1.408 -2.566 0 C-N-CA 124.161 0.984 . . . . 0.0 110.298 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 116' ' ' ASN . 49.7 mt -79.9 -54.47 11.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 174.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.5 t -47.71 -44.79 28.03 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 125.787 1.635 . . . . 0.0 112.584 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.458 ' HG ' HG12 ' B' ' 54' ' ' ILE . 9.7 mp -82.85 10.65 7.3 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.86 85.17 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.516 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.3 mm? -67.74 -63.48 1.05 Allowed 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 118.106 0.953 . . . . 0.0 109.121 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 C--N 1.305 -1.359 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.244 -173.281 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.426 -1.659 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -146.03 160.45 41.86 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -76.22 125.81 29.84 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.476 ' HA2' ' SD ' ' B' ' 111' ' ' MET . . . 140.12 -34.49 2.0 Allowed Glycine 0 N--CA 1.425 -2.081 0 C-N-CA 119.507 -1.33 . . . . 0.0 113.617 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -100.11 174.21 6.27 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 118.078 0.939 . . . . 0.0 111.992 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 105' ' ' TYR . 53.5 t -110.36 139.42 33.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.115 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 89.7 m-85 -137.57 147.67 45.28 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 126.072 1.749 . . . . 0.0 109.191 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.535 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.0 mp -88.16 156.33 19.3 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.19 147.64 32.67 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.956 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -82.61 107.66 15.42 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.205 1.003 . . . . 0.0 110.346 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.677 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 10.8 mt -108.9 28.01 8.9 Favored 'General case' 0 CA--C 1.484 -1.578 0 CA-C-O 123.451 1.596 . . . . 0.0 109.206 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.666 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 15.3 m -76.45 -178.62 0.97 Allowed Pre-proline 1 C--N 1.216 -5.223 0 CA-C-N 112.785 -2.007 . . . . 0.0 107.759 170.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.666 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 17.1 43.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.393 2.873 1 C-N-CA 125.396 4.064 . . . . 0.0 118.029 -160.374 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.495 HG13 ' O ' ' B' ' 24' ' ' LEU . 4.9 m -70.4 177.93 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.972 0 CA-C-O 122.171 0.986 . . . . 0.0 112.154 172.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -94.05 116.3 28.71 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.59 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.97 -108.65 0.77 Allowed Glycine 0 CA--C 1.499 -0.91 0 CA-C-N 114.622 -1.172 . . . . 0.0 114.966 172.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 10.3 m -90.97 10.55 26.08 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.544 -0.828 . . . . 0.0 113.06 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.483 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 34.9 mt-10 -62.82 -179.97 0.32 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.868 0.842 . . . . 0.0 112.777 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.596 ' NE2' ' HG3' ' B' ' 36' ' ' ARG . 0.0 OUTLIER -100.2 121.71 41.88 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.677 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -106.01 155.0 16.88 Favored Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.88 176.63 15.52 Favored Glycine 0 C--N 1.307 -1.08 0 CA-C-N 113.383 -1.409 . . . . 0.0 110.19 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.97 99.67 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . 0.596 ' HG3' ' NE2' ' B' ' 32' ' ' GLN . 29.5 mmt180 -126.52 150.96 72.14 Favored Pre-proline 0 C--N 1.245 -3.974 0 CA-C-N 113.822 -1.536 . . . . 0.0 111.02 -172.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 25.1 Cg_exo -64.92 144.99 84.75 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 122.439 2.093 . . . . 0.0 112.208 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 31.0 m -129.15 155.23 41.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.453 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.582 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 30.7 m -99.87 129.01 51.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 21.7 mm -92.37 107.07 18.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.31 -7.52 10.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.679 0.752 . . . . 0.0 109.129 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.576 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.6 OUTLIER -49.82 148.68 2.97 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 126.099 1.759 . . . . 0.0 113.951 -170.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -61.83 -178.41 0.15 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.898 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' B' ' 48' ' ' LYS . 15.9 t70 -80.04 -47.56 14.7 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.483 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.6 m -69.97 -30.97 68.45 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.749 -172.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.23 -27.29 72.21 Favored Glycine 0 C--O 1.214 -1.129 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.537 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.516 ' N ' HE22 ' B' ' 42' ' ' GLN . 79.6 m-20 -78.37 -35.28 47.55 Favored 'General case' 0 CA--C 1.491 -1.318 0 O-C-N 122.554 -0.38 . . . . 0.0 110.586 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' B' ' 44' ' ' ASP . 51.7 mmtt -78.27 -60.83 2.21 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.358 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.436 ' CD2' ' HB2' ' B' ' 48' ' ' LYS . 69.1 m-85 -107.67 -11.07 15.5 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -167.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 19.1 t -106.14 143.03 26.11 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 121.711 -0.618 . . . . 0.0 109.515 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -75.79 -22.36 13.55 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.146 1.897 . . . . 0.0 110.323 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 0.8 OUTLIER -84.91 152.16 23.73 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.6 -175.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.478 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 58.9 t -136.47 140.05 44.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.706 HD11 HD13 ' B' ' 91' ' ' ILE . 4.1 tp -99.27 124.39 52.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 171.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 22.1 m -132.19 166.04 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.817 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.582 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -124.09 141.36 52.12 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.1 129.06 37.6 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.611 HG12 HD12 ' B' ' 86' ' ' ILE . 53.7 mt -87.61 123.02 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.915 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 25.8 m -120.42 159.6 24.77 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.389 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 176.97 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.2 tt . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -66.54 7.89 0.36 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 123.346 2.698 . . . . 0.0 115.704 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 74.8 p -98.37 -18.83 18.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.899 0.857 . . . . 0.0 108.738 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -101.25 129.41 47.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.57 130.34 70.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' B' ' 84' ' ' SER . 12.1 pt-20 -101.23 130.69 47.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.927 0.394 . . . . 0.0 110.179 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.517 HD11 HG12 ' B' ' 86' ' ' ILE . 0.0 OUTLIER -124.04 147.75 28.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.94 125.42 20.26 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 125.252 1.421 . . . . 0.0 113.287 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -61.96 -38.45 88.55 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.754 0.787 . . . . 0.0 111.234 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -61.75 -27.35 68.67 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.903 -1.499 . . . . 0.0 112.991 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -90.67 -37.1 13.97 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.976 0.893 . . . . 0.0 109.406 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.42 ' OH ' HD23 ' B' ' 106' ' ' LEU . 31.2 m-85 -94.3 12.4 27.03 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.372 -171.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt 61.0 38.43 17.36 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.549 1.139 . . . . 0.0 113.724 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 22.2 mt -123.36 174.53 7.28 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.528 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.95 -11.81 26.03 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.062 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -136.05 149.89 48.96 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -68.26 156.07 38.42 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.464 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' B' ' 72' ' ' GLU . 19.7 t -103.07 149.89 24.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.365 -171.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 41.4 t -123.58 124.81 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.288 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.611 HD12 HG12 ' B' ' 58' ' ' ILE . 19.4 mm -101.14 130.86 49.91 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.515 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 76.5 mt -102.76 102.52 12.68 Favored 'General case' 0 N--CA 1.406 -2.653 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.8 mm? -81.7 2.5 29.46 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.793 -174.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -101.79 -39.19 7.52 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.204 173.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -83.53 68.93 9.97 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.277 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.706 HD13 HD11 ' B' ' 54' ' ' ILE . 2.1 pp -110.23 -179.15 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.767 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.575 ' NH1' HD22 ' B' ' 24' ' ' LEU . 0.0 OUTLIER -167.25 165.03 15.47 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 90' ' ' GLN . 50.1 m -117.8 118.66 32.64 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 62.0 mt -131.54 138.61 48.98 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.83 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 4.2 p-10 -73.87 151.82 40.37 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 118.901 -1.12 . . . . 0.0 109.825 173.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -48.28 -20.98 0.44 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.83 1.652 . . . . 0.0 114.983 -175.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -72.91 -23.87 60.76 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.458 0.703 . . . . 0.0 110.575 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -74.32 -33.49 63.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.343 0.592 . . . . 0.0 109.867 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.25 122.8 23.41 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.39 1.076 . . . . 0.0 110.73 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -99.5 -62.13 1.28 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.4 pt-20 -143.42 148.7 36.55 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 122.054 0.931 . . . . 0.0 112.551 -167.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -79.3 111.34 15.45 Favored 'General case' 0 C--N 1.276 -2.596 0 C-N-CA 127.769 2.428 . . . . 0.0 107.89 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -105.65 -61.94 1.43 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.357 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.443 ' CG2' HG21 ' B' ' 19' ' ' VAL . 8.3 t -125.44 -159.21 0.88 Allowed 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.577 ' O ' HG23 ' B' ' 19' ' ' VAL . 37.9 m-85 -122.73 -87.39 0.64 Allowed 'General case' 0 C--O 1.176 -2.796 0 C-N-CA 118.387 -1.325 . . . . 0.0 112.445 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' B' ' 17' ' ' GLY . 1.5 mt 137.78 155.22 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 130.962 3.705 . . . . 0.0 106.035 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 88.2 p -100.88 155.65 17.82 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.33 -0.948 . . . . 0.0 108.709 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' B' ' 111' ' ' MET . 12.9 m-20 -58.29 -40.34 81.7 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -74.23 -39.07 63.33 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.72 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -70.67 -24.96 62.78 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.433 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -54.08 -41.98 68.81 Favored 'General case' 0 N--CA 1.413 -2.283 0 C-N-CA 123.742 0.817 . . . . 0.0 110.256 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.705 ' HE2' ' N ' ' B' ' 112' ' ' LYS . 0.6 OUTLIER -70.69 -23.98 62.58 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.285 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . 0.648 ' HA ' ' ND2' ' B' ' 116' ' ' ASN 0.263 18.5 mt-10 -86.82 -37.63 17.6 Favored 'General case' 0 N--CA 1.387 -3.587 0 C-N-CA 118.363 -1.335 . . . . 0.0 110.533 -173.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.34 -46.58 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.282 0 CA-C-N 112.79 -2.004 . . . . 0.0 108.675 169.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 66.4 m-20 -60.34 -53.56 56.22 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 111.186 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.648 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 4.0 p30 -66.36 -40.58 89.87 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.256 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.464 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -59.9 -35.38 74.74 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 121.217 0.532 . . . . 0.0 109.579 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 8.9 tp -71.05 -45.92 62.96 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.38 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.511 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 3.0 ttp -67.23 -25.14 65.94 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.333 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.515 HG13 ' O ' ' B' ' 116' ' ' ASN . 45.7 mt -80.1 -53.35 13.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 33.8 t -47.65 -45.68 28.17 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.043 1.337 . . . . 0.0 112.248 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.502 ' HG ' HG12 ' A' ' 54' ' ' ILE . 9.6 mp -81.93 10.56 6.23 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.64 9.34 83.31 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 170.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.511 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.4 mm? -72.49 -62.08 1.57 Allowed 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 118.284 1.042 . . . . 0.0 108.884 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--N 1.303 -1.43 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.857 -173.529 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.465 HD12 ' NZ ' ' A' ' 96' ' ' LYS . 59.8 mt . . . . . 0 N--CA 1.424 -1.734 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -144.4 160.62 40.74 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.549 ' HD3' ' O ' ' A' ' 41' ' ' ILE . 49.8 ttp180 -72.8 113.55 9.97 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.711 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 144.78 -27.88 1.9 Allowed Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.069 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.97 138.49 35.21 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 121.25 0.547 . . . . 0.0 111.045 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 104' ' ' THR . 62.8 t -89.89 121.14 39.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.706 174.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 23.0 m-85 -110.9 145.87 37.53 Favored 'General case' 0 C--N 1.264 -3.122 0 C-N-CA 124.135 0.974 . . . . 0.0 109.892 173.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.9 mp -84.34 151.45 24.72 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.5 154.7 36.02 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-O 121.794 0.807 . . . . 0.0 111.395 -173.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 98' ' ' ARG . 22.2 t70 -88.99 95.14 10.2 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.556 HD23 ' HD2' ' A' ' 92' ' ' ARG 0.259 1.3 tt -92.09 -11.17 36.49 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -174.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.569 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 4.5 m -33.71 -177.64 0.0 OUTLIER Pre-proline 0 CA--C 1.596 2.738 0 C-N-CA 129.589 3.156 . . . . 0.0 114.978 171.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 31.76 37.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 123.796 2.997 . . . . 0.0 117.404 -154.272 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 8.5 m -73.19 146.83 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.616 163.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -114.75 124.43 51.76 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.42 -109.08 1.94 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 114.941 -1.027 . . . . 0.0 114.659 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.6 m -64.29 -21.23 66.53 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 124.76 1.224 . . . . 0.0 112.873 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 79.2 mt-10 -69.97 142.92 52.78 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -126.73 115.58 19.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.541 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -160.26 -88.52 0.07 OUTLIER Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 118.958 -1.592 . . . . 0.0 114.32 173.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.99 -145.93 27.6 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 -168.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.96 122.11 54.95 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.266 0 CA-C-N 119.804 1.802 . . . . 0.0 108.486 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -146.91 163.04 30.87 Favored Pre-proline 0 C--N 1.288 -2.076 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.967 -174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 17.0 Cg_exo -70.02 138.25 36.58 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 121.74 1.627 . . . . 0.0 109.208 167.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.83 162.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.532 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 31.6 m -102.3 128.83 54.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.054 175.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.8 mm -87.14 109.56 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -105.58 -17.87 7.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.764 -177.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.655 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 7.1 tt0 -64.3 164.62 10.85 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -170.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.627 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 21.4 p-10 -62.63 180.0 0.3 Allowed 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.844 1.658 . . . . 0.0 111.913 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.34 -48.04 37.56 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.674 -1.603 . . . . 0.0 113.069 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.3 m -86.6 -25.22 25.07 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -162.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 50' ' ' SER . . . -63.19 -30.15 76.63 Favored Glycine 0 C--O 1.192 -2.486 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -68.23 -36.44 79.5 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.428 0.633 . . . . 0.0 110.24 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -81.99 -50.39 9.17 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.615 -172.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -97.67 -15.37 20.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -172.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 23.1 t -114.45 145.92 34.79 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.14 -3.01 10.25 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.468 2.112 . . . . 0.0 111.67 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 p -111.66 139.33 47.21 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.487 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.655 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -137.65 139.72 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 120.811 0.338 . . . . 0.0 111.549 176.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 5.1 tt -87.51 129.02 39.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.014 0 CA-C-O 121.595 0.712 . . . . 0.0 112.477 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 21.9 m -133.88 168.21 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.229 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.532 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -125.69 140.68 52.5 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.68 128.76 37.19 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.578 HG12 ' CD1' ' A' ' 86' ' ' ILE . 62.7 mt -86.85 130.34 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.486 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.5 m -128.23 114.72 17.3 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.268 0.556 . . . . 0.0 111.931 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.712 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 176.043 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 tt . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.95 -5.05 6.92 Favored 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.979 3.119 . . . . 0.0 116.253 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.2 p -92.78 -12.3 31.59 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.857 0.836 . . . . 0.0 109.522 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -107.45 129.59 54.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.2 p -128.15 136.34 60.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.745 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -99.55 137.98 37.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.992 0.901 . . . . 0.0 112.316 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.725 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -119.92 160.69 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.117 -179.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.3 117.57 18.11 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -53.09 -44.6 67.7 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -52.37 -39.58 60.97 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 125.455 1.502 . . . . 0.0 111.15 177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.468 ' HD3' ' OG ' ' A' ' 107' ' ' SER . 40.2 ttmt -74.62 -35.75 62.92 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 -176.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 73' ' ' ILE . 2.7 m-85 -97.51 8.86 43.83 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.645 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.3 tttm 71.81 11.32 6.29 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 125.185 1.394 . . . . 0.0 113.495 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.02 170.92 11.14 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-O 122.384 1.088 . . . . 0.0 109.948 174.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -108.39 -4.85 17.03 Favored 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.994 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -128.63 147.42 50.73 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -52.74 134.24 36.5 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 124.045 0.84 . . . . 0.0 110.72 -177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.44 ' O ' HG12 ' A' ' 73' ' ' ILE . 13.9 m -102.14 122.96 45.16 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.163 -169.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 37.3 t -113.82 135.8 52.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.578 ' CD1' HG12 ' A' ' 58' ' ' ILE . 16.5 mm -106.14 136.64 39.83 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 N-CA-C 106.33 -1.729 . . . . 0.0 106.33 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.32 107.58 18.66 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.6 mm? -86.57 14.89 6.16 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.015 0.912 . . . . 0.0 111.498 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -114.57 -44.34 3.09 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.158 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 80.78 6.62 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.528 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -122.95 -178.14 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.915 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.556 ' HD2' HD23 ' A' ' 24' ' ' LEU 0.254 13.5 ptp180 -175.3 167.27 3.38 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 171.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 54' ' ' ILE . 94.1 m -108.65 121.78 45.73 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.188 -178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.1 mt -131.1 145.61 52.06 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 124.548 1.155 . . . . 0.0 111.142 -169.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 20.1 t70 -50.94 137.07 21.72 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.632 1.173 . . . . 0.0 112.782 172.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.465 ' NZ ' HD12 ' A' ' 14' ' ' ILE . 30.0 mtpp -55.9 -29.51 60.14 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.829 0.852 . . . . 0.0 112.435 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 9.1 mtmp? -87.75 -9.58 53.58 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.888 -175.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 12.1 ptm180 -90.65 -17.19 27.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.668 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.34 127.02 31.57 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 161.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -99.0 -59.73 1.67 Allowed 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -172.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 13.3 pt-20 -147.98 131.71 16.95 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -169.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -63.67 108.94 1.53 Allowed 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 128.552 2.741 . . . . 0.0 107.118 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.713 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 57.2 tp -106.32 -63.07 1.3 Allowed 'General case' 0 N--CA 1.411 -2.4 0 CA-C-O 122.386 1.089 . . . . 0.0 111.435 -171.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.769 HG22 ' H ' ' A' ' 105' ' ' TYR 0.291 19.9 m -138.32 -157.06 0.74 Allowed 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 113.76 -1.563 . . . . 0.0 111.437 -165.082 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.769 ' H ' HG22 ' A' ' 104' ' ' THR . 12.9 t80 -159.15 151.84 21.74 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 119.653 1.115 . . . . 0.0 110.513 -161.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -115.1 138.37 50.96 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.37 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.468 ' OG ' ' HD3' ' A' ' 77' ' ' LYS . 19.7 m -79.79 157.33 27.1 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.534 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 111' ' ' MET . 26.1 t70 -63.61 -37.39 87.16 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.195 0.598 . . . . 0.0 112.197 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.23 -40.35 95.85 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 123.329 0.652 . . . . 0.0 110.696 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HE3' HG23 ' A' ' 73' ' ' ILE . 14.9 tppt? -77.98 -27.42 49.12 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.957 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.528 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 1.3 mmt -50.09 -46.84 53.84 Favored 'General case' 0 CA--C 1.461 -2.447 0 CA-C-O 122.223 1.011 . . . . 0.0 109.345 171.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 8.0 mmpt? -72.94 -12.36 60.92 Favored 'General case' 0 N--CA 1.392 -3.337 0 CA-C-N 113.853 -1.521 . . . . 0.0 114.012 -177.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -90.7 -52.1 5.05 Favored 'General case' 0 N--CA 1.385 -3.709 0 C-N-CA 117.469 -1.692 . . . . 0.0 107.59 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -51.87 -59.28 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 113.217 -1.81 . . . . 0.0 113.141 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 56.7 m-20 -59.22 -39.37 82.48 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 123.534 1.635 . . . . 0.0 110.732 -177.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -80.56 -41.95 23.2 Favored 'General case' 0 C--N 1.256 -3.468 0 CA-C-N 112.442 -2.163 . . . . 0.0 112.722 -172.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.453 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.45 -35.38 73.93 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 122.191 0.996 . . . . 0.0 108.332 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 3.9 tp -68.09 -40.36 82.68 Favored 'General case' 0 N--CA 1.384 -3.757 0 CA-C-N 113.211 -1.813 . . . . 0.0 110.141 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.2 ttp -72.02 -19.94 61.78 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.33 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.492 HG23 HD21 ' A' ' 125' ' ' ASN . 54.1 mt -84.7 -52.75 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.8 t -47.93 -46.33 31.95 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.938 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.06 5.71 13.46 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.04 81.91 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 116.48 1.352 . . . . 0.0 116.48 171.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' B' ' 115' ' ' ASP . 5.9 mt -73.28 -52.51 13.7 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 117.413 -1.715 . . . . 0.0 107.867 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.492 HD21 HG23 ' A' ' 120' ' ' ILE . 20.2 m120 . . . . . 0 C--N 1.313 -1.019 0 CA-C-N 113.191 -1.822 . . . . 0.0 115.149 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.458 HD12 ' NZ ' ' B' ' 96' ' ' LYS . 62.1 mt . . . . . 0 N--CA 1.43 -1.426 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -144.87 160.73 40.82 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' B' ' 41' ' ' ILE . 50.5 ttp180 -71.39 114.4 9.41 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 143.31 -27.74 2.11 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.388 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -97.73 138.51 35.0 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.244 0.545 . . . . 0.0 111.05 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.427 ' HB ' ' H ' ' B' ' 104' ' ' THR . 64.7 t -89.76 123.44 41.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.528 174.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -113.04 146.29 39.38 Favored 'General case' 0 C--N 1.267 -3.016 0 C-N-CA 124.122 0.969 . . . . 0.0 109.806 172.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.602 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.1 mp -83.34 152.21 25.19 Favored 'General case' 0 N--CA 1.399 -2.983 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 167.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.38 156.84 40.34 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-O 121.785 0.802 . . . . 0.0 111.428 -173.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.98 93.88 8.99 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.556 HD22 ' HA3' ' B' ' 33' ' ' GLY 0.25 1.6 tt -90.58 -11.24 40.59 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -174.401 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.622 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 9.2 m -33.55 -177.45 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.668 0 C-N-CA 129.497 3.119 . . . . 0.0 115.364 170.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 31.59 36.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 123.751 2.968 . . . . 0.0 117.421 -154.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.542 HG13 ' O ' ' B' ' 24' ' ' LEU . 6.9 m -73.24 148.51 8.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.61 164.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -117.48 122.51 43.93 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.75 -111.89 4.14 Favored Glycine 0 C--N 1.32 -0.344 0 CA-C-N 115.087 -0.96 . . . . 0.0 114.121 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 18.2 m -60.17 -21.86 62.19 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.651 1.18 . . . . 0.0 113.122 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.517 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 73.2 mt-10 -70.3 143.48 52.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -128.25 117.22 21.12 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.556 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -160.51 -91.66 0.08 OUTLIER Glycine 0 N--CA 1.415 -2.757 0 C-N-CA 119.437 -1.363 . . . . 0.0 113.964 173.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.96 -147.45 27.66 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 105.391 -3.084 . . . . 0.0 105.391 -167.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.95 122.08 51.41 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 119.766 1.783 . . . . 0.0 108.821 172.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -145.86 162.94 33.68 Favored Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.9 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 18.4 Cg_exo -69.98 138.46 37.15 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.855 1.704 . . . . 0.0 109.008 167.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.54 161.98 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 29.1 m -101.5 129.44 52.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.186 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 33.9 mm -88.26 109.58 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.479 ' O ' ' HD3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -105.64 -18.01 7.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.734 -177.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.665 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 7.0 tt0 -64.92 163.73 13.9 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -170.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.63 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 13.3 p-10 -65.11 178.89 0.78 Allowed 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.876 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.05 -47.76 49.25 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 112.827 -1.988 . . . . 0.0 113.039 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.426 ' HA ' ' HD2' ' B' ' 48' ' ' LYS . 3.5 m -87.28 -24.16 24.44 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -162.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' B' ' 50' ' ' SER . . . -63.69 -30.27 77.15 Favored Glycine 0 C--O 1.2 -1.986 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -66.29 -40.25 89.92 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 120.886 0.374 . . . . 0.0 110.624 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' B' ' 45' ' ' THR . 28.5 mttt -78.76 -54.9 5.61 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-O 121.06 0.457 . . . . 0.0 112.04 -175.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -88.07 -25.06 23.25 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' B' ' 46' ' ' GLY . 13.9 t -107.6 144.83 30.05 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.93 -6.1 12.26 Favored 'Trans proline' 0 C--O 1.241 0.639 0 C-N-CA 122.433 2.089 . . . . 0.0 111.631 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 3.7 p -107.68 142.3 37.87 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.336 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.665 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.1 OUTLIER -140.5 139.64 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 120.803 0.335 . . . . 0.0 111.6 176.067 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' B' ' 93' ' ' THR . 4.8 tt -87.7 130.08 38.0 Favored 'Isoleucine or valine' 0 C--O 1.247 0.941 0 CA-C-O 121.611 0.72 . . . . 0.0 112.901 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.492 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 20.0 m -134.67 167.91 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.169 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.525 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -125.15 140.25 53.04 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.97 127.75 33.94 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.57 HG12 ' CD1' ' B' ' 86' ' ' ILE . 60.0 mt -85.54 130.81 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.535 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 91.7 m -128.26 112.76 14.83 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.43 0.633 . . . . 0.0 111.856 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.053 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 175.52 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.8 tt . . . . . 0 CA--C 1.548 0.894 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.24 -12.99 21.95 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.854 3.036 . . . . 0.0 116.272 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 69.9 p -87.27 -13.51 43.51 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.763 0.792 . . . . 0.0 110.038 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -105.7 130.44 53.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 9.9 p -129.02 136.75 58.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.798 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -98.37 137.68 36.73 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-O 121.925 0.869 . . . . 0.0 112.025 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.715 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.3 OUTLIER -120.13 158.22 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.394 -179.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -72.95 116.19 13.16 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -53.2 -43.28 67.07 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -53.22 -43.33 67.18 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 125.127 1.371 . . . . 0.0 111.011 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . 0.513 ' HD3' ' OG ' ' B' ' 107' ' ' SER . 41.0 ttmt -71.82 -34.57 69.44 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.208 -175.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.715 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.1 m-85 -96.82 7.97 45.41 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.369 0.604 . . . . 0.0 111.106 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 61.2 tttm 70.5 13.35 7.43 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.957 1.303 . . . . 0.0 113.206 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.58 167.29 13.52 Favored 'General case' 0 CA--C 1.478 -1.796 0 CA-C-O 122.212 1.006 . . . . 0.0 110.235 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -99.86 -11.74 20.47 Favored 'General case' 0 C--N 1.271 -2.825 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.041 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -126.29 149.6 49.02 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.45 132.96 35.48 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 124.225 0.953 . . . . 0.0 110.116 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.419 ' O ' HG12 ' B' ' 73' ' ' ILE . 10.9 m -102.39 121.99 43.41 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.826 -169.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 39.1 t -113.49 135.03 54.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.57 ' CD1' HG12 ' B' ' 58' ' ' ILE . 17.2 mm -104.94 135.91 40.9 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.853 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.4 mt -105.14 107.68 18.8 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' B' ' 118' ' ' LEU . 3.7 mm? -85.64 12.28 9.09 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.908 0.861 . . . . 0.0 111.567 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.39 -44.01 3.43 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.492 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.23 80.56 6.87 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.254 1.026 . . . . 0.0 108.252 178.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.525 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.2 pp -123.1 -178.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.033 -1.439 . . . . 0.0 108.192 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.524 ' HD2' HD23 ' B' ' 24' ' ' LEU . 13.6 ptp180 -175.3 167.56 3.37 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 171.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' B' ' 54' ' ' ILE . 96.0 m -108.5 121.84 45.81 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.173 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.444 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 71.7 mt -131.22 145.33 51.88 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 124.707 1.254 . . . . 0.0 110.93 -169.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.621 ' O ' ' HG2' ' B' ' 98' ' ' ARG . 27.5 t70 -52.52 136.42 32.17 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.977 0.911 . . . . 0.0 112.911 172.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.458 ' NZ ' HD12 ' B' ' 14' ' ' ILE . 29.0 mtpp -54.65 -29.85 53.53 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.115 0.966 . . . . 0.0 112.371 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.48 ' HB2' ' OD2' ' B' ' 95' ' ' ASP . 9.8 mtmp? -83.7 -17.95 39.58 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.585 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.621 ' HG2' ' O ' ' B' ' 95' ' ' ASP . 11.8 ptm180 -86.25 -17.85 33.64 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.814 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.68 121.35 16.27 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 162.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -92.19 -60.39 1.86 Allowed 'General case' 0 C--N 1.268 -2.938 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -170.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.449 ' HG3' HD13 ' B' ' 21' ' ' LEU . 10.6 pt-20 -148.68 130.19 14.86 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-O 122.512 1.149 . . . . 0.0 114.044 -168.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -61.14 110.89 1.51 Allowed 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 128.497 2.719 . . . . 0.0 106.924 173.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.679 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 53.7 tp -107.44 -64.19 1.22 Allowed 'General case' 0 N--CA 1.402 -2.853 0 CA-C-O 121.94 0.876 . . . . 0.0 111.05 -172.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.734 HG22 ' H ' ' B' ' 105' ' ' TYR 0.291 17.4 m -138.12 -157.12 0.74 Allowed 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.216 -164.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.734 ' H ' HG22 ' B' ' 104' ' ' THR . 11.9 t80 -158.32 153.63 25.78 Favored 'General case' 0 N--CA 1.402 -2.859 0 CA-C-N 119.703 1.138 . . . . 0.0 110.1 -161.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.04 138.9 50.34 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.351 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . 0.513 ' OG ' ' HD3' ' B' ' 77' ' ' LYS . 27.7 m -82.76 156.75 23.54 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.411 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' B' ' 111' ' ' MET . 20.0 t70 -61.96 -36.78 82.46 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.42 0.629 . . . . 0.0 111.765 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -62.1 -40.95 97.61 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.623 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.457 ' HE3' HG23 ' B' ' 73' ' ' ILE . 13.6 tppt? -77.24 -28.74 53.75 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.175 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.5 OUTLIER -49.33 -46.17 46.46 Favored 'General case' 0 CA--C 1.459 -2.536 0 CA-C-O 122.143 0.973 . . . . 0.0 109.088 171.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.563 ' HE2' ' HA ' ' B' ' 112' ' ' LYS . 6.1 mmpt? -71.48 -16.22 62.35 Favored 'General case' 0 N--CA 1.38 -3.926 0 CA-C-N 113.841 -1.527 . . . . 0.0 114.848 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -89.89 -51.59 5.41 Favored 'General case' 0 N--CA 1.388 -3.566 0 C-N-CA 117.014 -1.874 . . . . 0.0 107.27 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.72 -59.62 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 113.36 -1.745 . . . . 0.0 113.293 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 49.1 m-20 -59.47 -40.3 86.49 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 123.713 1.721 . . . . 0.0 111.32 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.406 ' O ' HG13 ' B' ' 120' ' ' ILE 0.351 25.9 t30 -80.74 -40.38 25.34 Favored 'General case' 0 C--N 1.255 -3.54 0 CA-C-N 112.711 -2.04 . . . . 0.0 112.391 -171.397 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -63.58 -32.98 74.61 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 121.981 0.896 . . . . 0.0 108.681 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.8 tp -67.45 -39.67 85.35 Favored 'General case' 0 N--CA 1.38 -3.939 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.576 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 8.6 ttp -71.83 -20.37 61.84 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 123.61 0.764 . . . . 0.0 110.042 -175.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.495 HG23 HD21 ' B' ' 125' ' ' ASN . 63.5 mt -84.3 -53.17 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.2 t -47.72 -46.09 29.32 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.993 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 8.7 mp -79.75 5.83 12.44 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.65 9.77 79.0 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 116.195 1.238 . . . . 0.0 116.195 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.424 HD22 ' HB3' ' A' ' 115' ' ' ASP . 6.2 mt -71.56 -54.37 10.71 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 119.498 1.649 . . . . 0.0 107.762 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.495 HD21 HG23 ' B' ' 120' ' ' ILE . 21.3 m120 . . . . . 0 C--N 1.312 -1.045 0 CA-C-N 113.049 -1.887 . . . . 0.0 115.031 -177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mt . . . . . 0 N--CA 1.438 -1.037 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -115.6 144.36 44.01 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 19.7 ptt180 -73.87 152.3 40.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.879 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.17 -2.71 79.28 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.977 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -97.71 177.88 5.33 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 3.9 t -133.62 134.45 56.55 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 C-N-CA 122.806 0.442 . . . . 0.0 111.844 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.486 ' O ' HG22 ' A' ' 38' ' ' VAL . 12.5 m-85 -131.51 144.32 51.04 Favored 'General case' 0 CA--C 1.467 -2.232 0 C-N-CA 124.46 1.104 . . . . 0.0 110.146 177.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mp -79.58 151.49 30.62 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 169.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.01 139.47 23.64 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.278 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -74.37 92.65 2.32 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.146 0.974 . . . . 0.0 109.773 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.587 ' O ' HG13 ' A' ' 27' ' ' VAL . 83.7 mt -82.19 -12.41 58.14 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-N 113.892 -1.504 . . . . 0.0 112.11 -177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -90.83 61.79 0.0 OUTLIER Pre-proline 0 C--N 1.257 -3.453 0 N-CA-C 119.754 3.242 . . . . 0.0 119.754 -176.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' B' ' 26' ' ' PRO . 1.1 Cg_endo -117.68 22.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 N-CA-C 108.46 -1.4 . . . . 0.0 108.46 148.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 24' ' ' LEU . 14.1 m -72.81 157.97 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.943 0.878 . . . . 0.0 113.364 -172.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -124.01 156.3 36.71 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.721 -1.581 . . . . 0.0 107.163 175.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.95 -135.44 15.09 Favored Glycine 0 N--CA 1.418 -2.556 0 O-C-N 124.131 0.894 . . . . 0.0 112.068 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.6 m -94.34 6.93 47.2 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.476 -0.362 . . . . 0.0 111.686 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 7.1 mm-40 -71.33 153.14 42.58 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 119.374 -0.931 . . . . 0.0 112.959 -176.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -81.85 119.15 23.55 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -171.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.4 158.97 17.19 Favored Glycine 0 CA--C 1.472 -2.651 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.495 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . 111.63 137.97 7.39 Favored Glycine 0 C--N 1.276 -2.793 0 CA-C-N 113.016 -1.592 . . . . 0.0 109.972 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 p -64.6 119.13 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.124 0 CA-C-O 122.365 1.079 . . . . 0.0 109.039 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -144.93 149.22 41.77 Favored Pre-proline 0 C--N 1.267 -3.015 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.209 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 33.3 Cg_exo -58.76 136.59 74.82 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.311 2.007 . . . . 0.0 111.37 171.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 20' ' ' TYR . 29.4 m -122.51 161.68 23.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 123.933 0.893 . . . . 0.0 108.721 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.6 m -101.48 132.11 47.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 120.722 0.296 . . . . 0.0 110.697 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mm -86.04 105.12 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -97.39 -23.46 4.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.535 -177.081 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.65 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -64.5 168.49 5.8 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -167.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.58 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 12.9 p-10 -66.53 177.62 1.5 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.464 -1.698 . . . . 0.0 110.632 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 16.8 t70 -89.18 -29.56 19.21 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.188 -176.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.586 ' HA ' ' CD ' ' A' ' 48' ' ' LYS . 45.1 m -82.79 -26.17 32.06 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.42 -21.69 74.44 Favored Glycine 0 C--O 1.196 -2.238 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -82.12 -26.79 33.25 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.273 0.559 . . . . 0.0 109.931 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.586 ' CD ' ' HA ' ' A' ' 45' ' ' THR . 6.6 mtpp -82.94 -57.98 3.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.978 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -96.35 -35.86 11.06 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.6 m -90.84 158.74 41.71 Favored Pre-proline 0 C--N 1.29 -2.02 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -87.86 -11.45 4.69 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.38 1.387 . . . . 0.0 110.849 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 17.0 p -96.26 149.88 21.17 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.504 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -148.58 137.95 15.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.363 170.511 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.65 HG22 ' HG3' ' A' ' 42' ' ' GLN . 15.0 tt -86.47 135.32 25.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-O 121.444 0.64 . . . . 0.0 110.29 175.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.99 146.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.994 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 91' ' ' ILE . . . -109.76 135.64 50.36 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.78 145.1 48.93 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.44 HG12 HD12 ' A' ' 86' ' ' ILE . 49.1 mt -100.79 143.74 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.969 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 m -92.35 173.37 7.84 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.888 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 171.082 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 mt . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.0 2.44 2.14 Favored 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.101 1.867 . . . . 0.0 113.841 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 p -100.91 -18.93 16.13 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.483 0.659 . . . . 0.0 109.728 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -102.03 130.09 48.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.28 136.94 52.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.568 173.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 10.2 pt-20 -101.38 146.61 27.36 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.082 0.468 . . . . 0.0 112.188 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.8 pt -112.75 146.08 17.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.11 109.0 6.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.842 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -60.32 -36.15 77.26 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.637 0.732 . . . . 0.0 112.789 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -51.4 -52.1 48.91 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.19 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -91.05 -25.62 19.57 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.361 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' A' ' 106' ' ' LEU . 1.9 m-85 -88.55 20.5 3.36 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 123.635 0.774 . . . . 0.0 111.858 -172.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 56.75 27.61 13.02 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.31 170.76 8.0 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.843 0.83 . . . . 0.0 109.718 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -99.8 -16.94 17.91 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.231 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.73 140.0 52.27 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.027 -173.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -85.81 102.8 14.0 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.0 t -103.28 172.75 6.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -165.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 37.7 t -123.9 142.97 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.44 HD12 HG12 ' A' ' 58' ' ' ILE . 20.9 mm -106.44 133.31 51.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.8 mt -105.95 107.06 17.87 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 121.462 0.648 . . . . 0.0 109.737 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.6 mm? -84.26 16.96 2.73 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.608 -175.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.03 -40.28 3.52 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 122.13 0.967 . . . . 0.0 109.019 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.19 72.82 4.61 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.56 ' O ' ' HB ' ' B' ' 93' ' ' THR . 8.0 mt -106.62 -174.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.533 ' H ' HG22 ' A' ' 91' ' ' ILE . 5.7 ptp180 -175.14 174.89 2.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 124.004 0.922 . . . . 0.0 109.733 166.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.559 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 68.0 m -125.27 130.05 51.26 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -132.99 143.08 49.2 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -80.54 153.05 28.32 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.876 175.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -47.12 -18.21 0.08 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 126.523 1.929 . . . . 0.0 115.333 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -74.31 -27.15 60.58 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.317 0.58 . . . . 0.0 111.132 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -74.84 -35.73 62.38 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.449 0.7 . . . . 0.0 110.47 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mp -74.6 122.98 23.98 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.398 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.45 -59.61 1.84 Allowed 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -154.85 135.55 13.56 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.478 0.656 . . . . 0.0 112.6 -168.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -64.62 121.26 14.04 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.608 173.462 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -113.78 -61.92 1.67 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.446 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.516 HG22 HG11 ' A' ' 19' ' ' VAL . 5.2 t -126.3 -164.35 1.32 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.069 -1.452 . . . . 0.0 112.348 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -159.84 147.14 16.61 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.812 0.845 . . . . 0.0 112.651 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.586 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . 13.1 mt -98.65 155.34 17.36 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.959 -1.473 . . . . 0.0 108.476 177.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.8 m -86.36 167.86 14.37 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 111' ' ' MET . 22.2 t70 -56.58 -43.62 80.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.69 0.796 . . . . 0.0 112.381 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.13 -41.55 98.36 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -67.23 -33.66 75.83 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.513 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -55.1 -42.41 72.85 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 123.967 0.907 . . . . 0.0 110.313 175.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.668 ' HE2' ' N ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -76.22 -11.98 60.01 Favored 'General case' 0 CA--C 1.472 -2.046 0 C-N-CA 122.947 0.499 . . . . 0.0 111.544 179.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -86.67 -43.47 12.59 Favored 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -55.92 -58.92 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.111 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.316 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.89 -49.92 62.06 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-O 123.311 1.529 . . . . 0.0 110.344 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.665 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 1.3 t30 -68.97 -49.76 55.07 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 112.203 -2.272 . . . . 0.0 112.743 -173.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.45 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.07 -39.75 83.08 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 2.4 tp -64.32 -47.36 79.73 Favored 'General case' 1 N--CA 1.378 -4.07 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.498 -175.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.685 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 1.9 ptm -71.19 -19.74 62.36 Favored 'General case' 0 C--O 1.202 -1.424 0 O-C-N 121.568 -0.707 . . . . 0.0 112.513 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 116' ' ' ASN . 54.2 mt -76.76 -53.54 14.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -55.89 -30.94 62.35 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.236 -1.802 . . . . 0.0 111.555 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.573 HD22 HG21 ' B' ' 54' ' ' ILE . 44.2 mt -101.6 5.48 41.66 Favored 'General case' 0 N--CA 1.425 -1.696 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.527 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.38 5.36 72.53 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 117.729 1.851 . . . . 0.0 117.729 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.685 ' HB2' ' HB2' ' A' ' 119' ' ' MET . 6.9 mp -71.26 -45.18 63.77 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 120.544 2.172 . . . . 0.0 108.665 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.6 m120 . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 126.532 1.933 . . . . 0.0 116.006 177.08 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -114.5 144.83 42.72 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.558 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 19.9 ptt180 -75.31 147.4 40.2 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.777 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.02 -2.88 60.07 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.32 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -97.25 174.87 6.5 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 5.6 t -132.94 131.6 59.07 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.9 0 C-N-CA 123.596 0.759 . . . . 0.0 111.49 -176.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.5 ' O ' HG22 ' B' ' 38' ' ' VAL . 8.4 m-85 -129.26 144.16 51.12 Favored 'General case' 0 CA--C 1.465 -2.296 0 C-N-CA 124.167 0.987 . . . . 0.0 110.396 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -79.94 151.1 30.27 Favored 'General case' 0 N--CA 1.4 -2.942 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.03 139.71 23.82 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.155 -175.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.64 92.29 1.95 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.048 0.928 . . . . 0.0 109.455 173.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.572 ' O ' HG13 ' B' ' 27' ' ' VAL . 90.2 mt -83.09 -9.97 58.94 Favored 'General case' 0 CA--C 1.474 -1.947 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.787 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.434 ' HB3' ' H ' ' B' ' 34' ' ' GLY . 0.1 OUTLIER -91.91 61.3 0.0 OUTLIER Pre-proline 0 C--N 1.247 -3.879 0 N-CA-C 119.262 3.06 . . . . 0.0 119.262 -176.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.429 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -117.74 21.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.255 0 N-CA-C 108.476 -1.394 . . . . 0.0 108.476 150.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.572 HG13 ' O ' ' B' ' 24' ' ' LEU . 15.2 m -72.62 157.91 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-O 122.085 0.945 . . . . 0.0 113.154 -171.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -124.05 155.98 37.35 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.354 -1.748 . . . . 0.0 107.679 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.26 -135.32 14.02 Favored Glycine 0 N--CA 1.421 -2.326 0 O-C-N 123.997 0.811 . . . . 0.0 112.109 173.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -94.75 8.41 42.63 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 122.661 0.384 . . . . 0.0 111.846 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.08 151.9 42.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.58 118.45 21.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 121.16 0.505 . . . . 0.0 109.857 -171.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.89 155.62 18.75 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-N 114.701 -1.136 . . . . 0.0 115.264 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.434 ' H ' ' HB3' ' B' ' 25' ' ' SER . . . 112.43 137.84 7.13 Favored Glycine 0 N--CA 1.418 -2.524 0 CA-C-N 113.023 -1.588 . . . . 0.0 110.364 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 p -63.62 119.67 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-O 122.4 1.095 . . . . 0.0 108.86 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -145.49 149.74 41.68 Favored Pre-proline 0 C--N 1.265 -3.068 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.304 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.2 Cg_exo -59.07 136.85 75.91 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.137 1.891 . . . . 0.0 111.201 171.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -122.76 161.02 24.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 123.968 0.907 . . . . 0.0 108.61 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 30.0 m -100.93 132.05 47.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 120.748 0.308 . . . . 0.0 110.723 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 26.1 mm -86.06 105.91 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.43 HG23 HG23 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -97.53 -25.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.383 -177.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.641 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.1 OUTLIER -63.12 167.85 4.65 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -167.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.575 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 14.5 p-10 -66.41 176.26 1.92 Allowed 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.083 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.98 -30.13 21.5 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.648 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . 0.522 ' HA ' ' CD ' ' B' ' 48' ' ' LYS . 28.3 m -84.0 -25.52 29.89 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -170.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -68.61 -21.46 74.69 Favored Glycine 0 C--O 1.194 -2.394 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 176.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -82.88 -27.94 30.38 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.181 0.515 . . . . 0.0 110.018 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.522 ' CD ' ' HA ' ' B' ' 45' ' ' THR . 4.4 mtpp -80.74 -58.48 3.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.869 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -97.39 -35.89 10.54 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -172.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 38.5 m -88.11 156.59 51.74 Favored Pre-proline 0 C--N 1.292 -1.91 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.193 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -86.97 -12.32 5.06 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 121.22 1.28 . . . . 0.0 110.663 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 19.0 p -96.14 149.29 21.79 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.479 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.8 OUTLIER -148.1 137.87 16.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 O-C-N 123.94 0.775 . . . . 0.0 109.258 170.499 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.641 HG22 ' HG3' ' B' ' 42' ' ' GLN . 15.6 tt -86.54 135.47 25.05 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 CA-C-O 121.278 0.561 . . . . 0.0 110.277 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.67 145.65 29.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.965 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' B' ' 91' ' ' ILE . . . -109.59 135.17 51.0 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.76 145.87 48.47 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.439 HG12 HD12 ' B' ' 86' ' ' ILE . 45.6 mt -101.91 145.22 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.859 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 5.0 m -93.6 176.85 6.21 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.074 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 171.37 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.0 mt . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.05 6.86 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 122.32 2.013 . . . . 0.0 113.695 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -106.05 -18.52 14.0 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.529 0.681 . . . . 0.0 109.476 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -102.43 130.18 49.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.26 137.39 50.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 8.6 pt-20 -101.08 150.67 22.68 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.998 0.428 . . . . 0.0 112.152 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . . . . . . . . . 21.0 pt -117.16 144.41 25.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.78 109.76 5.16 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.869 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.6 -38.55 85.06 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.343 0.592 . . . . 0.0 112.499 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -51.22 -51.76 50.87 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.591 -1.64 . . . . 0.0 113.55 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -88.12 -26.43 22.49 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 118.764 -1.175 . . . . 0.0 112.022 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' B' ' 106' ' ' LEU . 1.7 m-85 -89.79 19.14 4.94 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 123.722 0.809 . . . . 0.0 111.547 -171.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 60.23 23.83 13.21 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 124.542 1.137 . . . . 0.0 113.818 169.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 mt -110.59 165.84 11.48 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.058 0.933 . . . . 0.0 110.52 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.52 -14.3 25.22 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.404 -1.726 . . . . 0.0 108.853 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.68 139.16 53.79 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.005 -174.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -85.13 103.77 14.42 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 41.8 t -104.56 172.83 6.58 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -164.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' B' ' 72' ' ' GLU . 38.4 t -124.42 142.68 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.439 HD12 HG12 ' B' ' 58' ' ' ILE . 19.8 mm -106.26 133.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 80.1 mt -106.04 106.99 17.76 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.495 0.664 . . . . 0.0 109.541 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.7 mm? -84.31 16.47 3.03 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.771 0.796 . . . . 0.0 111.599 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.6 -40.28 3.41 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 122.254 1.026 . . . . 0.0 109.168 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.49 74.16 5.18 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.559 ' O ' ' HB ' ' A' ' 93' ' ' THR . 8.4 mt -107.64 -174.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.522 ' NH1' ' HB3' ' B' ' 24' ' ' LEU . 5.8 ptp180 -174.48 173.76 2.87 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 123.923 0.889 . . . . 0.0 109.659 167.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 59.7 m -126.02 128.13 46.97 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -132.26 142.7 49.49 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.889 -172.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 0.8 OUTLIER -80.09 153.34 28.8 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.009 175.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -46.56 -20.78 0.13 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 126.5 1.92 . . . . 0.0 115.082 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -75.59 -22.41 56.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.023 0.439 . . . . 0.0 111.391 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -77.74 -36.82 50.33 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 122.994 0.518 . . . . 0.0 110.127 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.73 124.49 26.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 124.072 0.949 . . . . 0.0 110.547 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -96.0 -60.66 1.59 Allowed 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.3 pt-20 -154.72 135.24 13.42 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.396 0.617 . . . . 0.0 112.503 -167.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -63.94 122.6 16.89 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.837 172.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.3 tp -114.52 -62.48 1.59 Allowed 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.806 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.519 HG22 HG11 ' B' ' 19' ' ' VAL . 5.2 t -125.81 -164.68 1.33 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.702 -1.599 . . . . 0.0 112.458 -176.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -159.77 145.05 15.42 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.635 0.774 . . . . 0.0 111.866 -172.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.548 ' HA ' ' CE2' ' B' ' 78' ' ' TYR . 14.6 mt -98.22 156.43 16.7 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.526 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 49.7 m -84.08 169.22 15.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.389 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' B' ' 111' ' ' MET . 12.1 t70 -59.0 -44.84 91.73 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.905 0.882 . . . . 0.0 111.875 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.31 -40.0 96.12 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.22 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -67.88 -33.11 74.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -55.08 -42.87 73.35 Favored 'General case' 0 N--CA 1.41 -2.431 0 C-N-CA 123.617 0.767 . . . . 0.0 110.205 175.068 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.707 ' O ' ' HB3' ' B' ' 116' ' ' ASN . 0.4 OUTLIER -74.94 -13.25 60.51 Favored 'General case' 0 CA--C 1.466 -2.276 0 C-N-CA 122.568 0.347 . . . . 0.0 111.738 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . 0.427 ' HA ' HD22 ' B' ' 116' ' ' ASN . 34.6 mt-10 -86.01 -43.3 13.26 Favored 'General case' 0 N--CA 1.39 -3.435 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.78 -57.54 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.961 0 CA-C-N 112.906 -1.952 . . . . 0.0 111.922 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.7 -51.97 58.1 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 122.958 1.361 . . . . 0.0 109.56 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.707 ' HB3' ' O ' ' B' ' 112' ' ' LYS . 0.1 OUTLIER -70.06 -42.31 72.99 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 112.658 -2.065 . . . . 0.0 113.826 -171.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.42 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -64.25 -40.91 97.0 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 2.5 tp -62.37 -45.89 91.12 Favored 'General case' 0 N--CA 1.382 -3.832 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.181 -176.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.695 ' HB2' ' HB2' ' B' ' 124' ' ' LEU . 2.0 ptm -72.14 -19.4 61.78 Favored 'General case' 0 C--O 1.205 -1.247 0 O-C-N 121.638 -0.664 . . . . 0.0 112.603 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 116' ' ' ASN . 59.0 mt -77.54 -53.72 13.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 173.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 9.9 t -55.37 -31.08 61.47 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.62 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.619 HD22 HG21 ' A' ' 54' ' ' ILE . 46.0 mt -101.41 5.62 42.18 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.13 10.42 71.59 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 117.419 1.727 . . . . 0.0 117.419 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' B' ' 119' ' ' MET . 7.0 mp -74.33 -44.11 53.86 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 120.402 2.101 . . . . 0.0 108.277 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.426 HD21 HG23 ' B' ' 120' ' ' ILE . 21.3 m120 . . . . . 0 N--CA 1.488 1.454 0 C-N-CA 126.716 2.007 . . . . 0.0 116.328 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.7 mt . . . . . 0 C--O 1.241 0.635 0 CA-C-O 120.882 0.372 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -114.97 153.87 29.8 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.523 ' HG2' ' SD ' ' A' ' 111' ' ' MET . 43.5 ttt180 -73.02 114.0 10.69 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.58 -7.54 10.35 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.478 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -81.31 172.34 13.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.153 0.978 . . . . 0.0 109.305 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.509 HG11 HG22 ' A' ' 104' ' ' THR . 19.6 t -133.07 135.14 57.25 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.129 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.457 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.1 m-85 -134.84 148.7 50.21 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -81.33 151.59 27.94 Favored 'General case' 0 N--CA 1.401 -2.906 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.455 171.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -129.74 133.91 47.3 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.038 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.631 ' HA ' ' HB ' ' A' ' 35' ' ' VAL 0.293 2.3 p-10 -88.47 99.71 12.49 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 117.875 -1.53 . . . . 0.0 111.282 178.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 4.5 mm? -84.84 40.22 0.79 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.788 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.539 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.292 2.7 m -67.74 170.22 7.64 Favored Pre-proline 0 C--N 1.261 -3.266 0 C-N-CA 127.835 2.454 . . . . 0.0 107.798 170.278 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.1 OUTLIER 2.23 53.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.408 3.688 1 C-N-CA 127.38 5.387 . . . . 0.0 118.051 -173.397 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.17 178.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.459 172.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -104.14 116.36 32.06 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -175.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.55 -117.69 11.71 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.297 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -94.48 19.57 9.52 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 160.41 30.09 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 173.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.605 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -75.57 119.26 19.39 Favored 'General case' 0 C--O 1.192 -1.967 0 CA-C-O 120.613 0.244 . . . . 0.0 110.705 -172.01 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -90.69 146.17 18.32 Favored Glycine 0 CA--C 1.474 -2.529 0 CA-C-O 121.636 0.576 . . . . 0.0 113.736 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 104.9 136.87 8.87 Favored Glycine 0 N--CA 1.421 -2.338 0 CA-C-N 113.511 -1.345 . . . . 0.0 111.343 176.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 1.3 p -67.76 120.01 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 CA-C-O 122.694 1.235 . . . . 0.0 110.324 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -139.68 156.77 70.95 Favored Pre-proline 0 C--N 1.266 -3.036 0 CA-C-N 112.814 -1.994 . . . . 0.0 110.434 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.609 ' HB2' HD12 ' A' ' 58' ' ' ILE . 34.5 Cg_exo -65.81 143.95 75.54 Favored 'Trans proline' 0 CA--C 1.555 1.531 0 C-N-CA 122.776 2.318 . . . . 0.0 112.216 172.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 20' ' ' TYR . 28.7 m -127.22 158.66 38.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.867 0.867 . . . . 0.0 109.218 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.71 134.76 45.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 O-C-N 123.154 0.284 . . . . 0.0 110.699 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 mm -82.12 96.94 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.423 ' C ' HD13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.43 -26.01 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.45 -178.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.521 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 4.5 pt20 -61.63 168.77 2.73 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 117.036 2.236 . . . . 0.0 117.036 -171.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -64.33 170.05 4.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 113.488 -1.687 . . . . 0.0 111.771 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.45 ' HA ' ' ND2' ' A' ' 47' ' ' ASN . 17.8 m-20 -81.07 -28.74 35.19 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 m -76.75 -34.93 58.03 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 122.197 -0.315 . . . . 0.0 110.607 -172.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.39 -25.68 74.64 Favored Glycine 0 C--O 1.21 -1.398 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.671 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.45 ' ND2' ' HA ' ' A' ' 44' ' ' ASP . 91.5 m-20 -63.1 -31.75 72.96 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.541 0.686 . . . . 0.0 109.983 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.505 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 20.0 mmmt -92.29 -64.21 1.14 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.947 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 54.9 m-85 -78.47 -36.19 45.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -167.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.531 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 58.9 m -93.63 133.21 28.44 Favored Pre-proline 0 N--CA 1.416 -2.13 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.363 -173.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -69.75 -21.52 33.41 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.631 1.554 . . . . 0.0 109.117 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 6.9 p -89.78 133.44 34.7 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.066 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.521 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 85.5 t -121.07 140.81 44.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.438 HG23 ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -113.01 124.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 122.213 1.006 . . . . 0.0 109.911 175.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.454 HG13 HG12 ' A' ' 53' ' ' VAL . 24.5 m -133.59 173.03 15.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.989 -173.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.515 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -124.94 146.38 49.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.72 131.23 41.38 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 37' ' ' PRO . 64.8 mt -90.07 124.66 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 113.891 -1.504 . . . . 0.0 107.356 172.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.673 ' HB ' HG23 ' A' ' 85' ' ' VAL . 64.7 m -123.07 154.24 38.82 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.543 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.113 -178.372 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.592 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 64.7 Cg_endo -71.56 35.79 0.29 Allowed 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 121.68 1.586 . . . . 0.0 113.906 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.9 p -124.02 -19.05 5.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.032 0.92 . . . . 0.0 108.576 171.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.535 ' CD2' HD22 ' A' ' 87' ' ' LEU . 36.1 m170 -124.24 129.91 51.61 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.3 p -125.88 136.35 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.457 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.99 135.54 45.3 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.744 0.783 . . . . 0.0 111.898 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.679 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -120.3 155.39 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.334 0 CA-C-N 113.877 -1.511 . . . . 0.0 112.646 -173.183 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -67.83 112.36 4.84 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 125.38 1.472 . . . . 0.0 108.871 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -44.06 -50.77 8.3 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.694 1.598 . . . . 0.0 112.68 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -66.18 -23.65 66.5 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 124.944 1.298 . . . . 0.0 114.398 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -84.86 -31.42 23.78 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.148 0.975 . . . . 0.0 109.496 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.679 ' CE1' HG21 ' A' ' 73' ' ' ILE . 4.2 m-85 -90.42 -8.22 51.13 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.631 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 62.15 25.7 15.4 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.866 1.267 . . . . 0.0 112.599 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 7.4 mp -85.07 172.52 11.2 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-O 122.992 1.377 . . . . 0.0 113.828 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.97 -23.97 61.52 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 111.518 -2.583 . . . . 0.0 110.651 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -152.31 160.03 43.39 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.377 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -56.04 136.36 52.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 123.993 0.808 . . . . 0.0 110.991 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 m -103.28 135.03 45.67 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.376 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.673 HG23 ' HB ' ' A' ' 59' ' ' THR . 1.1 m -116.84 131.62 68.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.572 ' CD1' HG12 ' A' ' 58' ' ' ILE . 23.1 mm -107.37 127.46 63.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.535 HD22 ' CD2' ' A' ' 70' ' ' HIS . 22.7 mt -103.69 109.82 21.67 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.565 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -87.84 8.18 27.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.275 -172.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -110.27 -35.82 5.98 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 122.122 0.963 . . . . 0.0 108.502 172.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 5.8 tp60 -87.22 64.33 8.28 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.181 -1.372 . . . . 0.0 107.747 175.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.515 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -108.23 -176.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.418 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.605 ' NH2' ' HB3' ' A' ' 32' ' ' GLN . 8.2 ptp85 -164.98 163.89 20.7 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 52.3 m -122.5 116.39 23.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.3 mt -131.83 141.52 49.46 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.328 1.051 . . . . 0.0 109.412 -170.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.7 p30 -71.12 152.05 43.84 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.109 174.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 50' ' ' SER . 94.7 mttt -44.74 -26.03 0.35 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 126.245 1.818 . . . . 0.0 114.798 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -86.97 -14.6 41.26 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -81.59 -27.66 34.14 Favored 'General case' 0 N--CA 1.395 -3.188 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.34 117.89 15.63 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 169.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -89.35 -58.85 2.38 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.0 pt-20 -151.35 133.54 15.25 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 121.845 0.831 . . . . 0.0 112.6 -170.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -60.57 115.74 3.83 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 127.485 2.314 . . . . 0.0 107.61 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -111.71 -62.77 1.51 Allowed 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.664 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.509 HG22 HG11 ' A' ' 19' ' ' VAL . 3.5 t -129.63 -163.61 1.32 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.486 -1.285 . . . . 0.0 111.794 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -160.98 147.02 14.67 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 123.976 0.91 . . . . 0.0 111.028 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -114.68 161.69 17.78 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.615 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 p -82.97 151.64 25.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 111' ' ' MET . 25.5 t70 -59.16 -36.41 75.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.09 -23.04 59.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.46 0.648 . . . . 0.0 110.82 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.625 ' HD3' ' CG2' ' A' ' 73' ' ' ILE . 15.8 ttmm -85.94 -24.58 26.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.751 0.786 . . . . 0.0 109.578 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.566 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -53.73 -33.89 57.1 Favored 'General case' 0 N--CA 1.422 -1.841 0 C-N-CA 124.462 1.105 . . . . 0.0 109.818 170.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.599 ' HE2' ' N ' ' A' ' 112' ' ' LYS . 7.1 mmpt? -69.78 -23.3 63.33 Favored 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.398 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -84.32 -31.25 24.95 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -173.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.421 HG13 HD11 ' A' ' 88' ' ' LEU . 1.6 t -67.15 -40.29 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.267 173.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.563 ' OD1' ' HG ' ' B' ' 124' ' ' LEU . 31.4 m-20 -63.07 -31.31 72.42 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.742 1.258 . . . . 0.0 110.607 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.71 ' O ' HD13 ' A' ' 120' ' ' ILE . 10.3 m-80 -80.06 -9.02 59.67 Favored 'General case' 1 N--CA 1.569 5.487 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.514 -176.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 68' ' ' PRO 0.275 . . -99.57 -49.0 4.55 Favored 'General case' 2 N--CA 1.344 -5.732 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 175.573 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 4.2 tp -67.61 -45.65 74.83 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.524 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 3.6 ttp -66.1 -22.48 66.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.653 0.781 . . . . 0.0 109.92 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -88.18 -51.56 12.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 t -54.15 -27.6 34.62 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 126.607 1.963 . . . . 0.0 111.926 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 56.0 mt -102.23 7.11 40.87 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.594 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.54 1.66 85.5 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 124' ' ' LEU . 3.2 mp -65.96 -52.46 49.44 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.81 1.305 . . . . 0.0 109.217 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.7 m120 . . . . . 0 C--N 1.311 -1.088 0 CA-C-N 113.789 -1.55 . . . . 0.0 113.353 178.251 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt . . . . . 0 C--O 1.241 0.648 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -117.85 149.39 40.93 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.542 ' HG2' ' SD ' ' B' ' 111' ' ' MET . 42.7 ttt180 -68.38 114.23 6.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.52 1.6 19.86 Favored Glycine 0 N--CA 1.43 -1.7 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.377 -176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -90.97 173.96 7.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.482 HG11 HG22 ' B' ' 104' ' ' THR . 22.3 t -134.18 134.34 55.29 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.096 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.55 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 28.9 m-85 -133.93 148.72 51.23 Favored 'General case' 0 CA--C 1.475 -1.912 0 C-N-CA 124.645 1.178 . . . . 0.0 107.924 177.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.548 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.4 mp -82.39 150.59 27.05 Favored 'General case' 0 N--CA 1.401 -2.881 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.485 171.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.36 134.38 48.84 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.124 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.608 ' HA ' ' HB ' ' B' ' 35' ' ' VAL 0.277 3.6 p-10 -90.27 99.13 12.2 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.693 -1.603 . . . . 0.0 111.314 178.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.631 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 4.2 mm? -83.09 40.44 0.7 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.54 -1.663 . . . . 0.0 111.679 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.48 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.272 5.6 m -66.55 166.66 16.64 Favored Pre-proline 0 C--N 1.269 -2.93 0 C-N-CA 127.528 2.331 . . . . 0.0 108.299 170.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 1.1 Cg_exo 5.66 53.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.399 3.228 1 C-N-CA 127.439 5.426 . . . . 0.0 117.674 -176.012 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.16 177.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 113.594 -1.639 . . . . 0.0 111.449 171.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -103.02 116.93 33.48 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.23 -176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.68 -121.19 19.16 Favored Glycine 0 CA--C 1.488 -1.631 0 CA-C-N 114.707 -1.133 . . . . 0.0 113.744 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.1 m -93.39 21.49 6.08 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.49 163.2 23.97 Favored 'General case' 0 C--O 1.256 1.443 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 172.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.612 ' HB3' HH22 ' B' ' 92' ' ' ARG . 0.8 OUTLIER -78.22 116.8 18.92 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 122.768 0.427 . . . . 0.0 109.989 -174.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -91.34 142.46 16.11 Favored Glycine 0 CA--C 1.465 -3.061 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.817 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 111.81 137.73 7.27 Favored Glycine 0 N--CA 1.422 -2.275 0 CA-C-N 114.299 -0.95 . . . . 0.0 111.219 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.608 ' HB ' ' HA ' ' B' ' 23' ' ' ASP . 0.8 OUTLIER -72.82 121.64 23.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-O 122.499 1.142 . . . . 0.0 109.292 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -139.74 156.32 71.01 Favored Pre-proline 0 C--N 1.262 -3.198 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.366 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.64 ' HB2' HD12 ' B' ' 58' ' ' ILE . 31.3 Cg_exo -65.6 143.93 76.84 Favored 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 122.725 2.283 . . . . 0.0 111.898 172.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.479 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.9 m -127.19 158.36 38.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 123.6 0.76 . . . . 0.0 109.185 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.89 134.34 45.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.514 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.89 97.03 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.416 ' C ' HD13 ' B' ' 41' ' ' ILE . 0.0 OUTLIER -93.81 -24.74 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.376 -178.449 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.534 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 4.1 pt20 -61.52 168.01 3.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 117.287 2.328 . . . . 0.0 117.287 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -62.54 169.57 2.94 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.971 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.06 -28.82 32.2 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -75.95 -38.01 58.03 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 122.293 -0.254 . . . . 0.0 110.539 -172.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.18 -28.55 73.68 Favored Glycine 0 C--O 1.212 -1.244 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -59.18 -34.15 71.79 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.779 0.8 . . . . 0.0 110.26 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.517 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 19.8 mmmt -92.01 -61.23 1.67 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.298 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 60.3 m-85 -80.44 -35.66 34.7 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -167.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.478 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 19.6 m -94.32 134.5 25.53 Favored Pre-proline 0 C--N 1.292 -1.921 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.587 -174.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.91 -20.08 29.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.931 1.754 . . . . 0.0 109.736 173.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 3.0 p -92.61 136.04 33.57 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.107 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.534 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 93.3 t -121.34 140.53 45.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -112.01 123.97 68.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-O 122.153 0.978 . . . . 0.0 109.705 175.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.479 HG13 HG12 ' B' ' 53' ' ' VAL . 27.7 m -133.07 172.8 15.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.957 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.52 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -124.58 146.04 49.27 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.3 131.36 41.84 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' B' ' 37' ' ' PRO . 60.8 mt -89.84 125.76 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . 0.713 ' HB ' HG23 ' B' ' 85' ' ' VAL . 41.2 m -123.55 149.58 45.09 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.672 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.578 179.933 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 mp . . . . . 0 CA--C 1.494 -1.176 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . 0.451 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 59.1 Cg_endo -69.82 37.1 0.24 Allowed 'Trans proline' 0 CA--C 1.553 1.464 0 C-N-CA 122.16 1.907 . . . . 0.0 113.877 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 59.4 p -127.03 -19.11 4.46 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . 0.519 ' CD2' HD22 ' B' ' 87' ' ' LEU . 31.9 m170 -123.49 129.94 51.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.68 136.25 61.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.171 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.13 139.82 37.24 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-O 121.294 0.569 . . . . 0.0 111.603 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.657 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -125.59 155.1 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.499 -174.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -66.74 114.78 5.9 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.033 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -45.62 -53.89 8.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.327 1.451 . . . . 0.0 112.163 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -61.45 -27.26 68.44 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -82.3 -34.25 28.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.705 0.764 . . . . 0.0 109.734 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.657 ' CE1' HG21 ' B' ' 73' ' ' ILE . 4.1 m-85 -86.92 -7.96 57.69 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.647 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 65.22 23.14 12.22 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.982 1.313 . . . . 0.0 112.66 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.04 173.77 10.24 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 123.018 1.39 . . . . 0.0 114.051 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.74 -23.21 56.0 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 111.917 -2.401 . . . . 0.0 110.56 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -149.06 159.59 44.09 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.3 138.16 57.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 123.74 0.65 . . . . 0.0 110.464 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 11.3 m -103.11 134.2 46.93 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.079 -167.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.713 HG23 ' HB ' ' B' ' 59' ' ' THR . 1.1 m -116.64 131.99 67.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.565 ' CD1' HG12 ' B' ' 58' ' ' ILE . 23.6 mm -107.42 127.74 63.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 175.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.519 HD22 ' CD2' ' B' ' 70' ' ' HIS . 24.0 mt -103.06 109.22 20.7 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -177.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.5 mm? -88.83 7.7 32.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.71 0.767 . . . . 0.0 112.179 -172.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -108.76 -34.43 6.68 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-O 122.359 1.076 . . . . 0.0 108.542 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . 0.658 HE22 ' NH2' ' B' ' 92' ' ' ARG . 0.3 OUTLIER -92.79 72.85 4.91 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.52 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.3 pp -114.74 -175.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.712 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.658 ' NH2' HE22 ' B' ' 90' ' ' GLN . 8.5 ptp85 -164.91 164.67 20.74 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 53.5 m -122.58 115.52 22.3 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 68.4 mt -131.81 141.18 49.38 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.396 1.078 . . . . 0.0 109.344 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 3.5 p-10 -72.16 152.68 42.12 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.301 174.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.478 ' HE3' ' O ' ' B' ' 50' ' ' SER . 93.3 mttt -46.65 -21.21 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.199 1.8 . . . . 0.0 115.145 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -89.0 -18.31 27.63 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -79.69 -27.34 40.73 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.71 120.53 19.43 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -91.87 -57.72 2.64 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 12.8 pt-20 -151.29 134.7 16.15 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.93 0.871 . . . . 0.0 112.728 -170.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -62.02 113.38 2.79 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 127.647 2.379 . . . . 0.0 108.8 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -109.81 -62.08 1.55 Allowed 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.769 -176.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.482 HG22 HG11 ' B' ' 19' ' ' VAL . 2.0 t -131.18 -164.48 1.44 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.45 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -161.05 145.01 13.37 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 123.838 0.855 . . . . 0.0 111.558 -171.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.78 162.37 16.39 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.542 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.8 p -83.18 149.56 26.77 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.151 0.58 . . . . 0.0 112.105 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' B' ' 111' ' ' MET . 26.9 t70 -59.55 -32.71 70.58 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.875 0.87 . . . . 0.0 113.129 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -76.81 -25.36 53.21 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.196 0.522 . . . . 0.0 110.596 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.579 ' HD3' ' CG2' ' B' ' 73' ' ' ILE . 15.8 ttmm -85.08 -24.62 28.02 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.877 0.846 . . . . 0.0 109.207 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.542 ' SD ' ' HG2' ' B' ' 16' ' ' ARG . 0.1 OUTLIER -52.92 -34.38 54.86 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 124.708 1.203 . . . . 0.0 109.983 169.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.574 ' HE2' ' N ' ' B' ' 112' ' ' LYS . 7.1 mmpt? -69.78 -24.05 63.45 Favored 'General case' 0 N--CA 1.402 -2.866 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.25 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -85.21 -32.49 22.61 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . 0.44 HG13 HD11 ' B' ' 88' ' ' LEU . 1.8 t -63.53 -42.15 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.48 0 CA-C-N 112.692 -2.049 . . . . 0.0 109.934 171.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.537 ' OD1' ' HG ' ' A' ' 124' ' ' LEU . 42.8 m-20 -60.31 -40.88 92.12 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 122.035 0.921 . . . . 0.0 109.87 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.748 ' O ' HD13 ' B' ' 120' ' ' ILE . 1.1 m-80 -64.29 -21.56 66.64 Favored 'General case' 0 N--CA 1.52 3.063 0 C-N-CA 125.362 1.465 . . . . 0.0 112.604 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.556 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -84.48 -53.03 5.71 Favored 'General case' 2 C--N 1.23 -4.605 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 4.1 tp -65.41 -46.76 78.73 Favored 'General case' 0 N--CA 1.4 -2.955 0 C-N-CA 124.494 1.117 . . . . 0.0 113.978 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.481 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 3.6 ttp -66.98 -24.85 66.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 123.644 0.778 . . . . 0.0 109.999 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.748 HD13 ' O ' ' B' ' 116' ' ' ASN . 2.5 mp -88.52 -45.83 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.0 t -55.18 -29.85 58.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.928 1.291 . . . . 0.0 111.359 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 58.4 mt -99.96 7.43 44.81 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 120.201 -0.599 . . . . 0.0 112.149 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.41 1.06 89.44 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 116.215 1.246 . . . . 0.0 116.215 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.578 ' H ' HD12 ' B' ' 124' ' ' LEU . 3.4 mp -64.96 -51.08 63.73 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 118.832 1.316 . . . . 0.0 109.302 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m120 . . . . . 0 C--N 1.309 -1.179 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.513 179.211 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.414 -2.227 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.454 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 35.6 ptt180 -125.5 158.42 34.53 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -173.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.59 132.49 39.5 Favored 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.81 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.17 -6.17 56.14 Favored Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.165 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.454 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 5.6 t70 -97.12 178.08 5.37 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 4.1 t -135.57 130.61 50.29 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 CA-C-O 121.491 0.662 . . . . 0.0 112.075 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 39.9 m-85 -130.49 145.53 51.87 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.316 176.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -80.31 149.83 30.17 Favored 'General case' 0 N--CA 1.395 -3.189 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 170.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.62 141.68 37.09 Favored 'General case' 0 C--N 1.257 -3.45 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.622 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.29 84.06 6.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.536 ' O ' HG13 ' A' ' 27' ' ' VAL . 91.6 mt -65.53 -27.81 68.72 Favored 'General case' 0 CA--C 1.468 -2.176 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.251 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.514 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 2.1 m -33.82 176.0 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.164 0 C-N-CA 128.375 2.67 . . . . 0.0 114.599 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.585 ' HB2' ' NE2' ' B' ' 28' ' ' GLN . 0.1 OUTLIER 22.92 51.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.108 0 C-N-CA 123.108 2.538 . . . . 0.0 115.554 -152.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 14.9 m -72.02 -178.27 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.421 165.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.535 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 31.8 mm-40 -115.04 124.43 51.59 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.581 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.96 -109.1 1.67 Allowed Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 113.728 -1.578 . . . . 0.0 115.779 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -93.06 8.81 38.45 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.669 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 48.9 mt-10 -64.65 156.34 30.46 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 118.203 -1.399 . . . . 0.0 109.603 174.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.41 HE22 ' HG3' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -73.33 108.92 6.47 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -175.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.16 147.73 19.37 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 116.136 1.215 . . . . 0.0 116.136 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.48 157.19 12.38 Favored Glycine 0 N--CA 1.414 -2.83 0 CA-C-N 113.319 -1.44 . . . . 0.0 110.276 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -77.92 112.44 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 122.583 1.182 . . . . 0.0 108.283 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.41 ' HG3' HE22 ' A' ' 32' ' ' GLN . 17.5 mmt180 -134.16 158.73 74.62 Favored Pre-proline 0 C--N 1.259 -3.345 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.891 -172.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 36.0 Cg_exo -64.56 134.86 43.04 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.656 2.238 . . . . 0.0 110.984 173.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 20' ' ' TYR . 35.4 m -121.1 160.4 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 29.8 m -98.8 129.75 48.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -86.66 101.22 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.43 -20.71 5.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.636 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -55.02 158.54 2.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.232 1.413 . . . . 0.0 114.675 -170.668 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 172.28 4.89 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.322 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.21 -47.22 65.44 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.596 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -71.18 -34.17 70.67 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.919 -169.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.31 75.53 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.805 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -63.54 -35.17 79.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.187 0.517 . . . . 0.0 110.231 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -87.17 -53.39 4.88 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.301 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -96.64 -10.43 27.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -167.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.1 t -113.26 143.3 28.99 Favored Pre-proline 0 C--N 1.294 -1.83 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.191 -177.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 33.6 Cg_endo -71.39 -27.62 19.07 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.734 1.623 . . . . 0.0 109.892 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 p -97.18 142.8 28.65 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.117 -175.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.48 141.02 36.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.758 HG21 HD22 ' B' ' 122' ' ' LEU . 12.1 tt -82.02 133.79 28.44 Favored 'Isoleucine or valine' 0 C--O 1.257 1.451 0 CA-C-O 121.512 0.673 . . . . 0.0 110.739 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -136.27 155.49 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.283 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.525 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -121.01 141.13 51.02 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.06 129.8 38.56 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.51 HD12 ' HB2' ' A' ' 37' ' ' PRO . 57.7 mt -86.38 115.41 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 173.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.3 m -101.24 104.95 16.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.488 0.661 . . . . 0.0 110.903 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.855 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.66 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.5 tt . . . . . 0 N--CA 1.439 -1.004 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 9.3 Cg_endo -52.29 -34.07 58.23 Favored 'Trans proline' 0 C--O 1.208 -1.015 0 C-N-CA 122.832 2.355 . . . . 0.0 114.139 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 p -73.6 -18.96 60.99 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-N 118.238 0.472 . . . . 0.0 112.043 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -104.42 129.17 52.4 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 87.7 t -118.7 112.68 38.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.186 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -82.3 118.89 23.48 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.642 HD12 ' CD2' ' A' ' 78' ' ' TYR . 8.0 pt -101.74 133.27 45.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.268 -174.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.45 118.45 4.47 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.294 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.687 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 43.6 mttp -43.05 -48.6 6.15 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.653 1.216 . . . . 0.0 109.266 173.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -62.46 -29.13 70.3 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 112.781 -2.008 . . . . 0.0 113.28 -173.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -91.72 -29.03 17.05 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.489 0.661 . . . . 0.0 111.093 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.642 ' CD2' HD12 ' A' ' 73' ' ' ILE . 23.0 m-85 -95.84 9.58 40.04 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.256 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 tttm 61.63 27.84 17.17 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.385 1.088 . . . . 0.0 110.148 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.31 176.47 5.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.936 0.874 . . . . 0.0 109.915 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -102.79 -8.63 20.65 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.875 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.503 ' C ' ' HG2' ' A' ' 75' ' ' LYS . 9.9 ptpp? -144.1 143.56 31.19 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.687 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 34.0 m-20 -70.63 120.1 15.75 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.499 ' HB3' HD11 ' A' ' 73' ' ' ILE . 25.3 t -104.57 174.05 6.04 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -175.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 13.3 t -122.39 139.5 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.498 ' CD1' HG12 ' A' ' 58' ' ' ILE . 19.6 mm -104.16 127.41 58.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 172.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.5 mt -102.41 104.9 15.4 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.557 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 4.0 mm? -83.06 3.33 30.88 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.653 0.74 . . . . 0.0 112.195 -175.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -97.79 -36.23 10.28 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 122.25 1.024 . . . . 0.0 108.352 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.438 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 3.1 tp60 -94.92 76.5 3.58 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.851 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.525 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -125.78 175.88 7.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -165.06 173.59 11.32 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.3 m -118.47 121.73 41.0 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.609 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.49 ' HB3' ' HG3' ' A' ' 98' ' ' ARG . 77.0 mt -131.94 149.34 52.46 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.949 -173.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -57.55 143.64 40.17 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 170.17 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 19.0 pttm -53.8 -33.55 56.39 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.988 0.899 . . . . 0.0 112.565 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.494 ' HD3' ' HB3' ' A' ' 95' ' ' ASP . 28.9 mtpt -47.5 -31.38 4.23 Favored 'General case' 0 C--N 1.278 -2.542 0 C-N-CA 127.062 2.145 . . . . 0.0 113.436 170.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.49 ' HG3' ' HB3' ' A' ' 94' ' ' LEU . 2.4 mmp_? -69.57 -31.22 69.27 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.508 0.67 . . . . 0.0 110.323 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 7.2 mp -70.75 131.45 43.87 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.181 1.393 . . . . 0.0 110.712 175.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -99.97 -57.45 2.13 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.281 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 13.2 pt-20 -159.26 146.59 17.19 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-O 121.39 0.614 . . . . 0.0 111.377 -169.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 64.9 tttp -62.65 125.62 24.55 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 126.601 1.96 . . . . 0.0 110.559 173.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 tp -114.74 -61.75 1.7 Allowed 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.179 174.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.469 HG22 HG11 ' A' ' 19' ' ' VAL . 5.3 t -129.35 -159.84 0.99 Allowed 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.554 -1.259 . . . . 0.0 111.98 -177.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -161.05 142.29 11.7 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.258 1.423 . . . . 0.0 109.519 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -105.31 156.57 18.02 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 m -81.81 158.93 23.91 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.475 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.32 -32.33 71.13 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.866 1.267 . . . . 0.0 112.007 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 5.4 p-10 -66.91 -28.23 68.14 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.565 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -73.67 -28.76 61.93 Favored 'General case' 0 CA--C 1.483 -1.622 0 O-C-N 123.404 0.44 . . . . 0.0 111.443 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.42 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -53.06 -48.02 68.01 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-O 121.987 0.899 . . . . 0.0 108.847 174.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.42 ' HE2' ' C ' ' A' ' 111' ' ' MET . 9.0 mmpt? -79.46 -9.82 59.68 Favored 'General case' 0 N--CA 1.39 -3.444 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.655 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 109' ' ' ASP . 38.1 mt-10 -86.54 -43.73 12.49 Favored 'General case' 0 CA--C 1.471 -2.095 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 176.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.0 t -49.81 -47.17 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.037 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -53.87 -41.64 67.75 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.091 0.948 . . . . 0.0 111.262 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.658 ' O ' HD13 ' A' ' 120' ' ' ILE . 24.1 m-80 -80.41 -22.93 40.75 Favored 'General case' 0 CA--C 1.434 -3.502 0 CA-C-O 123.315 1.531 . . . . 0.0 110.21 -173.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 121' ' ' SER . . . -84.37 -37.65 21.27 Favored 'General case' 2 N--CA 1.342 -5.844 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.625 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.711 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -82.67 -55.35 4.49 Favored 'General case' 1 N--CA 1.372 -4.352 0 C-N-CA 123.124 0.57 . . . . 0.0 112.23 -175.159 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.3 mtp -56.85 -35.52 68.95 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -75.27 -45.33 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.445 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.613 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 7.7 t -62.05 -32.12 72.6 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.257 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.762 HD22 HG21 ' B' ' 54' ' ' ILE . 13.0 mt -101.17 1.51 39.18 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.434 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.5 16.24 80.54 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.3 mp -67.99 -52.15 39.05 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-N 119.413 1.606 . . . . 0.0 110.411 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 m120 . . . . . 0 C--N 1.313 -0.984 0 O-C-N 125.654 1.846 . . . . 0.0 114.374 -174.633 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 70.2 mt . . . . . 0 N--CA 1.422 -1.873 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.42 ' HG3' ' HB2' ' B' ' 18' ' ' ASP . 34.9 ptt180 -119.79 157.55 28.38 Favored 'General case' 0 C--N 1.275 -2.666 0 O-C-N 123.828 0.705 . . . . 0.0 110.061 -172.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.27 125.81 29.92 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.846 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.28 -6.86 32.28 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.835 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . 0.454 ' CG ' ' HZ3' ' B' ' 102' ' ' LYS . 5.3 t70 -97.09 177.83 5.46 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 4.8 t -134.65 130.47 53.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-O 121.411 0.624 . . . . 0.0 112.039 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.467 ' O ' HG22 ' B' ' 38' ' ' VAL . 39.4 m-85 -130.12 145.17 51.68 Favored 'General case' 0 CA--C 1.472 -2.023 0 C-N-CA 124.993 1.317 . . . . 0.0 109.118 176.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.3 mp -79.28 151.75 30.94 Favored 'General case' 0 N--CA 1.395 -3.179 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 170.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.71 141.68 33.31 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.925 -176.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.8 83.96 6.43 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.537 ' O ' HG13 ' B' ' 27' ' ' VAL . 90.8 mt -64.92 -26.88 68.5 Favored 'General case' 0 CA--C 1.469 -2.162 0 CA-C-N 112.995 -1.911 . . . . 0.0 111.137 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 2.7 m -34.13 178.35 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.351 0 C-N-CA 128.709 2.804 . . . . 0.0 114.883 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.535 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 0.1 OUTLIER 22.44 50.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.676 0 C-N-CA 122.961 2.441 . . . . 0.0 115.277 -153.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 11.5 m -71.3 -178.95 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.612 166.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 26' ' ' PRO . 31.1 mm-40 -115.14 128.57 56.28 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.36 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.52 -108.97 0.9 Allowed Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.152 -1.385 . . . . 0.0 115.248 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 66.8 m -93.44 7.66 43.65 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.636 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 50.1 mt-10 -62.57 159.98 14.8 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 117.852 -1.539 . . . . 0.0 109.981 175.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.428 HE22 ' HG3' ' B' ' 36' ' ' ARG . 1.0 OUTLIER -75.61 110.23 9.84 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -176.025 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.04 146.93 18.62 Favored Glycine 0 CA--C 1.484 -1.879 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -174.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.85 157.54 11.69 Favored Glycine 0 N--CA 1.412 -2.9 0 CA-C-N 113.331 -1.435 . . . . 0.0 110.29 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -77.68 113.58 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 122.631 1.205 . . . . 0.0 107.78 175.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . 0.428 ' HG3' HE22 ' B' ' 32' ' ' GLN . 19.5 mmt180 -135.63 158.77 73.57 Favored Pre-proline 0 C--N 1.259 -3.369 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.121 -171.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.2 Cg_exo -64.62 134.24 40.21 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.59 2.193 . . . . 0.0 110.925 172.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.467 HG22 ' O ' ' B' ' 20' ' ' TYR . 35.0 m -120.92 160.11 22.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 32.8 m -98.78 130.09 48.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -87.14 100.6 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.08 -20.99 5.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.522 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.586 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -54.61 158.4 2.56 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -170.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.03 170.72 6.38 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.196 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.52 -44.81 70.27 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.443 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 18.7 m -72.17 -34.83 68.76 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 122.697 0.399 . . . . 0.0 111.658 -170.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.78 -30.38 76.84 Favored Glycine 0 C--O 1.219 -0.822 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.71 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -64.67 -27.23 68.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.952 0.406 . . . . 0.0 110.512 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.427 ' HB2' ' CD2' ' B' ' 49' ' ' TYR . 6.7 mmtt -93.17 -53.98 3.9 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' B' ' 48' ' ' LYS . 96.0 m-85 -100.77 1.2 40.05 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -166.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -121.16 142.05 34.22 Favored Pre-proline 0 C--N 1.292 -1.929 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.533 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 37.4 Cg_endo -71.61 -27.04 19.06 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.489 1.46 . . . . 0.0 109.539 174.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.0 146.7 24.4 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.064 -176.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.425 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.4 OUTLIER -143.05 140.49 27.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.762 HG21 HD22 ' A' ' 122' ' ' LEU . 12.4 tt -82.13 133.41 29.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.237 0 CA-C-O 121.375 0.607 . . . . 0.0 110.677 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 36.0 m -135.59 156.33 37.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.349 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.537 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -121.6 140.41 52.28 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.85 128.81 36.52 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' B' ' 37' ' ' PRO . 55.5 mt -86.09 117.05 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 173.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.2 m -102.4 105.16 15.7 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.217 0.532 . . . . 0.0 111.077 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.439 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.802 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.435 -1.176 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 8.5 Cg_endo -52.71 -32.1 53.7 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 122.672 2.248 . . . . 0.0 114.375 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 32.4 p -73.8 -19.33 60.79 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.082 0.468 . . . . 0.0 112.038 -172.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -104.83 129.54 53.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 96.2 t -118.68 114.11 43.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.599 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.76 117.11 22.43 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.648 HD12 ' CD2' ' B' ' 78' ' ' TYR . 8.8 pt -101.43 132.95 46.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.18 -174.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.44 119.5 6.15 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.211 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . 0.672 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 39.9 mttp -43.19 -49.21 6.56 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.587 1.155 . . . . 0.0 109.059 173.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -61.57 -29.59 70.12 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.902 -1.954 . . . . 0.0 113.198 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . 0.408 ' HD2' ' HE2' ' B' ' 110' ' ' LYS . 94.7 mttt -91.71 -29.72 16.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.329 0.585 . . . . 0.0 111.076 -176.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.648 ' CD2' HD12 ' B' ' 73' ' ' ILE . 21.0 m-85 -95.9 7.99 44.85 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.035 -176.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 tttm 60.8 31.83 20.09 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 122.324 1.059 . . . . 0.0 109.972 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -111.86 176.29 5.08 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.495 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' B' ' 75' ' ' LYS . 7.3 p-10 -99.48 -9.83 22.89 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.914 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.488 ' C ' ' HG2' ' B' ' 75' ' ' LYS . 10.0 ptpp? -141.77 143.64 33.57 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.102 -174.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.672 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 27.3 m-20 -71.5 119.27 15.41 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 173.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.529 ' O ' HG12 ' B' ' 73' ' ' ILE . 23.3 t -105.25 173.28 6.37 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 13.4 t -120.43 139.94 46.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.479 HD12 HG12 ' B' ' 58' ' ' ILE . 19.1 mm -104.18 127.68 58.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 172.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 88.0 mt -103.23 105.95 16.36 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.6 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.9 mm? -83.33 -3.98 58.02 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.039 -176.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.52 -34.48 15.53 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.256 1.027 . . . . 0.0 108.778 174.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . 0.465 ' OE1' ' HA ' ' B' ' 31' ' ' GLU . 3.5 tp60 -97.02 76.71 2.7 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.168 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.537 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.3 pp -125.13 176.6 5.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -165.43 173.83 10.66 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 47.4 m -118.8 122.23 41.91 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 64.9 mt -131.92 150.37 52.17 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.894 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.505 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 0.7 OUTLIER -58.44 142.47 48.52 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 169.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' B' ' 99' ' ' LEU . 18.0 pttm -51.82 -36.26 47.34 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.7 0.762 . . . . 0.0 112.435 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.481 ' HD3' ' HB3' ' B' ' 95' ' ' ASP . 28.3 mtpt -44.42 -34.63 2.1 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 126.684 1.994 . . . . 0.0 113.637 171.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -67.43 -29.55 69.05 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.568 0.747 . . . . 0.0 110.71 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' B' ' 96' ' ' LYS . 7.5 mp -72.48 129.63 38.78 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 125.52 1.528 . . . . 0.0 110.611 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -95.95 -58.04 2.2 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.443 -1.253 . . . . 0.0 114.097 -175.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 16.1 pt-20 -161.06 147.18 14.63 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.535 0.683 . . . . 0.0 111.847 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 64.8 tttp -61.17 124.33 20.24 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 126.974 2.11 . . . . 0.0 110.609 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.7 tp -114.57 -61.45 1.75 Allowed 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.348 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.473 HG22 HG11 ' B' ' 19' ' ' VAL . 5.8 t -129.72 -158.25 0.88 Allowed 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 118.179 -1.409 . . . . 0.0 112.063 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -160.28 148.83 16.9 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 126.063 1.745 . . . . 0.0 109.038 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.427 ' HB3' ' CZ ' ' B' ' 78' ' ' TYR . 3.8 pp -112.4 154.77 25.28 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.8 m -80.6 161.13 24.87 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.374 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.67 -32.98 73.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.87 0.868 . . . . 0.0 112.522 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.541 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 5.4 p-10 -62.4 -32.02 72.79 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.408 ' HE2' ' HD2' ' B' ' 77' ' ' LYS . 2.8 mptp? -70.78 -28.85 64.97 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.433 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.1 OUTLIER -54.65 -47.78 73.11 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.433 ' HE2' ' C ' ' B' ' 111' ' ' MET . 9.0 mmpt? -78.38 -12.27 59.99 Favored 'General case' 0 N--CA 1.389 -3.496 0 CA-C-N 114.508 -1.224 . . . . 0.0 113.754 -177.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' B' ' 109' ' ' ASP . 44.3 mt-10 -85.85 -41.64 14.83 Favored 'General case' 0 CA--C 1.47 -2.1 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 177.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 t -51.6 -47.02 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-N 112.911 -1.949 . . . . 0.0 110.731 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -53.04 -48.83 67.34 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.688 0.756 . . . . 0.0 110.276 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.702 ' O ' HD13 ' B' ' 120' ' ' ILE . 10.3 m-80 -69.82 -24.3 63.45 Favored 'General case' 0 N--CA 1.512 2.643 0 C-N-CA 125.004 1.322 . . . . 0.0 112.184 -176.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.6 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -83.41 -44.38 14.86 Favored 'General case' 2 C--N 1.231 -4.546 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.035 177.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.732 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.0 OUTLIER -73.51 -55.72 5.97 Favored 'General case' 1 N--CA 1.374 -4.269 0 C-N-CA 123.349 0.66 . . . . 0.0 112.162 -173.634 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 38.8 mtp -56.88 -37.88 71.97 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.702 HD13 ' O ' ' B' ' 116' ' ' ASN . 1.5 mp -77.06 -39.84 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 60.7 m -58.54 -35.87 72.97 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.625 0.726 . . . . 0.0 110.818 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.758 HD22 HG21 ' A' ' 54' ' ' ILE . 11.0 mt -101.17 -0.01 36.81 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.706 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.85 17.72 79.56 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 115.81 1.084 . . . . 0.0 115.81 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.43 -54.35 21.05 Favored 'General case' 0 CA--C 1.479 -1.753 0 CA-C-N 119.111 1.455 . . . . 0.0 110.021 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 m120 . . . . . 0 C--N 1.305 -1.364 0 CA-C-N 113.575 -1.648 . . . . 0.0 113.937 -173.831 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.433 -1.284 0 CA-C-O 120.76 0.315 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -121.45 153.55 37.73 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.456 172.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -75.43 139.67 42.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.799 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.13 -11.19 51.8 Favored Glycine 0 C--N 1.306 -1.101 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.007 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -97.31 173.46 7.2 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 4.6 t -130.68 130.55 64.72 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 C-N-CA 123.21 0.604 . . . . 0.0 111.763 -175.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 85.4 m-85 -127.03 143.95 51.15 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.907 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -75.16 147.56 40.36 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 169.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -135.86 129.42 32.32 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.706 -1.588 . . . . 0.0 107.635 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 10.1 t70 -84.99 91.08 7.98 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.351 174.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.582 ' O ' HD22 ' A' ' 24' ' ' LEU 0.432 0.0 OUTLIER -114.82 62.1 0.68 Allowed 'General case' 0 N--CA 1.385 -3.699 0 CA-C-O 124.203 1.954 . . . . 0.0 111.999 175.788 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.435 ' OG ' ' HA2' ' A' ' 34' ' ' GLY . 1.4 m -107.04 60.39 0.2 Allowed Pre-proline 0 C--N 1.266 -3.03 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.554 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -115.27 23.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.276 0 N-CA-C 108.456 -1.402 . . . . 0.0 108.456 158.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.623 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 20.1 m -88.65 158.13 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -172.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.423 ' NE2' HH22 ' B' ' 98' ' ' ARG . 0.0 OUTLIER -155.74 160.57 40.42 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 113.005 -1.907 . . . . 0.0 107.049 178.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.51 -142.82 17.47 Favored Glycine 0 C--N 1.297 -1.624 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.411 ' HB2' ' CB ' ' B' ' 95' ' ' ASP . 22.3 m -94.46 15.33 18.06 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 117.053 0.427 . . . . 0.0 110.99 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.623 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 46.3 mt-10 -70.33 157.62 37.4 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -134.99 112.87 10.95 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.494 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -145.0 -109.86 0.66 Allowed Glycine 0 N--CA 1.411 -2.975 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.545 176.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 82.95 178.11 52.24 Favored Glycine 0 N--CA 1.4 -3.76 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -172.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 23' ' ' ASP . 1.4 p -87.45 99.36 8.47 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-O 123.556 1.646 . . . . 0.0 107.44 173.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -140.9 153.03 67.03 Favored Pre-proline 0 C--N 1.268 -2.944 0 CA-C-N 111.724 -2.489 . . . . 0.0 109.01 -168.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.58 ' HB2' HD12 ' A' ' 58' ' ' ILE . 33.5 Cg_exo -60.88 141.09 93.65 Favored 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 122.623 2.216 . . . . 0.0 112.9 175.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 20' ' ' TYR . 27.4 m -126.15 157.87 36.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 34.6 m -100.1 129.86 50.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.9 mm -88.73 98.06 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -18.86 6.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.533 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.69 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -51.26 152.78 2.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -173.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -43.11 146.28 0.44 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.556 2.343 . . . . 0.0 113.23 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -66.26 -37.53 85.69 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.544 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 m -87.68 -30.67 20.22 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.374 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.07 -31.33 78.4 Favored Glycine 0 C--O 1.206 -1.626 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.478 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.632 ' N ' HE22 ' A' ' 42' ' ' GLN . 30.0 p30 -71.95 -20.85 61.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.172 0.511 . . . . 0.0 111.019 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -86.63 -51.64 6.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -85.48 -36.07 20.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -171.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.5 m -97.15 145.92 30.44 Favored Pre-proline 0 C--N 1.291 -1.975 0 O-C-N 121.988 -0.445 . . . . 0.0 110.986 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -80.27 -15.09 11.6 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.916 1.744 . . . . 0.0 109.838 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 1.9 p -96.29 146.09 25.02 Favored 'General case' 0 N--CA 1.42 -1.927 0 C-N-CA 125.007 1.323 . . . . 0.0 110.412 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.75 138.6 22.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.236 0.541 . . . . 0.0 110.746 173.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.69 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -85.34 124.64 40.2 Favored 'Isoleucine or valine' 0 C--O 1.253 1.244 0 C-N-CA 124.435 1.094 . . . . 0.0 110.19 177.059 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.67 171.11 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.419 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.584 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -129.65 142.76 50.67 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.97 129.68 37.27 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.639 HG12 HD12 ' A' ' 86' ' ' ILE . 59.3 mt -85.52 117.57 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.5 174.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.4 m -107.21 111.87 24.47 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.863 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.863 -176.203 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.2 tt . . . . . 0 N--CA 1.425 -1.677 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.575 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 12.4 Cg_endo -56.12 -28.48 70.37 Favored 'Trans proline' 0 C--O 1.2 -1.41 0 C-N-CA 122.363 2.042 . . . . 0.0 114.274 -176.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.0 p -74.08 -18.92 60.76 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.064 0.459 . . . . 0.0 111.515 -174.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.8 m170 -104.64 128.95 52.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.401 HG12 HD13 ' A' ' 73' ' ' ILE . 59.1 t -130.22 124.68 58.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -98.34 133.46 42.71 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.625 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -115.53 158.37 15.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.907 -173.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.502 ' OE1' ' HE3' ' A' ' 110' ' ' LYS . 2.3 mp0 -66.3 113.58 4.71 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.093 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -52.51 -42.11 64.04 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.716 0.806 . . . . 0.0 112.556 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.463 ' HD3' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -61.06 -30.7 70.49 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.463 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 5.0 ttmp? -85.75 -34.99 21.05 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.716 0.769 . . . . 0.0 109.259 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.625 ' CE1' HG21 ' A' ' 73' ' ' ILE . 4.7 m-85 -84.71 5.29 28.87 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.937 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt 68.06 26.47 7.25 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.761 1.224 . . . . 0.0 111.227 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.8 mt -117.56 179.2 4.13 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.456 0.646 . . . . 0.0 110.759 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -108.87 -18.89 13.58 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.51 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -118.51 147.23 43.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.25 123.71 22.85 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 t -102.93 150.72 23.25 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.082 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.3 136.26 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.639 HD12 HG12 ' A' ' 58' ' ' ILE . 19.4 mm -104.49 131.14 54.12 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.967 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.8 mt -100.97 102.57 13.62 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.9 mm? -82.92 4.62 24.94 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.003 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.52 -42.91 7.47 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.912 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.457 ' HA ' HG21 ' B' ' 93' ' ' THR . 0.0 OUTLIER -91.01 76.71 6.17 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.668 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.584 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -117.02 178.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.479 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.417 ' HD2' HD23 ' A' ' 24' ' ' LEU . 15.6 ptp180 -173.81 163.3 4.14 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.475 HG21 ' HA ' ' B' ' 90' ' ' GLN . 61.4 m -107.77 124.18 49.66 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.421 -178.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.405 ' HB3' ' HG3' ' A' ' 98' ' ' ARG . 43.2 mt -132.42 145.62 51.35 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.73 -172.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.1 p30 -76.32 153.63 35.72 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.981 175.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -44.37 -22.14 0.06 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.463 1.905 . . . . 0.0 115.352 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.22 -18.6 60.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 118.206 0.457 . . . . 0.0 110.739 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 32.4 mmt180 -75.12 -38.81 60.95 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.6 mp -68.15 125.21 25.66 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.697 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 23' ' ' ASP . 67.9 mttm -103.99 -64.95 1.05 Allowed 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.304 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.4 pt-20 -150.88 144.28 24.9 Favored 'General case' 0 N--CA 1.412 -2.337 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.069 -166.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -70.59 125.88 28.06 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.425 -1.716 . . . . 0.0 111.098 176.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 tp -114.57 -62.01 1.66 Allowed 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.069 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.499 HG22 HG11 ' A' ' 19' ' ' VAL . 3.8 t -127.81 -167.22 1.72 Allowed 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.639 -1.625 . . . . 0.0 111.626 -177.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -160.81 143.98 13.12 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 124.73 1.212 . . . . 0.0 109.512 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.6 pp -114.18 159.63 19.88 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.762 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.2 t -82.38 159.33 23.04 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.793 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 111' ' ' MET . 18.9 t70 -63.59 -33.31 75.33 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.439 0.638 . . . . 0.0 111.303 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.5 -28.06 65.73 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.102 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.502 ' HE3' ' OE1' ' A' ' 74' ' ' GLU . 5.7 mptp? -76.17 -29.0 57.54 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.078 0.466 . . . . 0.0 110.263 175.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -59.18 -36.31 75.11 Favored 'General case' 0 N--CA 1.416 -2.146 0 C-N-CA 123.521 0.728 . . . . 0.0 109.533 174.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.485 ' HE2' ' C ' ' A' ' 111' ' ' MET . 7.6 mmpt? -78.08 -10.99 59.88 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.34 -38.43 18.8 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 1.7 t -54.61 -39.86 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 112.432 -2.167 . . . . 0.0 110.884 173.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.44 -35.18 69.77 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 122.243 1.02 . . . . 0.0 111.801 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.553 ' O ' HD13 ' A' ' 120' ' ' ILE . 16.4 m-80 -83.89 -18.81 36.18 Favored 'General case' 0 CA--C 1.433 -3.528 0 C-N-CA 125.235 1.414 . . . . 0.0 110.083 -171.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 68' ' ' PRO . . . -84.56 -57.14 3.26 Favored 'General case' 2 N--CA 1.34 -5.952 0 CA-C-N 111.881 -2.418 . . . . 0.0 108.921 171.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 tp -67.34 -45.37 76.61 Favored 'General case' 0 N--CA 1.404 -2.727 0 C-N-CA 125.984 1.714 . . . . 0.0 113.592 -170.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 34.1 mtp -67.64 -22.06 65.34 Favored 'General case' 0 C--O 1.199 -1.575 0 O-C-N 121.704 -0.622 . . . . 0.0 111.839 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.0 OUTLIER -87.13 -45.56 16.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -178.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 10.8 t -56.31 -46.82 79.67 Favored 'General case' 0 C--N 1.277 -2.584 0 C-N-CA 126.618 1.967 . . . . 0.0 111.251 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.614 ' HG ' HG21 ' B' ' 54' ' ' ILE . 7.8 mp -89.44 3.84 51.03 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 123.149 0.579 . . . . 0.0 111.254 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.24 32.66 84.89 Favored Glycine 0 CA--C 1.539 1.583 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 175.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.3 mp -78.19 -34.21 49.63 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 118.651 1.226 . . . . 0.0 109.024 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 . . . . . 0 CA--C 1.549 0.929 0 C-N-CA 129.216 3.006 . . . . 0.0 117.565 179.597 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 53.7 mt . . . . . 0 N--CA 1.441 -0.901 0 CA-C-O 120.685 0.279 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -119.73 156.64 30.15 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.696 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -77.76 139.67 39.39 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.089 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.36 -11.94 51.25 Favored Glycine 0 C--N 1.309 -0.941 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.496 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -97.18 176.74 5.82 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 4.9 t -132.93 129.54 57.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-O 121.44 0.638 . . . . 0.0 112.209 -175.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.449 ' O ' HG22 ' B' ' 38' ' ' VAL . 83.1 m-85 -126.89 143.08 51.37 Favored 'General case' 0 CA--C 1.46 -2.486 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.458 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.592 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -79.41 149.88 31.49 Favored 'General case' 0 N--CA 1.39 -3.43 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.905 170.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -136.76 131.48 33.46 Favored 'General case' 0 C--N 1.259 -3.364 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.132 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' B' ' 35' ' ' VAL . 8.8 t70 -81.84 96.1 7.52 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.037 171.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.582 HD22 ' O ' ' B' ' 24' ' ' LEU 0.475 0.0 OUTLIER -118.19 60.23 0.79 Allowed 'General case' 1 N--CA 1.376 -4.175 0 CA-C-O 124.078 1.894 . . . . 0.0 111.963 172.158 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HA2' ' B' ' 34' ' ' GLY . 1.3 m -105.08 59.89 0.12 Allowed Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 113.264 -1.789 . . . . 0.0 111.687 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.462 ' HD2' HG13 ' B' ' 27' ' ' VAL . 27.9 Cg_endo -116.95 24.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.594 0 N-CA-C 108.054 -1.556 . . . . 0.0 108.054 158.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.663 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 21.7 m -91.46 153.6 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . 0.618 ' N ' HE21 ' B' ' 28' ' ' GLN 0.467 0.0 OUTLIER -128.1 -64.61 0.95 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 119.336 3.087 . . . . 0.0 119.336 -177.385 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.5 -114.65 0.02 OUTLIER Glycine 0 C--N 1.313 -0.696 0 C-N-CA 120.555 -0.831 . . . . 0.0 114.076 -173.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.443 ' HB2' ' CB ' ' A' ' 95' ' ' ASP . 19.4 m -94.15 20.36 8.11 Favored 'General case' 0 C--N 1.271 -2.808 0 O-C-N 122.003 -0.704 . . . . 0.0 109.503 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.663 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 45.6 mt-10 -75.64 162.83 27.92 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.401 ' HB3' HE21 ' B' ' 90' ' ' GLN . 6.4 tp60 -138.41 112.71 8.7 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.515 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -147.18 -113.69 0.78 Allowed Glycine 0 N--CA 1.411 -2.999 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.124 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.459 ' HA2' ' OG ' ' B' ' 25' ' ' SER . . . 86.99 176.53 49.18 Favored Glycine 0 N--CA 1.399 -3.826 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 -172.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' B' ' 23' ' ' ASP . 1.6 p -84.53 99.58 6.97 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -141.46 151.17 60.15 Favored Pre-proline 0 C--N 1.262 -3.224 0 CA-C-N 112.096 -2.32 . . . . 0.0 109.26 -169.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 52.1 Cg_exo -59.0 139.69 91.99 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.825 2.35 . . . . 0.0 112.878 174.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.449 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -125.75 158.36 34.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.5 m -100.39 129.59 50.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 24.3 mm -88.23 98.47 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.95 -18.82 6.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.486 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.681 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.0 OUTLIER -50.81 152.07 2.23 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -41.74 145.99 0.28 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 127.69 2.396 . . . . 0.0 113.761 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.76 -39.4 93.55 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.975 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -87.73 -29.33 21.16 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.13 0.491 . . . . 0.0 110.949 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.25 -30.95 77.46 Favored Glycine 0 C--O 1.206 -1.65 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.039 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.67 ' N ' HE22 ' B' ' 42' ' ' GLN . 29.8 p30 -72.54 -20.55 61.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.064 0.459 . . . . 0.0 111.166 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.12 -53.91 4.78 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.151 0.501 . . . . 0.0 109.817 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -82.79 -35.72 26.24 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.409 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 70.1 m -94.84 143.2 25.76 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-O 120.855 0.36 . . . . 0.0 111.192 -176.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.88 -14.54 12.38 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.072 1.848 . . . . 0.0 109.524 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 1.9 p -97.18 147.93 23.59 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 125.11 1.364 . . . . 0.0 110.052 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.33 138.94 20.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.291 0.567 . . . . 0.0 110.888 173.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.681 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -85.01 124.19 39.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 C-N-CA 124.675 1.19 . . . . 0.0 109.881 177.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.78 171.15 17.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.429 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.59 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -129.82 142.97 50.6 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.0 130.31 38.21 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.655 HG12 HD12 ' B' ' 86' ' ' ILE . 57.8 mt -85.46 117.23 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.513 174.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 22.0 m -105.05 108.83 20.57 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.067 -177.241 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.4 tt . . . . . 0 N--CA 1.416 -2.164 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . 0.563 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 12.4 Cg_endo -56.72 -28.41 75.64 Favored 'Trans proline' 0 C--O 1.204 -1.18 0 C-N-CA 122.257 1.971 . . . . 0.0 114.182 -177.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 62.4 p -73.95 -19.17 60.76 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.046 0.45 . . . . 0.0 111.68 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -105.38 129.07 53.78 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.404 ' CG2' ' HB2' ' B' ' 117' ' ' ALA . 70.8 t -130.31 125.85 60.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.41 134.38 39.66 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.608 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -118.14 153.95 20.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.272 -174.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.55 ' OE1' ' HE3' ' B' ' 110' ' ' LYS . 3.7 mp0 -65.02 113.04 3.62 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.49 -178.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -50.71 -41.64 56.28 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 124.272 1.029 . . . . 0.0 112.634 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -22.04 66.17 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.252 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -91.36 -36.32 13.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.644 0.735 . . . . 0.0 109.071 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.608 ' CE1' HG21 ' B' ' 73' ' ' ILE . 4.5 m-85 -83.38 8.11 14.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.433 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 67.09 20.38 10.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.824 1.249 . . . . 0.0 111.757 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -111.0 179.66 3.98 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.1 0.476 . . . . 0.0 110.798 -174.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.86 -24.44 12.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.199 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -116.64 147.33 42.01 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.07 123.09 23.74 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.546 0.689 . . . . 0.0 109.237 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 22.6 t -102.88 154.11 19.53 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.72 -167.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.0 t -116.18 136.08 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.655 HD12 HG12 ' B' ' 58' ' ' ILE . 21.3 mm -104.66 131.87 52.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.932 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 66.2 mt -101.65 103.14 13.93 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.574 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.9 mm? -82.88 -0.41 48.17 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.535 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -94.37 -40.67 9.81 Favored 'General case' 0 N--CA 1.413 -2.294 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.94 173.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . 0.475 ' HA ' HG21 ' A' ' 93' ' ' THR . 0.0 OUTLIER -91.04 76.67 6.16 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.27 1.033 . . . . 0.0 108.59 178.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.59 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.5 pp -117.33 178.77 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.584 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.418 ' HD2' HD23 ' B' ' 24' ' ' LEU . 15.5 ptp180 -173.8 163.58 4.18 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 90' ' ' GLN . 65.5 m -108.15 124.21 49.91 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.569 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.44 ' HB3' ' HG3' ' B' ' 98' ' ' ARG . 45.7 mt -132.34 145.85 51.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.739 -172.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 1.9 p-10 -77.8 153.5 32.77 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.412 176.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 50' ' ' SER . 99.5 mttt -44.69 -21.76 0.06 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.129 1.772 . . . . 0.0 115.446 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -73.7 -19.17 60.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.11 0.481 . . . . 0.0 110.745 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.534 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 31.5 mmt180 -74.98 -38.73 61.57 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.876 -0.515 . . . . 0.0 109.875 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.5 123.12 20.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.092 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -102.67 -65.08 1.01 Allowed 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 114.165 -1.379 . . . . 0.0 113.46 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.0 pt-20 -149.03 139.83 22.77 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.328 0.585 . . . . 0.0 111.349 -165.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.2 OUTLIER -69.76 123.5 21.57 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.754 -1.566 . . . . 0.0 111.592 176.203 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.07 -62.37 1.61 Allowed 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.249 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.532 HG22 HG11 ' B' ' 19' ' ' VAL . 3.2 t -126.91 -168.25 1.85 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 117.432 -1.707 . . . . 0.0 112.434 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -160.49 142.28 12.53 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 124.468 1.107 . . . . 0.0 110.205 -175.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -112.14 159.33 18.64 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.647 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 32.5 t -82.59 161.91 22.1 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' B' ' 111' ' ' MET . 16.7 t70 -62.1 -34.2 75.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.758 0.823 . . . . 0.0 111.373 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.01 -27.56 62.81 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.55 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 5.6 mptp? -75.0 -29.27 60.83 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 120.874 0.368 . . . . 0.0 110.02 175.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.481 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -57.54 -38.31 74.5 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.655 174.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.45 ' HE2' ' C ' ' B' ' 111' ' ' MET . 7.6 mmpt? -77.34 -13.74 59.87 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.13 -35.37 21.8 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 t -56.88 -41.36 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.568 0 CA-C-N 112.32 -2.218 . . . . 0.0 110.099 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -44.54 76.98 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.831 0.824 . . . . 0.0 110.489 174.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.732 ' O ' HD13 ' B' ' 120' ' ' ILE . 1.1 m-80 -70.61 -20.91 62.71 Favored 'General case' 0 CA--C 1.474 -1.98 0 CA-C-O 122.384 1.088 . . . . 0.0 111.135 -176.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.574 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -84.26 -53.85 5.2 Favored 'General case' 2 C--N 1.235 -4.405 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.291 173.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.67 -46.77 74.61 Favored 'General case' 0 N--CA 1.403 -2.798 0 C-N-CA 126.194 1.798 . . . . 0.0 113.471 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 38.4 mtp -66.05 -24.91 66.82 Favored 'General case' 0 C--O 1.2 -1.504 0 O-C-N 121.754 -0.591 . . . . 0.0 111.395 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.732 HD13 ' O ' ' B' ' 116' ' ' ASN . 1.3 mp -86.95 -40.77 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 70.5 m -57.12 -46.88 82.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 122.124 0.964 . . . . 0.0 111.145 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.598 ' HG ' HG21 ' A' ' 54' ' ' ILE . 7.4 mp -88.4 3.37 50.18 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.806 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.5 32.0 79.62 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.28 -37.04 63.8 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 119.041 1.421 . . . . 0.0 108.696 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.588 HD22 HG13 ' B' ' 120' ' ' ILE . 5.0 t-20 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 128.489 2.716 . . . . 0.0 117.443 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 N--CA 1.429 -1.512 0 CA-C-O 121.915 0.864 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -110.02 154.64 22.91 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.906 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -84.63 129.89 34.78 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.021 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.6 0.38 43.0 Favored Glycine 0 C--N 1.308 -0.992 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.644 -175.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -97.33 170.14 9.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 104' ' ' THR . 12.0 t -131.73 133.9 60.87 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 C-N-CA 124.063 0.945 . . . . 0.0 112.021 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 93.1 m-85 -132.41 145.83 51.51 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.573 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER -76.96 148.64 36.2 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 169.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -143.78 149.07 36.52 Favored 'General case' 0 C--N 1.257 -3.452 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.669 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -74.45 85.78 2.02 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 124.238 1.971 . . . . 0.0 108.044 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 24' ' ' LEU . 2.0 tm? -87.94 13.15 11.52 Favored 'General case' 0 N--CA 1.407 -2.615 0 CA-C-N 111.198 -2.728 . . . . 0.0 111.662 -166.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 p -104.67 62.23 0.11 Allowed Pre-proline 0 N--CA 1.414 -2.236 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -113.47 23.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 121.712 1.608 . . . . 0.0 108.314 158.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.65 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 12.8 m -78.87 -179.1 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.702 -173.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.9 154.29 50.51 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.658 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.42 -108.99 1.16 Allowed Glycine 0 CA--C 1.502 -0.77 0 N-CA-C 116.271 1.268 . . . . 0.0 116.271 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 m -93.75 -6.63 45.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.236 -174.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 50.2 mt-10 -60.24 159.17 10.25 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.454 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.433 HE22 ' HG3' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -81.21 113.02 19.07 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -173.045 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.75 159.51 15.87 Favored Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 115.626 1.011 . . . . 0.0 115.626 -177.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 24' ' ' LEU . . . 110.43 146.31 10.89 Favored Glycine 0 N--CA 1.415 -2.764 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 22' ' ' ALA . 3.6 p -61.55 122.61 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 CA-C-O 122.507 1.146 . . . . 0.0 109.382 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.433 ' HG3' HE22 ' A' ' 32' ' ' GLN . 14.4 mmt85 -141.3 162.23 48.69 Favored Pre-proline 0 C--N 1.264 -3.124 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.753 -169.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HB2' HD12 ' A' ' 58' ' ' ILE . 1.3 Cg_endo -80.08 142.35 15.33 Favored 'Trans proline' 0 N--CA 1.427 -2.429 0 C-N-CA 121.785 1.657 . . . . 0.0 109.736 171.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 22.4 m -123.54 155.17 29.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.068 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.518 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 35.5 m -99.38 132.9 43.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.79 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.459 HD13 HG12 ' A' ' 55' ' ' VAL . 22.9 mm -90.97 105.2 16.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -99.56 -15.58 7.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.817 -179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.641 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 2.8 tt0 -55.47 162.65 1.5 Allowed 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 126.035 1.734 . . . . 0.0 114.518 -168.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.512 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 1.5 p30 -75.93 177.12 7.25 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.829 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.24 -34.53 49.12 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 m -75.3 -24.62 57.49 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.128 0.49 . . . . 0.0 110.504 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.38 -23.06 73.35 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -83.44 -19.7 35.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.451 0.643 . . . . 0.0 109.91 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -89.93 -66.77 0.89 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.315 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -107.87 2.13 23.23 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.3 m -108.09 134.4 20.16 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.51 -22.92 20.68 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 121.671 1.58 . . . . 0.0 109.364 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 p -86.97 158.94 19.16 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.631 -1.622 . . . . 0.0 111.551 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.641 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 66.2 t -137.64 140.4 41.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 173.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.451 HD13 ' CD2' ' B' ' 122' ' ' LEU . 5.8 tt -105.9 127.48 60.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.548 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 34.1 m -132.01 174.65 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.263 -174.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -131.52 146.51 52.27 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.81 138.44 38.97 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 37' ' ' PRO . 81.6 mt -99.89 127.32 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.707 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -141.67 138.28 32.37 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.004 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.089 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 176.879 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tt . . . . . 0 N--CA 1.432 -1.359 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 27.0 Cg_exo -62.54 -35.04 73.29 Favored 'Trans proline' 0 C--O 1.196 -1.62 0 C-N-CA 121.431 1.421 . . . . 0.0 114.136 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.2 p -73.36 -18.59 61.16 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -114.67 128.97 56.61 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.1 127.73 75.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 118.704 0.684 . . . . 0.0 109.863 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -97.76 130.3 44.72 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.139 0.495 . . . . 0.0 110.406 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.505 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -110.31 169.61 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.4 ' H ' HG22 ' A' ' 73' ' ' ILE . 44.4 mt-10 -89.04 137.17 32.56 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.385 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 82' ' ' LYS . 58.4 tttm -50.36 -42.46 53.21 Favored 'General case' 0 C--O 1.207 -1.141 0 O-C-N 124.351 1.032 . . . . 0.0 109.997 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.435 ' HG3' ' H ' ' A' ' 76' ' ' LYS . 46.5 mttp -54.11 -49.67 68.61 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 125.623 1.569 . . . . 0.0 111.494 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.02 -40.45 38.88 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 2.4 m-85 -77.4 -8.84 58.35 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 78' ' ' TYR . 17.4 ptmt 52.74 34.0 15.22 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.571 1.549 . . . . 0.0 110.692 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.66 -173.83 2.64 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.246 -171.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.13 -29.43 67.48 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.068 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 14.4 ptmm? -166.87 168.14 14.31 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -52.4 138.46 27.11 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.48 137.98 53.44 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -169.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.1 t -107.97 142.05 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.597 HD12 HG12 ' A' ' 58' ' ' ILE . 16.6 mm -109.9 135.3 49.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.62 106.88 17.58 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -89.5 10.4 22.96 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.602 0.715 . . . . 0.0 111.79 -175.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.4 -34.28 6.83 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.955 0.883 . . . . 0.0 109.662 173.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.578 ' HA ' HG21 ' B' ' 93' ' ' THR . 0.3 OUTLIER -101.2 88.39 3.48 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.687 177.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.562 ' O ' ' HD2' ' A' ' 92' ' ' ARG . 2.1 pp -121.97 178.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.943 -174.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.562 ' HD2' ' O ' ' A' ' 91' ' ' ILE . 18.2 mmm180 -136.76 172.97 12.23 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.75 0.786 . . . . 0.0 111.521 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.578 HG21 ' HA ' ' B' ' 90' ' ' GLN . 52.9 m -139.84 119.21 12.93 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 171.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 64.2 mt -134.27 145.05 48.73 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.807 0.843 . . . . 0.0 111.345 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.83 145.49 52.5 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 119.503 1.047 . . . . 0.0 109.656 165.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -49.36 -34.91 17.18 Favored 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -57.03 -23.8 49.11 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 125.374 1.469 . . . . 0.0 112.64 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 6.2 mmp_? -74.5 -27.73 60.68 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.556 0.693 . . . . 0.0 109.445 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.29 107.86 8.83 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 122.944 1.354 . . . . 0.0 110.937 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.62 -63.5 1.36 Allowed 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 113.039 -1.891 . . . . 0.0 114.875 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.5 pt-20 -158.29 150.02 21.42 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-O 121.814 0.816 . . . . 0.0 111.485 -170.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 66.2 mttm -61.3 126.44 27.37 Favored 'General case' 0 C--N 1.273 -2.738 0 C-N-CA 127.284 2.234 . . . . 0.0 111.832 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 tp -115.63 -62.45 1.59 Allowed 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.725 171.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.53 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 2.7 t -127.98 -167.16 1.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.142 -1.423 . . . . 0.0 112.33 -177.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.74 135.23 8.33 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 125.598 1.559 . . . . 0.0 110.712 -172.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 mt -87.08 157.48 19.4 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 124.098 0.959 . . . . 0.0 111.344 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.466 ' HB2' ' HD3' ' A' ' 110' ' ' LYS . 7.5 m -84.08 161.22 20.75 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 111' ' ' MET . 4.9 m-20 -62.4 -36.52 82.59 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.538 0.735 . . . . 0.0 112.576 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -79.79 -26.63 40.52 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.576 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.466 ' HD3' ' HB2' ' A' ' 107' ' ' SER . 2.5 mptp? -70.54 -26.45 63.56 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.98 0.419 . . . . 0.0 110.687 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.468 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -57.26 -39.18 75.1 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 123.903 0.881 . . . . 0.0 109.667 172.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.468 ' HE2' ' C ' ' A' ' 111' ' ' MET . 7.9 mmpt? -83.36 -11.1 58.0 Favored 'General case' 0 N--CA 1.397 -3.117 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.426 ' OE1' ' HG3' ' A' ' 110' ' ' LYS . 36.7 mt-10 -84.78 -37.16 21.14 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 1.4 t -55.04 -36.91 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-N 112.835 -1.984 . . . . 0.0 110.617 172.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.56 -35.36 80.73 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.401 1.096 . . . . 0.0 111.153 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.659 ' O ' HD13 ' A' ' 120' ' ' ILE . 13.4 m-80 -81.13 -15.03 57.04 Favored 'General case' 1 N--CA 1.555 4.823 0 CA-C-O 124.165 1.936 . . . . 0.0 109.596 -174.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.555 ' HB3' ' HG ' ' A' ' 88' ' ' LEU 0.337 . . -91.01 -51.31 5.4 Favored 'General case' 2 N--CA 1.346 -5.635 0 CA-C-N 111.867 -2.424 . . . . 0.0 105.254 175.109 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.621 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 3.3 tp -69.27 -47.47 64.53 Favored 'General case' 0 N--CA 1.393 -3.29 0 C-N-CA 124.518 1.127 . . . . 0.0 113.165 -171.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.5 mtp -64.77 -28.34 69.51 Favored 'General case' 0 C--O 1.195 -1.804 0 O-C-N 121.451 -0.78 . . . . 0.0 111.608 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.659 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -77.86 -48.67 23.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 23.1 t -56.48 -33.55 66.08 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 113.076 -1.875 . . . . 0.0 111.286 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 20.1 mt -104.48 7.32 35.34 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.021 0.439 . . . . 0.0 110.664 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.44 78.21 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.413 ' CD1' ' HB2' ' A' ' 122' ' ' LEU . 6.9 mp -80.51 -51.38 8.85 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 119.113 1.456 . . . . 0.0 108.927 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 CA--C 1.557 1.215 0 CA-C-N 113.068 -1.878 . . . . 0.0 112.833 -173.215 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.432 -1.341 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -113.59 155.99 24.46 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.879 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.21 135.08 34.5 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.95 2.17 58.33 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.743 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . 0.411 ' CG ' ' HZ2' ' B' ' 102' ' ' LYS . 10.1 t70 -97.79 168.4 10.34 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 13.6 t -131.88 133.84 60.63 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 C-N-CA 123.805 0.842 . . . . 0.0 112.252 -176.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 89.9 m-85 -132.44 145.52 51.26 Favored 'General case' 0 CA--C 1.483 -1.628 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.417 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 0.8 OUTLIER -76.25 149.2 37.19 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 169.448 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.482 ' O ' HG23 ' B' ' 35' ' ' VAL . . . -144.35 148.66 35.02 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.891 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.5 85.64 1.54 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 124.022 1.868 . . . . 0.0 107.741 172.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.52 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.1 tm? -88.8 12.95 13.66 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 111.33 -2.668 . . . . 0.0 111.769 -166.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 17.8 p -104.59 62.38 0.1 Allowed Pre-proline 0 CA--C 1.582 2.202 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -112.82 23.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 121.676 1.584 . . . . 0.0 108.316 159.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 16.1 m -78.42 -179.17 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.327 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.68 154.17 48.59 Favored 'General case' 0 C--O 1.206 -1.228 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.775 175.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.11 -112.0 3.26 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 115.307 0.883 . . . . 0.0 115.307 170.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -94.51 -2.85 50.96 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.532 0.333 . . . . 0.0 110.816 -173.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.67 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 51.7 mt-10 -60.71 158.84 11.91 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.167 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.413 HE22 ' HG3' ' B' ' 36' ' ' ARG . 0.9 OUTLIER -80.98 112.28 18.23 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -172.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.53 156.25 17.79 Favored Glycine 0 CA--C 1.473 -2.553 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' B' ' 24' ' ' LEU . . . 114.18 149.3 10.01 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 22' ' ' ALA . 3.2 p -63.53 125.73 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-O 122.526 1.155 . . . . 0.0 108.933 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . 0.413 ' HG3' HE22 ' B' ' 32' ' ' GLN . 9.7 mmt85 -142.09 160.98 53.25 Favored Pre-proline 0 C--N 1.268 -2.952 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.068 -168.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.617 ' HB2' HD12 ' B' ' 58' ' ' ILE . 0.9 OUTLIER -80.62 142.06 14.19 Favored 'Trans proline' 0 N--CA 1.426 -2.442 0 C-N-CA 121.714 1.609 . . . . 0.0 109.38 170.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 24.3 m -123.22 155.59 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.18 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.518 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 35.7 m -99.65 132.97 44.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.789 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.441 HD13 HG12 ' B' ' 55' ' ' VAL . 22.7 mm -91.52 105.42 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.501 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -99.44 -16.15 7.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.844 -179.23 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.652 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 2.8 tt0 -54.89 162.81 1.14 Allowed 'General case' 0 N--CA 1.424 -1.743 0 C-N-CA 126.369 1.868 . . . . 0.0 114.986 -167.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.502 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 2.2 p30 -74.78 175.83 7.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.934 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -77.24 -34.78 55.81 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 21.6 m -75.39 -25.53 57.71 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.156 0.503 . . . . 0.0 110.222 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.63 -23.99 72.41 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -83.23 -20.22 34.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.986 0.422 . . . . 0.0 110.28 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -88.87 -66.95 0.87 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.994 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -100.15 -23.4 14.86 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -167.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' B' ' 51' ' ' PRO . 15.2 m -83.85 136.17 41.94 Favored Pre-proline 0 N--CA 1.423 -1.822 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 50' ' ' SER . 8.0 Cg_exo -74.27 -21.72 17.32 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 121.706 1.604 . . . . 0.0 108.754 173.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -89.18 158.11 18.02 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 113.342 -1.754 . . . . 0.0 111.276 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.652 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 60.4 t -137.82 140.29 41.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.457 HD13 ' CD2' ' A' ' 122' ' ' LEU . 5.6 tt -106.43 127.91 61.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 174.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.56 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 33.9 m -132.91 174.16 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.212 -173.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.518 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -130.74 146.71 52.28 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.53 137.43 38.62 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' B' ' 37' ' ' PRO . 82.0 mt -98.35 128.56 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 113.323 -1.762 . . . . 0.0 107.736 176.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.5 t -140.89 141.38 34.58 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 119.581 -0.847 . . . . 0.0 111.621 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.242 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.149 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.2 tt . . . . . 0 N--CA 1.44 -0.973 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . 0.455 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 74.9 Cg_exo -54.41 -40.57 82.52 Favored 'Trans proline' 0 C--O 1.208 -1.017 0 C-N-CA 122.187 1.924 . . . . 0.0 114.659 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 57.8 p -72.63 -18.47 61.58 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -168.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . 0.475 ' CD2' HD22 ' B' ' 87' ' ' LEU . 53.6 m170 -113.47 128.88 56.6 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' B' ' 117' ' ' ALA . 57.3 t -121.32 130.01 75.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 O-C-N 121.545 -0.722 . . . . 0.0 109.854 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -98.53 135.72 39.67 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.114 0.483 . . . . 0.0 109.735 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.517 HG21 ' CE1' ' B' ' 78' ' ' TYR . 1.2 mm -112.32 174.95 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.427 ' H ' HG22 ' B' ' 73' ' ' ILE . 41.0 mt-10 -92.99 139.08 30.9 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.223 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -51.79 -41.08 61.42 Favored 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 124.724 1.21 . . . . 0.0 109.697 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -59.21 -41.24 88.13 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 125.961 1.704 . . . . 0.0 111.686 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' B' ' 77' ' ' LYS . 0.2 OUTLIER -84.77 -39.05 18.89 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -176.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.569 ' O ' ' HG2' ' B' ' 79' ' ' LYS . 2.3 m-85 -79.14 -7.85 58.52 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.521 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' B' ' 78' ' ' TYR . 17.8 ptmt 52.71 33.25 13.51 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.63 1.572 . . . . 0.0 110.593 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.34 -175.89 3.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.463 -172.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.79 -29.88 70.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.93 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -165.99 165.96 17.65 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -50.91 135.31 24.59 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.08 139.38 49.93 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -169.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.09 142.6 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.594 HD12 HG12 ' B' ' 58' ' ' ILE . 16.2 mm -111.71 136.17 48.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.475 HD22 ' CD2' ' B' ' 70' ' ' HIS . 42.9 mt -106.35 106.25 16.68 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.605 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.8 mm? -89.07 10.39 21.9 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.714 0.769 . . . . 0.0 112.07 -175.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.67 -34.26 6.76 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.723 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . 0.578 ' HA ' HG21 ' A' ' 93' ' ' THR . 0.3 OUTLIER -100.99 87.56 3.31 Favored 'General case' 0 N--CA 1.406 -2.647 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 2.1 pp -121.49 178.91 2.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.061 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' B' ' 91' ' ' ILE . 18.3 mmm180 -136.8 172.46 12.97 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.73 0.776 . . . . 0.0 111.312 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 90' ' ' GLN . 54.6 m -139.82 119.35 13.09 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 170.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 65.9 mt -134.18 146.79 50.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 110.874 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -63.26 151.12 41.47 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.073 1.306 . . . . 0.0 109.668 165.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -51.22 -34.67 33.19 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -56.23 -25.42 47.51 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 125.076 1.35 . . . . 0.0 112.912 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 5.7 mmp_? -73.91 -29.17 61.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.397 0.618 . . . . 0.0 109.733 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.2 mp -75.46 107.73 7.79 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 125.045 1.338 . . . . 0.0 111.051 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.79 -65.77 0.97 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 112.882 -1.963 . . . . 0.0 114.932 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.2 pt-20 -156.32 146.34 21.25 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-O 121.504 0.669 . . . . 0.0 111.25 -169.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 67.6 mttm -60.52 126.43 27.4 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 126.639 1.976 . . . . 0.0 111.902 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -115.09 -61.92 1.68 Allowed 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.503 172.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.545 ' O ' ' HB ' ' B' ' 19' ' ' VAL . 3.4 t -127.23 -168.22 1.85 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 117.99 -1.484 . . . . 0.0 112.432 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -160.12 133.6 6.96 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 125.584 1.554 . . . . 0.0 110.456 -171.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 mt -84.29 162.67 20.01 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 124.009 0.924 . . . . 0.0 112.021 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . 0.431 ' HB2' ' HD3' ' B' ' 110' ' ' LYS . 3.7 m -87.94 162.08 17.08 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.701 171.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.76 -31.79 71.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.45 -30.81 42.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.535 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.467 ' HG2' HG23 ' B' ' 73' ' ' ILE . 2.6 mptp? -67.78 -28.91 68.0 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.011 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.464 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.0 OUTLIER -55.46 -38.8 69.54 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 123.907 0.883 . . . . 0.0 109.988 172.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.464 ' HE2' ' C ' ' B' ' 111' ' ' MET . 7.8 mmpt? -83.99 -13.08 54.21 Favored 'General case' 0 N--CA 1.399 -2.998 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -84.4 -33.43 23.75 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.4 t -58.02 -39.71 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.404 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.2 172.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.05 -42.6 98.79 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.009 0.909 . . . . 0.0 110.067 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.624 ' O ' HD13 ' B' ' 120' ' ' ILE . 10.4 m-80 -69.51 -21.01 63.7 Favored 'General case' 0 CA--C 1.456 -2.639 0 C-N-CA 125.01 1.324 . . . . 0.0 111.923 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.605 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -83.39 -50.57 8.2 Favored 'General case' 2 N--CA 1.366 -4.666 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.839 173.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 3.3 tp -71.77 -48.21 48.33 Favored 'General case' 0 N--CA 1.393 -3.296 0 C-N-CA 124.546 1.138 . . . . 0.0 113.098 -171.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 37.7 mtp -63.66 -31.35 72.5 Favored 'General case' 0 C--O 1.197 -1.662 0 O-C-N 121.451 -0.781 . . . . 0.0 111.076 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.624 HD13 ' O ' ' B' ' 116' ' ' ASN . 1.4 mp -78.78 -42.93 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -56.71 -35.48 68.57 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.028 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 19.3 mt -104.18 6.57 35.74 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.936 -0.478 . . . . 0.0 111.151 -176.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.74 23.16 78.08 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 115.891 1.117 . . . . 0.0 115.891 173.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' B' ' 122' ' ' LEU . 7.1 mp -79.55 -51.86 8.76 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 118.954 1.377 . . . . 0.0 108.361 177.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.492 ' ND2' HG13 ' B' ' 120' ' ' ILE . 1.6 t-20 . . . . . 0 C--N 1.306 -1.312 0 CA-C-N 113.118 -1.855 . . . . 0.0 112.748 -173.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.3 mt . . . . . 0 C--O 1.246 0.885 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -146.89 161.41 40.78 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.9 ptm85 -84.05 122.03 28.23 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.823 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 130.76 -19.44 4.99 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.039 -175.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -92.42 147.31 23.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.957 0.884 . . . . 0.0 110.261 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.623 ' HB ' ' H ' ' A' ' 104' ' ' THR . 51.6 t -98.62 118.15 44.72 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.271 173.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.432 ' O ' HG22 ' A' ' 38' ' ' VAL . 19.9 m-85 -108.46 145.73 34.22 Favored 'General case' 0 CA--C 1.458 -2.562 0 C-N-CA 124.673 1.189 . . . . 0.0 112.24 176.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -80.7 145.58 31.51 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 166.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -143.92 133.12 23.05 Favored 'General case' 0 C--N 1.259 -3.343 0 CA-C-N 113.743 -1.572 . . . . 0.0 108.383 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HA ' ' HB ' ' A' ' 35' ' ' VAL . 6.8 p-10 -88.57 85.35 6.81 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-O 121.593 0.711 . . . . 0.0 109.925 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.537 ' O ' HD22 ' A' ' 24' ' ' LEU 0.459 0.0 OUTLIER -107.2 60.82 0.62 Allowed 'General case' 0 N--CA 1.393 -3.295 0 C-N-CA 116.887 -1.925 . . . . 0.0 113.121 178.557 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.581 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 25.2 p -113.59 62.48 0.95 Allowed Pre-proline 0 C--N 1.271 -2.829 0 CA-C-N 113.491 -1.686 . . . . 0.0 113.62 173.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.457 ' HD3' ' C ' ' A' ' 24' ' ' LEU . 24.4 Cg_endo -115.41 26.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.26 0 N-CA-C 107.883 -1.622 . . . . 0.0 107.883 159.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 17.4 m -94.32 159.61 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.457 -173.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.58 151.72 36.73 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.548 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.34 -132.2 11.52 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.302 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -93.85 11.94 27.61 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.652 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 42.6 mt-10 -68.09 151.51 46.92 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 170.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -131.58 114.96 15.48 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.495 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -147.72 -120.21 1.15 Allowed Glycine 0 N--CA 1.406 -3.347 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.964 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.581 ' HA2' ' HB3' ' A' ' 25' ' ' SER . . . 98.54 172.79 32.17 Favored Glycine 0 N--CA 1.408 -3.175 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 -171.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 1.1 p -88.94 104.09 14.56 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.075 0 CA-C-O 123.033 1.396 . . . . 0.0 108.303 173.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -133.13 163.35 51.74 Favored Pre-proline 0 C--N 1.271 -2.829 0 CA-C-N 112.536 -2.12 . . . . 0.0 110.894 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.542 ' HB2' HD12 ' A' ' 58' ' ' ILE . 14.5 Cg_exo -70.87 141.3 40.38 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.746 1.631 . . . . 0.0 109.749 166.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 20' ' ' TYR . 32.3 m -127.12 162.52 31.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 124.511 1.125 . . . . 0.0 108.182 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 34.8 m -104.1 128.89 57.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.671 176.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.423 HD13 HG12 ' A' ' 55' ' ' VAL . 33.0 mm -88.61 104.96 15.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -99.96 -16.34 7.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.594 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -43.75 139.28 2.32 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 127.168 2.187 . . . . 0.0 114.667 -170.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -46.81 145.64 1.9 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.22 -32.81 74.11 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -79.11 -25.76 42.95 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.408 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.77 -33.46 80.32 Favored Glycine 0 C--O 1.199 -2.058 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.553 ' N ' HE22 ' A' ' 42' ' ' GLN 0.257 20.1 p30 -75.45 -19.68 59.3 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.366 -178.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -85.46 -59.3 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.235 172.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.52 -19.06 18.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -167.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 m -102.22 135.91 19.53 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.524 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.69 -12.55 16.59 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.066 1.844 . . . . 0.0 110.783 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 3.0 p -100.21 134.14 43.57 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.485 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 93' ' ' THR . 61.4 t -121.37 140.19 46.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.594 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 3.3 tp -105.72 125.1 61.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 123.543 0.737 . . . . 0.0 109.28 173.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.736 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 14.0 m -130.64 162.28 38.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.335 -175.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.553 ' HA ' HG22 ' A' ' 91' ' ' ILE . . . -118.99 132.37 56.06 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.056 0.942 . . . . 0.0 108.93 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.74 128.89 38.01 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.542 HD12 ' HB2' ' A' ' 37' ' ' PRO . 61.1 mt -85.63 132.67 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.795 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.3 m -125.92 133.92 51.72 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.192 0.52 . . . . 0.0 111.44 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 177.047 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.9 tt . . . . . 0 N--CA 1.442 -0.854 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.71 2.12 2.24 Favored 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 123.103 2.536 . . . . 0.0 116.018 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 121' ' ' SER . 51.9 p -92.0 -19.15 22.69 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 122.497 1.141 . . . . 0.0 108.715 176.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.458 ' CD2' HD22 ' A' ' 87' ' ' LEU . 28.9 m170 -101.15 133.35 45.82 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 171.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 4.4 p -133.44 145.51 33.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 117.046 -1.862 . . . . 0.0 112.434 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -87.66 124.54 33.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.636 1.174 . . . . 0.0 112.88 -173.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.555 HG21 ' CZ ' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -128.54 143.97 39.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.814 0.816 . . . . 0.0 112.852 175.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.432 ' OE2' ' HE3' ' A' ' 110' ' ' LYS . 1.3 mp0 -60.74 133.1 55.77 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.727 -178.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 83.8 tttt -55.11 -46.44 75.58 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.751 1.62 . . . . 0.0 109.889 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -58.5 -48.72 79.9 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 113.129 -1.85 . . . . 0.0 113.305 -174.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.535 ' HE2' ' OG ' ' A' ' 107' ' ' SER . 3.8 tmtm? -80.29 -38.27 31.11 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -171.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.555 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 4.5 m-85 -84.3 -7.03 59.45 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.601 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 67.93 28.12 6.99 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.43 179.4 5.54 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.533 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HE3' ' A' ' 75' ' ' LYS . 9.9 t70 -68.82 -28.09 66.43 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.605 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.449 ' HB3' ' NZ ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -150.25 166.8 28.82 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -176.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -60.31 146.48 43.85 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.0 t -120.55 160.03 24.01 Favored 'General case' 0 N--CA 1.414 -2.247 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.558 -168.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 26.5 t -127.91 127.1 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 174.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.481 HG22 HD22 ' A' ' 88' ' ' LEU . 1.5 mp -100.96 131.62 48.27 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 70' ' ' HIS . 22.6 mt -99.13 109.28 22.0 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 113.771 -1.559 . . . . 0.0 107.825 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.481 HD22 HG22 ' A' ' 86' ' ' ILE . 3.1 mm? -88.04 0.08 56.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.591 0.71 . . . . 0.0 111.313 -174.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -98.69 -24.71 14.95 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-O 122.263 1.03 . . . . 0.0 109.654 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.504 ' HA ' HG21 ' B' ' 93' ' ' THR . 0.0 OUTLIER -103.55 85.51 2.47 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.033 177.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.736 ' HB ' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -139.99 171.25 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.202 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -176.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.451 ' HD3' HD23 ' A' ' 24' ' ' LEU . 11.9 ptm180 -168.6 169.63 10.12 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.499 HG21 ' HA ' ' B' ' 90' ' ' GLN . 58.4 m -103.93 125.7 50.51 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.518 -1.674 . . . . 0.0 109.329 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.8 mt -132.59 140.77 48.39 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 126.065 1.746 . . . . 0.0 107.419 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.8 OUTLIER -80.09 153.43 28.74 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.007 175.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -37.96 -38.18 0.3 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.67 1.588 . . . . 0.0 114.759 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -54.94 -27.55 44.37 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 124.881 1.272 . . . . 0.0 112.281 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -84.18 -27.56 27.96 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.729 -0.607 . . . . 0.0 110.2 -176.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.0 mp -74.04 127.03 31.84 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 123.772 0.829 . . . . 0.0 109.479 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 23' ' ' ASP . 68.3 mttm -94.95 -66.65 0.9 Allowed 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.577 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.11 147.9 21.55 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-O 121.422 0.63 . . . . 0.0 111.247 -170.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 124.48 23.74 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.34 -1.754 . . . . 0.0 109.999 173.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.646 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 9.0 tp -112.64 -56.74 2.37 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.128 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.646 ' OG1' ' HG ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -124.59 -169.12 1.92 Allowed 'General case' 0 N--CA 1.394 -3.231 0 C-N-CA 118.833 -1.147 . . . . 0.0 113.986 -176.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 17' ' ' GLY . 8.4 p90 -161.28 142.01 11.17 Favored 'General case' 0 CA--C 1.487 -1.463 0 C-N-CA 125.58 1.552 . . . . 0.0 109.641 -170.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.72 152.15 34.92 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.535 ' OG ' ' HE2' ' A' ' 77' ' ' LYS . 15.8 m -77.02 171.28 15.05 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.834 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 111' ' ' MET . 9.4 m-20 -64.19 -36.94 85.7 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.272 0.558 . . . . 0.0 110.679 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 15.3 t70 -64.65 -39.31 93.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.947 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.502 ' N ' ' HD2' ' A' ' 110' ' ' LYS . 3.1 mptp? -75.84 -26.87 57.57 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.337 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.528 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -55.49 -39.94 71.07 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.851 1.26 . . . . 0.0 108.137 169.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 9.1 mmpt? -87.18 -1.66 58.06 Favored 'General case' 0 N--CA 1.394 -3.272 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.721 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 109' ' ' ASP . 32.7 mt-10 -90.89 -55.09 3.69 Favored 'General case' 0 N--CA 1.397 -3.113 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.63 -59.76 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-N 111.831 -2.44 . . . . 0.0 112.717 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 63.4 m-20 -62.71 -39.29 93.58 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 123.134 1.445 . . . . 0.0 111.023 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 17.7 t30 -74.01 -45.87 47.1 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 113.425 -1.716 . . . . 0.0 112.917 -172.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.68 73.35 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 12.5 tp -69.43 -40.28 77.33 Favored 'General case' 0 N--CA 1.389 -3.484 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.367 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.542 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 2.5 ttp -65.2 -27.98 69.06 Favored 'General case' 0 N--CA 1.408 -2.556 0 C-N-CA 123.775 0.83 . . . . 0.0 109.817 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.436 HG23 ' ND2' ' A' ' 125' ' ' ASN . 51.3 mt -80.29 -52.9 13.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.441 ' HA ' HG22 ' A' ' 69' ' ' THR . 38.1 t -50.39 -33.79 21.95 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.185 -1.825 . . . . 0.0 113.831 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 31.9 mt -97.5 9.35 42.63 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.006 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.51 10.73 81.35 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 115.741 1.056 . . . . 0.0 115.741 173.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.542 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.5 mm? -67.8 -54.34 19.91 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.436 ' ND2' HG23 ' A' ' 120' ' ' ILE . 25.2 m120 . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.037 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -146.82 161.56 40.42 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -83.55 124.06 30.38 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.26 175.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 127.14 -15.63 6.45 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.806 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -96.73 149.52 21.73 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.678 0.751 . . . . 0.0 109.694 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.599 ' HB ' ' H ' ' B' ' 104' ' ' THR . 51.0 t -100.68 121.74 51.84 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.253 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.435 ' O ' HG22 ' B' ' 38' ' ' VAL . 20.6 m-85 -111.83 146.25 38.0 Favored 'General case' 0 CA--C 1.456 -2.646 0 C-N-CA 124.193 0.997 . . . . 0.0 111.967 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.09 145.29 31.17 Favored 'General case' 0 C--N 1.267 -2.992 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 167.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -144.0 131.77 21.35 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 113.747 -1.57 . . . . 0.0 108.009 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.447 ' HA ' ' HB ' ' B' ' 35' ' ' VAL . 6.1 p-10 -87.72 89.76 8.12 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.79 174.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.551 HD22 ' O ' ' B' ' 24' ' ' LEU 0.452 0.0 OUTLIER -108.85 59.84 0.6 Allowed 'General case' 0 N--CA 1.393 -3.295 0 CA-C-O 124.196 1.951 . . . . 0.0 112.426 177.533 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.588 ' HB3' ' HA2' ' B' ' 34' ' ' GLY . 10.9 p -111.62 62.62 0.53 Allowed Pre-proline 0 C--N 1.267 -2.992 0 CA-C-N 113.141 -1.845 . . . . 0.0 113.433 174.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.502 ' HD3' ' C ' ' B' ' 24' ' ' LEU . 22.3 Cg_endo -116.89 26.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.082 0 N-CA-C 107.692 -1.695 . . . . 0.0 107.692 158.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 18.6 m -95.01 156.39 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.87 151.74 37.56 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.535 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.04 -132.05 11.03 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -94.02 10.94 31.55 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.641 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 43.4 mt-10 -66.93 151.6 47.28 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -132.89 116.57 16.64 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -173.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . 0.514 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -149.27 -116.21 0.81 Allowed Glycine 0 N--CA 1.404 -3.494 0 C-N-CA 119.88 -1.152 . . . . 0.0 114.013 175.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.588 ' HA2' ' HB3' ' B' ' 25' ' ' SER . . . 96.63 177.83 35.36 Favored Glycine 0 N--CA 1.413 -2.886 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -171.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' B' ' 23' ' ' ASP . 1.0 OUTLIER -93.74 102.87 14.08 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-O 123.167 1.46 . . . . 0.0 107.95 172.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -132.13 163.52 49.66 Favored Pre-proline 0 C--N 1.268 -2.966 0 CA-C-N 111.978 -2.374 . . . . 0.0 110.765 -172.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.512 ' HB2' HD12 ' B' ' 58' ' ' ILE . 14.0 Cg_exo -71.21 140.92 38.3 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 121.671 1.581 . . . . 0.0 109.865 165.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.435 HG22 ' O ' ' B' ' 20' ' ' TYR . 28.3 m -126.89 162.63 31.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 124.667 1.187 . . . . 0.0 108.157 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.6 m -104.72 129.66 56.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.671 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 32.1 mm -89.22 105.16 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.41 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.1 OUTLIER -100.07 -17.37 6.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.596 HE22 ' N ' ' B' ' 47' ' ' ASN . 0.6 OUTLIER -43.13 140.51 1.47 Allowed 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 127.03 2.132 . . . . 0.0 114.686 -170.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -47.89 149.55 1.31 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.331 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.576 ' HA ' ' ND2' ' B' ' 47' ' ' ASN . 30.0 t70 -71.83 -32.07 67.18 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.743 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 3.8 m -76.98 -25.07 52.31 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.127 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.62 -35.83 90.47 Favored Glycine 0 C--O 1.199 -2.048 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.596 ' N ' HE22 ' B' ' 42' ' ' GLN . 13.0 p30 -74.35 -19.09 60.57 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.339 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' B' ' 44' ' ' ASP . 14.0 mptt -85.64 -61.59 1.72 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.203 174.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -96.58 -16.68 20.92 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 -168.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -98.62 140.75 22.01 Favored Pre-proline 0 C--N 1.302 -1.473 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.306 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.43 -11.77 11.68 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.932 1.754 . . . . 0.0 110.26 173.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.4 p -101.35 137.69 39.36 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 124.879 1.271 . . . . 0.0 111.455 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' B' ' 93' ' ' THR . 60.2 t -124.22 140.21 48.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.564 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 3.2 tp -105.69 124.74 60.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 123.455 0.702 . . . . 0.0 109.402 173.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.721 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 13.6 m -130.64 162.54 38.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.328 -175.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' B' ' 91' ' ' ILE . . . -118.89 132.79 56.11 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 124.27 1.028 . . . . 0.0 108.759 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.1 129.54 39.71 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' B' ' 37' ' ' PRO . 60.5 mt -86.64 133.18 30.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.202 174.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 75.1 m -127.11 133.01 50.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.24 0.543 . . . . 0.0 112.223 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 176.546 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.1 tt . . . . . 0 C--O 1.215 -0.722 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.82 -4.32 4.58 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 123.821 3.014 . . . . 0.0 116.153 -174.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 74.8 p -87.21 -18.99 29.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.407 1.098 . . . . 0.0 108.848 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . 0.447 ' CD2' HD22 ' B' ' 87' ' ' LEU . 33.5 m170 -99.83 134.8 42.2 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 170.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 5.1 p -134.24 144.98 33.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 116.979 -1.888 . . . . 0.0 112.364 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -88.62 127.88 35.57 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.25 1.02 . . . . 0.0 112.149 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.575 HG21 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -128.33 149.12 32.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 O-C-N 123.708 0.63 . . . . 0.0 112.063 175.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -64.19 131.89 48.74 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.329 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -54.62 -46.69 73.92 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 125.732 1.613 . . . . 0.0 109.813 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -56.29 -50.21 72.04 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.851 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -78.78 -39.06 36.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.63 -170.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.575 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 4.4 m-85 -84.14 -6.99 59.49 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.977 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 68.6 29.28 5.52 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.19 178.88 5.38 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.382 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -70.59 -25.0 62.86 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.422 -1.717 . . . . 0.0 111.156 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.411 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -151.68 163.52 38.94 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -176.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.37 143.92 43.42 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 22.1 t -121.3 156.83 31.69 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 119.639 -0.825 . . . . 0.0 112.257 -167.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 25.9 t -123.7 126.97 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.46 HG22 HD22 ' B' ' 88' ' ' LEU . 1.5 mp -100.24 131.33 47.93 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.158 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.447 HD22 ' CD2' ' B' ' 70' ' ' HIS . 31.8 mt -98.99 108.15 20.76 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.03 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.46 HD22 HG22 ' B' ' 86' ' ' ILE . 3.3 mm? -86.97 -0.26 56.3 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.723 0.773 . . . . 0.0 111.52 -174.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -100.15 -22.65 15.1 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 122.372 1.082 . . . . 0.0 109.928 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . 0.499 ' HA ' HG21 ' A' ' 93' ' ' THR . 0.0 OUTLIER -104.62 85.66 2.36 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.992 177.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.721 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 0.3 OUTLIER -140.1 171.41 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.494 ' HD3' HD23 ' B' ' 24' ' ' LEU . 11.7 ptm180 -168.98 169.34 9.67 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 90' ' ' GLN . 72.0 m -104.43 126.31 51.41 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.549 -177.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -132.55 142.88 49.37 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 126.069 1.748 . . . . 0.0 107.432 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 1.7 p-10 -81.18 152.06 27.9 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.019 -1.473 . . . . 0.0 108.96 175.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -35.48 -40.01 0.15 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.891 1.676 . . . . 0.0 115.148 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -51.34 -31.79 23.26 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 125.027 1.331 . . . . 0.0 112.632 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -79.93 -27.51 39.84 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.963 0.411 . . . . 0.0 110.193 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -75.01 124.56 27.19 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 122.01 0.91 . . . . 0.0 109.563 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -95.49 -60.08 1.74 Allowed 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.902 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -161.02 148.43 15.4 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-O 121.504 0.669 . . . . 0.0 111.737 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.63 121.06 18.12 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.85 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.628 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 8.4 tp -109.37 -55.39 2.43 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.628 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 0.3 OUTLIER -124.13 -168.57 1.82 Allowed 'General case' 0 N--CA 1.391 -3.424 0 C-N-CA 118.421 -1.312 . . . . 0.0 114.497 -176.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . 0.493 ' H ' HG22 ' B' ' 104' ' ' THR . 19.9 p90 -161.48 141.69 10.68 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 125.808 1.643 . . . . 0.0 109.383 -171.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.9 150.73 36.6 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.44 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t -78.25 170.18 17.05 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.473 -175.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.508 ' O ' ' HB3' ' B' ' 111' ' ' MET . 4.6 m-20 -60.8 -38.48 85.49 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.683 0.793 . . . . 0.0 111.121 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 27.1 t70 -64.58 -38.27 90.44 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.148 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.495 ' HD2' ' N ' ' B' ' 110' ' ' LYS . 2.6 mptp? -75.55 -27.71 58.74 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.247 -178.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.508 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.2 OUTLIER -54.87 -40.25 69.52 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 124.912 1.285 . . . . 0.0 108.058 170.041 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' B' ' 112' ' ' LYS . 7.7 mmpt? -86.6 -2.43 58.49 Favored 'General case' 0 N--CA 1.384 -3.769 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.314 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' B' ' 109' ' ' ASP . 38.3 mt-10 -90.69 -55.51 3.54 Favored 'General case' 0 C--N 1.261 -3.271 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 172.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.18 -59.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 CA-C-N 111.594 -2.548 . . . . 0.0 112.786 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 56.7 m-20 -62.65 -40.24 96.42 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.14 1.448 . . . . 0.0 111.227 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.332 43.1 t30 -75.1 -42.96 55.52 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 113.531 -1.668 . . . . 0.0 112.602 -170.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -64.18 -31.76 73.08 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 11.2 tp -70.72 -35.09 72.56 Favored 'General case' 0 N--CA 1.39 -3.445 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.047 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.554 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 2.3 ttp -69.05 -21.49 64.09 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-O 121.686 0.755 . . . . 0.0 109.303 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' B' ' 117' ' ' ALA . 51.6 mt -87.89 -53.5 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' B' ' 118' ' ' LEU . 79.1 p -53.94 -28.48 37.33 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 26.2 mt -97.06 5.28 50.64 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.187 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.15 13.01 78.14 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 115.954 1.142 . . . . 0.0 115.954 172.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.554 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.5 mm? -68.32 -52.95 27.84 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 23.7 m120 . . . . . 0 C--O 1.241 0.65 0 CA-C-N 112.979 -1.919 . . . . 0.0 109.474 -179.375 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -146.54 156.91 43.59 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -70.36 124.91 25.32 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 169.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.14 -26.21 3.78 Favored Glycine 0 C--N 1.302 -1.359 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.093 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -97.41 167.43 11.0 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.776 0.798 . . . . 0.0 109.427 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.472 HG11 HG22 ' A' ' 104' ' ' THR . 24.7 t -122.42 139.39 49.48 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.56 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.516 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.2 m-85 -133.5 148.66 51.7 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.4 151.62 39.65 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 168.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -141.58 135.48 30.1 Favored 'General case' 0 CA--C 1.454 -2.736 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.217 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.39 93.59 9.58 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 166.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.471 HD13 ' HD3' ' A' ' 92' ' ' ARG . 1.1 pp -109.83 28.9 8.12 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.282 -1.327 . . . . 0.0 107.814 -174.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.29 62.25 0.0 OUTLIER Pre-proline 0 C--N 1.267 -3.002 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -112.87 25.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.938 0 N-CA-C 107.232 -1.872 . . . . 0.0 107.232 153.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.695 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 13.9 m -83.56 160.45 3.49 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -173.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.52 145.84 31.21 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 113.311 -1.768 . . . . 0.0 113.249 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.32 -114.21 6.65 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.602 -1.181 . . . . 0.0 114.637 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -78.34 -9.1 59.12 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 123.827 0.851 . . . . 0.0 112.963 -173.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.695 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 50.7 mt-10 -71.3 159.89 33.78 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -132.29 111.41 11.35 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -174.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.0 -162.54 15.11 Favored Glycine 0 N--CA 1.408 -3.23 0 C-N-CA 119.155 -1.497 . . . . 0.0 115.02 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.6 -156.81 26.45 Favored Glycine 0 N--CA 1.407 -3.283 0 N-CA-C 103.419 -3.872 . . . . 0.0 103.419 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 59.3 t -83.03 99.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.438 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 169.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -130.8 146.51 62.33 Favored Pre-proline 0 C--N 1.252 -3.652 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.277 -172.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HB2' HD12 ' A' ' 58' ' ' ILE . 25.4 Cg_exo -62.98 137.12 60.49 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 121.702 1.601 . . . . 0.0 109.929 171.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 31.1 m -127.6 154.87 38.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 29.8 m -97.77 129.92 47.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.125 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.415 HD13 HG12 ' A' ' 55' ' ' VAL . 25.9 mm -91.36 107.19 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -13.82 9.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.285 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.533 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 5.0 pt20 -52.11 165.24 0.23 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 -169.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -65.51 174.43 2.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.613 -2.085 . . . . 0.0 112.118 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 9.9 t70 -72.56 -48.24 41.65 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.268 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.5 m -70.38 -30.98 68.03 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.477 0.711 . . . . 0.0 112.253 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 50' ' ' SER . . . -62.32 -33.41 86.05 Favored Glycine 0 C--O 1.205 -1.67 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.691 -175.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.52 ' N ' HE22 ' A' ' 42' ' ' GLN . 10.1 p30 -84.65 -37.13 21.4 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.841 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.645 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 24.4 mmtp -67.6 -63.19 1.11 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.386 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.645 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 19.0 m-85 -102.09 -35.86 8.77 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -168.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.477 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 22.5 m -82.47 157.92 66.88 Favored Pre-proline 0 N--CA 1.422 -1.832 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.677 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 86.4 Cg_endo -86.95 -20.85 2.23 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 121.099 1.199 . . . . 0.0 111.797 174.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.483 HG21 ' HG2' ' B' ' 90' ' ' GLN . 11.3 p -99.6 135.3 41.23 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.533 ' HB ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -133.42 139.2 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.906 176.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.5 tt -81.74 126.85 39.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.964 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 34.5 m -132.97 154.98 40.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.582 174.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.586 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -115.91 133.09 56.39 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.3 136.02 56.76 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.521 HG12 HD12 ' A' ' 86' ' ' ILE . 49.2 mt -98.07 131.47 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.736 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 m -105.54 108.34 19.81 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.479 -178.839 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tt . . . . . 0 C--O 1.206 -1.234 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.12 -4.7 12.05 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 122.427 2.084 . . . . 0.0 115.246 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.3 p -100.09 -17.92 17.22 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.377 0.608 . . . . 0.0 111.363 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -118.55 128.45 54.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.411 HG12 HD13 ' A' ' 73' ' ' ILE . 61.0 t -111.27 134.26 54.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.208 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -99.69 124.79 45.28 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 123.744 0.653 . . . . 0.0 109.363 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.521 HD11 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -116.35 153.27 18.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.209 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -54.08 129.56 34.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.058 -1.428 . . . . 0.0 112.815 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.644 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 93.1 mttt -51.98 -56.79 12.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.457 178.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -67.98 -45.84 73.03 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.193 -169.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -62.84 -33.05 74.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.016 0.436 . . . . 0.0 111.394 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.492 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 12.1 m-85 -92.9 2.31 56.85 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 123.924 0.89 . . . . 0.0 111.14 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.3 tptt 72.22 15.95 5.28 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.507 1.523 . . . . 0.0 113.562 171.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.53 175.42 6.56 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-O 122.492 1.139 . . . . 0.0 110.983 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.495 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 10.3 t70 -85.08 -27.08 26.54 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 112.944 -1.934 . . . . 0.0 110.1 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.499 ' HB3' ' NZ ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -139.31 157.09 46.5 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.42 -174.19 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.644 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 6.5 m-20 -45.89 135.44 7.15 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 124.92 1.388 . . . . 0.0 112.055 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 73' ' ' ILE . 15.4 m -103.73 121.8 43.76 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.667 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.8 t -107.74 136.51 42.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.521 HD12 HG12 ' A' ' 58' ' ' ILE . 15.9 mm -111.68 134.41 54.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.1 mt -104.91 97.42 7.29 Favored 'General case' 0 N--CA 1.416 -2.164 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.0 mm? -81.25 -9.42 59.77 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.497 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -95.41 -25.93 16.07 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.762 0.791 . . . . 0.0 111.292 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' B' ' 93' ' ' THR . 1.1 tm0? -80.28 -60.88 2.16 Favored 'General case' 0 C--O 1.164 -3.433 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.246 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.586 HG22 ' CB ' ' A' ' 56' ' ' ALA . 1.3 pp 30.05 -174.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.529 3.475 0 C-N-CA 129.646 3.178 . . . . 0.0 116.814 175.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.471 ' HD3' HD13 ' A' ' 24' ' ' LEU . 8.7 ptm85 -176.96 159.6 1.72 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 167.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' B' ' 90' ' ' GLN . 0.0 OUTLIER -114.54 108.36 16.74 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.743 1.217 . . . . 0.0 109.356 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.535 ' HB2' ' CZ ' ' A' ' 98' ' ' ARG . 64.9 mt -131.82 149.58 52.42 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -173.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.677 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 11.8 t70 -50.72 145.17 7.22 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 173.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 33.1 pttt -55.58 -29.74 59.6 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.589 1.556 . . . . 0.0 114.608 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 20.1 ttmm -47.56 -39.08 15.63 Favored 'General case' 0 C--N 1.274 -2.677 0 C-N-CA 126.243 1.817 . . . . 0.0 112.476 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.535 ' CZ ' ' HB2' ' A' ' 94' ' ' LEU . 1.7 ppt_? -73.39 -15.01 61.37 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 10.4 mp -61.75 120.6 10.98 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.912 0.885 . . . . 0.0 110.028 170.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.08 -64.27 1.08 Allowed 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.367 -177.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.4 pt-20 -156.67 145.32 19.95 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 121.786 0.803 . . . . 0.0 111.807 -172.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -60.81 120.82 10.86 Favored 'General case' 0 C--N 1.281 -2.379 0 C-N-CA 128.132 2.573 . . . . 0.0 108.814 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -114.66 -62.67 1.57 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.704 -0.798 . . . . 0.0 112.466 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.472 HG22 HG11 ' A' ' 19' ' ' VAL . 5.4 t -128.8 -160.98 1.07 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.243 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -159.39 149.25 18.77 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.052 0.941 . . . . 0.0 112.326 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.56 135.39 49.1 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 113.853 -1.522 . . . . 0.0 112.264 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 111' ' ' MET . 7.0 m -76.4 165.95 24.11 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 124.248 1.019 . . . . 0.0 110.597 176.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 111' ' ' MET . 23.3 t70 -67.71 -42.98 81.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.86 -28.86 69.28 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.737 0.78 . . . . 0.0 109.382 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 110' ' ' LYS . 71.5 mmtt -79.78 -28.78 40.3 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.684 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.8 OUTLIER -53.65 -44.55 69.69 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.153 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 10.0 mmpt? -75.13 -8.32 56.24 Favored 'General case' 0 N--CA 1.396 -3.161 0 CA-C-N 114.421 -1.263 . . . . 0.0 114.173 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -89.26 -51.56 5.51 Favored 'General case' 0 N--CA 1.397 -3.079 0 C-N-CA 116.735 -1.986 . . . . 0.0 106.264 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -53.72 -59.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 112.615 -2.084 . . . . 0.0 113.351 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 45.8 m-20 -59.73 -39.19 83.87 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 123.241 1.496 . . . . 0.0 110.989 -177.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 10.9 t30 -77.97 -40.46 39.25 Favored 'General case' 0 C--N 1.261 -3.275 0 CA-C-N 112.718 -2.037 . . . . 0.0 111.669 -173.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.525 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.69 -36.58 81.29 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.505 ' HA ' ' OG ' ' A' ' 121' ' ' SER . 5.2 tp -70.14 -37.02 75.18 Favored 'General case' 0 N--CA 1.394 -3.24 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.2 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.504 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 1.5 ttp -66.87 -22.99 65.96 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.872 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 117' ' ' ALA . 45.0 mt -88.07 -50.95 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 118' ' ' LEU . 83.5 p -59.33 -22.26 61.02 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.644 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 32.9 mt -103.73 1.28 31.58 Favored 'General case' 0 C--O 1.201 -1.486 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.501 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.35 16.86 54.71 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 117.137 1.615 . . . . 0.0 117.137 171.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.504 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.2 mm? -74.0 -52.34 13.08 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.414 ' ND2' HG23 ' A' ' 120' ' ' ILE . 23.3 m120 . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 112.47 -2.15 . . . . 0.0 112.546 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 N--CA 1.428 -1.558 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -145.8 156.89 43.88 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -70.24 128.92 37.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.92 -26.33 4.02 Favored Glycine 0 C--N 1.307 -1.051 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.551 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -97.42 169.69 9.57 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 121.762 0.791 . . . . 0.0 109.183 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.468 ' HB ' ' H ' ' B' ' 104' ' ' THR . 23.4 t -123.84 140.16 48.15 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.885 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.728 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 35.3 m-85 -132.9 148.96 52.29 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 124.162 0.985 . . . . 0.0 109.087 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.02 149.57 39.2 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 167.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -140.35 134.49 30.97 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.71 -175.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -86.5 93.58 9.2 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 166.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.462 HD13 ' HD3' ' B' ' 92' ' ' ARG . 1.1 pp -108.8 28.7 8.16 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.842 1.306 . . . . 0.0 108.011 -175.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.416 ' OG ' ' HA2' ' B' ' 34' ' ' GLY . 1.0 OUTLIER -90.27 62.72 0.0 OUTLIER Pre-proline 0 C--N 1.266 -3.058 0 N-CA-C 116.712 2.115 . . . . 0.0 116.712 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -113.67 25.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.981 0 N-CA-C 107.42 -1.8 . . . . 0.0 107.42 151.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.692 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 15.1 m -82.29 162.26 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -173.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.39 147.86 31.72 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.802 -1.544 . . . . 0.0 113.033 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.34 -114.53 6.79 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 114.622 -1.172 . . . . 0.0 114.323 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -75.56 -11.76 60.08 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 123.855 0.862 . . . . 0.0 113.168 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.692 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 50.3 mt-10 -71.03 158.4 36.57 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -131.91 112.6 12.58 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.4 -161.63 13.84 Favored Glycine 0 N--CA 1.408 -3.192 0 C-N-CA 119.379 -1.391 . . . . 0.0 114.971 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.416 ' HA2' ' OG ' ' B' ' 25' ' ' SER . . . 141.6 -158.53 26.6 Favored Glycine 0 C--N 1.267 -3.279 0 N-CA-C 103.403 -3.879 . . . . 0.0 103.403 -173.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 61.8 t -82.37 98.98 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 169.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -130.72 146.78 63.4 Favored Pre-proline 0 C--N 1.253 -3.592 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.096 -172.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.562 ' HB2' HD12 ' B' ' 58' ' ' ILE . 27.2 Cg_exo -63.49 138.03 63.07 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.766 1.644 . . . . 0.0 110.16 171.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 30.2 m -128.44 154.72 39.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.569 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 28.1 m -97.72 129.7 47.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.094 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 25.8 mm -91.31 106.27 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -14.77 9.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.25 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.575 ' OE1' ' HB3' ' B' ' 47' ' ' ASN . 0.1 OUTLIER -53.79 164.71 0.53 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -170.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -64.01 175.03 1.31 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.514 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' B' ' 48' ' ' LYS . 12.8 t70 -74.31 -47.32 35.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.866 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.9 m -70.52 -31.34 68.38 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.637 0.775 . . . . 0.0 112.199 -169.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' B' ' 50' ' ' SER . . . -62.48 -32.4 82.97 Favored Glycine 0 C--O 1.21 -1.401 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.424 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.575 ' HB3' ' OE1' ' B' ' 42' ' ' GLN . 9.7 p30 -84.65 -39.04 19.1 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.475 -0.89 . . . . 0.0 112.096 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.656 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 25.9 mmtp -65.74 -63.25 1.13 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.096 0.474 . . . . 0.0 111.726 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . 0.656 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 19.1 m-85 -102.14 -36.3 8.59 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -168.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.487 ' HB2' ' HA2' ' B' ' 46' ' ' GLY . 25.8 m -80.85 157.98 71.03 Favored Pre-proline 0 N--CA 1.418 -2.032 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.671 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 83.8 Cg_endo -87.39 -21.37 1.92 Allowed 'Trans proline' 0 N--CA 1.431 -2.162 0 C-N-CA 121.202 1.268 . . . . 0.0 111.662 173.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.457 HG21 ' HG2' ' A' ' 90' ' ' GLN . 9.5 p -99.41 135.12 41.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -170.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.98 138.79 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.316 175.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tt -82.3 127.39 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 124.979 1.311 . . . . 0.0 110.732 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 34.7 m -132.77 154.99 40.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.395 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.592 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -115.43 132.82 56.5 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.98 136.5 57.38 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.562 HD12 ' HB2' ' B' ' 37' ' ' PRO . 63.5 mt -97.34 132.26 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.702 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' B' ' 85' ' ' VAL . 26.3 m -106.13 106.11 16.46 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 174.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.519 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.001 -178.76 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 8.6 tt . . . . . 0 C--O 1.213 -0.847 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.84 -3.39 4.55 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 122.962 2.441 . . . . 0.0 115.301 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 66.6 p -103.37 -15.64 15.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.309 0.576 . . . . 0.0 111.19 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -119.07 129.01 54.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 52.8 t -111.38 132.99 58.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.16 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -99.58 119.8 38.64 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.355 0.662 . . . . 0.0 109.557 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.526 HD11 HG12 ' B' ' 86' ' ' ILE . 0.0 OUTLIER -111.11 153.54 12.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.545 ' OE1' ' HE3' ' B' ' 110' ' ' LYS . 1.6 mp0 -53.1 128.99 29.54 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.818 1.324 . . . . 0.0 111.956 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . 0.634 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 94.0 mttt -52.15 -56.35 15.1 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.209 0.943 . . . . 0.0 111.364 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -68.81 -43.08 76.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.845 -168.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . 0.437 ' HB2' ' HE3' ' B' ' 77' ' ' LYS . 38.8 ttmt -64.95 -33.5 76.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.239 0.543 . . . . 0.0 110.878 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.422 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 14.7 m-85 -91.68 2.18 56.65 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.197 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 41.7 tptt 71.83 20.05 4.65 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.072 1.349 . . . . 0.0 113.074 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.71 174.05 6.41 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 122.573 1.178 . . . . 0.0 111.217 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -84.07 -26.09 29.3 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.88 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.443 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -140.97 156.75 46.0 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.385 -172.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.634 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 10.9 m-20 -46.64 135.28 8.87 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.902 1.376 . . . . 0.0 112.126 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . 0.429 ' O ' HG12 ' B' ' 73' ' ' ILE . 14.9 m -103.89 122.6 45.51 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.887 -177.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' B' ' 59' ' ' THR . 8.9 t -107.88 137.16 40.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.539 ' CD1' HG12 ' B' ' 58' ' ' ILE . 16.5 mm -111.67 135.05 52.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 18.8 mt -105.38 98.72 8.38 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.1 mm? -82.03 -9.82 59.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.324 -172.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -95.58 -26.19 15.87 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.316 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -80.2 -60.7 2.23 Favored 'General case' 0 C--O 1.162 -3.534 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.138 -178.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.592 HG22 ' CB ' ' B' ' 56' ' ' ALA . 1.3 pp 30.02 -174.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 C-N-CA 129.605 3.162 . . . . 0.0 116.836 175.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.464 ' HE ' HD21 ' B' ' 94' ' ' LEU . 8.5 ptm85 -176.95 159.72 1.73 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 167.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -114.83 108.63 17.01 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.916 1.286 . . . . 0.0 109.453 179.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.53 ' HB2' ' CZ ' ' B' ' 98' ' ' ARG . 65.2 mt -131.77 150.94 51.99 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 11.7 t70 -51.9 146.12 8.84 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.32 0.509 . . . . 0.0 111.446 173.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' B' ' 99' ' ' LEU . 31.5 pttt -54.48 -33.34 59.58 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.095 1.358 . . . . 0.0 114.256 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -41.28 -40.69 1.71 Allowed 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 126.742 2.017 . . . . 0.0 113.693 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.53 ' CZ ' ' HB2' ' B' ' 94' ' ' LEU . 1.7 ppt_? -73.72 -13.95 61.05 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' B' ' 96' ' ' LYS . 10.1 mp -63.39 118.48 8.13 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 123.83 0.852 . . . . 0.0 109.81 170.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.19 -64.07 1.1 Allowed 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.304 -1.317 . . . . 0.0 112.094 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 12.2 pt-20 -156.76 145.86 20.28 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-O 121.815 0.817 . . . . 0.0 111.55 -172.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -60.39 122.57 14.91 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 128.152 2.581 . . . . 0.0 108.891 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 13.0 tp -114.97 -62.33 1.62 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 119.566 -0.853 . . . . 0.0 112.393 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.468 ' H ' ' HB ' ' B' ' 19' ' ' VAL . 5.4 t -129.3 -160.79 1.06 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.317 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -159.31 147.76 17.86 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.262 1.025 . . . . 0.0 112.289 -169.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.79 140.52 36.95 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.0 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 15.1 t -82.91 162.41 21.55 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.074 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' B' ' 111' ' ' MET . 15.8 t70 -63.9 -44.74 92.09 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 122.73 0.412 . . . . 0.0 111.828 -175.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.7 -30.39 71.5 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.575 0.702 . . . . 0.0 110.363 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.545 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 70.0 mmtt -80.29 -27.01 38.62 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.999 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.4 OUTLIER -53.93 -44.36 70.58 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 169.131 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.42 ' HE2' ' N ' ' B' ' 112' ' ' LYS . 9.7 mmpt? -75.7 -8.2 56.23 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 114.215 -1.357 . . . . 0.0 113.792 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -89.92 -50.95 5.73 Favored 'General case' 0 N--CA 1.398 -3.055 0 C-N-CA 117.215 -1.794 . . . . 0.0 106.922 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -54.26 -59.85 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-N 112.586 -2.097 . . . . 0.0 112.96 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 47.1 m-20 -58.57 -42.06 87.1 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 123.07 1.414 . . . . 0.0 111.281 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.313 14.8 t30 -74.74 -40.9 61.0 Favored 'General case' 0 C--N 1.266 -3.044 0 CA-C-N 113.059 -1.882 . . . . 0.0 111.551 -174.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.428 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -63.78 -35.48 80.73 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.516 ' HA ' ' OG ' ' B' ' 121' ' ' SER . 5.2 tp -69.64 -36.94 76.54 Favored 'General case' 0 N--CA 1.394 -3.272 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.789 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.529 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 1.3 ttp -67.18 -22.58 65.74 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.375 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' B' ' 117' ' ' ALA . 60.3 mt -87.23 -53.92 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . 0.516 ' OG ' ' HA ' ' B' ' 118' ' ' LEU . 78.1 p -55.37 -24.25 28.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.134 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 32.8 mt -101.48 0.66 37.09 Favored 'General case' 0 C--O 1.2 -1.504 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.958 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.33 16.48 55.41 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 116.98 1.552 . . . . 0.0 116.98 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.529 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.2 mm? -73.6 -51.72 15.88 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 22.2 m120 . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 112.488 -2.142 . . . . 0.0 112.252 179.811 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.534 ' HB ' ' OD1' ' A' ' 47' ' ' ASN . 60.9 mt . . . . . 0 N--CA 1.428 -1.556 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -116.38 144.68 43.97 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 172.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 41' ' ' ILE . 4.7 ttp180 -63.81 114.42 4.03 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 174.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.33 -16.52 5.43 Favored Glycine 0 N--CA 1.421 -2.35 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.78 172.02 12.91 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 122.815 1.293 . . . . 0.0 110.516 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.424 HG11 HG22 ' A' ' 104' ' ' THR . 12.6 t -132.68 128.99 58.18 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.425 0 CA-C-N 112.356 -2.202 . . . . 0.0 109.445 175.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 37.3 m-85 -126.38 147.38 49.77 Favored 'General case' 0 C--N 1.277 -2.567 0 C-N-CA 125.1 1.36 . . . . 0.0 108.325 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -82.17 161.48 22.77 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 170.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.17 133.08 13.24 Favored 'General case' 0 C--N 1.28 -2.424 0 O-C-N 123.982 0.801 . . . . 0.0 109.307 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.62 81.75 8.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 123.56 1.648 . . . . 0.0 109.258 173.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.519 ' C ' ' HD3' ' A' ' 26' ' ' PRO . 4.3 pp -89.27 3.66 51.32 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 113.009 -1.905 . . . . 0.0 111.95 -175.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.587 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 2.3 p -89.72 60.24 0.0 OUTLIER Pre-proline 0 C--N 1.272 -2.785 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.519 ' HD3' ' C ' ' A' ' 24' ' ' LEU . 19.1 Cg_endo -118.83 30.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.582 0 N-CA-C 106.889 -2.004 . . . . 0.0 106.889 152.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 24' ' ' LEU . 35.3 m -71.2 176.68 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.491 -173.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.25 138.45 31.41 Favored 'General case' 0 N--CA 1.41 -2.458 0 CA-C-N 114.004 -1.453 . . . . 0.0 113.8 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.04 -133.1 11.75 Favored Glycine 0 N--CA 1.421 -2.346 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.229 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.5 m -93.76 18.5 10.17 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 47.6 mt-10 -70.36 167.92 17.11 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.561 HE21 ' C ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -101.21 119.08 38.22 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -174.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.27 151.93 17.55 Favored Glycine 0 CA--C 1.483 -1.914 0 N-CA-C 115.82 1.088 . . . . 0.0 115.82 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.587 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . 137.18 137.28 3.6 Favored Glycine 0 C--N 1.293 -1.821 0 CA-C-N 113.313 -1.444 . . . . 0.0 111.367 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 35' ' ' VAL . 2.7 p -72.09 105.83 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 123.17 1.462 . . . . 0.0 107.752 173.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -136.08 161.18 63.98 Favored Pre-proline 0 C--N 1.253 -3.617 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.792 -172.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 18.6 Cg_exo -67.68 142.87 59.85 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.025 1.817 . . . . 0.0 110.201 170.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 20' ' ' TYR . 27.8 m -123.18 158.56 28.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 123.608 0.763 . . . . 0.0 109.325 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 33.8 m -102.03 132.4 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.704 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mm -85.16 105.94 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.546 ' O ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -103.59 -12.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.946 -178.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.643 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 3.4 mt-30 -42.0 157.56 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 120.706 3.595 . . . . 0.0 120.706 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -69.3 145.79 52.76 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 110.815 -2.902 . . . . 0.0 108.024 164.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 47' ' ' ASN . 20.5 t70 -62.64 -30.88 71.69 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.84 -177.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.0 m -86.87 -27.1 23.64 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.969 -1.092 . . . . 0.0 111.793 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.499 ' C ' HE22 ' A' ' 42' ' ' GLN . . . -67.59 -25.79 73.84 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 174.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.534 ' OD1' ' HB ' ' A' ' 14' ' ' ILE . 35.0 t30 -71.18 -39.39 71.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.991 -1.105 . . . . 0.0 109.77 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -74.26 -60.97 2.02 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . 0.46 16.6 p90 -128.36 2.03 5.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 119.352 3.093 . . . . 0.0 119.352 -173.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.5 m -86.86 134.21 37.72 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 172.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 34.0 Cg_exo -63.53 -29.54 70.81 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 121.606 1.538 . . . . 0.0 109.828 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.427 HG21 ' HG2' ' B' ' 90' ' ' GLN . 2.5 p -95.03 139.82 30.85 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.688 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.643 ' HB ' ' OE1' ' A' ' 42' ' ' GLN . 1.1 m -131.53 157.77 43.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.462 HG21 HD22 ' B' ' 122' ' ' LEU . 8.7 tt -109.56 131.12 61.32 Favored 'Isoleucine or valine' 0 C--O 1.251 1.156 0 CA-C-O 121.144 0.497 . . . . 0.0 109.798 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.455 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 30.0 m -137.73 160.4 33.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.952 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -120.2 142.25 49.17 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.21 143.97 36.69 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.616 HG12 ' CD1' ' A' ' 86' ' ' ILE . 67.7 mt -97.99 140.04 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-N 113.286 -1.779 . . . . 0.0 109.251 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.7 m -137.74 116.89 12.58 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.285 0.634 . . . . 0.0 110.122 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -0.922 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.576 -178.624 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--O 1.205 -1.278 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.71 -6.73 11.26 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 122.439 2.093 . . . . 0.0 113.503 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.8 p -96.05 -18.0 20.53 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.434 0.635 . . . . 0.0 111.018 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.444 ' CD2' HD22 ' A' ' 87' ' ' LEU . 46.3 m170 -114.12 128.4 56.36 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.13 138.59 54.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 121.854 -0.529 . . . . 0.0 111.02 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.43 140.49 29.75 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.722 0.772 . . . . 0.0 111.745 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.895 HG21 ' CE1' ' A' ' 78' ' ' TYR . 3.0 mm -108.99 -176.19 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.623 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 73' ' ' ILE . 5.5 mm-40 -117.69 133.76 55.6 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -173.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.649 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 73.1 mttt -44.09 -53.24 6.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.64 1.213 . . . . 0.0 110.723 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -61.12 -32.25 71.94 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.701 -1.59 . . . . 0.0 113.93 -173.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -85.2 -27.82 25.86 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.622 0.725 . . . . 0.0 109.586 -173.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.895 ' CE1' HG21 ' A' ' 73' ' ' ILE . 2.1 m-85 -97.01 0.18 48.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.735 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.8 tttp 66.42 19.43 10.94 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 121.627 0.727 . . . . 0.0 111.148 176.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.455 ' HB3' ' H ' ' A' ' 82' ' ' LYS . 7.8 mp -96.94 172.18 8.02 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-O 122.927 1.346 . . . . 0.0 112.827 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.54 -24.27 42.29 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.613 -2.539 . . . . 0.0 109.725 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.489 ' HB3' ' NZ ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -137.54 152.66 49.69 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.425 -173.191 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.649 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 11.7 p-10 -75.9 142.21 42.15 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.35 -1.296 . . . . 0.0 108.741 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -136.97 159.08 42.96 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.705 -172.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.4 t -110.61 153.74 12.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 124.512 1.125 . . . . 0.0 108.151 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.616 ' CD1' HG12 ' A' ' 58' ' ' ILE . 13.2 mm -117.71 140.34 41.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.444 HD22 ' CD2' ' A' ' 70' ' ' HIS . 36.7 mt -105.46 104.61 14.37 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -86.27 -7.18 58.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.055 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.56 -38.02 15.23 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.967 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.519 HE21 ' HB3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -98.12 77.05 2.4 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.822 -179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.552 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -108.93 179.45 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . 0.264 7.6 ptp180 -163.3 160.92 24.36 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 175.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 96.8 m -117.55 114.67 23.78 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.764 -176.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.8 mt -131.7 147.4 52.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.275 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.59 ' OD1' ' HB3' ' A' ' 97' ' ' LYS . 2.7 p30 -72.04 152.09 42.67 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.042 172.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -48.01 -26.15 1.67 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 125.735 1.614 . . . . 0.0 114.202 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.59 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . 7.0 ttpm? -73.16 -18.86 61.23 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.128 0.571 . . . . 0.0 111.228 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.536 ' NE ' ' HA ' ' A' ' 98' ' ' ARG . 2.7 mmp_? -75.9 -31.03 59.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.39 0.614 . . . . 0.0 109.593 175.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.78 130.19 39.02 Favored 'General case' 0 CA--C 1.475 -1.911 0 CA-C-O 123.07 1.414 . . . . 0.0 110.595 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 13.9 tptt -90.25 -68.31 0.79 Allowed 'General case' 0 N--CA 1.391 -3.402 0 CA-C-N 111.745 -2.48 . . . . 0.0 113.023 -171.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 8.4 pt-20 -163.67 143.58 8.43 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 121.709 0.766 . . . . 0.0 111.829 -168.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -63.39 114.86 4.12 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 128.113 2.565 . . . . 0.0 109.531 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -112.0 -62.68 1.53 Allowed 'General case' 0 N--CA 1.417 -2.098 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.424 HG22 HG11 ' A' ' 19' ' ' VAL . 3.6 t -128.5 -162.5 1.19 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 117.736 -1.585 . . . . 0.0 112.912 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -160.41 140.43 11.32 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 125.228 1.411 . . . . 0.0 109.997 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.432 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 3.6 pp -108.81 157.49 18.54 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.156 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.432 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 11.8 m -89.82 174.03 7.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.323 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 111' ' ' MET . 11.0 m-20 -62.4 -32.56 73.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.202 1.001 . . . . 0.0 111.617 -177.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' A' ' 107' ' ' SER . 11.2 p-10 -70.46 -33.92 71.82 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.43 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -78.5 -28.5 46.34 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.495 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.578 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -47.47 -49.42 25.59 Favored 'General case' 0 CA--C 1.453 -2.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 168.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 9.9 mmpt? -76.71 -7.96 56.35 Favored 'General case' 0 N--CA 1.392 -3.372 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.4 -54.15 4.13 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 116.921 -1.911 . . . . 0.0 106.956 172.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -51.91 -59.03 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-N 112.359 -2.2 . . . . 0.0 112.968 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.554 ' O ' ' HB3' ' A' ' 118' ' ' LEU 0.261 26.0 t0 -61.41 -40.13 93.27 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.883 1.802 . . . . 0.0 109.718 -176.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 14.6 t30 -79.72 -41.99 25.57 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 112.171 -2.286 . . . . 0.0 112.009 -172.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.547 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.77 -36.11 80.08 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.554 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 3.0 tp -64.55 -41.8 96.1 Favored 'General case' 0 N--CA 1.382 -3.86 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.98 -176.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 34.3 mtp -61.53 -34.31 75.32 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-O 120.894 0.378 . . . . 0.0 110.882 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 117' ' ' ALA . 30.5 mt -75.07 -53.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.683 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.2 m -48.07 -34.9 10.3 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 113.254 -1.794 . . . . 0.0 113.156 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 23.2 mt -105.97 3.16 28.08 Favored 'General case' 0 C--O 1.188 -2.134 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.589 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.76 21.53 65.97 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 116.564 1.386 . . . . 0.0 116.564 172.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.74 -57.76 3.41 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 118.701 1.251 . . . . 0.0 110.022 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.9 m120 . . . . . 0 CA--C 1.559 1.324 0 CA-C-N 113.104 -1.862 . . . . 0.0 112.545 -169.05 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . 0.582 ' HB ' ' OD1' ' B' ' 47' ' ' ASN . 71.3 mt . . . . . 0 N--CA 1.433 -1.277 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -116.68 145.34 43.51 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . 0.568 ' HD2' ' O ' ' B' ' 41' ' ' ILE . 4.6 ttp180 -63.89 114.35 4.02 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 175.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.78 -18.14 5.41 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.11 171.8 11.29 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 122.888 1.328 . . . . 0.0 110.14 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.444 HG11 HG22 ' B' ' 104' ' ' THR . 10.4 t -133.35 128.65 55.6 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.576 0 CA-C-N 112.292 -2.231 . . . . 0.0 109.155 176.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.528 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 34.4 m-85 -125.86 147.02 49.57 Favored 'General case' 0 C--N 1.27 -2.865 0 C-N-CA 125.194 1.398 . . . . 0.0 108.407 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.607 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.6 mp -82.23 159.81 23.13 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 170.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.88 133.2 13.59 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.711 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.95 82.19 8.56 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 123.658 1.694 . . . . 0.0 109.666 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.511 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 4.4 pp -90.21 4.78 49.55 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.121 -174.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.572 ' HB3' ' N ' ' B' ' 34' ' ' GLY . 2.3 p -90.21 59.91 0.0 OUTLIER Pre-proline 0 C--N 1.277 -2.55 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.511 ' HD3' ' C ' ' B' ' 24' ' ' LEU . 17.5 Cg_endo -118.59 31.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.112 0 N-CA-C 106.711 -2.073 . . . . 0.0 106.711 152.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 33.3 m -71.14 173.05 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.39 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -142.83 120.28 11.67 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 114.8 1.408 . . . . 0.0 114.8 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.52 -131.08 10.44 Favored Glycine 0 N--CA 1.416 -2.689 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.873 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -93.79 17.03 12.7 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.525 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 41.2 mt-10 -70.46 171.62 9.79 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.401 ' HB3' HE21 ' B' ' 90' ' ' GLN . 0.0 OUTLIER -103.88 125.7 50.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -175.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.43 147.84 17.03 Favored Glycine 0 CA--C 1.486 -1.748 0 N-CA-C 115.409 0.923 . . . . 0.0 115.409 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . 0.572 ' N ' ' HB3' ' B' ' 25' ' ' SER . . . 140.62 137.51 3.46 Favored Glycine 0 C--N 1.288 -2.134 0 CA-C-N 113.727 -1.236 . . . . 0.0 111.787 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -73.64 104.26 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-O 122.998 1.38 . . . . 0.0 107.473 173.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -135.2 161.99 60.19 Favored Pre-proline 0 C--N 1.249 -3.784 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.08 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 19.7 Cg_exo -68.05 142.92 57.93 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 122.047 1.831 . . . . 0.0 110.173 170.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 20' ' ' TYR . 28.7 m -123.74 159.13 29.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 123.552 0.741 . . . . 0.0 109.273 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 32.6 m -102.0 132.3 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 120.524 0.202 . . . . 0.0 110.759 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 mm -84.93 105.89 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.568 ' O ' ' HD2' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -103.44 -12.07 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.033 -178.288 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.647 ' OE1' ' HB ' ' B' ' 53' ' ' VAL . 3.7 mt-30 -42.05 157.55 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 120.945 3.683 . . . . 0.0 120.945 -174.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -69.41 145.15 53.07 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 110.833 -2.894 . . . . 0.0 108.279 165.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' B' ' 47' ' ' ASN . 22.2 t70 -61.85 -30.14 70.65 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.673 -176.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.9 m -87.19 -28.4 22.43 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.879 -174.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.514 ' C ' HE22 ' B' ' 42' ' ' GLN . . . -66.79 -26.8 73.09 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.582 ' OD1' ' HB ' ' B' ' 14' ' ' ILE . 34.6 t30 -68.04 -39.16 83.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.738 -1.231 . . . . 0.0 110.019 176.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -76.52 -66.08 0.85 Allowed 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . 0.439 19.4 p90 -124.31 6.96 8.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 -171.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.436 ' OG ' ' HA2' ' B' ' 46' ' ' GLY . 19.6 m -92.28 131.03 35.68 Favored Pre-proline 0 N--CA 1.428 -1.573 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 171.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.4 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 27.3 Cg_exo -63.28 -28.9 72.64 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 121.62 1.547 . . . . 0.0 110.268 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . 0.467 HG21 ' HG2' ' A' ' 90' ' ' GLN . 1.8 p -94.9 138.84 32.14 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.398 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.647 ' HB ' ' OE1' ' B' ' 42' ' ' GLN . 1.2 m -130.49 158.86 42.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.466 HG21 HD22 ' A' ' 122' ' ' LEU . 9.0 tt -110.87 130.98 63.28 Favored 'Isoleucine or valine' 0 C--O 1.253 1.277 0 CA-C-O 121.269 0.557 . . . . 0.0 110.087 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 27.8 m -137.57 159.51 34.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.906 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.547 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -119.68 142.03 48.84 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.46 140.31 38.63 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.613 HG12 ' CD1' ' B' ' 86' ' ' ILE . 67.6 mt -93.89 140.43 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.253 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 90.9 m -138.12 111.95 8.34 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.388 0.675 . . . . 0.0 110.855 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.265 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 22.7 mt . . . . . 0 C--O 1.213 -0.852 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.02 -14.01 34.8 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.411 2.074 . . . . 0.0 113.855 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 67.2 p -93.88 -18.85 21.54 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.356 0.598 . . . . 0.0 111.361 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -109.26 128.75 55.32 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.02 139.01 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.662 -0.649 . . . . 0.0 110.847 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.22 143.2 26.82 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.788 0.804 . . . . 0.0 111.619 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.862 HG21 ' CE1' ' B' ' 78' ' ' TYR . 5.3 mm -112.59 166.45 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.595 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.56 ' H ' HG22 ' B' ' 73' ' ' ILE . 2.5 mm-40 -97.56 130.55 44.6 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 71.9 mttt -43.4 -52.68 5.83 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.769 1.228 . . . . 0.0 110.604 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -64.6 -25.56 68.02 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.875 1.67 . . . . 0.0 114.087 -173.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -91.36 -20.98 21.25 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.509 0.671 . . . . 0.0 109.586 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.862 ' CE1' HG21 ' B' ' 73' ' ' ILE . 2.0 m-85 -103.8 0.15 29.99 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.178 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 tttp 67.07 17.14 10.41 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.489 0.661 . . . . 0.0 111.855 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' B' ' 78' ' ' TYR . 7.8 mp -94.46 175.1 6.81 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 123.197 1.475 . . . . 0.0 113.143 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.96 -25.99 34.36 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 111.698 -2.501 . . . . 0.0 109.489 176.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.421 ' H ' ' HB3' ' B' ' 80' ' ' LEU . 0.3 OUTLIER -136.52 153.58 50.97 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.547 -172.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.655 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 8.9 p-10 -77.22 143.17 39.18 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 29.9 t -136.19 159.88 40.37 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.512 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 22.9 t -111.36 151.92 13.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.613 ' CD1' HG12 ' B' ' 58' ' ' ILE . 12.3 mm -116.18 139.34 43.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.5 mt -104.88 104.19 13.91 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.427 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.9 mm? -84.45 -8.86 58.82 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.124 -174.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.21 -37.68 15.91 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.373 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . 0.427 ' HG2' HG21 ' A' ' 52' ' ' THR . 0.0 OUTLIER -98.07 77.89 2.48 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.949 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.547 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.4 pp -109.26 179.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . . . . . . . . 0.265 8.0 ptp180 -163.28 161.56 24.79 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' B' ' 53' ' ' VAL . 90.5 m -117.85 115.13 24.34 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 113.735 -1.575 . . . . 0.0 108.534 -176.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 60.1 mt -131.79 148.25 52.55 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.957 -170.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.513 ' OD1' ' HB3' ' B' ' 97' ' ' LYS . 1.2 p30 -74.28 152.09 39.74 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.871 173.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -46.56 -28.97 1.59 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 125.693 1.597 . . . . 0.0 114.007 -175.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.513 ' HB3' ' OD1' ' B' ' 95' ' ' ASP . 7.0 ttpm? -71.77 -18.94 62.09 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 123.177 0.591 . . . . 0.0 111.517 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.537 ' HA ' ' NE ' ' B' ' 98' ' ' ARG . 2.3 mmp_? -76.29 -28.16 56.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.599 0.714 . . . . 0.0 109.695 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 7.8 mp -76.45 128.53 34.98 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 123.533 1.635 . . . . 0.0 111.037 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . 0.409 ' HB3' ' HG2' ' B' ' 101' ' ' GLU . 13.0 tptt -87.11 -67.42 0.82 Allowed 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 111.346 -2.661 . . . . 0.0 113.132 -171.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 9.1 pt-20 -166.27 146.36 6.18 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.707 0.765 . . . . 0.0 111.545 -169.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -63.98 116.2 5.63 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 128.354 2.662 . . . . 0.0 109.541 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.76 -62.72 1.55 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.755 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.444 HG22 HG11 ' B' ' 19' ' ' VAL . 4.6 t -128.63 -164.91 1.43 Allowed 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.66 -1.616 . . . . 0.0 112.153 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.32 134.79 7.48 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 124.817 1.247 . . . . 0.0 109.759 -171.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.466 ' HB3' ' CE1' ' B' ' 78' ' ' TYR . 3.6 pp -101.91 159.58 15.22 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.369 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 11.1 m -91.14 173.42 7.95 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.864 0.364 . . . . 0.0 111.112 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' B' ' 111' ' ' MET . 6.0 m-20 -64.45 -26.79 68.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.867 0.867 . . . . 0.0 112.258 -177.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.82 -38.18 67.24 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.01 -28.54 61.5 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.112 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.1 OUTLIER -47.36 -48.9 25.52 Favored 'General case' 0 CA--C 1.45 -2.881 0 CA-C-O 121.384 0.611 . . . . 0.0 109.567 167.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' B' ' 112' ' ' LYS . 9.3 mmpt? -78.63 -5.48 53.06 Favored 'General case' 0 N--CA 1.382 -3.845 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -176.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -91.16 -56.42 3.16 Favored 'General case' 0 N--CA 1.397 -3.109 0 C-N-CA 116.999 -1.88 . . . . 0.0 107.197 170.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -50.22 -59.78 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 112.203 -2.271 . . . . 0.0 113.282 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.598 ' O ' ' HB3' ' B' ' 118' ' ' LEU 0.275 17.2 t0 -60.66 -42.86 97.89 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 123.78 1.752 . . . . 0.0 109.826 -176.096 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.363 47.0 t30 -77.69 -41.68 37.16 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.095 -171.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -65.44 -34.17 77.66 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.598 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.1 tp -63.24 -41.69 99.11 Favored 'General case' 0 N--CA 1.381 -3.921 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.257 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 36.1 mtp -60.08 -37.89 81.26 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 120.714 0.292 . . . . 0.0 110.573 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' B' ' 117' ' ' ALA . 28.7 mt -71.06 -53.15 22.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 25.3 m -51.11 -32.64 23.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.783 178.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 22.5 mt -105.63 1.79 27.62 Favored 'General case' 0 C--O 1.19 -2.074 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.495 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.45 24.99 59.8 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.506 ' HG ' ' OD1' ' A' ' 115' ' ' ASP . 7.1 mp -83.47 -58.37 2.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.778 1.289 . . . . 0.0 110.194 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 18.1 m120 . . . . . 0 CA--C 1.562 1.424 0 CA-C-N 112.868 -1.969 . . . . 0.0 113.177 -168.92 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.425 -1.688 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -123.25 144.23 49.53 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -63.14 118.18 7.56 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.524 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.64 -19.4 5.03 Favored Glycine 0 N--CA 1.425 -2.049 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.724 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -83.13 171.47 13.67 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.353 1.073 . . . . 0.0 110.097 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.441 HG11 HG22 ' A' ' 104' ' ' THR . 13.3 t -132.38 128.03 57.79 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.373 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 24.2 m-85 -123.36 151.42 42.54 Favored 'General case' 0 C--N 1.271 -2.847 0 C-N-CA 125.274 1.43 . . . . 0.0 110.03 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.7 mp -88.63 150.17 23.17 Favored 'General case' 0 N--CA 1.396 -3.15 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -145.27 139.11 26.88 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.156 -176.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -81.86 89.95 6.38 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.533 1.158 . . . . 0.0 108.665 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.601 ' O ' HG13 ' A' ' 27' ' ' VAL . 82.2 mt -65.1 -19.45 65.99 Favored 'General case' 0 CA--C 1.481 -1.677 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.661 -178.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.569 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 10.0 m -33.75 175.0 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.322 0 C-N-CA 127.197 2.199 . . . . 0.0 114.252 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 27.32 48.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.677 0 C-N-CA 121.905 1.737 . . . . 0.0 114.588 -151.37 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 1.6 m -69.88 168.22 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.002 170.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.489 ' HG3' HD23 ' B' ' 94' ' ' LEU . 25.2 mm-40 -99.21 107.14 19.39 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.765 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.86 -122.31 26.68 Favored Glycine 0 C--N 1.298 -1.564 0 CA-C-N 113.998 -1.455 . . . . 0.0 113.371 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.4 m -81.71 20.97 0.87 Allowed 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.601 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 46.0 mt-10 -62.24 168.26 3.54 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 117.917 -1.513 . . . . 0.0 110.32 170.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.533 HE22 ' HG3' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -70.81 107.95 4.24 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -176.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.76 144.3 18.81 Favored Glycine 0 CA--C 1.499 -0.95 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 157.97 10.06 Favored Glycine 0 N--CA 1.421 -2.347 0 CA-C-N 113.019 -1.59 . . . . 0.0 111.538 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -81.9 104.89 11.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 171.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.533 ' HG3' HE22 ' A' ' 32' ' ' GLN . 18.4 mmt180 -129.46 157.18 77.14 Favored Pre-proline 0 C--N 1.26 -3.29 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.58 -167.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HB2' HD12 ' A' ' 58' ' ' ILE . 31.9 Cg_exo -63.22 144.88 92.79 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.211 1.941 . . . . 0.0 111.405 171.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 27.2 m -129.91 156.26 42.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 124.238 1.015 . . . . 0.0 109.067 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.6 m -100.22 131.99 46.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 mm -91.51 115.57 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.95 -14.25 10.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.265 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.539 HE22 ' N ' ' A' ' 47' ' ' ASN . 5.0 pt20 -53.69 163.12 0.73 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -168.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -64.94 -177.58 0.36 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.156 -2.293 . . . . 0.0 112.202 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -81.7 -42.73 19.47 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.969 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -82.69 -23.64 34.04 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -170.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.73 -32.41 74.17 Favored Glycine 0 C--O 1.204 -1.739 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.356 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.539 ' N ' HE22 ' A' ' 42' ' ' GLN . 8.3 p30 -81.52 -18.08 46.28 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.086 0.47 . . . . 0.0 111.792 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -86.65 -62.89 1.41 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.507 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -107.34 -15.26 14.68 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -168.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -91.43 141.46 26.03 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HA ' ' HE3' ' A' ' 96' ' ' LYS . 72.8 Cg_endo -81.86 -9.8 11.87 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.99 1.794 . . . . 0.0 111.381 176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 p -109.13 135.69 49.84 Favored 'General case' 0 N--CA 1.409 -2.509 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.791 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.439 HG13 ' OE1' ' A' ' 42' ' ' GLN . 95.0 t -123.74 139.75 49.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.567 HG21 HD22 ' B' ' 122' ' ' LEU . 9.3 tp -97.52 128.16 49.11 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 25.9 m -140.35 164.54 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.968 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -122.32 132.93 54.64 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.7 131.66 46.46 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.539 HD12 ' HB2' ' A' ' 37' ' ' PRO . 54.3 mt -91.68 106.11 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.785 176.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.3 m -102.46 140.94 36.07 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.698 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.459 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.768 -177.771 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.9 tt . . . . . 0 N--CA 1.426 -1.63 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.58 ' HB2' HD13 ' A' ' 120' ' ' ILE . 61.2 Cg_endo -71.5 2.56 4.41 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.632 2.221 . . . . 0.0 114.737 -174.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.506 ' HB ' ' HG3' ' A' ' 89' ' ' GLU . 68.0 p -103.31 -16.57 15.61 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.35 0.595 . . . . 0.0 111.483 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -109.91 129.82 55.6 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.3 p -123.01 132.71 70.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.512 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.67 130.0 34.95 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.941 0.877 . . . . 0.0 110.444 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.56 HD11 HG12 ' A' ' 86' ' ' ILE . 13.1 mm -97.1 169.99 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.458 ' N ' HG22 ' A' ' 73' ' ' ILE . 7.4 tp10 -106.34 109.57 21.54 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 168.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -50.93 -30.7 15.49 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 125.431 1.492 . . . . 0.0 114.678 -172.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.401 ' HG2' ' OE1' ' A' ' 74' ' ' GLU . 42.5 mmtm -49.37 -45.14 45.52 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 125.008 1.323 . . . . 0.0 111.508 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -79.06 -24.41 43.56 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.631 0.729 . . . . 0.0 111.678 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.538 ' HB2' ' HE3' ' A' ' 75' ' ' LYS . 4.0 m-85 -97.81 6.5 47.76 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.012 -175.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.466 ' O ' HD12 ' A' ' 80' ' ' LEU 0.394 61.8 pttt 43.28 64.3 1.26 Allowed 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 119.824 3.268 . . . . 0.0 119.824 176.345 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.597 HD22 ' HZ3' ' A' ' 75' ' ' LYS . 10.3 mp -141.76 -168.27 2.63 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 169.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -113.94 -9.11 13.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 123.679 0.612 . . . . 0.0 110.821 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 50.3 mttm -115.12 112.14 22.1 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.204 -173.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -35.66 144.24 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.984 1.714 . . . . 0.0 115.388 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.7 m -123.32 132.74 54.09 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.435 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 35.4 t -120.15 138.14 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 173.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.56 HG12 HD11 ' A' ' 73' ' ' ILE . 23.4 mm -104.31 131.26 53.59 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.2 mt -98.6 103.51 15.47 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.505 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -81.57 -17.64 47.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.506 ' HG3' ' HB ' ' A' ' 69' ' ' THR . 41.3 mt-10 -86.51 -7.73 58.15 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.766 0.793 . . . . 0.0 111.231 173.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 91' ' ' ILE . 14.5 tp60 -89.27 -100.68 0.09 Allowed 'General case' 0 C--O 1.192 -1.937 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 90' ' ' GLN . 1.1 pp 57.84 179.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 C-N-CA 127.574 2.35 . . . . 0.0 110.958 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.515 ' NH2' ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -176.77 176.43 1.5 Allowed 'General case' 0 C--N 1.311 -1.108 0 O-C-N 123.897 0.748 . . . . 0.0 112.233 172.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.449 HG21 ' O ' ' B' ' 90' ' ' GLN . 53.6 m -116.18 128.59 55.75 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.477 HD23 ' HG3' ' B' ' 28' ' ' GLN . 71.0 mt -131.72 141.65 49.59 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.886 -173.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.425 ' OD1' ' HG3' ' A' ' 97' ' ' LYS . 11.9 t0 -57.2 144.61 34.51 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 169.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 51' ' ' PRO . 16.8 pttp -55.41 -31.02 61.51 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.425 ' HG3' ' OD1' ' A' ' 95' ' ' ASP . 52.1 mttp -53.44 -28.82 32.27 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.919 174.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 8.9 mmp_? -74.27 -34.13 63.48 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 120.904 0.383 . . . . 0.0 110.269 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.9 mp -68.51 106.32 2.52 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.279 1.037 . . . . 0.0 110.268 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -83.74 -67.37 0.8 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.28 -1.782 . . . . 0.0 114.134 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.587 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.6 pt-20 -148.32 152.05 36.42 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-O 121.563 0.696 . . . . 0.0 110.16 -169.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 20' ' ' TYR . 30.8 mtpt -79.1 115.75 18.96 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-N 113.171 -1.831 . . . . 0.0 108.236 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 tp -104.28 -58.93 1.81 Allowed 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.288 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.441 HG22 HG11 ' A' ' 19' ' ' VAL . 5.2 t -132.54 -164.98 1.53 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 117.835 -1.546 . . . . 0.0 111.915 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.49 128.43 4.55 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 125.631 1.573 . . . . 0.0 109.876 -173.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.423 HD11 ' HE3' ' A' ' 111' ' ' MET . 3.7 pp -95.14 163.31 13.34 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.7 p -88.3 164.1 15.74 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 123.085 0.554 . . . . 0.0 112.049 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 111' ' ' MET . 22.7 t70 -61.99 -29.5 70.3 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.401 1.08 . . . . 0.0 113.37 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.13 -33.74 68.03 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -76.36 -32.25 58.51 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.502 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -52.37 -41.91 63.5 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 125.165 1.386 . . . . 0.0 110.549 175.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.657 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 2.2 mmmm -69.84 -21.73 63.34 Favored 'General case' 0 CA--C 1.465 -2.324 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.352 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -87.81 -46.56 9.33 Favored 'General case' 0 N--CA 1.398 -3.028 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 t -50.58 -54.6 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 CA-C-N 113.263 -1.79 . . . . 0.0 112.857 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 53.5 m-20 -66.24 -42.74 88.16 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 123.511 1.624 . . . . 0.0 111.946 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.657 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 3.8 t30 -74.93 -43.56 53.54 Favored 'General case' 0 C--N 1.26 -3.326 0 CA-C-N 112.76 -2.018 . . . . 0.0 112.52 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -60.71 -36.66 79.39 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.528 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 10.2 tp -65.33 -39.45 92.42 Favored 'General case' 0 N--CA 1.386 -3.675 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.105 -177.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.775 ' SD ' ' HA ' ' A' ' 125' ' ' ASN 0.265 7.4 ptp -74.92 -19.32 60.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 117.54 -1.664 . . . . 0.0 114.461 176.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 68' ' ' PRO . 30.4 mt -77.03 -50.04 21.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 175.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.1 p -60.78 -30.4 70.02 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 113.111 -1.858 . . . . 0.0 112.124 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.554 HD22 HG21 ' B' ' 54' ' ' ILE . 27.4 mt -107.2 0.7 23.49 Favored 'General case' 0 C--O 1.199 -1.589 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.84 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.64 26.21 65.78 Favored Glycine 0 CA--C 1.549 2.169 0 N-CA-C 116.964 1.546 . . . . 0.0 116.964 174.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.557 HD11 HD11 ' B' ' 124' ' ' LEU . 0.5 OUTLIER -113.9 15.93 18.45 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 119.263 1.531 . . . . 0.0 111.805 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.775 ' HA ' ' SD ' ' A' ' 119' ' ' MET . 2.4 t-20 . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 123.353 0.661 . . . . 0.0 112.705 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 56.8 mt . . . . . 0 N--CA 1.424 -1.766 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 24.4 mmm-85 -121.28 140.64 51.79 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -61.26 115.03 3.5 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.818 170.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.81 -16.31 5.33 Favored Glycine 0 N--CA 1.428 -1.891 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.066 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.18 172.52 11.83 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 122.266 1.032 . . . . 0.0 109.47 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.461 HG11 HG22 ' B' ' 104' ' ' THR . 12.3 t -132.88 129.09 57.66 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.174 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.265 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 23.0 m-85 -123.89 150.88 44.14 Favored 'General case' 0 C--N 1.271 -2.824 0 C-N-CA 125.322 1.449 . . . . 0.0 110.052 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 3.8 mp -87.95 150.18 23.61 Favored 'General case' 0 N--CA 1.391 -3.396 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 165.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -145.48 138.52 26.2 Favored 'General case' 0 C--N 1.26 -3.286 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.118 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.23 91.16 6.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.73 1.252 . . . . 0.0 108.477 171.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.572 ' O ' HG13 ' B' ' 27' ' ' VAL . 85.4 mt -65.83 -20.86 66.4 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-N 112.672 -2.058 . . . . 0.0 110.735 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.532 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 16.3 m -35.08 176.28 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.171 0 C-N-CA 126.97 2.108 . . . . 0.0 114.929 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 26.41 49.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.621 0 C-N-CA 121.817 1.678 . . . . 0.0 114.615 -149.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.594 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 1.8 m -69.99 172.9 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.337 170.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' GLN . . . . . 0.477 ' HG3' HD23 ' A' ' 94' ' ' LEU . 22.6 mm-40 -102.52 108.71 20.1 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.055 -1.43 . . . . 0.0 110.577 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.33 -120.61 13.81 Favored Glycine 0 C--N 1.304 -1.25 0 CA-C-N 114.248 -1.342 . . . . 0.0 114.097 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.0 m -81.25 20.19 0.87 Allowed 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.594 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 46.4 mt-10 -63.87 166.24 7.59 Favored 'General case' 0 C--O 1.248 0.995 0 C-N-CA 117.695 -1.602 . . . . 0.0 109.881 169.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' GLN . . . . . 0.483 HE22 ' HG3' ' B' ' 36' ' ' ARG . 0.9 OUTLIER -71.38 108.08 4.65 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.09 146.29 19.01 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 116.069 1.187 . . . . 0.0 116.069 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.09 152.68 8.71 Favored Glycine 0 N--CA 1.417 -2.598 0 CA-C-N 113.503 -1.349 . . . . 0.0 110.722 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 p -78.38 108.65 12.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' ARG . . . . . 0.483 ' HG3' HE22 ' B' ' 32' ' ' GLN . 11.0 mmt180 -133.99 156.87 78.84 Favored Pre-proline 0 C--N 1.263 -3.191 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.042 -166.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . 0.557 ' HB2' HD12 ' B' ' 58' ' ' ILE . 31.3 Cg_exo -63.39 144.04 89.99 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.486 2.124 . . . . 0.0 111.681 172.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 27.3 m -129.1 156.06 41.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 124.341 1.057 . . . . 0.0 109.193 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.5 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 31.8 m -99.74 131.69 46.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 30.3 mm -91.02 115.65 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.82 -14.87 10.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.241 -177.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.573 HE22 ' N ' ' B' ' 47' ' ' ASN . 4.9 pt20 -52.95 163.24 0.52 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 -168.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -65.78 -177.22 0.44 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.778 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.38 -47.94 14.89 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.7 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 20.4 m -78.17 -24.37 47.26 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -169.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -60.95 -32.35 79.68 Favored Glycine 0 C--O 1.204 -1.738 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.358 -176.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . 0.573 ' N ' HE22 ' B' ' 42' ' ' GLN . 9.9 p30 -81.49 -18.95 43.39 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.403 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -84.77 -66.66 0.87 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.015 0.436 . . . . 0.0 111.455 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -103.93 -13.71 16.25 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 19.3 m -94.72 140.03 22.44 Favored Pre-proline 0 C--N 1.295 -1.772 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.84 -6.45 11.45 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.106 1.871 . . . . 0.0 111.548 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.2 p -110.09 135.64 50.59 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.533 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.458 HG13 ' OE1' ' B' ' 42' ' ' GLN . 93.1 t -123.88 139.81 49.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.554 HG21 HD22 ' A' ' 122' ' ' LEU . 9.1 tp -97.19 128.67 48.22 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 27.4 m -140.72 164.52 21.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.035 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.5 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -122.38 132.82 54.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.15 130.55 43.47 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.557 HD12 ' HB2' ' B' ' 37' ' ' PRO . 56.8 mt -90.08 108.53 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.166 176.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -105.13 139.49 39.72 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.896 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.58 -178.719 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.422 -1.843 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' PRO . . . . . 0.474 ' HB2' HD13 ' B' ' 120' ' ' ILE . 49.2 Cg_endo -68.48 0.57 4.55 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.729 2.286 . . . . 0.0 115.098 -175.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' THR . . . . . 0.509 ' HB ' ' HG3' ' B' ' 89' ' ' GLU . 77.7 p -103.55 -15.92 15.69 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.302 0.572 . . . . 0.0 111.789 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -110.94 129.18 55.96 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 8.6 p -122.18 132.61 70.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.521 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -84.4 136.9 33.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.282 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ILE . . . . . 0.56 HD11 HG12 ' B' ' 86' ' ' ILE . 12.2 mm -108.66 157.17 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.413 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.444 ' N ' HG22 ' B' ' 73' ' ' ILE . 9.2 tp10 -94.38 109.13 21.01 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 173.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' LYS . . . . . 0.621 ' HZ3' HD22 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -52.72 -30.73 34.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . 0.438 ' H ' ' HG2' ' B' ' 76' ' ' LYS . 16.1 mmtp -50.96 -41.08 58.99 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 124.9 1.28 . . . . 0.0 112.038 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -80.25 -26.99 38.74 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.886 0.85 . . . . 0.0 111.435 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' TYR . . . . . 0.541 ' HB2' ' HE3' ' B' ' 75' ' ' LYS . 4.4 m-85 -95.2 5.88 50.57 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.234 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' LYS . . . . . 0.49 ' O ' HD12 ' B' ' 80' ' ' LEU 0.399 61.6 pttt 43.62 64.66 1.18 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 119.822 3.268 . . . . 0.0 119.822 176.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' LEU . . . . . 0.621 HD22 ' HZ3' ' B' ' 75' ' ' LYS . 10.3 mp -142.69 -169.87 3.09 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 169.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -116.52 -1.75 12.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.957 0.786 . . . . 0.0 110.813 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . 0.432 ' O ' ' HD3' ' B' ' 75' ' ' LYS . 52.6 mttm -120.79 111.11 17.17 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.79 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -33.14 143.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 127.179 2.191 . . . . 0.0 114.526 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -124.91 133.42 53.06 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.21 -170.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 39.9 t -120.07 138.23 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 174.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.56 HG12 HD11 ' B' ' 73' ' ' ILE . 24.2 mm -103.95 130.39 54.61 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 51.7 mt -98.6 103.19 15.11 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 -20.32 44.25 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.619 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' GLU . . . . . 0.509 ' HG3' ' HB ' ' B' ' 69' ' ' THR . 42.9 mt-10 -84.27 -9.26 58.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.711 0.767 . . . . 0.0 111.595 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' GLN . . . . . 0.555 ' O ' HG13 ' B' ' 91' ' ' ILE . 15.0 tp60 -86.82 -100.65 0.07 Allowed 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 172.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.555 HG13 ' O ' ' B' ' 90' ' ' GLN . 1.0 OUTLIER 57.75 179.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 C-N-CA 127.63 2.372 . . . . 0.0 111.033 -179.014 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' ARG . . . . . 0.484 ' NH2' ' HA ' ' B' ' 27' ' ' VAL . 0.1 OUTLIER -176.88 177.08 1.36 Allowed 'General case' 0 C--N 1.311 -1.089 0 O-C-N 123.911 0.757 . . . . 0.0 112.297 172.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 90' ' ' GLN . 51.9 m -116.76 128.81 55.66 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' LEU . . . . . 0.489 HD23 ' HG3' ' A' ' 28' ' ' GLN . 72.4 mt -131.45 142.1 49.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.058 -172.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' ASP . . . . . 0.43 ' OD1' ' HG3' ' B' ' 97' ' ' LYS . 11.0 t0 -56.6 143.92 33.91 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -57.65 -28.01 63.35 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.43 ' HG3' ' OD1' ' B' ' 95' ' ' ASP . 49.0 mttp -59.23 -22.74 61.54 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.329 174.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 8.0 mmp_? -78.15 -32.08 50.07 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.244 0.545 . . . . 0.0 109.732 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.43 105.52 2.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.475 1.131 . . . . 0.0 110.498 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.82 -64.2 1.21 Allowed 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 113.243 -1.799 . . . . 0.0 114.108 -173.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -152.55 152.39 31.81 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.426 0.632 . . . . 0.0 110.362 -171.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . 0.516 ' HG2' ' CZ ' ' B' ' 20' ' ' TYR . 32.5 mtpt -78.3 115.53 18.08 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 126.06 1.744 . . . . 0.0 108.323 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 tp -103.86 -59.02 1.79 Allowed 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.721 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' THR . . . . . 0.461 HG22 HG11 ' B' ' 19' ' ' VAL . 4.7 t -132.47 -164.66 1.49 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.675 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -160.82 130.29 4.89 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 125.272 1.429 . . . . 0.0 110.226 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.73 157.31 16.36 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -175.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -80.27 166.2 21.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.976 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' B' ' 111' ' ' MET . 19.7 t70 -70.42 -23.31 62.72 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.857 0.863 . . . . 0.0 112.398 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.51 -30.16 57.09 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -78.52 -32.99 48.28 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.458 ' HA ' ' HE3' ' B' ' 111' ' ' MET . 0.2 OUTLIER -50.97 -43.6 60.48 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 125.473 1.509 . . . . 0.0 110.337 175.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' B' ' 116' ' ' ASN . 0.3 OUTLIER -68.78 -20.98 64.36 Favored 'General case' 0 C--O 1.185 -2.292 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.329 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -87.4 -47.86 8.44 Favored 'General case' 0 CA--C 1.45 -2.893 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 t -49.57 -54.98 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.44 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.882 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.559 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 17.9 m-20 -64.44 -44.42 91.23 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-O 123.385 1.564 . . . . 0.0 112.074 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' ASN . . . . . 0.61 ' HB3' ' O ' ' B' ' 112' ' ' LYS 0.302 5.9 t30 -76.51 -41.33 47.25 Favored 'General case' 0 C--N 1.262 -3.212 0 C-N-CA 126.778 2.031 . . . . 0.0 112.815 -172.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.59 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -64.48 -33.56 76.16 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 10.0 tp -65.33 -39.64 92.68 Favored 'General case' 1 N--CA 1.378 -4.059 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.773 -178.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' MET . . . . . 0.8 ' SD ' ' HA ' ' B' ' 125' ' ' ASN 0.255 6.9 ptp -73.81 -19.93 60.61 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 117.821 -1.552 . . . . 0.0 114.155 176.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' B' ' 117' ' ' ALA . 43.0 mt -75.98 -52.04 18.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 78.5 p -59.09 -28.0 66.08 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.681 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.567 HD22 HG21 ' A' ' 54' ' ' ILE . 26.9 mt -108.22 -0.45 20.9 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.922 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.81 31.78 57.82 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.557 HD11 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -120.95 20.09 11.61 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.821 1.31 . . . . 0.0 111.577 179.445 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.8 ' HA ' ' SD ' ' B' ' 119' ' ' MET . 13.0 m120 . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.74 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 t -154.54 104.68 2.57 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.3 p -75.27 97.96 3.68 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -84.32 -27.04 28.06 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -136.54 152.98 51.09 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -98.34 -172.98 2.45 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -81.38 -0.93 43.58 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -173.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -126.04 -88.14 0.59 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.586 0.231 . . . . 0.0 110.507 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -140.16 -179.42 5.97 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.2 m -63.77 -46.96 82.92 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 174.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 173.26 -30.0 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.441 1.496 . . . . 0.0 107.033 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -72.89 127.07 90.14 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 113.572 -1.649 . . . . 0.0 108.452 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.53 -25.71 17.53 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 121.542 1.495 . . . . 0.0 110.086 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.2 mt -104.97 117.48 50.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.2 ttp180 -103.38 144.33 31.52 Favored 'General case' 1 N--CA 1.374 -4.244 0 C-N-CA 123.611 0.765 . . . . 0.0 109.131 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -71.1 120.57 16.85 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 99.36 -1.16 57.2 Favored Glycine 0 C--N 1.305 -1.161 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.972 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -97.32 119.55 36.05 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 105.507 -2.035 . . . . 0.0 105.507 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.495 ' HB ' ' H ' ' A' ' 104' ' ' THR . 87.6 t -83.81 128.26 39.0 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 C-N-CA 123.201 0.6 . . . . 0.0 112.288 -172.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 48.8 m-85 -115.29 141.38 48.11 Favored 'General case' 0 C--N 1.273 -2.721 0 C-N-CA 125.236 1.414 . . . . 0.0 111.425 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER -75.26 148.66 39.24 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 167.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.02 149.4 34.05 Favored 'General case' 0 C--N 1.262 -3.215 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.233 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.416 ' HB2' ' HE2' ' A' ' 100' ' ' LYS . 26.0 t0 -96.91 76.68 2.74 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 27' ' ' VAL 0.264 3.0 tt -71.58 -18.16 62.25 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.089 -2.778 . . . . 0.0 108.437 -173.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.521 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 5.1 m -32.82 -178.19 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.935 0 C-N-CA 129.739 3.216 . . . . 0.0 116.384 173.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.558 ' HB2' ' NE2' ' B' ' 28' ' ' GLN . 0.1 OUTLIER 25.95 43.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.137 0 C-N-CA 124.317 3.345 . . . . 0.0 116.648 -151.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.728 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 2.8 m -70.07 142.2 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.402 169.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.533 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 35.2 mm-40 -90.31 134.17 34.48 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 114.887 -1.052 . . . . 0.0 113.222 -172.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.84 -108.84 0.69 Allowed Glycine 0 N--CA 1.442 -0.923 0 O-C-N 124.564 1.165 . . . . 0.0 114.654 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.8 m -94.05 8.28 42.06 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.728 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 31.8 mt-10 -62.08 143.46 56.62 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 90' ' ' GLN . 2.1 tp60 -103.49 112.31 25.15 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.174 0.512 . . . . 0.0 110.872 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . 166.04 -178.62 40.61 Favored Glycine 0 N--CA 1.408 -3.179 0 C-N-CA 119.807 -1.187 . . . . 0.0 115.012 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 24' ' ' LEU . . . 178.08 -160.09 26.12 Favored Glycine 0 C--N 1.266 -3.313 1 N-CA-C 101.972 -4.451 . . . . 0.0 101.972 -178.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.9 p -73.73 120.04 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.124 0 CA-C-N 120.859 2.329 . . . . 0.0 109.071 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.414 ' NH1' ' HA ' ' A' ' 59' ' ' THR . 73.2 mtt180 -152.73 166.07 16.2 Favored Pre-proline 0 C--N 1.28 -2.418 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.423 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.655 ' HB2' HD12 ' A' ' 58' ' ' ILE . 11.0 Cg_exo -71.76 144.56 44.16 Favored 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.595 1.53 . . . . 0.0 109.978 169.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 28.7 m -128.19 158.26 40.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.507 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 35.9 m -101.76 130.33 51.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.832 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.433 HD13 HG12 ' A' ' 55' ' ' VAL . 35.9 mm -84.19 105.46 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.97 -10.19 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.035 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.666 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 2.5 tt0 -60.63 164.51 4.54 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -169.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 26.6 p-10 -68.38 -174.7 0.55 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.387 -1.733 . . . . 0.0 111.466 175.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -88.34 -38.36 15.2 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.194 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.452 ' HA ' ' HD2' ' A' ' 48' ' ' LYS . 4.0 m -81.83 -22.26 37.13 Favored 'General case' 0 C--N 1.316 -0.883 0 O-C-N 121.776 -0.578 . . . . 0.0 112.521 -171.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.63 -31.03 76.38 Favored Glycine 0 C--O 1.214 -1.116 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -71.09 -35.31 71.78 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.249 0.547 . . . . 0.0 110.563 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HD2' ' HA ' ' A' ' 45' ' ' THR . 34.4 mttp -79.63 -48.28 14.01 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -115.51 -27.79 7.03 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -172.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.417 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 61.9 m -86.12 148.33 47.41 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 120.036 -0.666 . . . . 0.0 109.992 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 2.9 Cg_endo -81.9 -17.01 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.579 1.519 . . . . 0.0 110.221 174.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.2 p -91.65 151.08 20.84 Favored 'General case' 0 N--CA 1.421 -1.894 0 C-N-CA 124.635 1.174 . . . . 0.0 111.982 -174.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.666 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 61.8 t -135.12 139.02 47.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.634 HG21 HD22 ' B' ' 122' ' ' LEU . 10.3 tt -93.14 134.51 30.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-O 121.094 0.473 . . . . 0.0 110.196 170.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 94' ' ' LEU . 22.1 m -139.62 164.22 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.368 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.537 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -122.82 138.29 54.69 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 176.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.1 132.43 45.83 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 37' ' ' PRO . 63.3 mt -92.09 136.84 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 113.981 -1.463 . . . . 0.0 107.901 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.414 ' HA ' ' NH1' ' A' ' 36' ' ' ARG . 95.8 m -129.52 139.89 51.41 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 84' ' ' SER . . . -60.12 -75.07 0.3 Allowed Glycine 0 C--O 1.222 -0.656 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.429 ' HD2' ' O ' ' A' ' 60' ' ' GLY . 28.5 mmm180 -133.37 157.25 45.99 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.3 tp -162.29 -54.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.027 0.441 . . . . 0.0 110.243 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -172.75 144.49 1.38 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -56.43 143.84 33.33 Favored 'General case' 0 C--N 1.311 -1.099 0 O-C-N 124.294 0.996 . . . . 0.0 110.069 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.28 75.45 0.53 Allowed 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.807 0.813 . . . . 0.0 110.748 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -103.13 -17.04 15.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.23 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.0 mt -101.48 140.55 21.34 Favored Pre-proline 0 C--N 1.299 -1.615 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.64 1.85 3.99 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 121.951 1.767 . . . . 0.0 113.069 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.0 p -98.71 -18.8 17.84 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 121.394 0.616 . . . . 0.0 109.872 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -97.88 129.95 44.8 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.815 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.58 142.7 43.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -103.93 148.69 25.88 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.955 0.407 . . . . 0.0 110.969 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.533 HD13 HD11 ' A' ' 86' ' ' ILE . 25.2 pt -124.6 134.46 66.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' O ' ' HD1' ' A' ' 78' ' ' TYR . 2.7 mp0 -59.96 115.71 3.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.373 1.069 . . . . 0.0 113.423 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HB3' ' C ' ' A' ' 82' ' ' LYS . 22.3 pttm -50.56 -36.42 34.43 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.965 0.906 . . . . 0.0 112.214 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -52.35 -53.16 48.2 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 113.326 -1.761 . . . . 0.0 112.627 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -92.64 -37.65 12.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.552 0.692 . . . . 0.0 111.996 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.537 ' CE2' ' HA ' ' A' ' 106' ' ' LEU . 71.3 m-85 -75.37 -5.92 47.32 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.921 -172.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp 75.5 24.1 1.39 Allowed 'General case' 0 C--N 1.348 0.521 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 167.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.67 179.0 4.4 Favored 'General case' 0 CA--C 1.489 -1.396 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.265 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -96.22 -5.29 40.74 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.485 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -140.89 150.51 43.29 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.193 -176.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -75.3 128.07 34.59 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 6.1 t -102.78 163.58 12.14 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -170.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.1 t -120.46 141.3 41.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.533 HD11 HD13 ' A' ' 73' ' ' ILE . 17.2 mm -107.48 133.2 52.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 72.9 mt -106.18 109.38 21.3 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.44 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -83.94 -2.68 57.02 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.509 0.671 . . . . 0.0 111.991 -175.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -97.0 -34.11 11.31 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 122.323 1.059 . . . . 0.0 109.677 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.428 ' HG2' ' HB3' ' A' ' 32' ' ' GLN . 9.7 tp60 -94.56 80.0 3.83 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 113.969 -1.469 . . . . 0.0 108.625 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.537 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.1 pp -122.71 -177.56 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.426 -0.954 . . . . 0.0 108.426 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -173.71 -178.24 1.56 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 123.784 0.677 . . . . 0.0 112.502 173.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 53.9 m -123.67 126.05 45.89 Favored 'General case' 0 N--CA 1.411 -2.42 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.499 HD12 HG21 ' A' ' 55' ' ' VAL . 74.7 mt -132.07 133.69 44.65 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.656 1.183 . . . . 0.0 109.784 -173.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.5 p-10 -78.09 153.84 31.86 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -44.78 -21.11 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.796 1.638 . . . . 0.0 115.015 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -74.17 -17.51 60.9 Favored 'General case' 0 CA--C 1.564 1.498 0 CA-C-O 121.209 0.528 . . . . 0.0 110.604 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.421 ' HD2' ' CB ' ' B' ' 28' ' ' GLN . 4.8 mmp_? -84.34 -38.52 20.25 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.073 0.549 . . . . 0.0 111.23 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.48 121.91 16.83 Favored 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 123.885 0.874 . . . . 0.0 111.1 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 23' ' ' ASP . 68.2 mttm -92.34 -62.55 1.38 Allowed 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.784 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.1 pt-20 -159.73 143.47 14.49 Favored 'General case' 0 N--CA 1.425 -1.684 0 CA-C-O 121.291 0.567 . . . . 0.0 112.075 -170.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.27 123.75 20.78 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.719 174.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.712 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 22.1 tp -114.3 -61.92 1.67 Allowed 'General case' 0 N--CA 1.414 -2.255 0 CA-C-O 122.394 1.092 . . . . 0.0 110.435 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.712 ' OG1' ' HG ' ' A' ' 103' ' ' LEU 0.26 3.7 m -126.54 -174.8 3.22 Favored 'General case' 0 N--CA 1.401 -2.892 0 CA-C-N 113.283 -1.78 . . . . 0.0 111.93 -164.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.432 ' H ' ' CG2' ' A' ' 104' ' ' THR . 0.4 OUTLIER -159.73 137.17 9.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.483 1.513 . . . . 0.0 109.645 -167.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.537 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . 6.9 mt -98.22 164.02 12.49 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.775 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.8 m -98.62 159.98 14.58 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 111' ' ' MET . 21.2 m-20 -63.59 -31.61 72.83 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.314 0.578 . . . . 0.0 112.307 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -67.76 -41.5 83.25 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 122.077 -0.389 . . . . 0.0 109.971 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -74.57 -24.21 58.88 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.378 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.482 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -56.59 -39.75 74.1 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 123.819 0.847 . . . . 0.0 108.857 170.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 8.4 mmpt? -79.99 -11.09 59.81 Favored 'General case' 0 N--CA 1.39 -3.474 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.233 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -88.94 -49.42 6.8 Favored 'General case' 0 N--CA 1.39 -3.426 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -50.26 -58.77 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.213 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.199 177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.78 -39.5 77.62 Favored 'General case' 0 N--CA 1.515 2.825 0 CA-C-O 123.452 1.596 . . . . 0.0 111.931 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.511 ' HB3' ' O ' ' A' ' 112' ' ' LYS 0.257 6.4 t30 -83.98 -46.62 11.87 Favored 'General case' 0 C--N 1.254 -3.574 0 CA-C-N 112.424 -2.171 . . . . 0.0 112.77 -170.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.516 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.54 -36.16 73.44 Favored 'General case' 0 CA--C 1.47 -2.102 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.546 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 7.4 tp -62.56 -47.11 85.32 Favored 'General case' 1 N--CA 1.363 -4.782 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.104 -177.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.633 ' SD ' ' HA ' ' A' ' 125' ' ' ASN 0.275 7.8 ptp -68.14 -22.59 64.86 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 178.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.3 mt -72.22 -51.98 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.426 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 174.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 10.3 t -55.52 -34.66 64.86 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 113.197 -1.82 . . . . 0.0 111.669 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.632 HD22 HG21 ' B' ' 54' ' ' ILE . 17.0 mt -110.38 8.4 23.28 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.769 -0.582 . . . . 0.0 111.266 -177.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.53 21.49 64.79 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 116.795 1.478 . . . . 0.0 116.795 171.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.782 HD11 HD11 ' B' ' 124' ' ' LEU . 0.6 OUTLIER -99.95 13.91 32.29 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 118.56 1.18 . . . . 0.0 111.485 -176.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.633 ' HA ' ' SD ' ' A' ' 119' ' ' MET . 20.1 m120 -38.32 130.72 1.25 Allowed 'General case' 0 N--CA 1.482 1.133 0 O-C-N 124.509 1.13 . . . . 0.0 113.357 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.99 9.16 2.6 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.679 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.51 3.47 6.31 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.292 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 76.47 133.85 0.05 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.226 1.81 . . . . 0.0 110.181 -173.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -72.26 -13.42 61.51 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.287 0.565 . . . . 0.0 111.478 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -90.07 -0.89 57.83 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.749 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -124.0 91.87 3.55 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.444 0.64 . . . . 0.0 110.149 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.4 m120 . . . . . 0 C--N 1.293 -1.849 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.116 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.73 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t -141.52 113.27 7.78 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -77.98 99.99 6.28 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -87.19 -22.16 25.45 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -141.3 159.98 41.09 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -101.3 -172.45 2.17 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.253 -178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -79.54 -17.53 53.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.472 . . . . 0.0 111.757 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -110.76 -84.46 0.56 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.23 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -142.71 177.57 8.23 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 m -62.08 -50.49 71.73 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 177.82 -34.02 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.809 1.644 . . . . 0.0 106.743 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.69 124.2 88.75 Favored Pre-proline 0 C--N 1.303 -1.446 0 CA-C-N 113.384 -1.735 . . . . 0.0 109.018 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.82 -26.13 19.39 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 121.772 1.648 . . . . 0.0 110.241 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 43.7 mt -104.97 116.78 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -102.78 146.1 28.76 Favored 'General case' 1 N--CA 1.377 -4.106 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -71.58 118.93 15.02 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 100.6 -0.66 55.51 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.971 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -97.43 119.39 35.87 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.493 ' HB ' ' H ' ' B' ' 104' ' ' THR . 86.0 t -83.72 128.51 38.75 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.65 0 C-N-CA 123.235 0.614 . . . . 0.0 112.255 -172.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 48.7 m-85 -115.78 140.39 49.26 Favored 'General case' 0 C--N 1.272 -2.784 0 C-N-CA 125.438 1.495 . . . . 0.0 111.329 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.514 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 0.8 OUTLIER -74.02 148.38 42.06 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 166.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -145.41 148.87 33.8 Favored 'General case' 0 C--N 1.259 -3.361 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.055 -176.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -96.11 79.48 3.2 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.549 ' O ' HG13 ' B' ' 27' ' ' VAL 0.262 3.0 tt -74.46 -16.96 60.84 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 111.553 -2.567 . . . . 0.0 108.477 -173.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.501 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 3.6 m -32.68 -178.12 0.0 OUTLIER Pre-proline 0 CA--C 1.601 2.922 0 C-N-CA 130.652 3.581 . . . . 0.0 116.432 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.533 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 0.1 OUTLIER 24.91 44.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.404 3.486 0 C-N-CA 124.343 3.362 . . . . 0.0 116.373 -152.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.716 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 2.6 m -69.79 140.56 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 CA-C-N 113.512 -1.676 . . . . 0.0 109.591 168.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . 0.558 ' NE2' ' HB2' ' A' ' 26' ' ' PRO . 33.7 mm-40 -89.83 132.83 35.05 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.766 -172.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.08 -108.61 0.68 Allowed Glycine 0 CA--C 1.501 -0.796 0 CA-C-N 114.735 -1.121 . . . . 0.0 114.81 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -93.99 6.92 46.96 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -174.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.716 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 33.7 mt-10 -63.53 140.09 58.84 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.469 ' HB3' ' HG2' ' B' ' 90' ' ' GLN . 0.6 OUTLIER -101.28 119.42 38.73 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 120.828 0.347 . . . . 0.0 111.37 -176.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.416 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . 161.72 -179.33 37.17 Favored Glycine 1 N--CA 1.393 -4.191 0 C-N-CA 118.717 -1.706 . . . . 0.0 114.785 170.231 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' B' ' 24' ' ' LEU . . . -177.9 -158.69 21.31 Favored Glycine 1 C--N 1.253 -4.06 1 N-CA-C 102.801 -4.12 . . . . 0.0 102.801 -178.815 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 7.2 p -75.98 108.72 8.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 120.208 2.004 . . . . 0.0 110.551 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -141.22 165.68 27.4 Favored Pre-proline 0 C--N 1.277 -2.587 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.33 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.649 ' HB2' HD12 ' B' ' 58' ' ' ILE . 11.6 Cg_exo -70.47 144.04 49.13 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 121.487 1.458 . . . . 0.0 109.871 169.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 29.3 m -128.02 158.7 39.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 35.1 m -102.08 130.46 51.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.891 177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.419 HD13 HG12 ' B' ' 55' ' ' VAL . 34.7 mm -84.37 105.72 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -10.66 8.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.813 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.527 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.0 OUTLIER -58.61 161.95 4.25 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 125.274 1.43 . . . . 0.0 114.723 -171.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -67.26 -172.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 113.409 -1.723 . . . . 0.0 111.771 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -89.67 -41.28 12.02 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.204 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.455 ' HA ' ' HD2' ' B' ' 48' ' ' LYS . 5.2 m -78.7 -21.91 47.46 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.71 -32.32 81.16 Favored Glycine 0 C--O 1.219 -0.811 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -69.76 -36.95 76.22 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.227 0.536 . . . . 0.0 110.494 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.455 ' HD2' ' HA ' ' B' ' 45' ' ' THR . 33.9 mttp -77.5 -50.13 13.28 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -115.4 -25.08 8.1 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 116.011 1.856 . . . . 0.0 116.011 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -88.32 150.02 46.0 Favored Pre-proline 0 C--N 1.303 -1.444 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.939 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.68 -16.4 6.69 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 121.506 1.471 . . . . 0.0 110.618 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.5 p -95.8 143.04 27.37 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 124.539 1.136 . . . . 0.0 112.18 -174.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.21 139.48 51.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.632 HG21 HD22 ' A' ' 122' ' ' LEU . 10.2 tt -92.14 134.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-O 120.948 0.404 . . . . 0.0 109.954 170.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.485 HG21 HD12 ' B' ' 94' ' ' LEU . 22.0 m -139.9 165.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 120.968 0.413 . . . . 0.0 110.255 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.541 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -124.15 138.83 54.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.52 134.54 47.8 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.649 HD12 ' HB2' ' B' ' 37' ' ' PRO . 64.7 mt -93.45 139.31 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.011 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 96.9 m -131.69 140.15 49.23 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' B' ' 84' ' ' SER . . . -60.33 -74.72 0.34 Allowed Glycine 0 C--O 1.219 -0.816 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' B' ' 60' ' ' GLY . 24.8 mmm180 -131.14 164.4 25.57 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 173.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 4.3 tp -167.73 -54.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 121.322 0.582 . . . . 0.0 110.326 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -170.42 147.11 2.94 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -59.81 145.01 46.98 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 123.922 0.764 . . . . 0.0 109.673 176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -70.03 73.21 0.44 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.758 0.789 . . . . 0.0 111.159 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -100.94 -14.84 17.73 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.774 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.8 mt -103.68 141.36 22.34 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -68.01 0.51 4.34 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.106 1.871 . . . . 0.0 113.255 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 58.0 p -100.58 -18.83 16.42 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.32 0.581 . . . . 0.0 110.368 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -97.33 129.99 44.54 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -130.86 144.44 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -104.9 151.36 23.96 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.931 0.396 . . . . 0.0 110.653 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.506 HD13 HD11 ' B' ' 86' ' ' ILE . 24.7 pt -127.17 137.17 58.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.487 ' O ' ' HD1' ' B' ' 78' ' ' TYR . 27.9 mp0 -60.44 116.25 4.17 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.399 1.08 . . . . 0.0 113.217 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . 0.448 ' HB3' ' C ' ' B' ' 82' ' ' LYS . 22.1 pttm -50.39 -36.72 33.98 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.704 0.764 . . . . 0.0 112.627 175.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -53.58 -52.7 58.93 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 113.342 -1.754 . . . . 0.0 113.072 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -92.32 -36.78 12.99 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.592 0.711 . . . . 0.0 111.358 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' B' ' 106' ' ' LEU . 76.6 m-85 -76.08 -7.39 54.6 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.766 -173.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 74.86 28.19 1.14 Allowed 'General case' 0 C--N 1.35 0.619 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 167.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.3 mp -107.69 -177.51 3.36 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.687 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -91.56 -19.45 22.74 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.814 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.448 ' C ' ' HB3' ' B' ' 75' ' ' LYS . 0.2 OUTLIER -128.46 153.79 46.75 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.061 -173.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -75.87 128.96 36.22 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.501 ' HB3' HD11 ' B' ' 73' ' ' ILE . 6.8 t -102.83 164.49 11.59 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -169.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.2 t -122.42 141.25 43.56 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.51 HD12 HG12 ' B' ' 58' ' ' ILE . 14.3 mm -108.31 132.72 55.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 177.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 70.0 mt -105.54 108.26 19.68 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.195 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.83 -3.98 55.32 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.134 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -95.87 -35.98 11.28 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.275 1.036 . . . . 0.0 109.804 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . 0.469 ' HG2' ' HB3' ' B' ' 32' ' ' GLN . 8.0 tp60 -93.05 80.6 4.55 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.057 -1.429 . . . . 0.0 108.63 177.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.541 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.1 pp -122.53 -177.62 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -173.17 -178.07 1.68 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.453 0.644 . . . . 0.0 112.503 173.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 54.1 m -124.36 126.0 45.26 Favored 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.485 HD12 HG21 ' B' ' 55' ' ' VAL . 81.6 mt -131.82 134.78 46.16 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 124.589 1.156 . . . . 0.0 109.816 -173.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 2.9 p-10 -78.23 153.93 31.47 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 177.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -44.6 -21.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.762 1.625 . . . . 0.0 114.897 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -71.96 -18.62 61.98 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.683 0.793 . . . . 0.0 110.484 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.442 ' HD2' ' HB3' ' A' ' 28' ' ' GLN . 3.0 mmp_? -86.55 -36.38 18.96 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.174 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.79 126.06 28.56 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.791 0.805 . . . . 0.0 110.418 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -95.62 -64.48 1.05 Allowed 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.301 -1.318 . . . . 0.0 113.489 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 16.9 pt-20 -157.93 143.6 17.09 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.35 0.595 . . . . 0.0 111.558 -170.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.1 OUTLIER -66.38 123.88 21.21 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 113.413 -1.721 . . . . 0.0 110.706 174.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.721 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 24.9 tp -114.38 -62.14 1.64 Allowed 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 122.56 1.171 . . . . 0.0 110.57 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.721 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 5.1 m -125.14 -175.79 3.4 Favored 'General case' 0 N--CA 1.406 -2.672 0 CA-C-N 112.837 -1.983 . . . . 0.0 111.872 -163.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.435 ' H ' ' CG2' ' B' ' 104' ' ' THR . 0.4 OUTLIER -159.52 139.31 11.61 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 125.77 1.628 . . . . 0.0 109.384 -168.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.523 ' HA ' ' CE2' ' B' ' 78' ' ' TYR . 6.9 mt -101.54 159.62 15.14 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.955 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m -90.4 158.37 17.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.093 174.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' B' ' 111' ' ' MET . 8.7 m-20 -64.48 -28.48 69.69 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.513 0.673 . . . . 0.0 111.952 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -73.89 -33.52 64.06 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.944 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.451 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 4.6 mptp? -79.96 -22.64 42.38 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.825 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.518 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -56.59 -38.76 72.46 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 170.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' B' ' 112' ' ' LYS . 6.9 mmpt? -78.8 -12.89 60.04 Favored 'General case' 0 N--CA 1.381 -3.921 0 CA-C-N 114.79 -1.095 . . . . 0.0 113.91 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -88.94 -50.47 6.17 Favored 'General case' 0 N--CA 1.391 -3.385 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 t -48.99 -59.6 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 113.256 -1.793 . . . . 0.0 113.224 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 5.0 m-20 -57.14 -41.87 79.9 Favored 'General case' 0 N--CA 1.514 2.726 0 CA-C-O 123.661 1.696 . . . . 0.0 112.352 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.586 ' O ' HD12 ' B' ' 120' ' ' ILE 0.345 22.0 t30 -83.64 -46.63 12.12 Favored 'General case' 0 C--N 1.251 -3.696 0 CA-C-N 112.319 -2.219 . . . . 0.0 112.285 -168.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -61.19 -32.52 72.28 Favored 'General case' 0 CA--C 1.48 -1.735 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.545 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 7.6 tp -62.38 -46.9 86.54 Favored 'General case' 1 N--CA 1.365 -4.684 0 CA-C-N 113.514 -1.676 . . . . 0.0 109.601 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.686 ' SD ' ' HA ' ' B' ' 125' ' ' ASN 0.288 7.9 ptp -66.55 -25.42 66.64 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 177.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.586 HD12 ' O ' ' B' ' 116' ' ' ASN . 4.5 mp -72.05 -46.66 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 C-N-CA 117.756 -1.577 . . . . 0.0 108.288 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 14.9 t -58.05 -34.37 70.01 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.316 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.634 HD22 HG21 ' A' ' 54' ' ' ILE . 13.7 mt -110.41 7.91 23.02 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 120.085 -0.646 . . . . 0.0 111.56 -175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.17 20.77 67.52 Favored Glycine 0 N--CA 1.468 0.808 0 N-CA-C 116.983 1.553 . . . . 0.0 116.983 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.782 HD11 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -101.26 18.64 19.43 Favored 'General case' 0 CA--C 1.496 -1.135 0 CA-C-N 118.361 1.08 . . . . 0.0 111.309 -177.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.686 ' HA ' ' SD ' ' B' ' 119' ' ' MET . 20.3 m120 -41.35 131.74 2.77 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.175 0.922 . . . . 0.0 112.21 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.55 11.13 3.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.891 0.853 . . . . 0.0 112.679 -172.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 42.2 t -121.9 4.63 5.98 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 CA-C-N 114.387 -1.279 . . . . 0.0 107.812 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 75.64 135.05 0.06 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.237 1.815 . . . . 0.0 110.452 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 p-80 -72.22 -13.47 61.54 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.806 -0.559 . . . . 0.0 111.741 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -92.31 3.69 54.88 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.118 0.485 . . . . 0.0 110.425 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -126.78 101.33 6.56 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.687 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.1 t -125.61 148.55 48.93 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.3 m -101.01 10.56 40.95 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 71.42 103.51 0.07 Allowed 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.883 1.273 . . . . 0.0 109.922 -177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -62.15 -54.03 46.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.388 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 176.05 -33.44 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -128.63 164.38 23.0 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.592 -2.094 . . . . 0.0 106.343 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -94.56 -60.21 1.76 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.431 ' C ' ' HG ' ' A' ' 10' ' ' SER . 19.3 p80 -119.96 -2.73 10.24 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.97 -178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.431 ' HG ' ' C ' ' A' ' 9' ' ' HIS . 50.4 p 61.13 -81.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.723 1.609 . . . . 0.0 113.814 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -74.86 124.87 27.64 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -80.5 148.89 67.34 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.28 156.4 10.61 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.866 2.377 . . . . 0.0 113.732 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.3 mt -66.19 133.37 31.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.253 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -102.91 121.91 43.49 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.982 -174.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -59.45 126.26 26.92 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.84 -7.05 44.67 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.204 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -97.56 -178.6 4.18 Favored 'General case' 0 N--CA 1.419 -2.011 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 14.2 t -135.49 136.32 50.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 C-N-CA 123.679 0.792 . . . . 0.0 110.622 -176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 33.2 m-85 -132.2 146.24 51.88 Favored 'General case' 0 CA--C 1.466 -2.281 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.0 mp -77.84 152.73 33.28 Favored 'General case' 0 N--CA 1.395 -3.184 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.647 170.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -130.07 144.03 51.12 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.897 -173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 13.3 t70 -89.33 86.66 6.87 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.261 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 4.5 mm? -88.89 41.07 1.01 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.196 1.398 . . . . 0.0 112.496 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.615 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 31.7 m -73.48 174.29 4.96 Favored Pre-proline 0 C--N 1.251 -3.698 0 C-N-CA 126.123 1.769 . . . . 0.0 108.232 171.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.615 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER 4.79 51.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.41 3.81 1 C-N-CA 127.971 5.781 . . . . 0.0 118.65 -178.01 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 31' ' ' GLU . 27.8 m -69.09 176.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 113.786 -1.552 . . . . 0.0 111.779 171.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 33.5 mm-40 -104.04 133.14 49.49 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.389 -176.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.76 -120.65 19.85 Favored Glycine 0 CA--C 1.505 -0.594 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.937 175.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.8 m -91.58 13.39 17.98 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -61.34 152.57 29.05 Favored 'General case' 0 C--O 1.252 1.225 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.71 177.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.527 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -71.88 120.86 18.08 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.157 -171.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -101.03 142.36 15.74 Favored Glycine 0 CA--C 1.476 -2.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.431 -178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 108.76 141.02 9.31 Favored Glycine 0 N--CA 1.429 -1.823 0 CA-C-N 114.401 -0.899 . . . . 0.0 111.122 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.3 t -57.57 117.63 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -139.33 148.31 56.3 Favored Pre-proline 0 C--N 1.253 -3.613 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.61 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 50.0 Cg_exo -63.0 138.48 68.15 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.823 2.349 . . . . 0.0 111.654 171.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 20' ' ' TYR . 30.6 m -123.93 156.22 31.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.486 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.9 m -100.93 132.05 47.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 120.809 0.338 . . . . 0.0 110.329 178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.466 ' CG2' ' HG2' ' A' ' 42' ' ' GLN . 23.4 mm -91.59 106.66 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -104.37 -9.76 9.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.517 179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.56 HE22 ' N ' ' A' ' 47' ' ' ASN . 4.5 pt20 -51.46 162.5 0.36 Allowed 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 -168.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -65.42 -177.08 0.38 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.285 -1.779 . . . . 0.0 111.765 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -73.89 -53.73 9.52 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-N 114.55 -1.204 . . . . 0.0 112.677 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.525 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 20.3 m -82.9 -22.39 33.95 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -166.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.58 -40.18 86.85 Favored Glycine 0 C--O 1.213 -1.219 0 O-C-N 123.059 0.224 . . . . 0.0 113.316 -176.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.56 ' N ' HE22 ' A' ' 42' ' ' GLN . 11.0 p30 -71.05 -20.72 62.34 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 45' ' ' THR . 2.5 mptp? -86.16 -68.03 0.77 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.157 0.503 . . . . 0.0 110.517 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.35 -29.51 24.41 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -168.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 m -91.12 143.35 28.32 Favored Pre-proline 0 N--CA 1.414 -2.238 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.54 -26.45 23.91 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 120.955 1.103 . . . . 0.0 109.709 175.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.0 p -82.01 147.9 28.93 Favored 'General case' 0 N--CA 1.414 -2.258 0 C-N-CA 125.915 1.686 . . . . 0.0 113.619 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.541 HG13 ' OE1' ' A' ' 42' ' ' GLN . 93.3 t -132.16 140.39 47.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.701 HD11 HD13 ' A' ' 91' ' ' ILE . 5.0 tp -103.86 124.72 58.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.426 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 25.1 m -134.02 167.92 25.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.988 -175.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -126.13 139.52 53.31 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.83 137.38 41.82 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' A' ' 37' ' ' PRO . 60.4 mt -95.6 134.99 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-N 113.115 -1.857 . . . . 0.0 108.468 175.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.5 m -103.6 124.78 49.44 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.44 -10.44 79.81 Favored Glycine 0 N--CA 1.465 0.583 0 C-N-CA 121.249 -0.501 . . . . 0.0 111.984 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -117.1 170.3 8.76 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.448 HG22 HG21 ' A' ' 85' ' ' VAL . 61.9 mt 70.84 135.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 O-C-N 124.349 1.031 . . . . 0.0 110.557 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -142.59 32.96 1.45 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.833 0.825 . . . . 0.0 109.132 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -128.96 124.66 35.64 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.234 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.05 111.42 15.34 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 120.71 0.29 . . . . 0.0 111.152 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -97.19 -41.41 8.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.004 0.431 . . . . 0.0 111.645 176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.681 ' H ' HD12 ' A' ' 67' ' ' ILE . 1.3 mp -87.28 138.95 32.06 Favored Pre-proline 0 C--N 1.309 -1.166 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.94 1.18 2.01 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 122.677 2.251 . . . . 0.0 113.706 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.9 p -91.69 -16.26 27.23 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-O 122.301 1.048 . . . . 0.0 108.288 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -107.34 129.31 54.92 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 73' ' ' ILE . 67.8 t -126.18 127.15 70.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.618 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -93.25 124.63 37.36 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.667 0.746 . . . . 0.0 109.8 176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.679 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -108.75 156.34 9.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.297 -175.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -63.25 119.78 10.27 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 123.779 0.674 . . . . 0.0 112.619 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -46.12 -46.77 17.28 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 126.071 1.748 . . . . 0.0 110.336 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -58.2 -32.31 68.15 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 126.673 1.989 . . . . 0.0 112.826 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -91.14 -39.04 12.36 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.712 0.768 . . . . 0.0 110.792 -174.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.679 ' CE1' HG21 ' A' ' 73' ' ' ILE . 4.2 m-85 -83.22 -9.45 59.14 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.793 -177.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.5 tttp 67.09 40.87 2.77 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.921 0.889 . . . . 0.0 111.096 174.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.41 -179.71 3.96 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.836 0.827 . . . . 0.0 111.073 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -90.8 -10.78 41.58 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.258 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -139.8 161.26 37.97 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.34 142.12 50.42 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.7 t -110.0 155.76 21.39 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.545 -171.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.448 HG21 HG22 ' A' ' 62' ' ' ILE . 12.6 t -117.74 128.11 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.483 HD13 HG13 ' A' ' 73' ' ' ILE . 1.6 mp -103.52 125.53 58.06 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.94 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 90' ' ' GLN . 67.0 mt -100.97 110.61 22.67 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 113.228 -1.806 . . . . 0.0 110.04 -175.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.56 HD12 HD23 ' A' ' 118' ' ' LEU . 3.6 mm? -83.84 3.25 34.48 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.732 -175.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -119.03 4.2 11.4 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.787 1.28 . . . . 0.0 108.39 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 8.5 tp60 -122.85 35.1 4.96 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.535 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.701 HD13 HD11 ' A' ' 54' ' ' ILE . 2.1 pp -85.94 -178.26 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.186 -178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.527 ' NH2' ' HB3' ' A' ' 32' ' ' GLN . 9.3 ptp85 -167.66 168.6 12.5 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 16.2 m -122.41 118.87 29.41 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.609 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 60.7 mt -131.89 140.1 48.97 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.255 -173.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.534 ' OD2' ' HB3' ' A' ' 97' ' ' LYS . 4.7 p-10 -72.89 151.26 42.01 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.635 175.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -45.54 -35.5 3.96 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.534 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 7.4 ttpm? -61.29 -26.1 67.56 Favored 'General case' 0 C--N 1.273 -2.753 0 C-N-CA 123.879 0.872 . . . . 0.0 112.634 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.441 ' NH1' ' HB3' ' A' ' 23' ' ' ASP . 2.3 mmp_? -75.53 -28.48 59.11 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.171 0.51 . . . . 0.0 110.813 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.05 124.22 24.5 Favored 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.492 1.117 . . . . 0.0 110.12 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -87.72 -63.64 1.27 Allowed 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 114.21 -1.359 . . . . 0.0 113.305 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.1 pt-20 -161.11 142.39 11.68 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-O 121.403 0.62 . . . . 0.0 111.969 -170.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -60.94 120.92 11.13 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 126.186 1.794 . . . . 0.0 110.731 174.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.53 -62.83 1.54 Allowed 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.518 HG22 HG11 ' A' ' 19' ' ' VAL . 4.8 t -125.41 -167.0 1.62 Allowed 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.263 -1.375 . . . . 0.0 111.626 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -161.2 135.18 6.86 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 124.092 0.957 . . . . 0.0 111.831 -171.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -105.4 163.36 12.69 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.176 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.5 p -90.86 170.14 10.34 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 121.282 0.563 . . . . 0.0 112.459 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 111' ' ' MET . 27.6 t70 -65.82 -30.82 71.5 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.292 1.037 . . . . 0.0 112.492 -175.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -75.44 -24.26 57.03 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 122.035 -0.415 . . . . 0.0 110.491 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' O ' HG22 ' A' ' 114' ' ' VAL . 0.7 OUTLIER -75.13 -26.65 59.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.356 174.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.486 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -55.01 -39.32 68.96 Favored 'General case' 0 CA--C 1.471 -2.085 0 CA-C-O 122.04 0.924 . . . . 0.0 109.818 172.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.494 ' HE2' ' N ' ' A' ' 112' ' ' LYS . 8.3 mmpt? -74.28 -15.21 60.98 Favored 'General case' 0 N--CA 1.393 -3.292 0 CA-C-N 114.214 -1.357 . . . . 0.0 113.112 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -86.93 -56.03 3.57 Favored 'General case' 0 N--CA 1.389 -3.51 0 C-N-CA 117.649 -1.62 . . . . 0.0 109.245 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 110' ' ' LYS . 22.0 m -57.33 -47.7 84.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -174.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.5 ' HB3' ' HG ' ' B' ' 124' ' ' LEU . 44.5 m-20 -60.53 -48.02 83.6 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 123.536 1.636 . . . . 0.0 109.931 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 12.1 t30 -76.06 -39.87 54.49 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 112.267 -2.242 . . . . 0.0 112.647 -168.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.513 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -60.25 -38.51 83.68 Favored 'General case' 0 CA--C 1.469 -2.142 0 CA-C-O 122.279 1.038 . . . . 0.0 108.605 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.56 HD23 HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -83.0 -27.82 30.12 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.297 -173.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.435 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 3.7 ttp -60.27 -30.09 69.23 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 124.079 0.951 . . . . 0.0 108.552 172.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 116' ' ' ASN . 52.9 mt -81.22 -55.61 7.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.9 t -49.76 -43.25 47.91 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 125.938 1.695 . . . . 0.0 111.935 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.485 ' HG ' HG12 ' B' ' 54' ' ' ILE . 9.0 mp -82.12 5.65 18.93 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.28 5.41 76.09 Favored Glycine 0 C--N 1.341 0.857 0 N-CA-C 115.905 1.122 . . . . 0.0 115.905 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' B' ' 115' ' ' ASP . 3.5 mp -73.23 -42.76 62.22 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 118.484 1.142 . . . . 0.0 108.63 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 60.99 168.38 0.09 Allowed 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 126.501 1.921 . . . . 0.0 114.836 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.44 24.28 0.57 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.104 0.954 . . . . 0.0 111.826 -173.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.56 -2.04 9.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 CA-C-O 122.789 1.28 . . . . 0.0 108.326 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.27 9.81 39.69 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.153 -175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.485 ' HB3' ' O ' ' B' ' 129' ' ' HIS . 90.1 m-70 -89.75 -50.96 5.76 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.672 -177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -116.34 171.69 7.67 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -136.17 142.93 44.2 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 C--N 1.294 -1.84 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.505 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.858 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 38.4 t -113.24 145.83 40.35 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 25.1 m -100.45 11.74 38.79 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 73.1 101.12 0.07 Allowed 'General case' 0 C--N 1.349 0.561 0 C-N-CA 124.619 1.167 . . . . 0.0 109.729 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -61.58 -53.38 57.01 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.49 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 179.6 -37.75 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 -176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -125.49 170.48 11.38 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 112.383 -2.189 . . . . 0.0 106.271 174.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -98.82 -56.44 2.44 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -124.29 -2.35 8.07 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.743 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p 57.72 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.301 1.441 . . . . 0.0 113.276 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -68.48 123.17 20.08 Favored 'General case' 0 C--O 1.249 1.038 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -78.15 147.38 72.91 Favored Pre-proline 0 C--N 1.313 -1.011 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.71 152.64 16.42 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.364 2.71 . . . . 0.0 113.972 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 86.5 mt -59.68 134.08 24.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.195 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -104.44 122.41 45.46 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.058 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -59.55 124.97 21.81 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 120.969 0.414 . . . . 0.0 110.105 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.51 -7.42 46.47 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.501 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -97.17 179.2 4.99 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 17.4 t -134.17 137.48 51.83 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 C-N-CA 123.546 0.738 . . . . 0.0 111.031 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 27.7 m-85 -132.99 145.41 50.85 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.3 mp -76.62 151.36 36.25 Favored 'General case' 0 N--CA 1.399 -2.981 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.664 170.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.63 143.83 51.0 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.341 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -87.36 84.45 7.19 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.167 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.517 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 4.4 mm? -88.17 40.93 0.98 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 123.172 1.463 . . . . 0.0 112.444 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.591 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.257 14.7 m -73.67 174.76 4.35 Favored Pre-proline 1 C--N 1.242 -4.097 0 CA-C-N 113.279 -1.782 . . . . 0.0 108.162 172.612 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 13.9 Cg_exo 3.19 53.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.406 3.571 1 C-N-CA 128.129 5.886 . . . . 0.0 118.077 -179.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 m -69.4 -178.64 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 113.44 -1.709 . . . . 0.0 111.836 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' B' ' 31' ' ' GLU . 33.1 mm-40 -109.79 132.7 53.91 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.624 -177.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.87 -125.74 40.6 Favored Glycine 0 CA--C 1.499 -0.964 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.263 175.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 39.6 m -93.55 22.18 5.62 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.38 -0.41 . . . . 0.0 112.03 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' B' ' 28' ' ' GLN . 0.0 OUTLIER -64.24 162.46 14.61 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 174.388 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.565 ' HB3' ' NH2' ' B' ' 92' ' ' ARG . 0.9 OUTLIER -79.92 117.42 20.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 120.87 0.367 . . . . 0.0 110.262 -173.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -98.07 145.8 17.93 Favored Glycine 0 CA--C 1.473 -2.556 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.514 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 106.54 138.96 9.24 Favored Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 114.431 -0.884 . . . . 0.0 111.18 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 32.9 t -56.93 119.42 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . 0.431 ' NH1' ' HA ' ' B' ' 59' ' ' THR . 58.7 mtt180 -140.7 148.43 52.87 Favored Pre-proline 0 C--N 1.256 -3.488 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.431 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.534 ' HB2' HD12 ' B' ' 58' ' ' ILE . 35.2 Cg_exo -64.1 138.49 62.2 Favored 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.707 2.271 . . . . 0.0 111.454 171.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.42 HG22 ' O ' ' B' ' 20' ' ' TYR . 31.5 m -123.54 156.41 30.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.472 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 33.1 m -100.86 132.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 120.896 0.379 . . . . 0.0 110.439 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.477 ' CG2' ' HG2' ' B' ' 42' ' ' GLN . 24.3 mm -91.69 107.15 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.417 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -104.48 -9.99 9.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.571 ' OE1' HG13 ' B' ' 53' ' ' VAL . 4.7 pt20 -51.67 162.19 0.43 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -168.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -67.04 -179.88 1.02 Allowed 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 113.263 -1.79 . . . . 0.0 111.852 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.25 -55.17 15.09 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.01 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.549 ' HA ' ' HD3' ' B' ' 48' ' ' LYS . 10.4 m -84.92 -22.3 29.32 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -164.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.64 -38.57 82.54 Favored Glycine 0 C--O 1.21 -1.381 0 O-C-N 123.236 0.335 . . . . 0.0 113.136 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.549 ' N ' HE22 ' B' ' 42' ' ' GLN . 10.2 p30 -71.79 -20.95 61.78 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.549 ' HD3' ' HA ' ' B' ' 45' ' ' THR . 2.8 mptp? -86.57 -67.75 0.79 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.138 0.494 . . . . 0.0 110.408 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -83.37 -35.78 24.86 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -169.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 18.7 m -86.09 143.31 37.06 Favored Pre-proline 0 N--CA 1.415 -2.215 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -71.28 -25.69 21.67 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.025 1.15 . . . . 0.0 109.309 175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.4 p -82.71 145.97 29.3 Favored 'General case' 0 N--CA 1.415 -2.188 0 C-N-CA 125.545 1.538 . . . . 0.0 113.579 -173.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.571 HG13 ' OE1' ' B' ' 42' ' ' GLN . 98.0 t -130.01 140.52 48.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 176.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.702 HD11 HD13 ' B' ' 91' ' ' ILE . 5.1 tp -103.76 124.57 58.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 CA-C-O 121.291 0.567 . . . . 0.0 109.697 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.418 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 24.8 m -134.15 167.09 26.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.965 -175.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.506 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -125.53 139.54 53.52 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.49 135.78 42.23 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' B' ' 37' ' ' PRO . 59.4 mt -93.98 135.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 113.248 -1.796 . . . . 0.0 108.05 174.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . 0.431 ' HA ' ' NH1' ' B' ' 36' ' ' ARG . 19.2 m -101.92 127.22 48.86 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -82.28 -12.23 80.98 Favored Glycine 0 N--CA 1.466 0.659 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.76 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -121.57 174.24 6.91 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.449 HG22 HG21 ' B' ' 85' ' ' VAL . 61.3 mt 71.53 138.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 O-C-N 124.044 0.84 . . . . 0.0 110.339 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -142.85 20.7 1.98 Allowed 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.281 -0.887 . . . . 0.0 109.755 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -118.6 124.17 46.8 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.426 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.86 112.06 17.88 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.591 0.234 . . . . 0.0 111.398 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -100.14 -35.5 9.64 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.153 0.501 . . . . 0.0 111.379 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.64 ' H ' HD12 ' B' ' 67' ' ' ILE . 0.9 OUTLIER -93.9 137.6 23.03 Favored Pre-proline 0 C--N 1.308 -1.23 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 -177.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.09 3.34 1.32 Allowed 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.768 2.312 . . . . 0.0 113.755 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 58.9 p -92.4 -15.9 26.62 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.455 1.121 . . . . 0.0 108.504 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 13.3 m170 -108.64 129.76 55.33 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.518 HG12 HD13 ' B' ' 73' ' ' ILE . 62.9 t -125.42 127.06 71.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 O-C-N 121.611 -0.681 . . . . 0.0 110.736 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.34 120.62 32.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.663 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.1 OUTLIER -106.6 154.28 7.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.449 -175.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -62.01 119.48 8.96 Favored 'General case' 0 C--O 1.251 1.176 0 O-C-N 124.202 0.939 . . . . 0.0 112.619 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -46.55 -46.33 19.27 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 126.147 1.779 . . . . 0.0 110.48 172.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -59.73 -31.33 69.52 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 126.219 1.807 . . . . 0.0 112.938 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -90.73 -39.44 12.42 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.199 0.523 . . . . 0.0 110.631 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.663 ' CE1' HG21 ' B' ' 73' ' ' ILE . 4.3 m-85 -83.29 -10.8 58.31 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.879 -177.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 61.9 tttp 70.41 34.2 2.3 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.31 1.044 . . . . 0.0 111.851 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.69 -179.79 4.07 Favored 'General case' 0 CA--C 1.492 -1.259 0 O-C-N 120.973 -1.08 . . . . 0.0 111.613 177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -87.82 -13.41 42.24 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.785 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -140.35 161.65 37.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -69.98 144.8 52.21 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 23.2 t -112.4 157.28 21.24 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -172.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.449 HG21 HG22 ' B' ' 62' ' ' ILE . 11.0 t -118.2 128.31 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.511 HD13 HG13 ' B' ' 73' ' ' ILE . 1.6 mp -103.12 124.75 57.44 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' B' ' 90' ' ' GLN . 74.5 mt -100.18 111.5 23.78 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.054 -175.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.54 HD12 HD23 ' B' ' 118' ' ' LEU . 3.6 mm? -84.06 2.75 37.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.614 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -119.15 4.79 11.29 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.818 1.294 . . . . 0.0 108.477 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' B' ' 87' ' ' LEU . 8.3 tp60 -123.61 35.33 4.87 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.159 -1.837 . . . . 0.0 106.481 176.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.702 HD13 HD11 ' B' ' 54' ' ' ILE . 2.1 pp -85.81 -178.31 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.192 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.565 ' NH2' ' HB3' ' B' ' 32' ' ' GLN . 9.6 ptp85 -167.53 168.93 12.49 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 11.0 m -122.37 118.29 28.08 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.594 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 64.8 mt -132.0 139.86 48.76 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.403 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.531 ' OD2' ' HB3' ' B' ' 97' ' ' LYS . 6.2 p-10 -71.47 151.59 43.81 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.193 -0.603 . . . . 0.0 110.193 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 pttm -46.21 -37.0 6.57 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.531 ' HB3' ' OD2' ' B' ' 95' ' ' ASP . 7.0 ttpm? -61.59 -24.47 66.7 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.667 176.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -74.6 -30.11 61.56 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 121.481 -0.762 . . . . 0.0 110.352 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -71.31 124.93 25.65 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.499 1.12 . . . . 0.0 110.428 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -88.22 -64.68 1.11 Allowed 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 113.745 -1.571 . . . . 0.0 112.732 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 9.9 pt-20 -161.25 142.12 11.28 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 121.502 0.668 . . . . 0.0 112.523 -171.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.2 OUTLIER -60.45 121.31 11.78 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 126.491 1.916 . . . . 0.0 110.938 174.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -114.82 -63.0 1.52 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.345 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.496 HG22 HG11 ' B' ' 19' ' ' VAL . 3.3 t -125.25 -166.54 1.55 Allowed 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 118.172 -1.411 . . . . 0.0 111.816 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -161.13 135.87 7.37 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 124.002 0.921 . . . . 0.0 112.112 -170.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 pp -108.79 157.4 18.61 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.02 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 7.1 p -86.82 175.49 8.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' B' ' 111' ' ' MET . 22.9 t70 -72.21 -29.47 64.0 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.151 0.5 . . . . 0.0 111.812 -174.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -70.2 -23.38 62.94 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.355 0.597 . . . . 0.0 109.91 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.441 ' O ' HG22 ' B' ' 114' ' ' VAL . 0.6 OUTLIER -78.8 -27.4 44.41 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 174.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.466 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.0 OUTLIER -55.51 -39.44 70.5 Favored 'General case' 0 CA--C 1.46 -2.487 0 CA-C-O 122.336 1.065 . . . . 0.0 109.131 172.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' B' ' 112' ' ' LYS . 6.9 mmpt? -71.98 -17.16 62.08 Favored 'General case' 1 N--CA 1.378 -4.053 0 CA-C-N 113.725 -1.579 . . . . 0.0 113.841 -178.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.97 -57.98 2.76 Favored 'General case' 0 N--CA 1.39 -3.436 0 C-N-CA 117.561 -1.656 . . . . 0.0 109.198 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 110' ' ' LYS . 22.9 m -54.85 -47.02 75.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -174.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.519 ' HB3' ' HG ' ' A' ' 124' ' ' LEU . 55.6 m-20 -61.3 -48.97 78.93 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 123.636 1.684 . . . . 0.0 110.535 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' B' ' 119' ' ' MET 0.349 27.0 t30 -77.13 -38.69 51.51 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 112.376 -2.193 . . . . 0.0 112.539 -167.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.425 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -62.63 -37.56 86.8 Favored 'General case' 0 CA--C 1.472 -2.047 0 CA-C-O 122.267 1.032 . . . . 0.0 108.812 178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.54 HD23 HD12 ' B' ' 88' ' ' LEU . 0.7 OUTLIER -82.66 -27.44 31.32 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.888 -174.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.437 ' HB3' ' O ' ' B' ' 116' ' ' ASN . 4.0 ttp -60.25 -31.44 70.21 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 59.6 mt -79.03 -56.39 7.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.2 t -48.64 -43.45 36.56 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.114 1.366 . . . . 0.0 112.235 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.49 ' HG ' HG12 ' A' ' 54' ' ' ILE . 8.6 mp -81.64 6.06 16.3 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.36 7.28 79.83 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 115.661 1.025 . . . . 0.0 115.661 172.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 115' ' ' ASP . 3.8 mp -73.59 -43.82 58.78 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 118.328 1.064 . . . . 0.0 108.422 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 61.18 169.54 0.1 Allowed 'General case' 0 N--CA 1.432 -1.355 0 C-N-CA 126.689 1.995 . . . . 0.0 114.72 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.04 27.16 0.68 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.811 0.815 . . . . 0.0 111.576 -173.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 16.0 t -101.75 -7.47 9.16 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-O 122.375 1.084 . . . . 0.0 108.38 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.43 8.59 44.67 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 113.891 -1.504 . . . . 0.0 112.407 -173.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.485 ' O ' ' HB3' ' A' ' 129' ' ' HIS . 96.4 m-70 -87.14 -51.04 6.22 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.588 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -118.58 167.84 11.25 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -130.45 144.74 51.59 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 19.5 m120 . . . . . 0 C--N 1.286 -2.163 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 175.922 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p -93.19 -51.13 5.17 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 122.614 0.366 . . . . 0.0 111.505 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 m -82.54 -42.76 17.95 Favored 'General case' 0 C--O 1.25 1.115 0 CA-C-O 121.554 0.692 . . . . 0.0 110.186 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -106.07 145.55 31.28 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -85.65 80.35 9.04 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.209 1.004 . . . . 0.0 111.048 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -124.03 116.22 22.47 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.479 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -84.85 123.9 30.99 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 173.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -76.73 102.43 6.22 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -104.14 112.94 26.16 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.901 -171.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -121.13 134.79 55.25 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.512 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -79.65 115.89 19.52 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.354 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' O ' HG13 ' A' ' 14' ' ' ILE . 16.0 t70 -87.87 145.37 36.51 Favored Pre-proline 0 C--N 1.28 -2.449 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 173.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.61 101.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.503 2.135 . . . . 0.0 113.171 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 12' ' ' ASP . 62.7 mt -85.82 125.45 40.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.221 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.445 ' HG2' ' OD2' ' A' ' 18' ' ' ASP . 8.4 ptp180 -121.59 157.99 29.54 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 171.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.535 HH22 ' HG2' ' B' ' 131' ' ' LYS . 28.6 ptt85 -69.36 113.65 6.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 168.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.495 ' HA2' ' SD ' ' A' ' 111' ' ' MET . . . 131.76 -9.07 5.51 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.875 -173.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD2' ' HG2' ' A' ' 15' ' ' ARG . 32.9 m-20 -96.46 173.19 7.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 122.016 0.912 . . . . 0.0 109.713 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 12.4 t -132.3 134.22 59.47 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 CA-C-N 113.607 -1.633 . . . . 0.0 110.794 178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.466 ' O ' HG22 ' A' ' 38' ' ' VAL . 50.7 m-85 -135.62 144.01 45.86 Favored 'General case' 0 CA--C 1.476 -1.877 0 C-N-CA 125.325 1.45 . . . . 0.0 108.977 176.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.637 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.9 mp -79.42 149.49 31.59 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-O 121.539 0.685 . . . . 0.0 111.097 173.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -138.67 134.23 33.37 Favored 'General case' 0 C--N 1.268 -2.938 0 CA-C-N 113.445 -1.707 . . . . 0.0 107.177 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.553 ' HA ' ' HB ' ' A' ' 35' ' ' VAL 0.326 3.2 p-10 -81.64 104.72 12.25 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 117.931 -1.508 . . . . 0.0 111.346 176.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 5.4 mt -90.55 37.78 0.92 Allowed 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 124.92 2.295 . . . . 0.0 110.273 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.576 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.282 7.3 m -63.62 171.91 2.02 Favored Pre-proline 1 C--N 1.223 -4.904 0 CA-C-N 109.364 -3.562 . . . . 0.0 107.314 167.599 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 1.0 OUTLIER 6.04 53.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.401 3.307 1 C-N-CA 126.977 5.118 . . . . 0.0 118.227 -174.73 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.3 m -69.32 -178.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.717 166.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.416 HE22 ' HB2' ' B' ' 26' ' ' PRO . 31.5 mm-40 -108.01 126.46 52.75 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.89 -117.9 9.82 Favored Glycine 0 N--CA 1.425 -2.058 0 CA-C-N 113.781 -1.554 . . . . 0.0 114.329 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.9 m -93.89 22.08 6.01 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.445 -0.878 . . . . 0.0 112.869 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.96 -176.36 0.68 Allowed 'General case' 0 C--O 1.247 0.948 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.934 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.412 ' OE1' ' HD2' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -88.8 109.11 19.9 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.56 -178.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.18 143.27 16.45 Favored Glycine 0 CA--C 1.472 -2.636 0 CA-C-N 115.149 -0.932 . . . . 0.0 114.281 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 108.07 137.1 8.12 Favored Glycine 0 N--CA 1.418 -2.535 0 CA-C-N 113.85 -1.175 . . . . 0.0 110.811 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 2.0 p -61.93 126.71 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-O 122.455 1.121 . . . . 0.0 111.053 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD2' ' OE1' ' A' ' 32' ' ' GLN . 84.4 mtt180 -149.61 166.27 15.62 Favored Pre-proline 0 C--N 1.266 -3.04 0 CA-C-N 112.927 -1.942 . . . . 0.0 108.2 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.637 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 3.8 Cg_exo -75.92 143.9 26.76 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 C-N-CA 121.903 1.735 . . . . 0.0 111.555 174.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 20' ' ' TYR . 28.6 m -118.45 158.53 19.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 34.3 m -102.36 133.05 47.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 120.767 0.318 . . . . 0.0 110.729 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 mm -88.72 104.9 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.403 ' C ' HD13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -104.4 -20.81 5.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.114 -178.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -54.88 165.95 0.56 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 -170.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -60.66 164.03 4.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.051 -1.886 . . . . 0.0 112.527 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.08 -39.32 79.13 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 113.904 -1.498 . . . . 0.0 112.52 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 m -86.97 -26.56 23.76 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -171.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.89 -37.2 92.22 Favored Glycine 0 C--O 1.201 -1.919 0 CA-C-N 116.354 -0.385 . . . . 0.0 113.402 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.535 ' OD1' ' HD2' ' A' ' 48' ' ' LYS . 27.5 p30 -69.55 -19.69 63.68 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.535 ' HD2' ' OD1' ' A' ' 47' ' ' ASN . 13.0 mptt -84.51 -61.73 1.73 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.118 0.485 . . . . 0.0 109.901 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -89.13 -21.93 23.11 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 -168.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.2 m -105.94 139.71 20.52 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.668 -0.645 . . . . 0.0 109.652 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.48 -22.26 14.17 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.437 1.425 . . . . 0.0 109.597 174.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 3.7 p -96.17 133.69 40.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 124.456 1.102 . . . . 0.0 111.889 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.24 145.96 34.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.3 tt -96.68 132.68 40.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.543 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.453 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 30.0 m -137.77 172.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.383 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.558 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -126.0 139.55 53.33 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.53 142.76 42.75 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.622 HD12 ' HB2' ' A' ' 37' ' ' PRO . 82.7 mt -101.86 129.53 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.759 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.8 m -119.27 105.31 11.21 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.82 150.05 22.05 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 55.6 mtp180 65.94 89.88 0.09 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.099 0.96 . . . . 0.0 112.063 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 61' ' ' ARG . 0.1 OUTLIER -178.04 -48.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 174.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 83' ' ' ASP . 2.4 m-20 60.08 -167.15 0.18 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.091 0.957 . . . . 0.0 110.394 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt 57.95 67.83 0.91 Allowed 'General case' 0 C--O 1.244 0.807 0 O-C-N 123.68 0.612 . . . . 0.0 111.383 173.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.57 -61.32 2.36 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.748 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.4 tttp 69.13 -57.29 0.53 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.248 1.419 . . . . 0.0 112.539 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.4 HD12 ' CE1' ' A' ' 70' ' ' HIS . 12.5 mt -80.19 139.25 52.52 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.14 -11.29 21.33 Favored 'Trans proline' 0 CA--C 1.563 1.927 0 C-N-CA 122.199 1.933 . . . . 0.0 113.723 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 69.7 p -90.21 -19.02 24.67 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.353 0.597 . . . . 0.0 110.702 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.4 ' CE1' HD12 ' A' ' 67' ' ' ILE . 26.1 m170 -95.1 130.27 41.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.49 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.82 132.87 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.34 132.95 52.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.298 0.571 . . . . 0.0 110.909 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.805 HG23 ' HG2' ' A' ' 110' ' ' LYS . 0.7 OUTLIER -107.53 165.53 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.021 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.475 ' H ' HG22 ' A' ' 73' ' ' ILE . 1.3 mp0 -69.54 110.08 4.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 124.074 0.95 . . . . 0.0 109.828 176.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 20.8 pttm -58.09 -35.89 72.08 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.563 0.696 . . . . 0.0 112.115 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -51.61 -45.72 63.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.327 -1.76 . . . . 0.0 111.03 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -82.98 -34.68 26.34 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.288 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.661 ' CE1' HG21 ' A' ' 73' ' ' ILE . 1.8 m-85 -73.35 -11.52 60.51 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.031 -177.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.2 tptt 78.45 18.94 0.99 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.879 1.272 . . . . 0.0 111.732 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.13 179.36 4.51 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 122.285 1.04 . . . . 0.0 110.988 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -97.11 -24.8 15.58 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.977 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -130.33 155.25 46.66 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.108 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.467 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 4.5 m-20 -56.74 142.68 39.48 Favored 'General case' 0 C--O 1.247 0.931 0 CA-C-O 122.021 0.915 . . . . 0.0 113.203 -175.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.9 m -108.02 128.63 54.83 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.158 -174.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.3 t -115.82 130.22 70.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 HD22 ' A' ' 88' ' ' LEU . 1.6 mp -107.22 129.68 60.61 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.843 0 CA-C-O 122.196 0.998 . . . . 0.0 108.575 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.0 mt -103.42 108.34 19.55 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 113.194 -1.821 . . . . 0.0 109.214 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.519 HD22 HG22 ' A' ' 86' ' ' ILE . 3.9 mm? -80.41 4.35 18.33 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.373 -175.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.12 -38.0 6.13 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.378 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.48 53.35 2.78 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.545 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.558 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.0 pp -97.21 -176.16 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -173.96 178.11 2.23 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 45.4 m -121.76 129.15 52.48 Favored 'General case' 0 N--CA 1.422 -1.859 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.884 -178.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.1 mt -133.17 145.56 50.74 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 124.373 1.069 . . . . 0.0 109.328 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.486 ' OD2' ' HB3' ' A' ' 97' ' ' LYS . 2.2 p-10 -79.73 151.16 30.57 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 118.284 -1.367 . . . . 0.0 110.115 173.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -39.14 -41.06 0.79 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.994 2.117 . . . . 0.0 114.521 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.486 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 7.0 ttpm? -63.65 -13.74 45.43 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 124.122 0.969 . . . . 0.0 112.401 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.534 ' NE ' ' HA ' ' A' ' 98' ' ' ARG . 3.7 mmp_? -89.73 -26.94 20.38 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.166 -0.959 . . . . 0.0 110.912 175.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -74.89 108.56 7.7 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-O 122.14 0.971 . . . . 0.0 109.514 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -93.83 -59.28 2.03 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -143.66 130.41 20.31 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.918 0.866 . . . . 0.0 113.232 -171.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 27.2 tttp -60.77 119.9 9.07 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 127.266 2.226 . . . . 0.0 108.184 175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.7 tp -114.5 -62.38 1.61 Allowed 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.804 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 78' ' ' TYR . 6.1 t -127.75 -160.49 1.02 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.238 -1.385 . . . . 0.0 112.457 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -159.37 149.97 19.42 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.371 1.868 . . . . 0.0 109.158 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -101.82 147.49 26.43 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.688 -177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -64.32 143.16 58.1 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 125.1 1.36 . . . . 0.0 108.608 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 111' ' ' MET . 7.0 p-10 -58.45 -37.39 75.34 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.29 -34.47 63.55 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.809 0.337 . . . . 0.0 110.606 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.805 ' HG2' HG23 ' A' ' 73' ' ' ILE . 16.7 tppt? -67.67 -33.58 75.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.495 ' SD ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -51.31 -46.18 62.47 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.693 173.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.696 ' HE2' ' N ' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -69.69 -17.78 63.5 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.72 -178.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -83.54 -38.67 21.41 Favored 'General case' 0 CA--C 1.442 -3.175 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.21 -42.99 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.671 0 O-C-N 126.13 2.144 . . . . 0.0 109.999 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.693 ' OD2' ' HA ' ' A' ' 112' ' ' LYS . 44.8 m-20 -57.4 -58.92 6.16 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.53 ' O ' HG13 ' A' ' 120' ' ' ILE . 1.7 m-80 -59.38 -47.39 85.63 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.3 -176.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.515 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -52.09 -43.81 64.09 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 124.341 1.056 . . . . 0.0 110.852 -178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 tp -67.21 -45.93 75.38 Favored 'General case' 1 N--CA 1.374 -4.252 0 C-N-CA 124.336 1.054 . . . . 0.0 109.971 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.2 mtp -67.82 -20.08 65.13 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 121.477 -0.765 . . . . 0.0 112.891 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 116' ' ' ASN . 49.4 mt -77.24 -55.75 9.79 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.162 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 173.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 26.2 t -53.22 -42.65 66.57 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.429 -1.714 . . . . 0.0 111.759 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.4 mp -90.06 -1.14 57.91 Favored 'General case' 0 N--CA 1.403 -2.782 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.65 13.14 82.84 Favored Glycine 0 C--N 1.336 0.539 0 N-CA-C 116.571 1.389 . . . . 0.0 116.571 170.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 128' ' ' ALA . 5.2 mp -79.57 -59.84 2.59 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-N 118.624 1.212 . . . . 0.0 110.985 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 43.37 -151.28 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.649 0 CA-C-N 114.286 -1.324 . . . . 0.0 110.65 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.3 16.49 24.74 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.061 0.934 . . . . 0.0 109.309 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.2 t -117.73 18.83 6.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.237 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 124' ' ' LEU . . . -81.11 -9.58 59.79 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 121.616 -0.678 . . . . 0.0 111.138 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -65.74 -52.36 51.79 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 120.925 0.393 . . . . 0.0 110.72 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -136.08 72.05 1.43 Allowed 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.014 0.911 . . . . 0.0 111.118 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.551 ' HG2' HH22 ' B' ' 16' ' ' ARG . 87.2 tttt -156.31 108.03 2.5 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.429 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 p30 . . . . . 0 C--N 1.298 -1.644 0 CA-C-O 118.569 -0.729 . . . . 0.0 109.409 178.902 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.837 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -96.46 -46.0 6.54 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 121.246 0.545 . . . . 0.0 111.731 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 12.3 m -86.64 -31.86 20.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.296 0.57 . . . . 0.0 110.314 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -121.97 146.43 47.15 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -83.36 79.67 9.33 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 122.012 0.91 . . . . 0.0 110.315 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -125.69 112.48 16.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.726 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -80.64 122.6 27.29 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -75.52 100.9 4.68 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -105.42 119.2 38.49 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.121 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 17.2 m -127.4 145.27 50.88 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -91.89 116.17 28.68 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.04 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -83.01 146.47 51.93 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 171.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.21 114.69 0.9 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 122.186 1.924 . . . . 0.0 111.04 174.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 75.6 mt -99.52 120.69 49.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.058 -175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -117.35 159.14 23.21 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.551 HH22 ' HG2' ' A' ' 131' ' ' LYS . 27.0 ptt85 -70.0 113.54 7.31 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.427 ' HA2' ' SD ' ' B' ' 111' ' ' MET . . . 133.34 -15.3 4.74 Favored Glycine 0 C--N 1.305 -1.163 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.666 -173.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -89.72 171.92 9.3 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-O 121.946 0.879 . . . . 0.0 109.047 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.408 HG11 HG22 ' B' ' 104' ' ' THR . 13.3 t -131.19 132.88 63.09 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.774 0 CA-C-N 113.695 -1.593 . . . . 0.0 110.841 177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.492 ' O ' HG22 ' B' ' 38' ' ' VAL . 75.6 m-85 -133.65 143.69 48.74 Favored 'General case' 0 CA--C 1.474 -1.957 0 C-N-CA 125.199 1.4 . . . . 0.0 109.463 176.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.652 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.9 mp -81.49 148.42 29.21 Favored 'General case' 0 N--CA 1.397 -3.095 0 CA-C-O 121.687 0.756 . . . . 0.0 110.99 173.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -136.59 134.73 37.72 Favored 'General case' 0 C--N 1.267 -2.981 0 CA-C-N 113.177 -1.829 . . . . 0.0 107.209 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.517 ' HA ' ' HB ' ' B' ' 35' ' ' VAL 0.333 3.6 p-10 -81.95 102.51 10.97 Favored 'General case' 0 C--N 1.279 -2.467 0 C-N-CA 117.975 -1.49 . . . . 0.0 111.658 175.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 4.9 mt -87.8 39.1 0.87 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 125.085 2.374 . . . . 0.0 110.396 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.572 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.287 6.6 m -64.62 171.87 2.55 Favored Pre-proline 1 C--N 1.22 -5.027 0 CA-C-N 109.363 -3.562 . . . . 0.0 107.219 167.083 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.3 OUTLIER 5.85 53.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.173 1 C-N-CA 127.153 5.235 . . . . 0.0 118.386 -174.746 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 28.5 m -69.29 -179.1 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 113.383 -1.735 . . . . 0.0 109.534 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . 0.419 HE22 ' HB2' ' A' ' 26' ' ' PRO . 32.1 mm-40 -106.52 130.95 54.21 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -176.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.99 -117.9 7.37 Favored Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 113.751 -1.568 . . . . 0.0 113.82 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.9 m -94.18 18.08 11.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.34 -0.93 . . . . 0.0 113.188 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.52 178.1 1.04 Allowed 'General case' 0 C--O 1.249 1.063 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.942 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.457 ' OE1' ' HD2' ' B' ' 36' ' ' ARG . 1.0 OUTLIER -83.52 108.81 16.89 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.522 -177.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.79 138.52 14.11 Favored Glycine 0 CA--C 1.479 -2.212 0 CA-C-N 114.904 -1.043 . . . . 0.0 114.324 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 117.5 136.92 5.71 Favored Glycine 0 N--CA 1.423 -2.168 0 CA-C-N 113.813 -1.193 . . . . 0.0 110.512 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' B' ' 23' ' ' ASP . 1.5 p -63.85 121.21 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-O 122.497 1.141 . . . . 0.0 110.9 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . 0.457 ' HD2' ' OE1' ' B' ' 32' ' ' GLN . 87.8 mtt180 -144.51 166.69 17.52 Favored Pre-proline 0 C--N 1.26 -3.319 0 CA-C-N 112.846 -1.979 . . . . 0.0 109.028 -174.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.652 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 5.4 Cg_exo -76.05 142.7 25.07 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 122.003 1.802 . . . . 0.0 111.507 174.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.492 HG22 ' O ' ' B' ' 20' ' ' TYR . 31.0 m -118.07 158.08 19.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.2 m -102.22 132.42 48.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 120.807 0.336 . . . . 0.0 110.79 178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 24.0 mm -88.09 104.25 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.47 -20.8 5.54 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.004 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -55.64 165.91 0.77 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 116.798 2.147 . . . . 0.0 116.798 -170.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -59.77 163.3 4.54 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 112.709 -2.042 . . . . 0.0 112.784 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.0 -37.97 75.83 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.498 -175.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 25.8 m -87.23 -28.35 22.42 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.03 -36.06 86.65 Favored Glycine 0 C--O 1.2 -1.99 0 CA-C-O 120.077 -0.291 . . . . 0.0 113.336 -175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.548 ' OD1' ' HD2' ' B' ' 48' ' ' LYS . 26.6 p30 -69.21 -19.58 63.97 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.548 ' HD2' ' OD1' ' B' ' 47' ' ' ASN . 13.1 mptt -85.66 -59.44 2.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.222 0.534 . . . . 0.0 110.369 174.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -89.25 -29.75 19.0 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -169.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.7 m -99.45 138.41 20.48 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -74.7 -22.09 15.89 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.281 1.32 . . . . 0.0 109.708 173.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 3.1 p -95.43 132.7 40.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.546 -176.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.32 146.38 34.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.42 ' CD1' HD11 ' A' ' 91' ' ' ILE . 4.8 tt -96.97 132.85 40.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 123.112 0.565 . . . . 0.0 110.317 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.462 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 28.3 m -138.03 171.93 14.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.556 -178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.558 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -125.05 139.8 53.47 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.12 142.03 41.77 Favored 'General case' 0 C--O 1.249 1.047 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.631 HD12 ' HB2' ' B' ' 37' ' ' PRO . 85.2 mt -100.2 133.11 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-N 113.281 -1.781 . . . . 0.0 109.389 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 95.7 m -123.41 104.72 9.26 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.89 149.78 22.55 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.437 ' O ' ' HB ' ' B' ' 62' ' ' ILE . 47.5 mtp180 68.65 86.65 0.13 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.02 0.928 . . . . 0.0 112.844 177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' B' ' 61' ' ' ARG . 0.1 OUTLIER -176.73 -47.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . 0.559 ' OD1' ' HB2' ' B' ' 83' ' ' ASP . 2.5 m-20 58.75 -168.8 0.14 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.103 0.961 . . . . 0.0 110.777 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt 60.26 66.48 0.95 Allowed 'General case' 0 C--O 1.243 0.718 0 O-C-N 123.815 0.697 . . . . 0.0 110.403 173.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.25 -60.89 2.53 Favored 'General case' 0 C--O 1.252 1.222 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.287 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 tttp 69.41 -52.8 0.6 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.306 1.443 . . . . 0.0 112.835 174.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 13.2 mt -85.69 142.14 36.78 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.98 -12.69 33.35 Favored 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 122.157 1.905 . . . . 0.0 113.671 177.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 72.6 p -88.78 -19.09 26.45 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.395 0.617 . . . . 0.0 110.651 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -96.21 130.26 43.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.38 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 95.1 t -126.53 130.45 71.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 O-C-N 122.174 -0.329 . . . . 0.0 110.359 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -101.32 139.49 36.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 177.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.78 HG23 ' HG2' ' B' ' 110' ' ' LYS . 0.7 OUTLIER -115.36 162.96 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 123.157 0.583 . . . . 0.0 111.754 -173.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.415 ' H ' HG22 ' B' ' 73' ' ' ILE . 1.3 mp0 -66.3 109.91 2.86 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 123.785 0.834 . . . . 0.0 110.409 177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . 0.451 ' HB3' ' HA ' ' B' ' 83' ' ' ASP . 20.0 pttm -58.13 -34.98 70.82 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-O 121.873 0.844 . . . . 0.0 112.066 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -53.32 -44.19 68.21 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.177 -1.828 . . . . 0.0 110.941 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -84.51 -35.2 23.06 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.472 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.636 ' CE1' HG21 ' B' ' 73' ' ' ILE . 1.6 m-85 -73.43 -11.49 60.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.926 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 81.59 13.81 0.61 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.222 1.409 . . . . 0.0 112.089 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.8 179.29 5.02 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 122.328 1.061 . . . . 0.0 111.189 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -96.27 -25.04 15.93 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 113.673 -1.603 . . . . 0.0 109.845 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -130.34 156.02 45.38 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.559 ' HB2' ' OD1' ' B' ' 63' ' ' ASN . 2.1 m-20 -54.08 144.22 20.09 Favored 'General case' 0 C--O 1.252 1.192 0 CA-C-O 121.959 0.885 . . . . 0.0 113.239 -175.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 13.1 m -108.27 128.18 54.5 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.644 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.5 t -115.76 129.94 71.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.481 HG22 HD22 ' B' ' 88' ' ' LEU . 1.6 mp -107.4 129.88 60.55 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 mt -102.9 108.87 20.23 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 113.563 -1.653 . . . . 0.0 109.019 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.481 HD22 HG22 ' B' ' 86' ' ' ILE . 3.8 mm? -80.01 4.48 16.87 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.585 0.707 . . . . 0.0 112.451 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.15 -38.9 5.87 Favored 'General case' 0 C--N 1.282 -2.326 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.96 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -85.55 63.67 8.2 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.116 176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.558 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.0 pp -108.66 -176.68 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -174.39 178.98 1.89 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 173.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.444 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 31.5 m -122.38 129.31 51.98 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.768 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 41.8 mt -133.49 145.46 50.21 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 124.513 1.125 . . . . 0.0 109.471 -174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' B' ' 97' ' ' LYS . 2.0 p30 -79.4 151.18 31.07 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 117.977 -1.489 . . . . 0.0 110.284 172.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -37.39 -42.25 0.48 Allowed 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 127.402 2.281 . . . . 0.0 114.685 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.468 ' HB3' ' OD2' ' B' ' 95' ' ' ASP . 7.5 ttpm? -61.17 -18.05 56.14 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 124.665 1.186 . . . . 0.0 112.472 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.589 ' HA ' ' NE ' ' B' ' 98' ' ' ARG . 4.0 mmp_? -88.31 -22.45 23.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.363 -0.835 . . . . 0.0 111.622 176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -78.31 107.83 11.2 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 121.976 0.894 . . . . 0.0 108.974 173.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -95.24 -57.98 2.27 Favored 'General case' 0 C--N 1.274 -2.702 0 N-CA-C 116.823 2.156 . . . . 0.0 116.823 -173.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.525 ' HG3' HD13 ' B' ' 21' ' ' LEU . 12.0 pt-20 -140.15 131.93 27.47 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.979 0.895 . . . . 0.0 112.737 -171.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -63.67 119.46 9.92 Favored 'General case' 0 C--N 1.28 -2.452 0 C-N-CA 127.151 2.18 . . . . 0.0 108.429 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 15.3 tp -115.1 -63.66 1.43 Allowed 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 118.564 -1.255 . . . . 0.0 112.048 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.408 HG22 HG11 ' B' ' 19' ' ' VAL . 6.1 t -125.57 -160.48 0.97 Allowed 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 117.645 -1.622 . . . . 0.0 112.897 -177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -159.75 150.89 19.54 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 126.803 2.041 . . . . 0.0 108.324 -173.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.34 155.69 17.66 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -70.96 145.76 49.88 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' B' ' 111' ' ' MET . 2.8 p-10 -62.85 -35.43 79.93 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -176.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.0 -33.17 63.71 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.202 0.525 . . . . 0.0 109.917 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.78 ' HG2' HG23 ' B' ' 73' ' ' ILE . 16.6 tppt? -68.65 -32.96 73.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.531 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -51.83 -45.48 63.97 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.958 173.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.704 ' HE2' ' N ' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -69.3 -16.88 63.66 Favored 'General case' 0 CA--C 1.477 -1.863 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.237 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . 0.588 ' HA ' ' ND2' ' B' ' 116' ' ' ASN . 32.6 mt-10 -85.53 -38.37 18.6 Favored 'General case' 1 N--CA 1.368 -4.55 0 C-N-CA 117.202 -1.799 . . . . 0.0 108.641 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.0 t -56.62 -44.36 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.141 0 CA-C-N 112.882 -1.963 . . . . 0.0 110.03 172.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.639 ' OD2' ' HA ' ' B' ' 112' ' ' LYS . 25.2 m-20 -56.32 -58.1 9.41 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.557 1.17 . . . . 0.0 108.991 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.588 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 1.3 p30 -66.34 -40.49 89.87 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.011 -1.449 . . . . 0.0 112.019 -173.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -59.14 -37.81 78.17 Favored 'General case' 0 CA--C 1.49 -1.364 0 O-C-N 123.636 0.585 . . . . 0.0 109.74 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.48 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.6 tp -69.56 -44.56 70.64 Favored 'General case' 1 N--CA 1.373 -4.294 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.871 -178.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 39.2 mtp -68.39 -19.92 64.65 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 121.643 -0.661 . . . . 0.0 112.124 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' B' ' 117' ' ' ALA . 45.6 mt -78.18 -55.43 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 173.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 34.3 t -52.21 -43.9 64.47 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.113 1.365 . . . . 0.0 111.843 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 8.1 mp -87.74 -2.37 58.57 Favored 'General case' 0 N--CA 1.409 -2.516 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 82.53 7.42 87.53 Favored Glycine 0 C--O 1.241 0.551 0 N-CA-C 117.116 1.606 . . . . 0.0 117.116 170.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 5.2 mp -75.8 -59.19 2.86 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 118.632 1.216 . . . . 0.0 110.937 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 45.14 -151.36 0.05 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.552 -169.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.56 19.66 20.16 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.997 0.903 . . . . 0.0 109.609 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 15.9 t -118.69 7.86 6.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.663 -176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.02 -16.85 63.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.39 -0.823 . . . . 0.0 112.284 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -59.59 -53.13 61.57 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.918 -175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -134.92 71.74 1.45 Allowed 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.282 1.039 . . . . 0.0 111.722 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . 0.535 ' HG2' HH22 ' A' ' 16' ' ' ARG . 87.3 tttt -160.66 108.81 1.6 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.732 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 8.4 p30 . . . . . 0 C--N 1.294 -1.816 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.287 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.615 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.5 m -87.93 95.48 10.13 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 117.447 0.624 . . . . 0.0 110.092 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 p -88.25 141.39 28.6 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.88 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -72.48 147.39 46.1 Favored 'General case' 0 C--O 1.251 1.147 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -71.55 99.82 2.13 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.399 0.618 . . . . 0.0 111.626 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -74.15 111.07 8.96 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.559 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -91.84 93.5 8.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.242 0.544 . . . . 0.0 109.859 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -121.64 -15.58 7.93 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.905 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 66.99 -93.64 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -167.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.3 m 50.13 30.7 4.4 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.738 0.815 . . . . 0.0 111.519 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -94.33 81.91 4.04 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.035 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -70.15 123.84 89.6 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -58.93 100.88 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 122.188 1.926 . . . . 0.0 112.33 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.0 mt -79.35 124.6 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -134.42 157.39 46.55 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 42' ' ' GLN . 20.3 ttt85 -67.86 130.5 43.17 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.33 173.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.34 -19.27 11.74 Favored Glycine 0 C--N 1.307 -1.034 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.158 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -93.51 176.06 6.52 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 122.112 0.958 . . . . 0.0 110.461 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 17.4 t -128.32 135.76 61.79 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.194 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.119 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 8.0 m-85 -128.59 145.44 51.14 Favored 'General case' 0 CA--C 1.462 -2.411 0 C-N-CA 124.461 1.104 . . . . 0.0 108.996 176.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.3 mp -78.9 148.42 32.74 Favored 'General case' 0 N--CA 1.391 -3.411 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 168.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.1 134.48 17.3 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.397 1.06 . . . . 0.0 110.654 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.92 88.58 1.85 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.237 171.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.532 ' O ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -109.13 25.45 11.79 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 123.265 1.507 . . . . 0.0 109.542 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.663 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 20.2 p -94.28 62.11 0.01 OUTLIER Pre-proline 0 N--CA 1.409 -2.509 0 CA-C-N 112.95 -1.932 . . . . 0.0 116.205 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HB2' ' HB2' ' B' ' 26' ' ' PRO . 13.7 Cg_endo -113.48 29.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.556 0 N-CA-C 106.288 -2.235 . . . . 0.0 106.288 153.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.673 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 35.3 m -73.5 165.21 3.2 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.645 -176.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.09 141.42 30.03 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 114.086 -1.416 . . . . 0.0 113.307 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.83 -108.82 2.31 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.786 -1.097 . . . . 0.0 115.354 172.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 m -84.46 -5.94 59.33 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 124.264 1.025 . . . . 0.0 113.074 -173.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.673 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 71.2 mt-10 -77.4 161.65 27.84 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.458 ' HG3' ' OE1' ' A' ' 90' ' ' GLN . 0.3 OUTLIER -125.33 156.5 38.59 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 159.71 -149.07 18.52 Favored Glycine 0 N--CA 1.407 -3.283 0 C-N-CA 118.462 -1.828 . . . . 0.0 114.417 177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.663 ' HA2' ' HB3' ' A' ' 25' ' ' SER . . . 140.55 -156.14 25.11 Favored Glycine 0 C--N 1.276 -2.772 0 N-CA-C 103.61 -3.796 . . . . 0.0 103.61 -171.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 p -96.0 100.07 10.27 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.168 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 165.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.0 ttm180 -131.63 146.45 61.92 Favored Pre-proline 0 C--N 1.258 -3.398 0 CA-C-N 113.065 -1.88 . . . . 0.0 109.671 -167.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 47.6 Cg_exo -56.28 134.36 63.78 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.395 2.063 . . . . 0.0 111.203 171.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 29.4 m -125.28 159.11 32.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.493 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.9 m -97.89 130.26 46.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.55 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.8 mm -88.73 101.88 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.69 -20.36 5.54 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.863 -177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.681 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -54.86 158.91 2.5 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -170.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.458 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 19.0 p-10 -63.51 175.41 1.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.886 -1.507 . . . . 0.0 112.418 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -52.89 52.46 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.27 -1.786 . . . . 0.0 112.937 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -80.55 -24.17 39.47 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -163.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.69 -26.35 72.97 Favored Glycine 0 C--O 1.212 -1.23 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.991 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -73.96 -32.76 63.61 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.497 0.665 . . . . 0.0 110.162 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mtpt -85.45 -64.48 1.15 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.689 -173.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -96.5 -28.67 14.3 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -171.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.1 m -86.4 155.02 57.15 Favored Pre-proline 0 C--N 1.298 -1.659 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.149 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.561 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . 61.6 Cg_endo -98.26 17.05 0.51 Allowed 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 122.779 2.319 . . . . 0.0 111.425 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 p -130.56 145.8 51.95 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.415 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.572 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -146.2 139.28 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.588 0.555 . . . . 0.0 111.565 174.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.681 HG22 ' HG3' ' A' ' 42' ' ' GLN . 8.9 tt -82.2 133.71 28.59 Favored 'Isoleucine or valine' 0 C--O 1.25 1.122 0 CA-C-O 121.663 0.744 . . . . 0.0 111.392 175.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 29.9 m -135.85 162.56 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.712 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.557 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -123.48 139.23 54.23 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.05 134.78 47.35 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.577 HG12 HD12 ' A' ' 86' ' ' ILE . 54.9 mt -93.25 112.71 26.82 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.038 176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.5 m -99.85 119.56 38.38 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.349 0.659 . . . . 0.0 109.747 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.13 17.62 53.66 Favored Glycine 0 C--O 1.221 -0.704 0 C-N-CA 120.581 -0.818 . . . . 0.0 114.992 -172.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -170.05 106.35 0.33 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.7 tt -166.52 168.46 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.484 ' OD1' ' HG2' ' A' ' 64' ' ' LYS . 28.4 t-20 -61.83 -68.55 0.31 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.532 1.06 . . . . 0.0 112.736 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.484 ' HG2' ' OD1' ' A' ' 63' ' ' ASN . 19.4 ptpt -167.8 -177.03 3.29 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-O 121.195 0.521 . . . . 0.0 110.721 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.97 77.05 1.29 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -95.33 -23.0 17.39 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.246 0.546 . . . . 0.0 111.261 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 tt -106.01 141.68 23.23 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.38 5.51 0.32 Allowed 'Trans proline' 0 CA--C 1.551 1.345 0 C-N-CA 123.436 2.757 . . . . 0.0 115.583 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.524 ' HA ' ' OG ' ' A' ' 121' ' ' SER . 68.4 p -96.77 -18.46 19.59 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 122.23 1.014 . . . . 0.0 109.137 176.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -102.03 129.91 48.46 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.3 p -124.62 137.55 56.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.252 175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -92.92 148.13 22.27 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.166 0.507 . . . . 0.0 111.352 -176.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 84' ' ' SER . 1.9 pp -124.6 148.15 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.816 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -90.55 108.82 20.04 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.676 0.75 . . . . 0.0 109.561 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HD2' ' C ' ' A' ' 81' ' ' ASP . 37.6 pttt -45.06 -39.07 5.43 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 126.217 1.807 . . . . 0.0 115.217 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -45.89 -49.38 15.62 Favored 'General case' 0 C--N 1.267 -2.984 0 C-N-CA 126.131 1.772 . . . . 0.0 111.8 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -91.76 -41.21 10.81 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 118.805 -1.158 . . . . 0.0 112.266 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.495 ' HD1' ' O ' ' A' ' 105' ' ' TYR . 2.3 m-85 -110.8 -19.48 12.82 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -164.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.453 ' HG2' ' HB2' ' A' ' 84' ' ' SER . 56.8 tptt -154.78 46.56 0.54 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 117.242 -1.783 . . . . 0.0 114.644 -167.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 0.0 OUTLIER 65.81 -131.66 0.22 Allowed 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.432 0.693 . . . . 0.0 111.151 163.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.51 ' C ' ' HD2' ' A' ' 75' ' ' LYS . 23.6 t70 -88.57 -5.76 57.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.652 1.181 . . . . 0.0 109.437 175.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -106.67 116.33 31.75 Favored 'General case' 0 C--O 1.213 -0.848 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.436 ' N ' ' HD3' ' A' ' 75' ' ' LYS . 5.0 p-10 -83.22 117.11 22.72 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 176.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.453 ' HB2' ' HG2' ' A' ' 79' ' ' LYS . 13.2 t -113.65 157.93 21.51 Favored 'General case' 0 N--CA 1.406 -2.658 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.676 -166.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.5 t -116.01 139.16 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.577 HD12 HG12 ' A' ' 58' ' ' ILE . 17.3 mm -105.27 129.95 57.25 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 52.0 mt -101.24 110.56 22.59 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.478 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.2 mm? -84.01 -7.33 59.43 Favored 'General case' 0 CA--C 1.5 -0.95 0 CA-C-O 121.677 0.751 . . . . 0.0 111.168 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.546 ' O ' HG21 ' B' ' 93' ' ' THR . 10.4 pt-20 -84.74 -42.25 15.41 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.185 173.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.458 ' OE1' ' HG3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -92.85 73.84 4.88 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.995 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.609 ' O ' ' HB ' ' B' ' 93' ' ' THR . 2.4 pp -117.58 179.73 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.91 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.524 ' NH1' HG12 ' A' ' 27' ' ' VAL 0.261 11.5 ptp180 -174.94 157.76 2.42 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.604 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 99.4 m -105.19 126.5 52.15 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.293 -1.321 . . . . 0.0 107.591 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.2 mt -131.36 150.13 52.27 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 124.137 0.898 . . . . 0.0 111.184 -169.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -51.52 141.56 15.72 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.707 0.629 . . . . 0.0 110.108 170.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 51' ' ' PRO . 44.4 mtmt -64.5 -18.82 65.15 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 120.981 0.42 . . . . 0.0 111.971 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -75.5 -9.64 58.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.11 0.481 . . . . 0.0 110.914 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.542 ' NE ' ' HA ' ' A' ' 98' ' ' ARG . 3.8 mmp_? -86.63 -36.5 18.77 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -73.39 121.74 20.96 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.616 174.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -106.05 -61.16 1.55 Allowed 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.2 pt-20 -143.1 130.6 21.16 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -168.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 22.0 ttmm -60.75 113.19 2.35 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 112.221 -2.263 . . . . 0.0 109.045 174.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.3 tp -112.97 -63.27 1.47 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.495 ' H ' ' HB ' ' A' ' 19' ' ' VAL 0.273 5.7 t -120.89 -167.08 1.42 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 117.703 -1.599 . . . . 0.0 111.115 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.495 ' O ' ' HD1' ' A' ' 78' ' ' TYR . 13.8 p90 -160.29 142.93 13.28 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 123.687 0.795 . . . . 0.0 111.66 -169.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.413 ' HA ' ' CD1' ' A' ' 78' ' ' TYR . 32.3 mt -111.55 161.4 16.22 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.142 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 111' ' ' MET . 30.2 p -92.63 167.14 12.11 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 123.906 0.882 . . . . 0.0 109.878 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -65.35 -31.41 72.52 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.458 0.647 . . . . 0.0 111.394 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.07 -38.51 79.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.858 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -70.86 -35.14 72.26 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.427 ' HG2' ' O ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -52.71 -49.21 65.81 Favored 'General case' 0 CA--C 1.483 -1.607 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.011 177.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.672 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 28.9 mtmm -50.08 -41.74 48.73 Favored 'General case' 0 CA--C 1.477 -1.836 0 O-C-N 124.319 1.012 . . . . 0.0 112.62 176.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -80.21 -32.17 38.58 Favored 'General case' 0 CA--C 1.443 -3.166 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -165.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.63 -55.64 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.761 0 CA-C-N 112.776 -2.011 . . . . 0.0 109.968 173.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 62.3 m-20 -57.46 -50.94 71.41 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 122.237 1.018 . . . . 0.0 110.495 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.672 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -61.6 -46.57 89.27 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 113.57 -1.65 . . . . 0.0 111.703 -178.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.478 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -58.76 -42.66 89.42 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 12.7 tp -65.56 -47.07 77.09 Favored 'General case' 0 N--CA 1.402 -2.874 0 C-N-CA 125.184 1.394 . . . . 0.0 110.299 -175.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.512 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.19 -29.46 57.94 Favored 'General case' 0 N--CA 1.414 -2.245 0 C-N-CA 124.832 1.253 . . . . 0.0 111.212 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 116' ' ' ASN . 40.6 mt -86.44 -54.0 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.524 ' OG ' ' HA ' ' A' ' 69' ' ' THR . 72.8 m -46.88 -33.56 4.64 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 113.516 -1.674 . . . . 0.0 112.757 176.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 21.7 mt -100.5 -0.29 38.17 Favored 'General case' 0 C--O 1.189 -2.113 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.999 -177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.51 7.78 71.69 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 119.591 -1.29 . . . . 0.0 116.295 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.512 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 4.9 mp -63.71 -50.17 70.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 CA-C-O 122.7 1.238 . . . . 0.0 108.353 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.609 ' C ' HD22 ' A' ' 125' ' ' ASN 0.305 0.0 OUTLIER -137.89 90.8 2.52 Favored 'General case' 1 N--CA 1.362 -4.847 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 170.438 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -138.17 7.75 2.67 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.881 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 43.7 t -106.01 -10.16 10.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 113.736 -1.575 . . . . 0.0 106.809 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.88 73.62 10.62 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 113.408 -1.724 . . . . 0.0 110.01 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -137.22 15.11 3.02 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -141.64 -57.07 0.48 Allowed 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 113.697 -1.592 . . . . 0.0 107.097 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -96.48 102.87 14.73 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 171.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.6 m120 . . . . . 0 C--N 1.303 -1.426 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.16 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.274 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m -79.28 107.12 11.81 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.563 0.697 . . . . 0.0 109.685 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 9.3 p -98.94 145.16 27.32 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.284 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -79.65 149.62 31.21 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 118.944 -1.102 . . . . 0.0 109.104 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -78.81 93.92 5.06 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.59 0.709 . . . . 0.0 111.971 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . 0.505 ' HB3' ' CD2' ' B' ' 8' ' ' HIS . 80.8 m80 -67.48 113.15 5.1 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.929 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -94.83 96.07 9.1 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.268 0.556 . . . . 0.0 110.068 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.505 ' CD2' ' HB3' ' B' ' 6' ' ' HIS . 11.6 m-70 -126.95 -8.05 6.04 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.375 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 61.19 -95.5 0.05 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -168.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 20.1 m 55.98 22.71 6.03 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.739 0.816 . . . . 0.0 111.805 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -87.43 81.96 7.67 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.816 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -67.31 126.42 92.51 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 173.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -60.34 100.36 0.15 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.155 1.903 . . . . 0.0 112.218 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.75 117.78 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' B' ' 18' ' ' ASP . 19.2 ptt180 -127.97 159.13 35.93 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' B' ' 42' ' ' GLN . 21.0 ttt85 -69.44 130.74 43.35 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.75 -20.34 10.08 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.002 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . 0.437 ' CG ' ' HE ' ' B' ' 15' ' ' ARG . 57.0 m-20 -93.74 175.47 6.72 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-O 122.272 1.034 . . . . 0.0 110.736 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 12.7 t -128.38 135.95 61.28 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.0 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.557 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 5.9 m-85 -129.16 145.93 51.2 Favored 'General case' 0 CA--C 1.466 -2.26 0 C-N-CA 124.506 1.122 . . . . 0.0 109.061 177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.517 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.4 mp -79.47 148.32 31.92 Favored 'General case' 0 N--CA 1.394 -3.254 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 167.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -150.83 134.75 16.66 Favored 'General case' 0 C--N 1.265 -3.099 0 O-C-N 124.361 1.038 . . . . 0.0 111.014 -174.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.8 86.72 1.26 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 171.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.476 ' C ' ' HD3' ' B' ' 26' ' ' PRO 0.252 0.0 OUTLIER -104.81 23.73 12.99 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 123.156 1.455 . . . . 0.0 109.643 -179.62 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.662 ' HB3' ' HA2' ' B' ' 34' ' ' GLY . 3.5 p -94.54 62.58 0.01 OUTLIER Pre-proline 0 N--CA 1.405 -2.676 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 176.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.565 ' HB2' ' HB2' ' A' ' 26' ' ' PRO . 15.5 Cg_endo -113.72 27.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.574 0 N-CA-C 106.822 -2.03 . . . . 0.0 106.822 153.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.666 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 34.1 m -72.84 165.87 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.886 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.19 140.98 29.64 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.863 -1.517 . . . . 0.0 113.698 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.65 -108.38 2.19 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 115.789 1.076 . . . . 0.0 115.789 171.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.9 m -79.41 -15.49 57.75 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 124.011 0.925 . . . . 0.0 112.5 -174.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.666 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 71.6 mt-10 -69.65 165.92 20.2 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.63 130.98 49.91 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -172.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.35 -163.11 36.36 Favored Glycine 0 N--CA 1.408 -3.212 0 C-N-CA 117.735 -2.174 . . . . 0.0 115.278 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.662 ' HA2' ' HB3' ' B' ' 25' ' ' SER . . . 158.9 -162.05 32.33 Favored Glycine 0 C--N 1.266 -3.321 1 N-CA-C 102.664 -4.174 . . . . 0.0 102.664 -171.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.4 p -89.42 99.85 9.94 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 166.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -132.44 147.19 64.68 Favored Pre-proline 0 C--N 1.257 -3.418 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.606 -167.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 51.3 Cg_exo -55.48 135.41 69.09 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.538 2.159 . . . . 0.0 112.034 173.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 28.2 m -126.21 158.65 35.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 C-N-CA 123.849 0.86 . . . . 0.0 108.969 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.495 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 32.9 m -98.01 130.55 46.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 120.672 0.272 . . . . 0.0 110.666 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 18.6 mm -88.91 102.09 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.22 -20.38 5.53 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.546 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.897 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.661 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -55.06 159.34 2.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -170.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.433 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 19.1 p-10 -62.47 178.95 0.37 Allowed 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.051 -1.431 . . . . 0.0 112.491 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.72 -46.59 30.2 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.006 -1.452 . . . . 0.0 111.958 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -79.4 -26.49 41.9 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -166.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.27 -26.74 72.64 Favored Glycine 0 C--O 1.209 -1.461 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.25 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -73.69 -31.16 63.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.759 0.79 . . . . 0.0 110.263 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 mtpt -85.08 -66.64 0.87 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.59 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -96.37 -27.55 14.89 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -170.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 43.5 m -86.07 154.15 57.56 Favored Pre-proline 0 C--N 1.295 -1.803 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.533 ' HA ' ' HE2' ' B' ' 96' ' ' LYS . 68.7 Cg_endo -98.52 15.01 0.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.643 2.229 . . . . 0.0 111.231 177.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.7 p -128.14 147.01 50.53 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.295 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.558 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -147.07 139.24 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 O-C-N 123.632 0.582 . . . . 0.0 111.254 174.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.661 HG22 ' HG3' ' B' ' 42' ' ' GLN . 8.5 tt -82.22 133.7 28.61 Favored 'Isoleucine or valine' 0 C--O 1.251 1.139 0 CA-C-O 121.73 0.776 . . . . 0.0 111.422 174.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 29.7 m -135.72 160.04 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.859 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.551 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -120.68 139.16 53.43 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.44 135.27 45.72 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.557 HG12 HD12 ' B' ' 86' ' ' ILE . 55.3 mt -90.97 113.74 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-N 113.71 -1.586 . . . . 0.0 107.457 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 41.1 m -101.03 110.05 22.03 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 121.769 0.795 . . . . 0.0 111.371 -175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.67 123.5 7.45 Favored Glycine 0 N--CA 1.419 -2.488 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 82.89 100.65 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.755 1.222 . . . . 0.0 112.581 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 16.9 tt -165.63 176.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 103.603 -2.74 . . . . 0.0 103.603 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -68.08 -66.87 0.51 Allowed 'General case' 0 C--O 1.241 0.617 0 CA-C-N 120.436 1.471 . . . . 0.0 112.704 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -170.56 177.21 4.06 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.202 0.525 . . . . 0.0 110.778 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -101.19 77.71 1.83 Allowed 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -97.28 -20.39 17.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.95 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 tt -109.52 139.33 21.04 Favored Pre-proline 0 C--N 1.292 -1.904 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.11 5.14 0.17 Allowed 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.489 2.793 . . . . 0.0 115.845 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . 0.482 ' HA ' ' OG ' ' B' ' 121' ' ' SER . 64.7 p -98.75 -18.62 17.9 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 122.16 0.981 . . . . 0.0 109.238 176.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 25.6 m170 -103.5 129.56 50.7 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.91 135.38 64.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.377 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.67 143.98 26.36 Favored 'General case' 0 C--O 1.257 1.495 0 CA-C-O 121.347 0.594 . . . . 0.0 111.642 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 84' ' ' SER . 2.0 pp -119.26 150.76 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.984 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.002 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -94.85 109.66 21.62 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 121.769 0.795 . . . . 0.0 110.565 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' B' ' 80' ' ' LEU . 38.6 pttt -43.67 -42.0 5.05 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 126.528 1.931 . . . . 0.0 115.252 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -46.0 -46.94 16.79 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 126.456 1.902 . . . . 0.0 111.736 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -92.19 -42.92 9.62 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.49 -0.884 . . . . 0.0 112.074 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.564 ' HD1' ' O ' ' B' ' 105' ' ' TYR . 7.1 m-85 -111.82 -18.3 12.74 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -164.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -156.09 47.84 0.48 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 117.756 -1.578 . . . . 0.0 114.478 -167.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' B' ' 75' ' ' LYS . 0.0 OUTLIER 63.68 -133.73 0.37 Allowed 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.962 0.905 . . . . 0.0 111.203 164.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.481 ' O ' ' HD2' ' B' ' 75' ' ' LYS . 12.7 t70 -86.08 -6.71 58.97 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 125.08 1.352 . . . . 0.0 110.057 175.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -105.47 114.95 29.43 Favored 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 119.383 -0.927 . . . . 0.0 113.349 -174.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.44 ' N ' ' HD3' ' B' ' 75' ' ' LYS . 7.2 p-10 -80.11 117.34 20.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.459 ' O ' HG13 ' B' ' 73' ' ' ILE . 14.7 t -114.11 158.26 21.51 Favored 'General case' 0 N--CA 1.407 -2.624 0 C-N-CA 118.828 -1.149 . . . . 0.0 109.579 -168.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 t -116.57 139.73 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.557 HD12 HG12 ' B' ' 58' ' ' ILE . 18.7 mm -104.96 129.98 56.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.74 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.27 110.32 22.55 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.2 mm? -84.02 -6.76 59.47 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.637 0.732 . . . . 0.0 111.013 -175.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . 0.561 ' O ' HG21 ' A' ' 93' ' ' THR . 10.5 pt-20 -86.99 -39.64 15.49 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.631 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.57 73.93 3.75 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.927 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.604 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.4 pp -117.76 179.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.949 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.524 ' NH1' HG12 ' B' ' 27' ' ' VAL 0.254 12.1 ptp180 -174.98 157.42 2.34 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 172.179 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.609 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 97.2 m -105.09 126.87 52.54 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.622 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 49.1 mt -131.28 150.18 52.25 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 124.246 0.966 . . . . 0.0 111.143 -169.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -50.65 140.01 15.22 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.23 0.612 . . . . 0.0 109.764 170.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' B' ' 51' ' ' PRO . 43.1 mtmt -61.45 -23.02 65.56 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 122.68 0.392 . . . . 0.0 111.622 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -70.3 -17.95 63.09 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.061 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' B' ' 98' ' ' ARG . 4.5 mmp_? -80.38 -33.32 37.27 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.827 -0.546 . . . . 0.0 109.937 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.8 mp -74.89 117.43 16.73 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 121.966 0.889 . . . . 0.0 109.759 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -100.64 -59.35 1.72 Allowed 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -147.28 133.95 19.94 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -170.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 21.6 ttmm -60.76 114.29 2.95 Favored 'General case' 0 C--N 1.284 -2.253 0 C-N-CA 127.458 2.303 . . . . 0.0 108.778 174.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 tp -112.78 -62.89 1.52 Allowed 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.505 HG22 HG11 ' B' ' 19' ' ' VAL . 5.0 t -122.1 -167.12 1.5 Allowed 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.119 -1.432 . . . . 0.0 111.022 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.564 ' O ' ' HD1' ' B' ' 78' ' ' TYR . 15.7 p90 -160.21 141.3 12.24 Favored 'General case' 0 CA--C 1.488 -1.428 0 C-N-CA 123.818 0.847 . . . . 0.0 111.359 -170.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.504 ' HA ' ' CD1' ' B' ' 78' ' ' TYR . 32.1 mt -107.23 168.18 9.4 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 124.305 1.003 . . . . 0.0 108.872 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' B' ' 111' ' ' MET . 39.6 p -95.69 167.62 11.17 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.151 0.58 . . . . 0.0 109.6 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' B' ' 111' ' ' MET . 33.5 t70 -67.4 -29.7 69.28 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.897 0.856 . . . . 0.0 109.913 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.16 -39.9 78.51 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.231 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -71.42 -32.58 68.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 107' ' ' SER . 0.5 OUTLIER -53.99 -48.77 70.06 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.836 177.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.738 ' O ' ' HB3' ' B' ' 116' ' ' ASN 0.271 20.1 mtmm -49.27 -43.23 42.84 Favored 'General case' 0 CA--C 1.467 -2.236 0 O-C-N 124.583 1.177 . . . . 0.0 111.96 175.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -79.44 -33.5 42.44 Favored 'General case' 0 CA--C 1.446 -3.037 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -163.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.18 -53.37 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.386 -3.644 0 CA-C-N 112.548 -2.115 . . . . 0.0 110.263 173.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 69.3 m-20 -58.63 -52.14 66.94 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-O 122.437 1.113 . . . . 0.0 110.219 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.738 ' HB3' ' O ' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -67.9 -30.51 69.87 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.394 -175.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.447 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -71.64 -45.52 61.77 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.631 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 11.0 tp -60.03 -47.38 86.1 Favored 'General case' 0 N--CA 1.4 -2.97 0 C-N-CA 125.78 1.632 . . . . 0.0 110.416 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.531 ' HE2' HG13 ' B' ' 120' ' ' ILE . 0.1 OUTLIER -54.14 -33.08 57.02 Favored 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 124.567 1.147 . . . . 0.0 111.303 178.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.531 HG13 ' HE2' ' B' ' 119' ' ' MET . 56.5 mt -82.79 -53.35 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' B' ' 69' ' ' THR . 44.2 m -47.55 -33.07 6.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.724 177.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 20.3 mt -100.3 -1.63 35.75 Favored 'General case' 0 C--O 1.189 -2.089 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.975 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' B' ' 126' ' ' ALA . . . 88.73 8.28 70.18 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 173.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.504 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 4.9 mp -63.58 -48.08 78.89 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.693 1.235 . . . . 0.0 108.683 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.62 ' C ' HD22 ' B' ' 125' ' ' ASN 0.292 0.0 OUTLIER -139.4 92.19 2.56 Favored 'General case' 1 N--CA 1.366 -4.65 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 170.127 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.407 ' HB3' ' HA2' ' B' ' 123' ' ' GLY . . . -140.7 10.79 2.25 Favored 'General case' 0 C--N 1.27 -2.858 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.823 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.37 -8.54 11.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 113.588 -1.642 . . . . 0.0 106.724 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.13 68.72 10.63 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 113.659 -1.609 . . . . 0.0 110.502 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -127.37 2.88 6.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.472 -1.24 . . . . 0.0 107.835 173.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -128.45 -59.44 1.15 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.822 -1.535 . . . . 0.0 107.431 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.1 102.15 14.68 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.0 m120 . . . . . 0 C--N 1.295 -1.8 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.151 0 N-CA-C 110.619 -0.992 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -153.82 123.33 6.64 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.0 t -137.0 110.92 8.21 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -82.05 118.35 22.95 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -102.85 114.76 29.3 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.458 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 85.4 t60 -65.27 130.74 44.42 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.411 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 26.0 m80 -75.17 -11.03 59.99 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.622 -173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.458 ' H ' ' CD2' ' A' ' 6' ' ' HIS . 24.9 t-80 60.29 60.1 2.13 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 122.872 1.32 . . . . 0.0 107.463 -173.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.411 ' CD2' ' HB2' ' A' ' 7' ' ' HIS . 4.7 p80 -116.38 11.33 14.94 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.124 -175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -88.78 96.29 10.62 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.146 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -92.99 80.62 4.58 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.774 0.797 . . . . 0.0 109.092 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -74.93 132.05 78.0 Favored Pre-proline 0 C--N 1.308 -1.222 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.104 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.47 160.99 40.2 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.999 2.466 . . . . 0.0 112.322 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.65 130.27 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.291 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -115.6 138.49 51.02 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 13.8 ptm180 -61.76 134.96 57.39 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.632 170.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.32 -12.81 36.71 Favored Glycine 0 N--CA 1.432 -1.623 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.811 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.79 166.71 22.6 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.512 1.149 . . . . 0.0 110.984 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.673 HG12 ' HB2' ' A' ' 103' ' ' LEU . 42.6 t -130.68 122.7 53.2 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.949 0 CA-C-N 112.71 -2.041 . . . . 0.0 108.994 176.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 88.3 m-85 -129.13 147.66 51.0 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 125.872 1.669 . . . . 0.0 110.571 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.3 mp -77.04 148.21 36.31 Favored 'General case' 0 N--CA 1.395 -3.181 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 167.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -139.97 146.6 39.33 Favored 'General case' 0 C--N 1.252 -3.662 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.904 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.551 ' O ' ' HD2' ' A' ' 98' ' ' ARG . 35.1 t70 -84.29 72.29 10.57 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 173.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.711 HD22 ' HA3' ' A' ' 33' ' ' GLY . 3.2 tt -76.79 -36.78 56.74 Favored 'General case' 0 N--CA 1.384 -3.756 0 CA-C-N 111.789 -2.459 . . . . 0.0 110.413 -167.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.659 ' CB ' ' H ' ' A' ' 34' ' ' GLY . 71.4 m -118.5 114.75 36.03 Favored Pre-proline 0 N--CA 1.398 -3.063 1 N-CA-C 121.812 4.005 . . . . 0.0 121.812 -168.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -106.78 27.81 0.06 OUTLIER 'Trans proline' 0 N--CA 1.419 -2.902 0 C-N-CA 123.616 2.878 . . . . 0.0 106.015 152.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.67 ' C ' HE21 ' A' ' 28' ' ' GLN . 26.7 m -88.48 158.42 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 CA-C-O 122.191 0.996 . . . . 0.0 112.816 -174.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.732 ' N ' HE21 ' A' ' 28' ' ' GLN . 0.0 OUTLIER -152.29 155.83 38.45 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 113.03 -1.895 . . . . 0.0 107.498 175.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.54 -130.93 10.42 Favored Glycine 0 N--CA 1.416 -2.696 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' B' ' 95' ' ' ASP . 4.7 m -93.92 -7.83 41.91 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.794 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.535 ' HG2' HH12 ' B' ' 92' ' ' ARG . 1.7 mp0 -70.87 155.98 40.14 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.624 -0.831 . . . . 0.0 110.264 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -133.75 120.63 20.79 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -171.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.711 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -155.75 -94.23 0.1 Allowed Glycine 1 N--CA 1.392 -4.292 0 C-N-CA 119.001 -1.571 . . . . 0.0 113.677 172.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.659 ' H ' ' CB ' ' A' ' 25' ' ' SER . . . 79.41 172.81 43.62 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -171.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 4.2 p -75.42 102.74 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.074 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 172.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -144.89 155.23 55.78 Favored Pre-proline 0 C--N 1.263 -3.177 0 CA-C-N 113.48 -1.691 . . . . 0.0 107.983 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 24.5 Cg_exo -66.39 139.33 53.93 Favored 'Trans proline' 0 C--O 1.247 0.964 0 C-N-CA 122.169 1.912 . . . . 0.0 112.803 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.1 m -127.49 163.36 30.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 C-N-CA 124.123 0.969 . . . . 0.0 109.817 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -106.37 134.31 48.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.329 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -89.38 108.99 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.455 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -105.34 -8.07 9.95 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.701 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.64 -178.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.455 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -62.89 169.1 3.44 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -170.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -65.18 175.44 1.64 Allowed 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.923 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.64 -49.66 37.9 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 113.975 -1.466 . . . . 0.0 112.328 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.402 HG22 ' CD2' ' A' ' 49' ' ' TYR . 7.1 m -86.88 -21.3 26.42 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -169.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.16 -37.02 53.76 Favored Glycine 0 C--O 1.196 -2.273 0 CA-C-N 117.9 0.318 . . . . 0.0 112.682 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.448 ' N ' HE22 ' A' ' 42' ' ' GLN . 8.4 p30 -63.62 -19.38 64.81 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -82.56 -63.82 1.3 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.039 0.536 . . . . 0.0 110.128 175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.402 ' CD2' HG22 ' A' ' 45' ' ' THR . 38.2 p90 -83.28 -35.36 25.35 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -172.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.1 m -83.03 136.52 43.87 Favored Pre-proline 0 N--CA 1.434 -1.238 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.45 -18.53 17.71 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 N-CA-C 108.34 -1.446 . . . . 0.0 108.34 170.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 11.4 p -91.4 150.67 21.16 Favored 'General case' 0 N--CA 1.415 -2.199 0 C-N-CA 125.201 1.4 . . . . 0.0 111.941 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.1 t -133.39 140.11 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 173.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.1 tt -110.23 128.7 66.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 CA-C-O 121.183 0.516 . . . . 0.0 109.929 177.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.516 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 32.7 m -132.39 173.18 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.941 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -128.41 143.68 51.03 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.02 132.77 41.58 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.3 mt -89.05 119.09 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.372 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.9 m -121.53 116.47 24.73 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-O 121.317 0.58 . . . . 0.0 110.834 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.481 ' HA3' ' HD2' ' A' ' 82' ' ' LYS . . . -97.2 171.17 26.63 Favored Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 173.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 76.88 -44.55 0.47 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.536 1.135 . . . . 0.0 112.51 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.8 mt -91.37 82.46 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.641 ' HA ' HG21 ' A' ' 85' ' ' VAL . 47.3 t-20 -100.49 94.89 6.38 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.66 0.743 . . . . 0.0 110.099 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -141.63 89.71 2.23 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.595 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.09 -145.03 0.39 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 76.72 12.35 2.45 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 122.471 1.129 . . . . 0.0 109.887 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.0 tt -128.31 132.09 24.15 Favored Pre-proline 0 C--N 1.293 -1.868 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.28 -4.22 1.59 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.64 2.894 . . . . 0.0 116.546 -173.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.9 p -101.97 -18.84 15.48 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 121.913 -0.492 . . . . 0.0 111.039 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -112.24 128.92 56.39 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.5 t -117.09 133.0 65.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.727 -176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -105.1 128.57 53.41 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.288 0.566 . . . . 0.0 110.559 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.491 HG21 ' CZ ' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -124.81 154.88 32.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 123.585 0.754 . . . . 0.0 112.046 -176.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -69.78 141.0 53.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 121.764 0.792 . . . . 0.0 112.246 -177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -60.85 -34.58 74.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.358 -1.746 . . . . 0.0 109.2 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -55.27 -53.07 60.78 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.479 -1.691 . . . . 0.0 114.395 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -88.52 -35.83 16.75 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.094 -173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.491 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 6.6 m-85 -78.35 -5.15 51.36 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.727 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt 50.44 36.62 13.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.698 1.999 . . . . 0.0 115.183 175.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 78' ' ' TYR . 8.8 mp -87.21 -176.78 5.8 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 122.106 0.955 . . . . 0.0 110.892 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.34 -7.34 48.15 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.82 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HD2' ' HA3' ' A' ' 60' ' ' GLY . 10.2 ptpp? -153.52 164.23 38.59 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -176.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -56.66 147.5 22.43 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.228 0.537 . . . . 0.0 111.001 173.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.3 m -108.09 132.51 53.5 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.744 -172.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 63' ' ' ASN . 8.3 t -118.44 124.45 73.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 174.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.519 HG22 HD22 ' A' ' 88' ' ' LEU . 1.7 mp -110.71 127.57 67.68 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.013 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.7 mt -99.91 103.64 15.23 Favored 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.241 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.519 HD22 HG22 ' A' ' 86' ' ' ILE . 3.3 mm? -86.11 70.89 10.62 Favored 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -176.83 -48.54 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -174.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.47 84.79 4.77 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 55' ' ' VAL . 2.0 pp -121.11 179.12 2.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.07 -175.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.567 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 12.1 tpt85 -152.31 146.79 25.66 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -174.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.7 m -115.5 120.11 38.43 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.567 ' HG ' ' HG3' ' A' ' 92' ' ' ARG . 29.4 mt -130.99 143.99 51.14 Favored 'General case' 0 C--O 1.198 -1.606 0 C-N-CA 125.235 1.414 . . . . 0.0 110.343 -171.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -77.03 152.4 35.14 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 117.075 -1.85 . . . . 0.0 110.957 170.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -42.31 -27.12 0.13 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 126.551 1.94 . . . . 0.0 115.767 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 9.5 ptpp? -71.25 -21.93 62.04 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 118.736 0.698 . . . . 0.0 111.465 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 36.2 mmt180 -68.35 -33.77 74.88 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.773 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.63 115.75 10.14 Favored 'General case' 0 CA--C 1.498 -1.055 0 C-N-CA 124.436 1.094 . . . . 0.0 110.939 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -96.89 -63.83 1.1 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.183 -1.372 . . . . 0.0 114.213 -174.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.6 pt-20 -156.05 143.77 19.52 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-O 121.939 0.876 . . . . 0.0 111.665 -172.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttmm -66.82 123.61 20.62 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 112.468 -2.151 . . . . 0.0 111.558 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.673 ' HB2' HG12 ' A' ' 19' ' ' VAL . 3.8 mm? -93.43 -62.82 1.29 Allowed 'General case' 0 CA--C 1.472 -2.042 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 78' ' ' TYR . 7.2 t -150.87 -155.66 0.64 Allowed 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.038 -1.892 . . . . 0.0 111.678 -173.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -161.37 148.3 14.69 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.974 1.71 . . . . 0.0 109.538 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.34 153.0 39.56 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.766 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.3 p -83.71 161.2 21.11 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.12 -40.38 95.72 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.036 0.922 . . . . 0.0 110.981 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.54 -16.3 62.37 Favored 'General case' 0 C--O 1.194 -1.829 0 C-N-CA 125.107 1.363 . . . . 0.0 111.282 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.412 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 67.1 mttm -91.33 -36.65 13.73 Favored 'General case' 0 C--N 1.285 -2.209 0 O-C-N 120.468 -1.395 . . . . 0.0 109.898 168.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.444 ' HG2' ' OD2' ' A' ' 115' ' ' ASP 0.327 38.5 ttm -64.4 -26.04 68.29 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -177.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.719 ' HE3' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -57.87 -14.5 6.21 Favored 'General case' 0 C--N 1.248 -3.818 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 173.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.719 ' N ' ' HE3' ' A' ' 112' ' ' LYS . 42.8 mt-10 -87.65 -54.44 4.26 Favored 'General case' 1 C--O 1.148 -4.254 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 171.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 111' ' ' MET . 2.1 t -47.05 -52.34 4.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-N 113.862 -1.517 . . . . 0.0 114.176 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 22.4 m-20 -66.05 -45.4 81.5 Favored 'General case' 0 N--CA 1.508 2.428 0 CA-C-O 123.536 1.636 . . . . 0.0 110.838 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 112' ' ' LYS 0.256 9.3 t30 -73.83 -39.84 63.76 Favored 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 112.937 -1.938 . . . . 0.0 113.037 -171.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.6 -39.05 79.32 Favored 'General case' 0 CA--C 1.483 -1.604 0 C-N-CA 125.447 1.499 . . . . 0.0 108.077 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.55 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 8.8 tp -70.06 -38.12 75.71 Favored 'General case' 1 N--CA 1.373 -4.286 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.964 -175.184 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 47.7 mtp -68.51 -19.59 64.53 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.891 -0.505 . . . . 0.0 111.31 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 117' ' ' ALA . 49.5 mt -82.22 -59.15 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.598 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.1 m -48.15 -47.69 34.67 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 125.067 1.479 . . . . 0.0 111.975 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.8 mp -88.19 -0.39 57.04 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.84 19.11 73.1 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 173.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.421 ' HG ' ' OD1' ' B' ' 115' ' ' ASP . 7.0 mp -70.52 -50.29 39.26 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 118.571 1.186 . . . . 0.0 108.508 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 37.64 -136.45 0.06 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.162 -1.835 . . . . 0.0 109.613 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.29 16.26 10.6 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.988 0.899 . . . . 0.0 108.702 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.6 t -128.93 -32.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.577 -171.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 61.82 -78.99 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 125.755 1.622 . . . . 0.0 112.559 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -102.37 117.84 35.6 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.885 0.374 . . . . 0.0 110.018 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -88.46 104.46 16.82 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 69.64 99.26 0.06 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.129 0.966 . . . . 0.0 111.774 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.52 HD22 ' C ' ' A' ' 132' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.391 -3.395 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.319 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t -145.8 113.36 6.33 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 33.9 t -130.13 111.35 12.37 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -74.69 121.9 22.4 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.739 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -104.03 117.8 35.15 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . 0.466 ' CD2' ' H ' ' B' ' 8' ' ' HIS . 79.1 t60 -69.83 128.26 35.78 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 19.1 m80 -73.61 -11.98 60.6 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.855 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.466 ' H ' ' CD2' ' B' ' 6' ' ' HIS . 27.6 t-80 62.86 45.46 5.59 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 123.168 1.461 . . . . 0.0 108.496 -175.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . 0.425 ' H ' ' CD2' ' B' ' 9' ' ' HIS . 4.5 p80 -100.27 14.18 31.83 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 113.691 -1.595 . . . . 0.0 109.729 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 3.0 p -87.75 94.46 9.75 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.841 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -94.11 87.47 5.31 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -85.48 138.21 36.19 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.557 -176.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.47 171.17 13.43 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.072 1.848 . . . . 0.0 112.232 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 69.2 mt -67.05 133.0 32.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -115.9 137.98 51.6 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 13.9 ptm180 -63.12 128.89 37.93 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.144 -1.023 . . . . 0.0 109.008 171.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.17 -11.94 26.58 Favored Glycine 0 N--CA 1.426 -2.017 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.458 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -76.42 166.99 22.65 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 122.544 1.164 . . . . 0.0 110.836 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.685 HG12 ' HB2' ' B' ' 103' ' ' LEU . 40.9 t -130.92 124.25 55.84 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.066 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.757 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -131.0 148.3 52.74 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 125.79 1.636 . . . . 0.0 110.015 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 1.3 mp -77.13 147.59 36.48 Favored 'General case' 0 N--CA 1.395 -3.207 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 167.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -140.82 145.42 36.26 Favored 'General case' 0 C--N 1.248 -3.82 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.161 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.606 ' O ' ' HD2' ' B' ' 98' ' ' ARG . 35.7 t70 -85.28 78.14 9.85 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 172.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.648 HD22 ' HA3' ' B' ' 33' ' ' GLY . 3.4 tt -79.34 -35.22 41.36 Favored 'General case' 0 N--CA 1.383 -3.805 0 CA-C-N 111.796 -2.456 . . . . 0.0 110.155 -167.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.655 ' CB ' ' H ' ' B' ' 34' ' ' GLY . 73.3 m -118.25 113.64 37.06 Favored Pre-proline 0 N--CA 1.405 -2.692 1 N-CA-C 122.231 4.16 . . . . 0.0 122.231 -168.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -103.95 24.14 0.11 Allowed 'Trans proline' 0 N--CA 1.418 -2.964 0 C-N-CA 123.056 2.504 . . . . 0.0 106.38 152.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' B' ' 25' ' ' SER . 19.3 m -85.82 165.02 2.32 Favored 'Isoleucine or valine' 0 C--N 1.373 1.624 0 CA-C-O 121.899 0.857 . . . . 0.0 112.337 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.93 159.13 34.56 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 113.187 -1.824 . . . . 0.0 106.77 174.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.96 -135.8 12.63 Favored Glycine 0 N--CA 1.421 -2.351 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 5.4 m -93.68 -0.6 55.98 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.797 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.478 ' HG2' HH12 ' A' ' 92' ' ' ARG . 1.4 mp0 -73.07 159.98 32.74 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.793 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -136.95 119.08 15.46 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.648 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -155.88 -95.16 0.11 Allowed Glycine 0 N--CA 1.4 -3.707 0 C-N-CA 118.928 -1.606 . . . . 0.0 114.095 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.655 ' H ' ' CB ' ' B' ' 25' ' ' SER . . . 80.27 -177.94 54.1 Favored Glycine 0 C--N 1.285 -2.284 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -171.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 3.5 p -83.27 99.91 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 CA-C-O 123.586 1.66 . . . . 0.0 107.175 172.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -140.66 154.03 68.63 Favored Pre-proline 0 C--N 1.257 -3.428 0 CA-C-N 113.023 -1.899 . . . . 0.0 108.149 -168.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 25.9 Cg_exo -66.11 138.56 52.43 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 122.239 1.959 . . . . 0.0 112.504 174.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.2 163.06 28.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 123.931 0.893 . . . . 0.0 109.902 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.85 134.1 48.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.364 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.408 HD13 HG12 ' B' ' 55' ' ' VAL . 27.2 mm -89.29 109.98 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.451 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -105.59 -8.22 10.05 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.734 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.534 -178.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.486 ' OE1' HG13 ' B' ' 53' ' ' VAL . 5.4 pt20 -64.22 169.61 4.4 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -169.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -65.08 173.37 2.45 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.276 -1.329 . . . . 0.0 111.458 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -72.95 -46.35 52.9 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.623 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.41 HG22 ' CD2' ' B' ' 49' ' ' TYR . 8.5 m -87.79 -21.59 25.02 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -169.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.58 -35.82 57.69 Favored Glycine 0 C--O 1.195 -2.288 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -64.77 -19.05 65.6 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -81.91 -62.11 1.73 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 122.928 0.491 . . . . 0.0 109.701 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.41 ' CD2' HG22 ' B' ' 45' ' ' THR . 34.9 p90 -83.94 -34.57 24.42 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 46.5 m -85.98 141.09 35.21 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -77.07 -19.84 13.41 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 121.222 1.281 . . . . 0.0 108.78 170.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 5.3 p -90.4 150.56 21.81 Favored 'General case' 0 N--CA 1.413 -2.298 0 C-N-CA 124.818 1.247 . . . . 0.0 112.111 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.486 HG13 ' OE1' ' B' ' 42' ' ' GLN . 94.4 t -132.28 140.06 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 tt -111.08 126.48 68.48 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.5 0 CA-C-O 121.294 0.569 . . . . 0.0 110.012 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.531 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 27.1 m -131.21 173.23 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.034 -174.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.455 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -128.21 143.91 51.08 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.67 134.95 40.44 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 115.567 1.692 . . . . 0.0 115.567 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 62.7 mt -90.75 122.39 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 CA-C-N 113.056 -1.883 . . . . 0.0 106.727 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 98.3 m -123.51 117.04 24.2 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.461 0.648 . . . . 0.0 110.666 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.434 ' HA3' ' HD2' ' B' ' 82' ' ' LYS . . . -98.53 168.97 23.14 Favored Glycine 0 N--CA 1.412 -2.915 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 173.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 78.27 -35.57 0.19 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.006 1.322 . . . . 0.0 112.525 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 64.0 mt -98.99 81.25 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . 0.629 ' HA ' HG21 ' B' ' 85' ' ' VAL . 24.4 t-20 -95.34 96.63 9.27 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -146.2 85.38 1.67 Allowed 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.99 -144.78 0.37 Allowed 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.716 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 75.38 16.35 2.67 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 122.536 1.16 . . . . 0.0 109.554 -175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tt -134.29 132.11 20.91 Favored Pre-proline 0 N--CA 1.421 -1.879 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.72 -18.35 12.04 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.759 2.972 . . . . 0.0 116.47 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 77.4 p -91.53 -19.13 23.1 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.079 0.399 . . . . 0.0 111.664 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -109.97 128.81 55.61 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.37 132.01 68.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.813 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.89 130.83 54.5 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.313 0.577 . . . . 0.0 110.275 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.496 HG21 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -125.24 154.64 33.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.634 -176.172 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.47 136.47 53.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.557 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -57.4 -34.22 68.65 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.385 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -55.78 -53.25 58.98 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 113.589 -1.641 . . . . 0.0 113.942 -177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -89.68 -31.86 17.3 Favored 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 119.295 -0.962 . . . . 0.0 111.052 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.496 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 6.2 m-85 -81.02 -5.68 57.89 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.735 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt 50.14 38.0 15.95 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.697 1.999 . . . . 0.0 115.151 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.43 HD12 ' O ' ' B' ' 78' ' ' TYR . 9.2 mp -88.93 -178.09 5.64 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 122.567 1.175 . . . . 0.0 111.032 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.84 -4.78 56.33 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.503 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.434 ' HD2' ' HA3' ' B' ' 60' ' ' GLY . 10.1 ptpp? -156.41 165.02 37.56 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -177.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -54.27 152.04 6.72 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.192 0.52 . . . . 0.0 110.953 172.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 15.9 m -111.51 131.42 55.24 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.167 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.629 HG21 ' HA ' ' B' ' 63' ' ' ASN . 8.0 t -117.79 124.33 72.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.508 HG22 HD22 ' B' ' 88' ' ' LEU . 1.6 mp -110.74 126.59 68.09 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 56.0 mt -98.47 102.22 13.89 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.215 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.508 HD22 HG22 ' B' ' 86' ' ' ILE . 3.6 mm? -83.95 72.06 10.46 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.753 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -178.39 -48.57 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 -174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.44 85.54 5.38 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 2.0 pp -122.19 179.05 2.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.153 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.575 ' HG3' ' HG ' ' B' ' 94' ' ' LEU . 12.2 tpt85 -152.41 146.76 25.57 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -174.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 86.0 m -115.92 119.49 36.1 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.575 ' HG ' ' HG3' ' B' ' 92' ' ' ARG . 22.7 mt -130.95 143.55 50.81 Favored 'General case' 0 C--O 1.196 -1.751 0 C-N-CA 125.352 1.461 . . . . 0.0 110.397 -171.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 0.3 OUTLIER -76.79 152.38 35.58 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 117.124 -1.83 . . . . 0.0 110.661 170.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -41.91 -27.51 0.12 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.416 1.886 . . . . 0.0 115.549 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -69.38 -21.84 63.76 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.697 0.681 . . . . 0.0 111.589 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 37.7 mmt180 -69.85 -35.68 74.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.105 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -70.19 114.47 8.37 Favored 'General case' 0 CA--C 1.492 -1.256 0 C-N-CA 124.113 0.965 . . . . 0.0 110.735 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -94.96 -65.75 0.96 Allowed 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.087 -1.415 . . . . 0.0 114.164 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -154.92 139.47 16.92 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 121.742 0.782 . . . . 0.0 111.837 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 22.4 ttmm -64.56 121.28 14.07 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 127.595 2.358 . . . . 0.0 111.628 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.685 ' HB2' HG12 ' B' ' 19' ' ' VAL . 3.8 mm? -91.91 -63.04 1.3 Allowed 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.401 ' H ' ' HB ' ' B' ' 19' ' ' VAL . 7.2 t -149.13 -156.27 0.71 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.827 -174.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -161.54 145.94 13.1 Favored 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 125.949 1.7 . . . . 0.0 109.886 -170.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.17 148.93 44.33 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.294 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.5 p -81.76 158.32 24.19 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.179 -0.918 . . . . 0.0 113.075 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -57.26 -42.36 81.4 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.621 1.168 . . . . 0.0 112.034 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -66.09 -16.51 64.0 Favored 'General case' 0 C--O 1.178 -2.681 0 C-N-CA 124.71 1.204 . . . . 0.0 111.366 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.419 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 66.3 mttm -90.63 -33.68 15.75 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.525 -1.359 . . . . 0.0 109.563 169.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.445 ' HG2' ' OD2' ' B' ' 115' ' ' ASP 0.307 34.7 ttm -65.06 -25.16 67.69 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.742 ' HE3' ' N ' ' B' ' 113' ' ' GLU . 0.0 OUTLIER -58.87 -13.8 7.26 Favored 'General case' 0 C--N 1.248 -3.826 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 174.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . 0.742 ' N ' ' HE3' ' B' ' 112' ' ' LYS . 43.8 mt-10 -87.22 -54.47 4.29 Favored 'General case' 0 CA--C 1.429 -3.703 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 172.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' B' ' 111' ' ' MET . 2.1 t -47.17 -52.67 4.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-N 113.01 -1.904 . . . . 0.0 113.93 -177.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 16.7 m-20 -64.21 -48.48 75.73 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 123.331 1.539 . . . . 0.0 111.145 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.435 ' O ' HG13 ' B' ' 120' ' ' ILE 0.316 9.0 t30 -72.03 -39.09 69.37 Favored 'General case' 0 C--N 1.268 -2.953 0 C-N-CA 126.77 2.028 . . . . 0.0 112.795 -170.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.477 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -62.23 -37.97 87.45 Favored 'General case' 0 CA--C 1.48 -1.725 0 C-N-CA 124.284 1.033 . . . . 0.0 108.565 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.507 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.9 tp -69.18 -36.48 77.38 Favored 'General case' 1 N--CA 1.366 -4.627 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.682 -176.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 46.5 mtp -69.28 -19.71 63.91 Favored 'General case' 0 N--CA 1.426 -1.638 0 O-C-N 121.997 -0.439 . . . . 0.0 110.932 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' B' ' 117' ' ' ALA . 52.1 mt -81.88 -58.39 3.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 13.2 m -52.18 -44.55 64.73 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.263 0.977 . . . . 0.0 111.433 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 7.2 mp -86.72 -1.82 58.04 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.8 17.5 71.36 Favored Glycine 0 C--O 1.225 -0.45 0 N-CA-C 116.696 1.439 . . . . 0.0 116.696 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.548 HD21 HD23 ' A' ' 118' ' ' LEU . 6.8 mp -68.58 -49.23 61.01 Favored 'General case' 0 CA--C 1.474 -1.975 0 CA-C-N 118.735 1.267 . . . . 0.0 108.042 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 38.25 -134.79 0.1 Allowed 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.008 -1.906 . . . . 0.0 110.196 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -124.95 19.28 8.45 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 122.04 0.924 . . . . 0.0 108.689 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 45.5 t -134.28 -36.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.949 -173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 66.33 -78.16 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 125.989 1.716 . . . . 0.0 111.896 -174.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -98.99 117.32 33.24 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 122.212 -0.305 . . . . 0.0 110.684 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -85.19 104.55 15.17 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 66.81 93.81 0.07 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.205 0.941 . . . . 0.0 112.652 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.398 -3.033 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 179.313 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.296 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m -65.86 -38.53 89.06 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 p -104.34 159.62 15.57 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.839 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -98.96 155.64 17.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.861 0.362 . . . . 0.0 110.172 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 11.5 p80 -110.55 80.7 1.33 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.886 0.851 . . . . 0.0 112.685 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -94.86 -54.29 3.52 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -107.98 3.94 24.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.418 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 5' ' ' HIS . 39.8 m80 -94.62 111.89 23.65 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -118.81 77.65 1.2 Allowed 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.163 0.506 . . . . 0.0 110.557 -177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.1 m -86.31 -37.99 17.95 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -104.33 96.77 6.85 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -87.84 161.77 43.41 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.7 152.52 34.27 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.607 2.205 . . . . 0.0 111.341 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.443 HG22 HG21 ' A' ' 40' ' ' ILE . 67.6 mt -84.31 131.47 33.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -102.3 129.4 48.73 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.586 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 1.1 ptm180 -61.99 118.08 6.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 169.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 128.07 -10.67 6.59 Favored Glycine 0 C--N 1.295 -1.719 0 C-N-CA 120.063 -1.065 . . . . 0.0 111.125 -172.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.72 175.33 6.85 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 122.574 1.178 . . . . 0.0 110.988 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.479 HG11 HG22 ' A' ' 104' ' ' THR . 10.8 t -133.39 134.72 56.92 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 CA-C-N 112.806 -1.997 . . . . 0.0 109.936 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 27.6 m-85 -133.22 147.82 52.0 Favored 'General case' 0 C--N 1.292 -1.922 0 C-N-CA 124.988 1.315 . . . . 0.0 108.11 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mp -81.01 150.69 28.77 Favored 'General case' 0 N--CA 1.408 -2.546 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.053 170.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.26 138.34 49.26 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.2 -176.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.41 ' HB3' ' NH1' ' A' ' 98' ' ' ARG . 20.7 t70 -79.94 90.38 5.34 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.966 0.888 . . . . 0.0 109.777 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.604 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 14.9 mt -100.1 19.37 16.49 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 124.055 1.883 . . . . 0.0 109.591 -176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.52 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.266 15.0 m -61.94 167.55 4.66 Favored Pre-proline 1 C--N 1.229 -4.656 0 CA-C-N 111.41 -2.632 . . . . 0.0 108.295 169.84 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.2 OUTLIER 9.6 50.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.397 3.092 1 C-N-CA 127.367 5.378 . . . . 0.0 118.011 -175.03 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.9 m -68.74 -178.84 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 113.764 -1.562 . . . . 0.0 111.887 170.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 13.6 mm100 -107.44 132.14 53.52 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.429 -1.259 . . . . 0.0 113.565 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.74 -135.66 35.64 Favored Glycine 0 N--CA 1.425 -2.09 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.853 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 m -91.77 20.35 5.67 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.87 -0.665 . . . . 0.0 111.088 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 28' ' ' GLN . 0.1 OUTLIER -65.57 152.41 44.15 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 175.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.407 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -78.15 110.31 13.02 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.769 -0.582 . . . . 0.0 110.786 -167.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -86.52 129.18 9.27 Favored Glycine 0 CA--C 1.49 -1.529 0 N-CA-C 116.244 1.257 . . . . 0.0 116.244 -178.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 131.41 137.06 3.99 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 113.427 -1.387 . . . . 0.0 110.076 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.91 119.37 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 CA-C-O 122.248 1.023 . . . . 0.0 109.775 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -142.53 158.02 61.2 Favored Pre-proline 0 C--N 1.271 -2.838 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.697 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 4.6 Cg_exo -72.15 142.2 37.54 Favored 'Trans proline' 0 N--CA 1.438 -1.752 0 C-N-CA 121.971 1.781 . . . . 0.0 111.386 174.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 20' ' ' TYR . 31.6 m -118.07 156.83 19.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.553 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 36.0 m -97.91 126.79 50.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.337 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.443 HG21 HG22 ' A' ' 14' ' ' ILE . 24.5 mm -87.2 103.92 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.7 -18.94 6.14 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.419 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.524 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.812 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -56.07 157.99 4.24 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -173.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.438 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 28.5 p-10 -71.19 -167.48 0.23 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.807 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -89.55 -38.69 13.8 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 112.726 -2.033 . . . . 0.0 112.841 -175.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.1 m -83.78 -28.22 28.3 Favored 'General case' 0 C--O 1.249 1.074 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.718 -170.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.88 -38.77 97.1 Favored Glycine 0 C--O 1.206 -1.647 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.602 ' N ' HE22 ' A' ' 42' ' ' GLN . 9.7 p30 -83.67 -20.72 33.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.237 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HB3' ' CD1' ' A' ' 49' ' ' TYR . 4.2 mptp? -76.02 -65.24 0.94 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.811 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.537 ' CD1' ' HB3' ' A' ' 48' ' ' LYS . 85.9 m-85 -99.02 -28.2 13.51 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -171.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.5 m -93.07 154.68 41.66 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . 59.4 Cg_endo -79.52 -18.92 10.48 Favored 'Trans proline' 0 C--O 1.21 -0.913 0 C-N-CA 121.69 1.593 . . . . 0.0 111.603 175.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 4.2 p -91.93 146.27 23.88 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.253 1.021 . . . . 0.0 113.081 -173.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.657 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -142.0 139.0 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 123.384 0.428 . . . . 0.0 110.491 172.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.812 HG22 ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -88.43 130.25 38.26 Favored 'Isoleucine or valine' 0 C--O 1.249 1.071 0 CA-C-O 121.799 0.809 . . . . 0.0 110.334 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.37 167.55 24.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.397 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.513 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -123.5 146.43 48.08 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.446 ' HB2' HH21 ' A' ' 92' ' ' ARG . . . -79.91 136.31 36.62 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.63 HD12 ' HB2' ' A' ' 37' ' ' PRO . 19.2 mt -87.3 130.66 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.708 172.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 56.9 m -122.29 157.44 31.73 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.24 -174.51 10.87 Favored Glycine 0 C--O 1.241 0.563 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.078 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -74.62 88.5 2.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.931 0.872 . . . . 0.0 110.259 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.3 pt -91.46 173.15 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.104 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.512 ' OD1' ' HG3' ' A' ' 64' ' ' LYS . 9.1 p30 -104.78 165.11 11.29 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HG3' ' OD1' ' A' ' 63' ' ' ASN . 63.0 mttp 73.74 94.34 0.07 Allowed 'General case' 0 C--O 1.248 0.987 0 C-N-CA 124.377 1.071 . . . . 0.0 112.948 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.45 102.59 5.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -71.31 -23.89 62.02 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 67' ' ' ILE 0.619 23.5 mm 109.84 -58.84 0.0 OUTLIER Pre-proline 0 CA--C 1.508 -0.651 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 172.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.36 1.94 1.09 Allowed 'Trans proline' 0 C--O 1.219 -0.433 0 CA-C-N 121.828 1.688 . . . . 0.0 114.289 -173.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.1 p -132.38 -10.86 3.23 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.9 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -133.82 129.11 36.06 Favored 'General case' 0 C--O 1.207 -1.165 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -174.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 p -130.51 131.71 64.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 118.812 -1.155 . . . . 0.0 112.223 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -79.63 124.14 28.27 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.606 HD13 HD11 ' A' ' 86' ' ' ILE . 13.0 pt -99.49 135.68 33.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.441 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -65.83 114.8 5.33 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.16 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.412 ' HD2' ' O ' ' A' ' 81' ' ' ASP . 20.9 pttp -51.46 -39.42 57.42 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.637 0.732 . . . . 0.0 112.141 177.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -68.4 -19.05 64.59 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.308 -1.315 . . . . 0.0 113.212 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -92.46 -36.18 13.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.94 0.876 . . . . 0.0 109.4 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.572 ' CD2' HD12 ' A' ' 73' ' ' ILE . 19.1 m-85 -92.83 7.53 43.36 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.669 -1.605 . . . . 0.0 113.471 -173.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.0 tptm 61.23 20.38 10.95 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 121.798 0.808 . . . . 0.0 110.746 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.2 mt -98.89 175.33 5.98 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.665 0.745 . . . . 0.0 111.011 -174.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.412 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 11.2 t70 -83.56 -44.76 14.29 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.619 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.421 ' HB3' ' NZ ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -129.92 158.72 38.76 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.552 -176.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -72.26 137.72 46.95 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.546 ' O ' HG12 ' A' ' 73' ' ' ILE . 0.5 OUTLIER -120.76 160.51 23.22 Favored 'General case' 0 C--N 1.275 -2.648 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -172.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.5 t -111.22 139.89 33.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 121.55 -0.719 . . . . 0.0 109.214 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.606 HD11 HD13 ' A' ' 73' ' ' ILE . 20.8 mm -104.37 135.99 39.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 36.8 mt -104.79 106.27 16.69 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.491 HD12 HD23 ' A' ' 118' ' ' LEU . 3.5 mm? -88.44 14.04 10.56 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.881 0.848 . . . . 0.0 111.505 -174.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -112.91 -34.85 5.63 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.173 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.38 65.79 4.58 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.551 ' O ' ' HB ' ' B' ' 93' ' ' THR . 1.8 pp -102.66 173.81 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 114.66 -1.154 . . . . 0.0 108.04 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.598 ' NH1' HD22 ' A' ' 24' ' ' LEU . 10.1 ptt180 -164.29 155.45 15.61 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 52.6 m -114.73 120.65 40.79 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.0 mt -131.58 144.58 51.18 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.03 -0.987 . . . . 0.0 108.98 -170.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 2.6 p30 -70.54 152.45 43.95 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.009 174.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 51' ' ' PRO . 56.8 mtmt -55.24 -18.34 5.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -176.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -85.36 -19.21 31.78 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.912 0.386 . . . . 0.0 110.347 176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.415 ' NE ' ' HA ' ' A' ' 98' ' ' ARG . 3.0 mmp_? -70.51 -34.39 72.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.23 121.05 20.64 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.384 173.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -95.44 -57.41 2.4 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.308 -1.315 . . . . 0.0 114.083 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.0 pt-20 -148.88 135.6 19.7 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 122.069 0.938 . . . . 0.0 113.322 -174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 55.3 tttp -60.89 110.71 1.41 Allowed 'General case' 0 C--N 1.279 -2.478 0 C-N-CA 128.625 2.77 . . . . 0.0 107.564 172.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 tp -111.13 -62.6 1.52 Allowed 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.299 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.479 HG22 HG11 ' A' ' 19' ' ' VAL . 6.0 t -127.03 -161.17 1.05 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.346 -1.342 . . . . 0.0 111.111 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -154.03 154.41 33.67 Favored 'General case' 0 N--CA 1.419 -1.979 0 C-N-CA 124.237 1.015 . . . . 0.0 110.803 -171.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.79 161.95 13.32 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.977 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.1 m -98.59 164.23 12.33 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 111' ' ' MET . 25.5 t70 -67.09 -33.3 75.19 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 118.481 0.582 . . . . 0.0 110.712 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.47 -47.43 85.71 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.612 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.597 ' O ' HG22 ' A' ' 114' ' ' VAL . 11.8 tptt -62.82 -32.97 74.27 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 173.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.537 ' CE ' ' HA ' ' A' ' 111' ' ' MET . 0.0 OUTLIER -51.01 -49.21 60.91 Favored 'General case' 0 CA--C 1.456 -2.662 0 CA-C-N 118.3 0.5 . . . . 0.0 109.656 169.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 9.3 mmpt? -75.17 -11.89 60.18 Favored 'General case' 0 N--CA 1.392 -3.371 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.545 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.252 30.4 mt-10 -87.48 -56.41 3.37 Favored 'General case' 0 N--CA 1.39 -3.462 0 C-N-CA 117.136 -1.826 . . . . 0.0 111.17 166.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 110' ' ' LYS . 35.7 m -61.18 -48.18 90.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.25 -48.13 82.87 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 123.488 1.613 . . . . 0.0 109.307 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 18.7 t30 -74.01 -42.05 60.93 Favored 'General case' 0 C--N 1.265 -3.07 0 CA-C-N 111.813 -2.449 . . . . 0.0 112.684 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.488 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.44 -40.93 96.27 Favored 'General case' 0 CA--C 1.46 -2.513 0 CA-C-O 122.365 1.079 . . . . 0.0 108.567 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.491 HD23 HD12 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -79.91 -25.44 40.56 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 113.847 -1.524 . . . . 0.0 110.939 -172.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.525 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 1.6 ttp -63.8 -26.82 68.8 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-O 121.924 0.869 . . . . 0.0 108.665 174.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 60.9 mt -84.23 -56.94 4.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 118' ' ' LEU . 15.1 t -47.2 -43.94 21.91 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.817 1.647 . . . . 0.0 112.116 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.773 ' HG ' HG21 ' B' ' 54' ' ' ILE . 8.3 mp -82.0 5.19 20.05 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.411 ' CA ' ' HB3' ' B' ' 43' ' ' ASN . . . 89.64 1.33 77.63 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 117.972 1.949 . . . . 0.0 117.972 176.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.525 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.2 mm? -67.28 -48.91 66.26 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 120.098 1.949 . . . . 0.0 107.804 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 54.75 -168.03 0.08 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 112.287 -2.233 . . . . 0.0 113.083 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.26 23.4 5.13 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.511 1.148 . . . . 0.0 109.306 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.5 t -90.42 -56.11 5.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.33 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 55.68 -86.74 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 112.818 -1.992 . . . . 0.0 111.779 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -110.66 129.8 55.73 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -91.75 -23.49 19.73 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -89.63 141.76 28.31 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.847 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 . . . . . 0 C--N 1.295 -1.793 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 172.475 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.232 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -68.3 -30.4 69.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.441 0.639 . . . . 0.0 109.782 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 16.7 p -109.56 150.81 27.64 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -89.58 158.85 17.47 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' B' ' 8' ' ' HIS . 10.8 p80 -113.69 65.6 0.66 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.751 0.786 . . . . 0.0 113.116 -176.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -83.37 -52.05 6.88 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -113.09 5.14 16.98 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.728 0.775 . . . . 0.0 109.861 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' B' ' 5' ' ' HIS . 39.0 m80 -94.44 107.96 19.91 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -114.68 81.15 1.51 Allowed 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.53 0.681 . . . . 0.0 109.308 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.8 m -88.93 -43.66 11.0 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -98.81 97.92 9.08 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -88.6 161.76 41.15 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.686 179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.26 152.29 25.91 Favored 'Trans proline' 0 C--O 1.256 1.387 0 C-N-CA 122.686 2.258 . . . . 0.0 112.028 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.458 HG22 HG21 ' B' ' 40' ' ' ILE . 66.6 mt -84.9 126.63 40.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -99.73 129.06 45.82 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.597 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 0.9 OUTLIER -61.14 119.63 8.75 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 169.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.54 -6.65 8.51 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.469 -173.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.35 175.36 6.46 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 122.206 1.003 . . . . 0.0 110.587 175.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.463 HG11 HG22 ' B' ' 104' ' ' THR . 16.2 t -132.98 134.33 58.13 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 113.296 -1.774 . . . . 0.0 110.355 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 32.2 m-85 -132.7 148.0 52.33 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 124.912 1.285 . . . . 0.0 108.314 174.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.647 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.6 mp -81.47 152.11 27.51 Favored 'General case' 0 N--CA 1.411 -2.409 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.043 170.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.33 138.21 46.26 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.703 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.434 ' HB3' ' NH1' ' B' ' 98' ' ' ARG . 27.2 t70 -78.32 89.87 4.36 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.984 0.897 . . . . 0.0 110.022 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.623 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 15.8 mt -98.2 17.1 19.39 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 123.895 1.807 . . . . 0.0 109.299 -177.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.534 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.262 15.7 m -60.33 166.65 3.81 Favored Pre-proline 1 C--N 1.236 -4.338 0 CA-C-N 111.916 -2.402 . . . . 0.0 107.955 169.729 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.1 OUTLIER 10.14 50.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.458 1 C-N-CA 127.209 5.273 . . . . 0.0 118.271 -174.764 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' B' ' 31' ' ' GLU . 24.3 m -68.83 -178.69 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 113.663 -1.608 . . . . 0.0 111.68 169.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' B' ' 31' ' ' GLU . 14.5 mm100 -108.36 129.66 55.23 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.388 -1.278 . . . . 0.0 113.569 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.74 -134.75 24.17 Favored Glycine 0 N--CA 1.431 -1.671 0 CA-C-N 114.612 -1.177 . . . . 0.0 112.16 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.9 m -93.48 22.1 5.64 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 122.936 0.494 . . . . 0.0 111.104 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' B' ' 28' ' ' GLN . 0.1 OUTLIER -66.43 151.94 46.14 Favored 'General case' 0 CA--C 1.563 1.474 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 174.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -77.52 110.1 12.02 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.867 0.365 . . . . 0.0 111.425 -169.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -86.54 139.88 16.9 Favored Glycine 0 CA--C 1.481 -2.049 0 CA-C-N 114.975 -1.011 . . . . 0.0 115.206 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 116.67 137.29 5.95 Favored Glycine 0 N--CA 1.42 -2.389 0 CA-C-N 113.652 -1.274 . . . . 0.0 110.048 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.2 124.47 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-O 121.942 0.877 . . . . 0.0 109.583 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -145.2 158.43 51.63 Favored Pre-proline 0 C--N 1.276 -2.629 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.299 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 3.7 Cg_exo -72.85 142.47 35.31 Favored 'Trans proline' 0 N--CA 1.437 -1.805 0 C-N-CA 122.053 1.835 . . . . 0.0 111.593 174.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.439 HG22 ' O ' ' B' ' 20' ' ' TYR . 29.9 m -118.34 156.7 20.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.496 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.514 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 27.3 m -97.82 126.98 50.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.416 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.458 HG21 HG22 ' B' ' 14' ' ' ILE . 20.6 mm -87.85 104.51 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.77 -18.69 6.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.364 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.835 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -56.51 158.26 4.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 113.645 0.979 . . . . 0.0 113.645 -173.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.433 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 25.9 p-10 -71.51 -167.22 0.24 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 123.124 1.44 . . . . 0.0 112.835 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -90.65 -38.37 13.15 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 112.782 -2.008 . . . . 0.0 112.909 -175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 3.6 m -83.75 -27.51 28.86 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.127 -170.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -64.62 -37.51 94.49 Favored Glycine 0 C--O 1.202 -1.861 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.613 ' N ' HE22 ' B' ' 42' ' ' GLN . 9.9 p30 -83.82 -20.89 32.42 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 119.761 -0.775 . . . . 0.0 110.234 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.485 ' HB3' ' CD1' ' B' ' 49' ' ' TYR . 4.9 mptp? -76.2 -66.35 0.81 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.603 -178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' B' ' 48' ' ' LYS . 87.7 m-85 -95.18 -30.18 14.15 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.785 -171.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 23.5 m -93.45 154.35 41.29 Favored Pre-proline 0 C--N 1.292 -1.931 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.82 -16.51 8.88 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.56 1.507 . . . . 0.0 111.209 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 9.0 p -92.9 146.43 23.64 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.231 1.013 . . . . 0.0 112.868 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.636 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -142.34 138.79 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 O-C-N 123.649 0.593 . . . . 0.0 110.29 172.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.835 HG22 ' HG3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -88.75 130.15 38.65 Favored 'Isoleucine or valine' 0 C--O 1.25 1.098 0 CA-C-O 121.742 0.782 . . . . 0.0 110.287 176.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.25 168.2 22.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.424 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.539 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -124.02 146.74 48.33 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.515 ' HB2' HH21 ' B' ' 92' ' ' ARG . . . -78.35 136.37 37.68 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.62 HD12 ' HB2' ' B' ' 37' ' ' PRO . 20.8 mt -88.49 127.25 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.218 0 CA-C-N 114.14 -1.391 . . . . 0.0 107.352 172.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 60.2 m -117.77 160.33 21.53 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.28 178.76 26.32 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.984 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -68.34 101.76 1.27 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 43.9 pt -110.29 170.94 3.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.566 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . 0.509 ' OD1' ' HG3' ' B' ' 64' ' ' LYS . 10.0 p30 -105.16 165.76 10.87 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 176.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.509 ' HG3' ' OD1' ' B' ' 63' ' ' ASN . 62.4 mttp 75.24 80.85 0.1 Allowed 'General case' 0 C--O 1.243 0.756 0 C-N-CA 125.018 1.327 . . . . 0.0 112.502 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.75 109.61 14.91 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -77.41 -22.22 51.89 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' B' ' 67' ' ' ILE 0.602 24.1 mm 109.25 -58.57 0.0 OUTLIER Pre-proline 0 CA--C 1.509 -0.614 0 N-CA-C 120.24 3.422 . . . . 0.0 120.24 171.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.35 2.32 0.94 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 CA-C-N 121.691 1.64 . . . . 0.0 113.991 -173.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 28.8 p -132.39 -11.94 3.15 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.768 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -135.48 129.21 32.8 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -173.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 p -131.35 133.17 62.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.648 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.86 125.76 29.8 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.631 HD13 HD11 ' B' ' 86' ' ' ILE . 12.3 pt -99.28 133.37 42.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.692 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -64.62 117.28 7.18 Favored 'General case' 0 N--CA 1.44 -0.945 0 O-C-N 123.848 0.717 . . . . 0.0 110.39 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . 0.507 ' HD2' ' O ' ' B' ' 81' ' ' ASP . 21.2 pttp -53.65 -38.92 64.59 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.28 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -69.07 -19.28 64.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.47 -1.241 . . . . 0.0 112.546 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -91.61 -35.15 14.4 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.865 0.84 . . . . 0.0 109.106 177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.574 ' CD2' HD12 ' B' ' 73' ' ' ILE . 17.1 m-85 -93.3 7.79 42.96 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.548 -173.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 23.2 tptm 61.42 23.41 13.67 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 121.802 0.81 . . . . 0.0 109.996 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 29.3 mt -100.6 177.08 5.11 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.485 0.659 . . . . 0.0 111.058 -174.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.507 ' O ' ' HD2' ' B' ' 75' ' ' LYS . 20.3 t70 -83.21 -47.74 11.23 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.913 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.469 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -128.96 159.15 36.77 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.835 -175.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.73 145.22 52.45 Favored 'General case' 0 C--O 1.248 0.975 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.549 ' O ' HG12 ' B' ' 73' ' ' ILE . 0.3 OUTLIER -129.31 158.79 38.11 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -173.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.5 t -110.23 140.59 28.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.631 HD11 HD13 ' B' ' 73' ' ' ILE . 22.9 mm -105.01 136.14 40.03 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 176.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 35.6 mt -104.79 105.55 15.67 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.491 HD12 HD23 ' B' ' 118' ' ' LEU . 3.5 mm? -87.68 11.97 13.88 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.006 0.907 . . . . 0.0 111.324 -174.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -110.62 -34.25 6.34 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.178 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.05 66.58 3.57 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.551 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.9 pp -102.59 174.24 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.554 ' NH1' HD22 ' B' ' 24' ' ' LEU . 10.4 ptt180 -164.53 154.54 14.11 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 49.5 m -113.41 120.69 41.95 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.013 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 58.7 mt -131.43 144.47 51.21 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.825 -171.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 1.9 p30 -71.4 152.37 43.2 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.0 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -50.57 -25.49 4.18 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -81.44 -18.83 43.94 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 118.341 0.519 . . . . 0.0 110.93 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.434 ' NH1' ' HB3' ' B' ' 23' ' ' ASP . 3.3 mmp_? -69.17 -33.89 74.09 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 175.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' B' ' 21' ' ' LEU . 7.8 mp -73.54 124.15 25.33 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.361 173.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -99.02 -53.52 3.24 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 114.098 -1.41 . . . . 0.0 114.68 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 13.5 pt-20 -154.92 138.78 16.26 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 122.085 0.945 . . . . 0.0 113.163 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -61.77 112.25 2.2 Favored 'General case' 0 C--N 1.282 -2.354 0 C-N-CA 128.66 2.784 . . . . 0.0 107.358 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -112.2 -62.77 1.52 Allowed 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 119.735 -0.786 . . . . 0.0 112.244 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.463 HG22 HG11 ' B' ' 19' ' ' VAL . 6.7 t -125.59 -157.97 0.82 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.204 -1.398 . . . . 0.0 111.486 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -156.34 152.94 28.22 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 124.311 1.044 . . . . 0.0 111.005 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -105.1 151.54 23.88 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.289 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 19.8 m -90.43 166.79 13.07 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.539 ' O ' ' HB2' ' B' ' 111' ' ' MET . 33.8 t70 -67.44 -34.28 76.89 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 121.029 0.442 . . . . 0.0 111.23 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -62.11 -46.71 87.86 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.616 ' O ' HG22 ' B' ' 114' ' ' VAL . 11.9 tptt -62.86 -32.07 73.22 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.539 ' HA ' ' CE ' ' B' ' 111' ' ' MET . 0.0 OUTLIER -51.62 -47.94 63.47 Favored 'General case' 0 CA--C 1.445 -3.074 0 CA-C-O 121.245 0.545 . . . . 0.0 109.867 169.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' B' ' 112' ' ' LYS . 8.3 mmpt? -74.88 -14.06 60.62 Favored 'General case' 0 N--CA 1.384 -3.767 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . 0.252 31.6 mt-10 -87.17 -56.61 3.3 Favored 'General case' 0 N--CA 1.386 -3.633 0 C-N-CA 116.763 -1.975 . . . . 0.0 111.234 168.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . 0.616 HG22 ' O ' ' B' ' 110' ' ' LYS . 36.0 m -60.56 -47.81 91.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.95 -50.87 71.65 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 123.365 1.555 . . . . 0.0 109.665 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.316 26.9 t30 -73.2 -40.47 64.73 Favored 'General case' 0 N--CA 1.397 -3.104 0 CA-C-N 112.1 -2.318 . . . . 0.0 112.792 -172.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.444 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -62.38 -40.04 95.15 Favored 'General case' 0 CA--C 1.46 -2.484 0 CA-C-O 122.225 1.012 . . . . 0.0 108.666 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.491 HD23 HD12 ' B' ' 88' ' ' LEU . 0.6 OUTLIER -79.56 -25.28 41.65 Favored 'General case' 0 N--CA 1.407 -2.62 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.739 -173.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.529 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 1.8 ttp -63.47 -27.5 69.33 Favored 'General case' 0 N--CA 1.399 -3.014 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.496 HG23 ' ND2' ' B' ' 125' ' ' ASN . 64.1 mt -83.98 -56.99 4.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . 0.447 ' HB3' ' HA ' ' B' ' 118' ' ' LEU . 21.9 t -47.09 -43.45 20.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.216 1.406 . . . . 0.0 112.283 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.79 ' HG ' HG21 ' A' ' 54' ' ' ILE . 8.2 mp -82.2 5.36 20.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.424 ' CA ' ' HB3' ' A' ' 43' ' ' ASN . . . 89.66 1.39 77.49 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 117.862 1.905 . . . . 0.0 117.862 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.529 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.1 mm? -67.41 -49.58 63.18 Favored 'General case' 0 C--O 1.249 1.048 0 CA-C-N 120.271 2.035 . . . . 0.0 107.749 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.496 ' ND2' HG23 ' B' ' 120' ' ' ILE . 1.5 t-20 53.95 -168.25 0.07 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 112.514 -2.13 . . . . 0.0 113.01 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -91.24 19.04 6.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.98 0.895 . . . . 0.0 110.316 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.35 -57.57 4.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.537 -1.21 . . . . 0.0 109.439 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 57.43 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 113.135 -1.848 . . . . 0.0 111.689 -176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -112.78 131.54 55.64 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -88.39 -38.61 14.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -74.85 142.92 44.09 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.029 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 . . . . . 0 C--N 1.301 -1.521 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 171.498 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.497 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -81.68 171.78 14.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.957 -0.756 . . . . 0.0 108.957 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.428 ' OG ' ' HA ' ' A' ' 7' ' ' HIS . 23.1 t 66.73 26.08 9.62 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.455 0.702 . . . . 0.0 110.976 174.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -88.44 -23.92 23.16 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 122.139 -0.351 . . . . 0.0 111.458 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -83.92 -38.43 21.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.439 0.638 . . . . 0.0 109.767 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -155.36 141.65 18.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.428 ' HA ' ' OG ' ' A' ' 3' ' ' SER . 23.6 p80 -85.71 -31.21 22.58 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.721 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -107.68 92.33 4.02 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -82.41 -64.5 1.16 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.9 m -159.72 86.79 0.79 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.147 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -94.2 108.57 20.42 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -80.51 138.0 51.52 Favored Pre-proline 0 C--N 1.305 -1.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.691 -176.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.87 27.67 0.6 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.82 3.013 . . . . 0.0 112.405 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 47' ' ' ASN . 59.3 mt -85.13 118.31 31.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 48.3 mmt-85 -117.22 152.75 34.16 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -64.25 122.0 15.61 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 113.33 -11.97 23.88 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.12 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -78.01 156.55 30.07 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-O 122.108 0.956 . . . . 0.0 110.123 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.463 ' HB ' ' H ' ' A' ' 104' ' ' THR . 93.3 t -116.24 118.81 60.0 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.391 0 CA-C-N 113.677 -1.601 . . . . 0.0 110.345 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 44.2 m-85 -116.43 138.98 50.93 Favored 'General case' 0 C--O 1.181 -2.509 0 C-N-CA 126.072 1.749 . . . . 0.0 111.207 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.8 mp -82.48 147.87 28.46 Favored 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 121.392 0.615 . . . . 0.0 109.9 169.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -144.0 142.17 30.55 Favored 'General case' 0 C--N 1.274 -2.717 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.985 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.24 95.27 5.61 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 123.059 1.409 . . . . 0.0 110.256 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.823 ' O ' HG13 ' A' ' 27' ' ' VAL . 66.7 mt -88.42 -14.58 37.67 Favored 'General case' 0 C--O 1.177 -2.763 0 CA-C-N 113.214 -1.812 . . . . 0.0 112.554 -175.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 4.6 p -87.3 56.48 0.0 OUTLIER Pre-proline 0 C--N 1.256 -3.497 0 N-CA-C 120.472 3.508 . . . . 0.0 120.472 -173.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -127.63 41.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.639 0 C-N-CA 124.216 3.277 . . . . 0.0 106.709 142.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 24' ' ' LEU . 6.6 m -69.02 176.16 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.526 HE22 ' HB2' ' B' ' 26' ' ' PRO . 35.7 mm-40 -89.71 109.69 20.64 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.462 -1.699 . . . . 0.0 112.5 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.97 -108.56 0.56 Allowed Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.262 -1.335 . . . . 0.0 114.924 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.8 m -89.15 17.92 5.5 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -175.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 39.1 mt-10 -67.76 -175.06 0.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.969 172.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.414 ' NE2' ' HG3' ' A' ' 36' ' ' ARG . 13.1 tm0? -99.09 121.17 40.63 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.78 164.29 13.9 Favored Glycine 0 CA--C 1.478 -2.252 0 CA-C-O 122.012 0.784 . . . . 0.0 114.99 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.507 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . 115.68 156.71 11.07 Favored Glycine 0 N--CA 1.419 -2.48 0 CA-C-N 113.431 -1.385 . . . . 0.0 109.666 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -82.74 100.48 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.342 0 CA-C-O 123.904 1.811 . . . . 0.0 107.604 176.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.414 ' HG3' ' NE2' ' A' ' 32' ' ' GLN . 28.4 mmt180 -127.26 161.34 54.89 Favored Pre-proline 0 C--N 1.255 -3.502 0 CA-C-N 112.253 -2.249 . . . . 0.0 108.888 -170.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.7 ' HB2' HD12 ' A' ' 58' ' ' ILE . 5.2 Cg_exo -76.74 142.07 22.4 Favored 'Trans proline' 0 N--CA 1.431 -2.187 0 C-N-CA 121.772 1.648 . . . . 0.0 112.146 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 20' ' ' TYR . 27.6 m -119.84 156.81 22.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 124.419 1.087 . . . . 0.0 108.475 177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 21.2 m -105.57 133.82 48.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.3 mm -81.85 103.24 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' B' ' 122' ' ' LEU . 0.0 OUTLIER -98.37 -19.22 6.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.777 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.547 HE22 ' N ' ' A' ' 47' ' ' ASN . 3.1 tt0 -57.05 163.8 1.9 Allowed 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 125.51 1.524 . . . . 0.0 114.567 -173.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 27.4 p-10 -65.85 177.76 1.23 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.539 -1.664 . . . . 0.0 112.423 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -75.38 -41.56 56.06 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.556 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.8 m -85.28 -26.36 26.68 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.484 -171.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.3 -33.21 79.61 Favored Glycine 0 C--O 1.213 -1.214 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.547 ' N ' HE22 ' A' ' 42' ' ' GLN 0.262 6.7 p30 -69.63 -18.97 63.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -92.35 -68.02 0.82 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.106 0.479 . . . . 0.0 110.297 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -91.89 -16.24 26.96 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -165.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.5 m -90.73 133.83 31.74 Favored Pre-proline 0 N--CA 1.417 -2.105 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -65.68 -27.97 52.5 Favored 'Trans proline' 0 CA--C 1.509 -0.752 0 C-N-CA 121.752 1.635 . . . . 0.0 108.698 174.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 2.4 p -94.35 137.98 32.87 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 113.333 -1.758 . . . . 0.0 112.115 -175.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.542 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 90.4 t -122.06 140.16 46.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.701 HD13 HD11 ' B' ' 91' ' ' ILE . 1.5 tp -106.09 125.73 61.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-O 121.7 0.762 . . . . 0.0 110.943 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.7 m -133.34 171.11 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.103 -176.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.52 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -124.78 142.83 51.15 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.508 ' HB2' HH11 ' A' ' 92' ' ' ARG . . . -84.18 142.53 30.26 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 ' HB2' ' A' ' 37' ' ' PRO . 16.2 mt -85.59 138.49 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.963 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 m -119.79 134.75 55.12 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.97 51.97 1.64 Allowed Glycine 0 N--CA 1.478 1.439 0 CA-C-O 121.36 0.422 . . . . 0.0 112.567 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . 0.262 41.5 mtp85 71.91 167.96 0.31 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 127.587 2.355 . . . . 0.0 112.415 -175.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.3 tt -155.13 -48.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.584 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -167.99 -82.04 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.185 178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -170.04 170.22 7.64 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.408 ' HB2' ' HG3' ' A' ' 72' ' ' GLU . . . -80.37 76.49 7.18 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.474 1.131 . . . . 0.0 109.305 175.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -85.17 -21.19 29.29 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.788 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 tt -130.6 141.12 40.79 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.92 -3.61 0.71 Allowed 'Trans proline' 0 CA--C 1.558 1.694 0 C-N-CA 124.048 3.165 . . . . 0.0 116.435 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.4 p -90.45 -18.96 24.47 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 118.921 0.782 . . . . 0.0 109.641 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -86.25 129.59 34.8 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.065 175.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.44 120.6 59.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.408 ' HG3' ' HB2' ' A' ' 65' ' ' ALA . 26.2 mt-10 -86.08 132.34 34.06 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.481 HD13 ' CG ' ' A' ' 78' ' ' TYR . 2.8 pp -84.6 157.33 3.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.987 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HG2' ' CG ' ' A' ' 76' ' ' LYS . 19.8 tt0 -77.59 107.88 10.37 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 83' ' ' ASP . 62.7 pttt -55.22 -42.17 73.0 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.459 ' CG ' ' HG2' ' A' ' 74' ' ' GLU . 11.1 ptmm? -59.02 -32.75 70.01 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.222 -178.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -91.39 -26.7 18.76 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.681 0.753 . . . . 0.0 109.84 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.481 ' CG ' HD13 ' A' ' 73' ' ' ILE . 2.8 m-85 -80.44 2.7 24.03 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.274 -178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 71.63 20.65 4.64 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.502 1.121 . . . . 0.0 111.068 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 mt -110.89 168.57 9.38 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.852 0.834 . . . . 0.0 111.248 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.481 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 14.7 t70 -93.2 -35.36 13.18 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 113.646 -1.615 . . . . 0.0 108.928 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -119.65 145.81 46.13 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.076 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 75' ' ' LYS . 8.4 p-10 -76.08 147.39 38.68 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.389 0.614 . . . . 0.0 110.113 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.2 t -112.57 175.9 5.24 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.06 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.7 t -127.76 141.41 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.575 ' CD1' HG12 ' A' ' 58' ' ' ILE . 25.1 mm -109.36 133.36 54.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 174.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.5 mt -102.52 107.54 18.54 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -79.52 15.63 1.25 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.789 0.835 . . . . 0.0 112.46 -174.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.27 -39.79 3.01 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.649 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -83.68 51.96 2.15 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 125.332 1.453 . . . . 0.0 108.237 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.709 HD11 HD13 ' B' ' 54' ' ' ILE . 2.0 pp -96.29 -179.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.63 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.508 HH11 ' HB2' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -168.0 163.13 13.62 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 179.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.6 m -117.77 119.93 36.39 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.414 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.2 mt -131.44 137.75 48.76 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.895 -171.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 2.8 p-10 -74.35 153.16 39.42 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.445 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -38.99 -36.76 0.31 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 126.231 1.812 . . . . 0.0 112.837 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -64.52 -22.34 66.94 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.943 0.897 . . . . 0.0 111.54 -175.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 4.7 mmp_? -79.83 -33.54 40.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.257 0.551 . . . . 0.0 109.577 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -74.53 101.89 4.33 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-O 122.601 1.191 . . . . 0.0 111.715 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -86.7 -65.09 1.05 Allowed 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 113.518 -1.674 . . . . 0.0 115.13 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 9.3 pt-20 -139.46 126.66 21.25 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -169.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 20' ' ' TYR . 18.8 ptmt -71.45 114.07 9.14 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 113.319 -1.764 . . . . 0.0 110.986 171.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.631 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 24.0 tp -103.49 -56.73 2.16 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.005 -173.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.631 ' OG1' ' HG ' ' A' ' 103' ' ' LEU 0.285 3.5 m -135.42 -174.05 3.52 Favored 'General case' 0 N--CA 1.391 -3.384 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.573 -165.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.472 ' H ' ' CG2' ' A' ' 104' ' ' THR . 0.6 OUTLIER -160.64 134.93 7.24 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.489 1.516 . . . . 0.0 110.92 -166.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.59 153.4 22.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.345 0.658 . . . . 0.0 112.539 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.432 ' HB2' ' HD3' ' A' ' 110' ' ' LYS . 2.0 m -75.87 159.7 30.68 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.888 177.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 111' ' ' MET . 38.1 t70 -58.45 -51.93 67.76 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 3.5 p-10 -73.14 -26.69 61.3 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.717 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.432 ' HD3' ' HB2' ' A' ' 107' ' ' SER . 2.0 mptp? -67.41 -27.26 66.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.585 176.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.412 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -57.38 -39.78 76.78 Favored 'General case' 0 N--CA 1.418 -2.044 0 C-N-CA 123.527 0.731 . . . . 0.0 110.473 174.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.604 ' HE2' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -74.11 -19.8 60.46 Favored 'General case' 0 CA--C 1.483 -1.622 0 C-N-CA 123.245 0.618 . . . . 0.0 111.386 -178.558 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.489 ' HA ' ' ND2' ' A' ' 116' ' ' ASN . 21.0 mt-10 -85.83 -36.87 19.76 Favored 'General case' 0 N--CA 1.399 -2.983 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.68 -46.77 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-N 113.153 -1.84 . . . . 0.0 109.829 170.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.495 ' OD2' ' HA ' ' A' ' 112' ' ' LYS . 37.4 m-20 -60.21 -57.74 11.49 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.88 0.848 . . . . 0.0 109.976 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 113' ' ' GLU . 0.4 OUTLIER -64.88 -39.43 93.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.836 -1.075 . . . . 0.0 112.624 -172.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.487 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -58.99 -40.26 84.3 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 2.8 tp -68.36 -38.02 81.03 Favored 'General case' 1 N--CA 1.365 -4.705 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.356 -175.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 46.2 mtp -66.17 -29.67 70.0 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 121.755 -0.59 . . . . 0.0 111.261 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 116' ' ' ASN . 26.5 mt -77.33 -54.35 12.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.5 t -52.67 -36.81 57.68 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.565 -1.652 . . . . 0.0 111.358 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.533 ' HB3' ' CD1' ' B' ' 41' ' ' ILE . 42.0 mt -101.49 7.32 42.48 Favored 'General case' 0 N--CA 1.428 -1.529 0 O-C-N 121.961 -0.462 . . . . 0.0 111.512 -178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.79 21.91 75.24 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 116.794 1.478 . . . . 0.0 116.794 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 128' ' ' ALA . 7.2 mp -78.46 -46.94 18.51 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 118.829 1.315 . . . . 0.0 109.292 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 44.44 -148.01 0.08 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 113.274 -1.785 . . . . 0.0 110.229 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.41 15.9 9.8 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.157 -0.964 . . . . 0.0 110.16 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.5 t -92.94 -3.62 10.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.973 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 124' ' ' LEU . . . -67.8 -62.63 1.32 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.788 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 -92.61 76.22 5.02 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-O 122.094 0.95 . . . . 0.0 111.036 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -96.13 96.29 8.74 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 173.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . 0.253 43.8 tptt -86.37 99.79 11.86 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -170.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 . . . . . 0 C--N 1.285 -2.221 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 166.875 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.425 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 21.4 m -81.73 171.66 14.3 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 122.568 0.347 . . . . 0.0 110.273 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 25.2 t 69.67 23.14 5.9 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.808 0.843 . . . . 0.0 110.37 175.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -90.02 -16.03 30.64 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.181 0.515 . . . . 0.0 111.535 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -92.41 -42.81 9.56 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -152.99 139.63 18.83 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.752 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -80.92 -35.63 32.12 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.391 0.615 . . . . 0.0 110.492 -176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -105.81 89.27 3.03 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.861 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -79.36 -67.82 0.72 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 173.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 38.8 m -155.64 91.99 1.35 Allowed 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -101.1 105.93 17.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -77.32 137.95 64.18 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.363 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -82.78 29.88 0.54 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.767 2.978 . . . . 0.0 111.907 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 66.0 mt -87.09 119.0 34.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.9 mmt-85 -119.44 154.56 33.52 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -64.27 120.36 12.01 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 116.46 -13.93 15.53 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 120.354 -0.927 . . . . 0.0 111.998 -178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . 0.413 ' O ' HG12 ' B' ' 40' ' ' ILE . 14.1 m-20 -75.67 155.05 36.14 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.33 1.062 . . . . 0.0 110.844 178.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.477 ' HB ' ' H ' ' B' ' 104' ' ' THR . 89.9 t -115.56 118.59 59.28 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.516 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.894 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.532 ' CZ ' ' HB3' ' B' ' 102' ' ' LYS . 48.2 m-85 -115.52 140.44 49.15 Favored 'General case' 0 CA--C 1.455 -2.707 0 C-N-CA 125.986 1.714 . . . . 0.0 110.671 176.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -82.34 148.68 28.15 Favored 'General case' 0 N--CA 1.392 -3.33 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.782 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -146.07 143.6 29.5 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.733 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' B' ' 25' ' ' SER . 4.8 p-10 -75.52 93.1 2.95 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-O 122.325 1.059 . . . . 0.0 110.001 173.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.746 ' O ' HG13 ' B' ' 27' ' ' VAL . 69.5 mt -89.6 21.8 3.3 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -176.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.639 ' HB2' ' HD2' ' B' ' 26' ' ' PRO 0.264 5.4 p -79.54 -165.62 0.07 OUTLIER Pre-proline 0 N--CA 1.39 -3.427 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 176.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.639 ' HD2' ' HB2' ' B' ' 25' ' ' SER . 31.7 Cg_exo 18.39 40.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.42 1 C-N-CA 125.385 4.057 . . . . 0.0 118.193 -156.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.746 HG13 ' O ' ' B' ' 24' ' ' LEU . 7.0 m -70.56 177.8 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 122.213 1.006 . . . . 0.0 112.786 174.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -90.08 109.15 20.22 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.117 -1.401 . . . . 0.0 112.724 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 47.39 -108.49 0.31 Allowed Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 113.887 -1.506 . . . . 0.0 114.69 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 19.8 m -87.28 17.65 4.25 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.0 -170.57 0.11 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 118.87 0.759 . . . . 0.0 111.292 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -103.67 118.85 37.68 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -102.88 167.04 16.91 Favored Glycine 0 CA--C 1.473 -2.583 0 CA-C-O 122.218 0.899 . . . . 0.0 115.306 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 113.36 154.2 11.42 Favored Glycine 0 N--CA 1.408 -3.191 0 CA-C-N 112.861 -1.669 . . . . 0.0 109.719 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -80.84 103.05 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-O 123.167 1.46 . . . . 0.0 107.287 177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -130.54 161.71 59.15 Favored Pre-proline 0 C--N 1.254 -3.582 0 CA-C-N 113.267 -1.788 . . . . 0.0 108.949 -170.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.674 ' HB2' HD12 ' B' ' 58' ' ' ILE . 4.7 Cg_exo -75.57 141.81 25.49 Favored 'Trans proline' 0 N--CA 1.431 -2.193 0 C-N-CA 121.812 1.675 . . . . 0.0 112.33 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -120.86 156.95 24.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 124.568 1.147 . . . . 0.0 108.512 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.429 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 21.8 m -105.46 133.6 49.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 116.572 -0.286 . . . . 0.0 110.502 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.413 HG12 ' O ' ' B' ' 18' ' ' ASP . 30.6 mm -81.69 102.02 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.3 -19.31 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.287 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.637 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.535 HE22 ' N ' ' B' ' 47' ' ' ASN . 2.6 tt0 -56.67 162.19 2.41 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 125.462 1.505 . . . . 0.0 114.475 -173.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.525 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 21.8 p-10 -63.8 -175.86 0.16 Allowed 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.472 -1.694 . . . . 0.0 112.492 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.76 -42.73 17.6 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.63 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 9.7 m -85.15 -26.17 27.0 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.545 -170.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.1 -34.49 84.08 Favored Glycine 0 C--O 1.217 -0.909 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.535 ' N ' HE22 ' B' ' 42' ' ' GLN 0.264 8.8 p30 -69.1 -18.77 64.02 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -92.65 -67.37 0.86 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 121.231 0.539 . . . . 0.0 110.782 175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -93.43 -11.79 31.33 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -166.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 69.4 m -94.65 134.47 25.16 Favored Pre-proline 0 N--CA 1.42 -1.943 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.55 -27.51 39.09 Favored 'Trans proline' 0 CA--C 1.511 -0.643 0 C-N-CA 121.872 1.715 . . . . 0.0 109.044 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.7 p -94.82 137.7 33.57 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.834 -174.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.518 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 89.4 t -121.86 140.21 46.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.709 HD13 HD11 ' A' ' 91' ' ' ILE . 1.4 tp -105.9 125.66 61.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-O 121.668 0.746 . . . . 0.0 111.257 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.406 HG12 HD13 ' B' ' 40' ' ' ILE . 34.1 m -133.32 172.44 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.994 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.524 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -127.03 142.5 51.53 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 176.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.525 ' HB2' HH11 ' B' ' 92' ' ' ARG . . . -83.3 142.95 30.71 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' B' ' 37' ' ' PRO . 17.2 mt -88.31 135.36 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 113.247 -1.797 . . . . 0.0 107.442 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 38.3 m -116.16 134.78 54.55 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.09 50.94 1.62 Allowed Glycine 0 N--CA 1.478 1.454 0 CA-C-O 121.732 0.629 . . . . 0.0 112.327 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 71.79 163.08 0.26 Allowed 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 127.17 2.188 . . . . 0.0 112.693 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 11.5 tt -150.34 -47.59 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.189 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -169.45 -79.34 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.093 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' B' ' 65' ' ' ALA . 16.4 tppt? -170.34 167.35 8.41 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.444 ' H ' ' HD3' ' B' ' 64' ' ' LYS . . . -77.54 77.84 4.06 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.216 1.008 . . . . 0.0 108.679 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -86.12 -18.06 33.34 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.314 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 tt -134.1 142.31 42.76 Favored Pre-proline 0 C--N 1.296 -1.746 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -55.15 -12.53 5.41 Favored 'Trans proline' 0 CA--C 1.551 1.335 0 C-N-CA 124.038 3.158 . . . . 0.0 116.258 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 59.2 p -83.95 -19.11 35.22 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-O 121.63 0.729 . . . . 0.0 109.829 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -85.38 129.1 34.89 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.09 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -123.91 121.67 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.818 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -87.77 133.5 33.86 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.491 HD13 ' CG ' ' B' ' 78' ' ' TYR . 2.8 pp -85.9 156.46 3.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.369 -177.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.434 ' HG2' ' CG ' ' B' ' 76' ' ' LYS . 16.0 tt0 -76.26 107.45 8.51 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' B' ' 83' ' ' ASP . 62.2 pttt -56.25 -41.83 76.39 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . 0.434 ' CG ' ' HG2' ' B' ' 74' ' ' GLU . 10.8 ptmm? -59.71 -30.78 69.04 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 114.503 -1.226 . . . . 0.0 113.367 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -91.47 -31.18 16.08 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.561 0.696 . . . . 0.0 109.404 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.491 ' CG ' HD13 ' B' ' 73' ' ' ILE . 3.0 m-85 -76.39 1.3 16.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.442 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 74.55 12.78 3.77 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.994 1.318 . . . . 0.0 111.816 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 19.2 mt -104.46 168.48 9.06 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.873 0.844 . . . . 0.0 111.896 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' B' ' 75' ' ' LYS . 18.3 t70 -91.51 -35.85 14.07 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.131 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.28 147.85 44.46 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.636 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' B' ' 75' ' ' LYS . 7.3 p-10 -76.84 147.97 36.81 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.157 0.503 . . . . 0.0 110.324 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -113.19 175.2 5.55 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.091 -174.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 t -126.82 141.79 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.587 ' CD1' HG12 ' B' ' 58' ' ' ILE . 25.0 mm -109.07 133.04 55.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 174.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 61.9 mt -102.22 107.07 18.01 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.994 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.7 mm? -79.01 14.02 1.56 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.821 0.849 . . . . 0.0 112.439 -174.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -116.61 -39.4 3.33 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.881 0.848 . . . . 0.0 108.944 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -84.04 52.0 2.2 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 125.229 1.412 . . . . 0.0 108.291 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.701 HD11 HD13 ' A' ' 54' ' ' ILE . 2.0 pp -96.46 -179.59 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.693 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.525 HH11 ' HB2' ' B' ' 57' ' ' ALA . 0.0 OUTLIER -167.92 163.12 13.8 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 17.9 m -118.1 119.59 35.21 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.48 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 51.4 mt -131.47 138.38 48.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.113 -171.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 3.7 p-10 -74.03 152.9 39.89 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.707 175.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -38.27 -32.74 0.08 Allowed 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 126.853 2.061 . . . . 0.0 113.697 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -69.31 -25.51 64.26 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.279 0.632 . . . . 0.0 110.901 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 2.1 mmp_? -76.41 -33.36 58.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.3 mp -73.32 103.65 4.07 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.108 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -87.14 -61.88 1.63 Allowed 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.3 pt-20 -144.39 130.24 19.3 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.846 0.832 . . . . 0.0 113.003 -171.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.532 ' HB3' ' CZ ' ' B' ' 20' ' ' TYR . 19.4 ptmt -73.75 110.84 8.36 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 113.145 -1.843 . . . . 0.0 111.111 173.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.641 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 23.9 tp -101.48 -56.63 2.25 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.796 -172.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.641 ' OG1' ' HG ' ' B' ' 103' ' ' LEU 0.285 4.1 m -134.48 -175.0 3.73 Favored 'General case' 0 N--CA 1.387 -3.613 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.31 -166.016 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.48 ' H ' ' CG2' ' B' ' 104' ' ' THR . 0.4 OUTLIER -160.6 134.96 7.3 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 125.476 1.51 . . . . 0.0 110.383 -166.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 11.1 mt -85.67 157.3 20.36 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.523 0.729 . . . . 0.0 112.517 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.416 ' HB2' ' HD3' ' B' ' 110' ' ' LYS . 2.3 m -78.97 165.5 23.4 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.775 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' B' ' 111' ' ' MET . 27.8 t70 -61.29 -53.01 62.23 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 3.7 p-10 -72.35 -28.52 63.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.446 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.416 ' HD3' ' HB2' ' B' ' 107' ' ' SER . 2.2 mptp? -66.51 -26.9 67.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.748 0.308 . . . . 0.0 111.221 177.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.448 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -59.03 -40.03 83.78 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 123.199 0.599 . . . . 0.0 110.397 173.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.609 ' HE2' ' N ' ' B' ' 112' ' ' LYS . 0.5 OUTLIER -75.37 -16.91 60.34 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.056 0.455 . . . . 0.0 111.59 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . 0.443 ' HA ' ' ND2' ' B' ' 116' ' ' ASN . 48.7 mt-10 -84.54 -38.32 20.15 Favored 'General case' 0 CA--C 1.443 -3.152 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.28 -48.55 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.994 0 CA-C-N 112.685 -2.052 . . . . 0.0 110.022 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.544 ' OD2' ' HA ' ' B' ' 112' ' ' LYS . 49.0 m-20 -59.56 -59.02 6.11 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.726 0.774 . . . . 0.0 110.461 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 0.5 OUTLIER -64.82 -37.55 88.0 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.792 -1.095 . . . . 0.0 112.017 -172.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.456 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -60.15 -39.45 86.38 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.482 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 3.0 tp -69.78 -38.26 76.64 Favored 'General case' 1 N--CA 1.366 -4.661 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.984 -175.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 48.4 mtp -65.52 -34.77 79.04 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 121.769 -0.582 . . . . 0.0 110.927 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' B' ' 117' ' ' ALA . 23.7 mt -71.89 -53.95 18.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 20.3 t -52.76 -35.78 56.85 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.784 1.234 . . . . 0.0 111.443 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.534 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 39.8 mt -102.34 6.54 40.41 Favored 'General case' 0 N--CA 1.428 -1.548 0 O-C-N 121.894 -0.504 . . . . 0.0 111.508 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.26 20.69 76.88 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 172.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' B' ' 128' ' ' ALA . 7.1 mp -77.48 -49.31 15.03 Favored 'General case' 0 CA--C 1.478 -1.791 0 CA-C-N 118.876 1.338 . . . . 0.0 109.056 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 44.53 -149.41 0.06 Allowed 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 113.443 -1.708 . . . . 0.0 110.148 -172.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.25 14.95 9.79 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.919 -1.113 . . . . 0.0 110.651 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 36.7 t -92.35 -4.19 10.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.125 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' B' ' 124' ' ' LEU . . . -65.34 -70.01 0.26 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.608 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -83.78 79.25 9.53 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 122.18 0.99 . . . . 0.0 110.736 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -100.4 96.65 7.56 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -90.29 100.58 13.39 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -167.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 166.609 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.128 0 N-CA-C 110.369 -1.093 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.4 m -89.28 104.31 16.87 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.194 0.521 . . . . 0.0 110.021 -177.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 t -90.0 106.9 18.78 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -87.29 118.05 26.46 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -73.65 -29.49 62.36 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.986 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.5 m-70 -100.8 87.85 3.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -81.4 -47.65 12.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -122.54 171.3 9.21 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.673 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -130.63 126.59 37.02 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 m -79.98 -5.3 55.46 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.305 0.574 . . . . 0.0 111.017 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -68.75 115.8 8.52 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.074 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -99.74 121.2 55.26 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.62 134.02 56.36 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 C-N-CA 122.331 2.021 . . . . 0.0 109.602 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.448 ' HB ' ' OD1' ' A' ' 47' ' ' ASN . 65.1 mt -62.08 120.35 8.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.196 0.522 . . . . 0.0 110.143 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -103.28 138.82 39.54 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -76.59 134.43 39.37 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.353 -1.339 . . . . 0.0 108.334 173.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.31 -5.53 55.42 Favored Glycine 0 C--N 1.302 -1.356 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.93 -177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.25 166.69 11.78 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 121.582 0.706 . . . . 0.0 110.114 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.632 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 37.4 t -120.05 133.7 65.95 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 CA-C-N 114.107 -1.406 . . . . 0.0 109.422 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.595 ' O ' HG22 ' A' ' 38' ' ' VAL . 44.4 m-85 -136.67 147.34 46.77 Favored 'General case' 0 CA--C 1.469 -2.165 0 C-N-CA 124.623 1.169 . . . . 0.0 107.957 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.7 mp -74.42 148.86 40.77 Favored 'General case' 0 N--CA 1.407 -2.591 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.087 171.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -143.63 135.3 26.3 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.097 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.19 94.46 3.53 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.77 174.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 9.2 mt -89.45 5.0 47.26 Favored 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 124.776 1.23 . . . . 0.0 110.086 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.609 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 4.6 m -52.96 -177.66 0.04 OUTLIER Pre-proline 1 C--N 1.241 -4.142 0 C-N-CA 126.817 2.047 . . . . 0.0 113.283 174.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 19.97 35.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.41 3.784 1 C-N-CA 125.716 4.277 . . . . 0.0 119.465 -157.956 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 5.8 m -70.89 173.47 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.565 168.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.41 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 33.8 mm-40 -111.71 141.4 45.36 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 50.89 -111.87 1.43 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 114.786 -1.097 . . . . 0.0 115.023 175.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.4 m -94.16 4.4 53.94 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 123.425 0.69 . . . . 0.0 112.697 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 77.2 mt-10 -64.05 144.0 57.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.524 ' HG3' ' NH2' ' A' ' 36' ' ' ARG . 5.8 tp60 -117.73 111.47 19.16 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -170.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -126.64 -109.44 1.63 Allowed Glycine 1 N--CA 1.383 -4.844 0 C-N-CA 118.361 -1.876 . . . . 0.0 116.453 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 75.97 177.08 41.9 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 -168.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.5 p -91.44 106.43 17.61 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.288 0 O-C-N 120.617 -1.519 . . . . 0.0 108.897 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.524 ' NH2' ' HG3' ' A' ' 32' ' ' GLN . 62.8 mtm180 -135.17 157.8 76.07 Favored Pre-proline 0 C--N 1.275 -2.672 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.648 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 31.9 Cg_exo -66.12 138.55 52.34 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.098 2.532 . . . . 0.0 112.132 173.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 20' ' ' TYR . 20.5 m -126.35 164.03 27.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 C-N-CA 123.5 0.72 . . . . 0.0 110.234 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 27.4 m -105.73 134.5 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.9 mm -95.01 118.06 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 123.093 0.557 . . . . 0.0 110.195 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.92 -8.62 12.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.587 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.412 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 5.9 pt20 -63.42 165.66 7.49 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -167.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.458 ' HB3' ' N ' ' B' ' 123' ' ' GLY . 18.4 p-10 -75.29 -173.14 1.95 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 111.823 -2.444 . . . . 0.0 113.423 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -79.55 -43.98 22.01 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 113.076 -1.874 . . . . 0.0 113.411 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 m -86.19 -25.73 25.49 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -168.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 50' ' ' SER . . . -71.52 -20.97 78.74 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.448 ' OD1' ' HB ' ' A' ' 14' ' ' ILE . 31.2 t-20 -72.86 -32.33 65.36 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 113.834 -1.183 . . . . 0.0 108.526 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -90.04 -66.73 0.9 Allowed 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.534 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -98.81 -35.62 10.07 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -168.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.598 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 15.2 t -75.54 128.76 83.4 Favored Pre-proline 0 N--CA 1.435 -1.199 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.801 -174.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.545 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 61.2 Cg_endo -74.72 -11.75 22.05 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.985 1.79 . . . . 0.0 110.155 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 p -107.56 121.39 44.55 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.935 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.412 ' HB ' ' OE1' ' A' ' 42' ' ' GLN . 1.3 m -121.73 167.5 15.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.856 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.727 ' HA ' ' O ' ' A' ' 92' ' ' ARG . 13.7 tt -108.29 125.07 65.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 123.575 0.75 . . . . 0.0 112.054 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.67 HG22 ' CD2' ' A' ' 94' ' ' LEU . 3.7 m -137.48 163.56 30.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.715 ' HA ' HG13 ' A' ' 91' ' ' ILE . . . -123.08 131.21 53.6 Favored 'General case' 0 N--CA 1.416 -2.16 0 O-C-N 123.365 0.416 . . . . 0.0 111.172 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.656 ' N ' HG21 ' A' ' 91' ' ' ILE . . . -66.0 130.63 43.91 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.539 HG12 HD12 ' A' ' 86' ' ' ILE . 56.4 mt -85.49 138.31 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 112.661 -2.063 . . . . 0.0 106.994 174.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.2 t -148.36 179.99 7.37 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.64 162.72 32.67 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 68.21 79.35 0.22 Allowed 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.437 1.095 . . . . 0.0 111.718 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.403 ' H ' ' H ' ' A' ' 63' ' ' ASN . 15.2 tt -142.45 -7.43 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.783 175.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.403 ' H ' ' H ' ' A' ' 62' ' ' ILE . 61.2 m-80 71.73 -66.42 0.3 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.436 1.495 . . . . 0.0 112.502 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -113.63 129.66 56.53 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.402 0.62 . . . . 0.0 111.799 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.9 26.39 10.55 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.106 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -80.6 62.58 4.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.757 0.789 . . . . 0.0 112.119 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -143.35 137.12 14.37 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.4 9.34 0.25 Allowed 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 122.254 1.969 . . . . 0.0 114.145 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.0 p -118.5 -6.49 10.71 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.083 0.468 . . . . 0.0 110.613 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.471 ' CD2' HD22 ' A' ' 87' ' ' LEU . 43.4 m170 -122.6 129.32 51.76 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.2 m -122.02 139.4 49.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.618 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -94.75 129.71 41.56 Favored 'General case' 0 C--O 1.251 1.177 0 CA-C-O 121.567 0.699 . . . . 0.0 111.081 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.724 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -120.6 158.57 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.23 178.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -79.18 128.65 33.57 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.681 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -47.48 -48.35 27.04 Favored 'General case' 0 C--O 1.21 -0.99 0 C-N-CA 125.369 1.468 . . . . 0.0 110.699 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -56.35 -45.0 80.63 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 126.489 1.916 . . . . 0.0 112.64 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -71.79 -34.99 69.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.98 -175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.724 ' CE1' HG21 ' A' ' 73' ' ' ILE . 3.6 m-85 -95.3 -9.89 31.77 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.192 -176.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 61.46 29.95 18.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.883 1.273 . . . . 0.0 112.863 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 7.6 mp -88.73 -179.56 6.03 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 122.629 1.204 . . . . 0.0 112.973 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -73.7 -26.0 60.5 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 112.655 -2.066 . . . . 0.0 109.871 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -147.83 166.87 26.28 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -59.25 141.86 53.3 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 175.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 m -103.08 137.34 41.39 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.808 -168.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.42 137.62 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.539 HD12 HG12 ' A' ' 58' ' ' ILE . 20.3 mm -116.17 138.44 46.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.528 ' O ' HD11 ' A' ' 91' ' ' ILE . 36.6 mt -104.46 140.78 37.46 Favored 'General case' 0 N--CA 1.409 -2.511 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.551 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.3 mm? -111.83 2.01 16.86 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-O 122.28 1.038 . . . . 0.0 111.27 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -99.98 -33.45 10.5 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.638 -1.165 . . . . 0.0 111.93 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.802 ' HB3' HD13 ' A' ' 91' ' ' ILE . 1.1 tm0? -80.42 -2.71 46.84 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-N 113.952 -1.476 . . . . 0.0 112.861 -171.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.802 HD13 ' HB3' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -150.91 148.22 15.15 Favored 'Isoleucine or valine' 1 CA--C 1.421 -4.01 0 CA-C-O 117.516 -1.23 . . . . 0.0 112.651 -163.538 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.896 ' HB3' ' HB3' ' B' ' 92' ' ' ARG 0.264 40.0 mtm-85 179.84 -53.04 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.767 1 N-CA-C 121.934 4.05 . . . . 0.0 121.934 -174.982 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.724 ' OG1' ' HB2' ' B' ' 92' ' ' ARG . 42.2 m -123.2 101.0 7.14 Favored 'General case' 0 N--CA 1.531 3.599 0 O-C-N 121.009 -1.057 . . . . 0.0 112.994 -170.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.67 ' CD2' HG22 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -132.1 126.11 32.96 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.174 -1.375 . . . . 0.0 109.646 -172.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 15.7 t0 -56.25 146.3 24.04 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.46 0.704 . . . . 0.0 111.375 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.598 ' HE2' ' O ' ' A' ' 50' ' ' SER . 67.8 mttm -53.95 -33.36 56.64 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.306 1.042 . . . . 0.0 111.692 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HG3' ' OD1' ' A' ' 95' ' ' ASP . 48.1 mttp -61.73 -22.16 65.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.28 0.632 . . . . 0.0 111.102 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 34.1 mtp180 -79.3 -37.85 36.72 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.2 mp -71.25 118.25 13.81 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.284 1.033 . . . . 0.0 111.242 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -99.2 -66.92 0.87 Allowed 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.3 pt-20 -156.11 144.46 19.96 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.475 0.655 . . . . 0.0 112.561 -165.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -65.38 119.89 11.81 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 128.243 2.617 . . . . 0.0 113.656 -178.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.575 HD23 HG12 ' A' ' 19' ' ' VAL 0.295 1.7 mm? -100.42 -64.1 1.07 Allowed 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 123.402 1.572 . . . . 0.0 110.405 174.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.576 ' H ' ' HB ' ' A' ' 19' ' ' VAL . 18.4 m -127.08 -178.96 4.62 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 111.608 -2.542 . . . . 0.0 111.871 -162.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.451 ' H ' ' CG2' ' A' ' 104' ' ' THR . 12.8 p90 -160.77 131.6 5.42 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.999 1.72 . . . . 0.0 110.473 -172.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -107.22 162.19 14.1 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.295 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.6 p -90.22 170.5 10.24 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.571 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 111' ' ' MET . 6.7 p-10 -63.6 -30.83 71.88 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.789 0.836 . . . . 0.0 112.901 -173.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -69.32 -36.86 77.39 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.52 0.676 . . . . 0.0 110.157 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.528 ' O ' HG22 ' A' ' 114' ' ' VAL . 72.3 mmtt -78.28 -29.73 48.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.877 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.481 ' CE ' ' HA ' ' A' ' 111' ' ' MET . 0.2 OUTLIER -52.69 -42.61 64.95 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 124.122 0.969 . . . . 0.0 109.483 169.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.598 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 7.2 mmpt? -68.04 -46.74 70.32 Favored 'General case' 1 N--CA 1.377 -4.119 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -178.007 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.27 -34.19 76.89 Favored 'General case' 0 N--CA 1.415 -2.217 0 C-N-CA 118.661 -1.216 . . . . 0.0 111.761 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 110' ' ' LYS . 20.9 m -71.24 -45.3 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 120.276 -0.57 . . . . 0.0 112.276 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -56.36 -52.87 62.99 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.365 0.602 . . . . 0.0 110.153 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . 0.326 51.2 m-20 -60.86 -52.87 63.23 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.91 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.551 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -51.32 -39.8 57.71 Favored 'General case' 0 CA--C 1.461 -2.472 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.748 -174.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.695 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 1.6 tp -68.43 -46.09 70.8 Favored 'General case' 1 N--CA 1.362 -4.84 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.455 -179.24 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 43.4 mtp -64.81 -34.59 78.72 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 117' ' ' ALA . 56.4 mt -63.45 -52.7 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.039 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 175.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.6 t -53.91 -21.48 7.95 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 112.973 -1.921 . . . . 0.0 112.735 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 34.4 mt -111.36 -5.6 14.62 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.494 ' N ' ' HB3' ' B' ' 43' ' ' ASN . . . 76.63 23.97 68.76 Favored Glycine 0 CA--C 1.5 -0.889 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.399 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.434 ' HB3' ' SD ' ' B' ' 119' ' ' MET . 58.0 mt -83.02 -59.65 2.41 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 54.7 145.69 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -93.15 6.43 48.02 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 122.121 0.963 . . . . 0.0 110.411 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.7 t -131.6 99.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.639 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.25 28.69 5.69 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -96.28 -41.48 8.64 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.017 -1.447 . . . . 0.0 111.22 -173.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -87.57 -25.83 23.42 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -164.22 150.38 11.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.1 m120 . . . . . 0 C--N 1.291 -1.957 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 171.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.161 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m -87.6 107.05 18.42 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.108 0.48 . . . . 0.0 110.266 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 10.3 t -93.92 99.27 11.64 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -79.56 122.18 26.16 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -75.33 -31.71 60.68 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 123.632 0.582 . . . . 0.0 110.961 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -96.44 89.24 4.97 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -83.33 -46.42 12.62 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.333 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -127.43 168.21 15.18 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.612 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -123.36 135.8 54.34 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.5 m -86.06 -6.32 59.05 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.131 0.491 . . . . 0.0 110.412 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -69.32 118.25 11.97 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.129 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -98.69 120.83 58.05 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -53.91 134.69 60.51 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.114 1.876 . . . . 0.0 109.635 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 63.6 mt -62.27 122.34 12.8 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 O-C-N 123.363 0.414 . . . . 0.0 110.223 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -105.0 134.46 48.06 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -74.85 123.8 25.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 118.611 -1.235 . . . . 0.0 109.165 174.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.29 -5.98 28.51 Favored Glycine 0 C--N 1.301 -1.411 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.763 -176.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.29 165.23 12.49 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 121.574 0.702 . . . . 0.0 109.679 177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 35.7 t -118.48 133.0 66.7 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.523 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.622 ' O ' HG22 ' B' ' 38' ' ' VAL . 39.6 m-85 -135.82 146.5 47.6 Favored 'General case' 0 C--O 1.188 -2.165 0 C-N-CA 124.857 1.263 . . . . 0.0 108.411 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 1.8 mp -74.32 148.94 40.91 Favored 'General case' 0 N--CA 1.407 -2.61 0 C-N-CA 119.629 -0.828 . . . . 0.0 108.989 171.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -144.42 136.21 25.93 Favored 'General case' 0 C--N 1.264 -3.133 0 O-C-N 124.416 1.073 . . . . 0.0 110.163 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -75.87 94.4 3.33 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.082 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 9.5 mt -89.36 4.74 47.96 Favored 'General case' 0 C--O 1.199 -1.6 0 C-N-CA 124.6 1.16 . . . . 0.0 110.222 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.583 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 4.1 m -53.96 -177.11 0.04 OUTLIER Pre-proline 1 C--N 1.241 -4.132 0 C-N-CA 126.733 2.013 . . . . 0.0 112.564 173.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 20.17 35.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.405 3.549 1 C-N-CA 125.942 4.428 . . . . 0.0 119.414 -157.511 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.605 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 3.7 m -71.08 172.85 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.1 167.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . 0.4 ' NE2' ' HB2' ' A' ' 26' ' ' PRO . 33.0 mm-40 -112.27 135.61 52.73 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -174.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.75 -112.15 4.12 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 114.785 -1.098 . . . . 0.0 114.362 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -93.43 -0.43 56.48 Favored 'General case' 0 N--CA 1.417 -2.102 0 C-N-CA 123.405 0.682 . . . . 0.0 112.275 -176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.605 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 77.4 mt-10 -61.14 141.1 57.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.511 ' HG3' ' NH2' ' B' ' 36' ' ' ARG . 5.3 tp60 -116.05 112.81 22.31 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -169.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.404 ' CA ' ' HB3' ' B' ' 24' ' ' LEU . . . -127.95 -106.77 1.36 Allowed Glycine 1 N--CA 1.378 -5.208 0 C-N-CA 118.149 -1.977 . . . . 0.0 116.688 -177.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 74.48 175.44 34.09 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 107.663 -2.175 . . . . 0.0 107.663 -168.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 5.3 p -89.19 108.98 19.72 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.393 0 O-C-N 120.475 -1.603 . . . . 0.0 108.73 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . 0.511 ' NH2' ' HG3' ' B' ' 32' ' ' GLN . 65.1 mtm180 -137.76 157.72 72.94 Favored Pre-proline 0 C--N 1.281 -2.397 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.429 -174.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.3 Cg_exo -66.29 138.65 51.9 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.061 2.507 . . . . 0.0 111.902 173.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.622 HG22 ' O ' ' B' ' 20' ' ' TYR . 20.6 m -126.9 162.71 31.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 123.74 0.816 . . . . 0.0 110.074 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 27.1 m -104.57 134.28 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 31.9 mm -94.23 118.64 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 122.835 0.454 . . . . 0.0 110.054 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 -8.8 12.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.577 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.416 HE22 ' N ' ' B' ' 47' ' ' ASN . 6.3 pt20 -63.51 165.71 7.6 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 117.638 2.459 . . . . 0.0 117.638 -167.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.494 ' HB3' ' N ' ' A' ' 123' ' ' GLY . 14.3 p-10 -77.46 -174.19 3.23 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 112.088 -2.324 . . . . 0.0 113.413 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' B' ' 47' ' ' ASN . 2.7 t70 -72.44 -47.4 49.24 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 112.837 -1.983 . . . . 0.0 113.909 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -86.65 -25.71 24.73 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -165.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' B' ' 50' ' ' SER . . . -70.75 -21.23 77.91 Favored Glycine 0 C--O 1.218 -0.889 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' B' ' 44' ' ' ASP . 39.1 t-20 -72.77 -32.04 65.32 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.703 -1.248 . . . . 0.0 108.259 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -91.64 -65.38 1.01 Allowed 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -100.15 -35.56 9.62 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -168.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.583 ' O ' ' HE2' ' B' ' 96' ' ' LYS . 14.6 t -76.93 132.23 71.62 Favored Pre-proline 0 N--CA 1.433 -1.323 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -175.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.551 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 62.3 Cg_endo -77.53 -11.12 17.25 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.792 1.661 . . . . 0.0 110.154 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 1.9 p -106.38 121.83 45.03 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.745 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 1.3 m -121.82 167.96 14.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' B' ' 92' ' ' ARG . 13.8 tt -109.2 125.24 66.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 123.695 0.798 . . . . 0.0 112.099 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.663 HG22 ' CD2' ' B' ' 94' ' ' LEU . 3.7 m -137.72 163.97 29.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.694 ' HA ' HG13 ' B' ' 91' ' ' ILE . . . -123.47 130.8 53.22 Favored 'General case' 0 N--CA 1.415 -2.176 0 O-C-N 123.387 0.429 . . . . 0.0 111.317 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.669 ' H ' HG21 ' B' ' 91' ' ' ILE . . . -65.04 132.69 49.88 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.559 HG12 HD12 ' B' ' 86' ' ' ILE . 57.6 mt -89.26 134.08 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 112.645 -2.07 . . . . 0.0 107.346 175.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -144.88 179.68 7.17 Favored 'General case' 0 N--CA 1.416 -2.17 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.72 166.91 33.02 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 65.59 77.94 0.29 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 122.196 0.998 . . . . 0.0 112.241 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.438 HG22 HG21 ' B' ' 85' ' ' VAL . 14.1 tt -140.88 -8.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.173 -0.922 . . . . 0.0 108.753 175.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 73.81 -64.81 0.38 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.509 1.523 . . . . 0.0 112.218 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -117.03 128.02 54.75 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.19 0.519 . . . . 0.0 111.541 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -111.53 31.31 6.23 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.112 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -84.7 61.21 6.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.858 0.837 . . . . 0.0 111.763 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp -142.11 139.75 18.45 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -69.35 9.79 0.49 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.135 1.89 . . . . 0.0 113.599 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 72.9 p -117.61 -7.85 11.0 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.079 0.466 . . . . 0.0 110.748 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.587 ' CD2' HD22 ' B' ' 87' ' ' LEU . 61.9 m170 -123.23 129.34 51.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.428 HG23 HD11 ' B' ' 73' ' ' ILE . 32.9 m -122.19 139.72 48.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.541 -177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -97.11 130.6 44.36 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 121.698 0.761 . . . . 0.0 111.439 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.728 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -123.54 154.2 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.666 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -74.77 127.04 32.21 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.197 -176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -45.95 -44.76 15.09 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.173 1.389 . . . . 0.0 111.5 175.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 48.9 mttp -59.86 -45.31 92.86 Favored 'General case' 0 C--N 1.29 -1.979 0 C-N-CA 126.392 1.877 . . . . 0.0 112.478 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -72.41 -35.19 68.31 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.93 -174.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.728 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.8 m-85 -95.78 -6.02 40.57 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.704 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt 57.06 31.68 20.36 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.439 1.096 . . . . 0.0 112.864 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' B' ' 78' ' ' TYR . 6.8 mp -87.8 -178.82 6.14 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 122.652 1.215 . . . . 0.0 112.844 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -75.51 -25.42 57.26 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 112.935 -1.939 . . . . 0.0 109.735 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -148.04 168.79 21.43 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -60.34 144.42 50.72 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.098 0.475 . . . . 0.0 109.826 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 8.0 m -103.25 136.79 42.37 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.61 -168.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.438 HG21 HG22 ' B' ' 62' ' ' ILE . 21.8 t -120.29 135.87 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 174.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.559 HD12 HG12 ' B' ' 58' ' ' ILE . 21.0 mm -114.89 138.1 46.23 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.834 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.587 HD22 ' CD2' ' B' ' 70' ' ' HIS . 31.4 mt -104.25 141.32 36.49 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' B' ' 118' ' ' LEU . 3.4 mm? -111.59 1.42 16.82 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-O 122.173 0.987 . . . . 0.0 111.296 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . 0.417 ' HA ' HH12 ' B' ' 92' ' ' ARG . 8.7 pt-20 -100.77 -33.44 10.25 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 114.57 -1.196 . . . . 0.0 112.021 -177.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . 0.796 ' HB3' HD13 ' B' ' 91' ' ' ILE . 1.0 OUTLIER -81.24 -2.03 47.21 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-N 114.077 -1.419 . . . . 0.0 112.531 -171.016 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.796 HD13 ' HB3' ' B' ' 90' ' ' GLN . 0.0 OUTLIER -150.8 147.68 15.59 Favored 'Isoleucine or valine' 1 CA--C 1.418 -4.103 0 CA-C-O 117.6 -1.19 . . . . 0.0 112.429 -163.715 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.896 ' HB3' ' HB3' ' A' ' 92' ' ' ARG 0.273 41.2 mtm-85 179.83 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.752 1 N-CA-C 121.929 4.048 . . . . 0.0 121.929 -174.913 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.722 ' OG1' ' HB2' ' A' ' 92' ' ' ARG . 29.8 m -122.84 101.04 7.21 Favored 'General case' 0 N--CA 1.531 3.593 0 O-C-N 121.029 -1.044 . . . . 0.0 112.871 -171.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.663 ' CD2' HG22 ' B' ' 55' ' ' VAL . 0.1 OUTLIER -132.17 125.72 31.89 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.57 -173.155 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 11.0 t0 -56.94 147.47 23.71 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.439 0.696 . . . . 0.0 111.674 172.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.583 ' HE2' ' O ' ' B' ' 50' ' ' SER . 67.8 mttm -54.49 -33.0 58.99 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.455 1.102 . . . . 0.0 111.833 177.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.444 ' HZ3' ' CG ' ' B' ' 95' ' ' ASP . 44.9 mttp -62.26 -23.36 66.65 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.257 0.623 . . . . 0.0 111.192 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 32.9 mtp180 -78.13 -38.51 43.64 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 mp -70.26 118.1 12.66 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 124.189 0.995 . . . . 0.0 111.121 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -97.41 -69.67 0.75 Allowed 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.593 -1.185 . . . . 0.0 113.678 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.8 pt-20 -156.52 149.08 23.59 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-O 121.584 0.707 . . . . 0.0 112.476 -166.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 2.3 ptmt -67.71 124.74 24.11 Favored 'General case' 0 C--N 1.287 -2.116 0 C-N-CA 127.449 2.3 . . . . 0.0 114.93 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.574 HD23 HG12 ' B' ' 19' ' ' VAL 0.287 2.0 mm? -102.27 -63.73 1.13 Allowed 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 123.389 1.566 . . . . 0.0 110.548 174.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.513 ' H ' ' HB ' ' B' ' 19' ' ' VAL . 22.8 m -131.13 -177.75 4.53 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 111.508 -2.587 . . . . 0.0 112.299 -161.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.42 ' H ' ' CG2' ' B' ' 104' ' ' THR . 13.7 p90 -160.93 132.57 5.7 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 125.502 1.521 . . . . 0.0 111.185 -171.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 pp -107.0 161.83 14.39 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.276 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 5.1 p -90.66 172.69 8.49 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.082 0.467 . . . . 0.0 111.857 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -64.39 -31.59 72.87 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 123.705 0.802 . . . . 0.0 112.644 -174.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -69.2 -35.68 76.48 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.558 0.695 . . . . 0.0 109.277 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.556 ' O ' HG22 ' B' ' 114' ' ' VAL . 73.3 mmtt -79.15 -30.27 43.51 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.178 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.492 ' HA ' ' HE3' ' B' ' 111' ' ' MET . 0.2 OUTLIER -52.23 -41.79 63.04 Favored 'General case' 0 N--CA 1.42 -1.96 0 O-C-N 124.142 0.902 . . . . 0.0 109.132 169.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' B' ' 112' ' ' LYS . 6.5 mmpt? -67.9 -47.57 68.41 Favored 'General case' 1 N--CA 1.375 -4.212 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -178.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -64.8 -38.23 90.28 Favored 'General case' 0 N--CA 1.41 -2.437 0 C-N-CA 118.225 -1.39 . . . . 0.0 111.469 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . 0.556 HG22 ' O ' ' B' ' 110' ' ' LYS . 25.6 m -68.93 -46.58 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.651 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -57.33 -52.91 63.45 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.12 0.486 . . . . 0.0 110.421 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.358 86.2 m-20 -59.19 -54.29 48.55 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.004 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.411 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -56.22 -37.29 69.48 Favored 'General case' 0 CA--C 1.46 -2.512 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.072 -171.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.703 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.6 tp -66.22 -45.36 80.95 Favored 'General case' 1 N--CA 1.358 -5.042 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.846 179.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.434 ' SD ' ' HB3' ' A' ' 124' ' ' LEU . 47.0 mtp -66.15 -32.61 74.16 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 177.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' B' ' 117' ' ' ALA . 53.7 mt -64.49 -54.6 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.1 t -50.52 -22.59 2.02 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 113.825 -1.534 . . . . 0.0 113.184 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 31.5 mt -111.14 -4.65 14.96 Favored 'General case' 0 C--O 1.207 -1.141 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.458 ' N ' ' HB3' ' A' ' 43' ' ' ASN . . . 75.1 23.28 74.76 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.449 179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 52.4 mt -81.37 -58.62 2.96 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 52.27 145.13 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 127.118 2.167 . . . . 0.0 116.264 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.29 10.59 29.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-O 121.805 0.812 . . . . 0.0 110.84 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 41.3 t -136.12 99.78 2.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.292 -1.322 . . . . 0.0 108.432 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -124.93 22.54 8.02 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.076 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -89.77 -40.97 12.14 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.865 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -88.45 -30.68 19.24 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -173.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -160.19 145.3 14.91 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 C--N 1.284 -2.278 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 172.356 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.97 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p -88.79 108.34 19.46 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.713 0.768 . . . . 0.0 112.584 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.1 m -94.48 107.17 19.15 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -132.65 119.69 20.75 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.688 0.756 . . . . 0.0 112.247 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -95.24 -24.93 16.57 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 60.73 -83.64 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.643 1.577 . . . . 0.0 112.03 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -173.25 -86.61 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 57.19 -170.18 0.1 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.893 1.277 . . . . 0.0 113.061 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -77.53 142.06 39.26 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -73.55 152.7 40.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.585 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.04 103.07 1.76 Allowed 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -86.17 113.48 52.29 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.92 165.14 24.66 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.544 2.163 . . . . 0.0 112.752 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.8 mt -57.73 122.54 7.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.144 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -108.69 151.01 26.75 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -71.2 124.11 23.74 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 110.65 -2.91 29.1 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.479 -1.343 . . . . 0.0 112.968 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -84.84 161.1 20.04 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.451 HG21 HG22 ' A' ' 104' ' ' THR . 78.4 t -121.92 108.01 21.14 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.655 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.85 174.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.2 m-85 -99.56 147.02 25.78 Favored 'General case' 0 C--N 1.255 -3.506 0 C-N-CA 124.809 1.244 . . . . 0.0 109.567 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.5 mp -83.08 146.67 28.56 Favored 'General case' 0 N--CA 1.382 -3.851 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 166.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -142.33 140.09 32.02 Favored 'General case' 0 C--N 1.256 -3.497 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.972 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -84.98 90.48 7.84 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.594 ' O ' HG13 ' A' ' 27' ' ' VAL . 51.3 mt -73.58 -21.67 60.27 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.966 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.589 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 4.4 m -32.91 174.46 0.0 OUTLIER Pre-proline 0 CA--C 1.57 1.738 0 C-N-CA 129.064 2.945 . . . . 0.0 115.684 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.66 ' HB2' HE22 ' B' ' 28' ' ' GLN . 0.0 OUTLIER 23.38 52.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.414 -3.199 0 C-N-CA 123.094 2.529 . . . . 0.0 114.555 -151.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -68.33 141.48 17.53 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 CA-C-N 112.385 -2.189 . . . . 0.0 110.026 171.093 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.604 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 84.8 mm-40 -89.84 120.16 30.84 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.092 -1.413 . . . . 0.0 111.965 -173.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.19 -110.7 1.64 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.061 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.428 ' HB2' ' HB3' ' B' ' 95' ' ' ASP . 33.4 m -94.1 10.16 34.84 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 98.3 mt-10 -61.64 143.17 56.52 Favored 'General case' 0 C--N 1.345 0.392 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.3 118.51 31.36 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 119.754 -0.165 . . . . 0.0 111.424 -169.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.05 -171.17 23.48 Favored Glycine 0 N--CA 1.414 -2.783 0 N-CA-C 120.093 2.797 . . . . 0.0 120.093 162.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.28 -152.58 6.9 Favored Glycine 0 C--N 1.264 -3.471 1 N-CA-C 102.349 -4.301 . . . . 0.0 102.349 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.1 113.22 15.93 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-N 121.125 2.462 . . . . 0.0 109.953 176.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -143.73 162.04 43.42 Favored Pre-proline 0 C--N 1.277 -2.569 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.195 -175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.557 ' HB2' HD12 ' A' ' 58' ' ' ILE . 19.9 Cg_exo -72.29 143.44 39.38 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.479 2.119 . . . . 0.0 111.5 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 28.6 m -128.69 160.09 39.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 C-N-CA 124.197 0.999 . . . . 0.0 109.531 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.0 m -104.92 131.84 53.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.608 0.242 . . . . 0.0 110.553 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.403 HD13 HG12 ' A' ' 55' ' ' VAL . 24.3 mm -89.85 108.44 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.8 -18.34 7.26 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.701 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.667 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -52.81 156.84 1.84 Allowed 'General case' 0 C--O 1.245 0.846 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -171.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.429 ' HA ' ' HA3' ' B' ' 123' ' ' GLY . 13.1 p-10 -56.83 155.36 7.94 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-N 113.248 -1.796 . . . . 0.0 112.075 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -72.18 -27.44 62.57 Favored 'General case' 0 C--N 1.264 -3.112 0 CA-C-N 113.593 -1.64 . . . . 0.0 112.386 -171.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.3 m -83.85 -37.18 22.79 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.29 -0.256 . . . . 0.0 111.102 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.01 -27.34 73.7 Favored Glycine 0 CA--C 1.501 -0.82 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.439 ' N ' HE22 ' A' ' 42' ' ' GLN . 94.8 m-20 -58.96 -33.66 70.89 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.127 0.489 . . . . 0.0 109.859 176.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.529 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 10.2 mmmm -93.22 -60.69 1.73 Allowed 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.956 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.529 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 71.0 m-85 -93.83 -36.14 12.39 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 -165.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.6 m -80.82 138.65 50.18 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.02 -17.9 40.72 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 121.899 1.733 . . . . 0.0 111.077 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 4.7 p -98.54 158.49 15.56 Favored 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 124.856 1.263 . . . . 0.0 111.498 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.634 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -152.51 138.87 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.196 0.598 . . . . 0.0 110.454 170.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.667 HG22 ' HG3' ' A' ' 42' ' ' GLN . 8.6 tt -83.69 135.06 25.57 Favored 'Isoleucine or valine' 0 C--O 1.249 1.065 0 CA-C-O 121.4 0.619 . . . . 0.0 110.476 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 32.8 m -139.27 156.26 27.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.481 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.534 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -115.79 139.33 50.28 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 138.45 43.78 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 115.718 1.748 . . . . 0.0 115.718 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.585 HG12 HD12 ' A' ' 86' ' ' ILE . 64.1 mt -96.13 134.65 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 113.129 -1.85 . . . . 0.0 107.533 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.1 t -137.29 143.53 42.2 Favored 'General case' 0 N--CA 1.414 -2.27 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.591 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.72 162.6 37.74 Favored Glycine 0 N--CA 1.42 -2.372 0 N-CA-C 107.106 -2.398 . . . . 0.0 107.106 170.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 67.36 -164.34 0.22 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.5 mm 68.69 82.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 122.446 1.117 . . . . 0.0 108.042 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -87.12 -10.54 52.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.558 -174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -84.62 82.31 8.47 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.438 ' HA ' ' HB2' ' A' ' 70' ' ' HIS . . . -117.45 12.86 14.32 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 121.389 0.614 . . . . 0.0 110.94 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -83.35 68.27 9.62 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 122.626 1.203 . . . . 0.0 108.321 175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 tt -165.94 140.89 3.89 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -62.05 -10.93 19.44 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 122.647 2.231 . . . . 0.0 115.53 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.3 p -98.22 -16.38 19.46 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -176.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 65' ' ' ALA . 48.1 m170 -113.1 128.7 56.56 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.3 t -124.91 125.7 70.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.372 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -91.7 118.63 30.84 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.51 0.672 . . . . 0.0 109.508 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.889 HG21 ' CE1' ' A' ' 78' ' ' TYR . 3.2 mm -96.09 158.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.607 -173.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.08 120.2 14.56 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 123.743 0.817 . . . . 0.0 110.221 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 85.6 tttt -46.67 -51.27 16.33 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 126.198 1.799 . . . . 0.0 111.575 176.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -56.93 -49.48 75.48 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 126.282 1.833 . . . . 0.0 112.111 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.445 ' HD3' ' OG ' ' A' ' 107' ' ' SER . 39.4 ttmt -69.22 -33.61 73.58 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.425 0.69 . . . . 0.0 110.535 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.889 ' CE1' HG21 ' A' ' 73' ' ' ILE . 3.2 m-85 -88.63 -11.19 46.1 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.617 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.4 tttm 67.22 24.63 9.13 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 123.433 0.693 . . . . 0.0 111.16 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.456 HD13 ' HB3' ' A' ' 78' ' ' TYR . 7.2 mp -94.86 178.62 5.51 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-O 122.616 1.198 . . . . 0.0 112.44 179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.413 ' O ' ' HE3' ' A' ' 75' ' ' LYS . 2.2 m-20 -73.54 -20.71 60.57 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 112.555 -2.111 . . . . 0.0 111.733 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 83' ' ' ASP . 11.6 ptmm? -158.48 169.97 23.25 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 9.9 p-10 -51.85 135.96 29.0 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 m -109.12 135.5 50.16 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.4 t -107.69 135.86 44.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.585 HD12 HG12 ' A' ' 58' ' ' ILE . 18.2 mm -112.19 135.39 51.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.0 mt -104.49 106.23 16.65 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.502 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -84.05 -5.61 59.26 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.687 -174.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -91.62 -39.56 11.81 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.986 174.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.05 79.32 4.07 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.325 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.534 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -114.73 -176.78 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -166.61 173.68 9.49 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 120.865 0.364 . . . . 0.0 111.57 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 67.5 m -123.34 124.32 42.69 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.2 mt -130.88 142.8 50.4 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.688 -171.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.9 p30 -74.56 152.39 39.32 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.352 174.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -47.54 -27.5 1.83 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.902 1.281 . . . . 0.0 114.31 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.3 -18.49 57.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 120.867 0.365 . . . . 0.0 111.433 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -73.21 -34.09 65.73 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.41 ' HB3' ' CD2' ' A' ' 20' ' ' TYR . 7.8 mp -76.63 126.16 30.49 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 125.248 1.419 . . . . 0.0 110.145 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -91.96 -67.33 0.86 Allowed 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 114.563 -1.198 . . . . 0.0 112.744 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 14.6 pt-20 -153.25 152.88 31.67 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.518 -166.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.452 ' HE2' ' OH ' ' A' ' 20' ' ' TYR . 70.6 mttt -73.41 123.94 24.82 Favored 'General case' 0 C--N 1.279 -2.487 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.776 174.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.574 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 18.8 tp -109.38 -60.99 1.69 Allowed 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 122.653 1.216 . . . . 0.0 108.438 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.574 ' OG1' ' HG ' ' A' ' 103' ' ' LEU . 2.3 m -127.36 178.72 5.87 Favored 'General case' 0 N--CA 1.381 -3.879 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.227 -166.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -160.45 139.69 10.72 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 125.121 1.368 . . . . 0.0 109.903 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 pp -115.05 161.59 18.15 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.252 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.445 ' OG ' ' HD3' ' A' ' 77' ' ' LYS . 34.3 p -88.12 172.66 9.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.174 0.512 . . . . 0.0 111.628 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 111' ' ' MET . 28.3 t70 -66.14 -30.35 70.81 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.112 0.565 . . . . 0.0 111.855 -176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -69.47 -30.61 68.53 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 114' ' ' VAL . 14.4 tppt? -77.65 -30.11 51.99 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.585 -178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -49.04 -47.12 45.01 Favored 'General case' 0 CA--C 1.48 -1.738 0 O-C-N 123.896 0.747 . . . . 0.0 110.75 171.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.754 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -65.64 -34.58 78.56 Favored 'General case' 0 N--CA 1.41 -2.448 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.807 -178.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.84 -41.68 59.4 Favored 'General case' 0 N--CA 1.4 -2.944 0 C-N-CA 118.176 -1.41 . . . . 0.0 112.121 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 110' ' ' LYS . 19.7 m -67.16 -45.35 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 118.921 -0.561 . . . . 0.0 112.103 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -54.28 -51.69 63.78 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-O 123.2 1.476 . . . . 0.0 109.397 177.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.754 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -76.31 -30.58 57.76 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 112.998 -1.91 . . . . 0.0 115.031 -172.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.502 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -70.68 -41.9 71.44 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.537 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 1.9 tp -62.33 -44.19 97.08 Favored 'General case' 0 N--CA 1.394 -3.237 0 C-N-CA 125.479 1.511 . . . . 0.0 108.741 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.646 ' CG ' ' HA ' ' A' ' 125' ' ' ASN . 21.2 ttm -48.61 -37.46 18.22 Favored 'General case' 0 N--CA 1.406 -2.664 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.5 mt -82.5 -50.12 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.665 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.5 m -48.81 -35.56 14.75 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.02 -1.9 . . . . 0.0 112.722 176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.553 HD22 HG21 ' B' ' 54' ' ' ILE . 23.1 mt -103.19 -3.03 26.32 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 120.055 -0.658 . . . . 0.0 112.028 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' B' ' 43' ' ' ASN . . . 76.34 29.52 58.17 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 117.359 1.704 . . . . 0.0 117.359 172.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.645 HD11 HD11 ' B' ' 124' ' ' LEU . 0.2 OUTLIER -100.05 -46.02 5.47 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 118.947 1.373 . . . . 0.0 111.897 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.646 ' HA ' ' CG ' ' A' ' 119' ' ' MET . 1.6 t-20 49.29 -160.3 0.05 Allowed 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.087 -168.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.76 82.47 7.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.2 p 61.7 -5.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 129.19 2.996 . . . . 0.0 114.216 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.08 116.55 4.68 Favored 'General case' 0 C--N 1.271 -2.828 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -77.27 -33.16 55.93 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.497 0.498 . . . . 0.0 109.948 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -109.86 137.79 47.14 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -90.47 97.54 11.24 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--N 1.289 -2.048 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -178.407 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.472 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p -89.21 99.06 12.13 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.122 0.487 . . . . 0.0 112.173 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 48.3 m -81.02 108.95 15.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 173.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -129.64 127.77 41.27 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.443 0.64 . . . . 0.0 112.17 -175.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -103.3 -26.06 13.08 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 174.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 63.42 -83.07 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.717 1.607 . . . . 0.0 112.216 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -172.47 -83.06 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 54.17 -173.55 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.625 1.17 . . . . 0.0 113.963 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -77.98 132.44 37.84 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.2 m -67.62 147.48 52.67 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.628 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -61.27 113.95 2.9 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -95.13 113.72 62.11 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.71 168.08 14.1 Favored 'Trans proline' 0 C--O 1.247 0.925 0 C-N-CA 122.42 2.08 . . . . 0.0 112.365 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt -61.97 122.76 13.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -108.88 145.71 34.9 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -66.23 125.98 27.27 Favored 'General case' 0 C--N 1.305 -1.37 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 172.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.65 -5.81 31.25 Favored Glycine 0 N--CA 1.426 -1.974 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.694 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -83.4 162.97 20.85 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.482 HG21 HG22 ' B' ' 104' ' ' THR . 75.1 t -122.53 110.14 26.02 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.766 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.732 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 30.3 m-85 -101.44 146.3 27.8 Favored 'General case' 0 C--N 1.26 -3.32 0 C-N-CA 124.875 1.27 . . . . 0.0 109.779 176.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 3.8 mp -81.13 146.14 30.7 Favored 'General case' 0 N--CA 1.388 -3.569 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 166.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.33 141.11 33.88 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.931 -173.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -85.58 89.19 7.65 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.616 ' O ' HG13 ' B' ' 27' ' ' VAL . 56.9 mt -73.03 -22.09 60.7 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.073 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.603 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 3.8 m -33.14 175.02 0.0 OUTLIER Pre-proline 0 CA--C 1.573 1.859 0 C-N-CA 129.433 3.093 . . . . 0.0 115.603 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.604 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 0.0 OUTLIER 23.8 50.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.119 0 C-N-CA 123.205 2.603 . . . . 0.0 114.998 -152.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.616 HG13 ' O ' ' B' ' 24' ' ' LEU . 0.5 OUTLIER -68.18 143.09 15.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.107 172.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . 0.66 HE22 ' HB2' ' A' ' 26' ' ' PRO . 82.8 mm-40 -89.72 118.86 29.63 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 113.942 -1.481 . . . . 0.0 112.301 -173.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.3 -108.72 1.4 Allowed Glycine 0 C--N 1.309 -0.935 0 CA-C-N 115.419 -0.81 . . . . 0.0 113.584 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 95' ' ' ASP . 43.9 m -94.71 8.67 41.69 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.583 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 98.8 mt-10 -61.56 142.59 56.99 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 173.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.84 117.65 30.38 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 122.374 -0.204 . . . . 0.0 111.351 -169.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.36 -173.85 22.54 Favored Glycine 0 N--CA 1.412 -2.942 0 N-CA-C 120.327 2.891 . . . . 0.0 120.327 163.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.28 -151.87 6.42 Favored Glycine 0 C--N 1.264 -3.459 1 N-CA-C 102.124 -4.391 . . . . 0.0 102.124 177.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.49 114.96 18.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 CA-C-N 120.997 2.399 . . . . 0.0 109.867 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -145.21 161.6 41.2 Favored Pre-proline 0 C--N 1.284 -2.271 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.113 -175.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 21.2 Cg_exo -71.91 143.15 40.35 Favored 'Trans proline' 0 CA--C 1.551 1.366 0 C-N-CA 122.599 2.199 . . . . 0.0 111.86 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 29.7 m -127.91 159.64 38.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 124.129 0.971 . . . . 0.0 109.754 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.404 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.1 m -103.76 132.56 49.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 CA-C-O 120.642 0.258 . . . . 0.0 110.357 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.4 HD13 HG12 ' B' ' 55' ' ' VAL . 24.4 mm -91.04 107.13 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.86 -18.89 6.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.89 178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.649 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -52.14 157.24 1.4 Allowed 'General case' 0 C--O 1.245 0.845 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -170.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 10.9 p-10 -56.88 158.17 5.03 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 113.182 -1.826 . . . . 0.0 112.325 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.49 -28.76 62.1 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 113.615 -1.629 . . . . 0.0 112.096 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 56.9 m -85.2 -35.24 21.76 Favored 'General case' 0 C--N 1.315 -0.901 0 O-C-N 122.175 -0.328 . . . . 0.0 111.764 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.421 ' C ' HE22 ' B' ' 42' ' ' GLN . . . -68.5 -26.2 74.48 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.459 ' N ' HE22 ' B' ' 42' ' ' GLN . 94.6 m-20 -60.39 -32.74 71.6 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.12 0.486 . . . . 0.0 109.845 176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.535 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 11.0 mmmm -93.1 -63.35 1.23 Allowed 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.136 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.535 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 67.6 m-85 -91.89 -35.82 13.83 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -166.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 45.5 m -82.06 138.49 45.97 Favored Pre-proline 0 C--N 1.308 -1.212 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.66 -18.74 37.3 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 121.927 1.752 . . . . 0.0 111.178 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 3.0 p -98.81 155.64 17.26 Favored 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 124.781 1.232 . . . . 0.0 111.269 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.619 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -150.25 138.75 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 O-C-N 123.585 0.553 . . . . 0.0 110.387 171.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.649 HG22 ' HG3' ' B' ' 42' ' ' GLN . 8.8 tt -83.45 134.02 27.85 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 CA-C-O 121.46 0.647 . . . . 0.0 110.576 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 32.3 m -138.47 155.25 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.494 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.531 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -115.26 139.54 49.87 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.09 138.43 43.94 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.576 HG12 HD12 ' B' ' 86' ' ' ILE . 61.2 mt -96.14 134.48 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 113.285 -1.78 . . . . 0.0 107.422 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -137.46 141.42 41.58 Favored 'General case' 0 N--CA 1.405 -2.718 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.87 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -84.41 161.94 37.69 Favored Glycine 0 N--CA 1.419 -2.455 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 169.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 69.65 -168.85 0.17 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.747 0.773 . . . . 0.0 109.503 -176.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 33.5 mm 69.36 84.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -89.87 -9.57 48.52 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.085 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -85.87 82.34 8.19 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' B' ' 70' ' ' HIS . . . -116.75 14.28 15.27 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.906 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 25.7 ttmm -84.71 68.51 10.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.397 1.094 . . . . 0.0 108.308 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 7.9 tt -165.04 138.0 3.69 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -62.21 -5.84 7.23 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.797 2.331 . . . . 0.0 115.538 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 80.6 p -102.05 -16.19 16.52 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.334 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.431 ' HB2' ' HA ' ' B' ' 65' ' ' ALA . 46.4 m170 -112.34 128.5 56.3 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 175.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -126.57 126.3 68.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.76 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -92.6 123.35 35.83 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.556 0.693 . . . . 0.0 109.373 176.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.871 HG21 ' CE1' ' B' ' 78' ' ' TYR . 2.8 mm -100.77 155.52 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.946 -173.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.433 ' CD ' ' HZ1' ' B' ' 110' ' ' LYS . 2.4 mp0 -64.73 119.98 11.59 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 123.996 0.918 . . . . 0.0 110.527 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . 0.496 ' HE3' ' O ' ' B' ' 81' ' ' ASP . 85.7 tttt -48.2 -49.08 34.23 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 126.504 1.922 . . . . 0.0 111.408 177.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -60.6 -45.85 92.44 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 125.871 1.668 . . . . 0.0 111.76 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -72.27 -33.78 67.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.71 -174.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.871 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.2 m-85 -87.83 -11.1 48.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.247 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 59.7 tttm 66.44 26.34 10.09 Favored 'General case' 0 CA--C 1.561 1.374 0 CA-C-O 121.748 0.785 . . . . 0.0 111.07 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' B' ' 78' ' ' TYR . 6.8 mp -95.09 -178.76 4.58 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-O 122.448 1.118 . . . . 0.0 112.658 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.496 ' O ' ' HE3' ' B' ' 75' ' ' LYS . 4.9 m-20 -70.57 -28.64 65.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.626 -2.079 . . . . 0.0 110.104 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -154.04 171.21 19.45 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -53.69 135.66 40.68 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 7.1 m -109.44 135.49 50.39 Favored 'General case' 0 C--N 1.283 -2.326 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -172.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 t -107.73 136.55 42.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.576 HD12 HG12 ' B' ' 58' ' ' ILE . 13.7 mm -113.78 135.36 53.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' B' ' 70' ' ' HIS . 44.5 mt -104.78 104.88 14.74 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.28 -7.41 59.63 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.594 -174.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -90.99 -38.49 12.8 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.1 175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.26 77.73 3.46 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.26 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.531 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.4 pp -113.45 -176.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.401 ' NH1' HG12 ' B' ' 27' ' ' VAL . 14.1 ptm180 -166.47 174.06 9.3 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 123.329 0.393 . . . . 0.0 111.55 172.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 68.8 m -123.63 124.62 43.18 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 74.7 mt -131.28 142.98 50.21 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.8 -171.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 3.9 p-10 -74.95 152.66 38.79 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.412 174.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -46.04 -30.0 1.69 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.019 1.328 . . . . 0.0 114.222 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -74.05 -19.75 60.52 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 120.945 0.402 . . . . 0.0 111.289 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -72.32 -34.11 67.85 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.417 ' HB3' ' CD2' ' B' ' 20' ' ' TYR . 7.8 mp -77.17 125.76 29.85 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.147 1.379 . . . . 0.0 110.174 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -93.3 -64.72 1.06 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.669 -1.151 . . . . 0.0 113.37 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -155.06 151.1 27.97 Favored 'General case' 0 N--CA 1.407 -2.587 0 CA-C-O 121.632 0.73 . . . . 0.0 111.283 -169.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.473 ' HE2' ' OH ' ' B' ' 20' ' ' TYR . 67.2 mttt -70.85 126.19 28.91 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 112.925 -1.943 . . . . 0.0 109.755 174.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.506 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 18.8 tp -112.14 -62.02 1.63 Allowed 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.731 1.253 . . . . 0.0 108.657 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.506 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 1.6 m -125.98 178.44 5.75 Favored 'General case' 0 N--CA 1.383 -3.823 0 CA-C-N 112.879 -1.964 . . . . 0.0 110.356 -166.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -160.74 137.7 8.97 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 124.825 1.25 . . . . 0.0 109.991 -170.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -110.98 164.0 13.25 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.748 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -91.96 171.56 9.04 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.548 0.213 . . . . 0.0 111.177 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' B' ' 111' ' ' MET . 27.6 t70 -62.75 -28.69 70.14 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.232 0.539 . . . . 0.0 111.39 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -70.11 -29.11 65.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.837 176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.509 ' O ' HG22 ' B' ' 114' ' ' VAL . 14.1 tppt? -81.16 -29.26 34.74 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.812 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.486 ' HA ' ' CE ' ' B' ' 111' ' ' MET . 0.1 OUTLIER -47.81 -43.5 27.92 Favored 'General case' 0 CA--C 1.445 -3.078 0 O-C-N 124.173 0.921 . . . . 0.0 109.964 170.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.518 ' HE2' ' N ' ' B' ' 112' ' ' LYS . 6.9 mmpt? -61.15 -54.02 49.66 Favored 'General case' 1 N--CA 1.37 -4.451 0 CA-C-N 113.614 -1.63 . . . . 0.0 113.675 -178.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -62.41 -43.88 97.76 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 120.333 -0.547 . . . . 0.0 112.092 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . 0.509 HG22 ' O ' ' B' ' 110' ' ' LYS . 20.6 m -63.21 -43.14 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 O-C-N 123.67 0.606 . . . . 0.0 111.814 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -56.5 -54.85 40.96 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 123.479 0.487 . . . . 0.0 111.08 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' B' ' 119' ' ' MET 0.273 17.3 m-80 -61.7 -45.26 94.74 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.242 0.544 . . . . 0.0 110.252 -177.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.54 -43.86 97.77 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.003 -173.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.602 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.6 tp -63.03 -46.59 86.86 Favored 'General case' 0 N--CA 1.387 -3.612 0 C-N-CA 124.287 1.035 . . . . 0.0 108.338 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.74 ' SD ' ' HA ' ' B' ' 125' ' ' ASN . 15.4 ttm -49.63 -44.08 47.15 Favored 'General case' 0 N--CA 1.406 -2.66 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 29.9 mt -72.34 -50.87 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 45.8 m -49.79 -34.07 18.39 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.485 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 22.3 mt -102.8 -4.19 25.29 Favored 'General case' 0 C--O 1.198 -1.627 0 C-N-CA 119.973 -0.691 . . . . 0.0 112.116 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 43' ' ' ASN . . . 76.78 30.76 55.6 Favored Glycine 0 C--N 1.341 0.848 0 N-CA-C 117.469 1.747 . . . . 0.0 117.469 172.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.645 HD11 HD11 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -101.89 -47.27 4.64 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 118.696 1.248 . . . . 0.0 112.511 179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.74 ' HA ' ' SD ' ' B' ' 119' ' ' MET 0.345 14.1 m120 48.16 -158.56 0.05 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.528 -167.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . 0.402 ' O ' HG12 ' B' ' 127' ' ' VAL . . . -82.7 79.62 9.05 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 120.932 -1.105 . . . . 0.0 110.445 -175.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.402 HG12 ' O ' ' B' ' 126' ' ' ALA . 7.3 p 65.26 -4.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 129.19 2.996 . . . . 0.0 113.024 178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -150.02 123.23 8.91 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.355 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.46 ' HA ' ' HB2' ' B' ' 125' ' ' ASN . 41.7 t-80 -85.49 -30.07 23.75 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.774 0.797 . . . . 0.0 109.072 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -111.82 131.19 55.51 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -87.55 91.15 8.64 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--N 1.291 -1.954 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.913 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.3 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.6 t 73.4 18.54 3.64 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.892 1.277 . . . . 0.0 111.364 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 p -90.57 -3.71 57.38 Favored 'General case' 0 N--CA 1.441 -0.907 0 O-C-N 122.133 -0.354 . . . . 0.0 111.112 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -76.53 102.04 5.9 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -87.05 -16.63 35.04 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.45 135.1 54.6 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -81.35 85.96 6.35 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 122.191 0.996 . . . . 0.0 110.934 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -96.98 -8.2 31.14 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.662 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -94.76 -53.3 3.91 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.8 m 48.65 80.91 0.05 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.038 1.335 . . . . 0.0 113.114 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -123.08 130.42 52.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.03 140.58 80.61 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.29 150.54 59.07 Favored 'Trans proline' 0 C--O 1.25 1.099 0 C-N-CA 122.195 1.93 . . . . 0.0 112.212 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.34 142.04 13.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -146.77 160.72 41.9 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -77.64 122.11 24.87 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.533 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.432 ' HA2' ' SD ' ' A' ' 111' ' ' MET . . . 142.8 -30.63 2.04 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 119.395 -1.383 . . . . 0.0 113.996 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -100.43 173.87 6.37 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 118.075 0.937 . . . . 0.0 111.658 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 105' ' ' TYR . 54.0 t -110.98 138.71 38.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.291 -1.322 . . . . 0.0 111.836 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 92.2 m-85 -137.32 147.11 45.37 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 126.26 1.824 . . . . 0.0 108.731 175.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.2 mp -86.57 157.38 19.75 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 171.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -144.7 146.6 32.29 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.129 -0.942 . . . . 0.0 108.865 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -82.46 108.77 16.12 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.643 0.735 . . . . 0.0 109.63 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.606 ' O ' ' HA2' ' A' ' 33' ' ' GLY . 15.4 mt -108.91 28.26 8.64 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-O 123.698 1.713 . . . . 0.0 109.073 -175.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.671 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 15.1 m -73.55 -178.62 0.75 Allowed Pre-proline 1 C--N 1.213 -5.358 0 CA-C-N 112.732 -2.031 . . . . 0.0 108.714 169.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.671 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.1 OUTLIER 17.23 42.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.148 0 C-N-CA 124.976 3.784 . . . . 0.0 118.016 -159.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 24' ' ' LEU . 5.2 m -70.2 174.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.054 0 CA-C-O 122.328 1.061 . . . . 0.0 112.234 172.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -92.49 110.56 21.97 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.005 -1.452 . . . . 0.0 114.198 -174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.65 -108.69 0.75 Allowed Glycine 0 N--CA 1.437 -1.249 0 CA-C-N 113.918 -1.492 . . . . 0.0 114.784 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 29.7 m -86.58 13.85 7.85 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 36.0 mt-10 -67.4 -175.29 0.47 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.887 0.851 . . . . 0.0 112.063 173.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.594 ' NE2' ' HG3' ' A' ' 36' ' ' ARG . 12.1 tm0? -106.47 126.59 52.45 Favored 'General case' 0 N--CA 1.408 -2.531 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.606 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -111.54 163.65 12.2 Favored Glycine 0 CA--C 1.498 -0.989 0 N-CA-C 116.871 1.508 . . . . 0.0 116.871 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.8 171.64 18.96 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 113.614 -1.293 . . . . 0.0 110.51 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.53 102.08 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.669 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.594 ' HG3' ' NE2' ' A' ' 32' ' ' GLN . 26.0 mmt180 -128.55 151.91 77.58 Favored Pre-proline 0 C--N 1.251 -3.715 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.88 -174.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 23.4 Cg_exo -65.46 144.92 81.32 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.839 2.359 . . . . 0.0 112.54 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 30.1 m -129.23 154.97 40.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.619 177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 29.7 m -99.32 128.69 50.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.496 176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.5 mm -92.24 106.44 17.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.06 -6.57 10.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.817 0.817 . . . . 0.0 109.085 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.593 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -51.15 146.64 6.27 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 125.853 1.661 . . . . 0.0 113.946 -170.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -60.95 -179.01 0.11 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.942 -1.481 . . . . 0.0 113.098 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 19.0 t70 -77.27 -48.54 17.2 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.151 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -70.25 -28.58 65.35 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.542 -171.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.01 -28.15 73.7 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.525 ' N ' HE22 ' A' ' 42' ' ' GLN . 87.0 m-20 -75.84 -37.59 58.88 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.278 0.561 . . . . 0.0 110.174 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 49' ' ' TYR . 49.8 mmtt -79.31 -61.6 1.95 Allowed 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.257 -176.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.439 ' CD2' ' HB2' ' A' ' 48' ' ' LYS . 55.7 m-85 -111.24 6.6 20.71 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -167.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 22.7 t -119.84 141.6 31.59 Favored Pre-proline 0 C--N 1.306 -1.298 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.314 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 10.2 Cg_exo -74.17 -23.34 15.83 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.073 1.848 . . . . 0.0 110.366 175.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 0.7 OUTLIER -85.17 154.71 21.82 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.813 -175.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.46 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 57.9 t -138.4 140.07 40.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.713 HD11 HD13 ' A' ' 91' ' ' ILE . 3.8 tp -99.08 125.56 52.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 171.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 21.6 m -132.68 166.54 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.743 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.583 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -124.88 141.19 52.28 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 176.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.53 130.76 42.06 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.622 HG12 HD12 ' A' ' 86' ' ' ILE . 56.1 mt -90.13 120.42 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.085 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.482 HG21 HD13 ' A' ' 62' ' ' ILE . 22.9 m -119.3 155.47 31.76 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.79 -177.9 42.82 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.486 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 17.6 tpt180 -57.73 108.42 0.57 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 122.882 0.473 . . . . 0.0 110.836 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.482 HD13 HG21 ' A' ' 59' ' ' THR . 20.9 pt -127.82 -28.58 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.422 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -160.42 147.14 15.66 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -170.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -86.73 137.74 32.2 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.38 80.9 0.76 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.163 0.982 . . . . 0.0 113.16 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -90.08 -38.75 13.35 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.911 176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 tt -97.95 136.26 21.15 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -65.71 -1.1 4.47 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.198 2.599 . . . . 0.0 115.869 -175.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.1 p -91.32 -18.74 23.83 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-O 121.728 0.775 . . . . 0.0 109.432 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -101.5 129.26 47.53 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.18 127.81 69.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 84' ' ' SER . 12.8 pt-20 -99.08 131.08 45.38 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.088 0.47 . . . . 0.0 110.472 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.508 HD11 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -124.78 145.99 31.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.47 123.91 13.38 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 126.304 1.842 . . . . 0.0 113.332 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -58.67 -39.4 80.54 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.702 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 51.2 pttt -61.48 -27.76 68.8 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.974 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -91.43 -35.47 14.34 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.103 0.954 . . . . 0.0 109.549 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.401 ' OH ' HD23 ' A' ' 106' ' ' LEU . 32.9 m-85 -96.16 13.41 27.42 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.366 -171.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt 59.7 39.29 21.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.566 1.146 . . . . 0.0 114.064 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.86 174.31 7.62 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.792 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.0 -16.25 26.77 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.076 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -133.34 152.06 51.9 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.486 ' OD2' ' HD3' ' A' ' 61' ' ' ARG . 9.6 p-10 -69.11 157.17 37.39 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 120.902 0.382 . . . . 0.0 110.308 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 72' ' ' GLU . 21.3 t -103.41 151.79 22.36 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.388 -172.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.5 t -125.37 124.32 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.622 HD12 HG12 ' A' ' 58' ' ' ILE . 20.1 mm -100.95 130.36 50.45 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.662 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 76.6 mt -102.59 102.91 13.18 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -82.58 6.29 18.13 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.901 -174.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.16 -38.31 6.31 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.285 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.412 ' HA ' HG21 ' B' ' 93' ' ' THR . 4.6 tp60 -83.82 69.33 10.21 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.373 -1.285 . . . . 0.0 107.826 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.713 HD13 HD11 ' A' ' 54' ' ' ILE . 2.1 pp -111.44 -179.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.723 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.446 ' O ' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -167.28 165.31 15.27 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.2 m -118.19 118.73 32.66 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.1 mt -131.69 138.51 48.72 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.8 -172.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 4.5 p-10 -73.91 152.1 40.24 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 118.95 -1.1 . . . . 0.0 110.015 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -47.69 -20.52 0.28 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.825 1.65 . . . . 0.0 115.197 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -71.39 -26.36 62.74 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.91 0.884 . . . . 0.0 110.735 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -74.26 -34.5 63.61 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.205 0.526 . . . . 0.0 110.212 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.2 mp -72.52 124.98 26.32 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 124.657 1.183 . . . . 0.0 109.973 176.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -101.93 -60.17 1.58 Allowed 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 115.351 1.611 . . . . 0.0 115.351 -176.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -147.88 138.61 23.18 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 121.716 0.77 . . . . 0.0 112.719 -166.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 28.9 tttp -66.1 116.14 6.88 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 127.673 2.389 . . . . 0.0 107.414 174.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -110.16 -60.23 1.83 Allowed 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.76 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.414 ' CG2' HG21 ' A' ' 19' ' ' VAL . 10.6 t -127.64 -157.41 0.81 Allowed 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.637 ' O ' HG23 ' A' ' 19' ' ' VAL . 38.0 m-85 -123.48 -89.0 0.6 Allowed 'General case' 0 C--O 1.177 -2.763 0 C-N-CA 118.029 -1.468 . . . . 0.0 112.573 -172.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 1.5 mt 139.75 151.97 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 131.358 3.863 . . . . 0.0 105.484 -176.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 79.0 p -97.59 154.49 17.5 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.153 -1.019 . . . . 0.0 108.746 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.511 ' O ' ' HD2' ' A' ' 112' ' ' LYS . 4.9 m-20 -58.54 -36.96 74.7 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -175.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 18.4 p-10 -76.74 -41.52 44.68 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.396 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -67.64 -25.63 65.83 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.544 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.465 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -53.71 -42.28 67.86 Favored 'General case' 0 N--CA 1.416 -2.146 0 C-N-CA 124.122 0.969 . . . . 0.0 110.421 171.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.672 ' HE2' ' N ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -71.25 -25.44 62.47 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.367 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.606 ' HA ' ' ND2' ' A' ' 116' ' ' ASN . 10.6 mt-10 -87.08 -35.19 18.85 Favored 'General case' 0 N--CA 1.394 -3.227 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.762 -171.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.7 t -58.75 -47.04 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.016 0 CA-C-N 112.856 -1.975 . . . . 0.0 108.501 169.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.506 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 68.5 m-20 -58.39 -52.82 63.98 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.129 0.49 . . . . 0.0 111.054 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.606 ' ND2' ' HA ' ' A' ' 113' ' ' GLU . 3.8 p30 -64.85 -42.96 94.47 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.109 -0.637 . . . . 0.0 111.743 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -56.32 -38.21 71.0 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-O 121.22 0.534 . . . . 0.0 109.903 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 8.9 tp -69.94 -46.27 65.66 Favored 'General case' 0 N--CA 1.392 -3.374 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.921 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.516 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 3.1 ttp -68.06 -23.48 64.96 Favored 'General case' 0 N--CA 1.408 -2.566 0 C-N-CA 124.161 0.984 . . . . 0.0 110.298 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 116' ' ' ASN . 49.7 mt -79.9 -54.47 11.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 174.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.5 t -47.71 -44.79 28.03 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 125.787 1.635 . . . . 0.0 112.584 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.458 ' HG ' HG12 ' B' ' 54' ' ' ILE . 9.7 mp -82.85 10.65 7.3 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 85.92 3.86 85.17 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.516 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.3 mm? -67.74 -63.48 1.05 Allowed 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 118.106 0.953 . . . . 0.0 109.121 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 61.08 144.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.244 -173.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.48 11.14 27.08 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 122.212 1.006 . . . . 0.0 110.105 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.0 t -123.67 95.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.72 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 66.27 66.1 0.48 Allowed 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 114.043 -1.435 . . . . 0.0 112.865 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -83.44 -59.98 2.28 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -103.05 135.81 44.04 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt 71.83 104.66 0.07 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.65 1.18 . . . . 0.0 111.979 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.666 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.64 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 38.7 t 70.56 11.66 7.32 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.482 1.113 . . . . 0.0 112.684 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 6.4 p -90.28 6.27 43.65 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.779 -0.576 . . . . 0.0 111.715 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -82.5 92.51 7.08 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -81.71 -16.71 50.31 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 122.297 1.046 . . . . 0.0 109.44 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -118.29 129.24 55.34 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 174.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -82.24 84.64 7.02 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.319 1.057 . . . . 0.0 110.637 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -98.38 -2.51 39.04 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.616 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -95.07 -51.31 4.7 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 46.2 m 49.72 80.45 0.07 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.521 1.128 . . . . 0.0 113.543 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -125.25 133.87 52.52 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -82.1 139.34 45.76 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -67.89 148.14 75.96 Favored 'Trans proline' 0 C--O 1.251 1.145 0 C-N-CA 122.289 1.993 . . . . 0.0 112.351 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 73.1 mt -91.51 140.52 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -146.03 160.45 41.86 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -76.22 125.81 29.84 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.476 ' HA2' ' SD ' ' B' ' 111' ' ' MET . . . 140.12 -34.49 2.0 Allowed Glycine 0 N--CA 1.425 -2.081 0 C-N-CA 119.507 -1.33 . . . . 0.0 113.617 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -100.11 174.21 6.27 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 118.078 0.939 . . . . 0.0 111.992 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 105' ' ' TYR . 53.5 t -110.36 139.42 33.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.115 176.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 89.7 m-85 -137.57 147.67 45.28 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 126.072 1.749 . . . . 0.0 109.191 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.535 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.0 mp -88.16 156.33 19.3 Favored 'General case' 0 N--CA 1.412 -2.344 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.19 147.64 32.67 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.956 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -82.61 107.66 15.42 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 122.205 1.003 . . . . 0.0 110.346 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.677 ' O ' ' HA2' ' B' ' 33' ' ' GLY . 10.8 mt -108.9 28.01 8.9 Favored 'General case' 0 CA--C 1.484 -1.578 0 CA-C-O 123.451 1.596 . . . . 0.0 109.206 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.666 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 15.3 m -76.45 -178.62 0.97 Allowed Pre-proline 1 C--N 1.216 -5.223 0 CA-C-N 112.785 -2.007 . . . . 0.0 107.759 170.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.666 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 17.1 43.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.393 2.873 1 C-N-CA 125.396 4.064 . . . . 0.0 118.029 -160.374 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.495 HG13 ' O ' ' B' ' 24' ' ' LEU . 4.9 m -70.4 177.93 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.972 0 CA-C-O 122.171 0.986 . . . . 0.0 112.154 172.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -94.05 116.3 28.71 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.59 -176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.97 -108.65 0.77 Allowed Glycine 0 CA--C 1.499 -0.91 0 CA-C-N 114.622 -1.172 . . . . 0.0 114.966 172.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 10.3 m -90.97 10.55 26.08 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.544 -0.828 . . . . 0.0 113.06 -174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.483 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 34.9 mt-10 -62.82 -179.97 0.32 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.868 0.842 . . . . 0.0 112.777 176.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.596 ' NE2' ' HG3' ' B' ' 36' ' ' ARG . 0.0 OUTLIER -100.2 121.71 41.88 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -177.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.677 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -106.01 155.0 16.88 Favored Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 116.612 1.405 . . . . 0.0 116.612 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.88 176.63 15.52 Favored Glycine 0 C--N 1.307 -1.08 0 CA-C-N 113.383 -1.409 . . . . 0.0 110.19 175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.97 99.67 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.036 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . 0.596 ' HG3' ' NE2' ' B' ' 32' ' ' GLN . 29.5 mmt180 -126.52 150.96 72.14 Favored Pre-proline 0 C--N 1.245 -3.974 0 CA-C-N 113.822 -1.536 . . . . 0.0 111.02 -172.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 25.1 Cg_exo -64.92 144.99 84.75 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 122.439 2.093 . . . . 0.0 112.208 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 31.0 m -129.15 155.23 41.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.453 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.582 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 30.7 m -99.87 129.01 51.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 176.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 21.7 mm -92.37 107.07 18.52 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.31 -7.52 10.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.679 0.752 . . . . 0.0 109.129 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.576 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.6 OUTLIER -49.82 148.68 2.97 Favored 'General case' 0 N--CA 1.424 -1.746 0 C-N-CA 126.099 1.759 . . . . 0.0 113.951 -170.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -61.83 -178.41 0.15 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.898 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' B' ' 48' ' ' LYS . 15.9 t70 -80.04 -47.56 14.7 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.483 -175.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.6 m -69.97 -30.97 68.45 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.749 -172.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.23 -27.29 72.21 Favored Glycine 0 C--O 1.214 -1.129 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.537 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.516 ' N ' HE22 ' B' ' 42' ' ' GLN . 79.6 m-20 -78.37 -35.28 47.55 Favored 'General case' 0 CA--C 1.491 -1.318 0 O-C-N 122.554 -0.38 . . . . 0.0 110.586 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' B' ' 44' ' ' ASP . 51.7 mmtt -78.27 -60.83 2.21 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.358 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.436 ' CD2' ' HB2' ' B' ' 48' ' ' LYS . 69.1 m-85 -107.67 -11.07 15.5 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -167.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 19.1 t -106.14 143.03 26.11 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 121.711 -0.618 . . . . 0.0 109.515 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -75.79 -22.36 13.55 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.146 1.897 . . . . 0.0 110.323 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 0.8 OUTLIER -84.91 152.16 23.73 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.6 -175.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.478 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 58.9 t -136.47 140.05 44.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.706 HD11 HD13 ' B' ' 91' ' ' ILE . 4.1 tp -99.27 124.39 52.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 171.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.487 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 22.1 m -132.19 166.04 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.817 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.582 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -124.09 141.36 52.12 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.1 129.06 37.6 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.611 HG12 HD12 ' B' ' 86' ' ' ILE . 53.7 mt -87.61 123.02 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.915 173.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . 0.486 HG21 HD13 ' B' ' 62' ' ' ILE . 25.8 m -120.42 159.6 24.77 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.13 -172.34 42.28 Favored Glycine 0 N--CA 1.435 -1.389 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.498 ' HD3' ' OD2' ' B' ' 83' ' ' ASP . 16.6 tpt180 -63.41 106.2 0.88 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.329 0.585 . . . . 0.0 110.694 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.486 HD13 HG21 ' B' ' 59' ' ' THR . 22.2 pt -123.48 -39.76 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.637 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -155.17 139.34 16.55 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -172.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -71.84 137.99 47.94 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 123.857 0.723 . . . . 0.0 109.903 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -71.83 81.27 0.89 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.744 0.783 . . . . 0.0 112.952 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -90.82 -42.13 10.83 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.556 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.2 tt -94.01 134.37 26.12 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -66.54 7.89 0.36 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 123.346 2.698 . . . . 0.0 115.704 -176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 74.8 p -98.37 -18.83 18.09 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.899 0.857 . . . . 0.0 108.738 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -101.25 129.41 47.19 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 48.0 t -127.57 130.34 70.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' B' ' 84' ' ' SER . 12.1 pt-20 -101.23 130.69 47.39 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.927 0.394 . . . . 0.0 110.179 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.517 HD11 HG12 ' B' ' 86' ' ' ILE . 0.0 OUTLIER -124.04 147.75 28.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -54.94 125.42 20.26 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 125.252 1.421 . . . . 0.0 113.287 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -61.96 -38.45 88.55 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-O 121.754 0.787 . . . . 0.0 111.234 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -61.75 -27.35 68.67 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.903 -1.499 . . . . 0.0 112.991 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -90.67 -37.1 13.97 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.976 0.893 . . . . 0.0 109.406 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.42 ' OH ' HD23 ' B' ' 106' ' ' LEU . 31.2 m-85 -94.3 12.4 27.03 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.557 -1.201 . . . . 0.0 112.372 -171.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt 61.0 38.43 17.36 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.549 1.139 . . . . 0.0 113.724 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 22.2 mt -123.36 174.53 7.28 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.563 -0.855 . . . . 0.0 110.528 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.95 -11.81 26.03 Favored 'General case' 0 CA--C 1.498 -1.02 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.062 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -136.05 149.89 48.96 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.498 ' OD2' ' HD3' ' B' ' 61' ' ' ARG . 8.9 p-10 -68.26 156.07 38.42 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.837 0.351 . . . . 0.0 110.464 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' B' ' 72' ' ' GLU . 19.7 t -103.07 149.89 24.14 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.365 -171.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 41.4 t -123.58 124.81 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.288 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.611 HD12 HG12 ' B' ' 58' ' ' ILE . 19.4 mm -101.14 130.86 49.91 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.515 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.431 HD21 HD11 ' B' ' 62' ' ' ILE . 76.5 mt -102.76 102.52 12.68 Favored 'General case' 0 N--CA 1.406 -2.653 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.8 mm? -81.7 2.5 29.46 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.793 -174.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -101.79 -39.19 7.52 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.204 173.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -83.53 68.93 9.97 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.277 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.706 HD13 HD11 ' B' ' 54' ' ' ILE . 2.1 pp -110.23 -179.15 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.767 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.575 ' NH1' HD22 ' B' ' 24' ' ' LEU . 0.0 OUTLIER -167.25 165.03 15.47 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 90' ' ' GLN . 50.1 m -117.8 118.66 32.64 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 62.0 mt -131.54 138.61 48.98 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.83 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.479 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 4.2 p-10 -73.87 151.82 40.37 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 118.901 -1.12 . . . . 0.0 109.825 173.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -48.28 -20.98 0.44 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.83 1.652 . . . . 0.0 114.983 -175.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -72.91 -23.87 60.76 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.458 0.703 . . . . 0.0 110.575 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -74.32 -33.49 63.19 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.343 0.592 . . . . 0.0 109.867 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.25 122.8 23.41 Favored 'General case' 0 CA--C 1.502 -0.871 0 C-N-CA 124.39 1.076 . . . . 0.0 110.73 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -99.5 -62.13 1.28 Allowed 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.4 pt-20 -143.42 148.7 36.55 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-O 122.054 0.931 . . . . 0.0 112.551 -167.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -79.3 111.34 15.45 Favored 'General case' 0 C--N 1.276 -2.596 0 C-N-CA 127.769 2.428 . . . . 0.0 107.89 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -105.65 -61.94 1.43 Allowed 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.357 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.443 ' CG2' HG21 ' B' ' 19' ' ' VAL . 8.3 t -125.44 -159.21 0.88 Allowed 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.577 ' O ' HG23 ' B' ' 19' ' ' VAL . 37.9 m-85 -122.73 -87.39 0.64 Allowed 'General case' 0 C--O 1.176 -2.796 0 C-N-CA 118.387 -1.325 . . . . 0.0 112.445 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' B' ' 17' ' ' GLY . 1.5 mt 137.78 155.22 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 130.962 3.705 . . . . 0.0 106.035 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 88.2 p -100.88 155.65 17.82 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.33 -0.948 . . . . 0.0 108.709 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' B' ' 111' ' ' MET . 12.9 m-20 -58.29 -40.34 81.7 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -74.23 -39.07 63.33 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.72 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -70.67 -24.96 62.78 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.433 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -54.08 -41.98 68.81 Favored 'General case' 0 N--CA 1.413 -2.283 0 C-N-CA 123.742 0.817 . . . . 0.0 110.256 171.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.705 ' HE2' ' N ' ' B' ' 112' ' ' LYS . 0.6 OUTLIER -70.69 -23.98 62.58 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.285 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . 0.648 ' HA ' ' ND2' ' B' ' 116' ' ' ASN 0.263 18.5 mt-10 -86.82 -37.63 17.6 Favored 'General case' 0 N--CA 1.387 -3.587 0 C-N-CA 118.363 -1.335 . . . . 0.0 110.533 -173.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 t -56.34 -46.58 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.282 0 CA-C-N 112.79 -2.004 . . . . 0.0 108.675 169.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 66.4 m-20 -60.34 -53.56 56.22 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.988 0.423 . . . . 0.0 111.186 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.648 ' ND2' ' HA ' ' B' ' 113' ' ' GLU . 4.0 p30 -66.36 -40.58 89.87 Favored 'General case' 0 CA--C 1.491 -1.312 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.256 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.464 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -59.9 -35.38 74.74 Favored 'General case' 0 CA--C 1.493 -1.242 0 CA-C-O 121.217 0.532 . . . . 0.0 109.579 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 8.9 tp -71.05 -45.92 62.96 Favored 'General case' 0 N--CA 1.393 -3.302 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.38 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.511 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 3.0 ttp -67.23 -25.14 65.94 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.333 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.515 HG13 ' O ' ' B' ' 116' ' ' ASN . 45.7 mt -80.1 -53.35 13.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 174.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 33.8 t -47.65 -45.68 28.17 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.043 1.337 . . . . 0.0 112.248 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.502 ' HG ' HG12 ' A' ' 54' ' ' ILE . 9.6 mp -81.93 10.56 6.23 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.64 9.34 83.31 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 170.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.511 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.4 mm? -72.49 -62.08 1.57 Allowed 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 118.284 1.042 . . . . 0.0 108.884 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.86 147.08 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.857 -173.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -111.98 14.78 20.86 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.816 0.817 . . . . 0.0 110.203 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 45.1 t -130.09 99.46 4.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 114.406 -1.27 . . . . 0.0 107.855 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 64.27 65.93 0.65 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.597 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -84.74 -58.9 2.52 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -103.82 136.88 42.68 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt 69.73 112.06 0.05 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.437 1.095 . . . . 0.0 110.688 -175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.298 -1.65 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.612 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 p -71.51 -21.08 61.97 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 122.412 -0.463 . . . . 0.0 111.607 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 t -87.9 -6.33 58.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.273 0.559 . . . . 0.0 109.57 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -82.88 101.98 11.36 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -92.2 -63.39 1.24 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -134.09 156.8 47.62 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.002 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 73.56 -165.68 0.1 Allowed 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.611 1.195 . . . . 0.0 110.164 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 71.9 -176.91 0.19 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.424 1.09 . . . . 0.0 110.061 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 61.29 -92.81 0.04 OUTLIER 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.997 0.919 . . . . 0.0 110.177 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 50.5 m -158.85 23.47 0.21 Allowed 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -104.42 121.4 43.35 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.452 -170.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -111.72 120.94 41.16 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 165.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.89 -10.81 30.2 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 122.308 2.006 . . . . 0.0 113.66 -176.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.465 HD12 ' NZ ' ' A' ' 96' ' ' LYS . 59.8 mt -95.89 117.32 39.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -144.4 160.62 40.74 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.549 ' HD3' ' O ' ' A' ' 41' ' ' ILE . 49.8 ttp180 -72.8 113.55 9.97 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.711 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 144.78 -27.88 1.9 Allowed Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.069 -178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -97.97 138.49 35.21 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 121.25 0.547 . . . . 0.0 111.045 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.421 ' HB ' ' H ' ' A' ' 104' ' ' THR . 62.8 t -89.89 121.14 39.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.706 174.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 23.0 m-85 -110.9 145.87 37.53 Favored 'General case' 0 C--N 1.264 -3.122 0 C-N-CA 124.135 0.974 . . . . 0.0 109.892 173.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.9 mp -84.34 151.45 24.72 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 167.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.5 154.7 36.02 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-O 121.794 0.807 . . . . 0.0 111.395 -173.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 98' ' ' ARG . 22.2 t70 -88.99 95.14 10.2 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 176.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.556 HD23 ' HD2' ' A' ' 92' ' ' ARG 0.259 1.3 tt -92.09 -11.17 36.49 Favored 'General case' 0 C--N 1.275 -2.634 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -174.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.569 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 4.5 m -33.71 -177.64 0.0 OUTLIER Pre-proline 0 CA--C 1.596 2.738 0 C-N-CA 129.589 3.156 . . . . 0.0 114.978 171.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 31.76 37.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 123.796 2.997 . . . . 0.0 117.404 -154.272 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 8.5 m -73.19 146.83 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.616 163.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -114.75 124.43 51.76 Favored 'General case' 0 C--N 1.278 -2.54 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.42 -109.08 1.94 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 114.941 -1.027 . . . . 0.0 114.659 175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.6 m -64.29 -21.23 66.53 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 124.76 1.224 . . . . 0.0 112.873 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 79.2 mt-10 -69.97 142.92 52.78 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -126.73 115.58 19.63 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -170.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.541 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -160.26 -88.52 0.07 OUTLIER Glycine 0 N--CA 1.422 -2.264 0 C-N-CA 118.958 -1.592 . . . . 0.0 114.32 173.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.99 -145.93 27.6 Favored Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 105.847 -2.901 . . . . 0.0 105.847 -168.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.96 122.11 54.95 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.266 0 CA-C-N 119.804 1.802 . . . . 0.0 108.486 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -146.91 163.04 30.87 Favored Pre-proline 0 C--N 1.288 -2.076 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.967 -174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 17.0 Cg_exo -70.02 138.25 36.58 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 121.74 1.627 . . . . 0.0 109.208 167.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.83 162.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.532 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 31.6 m -102.3 128.83 54.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.054 175.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.8 mm -87.14 109.56 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -105.58 -17.87 7.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.764 -177.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.655 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 7.1 tt0 -64.3 164.62 10.85 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -170.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.627 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 21.4 p-10 -62.63 180.0 0.3 Allowed 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.844 1.658 . . . . 0.0 111.913 179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.34 -48.04 37.56 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.674 -1.603 . . . . 0.0 113.069 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.3 m -86.6 -25.22 25.07 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -162.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 50' ' ' SER . . . -63.19 -30.15 76.63 Favored Glycine 0 C--O 1.192 -2.486 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -68.23 -36.44 79.5 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.428 0.633 . . . . 0.0 110.24 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -81.99 -50.39 9.17 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.615 -172.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.4 m-30 -97.67 -15.37 20.43 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -172.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 23.1 t -114.45 145.92 34.79 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.14 -3.01 10.25 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.468 2.112 . . . . 0.0 111.67 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 p -111.66 139.33 47.21 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.487 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.655 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -137.65 139.72 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 120.811 0.338 . . . . 0.0 111.549 176.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 93' ' ' THR . 5.1 tt -87.51 129.02 39.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.014 0 CA-C-O 121.595 0.712 . . . . 0.0 112.477 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.469 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 21.9 m -133.88 168.21 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.229 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.532 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -125.69 140.68 52.5 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.68 128.76 37.19 Favored 'General case' 0 C--O 1.248 0.987 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.578 HG12 ' CD1' ' A' ' 86' ' ' ILE . 62.7 mt -86.85 130.34 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.486 173.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 61' ' ' ARG . 88.5 m -128.23 114.72 17.3 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 121.268 0.556 . . . . 0.0 111.931 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.65 32.9 6.94 Favored Glycine 0 C--N 1.313 -0.712 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.463 ' H ' HG22 ' A' ' 59' ' ' THR . 41.8 ttm180 -116.28 10.45 14.81 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.174 0.988 . . . . 0.0 109.629 -177.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.455 HG23 HG21 ' A' ' 85' ' ' VAL . 12.7 tt -147.36 152.93 12.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -129.19 169.22 15.06 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp 67.0 97.54 0.05 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.551 1.14 . . . . 0.0 112.796 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.436 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . . . -98.49 100.12 11.34 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -104.38 -44.98 4.79 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 tt -70.32 130.23 89.57 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.742 176.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.95 -5.05 6.92 Favored 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.979 3.119 . . . . 0.0 116.253 -175.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 72.2 p -92.78 -12.3 31.59 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.857 0.836 . . . . 0.0 109.522 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -107.45 129.59 54.92 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 11.2 p -128.15 136.34 60.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.745 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 65' ' ' ALA . 8.4 pt-20 -99.55 137.98 37.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.992 0.901 . . . . 0.0 112.316 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.725 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -119.92 160.69 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.117 -179.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.3 117.57 18.11 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -53.09 -44.6 67.7 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -52.37 -39.58 60.97 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 125.455 1.502 . . . . 0.0 111.15 177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.468 ' HD3' ' OG ' ' A' ' 107' ' ' SER . 40.2 ttmt -74.62 -35.75 62.92 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.288 -176.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.725 ' CE1' HG21 ' A' ' 73' ' ' ILE . 2.7 m-85 -97.51 8.86 43.83 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.645 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 58.3 tttm 71.81 11.32 6.29 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 125.185 1.394 . . . . 0.0 113.495 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.02 170.92 11.14 Favored 'General case' 0 CA--C 1.476 -1.868 0 CA-C-O 122.384 1.088 . . . . 0.0 109.948 174.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -108.39 -4.85 17.03 Favored 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.994 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -128.63 147.42 50.73 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -52.74 134.24 36.5 Favored 'General case' 0 CA--C 1.499 -0.981 0 O-C-N 124.045 0.84 . . . . 0.0 110.72 -177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.44 ' O ' HG12 ' A' ' 73' ' ' ILE . 13.9 m -102.14 122.96 45.16 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.163 -169.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 37.3 t -113.82 135.8 52.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.578 ' CD1' HG12 ' A' ' 58' ' ' ILE . 16.5 mm -106.14 136.64 39.83 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 N-CA-C 106.33 -1.729 . . . . 0.0 106.33 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.32 107.58 18.66 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.6 mm? -86.57 14.89 6.16 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.015 0.912 . . . . 0.0 111.498 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -114.57 -44.34 3.09 Favored 'General case' 0 C--N 1.279 -2.482 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.158 176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 80.78 6.62 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.528 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -122.95 -178.14 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.915 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.556 ' HD2' HD23 ' A' ' 24' ' ' LEU 0.254 13.5 ptp180 -175.3 167.27 3.38 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 171.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 54' ' ' ILE . 94.1 m -108.65 121.78 45.73 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.188 -178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.1 mt -131.1 145.61 52.06 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 124.548 1.155 . . . . 0.0 111.142 -169.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 98' ' ' ARG . 20.1 t70 -50.94 137.07 21.72 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.632 1.173 . . . . 0.0 112.782 172.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.465 ' NZ ' HD12 ' A' ' 14' ' ' ILE . 30.0 mtpp -55.9 -29.51 60.14 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.829 0.852 . . . . 0.0 112.435 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HB2' ' OD2' ' A' ' 95' ' ' ASP . 9.1 mtmp? -87.75 -9.58 53.58 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.888 -175.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.627 ' HG2' ' O ' ' A' ' 95' ' ' ASP . 12.1 ptm180 -90.65 -17.19 27.26 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.668 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.7 mp -69.34 127.02 31.57 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 161.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -99.0 -59.73 1.67 Allowed 'General case' 0 C--N 1.272 -2.796 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 -172.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 13.3 pt-20 -147.98 131.71 16.95 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -169.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -63.67 108.94 1.53 Allowed 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 128.552 2.741 . . . . 0.0 107.118 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.713 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 57.2 tp -106.32 -63.07 1.3 Allowed 'General case' 0 N--CA 1.411 -2.4 0 CA-C-O 122.386 1.089 . . . . 0.0 111.435 -171.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.769 HG22 ' H ' ' A' ' 105' ' ' TYR 0.291 19.9 m -138.32 -157.06 0.74 Allowed 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 113.76 -1.563 . . . . 0.0 111.437 -165.082 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.769 ' H ' HG22 ' A' ' 104' ' ' THR . 12.9 t80 -159.15 151.84 21.74 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 119.653 1.115 . . . . 0.0 110.513 -161.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -115.1 138.37 50.96 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.37 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.468 ' OG ' ' HD3' ' A' ' 77' ' ' LYS . 19.7 m -79.79 157.33 27.1 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.534 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 111' ' ' MET . 26.1 t70 -63.61 -37.39 87.16 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.195 0.598 . . . . 0.0 112.197 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -62.23 -40.35 95.85 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 123.329 0.652 . . . . 0.0 110.696 174.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HE3' HG23 ' A' ' 73' ' ' ILE . 14.9 tppt? -77.98 -27.42 49.12 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.957 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.528 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 1.3 mmt -50.09 -46.84 53.84 Favored 'General case' 0 CA--C 1.461 -2.447 0 CA-C-O 122.223 1.011 . . . . 0.0 109.345 171.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 8.0 mmpt? -72.94 -12.36 60.92 Favored 'General case' 0 N--CA 1.392 -3.337 0 CA-C-N 113.853 -1.521 . . . . 0.0 114.012 -177.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -90.7 -52.1 5.05 Favored 'General case' 0 N--CA 1.385 -3.709 0 C-N-CA 117.469 -1.692 . . . . 0.0 107.59 173.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -51.87 -59.28 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 113.217 -1.81 . . . . 0.0 113.141 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 56.7 m-20 -59.22 -39.37 82.48 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 123.534 1.635 . . . . 0.0 110.732 -177.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -80.56 -41.95 23.2 Favored 'General case' 0 C--N 1.256 -3.468 0 CA-C-N 112.442 -2.163 . . . . 0.0 112.722 -172.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.453 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.45 -35.38 73.93 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 122.191 0.996 . . . . 0.0 108.332 176.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 3.9 tp -68.09 -40.36 82.68 Favored 'General case' 0 N--CA 1.384 -3.757 0 CA-C-N 113.211 -1.813 . . . . 0.0 110.141 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.2 ttp -72.02 -19.94 61.78 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.33 -174.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.492 HG23 HD21 ' A' ' 125' ' ' ASN . 54.1 mt -84.7 -52.75 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 175.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.8 t -47.93 -46.33 31.95 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.938 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.06 5.71 13.46 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.18 11.04 81.91 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 116.48 1.352 . . . . 0.0 116.48 171.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.455 HD22 ' HB3' ' B' ' 115' ' ' ASP . 5.9 mt -73.28 -52.51 13.7 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 117.413 -1.715 . . . . 0.0 107.867 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.492 HD21 HG23 ' A' ' 120' ' ' ILE . 20.2 m120 56.93 149.72 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 113.191 -1.822 . . . . 0.0 115.149 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -102.51 89.46 3.54 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 174.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . 0.364 11.8 p 45.95 71.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 123.806 1.765 . . . . 0.0 113.926 -174.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 125' ' ' ASN . . . -139.6 16.7 2.53 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 112.434 -2.167 . . . . 0.0 107.799 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -127.57 148.79 50.35 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 69.85 -54.48 0.61 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.355 1.062 . . . . 0.0 111.285 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -132.97 106.42 7.66 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 123.587 0.755 . . . . 0.0 109.095 175.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 C--N 1.295 -1.799 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.689 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.49 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 11.4 p -71.64 -19.42 62.1 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.194 0.521 . . . . 0.0 111.834 -178.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 21.7 t -89.3 -2.99 58.66 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.446 0.641 . . . . 0.0 109.669 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -86.24 100.15 12.06 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -92.19 -51.58 5.1 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -143.68 160.66 40.29 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.465 ' HA ' ' O ' ' B' ' 11' ' ' GLN . 78.5 m-70 69.5 -164.6 0.17 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 124.324 1.015 . . . . 0.0 110.518 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 70.19 -178.67 0.22 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.033 0.933 . . . . 0.0 109.847 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 59.65 -93.67 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.734 0.813 . . . . 0.0 110.471 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 39.8 m -158.8 26.69 0.22 Allowed 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' B' ' 7' ' ' HIS . 29.0 tt0 -107.88 120.03 41.12 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.025 -173.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -111.02 118.1 48.75 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 166.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.8 -25.5 78.54 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.681 2.254 . . . . 0.0 113.379 -174.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.458 HD12 ' NZ ' ' B' ' 96' ' ' LYS . 62.1 mt -83.67 118.19 30.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -175.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -144.87 160.73 40.82 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' B' ' 41' ' ' ILE . 50.5 ttp180 -71.39 114.4 9.41 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 143.31 -27.74 2.11 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.388 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -97.73 138.51 35.0 Favored 'General case' 0 N--CA 1.425 -1.711 0 CA-C-O 121.244 0.545 . . . . 0.0 111.05 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.427 ' HB ' ' H ' ' B' ' 104' ' ' THR . 64.7 t -89.76 123.44 41.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.528 174.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -113.04 146.29 39.38 Favored 'General case' 0 C--N 1.267 -3.016 0 C-N-CA 124.122 0.969 . . . . 0.0 109.806 172.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.602 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.1 mp -83.34 152.21 25.19 Favored 'General case' 0 N--CA 1.399 -2.983 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 167.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.38 156.84 40.34 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-O 121.785 0.802 . . . . 0.0 111.428 -173.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.98 93.88 8.99 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.556 HD22 ' HA3' ' B' ' 33' ' ' GLY 0.25 1.6 tt -90.58 -11.24 40.59 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -174.401 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.622 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 9.2 m -33.55 -177.45 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.668 0 C-N-CA 129.497 3.119 . . . . 0.0 115.364 170.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.622 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 31.59 36.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 123.751 2.968 . . . . 0.0 117.421 -154.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.542 HG13 ' O ' ' B' ' 24' ' ' LEU . 6.9 m -73.24 148.51 8.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.61 164.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -117.48 122.51 43.93 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.75 -111.89 4.14 Favored Glycine 0 C--N 1.32 -0.344 0 CA-C-N 115.087 -0.96 . . . . 0.0 114.121 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 18.2 m -60.17 -21.86 62.19 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.651 1.18 . . . . 0.0 113.122 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.517 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 73.2 mt-10 -70.3 143.48 52.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 -177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 -128.25 117.22 21.12 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.556 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -160.51 -91.66 0.08 OUTLIER Glycine 0 N--CA 1.415 -2.757 0 C-N-CA 119.437 -1.363 . . . . 0.0 113.964 173.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.96 -147.45 27.66 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 105.391 -3.084 . . . . 0.0 105.391 -167.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.95 122.08 51.41 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 119.766 1.783 . . . . 0.0 108.821 172.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -145.86 162.94 33.68 Favored Pre-proline 0 C--N 1.29 -2.004 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.9 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 18.4 Cg_exo -69.98 138.46 37.15 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 121.855 1.704 . . . . 0.0 109.008 167.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 27.3 m -125.54 161.98 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.524 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 29.1 m -101.5 129.44 52.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.186 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 33.9 mm -88.26 109.58 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.852 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.479 ' O ' ' HD3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -105.64 -18.01 7.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.734 -177.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.665 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 7.0 tt0 -64.92 163.73 13.9 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -170.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.63 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 13.3 p-10 -65.11 178.89 0.78 Allowed 'General case' 0 CA--C 1.5 -0.95 0 CA-C-N 114.023 -1.444 . . . . 0.0 111.876 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.05 -47.76 49.25 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 112.827 -1.988 . . . . 0.0 113.039 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.426 ' HA ' ' HD2' ' B' ' 48' ' ' LYS . 3.5 m -87.28 -24.16 24.44 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -162.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' B' ' 50' ' ' SER . . . -63.69 -30.27 77.15 Favored Glycine 0 C--O 1.2 -1.986 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -66.29 -40.25 89.92 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 120.886 0.374 . . . . 0.0 110.624 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' B' ' 45' ' ' THR . 28.5 mttt -78.76 -54.9 5.61 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-O 121.06 0.457 . . . . 0.0 112.04 -175.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -88.07 -25.06 23.25 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' B' ' 46' ' ' GLY . 13.9 t -107.6 144.83 30.05 Favored Pre-proline 0 C--N 1.296 -1.752 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.93 -6.1 12.26 Favored 'Trans proline' 0 C--O 1.241 0.639 0 C-N-CA 122.433 2.089 . . . . 0.0 111.631 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 3.7 p -107.68 142.3 37.87 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.336 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.665 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.1 OUTLIER -140.5 139.64 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-O 120.803 0.335 . . . . 0.0 111.6 176.067 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' B' ' 93' ' ' THR . 4.8 tt -87.7 130.08 38.0 Favored 'Isoleucine or valine' 0 C--O 1.247 0.941 0 CA-C-O 121.611 0.72 . . . . 0.0 112.901 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.492 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 20.0 m -134.67 167.91 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.169 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.525 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -125.15 140.25 53.04 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.97 127.75 33.94 Favored 'General case' 0 C--O 1.248 1.024 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.57 HG12 ' CD1' ' B' ' 86' ' ' ILE . 60.0 mt -85.54 130.81 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 114.322 -1.308 . . . . 0.0 107.535 173.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . 0.41 HG22 ' H ' ' B' ' 61' ' ' ARG . 91.7 m -128.26 112.76 14.83 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.43 0.633 . . . . 0.0 111.856 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.0 43.39 1.7 Allowed Glycine 0 C--N 1.307 -1.053 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 175.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.41 ' H ' HG22 ' B' ' 59' ' ' THR . 43.5 ttm180 -123.56 3.89 8.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.812 0.815 . . . . 0.0 109.339 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.467 HG23 HG21 ' B' ' 85' ' ' VAL . 12.3 tt -144.65 154.21 14.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -176.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -130.06 171.35 12.91 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp 68.3 96.36 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.107 0.963 . . . . 0.0 112.883 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -100.54 92.88 5.33 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.379 175.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . 0.432 ' HD3' ' O ' ' B' ' 66' ' ' LYS . 11.1 tmtt? -98.91 -38.74 8.89 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.8 tt -75.93 130.06 79.42 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.526 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.24 -12.99 21.95 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.854 3.036 . . . . 0.0 116.272 -174.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 69.9 p -87.27 -13.51 43.51 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.763 0.792 . . . . 0.0 110.038 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -105.7 130.44 53.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 9.9 p -129.02 136.75 58.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.798 175.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -98.37 137.68 36.73 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-O 121.925 0.869 . . . . 0.0 112.025 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.715 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.3 OUTLIER -120.13 158.22 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.394 -179.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -72.95 116.19 13.16 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -53.2 -43.28 67.07 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -53.22 -43.33 67.18 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 125.127 1.371 . . . . 0.0 111.011 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . 0.513 ' HD3' ' OG ' ' B' ' 107' ' ' SER . 41.0 ttmt -71.82 -34.57 69.44 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.208 -175.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.715 ' CE1' HG21 ' B' ' 73' ' ' ILE . 3.1 m-85 -96.82 7.97 45.41 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.369 0.604 . . . . 0.0 111.106 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 61.2 tttm 70.5 13.35 7.43 Favored 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 124.957 1.303 . . . . 0.0 113.206 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.58 167.29 13.52 Favored 'General case' 0 CA--C 1.478 -1.796 0 CA-C-O 122.212 1.006 . . . . 0.0 110.235 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -99.86 -11.74 20.47 Favored 'General case' 0 C--N 1.271 -2.825 0 CA-C-N 113.557 -1.656 . . . . 0.0 109.041 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -126.29 149.6 49.02 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.45 132.96 35.48 Favored 'General case' 0 CA--C 1.493 -1.218 0 O-C-N 124.225 0.953 . . . . 0.0 110.116 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.419 ' O ' HG12 ' B' ' 73' ' ' ILE . 10.9 m -102.39 121.99 43.41 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.826 -169.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.467 HG21 HG23 ' B' ' 62' ' ' ILE . 39.1 t -113.49 135.03 54.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 175.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.57 ' CD1' HG12 ' B' ' 58' ' ' ILE . 17.2 mm -104.94 135.91 40.9 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.853 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.4 mt -105.14 107.68 18.8 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' B' ' 118' ' ' LEU . 3.7 mm? -85.64 12.28 9.09 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.908 0.861 . . . . 0.0 111.567 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.39 -44.01 3.43 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.492 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.23 80.56 6.87 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 122.254 1.026 . . . . 0.0 108.252 178.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.525 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.2 pp -123.1 -178.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 CA-C-N 114.033 -1.439 . . . . 0.0 108.192 -177.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.524 ' HD2' HD23 ' B' ' 24' ' ' LEU . 13.6 ptp180 -175.3 167.56 3.37 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 171.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' B' ' 54' ' ' ILE . 96.0 m -108.5 121.84 45.81 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.173 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.444 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 71.7 mt -131.22 145.33 51.88 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 124.707 1.254 . . . . 0.0 110.93 -169.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.621 ' O ' ' HG2' ' B' ' 98' ' ' ARG . 27.5 t70 -52.52 136.42 32.17 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.977 0.911 . . . . 0.0 112.911 172.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.458 ' NZ ' HD12 ' B' ' 14' ' ' ILE . 29.0 mtpp -54.65 -29.85 53.53 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.115 0.966 . . . . 0.0 112.371 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.48 ' HB2' ' OD2' ' B' ' 95' ' ' ASP . 9.8 mtmp? -83.7 -17.95 39.58 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.585 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.621 ' HG2' ' O ' ' B' ' 95' ' ' ASP . 11.8 ptm180 -86.25 -17.85 33.64 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.814 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.68 121.35 16.27 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 162.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -92.19 -60.39 1.86 Allowed 'General case' 0 C--N 1.268 -2.938 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 -170.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.449 ' HG3' HD13 ' B' ' 21' ' ' LEU . 10.6 pt-20 -148.68 130.19 14.86 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-O 122.512 1.149 . . . . 0.0 114.044 -168.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -61.14 110.89 1.51 Allowed 'General case' 0 C--N 1.283 -2.32 0 C-N-CA 128.497 2.719 . . . . 0.0 106.924 173.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.679 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 53.7 tp -107.44 -64.19 1.22 Allowed 'General case' 0 N--CA 1.402 -2.853 0 CA-C-O 121.94 0.876 . . . . 0.0 111.05 -172.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.734 HG22 ' H ' ' B' ' 105' ' ' TYR 0.291 17.4 m -138.12 -157.12 0.74 Allowed 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 113.766 -1.561 . . . . 0.0 111.216 -164.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.734 ' H ' HG22 ' B' ' 104' ' ' THR . 11.9 t80 -158.32 153.63 25.78 Favored 'General case' 0 N--CA 1.402 -2.859 0 CA-C-N 119.703 1.138 . . . . 0.0 110.1 -161.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 6.5 mp -115.04 138.9 50.34 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.351 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.513 ' OG ' ' HD3' ' B' ' 77' ' ' LYS . 27.7 m -82.76 156.75 23.54 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.411 176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' B' ' 111' ' ' MET . 20.0 t70 -61.96 -36.78 82.46 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.42 0.629 . . . . 0.0 111.765 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -62.1 -40.95 97.61 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.623 175.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.457 ' HE3' HG23 ' B' ' 73' ' ' ILE . 13.6 tppt? -77.24 -28.74 53.75 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.175 -179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.5 OUTLIER -49.33 -46.17 46.46 Favored 'General case' 0 CA--C 1.459 -2.536 0 CA-C-O 122.143 0.973 . . . . 0.0 109.088 171.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.563 ' HE2' ' HA ' ' B' ' 112' ' ' LYS . 6.1 mmpt? -71.48 -16.22 62.35 Favored 'General case' 0 N--CA 1.38 -3.926 0 CA-C-N 113.841 -1.527 . . . . 0.0 114.848 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -89.89 -51.59 5.41 Favored 'General case' 0 N--CA 1.388 -3.566 0 C-N-CA 117.014 -1.874 . . . . 0.0 107.27 175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.72 -59.62 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 113.36 -1.745 . . . . 0.0 113.293 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 49.1 m-20 -59.47 -40.3 86.49 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 123.713 1.721 . . . . 0.0 111.32 -177.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.406 ' O ' HG13 ' B' ' 120' ' ' ILE 0.351 25.9 t30 -80.74 -40.38 25.34 Favored 'General case' 0 C--N 1.255 -3.54 0 CA-C-N 112.711 -2.04 . . . . 0.0 112.391 -171.397 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -63.58 -32.98 74.61 Favored 'General case' 0 CA--C 1.485 -1.529 0 CA-C-O 121.981 0.896 . . . . 0.0 108.681 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.542 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.8 tp -67.45 -39.67 85.35 Favored 'General case' 0 N--CA 1.38 -3.939 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.576 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 8.6 ttp -71.83 -20.37 61.84 Favored 'General case' 0 N--CA 1.407 -2.594 0 C-N-CA 123.61 0.764 . . . . 0.0 110.042 -175.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.495 HG23 HD21 ' B' ' 125' ' ' ASN . 63.5 mt -84.3 -53.17 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 23.2 t -47.72 -46.09 29.32 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.993 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 8.7 mp -79.75 5.83 12.44 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.65 9.77 79.0 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 116.195 1.238 . . . . 0.0 116.195 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.424 HD22 ' HB3' ' A' ' 115' ' ' ASP . 6.2 mt -71.56 -54.37 10.71 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 119.498 1.649 . . . . 0.0 107.762 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.495 HD21 HG23 ' B' ' 120' ' ' ILE . 21.3 m120 56.26 149.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 113.049 -1.887 . . . . 0.0 115.031 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -101.77 89.29 3.63 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . 0.372 10.9 p 45.69 72.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 125.993 1.717 . . . . 0.0 113.963 -173.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' B' ' 125' ' ' ASN . . . -139.29 19.41 2.58 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 112.99 -1.914 . . . . 0.0 107.105 176.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -130.47 149.84 51.96 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 112.481 -2.145 . . . . 0.0 105.397 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 72.19 -53.07 0.7 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.147 0.979 . . . . 0.0 110.858 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -134.58 113.31 11.63 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 124.207 1.003 . . . . 0.0 109.172 175.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 . . . . . 0 C--N 1.296 -1.752 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.24 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.743 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.8 m -79.08 85.63 4.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.736 0.779 . . . . 0.0 110.811 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 m -147.61 133.77 19.39 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -89.78 114.99 26.78 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -88.77 94.02 9.77 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.358 0.599 . . . . 0.0 109.763 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -99.73 97.84 8.74 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -141.42 1.68 1.59 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -88.37 -40.29 13.67 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -109.17 162.93 13.81 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.8 m -150.93 130.64 13.14 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.447 ' HB2' ' HE2' ' A' ' 96' ' ' LYS . 23.4 pt20 -86.75 82.29 7.9 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.458 1.123 . . . . 0.0 109.941 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -56.61 154.8 16.07 Favored Pre-proline 0 C--O 1.245 0.816 0 CA-C-N 112.864 -1.971 . . . . 0.0 112.564 -175.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -67.02 114.17 3.08 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.557 2.171 . . . . 0.0 109.934 173.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mt -77.22 147.75 7.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.575 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -115.6 144.36 44.01 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 42' ' ' GLN . 19.7 ptt180 -73.87 152.3 40.25 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.879 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.17 -2.71 79.28 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.977 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -97.71 177.88 5.33 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 3.9 t -133.62 134.45 56.55 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.66 0 C-N-CA 122.806 0.442 . . . . 0.0 111.844 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.486 ' O ' HG22 ' A' ' 38' ' ' VAL . 12.5 m-85 -131.51 144.32 51.04 Favored 'General case' 0 CA--C 1.467 -2.232 0 C-N-CA 124.46 1.104 . . . . 0.0 110.146 177.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.7 mp -79.58 151.49 30.62 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 169.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.01 139.47 23.64 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.278 -175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -74.37 92.65 2.32 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 122.146 0.974 . . . . 0.0 109.773 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.587 ' O ' HG13 ' A' ' 27' ' ' VAL . 83.7 mt -82.19 -12.41 58.14 Favored 'General case' 0 CA--C 1.477 -1.839 0 CA-C-N 113.892 -1.504 . . . . 0.0 112.11 -177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.433 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -90.83 61.79 0.0 OUTLIER Pre-proline 0 C--N 1.257 -3.453 0 N-CA-C 119.754 3.242 . . . . 0.0 119.754 -176.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' B' ' 26' ' ' PRO . 1.1 Cg_endo -117.68 22.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.236 0 N-CA-C 108.46 -1.4 . . . . 0.0 108.46 148.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 24' ' ' LEU . 14.1 m -72.81 157.97 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.943 0.878 . . . . 0.0 113.364 -172.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -124.01 156.3 36.71 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 113.721 -1.581 . . . . 0.0 107.163 175.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.95 -135.44 15.09 Favored Glycine 0 N--CA 1.418 -2.556 0 O-C-N 124.131 0.894 . . . . 0.0 112.068 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.6 m -94.34 6.93 47.2 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.476 -0.362 . . . . 0.0 111.686 -175.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 7.1 mm-40 -71.33 153.14 42.58 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 119.374 -0.931 . . . . 0.0 112.959 -176.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -81.85 119.15 23.55 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -171.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.4 158.97 17.19 Favored Glycine 0 CA--C 1.472 -2.651 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.495 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . 111.63 137.97 7.39 Favored Glycine 0 C--N 1.276 -2.793 0 CA-C-N 113.016 -1.592 . . . . 0.0 109.972 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 p -64.6 119.13 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.124 0 CA-C-O 122.365 1.079 . . . . 0.0 109.039 176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -144.93 149.22 41.77 Favored Pre-proline 0 C--N 1.267 -3.015 0 CA-C-N 114.271 -1.332 . . . . 0.0 108.209 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 33.3 Cg_exo -58.76 136.59 74.82 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.311 2.007 . . . . 0.0 111.37 171.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 20' ' ' TYR . 29.4 m -122.51 161.68 23.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 123.933 0.893 . . . . 0.0 108.721 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.6 m -101.48 132.11 47.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 120.722 0.296 . . . . 0.0 110.697 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mm -86.04 105.12 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.427 HG23 HG23 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -97.39 -23.46 4.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.535 -177.081 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.65 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -64.5 168.49 5.8 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -167.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.58 ' H ' ' HG2' ' A' ' 42' ' ' GLN . 12.9 p-10 -66.53 177.62 1.5 Allowed 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.464 -1.698 . . . . 0.0 110.632 177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 16.8 t70 -89.18 -29.56 19.21 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.188 -176.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.586 ' HA ' ' CD ' ' A' ' 48' ' ' LYS . 45.1 m -82.79 -26.17 32.06 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -170.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.42 -21.69 74.44 Favored Glycine 0 C--O 1.196 -2.238 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -82.12 -26.79 33.25 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.273 0.559 . . . . 0.0 109.931 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.586 ' CD ' ' HA ' ' A' ' 45' ' ' THR . 6.6 mtpp -82.94 -57.98 3.06 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.978 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -96.35 -35.86 11.06 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.6 m -90.84 158.74 41.71 Favored Pre-proline 0 C--N 1.29 -2.02 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -87.86 -11.45 4.69 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 C-N-CA 121.38 1.387 . . . . 0.0 110.849 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 17.0 p -96.26 149.88 21.17 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.504 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -148.58 137.95 15.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.363 170.511 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.65 HG22 ' HG3' ' A' ' 42' ' ' GLN . 15.0 tt -86.47 135.32 25.36 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-O 121.444 0.64 . . . . 0.0 110.29 175.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.7 m -136.99 146.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.994 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 91' ' ' ILE . . . -109.76 135.64 50.36 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.78 145.1 48.93 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 115.19 1.552 . . . . 0.0 115.19 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.44 HG12 HD12 ' A' ' 86' ' ' ILE . 49.1 mt -100.79 143.74 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.969 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 m -92.35 173.37 7.84 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.25 -73.23 0.9 Allowed Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 171.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 83' ' ' ASP . 78.4 ttt180 -167.86 144.51 4.14 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.9 tt -164.88 -39.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.9 m120 63.38 -178.46 0.15 Allowed 'General case' 0 C--O 1.249 1.069 0 C-N-CA 124.329 1.052 . . . . 0.0 113.119 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.5 mttm 62.66 71.73 0.51 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.175 0.99 . . . . 0.0 109.067 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 70' ' ' HIS . . . -52.35 -71.9 0.06 Allowed 'General case' 0 C--O 1.246 0.918 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.219 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt 66.63 -56.63 0.4 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.277 1.431 . . . . 0.0 113.329 175.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.69 136.84 70.5 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.0 2.44 2.14 Favored 'Trans proline' 0 CA--C 1.552 1.393 0 C-N-CA 122.101 1.867 . . . . 0.0 113.841 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 p -100.91 -18.93 16.13 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.483 0.659 . . . . 0.0 109.728 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.432 ' O ' ' HB1' ' A' ' 65' ' ' ALA . 17.5 m170 -102.03 130.09 48.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.1 p -134.28 136.94 52.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.568 173.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 10.2 pt-20 -101.38 146.61 27.36 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.082 0.468 . . . . 0.0 112.188 -177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.8 pt -112.75 146.08 17.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.11 109.0 6.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.842 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -60.32 -36.15 77.26 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.637 0.732 . . . . 0.0 112.789 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -51.4 -52.1 48.91 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.19 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -91.05 -25.62 19.57 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.811 -0.756 . . . . 0.0 111.361 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' A' ' 106' ' ' LEU . 1.9 m-85 -88.55 20.5 3.36 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 123.635 0.774 . . . . 0.0 111.858 -172.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 56.75 27.61 13.02 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 170.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.31 170.76 8.0 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.843 0.83 . . . . 0.0 109.718 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -99.8 -16.94 17.91 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.231 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.73 140.0 52.27 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.027 -173.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.528 ' O ' ' HG3' ' A' ' 61' ' ' ARG . 4.4 t70 -85.81 102.8 14.0 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.0 t -103.28 172.75 6.63 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -165.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 72' ' ' GLU . 37.7 t -123.9 142.97 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.44 HD12 HG12 ' A' ' 58' ' ' ILE . 20.9 mm -106.44 133.31 51.3 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.8 mt -105.95 107.06 17.87 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 121.462 0.648 . . . . 0.0 109.737 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.6 mm? -84.26 16.96 2.73 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.608 -175.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.03 -40.28 3.52 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 122.13 0.967 . . . . 0.0 109.019 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -93.19 72.82 4.61 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.56 ' O ' ' HB ' ' B' ' 93' ' ' THR . 8.0 mt -106.62 -174.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.533 ' H ' HG22 ' A' ' 91' ' ' ILE . 5.7 ptp180 -175.14 174.89 2.35 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 124.004 0.922 . . . . 0.0 109.733 166.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.559 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 68.0 m -125.27 130.05 51.26 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -132.99 143.08 49.2 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -173.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -80.54 153.05 28.32 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.876 175.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 11' ' ' GLN . 60.2 mtpt -47.12 -18.21 0.08 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 126.523 1.929 . . . . 0.0 115.333 -176.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -74.31 -27.15 60.58 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.317 0.58 . . . . 0.0 111.132 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -74.84 -35.73 62.38 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 123.449 0.7 . . . . 0.0 110.47 -178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.3 mp -74.6 122.98 23.98 Favored 'General case' 0 CA--C 1.494 -1.21 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.398 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.45 -59.61 1.84 Allowed 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.5 pt-20 -154.85 135.55 13.56 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.478 0.656 . . . . 0.0 112.6 -168.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -64.62 121.26 14.04 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.608 173.462 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -113.78 -61.92 1.67 Allowed 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.446 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.516 HG22 HG11 ' A' ' 19' ' ' VAL . 5.2 t -126.3 -164.35 1.32 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.069 -1.452 . . . . 0.0 112.348 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -159.84 147.14 16.61 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 123.812 0.845 . . . . 0.0 112.651 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.586 ' HA ' ' CE2' ' A' ' 78' ' ' TYR . 13.1 mt -98.65 155.34 17.36 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 113.959 -1.473 . . . . 0.0 108.476 177.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.8 m -86.36 167.86 14.37 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 111' ' ' MET . 22.2 t70 -56.58 -43.62 80.23 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.69 0.796 . . . . 0.0 112.381 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.13 -41.55 98.36 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -67.23 -33.66 75.83 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.513 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -55.1 -42.41 72.85 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 123.967 0.907 . . . . 0.0 110.313 175.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.668 ' HE2' ' N ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -76.22 -11.98 60.01 Favored 'General case' 0 CA--C 1.472 -2.046 0 C-N-CA 122.947 0.499 . . . . 0.0 111.544 179.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -86.67 -43.47 12.59 Favored 'General case' 0 N--CA 1.403 -2.821 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -55.92 -58.92 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.111 0 CA-C-N 112.801 -2.0 . . . . 0.0 112.316 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -51.89 -49.92 62.06 Favored 'General case' 0 N--CA 1.512 2.654 0 CA-C-O 123.311 1.529 . . . . 0.0 110.344 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.665 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 1.3 t30 -68.97 -49.76 55.07 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 112.203 -2.272 . . . . 0.0 112.743 -173.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.45 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -59.07 -39.75 83.08 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 2.4 tp -64.32 -47.36 79.73 Favored 'General case' 1 N--CA 1.378 -4.07 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.498 -175.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.685 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 1.9 ptm -71.19 -19.74 62.36 Favored 'General case' 0 C--O 1.202 -1.424 0 O-C-N 121.568 -0.707 . . . . 0.0 112.513 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 116' ' ' ASN . 54.2 mt -76.76 -53.54 14.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 174.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 t -55.89 -30.94 62.35 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.236 -1.802 . . . . 0.0 111.555 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.573 HD22 HG21 ' B' ' 54' ' ' ILE . 44.2 mt -101.6 5.48 41.66 Favored 'General case' 0 N--CA 1.425 -1.696 0 C-N-CA 120.024 -0.67 . . . . 0.0 112.527 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 89.38 5.36 72.53 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 117.729 1.851 . . . . 0.0 117.729 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.685 ' HB2' ' HB2' ' A' ' 119' ' ' MET . 6.9 mp -71.26 -45.18 63.77 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 120.544 2.172 . . . . 0.0 108.665 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.6 m120 54.46 133.25 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.532 1.933 . . . . 0.0 116.006 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.48 73.66 9.47 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 122.053 0.93 . . . . 0.0 110.455 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.2 t -122.38 2.79 6.05 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.459 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.39 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 67.14 132.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.505 -1.68 . . . . 0.0 112.896 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -72.19 -41.56 66.82 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 171.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 53.11 73.09 0.38 Allowed 'General case' 0 C--O 1.241 0.642 0 CA-C-N 113.739 -1.573 . . . . 0.0 109.783 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -77.76 90.32 4.03 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 122.194 0.997 . . . . 0.0 112.14 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 . . . . . 0 C--N 1.299 -1.61 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.714 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.264 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -82.56 92.15 7.05 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-O 121.747 0.784 . . . . 0.0 110.047 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 34.1 m -150.12 135.45 18.07 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -91.94 109.36 20.7 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -84.57 96.1 9.06 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -101.28 96.3 7.09 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.157 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -139.19 -3.03 1.59 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -83.31 -38.92 21.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -110.27 164.32 12.78 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.2 m -150.03 134.71 17.57 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -91.91 80.4 5.2 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 122.371 1.081 . . . . 0.0 109.164 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -59.11 155.41 34.11 Favored Pre-proline 0 C--O 1.243 0.739 0 CA-C-N 113.501 -1.681 . . . . 0.0 113.063 -174.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.46 113.27 2.85 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.442 2.095 . . . . 0.0 110.055 174.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 44.0 mt -75.91 147.44 7.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.295 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -114.5 144.83 42.72 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.558 ' HB3' ' O ' ' B' ' 42' ' ' GLN . 19.9 ptt180 -75.31 147.4 40.2 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.777 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.02 -2.88 60.07 Favored Glycine 0 N--CA 1.435 -1.404 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.32 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -97.25 174.87 6.5 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 5.6 t -132.94 131.6 59.07 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.9 0 C-N-CA 123.596 0.759 . . . . 0.0 111.49 -176.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.5 ' O ' HG22 ' B' ' 38' ' ' VAL . 8.4 m-85 -129.26 144.16 51.12 Favored 'General case' 0 CA--C 1.465 -2.296 0 C-N-CA 124.167 0.987 . . . . 0.0 110.396 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -79.94 151.1 30.27 Favored 'General case' 0 N--CA 1.4 -2.942 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.03 139.71 23.82 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.155 -175.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -73.64 92.29 1.95 Allowed 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 122.048 0.928 . . . . 0.0 109.455 173.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.572 ' O ' HG13 ' B' ' 27' ' ' VAL . 90.2 mt -83.09 -9.97 58.94 Favored 'General case' 0 CA--C 1.474 -1.947 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.787 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.434 ' HB3' ' H ' ' B' ' 34' ' ' GLY . 0.1 OUTLIER -91.91 61.3 0.0 OUTLIER Pre-proline 0 C--N 1.247 -3.879 0 N-CA-C 119.262 3.06 . . . . 0.0 119.262 -176.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.429 ' HB2' ' O ' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -117.74 21.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.255 0 N-CA-C 108.476 -1.394 . . . . 0.0 108.476 150.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.572 HG13 ' O ' ' B' ' 24' ' ' LEU . 15.2 m -72.62 157.91 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-O 122.085 0.945 . . . . 0.0 113.154 -171.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -124.05 155.98 37.35 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 113.354 -1.748 . . . . 0.0 107.679 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.26 -135.32 14.02 Favored Glycine 0 N--CA 1.421 -2.326 0 O-C-N 123.997 0.811 . . . . 0.0 112.109 173.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -94.75 8.41 42.63 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 122.661 0.384 . . . . 0.0 111.846 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.08 151.9 42.76 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.58 118.45 21.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 121.16 0.505 . . . . 0.0 109.857 -171.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.89 155.62 18.75 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-N 114.701 -1.136 . . . . 0.0 115.264 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.434 ' H ' ' HB3' ' B' ' 25' ' ' SER . . . 112.43 137.84 7.13 Favored Glycine 0 N--CA 1.418 -2.524 0 CA-C-N 113.023 -1.588 . . . . 0.0 110.364 177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 p -63.62 119.67 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.826 0 CA-C-O 122.4 1.095 . . . . 0.0 108.86 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -145.49 149.74 41.68 Favored Pre-proline 0 C--N 1.265 -3.068 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.304 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.2 Cg_exo -59.07 136.85 75.91 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.137 1.891 . . . . 0.0 111.201 171.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -122.76 161.02 24.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 123.968 0.907 . . . . 0.0 108.61 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 30.0 m -100.93 132.05 47.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 120.748 0.308 . . . . 0.0 110.723 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 26.1 mm -86.06 105.91 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.43 HG23 HG23 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -97.53 -25.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.383 -177.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.641 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.1 OUTLIER -63.12 167.85 4.65 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -167.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.575 ' H ' ' HG2' ' B' ' 42' ' ' GLN . 14.5 p-10 -66.41 176.26 1.92 Allowed 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.083 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.98 -30.13 21.5 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.648 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . 0.522 ' HA ' ' CD ' ' B' ' 48' ' ' LYS . 28.3 m -84.0 -25.52 29.89 Favored 'General case' 0 C--O 1.246 0.87 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -170.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -68.61 -21.46 74.69 Favored Glycine 0 C--O 1.194 -2.394 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 176.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -82.88 -27.94 30.38 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.181 0.515 . . . . 0.0 110.018 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.522 ' CD ' ' HA ' ' B' ' 45' ' ' THR . 4.4 mtpp -80.74 -58.48 3.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.869 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -97.39 -35.89 10.54 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -172.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 38.5 m -88.11 156.59 51.74 Favored Pre-proline 0 C--N 1.292 -1.91 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.193 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -86.97 -12.32 5.06 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 121.22 1.28 . . . . 0.0 110.663 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 19.0 p -96.14 149.29 21.79 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -173.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.479 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.8 OUTLIER -148.1 137.87 16.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 O-C-N 123.94 0.775 . . . . 0.0 109.258 170.499 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.641 HG22 ' HG3' ' B' ' 42' ' ' GLN . 15.6 tt -86.54 135.47 25.05 Favored 'Isoleucine or valine' 0 C--O 1.253 1.239 0 CA-C-O 121.278 0.561 . . . . 0.0 110.277 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.67 145.65 29.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.965 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' B' ' 91' ' ' ILE . . . -109.59 135.17 51.0 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.76 145.87 48.47 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.439 HG12 HD12 ' B' ' 86' ' ' ILE . 45.6 mt -101.91 145.22 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 CA-C-N 113.062 -1.881 . . . . 0.0 107.859 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 5.0 m -93.6 176.85 6.21 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.62 -72.02 1.14 Allowed Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 171.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' B' ' 83' ' ' ASP . 77.8 ttt180 -168.06 144.94 4.1 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 14.2 tt -165.16 -39.51 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 19.1 m120 63.07 -177.22 0.15 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.479 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 61.98 68.02 0.71 Allowed 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 124.043 0.84 . . . . 0.0 109.471 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' B' ' 70' ' ' HIS . . . -49.49 -70.29 0.09 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.256 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt 64.09 -59.99 0.2 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.004 1.322 . . . . 0.0 113.847 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.0 mt -72.82 137.41 79.85 Favored Pre-proline 0 C--N 1.308 -1.229 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.05 6.86 0.72 Allowed 'Trans proline' 0 CA--C 1.55 1.317 0 C-N-CA 122.32 2.013 . . . . 0.0 113.695 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -106.05 -18.52 14.0 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.529 0.681 . . . . 0.0 109.476 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.444 ' O ' ' HB1' ' B' ' 65' ' ' ALA . 26.7 m170 -102.43 130.18 49.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.26 137.39 50.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 8.6 pt-20 -101.08 150.67 22.68 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 120.998 0.428 . . . . 0.0 112.152 -176.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . . . . . . . . . 21.0 pt -117.16 144.41 25.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.78 109.76 5.16 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.869 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.6 -38.55 85.06 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-O 121.343 0.592 . . . . 0.0 112.499 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -51.22 -51.76 50.87 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 113.591 -1.64 . . . . 0.0 113.55 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -88.12 -26.43 22.49 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 118.764 -1.175 . . . . 0.0 112.022 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' B' ' 106' ' ' LEU . 1.7 m-85 -89.79 19.14 4.94 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 123.722 0.809 . . . . 0.0 111.547 -171.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 60.23 23.83 13.21 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 124.542 1.137 . . . . 0.0 113.818 169.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 30.2 mt -110.59 165.84 11.48 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 122.058 0.933 . . . . 0.0 110.52 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.52 -14.3 25.22 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.404 -1.726 . . . . 0.0 108.853 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.68 139.16 53.79 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.005 -174.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' B' ' 61' ' ' ARG . 4.6 t70 -85.13 103.77 14.42 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 41.8 t -104.56 172.83 6.58 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -164.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' B' ' 72' ' ' GLU . 38.4 t -124.42 142.68 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.439 HD12 HG12 ' B' ' 58' ' ' ILE . 19.8 mm -106.26 133.59 50.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 80.1 mt -106.04 106.99 17.76 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-O 121.495 0.664 . . . . 0.0 109.541 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.7 mm? -84.31 16.47 3.03 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.771 0.796 . . . . 0.0 111.599 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.6 -40.28 3.41 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-O 122.254 1.026 . . . . 0.0 109.168 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -92.49 74.16 5.18 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.559 ' O ' ' HB ' ' A' ' 93' ' ' THR . 8.4 mt -107.64 -174.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.522 ' NH1' ' HB3' ' B' ' 24' ' ' LEU . 5.8 ptp180 -174.48 173.76 2.87 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 123.923 0.889 . . . . 0.0 109.659 167.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 59.7 m -126.02 128.13 46.97 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 86.4 mt -132.26 142.7 49.49 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.889 -172.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 0.8 OUTLIER -80.09 153.34 28.8 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.009 175.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -46.56 -20.78 0.13 Allowed 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 126.5 1.92 . . . . 0.0 115.082 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -75.59 -22.41 56.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.023 0.439 . . . . 0.0 111.391 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -77.74 -36.82 50.33 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 122.994 0.518 . . . . 0.0 110.127 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.73 124.49 26.13 Favored 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 124.072 0.949 . . . . 0.0 110.547 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -96.0 -60.66 1.59 Allowed 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.3 pt-20 -154.72 135.24 13.42 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 121.396 0.617 . . . . 0.0 112.503 -167.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -63.94 122.6 16.89 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 113.792 -1.549 . . . . 0.0 110.837 172.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.3 tp -114.52 -62.48 1.59 Allowed 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.806 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.519 HG22 HG11 ' B' ' 19' ' ' VAL . 5.2 t -125.81 -164.68 1.33 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 117.702 -1.599 . . . . 0.0 112.458 -176.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -159.77 145.05 15.42 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 123.635 0.774 . . . . 0.0 111.866 -172.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.548 ' HA ' ' CE2' ' B' ' 78' ' ' TYR . 14.6 mt -98.22 156.43 16.7 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.526 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 49.7 m -84.08 169.22 15.13 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.389 175.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' B' ' 111' ' ' MET . 12.1 t70 -59.0 -44.84 91.73 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.905 0.882 . . . . 0.0 111.875 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.31 -40.0 96.12 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.22 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -67.88 -33.11 74.1 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -55.08 -42.87 73.35 Favored 'General case' 0 N--CA 1.41 -2.431 0 C-N-CA 123.617 0.767 . . . . 0.0 110.205 175.068 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.707 ' O ' ' HB3' ' B' ' 116' ' ' ASN . 0.4 OUTLIER -74.94 -13.25 60.51 Favored 'General case' 0 CA--C 1.466 -2.276 0 C-N-CA 122.568 0.347 . . . . 0.0 111.738 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . 0.427 ' HA ' HD22 ' B' ' 116' ' ' ASN . 34.6 mt-10 -86.01 -43.3 13.26 Favored 'General case' 0 N--CA 1.39 -3.435 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.4 t -55.78 -57.54 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.961 0 CA-C-N 112.906 -1.952 . . . . 0.0 111.922 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -52.7 -51.97 58.1 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 122.958 1.361 . . . . 0.0 109.56 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.707 ' HB3' ' O ' ' B' ' 112' ' ' LYS . 0.1 OUTLIER -70.06 -42.31 72.99 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 112.658 -2.065 . . . . 0.0 113.826 -171.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.42 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -64.25 -40.91 97.0 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 2.5 tp -62.37 -45.89 91.12 Favored 'General case' 0 N--CA 1.382 -3.832 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.181 -176.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.695 ' HB2' ' HB2' ' B' ' 124' ' ' LEU . 2.0 ptm -72.14 -19.4 61.78 Favored 'General case' 0 C--O 1.205 -1.247 0 O-C-N 121.638 -0.664 . . . . 0.0 112.603 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 116' ' ' ASN . 59.0 mt -77.54 -53.72 13.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 173.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 9.9 t -55.37 -31.08 61.47 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.62 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.619 HD22 HG21 ' A' ' 54' ' ' ILE . 46.0 mt -101.41 5.62 42.18 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.13 10.42 71.59 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 117.419 1.727 . . . . 0.0 117.419 172.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' B' ' 119' ' ' MET . 7.0 mp -74.33 -44.11 53.86 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 120.402 2.101 . . . . 0.0 108.277 178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.426 HD21 HG23 ' B' ' 120' ' ' ILE . 21.3 m120 51.99 129.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 126.716 2.007 . . . . 0.0 116.328 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.81 80.35 9.17 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 121.867 0.841 . . . . 0.0 110.64 -175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.87 -0.82 3.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.284 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 65.9 132.12 0.02 OUTLIER 'General case' 0 C--O 1.24 0.56 0 C-N-CA 126.183 1.793 . . . . 0.0 112.695 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -70.21 -44.15 69.21 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 56.72 78.49 0.21 Allowed 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 113.37 -1.741 . . . . 0.0 109.946 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -80.15 87.62 5.48 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.439 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 . . . . . 0 C--N 1.308 -1.196 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.365 177.822 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.743 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 p -67.21 -53.08 33.55 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.12 0.486 . . . . 0.0 110.146 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.5 m -85.93 91.0 8.24 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -72.6 106.26 4.57 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.881 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.0 m80 56.06 37.44 28.85 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.948 0.899 . . . . 0.0 111.374 178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -84.29 -56.48 3.62 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -88.58 -50.06 6.51 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.585 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -93.23 74.24 4.61 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 122.148 0.975 . . . . 0.0 111.593 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -103.38 -75.59 0.61 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.669 -1.151 . . . . 0.0 109.375 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.4 p -98.2 -35.25 10.43 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.677 0.751 . . . . 0.0 109.124 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -117.98 107.05 13.58 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.486 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -77.04 139.61 65.62 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.29 99.06 0.16 Allowed 'Trans proline' 0 C--O 1.254 1.306 0 C-N-CA 121.926 1.75 . . . . 0.0 112.029 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.7 mt -79.98 128.27 38.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.614 -1.176 . . . . 0.0 111.25 -176.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -114.97 153.87 29.8 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.523 ' HG2' ' SD ' ' A' ' 111' ' ' MET . 43.5 ttt180 -73.02 114.0 10.69 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.58 -7.54 10.35 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.478 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -81.31 172.34 13.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.153 0.978 . . . . 0.0 109.305 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.509 HG11 HG22 ' A' ' 104' ' ' THR . 19.6 t -133.07 135.14 57.25 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.129 0 CA-C-N 113.734 -1.575 . . . . 0.0 110.457 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.1 m-85 -134.84 148.7 50.21 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -81.33 151.59 27.94 Favored 'General case' 0 N--CA 1.401 -2.906 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.455 171.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -129.74 133.91 47.3 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 114.438 -1.256 . . . . 0.0 108.038 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.631 ' HA ' ' HB ' ' A' ' 35' ' ' VAL 0.293 2.3 p-10 -88.47 99.71 12.49 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 117.875 -1.53 . . . . 0.0 111.282 178.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 34' ' ' GLY . 4.5 mm? -84.84 40.22 0.79 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.788 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.539 ' HB3' ' HD2' ' A' ' 26' ' ' PRO 0.292 2.7 m -67.74 170.22 7.64 Favored Pre-proline 0 C--N 1.261 -3.266 0 C-N-CA 127.835 2.454 . . . . 0.0 107.798 170.278 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.1 OUTLIER 2.23 53.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.408 3.688 1 C-N-CA 127.38 5.387 . . . . 0.0 118.051 -173.397 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.17 178.08 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 114.25 -1.341 . . . . 0.0 111.459 172.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -104.14 116.36 32.06 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -175.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.55 -117.69 11.71 Favored Glycine 0 N--CA 1.433 -1.537 0 CA-C-N 114.333 -1.303 . . . . 0.0 113.297 174.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.4 m -94.48 19.57 9.52 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.59 160.41 30.09 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 173.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.605 ' HB3' ' NH2' ' A' ' 92' ' ' ARG . 0.9 OUTLIER -75.57 119.26 19.39 Favored 'General case' 0 C--O 1.192 -1.967 0 CA-C-O 120.613 0.244 . . . . 0.0 110.705 -172.01 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 24' ' ' LEU . . . -90.69 146.17 18.32 Favored Glycine 0 CA--C 1.474 -2.529 0 CA-C-O 121.636 0.576 . . . . 0.0 113.736 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 24' ' ' LEU . . . 104.9 136.87 8.87 Favored Glycine 0 N--CA 1.421 -2.338 0 CA-C-N 113.511 -1.345 . . . . 0.0 111.343 176.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 1.3 p -67.76 120.01 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 CA-C-O 122.694 1.235 . . . . 0.0 110.324 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -139.68 156.77 70.95 Favored Pre-proline 0 C--N 1.266 -3.036 0 CA-C-N 112.814 -1.994 . . . . 0.0 110.434 -173.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.609 ' HB2' HD12 ' A' ' 58' ' ' ILE . 34.5 Cg_exo -65.81 143.95 75.54 Favored 'Trans proline' 0 CA--C 1.555 1.531 0 C-N-CA 122.776 2.318 . . . . 0.0 112.216 172.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 20' ' ' TYR . 28.7 m -127.22 158.66 38.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 123.867 0.867 . . . . 0.0 109.218 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.71 134.76 45.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 O-C-N 123.154 0.284 . . . . 0.0 110.699 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 mm -82.12 96.94 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.423 ' C ' HD13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -93.43 -26.01 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.45 -178.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.521 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 4.5 pt20 -61.63 168.77 2.73 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 117.036 2.236 . . . . 0.0 117.036 -171.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -64.33 170.05 4.14 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 113.488 -1.687 . . . . 0.0 111.771 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.45 ' HA ' ' ND2' ' A' ' 47' ' ' ASN . 17.8 m-20 -81.07 -28.74 35.19 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 m -76.75 -34.93 58.03 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 122.197 -0.315 . . . . 0.0 110.607 -172.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.39 -25.68 74.64 Favored Glycine 0 C--O 1.21 -1.398 0 C-N-CA 120.207 -0.997 . . . . 0.0 110.671 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.45 ' ND2' ' HA ' ' A' ' 44' ' ' ASP . 91.5 m-20 -63.1 -31.75 72.96 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.541 0.686 . . . . 0.0 109.983 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.505 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 20.0 mmmt -92.29 -64.21 1.14 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.947 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 54.9 m-85 -78.47 -36.19 45.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -167.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.531 ' O ' ' HE3' ' A' ' 96' ' ' LYS . 58.9 m -93.63 133.21 28.44 Favored Pre-proline 0 N--CA 1.416 -2.13 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.363 -173.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -69.75 -21.52 33.41 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.631 1.554 . . . . 0.0 109.117 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 6.9 p -89.78 133.44 34.7 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.066 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.521 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 85.5 t -121.07 140.81 44.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.438 HG23 ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -113.01 124.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 122.213 1.006 . . . . 0.0 109.911 175.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.454 HG13 HG12 ' A' ' 53' ' ' VAL . 24.5 m -133.59 173.03 15.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.989 -173.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.515 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -124.94 146.38 49.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.72 131.23 41.38 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 37' ' ' PRO . 64.8 mt -90.07 124.66 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 113.891 -1.504 . . . . 0.0 107.356 172.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.673 ' HB ' HG23 ' A' ' 85' ' ' VAL . 64.7 m -123.07 154.24 38.82 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.23 7.86 14.26 Favored Glycine 0 N--CA 1.464 0.543 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.113 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.476 ' H ' HG22 ' A' ' 59' ' ' THR . 23.0 mmt180 -137.87 179.65 6.3 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 55.3 mt 69.39 25.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 124.112 1.911 . . . . 0.0 106.081 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.401 ' HA ' HG11 ' A' ' 85' ' ' VAL . 25.7 p-10 -79.66 85.91 5.33 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 112.965 -1.925 . . . . 0.0 111.763 -175.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -161.65 47.42 0.19 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -87.13 82.66 7.62 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.411 -1.268 . . . . 0.0 112.811 -169.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -113.84 1.5 14.81 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.243 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.557 ' H ' HD12 ' A' ' 67' ' ' ILE . 1.9 mp -96.66 138.51 21.41 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.592 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 64.7 Cg_endo -71.56 35.79 0.29 Allowed 'Trans proline' 0 CA--C 1.554 1.483 0 C-N-CA 121.68 1.586 . . . . 0.0 113.906 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 71.9 p -124.02 -19.05 5.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.032 0.92 . . . . 0.0 108.576 171.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.535 ' CD2' HD22 ' A' ' 87' ' ' LEU . 36.1 m170 -124.24 129.91 51.61 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.3 p -125.88 136.35 61.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.457 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.99 135.54 45.3 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.744 0.783 . . . . 0.0 111.898 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.679 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -120.3 155.39 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.334 0 CA-C-N 113.877 -1.511 . . . . 0.0 112.646 -173.183 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -67.83 112.36 4.84 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 125.38 1.472 . . . . 0.0 108.871 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -44.06 -50.77 8.3 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.694 1.598 . . . . 0.0 112.68 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -66.18 -23.65 66.5 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 124.944 1.298 . . . . 0.0 114.398 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -84.86 -31.42 23.78 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.148 0.975 . . . . 0.0 109.496 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.679 ' CE1' HG21 ' A' ' 73' ' ' ILE . 4.2 m-85 -90.42 -8.22 51.13 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.631 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 62.15 25.7 15.4 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.866 1.267 . . . . 0.0 112.599 176.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.417 ' CD1' ' HB3' ' A' ' 78' ' ' TYR . 7.4 mp -85.07 172.52 11.2 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-O 122.992 1.377 . . . . 0.0 113.828 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.97 -23.97 61.52 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 111.518 -2.583 . . . . 0.0 110.651 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -152.31 160.03 43.39 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.377 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -56.04 136.36 52.23 Favored 'General case' 0 CA--C 1.514 -0.433 0 O-C-N 123.993 0.808 . . . . 0.0 110.991 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 m -103.28 135.03 45.67 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.376 -167.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.673 HG23 ' HB ' ' A' ' 59' ' ' THR . 1.1 m -116.84 131.62 68.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.572 ' CD1' HG12 ' A' ' 58' ' ' ILE . 23.1 mm -107.37 127.46 63.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.535 HD22 ' CD2' ' A' ' 70' ' ' HIS . 22.7 mt -103.69 109.82 21.67 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.565 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.7 mm? -87.84 8.18 27.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.275 -172.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -110.27 -35.82 5.98 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 122.122 0.963 . . . . 0.0 108.502 172.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 87' ' ' LEU . 5.8 tp60 -87.22 64.33 8.28 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.181 -1.372 . . . . 0.0 107.747 175.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.515 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -108.23 -176.12 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.418 -177.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.605 ' NH2' ' HB3' ' A' ' 32' ' ' GLN . 8.2 ptp85 -164.98 163.89 20.7 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' B' ' 91' ' ' ILE . 52.3 m -122.5 116.39 23.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.3 mt -131.83 141.52 49.46 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.328 1.051 . . . . 0.0 109.412 -170.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.7 p30 -71.12 152.05 43.84 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.109 174.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.531 ' HE3' ' O ' ' A' ' 50' ' ' SER . 94.7 mttt -44.74 -26.03 0.35 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 126.245 1.818 . . . . 0.0 114.798 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -86.97 -14.6 41.26 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -81.59 -27.66 34.14 Favored 'General case' 0 N--CA 1.395 -3.188 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.34 117.89 15.63 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 169.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -89.35 -58.85 2.38 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.0 pt-20 -151.35 133.54 15.25 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 121.845 0.831 . . . . 0.0 112.6 -170.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.4 tttp -60.57 115.74 3.83 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 127.485 2.314 . . . . 0.0 107.61 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.4 tp -111.71 -62.77 1.51 Allowed 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.664 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.509 HG22 HG11 ' A' ' 19' ' ' VAL . 3.5 t -129.63 -163.61 1.32 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.486 -1.285 . . . . 0.0 111.794 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -160.98 147.02 14.67 Favored 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 123.976 0.91 . . . . 0.0 111.028 -172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -114.68 161.69 17.78 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.615 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 p -82.97 151.64 25.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 111' ' ' MET . 25.5 t70 -59.16 -36.41 75.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -74.09 -23.04 59.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.46 0.648 . . . . 0.0 110.82 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.625 ' HD3' ' CG2' ' A' ' 73' ' ' ILE . 15.8 ttmm -85.94 -24.58 26.49 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.751 0.786 . . . . 0.0 109.578 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.566 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -53.73 -33.89 57.1 Favored 'General case' 0 N--CA 1.422 -1.841 0 C-N-CA 124.462 1.105 . . . . 0.0 109.818 170.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.599 ' HE2' ' N ' ' A' ' 112' ' ' LYS . 7.1 mmpt? -69.78 -23.3 63.33 Favored 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.398 -177.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -84.32 -31.25 24.95 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -173.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.421 HG13 HD11 ' A' ' 88' ' ' LEU . 1.6 t -67.15 -40.29 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-N 112.256 -2.247 . . . . 0.0 110.267 173.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.563 ' OD1' ' HG ' ' B' ' 124' ' ' LEU . 31.4 m-20 -63.07 -31.31 72.42 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.742 1.258 . . . . 0.0 110.607 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.71 ' O ' HD13 ' A' ' 120' ' ' ILE . 10.3 m-80 -80.06 -9.02 59.67 Favored 'General case' 1 N--CA 1.569 5.487 0 CA-C-N 113.439 -1.71 . . . . 0.0 110.514 -176.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 68' ' ' PRO 0.275 . . -99.57 -49.0 4.55 Favored 'General case' 2 N--CA 1.344 -5.732 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 175.573 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 4.2 tp -67.61 -45.65 74.83 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.531 ' SD ' ' HE1' ' B' ' 129' ' ' HIS . 3.6 ttp -66.1 -22.48 66.4 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.653 0.781 . . . . 0.0 109.92 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -88.18 -51.56 12.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.3 t -54.15 -27.6 34.62 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 126.607 1.963 . . . . 0.0 111.926 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 56.0 mt -102.23 7.11 40.87 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.594 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.54 1.66 85.5 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 171.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 124' ' ' LEU . 3.2 mp -65.96 -52.46 49.44 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 118.81 1.305 . . . . 0.0 109.217 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.7 m120 56.39 -174.1 0.06 Allowed 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 113.789 -1.55 . . . . 0.0 113.353 178.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.04 34.88 0.62 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.142 0.972 . . . . 0.0 110.525 -178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 63.8 t -83.01 -16.17 11.47 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.298 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 67.31 152.1 0.08 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.09 -1.868 . . . . 0.0 112.54 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.587 ' HE1' ' SD ' ' B' ' 119' ' ' MET . 34.4 m170 -79.9 -38.88 31.61 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.811 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -112.73 87.31 2.55 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.382 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -86.89 107.66 18.45 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.658 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.5 m120 . . . . . 0 C--N 1.293 -1.862 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 176.951 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.544 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 8.7 p -66.33 -48.68 69.51 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.083 0.468 . . . . 0.0 109.872 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 26.0 m -90.05 80.33 6.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -59.37 104.96 0.3 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.55 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.411 ' O ' ' HB2' ' B' ' 9' ' ' HIS . 34.4 m80 58.12 28.97 17.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.449 1.099 . . . . 0.0 112.085 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -73.01 -53.51 10.97 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -90.11 -56.87 3.05 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.772 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -82.69 79.84 8.98 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.342 1.067 . . . . 0.0 111.008 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' B' ' 5' ' ' HIS . 20.4 t-80 -113.3 -76.51 0.59 Allowed 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.076 -0.965 . . . . 0.0 108.961 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 9.5 p -94.02 -33.87 13.24 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.471 0.653 . . . . 0.0 109.776 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -121.66 107.58 12.53 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.194 177.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -76.66 135.59 68.13 Favored Pre-proline 0 C--N 1.295 -1.797 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.13 99.41 0.08 OUTLIER 'Trans proline' 0 C--O 1.25 1.111 0 C-N-CA 122.036 1.824 . . . . 0.0 111.766 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 64.7 mt -82.61 130.57 35.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.358 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -117.85 149.39 40.93 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.542 ' HG2' ' SD ' ' B' ' 111' ' ' MET . 42.7 ttt180 -68.38 114.23 6.64 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 176.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.52 1.6 19.86 Favored Glycine 0 N--CA 1.43 -1.7 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.377 -176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -90.97 173.96 7.68 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.482 HG11 HG22 ' B' ' 104' ' ' THR . 22.3 t -134.18 134.34 55.29 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.096 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.55 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 28.9 m-85 -133.93 148.72 51.23 Favored 'General case' 0 CA--C 1.475 -1.912 0 C-N-CA 124.645 1.178 . . . . 0.0 107.924 177.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.548 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.4 mp -82.39 150.59 27.05 Favored 'General case' 0 N--CA 1.401 -2.881 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.485 171.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.36 134.38 48.84 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.124 -177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.608 ' HA ' ' HB ' ' B' ' 35' ' ' VAL 0.277 3.6 p-10 -90.27 99.13 12.2 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.693 -1.603 . . . . 0.0 111.314 178.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.631 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 4.2 mm? -83.09 40.44 0.7 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 113.54 -1.663 . . . . 0.0 111.679 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.48 ' HB3' ' HD2' ' B' ' 26' ' ' PRO 0.272 5.6 m -66.55 166.66 16.64 Favored Pre-proline 0 C--N 1.269 -2.93 0 C-N-CA 127.528 2.331 . . . . 0.0 108.299 170.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 1.1 Cg_exo 5.66 53.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.399 3.228 1 C-N-CA 127.439 5.426 . . . . 0.0 117.674 -176.012 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.16 177.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 113.594 -1.639 . . . . 0.0 111.449 171.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -103.02 116.93 33.48 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.23 -176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.68 -121.19 19.16 Favored Glycine 0 CA--C 1.488 -1.631 0 CA-C-N 114.707 -1.133 . . . . 0.0 113.744 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 24.1 m -93.39 21.49 6.08 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -176.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.49 163.2 23.97 Favored 'General case' 0 C--O 1.256 1.443 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 172.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.612 ' HB3' HH22 ' B' ' 92' ' ' ARG . 0.8 OUTLIER -78.22 116.8 18.92 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 122.768 0.427 . . . . 0.0 109.989 -174.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' B' ' 24' ' ' LEU . . . -91.34 142.46 16.11 Favored Glycine 0 CA--C 1.465 -3.061 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.817 178.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.631 ' O ' ' HB2' ' B' ' 24' ' ' LEU . . . 111.81 137.73 7.27 Favored Glycine 0 N--CA 1.422 -2.275 0 CA-C-N 114.299 -0.95 . . . . 0.0 111.219 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.608 ' HB ' ' HA ' ' B' ' 23' ' ' ASP . 0.8 OUTLIER -72.82 121.64 23.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-O 122.499 1.142 . . . . 0.0 109.292 -179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -139.74 156.32 71.01 Favored Pre-proline 0 C--N 1.262 -3.198 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.366 -173.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.64 ' HB2' HD12 ' B' ' 58' ' ' ILE . 31.3 Cg_exo -65.6 143.93 76.84 Favored 'Trans proline' 0 CA--C 1.555 1.549 0 C-N-CA 122.725 2.283 . . . . 0.0 111.898 172.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.479 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.9 m -127.19 158.36 38.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 C-N-CA 123.6 0.76 . . . . 0.0 109.185 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.89 134.34 45.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.514 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 29.3 mm -81.89 97.03 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.416 ' C ' HD13 ' B' ' 41' ' ' ILE . 0.0 OUTLIER -93.81 -24.74 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.376 -178.449 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.534 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 4.1 pt20 -61.52 168.01 3.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 117.287 2.328 . . . . 0.0 117.287 -171.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -62.54 169.57 2.94 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 113.139 -1.846 . . . . 0.0 111.971 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.06 -28.82 32.2 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -75.95 -38.01 58.03 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 122.293 -0.254 . . . . 0.0 110.539 -172.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.18 -28.55 73.68 Favored Glycine 0 C--O 1.212 -1.244 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -59.18 -34.15 71.79 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 121.779 0.8 . . . . 0.0 110.26 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.517 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 19.8 mmmt -92.01 -61.23 1.67 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.298 -177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 60.3 m-85 -80.44 -35.66 34.7 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -167.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.478 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 19.6 m -94.32 134.5 25.53 Favored Pre-proline 0 C--N 1.292 -1.921 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.587 -174.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.91 -20.08 29.84 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 121.931 1.754 . . . . 0.0 109.736 173.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 3.0 p -92.61 136.04 33.57 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.107 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.534 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 93.3 t -121.34 140.53 45.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -112.01 123.97 68.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-O 122.153 0.978 . . . . 0.0 109.705 175.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.479 HG13 HG12 ' B' ' 53' ' ' VAL . 27.7 m -133.07 172.8 15.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.957 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.52 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -124.58 146.04 49.27 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.3 131.36 41.84 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' B' ' 37' ' ' PRO . 60.8 mt -89.84 125.76 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . 0.713 ' HB ' HG23 ' B' ' 85' ' ' VAL . 41.2 m -123.55 149.58 45.09 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.81 12.75 22.6 Favored Glycine 0 N--CA 1.466 0.672 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.578 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.469 ' H ' HG22 ' B' ' 59' ' ' THR . 29.0 mmt180 -143.51 -179.92 6.73 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' B' ' 61' ' ' ARG . 68.5 mt 70.06 24.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-O 123.895 1.807 . . . . 0.0 106.559 -174.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . 0.422 ' HA ' HG11 ' B' ' 85' ' ' VAL . 27.4 p-10 -79.12 91.25 4.9 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 112.983 -1.917 . . . . 0.0 111.865 -175.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -163.59 45.08 0.12 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.74 83.14 7.79 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.355 -1.293 . . . . 0.0 112.737 -170.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -115.88 3.87 13.8 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.028 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.484 ' H ' HD12 ' B' ' 67' ' ' ILE . 2.5 mp -100.8 136.16 19.89 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . 0.451 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 59.1 Cg_endo -69.82 37.1 0.24 Allowed 'Trans proline' 0 CA--C 1.553 1.464 0 C-N-CA 122.16 1.907 . . . . 0.0 113.877 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 59.4 p -127.03 -19.11 4.46 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.519 ' CD2' HD22 ' B' ' 87' ' ' LEU . 31.9 m170 -123.49 129.94 51.97 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.68 136.25 61.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.171 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.13 139.82 37.24 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-O 121.294 0.569 . . . . 0.0 111.603 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.657 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -125.59 155.1 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.499 -174.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -66.74 114.78 5.9 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.033 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -45.62 -53.89 8.51 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.327 1.451 . . . . 0.0 112.163 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -61.45 -27.26 68.44 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -82.3 -34.25 28.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.705 0.764 . . . . 0.0 109.734 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.657 ' CE1' HG21 ' B' ' 73' ' ' ILE . 4.1 m-85 -86.92 -7.96 57.69 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.647 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 65.22 23.14 12.22 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.982 1.313 . . . . 0.0 112.66 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.04 173.77 10.24 Favored 'General case' 0 CA--C 1.494 -1.194 0 CA-C-O 123.018 1.39 . . . . 0.0 114.051 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.74 -23.21 56.0 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 111.917 -2.401 . . . . 0.0 110.56 177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -149.06 159.59 44.09 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.3 138.16 57.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 123.74 0.65 . . . . 0.0 110.464 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 11.3 m -103.11 134.2 46.93 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.079 -167.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.713 HG23 ' HB ' ' B' ' 59' ' ' THR . 1.1 m -116.64 131.99 67.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.565 ' CD1' HG12 ' B' ' 58' ' ' ILE . 23.6 mm -107.42 127.74 63.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 175.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.519 HD22 ' CD2' ' B' ' 70' ' ' HIS . 24.0 mt -103.06 109.22 20.7 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -177.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.5 mm? -88.83 7.7 32.85 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.71 0.767 . . . . 0.0 112.179 -172.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -108.76 -34.43 6.68 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-O 122.359 1.076 . . . . 0.0 108.542 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . 0.658 HE22 ' NH2' ' B' ' 92' ' ' ARG . 0.3 OUTLIER -92.79 72.85 4.91 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 176.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.52 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.3 pp -114.74 -175.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.712 -177.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.658 ' NH2' HE22 ' B' ' 90' ' ' GLN . 8.5 ptp85 -164.91 164.67 20.74 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 91' ' ' ILE . 53.5 m -122.58 115.52 22.3 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 68.4 mt -131.81 141.18 49.38 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 124.396 1.078 . . . . 0.0 109.344 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 3.5 p-10 -72.16 152.68 42.12 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.301 174.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.478 ' HE3' ' O ' ' B' ' 50' ' ' SER . 93.3 mttt -46.65 -21.21 0.17 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.199 1.8 . . . . 0.0 115.145 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -89.0 -18.31 27.63 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -79.69 -27.34 40.73 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.71 120.53 19.43 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -91.87 -57.72 2.64 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 12.8 pt-20 -151.29 134.7 16.15 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.93 0.871 . . . . 0.0 112.728 -170.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -62.02 113.38 2.79 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 127.647 2.379 . . . . 0.0 108.8 175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -109.81 -62.08 1.55 Allowed 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.006 -0.678 . . . . 0.0 112.769 -176.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.482 HG22 HG11 ' B' ' 19' ' ' VAL . 2.0 t -131.18 -164.48 1.44 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.48 -1.288 . . . . 0.0 112.45 -177.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -161.05 145.01 13.37 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 123.838 0.855 . . . . 0.0 111.558 -171.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 pp -113.78 162.37 16.39 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.542 178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.8 p -83.18 149.56 26.77 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.151 0.58 . . . . 0.0 112.105 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' B' ' 111' ' ' MET . 26.9 t70 -59.55 -32.71 70.58 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.875 0.87 . . . . 0.0 113.129 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -76.81 -25.36 53.21 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.196 0.522 . . . . 0.0 110.596 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.579 ' HD3' ' CG2' ' B' ' 73' ' ' ILE . 15.8 ttmm -85.08 -24.62 28.02 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.877 0.846 . . . . 0.0 109.207 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.542 ' SD ' ' HG2' ' B' ' 16' ' ' ARG . 0.1 OUTLIER -52.92 -34.38 54.86 Favored 'General case' 0 N--CA 1.425 -1.685 0 C-N-CA 124.708 1.203 . . . . 0.0 109.983 169.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.574 ' HE2' ' N ' ' B' ' 112' ' ' LYS . 7.1 mmpt? -69.78 -24.05 63.45 Favored 'General case' 0 N--CA 1.402 -2.866 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.25 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -85.21 -32.49 22.61 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . 0.44 HG13 HD11 ' B' ' 88' ' ' LEU . 1.8 t -63.53 -42.15 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.48 0 CA-C-N 112.692 -2.049 . . . . 0.0 109.934 171.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.537 ' OD1' ' HG ' ' A' ' 124' ' ' LEU . 42.8 m-20 -60.31 -40.88 92.12 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 122.035 0.921 . . . . 0.0 109.87 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.748 ' O ' HD13 ' B' ' 120' ' ' ILE . 1.1 m-80 -64.29 -21.56 66.64 Favored 'General case' 0 N--CA 1.52 3.063 0 C-N-CA 125.362 1.465 . . . . 0.0 112.604 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.556 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -84.48 -53.03 5.71 Favored 'General case' 2 C--N 1.23 -4.605 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 172.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 4.1 tp -65.41 -46.76 78.73 Favored 'General case' 0 N--CA 1.4 -2.955 0 C-N-CA 124.494 1.117 . . . . 0.0 113.978 -172.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.587 ' SD ' ' HE1' ' A' ' 129' ' ' HIS . 3.6 ttp -66.98 -24.85 66.09 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 123.644 0.778 . . . . 0.0 109.999 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.748 HD13 ' O ' ' B' ' 116' ' ' ASN . 2.5 mp -88.52 -45.83 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 26.0 t -55.18 -29.85 58.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.928 1.291 . . . . 0.0 111.359 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 58.4 mt -99.96 7.43 44.81 Favored 'General case' 0 N--CA 1.421 -1.914 0 C-N-CA 120.201 -0.599 . . . . 0.0 112.149 -178.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.41 1.06 89.44 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 116.215 1.246 . . . . 0.0 116.215 171.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.578 ' H ' HD12 ' B' ' 124' ' ' LEU . 3.4 mp -64.96 -51.08 63.73 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 118.832 1.316 . . . . 0.0 109.302 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m120 56.49 -169.27 0.09 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.513 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.81 29.49 1.17 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.573 0.701 . . . . 0.0 111.056 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.52 -19.93 14.07 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.496 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 71.01 157.71 0.18 Allowed 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 126.529 1.932 . . . . 0.0 113.466 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.531 ' HE1' ' SD ' ' A' ' 119' ' ' MET . 31.4 m170 -92.94 1.1 57.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.137 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -150.77 92.97 1.89 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -96.93 97.1 8.99 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.309 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.3 m120 . . . . . 0 C--N 1.294 -1.81 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.687 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.734 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 m -93.03 88.13 6.01 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.9 t -81.12 -32.84 33.61 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 176.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -118.35 125.85 50.89 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.96 -1.473 . . . . 0.0 107.492 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -97.41 108.87 21.69 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -67.14 129.83 41.16 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.389 -177.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -89.94 -175.41 4.58 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.505 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 63.46 31.71 14.8 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.672 1.225 . . . . 0.0 108.903 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -69.75 -39.47 76.71 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.6 m -81.27 89.38 6.05 Favored 'General case' 0 N--CA 1.408 -2.525 0 CA-C-N 113.764 -1.562 . . . . 0.0 106.864 171.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.464 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 97.6 mt-30 -59.05 125.21 22.67 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.132 -176.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -84.68 103.01 2.62 Favored Pre-proline 0 C--N 1.319 -0.726 0 C-N-CA 124.65 1.18 . . . . 0.0 108.646 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 11' ' ' GLN . 4.6 Cg_exo -77.06 -53.12 0.07 OUTLIER 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.762 2.308 . . . . 0.0 110.341 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.9 mt -84.77 108.9 17.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 172.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.454 ' HG3' ' HB2' ' A' ' 18' ' ' ASP . 35.6 ptt180 -125.5 158.42 34.53 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -173.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -76.59 132.49 39.5 Favored 'General case' 0 N--CA 1.418 -2.053 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.81 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.17 -6.17 56.14 Favored Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.165 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.454 ' HB2' ' HG3' ' A' ' 15' ' ' ARG . 5.6 t70 -97.12 178.08 5.37 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 4.1 t -135.57 130.61 50.29 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 CA-C-O 121.491 0.662 . . . . 0.0 112.075 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 39.9 m-85 -130.49 145.53 51.87 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.316 176.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -80.31 149.83 30.17 Favored 'General case' 0 N--CA 1.395 -3.189 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 170.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.62 141.68 37.09 Favored 'General case' 0 C--N 1.257 -3.45 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.622 -175.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -80.29 84.06 6.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.536 ' O ' HG13 ' A' ' 27' ' ' VAL . 91.6 mt -65.53 -27.81 68.72 Favored 'General case' 0 CA--C 1.468 -2.176 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.251 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.514 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 2.1 m -33.82 176.0 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.164 0 C-N-CA 128.375 2.67 . . . . 0.0 114.599 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.585 ' HB2' ' NE2' ' B' ' 28' ' ' GLN . 0.1 OUTLIER 22.92 51.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.108 0 C-N-CA 123.108 2.538 . . . . 0.0 115.554 -152.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 14.9 m -72.02 -178.27 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 113.374 -1.739 . . . . 0.0 110.421 165.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.535 ' NE2' ' HB2' ' B' ' 26' ' ' PRO . 31.8 mm-40 -115.04 124.43 51.59 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.581 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.96 -109.1 1.67 Allowed Glycine 0 N--CA 1.432 -1.61 0 CA-C-N 113.728 -1.578 . . . . 0.0 115.779 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 m -93.06 8.81 38.45 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -174.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.669 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 48.9 mt-10 -64.65 156.34 30.46 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 118.203 -1.399 . . . . 0.0 109.603 174.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.41 HE22 ' HG3' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -73.33 108.92 6.47 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -175.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -90.16 147.73 19.37 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 116.136 1.215 . . . . 0.0 116.136 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.48 157.19 12.38 Favored Glycine 0 N--CA 1.414 -2.83 0 CA-C-N 113.319 -1.44 . . . . 0.0 110.276 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -77.92 112.44 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 CA-C-O 122.583 1.182 . . . . 0.0 108.283 175.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.41 ' HG3' HE22 ' A' ' 32' ' ' GLN . 17.5 mmt180 -134.16 158.73 74.62 Favored Pre-proline 0 C--N 1.259 -3.345 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.891 -172.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 36.0 Cg_exo -64.56 134.86 43.04 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.656 2.238 . . . . 0.0 110.984 173.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 20' ' ' TYR . 35.4 m -121.1 160.4 22.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.484 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 29.8 m -98.8 129.75 48.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 174.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -86.66 101.22 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.43 -20.71 5.46 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.636 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.575 ' HG3' HG22 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -55.02 158.54 2.78 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.232 1.413 . . . . 0.0 114.675 -170.668 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 172.28 4.89 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.776 -1.102 . . . . 0.0 112.322 178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -69.21 -47.22 65.44 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.596 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -71.18 -34.17 70.67 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.919 -169.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.22 -30.31 75.53 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.805 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -63.54 -35.17 79.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.187 0.517 . . . . 0.0 110.231 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -87.17 -53.39 4.88 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.301 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -96.64 -10.43 27.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -167.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.1 t -113.26 143.3 28.99 Favored Pre-proline 0 C--N 1.294 -1.83 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.191 -177.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 33.6 Cg_endo -71.39 -27.62 19.07 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 121.734 1.623 . . . . 0.0 109.892 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 p -97.18 142.8 28.65 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.117 -175.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.48 141.02 36.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.758 HG21 HD22 ' B' ' 122' ' ' LEU . 12.1 tt -82.02 133.79 28.44 Favored 'Isoleucine or valine' 0 C--O 1.257 1.451 0 CA-C-O 121.512 0.673 . . . . 0.0 110.739 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -136.27 155.49 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.283 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.525 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -121.01 141.13 51.02 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.06 129.8 38.56 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 114.884 1.438 . . . . 0.0 114.884 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.51 HD12 ' HB2' ' A' ' 37' ' ' PRO . 57.7 mt -86.38 115.41 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 173.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.3 m -101.24 104.95 16.01 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.488 0.661 . . . . 0.0 110.903 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.63 49.87 0.86 Allowed Glycine 0 CA--C 1.5 -0.855 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -153.52 8.31 0.38 Allowed 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 122.895 0.478 . . . . 0.0 110.545 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.0 mt -146.23 157.2 11.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 -177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -144.19 -173.97 4.16 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 173.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.7 tttt 78.42 103.54 0.07 Allowed 'General case' 0 C--O 1.246 0.914 0 O-C-N 124.337 1.023 . . . . 0.0 111.287 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.537 ' HB2' ' HG3' ' A' ' 72' ' ' GLU . . . -92.14 -95.31 0.14 Allowed 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.003 172.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 60.28 22.52 11.96 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.63 0.729 . . . . 0.0 111.122 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 65' ' ' ALA . 5.5 tt -160.16 136.36 6.29 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 9.3 Cg_endo -52.29 -34.07 58.23 Favored 'Trans proline' 0 C--O 1.208 -1.015 0 C-N-CA 122.832 2.355 . . . . 0.0 114.139 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 p -73.6 -18.96 60.99 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-N 118.238 0.472 . . . . 0.0 112.043 -172.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -104.42 129.17 52.4 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 87.7 t -118.7 112.68 38.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.186 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.537 ' HG3' ' HB2' ' A' ' 65' ' ' ALA . 37.2 mt-10 -82.3 118.89 23.48 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.642 HD12 ' CD2' ' A' ' 78' ' ' TYR . 8.0 pt -101.74 133.27 45.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.268 -174.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -55.45 118.45 4.47 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.294 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.687 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 43.6 mttp -43.05 -48.6 6.15 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-O 122.653 1.216 . . . . 0.0 109.266 173.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -62.46 -29.13 70.3 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 112.781 -2.008 . . . . 0.0 113.28 -173.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -91.72 -29.03 17.05 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.489 0.661 . . . . 0.0 111.093 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.642 ' CD2' HD12 ' A' ' 73' ' ' ILE . 23.0 m-85 -95.84 9.58 40.04 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.256 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 tttm 61.63 27.84 17.17 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.385 1.088 . . . . 0.0 110.148 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.31 176.47 5.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.936 0.874 . . . . 0.0 109.915 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -102.79 -8.63 20.65 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 113.706 -1.588 . . . . 0.0 109.875 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.503 ' C ' ' HG2' ' A' ' 75' ' ' LYS . 9.9 ptpp? -144.1 143.56 31.19 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -176.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.687 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 34.0 m-20 -70.63 120.1 15.75 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.499 ' HB3' HD11 ' A' ' 73' ' ' ILE . 25.3 t -104.57 174.05 6.04 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -175.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 13.3 t -122.39 139.5 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.498 ' CD1' HG12 ' A' ' 58' ' ' ILE . 19.6 mm -104.16 127.41 58.43 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 172.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 88.5 mt -102.41 104.9 15.4 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.557 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 4.0 mm? -83.06 3.33 30.88 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.653 0.74 . . . . 0.0 112.195 -175.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -97.79 -36.23 10.28 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 122.25 1.024 . . . . 0.0 108.352 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.438 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 3.1 tp60 -94.92 76.5 3.58 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.851 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.525 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.2 pp -125.78 175.88 7.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -165.06 173.59 11.32 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 172.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.3 m -118.47 121.73 41.0 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.052 -0.977 . . . . 0.0 108.609 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.49 ' HB3' ' HG3' ' A' ' 98' ' ' ARG . 77.0 mt -131.94 149.34 52.46 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.949 -173.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HB3' ' HD3' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -57.55 143.64 40.17 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 170.17 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 19.0 pttm -53.8 -33.55 56.39 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.988 0.899 . . . . 0.0 112.565 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.494 ' HD3' ' HB3' ' A' ' 95' ' ' ASP . 28.9 mtpt -47.5 -31.38 4.23 Favored 'General case' 0 C--N 1.278 -2.542 0 C-N-CA 127.062 2.145 . . . . 0.0 113.436 170.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.49 ' HG3' ' HB3' ' A' ' 94' ' ' LEU . 2.4 mmp_? -69.57 -31.22 69.27 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.508 0.67 . . . . 0.0 110.323 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 7.2 mp -70.75 131.45 43.87 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.181 1.393 . . . . 0.0 110.712 175.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -99.97 -57.45 2.13 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.281 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 13.2 pt-20 -159.26 146.59 17.19 Favored 'General case' 0 N--CA 1.42 -1.931 0 CA-C-O 121.39 0.614 . . . . 0.0 111.377 -169.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 64.9 tttp -62.65 125.62 24.55 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 126.601 1.96 . . . . 0.0 110.559 173.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 tp -114.74 -61.75 1.7 Allowed 'General case' 0 N--CA 1.419 -2.002 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.179 174.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.469 HG22 HG11 ' A' ' 19' ' ' VAL . 5.3 t -129.35 -159.84 0.99 Allowed 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 118.554 -1.259 . . . . 0.0 111.98 -177.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -161.05 142.29 11.7 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 125.258 1.423 . . . . 0.0 109.519 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -105.31 156.57 18.02 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 m -81.81 158.93 23.91 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.475 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.32 -32.33 71.13 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 124.866 1.267 . . . . 0.0 112.007 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 5.4 p-10 -66.91 -28.23 68.14 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.565 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -73.67 -28.76 61.93 Favored 'General case' 0 CA--C 1.483 -1.622 0 O-C-N 123.404 0.44 . . . . 0.0 111.443 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.42 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -53.06 -48.02 68.01 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-O 121.987 0.899 . . . . 0.0 108.847 174.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.42 ' HE2' ' C ' ' A' ' 111' ' ' MET . 9.0 mmpt? -79.46 -9.82 59.68 Favored 'General case' 0 N--CA 1.39 -3.444 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.655 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 109' ' ' ASP . 38.1 mt-10 -86.54 -43.73 12.49 Favored 'General case' 0 CA--C 1.471 -2.095 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 176.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.0 t -49.81 -47.17 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.037 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -53.87 -41.64 67.75 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 122.091 0.948 . . . . 0.0 111.262 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.658 ' O ' HD13 ' A' ' 120' ' ' ILE . 24.1 m-80 -80.41 -22.93 40.75 Favored 'General case' 0 CA--C 1.434 -3.502 0 CA-C-O 123.315 1.531 . . . . 0.0 110.21 -173.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 121' ' ' SER . . . -84.37 -37.65 21.27 Favored 'General case' 2 N--CA 1.342 -5.844 0 CA-C-N 113.311 -1.768 . . . . 0.0 109.625 178.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.711 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -82.67 -55.35 4.49 Favored 'General case' 1 N--CA 1.372 -4.352 0 C-N-CA 123.124 0.57 . . . . 0.0 112.23 -175.159 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.3 mtp -56.85 -35.52 68.95 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.658 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -75.27 -45.33 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.445 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -176.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.613 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 7.7 t -62.05 -32.12 72.6 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.257 -177.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.762 HD22 HG21 ' B' ' 54' ' ' ILE . 13.0 mt -101.17 1.51 39.18 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.434 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.5 16.24 80.54 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 116.036 1.174 . . . . 0.0 116.036 173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 9.3 mp -67.99 -52.15 39.05 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-N 119.413 1.606 . . . . 0.0 110.411 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.6 m120 45.35 115.25 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.984 0 O-C-N 125.654 1.846 . . . . 0.0 114.374 -174.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.462 ' HB1' ' CD2' ' B' ' 129' ' ' HIS . . . -68.69 88.08 0.35 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.179 -0.919 . . . . 0.0 113.332 -171.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.1 t -136.11 9.24 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.177 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.53 -56.47 2.4 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.157 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 72.63 -17.68 0.38 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.156 1.383 . . . . 0.0 112.405 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -162.42 -172.74 3.28 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.577 ' HE2' ' HG2' ' B' ' 113' ' ' GLU . 28.1 tptp -64.82 126.44 27.96 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-O 121.905 0.86 . . . . 0.0 110.07 176.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.283 -2.305 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.102 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.5 m -87.42 82.74 7.45 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.244 0.545 . . . . 0.0 110.701 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 22.8 t -78.72 -29.45 45.36 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -121.38 121.74 38.29 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 175.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -93.47 114.25 26.59 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -76.27 125.36 29.04 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.464 0.478 . . . . 0.0 109.938 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -86.58 -174.65 5.1 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.528 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 64.76 30.86 12.18 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.302 1.049 . . . . 0.0 109.197 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -70.8 -37.8 73.31 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 44.7 m -82.16 90.27 6.56 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 168.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.489 ' O ' ' HD3' ' B' ' 13' ' ' PRO . 97.8 mt-30 -54.46 129.02 34.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.465 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -91.49 103.24 7.2 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' B' ' 11' ' ' GLN . 3.7 Cg_exo -75.25 -53.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.657 2.238 . . . . 0.0 110.613 -178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 70.2 mt -83.31 101.66 8.27 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 172.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.42 ' HG3' ' HB2' ' B' ' 18' ' ' ASP . 34.9 ptt180 -119.79 157.55 28.38 Favored 'General case' 0 C--N 1.275 -2.666 0 O-C-N 123.828 0.705 . . . . 0.0 110.061 -172.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.27 125.81 29.92 Favored 'General case' 0 N--CA 1.428 -1.543 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.846 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.28 -6.86 32.28 Favored Glycine 0 N--CA 1.434 -1.446 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.835 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . 0.454 ' CG ' ' HZ3' ' B' ' 102' ' ' LYS . 5.3 t70 -97.09 177.83 5.46 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 4.8 t -134.65 130.47 53.15 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-O 121.411 0.624 . . . . 0.0 112.039 -176.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.467 ' O ' HG22 ' B' ' 38' ' ' VAL . 39.4 m-85 -130.12 145.17 51.68 Favored 'General case' 0 CA--C 1.472 -2.023 0 C-N-CA 124.993 1.317 . . . . 0.0 109.118 176.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.3 mp -79.28 151.75 30.94 Favored 'General case' 0 N--CA 1.395 -3.179 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 170.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.71 141.68 33.31 Favored 'General case' 0 C--N 1.262 -3.198 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.925 -176.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.8 83.96 6.43 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 175.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.537 ' O ' HG13 ' B' ' 27' ' ' VAL . 90.8 mt -64.92 -26.88 68.5 Favored 'General case' 0 CA--C 1.469 -2.162 0 CA-C-N 112.995 -1.911 . . . . 0.0 111.137 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.533 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 2.7 m -34.13 178.35 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.351 0 C-N-CA 128.709 2.804 . . . . 0.0 114.883 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.535 ' HB2' ' NE2' ' A' ' 28' ' ' GLN . 0.1 OUTLIER 22.44 50.57 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.676 0 C-N-CA 122.961 2.441 . . . . 0.0 115.277 -153.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 11.5 m -71.3 -178.95 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.612 166.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 26' ' ' PRO . 31.1 mm-40 -115.14 128.57 56.28 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.36 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.52 -108.97 0.9 Allowed Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 114.152 -1.385 . . . . 0.0 115.248 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 66.8 m -93.44 7.66 43.65 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.636 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 50.1 mt-10 -62.57 159.98 14.8 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 117.852 -1.539 . . . . 0.0 109.981 175.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.428 HE22 ' HG3' ' B' ' 36' ' ' ARG . 1.0 OUTLIER -75.61 110.23 9.84 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -176.025 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.04 146.93 18.62 Favored Glycine 0 CA--C 1.484 -1.879 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -174.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.85 157.54 11.69 Favored Glycine 0 N--CA 1.412 -2.9 0 CA-C-N 113.331 -1.435 . . . . 0.0 110.29 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -77.68 113.58 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 122.631 1.205 . . . . 0.0 107.78 175.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . 0.428 ' HG3' HE22 ' B' ' 32' ' ' GLN . 19.5 mmt180 -135.63 158.77 73.57 Favored Pre-proline 0 C--N 1.259 -3.369 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.121 -171.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 31.2 Cg_exo -64.62 134.24 40.21 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.59 2.193 . . . . 0.0 110.925 172.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.467 HG22 ' O ' ' B' ' 20' ' ' TYR . 35.0 m -120.92 160.11 22.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 32.8 m -98.78 130.09 48.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 175.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 26.6 mm -87.14 100.6 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.08 -20.99 5.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.522 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.586 ' HG3' HG22 ' B' ' 54' ' ' ILE . 0.0 OUTLIER -54.61 158.4 2.56 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -170.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.03 170.72 6.38 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.196 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -69.52 -44.81 70.27 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.443 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 18.7 m -72.17 -34.83 68.76 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 122.697 0.399 . . . . 0.0 111.658 -170.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.78 -30.38 76.84 Favored Glycine 0 C--O 1.219 -0.822 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.71 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -64.67 -27.23 68.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.952 0.406 . . . . 0.0 110.512 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.427 ' HB2' ' CD2' ' B' ' 49' ' ' TYR . 6.7 mmtt -93.17 -53.98 3.9 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.901 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' B' ' 48' ' ' LYS . 96.0 m-85 -100.77 1.2 40.05 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -166.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -121.16 142.05 34.22 Favored Pre-proline 0 C--N 1.292 -1.929 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.533 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 37.4 Cg_endo -71.61 -27.04 19.06 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.489 1.46 . . . . 0.0 109.539 174.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.0 146.7 24.4 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.064 -176.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.425 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 0.4 OUTLIER -143.05 140.49 27.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 172.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.762 HG21 HD22 ' A' ' 122' ' ' LEU . 12.4 tt -82.13 133.41 29.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.237 0 CA-C-O 121.375 0.607 . . . . 0.0 110.677 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 36.0 m -135.59 156.33 37.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.349 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.537 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -121.6 140.41 52.28 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -73.85 128.81 36.52 Favored 'General case' 0 C--O 1.249 1.032 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' B' ' 37' ' ' PRO . 55.5 mt -86.09 117.05 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 173.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.2 m -102.4 105.16 15.7 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 121.217 0.532 . . . . 0.0 111.077 -175.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.5 47.99 1.03 Allowed Glycine 0 CA--C 1.507 -0.439 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -153.6 12.43 0.46 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.279 0.561 . . . . 0.0 110.81 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 62.4 mt -149.06 153.22 11.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' B' ' 64' ' ' LYS . 6.3 m120 -141.81 -172.03 3.47 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' B' ' 63' ' ' ASN . 76.6 tttt 76.32 106.87 0.08 Allowed 'General case' 0 C--O 1.244 0.797 0 O-C-N 124.244 0.965 . . . . 0.0 110.774 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' B' ' 72' ' ' GLU . . . -93.38 -94.52 0.16 Allowed 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 59.63 25.73 14.69 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.912 0.885 . . . . 0.0 111.162 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.405 HG22 ' O ' ' B' ' 65' ' ' ALA . 5.8 tt -161.56 136.94 5.65 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 8.5 Cg_endo -52.71 -32.1 53.7 Favored 'Trans proline' 0 C--O 1.209 -0.962 0 C-N-CA 122.672 2.248 . . . . 0.0 114.375 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 32.4 p -73.8 -19.33 60.79 Favored 'General case' 0 C--O 1.249 1.043 0 CA-C-O 121.082 0.468 . . . . 0.0 112.038 -172.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -104.83 129.54 53.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 96.2 t -118.68 114.11 43.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.599 175.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' B' ' 65' ' ' ALA . 45.5 mt-10 -82.76 117.11 22.43 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 174.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.648 HD12 ' CD2' ' B' ' 78' ' ' TYR . 8.8 pt -101.43 132.95 46.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.18 -174.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -56.44 119.5 6.15 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.211 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . 0.672 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 39.9 mttp -43.19 -49.21 6.56 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 124.587 1.155 . . . . 0.0 109.059 173.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -61.57 -29.59 70.12 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 112.902 -1.954 . . . . 0.0 113.198 -173.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . 0.408 ' HD2' ' HE2' ' B' ' 110' ' ' LYS . 94.7 mttt -91.71 -29.72 16.68 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.329 0.585 . . . . 0.0 111.076 -176.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.648 ' CD2' HD12 ' B' ' 73' ' ' ILE . 21.0 m-85 -95.9 7.99 44.85 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.035 -176.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 64.3 tttm 60.8 31.83 20.09 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-O 122.324 1.059 . . . . 0.0 109.972 174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 15.3 mt -111.86 176.29 5.08 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.495 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . 0.414 ' O ' ' HD3' ' B' ' 75' ' ' LYS . 7.3 p-10 -99.48 -9.83 22.89 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.914 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.488 ' C ' ' HG2' ' B' ' 75' ' ' LYS . 10.0 ptpp? -141.77 143.64 33.57 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.102 -174.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.672 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 27.3 m-20 -71.5 119.27 15.41 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 173.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.529 ' O ' HG12 ' B' ' 73' ' ' ILE . 23.3 t -105.25 173.28 6.37 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -175.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 13.4 t -120.43 139.94 46.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.479 HD12 HG12 ' B' ' 58' ' ' ILE . 19.1 mm -104.18 127.68 58.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 172.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 88.0 mt -103.23 105.95 16.36 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.6 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.9 mm? -83.33 -3.98 58.02 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.039 -176.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.52 -34.48 15.53 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.256 1.027 . . . . 0.0 108.778 174.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . 0.465 ' OE1' ' HA ' ' B' ' 31' ' ' GLU . 3.5 tp60 -97.02 76.71 2.7 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.168 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.537 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.3 pp -125.13 176.6 5.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -165.43 173.83 10.66 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 172.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . . . . . . . . . 47.4 m -118.8 122.23 41.91 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 64.9 mt -131.92 150.37 52.17 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.894 -173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.505 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 0.7 OUTLIER -58.44 142.47 48.52 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 169.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' B' ' 99' ' ' LEU . 18.0 pttm -51.82 -36.26 47.34 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.7 0.762 . . . . 0.0 112.435 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.481 ' HD3' ' HB3' ' B' ' 95' ' ' ASP . 28.3 mtpt -44.42 -34.63 2.1 Favored 'General case' 0 C--N 1.286 -2.155 0 C-N-CA 126.684 1.994 . . . . 0.0 113.637 171.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -67.43 -29.55 69.05 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.568 0.747 . . . . 0.0 110.71 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' B' ' 96' ' ' LYS . 7.5 mp -72.48 129.63 38.78 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 125.52 1.528 . . . . 0.0 110.611 176.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -95.95 -58.04 2.2 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.443 -1.253 . . . . 0.0 114.097 -175.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 16.1 pt-20 -161.06 147.18 14.63 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-O 121.535 0.683 . . . . 0.0 111.847 -170.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 64.8 tttp -61.17 124.33 20.24 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 126.974 2.11 . . . . 0.0 110.609 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.7 tp -114.57 -61.45 1.75 Allowed 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 120.219 -0.592 . . . . 0.0 111.348 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.473 HG22 HG11 ' B' ' 19' ' ' VAL . 5.8 t -129.72 -158.25 0.88 Allowed 'General case' 0 C--N 1.292 -1.931 0 C-N-CA 118.179 -1.409 . . . . 0.0 112.063 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -160.28 148.83 16.9 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 126.063 1.745 . . . . 0.0 109.038 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.427 ' HB3' ' CZ ' ' B' ' 78' ' ' TYR . 3.8 pp -112.4 154.77 25.28 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.8 m -80.6 161.13 24.87 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.374 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.67 -32.98 73.19 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.87 0.868 . . . . 0.0 112.522 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.541 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 5.4 p-10 -62.4 -32.02 72.79 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.408 ' HE2' ' HD2' ' B' ' 77' ' ' LYS . 2.8 mptp? -70.78 -28.85 64.97 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.433 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.1 OUTLIER -54.65 -47.78 73.11 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 174.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.433 ' HE2' ' C ' ' B' ' 111' ' ' MET . 9.0 mmpt? -78.38 -12.27 59.99 Favored 'General case' 0 N--CA 1.389 -3.496 0 CA-C-N 114.508 -1.224 . . . . 0.0 113.754 -177.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . 0.577 ' HG2' ' HE2' ' A' ' 131' ' ' LYS . 44.3 mt-10 -85.85 -41.64 14.83 Favored 'General case' 0 CA--C 1.47 -2.1 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 177.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 t -51.6 -47.02 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-N 112.911 -1.949 . . . . 0.0 110.731 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -53.04 -48.83 67.34 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.688 0.756 . . . . 0.0 110.276 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.702 ' O ' HD13 ' B' ' 120' ' ' ILE . 10.3 m-80 -69.82 -24.3 63.45 Favored 'General case' 0 N--CA 1.512 2.643 0 C-N-CA 125.004 1.322 . . . . 0.0 112.184 -176.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.6 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -83.41 -44.38 14.86 Favored 'General case' 2 C--N 1.231 -4.546 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.035 177.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.732 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 1.0 OUTLIER -73.51 -55.72 5.97 Favored 'General case' 1 N--CA 1.374 -4.269 0 C-N-CA 123.349 0.66 . . . . 0.0 112.162 -173.634 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 38.8 mtp -56.88 -37.88 71.97 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.702 HD13 ' O ' ' B' ' 116' ' ' ASN . 1.5 mp -77.06 -39.84 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.881 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 60.7 m -58.54 -35.87 72.97 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.625 0.726 . . . . 0.0 110.818 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.758 HD22 HG21 ' A' ' 54' ' ' ILE . 11.0 mt -101.17 -0.01 36.81 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.706 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.85 17.72 79.56 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 115.81 1.084 . . . . 0.0 115.81 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 9.6 mp -67.43 -54.35 21.05 Favored 'General case' 0 CA--C 1.479 -1.753 0 CA-C-N 119.111 1.455 . . . . 0.0 110.021 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 m120 49.57 118.82 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.575 -1.648 . . . . 0.0 113.937 -173.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.6 86.29 2.11 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.749 0.785 . . . . 0.0 112.783 -172.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.3 t -132.75 6.11 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 113.888 -1.505 . . . . 0.0 107.106 173.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.72 -59.96 1.85 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.783 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.462 ' CD2' ' HB1' ' A' ' 126' ' ' ALA . 25.9 t-80 71.65 -12.8 0.61 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 124.919 1.287 . . . . 0.0 112.133 173.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -161.26 -175.04 4.61 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -70.43 120.7 16.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.444 0.64 . . . . 0.0 109.83 174.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.3 -1.547 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.663 -178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.573 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m -92.44 -67.71 0.84 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.2 p -109.19 -3.64 17.13 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.53 0.681 . . . . 0.0 109.788 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -116.04 115.63 26.45 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -130.0 123.12 29.82 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -81.33 107.18 13.9 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -83.42 96.94 8.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.864 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.27 153.68 27.88 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.404 ' H ' ' CD2' ' A' ' 9' ' ' HIS . 1.7 p80 -87.44 98.25 11.27 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 174.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.4 m -66.84 -26.02 66.71 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.346 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -150.82 136.32 17.92 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 120.844 0.354 . . . . 0.0 110.908 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.502 ' HB2' ' NH1' ' A' ' 15' ' ' ARG . 39.6 m-20 -109.43 142.71 26.25 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 173.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.22 -31.53 93.17 Favored 'Trans proline' 0 N--CA 1.472 0.218 0 C-N-CA 122.673 2.249 . . . . 0.0 113.922 -175.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 55.8 mt -107.18 116.39 50.73 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.364 -173.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.502 ' NH1' ' HB2' ' A' ' 12' ' ' ASP . 32.2 mmt180 -121.45 153.55 37.73 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.456 172.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -75.43 139.67 42.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.799 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.13 -11.19 51.8 Favored Glycine 0 C--N 1.306 -1.101 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.007 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -97.31 173.46 7.2 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 102' ' ' LYS . 4.6 t -130.68 130.55 64.72 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.935 0 C-N-CA 123.21 0.604 . . . . 0.0 111.763 -175.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 85.4 m-85 -127.03 143.95 51.15 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.907 177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -75.16 147.56 40.36 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 169.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -135.86 129.42 32.32 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.706 -1.588 . . . . 0.0 107.635 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 10.1 t70 -84.99 91.08 7.98 Favored 'General case' 0 C--N 1.277 -2.582 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.351 174.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.582 ' O ' HD22 ' A' ' 24' ' ' LEU 0.432 0.0 OUTLIER -114.82 62.1 0.68 Allowed 'General case' 0 N--CA 1.385 -3.699 0 CA-C-O 124.203 1.954 . . . . 0.0 111.999 175.788 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.435 ' OG ' ' HA2' ' A' ' 34' ' ' GLY . 1.4 m -107.04 60.39 0.2 Allowed Pre-proline 0 C--N 1.266 -3.03 0 CA-C-N 113.1 -1.864 . . . . 0.0 112.554 175.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -115.27 23.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.276 0 N-CA-C 108.456 -1.402 . . . . 0.0 108.456 158.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.623 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 20.1 m -88.65 158.13 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -172.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.423 ' NE2' HH22 ' B' ' 98' ' ' ARG . 0.0 OUTLIER -155.74 160.57 40.42 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 113.005 -1.907 . . . . 0.0 107.049 178.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.51 -142.82 17.47 Favored Glycine 0 C--N 1.297 -1.624 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.411 ' HB2' ' CB ' ' B' ' 95' ' ' ASP . 22.3 m -94.46 15.33 18.06 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 117.053 0.427 . . . . 0.0 110.99 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.623 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 46.3 mt-10 -70.33 157.62 37.4 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -134.99 112.87 10.95 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.494 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -145.0 -109.86 0.66 Allowed Glycine 0 N--CA 1.411 -2.975 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.545 176.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' HA2' ' OG ' ' A' ' 25' ' ' SER . . . 82.95 178.11 52.24 Favored Glycine 0 N--CA 1.4 -3.76 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 -172.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 23' ' ' ASP . 1.4 p -87.45 99.36 8.47 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-O 123.556 1.646 . . . . 0.0 107.44 173.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -140.9 153.03 67.03 Favored Pre-proline 0 C--N 1.268 -2.944 0 CA-C-N 111.724 -2.489 . . . . 0.0 109.01 -168.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.58 ' HB2' HD12 ' A' ' 58' ' ' ILE . 33.5 Cg_exo -60.88 141.09 93.65 Favored 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 122.623 2.216 . . . . 0.0 112.9 175.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 20' ' ' TYR . 27.4 m -126.15 157.87 36.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.501 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 34.6 m -100.1 129.86 50.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.9 mm -88.73 98.06 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -18.86 6.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.533 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.69 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -51.26 152.78 2.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -173.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -43.11 146.28 0.44 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.556 2.343 . . . . 0.0 113.23 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -66.26 -37.53 85.69 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-N 113.605 -1.634 . . . . 0.0 111.544 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 m -87.68 -30.67 20.22 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.374 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.07 -31.33 78.4 Favored Glycine 0 C--O 1.206 -1.626 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.478 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.632 ' N ' HE22 ' A' ' 42' ' ' GLN . 30.0 p30 -71.95 -20.85 61.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.172 0.511 . . . . 0.0 111.019 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -86.63 -51.64 6.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -85.48 -36.07 20.8 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -171.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.5 m -97.15 145.92 30.44 Favored Pre-proline 0 C--N 1.291 -1.975 0 O-C-N 121.988 -0.445 . . . . 0.0 110.986 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -80.27 -15.09 11.6 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 121.916 1.744 . . . . 0.0 109.838 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 1.9 p -96.29 146.09 25.02 Favored 'General case' 0 N--CA 1.42 -1.927 0 C-N-CA 125.007 1.323 . . . . 0.0 110.412 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.75 138.6 22.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.236 0.541 . . . . 0.0 110.746 173.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.69 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -85.34 124.64 40.2 Favored 'Isoleucine or valine' 0 C--O 1.253 1.244 0 C-N-CA 124.435 1.094 . . . . 0.0 110.19 177.059 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.0 m -129.67 171.11 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.419 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.584 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -129.65 142.76 50.67 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.97 129.68 37.27 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.639 HG12 HD12 ' A' ' 86' ' ' ILE . 59.3 mt -85.52 117.57 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.5 174.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.4 m -107.21 111.87 24.47 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.25 -31.6 77.74 Favored Glycine 0 CA--C 1.5 -0.863 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.863 -176.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -144.11 123.98 13.48 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-O 121.044 0.45 . . . . 0.0 110.728 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.5 tt -173.1 -38.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 175.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.72 -173.07 0.15 Allowed 'General case' 0 C--O 1.243 0.731 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.72 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.0 mttm 61.67 73.91 0.46 Allowed 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 124.908 1.283 . . . . 0.0 114.407 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.38 72.72 7.03 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.2 tttp -114.04 12.65 18.0 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 123.016 1.389 . . . . 0.0 108.508 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.2 tt -138.41 140.53 28.48 Favored Pre-proline 0 C--N 1.28 -2.442 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.575 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 12.4 Cg_endo -56.12 -28.48 70.37 Favored 'Trans proline' 0 C--O 1.2 -1.41 0 C-N-CA 122.363 2.042 . . . . 0.0 114.274 -176.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.0 p -74.08 -18.92 60.76 Favored 'General case' 0 C--O 1.251 1.18 0 CA-C-O 121.064 0.459 . . . . 0.0 111.515 -174.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.8 m170 -104.64 128.95 52.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.401 HG12 HD13 ' A' ' 73' ' ' ILE . 59.1 t -130.22 124.68 58.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -98.34 133.46 42.71 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.625 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.1 OUTLIER -115.53 158.37 15.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.907 -173.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.502 ' OE1' ' HE3' ' A' ' 110' ' ' LYS . 2.3 mp0 -66.3 113.58 4.71 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.093 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -52.51 -42.11 64.04 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 123.716 0.806 . . . . 0.0 112.556 175.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.463 ' HD3' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -61.06 -30.7 70.49 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -179.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.463 ' N ' ' HD3' ' A' ' 76' ' ' LYS . 5.0 ttmp? -85.75 -34.99 21.05 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.716 0.769 . . . . 0.0 109.259 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.625 ' CE1' HG21 ' A' ' 73' ' ' ILE . 4.7 m-85 -84.71 5.29 28.87 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.937 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt 68.06 26.47 7.25 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.761 1.224 . . . . 0.0 111.227 174.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.8 mt -117.56 179.2 4.13 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.456 0.646 . . . . 0.0 110.759 -175.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -108.87 -18.89 13.58 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.51 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -118.51 147.23 43.87 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.25 123.71 22.85 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 t -102.93 150.72 23.25 Favored 'General case' 0 N--CA 1.413 -2.315 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.082 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.3 136.26 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.639 HD12 HG12 ' A' ' 58' ' ' ILE . 19.4 mm -104.49 131.14 54.12 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.967 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.8 mt -100.97 102.57 13.62 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.9 mm? -82.92 4.62 24.94 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.003 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.52 -42.91 7.47 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.912 172.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.457 ' HA ' HG21 ' B' ' 93' ' ' THR . 0.0 OUTLIER -91.01 76.71 6.17 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.668 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.584 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -117.02 178.61 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.479 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.417 ' HD2' HD23 ' A' ' 24' ' ' LEU . 15.6 ptp180 -173.81 163.3 4.14 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.475 HG21 ' HA ' ' B' ' 90' ' ' GLN . 61.4 m -107.77 124.18 49.66 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.421 -178.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.405 ' HB3' ' HG3' ' A' ' 98' ' ' ARG . 43.2 mt -132.42 145.62 51.35 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.73 -172.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 3.1 p30 -76.32 153.63 35.72 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.981 175.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -44.37 -22.14 0.06 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.463 1.905 . . . . 0.0 115.352 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.22 -18.6 60.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 118.206 0.457 . . . . 0.0 110.739 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 32.4 mmt180 -75.12 -38.81 60.95 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.6 mp -68.15 125.21 25.66 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.697 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 23' ' ' ASP . 67.9 mttm -103.99 -64.95 1.05 Allowed 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.304 -177.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 10.4 pt-20 -150.88 144.28 24.9 Favored 'General case' 0 N--CA 1.412 -2.337 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.069 -166.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -70.59 125.88 28.06 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 113.425 -1.716 . . . . 0.0 111.098 176.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.4 tp -114.57 -62.01 1.66 Allowed 'General case' 0 N--CA 1.417 -2.094 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.069 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.499 HG22 HG11 ' A' ' 19' ' ' VAL . 3.8 t -127.81 -167.22 1.72 Allowed 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.639 -1.625 . . . . 0.0 111.626 -177.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -160.81 143.98 13.12 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 124.73 1.212 . . . . 0.0 109.512 -175.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.6 pp -114.18 159.63 19.88 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.762 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 27.2 t -82.38 159.33 23.04 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.793 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 111' ' ' MET . 18.9 t70 -63.59 -33.31 75.33 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.439 0.638 . . . . 0.0 111.303 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -69.5 -28.06 65.73 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.102 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.502 ' HE3' ' OE1' ' A' ' 74' ' ' GLU . 5.7 mptp? -76.17 -29.0 57.54 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-O 121.078 0.466 . . . . 0.0 110.263 175.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.494 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -59.18 -36.31 75.11 Favored 'General case' 0 N--CA 1.416 -2.146 0 C-N-CA 123.521 0.728 . . . . 0.0 109.533 174.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.485 ' HE2' ' C ' ' A' ' 111' ' ' MET . 7.6 mmpt? -78.08 -10.99 59.88 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.34 -38.43 18.8 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.458 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 1.7 t -54.61 -39.86 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.386 0 CA-C-N 112.432 -2.167 . . . . 0.0 110.884 173.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.44 -35.18 69.77 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 122.243 1.02 . . . . 0.0 111.801 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.553 ' O ' HD13 ' A' ' 120' ' ' ILE . 16.4 m-80 -83.89 -18.81 36.18 Favored 'General case' 0 CA--C 1.433 -3.528 0 C-N-CA 125.235 1.414 . . . . 0.0 110.083 -171.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 68' ' ' PRO . . . -84.56 -57.14 3.26 Favored 'General case' 2 N--CA 1.34 -5.952 0 CA-C-N 111.881 -2.418 . . . . 0.0 108.921 171.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.2 tp -67.34 -45.37 76.61 Favored 'General case' 0 N--CA 1.404 -2.727 0 C-N-CA 125.984 1.714 . . . . 0.0 113.592 -170.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 34.1 mtp -67.64 -22.06 65.34 Favored 'General case' 0 C--O 1.199 -1.575 0 O-C-N 121.704 -0.622 . . . . 0.0 111.839 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.0 OUTLIER -87.13 -45.56 16.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 -178.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 10.8 t -56.31 -46.82 79.67 Favored 'General case' 0 C--N 1.277 -2.584 0 C-N-CA 126.618 1.967 . . . . 0.0 111.251 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.614 ' HG ' HG21 ' B' ' 54' ' ' ILE . 7.8 mp -89.44 3.84 51.03 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 123.149 0.579 . . . . 0.0 111.254 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.24 32.66 84.89 Favored Glycine 0 CA--C 1.539 1.583 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 175.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.3 mp -78.19 -34.21 49.63 Favored 'General case' 0 CA--C 1.49 -1.343 0 CA-C-N 118.651 1.226 . . . . 0.0 109.024 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 25.25 124.38 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 129.216 3.006 . . . . 0.0 117.565 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.69 9.03 6.74 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.057 -1.027 . . . . 0.0 112.365 -177.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.1 t -127.7 18.91 3.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -75.75 -19.82 58.76 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 122.293 1.044 . . . . 0.0 109.334 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -143.23 -179.08 6.18 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -94.24 150.93 19.84 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.706 -179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -54.91 120.9 7.54 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.7 m120 . . . . . 0 N--CA 1.432 -1.367 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 171.635 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.778 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -74.65 -73.44 0.24 Allowed 'General case' 0 C--O 1.246 0.885 0 CA-C-N 117.117 0.459 . . . . 0.0 110.323 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 20.7 p -114.21 16.94 17.92 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.656 0.741 . . . . 0.0 109.474 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -131.43 115.56 16.36 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -133.14 129.44 37.89 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -86.57 109.36 19.07 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -87.4 93.69 9.48 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.607 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.47 161.62 42.08 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -93.76 99.02 11.49 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.489 0.661 . . . . 0.0 109.253 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.3 m -65.98 -27.05 67.85 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.319 -175.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -150.0 136.13 18.76 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.078 -176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . 0.52 ' HB2' ' NH1' ' B' ' 15' ' ' ARG . 46.6 m-20 -108.66 142.5 25.57 Favored Pre-proline 0 C--N 1.3 -1.556 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.33 -29.07 79.26 Favored 'Trans proline' 0 C--O 1.213 -0.746 0 C-N-CA 122.398 2.065 . . . . 0.0 114.153 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 53.7 mt -108.54 116.01 50.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.641 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.52 ' NH1' ' HB2' ' B' ' 12' ' ' ASP . 29.9 mmt180 -119.73 156.64 30.15 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.696 172.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -77.76 139.67 39.39 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.089 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.36 -11.94 51.25 Favored Glycine 0 C--N 1.309 -0.941 0 C-N-CA 121.119 -0.563 . . . . 0.0 112.496 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -97.18 176.74 5.82 Favored 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 4.9 t -132.93 129.54 57.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-O 121.44 0.638 . . . . 0.0 112.209 -175.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.449 ' O ' HG22 ' B' ' 38' ' ' VAL . 83.1 m-85 -126.89 143.08 51.37 Favored 'General case' 0 CA--C 1.46 -2.486 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.458 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.592 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.5 mp -79.41 149.88 31.49 Favored 'General case' 0 N--CA 1.39 -3.43 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.905 170.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -136.76 131.48 33.46 Favored 'General case' 0 C--N 1.259 -3.364 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.132 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' B' ' 35' ' ' VAL . 8.8 t70 -81.84 96.1 7.52 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.037 171.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.582 HD22 ' O ' ' B' ' 24' ' ' LEU 0.475 0.0 OUTLIER -118.19 60.23 0.79 Allowed 'General case' 1 N--CA 1.376 -4.175 0 CA-C-O 124.078 1.894 . . . . 0.0 111.963 172.158 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HA2' ' B' ' 34' ' ' GLY . 1.3 m -105.08 59.89 0.12 Allowed Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 113.264 -1.789 . . . . 0.0 111.687 174.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.462 ' HD2' HG13 ' B' ' 27' ' ' VAL . 27.9 Cg_endo -116.95 24.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.594 0 N-CA-C 108.054 -1.556 . . . . 0.0 108.054 158.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.663 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 21.7 m -91.46 153.6 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . 0.618 ' N ' HE21 ' B' ' 28' ' ' GLN 0.467 0.0 OUTLIER -128.1 -64.61 0.95 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 119.336 3.087 . . . . 0.0 119.336 -177.385 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.5 -114.65 0.02 OUTLIER Glycine 0 C--N 1.313 -0.696 0 C-N-CA 120.555 -0.831 . . . . 0.0 114.076 -173.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.443 ' HB2' ' CB ' ' A' ' 95' ' ' ASP . 19.4 m -94.15 20.36 8.11 Favored 'General case' 0 C--N 1.271 -2.808 0 O-C-N 122.003 -0.704 . . . . 0.0 109.503 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.663 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 45.6 mt-10 -75.64 162.83 27.92 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.401 ' HB3' HE21 ' B' ' 90' ' ' GLN . 6.4 tp60 -138.41 112.71 8.7 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.515 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -147.18 -113.69 0.78 Allowed Glycine 0 N--CA 1.411 -2.999 0 C-N-CA 120.122 -1.037 . . . . 0.0 113.124 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.459 ' HA2' ' OG ' ' B' ' 25' ' ' SER . . . 86.99 176.53 49.18 Favored Glycine 0 N--CA 1.399 -3.826 0 N-CA-C 107.562 -2.215 . . . . 0.0 107.562 -172.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' B' ' 23' ' ' ASP . 1.6 p -84.53 99.58 6.97 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.768 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 173.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -141.46 151.17 60.15 Favored Pre-proline 0 C--N 1.262 -3.224 0 CA-C-N 112.096 -2.32 . . . . 0.0 109.26 -169.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 52.1 Cg_exo -59.0 139.69 91.99 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.825 2.35 . . . . 0.0 112.878 174.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.449 HG22 ' O ' ' B' ' 20' ' ' TYR . 27.0 m -125.75 158.36 34.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.5 m -100.39 129.59 50.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 24.3 mm -88.23 98.47 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.95 -18.82 6.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.486 -178.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.681 ' HG3' ' H ' ' B' ' 54' ' ' ILE . 0.0 OUTLIER -50.81 152.07 2.23 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -174.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -41.74 145.99 0.28 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 127.69 2.396 . . . . 0.0 113.761 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.76 -39.4 93.55 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 113.826 -1.534 . . . . 0.0 110.975 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -87.73 -29.33 21.16 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.13 0.491 . . . . 0.0 110.949 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.25 -30.95 77.46 Favored Glycine 0 C--O 1.206 -1.65 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.039 -176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.67 ' N ' HE22 ' B' ' 42' ' ' GLN . 29.8 p30 -72.54 -20.55 61.31 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.064 0.459 . . . . 0.0 111.166 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.12 -53.91 4.78 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.151 0.501 . . . . 0.0 109.817 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -82.79 -35.72 26.24 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.409 ' O ' ' HE3' ' B' ' 96' ' ' LYS . 70.1 m -94.84 143.2 25.76 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-O 120.855 0.36 . . . . 0.0 111.192 -176.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.88 -14.54 12.38 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.072 1.848 . . . . 0.0 109.524 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 1.9 p -97.18 147.93 23.59 Favored 'General case' 0 N--CA 1.425 -1.715 0 C-N-CA 125.11 1.364 . . . . 0.0 110.052 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.33 138.94 20.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.291 0.567 . . . . 0.0 110.888 173.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.681 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -85.01 124.19 39.77 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 C-N-CA 124.675 1.19 . . . . 0.0 109.881 177.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.9 m -129.78 171.15 17.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.429 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.59 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -129.82 142.97 50.6 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.0 130.31 38.21 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.655 HG12 HD12 ' B' ' 86' ' ' ILE . 57.8 mt -85.46 117.23 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 113.988 -1.46 . . . . 0.0 107.513 174.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 22.0 m -105.05 108.83 20.57 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.64 -37.68 93.85 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.067 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -142.45 125.24 16.0 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.969 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 tt -170.86 -42.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 175.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 67.63 -173.76 0.19 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.691 1.196 . . . . 0.0 112.646 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 mttm 62.49 71.71 0.52 Allowed 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.738 1.615 . . . . 0.0 114.563 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.99 70.39 8.52 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -114.42 13.74 17.74 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 123.272 1.51 . . . . 0.0 108.622 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 4.4 tt -138.56 140.58 28.28 Favored Pre-proline 0 C--N 1.278 -2.509 0 N-CA-C 104.523 -2.399 . . . . 0.0 104.523 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . 0.563 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 12.4 Cg_endo -56.72 -28.41 75.64 Favored 'Trans proline' 0 C--O 1.204 -1.18 0 C-N-CA 122.257 1.971 . . . . 0.0 114.182 -177.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 62.4 p -73.95 -19.17 60.76 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.046 0.45 . . . . 0.0 111.68 -174.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -105.38 129.07 53.78 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.404 ' CG2' ' HB2' ' B' ' 117' ' ' ALA . 70.8 t -130.31 125.85 60.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 175.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.41 134.38 39.66 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.608 HG21 ' CE1' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -118.14 153.95 20.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.272 -174.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.55 ' OE1' ' HE3' ' B' ' 110' ' ' LYS . 3.7 mp0 -65.02 113.04 3.62 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.49 -178.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 26.4 pttt -50.71 -41.64 56.28 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 124.272 1.029 . . . . 0.0 112.634 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -22.04 66.17 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.252 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -91.36 -36.32 13.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.644 0.735 . . . . 0.0 109.071 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.608 ' CE1' HG21 ' B' ' 73' ' ' ILE . 4.5 m-85 -83.38 8.11 14.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.433 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 67.09 20.38 10.34 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.824 1.249 . . . . 0.0 111.757 174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -111.0 179.66 3.98 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.1 0.476 . . . . 0.0 110.798 -174.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -105.86 -24.44 12.46 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.199 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -116.64 147.33 42.01 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.07 123.09 23.74 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 121.546 0.689 . . . . 0.0 109.237 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 22.6 t -102.88 154.11 19.53 Favored 'General case' 0 N--CA 1.413 -2.313 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.72 -167.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 16.0 t -116.18 136.08 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.655 HD12 HG12 ' B' ' 58' ' ' ILE . 21.3 mm -104.66 131.87 52.66 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.932 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 66.2 mt -101.65 103.14 13.93 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.574 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.9 mm? -82.88 -0.41 48.17 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.535 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -94.37 -40.67 9.81 Favored 'General case' 0 N--CA 1.413 -2.294 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.94 173.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . 0.475 ' HA ' HG21 ' A' ' 93' ' ' THR . 0.0 OUTLIER -91.04 76.67 6.16 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.27 1.033 . . . . 0.0 108.59 178.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.59 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.5 pp -117.33 178.77 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.584 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.418 ' HD2' HD23 ' B' ' 24' ' ' LEU . 15.5 ptp180 -173.8 163.58 4.18 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 90' ' ' GLN . 65.5 m -108.15 124.21 49.91 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.569 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.44 ' HB3' ' HG3' ' B' ' 98' ' ' ARG . 45.7 mt -132.34 145.85 51.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.739 -172.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 1.9 p-10 -77.8 153.5 32.77 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.412 176.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' B' ' 50' ' ' SER . 99.5 mttt -44.69 -21.76 0.06 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.129 1.772 . . . . 0.0 115.446 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -73.7 -19.17 60.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.11 0.481 . . . . 0.0 110.745 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.534 ' HD2' ' O ' ' B' ' 23' ' ' ASP . 31.5 mmt180 -74.98 -38.73 61.57 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.876 -0.515 . . . . 0.0 109.875 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.5 mp -69.5 123.12 20.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.092 177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -102.67 -65.08 1.01 Allowed 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 114.165 -1.379 . . . . 0.0 113.46 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 10.0 pt-20 -149.03 139.83 22.77 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.328 0.585 . . . . 0.0 111.349 -165.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 0.2 OUTLIER -69.76 123.5 21.57 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.754 -1.566 . . . . 0.0 111.592 176.203 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.6 tp -114.07 -62.37 1.61 Allowed 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.249 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.532 HG22 HG11 ' B' ' 19' ' ' VAL . 3.2 t -126.91 -168.25 1.85 Allowed 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 117.432 -1.707 . . . . 0.0 112.434 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -160.49 142.28 12.53 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 124.468 1.107 . . . . 0.0 110.205 -175.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -112.14 159.33 18.64 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.647 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 32.5 t -82.59 161.91 22.1 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' B' ' 111' ' ' MET . 16.7 t70 -62.1 -34.2 75.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.758 0.823 . . . . 0.0 111.373 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.01 -27.56 62.81 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.55 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 5.6 mptp? -75.0 -29.27 60.83 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 120.874 0.368 . . . . 0.0 110.02 175.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.481 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.0 OUTLIER -57.54 -38.31 74.5 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.655 174.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.45 ' HE2' ' C ' ' B' ' 111' ' ' MET . 7.6 mmpt? -77.34 -13.74 59.87 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.13 -35.37 21.8 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.5 t -56.88 -41.36 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.568 0 CA-C-N 112.32 -2.218 . . . . 0.0 110.099 172.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -44.54 76.98 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.831 0.824 . . . . 0.0 110.489 174.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.732 ' O ' HD13 ' B' ' 120' ' ' ILE . 1.1 m-80 -70.61 -20.91 62.71 Favored 'General case' 0 CA--C 1.474 -1.98 0 CA-C-O 122.384 1.088 . . . . 0.0 111.135 -176.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.574 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -84.26 -53.85 5.2 Favored 'General case' 2 C--N 1.235 -4.405 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.291 173.35 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.67 -46.77 74.61 Favored 'General case' 0 N--CA 1.403 -2.798 0 C-N-CA 126.194 1.798 . . . . 0.0 113.471 -172.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 38.4 mtp -66.05 -24.91 66.82 Favored 'General case' 0 C--O 1.2 -1.504 0 O-C-N 121.754 -0.591 . . . . 0.0 111.395 -177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.732 HD13 ' O ' ' B' ' 116' ' ' ASN . 1.3 mp -86.95 -40.77 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.719 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 70.5 m -57.12 -46.88 82.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 122.124 0.964 . . . . 0.0 111.145 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.598 ' HG ' HG21 ' A' ' 54' ' ' ILE . 7.4 mp -88.4 3.37 50.18 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.806 178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.5 32.0 79.62 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 116.069 1.188 . . . . 0.0 116.069 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.28 -37.04 63.8 Favored 'General case' 0 CA--C 1.481 -1.69 0 CA-C-N 119.041 1.421 . . . . 0.0 108.696 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.588 HD22 HG13 ' B' ' 120' ' ' ILE . 5.0 t-20 26.3 119.45 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 128.489 2.716 . . . . 0.0 117.443 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.49 6.62 6.72 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.429 -0.795 . . . . 0.0 112.358 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 17.2 t -122.23 15.39 5.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 CA-C-O 122.686 1.231 . . . . 0.0 107.975 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.96 -15.22 60.68 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.254 177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -148.63 173.56 13.06 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -88.25 149.44 23.82 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.154 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -54.24 123.78 13.85 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.942 0.897 . . . . 0.0 113.388 -177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 C--N 1.309 -1.177 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 174.17 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.095 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -124.86 -172.41 2.57 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 p 60.15 176.03 0.09 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.076 0.951 . . . . 0.0 113.246 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -90.26 -47.95 7.45 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.392 -0.817 . . . . 0.0 109.786 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -93.06 85.72 5.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.411 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -152.8 96.99 2.17 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -82.56 128.44 34.31 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -72.76 109.32 6.28 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.475 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 63.4 m170 -71.2 -39.88 71.51 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.8 m 72.54 -35.55 0.33 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.338 1.455 . . . . 0.0 111.814 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -147.83 106.67 3.83 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HB2' ' CE ' ' A' ' 102' ' ' LYS . 4.7 m-20 -85.82 154.71 58.6 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 174.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.09 144.06 81.45 Favored 'Trans proline' 0 C--O 1.252 1.198 0 C-N-CA 122.326 2.017 . . . . 0.0 111.152 178.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.4 mt -71.2 114.86 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-O 121.915 0.864 . . . . 0.0 109.107 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -110.02 154.64 22.91 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.906 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -84.63 129.89 34.78 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.021 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 104.6 0.38 43.0 Favored Glycine 0 C--N 1.308 -0.992 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.644 -175.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -97.33 170.14 9.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 104' ' ' THR . 12.0 t -131.73 133.9 60.87 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 C-N-CA 124.063 0.945 . . . . 0.0 112.021 -176.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 93.1 m-85 -132.41 145.83 51.51 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.573 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 0.7 OUTLIER -76.96 148.64 36.2 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 169.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 35' ' ' VAL . . . -143.78 149.07 36.52 Favored 'General case' 0 C--N 1.257 -3.452 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.669 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -74.45 85.78 2.02 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 124.238 1.971 . . . . 0.0 108.044 172.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 24' ' ' LEU . 2.0 tm? -87.94 13.15 11.52 Favored 'General case' 0 N--CA 1.407 -2.615 0 CA-C-N 111.198 -2.728 . . . . 0.0 111.662 -166.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 p -104.67 62.23 0.11 Allowed Pre-proline 0 N--CA 1.414 -2.236 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -113.47 23.71 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 121.712 1.608 . . . . 0.0 108.314 158.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.65 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 12.8 m -78.87 -179.1 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.702 -173.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.9 154.29 50.51 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.658 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.42 -108.99 1.16 Allowed Glycine 0 CA--C 1.502 -0.77 0 N-CA-C 116.271 1.268 . . . . 0.0 116.271 170.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.0 m -93.75 -6.63 45.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 119.288 -0.387 . . . . 0.0 111.236 -174.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.65 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 50.2 mt-10 -60.24 159.17 10.25 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.454 -176.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.433 HE22 ' HG3' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -81.21 113.02 19.07 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -173.045 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.75 159.51 15.87 Favored Glycine 0 CA--C 1.471 -2.678 0 N-CA-C 115.626 1.011 . . . . 0.0 115.626 -177.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 24' ' ' LEU . . . 110.43 146.31 10.89 Favored Glycine 0 N--CA 1.415 -2.764 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 22' ' ' ALA . 3.6 p -61.55 122.61 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.069 0 CA-C-O 122.507 1.146 . . . . 0.0 109.382 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.433 ' HG3' HE22 ' A' ' 32' ' ' GLN . 14.4 mmt85 -141.3 162.23 48.69 Favored Pre-proline 0 C--N 1.264 -3.124 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.753 -169.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.627 ' HB2' HD12 ' A' ' 58' ' ' ILE . 1.3 Cg_endo -80.08 142.35 15.33 Favored 'Trans proline' 0 N--CA 1.427 -2.429 0 C-N-CA 121.785 1.657 . . . . 0.0 109.736 171.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 22.4 m -123.54 155.17 29.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.068 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.518 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 35.5 m -99.38 132.9 43.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.79 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.459 HD13 HG12 ' A' ' 55' ' ' VAL . 22.9 mm -90.97 105.2 16.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -99.56 -15.58 7.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.817 -179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.641 ' OE1' ' HA ' ' A' ' 53' ' ' VAL . 2.8 tt0 -55.47 162.65 1.5 Allowed 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 126.035 1.734 . . . . 0.0 114.518 -168.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.512 ' N ' ' HG2' ' A' ' 42' ' ' GLN . 1.5 p30 -75.93 177.12 7.25 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.829 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.24 -34.53 49.12 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 m -75.3 -24.62 57.49 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.128 0.49 . . . . 0.0 110.504 -172.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.38 -23.06 73.35 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -83.44 -19.7 35.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.451 0.643 . . . . 0.0 109.91 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -89.93 -66.77 0.89 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.315 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -107.87 2.13 23.23 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.3 m -108.09 134.4 20.16 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.51 -22.92 20.68 Favored 'Trans proline' 0 C--O 1.239 0.529 0 C-N-CA 121.671 1.58 . . . . 0.0 109.364 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 p -86.97 158.94 19.16 Favored 'General case' 0 N--CA 1.419 -1.976 0 CA-C-N 113.631 -1.622 . . . . 0.0 111.551 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.641 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 66.2 t -137.64 140.4 41.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 173.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.451 HD13 ' CD2' ' B' ' 122' ' ' LEU . 5.8 tt -105.9 127.48 60.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.548 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 34.1 m -132.01 174.65 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.263 -174.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -131.52 146.51 52.27 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.81 138.44 38.97 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 37' ' ' PRO . 81.6 mt -99.89 127.32 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.707 176.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.8 t -141.67 138.28 32.37 Favored 'General case' 0 N--CA 1.42 -1.957 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.004 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -101.3 9.52 57.66 Favored Glycine 0 C--N 1.306 -1.089 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -60.44 -51.58 68.87 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.272 1.029 . . . . 0.0 112.811 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.655 HG23 HG21 ' A' ' 85' ' ' VAL . 16.3 tt -96.23 153.11 3.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -118.96 12.16 12.72 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.055 -175.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' H ' HG12 ' A' ' 62' ' ' ILE . 59.6 mttp -141.71 158.42 43.84 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.37 -79.55 0.59 Allowed 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp 57.62 28.95 16.44 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.483 1.513 . . . . 0.0 111.393 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tt -155.58 147.16 16.94 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.529 ' O ' ' HA ' ' A' ' 117' ' ' ALA . 27.0 Cg_exo -62.54 -35.04 73.29 Favored 'Trans proline' 0 C--O 1.196 -1.62 0 C-N-CA 121.431 1.421 . . . . 0.0 114.136 179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.2 p -73.36 -18.59 61.16 Favored 'General case' 0 C--O 1.25 1.121 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -114.67 128.97 56.61 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.8 t -122.1 127.73 75.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 118.704 0.684 . . . . 0.0 109.863 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -97.76 130.3 44.72 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.139 0.495 . . . . 0.0 110.406 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.505 HG21 ' CE1' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -110.31 169.61 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.4 ' H ' HG22 ' A' ' 73' ' ' ILE . 44.4 mt-10 -89.04 137.17 32.56 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.385 -176.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 82' ' ' LYS . 58.4 tttm -50.36 -42.46 53.21 Favored 'General case' 0 C--O 1.207 -1.141 0 O-C-N 124.351 1.032 . . . . 0.0 109.997 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.435 ' HG3' ' H ' ' A' ' 76' ' ' LYS . 46.5 mttp -54.11 -49.67 68.61 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 125.623 1.569 . . . . 0.0 111.494 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.02 -40.45 38.88 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.553 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 2.4 m-85 -77.4 -8.84 58.35 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 78' ' ' TYR . 17.4 ptmt 52.74 34.0 15.22 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.571 1.549 . . . . 0.0 110.692 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.66 -173.83 2.64 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.246 -171.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.13 -29.43 67.48 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.068 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 14.4 ptmm? -166.87 168.14 14.31 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -52.4 138.46 27.11 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.48 137.98 53.44 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -169.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.655 HG21 HG23 ' A' ' 62' ' ' ILE . 21.1 t -107.97 142.05 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.597 HD12 HG12 ' A' ' 58' ' ' ILE . 16.6 mm -109.9 135.3 49.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 48.5 mt -105.62 106.88 17.58 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -89.5 10.4 22.96 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.602 0.715 . . . . 0.0 111.79 -175.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.4 -34.28 6.83 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-O 121.955 0.883 . . . . 0.0 109.662 173.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.578 ' HA ' HG21 ' B' ' 93' ' ' THR . 0.3 OUTLIER -101.2 88.39 3.48 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.471 -1.24 . . . . 0.0 107.687 177.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.562 ' O ' ' HD2' ' A' ' 92' ' ' ARG . 2.1 pp -121.97 178.36 3.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.943 -174.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.562 ' HD2' ' O ' ' A' ' 91' ' ' ILE . 18.2 mmm180 -136.76 172.97 12.23 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.75 0.786 . . . . 0.0 111.521 -177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.578 HG21 ' HA ' ' B' ' 90' ' ' GLN . 52.9 m -139.84 119.21 12.93 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 171.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 64.2 mt -134.27 145.05 48.73 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.807 0.843 . . . . 0.0 111.345 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.83 145.49 52.5 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 119.503 1.047 . . . . 0.0 109.656 165.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -49.36 -34.91 17.18 Favored 'General case' 0 N--CA 1.509 2.502 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -57.03 -23.8 49.11 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 125.374 1.469 . . . . 0.0 112.64 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 6.2 mmp_? -74.5 -27.73 60.68 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.556 0.693 . . . . 0.0 109.445 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.29 107.86 8.83 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 122.944 1.354 . . . . 0.0 110.937 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.62 -63.5 1.36 Allowed 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 113.039 -1.891 . . . . 0.0 114.875 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.5 pt-20 -158.29 150.02 21.42 Favored 'General case' 0 N--CA 1.416 -2.136 0 CA-C-O 121.814 0.816 . . . . 0.0 111.485 -170.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 66.2 mttm -61.3 126.44 27.37 Favored 'General case' 0 C--N 1.273 -2.738 0 C-N-CA 127.284 2.234 . . . . 0.0 111.832 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.5 tp -115.63 -62.45 1.59 Allowed 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.725 171.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.53 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 2.7 t -127.98 -167.16 1.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.142 -1.423 . . . . 0.0 112.33 -177.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -159.74 135.23 8.33 Favored 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 125.598 1.559 . . . . 0.0 110.712 -172.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 mt -87.08 157.48 19.4 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 124.098 0.959 . . . . 0.0 111.344 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.466 ' HB2' ' HD3' ' A' ' 110' ' ' LYS . 7.5 m -84.08 161.22 20.75 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 111' ' ' MET . 4.9 m-20 -62.4 -36.52 82.59 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 123.538 0.735 . . . . 0.0 112.576 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -79.79 -26.63 40.52 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.576 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.466 ' HD3' ' HB2' ' A' ' 107' ' ' SER . 2.5 mptp? -70.54 -26.45 63.56 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 120.98 0.419 . . . . 0.0 110.687 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.468 ' C ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -57.26 -39.18 75.1 Favored 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 123.903 0.881 . . . . 0.0 109.667 172.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.468 ' HE2' ' C ' ' A' ' 111' ' ' MET . 7.9 mmpt? -83.36 -11.1 58.0 Favored 'General case' 0 N--CA 1.397 -3.117 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.426 ' OE1' ' HG3' ' A' ' 110' ' ' LYS . 36.7 mt-10 -84.78 -37.16 21.14 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 117' ' ' ALA . 1.4 t -55.04 -36.91 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 CA-C-N 112.835 -1.984 . . . . 0.0 110.617 172.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.56 -35.36 80.73 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.401 1.096 . . . . 0.0 111.153 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.659 ' O ' HD13 ' A' ' 120' ' ' ILE . 13.4 m-80 -81.13 -15.03 57.04 Favored 'General case' 1 N--CA 1.555 4.823 0 CA-C-O 124.165 1.936 . . . . 0.0 109.596 -174.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.555 ' HB3' ' HG ' ' A' ' 88' ' ' LEU 0.337 . . -91.01 -51.31 5.4 Favored 'General case' 2 N--CA 1.346 -5.635 0 CA-C-N 111.867 -2.424 . . . . 0.0 105.254 175.109 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.621 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 3.3 tp -69.27 -47.47 64.53 Favored 'General case' 0 N--CA 1.393 -3.29 0 C-N-CA 124.518 1.127 . . . . 0.0 113.165 -171.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.5 mtp -64.77 -28.34 69.51 Favored 'General case' 0 C--O 1.195 -1.804 0 O-C-N 121.451 -0.78 . . . . 0.0 111.608 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.659 HD13 ' O ' ' A' ' 116' ' ' ASN . 1.2 mp -77.86 -48.67 23.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 23.1 t -56.48 -33.55 66.08 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 113.076 -1.875 . . . . 0.0 111.286 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 20.1 mt -104.48 7.32 35.34 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.021 0.439 . . . . 0.0 110.664 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.81 22.44 78.21 Favored Glycine 0 N--CA 1.431 -1.646 0 N-CA-C 116.247 1.259 . . . . 0.0 116.247 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.413 ' CD1' ' HB2' ' A' ' 122' ' ' LEU . 6.9 mp -80.51 -51.38 8.85 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 119.113 1.456 . . . . 0.0 108.927 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 50.47 -173.02 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 113.068 -1.878 . . . . 0.0 112.833 -173.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.85 103.93 5.56 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.1 p 57.24 18.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 126.664 1.986 . . . . 0.0 111.776 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 57.54 -159.46 0.26 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.628 -1.623 . . . . 0.0 109.926 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -79.0 80.12 5.36 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.668 0.747 . . . . 0.0 109.39 176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -84.93 111.15 19.42 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.214 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -130.59 97.41 4.37 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 . . . . . 0 C--N 1.286 -2.156 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.05 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.717 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 26.4 m -123.47 -173.52 2.75 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 23.1 m 67.41 177.8 0.24 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.916 0.886 . . . . 0.0 111.726 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -93.34 -53.09 4.23 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 -88.96 86.94 7.04 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 121.689 0.757 . . . . 0.0 109.871 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -152.08 103.59 2.9 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 174.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -87.94 127.45 35.37 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -75.35 112.03 11.23 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . 0.416 ' C ' ' H ' ' B' ' 11' ' ' GLN . 62.4 m170 -75.44 -33.67 60.91 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.427 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 41.3 m 71.44 -35.64 0.34 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.107 1.363 . . . . 0.0 111.668 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . 0.416 ' H ' ' C ' ' B' ' 9' ' ' HIS . 50.0 tt0 -149.73 99.37 2.86 Favored 'General case' 0 N--CA 1.421 -1.924 0 C-N-CA 123.584 0.754 . . . . 0.0 109.058 176.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . 0.486 ' HB2' ' CE ' ' B' ' 102' ' ' LYS . 6.8 m-20 -75.7 154.6 85.35 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -56.03 148.66 57.1 Favored 'Trans proline' 0 C--O 1.252 1.219 0 C-N-CA 122.435 2.09 . . . . 0.0 111.544 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 62.8 mt -75.72 118.03 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -113.59 155.99 24.46 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.879 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.21 135.08 34.5 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.95 2.17 58.33 Favored Glycine 0 C--N 1.305 -1.166 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.743 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . 0.411 ' CG ' ' HZ2' ' B' ' 102' ' ' LYS . 10.1 t70 -97.79 168.4 10.34 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' B' ' 102' ' ' LYS . 13.6 t -131.88 133.84 60.63 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 C-N-CA 123.805 0.842 . . . . 0.0 112.252 -176.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 89.9 m-85 -132.44 145.52 51.26 Favored 'General case' 0 CA--C 1.483 -1.628 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.417 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 0.8 OUTLIER -76.25 149.2 37.19 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 169.448 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.482 ' O ' HG23 ' B' ' 35' ' ' VAL . . . -144.35 148.66 35.02 Favored 'General case' 0 C--N 1.257 -3.448 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.891 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -73.5 85.64 1.54 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 124.022 1.868 . . . . 0.0 107.741 172.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.52 HD13 ' O ' ' B' ' 24' ' ' LEU . 2.1 tm? -88.8 12.95 13.66 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 111.33 -2.668 . . . . 0.0 111.769 -166.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 17.8 p -104.59 62.38 0.1 Allowed Pre-proline 0 CA--C 1.582 2.202 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -112.82 23.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 121.676 1.584 . . . . 0.0 108.316 159.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 16.1 m -78.42 -179.17 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.926 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.327 -173.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.68 154.17 48.59 Favored 'General case' 0 C--O 1.206 -1.228 0 CA-C-N 114.556 -1.202 . . . . 0.0 112.775 175.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.11 -112.0 3.26 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 115.307 0.883 . . . . 0.0 115.307 170.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -94.51 -2.85 50.96 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.532 0.333 . . . . 0.0 110.816 -173.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.67 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 51.7 mt-10 -60.71 158.84 11.91 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.167 -178.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.413 HE22 ' HG3' ' B' ' 36' ' ' ARG . 0.9 OUTLIER -80.98 112.28 18.23 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -172.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.53 156.25 17.79 Favored Glycine 0 CA--C 1.473 -2.553 0 N-CA-C 115.298 0.879 . . . . 0.0 115.298 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' B' ' 24' ' ' LEU . . . 114.18 149.3 10.01 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 22' ' ' ALA . 3.2 p -63.53 125.73 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.057 0 CA-C-O 122.526 1.155 . . . . 0.0 108.933 175.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . 0.413 ' HG3' HE22 ' B' ' 32' ' ' GLN . 9.7 mmt85 -142.09 160.98 53.25 Favored Pre-proline 0 C--N 1.268 -2.952 0 CA-C-N 113.773 -1.558 . . . . 0.0 110.068 -168.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.617 ' HB2' HD12 ' B' ' 58' ' ' ILE . 0.9 OUTLIER -80.62 142.06 14.19 Favored 'Trans proline' 0 N--CA 1.426 -2.442 0 C-N-CA 121.714 1.609 . . . . 0.0 109.38 170.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 24.3 m -123.22 155.59 29.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.18 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.518 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 35.7 m -99.65 132.97 44.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.789 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.441 HD13 HG12 ' B' ' 55' ' ' VAL . 22.7 mm -91.52 105.42 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.501 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -99.44 -16.15 7.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.844 -179.23 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.652 ' OE1' ' HA ' ' B' ' 53' ' ' VAL . 2.8 tt0 -54.89 162.81 1.14 Allowed 'General case' 0 N--CA 1.424 -1.743 0 C-N-CA 126.369 1.868 . . . . 0.0 114.986 -167.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.502 ' N ' ' HG2' ' B' ' 42' ' ' GLN . 2.2 p30 -74.78 175.83 7.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.934 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -77.24 -34.78 55.81 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 21.6 m -75.39 -25.53 57.71 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.156 0.503 . . . . 0.0 110.222 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.63 -23.99 72.41 Favored Glycine 0 N--CA 1.435 -1.406 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -83.23 -20.22 34.97 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.986 0.422 . . . . 0.0 110.28 178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -88.87 -66.95 0.87 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.994 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -100.15 -23.4 14.86 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -167.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.406 ' HA ' ' HD3' ' B' ' 51' ' ' PRO . 15.2 m -83.85 136.17 41.94 Favored Pre-proline 0 N--CA 1.423 -1.822 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' B' ' 50' ' ' SER . 8.0 Cg_exo -74.27 -21.72 17.32 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 121.706 1.604 . . . . 0.0 108.754 173.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -89.18 158.11 18.02 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-N 113.342 -1.754 . . . . 0.0 111.276 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.652 ' HA ' ' OE1' ' B' ' 42' ' ' GLN . 60.4 t -137.82 140.29 41.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 173.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.457 HD13 ' CD2' ' A' ' 122' ' ' LEU . 5.6 tt -106.43 127.91 61.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 174.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.56 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 33.9 m -132.91 174.16 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.212 -173.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.518 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -130.74 146.71 52.28 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.53 137.43 38.62 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' B' ' 37' ' ' PRO . 82.0 mt -98.35 128.56 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 113.323 -1.762 . . . . 0.0 107.736 176.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 14.5 t -140.89 141.38 34.58 Favored 'General case' 0 N--CA 1.411 -2.387 0 C-N-CA 119.581 -0.847 . . . . 0.0 111.621 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.97 8.63 50.17 Favored Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -60.08 -58.84 6.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.813 0.845 . . . . 0.0 112.499 -175.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.52 HG23 HG21 ' B' ' 85' ' ' VAL . 17.9 tt -89.08 154.12 3.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -178.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -113.18 -1.22 14.41 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.672 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.424 ' H ' HG12 ' B' ' 62' ' ' ILE . 62.7 mttp -134.14 151.39 51.34 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 122.197 -0.314 . . . . 0.0 110.423 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' B' ' 70' ' ' HIS . . . -108.8 -81.62 0.57 Allowed 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp 58.18 24.07 10.95 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.078 1.351 . . . . 0.0 111.332 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.2 tt -152.42 141.45 14.19 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . 0.455 ' O ' ' HA ' ' B' ' 117' ' ' ALA . 74.9 Cg_exo -54.41 -40.57 82.52 Favored 'Trans proline' 0 C--O 1.208 -1.017 0 C-N-CA 122.187 1.924 . . . . 0.0 114.659 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 57.8 p -72.63 -18.47 61.58 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -168.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.475 ' CD2' HD22 ' B' ' 87' ' ' LEU . 53.6 m170 -113.47 128.88 56.6 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' B' ' 117' ' ' ALA . 57.3 t -121.32 130.01 75.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 O-C-N 121.545 -0.722 . . . . 0.0 109.854 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -98.53 135.72 39.67 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.114 0.483 . . . . 0.0 109.735 176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.517 HG21 ' CE1' ' B' ' 78' ' ' TYR . 1.2 mm -112.32 174.95 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.427 ' H ' HG22 ' B' ' 73' ' ' ILE . 41.0 mt-10 -92.99 139.08 30.9 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.223 -178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -51.79 -41.08 61.42 Favored 'General case' 0 C--O 1.206 -1.208 0 C-N-CA 124.724 1.21 . . . . 0.0 109.697 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -59.21 -41.24 88.13 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 125.961 1.704 . . . . 0.0 111.686 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' B' ' 77' ' ' LYS . 0.2 OUTLIER -84.77 -39.05 18.89 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -176.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.569 ' O ' ' HG2' ' B' ' 79' ' ' LYS . 2.3 m-85 -79.14 -7.85 58.52 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.521 -178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' B' ' 78' ' ' TYR . 17.8 ptmt 52.71 33.25 13.51 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.63 1.572 . . . . 0.0 110.593 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.34 -175.89 3.14 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.463 -172.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.79 -29.88 70.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.93 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -165.99 165.96 17.65 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -50.91 135.31 24.59 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.08 139.38 49.93 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -169.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.52 HG21 HG23 ' B' ' 62' ' ' ILE . 21.8 t -108.09 142.6 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.594 HD12 HG12 ' B' ' 58' ' ' ILE . 16.2 mm -111.71 136.17 48.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.475 HD22 ' CD2' ' B' ' 70' ' ' HIS . 42.9 mt -106.35 106.25 16.68 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.605 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.8 mm? -89.07 10.39 21.9 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.714 0.769 . . . . 0.0 112.07 -175.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -108.67 -34.26 6.76 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 115.168 -0.923 . . . . 0.0 109.723 174.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . 0.578 ' HA ' HG21 ' A' ' 93' ' ' THR . 0.3 OUTLIER -100.99 87.56 3.31 Favored 'General case' 0 N--CA 1.406 -2.647 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 2.1 pp -121.49 178.91 2.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.061 -174.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' B' ' 91' ' ' ILE . 18.3 mmm180 -136.8 172.46 12.97 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.73 0.776 . . . . 0.0 111.312 -177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 90' ' ' GLN . 54.6 m -139.82 119.35 13.09 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 170.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 65.9 mt -134.18 146.79 50.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.276 1.03 . . . . 0.0 110.874 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -63.26 151.12 41.47 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.073 1.306 . . . . 0.0 109.668 165.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -51.22 -34.67 33.19 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -56.23 -25.42 47.51 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 125.076 1.35 . . . . 0.0 112.912 177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 5.7 mmp_? -73.91 -29.17 61.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.397 0.618 . . . . 0.0 109.733 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.2 mp -75.46 107.73 7.79 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 125.045 1.338 . . . . 0.0 111.051 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -82.79 -65.77 0.97 Allowed 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 112.882 -1.963 . . . . 0.0 114.932 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.2 pt-20 -156.32 146.34 21.25 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-O 121.504 0.669 . . . . 0.0 111.25 -169.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' B' ' 19' ' ' VAL . 67.6 mttm -60.52 126.43 27.4 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 126.639 1.976 . . . . 0.0 111.902 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 12.2 tp -115.09 -61.92 1.68 Allowed 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.503 172.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.545 ' O ' ' HB ' ' B' ' 19' ' ' VAL . 3.4 t -127.23 -168.22 1.85 Allowed 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 117.99 -1.484 . . . . 0.0 112.432 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -160.12 133.6 6.96 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 125.584 1.554 . . . . 0.0 110.456 -171.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 mt -84.29 162.67 20.01 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 124.009 0.924 . . . . 0.0 112.021 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.431 ' HB2' ' HD3' ' B' ' 110' ' ' LYS . 3.7 m -87.94 162.08 17.08 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.701 171.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.76 -31.79 71.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.45 -30.81 42.36 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.535 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.467 ' HG2' HG23 ' B' ' 73' ' ' ILE . 2.6 mptp? -67.78 -28.91 68.0 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.011 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.464 ' C ' ' HE2' ' B' ' 112' ' ' LYS . 0.0 OUTLIER -55.46 -38.8 69.54 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 123.907 0.883 . . . . 0.0 109.988 172.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.464 ' HE2' ' C ' ' B' ' 111' ' ' MET . 7.8 mmpt? -83.99 -13.08 54.21 Favored 'General case' 0 N--CA 1.399 -2.998 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -84.4 -33.43 23.75 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 1.4 t -58.02 -39.71 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.404 0 CA-C-N 112.617 -2.083 . . . . 0.0 110.2 172.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.05 -42.6 98.79 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.009 0.909 . . . . 0.0 110.067 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.624 ' O ' HD13 ' B' ' 120' ' ' ILE . 10.4 m-80 -69.51 -21.01 63.7 Favored 'General case' 0 CA--C 1.456 -2.639 0 C-N-CA 125.01 1.324 . . . . 0.0 111.923 -178.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.605 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -83.39 -50.57 8.2 Favored 'General case' 2 N--CA 1.366 -4.666 0 CA-C-N 113.753 -1.567 . . . . 0.0 108.839 173.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 3.3 tp -71.77 -48.21 48.33 Favored 'General case' 0 N--CA 1.393 -3.296 0 C-N-CA 124.546 1.138 . . . . 0.0 113.098 -171.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 37.7 mtp -63.66 -31.35 72.5 Favored 'General case' 0 C--O 1.197 -1.662 0 O-C-N 121.451 -0.781 . . . . 0.0 111.076 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.624 HD13 ' O ' ' B' ' 116' ' ' ASN . 1.4 mp -78.78 -42.93 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.8 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 47.7 t -56.71 -35.48 68.57 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.028 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 19.3 mt -104.18 6.57 35.74 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.936 -0.478 . . . . 0.0 111.151 -176.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.74 23.16 78.08 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 115.891 1.117 . . . . 0.0 115.891 173.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.444 ' CD1' ' HB2' ' B' ' 122' ' ' LEU . 7.1 mp -79.55 -51.86 8.76 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 118.954 1.377 . . . . 0.0 108.361 177.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.492 ' ND2' HG13 ' B' ' 120' ' ' ILE . 1.6 t-20 52.19 -171.1 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 113.118 -1.855 . . . . 0.0 112.748 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.44 103.35 4.54 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p 56.54 22.21 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 126.358 1.863 . . . . 0.0 111.528 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 54.53 -154.3 0.28 Allowed 'General case' 0 C--O 1.249 1.052 0 CA-C-N 112.837 -1.983 . . . . 0.0 109.992 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -82.8 81.97 8.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -86.57 107.54 18.18 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.303 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -128.1 99.45 5.48 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 C--N 1.301 -1.501 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.431 178.221 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.185 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -100.71 104.15 15.43 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 117.058 0.429 . . . . 0.0 109.844 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 m -78.96 -24.45 43.88 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -66.03 103.82 1.02 Allowed 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -111.95 -4.74 14.46 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.524 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -81.4 89.32 6.11 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -112.07 121.64 45.53 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -67.11 -54.33 22.39 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 54.48 -84.14 0.01 OUTLIER 'General case' 0 C--O 1.208 -1.113 0 C-N-CA 126.113 1.765 . . . . 0.0 114.084 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.7 m -88.29 0.74 55.79 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.243 0.544 . . . . 0.0 111.565 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -107.84 73.57 0.91 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.385 0.612 . . . . 0.0 112.158 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -108.15 126.79 28.89 Favored Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.17 96.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.9 2.4 . . . . 0.0 114.341 -174.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.3 mt -77.28 128.81 37.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.885 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 11.1 ptp85 -146.89 161.41 40.78 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.9 ptm85 -84.05 122.03 28.23 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.823 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . 130.76 -19.44 4.99 Favored Glycine 0 N--CA 1.437 -1.29 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.039 -175.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -92.42 147.31 23.01 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.957 0.884 . . . . 0.0 110.261 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.623 ' HB ' ' H ' ' A' ' 104' ' ' THR . 51.6 t -98.62 118.15 44.72 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.271 173.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.432 ' O ' HG22 ' A' ' 38' ' ' VAL . 19.9 m-85 -108.46 145.73 34.22 Favored 'General case' 0 CA--C 1.458 -2.562 0 C-N-CA 124.673 1.189 . . . . 0.0 112.24 176.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -80.7 145.58 31.51 Favored 'General case' 0 C--N 1.269 -2.93 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 166.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -143.92 133.12 23.05 Favored 'General case' 0 C--N 1.259 -3.343 0 CA-C-N 113.743 -1.572 . . . . 0.0 108.383 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HA ' ' HB ' ' A' ' 35' ' ' VAL . 6.8 p-10 -88.57 85.35 6.81 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-O 121.593 0.711 . . . . 0.0 109.925 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.537 ' O ' HD22 ' A' ' 24' ' ' LEU 0.459 0.0 OUTLIER -107.2 60.82 0.62 Allowed 'General case' 0 N--CA 1.393 -3.295 0 C-N-CA 116.887 -1.925 . . . . 0.0 113.121 178.557 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.581 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 25.2 p -113.59 62.48 0.95 Allowed Pre-proline 0 C--N 1.271 -2.829 0 CA-C-N 113.491 -1.686 . . . . 0.0 113.62 173.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.457 ' HD3' ' C ' ' A' ' 24' ' ' LEU . 24.4 Cg_endo -115.41 26.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.43 -2.26 0 N-CA-C 107.883 -1.622 . . . . 0.0 107.883 159.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 17.4 m -94.32 159.61 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 CA-C-N 115.157 -0.929 . . . . 0.0 113.457 -173.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -147.58 151.72 36.73 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.548 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.34 -132.2 11.52 Favored Glycine 0 N--CA 1.434 -1.482 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.302 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.6 m -93.85 11.94 27.61 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.652 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 42.6 mt-10 -68.09 151.51 46.92 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 170.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 tp60 -131.58 114.96 15.48 Favored 'General case' 0 N--CA 1.414 -2.261 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.495 ' HA3' HD22 ' A' ' 24' ' ' LEU . . . -147.72 -120.21 1.15 Allowed Glycine 0 N--CA 1.406 -3.347 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.964 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.581 ' HA2' ' HB3' ' A' ' 25' ' ' SER . . . 98.54 172.79 32.17 Favored Glycine 0 N--CA 1.408 -3.175 0 N-CA-C 106.901 -2.48 . . . . 0.0 106.901 -171.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 23' ' ' ASP . 1.1 p -88.94 104.09 14.56 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.075 0 CA-C-O 123.033 1.396 . . . . 0.0 108.303 173.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -133.13 163.35 51.74 Favored Pre-proline 0 C--N 1.271 -2.829 0 CA-C-N 112.536 -2.12 . . . . 0.0 110.894 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.542 ' HB2' HD12 ' A' ' 58' ' ' ILE . 14.5 Cg_exo -70.87 141.3 40.38 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.746 1.631 . . . . 0.0 109.749 166.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 20' ' ' TYR . 32.3 m -127.12 162.52 31.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 124.511 1.125 . . . . 0.0 108.182 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 34.8 m -104.1 128.89 57.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.671 176.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.423 HD13 HG12 ' A' ' 55' ' ' VAL . 33.0 mm -88.61 104.96 15.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -99.96 -16.34 7.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.594 ' HG3' ' H ' ' A' ' 54' ' ' ILE . 0.6 OUTLIER -43.75 139.28 2.32 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 127.168 2.187 . . . . 0.0 114.667 -170.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -46.81 145.64 1.9 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.868 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -67.22 -32.81 74.11 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -175.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 m -79.11 -25.76 42.95 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.408 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.77 -33.46 80.32 Favored Glycine 0 C--O 1.199 -2.058 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.553 ' N ' HE22 ' A' ' 42' ' ' GLN 0.257 20.1 p30 -75.45 -19.68 59.3 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.366 -178.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -85.46 -59.3 2.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.235 172.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.52 -19.06 18.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -167.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 m -102.22 135.91 19.53 Favored Pre-proline 0 C--N 1.302 -1.499 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.524 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.69 -12.55 16.59 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.066 1.844 . . . . 0.0 110.783 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 95' ' ' ASP . 3.0 p -100.21 134.14 43.57 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.485 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 93' ' ' THR . 61.4 t -121.37 140.19 46.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.594 ' H ' ' HG3' ' A' ' 42' ' ' GLN . 3.3 tp -105.72 125.1 61.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 123.543 0.737 . . . . 0.0 109.28 173.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.736 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 14.0 m -130.64 162.28 38.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.335 -175.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.553 ' HA ' HG22 ' A' ' 91' ' ' ILE . . . -118.99 132.37 56.06 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.056 0.942 . . . . 0.0 108.93 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.74 128.89 38.01 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.542 HD12 ' HB2' ' A' ' 37' ' ' PRO . 61.1 mt -85.63 132.67 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.795 174.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 61' ' ' ARG . 78.3 m -125.92 133.92 51.72 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 121.192 0.52 . . . . 0.0 111.44 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.51 36.06 3.01 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.516 ' H ' HG22 ' A' ' 59' ' ' THR . 39.4 ttm180 -115.35 -2.9 12.52 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.225 1.012 . . . . 0.0 108.795 -179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.6 tt -144.09 150.96 16.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -122.44 -27.65 4.4 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.644 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -106.73 118.58 37.04 Favored 'General case' 0 N--CA 1.427 -1.586 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.204 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.478 ' HB2' ' HG3' ' A' ' 72' ' ' GLU . . . -62.95 -57.91 9.13 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.79 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 72.8 -58.17 0.61 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.589 1.555 . . . . 0.0 111.44 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.9 tt -94.31 139.49 22.46 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.71 2.12 2.24 Favored 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 123.103 2.536 . . . . 0.0 116.018 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 121' ' ' SER . 51.9 p -92.0 -19.15 22.69 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 122.497 1.141 . . . . 0.0 108.715 176.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.458 ' CD2' HD22 ' A' ' 87' ' ' LEU . 28.9 m170 -101.15 133.35 45.82 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 171.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 4.4 p -133.44 145.51 33.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 117.046 -1.862 . . . . 0.0 112.434 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.478 ' HG3' ' HB2' ' A' ' 65' ' ' ALA . 21.4 mt-10 -87.66 124.54 33.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.636 1.174 . . . . 0.0 112.88 -173.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.555 HG21 ' CZ ' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -128.54 143.97 39.41 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 CA-C-O 121.814 0.816 . . . . 0.0 112.852 175.152 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.432 ' OE2' ' HE3' ' A' ' 110' ' ' LYS . 1.3 mp0 -60.74 133.1 55.77 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.727 -178.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 81' ' ' ASP . 83.8 tttt -55.11 -46.44 75.58 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.751 1.62 . . . . 0.0 109.889 175.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -58.5 -48.72 79.9 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 113.129 -1.85 . . . . 0.0 113.305 -174.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.535 ' HE2' ' OG ' ' A' ' 107' ' ' SER . 3.8 tmtm? -80.29 -38.27 31.11 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -171.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.555 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 4.5 m-85 -84.3 -7.03 59.45 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.601 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp 67.93 28.12 6.99 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 173.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.43 179.4 5.54 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.533 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.429 ' O ' ' HE3' ' A' ' 75' ' ' LYS . 9.9 t70 -68.82 -28.09 66.43 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.605 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.449 ' HB3' ' NZ ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -150.25 166.8 28.82 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -176.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -60.31 146.48 43.85 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.0 t -120.55 160.03 24.01 Favored 'General case' 0 N--CA 1.414 -2.247 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.558 -168.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 26.5 t -127.91 127.1 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.276 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 174.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.481 HG22 HD22 ' A' ' 88' ' ' LEU . 1.5 mp -100.96 131.62 48.27 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 70' ' ' HIS . 22.6 mt -99.13 109.28 22.0 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 113.771 -1.559 . . . . 0.0 107.825 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.481 HD22 HG22 ' A' ' 86' ' ' ILE . 3.1 mm? -88.04 0.08 56.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.591 0.71 . . . . 0.0 111.313 -174.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -98.69 -24.71 14.95 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-O 122.263 1.03 . . . . 0.0 109.654 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.504 ' HA ' HG21 ' B' ' 93' ' ' THR . 0.0 OUTLIER -103.55 85.51 2.47 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.033 177.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.736 ' HB ' ' O ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -139.99 171.25 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.202 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -176.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.451 ' HD3' HD23 ' A' ' 24' ' ' LEU . 11.9 ptm180 -168.6 169.63 10.12 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.499 HG21 ' HA ' ' B' ' 90' ' ' GLN . 58.4 m -103.93 125.7 50.51 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 113.518 -1.674 . . . . 0.0 109.329 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 24.8 mt -132.59 140.77 48.39 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 126.065 1.746 . . . . 0.0 107.419 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 52' ' ' THR . 0.8 OUTLIER -80.09 153.43 28.74 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.755 -1.178 . . . . 0.0 109.007 175.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -37.96 -38.18 0.3 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.67 1.588 . . . . 0.0 114.759 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -54.94 -27.55 44.37 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 124.881 1.272 . . . . 0.0 112.281 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -84.18 -27.56 27.96 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.729 -0.607 . . . . 0.0 110.2 -176.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.0 mp -74.04 127.03 31.84 Favored 'General case' 0 CA--C 1.482 -1.636 0 C-N-CA 123.772 0.829 . . . . 0.0 109.479 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 23' ' ' ASP . 68.3 mttm -94.95 -66.65 0.9 Allowed 'General case' 0 C--N 1.275 -2.647 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.577 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.11 147.9 21.55 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-O 121.422 0.63 . . . . 0.0 111.247 -170.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 124.48 23.74 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.34 -1.754 . . . . 0.0 109.999 173.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.646 ' HG ' ' OG1' ' A' ' 104' ' ' THR . 9.0 tp -112.64 -56.74 2.37 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.128 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.646 ' OG1' ' HG ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -124.59 -169.12 1.92 Allowed 'General case' 0 N--CA 1.394 -3.231 0 C-N-CA 118.833 -1.147 . . . . 0.0 113.986 -176.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 17' ' ' GLY . 8.4 p90 -161.28 142.01 11.17 Favored 'General case' 0 CA--C 1.487 -1.463 0 C-N-CA 125.58 1.552 . . . . 0.0 109.641 -170.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.72 152.15 34.92 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.535 ' OG ' ' HE2' ' A' ' 77' ' ' LYS . 15.8 m -77.02 171.28 15.05 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.834 -177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 111' ' ' MET . 9.4 m-20 -64.19 -36.94 85.7 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.272 0.558 . . . . 0.0 110.679 179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 113' ' ' GLU . 15.3 t70 -64.65 -39.31 93.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.947 175.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.502 ' N ' ' HD2' ' A' ' 110' ' ' LYS . 3.1 mptp? -75.84 -26.87 57.57 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.337 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.528 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -55.49 -39.94 71.07 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 124.851 1.26 . . . . 0.0 108.137 169.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 9.1 mmpt? -87.18 -1.66 58.06 Favored 'General case' 0 N--CA 1.394 -3.272 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.721 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 109' ' ' ASP . 32.7 mt-10 -90.89 -55.09 3.69 Favored 'General case' 0 N--CA 1.397 -3.113 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 171.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.63 -59.76 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-N 111.831 -2.44 . . . . 0.0 112.717 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 63.4 m-20 -62.71 -39.29 93.58 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 123.134 1.445 . . . . 0.0 111.023 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 17.7 t30 -74.01 -45.87 47.1 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 113.425 -1.716 . . . . 0.0 112.917 -172.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.68 73.35 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 12.5 tp -69.43 -40.28 77.33 Favored 'General case' 0 N--CA 1.389 -3.484 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.367 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.542 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 2.5 ttp -65.2 -27.98 69.06 Favored 'General case' 0 N--CA 1.408 -2.556 0 C-N-CA 123.775 0.83 . . . . 0.0 109.817 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.436 HG23 ' ND2' ' A' ' 125' ' ' ASN . 51.3 mt -80.29 -52.9 13.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.441 ' HA ' HG22 ' A' ' 69' ' ' THR . 38.1 t -50.39 -33.79 21.95 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 113.185 -1.825 . . . . 0.0 113.831 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 31.9 mt -97.5 9.35 42.63 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.006 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.51 10.73 81.35 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 115.741 1.056 . . . . 0.0 115.741 173.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.542 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.5 mm? -67.8 -54.34 19.91 Favored 'General case' 0 CA--C 1.48 -1.719 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.436 ' ND2' HG23 ' A' ' 120' ' ' ILE . 25.2 m120 51.57 -153.66 0.19 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 112.948 -1.933 . . . . 0.0 109.037 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.94 26.89 1.97 Allowed 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 122.257 1.027 . . . . 0.0 109.023 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.62 42.78 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.329 0 C-N-CA 126.044 1.738 . . . . 0.0 106.482 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -80.67 -16.89 52.82 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.429 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 72.35 124.24 0.03 OUTLIER 'General case' 0 C--O 1.248 1.007 0 C-N-CA 125.581 1.552 . . . . 0.0 112.35 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -83.22 139.11 33.31 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -80.21 94.87 6.13 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.67 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 C--N 1.305 -1.335 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.526 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.081 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m -126.65 108.66 11.3 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m -84.44 -14.38 49.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.705 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -73.95 91.78 2.05 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.214 1.007 . . . . 0.0 109.454 175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -99.1 -5.33 30.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.679 -1.146 . . . . 0.0 113.03 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -84.46 91.63 7.88 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.481 ' CE1' ' HB2' ' B' ' 9' ' ' HIS . 11.2 t-160 -114.81 123.47 49.29 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.146 -1.388 . . . . 0.0 107.563 -176.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -74.28 -55.49 5.97 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -175.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . 0.481 ' HB2' ' CE1' ' B' ' 7' ' ' HIS . 14.9 t-80 56.96 -81.97 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.463 1.505 . . . . 0.0 113.648 176.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.2 m -91.89 8.47 37.19 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.296 0.569 . . . . 0.0 111.039 -176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -116.16 76.44 1.02 Allowed 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.438 0.637 . . . . 0.0 111.136 177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -110.71 134.44 20.92 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 176.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.64 94.36 0.15 Allowed 'Trans proline' 0 C--O 1.239 0.567 0 C-N-CA 122.358 2.039 . . . . 0.0 113.1 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 65.1 mt -76.98 130.58 36.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -146.82 161.56 40.42 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -83.55 124.06 30.38 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.884 -0.727 . . . . 0.0 109.26 175.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' B' ' 105' ' ' TYR . . . 127.14 -15.63 6.45 Favored Glycine 0 N--CA 1.436 -1.31 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.806 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -96.73 149.52 21.73 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 121.678 0.751 . . . . 0.0 109.694 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.599 ' HB ' ' H ' ' B' ' 104' ' ' THR . 51.0 t -100.68 121.74 51.84 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.253 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.435 ' O ' HG22 ' B' ' 38' ' ' VAL . 20.6 m-85 -111.83 146.25 38.0 Favored 'General case' 0 CA--C 1.456 -2.646 0 C-N-CA 124.193 0.997 . . . . 0.0 111.967 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.09 145.29 31.17 Favored 'General case' 0 C--N 1.267 -2.992 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 167.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -144.0 131.77 21.35 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 113.747 -1.57 . . . . 0.0 108.009 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.447 ' HA ' ' HB ' ' B' ' 35' ' ' VAL . 6.1 p-10 -87.72 89.76 8.12 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.79 174.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.551 HD22 ' O ' ' B' ' 24' ' ' LEU 0.452 0.0 OUTLIER -108.85 59.84 0.6 Allowed 'General case' 0 N--CA 1.393 -3.295 0 CA-C-O 124.196 1.951 . . . . 0.0 112.426 177.533 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.588 ' HB3' ' HA2' ' B' ' 34' ' ' GLY . 10.9 p -111.62 62.62 0.53 Allowed Pre-proline 0 C--N 1.267 -2.992 0 CA-C-N 113.141 -1.845 . . . . 0.0 113.433 174.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.502 ' HD3' ' C ' ' B' ' 24' ' ' LEU . 22.3 Cg_endo -116.89 26.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.082 0 N-CA-C 107.692 -1.695 . . . . 0.0 107.692 158.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 18.6 m -95.01 156.39 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.785 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.87 151.74 37.56 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.535 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.04 -132.05 11.03 Favored Glycine 0 N--CA 1.435 -1.416 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -94.02 10.94 31.55 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.641 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 43.4 mt-10 -66.93 151.6 47.28 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -132.89 116.57 16.64 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -173.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . 0.514 ' HA3' HD22 ' B' ' 24' ' ' LEU . . . -149.27 -116.21 0.81 Allowed Glycine 0 N--CA 1.404 -3.494 0 C-N-CA 119.88 -1.152 . . . . 0.0 114.013 175.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.588 ' HA2' ' HB3' ' B' ' 25' ' ' SER . . . 96.63 177.83 35.36 Favored Glycine 0 N--CA 1.413 -2.886 0 N-CA-C 107.37 -2.292 . . . . 0.0 107.37 -171.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' B' ' 23' ' ' ASP . 1.0 OUTLIER -93.74 102.87 14.08 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.808 0 CA-C-O 123.167 1.46 . . . . 0.0 107.95 172.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -132.13 163.52 49.66 Favored Pre-proline 0 C--N 1.268 -2.966 0 CA-C-N 111.978 -2.374 . . . . 0.0 110.765 -172.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.512 ' HB2' HD12 ' B' ' 58' ' ' ILE . 14.0 Cg_exo -71.21 140.92 38.3 Favored 'Trans proline' 0 N--CA 1.437 -1.816 0 C-N-CA 121.671 1.581 . . . . 0.0 109.865 165.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.435 HG22 ' O ' ' B' ' 20' ' ' TYR . 28.3 m -126.89 162.63 31.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 124.667 1.187 . . . . 0.0 108.157 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 34.6 m -104.72 129.66 56.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.671 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 32.1 mm -89.22 105.16 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.41 HD13 ' N ' ' B' ' 42' ' ' GLN . 0.1 OUTLIER -100.07 -17.37 6.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.596 HE22 ' N ' ' B' ' 47' ' ' ASN . 0.6 OUTLIER -43.13 140.51 1.47 Allowed 'General case' 0 N--CA 1.422 -1.869 0 C-N-CA 127.03 2.132 . . . . 0.0 114.686 -170.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -47.89 149.55 1.31 Allowed 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.331 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.576 ' HA ' ' ND2' ' B' ' 47' ' ' ASN . 30.0 t70 -71.83 -32.07 67.18 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.743 -174.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 3.8 m -76.98 -25.07 52.31 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.127 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.62 -35.83 90.47 Favored Glycine 0 C--O 1.199 -2.048 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.596 ' N ' HE22 ' B' ' 42' ' ' GLN . 13.0 p30 -74.35 -19.09 60.57 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.339 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' B' ' 44' ' ' ASP . 14.0 mptt -85.64 -61.59 1.72 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.203 174.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -96.58 -16.68 20.92 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 115.583 1.698 . . . . 0.0 115.583 -168.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 59.9 m -98.62 140.75 22.01 Favored Pre-proline 0 C--N 1.302 -1.473 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.306 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.43 -11.77 11.68 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.932 1.754 . . . . 0.0 110.26 173.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' B' ' 95' ' ' ASP . 2.4 p -101.35 137.69 39.36 Favored 'General case' 0 N--CA 1.426 -1.656 0 C-N-CA 124.879 1.271 . . . . 0.0 111.455 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' B' ' 93' ' ' THR . 60.2 t -124.22 140.21 48.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.564 ' H ' ' HG3' ' B' ' 42' ' ' GLN . 3.2 tp -105.69 124.74 60.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 123.455 0.702 . . . . 0.0 109.402 173.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.721 ' O ' ' HB ' ' B' ' 91' ' ' ILE . 13.6 m -130.64 162.54 38.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.328 -175.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.551 ' HA ' HG22 ' B' ' 91' ' ' ILE . . . -118.89 132.79 56.11 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 124.27 1.028 . . . . 0.0 108.759 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.1 129.54 39.71 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' B' ' 37' ' ' PRO . 60.5 mt -86.64 133.18 30.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.202 174.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . 0.497 HG22 ' H ' ' B' ' 61' ' ' ARG . 75.1 m -127.11 133.01 50.48 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.24 0.543 . . . . 0.0 112.223 -176.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.19 41.49 1.77 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.497 ' H ' HG22 ' B' ' 59' ' ' THR . 42.1 ttm180 -118.27 -11.43 10.07 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.938 0.875 . . . . 0.0 109.468 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 12.3 tt -138.43 145.78 27.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -116.45 -29.39 6.18 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.999 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -103.37 123.61 47.14 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . 0.553 ' HB2' ' HG3' ' B' ' 72' ' ' GLU . . . -64.89 -59.06 4.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.403 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 61.8 tttp 72.32 -57.87 0.61 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.908 1.283 . . . . 0.0 111.655 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.1 tt -97.47 134.62 22.37 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -61.82 -4.32 4.58 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 123.821 3.014 . . . . 0.0 116.153 -174.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 74.8 p -87.21 -18.99 29.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 122.407 1.098 . . . . 0.0 108.848 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . 0.447 ' CD2' HD22 ' B' ' 87' ' ' LEU . 33.5 m170 -99.83 134.8 42.2 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 170.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 5.1 p -134.24 144.98 33.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 C-N-CA 116.979 -1.888 . . . . 0.0 112.364 177.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.553 ' HG3' ' HB2' ' B' ' 65' ' ' ALA . 31.2 mt-10 -88.62 127.88 35.57 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.25 1.02 . . . . 0.0 112.149 -175.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.575 HG21 ' CZ ' ' B' ' 78' ' ' TYR . 0.0 OUTLIER -128.33 149.12 32.89 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 O-C-N 123.708 0.63 . . . . 0.0 112.063 175.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -64.19 131.89 48.74 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.744 -1.116 . . . . 0.0 113.329 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -54.62 -46.69 73.92 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 125.732 1.613 . . . . 0.0 109.813 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -56.29 -50.21 72.04 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 112.899 -1.955 . . . . 0.0 112.851 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -78.78 -39.06 36.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.63 -170.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.575 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 4.4 m-85 -84.14 -6.99 59.49 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.977 -178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 68.6 29.28 5.52 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.19 178.88 5.38 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.382 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -70.59 -25.0 62.86 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 113.422 -1.717 . . . . 0.0 111.156 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.411 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -151.68 163.52 38.94 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -176.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -58.37 143.92 43.42 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 22.1 t -121.3 156.83 31.69 Favored 'General case' 0 N--CA 1.421 -1.89 0 C-N-CA 119.639 -0.825 . . . . 0.0 112.257 -167.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 25.9 t -123.7 126.97 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.072 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.46 HG22 HD22 ' B' ' 88' ' ' LEU . 1.5 mp -100.24 131.33 47.93 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.158 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.447 HD22 ' CD2' ' B' ' 70' ' ' HIS . 31.8 mt -98.99 108.15 20.76 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.03 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.46 HD22 HG22 ' B' ' 86' ' ' ILE . 3.3 mm? -86.97 -0.26 56.3 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.723 0.773 . . . . 0.0 111.52 -174.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -100.15 -22.65 15.1 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 122.372 1.082 . . . . 0.0 109.928 175.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . 0.499 ' HA ' HG21 ' A' ' 93' ' ' THR . 0.0 OUTLIER -104.62 85.66 2.36 Favored 'General case' 0 C--N 1.276 -2.618 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.992 177.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.721 ' HB ' ' O ' ' B' ' 55' ' ' VAL . 0.3 OUTLIER -140.1 171.41 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.163 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.494 ' HD3' HD23 ' B' ' 24' ' ' LEU . 11.7 ptm180 -168.98 169.34 9.67 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 115.478 1.659 . . . . 0.0 115.478 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 90' ' ' GLN . 72.0 m -104.43 126.31 51.41 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.549 -177.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 mt -132.55 142.88 49.37 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 126.069 1.748 . . . . 0.0 107.432 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' B' ' 52' ' ' THR . 1.7 p-10 -81.18 152.06 27.9 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.019 -1.473 . . . . 0.0 108.96 175.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -35.48 -40.01 0.15 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 125.891 1.676 . . . . 0.0 115.148 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -51.34 -31.79 23.26 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 125.027 1.331 . . . . 0.0 112.632 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -79.93 -27.51 39.84 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 120.963 0.411 . . . . 0.0 110.193 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 mp -75.01 124.56 27.19 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 122.01 0.91 . . . . 0.0 109.563 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -95.49 -60.08 1.74 Allowed 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 114.628 -1.169 . . . . 0.0 113.902 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -161.02 148.43 15.4 Favored 'General case' 0 N--CA 1.414 -2.25 0 CA-C-O 121.504 0.669 . . . . 0.0 111.737 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.63 121.06 18.12 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 113.357 -1.747 . . . . 0.0 109.85 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.628 ' HG ' ' OG1' ' B' ' 104' ' ' THR . 8.4 tp -109.37 -55.39 2.43 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.628 ' OG1' ' HG ' ' B' ' 103' ' ' LEU . 0.3 OUTLIER -124.13 -168.57 1.82 Allowed 'General case' 0 N--CA 1.391 -3.424 0 C-N-CA 118.421 -1.312 . . . . 0.0 114.497 -176.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.493 ' H ' HG22 ' B' ' 104' ' ' THR . 19.9 p90 -161.48 141.69 10.68 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 125.808 1.643 . . . . 0.0 109.383 -171.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.9 150.73 36.6 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.44 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t -78.25 170.18 17.05 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.473 -175.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.508 ' O ' ' HB3' ' B' ' 111' ' ' MET . 4.6 m-20 -60.8 -38.48 85.49 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.683 0.793 . . . . 0.0 111.121 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' B' ' 113' ' ' GLU . 27.1 t70 -64.58 -38.27 90.44 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.148 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.495 ' HD2' ' N ' ' B' ' 110' ' ' LYS . 2.6 mptp? -75.55 -27.71 58.74 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.247 -178.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.508 ' HB3' ' O ' ' B' ' 108' ' ' ASP . 0.2 OUTLIER -54.87 -40.25 69.52 Favored 'General case' 0 CA--C 1.488 -1.423 0 C-N-CA 124.912 1.285 . . . . 0.0 108.058 170.041 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' B' ' 112' ' ' LYS . 7.7 mmpt? -86.6 -2.43 58.49 Favored 'General case' 0 N--CA 1.384 -3.769 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.314 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' B' ' 109' ' ' ASP . 38.3 mt-10 -90.69 -55.51 3.54 Favored 'General case' 0 C--N 1.261 -3.271 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 172.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.18 -59.72 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 CA-C-N 111.594 -2.548 . . . . 0.0 112.786 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 56.7 m-20 -62.65 -40.24 96.42 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.14 1.448 . . . . 0.0 111.227 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.332 43.1 t30 -75.1 -42.96 55.52 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 113.531 -1.668 . . . . 0.0 112.602 -170.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -64.18 -31.76 73.08 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' B' ' 122' ' ' LEU . 11.2 tp -70.72 -35.09 72.56 Favored 'General case' 0 N--CA 1.39 -3.445 0 CA-C-N 113.919 -1.491 . . . . 0.0 110.047 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.554 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 2.3 ttp -69.05 -21.49 64.09 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-O 121.686 0.755 . . . . 0.0 109.303 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' B' ' 117' ' ' ALA . 51.6 mt -87.89 -53.5 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . 0.423 ' OG ' ' HA ' ' B' ' 118' ' ' LEU . 79.1 p -53.94 -28.48 37.33 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -177.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 26.2 mt -97.06 5.28 50.64 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.187 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.15 13.01 78.14 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 115.954 1.142 . . . . 0.0 115.954 172.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.554 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.5 mm? -68.32 -52.95 27.84 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 176.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 23.7 m120 51.71 -152.85 0.21 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 112.979 -1.919 . . . . 0.0 109.474 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.69 26.24 2.09 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 122.481 1.134 . . . . 0.0 108.947 173.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.7 t -105.06 39.77 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.01 0 C-N-CA 125.705 1.602 . . . . 0.0 106.962 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.73 -17.48 59.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.887 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 73.04 143.03 0.06 Allowed 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 125.549 1.54 . . . . 0.0 110.985 -178.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -100.02 145.78 27.5 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -84.06 96.5 8.91 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 C--N 1.3 -1.551 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.526 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.971 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -83.85 -10.02 58.33 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t -114.21 103.2 10.87 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -126.02 -53.96 1.51 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 71.16 174.74 0.3 Allowed 'General case' 0 C--O 1.246 0.915 0 C-N-CA 125.1 1.36 . . . . 0.0 113.183 176.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -157.67 173.47 16.79 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.8 m80 74.75 -52.57 0.68 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.734 1.213 . . . . 0.0 113.703 176.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -45.58 -39.26 7.38 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.601 1.16 . . . . 0.0 112.34 -174.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -119.64 -33.23 4.09 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.421 175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.5 m -59.71 -47.25 86.38 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -178.2 101.09 0.04 OUTLIER 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.78 129.91 82.45 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -65.17 98.99 0.33 Allowed 'Trans proline' 0 C--O 1.252 1.184 0 C-N-CA 122.406 2.07 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 63.8 mt -69.72 132.38 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.739 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.5 ptt180 -146.54 156.91 43.59 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -70.36 124.91 25.32 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 169.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.14 -26.21 3.78 Favored Glycine 0 C--N 1.302 -1.359 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.093 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -97.41 167.43 11.0 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-O 121.776 0.798 . . . . 0.0 109.427 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.472 HG11 HG22 ' A' ' 104' ' ' THR . 24.7 t -122.42 139.39 49.48 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.56 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.516 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 29.2 m-85 -133.5 148.66 51.7 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.4 151.62 39.65 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 168.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 35' ' ' VAL . . . -141.58 135.48 30.1 Favored 'General case' 0 CA--C 1.454 -2.736 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.217 -175.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -88.39 93.59 9.58 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 166.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.471 HD13 ' HD3' ' A' ' 92' ' ' ARG . 1.1 pp -109.83 28.9 8.12 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.282 -1.327 . . . . 0.0 107.814 -174.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.29 62.25 0.0 OUTLIER Pre-proline 0 C--N 1.267 -3.002 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -112.87 25.03 0.04 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.938 0 N-CA-C 107.232 -1.872 . . . . 0.0 107.232 153.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.695 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 13.9 m -83.56 160.45 3.49 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -173.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.52 145.84 31.21 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 113.311 -1.768 . . . . 0.0 113.249 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.32 -114.21 6.65 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.602 -1.181 . . . . 0.0 114.637 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.3 m -78.34 -9.1 59.12 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 123.827 0.851 . . . . 0.0 112.963 -173.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.695 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 50.7 mt-10 -71.3 159.89 33.78 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -132.29 111.41 11.35 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -174.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.0 -162.54 15.11 Favored Glycine 0 N--CA 1.408 -3.23 0 C-N-CA 119.155 -1.497 . . . . 0.0 115.02 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 142.6 -156.81 26.45 Favored Glycine 0 N--CA 1.407 -3.283 0 N-CA-C 103.419 -3.872 . . . . 0.0 103.419 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' ALA . 59.3 t -83.03 99.69 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.438 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 169.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -130.8 146.51 62.33 Favored Pre-proline 0 C--N 1.252 -3.652 0 CA-C-N 113.758 -1.565 . . . . 0.0 110.277 -172.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HB2' HD12 ' A' ' 58' ' ' ILE . 25.4 Cg_exo -62.98 137.12 60.49 Favored 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 121.702 1.601 . . . . 0.0 109.929 171.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 31.1 m -127.6 154.87 38.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 29.8 m -97.77 129.92 47.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.125 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.415 HD13 HG12 ' A' ' 55' ' ' VAL . 25.9 mm -91.36 107.19 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.857 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -13.82 9.76 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.285 -177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.533 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 5.0 pt20 -52.11 165.24 0.23 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 -169.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -65.51 174.43 2.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.613 -2.085 . . . . 0.0 112.118 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 9.9 t70 -72.56 -48.24 41.65 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.268 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.5 m -70.38 -30.98 68.03 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.477 0.711 . . . . 0.0 112.253 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 50' ' ' SER . . . -62.32 -33.41 86.05 Favored Glycine 0 C--O 1.205 -1.67 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.691 -175.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.52 ' N ' HE22 ' A' ' 42' ' ' GLN . 10.1 p30 -84.65 -37.13 21.4 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.841 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.645 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 24.4 mmtp -67.6 -63.19 1.11 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.386 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.645 ' CD1' ' HB2' ' A' ' 48' ' ' LYS . 19.0 m-85 -102.09 -35.86 8.77 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -168.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.477 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 22.5 m -82.47 157.92 66.88 Favored Pre-proline 0 N--CA 1.422 -1.832 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.677 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 86.4 Cg_endo -86.95 -20.85 2.23 Favored 'Trans proline' 0 N--CA 1.436 -1.906 0 C-N-CA 121.099 1.199 . . . . 0.0 111.797 174.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.483 HG21 ' HG2' ' B' ' 90' ' ' GLN . 11.3 p -99.6 135.3 41.23 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.533 ' HB ' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -133.42 139.2 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.906 176.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.5 tt -81.74 126.85 39.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.964 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 34.5 m -132.97 154.98 40.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.582 174.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.586 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -115.91 133.09 56.39 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.3 136.02 56.76 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.521 HG12 HD12 ' A' ' 86' ' ' ILE . 49.2 mt -98.07 131.47 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.736 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 m -105.54 108.34 19.81 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -90.27 44.98 2.95 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.294 -0.479 . . . . 0.0 112.479 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -162.53 172.99 14.6 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 81.2 mt 73.22 123.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.21 -0.991 0 O-C-N 124.387 1.055 . . . . 0.0 111.425 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -112.79 17.95 18.62 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.41 -0.806 . . . . 0.0 110.784 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -128.8 109.87 11.67 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.554 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.82 -70.73 0.71 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 172.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 54.58 33.09 18.33 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.837 1.255 . . . . 0.0 112.987 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tt -151.14 139.64 13.06 Favored Pre-proline 0 C--N 1.303 -1.43 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.12 -4.7 12.05 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 122.427 2.084 . . . . 0.0 115.246 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.3 p -100.09 -17.92 17.22 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-O 121.377 0.608 . . . . 0.0 111.363 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -118.55 128.45 54.57 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.411 HG12 HD13 ' A' ' 73' ' ' ILE . 61.0 t -111.27 134.26 54.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.208 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -99.69 124.79 45.28 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 123.744 0.653 . . . . 0.0 109.363 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.521 HD11 HG12 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -116.35 153.27 18.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.209 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -54.08 129.56 34.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.058 -1.428 . . . . 0.0 112.815 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.644 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 93.1 mttt -51.98 -56.79 12.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.457 178.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -67.98 -45.84 73.03 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.193 -169.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -62.84 -33.05 74.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.016 0.436 . . . . 0.0 111.394 -176.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.492 ' CZ ' HG21 ' A' ' 73' ' ' ILE . 12.1 m-85 -92.9 2.31 56.85 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 123.924 0.89 . . . . 0.0 111.14 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.3 tptt 72.22 15.95 5.28 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.507 1.523 . . . . 0.0 113.562 171.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.53 175.42 6.56 Favored 'General case' 0 CA--C 1.484 -1.56 0 CA-C-O 122.492 1.139 . . . . 0.0 110.983 176.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.495 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 10.3 t70 -85.08 -27.08 26.54 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 112.944 -1.934 . . . . 0.0 110.1 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.499 ' HB3' ' NZ ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -139.31 157.09 46.5 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.42 -174.19 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.644 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 6.5 m-20 -45.89 135.44 7.15 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 124.92 1.388 . . . . 0.0 112.055 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 73' ' ' ILE . 15.4 m -103.73 121.8 43.76 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.667 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.8 t -107.74 136.51 42.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.521 HD12 HG12 ' A' ' 58' ' ' ILE . 15.9 mm -111.68 134.41 54.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.1 mt -104.91 97.42 7.29 Favored 'General case' 0 N--CA 1.416 -2.164 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.0 mm? -81.25 -9.42 59.77 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.497 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -95.41 -25.93 16.07 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.762 0.791 . . . . 0.0 111.292 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' B' ' 93' ' ' THR . 1.1 tm0? -80.28 -60.88 2.16 Favored 'General case' 0 C--O 1.164 -3.433 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.246 -178.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.586 HG22 ' CB ' ' A' ' 56' ' ' ALA . 1.3 pp 30.05 -174.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.529 3.475 0 C-N-CA 129.646 3.178 . . . . 0.0 116.814 175.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.471 ' HD3' HD13 ' A' ' 24' ' ' LEU . 8.7 ptm85 -176.96 159.6 1.72 Allowed 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.517 1.302 . . . . 0.0 114.517 167.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' B' ' 90' ' ' GLN . 0.0 OUTLIER -114.54 108.36 16.74 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.743 1.217 . . . . 0.0 109.356 179.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.535 ' HB2' ' CZ ' ' A' ' 98' ' ' ARG . 64.9 mt -131.82 149.58 52.42 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -173.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.677 ' HA ' ' O ' ' A' ' 51' ' ' PRO . 11.8 t70 -50.72 145.17 7.22 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 173.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.506 ' O ' ' HB2' ' A' ' 99' ' ' LEU . 33.1 pttt -55.58 -29.74 59.6 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.589 1.556 . . . . 0.0 114.608 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 20.1 ttmm -47.56 -39.08 15.63 Favored 'General case' 0 C--N 1.274 -2.677 0 C-N-CA 126.243 1.817 . . . . 0.0 112.476 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.535 ' CZ ' ' HB2' ' A' ' 94' ' ' LEU . 1.7 ppt_? -73.39 -15.01 61.37 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -178.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 10.4 mp -61.75 120.6 10.98 Favored 'General case' 0 CA--C 1.489 -1.387 0 C-N-CA 123.912 0.885 . . . . 0.0 110.028 170.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -95.08 -64.27 1.08 Allowed 'General case' 0 C--N 1.283 -2.324 0 CA-C-N 114.258 -1.337 . . . . 0.0 112.367 -177.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 12.4 pt-20 -156.67 145.32 19.95 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 121.786 0.803 . . . . 0.0 111.807 -172.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -60.81 120.82 10.86 Favored 'General case' 0 C--N 1.281 -2.379 0 C-N-CA 128.132 2.573 . . . . 0.0 108.814 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 tp -114.66 -62.67 1.57 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.704 -0.798 . . . . 0.0 112.466 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.472 HG22 HG11 ' A' ' 19' ' ' VAL . 5.4 t -128.8 -160.98 1.07 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.243 -179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -159.39 149.25 18.77 Favored 'General case' 0 CA--C 1.504 -0.793 0 C-N-CA 124.052 0.941 . . . . 0.0 112.326 -169.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.56 135.39 49.1 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 113.853 -1.522 . . . . 0.0 112.264 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 111' ' ' MET . 7.0 m -76.4 165.95 24.11 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 124.248 1.019 . . . . 0.0 110.597 176.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 111' ' ' MET . 23.3 t70 -67.71 -42.98 81.11 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.86 -28.86 69.28 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.737 0.78 . . . . 0.0 109.382 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 110' ' ' LYS . 71.5 mmtt -79.78 -28.78 40.3 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.684 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.8 OUTLIER -53.65 -44.55 69.69 Favored 'General case' 0 CA--C 1.474 -1.968 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 169.153 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 10.0 mmpt? -75.13 -8.32 56.24 Favored 'General case' 0 N--CA 1.396 -3.161 0 CA-C-N 114.421 -1.263 . . . . 0.0 114.173 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -89.26 -51.56 5.51 Favored 'General case' 0 N--CA 1.397 -3.079 0 C-N-CA 116.735 -1.986 . . . . 0.0 106.264 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 t -53.72 -59.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.415 -2.216 0 CA-C-N 112.615 -2.084 . . . . 0.0 113.351 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 45.8 m-20 -59.73 -39.19 83.87 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 123.241 1.496 . . . . 0.0 110.989 -177.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 10.9 t30 -77.97 -40.46 39.25 Favored 'General case' 0 C--N 1.261 -3.275 0 CA-C-N 112.718 -2.037 . . . . 0.0 111.669 -173.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.525 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.69 -36.58 81.29 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.505 ' HA ' ' OG ' ' A' ' 121' ' ' SER . 5.2 tp -70.14 -37.02 75.18 Favored 'General case' 0 N--CA 1.394 -3.24 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.2 -177.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.504 ' HG2' ' HB2' ' A' ' 124' ' ' LEU . 1.5 ttp -66.87 -22.99 65.96 Favored 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.872 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 117' ' ' ALA . 45.0 mt -88.07 -50.95 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 118' ' ' LEU . 83.5 p -59.33 -22.26 61.02 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.644 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 32.9 mt -103.73 1.28 31.58 Favored 'General case' 0 C--O 1.201 -1.486 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.501 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.35 16.86 54.71 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 117.137 1.615 . . . . 0.0 117.137 171.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.504 ' HB2' ' HG2' ' A' ' 119' ' ' MET . 1.2 mm? -74.0 -52.34 13.08 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.414 ' ND2' HG23 ' A' ' 120' ' ' ILE . 23.3 m120 58.04 -171.69 0.1 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 112.47 -2.15 . . . . 0.0 112.546 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.03 20.16 1.04 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.042 0.925 . . . . 0.0 111.098 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.37 79.04 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.61 142.73 32.53 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.69 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -69.34 -27.03 64.99 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.481 0.657 . . . . 0.0 110.69 -173.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -101.03 24.63 9.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.082 177.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -126.6 131.03 51.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.042 0.449 . . . . 0.0 111.109 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.4 m120 . . . . . 0 C--O 1.256 1.417 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 175.097 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.393 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -84.28 -12.11 55.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.017 0.437 . . . . 0.0 111.569 -176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 48.0 t -117.76 110.39 17.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -133.21 -52.31 0.89 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 66.37 170.57 0.24 Allowed 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.683 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -152.55 171.72 17.68 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 52.6 m80 77.93 -52.62 0.51 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.739 1.215 . . . . 0.0 113.272 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -44.26 -42.95 6.99 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.897 1.279 . . . . 0.0 112.112 -174.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -114.23 -37.92 4.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.385 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 5.8 m -55.12 -57.04 13.38 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.667 0.787 . . . . 0.0 112.785 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -168.23 96.0 0.41 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -175.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -72.39 124.21 90.51 Favored Pre-proline 0 C--N 1.295 -1.774 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.43 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -61.59 106.85 0.45 Allowed 'Trans proline' 0 C--O 1.251 1.131 0 C-N-CA 123.024 2.482 . . . . 0.0 112.313 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -78.6 131.89 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.558 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.902 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -145.8 156.89 43.88 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -70.24 128.92 37.89 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 169.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.92 -26.33 4.02 Favored Glycine 0 C--N 1.307 -1.051 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.551 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -97.42 169.69 9.57 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-O 121.762 0.791 . . . . 0.0 109.183 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.468 ' HB ' ' H ' ' B' ' 104' ' ' THR . 23.4 t -123.84 140.16 48.15 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.885 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.728 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 35.3 m-85 -132.9 148.96 52.29 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 124.162 0.985 . . . . 0.0 109.087 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.02 149.57 39.2 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 167.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' B' ' 35' ' ' VAL . . . -140.35 134.49 30.97 Favored 'General case' 0 C--N 1.265 -3.089 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.71 -175.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -86.5 93.58 9.2 Favored 'General case' 0 C--N 1.276 -2.616 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 166.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.462 HD13 ' HD3' ' B' ' 92' ' ' ARG . 1.1 pp -108.8 28.7 8.16 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 122.842 1.306 . . . . 0.0 108.011 -175.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.416 ' OG ' ' HA2' ' B' ' 34' ' ' GLY . 1.0 OUTLIER -90.27 62.72 0.0 OUTLIER Pre-proline 0 C--N 1.266 -3.058 0 N-CA-C 116.712 2.115 . . . . 0.0 116.712 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -113.67 25.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -1.981 0 N-CA-C 107.42 -1.8 . . . . 0.0 107.42 151.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.692 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 15.1 m -82.29 162.26 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -173.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.39 147.86 31.72 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 113.802 -1.544 . . . . 0.0 113.033 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.34 -114.53 6.79 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 114.622 -1.172 . . . . 0.0 114.323 174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -75.56 -11.76 60.08 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 123.855 0.862 . . . . 0.0 113.168 -174.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.692 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 50.3 mt-10 -71.03 158.4 36.57 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 176.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -131.91 112.6 12.58 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.4 -161.63 13.84 Favored Glycine 0 N--CA 1.408 -3.192 0 C-N-CA 119.379 -1.391 . . . . 0.0 114.971 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.416 ' HA2' ' OG ' ' B' ' 25' ' ' SER . . . 141.6 -158.53 26.6 Favored Glycine 0 C--N 1.267 -3.279 0 N-CA-C 103.403 -3.879 . . . . 0.0 103.403 -173.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' B' ' 22' ' ' ALA . 61.8 t -82.37 98.98 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.647 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 169.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -130.72 146.78 63.4 Favored Pre-proline 0 C--N 1.253 -3.592 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.096 -172.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.562 ' HB2' HD12 ' B' ' 58' ' ' ILE . 27.2 Cg_exo -63.49 138.03 63.07 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 121.766 1.644 . . . . 0.0 110.16 171.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 30.2 m -128.44 154.72 39.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.569 178.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 28.1 m -97.72 129.7 47.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.094 177.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 25.8 mm -91.31 106.27 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -14.77 9.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.25 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.575 ' OE1' ' HB3' ' B' ' 47' ' ' ASN . 0.1 OUTLIER -53.79 164.71 0.53 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 -170.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -64.01 175.03 1.31 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.514 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' B' ' 48' ' ' LYS . 12.8 t70 -74.31 -47.32 35.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.866 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 10.9 m -70.52 -31.34 68.38 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 123.637 0.775 . . . . 0.0 112.199 -169.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' B' ' 50' ' ' SER . . . -62.48 -32.4 82.97 Favored Glycine 0 C--O 1.21 -1.401 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.424 -175.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.575 ' HB3' ' OE1' ' B' ' 42' ' ' GLN . 9.7 p30 -84.65 -39.04 19.1 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 119.475 -0.89 . . . . 0.0 112.096 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.656 ' HB2' ' CD1' ' B' ' 49' ' ' TYR . 25.9 mmtp -65.74 -63.25 1.13 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.096 0.474 . . . . 0.0 111.726 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . 0.656 ' CD1' ' HB2' ' B' ' 48' ' ' LYS . 19.1 m-85 -102.14 -36.3 8.59 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -168.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.487 ' HB2' ' HA2' ' B' ' 46' ' ' GLY . 25.8 m -80.85 157.98 71.03 Favored Pre-proline 0 N--CA 1.418 -2.032 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.671 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 83.8 Cg_endo -87.39 -21.37 1.92 Allowed 'Trans proline' 0 N--CA 1.431 -2.162 0 C-N-CA 121.202 1.268 . . . . 0.0 111.662 173.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.457 HG21 ' HG2' ' A' ' 90' ' ' GLN . 9.5 p -99.41 135.12 41.29 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -170.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.98 138.79 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.316 175.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tt -82.3 127.39 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 124.979 1.311 . . . . 0.0 110.732 174.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 34.7 m -132.77 154.99 40.8 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.395 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.592 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -115.43 132.82 56.5 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.98 136.5 57.38 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.562 HD12 ' HB2' ' B' ' 37' ' ' PRO . 63.5 mt -97.34 132.26 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.702 177.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' B' ' 85' ' ' VAL . 26.3 m -106.13 106.11 16.46 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 174.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.24 43.98 3.25 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 121.392 -0.432 . . . . 0.0 113.001 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -163.31 172.76 14.2 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 81.9 mt 76.07 125.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 O-C-N 124.559 1.162 . . . . 0.0 111.533 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -114.15 19.16 16.61 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.542 0.686 . . . . 0.0 110.43 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -131.91 107.84 8.99 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.415 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.11 -72.57 0.64 Allowed 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 172.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 56.71 31.53 19.51 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.312 1.045 . . . . 0.0 112.719 175.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 8.6 tt -151.66 134.8 9.06 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.84 -3.39 4.55 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 122.962 2.441 . . . . 0.0 115.301 -175.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 66.6 p -103.37 -15.64 15.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.309 0.576 . . . . 0.0 111.19 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -119.07 129.01 54.86 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 52.8 t -111.38 132.99 58.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.16 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -99.58 119.8 38.64 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.355 0.662 . . . . 0.0 109.557 177.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.526 HD11 HG12 ' B' ' 86' ' ' ILE . 0.0 OUTLIER -111.11 153.54 12.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.545 ' OE1' ' HE3' ' B' ' 110' ' ' LYS . 1.6 mp0 -53.1 128.99 29.54 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.818 1.324 . . . . 0.0 111.956 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . 0.634 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 94.0 mttt -52.15 -56.35 15.1 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.209 0.943 . . . . 0.0 111.364 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -68.81 -43.08 76.35 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.845 -168.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . 0.437 ' HB2' ' HE3' ' B' ' 77' ' ' LYS . 38.8 ttmt -64.95 -33.5 76.19 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.239 0.543 . . . . 0.0 110.878 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.422 ' CZ ' HG21 ' B' ' 73' ' ' ILE . 14.7 m-85 -91.68 2.18 56.65 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.197 -178.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 41.7 tptt 71.83 20.05 4.65 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.072 1.349 . . . . 0.0 113.074 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 7.1 mp -99.71 174.05 6.41 Favored 'General case' 0 CA--C 1.489 -1.403 0 CA-C-O 122.573 1.178 . . . . 0.0 111.217 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -84.07 -26.09 29.3 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.88 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.443 ' NZ ' ' HB3' ' B' ' 82' ' ' LYS . 0.2 OUTLIER -140.97 156.75 46.0 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.385 -172.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.634 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 10.9 m-20 -46.64 135.28 8.87 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.902 1.376 . . . . 0.0 112.126 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . 0.429 ' O ' HG12 ' B' ' 73' ' ' ILE . 14.9 m -103.89 122.6 45.51 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.887 -177.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' B' ' 59' ' ' THR . 8.9 t -107.88 137.16 40.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.539 ' CD1' HG12 ' B' ' 58' ' ' ILE . 16.5 mm -111.67 135.05 52.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 18.8 mt -105.38 98.72 8.38 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.1 mm? -82.03 -9.82 59.43 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.324 -172.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -95.58 -26.19 15.87 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.316 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -80.2 -60.7 2.23 Favored 'General case' 0 C--O 1.162 -3.534 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.138 -178.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.592 HG22 ' CB ' ' B' ' 56' ' ' ALA . 1.3 pp 30.02 -174.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.528 3.436 0 C-N-CA 129.605 3.162 . . . . 0.0 116.836 175.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.464 ' HE ' HD21 ' B' ' 94' ' ' LEU . 8.5 ptm85 -176.95 159.72 1.73 Allowed 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 167.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -114.83 108.63 17.01 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 124.916 1.286 . . . . 0.0 109.453 179.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.53 ' HB2' ' CZ ' ' B' ' 98' ' ' ARG . 65.2 mt -131.77 150.94 51.99 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.671 ' HA ' ' O ' ' B' ' 51' ' ' PRO . 11.7 t70 -51.9 146.12 8.84 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 118.32 0.509 . . . . 0.0 111.446 173.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' B' ' 99' ' ' LEU . 31.5 pttt -54.48 -33.34 59.58 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.095 1.358 . . . . 0.0 114.256 177.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -41.28 -40.69 1.71 Allowed 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 126.742 2.017 . . . . 0.0 113.693 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.53 ' CZ ' ' HB2' ' B' ' 94' ' ' LEU . 1.7 ppt_? -73.72 -13.95 61.05 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' B' ' 96' ' ' LYS . 10.1 mp -63.39 118.48 8.13 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 123.83 0.852 . . . . 0.0 109.81 170.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.19 -64.07 1.1 Allowed 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.304 -1.317 . . . . 0.0 112.094 -176.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 12.2 pt-20 -156.76 145.86 20.28 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-O 121.815 0.817 . . . . 0.0 111.55 -172.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -60.39 122.57 14.91 Favored 'General case' 0 C--N 1.278 -2.521 0 C-N-CA 128.152 2.581 . . . . 0.0 108.891 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 13.0 tp -114.97 -62.33 1.62 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 119.566 -0.853 . . . . 0.0 112.393 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.468 ' H ' ' HB ' ' B' ' 19' ' ' VAL . 5.4 t -129.3 -160.79 1.06 Allowed 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.317 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -159.31 147.76 17.86 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.262 1.025 . . . . 0.0 112.289 -169.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.79 140.52 36.95 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.0 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 15.1 t -82.91 162.41 21.55 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.074 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' B' ' 111' ' ' MET . 15.8 t70 -63.9 -44.74 92.09 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 122.73 0.412 . . . . 0.0 111.828 -175.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.7 -30.39 71.5 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.575 0.702 . . . . 0.0 110.363 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.545 ' HE3' ' OE1' ' B' ' 74' ' ' GLU . 70.0 mmtt -80.29 -27.01 38.62 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.999 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.445 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.4 OUTLIER -53.93 -44.36 70.58 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 169.131 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.42 ' HE2' ' N ' ' B' ' 112' ' ' LYS . 9.7 mmpt? -75.7 -8.2 56.23 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 114.215 -1.357 . . . . 0.0 113.792 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -89.92 -50.95 5.73 Favored 'General case' 0 N--CA 1.398 -3.055 0 C-N-CA 117.215 -1.794 . . . . 0.0 106.922 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -54.26 -59.85 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 CA-C-N 112.586 -2.097 . . . . 0.0 112.96 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 47.1 m-20 -58.57 -42.06 87.1 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 123.07 1.414 . . . . 0.0 111.281 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.313 14.8 t30 -74.74 -40.9 61.0 Favored 'General case' 0 C--N 1.266 -3.044 0 CA-C-N 113.059 -1.882 . . . . 0.0 111.551 -174.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.428 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . . . -63.78 -35.48 80.73 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.516 ' HA ' ' OG ' ' B' ' 121' ' ' SER . 5.2 tp -69.64 -36.94 76.54 Favored 'General case' 0 N--CA 1.394 -3.272 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.789 -178.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.529 ' HG2' ' HB2' ' B' ' 124' ' ' LEU . 1.3 ttp -67.18 -22.58 65.74 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.375 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' B' ' 117' ' ' ALA . 60.3 mt -87.23 -53.92 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . 0.516 ' OG ' ' HA ' ' B' ' 118' ' ' LEU . 78.1 p -55.37 -24.25 28.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.134 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 32.8 mt -101.48 0.66 37.09 Favored 'General case' 0 C--O 1.2 -1.504 0 C-N-CA 119.561 -0.856 . . . . 0.0 111.958 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.33 16.48 55.41 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 116.98 1.552 . . . . 0.0 116.98 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.529 ' HB2' ' HG2' ' B' ' 119' ' ' MET . 1.2 mm? -73.6 -51.72 15.88 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 22.2 m120 58.23 -170.04 0.12 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 112.488 -2.142 . . . . 0.0 112.252 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.96 19.54 2.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.814 0.816 . . . . 0.0 111.052 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.79 68.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.212 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.62 146.93 23.65 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.179 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -71.71 -24.96 61.89 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.404 0.621 . . . . 0.0 110.298 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -101.54 14.16 32.78 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.058 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -116.31 127.37 54.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.302 0.572 . . . . 0.0 111.028 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 13.2 m120 . . . . . 0 C--N 1.293 -1.881 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.8 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.192 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 m -78.62 98.4 6.16 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 121.594 0.711 . . . . 0.0 111.461 -178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -78.57 126.92 31.41 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -73.66 92.4 1.96 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.485 0.659 . . . . 0.0 109.788 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -82.04 -38.36 25.1 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.371 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -125.11 170.42 11.22 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.968 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -91.54 125.43 36.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -78.57 96.15 5.39 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -74.23 -30.21 62.06 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -172.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.7 p -65.42 114.72 5.02 Favored 'General case' 0 N--CA 1.439 -0.999 0 O-C-N 123.582 0.551 . . . . 0.0 110.104 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -86.42 -7.87 58.09 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.854 0.835 . . . . 0.0 109.074 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -96.59 113.18 62.2 Favored Pre-proline 0 N--CA 1.434 -1.228 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.203 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -91.55 3.39 4.21 Favored 'Trans proline' 0 C--O 1.251 1.137 0 C-N-CA 122.578 2.185 . . . . 0.0 112.133 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.534 ' HB ' ' OD1' ' A' ' 47' ' ' ASN . 60.9 mt -105.59 131.6 54.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -116.38 144.68 43.97 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 172.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 41' ' ' ILE . 4.7 ttp180 -63.81 114.42 4.03 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 174.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.33 -16.52 5.43 Favored Glycine 0 N--CA 1.421 -2.35 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -174.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.78 172.02 12.91 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 122.815 1.293 . . . . 0.0 110.516 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.424 HG11 HG22 ' A' ' 104' ' ' THR . 12.6 t -132.68 128.99 58.18 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.425 0 CA-C-N 112.356 -2.202 . . . . 0.0 109.445 175.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 37.3 m-85 -126.38 147.38 49.77 Favored 'General case' 0 C--N 1.277 -2.567 0 C-N-CA 125.1 1.36 . . . . 0.0 108.325 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.5 mp -82.17 161.48 22.77 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 170.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.17 133.08 13.24 Favored 'General case' 0 C--N 1.28 -2.424 0 O-C-N 123.982 0.801 . . . . 0.0 109.307 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.62 81.75 8.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 123.56 1.648 . . . . 0.0 109.258 173.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.519 ' C ' ' HD3' ' A' ' 26' ' ' PRO . 4.3 pp -89.27 3.66 51.32 Favored 'General case' 0 CA--C 1.478 -1.793 0 CA-C-N 113.009 -1.905 . . . . 0.0 111.95 -175.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.587 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 2.3 p -89.72 60.24 0.0 OUTLIER Pre-proline 0 C--N 1.272 -2.785 0 N-CA-C 117.142 2.275 . . . . 0.0 117.142 178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.519 ' HD3' ' C ' ' A' ' 24' ' ' LEU . 19.1 Cg_endo -118.83 30.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.424 -2.582 0 N-CA-C 106.889 -2.004 . . . . 0.0 106.889 152.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 24' ' ' LEU . 35.3 m -71.2 176.68 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.491 -173.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.25 138.45 31.41 Favored 'General case' 0 N--CA 1.41 -2.458 0 CA-C-N 114.004 -1.453 . . . . 0.0 113.8 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.04 -133.1 11.75 Favored Glycine 0 N--CA 1.421 -2.346 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.229 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.5 m -93.76 18.5 10.17 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 47.6 mt-10 -70.36 167.92 17.11 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 174.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.561 HE21 ' C ' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -101.21 119.08 38.22 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -174.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.27 151.93 17.55 Favored Glycine 0 CA--C 1.483 -1.914 0 N-CA-C 115.82 1.088 . . . . 0.0 115.82 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.587 ' H ' ' HB3' ' A' ' 25' ' ' SER . . . 137.18 137.28 3.6 Favored Glycine 0 C--N 1.293 -1.821 0 CA-C-N 113.313 -1.444 . . . . 0.0 111.367 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 35' ' ' VAL . 2.7 p -72.09 105.83 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 123.17 1.462 . . . . 0.0 107.752 173.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -136.08 161.18 63.98 Favored Pre-proline 0 C--N 1.253 -3.617 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.792 -172.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 18.6 Cg_exo -67.68 142.87 59.85 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.025 1.817 . . . . 0.0 110.201 170.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 20' ' ' TYR . 27.8 m -123.18 158.56 28.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 123.608 0.763 . . . . 0.0 109.325 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 33.8 m -102.03 132.4 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.704 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mm -85.16 105.94 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.546 ' O ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -103.59 -12.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.946 -178.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.643 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 3.4 mt-30 -42.0 157.56 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 120.706 3.595 . . . . 0.0 120.706 -174.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -69.3 145.79 52.76 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 110.815 -2.902 . . . . 0.0 108.024 164.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 47' ' ' ASN . 20.5 t70 -62.64 -30.88 71.69 Favored 'General case' 0 C--N 1.278 -2.533 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.84 -177.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.0 m -86.87 -27.1 23.64 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 118.969 -1.092 . . . . 0.0 111.793 -173.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.499 ' C ' HE22 ' A' ' 42' ' ' GLN . . . -67.59 -25.79 73.84 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 108.073 -2.011 . . . . 0.0 108.073 174.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.534 ' OD1' ' HB ' ' A' ' 14' ' ' ILE . 35.0 t30 -71.18 -39.39 71.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.991 -1.105 . . . . 0.0 109.77 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 mttt -74.26 -60.97 2.02 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . 0.46 16.6 p90 -128.36 2.03 5.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 119.352 3.093 . . . . 0.0 119.352 -173.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.5 m -86.86 134.21 37.72 Favored Pre-proline 0 N--CA 1.436 -1.139 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 172.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 34.0 Cg_exo -63.53 -29.54 70.81 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 121.606 1.538 . . . . 0.0 109.828 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.427 HG21 ' HG2' ' B' ' 90' ' ' GLN . 2.5 p -95.03 139.82 30.85 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.688 -173.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.643 ' HB ' ' OE1' ' A' ' 42' ' ' GLN . 1.1 m -131.53 157.77 43.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.462 HG21 HD22 ' B' ' 122' ' ' LEU . 8.7 tt -109.56 131.12 61.32 Favored 'Isoleucine or valine' 0 C--O 1.251 1.156 0 CA-C-O 121.144 0.497 . . . . 0.0 109.798 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.455 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 30.0 m -137.73 160.4 33.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.952 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 91' ' ' ILE . . . -120.2 142.25 49.17 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.21 143.97 36.69 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.616 HG12 ' CD1' ' A' ' 86' ' ' ILE . 67.7 mt -97.99 140.04 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-N 113.286 -1.779 . . . . 0.0 109.251 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.7 m -137.74 116.89 12.58 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.285 0.634 . . . . 0.0 110.122 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -115.64 54.44 0.58 Allowed Glycine 0 C--N 1.309 -0.922 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.576 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -124.89 2.72 8.09 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.037 0.446 . . . . 0.0 111.769 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.449 ' CG1' HG21 ' A' ' 85' ' ' VAL . 30.1 pt -140.02 164.9 22.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 174.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -101.87 -60.09 1.59 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.891 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -108.87 151.46 26.23 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.197 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.36 173.24 6.45 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.724 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -147.21 10.43 0.99 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.968 0.413 . . . . 0.0 111.121 178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.0 mt -127.99 139.01 34.17 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.71 -6.73 11.26 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 122.439 2.093 . . . . 0.0 113.503 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.8 p -96.05 -18.0 20.53 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.434 0.635 . . . . 0.0 111.018 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.444 ' CD2' HD22 ' A' ' 87' ' ' LEU . 46.3 m170 -114.12 128.4 56.36 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.13 138.59 54.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 O-C-N 121.854 -0.529 . . . . 0.0 111.02 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.43 140.49 29.75 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.722 0.772 . . . . 0.0 111.745 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.895 HG21 ' CE1' ' A' ' 78' ' ' TYR . 3.0 mm -108.99 -176.19 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.623 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 73' ' ' ILE . 5.5 mm-40 -117.69 133.76 55.6 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 -173.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.649 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 73.1 mttt -44.09 -53.24 6.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.64 1.213 . . . . 0.0 110.723 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -61.12 -32.25 71.94 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.701 -1.59 . . . . 0.0 113.93 -173.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -85.2 -27.82 25.86 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.622 0.725 . . . . 0.0 109.586 -173.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.895 ' CE1' HG21 ' A' ' 73' ' ' ILE . 2.1 m-85 -97.01 0.18 48.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.735 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 64.8 tttp 66.42 19.43 10.94 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 121.627 0.727 . . . . 0.0 111.148 176.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.455 ' HB3' ' H ' ' A' ' 82' ' ' LYS . 7.8 mp -96.94 172.18 8.02 Favored 'General case' 0 CA--C 1.487 -1.468 0 CA-C-O 122.927 1.346 . . . . 0.0 112.827 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.54 -24.27 42.29 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.613 -2.539 . . . . 0.0 109.725 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' HB3' ' NZ ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -137.54 152.66 49.69 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.425 -173.191 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.649 ' N ' ' HG2' ' A' ' 75' ' ' LYS . 11.7 p-10 -75.9 142.21 42.15 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.35 -1.296 . . . . 0.0 108.741 176.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.4 t -136.97 159.08 42.96 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.705 -172.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.449 HG21 ' CG1' ' A' ' 62' ' ' ILE . 23.4 t -110.61 153.74 12.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 124.512 1.125 . . . . 0.0 108.151 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.616 ' CD1' HG12 ' A' ' 58' ' ' ILE . 13.2 mm -117.71 140.34 41.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.444 HD22 ' CD2' ' A' ' 70' ' ' HIS . 36.7 mt -105.46 104.61 14.37 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -86.27 -7.18 58.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.055 -174.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -88.56 -38.02 15.23 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.967 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.519 HE21 ' HB3' ' A' ' 32' ' ' GLN . 0.0 OUTLIER -98.12 77.05 2.4 Favored 'General case' 0 N--CA 1.416 -2.154 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.822 -179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.552 HG22 ' CB ' ' A' ' 56' ' ' ALA . 2.4 pp -108.93 179.45 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . 0.264 7.6 ptp180 -163.3 160.92 24.36 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 175.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 96.8 m -117.55 114.67 23.78 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 113.813 -1.539 . . . . 0.0 108.764 -176.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.8 mt -131.7 147.4 52.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.275 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.59 ' OD1' ' HB3' ' A' ' 97' ' ' LYS . 2.7 p30 -72.04 152.09 42.67 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.042 172.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -48.01 -26.15 1.67 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 125.735 1.614 . . . . 0.0 114.202 -175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.59 ' HB3' ' OD1' ' A' ' 95' ' ' ASP . 7.0 ttpm? -73.16 -18.86 61.23 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.128 0.571 . . . . 0.0 111.228 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.536 ' NE ' ' HA ' ' A' ' 98' ' ' ARG . 2.7 mmp_? -75.9 -31.03 59.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.39 0.614 . . . . 0.0 109.593 175.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.78 130.19 39.02 Favored 'General case' 0 CA--C 1.475 -1.911 0 CA-C-O 123.07 1.414 . . . . 0.0 110.595 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 13.9 tptt -90.25 -68.31 0.79 Allowed 'General case' 0 N--CA 1.391 -3.402 0 CA-C-N 111.745 -2.48 . . . . 0.0 113.023 -171.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 8.4 pt-20 -163.67 143.58 8.43 Favored 'General case' 0 N--CA 1.414 -2.27 0 CA-C-O 121.709 0.766 . . . . 0.0 111.829 -168.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -63.39 114.86 4.12 Favored 'General case' 0 C--N 1.281 -2.39 0 C-N-CA 128.113 2.565 . . . . 0.0 109.531 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.0 tp -112.0 -62.68 1.53 Allowed 'General case' 0 N--CA 1.417 -2.098 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.424 HG22 HG11 ' A' ' 19' ' ' VAL . 3.6 t -128.5 -162.5 1.19 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 117.736 -1.585 . . . . 0.0 112.912 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -160.41 140.43 11.32 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 125.228 1.411 . . . . 0.0 109.997 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.432 ' HB3' ' CE1' ' A' ' 78' ' ' TYR . 3.6 pp -108.81 157.49 18.54 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.156 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.432 ' HB2' ' OD1' ' A' ' 109' ' ' ASP . 11.8 m -89.82 174.03 7.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.323 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.578 ' O ' ' HB2' ' A' ' 111' ' ' MET . 11.0 m-20 -62.4 -32.56 73.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.202 1.001 . . . . 0.0 111.617 -177.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' A' ' 107' ' ' SER . 11.2 p-10 -70.46 -33.92 71.82 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.43 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -78.5 -28.5 46.34 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.495 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.578 ' HB2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -47.47 -49.42 25.59 Favored 'General case' 0 CA--C 1.453 -2.758 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 168.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 9.9 mmpt? -76.71 -7.96 56.35 Favored 'General case' 0 N--CA 1.392 -3.372 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -90.4 -54.15 4.13 Favored 'General case' 0 N--CA 1.399 -3.022 0 C-N-CA 116.921 -1.911 . . . . 0.0 106.956 172.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -51.91 -59.03 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-N 112.359 -2.2 . . . . 0.0 112.968 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.554 ' O ' ' HB3' ' A' ' 118' ' ' LEU 0.261 26.0 t0 -61.41 -40.13 93.27 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 123.883 1.802 . . . . 0.0 109.718 -176.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 14.6 t30 -79.72 -41.99 25.57 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 112.171 -2.286 . . . . 0.0 112.009 -172.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.547 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . . . -61.77 -36.11 80.08 Favored 'General case' 0 CA--C 1.477 -1.848 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 176.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.554 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 3.0 tp -64.55 -41.8 96.1 Favored 'General case' 0 N--CA 1.382 -3.86 0 CA-C-N 113.61 -1.632 . . . . 0.0 110.98 -176.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 34.3 mtp -61.53 -34.31 75.32 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-O 120.894 0.378 . . . . 0.0 110.882 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 117' ' ' ALA . 30.5 mt -75.07 -53.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.683 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -176.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.2 m -48.07 -34.9 10.3 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 113.254 -1.794 . . . . 0.0 113.156 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 118' ' ' LEU . 23.2 mt -105.97 3.16 28.08 Favored 'General case' 0 C--O 1.188 -2.134 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.589 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.76 21.53 65.97 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 116.564 1.386 . . . . 0.0 116.564 172.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.74 -57.76 3.41 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 118.701 1.251 . . . . 0.0 110.022 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.9 m120 57.38 158.77 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 113.104 -1.862 . . . . 0.0 112.545 -169.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -84.66 11.12 9.52 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.556 -1.34 . . . . 0.0 111.811 -175.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 t -113.08 9.09 8.03 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.177 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.885 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 58.99 31.63 21.54 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.174 -1.375 . . . . 0.0 113.062 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 70.67 115.92 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.752 1.221 . . . . 0.0 112.657 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -132.38 124.22 28.28 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -80.26 133.58 36.0 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 123.376 0.422 . . . . 0.0 110.963 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 . . . . . 0 CA--C 1.488 -1.434 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.678 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.614 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m -80.57 100.46 8.62 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-O 121.252 0.549 . . . . 0.0 111.28 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 16.6 m -84.89 129.12 34.86 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -71.47 99.89 2.11 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -88.88 -33.09 17.44 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.355 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -129.0 177.11 7.36 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -95.12 128.8 42.23 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -81.71 94.39 6.98 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -74.78 -24.35 58.66 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -171.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 68.1 p -71.54 120.01 16.51 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.753 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -86.66 -11.13 52.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -97.89 115.11 65.77 Favored Pre-proline 0 N--CA 1.441 -0.924 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.817 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -91.8 5.68 3.64 Favored 'Trans proline' 0 C--O 1.253 1.245 0 C-N-CA 122.677 2.251 . . . . 0.0 112.07 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.582 ' HB ' ' OD1' ' B' ' 47' ' ' ASN . 71.3 mt -106.47 131.63 55.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -116.68 145.34 43.51 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.568 ' HD2' ' O ' ' B' ' 41' ' ' ILE . 4.6 ttp180 -63.89 114.35 4.02 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 175.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.78 -18.14 5.41 Favored Glycine 0 N--CA 1.421 -2.308 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.11 171.8 11.29 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-O 122.888 1.328 . . . . 0.0 110.14 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.444 HG11 HG22 ' B' ' 104' ' ' THR . 10.4 t -133.35 128.65 55.6 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.576 0 CA-C-N 112.292 -2.231 . . . . 0.0 109.155 176.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.528 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 34.4 m-85 -125.86 147.02 49.57 Favored 'General case' 0 C--N 1.27 -2.865 0 C-N-CA 125.194 1.398 . . . . 0.0 108.407 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.607 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 4.6 mp -82.23 159.81 23.13 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 170.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.88 133.2 13.59 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.711 179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -84.95 82.19 8.56 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 123.658 1.694 . . . . 0.0 109.666 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.511 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 4.4 pp -90.21 4.78 49.55 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 113.167 -1.833 . . . . 0.0 112.121 -174.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.572 ' HB3' ' N ' ' B' ' 34' ' ' GLY . 2.3 p -90.21 59.91 0.0 OUTLIER Pre-proline 0 C--N 1.277 -2.55 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.511 ' HD3' ' C ' ' B' ' 24' ' ' LEU . 17.5 Cg_endo -118.59 31.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.112 0 N-CA-C 106.711 -2.073 . . . . 0.0 106.711 152.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 33.3 m -71.14 173.05 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.39 -175.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -142.83 120.28 11.67 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 114.8 1.408 . . . . 0.0 114.8 -176.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.52 -131.08 10.44 Favored Glycine 0 N--CA 1.416 -2.689 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.873 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 25.0 m -93.79 17.03 12.7 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.525 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 41.2 mt-10 -70.46 171.62 9.79 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.401 ' HB3' HE21 ' B' ' 90' ' ' GLN . 0.0 OUTLIER -103.88 125.7 50.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -175.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.43 147.84 17.03 Favored Glycine 0 CA--C 1.486 -1.748 0 N-CA-C 115.409 0.923 . . . . 0.0 115.409 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.572 ' N ' ' HB3' ' B' ' 25' ' ' SER . . . 140.62 137.51 3.46 Favored Glycine 0 C--N 1.288 -2.134 0 CA-C-N 113.727 -1.236 . . . . 0.0 111.787 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 2.5 p -73.64 104.26 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-O 122.998 1.38 . . . . 0.0 107.473 173.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -135.2 161.99 60.19 Favored Pre-proline 0 C--N 1.249 -3.784 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.08 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' B' ' 21' ' ' LEU . 19.7 Cg_exo -68.05 142.92 57.93 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 122.047 1.831 . . . . 0.0 110.173 170.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 20' ' ' TYR . 28.7 m -123.74 159.13 29.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 123.552 0.741 . . . . 0.0 109.273 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 32.6 m -102.0 132.3 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 120.524 0.202 . . . . 0.0 110.759 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 27.8 mm -84.93 105.89 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.568 ' O ' ' HD2' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -103.44 -12.07 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.033 -178.288 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.647 ' OE1' ' HB ' ' B' ' 53' ' ' VAL . 3.7 mt-30 -42.05 157.55 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 120.945 3.683 . . . . 0.0 120.945 -174.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -69.41 145.15 53.07 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 110.833 -2.894 . . . . 0.0 108.279 165.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' B' ' 47' ' ' ASN . 22.2 t70 -61.85 -30.14 70.65 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.673 -176.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 28.9 m -87.19 -28.4 22.43 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.879 -174.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.514 ' C ' HE22 ' B' ' 42' ' ' GLN . . . -66.79 -26.8 73.09 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.582 ' OD1' ' HB ' ' B' ' 14' ' ' ILE . 34.6 t30 -68.04 -39.16 83.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 113.738 -1.231 . . . . 0.0 110.019 176.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -76.52 -66.08 0.85 Allowed 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . 0.439 19.4 p90 -124.31 6.96 8.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 119.004 2.964 . . . . 0.0 119.004 -171.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.436 ' OG ' ' HA2' ' B' ' 46' ' ' GLY . 19.6 m -92.28 131.03 35.68 Favored Pre-proline 0 N--CA 1.428 -1.573 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 171.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.4 ' O ' ' HA ' ' B' ' 95' ' ' ASP . 27.3 Cg_exo -63.28 -28.9 72.64 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 121.62 1.547 . . . . 0.0 110.268 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.467 HG21 ' HG2' ' A' ' 90' ' ' GLN . 1.8 p -94.9 138.84 32.14 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.398 -174.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.647 ' HB ' ' OE1' ' B' ' 42' ' ' GLN . 1.2 m -130.49 158.86 42.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.466 HG21 HD22 ' A' ' 122' ' ' LEU . 9.0 tt -110.87 130.98 63.28 Favored 'Isoleucine or valine' 0 C--O 1.253 1.277 0 CA-C-O 121.269 0.557 . . . . 0.0 110.087 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.491 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 27.8 m -137.57 159.51 34.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.906 179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.547 ' CB ' HG22 ' B' ' 91' ' ' ILE . . . -119.68 142.03 48.84 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.46 140.31 38.63 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.613 HG12 ' CD1' ' B' ' 86' ' ' ILE . 67.6 mt -93.89 140.43 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 113.123 -1.853 . . . . 0.0 109.253 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 90.9 m -138.12 111.95 8.34 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 123.388 0.675 . . . . 0.0 110.855 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.46 63.89 0.28 Allowed Glycine 0 C--N 1.303 -1.265 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -131.44 2.72 4.2 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.339 0.59 . . . . 0.0 111.36 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.45 ' CG1' HG21 ' B' ' 85' ' ' VAL . 31.9 pt -139.19 170.03 16.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 174.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -105.78 -55.95 2.25 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 118.596 0.635 . . . . 0.0 112.307 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -114.22 151.47 32.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.473 0.654 . . . . 0.0 112.013 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.99 160.39 15.81 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.622 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -136.34 1.99 2.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.207 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 22.7 mt -115.17 142.01 27.93 Favored Pre-proline 0 C--N 1.313 -1.021 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.02 -14.01 34.8 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.411 2.074 . . . . 0.0 113.855 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . . . . . . . . . 67.2 p -93.88 -18.85 21.54 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 121.356 0.598 . . . . 0.0 111.361 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -109.26 128.75 55.32 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 34.3 m -128.02 139.01 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.662 -0.649 . . . . 0.0 110.847 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.22 143.2 26.82 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.788 0.804 . . . . 0.0 111.619 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.862 HG21 ' CE1' ' B' ' 78' ' ' TYR . 5.3 mm -112.59 166.45 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.595 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.56 ' H ' HG22 ' B' ' 73' ' ' ILE . 2.5 mm-40 -97.56 130.55 44.6 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -176.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' B' ' 83' ' ' ASP . 71.9 mttt -43.4 -52.68 5.83 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.769 1.228 . . . . 0.0 110.604 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -64.6 -25.56 68.02 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.875 1.67 . . . . 0.0 114.087 -173.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -91.36 -20.98 21.25 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.509 0.671 . . . . 0.0 109.586 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.862 ' CE1' HG21 ' B' ' 73' ' ' ILE . 2.0 m-85 -103.8 0.15 29.99 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.178 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 tttp 67.07 17.14 10.41 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.489 0.661 . . . . 0.0 111.855 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' B' ' 78' ' ' TYR . 7.8 mp -94.46 175.1 6.81 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 123.197 1.475 . . . . 0.0 113.143 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -81.96 -25.99 34.36 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 111.698 -2.501 . . . . 0.0 109.489 176.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.421 ' H ' ' HB3' ' B' ' 80' ' ' LEU . 0.3 OUTLIER -136.52 153.58 50.97 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.547 -172.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.655 ' N ' ' HG2' ' B' ' 75' ' ' LYS . 8.9 p-10 -77.22 143.17 39.18 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 29.9 t -136.19 159.88 40.37 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.512 -171.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.45 HG21 ' CG1' ' B' ' 62' ' ' ILE . 22.9 t -111.36 151.92 13.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.613 ' CD1' HG12 ' B' ' 58' ' ' ILE . 12.3 mm -116.18 139.34 43.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 174.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.5 mt -104.88 104.19 13.91 Favored 'General case' 0 N--CA 1.42 -1.944 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.427 ' HG ' ' HB3' ' B' ' 117' ' ' ALA . 3.9 mm? -84.45 -8.86 58.82 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.124 -174.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -88.21 -37.68 15.91 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.373 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . 0.427 ' HG2' HG21 ' A' ' 52' ' ' THR . 0.0 OUTLIER -98.07 77.89 2.48 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.949 -179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.547 HG22 ' CB ' ' B' ' 56' ' ' ALA . 2.4 pp -109.26 179.41 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . . . . . . . . 0.265 8.0 ptp180 -163.28 161.56 24.79 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 174.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' B' ' 53' ' ' VAL . 90.5 m -117.85 115.13 24.34 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 113.735 -1.575 . . . . 0.0 108.534 -176.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . . . . . . . . . 60.1 mt -131.79 148.25 52.55 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.957 -170.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.513 ' OD1' ' HB3' ' B' ' 97' ' ' LYS . 1.2 p30 -74.28 152.09 39.74 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.871 173.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -46.56 -28.97 1.59 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 125.693 1.597 . . . . 0.0 114.007 -175.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.513 ' HB3' ' OD1' ' B' ' 95' ' ' ASP . 7.0 ttpm? -71.77 -18.94 62.09 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 123.177 0.591 . . . . 0.0 111.517 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.537 ' HA ' ' NE ' ' B' ' 98' ' ' ARG . 2.3 mmp_? -76.29 -28.16 56.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.599 0.714 . . . . 0.0 109.695 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 7.8 mp -76.45 128.53 34.98 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-O 123.533 1.635 . . . . 0.0 111.037 175.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . 0.409 ' HB3' ' HG2' ' B' ' 101' ' ' GLU . 13.0 tptt -87.11 -67.42 0.82 Allowed 'General case' 0 C--N 1.264 -3.149 0 CA-C-N 111.346 -2.661 . . . . 0.0 113.132 -171.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 9.1 pt-20 -166.27 146.36 6.18 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.707 0.765 . . . . 0.0 111.545 -169.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -63.98 116.2 5.63 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 128.354 2.662 . . . . 0.0 109.541 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 14.0 tp -113.76 -62.72 1.55 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.755 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.444 HG22 HG11 ' B' ' 19' ' ' VAL . 4.6 t -128.63 -164.91 1.43 Allowed 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.66 -1.616 . . . . 0.0 112.153 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.32 134.79 7.48 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 124.817 1.247 . . . . 0.0 109.759 -171.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.466 ' HB3' ' CE1' ' B' ' 78' ' ' TYR . 3.6 pp -101.91 159.58 15.22 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.369 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 11.1 m -91.14 173.42 7.95 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.864 0.364 . . . . 0.0 111.112 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' B' ' 111' ' ' MET . 6.0 m-20 -64.45 -26.79 68.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.867 0.867 . . . . 0.0 112.258 -177.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.82 -38.18 67.24 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -74.01 -28.54 61.5 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.112 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.507 ' HB2' ' O ' ' B' ' 108' ' ' ASP . 0.1 OUTLIER -47.36 -48.9 25.52 Favored 'General case' 0 CA--C 1.45 -2.881 0 CA-C-O 121.384 0.611 . . . . 0.0 109.567 167.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' B' ' 112' ' ' LYS . 9.3 mmpt? -78.63 -5.48 53.06 Favored 'General case' 0 N--CA 1.382 -3.845 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -176.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -91.16 -56.42 3.16 Favored 'General case' 0 N--CA 1.397 -3.109 0 C-N-CA 116.999 -1.88 . . . . 0.0 107.197 170.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 2.5 t -50.22 -59.78 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 CA-C-N 112.203 -2.271 . . . . 0.0 113.282 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.598 ' O ' ' HB3' ' B' ' 118' ' ' LEU 0.275 17.2 t0 -60.66 -42.86 97.89 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 123.78 1.752 . . . . 0.0 109.826 -176.096 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . . . . . . . . 0.363 47.0 t30 -77.69 -41.68 37.16 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.095 -171.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.482 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -65.44 -34.17 77.66 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.598 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 3.1 tp -63.24 -41.69 99.11 Favored 'General case' 0 N--CA 1.381 -3.921 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.257 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . . . . . . . . . 36.1 mtp -60.08 -37.89 81.26 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 120.714 0.292 . . . . 0.0 110.573 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' B' ' 117' ' ' ALA . 28.7 mt -71.06 -53.15 22.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 25.3 m -51.11 -32.64 23.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.542 -1.208 . . . . 0.0 112.783 178.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' B' ' 118' ' ' LEU . 22.5 mt -105.63 1.79 27.62 Favored 'General case' 0 C--O 1.19 -2.074 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.495 -177.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.45 24.99 59.8 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.342 1.297 . . . . 0.0 116.342 172.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.506 ' HG ' ' OD1' ' A' ' 115' ' ' ASP . 7.1 mp -83.47 -58.37 2.85 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.778 1.289 . . . . 0.0 110.194 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 18.1 m120 55.92 156.49 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 112.868 -1.969 . . . . 0.0 113.177 -168.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.2 12.1 3.09 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.412 -1.43 . . . . 0.0 112.151 -176.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.25 8.82 7.97 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.371 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 59.54 30.28 19.91 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.963 176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 70.94 111.93 0.06 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.507 1.123 . . . . 0.0 112.617 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -126.89 123.86 38.22 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -83.36 132.68 34.99 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.04 0.448 . . . . 0.0 110.728 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 . . . . . 0 C--N 1.299 -1.607 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.072 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.6 m 66.02 20.56 11.27 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.938 0.895 . . . . 0.0 111.814 -179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.8 m -118.9 98.16 6.06 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-O 121.385 0.612 . . . . 0.0 110.678 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -84.27 139.19 32.5 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.888 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -70.29 129.14 38.54 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -58.71 -44.04 90.24 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 123.603 0.564 . . . . 0.0 110.41 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -78.69 129.53 34.81 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 175.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -78.72 101.82 7.75 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -156.09 172.42 18.44 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.072 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -115.83 -48.64 2.75 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 176.54 124.9 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.466 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.91 107.05 16.59 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 169.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -65.5 -84.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.969 0 C-N-CA 121.582 1.522 . . . . 0.0 112.236 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.2 mt -117.85 115.69 49.3 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -123.25 144.23 49.53 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 175.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -63.14 118.18 7.56 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.261 -0.975 . . . . 0.0 109.524 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.64 -19.4 5.03 Favored Glycine 0 N--CA 1.425 -2.049 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.724 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -83.13 171.47 13.67 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.353 1.073 . . . . 0.0 110.097 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.441 HG11 HG22 ' A' ' 104' ' ' THR . 13.3 t -132.38 128.03 57.79 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 113.077 -1.874 . . . . 0.0 109.373 176.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 24.2 m-85 -123.36 151.42 42.54 Favored 'General case' 0 C--N 1.271 -2.847 0 C-N-CA 125.274 1.43 . . . . 0.0 110.03 178.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 3.7 mp -88.63 150.17 23.17 Favored 'General case' 0 N--CA 1.396 -3.15 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 98' ' ' ARG . . . -145.27 139.11 26.88 Favored 'General case' 0 C--N 1.26 -3.323 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.156 -176.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -81.86 89.95 6.38 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.533 1.158 . . . . 0.0 108.665 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.601 ' O ' HG13 ' A' ' 27' ' ' VAL . 82.2 mt -65.1 -19.45 65.99 Favored 'General case' 0 CA--C 1.481 -1.677 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.661 -178.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.569 ' HB3' ' HD2' ' A' ' 26' ' ' PRO . 10.0 m -33.75 175.0 0.0 OUTLIER Pre-proline 0 CA--C 1.585 2.322 0 C-N-CA 127.197 2.199 . . . . 0.0 114.252 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER 27.32 48.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.422 -2.677 0 C-N-CA 121.905 1.737 . . . . 0.0 114.588 -151.37 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 31' ' ' GLU . 1.6 m -69.88 168.22 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-N 114.042 -1.436 . . . . 0.0 111.002 170.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.489 ' HG3' HD23 ' B' ' 94' ' ' LEU . 25.2 mm-40 -99.21 107.14 19.39 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.765 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.86 -122.31 26.68 Favored Glycine 0 C--N 1.298 -1.564 0 CA-C-N 113.998 -1.455 . . . . 0.0 113.371 177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.4 m -81.71 20.97 0.87 Allowed 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.601 ' HB2' ' HB ' ' A' ' 27' ' ' VAL . 46.0 mt-10 -62.24 168.26 3.54 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 117.917 -1.513 . . . . 0.0 110.32 170.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.533 HE22 ' HG3' ' A' ' 36' ' ' ARG . 0.9 OUTLIER -70.81 107.95 4.24 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -176.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.76 144.3 18.81 Favored Glycine 0 CA--C 1.499 -0.95 0 N-CA-C 117.177 1.631 . . . . 0.0 117.177 -175.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 157.97 10.06 Favored Glycine 0 N--CA 1.421 -2.347 0 CA-C-N 113.019 -1.59 . . . . 0.0 111.538 177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 p -81.9 104.89 11.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 171.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.533 ' HG3' HE22 ' A' ' 32' ' ' GLN . 18.4 mmt180 -129.46 157.18 77.14 Favored Pre-proline 0 C--N 1.26 -3.29 0 CA-C-N 113.333 -1.758 . . . . 0.0 110.58 -167.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HB2' HD12 ' A' ' 58' ' ' ILE . 31.9 Cg_exo -63.22 144.88 92.79 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.211 1.941 . . . . 0.0 111.405 171.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 55' ' ' VAL . 27.2 m -129.91 156.26 42.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 124.238 1.015 . . . . 0.0 109.067 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.506 ' CG2' ' HB3' ' A' ' 56' ' ' ALA . 32.6 m -100.22 131.99 46.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.1 mm -91.51 115.57 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.95 -14.25 10.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.265 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.539 HE22 ' N ' ' A' ' 47' ' ' ASN . 5.0 pt20 -53.69 163.12 0.73 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 -168.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -64.94 -177.58 0.36 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 112.156 -2.293 . . . . 0.0 112.202 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -81.7 -42.73 19.47 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.969 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -82.69 -23.64 34.04 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -170.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.73 -32.41 74.17 Favored Glycine 0 C--O 1.204 -1.739 0 CA-C-N 116.329 -0.396 . . . . 0.0 113.356 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.539 ' N ' HE22 ' A' ' 42' ' ' GLN . 8.3 p30 -81.52 -18.08 46.28 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.086 0.47 . . . . 0.0 111.792 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -86.65 -62.89 1.41 Allowed 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.507 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -107.34 -15.26 14.68 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -168.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -91.43 141.46 26.03 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HA ' ' HE3' ' A' ' 96' ' ' LYS . 72.8 Cg_endo -81.86 -9.8 11.87 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 121.99 1.794 . . . . 0.0 111.381 176.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 p -109.13 135.69 49.84 Favored 'General case' 0 N--CA 1.409 -2.509 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.791 -174.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.439 HG13 ' OE1' ' A' ' 42' ' ' GLN . 95.0 t -123.74 139.75 49.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.567 HG21 HD22 ' B' ' 122' ' ' LEU . 9.3 tp -97.52 128.16 49.11 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 176.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 38' ' ' VAL . 25.9 m -140.35 164.54 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.968 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' HB3' ' CG2' ' A' ' 39' ' ' VAL . . . -122.32 132.93 54.64 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.7 131.66 46.46 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -176.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.539 HD12 ' HB2' ' A' ' 37' ' ' PRO . 54.3 mt -91.68 106.11 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.785 176.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.3 m -102.46 140.94 36.07 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.698 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -109.17 129.67 9.61 Favored Glycine 0 N--CA 1.434 -1.459 0 C-N-CA 119.897 -1.144 . . . . 0.0 112.768 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.46 ' HA ' ' OD1' ' A' ' 83' ' ' ASP . 76.9 mtm180 63.37 13.45 7.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.028 1.331 . . . . 0.0 114.585 174.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.9 mt -104.82 109.57 28.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.937 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.5 m120 71.29 157.49 0.18 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.547 1.539 . . . . 0.0 112.592 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -109.85 163.0 13.94 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 172.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.16 84.14 7.71 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -115.54 18.28 15.97 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 173.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.9 tt -145.32 137.58 13.37 Favored Pre-proline 0 N--CA 1.426 -1.63 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.58 ' HB2' HD13 ' A' ' 120' ' ' ILE . 61.2 Cg_endo -71.5 2.56 4.41 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.632 2.221 . . . . 0.0 114.737 -174.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.506 ' HB ' ' HG3' ' A' ' 89' ' ' GLU . 68.0 p -103.31 -16.57 15.61 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.35 0.595 . . . . 0.0 111.483 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -109.91 129.82 55.6 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 7.3 p -123.01 132.71 70.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.512 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.67 130.0 34.95 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.941 0.877 . . . . 0.0 110.444 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.56 HD11 HG12 ' A' ' 86' ' ' ILE . 13.1 mm -97.1 169.99 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' N ' HG22 ' A' ' 73' ' ' ILE . 7.4 tp10 -106.34 109.57 21.54 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 168.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -50.93 -30.7 15.49 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 125.431 1.492 . . . . 0.0 114.678 -172.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.401 ' HG2' ' OE1' ' A' ' 74' ' ' GLU . 42.5 mmtm -49.37 -45.14 45.52 Favored 'General case' 0 C--N 1.288 -2.098 0 C-N-CA 125.008 1.323 . . . . 0.0 111.508 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -79.06 -24.41 43.56 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.631 0.729 . . . . 0.0 111.678 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.538 ' HB2' ' HE3' ' A' ' 75' ' ' LYS . 4.0 m-85 -97.81 6.5 47.76 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.012 -175.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.466 ' O ' HD12 ' A' ' 80' ' ' LEU 0.394 61.8 pttt 43.28 64.3 1.26 Allowed 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 119.824 3.268 . . . . 0.0 119.824 176.345 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.597 HD22 ' HZ3' ' A' ' 75' ' ' LYS . 10.3 mp -141.76 -168.27 2.63 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 169.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -113.94 -9.11 13.06 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 123.679 0.612 . . . . 0.0 110.821 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 75' ' ' LYS . 50.3 mttm -115.12 112.14 22.1 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 120.493 -0.483 . . . . 0.0 112.204 -173.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.46 ' OD1' ' HA ' ' A' ' 61' ' ' ARG . 3.6 p30 -35.66 144.24 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.984 1.714 . . . . 0.0 115.388 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 71.7 m -123.32 132.74 54.09 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.435 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 35.4 t -120.15 138.14 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 173.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.56 HG12 HD11 ' A' ' 73' ' ' ILE . 23.4 mm -104.31 131.26 53.59 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.881 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.2 mt -98.6 103.51 15.47 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.806 -0.758 . . . . 0.0 109.505 -176.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 117' ' ' ALA . 3.8 mm? -81.57 -17.64 47.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.506 ' HG3' ' HB ' ' A' ' 69' ' ' THR . 41.3 mt-10 -86.51 -7.73 58.15 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.766 0.793 . . . . 0.0 111.231 173.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.539 ' O ' HG13 ' A' ' 91' ' ' ILE . 14.5 tp60 -89.27 -100.68 0.09 Allowed 'General case' 0 C--O 1.192 -1.937 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 90' ' ' GLN . 1.1 pp 57.84 179.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 C-N-CA 127.574 2.35 . . . . 0.0 110.958 -178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.515 ' NH2' ' HA ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -176.77 176.43 1.5 Allowed 'General case' 0 C--N 1.311 -1.108 0 O-C-N 123.897 0.748 . . . . 0.0 112.233 172.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.449 HG21 ' O ' ' B' ' 90' ' ' GLN . 53.6 m -116.18 128.59 55.75 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 106.735 -1.579 . . . . 0.0 106.735 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.477 HD23 ' HG3' ' B' ' 28' ' ' GLN . 71.0 mt -131.72 141.65 49.59 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.886 -173.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.425 ' OD1' ' HG3' ' A' ' 97' ' ' LYS . 11.9 t0 -57.2 144.61 34.51 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 169.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 51' ' ' PRO . 16.8 pttp -55.41 -31.02 61.51 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.425 ' HG3' ' OD1' ' A' ' 95' ' ' ASP . 52.1 mttp -53.44 -28.82 32.27 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.919 174.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 8.9 mmp_? -74.27 -34.13 63.48 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 120.904 0.383 . . . . 0.0 110.269 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.9 mp -68.51 106.32 2.52 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.279 1.037 . . . . 0.0 110.268 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -83.74 -67.37 0.8 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 113.28 -1.782 . . . . 0.0 114.134 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.587 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 11.6 pt-20 -148.32 152.05 36.42 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-O 121.563 0.696 . . . . 0.0 110.16 -169.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 20' ' ' TYR . 30.8 mtpt -79.1 115.75 18.96 Favored 'General case' 0 C--N 1.268 -2.96 0 CA-C-N 113.171 -1.831 . . . . 0.0 108.236 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.9 tp -104.28 -58.93 1.81 Allowed 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.288 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.441 HG22 HG11 ' A' ' 19' ' ' VAL . 5.2 t -132.54 -164.98 1.53 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 117.835 -1.546 . . . . 0.0 111.915 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -160.49 128.43 4.55 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 125.631 1.573 . . . . 0.0 109.876 -173.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.423 HD11 ' HE3' ' A' ' 111' ' ' MET . 3.7 pp -95.14 163.31 13.34 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -175.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.7 p -88.3 164.1 15.74 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 123.085 0.554 . . . . 0.0 112.049 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 111' ' ' MET . 22.7 t70 -61.99 -29.5 70.3 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.401 1.08 . . . . 0.0 113.37 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.13 -33.74 68.03 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -76.36 -32.25 58.51 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.502 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -52.37 -41.91 63.5 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 125.165 1.386 . . . . 0.0 110.549 175.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.657 ' O ' ' HB3' ' A' ' 116' ' ' ASN . 2.2 mmmm -69.84 -21.73 63.34 Favored 'General case' 0 CA--C 1.465 -2.324 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.352 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -87.81 -46.56 9.33 Favored 'General case' 0 N--CA 1.398 -3.028 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 t -50.58 -54.6 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 CA-C-N 113.263 -1.79 . . . . 0.0 112.857 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 53.5 m-20 -66.24 -42.74 88.16 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 123.511 1.624 . . . . 0.0 111.946 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.657 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 3.8 t30 -74.93 -43.56 53.54 Favored 'General case' 0 C--N 1.26 -3.326 0 CA-C-N 112.76 -2.018 . . . . 0.0 112.52 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -60.71 -36.66 79.39 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.528 ' HB3' ' O ' ' A' ' 115' ' ' ASP . 10.2 tp -65.33 -39.45 92.42 Favored 'General case' 0 N--CA 1.386 -3.675 0 CA-C-N 113.803 -1.544 . . . . 0.0 111.105 -177.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.775 ' SD ' ' HA ' ' A' ' 125' ' ' ASN 0.265 7.4 ptp -74.92 -19.32 60.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 117.54 -1.664 . . . . 0.0 114.461 176.502 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 68' ' ' PRO . 30.4 mt -77.03 -50.04 21.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 175.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.1 p -60.78 -30.4 70.02 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 113.111 -1.858 . . . . 0.0 112.124 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.554 HD22 HG21 ' B' ' 54' ' ' ILE . 27.4 mt -107.2 0.7 23.49 Favored 'General case' 0 C--O 1.199 -1.589 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.84 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.406 ' HA2' ' CE1' ' A' ' 129' ' ' HIS . . . 75.64 26.21 65.78 Favored Glycine 0 CA--C 1.549 2.169 0 N-CA-C 116.964 1.546 . . . . 0.0 116.964 174.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.557 HD11 HD11 ' B' ' 124' ' ' LEU . 0.5 OUTLIER -113.9 15.93 18.45 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 119.263 1.531 . . . . 0.0 111.805 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.775 ' HA ' ' SD ' ' A' ' 119' ' ' MET . 2.4 t-20 -43.31 124.59 3.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.353 0.661 . . . . 0.0 112.705 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.42 8.48 4.16 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -172.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.1 t -116.32 9.9 7.39 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 70.08 158.54 0.18 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.498 1.519 . . . . 0.0 112.21 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.406 ' CE1' ' HA2' ' A' ' 123' ' ' GLY . 37.4 m-70 -105.76 156.68 18.07 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.89 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -75.9 -40.51 54.23 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -129.34 128.87 43.97 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--N 1.297 -1.678 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -179.618 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.954 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m 62.08 25.08 15.0 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.117 0.967 . . . . 0.0 112.399 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 20.1 m -119.15 101.68 8.17 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -91.11 132.43 36.05 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -64.09 134.39 54.83 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 110.243 -0.281 . . . . 0.0 110.243 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -64.41 -37.41 87.43 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.375 0.607 . . . . 0.0 109.812 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -85.26 130.05 34.68 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -82.57 90.47 6.8 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.142 0.496 . . . . 0.0 109.759 -178.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -146.75 158.46 43.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.852 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.9 m -97.31 -53.04 3.6 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 171.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -179.11 126.63 0.09 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.296 178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.62 108.58 26.13 Favored Pre-proline 0 C--N 1.305 -1.335 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 170.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -65.05 -86.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.55 1.5 . . . . 0.0 112.482 -175.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 56.8 mt -115.62 114.87 47.57 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 24.4 mmm-85 -121.28 140.64 51.79 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -61.26 115.03 3.5 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.818 170.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.81 -16.31 5.33 Favored Glycine 0 N--CA 1.428 -1.891 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.066 -174.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -84.18 172.52 11.83 Favored 'General case' 0 N--CA 1.424 -1.772 0 CA-C-O 122.266 1.032 . . . . 0.0 109.47 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.461 HG11 HG22 ' B' ' 104' ' ' THR . 12.3 t -132.88 129.09 57.66 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.174 0 CA-C-N 113.255 -1.793 . . . . 0.0 109.265 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' B' ' 101' ' ' GLU . 23.0 m-85 -123.89 150.88 44.14 Favored 'General case' 0 C--N 1.271 -2.824 0 C-N-CA 125.322 1.449 . . . . 0.0 110.052 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' B' ' 37' ' ' PRO . 3.8 mp -87.95 150.18 23.61 Favored 'General case' 0 N--CA 1.391 -3.396 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 165.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' B' ' 98' ' ' ARG . . . -145.48 138.52 26.2 Favored 'General case' 0 C--N 1.26 -3.286 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.118 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -81.23 91.16 6.15 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 122.73 1.252 . . . . 0.0 108.477 171.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.572 ' O ' HG13 ' B' ' 27' ' ' VAL . 85.4 mt -65.83 -20.86 66.4 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-N 112.672 -2.058 . . . . 0.0 110.735 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.532 ' HB3' ' HD2' ' B' ' 26' ' ' PRO . 16.3 m -35.08 176.28 0.0 OUTLIER Pre-proline 0 CA--C 1.581 2.171 0 C-N-CA 126.97 2.108 . . . . 0.0 114.929 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER 26.41 49.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.423 -2.621 0 C-N-CA 121.817 1.678 . . . . 0.0 114.615 -149.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.594 ' HB ' ' HB2' ' B' ' 31' ' ' GLU . 1.8 m -69.99 172.9 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.337 170.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' GLN . . . . . 0.477 ' HG3' HD23 ' A' ' 94' ' ' LEU . 22.6 mm-40 -102.52 108.71 20.1 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 114.055 -1.43 . . . . 0.0 110.577 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 53.33 -120.61 13.81 Favored Glycine 0 C--N 1.304 -1.25 0 CA-C-N 114.248 -1.342 . . . . 0.0 114.097 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.0 m -81.25 20.19 0.87 Allowed 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.594 ' HB2' ' HB ' ' B' ' 27' ' ' VAL . 46.4 mt-10 -63.87 166.24 7.59 Favored 'General case' 0 C--O 1.248 0.995 0 C-N-CA 117.695 -1.602 . . . . 0.0 109.881 169.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' GLN . . . . . 0.483 HE22 ' HG3' ' B' ' 36' ' ' ARG . 0.9 OUTLIER -71.38 108.08 4.65 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.09 146.29 19.01 Favored Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 116.069 1.187 . . . . 0.0 116.069 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.09 152.68 8.71 Favored Glycine 0 N--CA 1.417 -2.598 0 CA-C-N 113.503 -1.349 . . . . 0.0 110.722 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 p -78.38 108.65 12.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' ARG . . . . . 0.483 ' HG3' HE22 ' B' ' 32' ' ' GLN . 11.0 mmt180 -133.99 156.87 78.84 Favored Pre-proline 0 C--N 1.263 -3.191 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.042 -166.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . 0.557 ' HB2' HD12 ' B' ' 58' ' ' ILE . 31.3 Cg_exo -63.39 144.04 89.99 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.486 2.124 . . . . 0.0 111.681 172.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' B' ' 55' ' ' VAL . 27.3 m -129.1 156.06 41.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 124.341 1.057 . . . . 0.0 109.193 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.5 ' CG2' ' HB3' ' B' ' 56' ' ' ALA . 31.8 m -99.74 131.69 46.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 30.3 mm -91.02 115.65 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.82 -14.87 10.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.265 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.241 -177.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.573 HE22 ' N ' ' B' ' 47' ' ' ASN . 4.9 pt20 -52.95 163.24 0.52 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 -168.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -65.78 -177.22 0.44 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 112.623 -2.081 . . . . 0.0 111.778 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -79.38 -47.94 14.89 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.7 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 20.4 m -78.17 -24.37 47.26 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -169.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' B' ' 50' ' ' SER . . . -60.95 -32.35 79.68 Favored Glycine 0 C--O 1.204 -1.738 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.358 -176.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . 0.573 ' N ' HE22 ' B' ' 42' ' ' GLN . 9.9 p30 -81.49 -18.95 43.39 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.403 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -84.77 -66.66 0.87 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.015 0.436 . . . . 0.0 111.455 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -103.93 -13.71 16.25 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -168.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' B' ' 46' ' ' GLY . 19.3 m -94.72 140.03 22.44 Favored Pre-proline 0 C--N 1.295 -1.772 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -82.84 -6.45 11.45 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.106 1.871 . . . . 0.0 111.548 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . . . . . . . . . 5.2 p -110.09 135.64 50.59 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.533 -175.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.458 HG13 ' OE1' ' B' ' 42' ' ' GLN . 93.1 t -123.88 139.81 49.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.554 HG21 HD22 ' A' ' 122' ' ' LEU . 9.1 tp -97.19 128.67 48.22 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' B' ' 38' ' ' VAL . 27.4 m -140.72 164.52 21.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.035 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.5 ' HB3' ' CG2' ' B' ' 39' ' ' VAL . . . -122.38 132.82 54.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.15 130.55 43.47 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.557 HD12 ' HB2' ' B' ' 37' ' ' PRO . 56.8 mt -90.08 108.53 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.166 176.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 24.5 m -105.13 139.49 39.72 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.95 130.04 9.91 Favored Glycine 0 N--CA 1.428 -1.896 0 C-N-CA 120.375 -0.916 . . . . 0.0 112.58 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 64.09 18.19 11.09 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 174.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 64.6 mt -110.89 105.76 19.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.617 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ASN . . . . . . . . . . . . . 13.5 m120 77.3 156.67 0.17 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.866 1.267 . . . . 0.0 113.004 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -109.08 167.44 10.09 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 171.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -91.81 85.23 5.55 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -174.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -112.99 8.64 18.54 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.545 1.164 . . . . 0.0 107.861 172.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 9.5 tt -132.06 134.87 25.67 Favored Pre-proline 0 N--CA 1.422 -1.843 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' PRO . . . . . 0.474 ' HB2' HD13 ' B' ' 120' ' ' ILE . 49.2 Cg_endo -68.48 0.57 4.55 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.729 2.286 . . . . 0.0 115.098 -175.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' THR . . . . . 0.509 ' HB ' ' HG3' ' B' ' 89' ' ' GLU . 77.7 p -103.55 -15.92 15.69 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-O 121.302 0.572 . . . . 0.0 111.789 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -110.94 129.18 55.96 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' B' ' 85' ' ' VAL . 8.6 p -122.18 132.61 70.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.521 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -84.4 136.9 33.68 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.282 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ILE . . . . . 0.56 HD11 HG12 ' B' ' 86' ' ' ILE . 12.2 mm -108.66 157.17 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.413 178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.444 ' N ' HG22 ' B' ' 73' ' ' ILE . 9.2 tp10 -94.38 109.13 21.01 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 173.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' LYS . . . . . 0.621 ' HZ3' HD22 ' B' ' 80' ' ' LEU . 0.0 OUTLIER -52.72 -30.73 34.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . 0.438 ' H ' ' HG2' ' B' ' 76' ' ' LYS . 16.1 mmtp -50.96 -41.08 58.99 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 124.9 1.28 . . . . 0.0 112.038 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -80.25 -26.99 38.74 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.886 0.85 . . . . 0.0 111.435 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.541 ' HB2' ' HE3' ' B' ' 75' ' ' LYS . 4.4 m-85 -95.2 5.88 50.57 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.234 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.49 ' O ' HD12 ' B' ' 80' ' ' LEU 0.399 61.6 pttt 43.62 64.66 1.18 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 119.822 3.268 . . . . 0.0 119.822 176.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.621 HD22 ' HZ3' ' B' ' 75' ' ' LYS . 10.3 mp -142.69 -169.87 3.09 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 169.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -116.52 -1.75 12.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 123.957 0.786 . . . . 0.0 110.813 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . 0.432 ' O ' ' HD3' ' B' ' 75' ' ' LYS . 52.6 mttm -120.79 111.11 17.17 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.79 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -33.14 143.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 127.179 2.191 . . . . 0.0 114.526 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -124.91 133.42 53.06 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.21 -170.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 39.9 t -120.07 138.23 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 174.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.56 HG12 HD11 ' B' ' 73' ' ' ILE . 24.2 mm -103.95 130.39 54.61 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 51.7 mt -98.6 103.19 15.11 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.4 -20.32 44.25 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.619 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' GLU . . . . . 0.509 ' HG3' ' HB ' ' B' ' 69' ' ' THR . 42.9 mt-10 -84.27 -9.26 58.65 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.711 0.767 . . . . 0.0 111.595 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLN . . . . . 0.555 ' O ' HG13 ' B' ' 91' ' ' ILE . 15.0 tp60 -86.82 -100.65 0.07 Allowed 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 172.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.555 HG13 ' O ' ' B' ' 90' ' ' GLN . 1.0 OUTLIER 57.75 179.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.493 -1.214 0 C-N-CA 127.63 2.372 . . . . 0.0 111.033 -179.014 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' ARG . . . . . 0.484 ' NH2' ' HA ' ' B' ' 27' ' ' VAL . 0.1 OUTLIER -176.88 177.08 1.36 Allowed 'General case' 0 C--N 1.311 -1.089 0 O-C-N 123.911 0.757 . . . . 0.0 112.297 172.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 90' ' ' GLN . 51.9 m -116.76 128.81 55.66 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' LEU . . . . . 0.489 HD23 ' HG3' ' A' ' 28' ' ' GLN . 72.4 mt -131.45 142.1 49.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.058 -172.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ASP . . . . . 0.43 ' OD1' ' HG3' ' B' ' 97' ' ' LYS . 11.0 t0 -56.6 143.92 33.91 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 169.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -57.65 -28.01 63.35 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.43 ' HG3' ' OD1' ' B' ' 95' ' ' ASP . 49.0 mttp -59.23 -22.74 61.54 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.329 174.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' B' ' 22' ' ' ALA . 8.0 mmp_? -78.15 -32.08 50.07 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.244 0.545 . . . . 0.0 109.732 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.2 mp -68.43 105.52 2.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.475 1.131 . . . . 0.0 110.498 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -83.82 -64.2 1.21 Allowed 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 113.243 -1.799 . . . . 0.0 114.108 -173.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' B' ' 20' ' ' TYR . 11.1 pt-20 -152.55 152.39 31.81 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-O 121.426 0.632 . . . . 0.0 110.362 -171.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.516 ' HG2' ' CZ ' ' B' ' 20' ' ' TYR . 32.5 mtpt -78.3 115.53 18.08 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 126.06 1.744 . . . . 0.0 108.323 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 tp -103.86 -59.02 1.79 Allowed 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.721 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' THR . . . . . 0.461 HG22 HG11 ' B' ' 19' ' ' VAL . 4.7 t -132.47 -164.66 1.49 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 117.997 -1.481 . . . . 0.0 111.675 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -160.82 130.29 4.89 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 125.272 1.429 . . . . 0.0 110.226 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.73 157.31 16.36 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -175.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -80.27 166.2 21.6 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.976 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' B' ' 111' ' ' MET . 19.7 t70 -70.42 -23.31 62.72 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.857 0.863 . . . . 0.0 112.398 -174.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.51 -30.16 57.09 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -78.52 -32.99 48.28 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.458 ' HA ' ' HE3' ' B' ' 111' ' ' MET . 0.2 OUTLIER -50.97 -43.6 60.48 Favored 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 125.473 1.509 . . . . 0.0 110.337 175.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' B' ' 116' ' ' ASN . 0.3 OUTLIER -68.78 -20.98 64.36 Favored 'General case' 0 C--O 1.185 -2.292 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.329 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -87.4 -47.86 8.44 Favored 'General case' 0 CA--C 1.45 -2.893 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' VAL . . . . . . . . . . . . . 3.1 t -49.57 -54.98 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.44 0 CA-C-N 113.141 -1.845 . . . . 0.0 112.882 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.559 ' O ' ' HB3' ' B' ' 118' ' ' LEU . 17.9 m-20 -64.44 -44.42 91.23 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-O 123.385 1.564 . . . . 0.0 112.074 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' ASN . . . . . 0.61 ' HB3' ' O ' ' B' ' 112' ' ' LYS 0.302 5.9 t30 -76.51 -41.33 47.25 Favored 'General case' 0 C--N 1.262 -3.212 0 C-N-CA 126.778 2.031 . . . . 0.0 112.815 -172.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.59 ' HA ' HD12 ' B' ' 120' ' ' ILE . . . -64.48 -33.56 76.16 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.559 ' HB3' ' O ' ' B' ' 115' ' ' ASP . 10.0 tp -65.33 -39.64 92.68 Favored 'General case' 1 N--CA 1.378 -4.059 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.773 -178.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' MET . . . . . 0.8 ' SD ' ' HA ' ' B' ' 125' ' ' ASN 0.255 6.9 ptp -73.81 -19.93 60.61 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 117.821 -1.552 . . . . 0.0 114.155 176.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' B' ' 117' ' ' ALA . 43.0 mt -75.98 -52.04 18.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' SER . . . . . . . . . . . . . 78.5 p -59.09 -28.0 66.08 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.207 -1.361 . . . . 0.0 112.681 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.567 HD22 HG21 ' A' ' 54' ' ' ILE . 26.9 mt -108.22 -0.45 20.9 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.047 -1.061 . . . . 0.0 111.922 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . 0.496 ' HA2' ' CE1' ' B' ' 129' ' ' HIS . . . 74.81 31.78 57.82 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 174.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.557 HD11 HD11 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -120.95 20.09 11.61 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 118.821 1.31 . . . . 0.0 111.577 179.445 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.8 ' HA ' ' SD ' ' B' ' 119' ' ' MET . 13.0 m120 -43.88 125.3 4.18 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 177.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.93 14.0 0.94 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.828 0.823 . . . . 0.0 112.303 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 14.3 t -119.85 7.28 6.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' ALA . . . . . . . . . . . . . . . 70.55 154.14 0.13 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 125.664 1.585 . . . . 0.0 112.664 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' HIS . . . . . 0.496 ' CE1' ' HA2' ' B' ' 123' ' ' GLY . 33.8 m-70 -99.83 160.61 14.17 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.332 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -79.51 -42.47 25.13 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.013 -0.994 . . . . 0.0 108.792 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -131.99 134.07 45.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 . . . . . 0 C--N 1.308 -1.221 0 CA-C-O 119.2 -0.428 . . . . 0.0 110.921 -178.855 . . . . . . . . 0 0 . 1 stop_ save_